PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brownell, KD; Roberto, CA				Brownell, Kelly D.; Roberto, Christina A.			Strategic science with policy impact	LANCET			English	Editorial Material							PUBLIC-HEALTH; OBESITY; FOOD		[Brownell, Kelly D.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Roberto, Christina A.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Duke University; Harvard University; Harvard T.H. Chan School of Public Health	Brownell, KD (corresponding author), Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA.	kelly.brownell@duke.edu						Brownell KD, 2014, NEW ENGL J MED, V370, P1773, DOI 10.1056/NEJMp1314072; Brownell KD, 2010, HEALTH AFFAIR, V29, P379, DOI 10.1377/hlthaff.2009.0739; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Harris JL, 2010, PEDIATRICS, V127, P71; Koplan JP, 2010, JAMA-J AM MED ASSOC, V304, P1487, DOI 10.1001/jama.2010.1436; Pomeranz JL, 2011, AM J PUBLIC HEALTH, V101, P425, DOI 10.2105/AJPH.2010.198697; Roberto CA, 2015, LANCET; Roberto CA, 2010, PEDIATRICS, V126, P88, DOI 10.1542/peds.2009-3433; Roberto CA, 2010, AM J PUBLIC HEALTH, V100, P312, DOI 10.2105/AJPH.2009.160226; Roberto CA, 2009, AM J PUBLIC HEALTH, V99, P820, DOI 10.2105/AJPH.2008.136457	11	57	57	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2445	2446		10.1016/S0140-6736(14)62397-7	http://dx.doi.org/10.1016/S0140-6736(14)62397-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK9AR	25703107				2022-12-28	WOS:000356532500009
J	Roberto, CA; Swinburn, B; Hawkes, C; Huang, TTK; Costa, SA; Ashe, M; Zwicker, L; Cawley, JH; Brownell, KD				Roberto, Christina A.; Swinburn, Boyd; Hawkes, Corinna; Huang, Terry T-K; Costa, Sergio A.; Ashe, Marice; Zwicker, Lindsey; Cawley, John H.; Brownell, Kelly D.			Patchy progress on obesity prevention: emerging examples, entrenched barriers, and new thinking	LANCET			English	Article							AMERICAN-HEART-ASSOCIATION; MIDDLE-INCOME COUNTRIES; NONCOMMUNICABLE DISEASES; PHYSICAL-ACTIVITY; PUBLIC-HEALTH; SCIENTIFIC STATEMENT; POLICY OPTIONS; FOOD; CHILDREN; BURDEN	Despite isolated areas of improvement, no country to date has reversed its obesity epidemic. Governments, together with a broad range of stakeholders, need to act urgently to decrease the prevalence of obesity. In this Series paper, we review several regulatory and non-regulatory actions taken around the world to address obesity and discuss some of the reasons for the scarce and fitful progress. Additionally, we preview the papers in this Lancet Series, which each identify high-priority actions on key obesity issues and challenge some of the entrenched dichotomies that dominate the thinking about obesity and its solutions. Although obesity is acknowledged as a complex issue, many debates about its causes and solutions are centred around overly simple dichotomies that present seemingly competing perspectives. Examples of such dichotomies explored in this Series include personal versus collective responsibilities for actions, supply versus demand-type explanations for consumption of unhealthy food, government regulation versus industry self-regulation, top-down versus bottom-up drivers for change, treatment versus prevention priorities, and a focus on undernutrition versus overnutrition. We also explore the dichotomy of individual versus environmental drivers of obesity and conclude that people bear some personal responsibility for their health, but environmental factors can readily support or undermine the ability of people to act in their own self-interest. We propose a reframing of obesity that emphasises the reciprocal nature of the interaction between the environment and the individual. Today's food environments exploit people's biological, psychological, social, and economic vulnerabilities, making it easier for them to eat unhealthy foods. This reinforces preferences and demands for foods of poor nutritional quality, furthering the unhealthy food environments. Regulatory actions from governments and increased efforts from industry and civil society will be necessary to break these vicious cycles.	[Roberto, Christina A.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Swinburn, Boyd] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Hawkes, Corinna] World Canc Res Fund Int, London, England; [Huang, Terry T-K; Costa, Sergio A.] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Huang, Terry T-K; Costa, Sergio A.] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE USA; [Ashe, Marice; Zwicker, Lindsey] ChangeLab Solut, Oakland, CA USA; [Zwicker, Lindsey] Law Ctr Prevent Gun Violence, San Francisco, CA USA; [Cawley, John H.] Cornell Univ, Ithaca, NY USA; [Brownell, Kelly D.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Auckland; City University of New York (CUNY) System; University of Nebraska System; University of Nebraska Medical Center; Cornell University; Duke University	Roberto, CA (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	croberto@hsph.harvard.edu	Cawley, John/E-6734-2010	Cawley, John/0000-0002-4805-9883; Costa, Sergio/0000-0002-2795-7705; Huang, Terry/0000-0001-5544-5187				Adams J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031578; Andreyeva T, 2008, HEALTH AFFAIR, V27, P1381, DOI 10.1377/hlthaff.27.5.1381; Barragan NC, 2014, HEALTH PROMOT PRACT, V15, P208, DOI 10.1177/1524839913507280; BEAUCHAMP GK, 1982, APPETITE, V3, P139, DOI 10.1016/S0195-6663(82)80007-X; BMOH, 2011, HLTH LIF IN; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Capacci S, 2012, NUTR REV, V70, P188, DOI 10.1111/j.1753-4887.2011.00442.x; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chandon P, 2012, NUTR REV, V70, P571, DOI 10.1111/j.1753-4887.2012.00518.x; Change Lab Solutions, AB SEAT PED FRIEND C; Change Lab Solutions, PED FRIENDL COD DIR; Change Lab Solutions (formerly Public Health Law & Policy), 2009, HLTH MOB VEND POL; ChangeLab Solutions, MOD HLTH BEV VEND AG; ChangeLab Solutions, 2009, HLTH CORN STOR STAT; Department of Health UK, 2012, PUBL HLTH RESP DEAL; Department of Health Victoria Australia, 2014, PREV POP HLTH HLTH T; DESOR JA, 1987, PHYSIOL BEHAV, V39, P639, DOI 10.1016/0031-9384(87)90166-1; Dietz WH, 2015, LANCET; Dowell D, 2012, LANCET, V380, P1787, DOI 10.1016/S0140-6736(12)60733-8; Ello-Martin JA, 2005, AM J CLIN NUTR, V82, p236S, DOI 10.1093/ajcn/82.1.236S; European Commission, AGR RUR DEV SCH FRUI; Ewing R, 2009, UNDERSTANDING RELATI; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Food and Agriculture Organization, 2013, AFR BEN BRAZ FAO SCH; Frank LD, 2005, AM J PREV MED, V28, P117, DOI 10.1016/j.amepre.2004.11.001; Fry C, 2012, PUTTING BUSINESS WOR; Galbraith-Emami S, 2013, OBES REV, V14, P960, DOI 10.1111/obr.12060; Gearhardt AN, 2012, ANNU REV CLIN PSYCHO, V8, P405, DOI 10.1146/annurev-clinpsy-032511-143129; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Government of South Africa, 2013, STRAT PLAN PREV CONT; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Hawkes C, 2013, OBES REV, V14, P159, DOI 10.1111/obr.12098; Hawkes C, 2011, INT J PEDIATR OBES, V6, P83, DOI 10.3109/17477166.2010.486836; Hawkes C., 2013, PROMOTING HLTH DIETS; Hawkes C, 2015, LANCET; Hawkes C, 2011, PUBLIC HEALTH NUTR, V14, P1403, DOI 10.1017/S1368980011000607; Healthy Weight Commitment Foundation, 2014, FIGHT OB BAL CAL CAL; Huang TT, 2015, LANCET; Jacobs Lawrence R., 2000, POLITICIANS DONT PAN; Jacoby E, 2012, WORLD NUTR, V11, P483; Jebb SA, 2012, NUTR BULL, V37, P355, DOI 10.1111/j.1467-3010.2012.01992.x; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Karpyn A, 2012, CHILD OBES, V8, P28, DOI 10.1089/chi.2011.0113; Kim S, 2013, HEALTH PROMOT INT, V28, P17, DOI 10.1093/heapro/das023; Krech R, 2010, HEALTH PROMOT INT, V25, P258, DOI 10.1093/heapro/daq034; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lachat C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001465; Lawrence RG, 2004, HARV INT J PRESS-POL, V9, P56, DOI 10.1177/1081180X04266581; Ledikwe JH, 2005, J NUTR, V135, P905, DOI 10.1093/jn/135.4.905; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lobstein T, 2015, LANCET; Montgomery KC, 2009, J ADOLESCENT HEALTH, V45, pS18, DOI 10.1016/j.jadohealth.2009.04.006; Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Nathanson CA, 1999, J HEALTH POLIT POLIC, V24, P421, DOI 10.1215/03616878-24-3-421; National Policy and Legal Analysis Network, 2009, EST LAND US PROT FAR; Nelson TE, 1997, POLIT BEHAV, V19, P221, DOI 10.1023/A:1024834831093; New York City Department of Health and Mental Hygiene, 2009, POUR POUNDS CAMP; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Organization WH, 2016, GLOBAL STATUS REPORT; Otsuki K., 2013, LOCAL FOOD REVOLUTIO; Philadelphia Department of Public Health, 2010, PED FRIENDL COD DIR; Popkin B, 2013, OBES REV, V14, P1, DOI 10.1111/obr.12108; Rosenbaum M, 2010, INT J OBESITY, V34, pS47, DOI 10.1038/ijo.2010.184; Safe Routes to School National Partnership, 2011, SAF ROUT SCH HELP CO; Samuelson W, 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; Schwartz C, 2009, BRIT J NUTR, V102, P1375, DOI 10.1017/S0007114509990286; Schwartz J, 2012, HEALTH AFFAIR, V31, P399, DOI 10.1377/hlthaff.2011.0224; Seskin S., 2012, COMPLETE STREETS POL; Seskin Stefanie, 2012, COMPLETE STREETS LOC; Stair P, 2008, CREAT IMPLEMENT HLTH; Stimson James A., 2004, TIDES CONSENT PUBLIC; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Thow AM, 2010, FOOD POLICY, V35, P556, DOI 10.1016/j.foodpol.2010.06.005; United States Department of Agriculture, 2013, USDA UNV HIST IMPR M; United States Department of Agriculture Foreign Agricultural Service. Global Agricultural Information Network, 2014, GLOB AGR INF NETW; Visser R, 2013, INT J OBES S, V3, pS1, DOI DOI 10.1038/ijosup.2013.1; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Wang H, 2013, OBES REV, V14, P134, DOI 10.1111/obr.12106; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WHO, 2013, 10 PAC HLTH MIN M; Wijesinha-Bettoni R, 2013, FOOD NUTR BULL, V34, P75, DOI 10.1177/156482651303400109; World Cancer Research Fund International, NUTR LAB STAND REG U; World Cancer Research Fund International, WCRF INT FOOD POL FR; World Cancer Research Fund International NOURISHING framework, US EC TOOLS ADDR FOO; World Health Organization, 2011, NONCOMMUNICABLE DIS; World Health Organization, NONC DIS GLOB MON FR; World Health Organization, 2012, ASS NAT CAP PREV CON; World Health Organization, 2007, WHO EUR MIN C COUNT; World Health Organization, 2012, 65 WORLD HLTH ASS; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2013, GLOB NUTR POL REV WH; Yale Rudd Center for Food Policy and Obesity, PLEDG FOOD MARK CHIL; Yancey AK, 2009, MILBANK Q, V87, P155, DOI 10.1111/j.1468-0009.2009.00551.x	98	529	547	6	129	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2400	2409		10.1016/S0140-6736(14)61744-X	http://dx.doi.org/10.1016/S0140-6736(14)61744-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK1XV	25703111				2022-12-28	WOS:000356003700034
J	Molina, JM; Orkin, C; Iser, DM; Zamora, FX; Nelson, M; Stephan, C; Massetto, B; Gaggar, A; Ni, L; Svarovskaia, E; Brainard, D; Subramanian, GM; McHutchison, JG; Puoti, M; Rockstroh, JK				Molina, Jean-Michel; Orkin, Chloe; Iser, David M.; Zamora, Francisco-Xavier; Nelson, Mark; Stephan, Christoph; Massetto, Benedetta; Gaggar, Anuj; Ni, Liyun; Svarovskaia, Evguenia; Brainard, Diana; Subramanian, G. Mani; McHutchison, John G.; Puoti, Massimo; Rockstroh, Juergen K.		PHOTON-2 Study Team	Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study	LANCET			English	Article							GENOTYPE 1; PEGYLATED-INTERFERON; COINFECTION; TRIAL; HCV; ATAZANAVIR; BILIRUBIN; CIRRHOSIS; THERAPY	Background Although interferon-free regimens are approved for patients co-infected with HIV and genotype-2 or genotype-3 hepatitis C virus (HCV), interferon-based regimens are still an option for those co-infected with HIV and HCV genotypes 1 or 4. These regimens are limited by clinically significant toxic effects and drug interactions with antiretroviral therapy. We aimed to assess the efficacy and safety of an interferon-free, all-oral regimen of sofosbuvir plus ribavirin in patients with HIV and HCV co-infection. Methods We did this open-label, non-randomised, uncontrolled, phase 3 study at 45 sites in seven European countries and Australia. We enrolled patients (aged >= 18 years) co-infected with stable HIV and chronic HCV genotypes 1-4, including those with compensated cirrhosis. Once-daily sofosbuvir (400 mg) plus twice-daily ribavirin (1000 mg in patients with bodyweights <75 kg and 1200 mg in those with weights >= 75 kg) was given for 24 weeks to all patients except treatment-naive patients with genotype-2 HCV, who received a 12-week regimen. The primary effi cacy endpoint was sustained virological response 12 weeks after treatment. We did analysis by modified intention to treat. This study is registered with ClinicalTrials.gov, number NCT01783678. Findings Between Feb 7, 2013, and July 29, 2013, we enrolled 275 eligible patients, of whom 262 (95%) completed treatment; 274 patients were included in the final analysis. Overall rates of sustained virological response 12 weeks after treatment were 85% (95% CI 77-91) in patients with genotype-1 HCV, 88% (69-98) in patients with genotype-2 HCV, 89% (81-94) in patients with genotype-3 HCV, and 84% (66-95) in patients with genotype-4 HCV. Response rates in treatment-naive patients with HCV genotypes 2 or 3 (89% [ 95% CI 67-99] and 91% [ 81-97], respectively) were similar to those in treatment-experienced patients infected with those genotypes (83% [36-100] and 86% [73-94], respectively). There was no emergence of sofosbuvir-resistance mutations in patients with HCV viral relapse. Six (2%) patients discontinued treatment because of adverse events. The most common adverse events were fatigue, insomnia, asthenia, and headache. Four (1%) patients had serious adverse events regarded as related to study treatment. Additionally, four (1%) patients receiving antiretroviral treatment had a transient HIV viral breakthrough; however, none required changes in antiretroviral regimen. Interpretation Sofosbuvir and ribavirin provided high rates of sustained virological response after 12 weeks of treatment in treatment-naive and treatment-experienced patients co-infected with HIV and HCV genotypes 1-4. The characteristics of this interferon-free combination regimen make sofosbuvir plus ribavirin a useful treatment option for this patient population.	[Molina, Jean-Michel] Univ Paris 07, Paris, France; [Molina, Jean-Michel] Hop St Louis, Dept Infect Dis, F-75010 Paris, France; [Orkin, Chloe] Barts Hlth Natl Hlth Serv Trust, London, England; [Iser, David M.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Zamora, Francisco-Xavier] Hosp Univ La Paz IdiPAZ, Internal Med Serv, HIV Unit, Madrid, Spain; [Nelson, Mark] Chelsea & Westminster Hosp, St Stephens Ctr, London, England; [Stephan, Christoph] Hosp Johann Wolfgang Goethe Univ, Dept Med, Infect Dis Unit, Frankfurt, Germany; [Ni, Liyun; Svarovskaia, Evguenia; Brainard, Diana; Subramanian, G. Mani; McHutchison, John G.] Gilead Sci, Foster City, CA USA; [Puoti, Massimo] AO Osped Niguarda Ca Granda, Div Infect Dis, Milan, Italy; [Rockstroh, Juergen K.] Univ Hosp Bonn, Dept Gen Internal Med 1, Bonn, Germany	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Barts Health NHS Trust; Florey Institute of Neuroscience & Mental Health; Hospital Universitario La Paz; Imperial College London; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Gilead Sciences; Ospedale Niguarda Ca' Granda; University of Bonn	Molina, JM (corresponding author), Hop St Louis, Malad Infect & Trop, F-75010 Paris, France.	jean-michel.molina@sls.aphp.fr	Berenguer, Juan/A-1347-2009; Stephan, Christoph/D-1305-2014; Puoti, Massimo/AAA-6580-2020	Berenguer, Juan/0000-0001-8541-8200; Stephan, Christoph/0000-0003-3777-9006; Gonzalez-Garcia, Juan/0000-0002-3652-002X; Puoti, Massimo/0000-0003-3278-7138	Gilead Sciences	Gilead Sciences(Gilead Sciences)	Gilead Sciences.	American Association for the Study of Liver Diseases and Infectious Diseases Society of America, REC TEST MAN TREAT H; Berenguer J, 2012, CLIN INFECT DIS, V55, P728, DOI 10.1093/cid/cis500; Chen JY, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.17; Ioannou GN, 2013, HEPATOLOGY, V57, P249, DOI 10.1002/hep.25800; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Mayne Pharma, 2021, NEXTST EST DROSP TAB; Osinusi A, 2014, ANN INTERN MED, V161, P634, DOI 10.7326/M14-1211; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Pineda JA, 2005, HEPATOLOGY, V41, P779, DOI 10.1002/hep.20626; Pineda JA, 2007, HEPATOLOGY, V46, P622, DOI 10.1002/hep.21757; Rockstroh JK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-234; Rodriguez-Novoa S, 2008, AIDS, V22, P2535, DOI 10.1097/QAD.0b013e3283177f38; Rodriguez-Torres M, 2015, JAIDS-J ACQ IMM DEF, V68, P543, DOI 10.1097/QAI.0000000000000516; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734; Svarovskaia ES, 2014, CLIN INFECT DIS, V59, P1666, DOI 10.1093/cid/ciu697; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zhang DL, 2005, DRUG METAB DISPOS, V33, P1729, DOI 10.1124/dmd.105.005447	21	141	151	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1098	1106		10.1016/S0140-6736(14)62483-1	http://dx.doi.org/10.1016/S0140-6736(14)62483-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25659285				2022-12-28	WOS:000351270400027
J	Colussi, TM; Costantino, DA; Zhu, JY; Donohue, JP; Korostelev, AA; Jaafar, ZA; Plank, TDM; Noller, HF; Kieft, JS				Colussi, Timothy M.; Costantino, David A.; Zhu, Jianyu; Donohue, John Paul; Korostelev, Andrei A.; Jaafar, Zane A.; Plank, Terra-Dawn M.; Noller, Harry F.; Kieft, Jeffrey S.			Initiation of translation in bacteria by a structured eukaryotic IRES RNA	NATURE			English	Article							RIBOSOME ENTRY SITE; CRICKET PARALYSIS VIRUS; INTERNAL RIBOSOME; VIRAL IRES; ELEMENT; BINDING; PROTEIN; DICISTROVIRIDAE; RECRUITMENT; REGION	The central dogma of gene expression (DNA to RNA to protein) is universal, but in different domains of life there are fundamental mechanistic differences within this pathway. For example, the canonical molecular signals used to initiate protein synthesis in bacteria and eukaryotes are mutually exclusive(1). However, the core structures and conformational dynamics of ribosomes that are responsible for the translation steps that take place after initiation are ancient and conserved across the domains of life(2). We wanted to explore whether an undiscovered RNA-based signal might be able to use these conserved features, bypassing mechanisms specific to each domain of life, and initiate protein synthesis in both bacteria and eukaryotes. Although structured internal ribosome entry site (IRES) RNAs can manipulate ribosomes to initiate translation in eukaryotic cells, an analogous RNA structure-based mechanism has not been observed in bacteria. Here we report our discovery that a eukaryotic viral IRES can initiate translation in live bacteria. We solved the crystal structure of this IRES bound to a bacterial ribosome to 3.8 angstrom resolution, revealing that despite differences between bacterial and eukaryotic ribosomes this IRES binds directly to both and occupies the space normally used by transfer RNAs. Initiation in both bacteria and eukaryotes depends on the structure of the IRES RNA, but in bacteria this RNA uses a different mechanism that includes a form of ribosome repositioning after initial recruitment. This IRES RNA bridges billions of years of evolutionary divergence and provides an example of an RNA structure-based translation initiation signal capable of operating in two domains of life.	[Colussi, Timothy M.; Costantino, David A.; Jaafar, Zane A.; Plank, Terra-Dawn M.; Kieft, Jeffrey S.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Colussi, Timothy M.; Costantino, David A.; Kieft, Jeffrey S.] Univ Colorado Denver, Sch Med, Howard Hughes Med Inst, Aurora, CO 80045 USA; [Zhu, Jianyu; Donohue, John Paul; Korostelev, Andrei A.; Noller, Harry F.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Zhu, Jianyu; Donohue, John Paul; Korostelev, Andrei A.; Noller, Harry F.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Sinsheimer Labs, Santa Cruz, CA 95064 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Kieft, JS (corresponding author), Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	jeffrey.kieft@ucdenver.edu		Korostelev, Andrei/0000-0003-1588-717X	National Institutes of Health (NIH) [GM-17129, GM-59140]; National Science Foundation [MCB-723300]; NIH [GM-103105, GM-97333, GM-81346]; Howard Hughes Medical Institute; American Heart Association [10PRE260143]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017129, R37GM017129, R01GM106105, R01GM097333, R01GM059140, R01GM081346] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Kieft laboratory for insight and discussion and the staff at the Advanced Photon Source for their support. The original PSIV IGR IRES-containing plasmid was from N. Nakashima and the source of the luciferase genes was a plasmid from A. Willis. This work was supported by grants GM-17129 and GM-59140 from the National Institutes of Health (NIH) and MCB-723300 from the National Science Foundation (to H.F.N.), grant GM-103105 from the NIH (to A.A.K.), and grants GM-97333 and GM-81346 from the NIH (to J.S.K.). J.S.K. is an Early Career Scientist of the Howard Hughes Medical Institute. T.-D.M.P. was an American Heart Association Predoctoral Scholar (10PRE260143).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; BERTHELOT F, 1973, MOL CELL BIOCHEM, V1, P63, DOI 10.1007/BF01659939; Costantino D, 2005, RNA, V11, P332, DOI 10.1261/rna.7184705; Costantino DA, 2008, NAT STRUCT MOL BIOL, V15, P57, DOI 10.1038/nsmb1351; DeLano W.L, PYMOL MOL GRAPHICS S; Deniz N, 2009, RNA, V15, P932, DOI 10.1261/rna.1315109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Hellen CUT, 2009, BBA-GENE REGUL MECH, V1789, P558, DOI 10.1016/j.bbagrm.2009.06.001; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Hertz MI, 2011, VIROLOGY, V411, P355, DOI 10.1016/j.virol.2011.01.005; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2001, COLD SPRING HARB SYM, V66, P285, DOI 10.1101/sqb.2001.66.285; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Koh CS, 2014, P NATL ACAD SCI USA, V111, P9139, DOI 10.1073/pnas.1406335111; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Malys N, 2011, CELL MOL LIFE SCI, V68, P991, DOI 10.1007/s00018-010-0588-z; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nishiyama T, 2003, NUCLEIC ACIDS RES, V31, P2434, DOI 10.1093/nar/gkg336; Nishiyama T, 2007, NUCLEIC ACIDS RES, V35, P1514, DOI 10.1093/nar/gkl1121; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pfingsten JS, 2006, SCIENCE, V314, P1450, DOI 10.1126/science.1133281; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Schuler M, 2006, NAT STRUCT MOL BIOL, V13, P1092, DOI 10.1038/nsmb1177; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Thompson SR, 2001, P NATL ACAD SCI USA, V98, P12972, DOI 10.1073/pnas.241286698; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Yamamoto H, 2007, J BIOL CHEM, V282, P7770, DOI 10.1074/jbc.M610887200; Zhu JY, 2011, P NATL ACAD SCI USA, V108, P1839, DOI 10.1073/pnas.1018582108	35	34	35	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					110	U255		10.1038/nature14219	http://dx.doi.org/10.1038/nature14219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25652826	Green Accepted			2022-12-28	WOS:000350304000046
J	Luca, VC; Jude, KM; Pierce, NW; Nachury, MV; Fischer, S; Garcia, KC				Luca, Vincent C.; Jude, Kevin M.; Pierce, Nathan W.; Nachury, Maxence V.; Fischer, Suzanne; Garcia, K. Christopher			Structural basis for Notch1 engagement of Delta-like 4	SCIENCE			English	Article							LIGAND-BINDING; ALAGILLE-SYNDROME; CIS-INTERACTIONS; MUTATIONS; JAGGED1; DOMAIN; RECOGNITION; MODULATION; FUCOSE	Notch receptors guide mammalian cell fate decisions by engaging the proteins Jagged and Delta-like (DLL). The 2.3 angstrom resolution crystal structure of the interacting regions of the Notch1-DLL4 complex reveals a two-site, antiparallel binding orientation assisted by Notch1 O-linked glycosylation. Notch1 epidermal growth factor-like repeats 11 and 12 interact with the DLL4 Delta/Serrate/Lag-2 (DSL) domain and module at the N-terminus of Notch ligands (MNNL) domains, respectively. Threonine and serine residues on Notch1 are functionalized with O-fucose and O-glucose, which act as surrogate amino acids by making specific, and essential, contacts to residues on DLL4. The elucidation of a direct chemical role for O-glycans in Notch1 ligand engagement demonstrates how, by relying on posttranslational modifications of their ligand binding sites, Notch proteins have linked their functional capacity to developmentally regulated biosynthetic pathways.	[Luca, Vincent C.; Jude, Kevin M.; Fischer, Suzanne; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Luca, Vincent C.; Jude, Kevin M.; Pierce, Nathan W.; Nachury, Maxence V.; Fischer, Suzanne; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Luca, Vincent C.; Jude, Kevin M.; Fischer, Suzanne; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Nachury, Maxence/A-8759-2008; Nachury, Maxence/H-3695-2019	Nachury, Maxence/0000-0003-4918-1562; Nachury, Maxence/0000-0003-4918-1562; Jude, Kevin/0000-0002-3675-5136	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Ludwig Cancer Foundation; HHMI; Cancer Research Institute postdoctoral fellowship; NIH-Immunology postdoctoral training grant; Stanford Discovery Innovation fund; HHMI fellowship of the Helen Hey Whitney Foundation;  [NIH-1RO1-GM097015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097015, R01GM089933] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Ludwig Cancer Foundation; HHMI(Howard Hughes Medical Institute); Cancer Research Institute postdoctoral fellowship; NIH-Immunology postdoctoral training grant; Stanford Discovery Innovation fund; HHMI fellowship of the Helen Hey Whitney Foundation; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Velasco, D. Waghray, and J. Spangler for assistance. We also thank the staff of the Advanced Photon Source for support and access to the 23-ID-D beamline; the staff of the Advanced Light Source for support and access to the 8.2.2 Howard Hughes Medical Institute (HHMI) beamline; and the staff of the Stanford Synchrotron Radiation Lightsource, which is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under contract DE-AC02-76SF00515. This work was supported by NIH-1RO1-GM097015, Ludwig Cancer Foundation, and the HHMI (K.C.G.). V.C.L. was supported by a Cancer Research Institute postdoctoral fellowship and an NIH-Immunology postdoctoral training grant. M.V.N. was supported by the Stanford Discovery Innovation fund, and N.W.P. was supported by an HHMI fellowship of the Helen Hey Whitney Foundation. K.C.G. and V.L. are inventors on a patent applied for by Stanford University describing high-affinity Notch ligands. Coordinates and structure factors of 1egf DLL4 and 2egf DLL4 have been deposited in the Protein Data Bank with accession codes 4XL1 and 4XLW.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Andrawes MB, 2013, J BIOL CHEM, V288, P25477, DOI 10.1074/jbc.M113.454850; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chillakuri CR, 2013, CELL REP, V5, P861, DOI 10.1016/j.celrep.2013.10.029; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Cordle J, 2008, J BIOL CHEM, V283, P11785, DOI 10.1074/jbc.M708424200; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Falk R, 2012, METHODS, V58, P69, DOI 10.1016/j.ymeth.2012.07.008; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fleming RJ, 1998, SEMIN CELL DEV BIOL, V9, P599, DOI 10.1006/scdb.1998.0260; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Held W, 2008, NAT REV IMMUNOL, V8, P269, DOI 10.1038/nri2278; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Milner LA, 1999, BLOOD, V93, P2431, DOI 10.1182/blood.V93.8.2431.408k33_2431_2448; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Niessen K, 2011, BLOOD, V118, P1989, DOI 10.1182/blood-2010-11-319129; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; Rana NA, 2011, CURR OPIN STRUC BIOL, V21, P583, DOI 10.1016/j.sbi.2011.08.008; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Spinner NB, 2001, HUM MUTAT, V17, P18, DOI 10.1002/1098-1004(2001)17:1<18::AID-HUMU3>3.0.CO;2-T; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Taylor P, 2014, P NATL ACAD SCI USA, V111, P7290, DOI 10.1073/pnas.1319683111; Tran IT, 2013, J CLIN INVEST, V123, P1590, DOI 10.1172/JCI65477; Warthen DM, 2006, HUM MUTAT, V27, P436, DOI 10.1002/humu.20310; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Whiteman P, 2013, J BIOL CHEM, V288, P7305, DOI 10.1074/jbc.M112.428854; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Yamamoto S, 2012, SCIENCE, V338, P1229, DOI 10.1126/science.1228745	49	165	178	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					847	853		10.1126/science.1261093	http://dx.doi.org/10.1126/science.1261093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700513	Green Submitted, Green Accepted			2022-12-28	WOS:000349761100037
J	Di Lorenzo, E				Di Lorenzo, Emanuele			CLIMATE SCIENCE The future of coastal ocean upwelling	NATURE			English	Editorial Material							ECOSYSTEM; CALIFORNIA; PACIFIC; INTENSIFICATION; VARIABILITY		Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Di Lorenzo, E (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	edl@gatech.edu	Di Lorenzo, Emanuele/E-9107-2012	Di Lorenzo, Emanuele/0000-0002-1935-7363	Directorate For Geosciences [1357426] Funding Source: National Science Foundation; Division Of Ocean Sciences [1356924, 1026607] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Di Lorenzo E, 2013, OCEANOGRAPHY, V26, P68, DOI 10.5670/oceanog.2013.76; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Gruber N, 2011, NAT GEOSCI, V4, P787, DOI [10.1038/NGEO1273, 10.1038/ngeo1273]; Jacox MG, 2014, GEOPHYS RES LETT, V41, P3189, DOI 10.1002/2014GL059589; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Rykaczewski RR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045019; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Song H, 2011, DYNAM ATMOS OCEANS, V52, P170, DOI 10.1016/j.dynatmoce.2011.03.001; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Sydeman WJ, 2013, GLOBAL CHANGE BIOL, V19, P1662, DOI 10.1111/gcb.12165; Wang DW, 2015, NATURE, V518, P390, DOI 10.1038/nature14235	15	15	17	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					310	311		10.1038/518310a	http://dx.doi.org/10.1038/518310a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25693560				2022-12-28	WOS:000349547400024
J	Davis, NS				Davis, N. S., Jr.			The Treatment of Asthma: Portion of a Lecture delivered in the Regular Course of 1888-89 (Reprinted from JAMA, vol 12, pg 726, 1889)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1889, JAMA, V12, P726	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					733	733		10.1001/jama.2014.11590	http://dx.doi.org/10.1001/jama.2014.11590			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25688798				2022-12-28	WOS:000349476100031
J	Ioannidis, JPA				Ioannidis, John P. A.			Stealth Research Is Biomedical Innovation Happening Outside the Peer-Reviewed Literature?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ioannidis, John P. A.] Stanford METRICS, SPRC, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford METRICS, Meta Res Innovat Ctr, Stanford, CA 94305 USA		Ioannidis, JPA (corresponding author), Stanford METRICS, SPRC, 1265 Welch Rd,Med Sch Off Bldg,Room X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011					[Anonymous], TEDMED SPEAKERS ELIZ; [Anonymous], THE BLOOD TESTS THAT; Armstrong J.S., 1997, SCI ENG ETHICS, V3, P63, DOI DOI 10.1007/S11948-997-0017-3; HORROBIN DF, 1990, JAMA-J AM MED ASSOC, V263, P1438, DOI 10.1001/jama.263.10.1438; Ioannidis JPA, 2014, PLOS MED, V11, DOI DOI 10.1371/J0UMAL.PMED.1001747; Loria K., 2014, THIS WOMANS REVOLUTI; Parloff R, 2014, FORTUNE; Topol EJ, 2013, CREATIVE DISRUPTION	8	45	45	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					663	664		10.1001/jama.2014.17662	http://dx.doi.org/10.1001/jama.2014.17662			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25688775				2022-12-28	WOS:000349476100006
J	Bonavita, E; Gentile, S; Rubino, M; Maina, V; Papait, R; Kunderfranco, P; Greco, C; Feruglio, F; Molgora, M; Laface, I; Tartari, S; Doni, A; Pasqualini, F; Barbati, E; Basso, G; Galdiero, MR; Nebuloni, M; Roncalli, M; Colombo, P; Laghi, L; Lambris, JD; Jaillon, S; Garlanda, C; Mantovani, A				Bonavita, Eduardo; Gentile, Stefania; Rubino, Marcello; Maina, Virginia; Papait, Roberto; Kunderfranco, Paolo; Greco, Carolina; Feruglio, Francesca; Molgora, Martina; Laface, Ilaria; Tartari, Silvia; Doni, Andrea; Pasqualini, Fabio; Barbati, Elisa; Basso, Gianluca; Galdiero, Maria Rosaria; Nebuloni, Manuela; Roncalli, Massimo; Colombo, Piergiuseppe; Laghi, Luigi; Lambris, John D.; Jaillon, Sebastien; Garlanda, Cecilia; Mantovani, Alberto			PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer	CELL			English	Article							LONG PENTRAXIN PTX3; INNATE IMMUNITY; FACTOR-H; RECOGNITION; POLARIZATION; CCL2; PROGRESSION; DEFICIENCY; ACTIVATION; PROTEIN	PTX3 is an essential component of the humoral arm of innate immunity, playing a nonredundant role in resistance against selected microbes and in the regulation of inflammation. PTX3 activates and regulates the Complement cascade by interacting with C1q and with Factor H. PTX3 deficiency was associated with increased susceptibility to mesenchymal and epithelial carcinogenesis. Increased susceptibility of Ptx3(-/-) mice was associated with enhanced macrophage infiltration, cytokine production, angiogenesis, and Trp53 mutations. Correlative evidence, gene-targeted mice, and pharmacological blocking experiments indicated that PTX3 deficiency resulted in amplification of Complement activation, CCL2 production, and tumor-promoting macrophage recruitment. PTX3 expression was epigenetically regulated in selected human tumors (e. g., leiomyosarcomas and colorectal cancer) by methylation of the promoter region and of a putative enhancer. Thus, PTX3, an effector molecule belonging to the humoral arm of innate immunity, acts as an extrinsic oncosuppressor gene in mouse and man by regulating Complement-dependent, macrophage-sustained, tumor-promoting inflammation.	[Bonavita, Eduardo; Gentile, Stefania; Rubino, Marcello; Maina, Virginia; Papait, Roberto; Kunderfranco, Paolo; Greco, Carolina; Feruglio, Francesca; Molgora, Martina; Laface, Ilaria; Tartari, Silvia; Doni, Andrea; Pasqualini, Fabio; Barbati, Elisa; Basso, Gianluca; Galdiero, Maria Rosaria; Roncalli, Massimo; Colombo, Piergiuseppe; Laghi, Luigi; Jaillon, Sebastien; Garlanda, Cecilia; Mantovani, Alberto] Humanitas Clin & Res Ctr, I-20089 Milan, Italy; [Papait, Roberto] CNR, Inst Genet & Biomed Res, I-20089 Milan, Italy; [Nebuloni, Manuela] Univ Milan, L Sacco Dept Clin Sci, Pathol Unit, I-20157 Milan, Italy; [Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Mantovani, Alberto] Humanitas Univ, I-20089 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Milan; University of Pennsylvania; Humanitas University	Garlanda, C (corresponding author), Humanitas Clin & Res Ctr, I-20089 Milan, Italy.	cecilia.garlanda@humanitasresearch.it; alberto.mantovani@humanitasresearch.it	Colombo, Piergiuseppe/AAA-9176-2019; Lambris, John/Q-5633-2018; Mantovani, Alberto/HCI-7449-2022; Bonavita, Eduardo/P-4370-2014; Greco, Carolina/GZG-2761-2022; Papait, Roberto/AAC-7659-2022; Bonavita, Eduardo/AAE-3702-2020; Pasqualini, Fabio/G-5610-2018; GALDIERO, MARIA ROSARIA/J-6869-2018; Greco, Carolina/G-1882-2019; Molgora, Martina/G-5591-2018; Kunderfranco, Paolo/ABH-9294-2020; Papait, Roberto/AAB-8291-2022; Kunderfranco, Paolo/GUQ-8968-2022; Laghi, Luigi/GZM-5831-2022; Garlanda, Cecilia/K-4601-2016; JAILLON, Sebastien/A-7537-2015; Kunderfranco, Paolo/J-7636-2016; NEBULONI, MANUELA/L-3969-2017	Colombo, Piergiuseppe/0000-0002-6161-6138; Lambris, John/0000-0002-9370-5776; Mantovani, Alberto/0000-0001-5578-236X; Bonavita, Eduardo/0000-0003-2335-5827; Papait, Roberto/0000-0002-9552-8259; Bonavita, Eduardo/0000-0003-2335-5827; Pasqualini, Fabio/0000-0003-4852-3794; GALDIERO, MARIA ROSARIA/0000-0002-8086-9130; Greco, Carolina/0000-0002-9895-5635; Molgora, Martina/0000-0001-7328-2844; Kunderfranco, Paolo/0000-0001-7477-8710; Kunderfranco, Paolo/0000-0001-7477-8710; Laghi, Luigi/0000-0003-4187-1059; Garlanda, Cecilia/0000-0002-1510-7703; JAILLON, Sebastien/0000-0002-5600-855X; Kunderfranco, Paolo/0000-0003-3636-3391; Doni, Andrea/0000-0001-9203-5814; Basso, Gianluca/0000-0002-8430-4727; Roncalli, Massimo/0000-0002-7901-8910; NEBULONI, MANUELA/0000-0002-2773-734X; Rubino, Marcello/0000-0003-3689-1733	European Commission (ERC) [280873]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [FIRB RBLA039LSF]; Italian Ministry of Health; Associazione Italiana Ricerca sul Cancro (AIRC); Associazione Italiana Ricerca sul Cancro (AIRC 5x1000)	European Commission (ERC)(European CommissionEuropean Commission Joint Research CentreEuropean Research Council (ERC)); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Ricerca sul Cancro (AIRC 5x1000)(Fondazione AIRC per la ricerca sul cancro)	We thank N. Polentarutti for technical assistance, S. Meri for generously providing SRC19-20, and B. Bottazzi and P. Bianchi for discussion. The contribution of the European Commission (ERC to A. M., FP7-HEALTH-2011-ADI-TEC-No280873), Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (project FIRB RBLA039LSF), Associazione Italiana Ricerca sul Cancro (AIRC and AIRC 5x1000), and the Italian Ministry of Health is gratefully acknowledged.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Banda NK, 2013, J IMMUNOL, V190, P3560, DOI 10.4049/jimmunol.1203271; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Braunschweig A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023991; Chiarini M, 2010, GENES IMMUN, V11, P665, DOI 10.1038/gene.2010.41; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Cunha C, 2014, NEW ENGL J MED, V370, P421, DOI 10.1056/NEJMoa1211161; de Visser KE, 2004, NEOPLASIA, V6, P768, DOI 10.1593/neo.04250; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Golay J, 2001, BLOOD, V98, P3383, DOI 10.1182/blood.V98.12.3383; Gout E, 2011, J IMMUNOL, V186, P5815, DOI 10.4049/jimmunol.1100180; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Inforzato A, 2013, SEMIN IMMUNOL, V25, P79, DOI 10.1016/j.smim.2013.05.002; Jaillon S, 2014, IMMUNITY, V40, P621, DOI 10.1016/j.immuni.2014.02.015; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Laoui D, 2014, CANCER RES, V74, P24, DOI 10.1158/0008-5472.CAN-13-1196; Lech M, 2013, KIDNEY INT, V83, P647, DOI 10.1038/ki.2012.463; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Moalli F, 2010, BLOOD, V116, P5170, DOI 10.1182/blood-2009-12-258376; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Pienta KJ, 2013, INVEST NEW DRUG, V31, P760, DOI 10.1007/s10637-012-9869-8; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Soares AC, 2006, MICROBES INFECT, V8, P1321, DOI 10.1016/j.micinf.2005.12.017; SOZZANI S, 1995, J IMMUNOL, V155, P3292; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang JX, 2011, WORLD J GASTROENTERO, V17, P4225, DOI 10.3748/wjg.v17.i37.4225; Watanabe H, 1999, JPN J CANCER RES, V90, P40, DOI 10.1111/j.1349-7006.1999.tb00663.x	49	258	268	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					700	714		10.1016/j.cell.2015.01.004	http://dx.doi.org/10.1016/j.cell.2015.01.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25679762	Bronze			2022-12-28	WOS:000349208800013
J	Guerreiro, R; Bras, J; Hardy, J				Guerreiro, Rita; Bras, Jose; Hardy, John			SnapShot: Genetics of ALS and FTD	CELL			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS		[Guerreiro, Rita; Bras, Jose; Hardy, John] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 1PJ, England	University of London; University College London	Guerreiro, R (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 1PJ, England.		Guerreiro, Rita J L/A-1327-2011; Bras, Jose MT/A-1428-2011; Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423; Guerreiro, Rita/0000-0001-5879-3486; Bras, Jose/0000-0001-8186-0333	Medical Research Council Funding Source: Medline; Wellcome Trust [WT089698] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Hardy J, 2014, EXP NEUROL, V262, P75, DOI 10.1016/j.expneurol.2013.11.006; Marangi G, 2014, BRAIN RES; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Smith BN, 2014, NEURON, V84, P324, DOI 10.1016/j.neuron.2014.09.027; Wong TH, 2014, BRAIN, V137, P1361, DOI 10.1093/brain/awu067	7	54	55	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					798	U485		10.1016/j.cell.2015.01.052	http://dx.doi.org/10.1016/j.cell.2015.01.052			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25679767	Bronze			2022-12-28	WOS:000349208800020
J	Welch, MD				Welch, Matthew D.			Cell Migration, Freshly Squeezed	CELL			English	Editorial Material							PLASTICITY; ACTIN	Migrating cells exhibit distinct motility modes and can switch between modes based on chemical or physical cues. Liu et al. and Ruprecht et al. now describe how confinement and contractility influence motility mode plasticity and instigate a mode termed stable bleb migration in embryonic and tumor cells.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Welch, MD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	welch@berkeley.edu			NIGMS NIH HHS [R01 GM059609] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Ruprecht V, 2015, CELL, V160, P673, DOI 10.1016/j.cell.2015.01.008; Yoshida K, 2001, J CELL SCI, V114, P2155	9	18	18	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					581	582		10.1016/j.cell.2015.01.053	http://dx.doi.org/10.1016/j.cell.2015.01.053			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25679757	Bronze			2022-12-28	WOS:000349208800003
J	Wolf, SM; Berlinger, N; Jennings, B				Wolf, Susan M.; Berlinger, Nancy; Jennings, Bruce			Forty Years of Work on End-of-Life Care - From Patients' Rights to Systemic Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FEEDING-TUBE INSERTION; DECISION-MAKING; PALLIATIVE CARE; TRANSITIONS; PROJECT; DEATH		[Wolf, Susan M.] Univ Minnesota, Consortium Law & Values Hlth Environm & Life Sci, Minneapolis, MN 55455 USA; [Berlinger, Nancy] Hastings Ctr, Garrison, NY USA; [Jennings, Bruce] Ctr Humans & Nat, Dobbs Ferry, NY USA	University of Minnesota System; University of Minnesota Twin Cities	Wolf, SM (corresponding author), Univ Minnesota, Consortium Law & Values Hlth Environm & Life Sci, Minneapolis, MN 55455 USA.							Abboud C, 2013, BLOOD, V121, P4439, DOI 10.1182/blood-2013-03-490003; American College of Physicians, PAP END LIF CONS PAN; American Medical Association, AMA POL END LIF CAR; American Nurses Association, POS STAT REG NURS RO; [Anonymous], 2014, NY TIMES, pA18; [Anonymous], 2013, IPAL PROJ IMPR PALL; [Anonymous], 2013, ONC IMPR ONC COMM SK; Aulino F, 2001, J ROY SOC MED, V94, P492, DOI 10.1177/014107680109400923; Back AL, 2013, J PALLIAT MED, V16, P1429, DOI 10.1089/jpm.2013.0193; Barfield RC, 2010, AM J BIOETHICS, V10, P28, DOI 10.1080/15265161003632930; Berlinger N., 2013, HASTINGS CTR GUIDELI, V2nd ed; Berlinger N, 2013, PEDIATRICS, V132, P789, DOI 10.1542/peds.2013-1378; Blinderman CD, 2012, JAMA-J AM MED ASSOC, V307, P917, DOI 10.1001/jama.2012.236; Committee on Approaching Death: Addressing Key End of Life Issues, 2014, DYING AM IMPR QUAL H; Feng ZL, 2012, HEALTH AFFAIR, V31, P1251, DOI 10.1377/hlthaff.2012.0129; Field M., 2002, CHILDREN DIE IMPROVI; Field MJ, 1997, APPROACHING DEATH IM; Fins JJ, 2005, HASTINGS CENT REP, V35, P22, DOI 10.2307/3527759; Goodman DC, 2013, TRENDS CANC CARE NEA; Greer JA, 2013, CA-CANCER J CLIN, V63, P349, DOI 10.3322/caac.21192; HAFEMEISTER TL, 1991, ISSUES LAW MED, V7, P53; *HAST CTR, 1987, GUID TERM LIF SUST T; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; LO B, 1995, JAMA-J AM MED ASSOC, V274, P1634, DOI 10.1001/jama.274.20.1634; Lunney J.R., 2003, DESCRIBING DEATH AM; MEISEL A, 2004, RIGHT DIE LAW END LI; Naylor MD, 2011, HEALTH AFFAIR, V30, P746, DOI 10.1377/hlthaff.2011.0041; Pathak EB, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005196; *PRES COMM STUD ET, 1983, DEC FOR LIF SUST TRE; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Schell JO, 2012, SEMIN DIALYSIS, V25, P611, DOI 10.1111/sdi.12017; Schmidt RJ, 2013, CLIN J AM SOC NEPHRO, V8, P1; *SUPPORT PRINC INV, 1996, JAMA-J AM MED ASSOC, V275, P1232, DOI DOI 10.1001/JAMA.1995.03530200027032; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Teno JM, 2011, J AM GERIATR SOC, V59, P881, DOI 10.1111/j.1532-5415.2011.03385.x; Teno JM, 2009, J PALLIAT MED, V12, P359, DOI 10.1089/jpm.2008.0168; Williams MV, 2014, SOUTH MED J, V107, P455, DOI 10.14423/SMJ.0000000000000140; WOLF SM, 1991, NEW ENGL J MED, V325, P1666, DOI 10.1056/NEJM199112053252334	39	33	33	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7					678	682		10.1056/NEJMms1410321	http://dx.doi.org/10.1056/NEJMms1410321			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA8CK	25671263				2022-12-28	WOS:000349143900017
J	Agoritsas, T; Heen, AF; Brandt, L; Alonso-Coello, P; Kristiansen, A; Akl, EA; Neumann, I; Tikkinen, KAO; van der Weijden, T; Elwyn, G; Montori, VM; Guyatt, GH; Vandvik, PO				Agoritsas, Thomas; Heen, Anja Fog; Brandt, Linn; Alonso-Coello, Pablo; Kristiansen, Annette; Akl, Elie A.; Neumann, Ignacio; Tikkinen, Kari A. O.; van der Weijden, Trudy; Elwyn, Glyn; Montori, Victor M.; Guyatt, Gordon H.; Vandvik, Per Olav			SPOTLIGHT: PATIENT CENTRED CARE Decision aids that really promote shared decision making: the pace quickens	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-PRACTICE GUIDELINES; TRUSTWORTHY GUIDELINES; SUPPORT INTERVENTIONS; IMPLEMENTATION; DELIBERATION; METAANALYSIS; INVOLVEMENT; ADAPTATION; DIFFICULT; EVALUATE		[Agoritsas, Thomas; Alonso-Coello, Pablo; Akl, Elie A.; Neumann, Ignacio; Tikkinen, Kari A. O.; Guyatt, Gordon H.] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, Div Gen Internal Med, Geneva, Switzerland; [Heen, Anja Fog; Brandt, Linn; Kristiansen, Annette; Vandvik, Per Olav] Innlandet Hosp Trust, Dept Med, Gjovik, Norway; [Heen, Anja Fog; Brandt, Linn; Kristiansen, Annette; Vandvik, Per Olav] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway; [Alonso-Coello, Pablo] Biomed Res Inst St Pau CIBER Epidemiol & Salud Pu, Iberoamer Cochrane Ctr, Barcelona, Spain; [Akl, Elie A.] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon; [Neumann, Ignacio] Pontificia Univ Catolica Chile, Sch Med, Dept Internal Med, Santiago, Chile; [Tikkinen, Kari A. O.] Univ Helsinki, Cent Hosp, Dept Urol, Helsinki, Finland; [Tikkinen, Kari A. O.] Univ Helsinki, Cent Hosp, Dept Publ Hlth, Helsinki, Finland; [Tikkinen, Kari A. O.] Univ Helsinki, Helsinki, Finland; [van der Weijden, Trudy] Maastricht Univ, Sch Publ Hlth & Primary Care, Dept Family Med, NL-6200 MD Maastricht, Netherlands; [Elwyn, Glyn] Dartmouth Inst Hlth Policy & Clin Practice, Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH USA; [Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN USA	McMaster University; University of Geneva; Innlandet Hospital Trust; University of Oslo; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; American University of Beirut; Pontificia Universidad Catolica de Chile; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Maastricht University; Dartmouth College; Mayo Clinic	Agoritsas, T (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	thomas.agoritsas@gmail.com	Agoritsas, Thomas/F-4321-2014; Neumann, Ignacio/ABB-5013-2020; Elwyn, G./L-4292-2015; Akl, Elie A/R-2079-2016; Akl, Elie/K-5269-2019; Elwyn, Glyn/B-4798-2009; Tikkinen, Kari/L-3632-2018	Agoritsas, Thomas/0000-0002-6182-9969; Akl, Elie A/0000-0002-3444-8618; van der weijden, trudy/0000-0002-7469-3781; Elwyn, Glyn/0000-0002-0917-6286; Montori, Victor/0000-0003-0595-2898; Tikkinen, Kari/0000-0002-1389-8214; Alonso-Coello, Pablo/0000-0002-8001-8504	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		[Anonymous], PAT DEC AIDS INV; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Boivin A, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.034835; Breslin M, 2008, PATIENT EDUC COUNS, V73, P465, DOI 10.1016/j.pec.2008.07.024; Cox K, 2007, BRIT J GEN PRACT, V57, P777; Coylewright M, 2014, CIRC-CARDIOVASC QUAL, V7, P360, DOI 10.1161/HCQ.0000000000000006; Djulbegovic B, 2014, JAMA-J AM MED ASSOC, V312, P1293, DOI 10.1001/jama.2014.10713; Dwamena F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003267.pub2; Edwards A, 2003, PATIENT EDUC COUNS, V50, P311, DOI 10.1016/S0738-3991(03)00055-7; Elwyn G, 2014, PATIENT EDUC COUNS, V97, P158, DOI 10.1016/j.pec.2014.07.027; Elwyn G, 2010, MED DECIS MAKING, V30, P701, DOI 10.1177/0272989X10386231; Elwyn G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-57; Giguere AMC, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0144-6; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hargraves I, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5811; Hoffmann TC, 2014, JAMA-J AM MED ASSOC, V312, P1295, DOI 10.1001/jama.2014.10186; Hoffmann TC, 2014, MED J AUSTRALIA, V201, P35, DOI 10.5694/mja14.00002; Kristiansen A, 2014, CHEST; Kristiansen A, 2014, CHEST, V146, P735, DOI 10.1378/chest.13-2993; Kristiansen A, 2014, CHEST, V146, P727, DOI 10.1378/chest.13-2828; Legare F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006732.pub2; Llewellyn-Thomas HA, 2013, MED CARE RES REV, V70, p50S, DOI 10.1177/1077558712461182; Lloyd A, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-102; Montori VM, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S5; Montori VM, 2007, PLOS MED, V4, P1303, DOI 10.1371/journal.pmed.0040233; Perneger TV, 2011, J GEN INTERN MED, V26, P1411, DOI 10.1007/s11606-011-1810-x; Stacey D., 2014, COCHRANE DB SYST REV, V4, pCD001431, DOI [10.1002/14651858.CD001431.pub5, DOI 10.1002/14651858.CD001431.PUB5, 10.1002/14651858.CD001431.pub4, DOI 10.1002/14651858.CD001431.PUB4]; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; Treweek S, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-6; Uhlig K, 2014, J GEN INTERN MED, V29, P670, DOI 10.1007/s11606-013-2659-y; van der Weijden T, 2012, J CLIN EPIDEMIOL, V65, P584, DOI 10.1016/j.jclinepi.2011.10.007; Vandvik PO, 2013, CHEST, V144, P381, DOI 10.1378/chest.13-0746; Walsh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g188; Wyatt KD, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-26	36	165	166	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								g7624	10.1136/bmj.g7624	http://dx.doi.org/10.1136/bmj.g7624			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670178	Green Published, Bronze			2022-12-28	WOS:000349318400028
J	Kieburtz, K; Tilley, BC; Elm, JJ; Babcock, D; Hauser, R; Ross, GW; Augustine, AH; Augustine, EU; Aminoff, MJ; Bodis-Wollner, IG; Boyd, J; Cambi, F; Chou, K; Christine, CW; Cines, M; Dahodwala, N; Derwent, L; Dewey, RB; Hawthorne, K; Houghton, DJ; Kamp, C; Leehey, M; Lew, MF; Liang, GSL; Luo, ST; Mari, Z; Morgan, JC; Parashos, S; Perez, A; Petrovitch, H; Rajan, S; Reichwein, S; Roth, JT; Schneider, JS; Shannon, KM; Simon, DK; Simuni, T; Singer, C; Sudarsky, L; Tanner, CM; Umeh, CC; Williams, K; Wills, AM				Kieburtz, Karl; Tilley, Barbara C.; Elm, Jordan J.; Babcock, Debra; Hauser, Robert; Ross, G. Webster; Augustine, Alicia H.; Augustine, Erika U.; Aminoff, Michael J.; Bodis-Wollner, Ivan G.; Boyd, James; Cambi, Franca; Chou, Kelvin; Christine, Chadwick W.; Cines, Michelle; Dahodwala, Nabila; Derwent, Lorelei; Dewey, Richard B., Jr.; Hawthorne, Katherine; Houghton, David J.; Kamp, Cornelia; Leehey, Maureen; Lew, Mark F.; Liang, Grace S. Lin; Luo, Sheng T.; Mari, Zoltan; Morgan, John C.; Parashos, Sotirios; Perez, Adriana; Petrovitch, Helen; Rajan, Suja; Reichwein, Sue; Roth, Jessie Tatsuno; Schneider, Jay S.; Shannon, Kathleen M.; Simon, David K.; Simuni, Tanya; Singer, Carlos; Sudarsky, Lewis; Tanner, Caroline M.; Umeh, Chizoba C.; Williams, Karen; Wills, Anne-Marie		Writing Grp NINDS Exploratory	Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUESTIONNAIRE; LEVODOPA; QUALITY; TESTS	IMPORTANCE There are no treatments available to slow or prevent the progression of Parkinson disease, despite its global prevalence and significant health care burden. The National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson Disease program was established to promote discovery of potential therapies. OBJECTIVE To determine whether creatine monohydrate was more effective than placebo in slowing long-term clinical decline in participants with Parkinson disease. DESIGN, SETTING, AND PATIENTS The Long-term Study 1, a multicenter, double-blind, parallel-group, placebo-controlled, 1: 1 randomized efficacy trial. Participants were recruited from 45 investigative sites in the United States and Canada and included 1741 men and women with early (within 5 years of diagnosis) and treated (receiving dopaminergic therapy) Parkinson disease. Participants were enrolled from March 2007 to May 2010 and followed up until September 2013. INTERVENTIONS Participants were randomized to placebo or creatine (10 g/d) monohydrate for a minimum of 5 years (maximum follow-up, 8 years). MAIN OUTCOMES AND MEASURES The primary outcome measure was a difference in clinical decline from baseline to 5-year follow-up, compared between the 2 treatment groups using a global statistical test. Clinical status was defined by 5 outcome measures: Modified Rankin Scale, Symbol Digit Modalities Test, PDQ-39 Summary Index, Schwab and England Activities of Daily Living scale, and ambulatory capacity. All outcomes were coded such that higher scores indicated worse outcomes and were analyzed by a global statistical test. Higher summed ranks (range, 5-4775) indicate worse outcomes. RESULTS The trial was terminated early for futility based on results of a planned interim analysis of participants enrolled at least 5 years prior to the date of the analysis (n = 955). The median follow-up time was 4 years. Of the 955 participants, the mean of the summed ranks for placebo was 2360 (95% CI, 2249-2470) and for creatine was 2414 (95% CI, 2304-2524). The global statistical test yielded t1865.8 = -0.75 (2-sided P = .45). There were no detectable differences (P <.01 to partially adjust for multiple comparisons) in adverse and serious adverse events by body system. CONCLUSIONS AND RELEVANCE Among patients with early and treated Parkinson disease, treatment with creatine monohydrate for at least 5 years, compared with placebo did not improve clinical outcomes. These findings do not support the use of creatine monohydrate in patients with Parkinson disease. Copyright 2015 American Medical Association. All rights reserved.	[Kieburtz, Karl; Augustine, Alicia H.; Augustine, Erika U.; Kamp, Cornelia] Univ Rochester, Rochester, NY 14642 USA; [Tilley, Barbara C.; Luo, Sheng T.; Perez, Adriana; Rajan, Suja] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Elm, Jordan J.] Med Univ S Carolina, Charleston, SC USA; [Babcock, Debra] NIH, Bethesda, MD 20892 USA; [Hauser, Robert] Univ S Florida, Tampa, FL USA; [Ross, G. Webster; Petrovitch, Helen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Aminoff, Michael J.; Christine, Chadwick W.; Roth, Jessie Tatsuno] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Bodis-Wollner, Ivan G.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Boyd, James] Univ Vermont, Burlington, VT 05405 USA; [Cambi, Franca] Univ Kentucky, Lexington, KY 40506 USA; [Chou, Kelvin] Univ Michigan, Ann Arbor, MI 48109 USA; [Cines, Michelle] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Dahodwala, Nabila; Reichwein, Sue] Univ Penn, Philadelphia, PA 19104 USA; [Derwent, Lorelei] Univ Calgary, Calgary, AB, Canada; [Dewey, Richard B., Jr.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Hawthorne, Katherine; Lew, Mark F.] Univ So Calif, Los Angeles, CA USA; [Houghton, David J.] Ochsner Med Ctr, New Orleans, LA USA; [Leehey, Maureen] Univ Colorado Denver, Aurora, CO USA; [Liang, Grace S. Lin; Tanner, Caroline M.] Parkinsons Inst & Clin Ctr, Sunnyvale, CA USA; [Mari, Zoltan] Johns Hopkins Univ, Baltimore, MD USA; [Morgan, John C.] Georgia Regents Univ, Augusta, GA USA; [Parashos, Sotirios] Struthers Parkinsons Ctr, Golden Valley, MN USA; [Schneider, Jay S.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Shannon, Kathleen M.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Simon, David K.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Simuni, Tanya; Williams, Karen] Northwestern Univ, Chicago, IL 60611 USA; [Singer, Carlos] Univ Miami, Miami, FL USA; [Sudarsky, Lewis; Umeh, Chizoba C.; Wills, Anne-Marie] Brigham & Womens Hosp, Boston, MA 02115 USA	University of Rochester; University of Texas System; University of Texas Health Science Center Houston; Medical University of South Carolina; National Institutes of Health (NIH) - USA; State University System of Florida; University of South Florida; Pacific Health Research & Education Institute; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Vermont; University of Kentucky; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland Baltimore; University of Pennsylvania; University of Calgary; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Southern California; Ochsner Health System; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Johns Hopkins University; University System of Georgia; Augusta University; Jefferson University; Rush University; Harvard University; Beth Israel Deaconess Medical Center; Northwestern University; University of Miami; Harvard University; Brigham & Women's Hospital	Kieburtz, K (corresponding author), Univ Rochester, Ctr Human Expt Therapeut, 265 Crittenden Blvd,POB 694, Rochester, NY 14642 USA.	karl.kieburtz@chet.rochester.edu	Dewey, Richard B/A-4288-2013; bodis-wollner, ivan/AAH-2631-2020; Mari, Zoltan/ABC-4879-2020; Singer, Carlos/AAI-6643-2020	Dewey, Richard B/0000-0002-6615-5035; Rajan, Suja/0000-0001-9558-3146; Luo, Sheng/0000-0003-4214-5809; Perez, Adriana/0000-0002-6859-9916	National Institute of Neurological Disorders and Stroke (NINDS) [U01NS43128]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U10NS044545, T32NS007338, U01NS043128, K12NS066098, K23NS072283, U10NS044504, P50NS091856, U10NS044460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034236] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R24MD001779] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Financial support for the LS-1 study was provided by National Institute of Neurological Disorders and Stroke (NINDS) grant U01NS43128.	Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bushnell DM, 1999, QUAL LIFE RES, V8, P345, DOI 10.1023/A:1008979705027; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Ellenberg SS., 2002, DATA MONITORING COMM; Elm JJ, 2012, MOVEMENT DISORD, V27, P1513, DOI 10.1002/mds.25175; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Gray R, 2014, LANCET, V384, P1196, DOI 10.1016/S0140-6736(14)60683-8; Huang P, 2005, BIOMETRICS, V61, P532, DOI 10.1111/j.1541-0420.2005.00322.x; Huang P, 2009, MOVEMENT DISORD, V24, P1732, DOI 10.1002/mds.22645; Jenkinson C, 2003, J CLIN EPIDEMIOL, V56, P843, DOI 10.1016/S0895-4356(03)00148-3; Kieburtz K, 2008, CLIN NEUROPHARMACOL, V31, P141, DOI 10.1097/WNF.0b013e3181342f32; Kieburtz K, 2007, NEUROLOGY, V68, P20; Klivenyi P, 2003, J MOL NEUROSCI, V21, P191, DOI 10.1385/JMN:21:3:191; Kowal SL, 2013, MOVEMENT DISORD, V28, P311, DOI 10.1002/mds.25292; KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612; LAN KKG, 1988, BIOMETRICS, V44, P579, DOI 10.2307/2531870; Luo S, 2016, STAT METHODS MED RES, V25, P821, DOI 10.1177/0962280212469358; Marinus J, 2003, NEUROLOGY, V61, P1222, DOI 10.1212/01.WNL.0000091864.39702.1C; Matthews RT, 1999, EXP NEUROL, V157, P142, DOI 10.1006/exnr.1999.7049; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Ravina B, 2006, NEUROLOGY, V66, P664; Ravina BM, 2003, NEUROLOGY, V60, P1234, DOI 10.1212/01.WNL.0000058760.13152.1A; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Schwab R.S., 1969, 3 S PARK DIS, P152; Shoulson I., 1989, QUANTIFICATION NEURO, P271; Smith A, 2002, SYMBOL DIGIT MODALIT; Tilley BC, 2006, NEUROLOGY, V66, P628, DOI 10.1212/01.wnl.0000201251.33253.fb; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Whitehead J, 1997, DESIGN ANAL SEQUENTI; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	31	130	132	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					584	593		10.1001/jama.2015.120	http://dx.doi.org/10.1001/jama.2015.120			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25668262	Green Accepted, Bronze			2022-12-28	WOS:000349070700018
J	Stunnenberg, HG; Vermeulen, M; Atlasi, Y				Stunnenberg, Hendrik G.; Vermeulen, Michiel; Atlasi, Yaser			A Me6Age for pluripotency	SCIENCE			English	Editorial Material							M(6)A RNA; GROUND-STATE		[Stunnenberg, Hendrik G.; Vermeulen, Michiel; Atlasi, Yaser] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Fac Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Stunnenberg, HG (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Fac Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands.		Vermeulen, Michiel/C-8883-2013; Atlasi, Yaser/F-2885-2018; Stunnenberg, Hendrik G./D-6875-2012; Atlasi, Yaser/AAI-5396-2021	Vermeulen, Michiel/0000-0003-0836-6894; Stunnenberg, Hendrik G./0000-0002-0066-1576; Atlasi, Yaser/0000-0002-7350-1784				Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Waddington C. H, 1940, ORG AND GENES; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	11	5	5	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					614	615		10.1126/science.aaa6262	http://dx.doi.org/10.1126/science.aaa6262			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657233				2022-12-28	WOS:000349145200024
J	Akyuz, N; Georgieva, ER; Zhou, Z; Stolzenberg, S; Cuendet, MA; Khelashvili, G; Altman, RB; Terry, DS; Freed, JH; Weinstein, H; Boudker, O; Blanchard, SC				Akyuz, Nurunisa; Georgieva, Elka R.; Zhou, Zhou; Stolzenberg, Sebastian; Cuendet, Michel A.; Khelashvili, George; Altman, Roger B.; Terry, Daniel S.; Freed, Jack H.; Weinstein, Harel; Boudker, Olga; Blanchard, Scott C.			Transport domain unlocking sets the uptake rate of an aspartate transporter	NATURE			English	Article							PAIR DISTANCE DISTRIBUTIONS; GLUTAMATE TRANSPORTER; MOLECULAR-DYNAMICS; SOFTWARE NEWS; FORCE-FIELD; SUBSTRATE; MEMBRANE; HOMOLOG; MODEL; FLUOROPHORES	Glutamate transporters terminate neurotransmission by clearing synaptically released glutamate from the extracellular space, allowing repeated rounds of signalling and preventing glutamate-mediated excitotoxicity. Crystallographic studies of a glutamate transporter homologue from the archaeon Pyrococcus horikoshii, Glt(Ph), showed that distinct transport domains translocate substrates into the cytoplasm by moving across the membrane within a central trimerization scaffold. Here we report direct observations of these 'elevator-like' transport domain motions in the context of reconstituted proteoliposomes and physiological ion gradients using single-molecule fluorescence resonance energy transfer (smFRET) imaging. We show that GltPh bearing two mutations introduced to impart characteristics of the human transporter exhibits markedly increased transport domain dynamics, which parallels an increased rate of substrate transport, thereby establishing a direct temporal relationship between transport domain motion and substrate uptake. Crystallographic and computational investigations corroborated these findings by revealing that the 'humanizing' mutations favour structurally 'unlocked' intermediate states in the transport cycle exhibiting increased solvent occupancy at the interface between the transport domain and the trimeric scaffold.	[Akyuz, Nurunisa; Zhou, Zhou; Stolzenberg, Sebastian; Cuendet, Michel A.; Khelashvili, George; Altman, Roger B.; Terry, Daniel S.; Weinstein, Harel; Boudker, Olga; Blanchard, Scott C.] Cornell Univ, Dept Physiol & Biophys, Weill Cornell Med Coll, New York, NY 10065 USA; [Georgieva, Elka R.; Freed, Jack H.] Cornell Univ, Natl Biomed Ctr Adv ESR Technol, Ithaca, NY 14853 USA; [Georgieva, Elka R.; Freed, Jack H.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Cuendet, Michel A.] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Weinstein, Harel] Cornell Univ, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, Weill Cornell Med Coll, New York, NY 10065 USA; [Blanchard, Scott C.] Triinst Training Program Chem Biol, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University; Swiss Institute of Bioinformatics; Cornell University	Blanchard, SC (corresponding author), Cornell Univ, Dept Physiol & Biophys, Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA.	olb2003@med.cornell.edu; scb2005@med.cornell.edu	Georgieva, Elka R./AAA-6785-2021; Cuendet, Michel A./AAE-9215-2019; Cuendet, Michel/GWQ-5721-2022; Blanchard, Scott C./A-5804-2009; WEINSTEIN, HAREL/O-8245-2019	Cuendet, Michel A./0000-0002-0754-3425; Blanchard, Scott C./0000-0003-2717-9365; WEINSTEIN, HAREL/0000-0003-3473-9818; Akyuz, Nurunisa/0000-0002-6340-1915; Altman, Russ/0000-0003-3859-2905; Georgieva, Elka R./0000-0001-9980-5260; Terry, Daniel/0000-0001-9021-0084	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; National Institute of Health [5U54GM087519, P01DA012408, R01GM098859, R21MH099491, P41GM103521, R010EB003150]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025862, U54GM087519, R01GM098859, P41GM103521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS085318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408] Funding Source: NIH RePORTER	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank P. Borbat for help with DEER data collection; H. Zhao for his help with fluorophore synthesis; G. Verdon, G. G. Gregario and S. Oh for discussions. The authors acknowledge the staff of X29 beamline at National Synchrotron Light Source and the computational resources at the Texas Advanced Computing Center at the University of Texas at Austin and the National Energy Research Scientific Computing Center, supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. The work was supported in part by the National Institute of Health grants 5U54GM087519 (to O.B. and H.W.); P01DA012408 (to H.W.); R01GM098859 and R21MH099491 (to S.C.B.); P41GM103521 and R010EB003150 (to J.H.F.).	Akyuz N, 2013, NATURE, V502, P114, DOI 10.1038/nature12265; Alejo JL, 2013, BIOPHYS J, V104, P2410, DOI 10.1016/j.bpj.2013.04.039; Altman RB, 2012, NAT METHODS, V9, P428, DOI 10.1038/nmeth.1988; [Anonymous], PYMOL MOL GRAPH SYST; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Borbat PP, 1997, J MAGN RESON, V127, P155, DOI 10.1006/jmre.1997.1201; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Chiang YW, 2005, J MAGN RESON, V177, P184, DOI 10.1016/j.jmr.2005.07.021; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erkens GB, 2013, NATURE, V502, P119, DOI 10.1038/nature12538; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; Georgieva ER, 2013, NAT STRUCT MOL BIOL, V20, P215, DOI 10.1038/nsmb.2494; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Hanelt I, 2013, NAT STRUCT MOL BIOL, V20, P210, DOI 10.1038/nsmb.2471; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MITCHELL P, 1967, ADV ENZYMOL RAMB, V29, P33; Mondal S, 2014, BIOPHYS J, V106, P2305, DOI 10.1016/j.bpj.2014.04.032; Mondal S, 2013, CHEM PHYS LIPIDS, V169, P27, DOI 10.1016/j.chemphyslip.2013.01.006; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Reyes N, 2013, NAT STRUCT MOL BIOL, V20, P634, DOI 10.1038/nsmb.2548; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2010, J NEUROCHEM, V114, P565, DOI 10.1111/j.1471-4159.2010.06796.x; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schmidt TH, 2012, J CHEM INF MODEL, V52, P2657, DOI [10.1021/ci3000453, 10.1021/ci30006531]; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stolzenberg S, 2012, J PHYS CHEM B, V116, P5372, DOI 10.1021/jp301726s; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Verdon G, 2014, ELIFE, V3, DOI 10.7554/eLife.02283; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zheng QS, 2014, CHEM SOC REV, V43, P1044, DOI 10.1039/c3cs60237k; Zheng QS, 2012, J PHYS CHEM LETT, V3, P2200, DOI 10.1021/jz300670p; Zhou XM, 2014, NATURE, V505, P569, DOI 10.1038/nature12811	55	113	116	0	71	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					68	+		10.1038/nature14158	http://dx.doi.org/10.1038/nature14158			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25652997	Green Accepted			2022-12-28	WOS:000349098000032
J	Lenzer, J				Lenzer, Jeanne			Why aren't the US Centers for Disease Control and Food and Drug Administration speaking with one voice on flu?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Jeanne.Lenzer@gmail.com						American Lung Association, 2010, TRENDS PNEUM INFL MO; Brownlee S, 2009, ATLANTIC, V304, P44; Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; Ebell MH, 2013, FAM PRACT, V30, P125, DOI 10.1093/fampra/cms059; Goldberg C, 2015, TOUGH FLU YEAR CDC T; Groves T, 2013, BMJ; Jefferson T., 2015, TRANSPARENCY OPAQUEN; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Roblin P, 2015, DOBSON LANCET TAMIFL; Sun BC, 2013, ANN EMERG MED, V61, P605, DOI 10.1016/j.annemergmed.2012.10.026	10	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2015	350								h658	10.1136/bmj.h658	http://dx.doi.org/10.1136/bmj.h658			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0JX	25655431				2022-12-28	WOS:000349313100016
J	Lee, MA; Downing, CP; Tyring, SK				Lee, Michael A.; Downing, Christopher P.; Tyring, Stephen K.			Skin and Mouth Lesions Plus Weight Loss in an Elderly Man	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							KAPOSI-SARCOMA		[Lee, Michael A.; Downing, Christopher P.; Tyring, Stephen K.] Ctr Clin Studies, Houston, TX USA; [Tyring, Stephen K.] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Lee, MA (corresponding author), 451 N Texas Ave, Webster, TX 77598 USA.	mlee@ccstexas.com						Fatahzadeh M, 2012, OR SURG OR MED OR PA, V113, P2, DOI 10.1016/j.tripleo.2011.05.011; Feller L, 2007, ORAL SURG ORAL MED O, V104, P521, DOI 10.1016/j.tripleo.2006.08.015; Howlader N., 2021, SEER CANC STAT REV, P1975; Karrer S, 2001, Am J Clin Dermatol, V2, P229, DOI 10.2165/00128071-200102040-00004; Ramirez-Amador V, 2010, ORAL ONCOL, V46, P135, DOI 10.1016/j.oraloncology.2009.12.006; Schwartz RA, 1996, J AM ACAD DERMATOL, V34, P804, DOI 10.1016/S0190-9622(96)90018-3; Schwartz RA, 2008, J AM ACAD DERMATOL, V59, P179, DOI 10.1016/j.jaad.2008.05.001	7	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					514	515		10.1001/jama.2014.17010	http://dx.doi.org/10.1001/jama.2014.17010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AV	25647208				2022-12-28	WOS:000349070300016
J	Kung, HH; Baumbach, RE; Bauer, ED; Thorsmolle, VK; Zhang, WL; Haule, K; Mydosh, JA; Blumberg, G				Kung, H. -H.; Baumbach, R. E.; Bauer, E. D.; Thorsmolle, V. K.; Zhang, W. -L.; Haule, K.; Mydosh, J. A.; Blumberg, G.			Chirality density wave of the "hidden order" phase in URu2Si2	SCIENCE			English	Article							SYMMETRY-BREAKING; RAMAN-SCATTERING; MAGNETIC EXCITATIONS; FERMI-SURFACE; LATTICE; TRANSITION; ENTROPY	A second-order phase transition in a physical system is associated with the emergence of an "order parameter" and a spontaneous symmetry breaking. The heavy fermion superconductor URu2Si2 has a "hidden order" (HO) phase below the temperature of 17.5 kelvin; the symmetry of the associated order parameter has remained ambiguous. Here we use polarization-resolved Raman spectroscopy to specify the symmetry of the low-energy excitations above and below the HO transition. We determine that the HO parameter breaks local vertical and diagonal reflection symmetries at the uranium sites, resulting in crystal field states with distinct chiral properties, which order to a commensurate chirality density wave ground state.	[Kung, H. -H.; Thorsmolle, V. K.; Zhang, W. -L.; Haule, K.; Blumberg, G.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Baumbach, R. E.; Bauer, E. D.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Mydosh, J. A.] Leiden Univ, Kamerlingh Onnes Lab, NL-2300 RA Leiden, Netherlands; [Blumberg, G.] NICPB, EE-12618 Tallinn, Estonia	Rutgers State University New Brunswick; United States Department of Energy (DOE); Los Alamos National Laboratory; Leiden University; Leiden University - Excl LUMC; National Institute of Chemical Physics & Biophysics (NICPB)	Blumberg, G (corresponding author), Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA.	skung@physics.rutgers.edu; haule@physics.rutgers.edu; girsh@physics.rutgers.edu	Kung, Hsiang-Hsi/R-4949-2016; Thorsmølle, Verner K/M-1095-2015; Zhang, Weilu/GLT-3291-2022	Kung, Hsiang-Hsi/0000-0002-2835-3196; Thorsmølle, Verner K/0000-0002-5890-4403; Haule, Kristjan/0000-0002-2284-1551; Zhang, Weilu/0000-0002-4616-5877; Blumberg, Girsh/0000-0003-0388-8327; Bauer, Eric/0000-0003-0017-1937	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0005463]; National Science Foundation under Award NSF [DMR-1104884]; NSF [DMR-1405303]; Institute for Complex Adaptive Matter (NSF-IMI) [DMR-0844115]; Direct For Mathematical & Physical Scien [1405303] Funding Source: National Science Foundation; Division Of Materials Research [1104884] Funding Source: National Science Foundation	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); National Science Foundation under Award NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Institute for Complex Adaptive Matter (NSF-IMI); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank J. Buhot, P. Chandra, P. Coleman, G. Kotliar, M.-A. Measson, D. K. Morr, L. Pascut, A. Sacuto, J. Thompson, and V. M. Yakovenko for discussions. G.B. and V.K.T. acknowledge support from the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Award DE-SC0005463. H.-H. K. acknowledges support from the National Science Foundation under Award NSF DMR-1104884. K.H. acknowledges support by NSF DMR-1405303. W.-L.Z. acknowledges support by the Institute for Complex Adaptive Matter (NSF-IMI grant DMR-0844115). Work at Los Alamos National Laboratory was performed under the auspices of the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering.	Aynajian P, 2010, P NATL ACAD SCI USA, V107, P10383, DOI 10.1073/pnas.1005892107; Bareille C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5326; Boariu FL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.156404; BONN DA, 1988, PHYS REV LETT, V61, P1305, DOI 10.1103/PhysRevLett.61.1305; Bourdarot F, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.067203; Bourdarot F, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.064719; BROHOLM C, 1991, PHYS REV B, V43, P12809, DOI 10.1103/PhysRevB.43.12809; Buhot J, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.266405; Chandra P, 2002, NATURE, V417, P831, DOI 10.1038/nature00795; Chandra P, 2013, NATURE, V493, P621, DOI 10.1038/nature11820; COOPER SL, 1987, PHYS REV B, V36, P5743, DOI 10.1103/PhysRevB.36.5743; Elgazzar S, 2009, NAT MATER, V8, P337, DOI [10.1038/nmat2395, 10.1038/NMAT2395]; Guo WT, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195105; Hall JS, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035132; Haule K, 2009, NAT PHYS, V5, P796, DOI 10.1038/NPHYS1392; Ikeda H, 2012, NAT PHYS, V8, P528, DOI [10.1038/NPHYS2330, 10.1038/nphys2330]; Jeffries JR, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.033103; KHVESHCHENKO DV, 1994, PHYS REV LETT, V73, P500, DOI 10.1103/PhysRevLett.73.500; KONINGST.JA, 1968, NATURE, V217, P445, DOI 10.1038/217445a0; MAPLE MB, 1986, PHYS REV LETT, V56, P185, DOI 10.1103/PhysRevLett.56.185; Mydosh JA, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1301; Okazaki R, 2011, SCIENCE, V331, P439, DOI 10.1126/science.1197358; Ovander L., 1960, OPT SPECTROSC+, V9, P302; PALSTRA TTM, 1985, PHYS REV LETT, V55, P2727, DOI 10.1103/PhysRevLett.55.2727; Rho H, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144420; SANTINI P, 1994, PHYS REV LETT, V73, P1027, DOI 10.1103/PhysRevLett.73.1027; Santini P, 2009, REV MOD PHYS, V81, P807, DOI 10.1103/RevModPhys.81.807; Schmidt AR, 2010, NATURE, V465, P570, DOI 10.1038/nature09073; SHASTRY BS, 1991, INT J MOD PHYS B, V5, P365, DOI 10.1142/S0217979291000237; STEWART GR, 1984, REV MOD PHYS, V56, P755, DOI 10.1103/RevModPhys.56.755; Tonegawa S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5188; Wiebe CR, 2007, NAT PHYS, V3, P96, DOI 10.1038/nphys522	32	80	81	1	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1339	1342		10.1126/science.1259729	http://dx.doi.org/10.1126/science.1259729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25678557	Green Submitted			2022-12-28	WOS:000351219600035
J	Kim, J				Kim, Joyce			Myxedema	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale New Haven Med Ctr, New Haven, CT 06504 USA	Yale University	Kim, J (corresponding author), Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA.								0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					764	764		10.1056/NEJMicm1403210	http://dx.doi.org/10.1056/NEJMicm1403210			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7PB	25693016				2022-12-28	WOS:000349818700011
J	Tajitsu, A; Sadakane, K; Naito, H; Arai, A; Aoki, W				Tajitsu, Akito; Sadakane, Kozo; Naito, Hiroyuki; Arai, Akira; Aoki, Wako			Explosive lithium production in the classical nova V339 Del (Nova Delphini 2013)	NATURE			English	Article							THERMONUCLEAR FORMATION; AGB STARS; LI-7; EVOLUTION; LINES; DISCOVERY; CREATION; BE-7	The origin of lithium (Li) and its production process have long been uncertain. Li could be produced by Big Bang nucleosynthesis, interactions of energetic cosmic rays with interstellar matter, evolved low-mass stars, novae, and supernova explosions. Chemical evolution models and observed stellar Li abundances suggest that at least half the Li may have been produced in red giants, asymptotic giant branch (AGB) stars, and novae(1-3). No direct evidence, however, for the supply of Li from evolved stellar objects to the Galactic medium has hitherto been found. Here we report the detection of highly blue-shifted resonance lines of the singly ionized radioactive isotope of beryllium, Be-7, in the near-ultraviolet spectra of the classical nova V339 Del (Nova Delphini 2013) 38 to 48 days after the explosion. Be-7 decays to form Li-7 within a short time (half-life of 53.22 days(4)). The Be-7 was created during the nova explosion via the alpha-capture reaction He-3(alpha,gamma)Be-7 (ref. 5). This result supports the theoretical prediction that a significant amount of 7Li is produced in classical nova explosions.	[Tajitsu, Akito] Subaru Telescope, Natl Astron Observ Japan, Hilo, HI 96720 USA; [Sadakane, Kozo] Osaka Kyoiku Univ, Astron Inst, Osaka 5828582, Japan; [Naito, Hiroyuki] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Naito, Hiroyuki] Nayoro Observ, Nayoro, Hokkaido 0960066, Japan; [Arai, Akira] Univ Hyogo, Ctr Astron, Sayo, Hyogo 6795313, Japan; [Arai, Akira] Kyoto Sangyo Univ, Koyama Astron Observ, Kita Ku, Kyoto 6038555, Japan; [Aoki, Wako] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Osaka University of Education; Nagoya University; University of Hyogo; Kyoto Sangyo University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Tajitsu, A (corresponding author), Subaru Telescope, Natl Astron Observ Japan, 650 North Aohoku Pl, Hilo, HI 96720 USA.	tajitsu@naoj.org		Arai, Akira/0000-0002-5756-067X				Ackermann M, 2014, SCIENCE, V345, P554, DOI 10.1126/science.1253947; Audi G, 2003, NUCL PHYS A, V729, P3, DOI 10.1016/j.nuclphysa.2003.11.001; BOFFIN HMJ, 1993, ASTRON ASTROPHYS, V279, P173; CAMERON AGW, 1971, ASTROPHYS J, V164, P111, DOI 10.1086/150821; DANTONA F, 1991, ASTRON ASTROPHYS, V248, P62; de la Reza R, 2000, ASTROPHYS J, V535, pL115, DOI 10.1086/312714; Deacon NR, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201423665; Denisenko D., 2013, IAU CIRC, V9258, P2; Hernanz M, 2008, CAM ASTROPH, P252; Jose J, 1998, ASTROPHYS J, V494, P680, DOI 10.1086/305244; Kramida A., 2013, NIST ATOMIC SPECTRA; Kurucz R. L., 1995, ATOMIC LINE DATA; MASSEY P, 1988, ASTROPHYS J, V328, P315, DOI 10.1086/166294; Mclaughlin D.B., 1960, STELLAR ATMOSPHERES, P585; Melo CHF, 2005, ASTRON ASTROPHYS, V439, P227, DOI 10.1051/0004-6361:20041805; Moore C. E., 1959, 36 NBS US DEP COMM, V36; Munari U., 2013, ASTRON TELEGR, V5304, P1; Munari U., 2013, INFORM B VARIABLE ST, V6087, P1; Naito H, 2013, PUBL ASTRON SOC JPN, V65, DOI 10.1093/pasj/65.2.37; Noguchi K, 2002, PUBL ASTRON SOC JPN, V54, P855, DOI 10.1093/pasj/54.6.855; Prantzos N, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201219043; Romano D, 1999, ASTRON ASTROPHYS, V352, P117; SACKMANN IJ, 1992, ASTROPHYS J, V392, pL71, DOI 10.1086/186428; Sackmann IJ, 1999, ASTROPHYS J, V510, P217, DOI 10.1086/306545; Sadakane K, 2010, PUBL ASTRON SOC JPN, V62, pL5, DOI 10.1093/pasj/62.1.L5; Schaefer GH, 2014, NATURE, V515, P234, DOI 10.1038/nature13834; Shenavrin V. I., 2013, ASTRON TELEGR, V5431, P1; Skopal A, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201424284; STARRFIELD S, 1978, ASTROPHYS J, V222, P600, DOI 10.1086/156175; Tajitsu Akito, 2010, Publications of the National Astronomical Observatory of Japan, V13, P1; Travaglio C, 2001, ASTROPHYS J, V559, P909, DOI 10.1086/322415; Ventura P, 2010, MON NOT R ASTRON SOC, V402, pL72, DOI 10.1111/j.1745-3933.2010.00805.x; Waagen E. O., 2013, AAVSO ALERT NOTICE, V489; Warner B., 1995, CAMB ASTROPHYS SER, V28, P257; WILLIAMS RE, 1992, ASTRON J, V104, P725, DOI 10.1086/116268; Williams R, 2008, ASTROPHYS J, V685, P451, DOI 10.1086/590056; Yan ZC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.243002	41	84	85	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					381	384		10.1038/nature14161	http://dx.doi.org/10.1038/nature14161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25693569	Green Submitted			2022-12-28	WOS:000349547400038
J	Artursson, P; Knight, SD				Artursson, Per; Knight, Stefan D.			Breaking the intestinal barrier to deliver drugs	SCIENCE			English	Editorial Material							CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; TIGHT JUNCTIONS; ARCHITECTURE; CLAUDINS; MICE		[Artursson, Per] Uppsala Univ, Dept Pharm & Sci Life Labs, S-75123 Uppsala, Sweden; [Knight, Stefan D.] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden	Uppsala University	Artursson, P (corresponding author), Uppsala Univ, Dept Pharm & Sci Life Labs, S-75123 Uppsala, Sweden.	per.artursson@farmaci.uu.se; stefan.knight@icm.uu.se	Knight, Stefan/D-4315-2015					Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Li XR, 2014, EUR J PHARM SCI, V52, P132, DOI 10.1016/j.ejps.2013.10.018; Romanov V, 2014, CANCER LETT, V351, P260, DOI 10.1016/j.canlet.2014.06.009; Saitoh Y, 2015, SCIENCE, V347, P775, DOI 10.1126/science.1261833; Shrestha A, 2014, INFECT IMMUN, V82, P4778, DOI 10.1128/IAI.02453-14; Suzuki H, 2015, J MOL BIOL, V427, P291, DOI 10.1016/j.jmb.2014.10.020; Suzuki H, 2014, SCIENCE, V344, P304, DOI 10.1126/science.1248571; Tamura A, 2014, SEMIN CELL DEV BIOL, V36, P177, DOI 10.1016/j.semcdb.2014.09.019; Turner JR, 2014, SEMIN CELL DEV BIOL, V36, P204, DOI 10.1016/j.semcdb.2014.09.022; Wada M, 2013, GASTROENTEROLOGY, V144, P369, DOI 10.1053/j.gastro.2012.10.035	10	17	18	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					716	717		10.1126/science.aaa6124	http://dx.doi.org/10.1126/science.aaa6124			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678646				2022-12-28	WOS:000349221300023
J	Perry, RJ; Camporez, JPG; Kursawe, R; Titchenell, PM; Zhang, DY; Perry, CJ; Jurczak, MJ; Abudukadier, A; Han, MS; Zhang, XM; Ruan, HB; Yang, XY; Caprio, S; Kaech, SM; Sul, HS; Birnbaum, MJ; Davis, RJ; Cline, GW; Petersen, KF; Shulman, GI				Perry, Rachel J.; Camporez, Joao-Paulo G.; Kursawe, Romy; Titchenell, Paul M.; Zhang, Dongyan; Perry, Curtis J.; Jurczak, Michael J.; Abudukadier, Abulizi; Han, Myoung Sook; Zhang, Xian-Man; Ruan, Hai-Bin; Yang, Xiaoyong; Caprio, Sonia; Kaech, Susan M.; Sul, Hei Sook; Birnbaum, Morris J.; Davis, Roger J.; Cline, Gary W.; Petersen, Kitt Falk; Shulman, Gerald I.			Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes	CELL			English	Article							NECROSIS-FACTOR-ALPHA; FATTY LIVER-DISEASE; PYRUVATE-CARBOXYLASE; GLUCOSE-HOMEOSTASIS; SIGNAL TRANSDUCER; LIPID DROPLETS; KINASE JAK1; INTERLEUKIN-6; ASSOCIATION; GLUCONEOGENESIS	Impaired insulin-mediated suppression of hepatic glucose production (HGP) plays a major role in the pathogenesis of type 2 diabetes (T2D), yet the molecular mechanism by which this occurs remains unknown. Using a novel in vivo metabolomics approach, we show that the major mechanism by which insulin suppresses HGP is through reductions in hepatic acetyl CoA by suppression of lipolysis in white adipose tissue (WAT) leading to reductions in pyruvate carboxylase flux. This mechanism was confirmed in mice and rats with genetic ablation of insulin signaling and mice lacking adipose triglyceride lipase. Insulin's ability to suppress hepatic acetyl CoA, PC activity, and lipolysis was lost in high-fat-fed rats, a phenomenon reversible by IL-6 neutralization and inducible by IL-6 infusion. Taken together, these data identify WAT-derived hepatic acetyl CoA as the main regulator of HGP by insulin and link it to inflammation-induced hepatic insulin resistance associated with obesity and T2D.	[Perry, Rachel J.; Zhang, Dongyan; Zhang, Xian-Man; Davis, Roger J.; Shulman, Gerald I.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06519 USA; [Perry, Rachel J.; Camporez, Joao-Paulo G.; Kursawe, Romy; Jurczak, Michael J.; Abudukadier, Abulizi; Cline, Gary W.; Petersen, Kitt Falk; Shulman, Gerald I.] Yale Univ, Dept Internal Med, New Haven, CT 06519 USA; [Perry, Rachel J.; Yang, Xiaoyong; Shulman, Gerald I.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Titchenell, Paul M.; Birnbaum, Morris J.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Perry, Curtis J.; Kaech, Susan M.] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA; [Han, Myoung Sook; Davis, Roger J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Yang, Xiaoyong] Yale Univ, Dept Comparat Med, New Haven, CT 06520 USA; [Caprio, Sonia] Yale Univ, Dept Pediat, New Haven, CT 06520 USA; [Sul, Hei Sook] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; University of Pennsylvania; Pennsylvania Medicine; Yale University; University of Massachusetts System; University of Massachusetts Worcester; Yale University; Yale University; University of California System; University of California Berkeley	Shulman, GI (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06519 USA.	gerald.shulman@yale.edu	Han, Zaiqi/AAI-2233-2019; Shulman, Gerald I./P-7176-2019; Camporez, Joao Paulo G/B-9122-2015; Ruan, Hai-Bin/AAN-7777-2021; Ruan, Hai-Bin/G-9907-2012	Shulman, Gerald I./0000-0003-1529-5668; Ruan, Hai-Bin/0000-0002-3858-1272; Ruan, Hai-Bin/0000-0002-3858-1272; Han, Myoung Sook/0000-0002-7226-2590; Perry, Rachel/0000-0003-0748-8064; Titchenell, Paul/0000-0002-9941-5649; Birnbaum, Morris/0000-0001-9972-8680; Davis, Roger/0000-0002-0130-1652; Camporez, Joao Paulo/0000-0003-3486-4301; Jurczak, Michael/0000-0002-6335-6915	NIH [R01 DK-40936, R24 DK-085638, R01 AG023686, P30 DK-45735, U24 DK-059635, T32 DK-101019, R01 DK-056886, R01 DK-093959, R01 NS-087568, R01 DK93928, UL1 TR-000142, R01-HD028016, R01-HD 04787, R01 DK085577, R24 DK-090963]; Novo Nordisk Foundation Center for Basic Metabolic Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD028016] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093928, R01DK089098, T32DK101019, P30DK045735, R24DK085638, U24DK059635, R24DK090963, R01DK056886, K01DK099402, R01DK085577, R01DK093959, F32DK101175, R01DK040936, P30DK034989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. James Dziura for assistance with the statistical analysis, Isis Pharmaceuticals and Dr. Sanjay Bhanot for providing us with the 2 '-O-methoxyethyl chimeric antisense oligonucleotide for the insulin receptor kinase, and Dr. Jianying Dong, Mario Kahn, John Stack, Gina Butrico, Ali Nasiri, Maria Batsu, and Wanling Zhu for their skilled technical assistance. This study was funded by grants from the NIH (R01 DK-40936, R24 DK-085638, R01 AG023686, P30 DK-45735, U24 DK-059635, T32 DK-101019, R01 DK-056886, R01 DK-093959, R01 NS-087568, R01 DK93928, UL1 TR-000142, R01-HD028016, R01-HD 04787, R01 DK085577, R24 DK-090963) and the Novo Nordisk Foundation Center for Basic Metabolic Research.	BARRITT GJ, 1966, BIOCHEM BIOPH RES CO, V24, P476, DOI 10.1016/0006-291X(66)90186-0; BEYLOT M, 1993, ANAL BIOCHEM, V212, P532, DOI 10.1006/abio.1993.1364; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; CARTEE GD, 1995, AM J PHYSIOL-ENDOC M, V268, pE902, DOI 10.1152/ajpendo.1995.268.5.E902; CAZZULO JJ, 1968, ARCH BIOCHEM BIOPHYS, V127, P563, DOI 10.1016/0003-9861(68)90263-4; Cernkovich ER, 2008, ENDOCRINOLOGY, V149, P1581, DOI 10.1210/en.2007-1148; CHISHOLM AB, 1983, BIOCHEM J, V214, P451, DOI 10.1042/bj2140451; COOPER TG, 1966, BIOCHEM BIOPH RES CO, V22, P285, DOI 10.1016/0006-291X(66)90479-7; Dalrymple R. H., 1973, Journal of Food Technology, V8, P439; Edgerton DS, 2009, DIABETES, V58, P2766, DOI 10.2337/db09-0328; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Fonseca-Alaniz MH, 2007, J PEDIAT-BRAZIL, V83, pS192, DOI [10.1590/S0021-75572007000700011, 10.2223/JPED.1709]; Glund S, 2007, DIABETES, V56, P1630, DOI 10.2337/db06-1733; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; HEPP KD, 1977, DIABETOLOGIA, V13, P177, DOI 10.1007/BF01219697; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Jordan SD, 2010, CELL MOL LIFE SCI, V67, P3255, DOI 10.1007/s00018-010-0414-7; Kado S, 1999, ACTA DIABETOL, V36, P67, DOI 10.1007/s005920050147; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; KEECH DB, 1963, J BIOL CHEM, V238, P2609; KREBS HA, 1965, BIOCHEM J, V94, P712, DOI 10.1042/bj0940712; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Kursawe R, 2010, DIABETES, V59, P2288, DOI 10.2337/db10-0113; Lewis GF, 1996, DIABETES, V45, P454, DOI 10.2337/diabetes.45.4.454; Lin HV, 2010, DIABETES, V59, P337, DOI 10.2337/db09-1303; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Manteiga S, 2013, WIRES SYST BIOL MED, V5, P425, DOI 10.1002/wsbm.1213; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Previs SF, 1999, AM J PHYSIOL-ENDOC M, V277, pE154, DOI 10.1152/ajpendo.1999.277.1.E154; Rebrin K, 1996, J CLIN INVEST, V98, P741, DOI 10.1172/JCI118846; Robbins GR, 2014, MOL CELL, V54, P297, DOI 10.1016/j.molcel.2014.03.029; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Savage DB, 2005, HYPERTENSION, V45, P828, DOI 10.1161/01.HYP.0000163475.04421.e4; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Steptoe A, 2014, P NATL ACAD SCI USA, V111, P15693, DOI 10.1073/pnas.1410401111; Straub RH, 2000, J CLIN ENDOCR METAB, V85, P1340, DOI 10.1210/jc.85.3.1340; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Vatner DF, 2013, AM J PHYSIOL-ENDOC M, V305, pE89, DOI 10.1152/ajpendo.00573.2012; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yuen DYC, 2009, DIABETES, V58, P1086, DOI 10.2337/db08-0775	54	415	424	8	179	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					745	758		10.1016/j.cell.2015.01.012	http://dx.doi.org/10.1016/j.cell.2015.01.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25662011	Bronze, Green Accepted			2022-12-28	WOS:000349208800016
J	Amin, F				Amin, Farhan			Commentary: Becoming a person centred practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Burnett Edgar Med Ctr, Barrow In Furness LA14 3HY, England		Amin, F (corresponding author), Burnett Edgar Med Ctr, Barrow In Furness LA14 3HY, England.	Farhan.amin@patientmemoirs.com	Amin, Farhan/Y-6943-2019; Amin, Farhan/U-2101-2019	Amin, Farhan/0000-0002-6385-5511				Dinsdale P., 2014, GUARDIAN; Royal College of General Practitioners, PATIENT ONLINE PRACT; Walker J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7785	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h269	10.1136/bmj.h269	http://dx.doi.org/10.1136/bmj.h269			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670192	Bronze			2022-12-28	WOS:000349318400010
J	Rogers, JA				Rogers, John A.			Electronics for the Human Body	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rogers, John A.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rogers, JA (corresponding author), Univ Illinois, Dept Chem, 2015 Frederick Seitz, Urbana, IL 61801 USA.	jrogers@illinois.edu	huang, yonggang/O-6236-2019; Rogers, John/L-2798-2016					Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325; Kim DH, 2012, ANNU REV BIOMED ENG, V14, P113, DOI [10.1146/annurev-bioeng-071811-150018, 10.1146/annurev.bioeng-071811-150018]; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437; Slepian M. J., 2011, INTERVENTIONAL CARDI, V3, P417; Viventi J, 2011, NAT NEUROSCI, V14, P1599, DOI 10.1038/nn.2973; Xu LZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4329; Xu S, 2014, SCIENCE, V344, P70, DOI 10.1126/science.1250169	8	64	66	1	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					561	562		10.1001/jama.2014.17915	http://dx.doi.org/10.1001/jama.2014.17915			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25668256				2022-12-28	WOS:000349070700009
J	Hemming, K; Haines, TP; Chilton, PJ; Girling, AJ; Lilford, RJ				Hemming, K.; Haines, T. P.; Chilton, P. J.; Girling, A. J.; Lilford, R. J.			The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SAMPLE-SIZE; BIAS		[Hemming, K.; Chilton, P. J.; Girling, A. J.] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Haines, T. P.] Monash Univ, Clayton, Vic 3800, Australia; [Lilford, R. J.] Univ Warwick, Coventry CV4 7AL, W Midlands, England	University of Birmingham; Monash University; University of Warwick	Hemming, K (corresponding author), Univ Birmingham, Birmingham B15 2TT, W Midlands, England.	k.hemming@bham.ac.uk	Haines, Terrence/E-9372-2015; Hemming, karla/AAB-3391-2021	Haines, Terrence/0000-0003-3150-6154; Hemming, karla/0000-0002-2226-6550; Chilton, Peter/0000-0001-8809-9735; Lilford, Richard/0000-0002-0634-984X; Girling, Alan/0000-0003-2022-045X	National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC) for West Midlands; Medical Research Council (MRC) Midland Hub for Trials Methodology Research [G0800808]; Australian National Health and Medical Research Council [1069758]; MRC [G0800808] Funding Source: UKRI; Medical Research Council [G0800808] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10008] Funding Source: researchfish	National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC) for West Midlands(National Institute for Health Research (NIHR)); Medical Research Council (MRC) Midland Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: RJL and PJC had financial support for the submitted work from the National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC) for West Midlands; KH, RJL, and AJG had financial support from the Medical Research Council (MRC) Midland Hub for Trials Methodology Research (grant No G0800808); TPH is supported by a Career Development Fellowship from the Australian National Health and Medical Research Council (1069758). No financial relationships with any organisations that might have an interest in the submitted work in the previous three years. No other relationships or activities that could appear to have influenced the submitted work.	[Anonymous], 1987, CANCER RES, V47, P5782; [Anonymous], 2014, DESIGN ANAL REPORT C; Bion J, 2013, BMJ QUAL SAF, V22, P110, DOI 10.1136/bmjqs-2012-001325; Bland J Martin, 2004, BMC Med Res Methodol, V4, P21, DOI 10.1186/1471-2288-4-21; Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Campbell Marion K, 2012, BMJ, V345, pe5661, DOI 10.1136/bmj.e5661; Camps Laura, 2012, Nurs Child Young People, V24, P26; Craine N, 2014, EUR J PUBLIC HLTH; Eldridge S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4006; Girling A, STAT MED UNPUB; Glass N, 1999, CHILD SOC, V13, P257, DOI DOI 10.1002/CHI569; Haines T, 2014, J CLIN EPIDEMIOL, V67, P144, DOI 10.1016/j.jclinepi.2013.08.014; Hemming K, 2015, STAT MED, V34, P181, DOI 10.1002/sim.6325; Hemming K, 2014, STATA J, V14, P363, DOI 10.1177/1536867X1401400208; Hemming K, 2013, J CLIN EPIDEMIOL, V66, P1427, DOI 10.1016/j.jclinepi.2013.07.007; Hemming K, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-102; Hughes J, 2003, UW BIOSTATISTICS WOR; Hughes JP, 2008, WILEY ENCY CLIN TRIA, P1, DOI DOI 10.1002/9780471462422.EOCT449; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; King G, 2007, J POLICY ANAL MANAG, V26, P479, DOI 10.1002/pam.20279; Leontjevas R, 2013, LANCET, V381, P2255, DOI 10.1016/S0140-6736(13)60590-5; Mdege ND, 2011, J CLIN EPIDEMIOL, V64, P936, DOI 10.1016/j.jclinepi.2010.12.003; Moberly T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3744; Pearse R, 2013, ENHANCED PERIOPERATI; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; SMITH MS, 1970, HARVARD EDUC REV, V40, P51, DOI 10.17763/haer.40.1.f3h6164m816t2552; Teerenstra S, 2012, STAT MED, V31, P2169, DOI 10.1002/sim.5352; Urlings-Strop LC, 2009, MED EDUC, V43, P175, DOI 10.1111/j.1365-2923.2008.03267.x; Woertman W, 2013, J CLIN EPIDEMIOL, V66, P752, DOI 10.1016/j.jclinepi.2013.01.009	29	622	625	8	48	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2015	350								h391	10.1136/bmj.h391	http://dx.doi.org/10.1136/bmj.h391			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0KK	25662947	Green Published, hybrid			2022-12-28	WOS:000349314500001
J	Alfirevic, Z; Keeney, E; Dowswell, T; Welton, NJ; Dias, S; Jones, LV; Navaratnam, K; Caldwell, DM				Alfirevic, Zarko; Keeney, Edna; Dowswell, Therese; Welton, Nicky J.; Dias, Sofia; Jones, Leanne V.; Navaratnam, Kate; Caldwell, Deborah M.			Labour induction with prostaglandins: a systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MISOPROSTOL; OUTCOMES; TRIALS	OBJECTIVES To assess the effectiveness and safety of prostaglandins used for labour induction. DESIGN Systematic review with Bayesian network meta-analysis DATA SOURCES The Cochrane Pregnancy and Childbirth Group's Database of Trials (which incorporates the results of a broad generic search for all pregnancy and postpartum trials). Sources included are CENTRAL, Medline, Embase, NHS Economic Evaluation Database, CINAHL, relevant journals, conference proceedings, and registries of ongoing trials. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Randomised clinical trials of prostaglandin or prostaglandin analogues used for third trimester cervical ripening or labour induction versus placebo or no treatment, alternative prostaglandin dose or administration, or a different type of prostaglandin. We included studies recruiting women with a viable fetus, but had no other restrictions relating to indication for labour induction or language of publication. Outcomes assessed were serious neonatal morbidity (trialist defined) or perinatal death; serious maternal morbidity (trialist defined) or death; vaginal delivery not achieved within 24 hours, caesarean section, and uterine hyperstimulation with fetal heart rate changes. RESULTS 280 randomised clinical trials were included (48 068 women) in the review. Maternal and neonatal mortality and serious morbidity were rarely reported and are summarized narratively. Unresolved inconsistency was observed for the hyperstimulation outcome. Relative to placebo, the odds of failing to achieve a vaginal delivery were lowest for vaginal misoprostol (>= 50 mu g) (odds ratio 0.06 (95% credible interval 0.02 to 0.12)), with a 39% absolute probability of event (95% credible interval 1% to 94%). Compared with placebo, odds of caesarean section were lowest for titrated oral misoprostol solution (< 50 mu g) (odds ratio 0.65 (0.49 to 0.83)), with an absolute probability of event of 15% (3% to 40%). CONCLUSIONS Low dose(< 50 mu g) titrated oral misoprostol solution had the lowest probability of caesarean section, whereas vaginal misprostol (>= 50 mu g) had the highest probability of achieving a vaginal delivery within 24 hours. These findings have important implications for a series of current national and international guidelines for induction of labour and future research in this area. SYSTEMATIC REVIEW REGISTRATION PROSPERO 2013:CRD42013005116	[Alfirevic, Zarko; Dowswell, Therese; Jones, Leanne V.; Navaratnam, Kate] Univ Liverpool, Ctr Womens Hlth Res, Liverpool L8 7SS, Merseyside, England; [Alfirevic, Zarko; Dowswell, Therese; Jones, Leanne V.; Navaratnam, Kate] Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England; [Keeney, Edna; Welton, Nicky J.; Dias, Sofia; Caldwell, Deborah M.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England	University of Liverpool; University of Liverpool; University of Bristol	Alfirevic, Z (corresponding author), Univ Liverpool, Ctr Womens Hlth Res, Liverpool L8 7SS, Merseyside, England.	zarko@liv.ac.uk	Dias, Sofia/F-1922-2010	Dias, Sofia/0000-0002-2172-0221; Welton, Nicky/0000-0003-2198-3205; , Deborah/0000-0001-8014-7480	National Institute for Health Research, UK [12/126/17]; MRC [G0902118]; Medical Research Council [MR/K025643/1, G0902118, MR/K023233/1, G0802413] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10114] Funding Source: researchfish; MRC [MR/K023233/1, G0802413, MR/K025643/1] Funding Source: UKRI	National Institute for Health Research, UK(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported in part by National Institute for Health Research, UK, HTA project 12/126/17 (www.netscc.ac.uk). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, NHS, or Department of Health. DMC is supported by an MRC Population Health Scientist postdoctoral fellowship (G0902118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins-Obstetrics, 2009, OBSTET GYNECOL, V114, P386, DOI DOI 10.1097/AOG.0B013E3181B48EF5; Austin SC, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.014; Barth J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001454; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P879; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chauhan SP, 2012, SEMIN PERINATOL, V36, P336, DOI 10.1053/j.semperi.2012.04.016; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cochrane Collaboration. Comparing Multiple Interventions Methods Group, 2014, COMP MULT INT COCHR; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Facchinetti F, 2012, J MATERN-FETAL NEO M, V25, P1965, DOI 10.3109/14767058.2012.668584; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hofmeyr G, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002074; Kelly A, 2001, COCHRANE DB SYST REV; Lee AW, 2014, J CLIN EPIDEMIOL, V67, P138, DOI 10.1016/j.jclinepi.2013.07.014; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Mozurkewich EL, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-84; National Institute for Health and Care Excellence, 2008, GUID METH TECHN APPR; National Institute for Health and Care Excellence, 2008, IND LAB CLIN GUID 70, V70; Padwal R, 2011, OBES REV, V12, P602, DOI 10.1111/j.1467-789X.2011.00866.x; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Tang J, 2013, INT J GYNECOL OBSTET, V121, P186, DOI 10.1016/j.ijgo.2012.12.009; The BUGS project, DIC DEV INF CRIT DOE; Wells G, 2009, INDIRECT EVIDENCE IN; Welton NJ., 2012, EVIDENCE SYNTHESIS D; WHO, 2011, WHO REC IND LAB; Wing DA, 1998, OBSTET GYNECOL, V91, P828, DOI 10.1016/S0029-7844(97)00553-X; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	33	66	69	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2015	350								h217	10.1136/bmj.h217	http://dx.doi.org/10.1136/bmj.h217			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0JX	25656228	hybrid, Green Published			2022-12-28	WOS:000349313100003
J	Dharnidharka, VR; Mohanakumar, T				Dharnidharka, Vikas R.; Mohanakumar, Thallachallour			New Approaches to Treating B-Cell Cancers Induced by Epstein-Barr Virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LYMPHOPROLIFERATIVE DISEASE		[Dharnidharka, Vikas R.] Washington Univ, Sch Med, Dept Pediat, Div Pediat Nephrol, St Louis, MO 63130 USA; [Mohanakumar, Thallachallour] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63130 USA; [Mohanakumar, Thallachallour] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Dharnidharka, VR (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Pediat Nephrol, St Louis, MO 63130 USA.							Dharnidharka VR, 2009, PEDIATR NEPHROL, V24, P731, DOI 10.1007/s00467-007-0582-3; Ricciardelli I, 2014, BLOOD, V124, P2514, DOI 10.1182/blood-2014-01-553362; Xiang Z, 2014, CANCER CELL, V26, P565, DOI 10.1016/j.ccr.2014.07.026	3	15	18	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2015	372	6					569	571		10.1056/NEJMcibr1415117	http://dx.doi.org/10.1056/NEJMcibr1415117			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CH	25651254				2022-12-28	WOS:000349143600016
J	Swinburn, B; Kraak, V; Rutter, H; Vandevijvere, S; Lobstein, T; Sacks, G; Gomes, F; Marsh, T; Magnusson, R				Swinburn, Boyd; Kraak, Vivica; Rutter, Harry; Vandevijvere, Stefanie; Lobstein, Tim; Sacks, Gary; Gomes, Fabio; Marsh, Tim; Magnusson, Roger			Strengthening of accountability systems to create healthy food environments and reduce global obesity	LANCET			English	Article							PUBLIC-HEALTH; SELF-REGULATION; POLICY; NUTRITION; AGREEMENTS; STANDARDS; COMPANIES; DISEASES; BURDEN	To achieve WHO's target to halt the rise in obesity and diabetes, dramatic actions are needed to improve the healthiness of food environments. Substantial debate surrounds who is responsible for delivering effective actions and what, specifically, these actions should entail. Arguments are often reduced to a debate between individual and collective responsibilities, and between hard regulatory or fiscal interventions and soft voluntary, education-based approaches. Genuine progress lies beyond the impasse of these entrenched dichotomies. We argue for a strengthening of accountability systems across all actors to substantially improve performance on obesity reduction. In view of the industry opposition and government reluctance to regulate for healthier food environments, quasiregulatory approaches might achieve progress. A four step accountability framework (take the account, share the account, hold to account, and respond to the account) is proposed. The framework identifies multiple levers for change, including quasiregulatory and other approaches that involve government-specified and government-monitored progress of private sector performance, government procurement mechanisms, improved transparency, monitoring of actions, and management of conflicts of interest. Strengthened accountability systems would support government leadership and stewardship, constrain the influence of private sector actors with major conflicts of interest on public policy development, and reinforce the engagement of civil society in creating demand for healthy food environments and in monitoring progress towards obesity action objectives.	[Swinburn, Boyd; Vandevijvere, Stefanie] Univ Auckland, Sch Populat Hlth, Auckland 1142, New Zealand; [Swinburn, Boyd; Kraak, Vivica; Sacks, Gary] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Geelong, Vic 3217, Australia; [Kraak, Vivica] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA USA; [Rutter, Harry] London Sch Hyg & Trop Med, London WC1, England; [Lobstein, Tim] World Obes Federat, London, England; [Gomes, Fabio] Minist Hlth, Natl Canc Inst Brazil, Rio De Janeiro, Brazil; [Marsh, Tim] UK Hlth Forum, London, England; [Magnusson, Roger] Univ Sydney, Sydney Law Sch, Sydney, NSW 2006, Australia	University of Auckland; Deakin University; World Health Organization; Virginia Polytechnic Institute & State University; University of London; London School of Hygiene & Tropical Medicine; National Cancer Institute (Inca); University of Sydney	Swinburn, B (corresponding author), Univ Auckland, Sch Populat Hlth, Auckland 1142, New Zealand.	boyd.swinburn@auckland.ac.nz	Kraak, Vivica I./T-7357-2019; Sacks, Gary/I-5731-2014; Rutter, Harry/HCI-8765-2022	Kraak, Vivica I./0000-0002-9303-5530; Sacks, Gary/0000-0001-9736-1539; Rutter, Harry/0000-0002-9322-0656	National Collaborative on Childhood Obesity Research; RWJF [260639, 61468, 66284]; CDC [U48/DP00064-00S1, 1U48DP001946]; Nutrition and Obesity Policy, Research and Evaluation Network; Office of Behavioural and Social Sciences Research of NIH; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000064, U48DP001946] Funding Source: NIH RePORTER	National Collaborative on Childhood Obesity Research; RWJF; CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Nutrition and Obesity Policy, Research and Evaluation Network; Office of Behavioural and Social Sciences Research of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was done as part of the Envision Project, supported by the National Collaborative on Childhood Obesity Research, which coordinates childhood obesity research across the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), US Department of Agriculture, and the Robert Wood Johnson Foundation (RWJF). This work was supported in part by grants from RWJF (grant numbers 260639, 61468 and 66284), CDC (U48/DP00064-00S1 and 1U48DP001946), including the Nutrition and Obesity Policy, Research and Evaluation Network, and the Office of Behavioural and Social Sciences Research of NIH. We thank Martin McKee and Mark Petticrew for their thoughtful input.	Access to Nutrition Index, 2013, ATNI GLOB IND COMP S; Alexander E, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-26; [Anonymous], 2014, COMMISSION CONSULT E; Beaglehole R, 2014, LANCET, V384, P105, DOI 10.1016/S0140-6736(14)61091-6; Beaglehole R, 2013, LANCET, V381, P602, DOI 10.1016/S0140-6736(13)60101-4; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Bottomley S, 2007, ANALYSING ASSESSING; Bovens M, 2007, EUR LAW J, V13, P447, DOI 10.1111/j.1468-0386.2007.00378.x; Bryden A, 2013, HEALTH POLICY, V110, P186, DOI 10.1016/j.healthpol.2013.02.009; CAISAN, 2011, PLAN NAC SEG AL NUTR; Center for Science in the Public Interest, 2012, NICK KNOCK PITCH JUN; Chan M., 2013, WHO DIR GEN ADDR HLT; Chapman S, 2004, J EPIDEMIOL COMMUN H, V58, P361, DOI 10.1136/jech.2003.018051; City NY, 2013, NEW YORK CIT HLTH CO; Clarke J, 2004, J SOC POLICY, V33, P27, DOI 10.1017/S0047279403007244; Corporate Europe Observatory, RED LIGHT CONS INF F; Cox R., BREAKINGVIEWS PEPSI; Department of Health, 2012, PUBL HLTH RESP DEAL; Department of Health, 2013, PUBL HLTH RESP DEAL; Dietz WH, 2015, LANCET, V385, P2521, DOI 10.1016/S0140-6736(14)61748-7; Dinsdale H, 2008, NATL CHILD MEASUREME; Dodgson R, 2002, 1 LOND CTR GLOB CHAN; Dorfman L, 2005, ACCELERATING POLICY; Elliott T, 2014, MED J AUSTRALIA, V200, P92, DOI 10.5694/mja13.11240; Friel S, 2013, OBES REV, V14, P120, DOI 10.1111/obr.12081; Galbraith-Emami S, 2013, OBES REV, V14, P960, DOI 10.1111/obr.12060; Gleeson D, 2013, LANCET, V381, P1507, DOI 10.1016/S0140-6736(13)60312-8; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Hastings G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5124; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Healthy Weight Commitment Foundation, FOOD BEV MAN PLEDG R; Horton R, 2014, LANCET, V383, P847, DOI 10.1016/S0140-6736(14)60409-8; Huang TTK, 2015, LANCET, V385, P2422, DOI 10.1016/S0140-6736(14)61743-8; Igumbor EU, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001253; Jacoby E, 2012, WORLD NUTR, V3, P483; Jonsson C, 2010, TRANSNATIONAL ACTORS IN GLOBAL GOVERNANCE: PATTERNS, EXPLANATIONS, AND IMPLICATIONS, P1; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Kraak VI, 2014, PUBLIC HEALTH NUTR, V17, P2467, DOI 10.1017/S1368980014000093; Kraak VI, 2012, PUBLIC HEALTH NUTR, V15, P503, DOI 10.1017/S1368980011002060; Kropp R, 2013, SUSTAINABILITY INVES; La Fontaine HA, 2004, PUBLIC HEALTH NUTR, V7, P563, DOI 10.1079/PHN2003572; Lang T., 2012, SUSTAINABLE DIETS BI; Layton L, 2011, WASHINGTON POST; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lintelo DT, 2013, HUNGER NUTR COMMITME; Lobstein T, 2015, LANCET, V385, P2510, DOI 10.1016/S0140-6736(14)61746-3; Magnusson RS, 2009, PUBLIC HEALTH, V123, P265, DOI 10.1016/j.puhe.2008.12.023; Mays N, RESPONSIBILITY DEAL; McDonald's Corporation, NOT 2012 ANN SHAR M; McGrady B., 2011, TRADE PUBLIC HLTH WT, DOI 10.1017/CBO9780511977305; MILIO N, 1989, SOC SCI MED, V29, P413, DOI 10.1016/0277-9536(89)90290-6; Monteiro CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001252; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; New York-Department of Health and Mental Hygiene, 2013, NEW YORK COD NEW YOR; Panjwani C, 2014, HEALTH POLICY, V114, P163, DOI 10.1016/j.healthpol.2013.11.002; Petticrew M, 2012, LANCET, V380, pS11; PLoS Medicine, 2012, PLOS MED, V9; Popkin BM, 2013, OBES REV, V14, P9, DOI 10.1111/obr.12104; Reeve B, 2013, AUST NZ J PUBL HEAL, V37, P494, DOI 10.1111/1753-6405.12134; Reeve B, 2013, J BIOETHIC INQ, V10, P149, DOI 10.1007/s11673-013-9441-z; Reuters investigators, FOOD FIGHT FOOD IND; Roberto CA, 2015, LANCET, V385, P2400, DOI 10.1016/S0140-6736(14)61744-X; Robinson TN, 2010, OBESITY, V18, pS17, DOI 10.1038/oby.2009.427; Rochlin S, 2008, MAKING PARTNERSHIPS; Ruggie John, 2011, REPORT SPECIAL REPRE; Sharma LL, 2010, AM J PUBLIC HEALTH, V100, P240, DOI 10.2105/AJPH.2009.160960; Slining MM, 2013, AM J PREV MED, V44, P174, DOI 10.1016/j.amepre.2012.09.064; Smith RD, 2009, LANCET, V373, P768, DOI 10.1016/S0140-6736(08)61780-8; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Swinburn B, 2013, OBES REV, V14, P1, DOI 10.1111/obr.12087; Swinburn B., 2014, BENCHMARKING FOOD EN; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; The parent's jury, FAM SHAM AW 2012 VIC; Thow AM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-249; Thow AM, 2014, B WORLD HEALTH ORGAN, V92, P139, DOI 10.2471/BLT.13.120543; Thow AM, 2010, FOOD POLICY, V35, P556, DOI 10.1016/j.foodpol.2010.06.005; Uusitalo U, 1996, BRIT MED J, V313, P1044, DOI 10.1136/bmj.313.7064.1044; Watzman N., 2011, FOOD MEDIA CO LOBBY; WHO, 2010, PARTN AG IT 18 1; WHO, 2011, KEEP PROM MEAS RES C; WHO, 2013, COMPRCH GLOB MON FRA; Wilson D, SPECIAL REPORT WASHI; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization Rotary International Centers for Disease Control and Prevention and UNICEF, 2013, GLOBAL ACTION PLAN P; World Trade Organization, 2011, BRIEF NOT SAM ACC WT	85	208	210	3	81	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2534	2545		10.1016/S0140-6736(14)61747-5	http://dx.doi.org/10.1016/S0140-6736(14)61747-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK9AR	25703108	Green Published			2022-12-28	WOS:000356532500028
J	Mock, CN; Donkor, P; Gawande, A; Jamison, DT; Kruk, ME; Debas, HT				Mock, Charles N.; Donkor, Peter; Gawande, Atul; Jamison, Dean T.; Kruk, Margaret E.; Debas, Haile T.		DCP3 Essential Surg Author Grp	Essential surgery: key messages from Disease Control Priorities, 3rd edition	LANCET			English	Review							ASSISTANT MEDICAL OFFICERS; SURGICAL SAFETY CHECKLIST; COST-EFFECTIVENESS; GLOBAL HEALTH; OBSTETRIC SURGERY; INCOME COUNTRIES; CESAREAN-SECTION; PULSE OXIMETRY; SIERRA-LEONE; MORTALITY	The World Bank will publish the nine volumes of Disease Control Priorities, 3rd edition, in 2015-16. Volume 1-Essential Surgery-identifies 44 surgical procedures as essential on the basis that they address substantial needs, are cost effective, and are feasible to implement. This report summarises and critically assesses the volume's five key findings. First, provision of essential surgical procedures would avert about 1.5 million deaths a year, or 6-7% of all avertable deaths in low-income and middle-income countries. Second, essential surgical procedures rank among the most cost effective of all health interventions. The surgical platform of the first-level hospital delivers 28 of the 44 essential procedures, making investment in this platform also highly cost effective. Third, measures to expand access to surgery, such as task sharing, have been shown to be safe and effective while countries make long-term investments in building surgical and anaesthesia workforces. Because emergency procedures constitute 23 of the 28 procedures provided at first-level hospitals, expansion of access requires that such facilities be widely geographically diffused. Fourth, substantial disparities remain in the safety of surgical care, driven by high perioperative mortality rates including anaesthesia-related deaths in low-income and middle-income countries. Feasible measures, such as WHO's Surgical Safety Checklist, have led to improvements in safety and quality. Fifth, the large burden of surgical disorders, cost-effectiveness of essential surgery, and strong public demand for surgical services suggest that universal coverage of essential surgery should be financed early on the path to universal health coverage. We point to estimates that full coverage of the component of universal coverage of essential surgery applicable to first-level hospitals would require just over US$3 billion annually of additional spending and yield a benefit-cost ratio of more than 10: 1. It would efficiently and equitably provide health benefits, financial protection, and contributions to stronger health systems.	[Mock, Charles N.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Mock, Charles N.; Jamison, Dean T.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Donkor, Peter] Kwame Nkrumah Univ Sci & Technol, Dept Surg, Kumasi, Ghana; [Gawande, Atul] Brigham & Womens Hosp, Ariadne Labs, Boston, MA 02115 USA; [Gawande, Atul] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Kruk, Margaret E.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Debas, Haile T.] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA; [Debas, Haile T.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kwame Nkrumah University Science & Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mock, CN (corresponding author), Univ Washington, Harborview Med Ctr, Box 359960, Seattle, WA 98104 USA.		Higashi, Hideki/D-3797-2011; Weiser, Thomas G/AAC-4609-2022; Johansson, Kjell Arne/ABE-3628-2020; Kruk, Margaret E/E-3058-2010	Higashi, Hideki/0000-0002-5534-0905; Weiser, Thomas G/0000-0002-3118-3888; Johansson, Kjell Arne/0000-0001-8912-8710; Kruk, Margaret E/0000-0002-9549-8432; Zelin, Nicole/0000-0002-8212-3981; Meara, John G./0000-0003-4369-3209; Horton, Susan/0000-0002-9243-4767; Namperumalsamy, Venkatesh Prajna/0000-0003-2019-4044; English, Michael/0000-0002-7427-0826; Nandi, Arindam/0000-0002-3967-2424; Ogunbodede, Eyitope/0000-0002-8808-9833	Disease Control Priorities Network project	Disease Control Priorities Network project	The Bill & Melinda Gates Foundation provides financial support for the Disease Control Priorities Network project, of which this volume is a part. The following individuals provided valuable comments and assistance on this report: Elizabeth Brouwer, Rachel Cox, Anna Dare, Sarah Greenberg, Andrew Leather, Rachel Nugent, and Gavin Yamey.	Alkire B, DIS CONTROL PRIORITI, V1; [Anonymous], 2014, GLOB IN EM ESS SURG; [Anonymous], 2003, SURG CAR DISTR HOSP; [Anonymous], 2014, ESS TRAUM CAR PROJ; Bainbridge D, 2012, LANCET, V380, P1075, DOI 10.1016/S0140-6736(12)60990-8; Belle J, 2010, J INFECT DEV COUNTR, V4, P419, DOI 10.3855/jidc.859; Bergstrom S, DIS CONTROL PRIORITI, V1; Bickler S, DIS CONTROL PRIORITE; Burn SL, 2014, B WORLD HEALTH ORGAN, V92, P858, DOI 10.2471/BLT.14.137315; Chao TE, 2014, LANCET GLOB HEALTH, V2, pE334, DOI 10.1016/S2214-109X(14)70213-X; Charles Mock CJ, 2010, STRENGTHENING CARE I; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; EICHHORN JH, 1986, JAMA-J AM MED ASSOC, V256, P1017; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Gosselin RA, 2006, WORLD J SURG, V30, P505, DOI 10.1007/s00268-005-0609-5; Gosselin RA, 2008, WORLD J SURG, V32, P2450, DOI 10.1007/s00268-008-9708-4; Gosselin RA, 2010, WORLD J SURG, V34, P415, DOI 10.1007/s00268-009-0230-0; Grimes CE, 2014, WORLD J SURG, V38, P252, DOI 10.1007/s00268-013-2243-y; Groen RS, 2012, LANCET, V380, P1082, DOI 10.1016/S0140-6736(12)61081-2; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; HOGBERG U, 1989, ACTA OBSTET GYN SCAN, V68, P351, DOI 10.3109/00016348909028671; Hounton SH, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-34; Hoyler M, 2014, WORLD J SURG, V38, P269, DOI 10.1007/s00268-013-2324-y; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jamison DT, 2013, GLOBAL PROBLEMS, SMART SOLUTIONS: COSTS AND BENEFITS, P390; Jamison DT, 2015, LANCET; JAVITT JC, 1993, ARCH OPHTHALMOL-CHIC, V111, P1615; Juillard CJ, 2009, WORLD J SURG, V33, P1075, DOI 10.1007/s00268-009-9959-8; Kruk ME, 2007, BJOG-INT J OBSTET GY, V114, P1253, DOI 10.1111/j.1471-0528.2007.01443.x; Kruk ME, 2014, HEALTH AFFAIR, V33, P1058, DOI 10.1377/hlthaff.2013.0637; Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417; Kushner AL, 2010, ARCH SURG-CHICAGO, V145, P154, DOI 10.1001/archsurg.2009.263; Kwok AC, 2013, ANN SURG, V257, P633, DOI 10.1097/SLA.0b013e3182777fa4; Kydland FE, 2013, GLOBAL PROBLEMS, SMART SOLUTIONS: COSTS AND BENEFITS, P701; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Luboga S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000200; McCord C, 2003, INT J GYNECOL OBSTET, V81, P83, DOI 10.1016/S0020-7292(03)00072-9; McCord C, 2009, HEALTH AFFAIR, V28, pW876, DOI 10.1377/hlthaff.28.5.w876; McQueen KAK, 2013, WORLD J SURG, V37, P2505, DOI 10.1007/s00268-013-2198-z; Meara JG, LANCET IN PRESS; Mock C., 2004, GUIDELINES ESSENTIAL; Mock C, 2006, WORLD J SURG, V30, P946, DOI 10.1007/s00268-005-0768-4; Mock C, 2010, WORLD J SURG, V34, P381, DOI 10.1007/s00268-009-0263-4; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; Mock CN, DIS CONTROL PRIORITI, V1; Ologunde R, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.022; Pereira C, 2011, INT J GYNECOL OBSTET, V114, P180, DOI 10.1016/j.ijgo.2011.05.004; Prinja S, DIS CONTROL PRIORITI, V1; Rose J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089693; Schecter W, DIS CONTROL PRIORITI, V1; Shrime M, DIS CONTROL PRIORITE, V1; Shrime M, DIS CONTROL PRIORITE, V1; Son Nguyen Thai, 2006, Int J Inj Contr Saf Promot, V13, P125; Stewart B, 2014, BRIT J SURG, V101, pE9, DOI 10.1002/bjs.9329; Thind A, DIS CONTROL PRIORITI, V1; Vo D, 2012, J ANESTH CLIN RES, V3, P1, DOI DOI 10.1007/S00268-012-1629-6; Weiser T, DIS CONTROL PRIORITE, V1; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Weiser TG, 2009, LANCET, V374, P1113, DOI 10.1016/S0140-6736(09)61161-2; WHO, 2011, GLOB HLTH EST; WHO, 2008, PHARMAFORUM 0121; WHO, 2011, LOC PROD ACC MED PRO; World Health Organization, 2008, WHO SURG SAF CHECKL; World Health Organization, 2012, LOC PROD TECHN TRANS; Yaffee AQ, 2012, TROP MED INT HEALTH, V17, P775, DOI 10.1111/j.1365-3156.2012.02984.x	66	179	181	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2209	2219		10.1016/S0140-6736(15)60091-5	http://dx.doi.org/10.1016/S0140-6736(15)60091-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ6DG	25662414	Green Accepted			2022-12-28	WOS:000355583000031
J	Hersch, J; Barratt, A; Jansen, J; Irwig, L; McGeechan, K; Jacklyn, G; Thornton, H; Dhillon, H; Houssami, N; McCaffery, K				Hersch, Jolyn; Barratt, Alexandra; Jansen, Jesse; Irwig, Les; McGeechan, Kevin; Jacklyn, Gemma; Thornton, Hazel; Dhillon, Haryana; Houssami, Nehmat; McCaffery, Kirsten			Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial	LANCET			English	Article							MAMMOGRAPHY; WOMEN; ENTHUSIASM; OUTCOMES; RISK	Background Mammography screening can reduce breast cancer mortality. However, most women are unaware that inconsequential disease can also be detected by screening, leading to overdiagnosis and overtreatment. We aimed to investigate whether including information about overdetection of breast cancer in a decision aid would help women aged around 50 years to make an informed choice about breast screening. Methods We did a community-based, parallel-group, randomised controlled trial in New South Wales, Australia, using a random cohort of women aged 48-50 years. Recruitment to the study was done by telephone; women were eligible if they had not had mammography in the past 2 years and did not have a personal or strong family history of breast cancer. With a computer program, we randomly assigned 879 participants to either the intervention decision aid (comprising evidence-based explanatory and quantitative information on overdetection, breast cancer mortality reduction, and false positives) or a control decision aid (including information on breast cancer mortality reduction and false positives). Participants and interviewers were masked to group assignment. The primary outcome was informed choice (defined as adequate knowledge and consistency between attitudes and screening intentions), which we assessed by telephone interview about 3 weeks after random allocation. The primary outcome was analysed in all women who completed the relevant follow-up interview questions fully. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12613001035718. Findings Between January, 2014, and July, 2014, 440 women were allocated to the intervention group and 439 were assigned to the control group. 21 women in the intervention group and 20 controls were lost to follow-up; a further ten women assigned to the intervention and 11 controls did not answer all questions on attitudes. Therefore, 409 women in the intervention group and 408 controls were analysed for the primary outcome. 99 (24%) of 409 women in the intervention group made an informed choice compared with 63 (15%) of 408 in the control group (difference 9%, 95% CI 3-14; p= 0.0017). Compared with controls, more women in the intervention group met the threshold for adequate overall knowledge (122/419 [29%] vs 71/419 [17%]; difference 12%, 95% CI 6-18; p<0.0001), fewer women expressed positive attitudes towards screening (282/409 [69%] vs 340/408 [83%]; 14%, 9-20; p<0.0001), and fewer women intended to be screened (308/419 [74%] vs 363/419 [87%]; 13%, 8-19; p<0.0001). When conceptual knowledge alone was considered, 203 (50%) of 409 women in the intervention group made an informed choice compared with 79 (19%) of 408 in the control group (p<0.0001). Interpretation Information on overdetection of breast cancer provided within a decision aid increased the number of women making an informed choice about breast screening. Becoming better informed might mean women are less likely to choose screening.	[Hersch, Jolyn; Jansen, Jesse; Irwig, Les; Houssami, Nehmat; McCaffery, Kirsten] Univ Sydney, STEP, Sydney, NSW 2006, Australia; [Hersch, Jolyn; Barratt, Alexandra; Jansen, Jesse; McGeechan, Kevin; Dhillon, Haryana; McCaffery, Kirsten] Univ Sydney, Ctr Med Psychol & Evidence Based Decis Making CeM, Sydney, NSW 2006, Australia; [Jacklyn, Gemma] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Dhillon, Haryana] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia; [Thornton, Hazel] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Leicester	McCaffery, K (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	kirsten.mccaffery@sydney.edu.au	Houssami, Nehmat/ABC-1103-2020; Hersch, Jolyn/H-7153-2013; McCaffery, Kirsten/K-7945-2019; Barratt, Alexandra/A-7349-2011; Jacklyn, Gemma/N-9407-2016; Dhillon, Haryana M/G-8503-2011	Houssami, Nehmat/0000-0002-3641-952X; Hersch, Jolyn/0000-0001-5225-6639; McCaffery, Kirsten/0000-0003-2696-5006; Barratt, Alexandra/0000-0002-2561-3319; Jacklyn, Gemma/0000-0002-4814-3241; Dhillon, Haryana M/0000-0003-4039-5169; McGeechan, Kevin/0000-0002-9679-9827	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Australian National Health and Medical Research Council.	Barratt A, 2005, BMJ-BRIT MED J, V330, P936, DOI 10.1136/bmj.38398.469479.8F; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Biller-Andorno N, 2014, NEW ENGL J MED, V370, P1965, DOI 10.1056/NEJMp1401875; BreastScreen NSW, 2012, EARL DET IS VIT; Canadian Partnership Against Cancer, 2013, QUAL DET BREAST CANC; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Depypere H, 2014, MATURITAS, V79, P481, DOI 10.1016/j.maturitas.2014.09.002; Dormandy E, 2006, PATIENT EDUC COUNS, V61, P56, DOI 10.1016/j.pec.2005.02.006; Durand MA, 2008, PATIENT EDUC COUNS, V71, P125, DOI 10.1016/j.pec.2007.12.004; Forbes LJL, 2014, J MED SCREEN, V21, P194, DOI 10.1177/0969141314555350; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; GLASZIOU PP, 1992, J CLIN EPIDEMIOL, V45, P1251, DOI 10.1016/0895-4356(92)90166-K; Gwyn K, 2003, CANCER EPIDEM BIOMAR, V12, P96; Hersch J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f158; Hersch J, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2014-004990, 10.1136/bmjopen-2014-006016]; Irwig L, 2006, BMJ-BRIT MED J, V332, P1148, DOI 10.1136/bmj.332.7550.1148; Jorgensen KJ, 2006, BMJ-BRIT MED J, V332, P538, DOI 10.1136/bmj.332.7540.538; Kerridge I, 2013, ETHICS LAW HLTH PROF, P328; Klein D, 2011, BREAST CANCER RES TR, V129, P125, DOI 10.1007/s10549-011-1408-3; Kryworuchko J, 2008, PATIENT EDUC COUNS, V73, P497, DOI 10.1016/j.pec.2008.07.011; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Mathieu E, 2007, ARCH INTERN MED, V167, P2039, DOI 10.1001/archinte.167.19.2039; Mathieu E, 2010, PATIENT EDUC COUNS, V81, P63, DOI 10.1016/j.pec.2010.01.001; National Breast and Ovarian Cancer Centre, 2010, ADV FAM ASP BREAST C; O'Connor AM, 1993, DECISIONAL CONFLICT; Pace LE, 2014, JAMA; Schleifer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052552; Schonberg MA, 2014, JAMA INTERN MED, V174, P417, DOI 10.1001/jamainternmed.2013.13639; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Sepucha KR, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S12; Smith SK, 2012, PATIENT EDUC COUNS, V89, P330, DOI 10.1016/j.pec.2012.07.009; Smith SK, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5370; Spielberger C. D., 1983, MIND GARDEN; Stacey D, 2014, COCHRANE DATABASE SY, V1; Thornton H, 2001, Med Sci Monit, V7, P531; Trevena LJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S7; Waller J, 2015, BRIT J CANCER, V112, P562, DOI 10.1038/bjc.2014.643; Waller J, 2014, BRIT J CANCER, V111, P1831, DOI 10.1038/bjc.2014.482; Waller J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002703; Welch HG, 2010, NEW ENGL J MED, V363, P1276, DOI 10.1056/NEJMe1008369; Woloshin S, 2012, NEW ENGL J MED, V367, P1677, DOI 10.1056/NEJMp1209407	41	185	189	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1642	1652		10.1016/S0140-6736(15)60123-4	http://dx.doi.org/10.1016/S0140-6736(15)60123-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG6NG	25701273	Green Submitted			2022-12-28	WOS:000353418000037
J	Psaila, B; Cooper, N				Psaila, Bethan; Cooper, Nichola			B-cell depletion in immune thrombocytopenia	LANCET			English	Editorial Material							RITUXIMAB; ADULTS; RESPONSES; PURPURA		[Psaila, Bethan; Cooper, Nichola] Univ London Imperial Coll Sci Technol & Med, Dept Haematol, London W12 0NN, England	Imperial College London	Cooper, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Haematol, London W12 0NN, England.	n.cooper@imperial.ac.uk		Psaila, Beth/0000-0001-8198-9663	Academy of Medical Sciences (AMS) [AMS-SGCL10-Psaila] Funding Source: researchfish; National Institute for Health Research [CL-2012-21-004] Funding Source: researchfish	Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))		Arnold DM, 2007, ANN INTERN MED, V146, P25, DOI 10.7326/0003-4819-146-1-200701020-00006; Arnold DM, 2012, BLOOD, V119, P1356, DOI 10.1182/blood-2011-08-374777; Bussel JB, 2014, HAEMATOLOGICA, V99, P1264, DOI 10.3324/haematol.2013.103291; Ghanima W, 2014, LANCET; Khellaf M., 2014, BLOOD; Nazi I, 2013, BLOOD, V122, P1946, DOI 10.1182/blood-2013-04-494096; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Patel VL, 2012, BLOOD, V119, P5989, DOI 10.1182/blood-2011-11-393975; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Saleh MN, 2000, SEMIN ONCOL, V27, P99; Stasi R, 2001, BLOOD, V98, P952, DOI 10.1182/blood.V98.4.952; Zaja F, 2010, BLOOD, V115, P2755, DOI 10.1182/blood-2009-07-229815	12	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1599	1601		10.1016/S0140-6736(14)61930-9	http://dx.doi.org/10.1016/S0140-6736(14)61930-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG6NG	25662418				2022-12-28	WOS:000353418000011
J	Weinberger, SE; Hoyt, DB; Lawrence, HC; Levin, S; Henley, DE; Alden, ER; Wilkerson, D; Benjamin, GC; Hubbard, WC				Weinberger, Steven E.; Hoyt, David B.; Lawrence, Hal C., III; Levin, Saul; Henley, Douglas E.; Alden, Errol R.; Wilkerson, Dean; Benjamin, Georges C.; Hubbard, William C.			Firearm-Related Injury and Death in the United States: A Call to Action From 8 Health Professional Organizations and the American Bar Association	ANNALS OF INTERNAL MEDICINE			English	Article							MENTAL-ILLNESS; GUN VIOLENCE	Deaths and injuries related to firearms constitute a major public health problem in the United States. In response to firearm violence and other firearm-related injuries and deaths, an interdisciplinary, interprofessional group of leaders of 8 national health professional organizations and the American Bar Association, representing the official policy positions of their organizations, advocate a series of measures aimed at reducing the health and public health consequences of firearms. The specific recommendations include universal background checks of gun purchasers, elimination of physician "gag laws," restricting the manufacture and sale of military-style assault weapons and large-capacity magazines for civilian use, and research to support strategies for reducing firearm-related injuries and deaths. The health professional organizations also advocate for improved access to mental health services and avoidance of stigmatization of persons with mental and substance use disorders through blanket reporting laws. The American Bar Association, acting through its Standing Committee on Gun Violence, confirms that none of these recommendations conflict with the Second Amendment or previous rulings of the U.S. Supreme Court.	[Weinberger, Steven E.] Amer Coll Physicians, Philadelphia, PA 19106 USA; Amer Coll Surg, Chicago, IL USA; Amer Bar Assoc, Chicago, IL 60611 USA; Amer Congress Obstetricians & Gynecologists, Washington, DC USA; Amer Publ Hlth Assoc, Washington, DC USA; Amer Psychiat Assoc, Arlington, VA USA; Amer Acad Family Phys, Leawood, KS USA; Amer Acad Pediat, Elk Grove Village, IL USA; Amer Coll Emergency Phys, Irving, TX USA	American College of Physicians; American College of Surgeons; American Academy of Pediatrics	Weinberger, SE (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	sweinberger@acponline.org						Alpers P, 2015, RATE CIVILIAN FIREAR; *AM PUBL HLTH ASS, 1998, HANDG INJ RED; American Academy of Family Physicians, 2015, FIR SAF ISS; American Academy of Pediatrics, FED POL KEEP CHILDR; American Bar Association Standing Committee on Gun Violence, POLICY; American College of Emergency Physicians, 2013, FIR SAF INJ PREV; American Congress of Obstetricians and Gynecologists, 2014, GUN VIOL SAF; American Psychiatric Association, 2014, POS STAT FIR ACC ACT; American Public Health Association, 2003, SUPP REN STRENGTH FE; Anglemyer A, 2014, ANN INTERN MED, V160, P101, DOI 10.7326/M13-1301; [Anonymous], 2013, NONF INJ REP 2001 20; [Anonymous], 2014, INJ PREV CONTR DAT S; Butkus R, 2014, ANN INTERN MED, V160, P858, DOI 10.7326/M14-0216; Centers for Disease Control and Prevention, FASTSTATS ALL INJ; Cook P.J., 1997, GUNS AM NATL SURVEY; Federal Bureau of Investigation, 2010, NAT INST CRIM BACKGR; Fisher CE, 2013, ANN INTERN MED, V159, P423, DOI 10.7326/0003-4819-159-5-201309030-00679; Frattaroli S, 2013, ANN INTERN MED, V158, P697, DOI 10.7326/0003-4819-158-9-201305070-00597; Friedman RA, 2006, NEW ENGL J MED, V355, P2064, DOI 10.1056/NEJMp068229; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Karp A, COMPLETING COUNT CIV; Krouse W. J., 2012, GUN CONTROL LEGISLAT, P8; Laine C, 2013, ANN INTERN MED, V158, P493, DOI 10.7326/0003-4819-158-6-201303190-00586; Law Center to Prevent Gun Violence, 2014, POSTH LIT SUMM; Miller T, 2012, COST FIREARM VIOLENC; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf; Treatment Advocacy Center, 2005, TREATM ADV CTR BRIEF; Weinberger SE, 2012, NEW ENGL J MED, V367, P1557, DOI 10.1056/NEJMsb1209858	28	139	139	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2015	162	7					513	U99		10.7326/M15-0337	http://dx.doi.org/10.7326/M15-0337			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4UT	25706470				2022-12-28	WOS:000353283400007
J	Qi, Z; Redding, S; Lee, JY; Gibb, B; Kwon, Y; Niu, HY; Gaines, WA; Sung, P; Greene, EC				Qi, Zhi; Redding, Sy; Lee, Ja Yil; Gibb, Bryan; Kwon, YoungHo; Niu, Hengyao; Gaines, William A.; Sung, Patrick; Greene, Eric C.			DNA Sequence Alignment by Microhomology Sampling during Homologous Recombination	CELL			English	Article							STRAND EXCHANGE; RECOGNITION; MECHANISM; BINDING; DYNAMICS; CURTAINS; PROTEIN; SEARCH	Homologous recombination (HR) mediates the exchange of genetic information between sister or homologous chromatids. During HR, members of the RecA/Rad51 family of recombinases must somehow search through vast quantities of DNA sequence to align and pair single-strand DNA (ssDNA) with a homologous double-strand DNA (dsDNA) template. Here, we use single-molecule imaging to visualize Rad51 as it aligns and pairs homologous DNA sequences in real time. We show that Rad51 uses a length-based recognition mechanism while interrogating dsDNA, enabling robust kinetic selection of 8-nucleotide (nt) tracts of microhomology, which kinetically confines the search to sites with a high probability of being a homologous target. Successful pairing with a ninth nucleotide coincides with an additional reduction in binding free energy, and subsequent strand exchange occurs in precise 3-nt steps, reflecting the base triplet organization of the presynaptic complex. These findings provide crucial new insights into the physical and evolutionary underpinnings of DNA recombination.	[Qi, Zhi; Lee, Ja Yil; Gibb, Bryan; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Redding, Sy] Columbia Univ, Dept Chem, New York, NY 10032 USA; [Kwon, YoungHo; Niu, Hengyao; Gaines, William A.; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Greene, Eric C.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Yale University; Columbia University; Howard Hughes Medical Institute	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 West 168th St, New York, NY 10032 USA.	ecg2108@columbia.edu	LEE, JA YIL/S-2207-2016; Gibb, Bryan/AAW-5554-2020; Niu, Hengyao/AAE-9269-2020	LEE, JA YIL/0000-0002-5726-9022; Gibb, Bryan/0000-0002-2094-344X; Redding, Sy/0000-0003-3463-7985	NIH [GM074739, RO1ES007061, CA146940]; NSF [MCB-1154511]; NATIONAL CANCER INSTITUTE [R01CA146940] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082848, R01GM074739] Funding Source: NIH RePORTER; Direct For Biological Sciences [1154511] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Lorraine Symington, Max Gottesman, Jonathan Dworkin, Hannah Klein, Rodney Rothstein, and members of the E.C.G. and P.S. laboratories for comments on the manuscript. We are grateful to Mara Prentiss for sharing results prior to publication, and Mauro Modesti for providing GFP-tagged hRPA expression constructs. This research was funded by NIH grants GM074739 (E.C.G), RO1ES007061 (P.S.), and CA146940 (E.C.G. and P.S.), and by NSF grant MCB-1154511 (E.C.G.). E.C.G. is an HHMI Early Career Scientist.	Adzuma K, 1998, J BIOL CHEM, V273, P31565, DOI 10.1074/jbc.273.47.31565; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Bianco P R, 1998, Front Biosci, V3, pD570; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; Danilowicz C, 2014, NUCLEIC ACIDS RES, V42, P526, DOI 10.1093/nar/gkt867; De Vlaminck I, 2012, MOL CELL, V46, P616, DOI 10.1016/j.molcel.2012.03.029; Eckert-Boulet N, 2010, FEBS LETT, V584, P3696, DOI 10.1016/j.febslet.2010.05.037; Eckert-Boulet N, 2009, DNA REPAIR, V8, P507, DOI 10.1016/j.dnarep.2009.01.015; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; Gibb B, 2012, ANAL CHEM, V84, P7607, DOI 10.1021/ac302117z; Gladyshev E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4509; Graham JS, 2011, NUCLEIC ACIDS RES, V39, P2249, DOI 10.1093/nar/gkq1140; Greene EC, 2010, METHOD ENZYMOL, V472, P293, DOI 10.1016/S0076-6879(10)72006-1; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hawkins M, 2013, NATURE, V503, P544, DOI 10.1038/nature12650; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; HSIEH P, 1992, P NATL ACAD SCI USA, V89, P6492, DOI 10.1073/pnas.89.14.6492; JINKSROBERTSON S, 1993, MOL CELL BIOL, V13, P3937, DOI 10.1128/MCB.13.7.3937; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Ragunathan K, 2012, ELIFE, V1, DOI 10.7554/eLife.00067; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Sing CE, 2014, NUCLEIC ACIDS RES, V42, P3783, DOI 10.1093/nar/gkt1327; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; Xiao J, 2006, CHEMBIOCHEM, V7, P1265, DOI 10.1002/cbic.200600038	36	136	140	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					856	869		10.1016/j.cell.2015.01.029	http://dx.doi.org/10.1016/j.cell.2015.01.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25684365	Bronze, Green Accepted			2022-12-28	WOS:000351116100009
J	Sanchez-Lavega, A; Munoz, AG; Garcia-Melendo, E; Perez-Hoyos, S; Gomez-Forrellad, JM; Pellier, C; Delcroix, M; Lopez-Valverde, MA; Gonzalez-Galindo, F; Jaeschke, W; Parker, D; Phillips, J; Peach, D				Sanchez-Lavega, A.; Garcia Munoz, A.; Garcia-Melendo, E.; Perez-Hoyos, S.; Gomez-Forrellad, J. M.; Pellier, C.; Delcroix, M.; Lopez-Valverde, M. A.; Gonzalez-Galindo, F.; Jaeschke, W.; Parker, D.; Phillips, J.; Peach, D.			An extremely high-altitude plume seen at Mars' morning terminator	NATURE			English	Article							CLOUDS; MESOSPHERE	The Martian limb.(that is, the observed 'edge' of the planet) represents a unique window into the complex atmospheric phenomena occurring there. Clouds of ice crystals (CO2 ice or H2O ice) have been observed numerous times by spacecraft and ground-based telescopes, showing that clouds are typically layered and always confined below an altitude of 100 kilometres; suspended dust has also been detected at altitudes up to 60 kilometres during major dust storms -6. Highly concentrated and localized patches of auroral emission controlled by magnetic field anomalies in the crust have been observed at an altitude of 130 kilometres'. Here we report the occurrence in March and April 2012 of two bright, extremely high-altitude plumes at the Martian terminator (the day-night boundary) at 200 to 250 kilometres or more above the surface, and thus well into the ionosphere and the exosphere'''. They were spotted at a longitude of about 1950 west, a latitude of about 45 (at Terra Cimmeria), extended about 500 to 1,000 kilometres in both the north-south and east-west directions, and lasted for about 10 days. The features exhibited day-to-day variability, and were seen at the morning terminator but not at the evening limb, which indicates rapid evolution in less than 10 hours and a cyclic behaviour. We used photometric measurements to explore two possible scenarios and investigate their nature. For particles reflecting solar radiation, clouds of CO2-ice or H2O-ice particles with an effective radius of 0.1 micrometres are favoured over dust. Alternatively, the plume could arise from auroral emission, of a brightness more than 1,000 times that of the Earth's aurora, over a region with a strong magnetic anomaly where aurorae have previously been detected'. Importantly, both explanations defy our current understanding of Mars' upper atmosphere.	[Sanchez-Lavega, A.; Garcia-Melendo, E.; Perez-Hoyos, S.] Univ Basque Country, ETS Ingn, Dept Fis Aplicada 1, Bilbao 48013, Spain; [Sanchez-Lavega, A.; Perez-Hoyos, S.; Lopez-Valverde, M. A.; Gonzalez-Galindo, F.] Unidad Asociada Grp Ciencias Planetarias UPV EHU, Bilbao 48013, Spain; [Garcia Munoz, A.] Estec, European Space Agcy, NL-2201 AZ Noordwijk, Netherlands; [Garcia-Melendo, E.; Gomez-Forrellad, J. M.] Fundacio Observ Esteve Duran, Seva 08553, Barcelona, Spain; [Pellier, C.; Delcroix, M.] Soc Astron France, Commission Surfaces Planetaires, F-75016 Paris, France; [Lopez-Valverde, M. A.; Gonzalez-Galindo, F.] CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain; [Jaeschke, W.] Assoc Lunar & Planetary Observers, W Chester, PA 19380 USA; [Parker, D.] Assoc Lunar & Planetary Observers, Coral Gables, FL 33156 USA; [Phillips, J.] Assoc Lunar & Planetary Observers, Mt Pleasant, SC 29464 USA; [Peach, D.] British Astron Assoc, London W1J 0DU, England	University of Basque Country; University of Basque Country; European Space Agency; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA)	Sanchez-Lavega, A (corresponding author), Univ Basque Country, ETS Ingn, Dept Fis Aplicada 1, Alameda Urquijo S-N, Bilbao 48013, Spain.	agustin.sanchez@ehu.es	Perez-Hoyos, Santiago/L-7543-2014; Sanchez-Lavega, Agustin/Z-3639-2019; Garcia-Melendo, Enrique/AAH-5658-2020; Gonzalez-Galindo, Francisco/I-2495-2015	Perez-Hoyos, Santiago/0000-0002-2587-4682; Sanchez-Lavega, Agustin/0000-0001-7234-7634; Gonzalez-Galindo, Francisco/0000-0001-9443-291X; Delcroix, Marc/0000-0002-9828-7390; Garcia Munoz, Antonio/0000-0003-1756-4825; Lopez-Valverde, M. A./0000-0002-7989-4267	Spanish MINECO [AYA2012-36666]; FEDER, Grupos Gobierno Vasco [IT765-13]; UPV/EHU [UFI11/55]; Spanish MINECO through CONSOLIDER programme ASTROMOL [CSD2009-00038, AYA2011-30613-CO2-1]; CSIC by European Social Fund	Spanish MINECO(Spanish Government); FEDER, Grupos Gobierno Vasco; UPV/EHU; Spanish MINECO through CONSOLIDER programme ASTROMOL; CSIC by European Social Fund	This work was supported by the Spanish MINECO project. AYA2012-36666, FEDER, Grupos Gobierno Vasco IT765-13 and UPV/EHU UFI11/55. The IAA (CSIC) team was supported by the Spanish MINECO through the CONSOLIDER programme ASTROMOL CSD2009-00038 and AYA2011-30613-CO2-1. F.G.-G. is funded by a CSIC JAE-Doc contract co-financed by the European Social Fund.	Bell III J. F., 2009, J GEOPHYS RES, V114, DOI DOI 10.1029/2009JG000923; Bertaux JL, 2005, NATURE, V435, P790, DOI 10.1038/nature03603; Chamberlain J. W., 2013, PHYS AURORA AIRGLOW; Clancy R. T., 2014, P 8 INT C MARS; Cordoba-Jabonero C, 2005, ICARUS, V175, P360, DOI 10.1016/j.icarus.2004.12.009; Fedorova AA, 2014, ICARUS, V231, P239, DOI 10.1016/j.icarus.2013.12.015; Fox JL, 2012, ICARUS, V221, P787, DOI 10.1016/j.icarus.2012.09.007; Gonzalez-Galindo F, 2013, J GEOPHYS RES-PLANET, V118, P2105, DOI 10.1002/jgre.20150; Gonzalez-Galindo F, 2011, ICARUS, V216, P10, DOI 10.1016/j.icarus.2011.08.006; Heavens NG, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003691; Heavens NG, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003692; Leblanc F, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013033; Maattanen A, 2010, ICARUS, V209, P452, DOI 10.1016/j.icarus.2010.05.017; Maattanen A, 2013, ICARUS, V223, P892, DOI 10.1016/j.icarus.2012.12.001; Minami M., 2003, COMMUNICATION MARS O, V283; Mishchenko MI, 2002, SCATTERING ABSORPTIO; Mitchell DL, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2005JE002564; Montmessin F, 2007, J GEOPHYS RES-PLANET, V112, DOI [10.1029/2006JE002772, 10.1029/2007JE002944]; Montmessin F, 2006, ICARUS, V183, P403, DOI 10.1016/j.icarus.2006.03.015; Pellier C., 2012, COMMUNICATIONS MARS; Sanchez-Lavega A, 2004, AM J PHYS, V72, P767, DOI 10.1119/1.1645279; Slanger TG, 2008, SPACE SCI REV, V139, P267, DOI 10.1007/s11214-008-9387-3; Spiga A, 2013, J GEOPHYS RES-PLANET, V118, P746, DOI 10.1002/jgre.20046; Strobel D. F., 2002, ATMOSPHERES SOLAR SY, V39-54, P191; WARREN SG, 1986, APPL OPTICS, V25, P2650, DOI 10.1364/AO.25.002650; Yagi M, 2012, ICARUS, V221, P682, DOI 10.1016/j.icarus.2012.07.022; ZUBER MT, 1992, J GEOPHYS RES-PLANET, V97, P7781, DOI 10.1029/92JE00341	27	21	21	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					525	528		10.1038/nature14162	http://dx.doi.org/10.1038/nature14162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25686601				2022-12-28	WOS:000350097300044
J	Dasheiff, R				Dasheiff, Richard			A career's twisting road	SCIENCE			English	Editorial Material								I wanted to be a physicist. When I was in elementary school, I corrected a teacher about the orbits of the planets. In high school, I told a teacher that we could directly image single atoms; she didn't believe me even after I showed her the journal article I saw it in. My parents were of two minds: proud of my scientific aptitude but, being of modest means and Jewish descent, hopeful their only son would become a "real" doctor someday, the medical kind. (sic) I enrolled in the University of Maryland (UMD), College Park, in 1969 and obtained two bachelor's degrees, in physics and astronomy, in 3 years. Michael A'Hearn, my astronomy adviser, told me he was content to add a tiny bit of knowledge to the world-prophetic words from the future team leader of Deep Impact, the space probe that blasted a hole in comet Tempel 1 35 years later. I decided that I, too, wanted to make a small contribution, in experimental physics.											0	0	0	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					918	918		10.1126/science.347.6224.918	http://dx.doi.org/10.1126/science.347.6224.918			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB6UB	25700522				2022-12-28	WOS:000349761100047
J	Duckworth, RA; Belloni, V; Anderson, SR				Duckworth, Renee A.; Belloni, Virginia; Anderson, Samantha R.			Cycles of species replacement emerge from locally induced maternal effects on offspring behavior in a passerine bird	SCIENCE			English	Article							DISPERSAL STRATEGIES; INDIVIDUAL BEHAVIOR; RANGE EXPANSION; HORMONES; TESTOSTERONE; CONSEQUENCES; MECHANISMS; EVOLUTION; DYNAMICS; ECOLOGY	An important question in ecology is how mechanistic processes occurring among individuals drive large-scale patterns of community formation and change. Here we show that in two species of bluebirds, cycles of replacement of one by the other emerge as an indirect consequence of maternal influence on offspring behavior in response to local resource availability. Sampling across broad temporal and spatial scales, we found that western bluebirds, the more competitive species, bias the birth order of offspring by sex in a way that influences offspring aggression and dispersal, setting the stage for rapid increases in population density that ultimately result in the replacement of their sister species. Our results provide insight into how predictable community dynamics can occur despite the contingency of local behavioral interactions.	[Duckworth, Renee A.; Belloni, Virginia; Anderson, Samantha R.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Belloni, Virginia] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA 70112 USA	University of Arizona; Tulane University	Duckworth, RA (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	rad3@email.arizona.edu		Belloni, Virginia/0000-0001-9807-1912	NSF [DEB-918095]	NSF(National Science Foundation (NSF))	We thank Mountain Bluebird Trails members for access to trails. A. Badyaev, D. Higginson, C. Gurguis, E. Morrison, S. Aguillon, J. Padway, and two anonymous reviewers provided helpful comments on a draft of this manuscript. This work was funded by NSF (grant DEB-918095). Data are available in the supplementary materials.	Badyaev AV, 2008, J EVOLUTION BIOL, V21, P449, DOI 10.1111/j.1420-9101.2007.01498.x; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; Bernardo J, 1996, AM ZOOL, V36, P83; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Dantzer B, 2013, SCIENCE, V340, P1215, DOI 10.1126/science.1235765; DENNO RF, 1991, AM NAT, V138, P1513, DOI 10.1086/285298; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Donohue K, 1999, AM NAT, V154, P674, DOI 10.1086/303273; Duckworth RA, 2008, AM NAT, V172, pS4, DOI 10.1086/588289; Duckworth RA, 2007, P NATL ACAD SCI USA, V104, P15017, DOI 10.1073/pnas.0706174104; Duckworth RA, 2014, AVIAN URBAN ECOLOGY: BEHAVIOURAL AND PHYSIOLOGICAL ADAPTATIONS, P181; Duckworth RA, 2009, PHILOS T R SOC B, V364, P1075, DOI 10.1098/rstb.2008.0294; Eising CM, 2006, BIOL LETTERS, V2, P20, DOI 10.1098/rsbl.2005.0391; Getty T, 1996, AM NAT, V148, P378, DOI 10.1086/285930; Ginzburg L. R., 2004, ECOLOGICAL ORBITS PL; GINZBURG LR, 1994, J ANIM ECOL, V63, P79, DOI 10.2307/5585; HARRISON RG, 1980, ANNU REV ECOL SYST, V11, P95, DOI 10.1146/annurev.es.11.110180.000523; HUTTO RL, 1995, CONSERV BIOL, V9, P1041, DOI [10.1046/j.1523-1739.1995.9051041.x, 10.1046/j.1523-1739.1995.9051033.x-i1]; Kotliar NB, 2007, ECOL APPL, V17, P491, DOI 10.1890/06-0253; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; Massot M, 2000, J EVOLUTION BIOL, V13, P707; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Saab VA, 2007, CONDOR, V109, P97, DOI 10.1650/0010-5422(2007)109[97:NDOCBI]2.0.CO;2; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Silverin B, 1998, ANIM BEHAV, V56, P811, DOI 10.1006/anbe.1998.0823; WERNER EE, 1992, AM NAT, V140, pS5, DOI 10.1086/285395; Wingfield JC, 2005, HORM BEHAV, V48, P253, DOI 10.1016/j.yhbeh.2005.05.009; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	31	77	79	1	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					875	877		10.1126/science.1260154	http://dx.doi.org/10.1126/science.1260154			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700519				2022-12-28	WOS:000349761100044
J	Winter, SS; Clark, BJ; Taube, JS				Winter, Shawn S.; Clark, Benjamin J.; Taube, Jeffrey S.			Disruption of the head direction cell network impairs the parahippocampal grid cell signal	SCIENCE			English	Article							ANTERIOR THALAMUS; PATH-INTEGRATION; ENTORHINAL CORTEX; OSCILLATORY INTERFERENCE; SPATIAL PERIODICITY; LESIONS; RAT; SYSTEM; HIPPOCAMPAL; NAVIGATION	Navigation depends onmultiple neural systems that encode the moment-to-moment changes in an animal's direction and location in space. These include head direction (HD) cells representing the orientation of the head and grid cells that fire at multiple locations, forming a repeating hexagonal grid pattern. Computational models hypothesize that generation of the grid cell signal relies upon HD information that ascends to the hippocampal network via the anterior thalamic nuclei (ATN). We inactivated or lesioned the ATN and subsequently recorded single units in the entorhinal cortex and parasubiculum. ATN manipulation significantly disrupted grid and HD cell characteristics while sparing theta rhythmicity in these regions. These results indicate that the HD signal via the ATN is necessary for the generation and function of grid cell activity.	[Winter, Shawn S.; Clark, Benjamin J.; Taube, Jeffrey S.] Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA	Dartmouth College	Taube, JS (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA.	jeffrey.taube@dartmouth.edu		Clark, Benjamin/0000-0002-2662-8520	National Institutes of Health [NS053907]; Postgraduate Scholarship-Doctoral program (PGS-D) from the Natural Sciences and Engineering Research Council of Canada; American Psychological Association Dissertation Research Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Postgraduate Scholarship-Doctoral program (PGS-D) from the Natural Sciences and Engineering Research Council of Canada; American Psychological Association Dissertation Research Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank J. Marcroft, S. Valerio, and J. Barry for technical support. This research was supported through the National Institutes of Health grant NS053907 (J.S.T.), a Postgraduate Scholarship-Doctoral program (PGS-D) from the Natural Sciences and Engineering Research Council of Canada (B.J.C.), and an American Psychological Association Dissertation Research Award (B.J.C.). Data will be made available upon request.	Bassett JP, 2007, J NEUROSCI, V27, P7564, DOI 10.1523/JNEUROSCI.0268-07.2007; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Frohardt RJ, 2006, BEHAV NEUROSCI, V120, P135, DOI 10.1037/0735-7044.120.1.135; Golob EJ, 1997, P NATL ACAD SCI USA, V94, P7645, DOI 10.1073/pnas.94.14.7645; Golob EJ, 1999, J NEUROSCI, V19, P7198, DOI 10.1523/JNEUROSCI.19-16-07198.1999; Goodridge JP, 1997, J NEUROSCI, V17, P9315; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Maaswinkel H, 1999, BEHAV BRAIN RES, V99, P143, DOI 10.1016/S0166-4328(98)00100-4; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Parron C, 2004, EXP BRAIN RES, V159, P349, DOI 10.1007/s00221-004-1960-8; Parron C, 2004, BEHAV BRAIN RES, V154, P345, DOI 10.1016/j.bbr.2004.03.006; Raudies F., 2014, BRAIN RES; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; TAUBE JS, 1995, J NEUROSCI, V15, P70; Terrazas A, 2005, J NEUROSCI, V25, P8085, DOI 10.1523/JNEUROSCI.0693-05.2005; Tsanov M, 2011, J NEUROSCI, V31, P9489, DOI 10.1523/JNEUROSCI.0353-11.2011; Warburton EC, 1999, BEHAV BRAIN RES, V98, P27; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011; Winter SS, 2013, HIPPOCAMPUS, V23, P139, DOI 10.1002/hipo.22075	26	133	133	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					870	874		10.1126/science.1259591	http://dx.doi.org/10.1126/science.1259591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700518	Green Accepted			2022-12-28	WOS:000349761100043
J	Ortega, R; Mazzini, M; Xue, K; Espaillat, D				Ortega, Rafael; Mazzini, Michael; Xue, Kristine; Espaillat, Diego			Electrocardiographic Monitoring in Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SCIENTIFIC STATEMENT; CLINICAL CARDIOLOGY	The uses of electrocardiographic (ECG) monitoring have evolved from the tracking of heart rate and basic rhythm to the detection of complex arrhythmias, myocardial ischemia, and changes in the QT interval. ECG is an inexpensive, reproducible, noninvasive technique that can be invaluable when it is performed correctly.(1-4) The accompanying video focuses on three-lead and five-lead configurations, which are commonly used in real-time ECG monitoring.	[Ortega, Rafael; Mazzini, Michael; Xue, Kristine; Espaillat, Diego] Boston Med Ctr, Boston, MA 02118 USA	Boston Medical Center	Ortega, R (corresponding author), Boston Med Ctr, Dept Anesthesiol, 88 E Newton St, Boston, MA 02118 USA.	rafael.ortega@bmc.org						Drew BJ, 2004, CIRCULATION, V110, P2721, DOI 10.1161/01.CIR.0000145144.56673.59; Drew BJ, 2005, CIRCULATION, V111, P378, DOI DOI 10.1161/01.CIR.0000145144.56673.59; Goldberger A L, 2012, HARRISONS PRINCIPLES, V2, P1831; Kligfield P, 2007, CIRCULATION, V115, P1306, DOI 10.1161/CIRCULATIONAHA.106.180200; Patel SI, 2008, ANESTHESIOLOGY, V108, P138, DOI 10.1097/01.anes.0000296537.62905.25	5	12	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					E11	U193		10.1056/NEJMvcm1400705	http://dx.doi.org/10.1056/NEJMvcm1400705			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7PB	25693030				2022-12-28	WOS:000349818700010
J	Hirsch, C				Hirsch, Calvin			An elastic-band exercise program improved fitness in older adults who use wheelchairs in nursing homes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.							Chen KM, 2014, NURS OUTLOOK; Fahlman MM, 2011, AM J HEALTH PROMOT, V25, P237, DOI 10.4278/ajhp.081125-QUAN-292; Juthani-Mehta M, 2013, J AM GERIATR SOC, V61, P1111, DOI 10.1111/jgs.12325	3	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4							JC3	10.7326/ACPJC-2015-162-4-003	http://dx.doi.org/10.7326/ACPJC-2015-162-4-003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686190				2022-12-28	WOS:000350232500006
J	Pisano, J; Cifu, AS				Pisano, Jennifer; Cifu, Adam S.			Use of Pneumococcal Vaccine in Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONJUGATE VACCINE; POLYSACCHARIDE VACCINE; IMMUNOGENICITY; SAFETY		[Pisano, Jennifer; Cifu, Adam S.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Bonten M, 2014, ABSTRACT PRESENTED A; Centers for Disease CP, 2013, ACTIVE BACTERIAL COR; Jackson LA, 2013, VACCINE, V31, P3577, DOI 10.1016/j.vaccine.2013.04.085; Jackson LA, 2013, VACCINE, V31, P3585, DOI 10.1016/j.vaccine.2013.05.010; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Pilishvili T, 2014, ABSTRACT PRESENTED A; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; SMITH JE, 2010, TLS TIMES LIT S 0924, P28; Tomczyk S, 2014, MMWR-MORBID MORTAL W, V63, P822; Torres A, 2015, EUR J CLIN MICROBIOL, V34, P19, DOI 10.1007/s10096-014-2208-6	10	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					719	720		10.1001/jama.2015.63	http://dx.doi.org/10.1001/jama.2015.63			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25688784				2022-12-28	WOS:000349476100018
J	Bressanelli, S				Bressanelli, Stephane			Kickstarting a viral RNA polymerase	SCIENCE			English	Editorial Material							HEPATITIS-C VIRUS; INSIGHTS; GENOME		Univ Paris 11, CNRS, CEA, I2BC, F-91198 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Bressanelli, S (corresponding author), Univ Paris 11, CNRS, CEA, I2BC, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	stephane.bressanelli@i2bc.paris-saclay.fr		Bressanelli, Stephane/0000-0002-0921-6727				Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Caillet-Saguy C, 2014, ANTIVIR RES, V105, P8, DOI 10.1016/j.antiviral.2014.02.006; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Harrus D, 2010, J BIOL CHEM, V285, P32906, DOI 10.1074/jbc.M110.151316; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Rice CM, 2014, NATURE, V510, P43, DOI 10.1038/510043a; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268	11	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					715	716		10.1126/science.aaa5980	http://dx.doi.org/10.1126/science.aaa5980			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678645				2022-12-28	WOS:000349221300022
J	Boulet, LP; O'Byrne, PM				Boulet, Louis-Philippe; O'Byrne, Paul M.			Asthma and Exercise-Induced Bronchoconstriction in Athletes	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							AIRWAY INFLAMMATION; PARTICULATE-MATTER; HYPERRESPONSIVENESS; DISORDERS; ALLERGY; ACADEMY; SPORTS		[Boulet, Louis-Philippe] Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [O'Byrne, Paul M.] McMaster Univ, Dept Med, Firestone Inst Resp Hlth, Hamilton, ON, Canada	Laval University; Quebec Heart & Lung Institute; McMaster University	Boulet, LP (corresponding author), Inst Univ Cardiol & Pneumol Quebec, 2725 Chemin, Ste Foy, PQ G1V 4G5, Canada.	lpboulet@med.ulaval.ca		O'Byrne, Paul/0000-0003-0979-281X	Merck; GlaxoSmithKline; AstraZeneca; Novartis; Genentech; Amgen; ONO; Boehringer Ingelheim; AsthmaCure; Forest; Verona; Chiesi; Takeda; Axican	Merck(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Novartis(Novartis); Genentech(Roche HoldingGenentech); Amgen(Amgen); ONO; Boehringer Ingelheim(Boehringer Ingelheim); AsthmaCure; Forest; Verona; Chiesi(Chiesi Pharmaceuticals Inc); Takeda(Takeda Pharmaceutical Company Ltd); Axican	Dr. Boulet reports receiving consulting and lecture fees from Merck, GlaxoSmithKline, AstraZeneca, and Novartis and grant support from GlaxoSmithKline, AstraZeneca, Novartis, Genentech, Amgen, ONO, Boehringer Ingelheim, and AsthmaCure. Dr. O'Byrne reports receiving consulting fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Forest, Verona, and Novartis, lecture fees from Chiesi and Takeda, and grant support from AstraZeneca, Novartis, Amgen, Genentech, ONO, and Axican. No other potential conflict of interest relevant to this article was reported.	Anderson SD, 2013, IMMUNOL ALLERGY CLIN, V33, P363, DOI 10.1016/j.iac.2013.02.006; Anderson SD, 2005, CURR ALLERGY ASTHM R, V5, P116, DOI 10.1007/s11882-005-0084-y; Bonini S, 2006, ALLERGY, V61, P681, DOI 10.1111/j.1398-9995.2006.01080.x; Bougault V, 2013, IMMUNOL ALLERGY CLIN, V33, P395, DOI 10.1016/j.iac.2013.02.008; Bougault V, 2012, J ALLERGY CLIN IMMUN, V129, P351, DOI 10.1016/j.jaci.2011.11.010; Bougault V, 2011, J ALLERGY CLIN IMMUN, V127, P892, DOI 10.1016/j.jaci.2010.11.003; Bougault V, 2010, CHEST, V138, p31S, DOI 10.1378/chest.09-1689; Bray SM, 2012, ANN ALLERG ASTHMA IM, V109, P281, DOI 10.1016/j.anai.2012.07.021; Carlsen KH, 2008, ALLERGY, V63, P492, DOI 10.1111/j.1398-9995.2008.01663.x; Carlsen KH, 2009, EUR RESPIR J, V33, P713, DOI 10.1183/09031936.00011909; Cutrufello PT, 2012, SPORTS MED, V42, P1041, DOI 10.2165/11635170-000000000-00000; Dempsey J, 1982, Can J Appl Sport Sci, V7, P4; Dickinson JW, 2006, BRIT J SPORT MED, V40, P179, DOI 10.1136/bjsm.2005.022764; Dryden Donna M, 2010, Evid Rep Technol Assess (Full Rep), P1; Duong M, 2008, CHEST, V133, P404, DOI 10.1378/chest.07-2048; Duong M, 2012, J ALLERGY CLIN IMMUN, V130, P535, DOI 10.1016/j.jaci.2012.02.051; Eichenberger PA, 2013, SPORTS MED, V43, P1157, DOI 10.1007/s40279-013-0077-2; Elkins MR, 2013, BRIT J SPORT MED, V47, P657, DOI 10.1136/bjsports-2012-091725; Fitch KD, 2008, J ALLERGY CLIN IMMUN, V122, P254, DOI 10.1016/j.jaci.2008.07.003; Fitch KD, 2012, BRIT J SPORT MED, V46, P413, DOI 10.1136/bjsports-2011-090814; Hancox RJ, 2002, AM J RESP CRIT CARE, V165, P1068, DOI 10.1164/ajrccm.165.8.200111-091bc; Helenius I, 2005, SPORTS MED, V35, P565, DOI 10.2165/00007256-200535070-00002; Helenius IJ, 1998, J ALLERGY CLIN IMMUN, V101, P646, DOI 10.1016/S0091-6749(98)70173-3; Karjalainen EM, 2000, AM J RESP CRIT CARE, V161, P2086, DOI 10.1164/ajrccm.161.6.9907025; Kippelen P, 2012, BRIT J SPORT MED, V46, P471, DOI 10.1136/bjsports-2012-091056; Langdeau JB, 2000, AM J RESP CRIT CARE, V161, P1479, DOI 10.1164/ajrccm.161.5.9909008; Larsson J, 2011, J APPL PHYSIOL, V110, P1029, DOI 10.1152/japplphysiol.00978.2010; Mickleborough TD, 2003, AM J RESP CRIT CARE, V168, P1181, DOI 10.1164/rccm.200303-373OC; Millqvist E, 2000, ALLERGY, V55, P672, DOI 10.1034/j.1398-9995.2000.00558.x; Parsons JP, 2013, AM J RESP CRIT CARE, V187, P1016, DOI 10.1164/rccm.201303-0437ST; Price OJ, 2013, ALLERGY, V68, P1343, DOI 10.1111/all.12265; Price OJ, 2014, SPORTS MED, V44, P1749, DOI 10.1007/s40279-014-0238-y; Rundell KW, 2008, J ALLERGY CLIN IMMUN, V122, P238, DOI 10.1016/j.jaci.2008.06.014; Rundell KW, 2005, INHAL TOXICOL, V17, P99, DOI 10.1080/08958370590899479; Subbarao P, 2006, J ALLERGY CLIN IMMUN, V117, P1008, DOI 10.1016/j.jaci.2005.11.048; Sue-Chu M, 2012, BRIT J SPORT MED, V46, P397, DOI 10.1136/bjsports-2011-090822; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Weiler JM, 2007, J ALLERGY CLIN IMMUN, V119, P1349, DOI 10.1016/j.jaci.2007.02.041; Weiler John M, 2010, Ann Allergy Asthma Immunol, V105, pS1, DOI 10.1016/j.anai.2010.09.021; Weiss Pnina, 2009, Allergy Asthma Clin Immunol, V5, P7, DOI 10.1186/1710-1492-5-7; Wilkinson M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010749.pub2	41	93	96	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7					641	648		10.1056/NEJMra1407552	http://dx.doi.org/10.1056/NEJMra1407552			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CK	25671256				2022-12-28	WOS:000349143900008
J	Keimer, B; Kivelson, SA; Norman, MR; Uchida, S; Zaanen, J				Keimer, B.; Kivelson, S. A.; Norman, M. R.; Uchida, S.; Zaanen, J.			From quantum matter to high-temperature superconductivity in copper oxides	NATURE			English	Review							QUASI-PARTICLE INTERFERENCE; NORMAL-STATE TRANSPORT; T-C SUPERCONDUCTORS; PSEUDOGAP STATE; SPIN DYNAMICS; FERMI-SURFACE; ELECTRONIC-STRUCTURE; FLUCTUATING STRIPES; PAIRING INTERACTION; PHASE COHERENCE	The discovery of high-temperature superconductivity in the copper oxides in 1986 triggered a huge amount of innovative scientific inquiry. In the almost three decades since, much has been learned about the novel forms of quantum matter that are exhibited in these strongly correlated electron systems. A qualitative understanding of the nature of the superconducting state itself has been achieved. However, unresolved issues include the astonishing complexity of the phase diagram, the unprecedented prominence of various forms of collective fluctuations, and the simplicity and insensitivity to material details of the 'normal' state at elevated temperatures.	[Keimer, B.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Kivelson, S. A.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Norman, M. R.] Argonne Natl Lab, Mat Sci Div, Argonne, IL 60439 USA; [Uchida, S.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Zaanen, J.] Leiden Univ, Lorentz Inst Theoret Phys, NL-2300 RA Leiden, Netherlands	Max Planck Society; Stanford University; United States Department of Energy (DOE); Argonne National Laboratory; University of Tokyo; Leiden University; Leiden University - Excl LUMC	Zaanen, J (corresponding author), Leiden Univ, Lorentz Inst Theoret Phys, POB 9506, NL-2300 RA Leiden, Netherlands.	jan@lorentz.leidenuniv.nl	Norman, Michael R/C-3644-2013	Norman, Michael R/0000-0002-9459-078X; Keimer, Bernhard/0000-0001-5220-9023; Kivelson, Steven/0000-0001-9149-9502	US DOE, Basic Energy Sciences, Materials Science and Engineering at Stanford University [DE-AC02-76SF00515]; Center for Emergent Superconductivity, an Energy Frontier Research Center - US DOE, Basic Energy Sciences [DE-AC0298CH1088]; Netherlands Organization for Scientific Research/Ministry of Science and Education (NWO/OCW); Templeton foundation	US DOE, Basic Energy Sciences, Materials Science and Engineering at Stanford University(United States Department of Energy (DOE)); Center for Emergent Superconductivity, an Energy Frontier Research Center - US DOE, Basic Energy Sciences(United States Department of Energy (DOE)); Netherlands Organization for Scientific Research/Ministry of Science and Education (NWO/OCW); Templeton foundation	We thank A. Yazdani for many discussions. S.A.K. was supported by the US DOE, Basic Energy Sciences, Materials Science and Engineering, under Award No. DE-AC02-76SF00515 at Stanford University. M.N. was supported by the Center for Emergent Superconductivity, an Energy Frontier Research Center funded by the US DOE, Basic Energy Sciences, under Award No. DE-AC0298CH1088. J.Z. acknowledges financial support by the Netherlands Organization for Scientific Research/Ministry of Science and Education (NWO/OCW), and a grant from the Templeton foundation: the opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton foundation.	ABRIKOSOV AA, 1961, SOV PHYS JETP-USSR, V12, P1243; ALLOUL H, 1989, PHYS REV LETT, V63, P1700, DOI 10.1103/PhysRevLett.63.1700; Anderson PW, 2007, SCIENCE, V316, P1705, DOI 10.1126/science.1140970; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Arai M, 1999, PHYS REV LETT, V83, P608, DOI 10.1103/PhysRevLett.83.608; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BEALMONOD MT, 1986, PHYS REV B, V34, P7716, DOI 10.1103/PhysRevB.34.7716; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Blanco-Canosa S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.054513; BUCHER B, 1993, PHYS REV LETT, V70, P2012, DOI 10.1103/PhysRevLett.70.2012; Carbotte JP, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/6/066501; CASTELLANI C, 1995, PHYS REV LETT, V75, P4650, DOI 10.1103/PhysRevLett.75.4650; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; CHAKRAVARTY S, 1988, PHYS REV LETT, V60, P1057, DOI 10.1103/PhysRevLett.60.1057; Chatterjee U, 2011, P NATL ACAD SCI USA, V108, P9346, DOI 10.1073/pnas.1101008108; CHIEN TR, 1991, PHYS REV LETT, V67, P2088, DOI 10.1103/PhysRevLett.67.2088; Cohen ML., 1972, AIP CONF P, V4, P17, DOI [10.1063/1.2946185, DOI 10.1063/1.2946185]; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; Corboz P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.046402; Corson J, 1999, NATURE, V398, P221, DOI 10.1038/18402; Neto EHD, 2014, SCIENCE, V343, P393, DOI 10.1126/science.1243479; Dahm T, 2009, NAT PHYS, V5, P217, DOI 10.1038/NPHYS1180; Dai PC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054525; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Dean MPM, 2013, NAT MATER, V12, P1018, DOI [10.1038/NMAT3723, 10.1038/nmat3723]; Ding H, 1996, NATURE, V382, P51, DOI 10.1038/382051a0; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Dubroka A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.047006; Fedorov AV, 1999, PHYS REV LETT, V82, P2179, DOI 10.1103/PhysRevLett.82.2179; Feng DL, 2000, SCIENCE, V289, P277, DOI 10.1126/science.289.5477.277; Fong HF, 2000, PHYS REV B, V61, P14773, DOI 10.1103/PhysRevB.61.14773; Fujita K, 2014, SCIENCE, V344, P612, DOI 10.1126/science.1248783; Garg A, 2008, NAT PHYS, V4, P762, DOI 10.1038/nphys1026; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Gozar A, 2008, NATURE, V455, P782, DOI 10.1038/nature07293; Hashimoto M, 2014, NAT PHYS, V10, P483, DOI [10.1038/NPHYS3009, 10.1038/nphys3009]; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Hinkov V, 2007, NAT PHYS, V3, P780, DOI 10.1038/nphys720; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; HOMES CC, 1993, PHYS REV LETT, V71, P1645, DOI 10.1103/PhysRevLett.71.1645; Howald C, 2003, P NATL ACAD SCI USA, V100, P9705, DOI 10.1073/pnas.1233768100; Hussey NE, 2004, PHILOS MAG, V84, P2847, DOI 10.1080/14786430410001716944; Iqbal N, 2010, STRING THEORY AND ITS APPLICATIONS: FROM MEV TO THE PLANCK SCALE, TASI 2010, P707, DOI 10.1142/9789814350525_0013; ITO T, 1993, PHYS REV LETT, V70, P3995, DOI 10.1103/PhysRevLett.70.3995; Kaiser S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.184516; Kaminski A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.207003; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Lanzara A, 2001, NATURE, V412, P510, DOI 10.1038/35087518; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Le Tacon M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.020501; Le Tacon M, 2011, NAT PHYS, V7, P725, DOI [10.1038/nphys2041, 10.1038/NPHYS2041]; Lee J, 2009, SCIENCE, V325, P1099, DOI 10.1126/science.1176369; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Leggett AJ, 1999, P NATL ACAD SCI USA, V96, P8365, DOI 10.1073/pnas.96.15.8365; Li L, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054510; Li Q, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.067001; Liu L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.126406; Loeser AG, 1996, SCIENCE, V273, P325, DOI 10.1126/science.273.5273.325; Maldacena J., 1999, International Journal of Theoretical Physics, V38, P1113, DOI 10.1023/A:1026654312961; Marshall DS, 1996, PHYS REV LETT, V76, P4841, DOI 10.1103/PhysRevLett.76.4841; MARTIN S, 1990, PHYS REV B, V41, P846, DOI 10.1103/PhysRevB.41.846; Matsui H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.217002; McElroy K, 2003, NATURE, V422, P592, DOI 10.1038/nature01496; MIYAKE K, 1986, PHYS REV B, V34, P6554, DOI 10.1103/PhysRevB.34.6554; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Neto EHD, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.161117; Norman MR, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174501; Norman MR, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.184514; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Paramekanti A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.054504; Parker CV, 2010, NATURE, V468, P677, DOI 10.1038/nature09597; Plate M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.077001; Puchkov AV, 1996, J PHYS-CONDENS MAT, V8, P10049, DOI 10.1088/0953-8984/8/48/023; Raghu S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.224505; Ramshaw B. J., 2014, QUANTUM CRITICAL POI; Reber TJ, 2012, NAT PHYS, V8, P606, DOI [10.1038/NPHYS2352, 10.1038/nphys2352]; Reznik D, 2006, NATURE, V440, P1170, DOI 10.1038/nature04704; Sachdev S., 1999, QUANTUM PHASE TRANSI; Scalapino DJ, 2012, REV MOD PHYS, V84, P1383, DOI 10.1103/RevModPhys.84.1383; Scalapino DJ, 2012, PHYSICA C, V481, P146, DOI 10.1016/j.physc.2012.04.004; SCALAPINO DJ, 1986, PHYS REV B, V34, P8190, DOI 10.1103/PhysRevB.34.8190; Sebastian SE, 2014, NATURE, V511, P61, DOI 10.1038/nature13326; Stoudenmire E. M., 2012, ANNU REV CONDEN MA P, V3, P61; Tabis W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6875; Tajima S, 2001, PHYS REV LETT, V86, P500, DOI 10.1103/PhysRevLett.86.500; TALLON JL, 1994, PHYSICA C, V235, P1821, DOI 10.1016/0921-4534(94)92132-6; Tranquada J. M., 2014, THEORY INTERTWINED O; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; UEMURA YJ, 1989, PHYS REV LETT, V62, P2317, DOI 10.1103/PhysRevLett.62.2317; Ulbrich H, 2012, PHYSICA C, V481, P31, DOI 10.1016/j.physc.2012.04.039; VAKNIN D, 1987, PHYS REV LETT, V58, P2802, DOI 10.1103/PhysRevLett.58.2802; Valla T, 2000, PHYS REV LETT, V85, P828, DOI 10.1103/PhysRevLett.85.828; VARMA CM, 1989, PHYS REV LETT, V63, P1996, DOI 10.1103/PhysRevLett.63.1996; Varma CM, 1997, PHYS REV B, V55, P14554, DOI 10.1103/PhysRevB.55.14554; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; Vignolle B, 2008, NATURE, V455, P952, DOI 10.1038/nature07323; Vishik IM, 2012, P NATL ACAD SCI USA, V109, P18332, DOI 10.1073/pnas.1209471109; Vishik IM, 2009, NAT PHYS, V5, P718, DOI 10.1038/NPHYS1375; Wakimoto S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.217004; WARREN WW, 1989, PHYS REV LETT, V62, P1193, DOI 10.1103/PhysRevLett.62.1193; White SR, 1998, PHYS REV LETT, V80, P1272, DOI 10.1103/PhysRevLett.80.1272; WOLLMAN DA, 1993, PHYS REV LETT, V71, P2134, DOI 10.1103/PhysRevLett.71.2134; Wu T., 2014, SHORT RANGE CHARGE O; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345; Yang HB, 2008, NATURE, V456, P77, DOI 10.1038/nature07400; Zaanen J, 2004, NATURE, V430, P512, DOI 10.1038/430512a; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391; Zaanen J., HOLOGRAPHIC IN PRESS; Zaanen J, 2007, SCIENCE, V315, P1372, DOI 10.1126/science.1139805	120	1206	1218	49	741	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					179	186		10.1038/nature14165	http://dx.doi.org/10.1038/nature14165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25673411	Green Published			2022-12-28	WOS:000349190300029
J	Tolle, SW; Back, AL; Meier, DE				Tolle, Susan W.; Back, Anthony L.; Meier, Diane E.			End-of-Life Advance Directive	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STANDARD ONCOLOGY CARE; PALLIATIVE CARE; SUSTAINING TREATMENT; PHYSICIAN ORDERS; ADVANCED CANCER; PREFERENCES; INTEGRATION; PATIENT; PROGRAM		[Tolle, Susan W.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Back, Anthony L.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Meier, Diane E.] Icahn Sch Med Mt Sinai, Ctr Adv Palliat Care, New York, NY 10029 USA	Oregon Health & Science University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai	Tolle, SW (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.							Back AL, 2009, ARCH INTERN MED, V169, P474, DOI 10.1001/archinternmed.2008.583; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Bernstein N., 2014, NY TIMES, pA1; Fromme EK, 2014, J AM GERIATR SOC, V62, P1246, DOI 10.1111/jgs.12889; Gawande A, 2014, BEING MORTAL MED WHA; Greer JA, 2013, CA-CANCER J CLIN, V63, P349, DOI 10.3322/caac.21192; Hickman SE, 2010, J AM GERIATR SOC, V58, P1241, DOI 10.1111/j.1532-5415.2010.02955.x; Kelley AS, 2010, NEW ENGL J MED, V363, P781, DOI 10.1056/NEJMe1004139; Krakauer Barak, 2014, J Clin Ethics, V25, P131; Meier DE, 2014, HEALTH AFFAIR, V33, P895, DOI [10.1377/HLTHAFF.2013.0517, 10.1377/hlthaff.2013.0517]; Smith TJ, 2012, J CLIN ONCOL, V30, P880, DOI 10.1200/JCO.2011.38.5161; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Tulsky JA, 2011, ANN INTERN MED, V155, P593, DOI 10.7326/0003-4819-155-9-201111010-00007; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410	14	16	16	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7					667	670		10.1056/NEJMclde1411152	http://dx.doi.org/10.1056/NEJMclde1411152			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA8CK	25671262				2022-12-28	WOS:000349143900015
J	Gaya, M; Castello, A; Montaner, B; Rogers, N; Sousa, CRE; Bruckbauer, A; Batista, FD				Gaya, Mauro; Castello, Angelo; Montaner, Beatriz; Rogers, Neil; Reis e Sousa, Caetano; Bruckbauer, Andreas; Batista, Facundo D.			Inflammation-induced disruption of SCS macrophages impairs B cell responses to secondary infection	SCIENCE			English	Article							SUBCAPSULAR SINUS MACROPHAGES; LYMPH-NODES; T-CELL; ANTIGEN; MIGRATION; ACTIVATION; INFLUENZA; DYNAMICS; DEFENSE; VIRUS	The layer of macrophages at the subcapsular sinus (SCS) captures pathogens entering the lymph node, preventing their global dissemination and triggering an immune response. However, how infection affects SCS macrophages remains largely unexplored. Here we show that infection and inflammation disrupt the organization of SCS macrophages in a manner that involves the migration of mature dendritic cells to the lymph node. This disrupted organization reduces the capacity of SCS macrophages to retain and present antigen in a subsequent secondary infection, resulting in diminished B cell responses. Thus, the SCS macrophage layer may act as a sensor or valve during infection to temporarily shut down the lymph node to further antigenic challenge. This shutdown may increase an organism's susceptibility to secondary infections.	[Gaya, Mauro; Castello, Angelo; Montaner, Beatriz; Bruckbauer, Andreas; Batista, Facundo D.] Canc Res UK, London Res Inst, Lymphocyte Interact Lab, London WC2A 3LY, England; [Rogers, Neil; Reis e Sousa, Caetano] Canc Res UK, London Res Inst, Immunobiol Lab, London WC2A 3LY, England	Cancer Research UK; Cancer Research UK	Batista, FD (corresponding author), Canc Res UK, London Res Inst, Lymphocyte Interact Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	facundo.batista@cancer.org.uk	Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Rogers, Neil/0000-0001-8977-7585; Montaner, Beatriz/0000-0001-9877-7317	Cancer Research UK; Cancer Research UK [15689, 15691] Funding Source: researchfish; The Francis Crick Institute [10035, 10136] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); The Francis Crick Institute	We thank A. Rot and D. Withers for the CCR7 knockout mouse strain. We thank L. Collinson, H. Armer, and C. Peddie from the electron microscopy facility for electron microscopy and 3View analysis of lymph nodes; the experimental histopathology facility for the initial preparation of tissue cryosections; and S. Lutter for assistance with whole-body imaging. We thank N. Harwood and J. Coleman for editing of the manuscript, and P. Barral J. Caamano, R. Germain, and the members of the Lymphocyte Interaction Laboratory for critical reading of the manuscript. We thank F. Sallusto for feedback and suggestion of the term "shut down." The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Supported by Cancer Research UK.	Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Coombes JL, 2012, CELL REP, V2, P124, DOI 10.1016/j.celrep.2012.06.001; DELEMARRE FGA, 1990, J LEUKOCYTE BIOL, V47, P251, DOI 10.1002/jlb.47.3.251; Garcia Z, 2012, BLOOD, V120, P4744, DOI 10.1182/blood-2012-02-408179; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kumar V, 2010, BLOOD, V115, P4725, DOI 10.1182/blood-2009-10-250118; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613	23	88	88	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					667	672		10.1126/science.aaa1300	http://dx.doi.org/10.1126/science.aaa1300			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657250				2022-12-28	WOS:000349145200046
J	Lee, BY; Moss, WJ; Privor-Dumm, L; Constenla, DO; Knoll, MD; O'Brien, KL				Lee, Bruce Y.; Moss, William J.; Privor-Dumm, Lois; Constenla, Dagna O.; Knoll, Maria D.; O'Brien, Katherine L.			Is the world ready for an Ebola vaccine?	LANCET			English	Editorial Material							IMPACT		[Lee, Bruce Y.; Moss, William J.; Privor-Dumm, Lois; Constenla, Dagna O.; Knoll, Maria D.; O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lee, BY (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, Baltimore, MD 21205 USA.	brucelee@jhu.edu		Deloria Knoll, Maria/0000-0001-9041-2671; Privor-Dumm, Lois/0000-0001-9807-2544; O'Brien, Katherine/0000-0002-0164-4030				[Anonymous], ANN PHARMACOTHER; Brown ST, 2014, VACCINE, V32, P4097, DOI 10.1016/j.vaccine.2014.04.090; Doumtsop JGT, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.4.2475; Freimuth VS, 2014, J HEALTH COMMUN, V19, P321, DOI 10.1080/10810730.2013.811323; Gulland A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6466; Kanapathipillai R, 2014, NEW ENGL J MED, V371, P2249, DOI 10.1056/NEJMp1412166; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; Lee BY, 2012, VACCINE, V30, P5637, DOI 10.1016/j.vaccine.2012.06.087; Lee BY, 2012, AM J PUBLIC HEALTH, V102, P269, DOI 10.2105/AJPH.2011.300218; Lee BY, 2010, VACCINE, V28, P2806, DOI 10.1016/j.vaccine.2009.09.047; Mire CE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002600; WHO, 2014, EXP EB VACC	12	4	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					203	204		10.1016/S0140-6736(14)62398-9	http://dx.doi.org/10.1016/S0140-6736(14)62398-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ2DL	25706696				2022-12-28	WOS:000348044800004
J	Volpato, S; Guralnik, JM				Volpato, Stefano; Guralnik, Jack M.			Hip fractures: comprehensive geriatric care and recovery	LANCET			English	Editorial Material							OLDER-ADULTS; DISABILITY		[Volpato, Stefano] Univ Ferrara, Dept Sci & Med, I-44100 Ferrara, Italy; [Guralnik, Jack M.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA	University of Ferrara; University System of Maryland; University of Maryland Baltimore	Volpato, S (corresponding author), Univ Ferrara, Dept Sci & Med, I-44100 Ferrara, Italy.	vlt@unife.it	VOLPATO, STEFANO/H-2977-2014	VOLPATO, STEFANO/0000-0003-4335-6034				Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hazzard WR, 1994, PRINCIPLES GERIATRIC; Hopkins RB, 2012, OSTEOPOROSIS INT, V23, P921, DOI 10.1007/s00198-011-1652-8; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Prestmo A, 2015, LANCET; Rubenstein LZ, 1991, J AM GERIATR SOC S, V39, p8S; Savino E, 2013, AM J MED, V126, P1068, DOI 10.1016/j.amjmed.2013.04.017; Volpato S, 2011, J GERONTOL A-BIOL, V66, P89, DOI 10.1093/gerona/glq167	12	11	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1594	1595		10.1016/S0140-6736(14)61592-0	http://dx.doi.org/10.1016/S0140-6736(14)61592-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG6NG	25662417				2022-12-28	WOS:000353418000008
J	Mungiu-Pippidi, A				Mungiu-Pippidi, Alina			Good governance powers innovation	NATURE			English	Editorial Material									Hertie Sch Governance, Berlin, Germany		Mungiu-Pippidi, A (corresponding author), Hertie Sch Governance, Berlin, Germany.	pippidi@hertie-school.org						Ariu A, 2013, EMBO REP, V14, P502, DOI 10.1038/embor.2013.59; Charron N., 2013, ALAND ANKARA EUROPEA; Mungiu-Pippidi A., 2014, ANTICORRUPTION REPOR, P90; Mungiu-Pippidi A., 2013, ANTICORRUPTION REPOR, V1, P14; North Douglass, 2013, VIOLENCE SOCIAL ORDE; Transparency International, 2013, GLOB CORR BAR	6	16	18	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					295	297		10.1038/518295a	http://dx.doi.org/10.1038/518295a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3SA	25693546	Bronze			2022-12-28	WOS:000349547400012
J	Tsankov, AM; Gu, HC; Akopian, V; Ziller, MJ; Donaghey, J; Amit, I; Gnirke, A; Meissner, A				Tsankov, Alexander M.; Gu, Hongcang; Akopian, Veronika; Ziller, Michael J.; Donaghey, Julie; Amit, Ido; Gnirke, Andreas; Meissner, Alexander			Transcription factor binding dynamics during human ES cell differentiation	NATURE			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; CHIP-SEQ; EPIGENOMIC ANALYSIS; REGULATORY NETWORK; SUPER-ENHANCERS; REGIONS; GENOME; STATE; SPECIFICATION	Pluripotent stem cells provide a powerful system to dissect the underlying molecular dynamics la ell fate changes during mammalian development. Here we report the integrative analysis of genome-wide binding data for 38 transcription factors with extensive epigenume and transcriptional data across the differentiation of human embryonic stem cells to the three germ layers. We describe core regulatory dynamics and show the lineage-specific behaviour of selected factors. In addition to the orchestrated remodelling of the chromatin landscape, we find that the binding of several transcription factors is strongly associated with. specific loss of DNA methylation in one germ layer, and in many cases a reciprocal gain in the other layers. Taken together, our work shows context-dependent rewiring of transcription factor binding, downstream signalling effectors, and the epigenome during human embryonic stem cell differentiation.	[Tsankov, Alexander M.; Gu, Hongcang; Ziller, Michael J.; Donaghey, Julie; Amit, Ido; Gnirke, Andreas; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Tsankov, Alexander M.; Akopian, Veronika; Ziller, Michael J.; Donaghey, Julie; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Tsankov, Alexander M.; Akopian, Veronika; Ziller, Michael J.; Donaghey, Julie; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Weizmann Institute of Science	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu		Gu, Hongcang/0000-0002-1439-7606	NIH [U01ES017155]; NIGMS [P01GM099117]; NHGRI [P50HG006193]; New York Stem Cell Foundation; NIH Ruth L. Kirschstein NRSA fellowship [5F32DK095537]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); New York Stem Cell Foundation; NIH Ruth L. Kirschstein NRSA fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank all members of the Meissner laboratory for their support and feedback. We also thank F. Kelley and other members of the Broad Technology Labs and Sequencing Platform as well as J. Doench and members of the Genetic Perturbation Platform at the Broad Institute. We would like to thank L. Gaffney for graphical support This work was supported by the NIH Common Fund (U01ES017155), NIGMS (P01GM099117), NHGRI (P50HG006193) and the New York Stem Cell Foundation. A.M.T. was supported by NIH Ruth L. Kirschstein NRSA fellowship 5F32DK095537. A.M. is a New York Stem Cell Foundation Robertson Investigator.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Bao YC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-169; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henikoff JG, 2011, P NATL ACAD SCI USA, V108, P18318, DOI 10.1073/pnas.1110731108; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Morsli H, 1999, DEVELOPMENT, V126, P2335; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; Villar D, 2014, NAT REV GENET, V15, P221, DOI 10.1038/nrg3481; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; You JS, 2011, P NATL ACAD SCI USA, V108, P14497, DOI 10.1073/pnas.1111309108; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	48	218	224	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					344	349		10.1038/nature14233	http://dx.doi.org/10.1038/nature14233			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25693565	Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000349547400031
J	Ebbert, JO; Hughes, JR; West, RJ; Rennard, SI; Russ, C; Mcrae, TD; Treadow, J; Yu, CR; Dutro, MP; Park, PW				Ebbert, Jon O.; Hughes, John R.; West, Robert J.; Rennard, Stephen I.; Russ, Cristina; Mcrae, Thomas D.; Treadow, Joan; Yu, Ching-Ray; Dutro, Michael P.; Park, Peter W.			Effect of Varenicline on Smoking Cessation Through Smoking Reduction A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST; NICOTINE REPLACEMENT; STOP SMOKING; SMOKERS; PLACEBO; QUIT; BEHAVIORS; EFFICACY; SUCCESS	IMPORTANCE Some cigarette smokers may not be ready to quit immediately but may be willing to reduce cigarette consumption with the goal of quitting. OBJECTIVE To determine the efficacy and safety of varenicline for increasing smoking abstinence rates through smoking reduction. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind, placebo-controlled, multinational clinical trial with a 24-week treatment period and 28-week follow-up conducted between July 2011 and July 2013 at 61 centers in 10 countries. The 1510 participants were cigarette smokers who were not willing or able to quit smoking within the next month but willing to reduce smoking and make a quit attempt within the next 3 months. Participants were recruited through advertising. INTERVENTIONS Twenty-four weeks of varenicline titrated to 1 mg twice daily or placebo with a reduction target of 50% or more in number of cigarettes smoked by 4 weeks, 75% or more by 8 weeks, and a quit attempt by 12 weeks. MAIN OUTCOMES AND MEASURES Primary efficacy end point was carbon monoxide-confirmed self-reported abstinence during weeks 15 through 24. Secondary outcomes were carbon monoxide-confirmed self-reported abstinence for weeks 21 through 24 and weeks 21 through 52. RESULTS The varenicline group (n = 760) had significantly higher continuous abstinence rates during weeks 15 through 24 vs the placebo group (n = 750) (32.1% for the varenicline group vs 6.9% for the placebo group; risk difference (RD), 25.2% [95% CI, 21.4%-29.0%]; relative risk (RR), 4.6 [95% CI, 3.5-6.1]). The varenicline group had significantly higher continuous abstinence rates vs the placebo group during weeks 21 through 24(37.8% for the varenicline group vs 12.5% for the placebo group; RD, 25.2% [95% CI, 21.1%-29.4%]; RR, 3.0 [95% CI, 2.4-3.7]) and weeks 21 through 52 (27.0% for the varenicline group vs 9.9% for the placebo group; RD, 17.1% [95% CI, 13.3%-20.9%]; RR, 2.7 [95% CI, 2.1-3.5]). Serious adverse events occurred in 3.7% of the varenicline group and 2.2% of the placebo group (P = .07). CONCLUSIONS AND RELEVANCE Among cigarette smokers not willing or able to quit within the next month but willing to reduce cigarette consumption and make a quit attempt at 3 months, use of varenicline for 24 weeks compared with placebo significantly increased smoking cessation rates at the end of treatment, and also at 1 year. Varenicline offers a treatment option for smokers whose needs are not addressed by clinical guidelines recommending abrupt smoking cessation.	[Ebbert, Jon O.] Mayo Clin, Rochester, MN 55905 USA; [Hughes, John R.] Univ Vermont, Dept Psychiat, Burlington, VT USA; [West, Robert J.] UCL, Dept Epidemiol & Publ Hlth, Hlth Behav Res Ctr, London WC1E 6BT, England; [Rennard, Stephen I.] Univ Nebraska Med Ctr, Div Pulm Crit Care Sleep & Allergy, Omaha, NE USA; [Russ, Cristina; Mcrae, Thomas D.; Treadow, Joan; Yu, Ching-Ray; Dutro, Michael P.; Park, Peter W.] Pfizer Inc, New York, NY USA	Mayo Clinic; University of Vermont; University of London; University College London; University of Nebraska System; University of Nebraska Medical Center; Pfizer	Ebbert, JO (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	ebbert.jon@mayo.edu	Hughes, John/H-9687-2013; West, Robert/B-5414-2009	Hughes, John/0000-0002-0092-9309; West, Robert/0000-0001-6398-0921	Pfizer; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1, MR/K023195/1B] Funding Source: researchfish	Pfizer(Pfizer); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by Pfizer.	Asfar T, 2011, ADDICT BEHAV, V36, P764, DOI 10.1016/j.addbeh.2011.02.003; Ashare RL, 2012, J PSYCHOPHARMACOL, V26, P1383, DOI 10.1177/0269881112449397; Aubin Henri-Jean, 2012, BMJ, V345, pe4439, DOI 10.1136/bmj.e4439; Baker TB, 2011, ANN BEHAV MED, V41, P192, DOI 10.1007/s12160-010-9252-y; Borland R, 2012, ADDICTION, V107, P673, DOI 10.1111/j.1360-0443.2011.03685.x; Cahill K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006103.pub3; Cheong Y, 2007, NICOTINE TOB RES, V9, P801, DOI 10.1080/14622200701484961; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Fiore MC, 2008, TREATING TOBACCO USE; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Hajek P, 2003, ADDICTION, V98, P1563, DOI 10.1046/j.1360-0443.2003.00497.x; Hatsukami DK, 2004, AM J MED, V116, P151, DOI 10.1016/j.amjmed.2003.07.018; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hughes JR, 2011, NICOTINE TOB RES, V13, P955, DOI 10.1093/ntr/ntr103; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lindson N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008033.pub2; Moore David, 2009, BMJ, V338, pb1024, DOI 10.1136/bmj.b1024; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Posner K, SUICIDALITY ISSUES C; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; Shiffman S, 2007, NICOTINE TOB RES, V9, P1177, DOI 10.1080/14622200701648441; Vangeli E, 2011, ADDICTION, V106, P2110, DOI 10.1111/j.1360-0443.2011.03565.x; Wang D, 2008, HEALTH TECHNOL ASSES, V12, P1; Wang D, 2008, HEALTH TECHNOL ASSES, V12, P1; Wewers ME, 2003, PREV MED, V36, P710, DOI 10.1016/S0091-7435(03)00044-6; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704	27	120	125	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					687	694		10.1001/jama.2015.280	http://dx.doi.org/10.1001/jama.2015.280			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB2RQ	25688780	Bronze, Green Accepted			2022-12-28	WOS:000349476100014
J	Hofmann, BM				Hofmann, Bjorn Morten			Too much technology	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PULMONARY-EMBOLISM; THYROID-CANCER; OVERDIAGNOSIS; MEDICINE; DISEASE; CARE; DIAGNOSIS; PREVALENCE; PHYSICIANS; HARMS		[Hofmann, Bjorn Morten] Univ Coll Gjovik, N-2802 Gjovik, Norway; [Hofmann, Bjorn Morten] Univ Oslo, Ctr Med Eth, Oslo, Norway; [Hofmann, Bjorn Morten] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA	Norwegian University of Science & Technology (NTNU); University of Oslo; Dartmouth College	Hofmann, BM (corresponding author), Univ Coll Gjovik, POB 1, N-2802 Gjovik, Norway.	b.m.hofmann@medisin.uio.no	Hofmann, Bjørn/AAI-7121-2020	Hofmann, Bjørn/0000-0001-6709-4265				Album D, 2008, SOC SCI MED, V66, P182, DOI 10.1016/j.socscimed.2007.07.003; [Anonymous], 2009, HLTH US 2009 SPEC FE; Appleby J, 2011, VARIATION HEALTHCARE; Augsburger James J, 2005, Trans Am Ophthalmol Soc, V103, P143; Augsburger JJ, 2005, T AM OPHTHAL SOC, V103, P46; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Bodenheimer T, 2005, ANN INTERN MED, V142, P932, DOI 10.7326/0003-4819-142-11-200506070-00012; Boenink M, 2010, MED HEALTH CARE PHIL, V13, P11, DOI 10.1007/s11019-009-9223-x; Brito JP, 2014, THYROID, V24, P402, DOI 10.1089/thy.2013.0425; Brito JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4706; Brownlee S., 2007, OVERTREATED WHY TOO; Burge AJ, 2008, CLIN RADIOL, V63, P381, DOI 10.1016/j.crad.2007.10.004; Carrier ER, 2012, HEALTH AFFAIR, V31, P827, DOI 10.1377/hlthaff.2011.1085; CASSELL EJ, 1993, HASTINGS CENT REP, V23, P32, DOI 10.2307/3562922; Chernew ME, 2004, HEALTH AFFAIR, V23, P122, DOI 10.1377/hlthaff.23.6.122; Colla CH, 2015, J GEN INTERN MED, V30, P221, DOI 10.1007/s11606-014-3070-z; Collado Megan, 2014, Find Brief, V42, P1; Cundy T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1567; Davis A., 1981, MED ITS TECHNOLOGY I; de Carvalho TM, 2015, INT J CANCER, V136, P1600, DOI 10.1002/ijc.29136; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Dybczak K, 2010, 400 DIR GEN EC MON A; Fisher ES, 1999, JAMA-J AM MED ASSOC, V281, P446, DOI 10.1001/jama.281.5.446; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Fuchs VR, 2001, HEALTH AFFAIR, V20, P30, DOI 10.1377/hlthaff.20.5.30; Gabbay J, 2006, BMJ-BRIT MED J, V332, P64, DOI 10.1136/bmj.332.7533.64; Haas M, 2012, AUST HEALTH REV, V36, P148, DOI 10.1071/AH11032; Heidegger M., 1977, QUESTION TECHNOLOGY, P115; Henshall C, 2012, INT J TECHNOL ASSESS, V28, P203, DOI 10.1017/S0266462312000372; Herndon MB, 2007, HEALTH AFFAIR, V26, P1702, DOI 10.1377/hlthaff.26.6.1702; Hodgkinson J, 2011, BMJ, V342, pd3621, DOI 10.1136/bmj.d3621; Hoff G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5843; Hofmann B, 2001, Med Health Care Philos, V4, P335, DOI 10.1023/A:1012069919089; Hofmann B, 2002, INT J TECHNOL ASSESS, V18, P675; Hofmann B., 2006, MEANS BECOME ENDS TE, P2; Hofmann B, 2002, TECHNOLOGICAL INVENT; Illich I., 1976, LIMITS TO MED; Latour B., 2005, REASSEMBLING SOCIAL; Le Couteur DG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5125; Lin GA, 2008, J GEN INTERN MED, V23, P1458, DOI 10.1007/s11606-008-0706-x; Loeb S, 2014, EUR UROL, V65, P1046, DOI 10.1016/j.eururo.2013.12.062; LUFT HS, 1986, INQUIRY-J HEALTH CAR, V23, P83; Luks VP, 2010, EUR RESPIR J, V36, P255, DOI 10.1183/09031936.00165109; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R, 2002, BMJ-BRIT MED J, V324, P859, DOI 10.1136/bmj.324.7342.859; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5157; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4298; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Moynihan RN, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001500; National Institute for Health and Care Excellence, 2011, NICE DO NOT DO REC; Payer L, 2006, DIS MONGERS DOCTORS; Pedersen T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002013.pub3; Prasad V, 2012, ARCH INTERN MED, V172, P955, DOI 10.1001/archinternmed.2012.195; Provenzale JM, 2009, AM J ROENTGENOL, V193, P1167, DOI 10.2214/AJR.08.1688; Richards, 1999, BMJ, V318, P268; Sandhu Gurdarshan S., 2012, Journal of the National Cancer Institute Monographs, P146, DOI 10.1093/jncimonographs/lgs031; Sorenson C, 2013, CLINICOECONOMIC OUTC, V5, P223, DOI 10.2147/CEOR.S39634; Tran, 2011, ROBOT ASSISTED SURG; Welch H, 2011, OVERDIAGNOSED MAKING; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Wennberg E., 2010, TRACKING MED; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368; Wilmshurst P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2822; Winner L., 1977, AUTONOMOUS TECHNOLOG; Wolf S, 1981, TECHNOLOGICAL IMPERA; Yudkin JS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4485	67	37	39	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2015	350								h705	10.1136/bmj.h705	http://dx.doi.org/10.1136/bmj.h705			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB8WA	25687230				2022-12-28	WOS:000349911300002
J	Saitoh, Y; Suzuki, H; Tani, K; Nishikawa, K; Irie, K; Ogura, Y; Tamura, A; Tsukita, S; Fujiyoshi, Y				Saitoh, Yasunori; Suzuki, Hiroshi; Tani, Kazutoshi; Nishikawa, Kouki; Irie, Katsumasa; Ogura, Yuki; Tamura, Atsushi; Tsukita, Sachiko; Fujiyoshi, Yoshinori			Structural insight into tight junction disassembly by Clostridium perfringens enterotoxin	SCIENCE			English	Article							INTEGRAL MEMBRANE-PROTEINS; C-TERMINAL FRAGMENT; EXTRACELLULAR LOOP; CLAUDINS; COMPLEX; BARRIER; STRANDS; DOMAIN; MODULATION; DIAGNOSIS	The C-terminal region of Clostridium perfringens enterotoxin (C-CPE) can bind to specific claudins, resulting in the disintegration of tight junctions (TJs) and an increase in the paracellular permeability across epithelial cell sheets. Here we present the structure of mammalian claudin-19 in complex with C-CPE at 3.7 angstrom resolution. The structure shows that C-CPE forms extensive hydrophobic and hydrophilic interactions with the two extracellular segments of claudin-19. The claudin-19/C-CPE complex shows no density of a short extracellular helix that is critical for claudins to assemble into TJ strands. The helix displacement may thus underlie C-CPE-mediated disassembly of TJs.	[Saitoh, Yasunori; Suzuki, Hiroshi; Tani, Kazutoshi; Nishikawa, Kouki; Irie, Katsumasa; Fujiyoshi, Yoshinori] Nagoya Univ, Cellular & Struct Physiol Inst, Chigusa Ku, Nagoya, Aichi 4648601, Japan; [Saitoh, Yasunori; Irie, Katsumasa; Fujiyoshi, Yoshinori] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ogura, Yuki; Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Frontier Biosci, Lab Biol Sci, Suita, Osaka 5650871, Japan; [Ogura, Yuki; Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan	Nagoya University; Nagoya University; Osaka University; Osaka University	Fujiyoshi, Y (corresponding author), Nagoya Univ, Cellular & Struct Physiol Inst, Chigusa Ku, Nagoya, Aichi 4648601, Japan.	yoshi@cespi.nagoya-u.ac.jp	Saitoh, Yasunori/M-9160-2017; Irie, Katsumasa/D-7332-2013; Tani, Kazutoshi/B-3705-2008; Suzuki, Hiroshi/D-5428-2013	Saitoh, Yasunori/0000-0002-7720-7902; Irie, Katsumasa/0000-0002-8178-1552; Tani, Kazutoshi/0000-0003-4835-154X; Suzuki, Hiroshi/0000-0001-5371-6385	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology-Core Research for Evolutionary Science and Technology; Japan New Energy and Industrial Technology Development Organization; National Institute of Biomedical Innovation; Grants-in-Aid for Scientific Research [26440024] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology-Core Research for Evolutionary Science and Technology; Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Uji, Y. Yamazaki, and Y. Ito for technical support; K. Abe for calculation of affinity values; the beamline staff members at BL32XU, BL38B1, and BL41XU of SPring-8 (Hyogo, Japan) for technical help during data collection; and T. Walz for critical reading of the manuscript. The synchrotron radiation experiments were performed with the approval of the Japan Synchrotron Radiation Research Institute (proposal nos. 2013A1112, 2013B1178, 2013B1342, and 2014A1501). This research was supported by Grants-in-Aid for Scientific Research (S) (to Y.F.), (A) (to S.T.), and (C) (to K.T.); Grants-in-Aid for Scientific Research in Innovative Areas (to S.T.); and the Platform for Drug Discovery, Information, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This research was also supported by the Japan Science and Technology-Core Research for Evolutionary Science and Technology (to S.T.), the Japan New Energy and Industrial Technology Development Organization, and the National Institute of Biomedical Innovation (to Y.F.). Y.S., H.S., and A.T. screened claudin genes. Y.S. performed protein expression, purification, crystallization, and binding assays. K.I. assisted in crystallization. Y.S., H.S., and K.I. collected x-ray data. H.S. and K.T. processed diffraction data and solved and refined the structure. K.N. took electron microscopy images. Y.O. and A.T. collected fluorescence microscopy images. Y.S., H.S., K.T., S.T., and Y.F. wrote the manuscript, and all authors commented on the paper. S.T. and Y.F. supervised the research. The authors declare no competing financial interests. Coordinates and structure factors were deposited in the Protein Data Bank under accession number 3X29.	English DP, 2013, INT J MOL SCI, V14, P10412, DOI 10.3390/ijms140510412; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Harada M, 2007, BIOCHEM PHARMACOL, V73, P206, DOI 10.1016/j.bcp.2006.10.002; Katahira J, 1997, J BIOL CHEM, V272, P26652, DOI 10.1074/jbc.272.42.26652; Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kimura J, 2010, J BIOL CHEM, V285, P401, DOI 10.1074/jbc.M109.051417; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; McClane BA, 2001, TOXICON, V39, P1781, DOI 10.1016/S0041-0101(01)00164-7; Mitchell LA, 2010, TOXINS, V2, P1595, DOI 10.3390/toxins2071595; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Suzuki H, 2014, SCIENCE, V344, P304, DOI 10.1126/science.1248571; Takahashi A, 2008, BIOCHEM PHARMACOL, V75, P1639, DOI 10.1016/j.bcp.2007.12.016; Tamura A, 2014, SEMIN CELL DEV BIOL, V36, P177, DOI 10.1016/j.semcdb.2014.09.019; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; Veshnyakova A, 2010, TOXINS, V2, P1336, DOI 10.3390/toxins2061336; Winkler L, 2009, J BIOL CHEM, V284, P18863, DOI 10.1074/jbc.M109.008623; Yelland TS, 2014, J MOL BIOL, V426, P3134, DOI 10.1016/j.jmb.2014.07.001	25	133	139	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					775	778		10.1126/science.1261833	http://dx.doi.org/10.1126/science.1261833			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678664				2022-12-28	WOS:000349221300049
J	Anderson, P; Miller, D				Anderson, Peter; Miller, David			Commentary: Sweet policies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUGARS; FOOD; WEB		[Anderson, Peter] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Anderson, Peter] Maastricht Univ, Fac Hlth, NL-6200 MD Maastricht, Netherlands; [Miller, David] Univ Bath, Bath BA2 7AY, Avon, England	Newcastle University - UK; Maastricht University; University of Bath	Anderson, P (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	peteranderson.mail@gmail.com	Miller, David/C-4803-2015	Miller, David/0000-0003-2408-845X				Anderson P, REFRAMING ADDICTIONS; [Anonymous], 2013, LANCET, V381, P963, DOI 10.1016/S0140-6736(13)60695-9; Benner S, 2013, AM ASS ADV SCI ANN M; Buckingham D, 2009, IMPACT COMMERCIAL WO; Buckingham D, 2009, INT J CULT POLICY, V15, P201, DOI 10.1080/10286630802651594; Dudley TR, 2014, DRUNKEN MONKEY WHY W; Fox F, 2006, SUPPING DEVIL SCI ME; Gmel G, 2010, ADDICTION, V105, P204, DOI 10.1111/j.1360-0443.2009.02764.x; Gornall J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h231; Gornall J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h220; Lieberman D., 2013, STORY HUMAN BODY; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; MacGregor GA, 2014, LANCET, V383, P929, DOI 10.1016/S0140-6736(14)60200-2; Miller D, IMPACT ADDI IN PRESS; Miller D, 2014, REFRAMING ADDICTION; Miller D, 2014, BMJ; Miller D, CORRUT BRIT IN PRESS; Miller D, 2010, CRIT SOC POLICY, V30, P564, DOI 10.1177/0261018310376805; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Peele S, 2010, ADDICT RES THEORY, V18, P389, DOI 10.3109/16066359.2010.488305; Schmidt LA, IMPACT ADDI IN PRESS; Schmidt LA, 2014, JAMA INTERN MED, V174, P525, DOI 10.1001/jamainternmed.2013.12991; Sorenson M, 2012, FOOD ADDICTION CURRE; Te Morenga LA, 2014, AM J CLIN NUTR, V100, P65, DOI 10.3945/ajcn.113.081521	26	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2015	350								h780	10.1136/bmj.h780	http://dx.doi.org/10.1136/bmj.h780			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0MG	25672619	Green Published			2022-12-28	WOS:000349319700023
J	Creed, M; Pascoli, VJ; Luscher, C				Creed, Meaghan; Pascoli, Vincent Jean; Luescher, Christian			Refining deep brain stimulation to emulate optogenetic treatment of synaptic pathology	SCIENCE			English	Article							PERMEABLE AMPA RECEPTORS; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; INCENTIVE-SENSITIZATION; COCAINE; PLASTICITY; EXPRESSION; POTENTIATION; DEPRESSION; ADDICTION	Circuit remodeling driven by pathological forms of synaptic plasticity underlies several psychiatric diseases, including addiction. Deep brain stimulation (DBS) has been applied to treat a number of neurological and psychiatric conditions, although its effects are transient and mediated by largely unknown mechanisms. Recently, optogenetic protocols that restore normal transmission at identified synapses in mice have provided proof of the idea that cocaine-adaptive behavior can be reversed in vivo. The most efficient protocol relies on the activation of metabotropic glutamate receptors, mGluRs, which depotentiates excitatory synaptic inputs onto dopamine D1 receptor medium-sized spiny neurons and normalizes drug-adaptive behavior. We discovered that acute low-frequency DBS, refined by selective blockade of dopamine D1 receptors, mimics optogenetic mGluR-dependent normalization of synaptic transmission. Consequently, there was a long-lasting abolishment of behavioral sensitization.	[Creed, Meaghan; Pascoli, Vincent Jean; Luescher, Christian] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Serv Neurol, Geneva, Switzerland	University of Geneva; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland.	christian.luscher@unige.ch	Creed, Meaghan/AAW-8136-2021; Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Creed, Meaghan/0000-0002-9658-2601	Swiss National Science Foundation; National Competence Center for Research Synapsy; European Brain Council; Carigest Foundation; Academic Society of Geneva; Fondation Divesa Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Competence Center for Research Synapsy; European Brain Council; Carigest Foundation; Academic Society of Geneva; Fondation Divesa Foundation	Funding was provided by the Swiss National Science Foundation, the National Competence Center for Research Synapsy, the European Brain Council (Advanced grant MeSSI), the Carigest Foundation, the Academic Society of Geneva, and the Fondation Divesa Foundation. We thank P. Pollak, D. Jabaudon, E. O'Connor, and A. Holtmaat for feedback on the manuscript and members of the Luscher lab for stimulating discussions. Data sets presented in this study are available at the University of Geneva open access data archive (www.archive-ouverte.unige.ch) with accession number 18515.	Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Cahill E, 2014, MOL PSYCHIATR, V19, P1295, DOI 10.1038/mp.2014.73; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chow BY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003101; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Creed MC, 2013, CURR OPIN NEUROBIOL, V23, P553, DOI 10.1016/j.conb.2013.03.005; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Follett KA, 2000, ANNU REV MED, V51, P135, DOI 10.1146/annurev.med.51.1.135; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Hahn PJ, 2010, J COMPUT NEUROSCI, V28, P425, DOI 10.1007/s10827-010-0225-8; Heinze HJ, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.022.2009; Huang CC, 2011, J NEUROSCI, V31, P4194, DOI 10.1523/JNEUROSCI.5239-10.2011; KALIVAS PW, 1988, J PHARMACOL EXP THER, V245, P1095; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Li Y, 1999, BEHAV BRAIN RES, V104, P119, DOI 10.1016/S0166-4328(99)00060-1; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luscher C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005710; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; MacAskill AF, 2014, NAT NEUROSCI, V17, P1198, DOI 10.1038/nn.3783; McCutcheon JE, 2011, J NEUROSCI, V31, P14536, DOI 10.1523/JNEUROSCI.3625-11.2011; Miocinovic S, 2013, JAMA NEUROL, V70, P163, DOI 10.1001/2013.jamaneurol.45; Muller UJ, 2013, ANN NY ACAD SCI, V1282, P119, DOI 10.1111/j.1749-6632.2012.06834.x; Okun M. S., 2010, NEW ENGL J MED, V28, P425; Pascoli V, 2014, NATURE, V509, P459, DOI 10.1038/nature13257; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Pierce RC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012880; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Reid MS, 1996, NEUROREPORT, V7, P1325, DOI 10.1097/00001756-199605170-00022; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schotanus SM, 2008, EUR J NEUROSCI, V27, P1957, DOI 10.1111/j.1460-9568.2008.06173.x; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; Thomas MJ, 2003, PHILOS T ROY SOC B, V358, P815, DOI 10.1098/rstb.2002.1236; Valjent E, 2010, NEUROPSYCHOPHARMACOL, V35, P401, DOI 10.1038/npp.2009.143; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vassoler FM, 2013, J NEUROSCI, V33, P14446, DOI 10.1523/JNEUROSCI.4804-12.2013; Williams NR, 2013, J CLIN INVEST, V123, P4546, DOI 10.1172/JCI68341; Wolf ME, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00072	44	182	190	0	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					659	664		10.1126/science.1260776	http://dx.doi.org/10.1126/science.1260776			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657248				2022-12-28	WOS:000349145200044
J	Cole, TB				Cole, Thomas B.			Coyote and Alders Alex Colville	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					448	449		10.1001/jama.2014.11555	http://dx.doi.org/10.1001/jama.2014.11555			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AV	25647189				2022-12-28	WOS:000349070300001
J	Etzioni, DA; Wasif, N; Dueck, AC; Cima, RR; Hohmann, SF; Naessens, JM; Mathur, AK; Habermann, EB				Etzioni, David A.; Wasif, Nabil; Dueck, Amylou C.; Cima, Robert R.; Hohmann, Samuel F.; Naessens, James M.; Mathur, Amit K.; Habermann, Elizabeth B.			Association of Hospital Participation in a Surgical Outcomes Monitoring Program With Inpatient Complications and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE Programs that analyze and report rates of surgical complications are an increasing focus of quality improvement efforts. The most comprehensive tool currently used for outcomes monitoring in the United States is the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP). OBJECTIVE To compare surgical outcomes experienced by patients treated at hospitals that did vs did not participate in the NSQIP. DESIGN, SETTING, AND PARTICIPANTS Data from the University HealthSystem Consortium from January 2009 to July 2013 were used to identify elective hospitalizations representing a broad spectrum of elective general/vascular operations in the United States. Data on hospital participation in the NSQIP were obtained through review of semiannual reports published by the ACS. Hospitalizations at any hospital that discontinued or initiated participation in the NSQIP during the study period were excluded after the date on which that hospital's status changed. A difference-in-differences approach was used to model the association between hospital-based participation in NSQIP and changes in rates of postoperative outcomes over time. EXPOSURE Hospital participation in the NSQIP. MAIN OUTCOMES AND MEASURES Risk-adjusted rates of any complications, serious complications, and mortality during a hospitalization for elective general/vascular surgery. RESULTS The cohort included 345 357 hospitalizations occurring in 113 different academic hospitals; 172 882 (50.1%) hospitalizations were in NSQIP hospitals. Hospitalized patients were predominantly female (61.5%), with a mean age of 55.7 years. The types of procedures performed most commonly in the analyzed hospitalizations were hernia repairs (15.7%), bariatric (10.5%), mastectomy (9.7%), and cholecystectomy (9.0%). After accounting for patient risk, procedure type, underlying hospital performance, and temporal trends, the difference-in-differences model demonstrated no statistically significant differences over time between NSQIP and non-NSQIP hospitals in terms of likelihood of complications (adjusted odds ratio, 1.00; 95% CI, 0.97-1.03), serious complications (adjusted odds ratio, 0.98; 95% CI, 0.94-1.03), or mortality (adjusted odds ratio, 1.04; 95% CI, 0.94-1.14). CONCLUSIONS AND RELEVANCE No association was found between hospital-based participation in the NSQIP and improvements in postoperative outcomes over time within a large cohort of patients undergoing elective general/vascular operations at academic hospitals in the United States. These findings suggest that a surgical outcomes reporting system does not provide a clear mechanism for quality improvement.	[Etzioni, David A.; Wasif, Nabil; Mathur, Amit K.] Mayo Clin Arizona, Dept Surg, Phoenix, AZ 85054 USA; [Etzioni, David A.; Wasif, Nabil; Dueck, Amylou C.; Cima, Robert R.; Naessens, James M.; Mathur, Amit K.; Habermann, Elizabeth B.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Surg Outcomes Div, Phoenix, AZ USA; [Cima, Robert R.] Mayo Clin Rochester, Dept Surg, Rochester, MN USA; [Hohmann, Samuel F.] Univ HealthSyst Consortium, Chicago, IL USA; [Hohmann, Samuel F.] Rush Univ, Dept Hlth Syst Management, Chicago, IL 60612 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Rush University	Etzioni, DA (corresponding author), Mayo Clin Arizona, Dept Surg, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA.	etzioni.david@mayo.edu		Habermann, Elizabeth/0000-0002-1140-003X				Abadie A, 2005, REV ECON STUD, V72, P1, DOI 10.1111/0034-6527.00321; Altom LK, 2012, AM J SURG, V204, P591, DOI 10.1016/j.amjsurg.2012.07.006; American College of Surgeons National Surgical Quality Improvement Program, 2014, ACS NSQIP SEMIANNUAL; Centers for Medicare & Medicaid Services, HOSPITAL ACQUIRED CO; Davenport DL, 2009, AM J MED QUAL, V24, P395, DOI 10.1177/1062860609339936; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Fetter RB, 1980, MED CARE S, V18, P1; Hall BL, 2009, ANN SURG, V250, P363, DOI 10.1097/SLA.0b013e3181b4148f; Hawn MT, 2011, ANN SURG, V254, P494, DOI 10.1097/SLA.0b013e31822c6929; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Health Care Cost Institute, 2014, 2013 HEALTH CARE COS; Ingraham AM, 2010, J AM COLL SURGEONS, V211, P705, DOI 10.1016/j.jamcollsurg.2010.09.006; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Lawson EH, 2012, ANN SURG, V256, P973, DOI 10.1097/SLA.0b013e31826b4c4f; Nicholas LH, 2010, ARCH SURG-CHICAGO, V145, P999, DOI 10.1001/archsurg.2010.191; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; Shih T, 2014, ANN SURG, V259, P677, DOI 10.1097/SLA.0000000000000425; Stulberg JJ, 2010, JAMA-J AM MED ASSOC, V303, P2479, DOI 10.1001/jama.2010.841; Urbach DR, 2014, NEW ENGL J MED, V370, P1029, DOI 10.1056/NEJMsa1308261	19	133	134	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					505	511		10.1001/jama.2015.90	http://dx.doi.org/10.1001/jama.2015.90			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AV	25647206	Bronze			2022-12-28	WOS:000349070300014
J	Hemmett, J; Qirjazi, E; Weir, MA; Moussa, M; Landry, YD; Gunaratnam, L				Hemmett, Juliya; Qirjazi, Elena; Weir, Matthew A.; Moussa, Madeleine; Landry, Yves D.; Gunaratnam, Lakshman			Cardiac, renal, and central nervous system dysfunction with eosinophilia: eosinophilic granulomatosis with polyangiitis	LANCET			English	Editorial Material							CHURG-STRAUSS-SYNDROME		[Hemmett, Juliya; Qirjazi, Elena; Weir, Matthew A.; Landry, Yves D.; Gunaratnam, Lakshman] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, Div Nephrol, London, ON N6G 0E7, Canada; [Moussa, Madeleine] Univ Western Ontario, Schulich Sch Med & Dent, Dept Pathol, London, ON N6G 0E7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Gunaratnam, L (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, Div Nephrol, 339 Windermere Rd, London, ON N6G 0E7, Canada.	Lakshman.Gunaratnam@lhsc.on.ca	Gunaratnam, Lakshman/G-3299-2011; Weir, Matthew/G-3354-2011	Gunaratnam, Lakshman/0000-0002-8845-1126; 				Cohen P, 2007, ARTHRIT RHEUM-ARTHR, V57, P686, DOI 10.1002/art.22679; Guillevin L, 1999, MEDICINE, V78, P26, DOI 10.1097/00005792-199901000-00003; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; Watts RA, 2000, ARTHRITIS RHEUM, V43, P414, DOI 10.1002/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0	5	4	4	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					480	480		10.1016/S0140-6736(14)62352-7	http://dx.doi.org/10.1016/S0140-6736(14)62352-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	25706976				2022-12-28	WOS:000348509900036
J	Romney, DK; Miller, SJ				Romney, David K.; Miller, Scott J.			Climbing Jacob's ladder	SCIENCE			English	Editorial Material							ROTATION; STATE		[Romney, David K.; Miller, Scott J.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Romney, DK (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	scott.miller@yale.edu	Miller, Scott/N-7761-2017	Miller, Scott/0000-0001-7817-1318; Romney, David/0000-0003-0498-7597				ALMENNINGEN A, 1985, J MOL STRUCT, V128, P59, DOI 10.1016/0022-2860(85)85041-9; Anslyn E.V., 2006, MODERN PHYS ORGANIC, P365; Han S, 2014, J ORG CHEM, V79, P8550, DOI 10.1021/jo501625f; Kemp JD, 1936, J CHEM PHYS, V4, P749, DOI 10.1063/1.1749784; KOSSIAKOFF AA, 1984, NATURE, V311, P582, DOI 10.1038/311582a0; PAULING L, 1948, NATURE, V161, P707, DOI 10.1038/161707a0; Pearson AD, 2015, SCIENCE, V347, P863, DOI 10.1126/science.aaa2424; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	10	2	2	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					829	829		10.1126/science.aaa5623	http://dx.doi.org/10.1126/science.aaa5623			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700504				2022-12-28	WOS:000349761100024
J	Amato, MBP; Meade, MO; Slutsky, AS; Brochard, L; Costa, ELV; Schoenfeld, DA; Stewart, TE; Briel, M; Talmor, D; Mercat, A; Richard, JCM; Carvalho, CRR; Brower, RG				Amato, Marcelo B. P.; Meade, Maureen O.; Slutsky, Arthur S.; Brochard, Laurent; Costa, Eduardo L. V.; Schoenfeld, David A.; Stewart, Thomas E.; Briel, Matthias; Talmor, Daniel; Mercat, Alain; Richard, Jean-Christophe M.; Carvalho, Carlos R. R.; Brower, Roy G.			Driving Pressure and Survival in the Acute Respiratory Distress Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							END-EXPIRATORY PRESSURE; ACUTE LUNG INJURY; RANDOMIZED CONTROLLED-TRIAL; TIDAL VOLUME VENTILATION; MECHANICAL VENTILATION; PULMONARY-EDEMA; STRATEGY; HYPERINFLATION; RECRUITMENT; AMPLITUDE	BACKGROUND Mechanical-ventilation strategies that use lower end-inspiratory (plateau) airway pressures, lower tidal volumes (V-T), and higher positive end-expiratory pressures (PEEPs) can improve survival in patients with the acute respiratory distress syndrome (ARDS), but the relative importance of each of these components is uncertain. Because respiratory-system compliance (C-RS) is strongly related to the volume of aerated remaining functional lung during disease (termed functional lung size), we hypothesized that driving pressure (Delta P=V-T/C-RS), in which V-T is intrinsically normalized to functional lung size (instead of predicted lung size in healthy persons), would be an index more strongly associated with survival than V-T or PEEP in patients who are not actively breathing. METHODS Using a statistical tool known as multilevel mediation analysis to analyze individual data from 3562 patients with ARDS enrolled in nine previously reported randomized trials, we examined Delta P as an independent variable associated with survival. In the mediation analysis, we estimated the isolated effects of changes in Delta P resulting from randomized ventilator settings while minimizing confounding due to the baseline severity of lung disease. RESULTS Among ventilation variables, Delta P was most strongly associated with survival. A 1-SD increment in Delta P (approximately 7 cm of water) was associated with increased mortality (relative risk, 1.41; 95% confidence interval [CI], 1.31 to 1.51; P<0.001), even in patients receiving "protective" plateau pressures and V-T (relative risk, 1.36; 95% CI, 1.17 to 1.58; P<0.001). Individual changes in V-T or PEEP after randomization were not independently associated with survival; they were associated only if they were among the changes that led to reductions in Delta P (mediation effects of Delta P, P=0.004 and P=0.001, respectively). CONCLUSIONS We found that Delta P was the ventilation variable that best stratified risk. Decreases in Delta P owing to changes in ventilator settings were strongly associated with increased survival. (Funded by Fundacao de Amparo e Pesquisa do Estado de Sao Paulo and others.)	[Amato, Marcelo B. P.; Costa, Eduardo L. V.; Carvalho, Carlos R. R.] Univ Sao Paulo, Heart Inst Incor, Div Pulm, Cardiopulm Dept, BR-01246903 Sao Paulo, Brazil; [Costa, Eduardo L. V.] Hosp Sirio Libanes, Res & Educ Inst, Sao Paulo, Brazil; [Meade, Maureen O.; Stewart, Thomas E.; Briel, Matthias] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Meade, Maureen O.; Stewart, Thomas E.; Briel, Matthias] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Slutsky, Arthur S.; Brochard, Laurent] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Slutsky, Arthur S.; Brochard, Laurent] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Slutsky, Arthur S.; Brochard, Laurent] Univ Toronto, Dept Med, Toronto, ON, Canada; [Schoenfeld, David A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Biostat Ctr, Boston, MA USA; [Talmor, Daniel] Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA; [Talmor, Daniel] Harvard Univ, Sch Med, Boston, MA USA; [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Mercat, Alain] Angers Univ Hosp, Dept Intens Care & Hyperbar Med, Angers, France; [Richard, Jean-Christophe M.] Gen Hosp Annecy, Emergency Dept, Annecy, France; [Richard, Jean-Christophe M.] Hop Henri Mondor, INSERM, UMR 955, F-94010 Creteil, France; [Brower, Roy G.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA	Universidade de Sao Paulo; Hospital Sirio Libanes; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Basel; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre Hospitalier Annecy Genevois; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Johns Hopkins University	Amato, MBP (corresponding author), Univ Sao Paulo, Fac Med, Av Dr Arnaldo 455,Sala 2144 2nd Fl, BR-01246903 Sao Paulo, Brazil.	amato.marcelo.bp@gmail.com	Mercat, Alain/AFU-4426-2022; amato, Marcelo Britto Passo/L-5001-2016; Slutsky, Arthur/M-3325-2019; Briel, Matthias/AAT-9284-2021; Costa, Eduardo/K-5841-2012; Carvalho, Carlos Roberto R/N-9827-2018	amato, Marcelo Britto Passo/0000-0003-3525-8282; Costa, Eduardo/0000-0002-6941-3626; Carvalho, Carlos Roberto R/0000-0002-1618-8509; Briel, Matthias/0000-0002-2070-5230	Fundacao de Amparo e Pesquisa do Estado de Sao Paulo	Fundacao de Amparo e Pesquisa do Estado de Sao Paulo	Funded by Fundacao de Amparo e Pesquisa do Estado de Sao Paulo and others.)	Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Garcia CSNB, 2004, RESP PHYSIOL NEUROBI, V144, P59, DOI 10.1016/j.resp.2004.07.023; GATTINONI L, 1987, AM REV RESPIR DIS, V136, P730, DOI 10.1164/ajrccm/136.3.730; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Gattinoni L, 2005, INTENS CARE MED, V31, P776, DOI 10.1007/s00134-005-2627-z; Gattinoni L, 1988, J Thorac Imaging, V3, P59, DOI 10.1097/00005382-198807000-00013; Grasso S, 2005, AM J RESP CRIT CARE, V171, P1002, DOI 10.1164/rccm.200407-940OC; Grasso S, 2007, AM J RESP CRIT CARE, V176, P761, DOI 10.1164/rccm.200702-193OC; Imai K., 2010, CAUSAL MEDIATION ANA, P129, DOI DOI 10.1007/978-1-4419-1764-5_8; Imai K, 2011, AM POLIT SCI REV, V105, P765, DOI 10.1017/S0003055411000414; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; Protti A, 2013, CRIT CARE MED, V41, P1046, DOI 10.1097/CCM.0b013e31827417a6; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ranieri VM, 1997, AM J RESP CRIT CARE, V156, P1082, DOI 10.1164/ajrccm.156.4.97-01052; Seah AS, 2011, ANN BIOMED ENG, V39, P1505, DOI 10.1007/s10439-010-0237-6; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Tschumperlin DJ, 2000, AM J RESP CRIT CARE, V162, P357, DOI 10.1164/ajrccm.162.2.9807003; Verbrugge SJC, 1998, INTENS CARE MED, V24, P172, DOI 10.1007/s001340050541; Vieira SRR, 1999, AM J RESP CRIT CARE, V159, P1612, DOI 10.1164/ajrccm.159.5.9805112; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556	34	1225	1310	6	91	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					747	755		10.1056/NEJMsa1410639	http://dx.doi.org/10.1056/NEJMsa1410639			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7PB	25693014	Green Published			2022-12-28	WOS:000349818700008
J	Hallonsten, O				Hallonsten, Olof			Europe needs fresh focus on big-science projects	NATURE			English	Editorial Material									Lund Univ, S-22100 Lund, Sweden	Lund University	Hallonsten, O (corresponding author), Lund Univ, S-22100 Lund, Sweden.	olof.hallonsten@fek.lu.se		Hallonsten, Olof/0000-0003-4546-3562				HALLONSTEN O, 2014, SCI PUBLIC POLICY	1	0	0	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					275	275		10.1038/518275a	http://dx.doi.org/10.1038/518275a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3SA	25693525	Bronze			2022-12-28	WOS:000349547400003
J	Ubel, PA; Comerford, DA; Johnson, E				Ubel, Peter A.; Comerford, David A.; Johnson, Eric			Healthcare.gov 3.0-Behavioral Economics and Insurance Exchanges	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ubel, Peter A.] Duke Univ, Fuqua Sch Business, Sch Med, Durham, NC 27706 USA; [Ubel, Peter A.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27706 USA; [Comerford, David A.] Univ Stirling, Econ Div, Stirling FK9 4LA, Scotland; [Comerford, David A.] Univ Stirling, Behav Sci Ctr, Stirling FK9 4LA, Scotland; [Johnson, Eric] Columbia Univ, Columbia Business Sch, New York, NY USA	Duke University; Duke University; University of Stirling; University of Stirling; Columbia University	Ubel, PA (corresponding author), Duke Univ, Fuqua Sch Business, Sch Med, Durham, NC 27706 USA.		Johnson, Eric/C-5668-2012	Johnson, Eric/0000-0001-7797-8347				Brockington D, 2003, POLIT BEHAV, V25, P1, DOI 10.1023/A:1022946710610; Johnson EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081521; Lynch JG, 2000, MARKET SCI, V19, P83, DOI 10.1287/mksc.19.1.83.15183	4	22	21	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					695	698		10.1056/NEJMp1414771	http://dx.doi.org/10.1056/NEJMp1414771			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB7PB	25693008				2022-12-28	WOS:000349818700002
J	Wessels, MR; Brigham, KS; DeMaria, A				Wessels, Michael R.; Brigham, Kathryn S.; DeMaria, Alfred, Jr.			Case 6-2015: A 16-Year-Old Boy with Coughing Spells	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACELLULAR PERTUSSIS-VACCINE; BORDETELLA-PERTUSSIS; ADVISORY-COMMITTEE; PREVENTING TETANUS; ADULT TETANUS; DIPHTHERIA; RECOMMENDATIONS; IMMUNIZATION; ADOLESCENTS; INFECTION		[Wessels, Michael R.] Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Brigham, Kathryn S.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [DeMaria, Alfred, Jr.] Massachusetts Dept Publ Hlth, William A Hinton State Lab Inst, Boston, MA USA; [Wessels, Michael R.; Brigham, Kathryn S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [DeMaria, Alfred, Jr.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Department of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wessels, MR (corresponding author), Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA.							Birkebaek NH, 1999, CLIN INFECT DIS, V29, P1239, DOI 10.1086/313448; Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; California Department of Public Health, PERT SUMM REP; Centers for Disease Control and Prevention, PERT SURV REP; Clark TA, 2012, TRENDS MICROBIOL, V20, P211, DOI 10.1016/j.tim.2012.03.003; CODY CL, 1981, PEDIATRICS, V68, P650; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Greenberg DP, 2009, PEDIATR INFECT DIS J, V28, P521, DOI 10.1097/INF.0b013e318199d2fc; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; Irwin RS, 2006, CHEST, V129, P1, DOI 10.1378/chest.129.1.1; Khoshoo V, 2009, CHEST, V136, P811, DOI 10.1378/chest.09-0649; Kirkland K. B., 2007, Morbidity and Mortality Weekly Report, V56, P837; Klein NP, 2013, PEDIATRICS, V131, pE1716, DOI 10.1542/peds.2012-3836; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Kretsinger Katrina, 2006, Morbidity and Mortality Weekly Report, V55, P1; Mandal S, 2012, PEDIATRICS, V129, pE424, DOI 10.1542/peds.2011-1710; MARCHANT CD, 1994, J INFECT DIS, V169, P1297, DOI 10.1093/infdis/169.6.1297; Menzies SL, 2009, CLIN VACCINE IMMUNOL, V16, P1781, DOI 10.1128/CVI.00248-09; MINK CM, 1992, CLIN INFECT DIS, V14, P464, DOI 10.1093/clinids/14.2.464; Misegades LK, 2012, JAMA-J AM MED ASSOC, V308, P2126, DOI 10.1001/jama.2012.14939; Pawloski LC, 2012, CLIN VACCINE IMMUNOL, V19, P875, DOI 10.1128/CVI.05686-11; Rank C, 2009, PEDIATR INFECT DIS J, V28, P152, DOI 10.1097/INF.0b013e318185608e; Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131; Shields MD, 2008, THORAX, V63, P1, DOI 10.1136/thx.2007.077370; SIBER GR, 1991, VACCINE, V9, P735, DOI 10.1016/0264-410X(91)90289-I; Skoff TH, 2012, ARCH PEDIAT ADOL MED, V166, P344, DOI 10.1001/archpediatrics.2011.1093; Tartof SY, 2013, PEDIATRICS, V131, pE1047, DOI 10.1542/peds.2012-1928; Thompson M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7027; Wagner JBC, 2013, PEDIATR CLIN N AM, V60, P951, DOI 10.1016/j.pcl.2013.04.004; Waites KB, 2003, PEDIATR PULM, V36, P267, DOI 10.1002/ppul.10346; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Wei SC, 2010, CLIN INFECT DIS, V51, P315, DOI 10.1086/653938; Witt MA, 2013, CLIN INFECT DIS, V56, P1248, DOI 10.1093/cid/cit046; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287; WRIGHT SW, 1995, JAMA-J AM MED ASSOC, V273, P1044, DOI 10.1001/jama.273.13.1044; Yih WK, 2000, J INFECT DIS, V182, P1409, DOI 10.1086/315863; YOUNG S A, 1987, Clinical Microbiology Newsletter, V9, P176, DOI 10.1016/0196-4399(87)90061-4	37	4	4	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					765	773		10.1056/NEJMcpc1411928	http://dx.doi.org/10.1056/NEJMcpc1411928			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7PB	25693017				2022-12-28	WOS:000349818700013
J	Coupland, C; Hill, T; Morriss, R; Arthur, A; Moore, M; Hippisley-Cox, J				Coupland, Carol; Hill, Trevor; Morriss, Richard; Arthur, Antony; Moore, Michael; Hippisley-Cox, Julia			Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; RANDOMIZED CONTROLLED-TRIALS; TIME TREND; DEPRESSION; ADULTS; RATES; ASSOCIATION; DISORDERS; ENGLAND; PLACEBO	OBJECTIVE To assess the associations between different antidepressant treatments and the rates of suicide and attempted suicide or self harm in people with depression. DESIGN Cohort study. SETTING Patients registered with UK general practices contributing data to the QResearch database. PARTICIPANTS 238 963 patients aged 20 to 64 years with a first diagnosis of depression between 1 January 2000 and 31 July 2011, followed up until 1 August 2012. EXPOSURES Antidepressant class (tricyclic and related antidepressants, selective serotonin reuptake inhibitors, other antidepressants), dose, and duration of use, and commonly prescribed individual antidepressant drugs. Cox proportional hazards models were used to calculate hazard ratios adjusting for potential confounding variables. MAIN OUTCOME MEASURES Suicide and attempted suicide or self harm during follow-up. RESULTS During follow-up, 87.7% (n=209 476) of the cohort received one or more prescriptions for antidepressants. The median duration of treatment was 221 days (interquartile range 79-590 days). During the first five years of follow-up 198 cases of suicide and 5243 cases of attempted suicide or self harm occurred. The difference in suicide rates during periods of treatment with tricyclic and related antidepressants compared with selective serotonin reuptake inhibitors was not significant (adjusted hazard ratio 0.84, 95% confidence interval 0.47 to 1.50), but the suicide rate was significantly increased during periods of treatment with other antidepressants (2.64, 1.74 to 3.99). The hazard ratio for suicide was significantly increased for mirtazapine compared with citalopram (3.70, 2.00 to 6.84). Absolute risks of suicide over one year ranged from 0.02% for amitriptyline to 0.19% for mirtazapine. There was no significant difference in the rate of attempted suicide or self harm with tricyclic antidepressants (0.96, 0.87 to 1.08) compared with selective serotonin reuptake inhibitors, but the rate of attempted suicide or self harm was significantly higher for other antidepressants (1.80, 1.61 to 2.00). The adjusted hazard ratios for attempted suicide or self harm were significantly increased for three of the most commonly prescribed drugs compared with citalopram: venlafaxine (1.85, 1.61 to 2.13), trazodone (1.73, 1.26 to 2.37), and mirtazapine (1.70, 1.44 to 2.02), and significantly reduced for amitriptyline (0.71, 0.59 to 0.85). The absolute risks of attempted suicide or self harm over one year ranged from 1.02% for amitriptyline to 2.96% for venlafaxine. Rates were highest in the first 28 days after starting treatment and remained increased in the first 28 days after stopping treatment. CONCLUSION Rates of suicide and attempted suicide or self harm were similar during periods of treatment with selective serotonin reuptake inhibitors and tricyclic and related antidepressants. Mirtazapine, venlafaxine, and trazodone were associated with the highest rates of suicide and attempted suicide or self harm, but the number of suicide events was small leading to imprecise estimates. As this is an observational study the findings may reflect indication biases and residual confounding from severity of depression and differing characteristics of patients prescribed these drugs. The increased rates in the first 28 days of starting and stopping antidepressants emphasise the need for careful monitoring of patients during these periods.	[Coupland, Carol; Hill, Trevor; Hippisley-Cox, Julia] Univ Nottingham, Sch Med, Div Primary Care, Nottingham NG7 2RD, England; [Morriss, Richard] Inst Mental Hlth, Nottingham, England; [Arthur, Antony] Univ E Anglia, Sch Hlth Sci, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England; [Moore, Michael] Univ Southampton, Sch Med, Aldermoor Hlth Ctr, Southampton, Hants, England	University of Nottingham; University of East Anglia; University of Southampton	Coupland, C (corresponding author), Univ Nottingham, Sch Med, Div Primary Care, Univ Pk, Nottingham NG7 2RD, England.	carol.coupland@nottingham.ac.uk	Moore, Michael/C-3447-2011; Hippisley-Cox, Julia/AAY-2788-2020	Moore, Michael/0000-0002-5127-4509; Hippisley-Cox, Julia/0000-0002-2479-7283; Morriss, Richard/0000-0003-2910-4121; Hill, Trevor/0000-0002-0277-4988; Arthur, Antony/0000-0001-8617-5714; Coupland, Carol/0000-0002-2327-3306	National Institute for Health Research (NIHR) School for Primary Care Research [81]; NIHR Collaboration for Leadership in Applied Health Research and Care East Midlands (CLAHRC EM)	National Institute for Health Research (NIHR) School for Primary Care Research(National Institute for Health Research (NIHR)); NIHR Collaboration for Leadership in Applied Health Research and Care East Midlands (CLAHRC EM)	This project was funded by the National Institute for Health Research (NIHR) School for Primary Care Research (project No 81). RM's contribution to the study has been funded through the NIHR Collaboration for Leadership in Applied Health Research and Care East Midlands (CLAHRC EM). The funding body did not play a role in the study design, writing of the manuscript, or the decision to submit the manuscript for publication.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Anderson IM, 2008, J PSYCHOPHARMACOL, V22, P343, DOI 10.1177/0269881107088441; Arroll B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007954; Barbui C, 2009, CAN MED ASSOC J, V180, P291, DOI 10.1503/cmaj.081514; Barr Ben, 2012, BMJ, V345, pe5142, DOI 10.1136/bmj.e5142; Cameron IM, 2011, J AFFECT DISORDERS, V130, P99, DOI 10.1016/j.jad.2010.10.010; Cassano P, 2002, J PSYCHOSOM RES, V53, P849, DOI 10.1016/S0022-3999(02)00304-5; Chang SS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5239; Coupland C, 2011, HLTH TECHNOL ASSESS, V15; Coupland C, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-135; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Department of Health, 2014, STAT UPD SUIC; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Friedman RA, 2007, NEW ENGL J MED, V356, P2343, DOI 10.1056/NEJMp078015; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P572, DOI 10.1001/archgenpsychiatry.2011.2044; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Gunnell D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6030; Hall GC, 2009, PHARMACOEPIDEM DR S, V18, P120, DOI 10.1002/pds.1686; Hall WD, 2006, LANCET, V367, P1959, DOI 10.1016/S0140-6736(06)68860-0; Hammad TA, 2006, J CLIN PSYCHOPHARM, V26, P203, DOI 10.1097/01.jcp.0000203198.11453.95; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Hawton K, 2010, BRIT J PSYCHIAT, V196, P354, DOI 10.1192/bjp.bp.109.070219; Healy D, 2003, J PSYCHIATR NEUROSCI, V28, P331; Hippisley-Cox J, 2001, BRIT MED J, V323, P666, DOI 10.1136/bmj.323.7314.666; Khan A, 2003, AM J PSYCHIAT, V160, P790, DOI 10.1176/appi.ajp.160.4.790; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Mines D, 2005, PHARMACOEPIDEM DR S, V14, P367, DOI 10.1002/pds.1095; National Institute for Health and Care Excellence, 2009, DEPR AD TREATM MAN D, V90; Office for National Statistics, 2013, SUIC UK 2011; Pompili M, 2010, PHARMACEUTICALS, V3, P2861, DOI 10.3390/ph3092861; Rubino A, 2007, BMJ-BRIT MED J, V334, P242, DOI 10.1136/bmj.39041.445104.BE; Schneeweiss S, 2010, ARCH GEN PSYCHIAT, V67, P497, DOI 10.1001/archgenpsychiatry.2010.39; Stone M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2880; Terluin B, 2002, GEN HOSP PSYCHIAT, V24, P396, DOI 10.1016/S0163-8343(02)00211-6; Tiihonen J, 2006, ARCH GEN PSYCHIAT, V63, P1358, DOI 10.1001/archpsyc.63.12.1358; Valenstein M, 2012, J CLIN PSYCHOPHARM, V32, P346, DOI 10.1097/JCP.0b013e3182539f11; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	38	49	50	3	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2015	350								h517	10.1136/BMJ.h517	http://dx.doi.org/10.1136/BMJ.h517			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB8WC	25693810	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000349911500003
J	Simon, G				Simon, Gregory			New use of atypical antipsychotics was linked to acute kidney injury and all-cause mortality at 90 days	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Grp Hlth Res Inst, Seattle, WA 98101 USA		Simon, G (corresponding author), Grp Hlth Res Inst, Seattle, WA 98101 USA.							Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; Maglione M, 2011, COMPARATIVE EFFECTIV, V43; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4							JC12	10.7326/ACPJC-2015-162-4-012	http://dx.doi.org/10.7326/ACPJC-2015-162-4-012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686187				2022-12-28	WOS:000350232500003
J	Worden, AZ; Follows, MJ; Giovannoni, SJ; Wilken, S; Zimmerman, AE; Keeling, PJ				Worden, Alexandra Z.; Follows, Michael J.; Giovannoni, Stephen J.; Wilken, Susanne; Zimmerman, Amy E.; Keeling, Patrick J.			Rethinking the marine carbon cycle: Factoring in the multifarious lifestyles of microbes	SCIENCE			English	Review							OPEN-OCEAN; FOOD-WEB; WIDESPREAD OCCURRENCE; BIOLOGICAL PROCESSES; NITROGEN-FIXATION; GRAZING IMPACT; CLIMATE-CHANGE; BACTERIAL; DIVERSITY; DYNAMICS	The profound influence of marine plankton on the global carbon cycle has been recognized for decades, particularly for photosynthetic microbes that form the base of ocean food chains. However, a comprehensive model of the carbon cycle is challenged by unicellular eukaryotes (protists) having evolved complex behavioral strategies and organismal interactions that extend far beyond photosynthetic lifestyles. As is also true for multicellular eukaryotes, these strategies and their associated physiological changes are difficult to deduce from genome sequences or gene repertoires-a problem compounded by numerous unknown function proteins. Here, we explore protistan trophic modes in marine food webs and broader biogeochemical influences. We also evaluate approaches that could resolve their activities, link them to biotic and abiotic factors, and integrate them into an ecosystems biology framework.	[Worden, Alexandra Z.; Wilken, Susanne; Zimmerman, Amy E.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Worden, Alexandra Z.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Worden, Alexandra Z.; Keeling, Patrick J.] Canadian Inst Adv Res, Integrated Microbial Biodivers Program, Toronto, ON M5G 1Z8, Canada; [Follows, Michael J.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	Monterey Bay Aquarium Research Institute; University of California System; University of California Santa Cruz; Canadian Institute for Advanced Research (CIFAR); Massachusetts Institute of Technology (MIT); Oregon State University; University of British Columbia	Worden, AZ (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	azworden@mbari.org	Worden, Alexandra Z./AAD-6567-2019	Wilken, Susanne/0000-0002-3852-557X; Worden, Alexandra/0000-0002-9888-9324; Keeling, Patrick/0000-0002-7644-0745	Guggenheim Fellowship; Tula Foundation; NSF [OCE-1436865, GBMF3305, GBMF3307]; Moore Marine Microbiology Investigator awards [GBMF3788, GBMF3778]	Guggenheim Fellowship; Tula Foundation; NSF(National Science Foundation (NSF)); Moore Marine Microbiology Investigator awards	We thank C. Bachy, F. Burki, S. Haddock, R. Harbeitner, and L. Klosterman for comments and criticism; T. A. Richards and A. Santoro for discussions; C. Alves-de-Souza, P. Burkhardt, K. Carpenter, J. Decelle, J. Fell, T. Heger, N. King, D. Klimov, C. Leander, K. K. Newell, N. Okamoto, F. Spiegel, T. Walsh, L. Weiss, and N. Yubuki for a subset of the images used here; and A. Gough, M. Salisbury, H. Hadaway, M. Stoermer, and D. Fierstein. Supported by a Guggenheim Fellowship and Tula Foundation award (P.J.K.), by NSF OCE-1436865 (S.J.G.), GBMF3305 (A.E.Z./A.Z.W.), GBMF3307 (S.W./A.Z.W.), and by Moore Marine Microbiology Investigator awards GBMF3788 and GBMF3778 (A.Z.W. and M.J.F., respectively).	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Alegado RA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016162; Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Ashworth J, 2013, P NATL ACAD SCI USA, V110, P7518, DOI 10.1073/pnas.1300962110; Azam F, 2004, SCIENCE, V303, P1622, DOI 10.1126/science.1093892; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Bachvaroff TR, 2012, APPL ENVIRON MICROB, V78, P334, DOI 10.1128/AEM.06678-11; Beardall J, 2009, PLANT ECOL DIVERS, V2, P191, DOI 10.1080/17550870903271363; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Bender SJ, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00003; Berge T, 2012, ISME J, V6, P1926, DOI 10.1038/ismej.2012.29; Bertrand EM, 2012, P NATL ACAD SCI USA, V109, pE1762, DOI 10.1073/pnas.1201731109; BIRD DF, 1986, SCIENCE, V231, P493, DOI 10.1126/science.231.4737.493; Blossom HE, 2012, HARMFUL ALGAE, V17, P40, DOI 10.1016/j.hal.2012.02.010; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Boyd PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063091; Boyd PW, 2012, MAR ECOL PROG SER, V470, P125, DOI 10.3354/meps10121; Brate J, 2012, PROTIST, V163, P767, DOI 10.1016/j.protis.2012.04.004; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Brussaard CPD, 2013, BIOGEOSCIENCES, V10, P719, DOI 10.5194/bg-10-719-2013; Burki F, 2014, CURR BIOL, V24, pR103, DOI 10.1016/j.cub.2013.12.025; Carini P, 2014, ISME J, V8, P1727, DOI 10.1038/ismej.2014.61; Caron DA, 2012, ANNU REV MAR SCI, V4, P467, DOI 10.1146/annurev-marine-120709-142802; Caron DA, 2009, ISME J, V3, P4, DOI 10.1038/ismej.2008.101; Chambouvet A, 2011, PROTIST, V162, P637, DOI 10.1016/j.protis.2010.12.001; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; Dayel MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095577; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Decelle J, 2012, P NATL ACAD SCI USA, V109, P18000, DOI 10.1073/pnas.1212303109; Deschamps P, 2012, GENOME BIOL EVOL, V4, P795, DOI 10.1093/gbe/evs053; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DROOP MR, 1968, J MAR BIOL ASSOC UK, V48, P689, DOI 10.1017/S0025315400019238; Duanmu DQ, 2014, P NATL ACAD SCI USA, V111, P15827, DOI 10.1073/pnas.1416751111; Dyhrman S, 2005, HARMFUL ALGAE, V4, P619, DOI 10.1016/j.hal.2004.08.011; ESTEP KW, 1986, LIMNOL OCEANOGR, V31, P646, DOI 10.4319/lo.1986.31.3.0646; Evans C, 2008, LIMNOL OCEANOGR, V53, P2035, DOI 10.4319/lo.2008.53.5.2035; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412; Floder S, 2006, PROTIST, V157, P291, DOI 10.1016/j.protis.2006.05.002; Flynn KJ, 2013, J PLANKTON RES, V35, P3, DOI 10.1093/plankt/fbs062; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Foster RA, 2011, ISME J, V5, P1484, DOI 10.1038/ismej.2011.26; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; Frias-Lopez J, 2009, ENVIRON MICROBIOL, V11, P512, DOI 10.1111/j.1462-2920.2008.01793.x; Giering SLC, 2014, NATURE, V507, P480, DOI 10.1038/nature13123; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; Gomez F, 2011, ENVIRON MICROBIOL, V13, P193, DOI 10.1111/j.1462-2920.2010.02320.x; Guasto JS, 2012, ANNU REV FLUID MECH, V44, P373, DOI 10.1146/annurev-fluid-120710-101156; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Guillou L, 2001, AQUAT MICROB ECOL, V26, P201, DOI 10.3354/ame026201; Guillou L, 2010, MICROBIOL TODAY, V37, P92; Haaber J, 2009, ISME J, V3, P430, DOI 10.1038/ismej.2008.125; Halsey KH, 2015, ANNU REV MAR SCI, V7, P265, DOI 10.1146/annurev-marine-010814-015813; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; Hartmann M, 2012, P NATL ACAD SCI USA, V109, P5756, DOI 10.1073/pnas.1118179109; Hendry KR, 2014, QUATERNARY SCI REV, V89, P13, DOI 10.1016/j.quascirev.2014.01.019; Higgins MB, 2012, P NATL ACAD SCI USA, V109, P2269, DOI 10.1073/pnas.1104313109; Hilton JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2748; Huff JT, 2014, CELL, V156, P1286, DOI 10.1016/j.cell.2014.01.029; Janouskovec J, 2012, CURR BIOL, V22, pR518, DOI 10.1016/j.cub.2012.04.047; Jardillier L, 2010, ISME J, V4, P1180, DOI 10.1038/ismej.2010.36; Jasti S, 2005, APPL ENVIRON MICROB, V71, P3483, DOI 10.1128/AEM.71.7.3483-3494.2005; Karl DM, 2012, P NATL ACAD SCI USA, V109, P1842, DOI 10.1073/pnas.1120312109; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; Keeling PJ, 2013, ENV MICROBIOL REP, V5, P5, DOI DOI 10.1111/1758-2229.12021; Kim E, 2011, P NATL ACAD SCI USA, V108, P1496, DOI 10.1073/pnas.1013337108; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kleiner M, 2012, P NATL ACAD SCI USA, V109, pE1173, DOI 10.1073/pnas.1121198109; KNIGHTJONES EW, 1951, NATURE, V167, P445, DOI 10.1038/167445a0; Landry ZC, 2013, METHOD ENZYMOL, V531, P61, DOI 10.1016/B978-0-12-407863-5.00004-6; Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x; Lehahn Y, 2014, CURR BIOL, V24, P2041, DOI 10.1016/j.cub.2014.07.046; Lewandowska AM, 2014, ECOL LETT, V17, P614, DOI 10.1111/ele.12265; Li Q, 2013, MICROB ECOL, V66, P823, DOI 10.1007/s00248-013-0275-3; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Lin YC, 2012, APPL ENVIRON MICROB, V78, P3387, DOI 10.1128/AEM.06952-11; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; Massana R, 2014, ISME J, V8, P854, DOI 10.1038/ismej.2013.204; Massana R, 2011, ANNU REV MICROBIOL, V65, P91, DOI 10.1146/annurev-micro-090110-102903; Massana R, 2009, ISME J, V3, P588, DOI 10.1038/ismej.2008.130; McCutcheon JP, 2011, CURR BIOL, V21, P1366, DOI 10.1016/j.cub.2011.06.051; McRose D, 2014, ISME J, V8, P2517, DOI 10.1038/ismej.2014.146; Meyer E, 2012, BIOL BULL-US, V223, P44, DOI 10.1086/BBLv223n1p44; Mills MM, 2010, NAT GEOSCI, V3, P412, DOI 10.1038/NGEO856; Mitra A, 2014, BIOGEOSCIENCES, V11, P995, DOI 10.5194/bg-11-995-2014; Monier A, 2013, ISME J, V7, P1764, DOI 10.1038/ismej.2013.70; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; Orsi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056335; Orsi WD, 2013, NATURE, V499, P205, DOI 10.1038/nature12230; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Palsson BO., 2006, SYSTEMS BIOL PROPERT; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Raghukumar S, 2011, BOT MAR, V54, P3, DOI 10.1515/BOT.2011.008; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Rendon-Maldonado JG, 1998, EXP PARASITOL, V89, P241, DOI 10.1006/expr.1998.4297; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Richardson TL, 2007, SCIENCE, V315, P838, DOI 10.1126/science.1133471; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; RILEY GA, 1946, J MAR RES, V6, P54; Roberts EC, 2011, J PLANKTON RES, V33, P833, DOI 10.1093/plankt/fbr005; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; Roy RS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04780; Sapp M, 2007, MICROB ECOL, V53, P683, DOI 10.1007/s00248-006-9162-5; Schmoker C, 2013, J PLANKTON RES, V35, P691, DOI 10.1093/plankt/fbt023; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; Seenivasan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059565; Sheik AR, 2014, ISME J, V8, P212, DOI 10.1038/ismej.2013.135; Sherr BF, 2007, OCEANOGRAPHY, V20, P130, DOI 10.5670/oceanog.2007.57; Sherr EB, 2013, DEEP-SEA RES PT II, V94, P57, DOI 10.1016/j.dsr2.2013.03.019; Short SM, 2012, ENVIRON MICROBIOL, V14, P2253, DOI 10.1111/j.1462-2920.2012.02706.x; Slamovits CH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1188; Slapeta J, 2006, MOL BIOL EVOL, V23, P23, DOI 10.1093/molbev/msj001; Steele JA, 2011, ISME J, V5, P1414, DOI 10.1038/ismej.2011.24; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Stoeck T, 2014, ADV ECOL, V2014, DOI DOI 10.1155/2014/532687; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Stoecker DK, 2003, AQUAT MICROB ECOL, V30, P175, DOI 10.3354/ame030175; Sun J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023973; SWANBERG NR, 1991, J PLANKTON RES, V13, P287, DOI 10.1093/plankt/13.2.287; Thomas R., 2012, LIMNOL OCEANOGR, V3, P1, DOI [10.1080/19475721.2012.672338, DOI 10.1080/19475721.2012.672338]; Thompson AW, 2012, SCIENCE, V337, P1546, DOI 10.1126/science.1222700; Tillmann U, 1998, AQUAT MICROB ECOL, V14, P155, DOI 10.3354/ame014155; Tittel J, 2003, P NATL ACAD SCI USA, V100, P12776, DOI 10.1073/pnas.2130696100; Treguer PJ, 2013, ANNU REV MAR SCI, V5, P477, DOI 10.1146/annurev-marine-121211-172346; Troost TA, 2005, MATH BIOSCI, V193, P159, DOI 10.1016/j.mbs.2004.06.010; Unrein F, 2014, ISME J, V8, P164, DOI 10.1038/ismej.2013.132; Vage S, 2013, AQUAT ECOL, V47, P329, DOI 10.1007/s10452-013-9447-y; van Ooijen G, 2012, JOVE-J VIS EXP, DOI 10.3791/4074; Vardi A, 2012, P NATL ACAD SCI USA, V109, P19327, DOI 10.1073/pnas.1208895109; Vaulot D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039648; Verhelst B, 2013, GENOME BIOL EVOL, V5, P2393, DOI 10.1093/gbe/evt189; Ward BA, 2012, LIMNOL OCEANOGR, V57, P1877, DOI 10.4319/lo.2012.57.6.1877; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0; Wells ML, 2002, BIOGEOCHEMISTRY MARI, P367, DOI DOI 10.1016/B978-012323841-2/50009-9; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Wilken S, 2013, ECOL LETT, V16, P225, DOI 10.1111/ele.12033; Wohlers J, 2009, P NATL ACAD SCI USA, V106, P7067, DOI 10.1073/pnas.0812743106; Worden AZ, 2012, CURR BIOL, V22, pR675, DOI 10.1016/j.cub.2012.07.054; Worden AZ, 2010, CURR OPIN MICROBIOL, V13, P652, DOI 10.1016/j.mib.2010.08.001; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Worden AZ, 2004, LIMNOL OCEANOGR, V49, P168, DOI 10.4319/lo.2004.49.1.0168; Worden AZ, 2003, AQUAT MICROB ECOL, V30, P159, DOI 10.3354/ame030159; Yoon HS, 2011, SCIENCE, V332, P714, DOI 10.1126/science.1203163; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819; Ziveri P, 2007, DEEP-SEA RES PT II, V54, P659, DOI 10.1016/j.dsr2.2007.01.006	159	393	404	64	557	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223							1257594	10.1126/science.1257594	http://dx.doi.org/10.1126/science.1257594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678667				2022-12-28	WOS:000349221300038
J	Chen, GB; Mulla, WA; Kucharavy, A; Tsai, HJ; Rubinstein, B; Conkright, J; McCroskey, S; Bradford, WD; Weems, L; Haug, JS; Seidel, CW; Berman, J; Li, R				Chen, Guangbo; Mulla, Wahid A.; Kucharavy, Andrei; Tsai, Hung-Ji; Rubinstein, Boris; Conkright, Juliana; McCroskey, Scott; Bradford, William D.; Weems, Lauren; Haug, Jeff S.; Seidel, Chris W.; Berman, Judith; Li, Rong			Targeting the Adaptability of Heterogeneous Aneuploids	CELL			English	Article							CHROMOSOMAL INSTABILITY; CANDIDA-ALBICANS; INTRATUMOR HETEROGENEITY; RESISTANT LEISHMANIA; PROTEIN HOMEOSTASIS; GENE AMPLIFICATION; ADAPTIVE EVOLUTION; BREAST-CANCER; YEAST; EXPRESSION	Aneuploid genomes, characterized by unbalanced chromosome stoichiometry (karyotype), are associated with cancer malignancy and drug resistance of pathogenic fungi. The phenotypic diversity resulting from karyotypic diversity endows the cell population with superior adaptability. We show here, using a combination of experimental data and a general stochastic model, that the degree of phenotypic variation, thus evolvability, escalates with the degree of overall growth suppression. Such scaling likely explains the challenge of treating aneuploidy diseases with a single stress-inducing agent. Instead, we propose the design of an "evolutionary trap'' (ET) targeting both karyotypic diversity and fitness. This strategy entails a selective condition "channeling'' a karyotypically divergent population into one with a predominant and predictably drugable karyotypic feature. We provide a proof-of-principle case in budding yeast and demonstrate the potential efficacy of this strategy toward aneuploidy-based azole resistance in Candida albicans. By analyzing existing pharmacogenomics data, we propose the potential design of an ET against glioblastoma.	[Chen, Guangbo; Mulla, Wahid A.; Kucharavy, Andrei; Tsai, Hung-Ji; Rubinstein, Boris; Conkright, Juliana; McCroskey, Scott; Bradford, William D.; Weems, Lauren; Haug, Jeff S.; Seidel, Chris W.; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Chen, Guangbo; Mulla, Wahid A.; Li, Rong] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Kucharavy, Andrei] Univ Paris 06, Sorbonne Univ, UMR 7238, F-75005 Paris, France; [Berman, Judith] Tel Aviv Univ, George Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Ramat Aviv, Israel	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University	Li, R (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	rli@stowers.org	Berman, Judith/AAS-5115-2021; Mulla, Wahid/C-2393-2019; Berman, Judith/ABA-8528-2021	Mulla, Wahid/0000-0003-3356-3902; Berman, Judith/0000-0002-8577-0084; Tsai, Hung-Ji/0000-0003-4192-9310	NIH [RO1GM059964]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Amon for providing the set of disomy aneuploid yeast strains and J. Gerton for sharing haploid yeast RNA-seq data. This work was supported by NIH grant RO1GM059964 to R.L.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Charles JS, 2010, GENETICS, V186, P537, DOI 10.1534/genetics.110.121533; Chen GB, 2012, BIOESSAYS, V34, P893, DOI 10.1002/bies.201200069; Chen GB, 2012, NATURE, V482, P246, DOI 10.1038/nature10795; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Harrison BD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001815; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Infante JJ, 2003, GENETICS, V165, P1745; Jones L, 2010, J EXP MED, V207, P2581, DOI 10.1084/jem.20091071; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kvitek DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000223; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Mannaert A, 2012, TRENDS PARASITOL, V28, P370, DOI 10.1016/j.pt.2012.06.003; Marichal P, 1997, ANTIMICROB AGENTS CH, V41, P2229, DOI 10.1128/AAC.41.10.2229; Marr KA, 1997, CLIN INFECT DIS, V25, P908, DOI 10.1086/515553; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Minning TA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-139; Mitelman F, 2012, MITELMAN DATABASE CH; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ng AP, 2010, BLOOD, V115, P3966, DOI 10.1182/blood-2009-09-242107; Ni M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001653; Okoli I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007025; Oromendia AB, 2014, DIS MODEL MECH, V7, P15, DOI 10.1242/dmm.013391; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Sareen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007630; Selmecki A, 2008, MOL MICROBIOL, V68, P624, DOI 10.1111/j.1365-2958.2008.06176.x; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; SINGH A, 1979, NATURE, V277, P146, DOI 10.1038/277146a0; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; SMITH TC, 1976, CLIN PHARMACOL THER, V19, P802; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Spitzer M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.31; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Taylor TE, 2012, CURR CANCER DRUG TAR, V12, P197; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Zhu J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002719	62	85	85	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					771	784		10.1016/j.cell.2015.01.026	http://dx.doi.org/10.1016/j.cell.2015.01.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25679766	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000349208800018
J	Slanetz, PJ; Freer, PE; Birdwell, RL				Slanetz, Priscilla J.; Freer, Phoebe E.; Birdwell, Robyn L.			Breast-Density Legislation - Practical Considerations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MAMMOGRAPHY; CANCER		[Slanetz, Priscilla J.] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Slanetz, Priscilla J.; Freer, Phoebe E.; Birdwell, Robyn L.] Harvard Univ, Sch Med, Boston, MA USA; [Freer, Phoebe E.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Birdwell, Robyn L.] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Slanetz, PJ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Radiol, 330 Brookline Ave, Boston, MA 02215 USA.			Freer, Phoebe/0000-0001-6886-7100; Slanetz, Priscilla/0000-0003-1248-5116				Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Hooley RJ, 2012, RADIOLOGY, V265, P59, DOI 10.1148/radiol.12120621; Kerlikowske K, 2011, ANN INTERN MED, V155, P493, DOI 10.7326/0003-4819-155-8-201110180-00005; Smith RA, 2004, RADIOL CLIN N AM, V42, P793, DOI 10.1016/j.rcl.2004.06.014; Tice JA, 2013, COMP CLIN EFFECTIVEN	5	48	48	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7					593	595		10.1056/NEJMp1413728	http://dx.doi.org/10.1056/NEJMp1413728			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA8CK	25671249				2022-12-28	WOS:000349143900001
J	Ormond-Walshe, S; Furniss, R; Harris, A; Winfield, K; Haigh, DA				Ormond-Walshe, Sarah; Furniss, Richard; Harris, Andrew; Winfield, Katie; Haigh, Dominic A.			Inquests into patients who die while under a deprivation of liberty order	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ormond-Walshe, Sarah] Inner South London, West London, England; [Ormond-Walshe, Sarah] Inner South London, London, Staffs, England; [Furniss, Richard] 42 Bedford Row Chambers, London, England; [Harris, Andrew] Inner South London, London, England; [Winfield, Katie] Keele Univ, Sch Med, Keele, Staffs, England; [Haigh, Dominic A.] Univ Oradea, Oradea, Romania	Keele University; University of Oradea	Ormond-Walshe, S (corresponding author), Inner South London, West London, England.							[Anonymous], 2014, ANN REPORT; [Anonymous], 2014, GUID 16 DEPR LIB SAF; Anthony D, 2005, CLIN EFFECTIVENESS N, V9, P26; McGhie F, 2014, INQUEST LAW, V30, P13	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2015	350								h501	10.1136/bmj.h501	http://dx.doi.org/10.1136/bmj.h501			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LA	25666725				2022-12-28	WOS:000349316200002
J	Amores-Hernandez, I; Besser, REJ; Dattani, MT; Inwald, DP				Amores-Hernandez, Irene; Besser, Rachel E. J.; Dattani, Mehul Tulsidas; Inwald, David Philip			A 12-year-old child with fever, headache, shock, and coma	LANCET			English	Editorial Material							ADDISONS-DISEASE		[Amores-Hernandez, Irene; Inwald, David Philip] St Marys Hosp, Paediat Intens Care Unit, London W2 1NY, England; [Besser, Rachel E. J.] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Dattani, Mehul Tulsidas] Inst Child Hlth, London, England	Imperial College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Inwald, DP (corresponding author), St Marys Hosp, Paediat Intens Care Unit, Praed St, London W2 1NY, England.	d.inwald@imperial.ac.uk		Besser, Rachel/0000-0002-4645-6324; Inwald, David/0000-0001-9518-7821				Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Condulis N, 1997, CLIN PEDIATR, V36, P711, DOI 10.1177/000992289703601208; Geenen C, 1996, CAN J NEUROL SCI, V23, P141, DOI 10.1017/S0317167100038889; Hsieh S, 2011, J CLIN ENDOCR METAB, V96, pE925, DOI 10.1210/jc.2011-0015; Myers KA, 2010, ENDOCR PRACT, V16, P433, DOI 10.4158/EP09282.CR	5	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					576	576						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AV	25705844				2022-12-28	WOS:000349213600036
J	Bonachela, JA; Pringle, RM; Sheffer, E; Coverdale, TC; Guyton, JA; Caylor, KK; Levin, SA; Tarnita, CE				Bonachela, Juan A.; Pringle, Robert M.; Sheffer, Efrat; Coverdale, Tyler C.; Guyton, Jennifer A.; Caylor, Kelly K.; Levin, Simon A.; Tarnita, Corina E.			Termite mounds can increase the robustness of dryland ecosystems to climatic change	SCIENCE			English	Article							MUSSEL BED ECOSYSTEMS; PATTERN-FORMATION; SELF-ORGANIZATION; VEGETATION; SYSTEMS; RESILIENCE; PATCHINESS; SOIL	Self-organized spatial vegetation patterning is widespread and has been described using models of scale-dependent feedback between plants and water on homogeneous substrates. As rainfall decreases, these models yield a characteristic sequence of patterns with increasingly sparse vegetation, followed by sudden collapse to desert. Thus, the final, spot-like pattern may provide early warning for such catastrophic shifts. In many arid ecosystems, however, termite nests impart substrate heterogeneity by altering soil properties, thereby enhancing plant growth. We show that termite-induced heterogeneity interacts with scale-dependent feedbacks to produce vegetation patterns at different spatial grains. Although the coarse-grained patterning resembles that created by scale-dependent feedback alone, it does not indicate imminent desertification. Rather, mound-field landscapes are more robust to aridity, suggesting that termites may help stabilize ecosystems under global change.	[Bonachela, Juan A.; Pringle, Robert M.; Sheffer, Efrat; Coverdale, Tyler C.; Guyton, Jennifer A.; Levin, Simon A.; Tarnita, Corina E.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Pringle, Robert M.; Caylor, Kelly K.; Tarnita, Corina E.] Mpala Res Ctr, Nanyuki, Kenya; [Caylor, Kelly K.] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA	Princeton University; Princeton University	Tarnita, CE (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	ctarnita@princeton.edu	Caylor, Kelly/ABF-2818-2020; Bonachela, Juan/H-9848-2016; Levin, Simon A/J-1218-2014	Caylor, Kelly/0000-0002-6466-6448; Bonachela, Juan/0000-0002-3316-8120; Levin, Simon A/0000-0002-8216-5639	U.S. National Science Foundation [DEB-1355122]; Princeton Environmental Institute; National Geographic Society [9291]; National Science Foundation [EAR-0847368, DEB-0816453]; Andrew W. Mellon Foundation; John Templeton Foundation [RFP-12-14]; NSF [LTREB 12-56034]	U.S. National Science Foundation(National Science Foundation (NSF)); Princeton Environmental Institute; National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); Andrew W. Mellon Foundation; John Templeton Foundation; NSF(National Science Foundation (NSF))	The data are located on the Dryad Digital Repository. This work is a product of U.S. National Science Foundation grant DEB-1355122 to C.E.T., R.M.P., and D. F. Doak. Additional support was provided by the Princeton Environmental Institute (Grand Challenges grant to R.M.P. and C.E.T.), the National Geographic Society (9291 to R.M.P.), the National Science Foundation (EAR-0847368 and DEB-0816453 to K.K.C.), the Andrew W. Mellon Foundation ("Dynamics of South African Vegetation" to S.A.L.), and the John Templeton Foundation (Foundational Questions in Evolutionary Biology RFP-12-14 to C.E.T. and S.A.L.). We thank the Government of Kenya for permission to conduct research; I. Cuesta, D. F. Doak, L. Hedin, R. Martinez-Garcia, J. D. Murray, J. van de Koppel, and T. P. Young for helpful discussions; three anonymous referees for insightful suggestions; K. Grabowski and M. Mohamed for field assistance; and T. P. Young, C. Riginos, and K. Veblen for access to the Kenya Long-term Exclosure Experiment (KLEE), funded by NSF LTREB 12-56034. C.E.T. conceived the study; C.E.T., R.M.P., and J.A.B. developed the theory; J.A.B. analyzed the model; E.S. performed the analysis of pattern in imagery and its comparison with simulation results; R.M.P., T.C.C., and J.A.G. collected field data; S.A.L., K.K.C., and E.S. contributed to discussions of the modeling and analysis; C.E.T., R.M.P., and J.A.B. wrote the first draft of the manuscript; and all authors contributed revisions.	Alba-Lynn C, 2008, OECOLOGIA, V157, P269, DOI 10.1007/s00442-008-1068-0; Bottinelli N., 2014, SOIL TILL RES, V2014, P1; Cramer MD, 2014, PALAEOGEOGR PALAEOCL, V409, P72, DOI 10.1016/j.palaeo.2014.04.026; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Davies AB, 2014, ECOGRAPHY, V37, P852, DOI 10.1111/ecog.00532; Deblauwe V, 2011, ECOGRAPHY, V34, P990, DOI 10.1111/j.1600-0587.2010.06694.x; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Getzin S, 2015, ECOGRAPHY, V38, P1, DOI 10.1111/ecog.00911; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Jouquet P, 2011, EUR J SOIL BIOL, V47, P215, DOI 10.1016/j.ejsobi.2011.05.005; Juergens N, 2013, SCIENCE, V339, P1618, DOI 10.1126/science.1222999; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; Korb J, 2001, OECOLOGIA, V127, P324, DOI 10.1007/s004420000597; Levick SR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1066; LEVIN SA, 1985, SIAM REV, V27, P45, DOI 10.1137/1027002; Levin SA, 2008, BIOSCIENCE, V58, P27, DOI 10.1641/B580107; Liu QX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6234; Maini PK, 1997, J CHEM SOC FARADAY T, V93, P3601, DOI 10.1039/a702602a; Malam Issa O, 1999, CATENA, V37, P175, DOI 10.1016/S0341-8162(99)00052-1; Mando A, 1996, GEODERMA, V74, P107, DOI 10.1016/S0016-7061(96)00058-4; MEINHARDT H, 1995, NATURE, V376, P722, DOI 10.1038/376722a0; Meron E, 2011, MATH MODEL NAT PHENO, V6, P163, DOI 10.1051/mmnp/20116109; Page KM, 2005, PHYSICA D, V202, P95, DOI 10.1016/j.physd.2005.01.022; Pringle RM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000377; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Satnoianu RA, 2000, J MATH BIOL, V41, P493, DOI 10.1007/s002850000056; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Seymour CL, 2014, SOIL BIOL BIOCHEM, V68, P95, DOI 10.1016/j.soilbio.2013.09.022; Sheffer E, 2013, ECOL LETT, V16, P127, DOI 10.1111/ele.12027; Sileshi GW, 2010, J VEG SCI, V21, P923, DOI 10.1111/j.1654-1103.2010.01197.x; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952	35	154	160	2	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					651	655		10.1126/science.1261487	http://dx.doi.org/10.1126/science.1261487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657247	Green Accepted			2022-12-28	WOS:000349145200042
J	Deutsch, SA				Deutsch, Stephanie A.			A Struggle for Certainty - Protecting the Vulnerable	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Deutsch, SA (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.			Deutsch, Stephanie/0000-0002-4143-3676					0	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2015	372	6					506	507		10.1056/NEJMp1409627	http://dx.doi.org/10.1056/NEJMp1409627			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA8CH	25651244				2022-12-28	WOS:000349143600004
J	Xu, WX; Goldberg, SI; Shubina, M; Turchin, A				Xu, Wenxin; Goldberg, Saveli I.; Shubina, Maria; Turchin, Alexander			Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BONFERRONI PROCEDURE; ENCOUNTER FREQUENCY; MULTIPLE TESTS; RISK-FACTORS; VALIDATION; METAANALYSIS; PREDICTORS; MANAGEMENT; REDUCTION; REGIMENS	OBJECTIVES To investigate the optimal systolic blood pressure goal above which new antihypertensive medications should be added or doses of existing medications increased ("systolic intensification threshold") and to determine the relation between delays in medication intensification and follow-up and the risk of cardiovascular events or death. DESIGN Retrospective cohort study. SETTING Primary care practices in the United Kingdom, 1986-2010. PARTICIPANTS 88 756 adults with hypertension from The Health Improvement Network nationwide primary care research database. MAIN OUTCOME MEASURES Rates of acute cardiovascular events or death from any cause for patients with different hypertension treatment strategies (defined by systolic intensification threshold, time to intensification, and time to follow-up over the course of a 10 year treatment strategy assessment period) after adjustment for age, sex, smoking status, socioeconomic deprivation, history of diabetes, cardiovascular disease or chronic kidney disease, Charlson comorbidity index, body mass index, medication possession ratio, and baseline blood pressure. RESULTS During a median follow-up of 37.4 months after the treatment strategy assessment period, 9985 (11.3%) participants had an acute cardiovascular event or died. No difference in risk of the outcome was seen between systolic intensification thresholds of 130-150 mm Hg, whereas systolic intensification thresholds greater than 150 mm Hg were associated with progressively greater risk (hazard ratio 1.21, 95% confidence interval 1.13 to 1.30; P < 0.001 for intensification threshold of 160 mm Hg). Outcome risk increased progressively from the lowest (0-1.4 months) to the highest fifth of time to medication intensification (hazard ratio 1.12, 1.05 to 1.20; P = 0.009 for intensification between 1.4 and 4.7 months after detection of elevated blood pressure). The highest fifth of time to follow-up (> 2.7 months) was also associated with increased outcome risk (hazard ratio 1.18, 1.11 to 1.25; P < 0.001). CONCLUSIONS Systolic intensification thresholds higher than 150 mm Hg, delays of greater than 1.4 months before medication intensification after systolic blood pressure elevation, and delays of greater than 2.7 months before blood pressure follow-up after antihypertensive medication intensification were associated with increased risk of an acute cardiovascular event or death. These findings support the importance of timely medical management and follow-up in the treatment of patients with hypertension.	[Xu, Wenxin] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Goldberg, Saveli I.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Shubina, Maria; Turchin, Alexander] Brigham & Womens Hosp, Div Endocrinol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Turchin, A (corresponding author), Brigham & Womens Hosp, Div Endocrinol, 221 Longwood Ave, Boston, MA 02115 USA.	aturchin@partners.org	Stoner, Lee/C-8504-2011	Stoner, Lee/0000-0002-0682-2270; Xu, Wenxin/0000-0002-8450-2037	Harvard Medical School Center for Primary Care	Harvard Medical School Center for Primary Care	This study was funded by the Harvard Medical School Center for Primary Care. This organization had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. All researchers acted independently of funders.	Al-Ansary LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053744; [Anonymous], 1982, NEW ENGL J MED, V307, P976; Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; Boreham R, 2002, NATL SURVEYS NHS PAT; Boutitie F, 2002, ANN INTERN MED, V136, P438, DOI 10.7326/0003-4819-136-6-200203190-00007; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COX DR, 1972, J R STAT SOC B, V34, P187; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Czernichow S, 2011, J HYPERTENS, V29, P4, DOI 10.1097/HJH.0b013e32834000be; Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; Egan BM, 2003, J INVEST MED, V51, P373, DOI 10.1136/jim-51-06-34; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Gail MH, 2009, STAT MED, V28, P1315, DOI 10.1002/sim.3473; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Guthmann Richard, 2005, J Clin Hypertens (Greenwich), V7, P327, DOI 10.1111/j.1524-6175.2005.04371.x; Hall GC, 2009, PHARMACOEPIDEM DR S, V18, P120, DOI 10.1002/pds.1686; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hsiao Chun-Ju, 2010, Natl Health Stat Report, P1; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; LICHTENSTEIN MJ, 1989, J FAM PRACTICE, V28, P667; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu LS, 2005, J HYPERTENS, V23, P2157, DOI 10.1097/01.hjh.0000194120.42722.ac; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Morrison F, 2011, ARCH INTERN MED, V171, P1542, DOI 10.1001/archinternmed.2011.400; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; Office for National Statistics, 2012, MORT STAT DEATHS DR; Okonofua EC, 2006, HYPERTENSION, V47, P345, DOI 10.1161/01.HYP.0000200702.76436.4b; Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699; Peterson ED, 2014, JAMA-J AM MED ASSOC, V311, P474, DOI 10.1001/jama.2013.284430; ROBINS J, 1987, J CHRON DIS, V40, pS139, DOI 10.1016/S0021-9681(87)80018-8; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; SCHULZ RM, 1982, CONTEMP PHARM PRACT, V5, P150; Shorr Ronald I., 2000, J Clin Hypertens (Greenwich), V2, P134; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Staessen JA, 2004, J HYPERTENS, V22, P847, DOI 10.1097/00004872-200404000-00029; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Turchin A, 2008, CIRCULATION, V117, P623, DOI 10.1161/CIRCULATIONAHA.107.733949; Turchin A, 2010, HYPERTENSION, V56, P68, DOI 10.1161/HYPERTENSIONAHA.109.148791; Voko Z, 1999, HYPERTENSION, V34, P1181, DOI 10.1161/01.HYP.34.6.1181; Wright JT, 2014, ANN INTERN MED, V160, P499, DOI 10.7326/M13-2981; Zhang YQ, 2011, EUR HEART J, V32, P1500, DOI 10.1093/eurheartj/ehr039	48	79	82	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2015	350								h158	10.1136/bmj.h158	http://dx.doi.org/10.1136/bmj.h158			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0JX	25655523	Green Published, hybrid			2022-12-28	WOS:000349313100001
J	Tait, AR; Voepel-Lewis, T				Tait, Alan R.; Voepel-Lewis, Terri			Digital Multimedia A New Approach for Informed Consent?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tait, Alan R.; Voepel-Lewis, Terri] Univ Michigan Hlth Syst, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Tait, Alan R.] Univ Michigan Hlth Syst, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Tait, AR (corresponding author), Univ Michigan Hlth Syst, Dept Anesthesiol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	atait@umich.edu						Department of Health and Human Services, 2011, FED REG, V76, P44512; Festinger DS, 2010, ETHICS BEHAV, V20, P387, DOI 10.1080/10508422.2010.491767; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Gokhale A, 1996, J IND TEACH EDUC, V33, P38; Hockley WE, 2008, MEM COGNITION, V36, P1351, DOI 10.3758/MC.36.7.1351; Krishna S, 2003, PEDIATRICS, V111, P503, DOI 10.1542/peds.111.3.503; Montori VM, 2014, JAMA-J AM MED ASSOC, V311, P465, DOI 10.1001/jama.2014.110; Schreiner MS, 2013, JAMA PEDIATR, V167, P603, DOI 10.1001/jamapediatrics.2013.152; Tait AR, 2003, ANESTHESIOLOGY, V98, P603, DOI 10.1097/00000542-200303000-00005; Waisel DB, 2011, ANESTH ANALG, V113, P13, DOI 10.1213/ANE.0b013e31821bfc1f	10	31	31	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					463	464		10.1001/jama.2014.17122	http://dx.doi.org/10.1001/jama.2014.17122			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA7AV	25647199				2022-12-28	WOS:000349070300007
J	Watts, G				Watts, Geoff			Guy Thwaites: building research coalitions in Vietnam	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					107	107		10.1016/S0140-6736(15)60009-5	http://dx.doi.org/10.1016/S0140-6736(15)60009-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY7BI	25706458				2022-12-28	WOS:000347715900011
J	Diao, JJ; Liu, R; Rong, YG; Zhao, ML; Zhang, J; Lai, Y; Zhou, QJ; Wilz, LM; Li, JX; Vivona, S; Pfuetzner, RA; Brunger, AT; Zhong, Q				Diao, Jiajie; Liu, Rong; Rong, Yueguang; Zhao, Minglei; Zhang, Jing; Lai, Ying; Zhou, Qiangjun; Wilz, Livia M.; Li, Jianxu; Vivona, Sandro; Pfuetzner, Richard A.; Brunger, Axel T.; Zhong, Qing			ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomes	NATURE			English	Article							SNARE COMPLEX; IN-VITRO; BECLIN 1; PROTEINS; CURVATURE; YEAST; RUBICON; SYSTEM; FORM	Autophagy, an important catabolic pathway implicated in a broad spectrum of human diseases, begins by forming double membrane autophagosomes that engulf cytosolic cargo and ends by fusing autophagosomes with lysosomes for degradation(1,2). Membrane fusion activity is required for early biogenesis of autophagosomes and late degradation in lysosomes(3-7). However, the key regulatory mechanisms of autophagic membrane tethering and fusion remain largely unknown. Here we report that ATG14 (also known as bedin-1-associated autophagy-related key regulator (Barkor) or ATG14L), an essential autophagy-specific regulator of the class III phosphatidylinositol 3-kinase complex(8-11), promotes membrane tethering of protein-free liposomes, and enhances hemifusion and full fusion of proteoliposomes reconstituted with the target (t)-SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) syntaxin 17 (STX17) and SNAP29, and the vesicle (v)-SNARE VAMP8 (vesicle-associated membrane protein 8). ATG14 binds to the SNARE core domain of STX17 through its coiled-coil domain, and stabilizes the STX17-SNAP29 binary t-SNARE complex on autophagosomes. The STX17 binding, membrane tethering and fusion-enhancing activities of ATG14 require its homo-oligomerization by cysteine repeats. In ATG14 homo-oligomerization-defective cells, autophagosomes still efficiently form but their fusion with endolysosomes is blocked. Recombinant ATG14 homo-oligomerization mutants also completely lose their ability to promote membrane tethering and to enhance SNARE-mediated fusion in vitro. Taken together, our data suggest an autophagy-specific membrane fusion mechanism in which oligomeric ATG14 directly binds to STX17-SNAP29 binary t-SNARE complex on autophagosomes and primes it for VAMP8 interaction to promote autophagosome-endolysosome fusion.	[Diao, Jiajie; Zhao, Minglei; Lai, Ying; Zhou, Qiangjun; Vivona, Sandro; Pfuetzner, Richard A.; Brunger, Axel T.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Diao, Jiajie; Zhao, Minglei; Lai, Ying; Zhou, Qiangjun; Vivona, Sandro; Pfuetzner, Richard A.; Brunger, Axel T.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Diao, Jiajie; Zhao, Minglei; Lai, Ying; Zhou, Qiangjun; Vivona, Sandro; Pfuetzner, Richard A.; Brunger, Axel T.] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Diao, Jiajie; Zhao, Minglei; Lai, Ying; Zhou, Qiangjun; Vivona, Sandro; Pfuetzner, Richard A.; Brunger, Axel T.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Diao, Jiajie; Zhao, Minglei; Lai, Ying; Zhou, Qiangjun; Vivona, Sandro; Pfuetzner, Richard A.; Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Liu, Rong; Rong, Yueguang; Zhang, Jing; Zhong, Qing] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75390 USA; [Liu, Rong; Rong, Yueguang; Zhang, Jing; Zhong, Qing] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Liu, Rong] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China; [Wilz, Livia M.; Li, Jianxu] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem Biophys & Struct Biol, Berkeley, CA 94720 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; China Agricultural University; University of California System; University of California Berkeley	Zhong, Q (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75390 USA.	qing.zhong@utsouthwestern.edu	Zhong, Qing/GLT-4858-2022; Lai, Ying/E-5220-2015; Zhao, Minglei/J-4446-2015; Diao, Jiajie/A-3425-2008	Zhong, Qing/0000-0001-6979-955X; Lai, Ying/0000-0001-5347-5155; Zhao, Minglei/0000-0001-5832-6060; Diao, Jiajie/0000-0003-4288-3203; Zhang, Jing/0000-0003-1513-0695; Zhou, Qiangjun/0000-0002-7768-0249; Brunger, Axel/0000-0001-5121-2036; Zhou, Qiangjun/0000-0003-1789-9588; RONG, YUEGUANG/0000-0001-6661-9664	National Institutes of Health (NIH) [P41 GM103403]; Welch Foundation [1-1864]; Cancer Prevention & Research Institute of Texas [RP140320]; American Cancer Society [RSG-11-274-01-CCG]; NIH [CA133228, R37-MH63105]; China Scholarship Council; National Cancer Institute of the NIH [5P30CA142543]; NATIONAL CANCER INSTITUTE [P30CA142543, R01CA133228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, T32GM007232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063105, R01MH063105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Prevention & Research Institute of Texas; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Q. Sun, W. Fan, M. Padolina and R. Bellerose for technical assistance, Y. Cheng and S. Wu for help in the cryo-electron microscopy experiments,A. Liang at OCS Microscopy Core of NewYork University Langone Medical Center for electron microscope analysis, the Northeastern Collaborative Access Team (supported by National Institutes of Health (NIH) P41 GM103403) at the Advanced Photon Source for X-ray data collection, and B. Levine and R. Sumpter for reading the manuscript. The work was supported by grants to Q.Z. from the Welch Foundation (1-1864), the Cancer Prevention & Research Institute of Texas (RP140320), an American Cancer Society Research Scholar Grant(RSG-11-274-01-CCG) and NIH R01 (CA133228),and NIH R01 (R37-MH63105) to A.T.B. The work was partly supported by China Scholarship Council to R.L. This work was also supported by the National Cancer Institute of the NIH under award number 5P30CA142543.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Diao JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00592; Diao JJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00109; Diao JJ, 2012, NAT PROTOC, V7, P921, DOI 10.1038/nprot.2012.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Huang WP, 2002, CELL STRUCT FUNCT, V27, P409, DOI 10.1247/csf.27.409; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Koyama-Honda I, 2013, AUTOPHAGY, V9, P1491, DOI 10.4161/auto.25529; Kyoung M, 2011, P NATL ACAD SCI USA, V108, pE304, DOI 10.1073/pnas.1107900108; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Nair U, 2011, AUTOPHAGY, V7, P1546, DOI 10.4161/auto.7.12.18424; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Strop P, 2008, J BIOL CHEM, V283, P1113, DOI 10.1074/jbc.M707912200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Su ZL, 2008, STRUCTURE, V16, P1138, DOI 10.1016/j.str.2008.03.018; Sun QM, 2011, J BIOL CHEM, V286, P185, DOI 10.1074/jbc.M110.126425; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takats S, 2014, MOL BIOL CELL, V25, P1338, DOI 10.1091/mbc.E13-08-0449; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467	39	346	362	8	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					563	+		10.1038/nature14147	http://dx.doi.org/10.1038/nature14147			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25686604	Green Accepted			2022-12-28	WOS:000353334500048
J	Goyal, M; Demchuk, AM; Menon, BK; Eesa, M; Rempel, JL; Thornton, J; Roy, D; Jovin, TG; Willinsky, RA; Sapkota, BL; Dowlatshahi, D; Frei, DF; Kamal, NR; Montanera, WJ; Poppe, AY; Ryckborst, KJ; Silver, FL; Shuaib, A; Tampieri, D; Williams, D; Bang, OY; Baxter, BW; Burns, PA; Choe, H; Heo, JH; Holmstedt, CA; Jankowitz, B; Kelly, M; Linares, G; Mandzia, JL; Shankar, J; Sohn, SI; Swartz, RH; Barber, PA; Coutts, SB; Smith, EE; Morrish, WF; Weill, A; Subramaniam, S; Mitha, AP; Wong, JH; Lowerison, MW; Sajobi, TT; Hill, MD				Goyal, M.; Demchuk, A. M.; Menon, B. K.; Eesa, M.; Rempel, J. L.; Thornton, J.; Roy, D.; Jovin, T. G.; Willinsky, R. A.; Sapkota, B. L.; Dowlatshahi, D.; Frei, D. F.; Kamal, N. R.; Montanera, W. J.; Poppe, A. Y.; Ryckborst, K. J.; Silver, F. L.; Shuaib, A.; Tampieri, D.; Williams, D.; Bang, O. Y.; Baxter, B. W.; Burns, P. A.; Choe, H.; Heo, J. -H.; Holmstedt, C. A.; Jankowitz, B.; Kelly, M.; Linares, G.; Mandzia, J. L.; Shankar, J.; Sohn, S. -I.; Swartz, R. H.; Barber, P. A.; Coutts, S. B.; Smith, E. E.; Morrish, W. F.; Weill, A.; Subramaniam, S.; Mitha, A. P.; Wong, J. H.; Lowerison, M. W.; Sajobi, T. T.; Hill, M. D.		ESCAPE Trial Investigators	Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; INTERVENTIONAL MANAGEMENT; COMPUTED-TOMOGRAPHY; III TRIAL; EARLY CT; THERAPY; REPERFUSION; RECANALIZATION; TIME; THROMBOLYSIS	BACKGROUND Among patients with a proximal vessel occlusion in the anterior circulation, 60 to 80% of patients die within 90 days after stroke onset or do not regain functional independence despite alteplase treatment. We evaluated rapid endovascular treatment in addition to standard care in patients with acute ischemic stroke with a small infarct core, a proximal intracranial arterial occlusion, and moderate-to-good collateral circulation. METHODS We randomly assigned participants to receive standard care (control group) or standard care plus endovascular treatment with the use of available thrombectomy devices (intervention group). Patients with a proximal intracranial occlusion in the anterior circulation were included up to 12 hours after symptom onset. Patients with a large infarct core or poor collateral circulation on computed tomography (CT) and CT angiography were excluded. Workflow times were measured against predetermined targets. The primary outcome was the score on the modified Rankin scale (range, 0 [no symptoms] to 6 [death]) at 90 days. A proportional odds model was used to calculate the common odds ratio as a measure of the likelihood that the intervention would lead to lower scores on the modified Rankin scale than would control care (shift analysis). RESULTS The trial was stopped early because of efficacy. At 22 centers worldwide, 316 participants were enrolled, of whom 238 received intravenous alteplase (120 in the intervention group and 118 in the control group). In the intervention group, the median time from study CT of the head to first reperfusion was 84 minutes. The rate of functional independence (90-day modified Rankin score of 0 to 2) was increased with the intervention (53.0%, vs. 29.3% in the control group; P<0.001). The primary outcome favored the intervention (common odds ratio, 2.6; 95% confidence interval, 1.7 to 3.8; P<0.001), and the intervention was associated with reduced mortality (10.4%, vs. 19.0% in the control group; P = 0.04). Symptomatic intracerebral hemorrhage occurred in 3.6% of participants in intervention group and 2.7% of participants in control group (P = 0.75). CONCLUSIONS Among patients with acute ischemic stroke with a proximal vessel occlusion, a small infarct core, and moderate-to-good collateral circulation, rapid endovascular treatment improved functional outcomes and reduced mortality.	[Goyal, M.; Menon, B. K.; Eesa, M.; Barber, P. A.; Morrish, W. F.; Hill, M. D.] Univ Calgary, Dept Radiol, Calgary, AB T2N 2T9, Canada; [Goyal, M.; Demchuk, A. M.; Menon, B. K.; Kamal, N. R.; Ryckborst, K. J.; Barber, P. A.; Coutts, S. B.; Smith, E. E.; Subramaniam, S.; Mitha, A. P.; Wong, J. H.; Hill, M. D.] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada; [Smith, E. E.; Sajobi, T. T.; Hill, M. D.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 2T9, Canada; [Goyal, M.; Demchuk, A. M.; Menon, B. K.; Kamal, N. R.; Barber, P. A.; Coutts, S. B.; Smith, E. E.; Mitha, A. P.; Wong, J. H.; Hill, M. D.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 2T9, Canada; [Lowerison, M. W.] Univ Calgary, Clin Res Unit, Calgary, AB T2N 2T9, Canada; [Rempel, J. L.] Univ Alberta, Dept Neurosurg, Edmonton, AB, Canada; [Shuaib, A.] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada; [Roy, D.; Weill, A.] Univ Montreal, Dept Radiol, Montreal, PQ, Canada; [Poppe, A. Y.] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Tampieri, D.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Willinsky, R. A.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Silver, F. L.] Univ Toronto, Toronto Gen Hosp, Div Neurol, Dept Med, Toronto, ON M5G 1L7, Canada; [Montanera, W. J.] Univ Toronto, St Michaels Hosp, Dept Med Imaging, Toronto, ON, Canada; [Swartz, R. H.] Univ Toronto, Dept Med, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Dowlatshahi, D.] Univ Ottawa, Dept Neurol, Ottawa, ON, Canada; [Kelly, M.] Univ Saskatchewan, Dept Med Imaging, Saskatoon, SK, Canada; [Mandzia, J. L.] London Hlth Sci Ctr, Dept Clin Neurol Sci, London, ON, Canada; [Shankar, J.] Dalhousie Univ, Dept Radiol, Halifax, NS, Canada; [Thornton, J.] Beaumont Hosp, Dept Neuroradiol, Dublin 9, Ireland; [Williams, D.] Beaumont Hosp, Dept Geriatr & Stroke Med, Dublin 9, Ireland; [Williams, D.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Jovin, T. G.] Univ Pittsburgh, Dept Neurol, Med Ctr, Pittsburgh, PA 15260 USA; [Jankowitz, B.] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA 15260 USA; [Choe, H.] Abington Mem Hosp, Inst Neurosci, Abington, PA 19001 USA; [Linares, G.] Temple Univ, Dept Neurol, Philadelphia, PA 19122 USA; [Linares, G.] Temple Univ, Dept Neurosurg, Philadelphia, PA 19122 USA; [Linares, G.] Temple Univ, Dept Radiol, Philadelphia, PA 19122 USA; [Sapkota, B. L.] Univ Tennessee, Acute Stroke Serv, Chattanooga, TN USA; [Baxter, B. W.] Erlanger Hosp, Dept Radiol, Chattanooga, TN USA; [Frei, D. F.] Colorado Neurol Inst, Englewood, CO USA; [Bang, O. Y.] Yonsei Univ, Coll Med, Dept Neurol, Samsung Med Ctr, Seoul, South Korea; [Heo, J. -H.] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Sohn, S. -I.] Keimyung Univ, Dept Neurol, Dongsan Med Ctr, Taegu, South Korea; [Burns, P. A.] Royal Victoria Hosp, Dept Neuroradiol, Belfast BT12 6BA, Antrim, North Ireland; [Holmstedt, C. A.] Med Univ S Carolina, Dept Neurol, Charleston, SC USA	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Alberta; University of Alberta; Universite de Montreal; Universite de Montreal; McGill University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Ottawa; University of Saskatchewan; London Health Sciences Centre; Dalhousie University; Royal College of Surgeons - Ireland; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Abington Memorial Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Tennessee System; University of Tennessee Health Science Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Keimyung University; Medical University of South Carolina	Hill, MD (corresponding author), Univ Calgary, Calgary Stroke Program, Dept Clin Neurosci, Hotchkiss Brain Inst,Foothills Hosp, Rm 1242A,1403 29th St NW, Calgary, AB T2N 2T9, Canada.	michael.hill@ucalgary.ca	Hill, Michael D/C-9073-2012; Smith, Eric E/C-5443-2012; MENON, BIJOY K/B-7718-2014; Butcher, Ken/AEP-3693-2022; Kamal, Noreen/I-9255-2017; Barber, Philip A/C-7108-2016; Kamal, Noreen/AAT-1641-2020; Demchuk, Andrew M/E-1103-2012; Goyal, Mayank/AAE-7323-2019; Field, Thalia S./GRR-7961-2022; Field, Thalia/G-8477-2019; Butcher, Ken/ABC-6632-2020; Field, Thalia/P-4103-2019; O'Neill, Desmond/D-1486-2013	Hill, Michael D/0000-0002-6269-1543; Smith, Eric E/0000-0003-3956-1668; Butcher, Ken/0000-0002-0590-7918; Kamal, Noreen/0000-0001-5957-2183; Demchuk, Andrew M/0000-0002-4930-7789; Field, Thalia S./0000-0002-1176-0633; Field, Thalia/0000-0002-1176-0633; Butcher, Ken/0000-0002-0590-7918; Field, Thalia/0000-0002-1176-0633; Dowlatshahi, Dar/0000-0003-1379-3612; iancu, daniela/0000-0003-2041-9178; Swartz, Rick/0000-0001-6571-5531; Kelly, Michael/0000-0002-3278-2620; Yu, Amy Ying Xin/0000-0002-7276-9551; Teitelbaum, Jeanne/0000-0002-9834-3882; Heo, Ji Hoe/0000-0001-9898-3321; Murphy, Sinead/0000-0002-7277-414X; Kalashyan, Hayrapet/0000-0002-7714-696X; Williams, David/0000-0002-1923-462X; weill, alain/0000-0002-0281-6201; Lowerison, Mark/0000-0001-9302-4017; O'Neill, Desmond/0000-0002-5542-9897; Sohn, Sung Il/0000-0002-6900-1242; Shankar, Jai/0000-0002-3707-9723; Sajobi, Tolulope/0000-0002-5696-5552	Covidien; Alberta Innovates [201300690] Funding Source: researchfish	Covidien; Alberta Innovates	Funded by Covidien and others; ESCAPE ClinicalTrials.gov number, NCT01778335.	Almekhlafi MA, 2013, J NEUROINTERV SURG, V5, P58, DOI 10.1136/neurintsurg-2012-010486; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; Bradley EH, 2006, CIRCULATION, V113, P1079, DOI 10.1161/CIRCULATIONAHA.105.590133; Broderick JP, 2013, NEW ENGL J MED, V368, P1265; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BC, 2013, NEW ENGL J MED, V368, P2431, DOI [10.1056/NEJMc1304759, 10.1056/NEJMoa1213701]; DELZOPPO GJ, 1992, ANN NEUROL, V32, P78, DOI 10.1002/ana.410320113; Demchuk AM, 2014, INT J STROKE; Demchuk AM, 2014, RADIOLOGY, V273, P202, DOI 10.1148/radiol.14132649; Demchuk AM, 2012, ANN NY ACAD SCI, V1268, P63, DOI 10.1111/j.1749-6632.2012.06732.x; Elm JJ, 2014, CLIN TRIALS, V11, P467, DOI 10.1177/1740774514538706; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Goyal M, 2014, STROKE, V45, pE252, DOI 10.1161/STROKEAHA.114.007366; Goyal M, 2014, CIRCULATION, V130, P265, DOI 10.1161/CIRCULATIONAHA.113.007826; Goyal M, 2013, STROKE, V44, P3591, DOI 10.1161/STROKEAHA.113.002522; Hong KS, 2009, STROKE, V40, P3828, DOI 10.1161/STROKEAHA.109.561365; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Krumholz HM, 2011, CIRCULATION, V124, P1038, DOI 10.1161/CIRCULATIONAHA.111.044107; Lindsay P, 2008, CAN MED ASSOC J, V179, pS1, DOI 10.1503/cmaj.081148.R2; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Menon BK, 2014, STROKE, V45, P2024, DOI 10.1161/STROKEAHA.114.005050; Molina CA, 2002, STROKE, V33, P1551, DOI 10.1161/01.STR.0000016323.13456.E5; Nambiar V, 2014, AM J NEURORADIOL, V35, P884, DOI 10.3174/ajnr.A3817; Nogueira RG, 2012, LANCET, V380, P1230; Parsons MW, 2010, J CEREBR BLOOD F MET, V30, P1214, DOI 10.1038/jcbfm.2010.3; Pereira VM, 2013, STROKE, V44, P2802, DOI 10.1161/STROKEAHA.113.001232; Puetz V, 2009, INT J STROKE, V4, P354, DOI 10.1111/j.1747-4949.2009.00337.x; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Sun CHJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000859; Sun CHJ, 2013, CIRCULATION, V127, P1139, DOI 10.1161/CIRCULATIONAHA.112.000506; von Kummer R, 2001, RADIOLOGY, V219, P95, DOI 10.1148/radiology.219.1.r01ap0695; VONKUMMER R, 1994, AM J NEURORADIOL, V15, P9; Yoo AJ, 2012, STROKE, V43, P1323, DOI 10.1161/STROKEAHA.111.639401; ZEUMER H, 1983, AM J NEURORADIOL, V4, P401; Zhao W, 2012, STAT METHODS MED RES	40	3786	4035	15	282	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					1019	1030		10.1056/NEJMoa1414905	http://dx.doi.org/10.1056/NEJMoa1414905			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD0XK	25671798	Green Published, Bronze			2022-12-28	WOS:000350797300006
J	Rutter, GA				Rutter, Guy A.			Pancreas micromanages autophagy	SCIENCE			English	Editorial Material							BETA-CELL MASS; AMPK		Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Cell Biol & Funct Genom, Div Diabet Endocrinol & Metab, London W12 0NN, England	Imperial College London	Rutter, GA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Cell Biol & Funct Genom, Div Diabet Endocrinol & Metab, London W12 0NN, England.	g.rutter@imperial.ac.uk		Rutter, Guy/0000-0001-6360-0343	MRC [MR/K001981/1] Funding Source: UKRI; Medical Research Council [MR/K001981/1] Funding Source: Medline; Wellcome Trust [098424] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Goginashvili A, 2015, SCIENCE, V347, P878, DOI 10.1126/science.aaa2628; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hardie DG, 2011, SCIENCE, V331, P410, DOI 10.1126/science.1201691; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kone M, 2014, FASEB J, V28, P4972, DOI 10.1096/fj.14-257667; Marsh BJ, 2007, MOL ENDOCRINOL, V21, P2255, DOI 10.1210/me.2007-0077; Rutter G. A., 2015, BIOCHEM J, V66, P202; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018	14	3	3	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					826	827		10.1126/science.aaa6810	http://dx.doi.org/10.1126/science.aaa6810			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700502				2022-12-28	WOS:000349761100022
J	Brezina, PR; Kutteh, WH				Brezina, Paul R.; Kutteh, William H.			Clinical applications of preimplantation genetic testing	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IN-VITRO FERTILIZATION; ESHRE PGD CONSORTIUM; PREGNANCY FOLLOW-UP; COMPARATIVE GENOMIC HYBRIDIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; POLYMORPHISM SNP MICROARRAY; THAWED EMBRYO-TRANSFER; CLEAVAGE-STAGE BIOPSY; SCREENING PGS; PRACTICE GUIDELINES	Genetic diagnostic technologies are rapidly changing the way medicine is practiced. Preimplantation genetic testing is a well established application of genetic testing within the context of in vitro fertilization cycles. It involves obtaining a cell(s) from a developing embryo in culture, which is then subjected to genetic diagnostic analysis; the resulting information is used to guide which embryos are transferred into the uterus. The potential applications and use of this technology have increased in recent years. Experts agree that preimplantation genetic diagnosis is clinically appropriate for many known genetic disorders. However, some applications of such testing, such as preimplantation genetic screening for aneuploidy, remain controversial. Clinical data suggest that preimplantation genetic screening may be useful, but further studies are needed to quantify the size of the effect and who would benefit most.	[Brezina, Paul R.; Kutteh, William H.] Vanderbilt Univ, Sch Med, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Nashville, TN 37232 USA; [Brezina, Paul R.; Kutteh, William H.] Fertil Associates Memphis, Memphis, TN USA	Vanderbilt University	Brezina, PR (corresponding author), Vanderbilt Univ, Sch Med, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Nashville, TN 37232 USA.	paul.r.brezina@vanderbilt.edu						Aflatoonian A, 2010, HUM REPROD, V25, pI99, DOI 10.1007/s10815-010-9412-9; Altarescu G, 2013, J ASSIST REPROD GEN, V30, P1595, DOI 10.1007/s10815-013-0044-8; Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1103, DOI 10.1016/j.fertnstert.2012.06.048; [Anonymous], 2011, Obstet Gynecol, V117, P1028, DOI 10.1097/AOG.0b013e31821922c2; [Anonymous], 2009, Obstet Gynecol, V113, P766, DOI 10.1097/AOG.0b013e31819e9f05; Berger VK, 2014, SEMIN REPROD MED, V32, P107, DOI 10.1055/s-0033-1363552; Bint SM, 2011, HUM REPROD, V26, P1575, DOI 10.1093/humrep/der080; Bisignano A, 2011, REPROD BIOMED ONLINE, V23, P677, DOI 10.1016/j.rbmo.2011.05.017; Bodurtha J, 2012, NEW ENGL J MED, V366, P64, DOI 10.1056/NEJMra1105043; Branicki W, 2011, HUM GENET, V129, P443, DOI 10.1007/s00439-010-0939-8; Bredenoord A, 2009, EUR J HUM GENET, V17, P1550, DOI 10.1038/ejhg.2009.88; Brezina PR, 2013, FERTIL STERIL, V100, pS69, DOI 10.1016/j.fertnstert.2013.07.1896; Brezina PR, 2013, CLIN MED INSIGHTS-RE, V7, P17, DOI 10.4137/CMRH.S10914; Brezina PR, 2013, CLIN MED INSIGHTS-RE, V7, P37, DOI 10.4137/CMRH.S10852; Brezina PR, 2014, OBSTET GYN CLIN N AM, V41, P41, DOI 10.1016/j.ogc.2013.10.006; Brezina PR, 2014, OBSTET GYN CLIN N AM, V41, P1, DOI 10.1016/j.ogc.2013.10.011; Brezina PR, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5908; Brezina PR, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/686253; Brezina PR, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2010.11.025; Brezina PR, 2012, FERTIL STERIL S, V97, pS24; BURGOYNE PS, 1991, HUM REPROD, V6, P555, DOI 10.1093/oxfordjournals.humrep.a137379; Checa MA, 2009, J ASSIST REPROD GEN, V26, P273, DOI 10.1007/s10815-009-9328-4; Chipko C, 2011, FERTIL STERIL, V96, pS21, DOI 10.1016/j.fertnstert.2011.07.091; Christianson MS, 2011, FERTIL STERIL, V96, pS21, DOI 10.1016/j.fertnstert.2011.07.092; Chuong FS, 2014, FERTIL STERIL, V102, pE174, DOI 10.1016/j.fertnstert.2014.07.594; Ciray HN, 2014, HUM REPROD, V29, P2650, DOI 10.1093/humrep/deu278; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Colls P, 2007, FERTIL STERIL, V88, P53, DOI 10.1016/j.fertnstert.2006.11.099; De Vos A, 2009, HUM REPROD, V24, P2988, DOI 10.1093/humrep/dep251; Dequeker E, 2001, NAT REV GENET, V2, P717, DOI 10.1038/35088588; Dickey RP, 2013, FERTIL STERIL, V100, pS531, DOI 10.1016/j.fertnstert.2013.07.292; Escudero T, 2008, AM J MED GENET A, V146A, P1662, DOI 10.1002/ajmg.a.32286; Ethics Comm Amer Soc Reprod Med, 2004, FERTIL STERIL, V82, pS232, DOI 10.1016/j.fertnstert.2004.05.013; Ferraretti AP, 2013, HUM REPROD, V28, P2318, DOI 10.1093/humrep/det278; Forman EJ, 2012, HUM REPROD, V27, P1217, DOI 10.1093/humrep/des020; Forman EJ, 2013, FERTIL STERIL, V100, P718, DOI 10.1016/j.fertnstert.2013.04.043; Forman EJ, 2012, SEMIN REPROD MED, V30, P236, DOI 10.1055/s-0032-1311526; Fortunato A, 2011, EUR J OBSTET GYN R B, V154, P125, DOI 10.1016/j.ejogrb.2010.10.012; Ginsburg ES, 2011, FERTIL STERIL, V96, P865, DOI 10.1016/j.fertnstert.2011.07.1139; Goossens V, 2012, HUM REPROD, V27, P1887, DOI 10.1093/humrep/des106; Grody WW, 2013, GENET MED, V15, P482, DOI 10.1038/gim.2013.47; Gutierrez-Mateo C, 2011, FERTIL STERIL, V95, P953, DOI 10.1016/j.fertnstert.2010.09.010; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; Handyside AH, 2013, FERTIL STERIL, V100, P595, DOI 10.1016/j.fertnstert.2013.07.1965; Handyside AH, 2011, REPROD BIOMED ONLINE, V23, P686, DOI 10.1016/j.rbmo.2011.09.012; Harper JC, 2008, HUM REPROD, V23, P741, DOI 10.1093/humrep/dem354; Harper JC, 2012, HUM REPROD UPDATE, V18, P234, DOI 10.1093/humupd/dmr052; Harper J, 2010, HUM REPROD, V25, P821, DOI 10.1093/humrep/dep476; Harper JC, 2013, EUR J HUM GENET, V21, pS1, DOI 10.1038/ejhg.2013.219; Harper JC, 2012, HUM GENET, V131, P175, DOI 10.1007/s00439-011-1056-z; Harton G, 2011, HUM REPROD, V26, P14, DOI 10.1093/humrep/deq229; Harton GL, 2011, HUM REPROD, V26, P33, DOI 10.1093/humrep/deq231; Harton GL, 2011, HUM REPROD, V26, P41, DOI 10.1093/humrep/deq265; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; HATTORI M, 1992, ELECTROPHORESIS, V13, P560, DOI 10.1002/elps.11501301114; Hellani A, 2008, REPROD BIOMED ONLINE, V17, P841, DOI 10.1016/S1472-6483(10)60413-0; Hollingsworth LD, 2005, HEALTH SOC WORK, V30, P126, DOI 10.1093/hsw/30.2.126; Hussey ND, 2002, MOL HUM REPROD, V8, P1136, DOI 10.1093/molehr/8.12.1136; Janssens S, 2014, J COMMUN GENET, V5, P13, DOI 10.1007/s12687-012-0131-z; Johnson DS, 2010, MOL HUM REPROD, V16, P944, DOI 10.1093/molehr/gaq062; Johnson DS, 2010, HUM REPROD, V25, P1066, DOI 10.1093/humrep/dep452; Kalousek D K, 1993, Birth Defects Orig Artic Ser, V29, P53; Kirkegaard K, 2014, HUM REPROD, V29, P2413, DOI 10.1093/humrep/deu236; Ko DS, 2010, AM J MED GENET A, V152A, P1428, DOI 10.1002/ajmg.a.33368; Kokkali G, 2007, HUM REPROD, V22, P1443, DOI 10.1093/humrep/del506; Kuliev A, 2005, REPROD BIOMED ONLINE, V11, P362, DOI 10.1016/S1472-6483(10)60845-0; Kuliev A, 2011, HEMOGLOBIN, V35, P547, DOI 10.3109/03630269.2011.608457; Laurie AD, 2010, J THROMB HAEMOST, V8, P783, DOI 10.1111/j.1538-7836.2010.03768.x; Li G, 2014, SYST BIOL REPROD MED, V60, P119, DOI 10.3109/19396368.2013.875241; Lim CK, 2008, FERTIL STERIL, V90, P2144, DOI 10.1016/j.fertnstert.2007.10.035; Liu YH, 2014, REPROD BIOL, V14, P249, DOI 10.1016/j.repbio.2014.08.003; Macklin R, 2010, SEMIN REPROD MED, V28, P315, DOI 10.1055/s-0030-1255179; Martin J, 2013, FERTIL STERIL, V99, P1054, DOI 10.1016/j.fertnstert.2013.02.001; Mastenbroek S, 2011, HUM REPROD UPDATE, V17, P454, DOI 10.1093/humupd/dmr003; Mastenbroek S, 2007, NEW ENGL J MED, V357, P9, DOI 10.1056/NEJMoa067744; Moutou C, 2014, HUM REPROD, V29, P880, DOI 10.1093/humrep/deu012; MUNNE S, 1994, BIOL REPROD, V51, P373, DOI 10.1095/biolreprod51.3.373; Natesan SA, 2014, GENET MED, V16, P838, DOI 10.1038/gim.2014.45; Northrop LE, 2010, MOL HUM REPROD, V16, P590, DOI 10.1093/molehr/gaq037; Novik V, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-18; Pfeifer S, 2012, FERTIL STERIL, V97, P835, DOI 10.1016/j.fertnstert.2011.11.050; Rechitsky S, 2001, MOL CELL ENDOCRINOL, V183, pS65, DOI 10.1016/S0303-7207(01)00576-7; Rechitsky S, 2013, REPROD BIOMED ONLINE, V26, P420, DOI 10.1016/j.rbmo.2013.01.006; Resetkova N, 2013, FERTIL STERIL, V100, pS99, DOI 10.1016/j.fertnstert.2013.07.1704; Ross LF, 2012, AM J MED GENET A, V158A, P19, DOI 10.1002/ajmg.a.34361; Rubio I, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.738; Sakkas D, 2014, METHODS MOL BIOL, V1154, P533, DOI 10.1007/978-1-4939-0659-8_24; SART CORS, CLIN SUMM REP SEC CL; Schaaf CP, 2011, LANCET, V377, P555, DOI 10.1016/S0140-6736(11)60201-8; Schoolcraft WB, 2010, FERTIL STERIL, V94, P1700, DOI 10.1016/j.fertnstert.2009.10.015; Scott KL, 2013, FERTIL STERIL, V100, P608, DOI 10.1016/j.fertnstert.2013.07.004; Scott RT, 2013, FERTIL STERIL, V100, P697, DOI 10.1016/j.fertnstert.2013.04.035; Scott RT, 2013, FERTIL STERIL, V100, P624, DOI 10.1016/j.fertnstert.2013.04.039; Scott RT, 2012, FERTIL STERIL, V97, P870, DOI 10.1016/j.fertnstert.2012.01.104; Scriven PN, 2010, HUM REPROD, V25, P2622, DOI 10.1093/humrep/deq196; Scriven PN, 1998, PRENATAL DIAG, V18, P1437, DOI 10.1002/(SICI)1097-0223(199812)18:13<1437::AID-PD497>3.3.CO;2-G; Shahine LK, 2014, SEMIN REPROD MED, V32, P93, DOI 10.1055/s-0033-1363550; Shapiro BS, 2013, FERTIL STERIL, V99, P389, DOI 10.1016/j.fertnstert.2012.09.044; Shapiro BS, 2012, FERTIL STERIL, V98, P1490, DOI 10.1016/j.fertnstert.2012.07.1136; Shapiro BS, 2011, FERTIL STERIL, V96, P516, DOI 10.1016/j.fertnstert.2011.02.059; Sharp RR, 2010, REPROD BIOMED ONLINE, V21, P838, DOI 10.1016/j.rbmo.2010.09.009; Simpson JL, 2013, FERTIL STERIL, V99, P1203, DOI 10.1016/j.fertnstert.2013.01.112; Soc Assisted Reprod Technology, 2008, FERTIL STERIL, V90, pS136, DOI 10.1016/j.fertnstert.2008.08.062; Stephenson MD, 2002, HUM REPROD, V17, P446, DOI 10.1093/humrep/17.2.446; Strom CM, 2012, CLIN LAB MED, V32, P651, DOI 10.1016/j.cll.2012.07.003; Tobler KJ, 2012, FERTIL STERIL, V98, pS54, DOI 10.1016/j.fertnstert.2012.07.197; Tobler KJ, 2013, FERTIL STERIL, V100, pS36, DOI 10.1016/j.fertnstert.2013.07.1784; Treff NR, 2013, FERTIL STERIL, V99, pE17, DOI 10.1016/j.fertnstert.2013.02.034; Treff NR, 2010, FERTIL STERIL, V94, P2017, DOI 10.1016/j.fertnstert.2010.01.052; Treff NR, 2010, MOL HUM REPROD, V16, P583, DOI 10.1093/molehr/gaq039; Treff NR, 2011, FERTIL STERIL, V95; Tuffs Annette, 2011, BMJ, V343, pd4425, DOI 10.1136/bmj.d4425; Uyar A, 2014, SEMIN REPROD MED, V32, P141, DOI 10.1055/s-0033-1363556; Van Rij MC, 2012, EUR J HUM GENET, V20, P368, DOI 10.1038/ejhg.2011.202; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Verlinsky Y, 2004, FERTIL STERIL, V82, P292, DOI 10.1016/j.fertnstert.2003.09.082; Verlinsky Y, 2004, FERTIL STERIL, V82, P926, DOI 10.1016/j.fertnstert.2004.03.041; Verlinsky Y, 2004, JAMA-J AM MED ASSOC, V291, P2079, DOI 10.1001/jama.291.17.2079; VERLINSKY Y, 1992, PRENATAL DIAG, V12, P103, DOI 10.1002/pd.1970120205; Verlinsky Y, 2007, REPROD BIOMED ONLINE, V14, P214, DOI 10.1016/S1472-6483(10)60790-0; Walsh S, 2013, FORENSIC SCI INT-GEN, V7, P98, DOI 10.1016/j.fsigen.2012.07.005; Wells D, 2003, BIOESSAYS, V25, P289, DOI 10.1002/bies.10232; Wells D, 2008, MOL HUM REPROD, V14, P703, DOI 10.1093/molehr/gan062; Whittaker AM, 2011, REPROD BIOMED ONLINE, V23, P609, DOI 10.1016/j.rbmo.2011.06.017; Wilton L, 2009, HUM REPROD, V24, P1221, DOI 10.1093/humrep/den488; Wong KM, 2014, SEMIN REPROD MED, V32, P127, DOI 10.1055/s-0033-1363554; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24; Zhao YL, 2011, BBA-GEN SUBJECTS, V1810, P843, DOI 10.1016/j.bbagen.2011.05.001	128	67	69	1	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2015	350								g7611	10.1136/bmj.g7611	http://dx.doi.org/10.1136/bmj.g7611			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WD	25697663				2022-12-28	WOS:000349911600001
J	Skipper, M				Skipper, Magdalena			Finches sequenced	NATURE			English	Editorial Material																		Lamichhaney S, 2015, NATURE, V518, P371, DOI 10.1038/nature14181	1	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					308	308		10.1038/518308a	http://dx.doi.org/10.1038/518308a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VC0SG	25693558	Bronze			2022-12-28	WOS:000427186300001
J	Chen, DF				Chen, Daniel F.			The Other AMA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		George Washington Univ, Sch Med & Hlth Sci, Div Geriatr & Palliat Care, Washington, DC 20052 USA	George Washington University	Chen, DF (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Div Geriatr & Palliat Care, Washington, DC 20052 USA.	dfchen@gmail.com						Alfandre D, 2013, JAMA-J AM MED ASSOC, V310, P2393, DOI 10.1001/jama.2013.280887; [Anonymous], HOSP ADJ EXP PER INP; [Anonymous], YOUT RIGHT FAST APP; Beales JL, 2009, CLIN GERIATR MED, V25, P149, DOI 10.1016/j.cger.2008.11.002; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; De Jonge KE, 2014, J AM GERIATR SOC, V62, P1825, DOI 10.1111/jgs.12974; Kaboli PJ, 2012, ANN INTERN MED, V157, P837, DOI 10.7326/0003-4819-157-12-201212180-00003; Reuben DB, 2014, NEW ENGL J MED, V370, P694, DOI 10.1056/NEJMp1315568	8	1	1	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					671	672		10.1001/jama.2014.13626	http://dx.doi.org/10.1001/jama.2014.13626			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25688776				2022-12-28	WOS:000349476100010
J	Mistry, PK; Lukina, E; Ben Turkia, H; Amato, D; Baris, H; Dasouki, M; Ghosn, M; Mehta, A; Packman, S; Pastores, G; Petakov, M; Assouline, S; Balwani, M; Danda, S; Hadjiev, E; Ortega, A; Shankar, S; Solano, MH; Ross, L; Angell, J; Peterschmitt, MJ				Mistry, Pramod K.; Lukina, Elena; Ben Turkia, Hadhami; Amato, Dominick; Baris, Hagit; Dasouki, Majed; Ghosn, Marwan; Mehta, Atul; Packman, Seymour; Pastores, Gregory; Petakov, Milan; Assouline, Sarit; Balwani, Manisha; Danda, Sumita; Hadjiev, Evgueniy; Ortega, Andres; Shankar, Suma; Helena Solano, Maria; Ross, Leorah; Angell, Jennifer; Peterschmitt, M. Judith			Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1 The ENGAGE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENZYME REPLACEMENT THERAPY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TARTRATE GENZ-112638; CHITOTRIOSIDASE; MIGLUSTAT; OUTCOMES; SAFETY; GLUCOCEREBROSIDASE; RECOMMENDATIONS; MACROPHAGE	IMPORTANCE Gaucher disease type 1 is characterized by hepatosplenomegaly, anemia, thrombocytopenia, and skeletal disease. A safe effective oral therapy is needed. OBJECTIVE To determine whether eliglustat, a novel oral substrate reduction therapy, safely reverses clinical manifestations in untreated adults with Gaucher disease type 1. DESIGN, SETTING, AND PARTICIPANTS Phase 3, randomized, double-blind, placebo-controlled trial conducted at 18 sites in 12 countries from November 2009 to July 2012 among eligible patients with splenomegaly plus thrombocytopenia and/or anemia. Of 72 patients screened, 40 were enrolled. INTERVENTIONS Patients were stratified by spleen volume and randomized 1:1 to receive eliglustat (50 or 100 mg twice daily; n = 20) or placebo (n = 20) for 9 months. MAIN OUTCOMES AND MEASURES The primary efficacy end point was percentage change in spleen volume in multiples of normal from baseline to 9 months; secondary efficacy end points were change in hemoglobin level and percentage changes in liver volume and platelet count. RESULTS All patients had baseline splenomegaly and thrombocytopenia (mostly moderate or severe), most had mild or moderate hepatomegaly, and 20% had mild anemia. Least-square mean spleen volume decreased by 27.77% (95% CI, -32.57% to -22.97%) in the eliglustat group (from 13.89 to 10.17 multiples of normal) vs an increase of 2.26% (95% CI, -2.54% to 7.06%) in the placebo group (from 12.50 to 12.84 multiples of normal) for an absolute treatment difference of -30.03% (95% CI, -36.82% to -23.24%; P < .001). For the secondary end points, the least-square mean absolute differences between groups all favored eliglustat, with a 1.22-g/dL increase in hemoglobin level (95% CI, 0.57-1.88 g/dL; P < .001), 6.64% decrease in liver volume (95% CI, -11.37% to -1.91%; P = .007), and 41.06% increase in platelet count (95% CI, 23.95%-58.17%; P < .001). No serious adverse events occurred. One patient in the eliglustat group withdrew (non-treatment related); 39 of the 40 patients transitioned to an open-label extension study CONCLUSIONS AND RELEVANCE Among previously untreated adults with Gaucher disease type 1, treatment with eliglustat compared with placebo for 9 months resulted in significant improvements in spleen volume, hemoglobin level, liver volume, and platelet count. The clinical significance of these findings is uncertain, and more definitive conclusions about clinical efficacy and utility will require comparison with the standard treatment of enzyme replacement therapy as well as longer-term follow-up.	[Mistry, Pramod K.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Lukina, Elena] Minist Publ Hlth Russia, Hematol Res Ctr, Moscow, Russia; [Ben Turkia, Hadhami] Hop La Rabta, Tunis, Tunisia; [Amato, Dominick] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Baris, Hagit] Rabin Med Ctr, Petah Tiqwa, Israel; [Baris, Hagit] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Dasouki, Majed] Univ Kansas, Med Ctr, Kansas City, MO USA; [Ghosn, Marwan] Hotel Dieu France Univ Hosp, Beirut, Lebanon; [Mehta, Atul] Royal Free Hosp, London NW3 2QG, England; [Packman, Seymour] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Pastores, Gregory] NYU, Sch Med, New York, NY USA; [Petakov, Milan] Univ Belgrade, Sch Med, Clin Ctr Serbia, Belgrade, Serbia; [Assouline, Sarit] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Balwani, Manisha] Mt Sinai Hosp, Icahn Sch Med, New York, NY 10029 USA; [Danda, Sumita] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Hadjiev, Evgueniy] Univ Hosp Alexandrovska, Sofia, Bulgaria; [Ortega, Andres] OCA Hosp, Monterrey, Mexico; [Shankar, Suma] Emory Univ, Atlanta, GA 30322 USA; [Helena Solano, Maria] Hosp San Jose Fdn Univ Ciencias Salud San Jose, Bogota, Colombia; [Ross, Leorah; Angell, Jennifer; Peterschmitt, M. Judith] Genzyme, Cambridge, MA USA	Yale University; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Universite de Tunis-El-Manar; Hopital La Rabta; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Kansas; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of California System; University of California San Francisco; New York University; Clinical Centre of Serbia; University of Belgrade; McGill University; Icahn School of Medicine at Mount Sinai; Christian Medical College & Hospital (CMCH) Vellore; Medical University Sofia; Emory University; Fundacion Universitaria de Ciencias de la Salud (FUCS); Sanofi-Aventis; Genzyme Corporation	Mistry, PK (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	pramod.mistry@yale.edu	Pastores, Gregory M./AAE-8647-2020; Mehta, Atul/GPC-7364-2022; Lukina, Elena/N-4536-2014	Lukina, Elena/0000-0002-8774-850X	Genzyme; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER	Genzyme(Sanofi-AventisGenzyme Corporation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This trial was funded by Genzyme.	Aerts JM, 2008, ACTA PAEDIATR, V97, P7, DOI 10.1111/j.1651-2227.2007.00641.x; Andersson HC, 2005, GENET MED, V7, P105, DOI 10.1097/01.GIM.0000153660.88672.3C; [Anonymous], 2008, ZAV PACK INS; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Chen M, 2008, ARCH PATHOL LAB MED, V132, P851, DOI 10.1043/1543-2165(2008)132[851:GDROTL]2.0.CO;2; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Cox TM, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-102; Cox TM, 2010, CURR OPIN INVEST DR, V11, P1169; de Fost M, 2006, BLOOD, V108, P830, DOI 10.1182/blood-2005-12-5072; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Giraldo P, 2001, HAEMATOLOGICA, V86, P977; Goligher EC, 2008, J RHEUMATOL, V35, P635; Grabowski G, 2011, METABOLIC MOL BASES; Grabowski GA, 2013, OMMBID ONLINE METABO; Hollak CEM, 2009, PHARMACOEPIDEM DR S, V18, P770, DOI 10.1002/pds.1779; Kamath RS, 2014, SKELETAL RADIOL, V43, P1353, DOI 10.1007/s00256-014-1891-9; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kuter DJ, 2013, BLOOD CELL MOL DIS, V51, P116, DOI 10.1016/j.bcmd.2013.04.005; Lukina E, 2014, BLOOD CELL MOL DIS, V53, P274, DOI 10.1016/j.bcmd.2014.04.002; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; Maas M, 2008, SKELETAL RADIOL, V37, P185, DOI 10.1007/s00256-007-0425-0; Mathias Susan D, 2011, J Support Oncol, V9, P72; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; Pastores GM, 2004, SEMIN HEMATOL, V41, P4, DOI 10.1053/j.seminhematol.2004.07.009; Peterschmitt MJ, 2011, J CLIN PHARMACOL, V51, P695, DOI 10.1177/0091270010372387; Robertson PL, 2007, AM J ROENTGENOL, V188, P1521, DOI 10.2214/AJR.06.1410; Rogers WH, 2000, PAIN MED, V1, P44, DOI 10.1046/j.1526-4637.2000.99102.x; Weinreb NJ, 2010, GENET MED, V12, P44, DOI 10.1097/GIM.0b013e3181c39194; Wennekes T, 2010, J MED CHEM, V53, P689, DOI 10.1021/jm901281m	31	87	90	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					695	706		10.1001/jama.2015.459	http://dx.doi.org/10.1001/jama.2015.459			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25688781	Bronze, Green Accepted			2022-12-28	WOS:000349476100015
J	Okumura, M				Okumura, Mitchio			Just add water dimers	SCIENCE			English	Editorial Material							CRIEGEE INTERMEDIATE CH2OO; OZONOLYSIS; SO2; NO2		CALTECH, Arthur Amos Noyes Lab Chem Phys, Pasadena, CA 91125 USA	California Institute of Technology	Okumura, M (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Pasadena, CA 91125 USA.	mo@caltech.edu	Okumura, Mitchio/I-3326-2013	Okumura, Mitchio/0000-0001-6874-1137	Direct For Mathematical & Physical Scien [1413712] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Beames JM, 2012, J AM CHEM SOC, V134, P20045, DOI 10.1021/ja310603j; Berndt T, 2014, PHYS CHEM CHEM PHYS, V16, P19130, DOI 10.1039/c4cp02345e; Chao W, 2015, SCIENCE, V347, P751, DOI 10.1126/science.1261549; CRIEGEE R, 1975, ANGEW CHEM INT EDIT, V14, P745, DOI 10.1002/anie.197507451; Donahue NM, 2011, PHYS CHEM CHEM PHYS, V13, P10848, DOI 10.1039/c0cp02564j; Johnson D, 2008, CHEM SOC REV, V37, P699, DOI 10.1039/b704260b; Lewis TR, 2015, PHYS CHEM CHEM PHYS, V17, P4859, DOI 10.1039/c4cp04750h; Ouyang B, 2013, PHYS CHEM CHEM PHYS, V15, P17070, DOI 10.1039/c3cp53024h; Percival CJ, 2013, FARADAY DISCUSS, V165, P45, DOI 10.1039/c3fd00048f; Ryzhkov AB, 2004, PHYS CHEM CHEM PHYS, V6, P5042, DOI 10.1039/b408414d; Stone D, 2014, PHYS CHEM CHEM PHYS, V16, P1139, DOI 10.1039/c3cp54391a; Taatjes CA, 2008, J AM CHEM SOC, V130, P11883, DOI 10.1021/ja804165q; Taatjes CA, 2014, PHYS CHEM CHEM PHYS, V16, P1704, DOI 10.1039/c3cp52842a; Vereecken L, 2014, PHYS CHEM CHEM PHYS, V16, P4039, DOI 10.1039/c3cp54514h; Welz O, 2012, SCIENCE, V335, P204, DOI 10.1126/science.1213229	15	9	9	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					718	719		10.1126/science.aaa5506	http://dx.doi.org/10.1126/science.aaa5506			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678647	Green Accepted			2022-12-28	WOS:000349221300024
J	Macilwain, C				Macilwain, Colin			And the winner is: not science	NATURE			English	Editorial Material												cfmworldview@googlemail.com							0	1	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					139	139		10.1038/518139a	http://dx.doi.org/10.1038/518139a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8SD	25673377	Bronze			2022-12-28	WOS:000349190300004
J	Mateos-Gomez, PA; Gong, FD; Nair, N; Miller, KM; Lazzerini-Denchi, E; Sfeir, A				Mateos-Gomez, Pedro A.; Gong, Fade; Nair, Nidhi; Miller, Kyle M.; Lazzerini-Denchi, Eros; Sfeir, Agnel			Mammalian polymerase theta promotes alternative NHEJ and suppresses recombination	NATURE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; DNA-REPLICATION; END-PROTECTION; REPAIR; TELOMERES; INSTABILITY; PATHWAYS; CELLS; MECHANISM	The alternative non-homologous end-joining (NHEJ) machinery facilitates several genomic rearrangements, some of which can lead to cellular transformation. This error-prone repair pathway is triggered upon telomere de-protection to promote the formation of deleterious chromosome end-to-end fusions(1-3). Using next-generation sequencing technology, here we show that repair by alternative NHEJ yields non-TTAGGG nucleotide insertions at fusion breakpoints of dysfunctional telomeres. Investigating the enzymatic activity responsible for the random insertions enabled us to identify polymerase theta (Pol theta; encoded by Polq in mice) as a crucial alternative NHEJ factor in mammalian cells. Polq inhibition suppresses alternative NHEJ at dysfunctional telomeres, and hinders chromosomal translocations at non-telomeric loci. In addition, we found that loss of Polq in mice results in increased rates of homology-directed repair, evident by recombination of dysfunctional telomeres and accumulation of RAD51 at double-stranded breaks. Lastly, we show that depletion of Pol theta has a synergistic effect on cell survival in the absence of BRCA genes, suggesting that the inhibition of this mutagenic polymerase represents a valid therapeutic avenue for tumours carrying mutations in homology-directed repair genes.	[Mateos-Gomez, Pedro A.; Sfeir, Agnel] NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med, New York, NY 10016 USA; [Gong, Fade; Miller, Kyle M.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Nair, Nidhi; Lazzerini-Denchi, Eros] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	New York University; University of Texas System; University of Texas Austin; Scripps Research Institute	Sfeir, A (corresponding author), NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med, New York, NY 10016 USA.	agnel.sfeir@med.nyu.edu	Denchi, Eros Lazzerini/AAD-8208-2020; Gong, Fade/M-1585-2015; Mateos-Gomez, Pedro A/E-9924-2018; lazzerini denchi, eros/F-7913-2010	Mateos-Gomez, Pedro A/0000-0002-5539-2289; lazzerini denchi, eros/0000-0001-5378-4644; Nair, Nidhi/0000-0003-4192-9812; Miller, Kyle/0000-0002-4544-0013	Breast Cancer Alliance; V-foundation; Department of Defense Breast Cancer Research Program [BC134020]; Pew-Stewart Scholars Award; Pew Scholars Award; Novartis Advanced Discovery Institute; National Institutes of Health (NIH) [AG038677]; Helen L. and Martin S. Kimmel Center for Stem Cell Biology; University of Texas at Austin; Cancer Prevention Research Institute of Texas (CPRIT) [R116]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038677] Funding Source: NIH RePORTER	Breast Cancer Alliance; V-foundation; Department of Defense Breast Cancer Research Program(United States Department of Defense); Pew-Stewart Scholars Award; Pew Scholars Award; Novartis Advanced Discovery Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen L. and Martin S. Kimmel Center for Stem Cell Biology; University of Texas at Austin; Cancer Prevention Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. de Lange, R. Greenberg, J. Shay, N. Shima, C. Cazaux and R. Wood for providing key reagents for this study. We are grateful to M. Ji, L. Walton Masters, A. Phillips, A. Pinzaru, F. Yeung, P. Tonzi and J. Wong for technical assistance. We thank S. Kabir and F. Lottersberger for critical reading of the manuscript. This work was supported by a grant from the Breast Cancer Alliance (A. S.), V-foundation (A. S.), Department of Defense Breast Cancer Research Program BC134020 (P. A. M.-G.), Pew-Stewart Scholars Award (A. S.), Pew Scholars Award (E.L.-D.), Novartis Advanced Discovery Institute (E.L.-D.), and a grant from the National Institutes of Health (NIH) AG038677 (E.L.-D.). The A. S. laboratory was supported by start-up funds from the Helen L. and Martin S. Kimmel Center for Stem Cell Biology. The K.M.M. laboratory was supported in part by start-up funds from the University of Texas at Austin and from the Cancer Prevention Research Institute of Texas (CPRIT, R116). K.M.M. is a CPRIT scholar.	Arana ME, 2008, NUCLEIC ACIDS RES, V36, P3847, DOI 10.1093/nar/gkn310; Audebert M, 2006, J MOL BIOL, V356, P257, DOI 10.1016/j.jmb.2005.11.028; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Bindra RS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt255; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Chan SH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001005; Chen H, 2013, MOL CELL, V50, P589, DOI 10.1016/j.molcel.2013.04.032; Deng SK, 2014, NAT STRUCT MOL BIOL, V21, P405, DOI 10.1038/nsmb.2786; Fernandez-Vidal A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5285; Higgins GS, 2010, ONCOTARGET, V1, P175, DOI 10.18632/oncotarget.124; Hogg M, 2012, NUCLEIC ACIDS RES, V40, P2611, DOI 10.1093/nar/gkr1102; Kawamura K, 2004, INT J CANCER, V109, P9, DOI 10.1002/ijc.11666; Koole W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4216; Lemee F, 2010, P NATL ACAD SCI USA, V107, P13390, DOI 10.1073/pnas.0910759107; Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873; Prasad R, 2009, NUCLEIC ACIDS RES, V37, P1868, DOI 10.1093/nar/gkp035; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Roerink SF, 2014, GENOME RES, V24, P954, DOI 10.1101/gr.170431.113; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Sfeir A, 2012, J CELL SCI, V125, P4173, DOI 10.1242/jcs.106831; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Shima N, 2003, GENETICS, V163, P1031; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020	34	391	420	3	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					254	U285		10.1038/nature14157	http://dx.doi.org/10.1038/nature14157			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25642960	Green Accepted			2022-12-28	WOS:000349190300043
J	Ruprecht, V; Wieser, S; Callan-Jones, A; Smutny, M; Morita, H; Sako, K; Barone, V; Ritsch-Marte, M; Sixt, M; Voituriez, R; Heisenberg, CP				Ruprecht, Verena; Wieser, Stefan; Callan-Jones, Andrew; Smutny, Michael; Morita, Hitoshi; Sako, Keisuke; Barone, Vanessa; Ritsch-Marte, Monika; Sixt, Michael; Voituriez, Raphael; Heisenberg, Carl-Philipp			Cortical Contractility Triggers a Stochastic Switch to Fast Amoeboid Cell Motility	CELL			English	Article							LYSOPHOSPHATIDIC ACID; MIGRATION; TENSION; INVASION; REVEAL	3D amoeboid cell migration is central to many developmental and disease-related processes such as cancer metastasis. Here, we identify a unique prototypic amoeboid cell migration mode in early zebrafish embryos, termed stable-bleb migration. Stable-bleb cells display an invariant polarized balloon-like shape with exceptional migration speed and persistence. Progenitor cells can be reversibly transformed into stable-bleb cells irrespective of their primary fate and motile characteristics by increasing myosin II activity through biochemical or mechanical stimuli. Using a combination of theory and experiments, we show that, in stable-bleb cells, cortical contractility fluctuations trigger a stochastic switch into amoeboid motility, and a positive feedback between cortical flows and gradients in contractility maintains stable-bleb cell polarization. We further show that rearward cortical flows drive stable-bleb cell migration in various adhesive and non-adhesive environments, unraveling a highly versatile amoeboid migration phenotype.	[Ruprecht, Verena; Wieser, Stefan; Smutny, Michael; Morita, Hitoshi; Sako, Keisuke; Barone, Vanessa; Sixt, Michael; Heisenberg, Carl-Philipp] IST Austria, A-3400 Klosterneuburg, Austria; [Voituriez, Raphael] Univ Paris 06, CNRS, Lab Jean Perrin, F-75005 Paris, France; [Voituriez, Raphael] Univ Paris 06, CNRS, Lab Phys Theor Mat Condensee, F-75005 Paris, France; [Wieser, Stefan; Ritsch-Marte, Monika] Med Univ Innsbruck, Div Biomed Phys, A-6020 Innsbruck, Austria; [Callan-Jones, Andrew] Univ Paris Diderot, CNRS, Lab Mat & Syst Complexes, UMR 7057, F-75204 Paris 13, France	Institute of Science & Technology - Austria; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Medical University of Innsbruck; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Ruprecht, V (corresponding author), IST Austria, A-3400 Klosterneuburg, Austria.	ruprecht.verena@gmail.com; heisenberg@ist.ac.at	wieser, stefan/ABH-4102-2020; voituriez, raphael/V-3418-2017; Ruprecht, Verena/H-7563-2017	wieser, stefan/0000-0002-2670-2217; Ruprecht, Verena/0000-0003-4088-8633; Barone, Vanessa/0000-0003-2676-3367; Morita, Hitoshi/0000-0002-9073-2664; Smutny, Michael/0000-0002-5920-9090; voituriez, raphael/0000-0001-8746-5713; sako, keisuke/0000-0002-6453-8075; Sixt, Michael/0000-0002-6620-9179; Heisenberg, Carl-Philipp/0000-0002-0912-4566	Agence Nationale de la Recherche (ANR) [ANR-09-PIRI-0027]; Human Frontiers in Science Program; Austrian Science Foundation (FWF) [T560-B17, I 812-B12]; Austrian Science Fund (FWF) [T 560, I 812] Funding Source: researchfish	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Human Frontiers in Science Program(Human Frontier Science Program); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We would like to thank R. Hausschild and E. Papusheva for technical assistance and the service facilities at the IST Austria for continuous support. The caRhoA plasmid was a kind gift of T. Kudoh and A. Takesono. We thank M. Piel and E. Paluch for exchanging unpublished data. This work was supported by grants from the Agence Nationale de la Recherche (ANR) to R. V. (ANR-09-PIRI-0027), the Human Frontiers in Science Program to M. S., and the Austrian Science Foundation (FWF): (T560-B17) and (I 812-B12) to V. R. and C.-P.H.	Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; Callan-Jones AC, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025022; Carvalho K, 2013, P NATL ACAD SCI USA, V110, P16456, DOI 10.1073/pnas.1221524110; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Hawkins RJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058103; Hawkins RJ, 2011, BIOPHYS J, V101, P1041, DOI 10.1016/j.bpj.2011.07.038; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lee SJ, 2008, FASEB J, V22, P3706, DOI 10.1096/fj.08-106088; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Row RH, 2011, DEV BIOL, V354, P102, DOI 10.1016/j.ydbio.2011.03.025; Salbreux G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058102; Shih WT, 2010, BIOPHYS J, V98, pL29, DOI 10.1016/j.bpj.2010.02.028; Sonnemann KJ, 2011, ANNU REV CELL DEV BI, V27, P237, DOI 10.1146/annurev-cellbio-092910-154251; Takesono A, 2012, P NATL ACAD SCI USA, V109, P3371, DOI 10.1073/pnas.1200642109; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yukiura H, 2011, J BIOL CHEM, V286, P43972, DOI 10.1074/jbc.M111.301093	30	241	242	3	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					673	685		10.1016/j.cell.2015.01.008	http://dx.doi.org/10.1016/j.cell.2015.01.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25679761	Green Published, hybrid			2022-12-28	WOS:000349208800011
J	Schlumberger, M; Tahara, M; Wirth, LJ; Robinson, B; Brose, MS; Elisei, R; Habra, MA; Newbold, K; Shah, MH; Hoff, AO; Gianoukakis, AG; Kiyota, N; Taylor, MH; Kim, SB; Krzyzanowska, MK; Dutcus, CE; de las Heras, B; Zhu, JM; Sherman, SI				Schlumberger, Martin; Tahara, Makoto; Wirth, Lori J.; Robinson, Bruce; Brose, Marcia S.; Elisei, Rossella; Habra, Mouhammed Amir; Newbold, Kate; Shah, Manisha H.; Hoff, Ana O.; Gianoukakis, Andrew G.; Kiyota, Naomi; Taylor, Matthew H.; Kim, Sung-Bae; Krzyzanowska, Monika K.; Dutcus, Corina E.; de las Heras, Begona; Zhu, Junming; Sherman, Steven I.			Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR PROGRESSION; DOUBLE-BLIND; LYMPH-NODE; PAPILLARY; CARCINOMA; METASTASES; TARGETS; VEGF; BRAF; EXPRESSION	Background Lenvatinib, an oral inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, fibroblast growth factor receptors 1 through 4, platelet-derived growth factor receptor a, RET, and KIT, showed clinical activity in a phase 2 study involving patients with differentiated thyroid cancer that was refractory to radioiodine (iodine-131). Methods In our phase 3, randomized, double-blind, multicenter study involving patients with progressive thyroid cancer that was refractory to iodine-131, we randomly assigned 261 patients to receive lenvatinib (at a daily dose of 24 mg per day in 28-day cycles) and 131 patients to receive placebo. At the time of disease progression, patients in the placebo group could receive open-label lenvatinib. The primary end point was progression-free survival. Secondary end points included the response rate, overall survival, and safety. Results The median progression-free survival was 18.3 months in the lenvatinib group and 3.6 months in the placebo group (hazard ratio for progression or death, 0.21; 99% confidence interval, 0.14 to 0.31; P<0.001). A progression-free survival benefit associated with lenvatinib was observed in all prespecified subgroups. The response rate was 64.8% in the lenvatinib group (4 complete responses and 165 partial responses) and 1.5% in the placebo group (P<0.001). The median overall survival was not reached in either group. Treatment-related adverse effects of any grade, which occurred in more than 40% of patients in the lenvatinib group, were hypertension (in 67.8% of the patients), diarrhea (in 59.4%), fatigue or asthenia (in 59.0%), decreased appetite (in 50.2%), decreased weight (in 46.4%), and nausea (in 41.0%). Discontinuations of the study drug because of adverse effects occurred in 37 patients who received lenvatinib (14.2%) and 3 patients who received placebo (2.3%). In the lenvatinib group, 6 of 20 deaths that occurred during the treatment period were considered to be drug-related. Conclusions Lenvatinib, as compared with placebo, was associated with significant improvements in progression-free survival and the response rate among patients with iodine-131-refractory thyroid cancer. Patients who received lenvatinib had more adverse effects. (Funded by Eisai; SELECT ClinicalTrials.gov number, NCT01321554.)	[Schlumberger, Martin] Inst Gustave Roussy, Ctr Reference Tumeurs Refractaires Thyroide, Dept Nucl Med & Endocrine Oncol, Villejuif, France; [Schlumberger, Martin] Univ Paris Sud, Villejuif, France; [Tahara, Makoto] Natl Canc Ctr Hosp East, Dept Head & Neck Med Oncol, Kashiwa, Chiba, Japan; [Kiyota, Naomi] Kobe Univ Hosp, Dept Med Oncol & Hematol, Kobe, Hyogo, Japan; [Wirth, Lori J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Robinson, Bruce] Univ Sydney, Kolling Inst Med Res, Sydney, NSW 2006, Australia; [Brose, Marcia S.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Brose, Marcia S.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Elisei, Rossella] Univ Pisa, Dept Clin & Expt Med, Endocrine Unit, Pisa, Italy; [Habra, Mouhammed Amir; Sherman, Steven I.] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Div Internal Med, Houston, TX 77030 USA; [Newbold, Kate] Royal Marsden Hosp NHS Trust, London, England; [de las Heras, Begona] Eisai, Hatfield, Herts, England; [Shah, Manisha H.] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Columbus, OH 43210 USA; [Hoff, Ana O.] Univ Sao Paulo, Dept Endocrinol, Endocrine Oncol Unit, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil; [Gianoukakis, Andrew G.] Harbor Univ Calif Los Angeles Med Ctr, Div Endocrinol & Metab, Torrance, CA USA; [Taylor, Matthew H.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Kim, Sung-Bae] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea; [Krzyzanowska, Monika K.] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada; [Dutcus, Corina E.; Zhu, Junming] Eisai, Woodcliff Lake, NJ USA	UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; National Cancer Center - Japan; Kobe University; Harvard University; Massachusetts General Hospital; University of Sydney; Kolling Institute of Medical Research; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pisa; University of Texas System; UTMD Anderson Cancer Center; Royal Marsden NHS Foundation Trust; Eisai Co Ltd; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Universidade de Sao Paulo; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Oregon Health & Science University; University of Ulsan; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Eisai Co Ltd	Schlumberger, M (corresponding author), Inst Gustave Roussy, Ctr Reference Tumeurs Refractaires Thyroide, Dept Nucl Med & Endocrine Oncol, Villejuif, France.	martin.schlumberger@gustaveroussy.fr	Newbold, Kate/AAA-9176-2022; Kiyota, Naomi/K-3226-2016; de Oliveira Hoff, Ana Amélia Fialho/A-5753-2013; Krzyzanowska, Monika K./ABG-3505-2020	Kiyota, Naomi/0000-0001-8021-6116; Krzyzanowska, Monika K./0000-0001-5533-7418; Sherman, Steven/0000-0002-3079-5153; Habra, Mouhammed Amir/0000-0002-4148-9637; ELISEI, ROSSELLA/0000-0002-5333-9257	Eisai; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Eisai(Eisai Co Ltd); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Eisai; SELECT ClinicalTrials.gov number, NCT01321554.	[Anonymous], 2007, GUID IND CLIN TRIAL; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bible KC, 2010, LANCET ONCOL, V11, P962, DOI 10.1016/S1470-2045(10)70203-5; Boelaert K, 2003, J CLIN ENDOCR METAB, V88, P2341, DOI 10.1210/jc.2002-021113; Brose MS, 2014, LANCET, V384, P319, DOI 10.1016/S0140-6736(14)60421-9; Busaidy NL, 2012, J THROID RES, V2012, DOI 10.1155/2012/618985; Cabanillas ME, 2011, J THROID RES, V2011, DOI 10.4061/2011/985780; Carr LL, 2010, CLIN CANCER RES, V16, P5260, DOI 10.1158/1078-0432.CCR-10-0994; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Eskens FALM, 2006, EUR J CANCER, V42, P3127, DOI 10.1016/j.ejca.2006.09.015; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; He GP, 2014, ONCOL LETT, V7, P439, DOI 10.3892/ol.2013.1713; Hoftijzer H, 2009, EUR J ENDOCRINOL, V161, P923, DOI 10.1530/EJE-09-0702; Keizer RJ, 2010, J PHARMACOKINET PHAR, V37, P347, DOI 10.1007/s10928-010-9164-2; Leboulleux S, 2012, LANCET ONCOL, V13, P897, DOI 10.1016/S1470-2045(12)70335-2; Locati LD, 2014, CANCER-AM CANCER SOC, V120, P2694, DOI 10.1002/cncr.28766; Matsui J, 2008, CLIN CANCER RES, V14, P5459, DOI 10.1158/1078-0432.CCR-07-5270; Matsui J, 2008, INT J CANCER, V122, P664, DOI 10.1002/ijc.23131; National Cancer Institute, 2013, PROT DEV CANC THER E; Nikiforov YE, 2002, ENDOCR PATHOL, V13, P3, DOI 10.1385/EP:13:1:03; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Rivera M, 2010, MODERN PATHOL, V23, P1191, DOI 10.1038/modpathol.2010.112; ROBINS JM, 1991, COMMUN STAT THEORY, V20, P2609, DOI 10.1080/03610929108830654; Salajegheh A, 2011, EJSO-EUR J SURG ONC, V37, P93, DOI 10.1016/j.ejso.2010.10.010; Schlumberger M, 2014, LANCET DIABETES ENDO, V2, P356, DOI 10.1016/S2213-8587(13)70215-8; Sherman SI, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.5503; St Bernard R, 2005, ENDOCRINOLOGY, V146, P1145, DOI 10.1210/en.2004-1134; Volante M, 2009, J CLIN ENDOCR METAB, V94, P4735, DOI 10.1210/jc.2009-1233; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yu XM, 2008, ANN SURG, V247, P483, DOI 10.1097/SLA.0b013e31815fa447	32	1053	1105	5	127	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7					621	630		10.1056/NEJMoa1406470	http://dx.doi.org/10.1056/NEJMoa1406470			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CK	25671254	Green Published			2022-12-28	WOS:000349143900006
J	Brown, SM				Brown, Samuel M.			We still lack patient centered visitation in intensive care units	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Brown, Samuel M.] Intermt Med Ctr, Ctr Humanizing Crit Care, Murray, UT 84107 USA; [Brown, Samuel M.] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA	Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah	Brown, SM (corresponding author), Intermt Med Ctr, Ctr Humanizing Crit Care, 5121 South Cottonwood St, Murray, UT 84107 USA.	samuel.brown@imail.org	Brown, Samuel M/E-6846-2015	Brown, Samuel M/0000-0003-1206-6261				Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Berwick DM, 2004, JAMA-J AM MED ASSOC, V292, P736, DOI 10.1001/jama.292.6.736; Carman KL, 2013, HEALTH AFFAIR, V32, P223, DOI 10.1377/hlthaff.2012.1133; Davydow DS, 2008, GEN HOSP PSYCHIAT, V30, P421, DOI 10.1016/j.genhosppsych.2008.05.006; Fumagalli S, 2006, CIRCULATION, V113, P946, DOI 10.1161/CIRCULATIONAHA.105.572537; Hardin SR, 2011, DIMENS CRIT CARE NUR, V30, P53, DOI 10.1097/DCC.0b013e3181fd03a0; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Liu V, 2013, CRIT CARE, V17, DOI 10.1186/cc12677; Lynn J, 1997, New Horiz, V5, P56; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Olsen Kristin Dahle, 2009, Intensive Crit Care Nurs, V25, P190, DOI 10.1016/j.iccn.2009.04.004	12	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2015	350								h792	10.1136/bmj.h792	http://dx.doi.org/10.1136/bmj.h792			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0MG	25672899				2022-12-28	WOS:000349319700025
J	O'Kane, M; Freedman, D; Zikmund-Fisher, BJ				O'Kane, Maurice; Freedman, Danielle; Zikmund-Fisher, Brian J.			Can patients use test results effectively if they have direct access?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREFERENCE REVERSALS; SEPARATE EVALUATIONS; NUMERACY; EVALUABILITY; JOINT		[O'Kane, Maurice] Western Hlth & Social Care Trust, Altnagelvin Hosp, Derry, Londonderry, North Ireland; [Freedman, Danielle] Luton & Dunstable Univ Hosp NHS Fdn Trust, Luton, Beds, England; [Zikmund-Fisher, Brian J.] Univ Michigan, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	O'Kane, M (corresponding author), Western Hlth & Social Care Trust, Altnagelvin Hosp, Derry, Londonderry, North Ireland.	Maurice.OKane@westerntrust.hscni.net; bzikmund@umich.edu	Zikmund-Fisher, Brian J./A-7677-2009	Zikmund-Fisher, Brian/0000-0002-1637-4176				Ahern DK, 2011, AM J PREV MED, V40, pS162, DOI 10.1016/j.amepre.2011.01.005; Bloomfield HE, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00005; Callen JL, 2012, J GEN INTERN MED, V27, P1334, DOI 10.1007/s11606-011-1949-5; Casalino LP, 2009, ARCH INTERN MED, V169, P1123, DOI 10.1001/archinternmed.2009.130; Christenson K, 2013, J PARTICIPATORY MED, V5, pe38; de Lusignan S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006021; Galesic M, 2010, ARCH INTERN MED, V170, P462, DOI 10.1001/archinternmed.2009.481; Hsee CK, 2010, PERSPECT PSYCHOL SCI, V5, P343, DOI 10.1177/1745691610374586; Hsee CK, 1999, PSYCHOL BULL, V125, P576, DOI 10.1037/0033-2909.125.5.576; Hsee CK, 1996, ORGAN BEHAV HUM DEC, V67, P247, DOI 10.1006/obhd.1996.0077; Lipkus IM, 2009, HEALTH EDUC BEHAV, V36, P1065, DOI 10.1177/1090198109341533; Nelson W, 2008, ANN BEHAV MED, V35, P261, DOI 10.1007/s12160-008-9037-8; Polonsky WH, 2011, DIABETES CARE, V34, P262, DOI 10.2337/dc10-1732; Walker J, 2014, NEW ENGL J MED, V370, P6, DOI 10.1056/NEJMp1310132; Zikmund-Fisher BJ, 2004, MED DECIS MAKING, V24, P142, DOI 10.1177/0272989X04263154; Zikmund-Fisher BJ, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3241; Zikmund-Fisher BJ, 2014, NUMERICAL REASONING IN JUDGMENTS AND DECISION MAKING ABOUT HEALTH, P80	18	14	14	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2015	350								h673	10.1136/bmj.h673	http://dx.doi.org/10.1136/bmj.h673			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB0MG	25673132				2022-12-28	WOS:000349319700013
J	Wicks, P				Wicks, Paul			SPOTLIGHT: PATIENT CENTRED CARE Commentary: Measuring what matters: the case for patient generated PROMS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FUNCTIONAL RATING-SCALE; REPORTED OUTCOMES; ALSFRS-R; VALIDATION; VERSION		PatientsLikeMe, Cambridge, MA 02141 USA		Wicks, P (corresponding author), PatientsLikeMe, 155 2nd St, Cambridge, MA 02141 USA.	pwicks@patientslikeme.com	Wicks, Paul/C-6128-2011	Wicks, Paul/0000-0002-2293-9284				Abdulla S, 2013, J NEUROL, V260, P2242, DOI 10.1007/s00415-013-6955-6; Brady CB, 2013, AMYOTROPH LAT SCL FR, V14, P591, DOI 10.3109/21678421.2013.822516; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; Fehnel S, 2013, EXPERT REV PHARM OUT, V13, P441, DOI 10.1586/14737167.2013.814957; Fleurence RL, 2014, HEALTH AFFAIR, V33, P1212, DOI 10.1377/hlthaff.2014.0113; Kasarskis EJ, 2005, AMYOTROPH LATERAL SC, V6, P50, DOI 10.1080/14660820510027107; Kaufmann P, 2005, NEUROLOGY, V64, P38, DOI 10.1212/01.WNL.0000148648.38313.64; Kaufmann P, 2007, AMYOTROPH LATERAL SC, V8, P42, DOI 10.1080/17482960600888156; Kuffner R, 2014, NAT BIOTECHNOL; Maier A, 2012, AMYOTROPH LATERAL SC, V13, P210, DOI 10.3109/17482968.2011.633268; Menke RAL, 2014, BRAIN, V137, P2546, DOI 10.1093/brain/awu162; Montes J, 2006, NEUROLOGY, V67, P1294, DOI 10.1212/01.wnl.0000238505.22066.fc; Nelson EC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7818; Phelps RG, 2014, J MED INTERNET RES, V16, P209, DOI 10.2196/jmir.3371; Rothman M, VALUE HLTH IN PRESS; Schwartzapfel B, 2009, BROWN ALUMNI MAG MAR; Snyder CF, 2014, J ONCOL PRACT, V10, pE299, DOI 10.1200/JOP.2014.001413; Tran VT, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-109; Wicks P, 2009, EUR J NEUROL, V16, P353, DOI 10.1111/j.1468-1331.2008.02434.x; Wicks P, 2014, QUAL LIFE RES, V23, P195, DOI 10.1007/s11136-013-0458-x; Wicks P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g368	23	4	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h54	10.1136/bmj.h54	http://dx.doi.org/10.1136/bmj.h54			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670198	Bronze			2022-12-28	WOS:000349318400001
J	Bernstein, R				Bernstein, Rachel			Science by any means necessary	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					686	686		10.1126/science.347.6222.686	http://dx.doi.org/10.1126/science.347.6222.686			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CX	25657252				2022-12-28	WOS:000349145200048
J	Verhagen, JH; Herfst, S; Fouchier, RAM				Verhagen, Josanne H.; Herfst, Sander; Fouchier, Ron A. M.			How a virus travels the world	SCIENCE			English	Editorial Material							AVIAN INFLUENZA-VIRUSES; TRANSMISSION; FERRETS; CHINA; H5N5		[Verhagen, Josanne H.; Herfst, Sander; Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, NL-3015 CE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Verhagen, JH (corresponding author), Erasmus MC, Dept Virosci, NL-3015 CE Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Herfst, Sander/0000-0001-9866-8903; Verhagen, Josanne/0000-0003-3133-5228				Adlhoch C, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.50.20996; Gilbert M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113569; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Jeong J, 2014, VET MICROBIOL, V173, P249, DOI 10.1016/j.vetmic.2014.08.002; Kim YI, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.75; Li QH, 2014, VET RES, V45, DOI 10.1186/s13567-014-0127-2; Liu CG, 2013, VET MICROBIOL, V167, P296, DOI 10.1016/j.vetmic.2013.09.004; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Shepard SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086921; Wong FYK, 2015, EMERG INFECT DIS, V21, P511, DOI 10.3201/eid2103.141488; Zhao G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046183; Zhao KK, 2013, VET MICROBIOL, V163, P351, DOI 10.1016/j.vetmic.2012.12.025	12	127	130	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					616	617		10.1126/science.aaa6724	http://dx.doi.org/10.1126/science.aaa6724			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657235				2022-12-28	WOS:000349145200026
J	Long, JCS; Loy, F; Morgan, MG				Long, Jane C. S.; Loy, Frank; Morgan, M. Granger			Start research on climate engineering	NATURE			English	Editorial Material									[Long, Jane C. S.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Loy, Frank] State Global Affairs, Columbus, OH USA; [Morgan, M. Granger] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Carnegie Mellon University	Long, JCS (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.	janecslong@gmail.com						Bipartisan Policy Center Task Force on Climate Remediation Research, 2011, GEOENG NAT STRAT PLA; IPCC, 2013, CLIMATE CHANGE 2022; Keith DW, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0175; Long JCS, 2013, ISSUES SCI TECHNOL, V29, P45; Morgan M. G., 2010, COOLING EARTH SOLAR; Parson EA, 2013, SCIENCE, V339, P1278, DOI 10.1126/science.1232527	6	24	27	0	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					29	31		10.1038/518029a	http://dx.doi.org/10.1038/518029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25652981	Bronze			2022-12-28	WOS:000349098000014
J	Perkel, JM				Perkel, Jeffrey M.			PICK UP PYTHON	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008				2014, NATURE, V515, P151	1	72	73	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					125	126		10.1038/518125a	http://dx.doi.org/10.1038/518125a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25653001	Bronze			2022-12-28	WOS:000349098000045
J	Limb, M				Limb, Matthew			NHS PROVISION Circle's NHS failure: where now for the private sector?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												limb@btinternet.com						Care Quality Commission, 2015, HINCH HLTH CAR NHS T; Department of Health, 2013, DALT REV EX NEW OPT; Iacobucci G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h179; Iacobucci G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h159	4	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2015	350								h325	10.1136/bmj.h325	http://dx.doi.org/10.1136/bmj.h325			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZB	25647165				2022-12-28	WOS:000348433200024
J	Haslinger, K; Peschke, M; Brieke, C; Maximowitsch, E; Cryle, MJ				Haslinger, Kristina; Peschke, Madeleine; Brieke, Clara; Maximowitsch, Egle; Cryle, Max J.			X-domain of peptide synthetases recruits oxygenases crucial for glycopeptide biosynthesis	NATURE			English	Article							PHENOL COUPLING REACTION; VANCOMYCIN-TYPE; CRYSTAL-STRUCTURE; GENE-CLUSTER; ANTIBIOTICS; CYTOCHROME-P450; TEICOPLANIN; INSIGHTS; CONDENSATION; CYCLIZATION	Non-ribosomal peptide synthetase (NRPS) mega-enzyme complexes are modular assembly lines that are involved in the biosynthesis of numerous peptide metabolites independently of the ribosome(1). The multiple interactions between catalytic domains within the NRPS machinery are further complemented by additional interactions with external enzymes, particularly focused on the final peptide maturation process. An important class of NRPS metabolites that require extensive external modification of the NRPS-bound peptide are the glycopeptide antibiotics (GPAs), which include vancomycin and teicoplanin(2,3). These clinically relevant peptide antibiotics undergo cytochrome P450-catalysed oxidative crosslinking of aromatic side chains to achieve their final, active conformation(4-12). However, the mechanism underlying the recruitment of the cytochrome P450 oxygenases to the NRPS-bound peptide was previously unknown. Here we show, through in vitro studies, that the X-domain(13,14), a conserved domain of unknown function present in the final module of all GPA NRPS machineries, is responsible for the recruitment of oxygenases to theN RPS-bound peptide to perform the essential side-chain crosslinking. X-ray crystallography shows that the X-domain is structurally related to condensation domains, but that its amino acid substitutions render it catalytically inactive. We found that the X-domain recruits cytochrome P450 oxygenases to the NRPS and determined the interface by solving the structure of a P450-X-domain complex. Additionally, we demonstrated that the modification of peptide precursors by oxygenases in vitro-in particular the installation of the second crosslink in GPA biosynthesis-occurs only in the presence of the X-domain. Our results indicate that the presentation of peptidyl carrier protein (PCP)-bound substrates for oxidation in GPA biosynthesis requires the presence of the NRPS X-domain to ensure conversion of the precursor peptide into a mature aglycone, and that the carrier protein domain alone is not always sufficient to generate a competent substrate for external cytochrome P450 oxygenases.	[Haslinger, Kristina; Peschke, Madeleine; Brieke, Clara; Maximowitsch, Egle; Cryle, Max J.] Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Max Planck Society	Cryle, MJ (corresponding author), Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany.	Max.Cryle@mpimf-heidelberg.mpg.de	Haslinger, Kristina/ABC-1310-2020; Cryle, Max/H-7656-2017	Haslinger, Kristina/0000-0003-1361-1508; Cryle, Max/0000-0002-9739-6157	Deutsche Forschungsgemeinschaft (Emmy-Noether Program) [CR 392/1-1]	Deutsche Forschungsgemeinschaft (Emmy-Noether Program)(German Research Foundation (DFG))	The authors thank A. Koch for assistance with protein expression; S. Bell for redox proteins; M. Gradl for assistance with mass spectrometry; M. Tarnawski and A. Meinhart for assistance with crystal harvesting and data processing; I. Schlichting and J. Wray for discussions; C. Roome for IT support; R. Sussmuth and A. Truman for sharing unpublished data. Diffraction data were collected at the Swiss Light Source, X10SA beamline, Paul Scherrer Institute, Villigen, Switzerland. We thank the Heidelberg team for data collection and the PXII staff for their support in setting up the beamline. M. J. C. is grateful to I. Schlichting for constant encouragement and to the Deutsche Forschungsgemeinschaft (Emmy-Noether Program, CR 392/1-1) for financial support.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bell SG, 2010, MOL BIOSYST, V6, P206, DOI 10.1039/b913487e; Bischoff D, 2001, ANGEW CHEM INT EDIT, V40, P4688, DOI 10.1002/1521-3773(20011217)40:24<4688::AID-ANIE4688>3.0.CO;2-M; Bischoff D, 2001, ANGEW CHEM INT EDIT, V40, P1693, DOI 10.1002/1521-3773(20010504)40:9<1693::AID-ANIE16930>3.0.CO;2-8; Bischoff D, 2005, CHEMBIOCHEM, V6, P267, DOI 10.1002/cbic.200400328; Bloudoff K, 2013, J MOL BIOL, V425, P3137, DOI 10.1016/j.jmb.2013.06.003; Bogomolovas J, 2009, PROTEIN EXPRES PURIF, V64, P16, DOI 10.1016/j.pep.2008.10.003; Brieke C, 2015, ORG BIOMOL CHEM, V13, P2012, DOI 10.1039/c4ob02452d; Brieke C, 2014, ORG LETT, V16, P2454, DOI 10.1021/ol500840f; Butler MS, 2014, J ANTIBIOT, V67, P631, DOI 10.1038/ja.2014.111; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; Cryle MJ, 2014, AMINO ACIDS PEP PROT, V38, P1, DOI 10.1039/9781849737081-00001; Cryle MJ, 2010, J BIOL CHEM, V285, P24562, DOI 10.1074/jbc.M110.131904; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geib N, 2008, BIOORG MED CHEM LETT, V18, P3081, DOI 10.1016/j.bmcl.2007.11.093; Hadatsch B, 2007, CHEM BIOL, V14, P1078, DOI 10.1016/j.chembiol.2007.08.014; Haslinger K, 2014, CHEMBIOCHEM, V15, P2719, DOI 10.1002/cbic.201402441; Haslinger K, 2014, ANGEW CHEM INT EDIT, V53, P8518, DOI 10.1002/anie.201404977; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Hur GH, 2012, NAT PROD REP, V29, P1074, DOI 10.1039/c2np20025b; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li TL, 2004, CHEM BIOL, V11, P107, DOI 10.1016/j.chembiol.2004.01.001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pootoolal J, 2002, P NATL ACAD SCI USA, V99, P8962, DOI 10.1073/pnas.102285099; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; Samel SA, 2014, ACTA CRYSTALLOGR D, V70, P1442, DOI 10.1107/S1399004714004398; Sosio M, 2004, MICROBIOL-SGM, V150, P95, DOI 10.1099/mic.0.26507-0; Stegmann E, 2006, J BIOTECHNOL, V124, P640, DOI 10.1016/j.jbiotec.2006.04.009; Stegmann E, 2010, CURR OPIN MICROBIOL, V13, P595, DOI 10.1016/j.mib.2010.08.011; Sunbul M, 2009, J MOL BIOL, V387, P883, DOI 10.1016/j.jmb.2009.02.010; Sussmuth RD, 1999, ANGEW CHEM INT EDIT, V38, P1976, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1976::AID-ANIE1976>3.0.CO;2-3; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Uhlmann S, 2013, ACS CHEM BIOL, V8, P2586, DOI 10.1021/cb400555e; van Wageningen AMA, 1998, CHEM BIOL, V5, P155, DOI 10.1016/S1074-5521(98)90060-6; Walsh CT, 2014, J ANTIBIOT, V67, P7, DOI 10.1038/ja.2013.49; Woithe K, 2007, J AM CHEM SOC, V129, P6887, DOI 10.1021/ja071038f; Yim G, 2014, J ANTIBIOT, V67, P31, DOI 10.1038/ja.2013.117; Zerbe K, 2004, ANGEW CHEM INT EDIT, V43, P6709, DOI 10.1002/anie.200461278; Zerbe K, 2002, J BIOL CHEM, V277, P47476, DOI 10.1074/jbc.M206342200	47	117	119	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					105	U271		10.1038/nature14141	http://dx.doi.org/10.1038/nature14141			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25686610				2022-12-28	WOS:000354040900042
J	Johansson, M; Brodersen, J				Johansson, Minna; Brodersen, John			Informed choice in screening needs more than information	LANCET			English	Editorial Material									[Johansson, Minna] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Johansson, Minna] FoUU Ctr Fyrbodal, Res Unit, S-46235 Vanersborg, Sweden; [Johansson, Minna] FoUU Ctr Fyrbodal, Sect Gen Practice, S-46235 Vanersborg, Sweden; [Brodersen, John] Univ Copenhagen, Res Unit Gen Practice, Copenhagen, Denmark; [Brodersen, John] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark	University of Gothenburg; University of Copenhagen; University of Copenhagen	Johansson, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden.	minna.johansson@vgregion.se		Brodersen, John Brandt/0000-0001-9369-3376				Brodersen J, 2013, ANN FAM MED, V11, P106, DOI 10.1370/afm.1466; Chen JY, 2014, CRIT PUBLIC HEALTH, V24, P62, DOI 10.1080/09581596.2013.788787; DeFrank JT, 2015, J GEN INTERN MED, V30, P242, DOI 10.1007/s11606-014-2996-5; Edwards AGK, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001865.pub3; Everett T., 2011, COCHRANE DB SYST REV, V5; Gotzsche P, 2009, BMJ-BRIT MED J, V338, P446; Heleno B, 2013, BMJ-BRIT MED J, V347, P5334; Hersch J, 2015, LANCET; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Ploug T, 2012, J EPIDEMIOL COMMUN H, V66, P1193, DOI 10.1136/jech-2012-201194; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; Wegwarth O, 2012, ANN INTERN MED, V156, P340, DOI 10.7326/0003-4819-156-5-201203060-00005	12	26	26	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1597	1599		10.1016/S0140-6736(15)60258-6	http://dx.doi.org/10.1016/S0140-6736(15)60258-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG6NG	25701272				2022-12-28	WOS:000353418000010
J	Wells, JA; Glassman, AR; Ayala, AR; Jampol, LM; Aiello, LP; Antoszyk, AN; Arnold-Bush, B; Baker, CW; Bressler, NM; Browning, DJ; Elman, MJ; Ferris, FL; Friedman, SM; Melia, M; Pieramici, DJ; Sun, JK; Beck, RW				Wells, John A.; Glassman, Adam R.; Ayala, Allison R.; Jampol, Lee M.; Aiello, Lloyd Paul; Antoszyk, Andrew N.; Arnold-Bush, Bambi; Baker, Carl W.; Bressler, Neil M.; Browning, David J.; Elman, Michael J.; Ferris, Frederick L.; Friedman, Scott M.; Melia, Michele; Pieramici, Dante J.; Sun, Jennifer K.; Beck, Roy W.		Diabet Retinopathy Clinical	Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINA STUDY-GROUP; INTRAVITREAL BEVACIZUMAB; RETINOPATHY; PREVALENCE; RISK	BACKGROUND The relative efficacy and safety of intravitreous aflibercept, bevacizumab, and ranibizumab in the treatment of diabetic macular edema are unknown. METHODS At 89 clinical sites, we randomly assigned 660 adults (mean age, 61 +/- 10 years) with diabetic macular edema involving the macular center to receive intravitreous aflibercept at a dose of 2.0 mg (224 participants), bevacizumab at a dose of 1.25 mg (218 participants), or ranibizumab at a dose of 0.3 mg (218 participants). The study drugs were administered as often as every 4 weeks, according to a protocol-specified algorithm. The primary outcome was the mean change in visual acuity at 1 year. RESULTS From baseline to 1 year, the mean visual-acuity letter score (range, 0 to 100, with higher scores indicating better visual acuity; a score of 85 is approximately 20/20) improved by 13.3 with aflibercept, by 9.7 with bevacizumab, and by 11.2 with ranibizumab. Although the improvement was greater with aflibercept than with the other two drugs (P<0.001 for aflibercept vs. bevacizumab and P = 0.03 for aflibercept vs. ranibizumab), it was not clinically meaningful, because the difference was driven by the eyes with worse visual acuity at baseline (P<0.001 for interaction). When the initial visual-acuity letter score was 78 to 69 (equivalent to approximately 20/32 to 20/40) (51% of participants), the mean improvement was 8.0 with aflibercept, 7.5 with bevacizumab, and 8.3 with ranibizumab (P>0.50 for each pairwise comparison). When the initial letter score was less than 69 (approximately 20/50 or worse), the mean improvement was 18.9 with aflibercept, 11.8 with bevacizumab, and 14.2 with ranibizumab (P<0.001 for aflibercept vs. bevacizumab, P = 0.003 for aflibercept vs. ranibizumab, and P = 0.21 for ranibizumab vs. bevacizumab). There were no significant differences among the study groups in the rates of serious adverse events (P = 0.40), hospitalization (P = 0.51), death (P = 0.72), or major cardiovascular events (P = 0.56). CONCLUSIONS Intravitreous aflibercept, bevacizumab, or ranibizumab improved vision in eyes with center-involved diabetic macular edema, but the relative effect depended on baseline visual acuity. When the initial visual-acuity loss was mild, there were no apparent differences, on average, among study groups. At worse levels of initial visual acuity, aflibercept was more effective at improving vision.	[Wells, John A.] Palmetto Retina Ctr, W Columbia, SC USA; [Glassman, Adam R.; Ayala, Allison R.; Arnold-Bush, Bambi; Melia, Michele; Beck, Roy W.] Jaeb Ctr Hlth Res, Tampa, FL 33647 USA; [Jampol, Lee M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Aiello, Lloyd Paul; Sun, Jennifer K.] Harvard Univ, Sch Med, Beetham Eye Inst, Joslin Diabet Ctr, Boston, MA USA; [Antoszyk, Andrew N.; Browning, David J.] Charlotte Eye Ear Nose & Throat Associates, Charlotte, NC USA; [Baker, Carl W.] Paducah Retinal Ctr, Paducah, KY USA; [Bressler, Neil M.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Elman, Michael J.] Elman Retina Grp, Baltimore, MD USA; [Ferris, Frederick L.] NEI, NIH, Bethesda, MD 20892 USA; [Friedman, Scott M.] Florida Retina Consultants, Lakeland, FL USA; [Pieramici, Dante J.] Calif Retina Consultants, Santa Barbara, CA USA	JAEB Center For Health Research; Northwestern University; Feinberg School of Medicine; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Glassman, AR (corresponding author), Jaeb Ctr Hlth Res, 15310 Amberly Dr,Suite 350, Tampa, FL 33647 USA.	drcrstat2@jaeb.org	Sun, Jennifer K/AAP-2734-2020; Hendrick, Andrew/A-5068-2019; Barkmeier, Andrew/AAV-1021-2020	Sun, Jennifer K/0000-0003-0915-6303; Ferris, Frederick/0000-0002-4933-0639; DiLoreto, David/0000-0002-1787-8069; Elman, Michael/0000-0001-7726-9508; Glassman, Adam/0000-0003-0173-1684	National Institutes of Health; NATIONAL EYE INSTITUTE [U10EY014231, U10EY018817, U10EY023207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT01627249.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 2004, BEV PACK INS; [Anonymous], 2012, AFL PACK INS; [Anonymous], 2014, LUC PACK INS; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Arevalo JF, 2013, RETINA-J RET VIT DIS, V33, P403, DOI 10.1097/IAE.0b013e3182695b83; Arevalo JF, 2009, GRAEF ARCH CLIN EXP, V247, P735, DOI 10.1007/s00417-008-1034-x; Beck RW, 2003, AM J OPHTHALMOL, V135, P194, DOI 10.1016/S0002-9394(02)01825-1; Bressler NM, 2012, RETINA-J RET VIT DIS, V32, P1821, DOI 10.1097/IAE.0b013e31825db6ba; Bressler SB, 2014, JAMA OPHTHALMOL, V132, P1113, DOI 10.1001/jamaophthalmol.2014.1698; Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034; Do DV, 2012, OPHTHALMOLOGY, V119, P1658, DOI 10.1016/j.ophtha.2012.02.010; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; European Medicines Agency, 2012, COMM MED PROD HUM US; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; International Diabetes Federation, 2014, DIAB FACTS FIG; Korobelnik JF, 2014, OPHTHALMOLOGY, V121, P2247, DOI 10.1016/j.ophtha.2014.05.006; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Michaelides M, 2010, OPHTHALMOLOGY, V117, P1078, DOI 10.1016/j.ophtha.2010.03.045; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Moja L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011230.pub2; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Quan DN, 2010, OPHTHALMOLOGY, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016; Rajendram R, 2012, ARCH OPHTHALMOL-CHIC, V130, P972, DOI 10.1001/archophthalmol.2012.393; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Scott IU, 2007, OPHTHALMOLOGY, V114, P1860, DOI 10.1016/j.ophtha.2007.05.062; Shea AM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1748, DOI 10.1001/archopht.126.12.1748; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Varma R, 2014, JAMA OPHTHALMOL, V132, P1334, DOI 10.1001/jamaophthalmol.2014.2854; Virgili G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007419.pub4; Yannuzzi NA, 2015, JAMA OPHTHALMOL, V133, P32, DOI 10.1001/jamaophthalmol.2014.3591; Zou LH, 2011, THERANOSTICS, V1, P395, DOI 10.7150/thno/v01p0395	34	1017	1047	8	102	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2015	372	13					1193	1203		10.1056/NEJMoa1414264	http://dx.doi.org/10.1056/NEJMoa1414264			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1QD	25692915	Green Accepted			2022-12-28	WOS:000351585900005
J	Osinusi, A; Townsend, K; Kohli, A; Nelson, A; Seamon, C; Meissner, EG; Bon, D; Silk, R; Gross, C; Price, A; Sajadi, M; Sidharthan, S; Sims, Z; Herrmann, E; Hogan, J; Teferi, G; Talwani, R; Proschan, M; Jenkins, V; Kleiner, DE; Wood, BJ; Subramanian, GM; Pang, PS; McHutchison, JG; Polis, MA; Fauci, AS; Masur, H; Kottilil, S				Osinusi, Anu; Townsend, Kerry; Kohli, Anita; Nelson, Amy; Seamon, Cassie; Meissner, Eric G.; Bon, Dimitra; Silk, Rachel; Gross, Chloe; Price, Angie; Sajadi, Mohammad; Sidharthan, Sreetha; Sims, Zayani; Herrmann, Eva; Hogan, John; Teferi, Gebeyehu; Talwani, Rohit; Proschan, Michael; Jenkins, Veronica; Kleiner, David E.; Wood, Brad J.; Subramanian, G. Mani; Pang, Phillip S.; McHutchison, John G.; Polis, Michael A.; Fauci, Anthony S.; Masur, Henry; Kottilil, Shyam			Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEPATITIS-C VIRUS; ALPHA-2A PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2A; PEGYLATED INTERFERON-ALPHA-2B; INFECTED PATIENTS; PHASE-2 TRIAL; DOUBLE-BLIND; COMBINATION; CLEARANCE; THERAPY	IMPORTANCE There is an unmet need for interferon-and ribavirin-free treatment for chronic hepatitis C virus (HCV) infection in patients co-infected with human immunodeficiency virus (HIV). OBJECTIVE To evaluate the rates of sustained virologic response (SVR) and adverse events in previously untreated patients with HCV genotype 1 and HIV co-infection following a 12-week treatment of the fixed-dose combination of ledipasvir and sofosbuvir. DESIGN, SETTING, AND PARTICIPANTS Open-label, single-center, phase 2b pilot study of previously untreated, noncirrhotic patients with HCV genotype 1 and HIV co-infection conducted at the Clinical Research Center of the National Institutes of Health, Bethesda, Maryland, from June 2013 to September 2014. Patients included those receiving antiretroviral therapy with HIV RNA values of 50 copies/mL or fewer and a CD4 T-lymphocyte count of 100 cells/mL or greater or patients with untreated HIV infection with a CD4 T-lymphocyte count of 500 cells/mL or greater. Serial measurements of safety parameters, virologic and host immune correlates, and adherence were performed. INTERVENTIONS Fifty patients with HCV genotype 1 never before treated for HCV were prescribed a fixed-dose combination of ledipasvir (90 mg) and sofosbuvir (400 mg) once daily for 12 weeks. MAIN OUTCOMES AND MEASURES The primary study outcome was the proportion of patients with sustained viral response (plasma HCV RNA level < 12 IU/mL) 12 weeks after end of treatment. RESULTS Forty-nine of 50 participants (98%[95% CI, 89% to 100%]) achieved SVR 12 weeks after end of treatment, whereas 1 patient experienced relapse at week 4 following treatment. In the patient with relapse, deep sequencing revealed a resistance associated mutation in the NS5A region conferring resistance to NS5A inhibitors, such as ledipasvir. The most common adverse events were nasal congestion (16% of patients) and myalgia (14%). There were no discontinuations or serious adverse events attributable to study drug. CONCLUSIONS AND RELEVANCE In this open-label, uncontrolled, pilot study enrolling patients co-infected with HCV genotype 1 and HIV, administration of an oral combination of ledipasvir and sofosbuvir for 12 weeks was associated with high rates of SVR after treatment completion. Larger studies that also include patients with cirrhosis and lower CD4 T-cell counts are required to understand if the results of this study generalize to all patients co-infected with HCV and HIV.	[Osinusi, Anu; Nelson, Amy; Silk, Rachel; Gross, Chloe; Price, Angie; Sajadi, Mohammad; Talwani, Rohit; Kottilil, Shyam] Univ Maryland, Inst Human Virol, Div Infect Dis, Baltimore, MD 21201 USA; [Osinusi, Anu; Townsend, Kerry; Nelson, Amy; Meissner, Eric G.; Polis, Michael A.; Fauci, Anthony S.; Kottilil, Shyam] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Osinusi, Anu; Subramanian, G. Mani; Pang, Phillip S.; McHutchison, John G.] Gilead Sci Inc, Foster City, CA 94404 USA; [Kohli, Anita; Seamon, Cassie; Sidharthan, Sreetha; Sims, Zayani; Masur, Henry] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Kohli, Anita; Silk, Rachel; Gross, Chloe; Price, Angie] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Clin Res Directorate, Clin Monitoring Res Program, Frederick, MD USA; [Meissner, Eric G.] Med Univ S Carolina, Coll Med, Dept Microbiol & Immunol, Charleston, SC USA; [Bon, Dimitra; Herrmann, Eva] Goethe Univ Frankfurt, Inst Biostat & Math Modeling, D-60054 Frankfurt, Germany; [Hogan, John; Teferi, Gebeyehu] Unity Hlth Care Inc, Washington, DC USA; [Proschan, Michael] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [Jenkins, Veronica] Family & Med Counseling Serv, Washington, DC USA; [Kleiner, David E.] NCI, Dept Pathol, Rockville, MD USA; [Wood, Brad J.] NIH, Ctr Intervent Oncol Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA; [Wood, Brad J.] NCI, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Gilead Sciences; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Medical University of South Carolina; Goethe University Frankfurt; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kottilil, S (corresponding author), Univ Maryland, Sch Med, Div Clin Care & Res, Inst Human Virol, 725 W Lombard St,Room S222, Baltimore, MD 21201 USA.	skottilil@ihv.umaryland.edu	Kleiner, David E/N-2770-2013; Kottilil, Shyam/ABF-7605-2021; Talwani, Rohit/B-8234-2019; Wood, Bradford J/M-7995-2017	Kleiner, David E/0000-0003-3442-4453; Wood, Bradford J/0000-0002-4297-0051; Nelson, Amy/0000-0001-9028-1894; , Mohammad/0000-0001-7798-3605	Regulatory Compliance and Human Participants Protection Branch of the National Institute of Allergy and Infectious Diseases (NIAID); National Cancer Institute, National Institutes of Health (NIH) [HHSN261200800001E]; NIAID; German Research Foundation (DFG) by the clinical research unit [KFO 129]; NIH; Gilead Sciences; NATIONAL CANCER INSTITUTE [ZIDBC011242] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL040015, ZIACL009010] Funding Source: NIH RePORTER	Regulatory Compliance and Human Participants Protection Branch of the National Institute of Allergy and Infectious Diseases (NIAID); National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); German Research Foundation (DFG) by the clinical research unit(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Sciences(Gilead Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	The Regulatory Compliance and Human Participants Protection Branch of the National Institute of Allergy and Infectious Diseases (NIAID) served as the study sponsor. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under contract HHSN261200800001E. This research was supported in part by the NIAID. The study was also supported in part by the German Research Foundation (DFG) by the clinical research unit KFO 129. The study was partially funded by a Collaborative Research and Development Agreement between NIH and Gilead Sciences.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Dieterich D, 2014, CLIN INFECT DIS, V59, P1579, DOI 10.1093/cid/ciu675; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Guedj J, 2010, J VIRAL HEPATITIS, V17, P825, DOI 10.1111/j.1365-2893.2010.01348.x; Guedj J, 2010, J THEOR BIOL, V267, P330, DOI 10.1016/j.jtbi.2010.08.036; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844; National Institute of Allergy and Infectious Diseases, 2004, DIV AIDS TABL GRAD S; Ninomiya M, 2012, J CLIN MICROBIOL, V50, P857, DOI 10.1128/JCM.05715-11; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P1987, DOI 10.1001/jama.2013.281319; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Sulkowski MS, 2013, J INFECT DIS, V207, pS26, DOI 10.1093/infdis/jis764; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632	25	161	165	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1232	1239		10.1001/jama.2015.1373	http://dx.doi.org/10.1001/jama.2015.1373			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25706232	Green Accepted, Bronze			2022-12-28	WOS:000351435500022
J	Du Toit, G; Roberts, G; Sayre, PH; Bahnson, HT; Radulovic, S; Santos, AF; Brough, HA; Phippard, D; Basting, M; Feeney, M; Turcanu, V; Sever, ML; Lorenzo, MG; Plaut, M; Lack, G				Du Toit, George; Roberts, Graham; Sayre, Peter H.; Bahnson, Henry T.; Radulovic, Suzana; Santos, Alexandra F.; Brough, Helen A.; Phippard, Deborah; Basting, Monica; Feeney, Mary; Turcanu, Victor; Sever, Michelle L.; Lorenzo, Margarita Gomez; Plaut, Marshall; Lack, Gideon		LEAP Study Team	Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOOD ALLERGY; ORAL IMMUNOTHERAPY; CHILDREN; PREVALENCE; RESPONSES; PROTEIN	BACKGROUND The prevalence of peanut allergy among children in Western countries has doubled in the past 10 years, and peanut allergy is becoming apparent in Africa and Asia. We evaluated strategies of peanut consumption and avoidance to determine which strategy is most effective in preventing the development of peanut allergy in infants at high risk for the allergy. METHODS We randomly assigned 640 infants with severe eczema, egg allergy, or both to consume or avoid peanuts until 60 months of age. Participants, who were at least 4 months but younger than 11 months of age at randomization, were assigned to separate study cohorts on the basis of preexisting sensitivity to peanut extract, which was determined with the use of a skin-prick test - one consisting of participants with no measurable wheal after testing and the other consisting of those with a wheal measuring 1 to 4 mm in diameter. The primary outcome, which was assessed independently in each cohort, was the proportion of participants with peanut allergy at 60 months of age. RESULTS Among the 530 infants in the intention-to-treat population who initially had negative results on the skin-prick test, the prevalence of peanut allergy at 60 months of age was 13.7% in the avoidance group and 1.9% in the consumption group (P<0.001). Among the 98 participants in the intention-to-treat population who initially had positive test results, the prevalence of peanut allergy was 35.3% in the avoidance group and 10.6% in the consumption group (P = 0.004). There was no significant between-group difference in the incidence of serious adverse events. Increases in levels of peanut-specific IgG4 antibody occurred predominantly in the consumption group; a greater percentage of participants in the avoidance group had elevated titers of peanut-specific IgE antibody. A larger wheal on the skin-prick test and a lower ratio of peanut-specific IgG4: IgE were associated with peanut allergy. CONCLUSIONS The early introduction of peanuts significantly decreased the frequency of the development of peanut allergy among children at high risk for this allergy and modulated immune responses to peanuts.	[Du Toit, George; Radulovic, Suzana; Santos, Alexandra F.; Brough, Helen A.; Basting, Monica; Feeney, Mary; Turcanu, Victor; Lack, Gideon] Kings Coll London, Div Asthma Allergy & Lung Biol, Dept Pediat Allergy, London WC2R 2LS, England; [Du Toit, George; Radulovic, Suzana; Santos, Alexandra F.; Brough, Helen A.; Basting, Monica; Feeney, Mary; Turcanu, Victor; Lack, Gideon] Guys & St Thomas Natl Hlth Serv Fdn Trust, London, England; [Roberts, Graham] Univ Southampton, Southampton, Hants, England; [Roberts, Graham] Natl Inst Hlth Res, Resp Biomed Res Unit, Southampton, Hants, England; [Roberts, Graham] David Hide Ctr, Newport, Wight, England; [Sayre, Peter H.] Univ Calif San Francisco, Div Hematol Oncol, Dept Med, San Francisco, CA 94143 USA; [Phippard, Deborah] Univ Calif San Francisco, Immune Tolerance Network, San Francisco, CA 94143 USA; [Bahnson, Henry T.; Sever, Michelle L.] Rho Fed Syst Div, Chapel Hill, NC USA; [Lorenzo, Margarita Gomez; Plaut, Marshall] NIAID, Bethesda, MD 20892 USA	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Southampton; University of California System; University of California San Francisco; Immune Tolerance Network; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lack, G (corresponding author), Guys & St Thomas NHS Fdn Trust, Childrens Allergy Unit, 2nd Fl,South Wing,Westminster Bridge Rd, London SE1 7EH, England.		O'Sullivan, Collin/AAZ-9506-2020	Brough, Helen/0000-0001-7203-0813; Du Toit, George/0000-0002-0321-2928; Asare, Adam/0000-0002-9299-3518; Santos, Alexandra/0000-0002-7805-1436; Roberts, Graham/0000-0003-2252-1248; Lack, Gideon/0000-0001-7350-4021	National Institute of Allergy and Infectious Diseases; MRC [MR/M008517/1, G0902018] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI109565, N01AI015416] Funding Source: NIH RePORTER; Medical Research Council [G0902018, G1000758, MR/M008517/1] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre] Funding Source: researchfish	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	Funded by the National Institute of Allergy and Infectious Diseases and others; ClinicalTrials.gov number, NCT00329784.)	[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Baker SS, 2000, PEDIATRICS, V106, P346; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Brough HA, 2013, J ALLERGY CLIN IMMUN, V132, P630, DOI 10.1016/j.jaci.2013.02.034; Brough HA, 2013, J ALLERGY CLIN IMMUN, V132, P623, DOI 10.1016/j.jaci.2013.02.035; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; *COMM TOX CHEM FOO, 1998, CONS PROD ENV PEAN A; Cummings AJ, 2010, ALLERGY, V65, P933, DOI 10.1111/j.1398-9995.2010.02342.x; de Silva D, 2014, ALLERGY, V69, P581, DOI 10.1111/all.12334; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Du Toit G, 2013, J ALLERGY CLIN IMMUN, V131, P135, DOI 10.1016/j.jaci.2012.09.015; Fox D, 1998, LANCET, V352, P1558; Fox DE, 1998, LANCET, V352, P741, DOI 10.1016/S0140-6736(05)60863-X; Gray CL, 2014, PEDIAT ALLERG IMM-UK, V25, P572, DOI 10.1111/pai.12270; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; Hourihane JO, 1997, CLIN EXP ALLERGY, V27, P634, DOI [10.1111/j.1365-2222.1997.tb01190.x, 10.1046/j.1365-2222.1997.d01-559.x]; Jones SM, 2014, J ALLERGY CLIN IMMUN, V133, P318, DOI 10.1016/j.jaci.2013.12.1040; Lieberman JA, 2011, CURR ALLERGY ASTHM R, V11, P58, DOI 10.1007/s11882-010-0149-4; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Nurmatov U, 2012, COCHRANE DB SYST REV, V9; Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305; Palmer DJ, 2013, J ALLERGY CLIN IMMUN, V132, P387, DOI 10.1016/j.jaci.2013.05.002; Prescott SL, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-21; Santos AF, J ALLERGY C IN PRESS; Savilahti EM, 2014, INT ARCH ALLERGY IMM, V164, P32, DOI 10.1159/000361023; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Sofianou-Katsoulis A, 2011, WORLD ALLERGY ORGAN, V4, P38, DOI 10.1097/WOX.0b013e318205ab27; Strid J, 2004, IMMUNOLOGY, V113, P293, DOI 10.1111/j.1365-2567.2004.01989.x; Varshney P, 2011, J ALLERGY CLIN IMMUN, V127, P654, DOI 10.1016/j.jaci.2010.12.1111; Venter C, 2010, ALLERGY, V65, P103, DOI 10.1111/j.1398-9995.2009.02176.x; Vickery BP, 2014, J ALLERGY CLIN IMMUN, V133, P468, DOI 10.1016/j.jaci.2013.11.007; Vickery BP, 2013, J ALLERGY CLIN IMMUN, V131, P128, DOI 10.1016/j.jaci.2012.10.048	32	1154	1177	14	211	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2015	372	9					803	813		10.1056/NEJMoa1414850	http://dx.doi.org/10.1056/NEJMoa1414850			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8SQ	25705822	Green Accepted			2022-12-28	WOS:000349901700005
J	Leghtas, Z; Touzard, S; Pop, IM; Kou, A; Vlastakis, B; Petrenko, A; Sliwa, KM; Narla, A; Shankar, S; Hatridge, MJ; Reagor, M; Frunzio, L; Schoelkopf, RJ; Mirrahimi, M; Devoret, MH				Leghtas, Z.; Touzard, S.; Pop, I. M.; Kou, A.; Vlastakis, B.; Petrenko, A.; Sliwa, K. M.; Narla, A.; Shankar, S.; Hatridge, M. J.; Reagor, M.; Frunzio, L.; Schoelkopf, R. J.; Mirrahimi, M.; Devoret, M. H.			Confining the state of light to a quantum manifold by engineered two-photon loss	SCIENCE			English	Article							SINGLE-PHOTON; NOISE	Physical systems usually exhibit quantum behavior, such as superpositions and entanglement, only when they are sufficiently decoupled from a lossy environment. Paradoxically, a specially engineered interaction with the environment can become a resource for the generation and protection of quantum states. This notion can be generalized to the confinement of a system into a manifold of quantum states, consisting of all coherent superpositions of multiple stable steady states. We have confined the state of a superconducting resonator to the quantum manifold spanned by two coherent states of opposite phases and have observed a Schrodinger cat state spontaneously squeeze out of vacuum before decaying into a classical mixture. This experiment points toward robustly encoding quantum information inmultidimensional steady-state manifolds.	[Leghtas, Z.; Touzard, S.; Pop, I. M.; Kou, A.; Vlastakis, B.; Petrenko, A.; Sliwa, K. M.; Narla, A.; Shankar, S.; Hatridge, M. J.; Reagor, M.; Frunzio, L.; Schoelkopf, R. J.; Mirrahimi, M.; Devoret, M. H.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Mirrahimi, M.] Inst Natl Rech Informat & Automat INRIA Paris Roc, F-78153 Le Chesnay, France	Yale University	Leghtas, Z (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.	zaki.leghtas@yale.edu	Pop, Ioan/ABE-6678-2020; Schoelkopf, Robert J/J-8178-2012; Narla, Anirudh/AAG-2987-2019; Frunzio, Luigi/O-1573-2019; Pop, Ioan M/S-2354-2017; Shankar, Shyam/K-5127-2013; Touzard, Steven/GNP-0888-2022	Pop, Ioan/0000-0002-0660-6543; Narla, Anirudh/0000-0002-1498-8641; Frunzio, Luigi/0000-0002-0272-5481; Pop, Ioan M/0000-0002-6776-9792; Shankar, Shyam/0000-0002-1311-9508; Touzard, Steven/0000-0002-3475-2839; Mirrahimi, Mazyar/0000-0001-9471-6031; Leghtas, Zaki/0000-0002-9172-1537	NSF Materials Research Science and Engineering Center Division of Material Research [1119826]; Army Research Office [W911NF-14-1-0011]; French Agence Nationale de la Recherche under the project EPOQ2 [ANR-09-JCJC-0070]; ENS Cachan	NSF Materials Research Science and Engineering Center Division of Material Research(National Science Foundation (NSF)); Army Research Office; French Agence Nationale de la Recherche under the project EPOQ2(French National Research Agency (ANR)); ENS Cachan	We thank L. Jiang and V. V. Albert for helpful discussions. Facilities use was supported by the Yale Institute for Nanoscience and Quantum Engineering and NSF Materials Research Science and Engineering Center Division of Material Research award 1119826. This research was supported by the Army Research Office under grant W911NF-14-1-0011. M.M. acknowledges support from the French Agence Nationale de la Recherche under the project EPOQ2 number ANR-09-JCJC-0070. S.T. acknowledges support from ENS Cachan.	Campagne-Ibarcq P, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021008; Carmichael H. J., 2008, SERIES THEORETICAL M; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; Deleglise S, 2008, NATURE, V455, P510, DOI 10.1038/nature07288; Drummond P., 2004, SERIES ATOMIC OPTICA; DYKMAN MI, 1980, PHYSICA A, V104, P480, DOI 10.1016/0378-4371(80)90010-2; Haroche S., 2006, EXPLORING QUANTUM; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Johnson BR, 2010, NAT PHYS, V6, P663, DOI 10.1038/NPHYS1710; Kirchmair G, 2013, NATURE, V495, P205, DOI 10.1038/nature11902; Krauter H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.080503; Lin Y, 2013, NATURE, V504, P415, DOI 10.1038/nature12801; Lutterbach LG, 1997, PHYS REV LETT, V78, P2547, DOI 10.1103/PhysRevLett.78.2547; Monroe C, 1996, SCIENCE, V272, P1131, DOI 10.1126/science.272.5265.1131; Murch KW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.183602; Ourjoumtsev A, 2007, NATURE, V448, P784, DOI 10.1038/nature06054; Riste D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.240502; Sayrin C, 2011, NATURE, V477, P73, DOI 10.1038/nature10376; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Shankar S, 2013, NATURE, V504, P419, DOI 10.1038/nature12802; Siddiqi I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.207002; Sun L, 2014, NATURE, V511, P444, DOI 10.1038/nature13436; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Vijay R, 2012, NATURE, V490, P77, DOI 10.1038/nature11505; Vlastakis B, 2013, SCIENCE, V342, P607, DOI 10.1126/science.1243289; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; WOLINSKY M, 1988, PHYS REV LETT, V60, P1836, DOI 10.1103/PhysRevLett.60.1836	28	262	269	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					853	857		10.1126/science.aaa2085	http://dx.doi.org/10.1126/science.aaa2085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700514	Green Submitted			2022-12-28	WOS:000349761100038
J	Prufer, K; Meyer, M				Pruefer, Kay; Meyer, Matthias			Comment on "Late Pleistocene human skeleton and mtDNA link Paleoamericans and modern Native Americans"	SCIENCE			English	Editorial Material							DNA-SEQUENCES	Chatters et al. (Reports, 16 May 2014, p. 750) reported the retrieval of DNA sequences from a 12,000-to 13,000-year-old human tooth discovered in an underwater cave in Mexico's Yucatan peninsula. They propose that this ancient human individual's mitochondrial DNA (mtDNA) belongs to haplogroup D1. However, our analysis of postmortem damage patterns finds no evidence for an ancient origin of these sequences.	[Pruefer, Kay; Meyer, Matthias] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Prufer, K (corresponding author), Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany.	pruefer@eva.mpg.de; mmeyer@eva.mpg.de						Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Chatters JC, 2014, SCIENCE, V344, P750, DOI 10.1126/science.1252619; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Gutierrez-Garcia TA, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0224; Handt O, 1996, AM J HUM GENET, V59, P368; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921	15	19	19	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224								10.1126/science.1260617	http://dx.doi.org/10.1126/science.1260617			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700510				2022-12-28	WOS:000349761100032
J	Cossell, L; Iacaruso, MF; Muir, DR; Houlton, R; Sader, EN; Ko, H; Hofer, SB; Mrsic-Flogel, TD				Cossell, Lee; Iacaruso, Maria Florencia; Muir, Dylan R.; Houlton, Rachael; Sader, Elie N.; Ko, Ho; Hofer, Sonja B.; Mrsic-Flogel, Thomas D.			Functional organization of excitatory synaptic strength in primary visual cortex	NATURE			English	Article							ORIENTATION SELECTIVITY; RECEPTIVE-FIELDS; IN-VIVO; NEURONS; MOUSE; CONNECTIVITY; INPUT; SPECIFICITY; LAYER-2/3; NETWORK	The strength of synaptic connections fundamentally determines how neurons influence each other's firing. Excitatory connection amplitudes between pairs of cortical neurons vary over two orders of magnitude, comprising only very few strong connections among many weaker ones(1-9). Although this highly skewed distribution of connection strengths is observed in diverse cortical areas(1-9), its functional significance remains unknown: it is not clear how connection strength relates to neuronal response properties, nor how strong and weak inputs contribute to information processing in local microcircuits. Here we reveal that the strength of connections between layer 2/3 (L2/3) pyramidal neurons in mouse primary visual cortex (V1) obeys a simple rule-the few strong connections occur between neurons with most correlated responses, while only weak connections link neurons with uncorrelated responses. Moreover, we show that strong and reciprocal connections occur between cells with similar spatial receptive field structure. Although weak connections far outnumber strong connections, each neuron receives the majority of its local excitation from a small number of strong inputs provided by the few neurons with similar responses to visual features. By dominating recurrent excitation, these infrequent yet powerful inputs disproportionately contribute to feature preference and selectivity. Therefore, our results show that the apparently complex organization of excitatory connection strength reflects the similarity of neuronal responses, and suggest that rare, strong connections mediate stimulus-specific response amplification in cortical microcircuits.	[Cossell, Lee; Iacaruso, Maria Florencia; Houlton, Rachael; Sader, Elie N.; Ko, Ho; Hofer, Sonja B.; Mrsic-Flogel, Thomas D.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6DE, England; [Cossell, Lee; Iacaruso, Maria Florencia; Muir, Dylan R.; Hofer, Sonja B.; Mrsic-Flogel, Thomas D.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Ko, Ho] Chinese Univ Hong Kong, Fac Med, Lui Che Woo Inst Innovat Med, Shatin, Hong Kong, Peoples R China; [Ko, Ho] Chinese Univ Hong Kong, Fac Med, Chow Yuk Ho Technol Ctr Innovat Med, Shatin, Hong Kong, Peoples R China	University of London; University College London; University of Basel; Chinese University of Hong Kong; Chinese University of Hong Kong	Mrsic-Flogel, TD (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, 21 Univ St, London WC1E 6DE, England.	thomas.mrsic-flogel@unibas.ch	Ko, Ho/I-7513-2016; Muir, Dylan/E-1910-2011; Ko, Ho/AAH-2755-2020	Ko, Ho/0000-0002-0254-3274; Muir, Dylan/0000-0003-3856-826X; Ko, Ho/0000-0002-0254-3274; Mrsic-Flogel, Tom/0000-0002-8947-408X; Hofer, Sonja/0000-0003-4921-8521	Wellcome Trust [095074]; European Research council; UCL; University of Basel Young Researchers fund	Wellcome Trust(Wellcome TrustEuropean Commission); European Research council(European Research Council (ERC)European Commission); UCL; University of Basel Young Researchers fund	We thank K. Harris, G. Keller, T. Margrie, J. Sjostrom, P. Znamenskiy and our laboratory members for discussions and comments, and T. Margrie, E. Rancz and J. Poulet for advice on in vivo whole-cell recordings. This work was supported by the Wellcome Trust (grant no. 095074) and the European Research council. L.C. was funded by the 4-year PhD programme in Neuroscience at UCL. M.F.I. was funded by a UCL International PhD fellowship. D.R.M. was supported by the University of Basel Young Researchers fund.	BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Druckmann S, 2012, CURR BIOL, V22, P2095, DOI 10.1016/j.cub.2012.08.058; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Levy RB, 2012, J NEUROSCI, V32, P5609, DOI 10.1523/JNEUROSCI.5158-11.2012; Li LY, 2013, NAT NEUROSCI, V16, P1179, DOI 10.1038/nn.3493; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Morishima M, 2011, J NEUROSCI, V31, P10380, DOI 10.1523/JNEUROSCI.0772-11.2011; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Nimmerjahn A., 2004, NATURE METHODS, V1, P1, DOI DOI 10.1038/NMETH706; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; Smyth D, 2003, J NEUROSCI, V23, P4746; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009	37	269	269	4	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					399	403		10.1038/nature14182	http://dx.doi.org/10.1038/nature14182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25652823	Green Accepted			2022-12-28	WOS:000349547400042
J	Kazura, JW				Kazura, James W.			Yaws Eradication - A Goal Finally within Reach	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA	Case Western Reserve University	Kazura, JW (corresponding author), Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA.							[Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P189; Marks M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003156; Mitja O, 2013, LANCET, V381, P763, DOI 10.1016/S0140-6736(12)62130-8; Mitja O, 2012, LANCET, V379, P342, DOI 10.1016/S0140-6736(11)61624-3	4	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					693	695		10.1056/NEJMp1415346	http://dx.doi.org/10.1056/NEJMp1415346			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB7PB	25693007	Bronze			2022-12-28	WOS:000349818700001
J	Plaschka, C; Lariviere, L; Wenzeck, L; Seizl, M; Hemann, M; Tegunov, D; Petrotchenko, EV; Borchers, CH; Baumeister, W; Herzog, F; Villa, E; Cramer, P				Plaschka, C.; Lariviere, L.; Wenzeck, L.; Seizl, M.; Hemann, M.; Tegunov, D.; Petrotchenko, E. V.; Borchers, C. H.; Baumeister, W.; Herzog, F.; Villa, E.; Cramer, P.			Architecture of the RNA polymerase II-Mediator core initiation complex	NATURE			English	Article							CHEMICAL CROSS-LINKING; TRANSCRIPTION INITIATION; STRUCTURAL BASIS; PREINITIATION COMPLEX; HEAD MODULE; TATA-BOX; PROTEIN; RECRUITMENT; SUBCOMPLEX; REVEALS	The conserved co-activator complex Mediator enables regulated transcription irntiation by RNA polymerase (Pol) II. Here we reconstitute an active 15-subunit core Mediator (cMed) comprising all essential Mediator subunits from Saccharomyces erevisiae. The cryo-electron microscopic structure of cMed bound to a core initiation complex was determined at 9.7 A resolution. cMed binds Pol II around the Rpb4-Rpb7 stalk near the carboxy-terminal domain (CTD). The Mediator head module binds the Pol II dock and the TFIIB ribbon and stabilizes the initiation complex. The Mediator middle module extends to the Fol II foot with a 'plank' that may influence polymerase conformation. The Mediator subunit Medl4 forms a 'beam' between the head and middle modules and connects to the tail module that is predicted to bind transcription activators located on upstream DNA. The Mediator 'arm' and 'hook' domains contribute to a 'cradle' that may position the CTD and TFIIH kinase to stimulate Pol II phosphorylation.	[Plaschka, C.; Cramer, P.] Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany; [Lariviere, L.; Wenzeck, L.; Seizl, M.; Hemann, M.; Herzog, F.] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Lariviere, L.; Wenzeck, L.; Seizl, M.; Hemann, M.; Herzog, F.] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Tegunov, D.; Baumeister, W.; Villa, E.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Petrotchenko, E. V.; Borchers, C. H.] Univ Victoria, Dept Biochem & Microbiol, Genome British Columbia Prot Ctr, Victoria, BC V8Z7X8, Canada; [Villa, E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	Max Planck Society; University of Munich; University of Munich; Max Planck Society; University of Victoria; University of California System; University of California San Diego	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany.	pcramer@mpibpc.mpg.de	Herzog, Franz/G-4832-2012; Tegunov, Dimitry/D-7834-2015; Villa, Elizabeth/D-1811-2010; BORCHERS, Christoph/U-5964-2019	Herzog, Franz/0000-0001-8270-1449; Tegunov, Dimitry/0000-0001-7019-3221; Villa, Elizabeth/0000-0003-4677-9809; Plaschka, Clemens/0000-0002-6020-9514	Boehringer Ingelheim fellowship; Elite Network of Bavaria; Genome Canada; Genome British Columbia Science and Technology Innovation Centre; Natural Sciences and Engineering Research Council of Canada; LMUexcellent initiative; Bavarian Research Center of Molecular Biosystems; Deutsche Forschungsgemeinschaft [GRK1721, SFB646]; European Research Council Advanced Grant TRANSIT; Jung-Stiftung; Volkswagen Foundation	Boehringer Ingelheim fellowship(Boehringer Ingelheim); Elite Network of Bavaria; Genome Canada(Genome Canada); Genome British Columbia Science and Technology Innovation Centre; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); LMUexcellent initiative; Bavarian Research Center of Molecular Biosystems; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council Advanced Grant TRANSIT; Jung-Stiftung; Volkswagen Foundation(Volkswagen)	We thank C. Bernecky, W. Muhlbacher, B. Schwalb, P. Eser, S. Etzold from the Cramer laboratory and J. Plitzko and O. Mihalache from the Baumeister laboratory for help. We thank J. Schuller, S. Pfeffer and F. Forster for help with negative-stain tomography data acquisition and reconstruction of the initial reference. We thank N. Sessler and K. Makepace from the Borchers laboratory for help with mass spectrometry. We thank M. Raabe and H. Urlaub for protein identification. We thank S. Hahn for providing Srb5 (3x Flag) and TFIIH (TAP-Rad3) yeast strains. M.S. was supported by a Boehringer Ingelheim fellowship and the Elite Network of Bavaria. C.H.B. was supported by Genome Canada and Genome British Columbia Science and Technology Innovation Centre funding and The Natural Sciences and Engineering Research Council of Canada grant. F.H. was supported by grants of the LMUexcellent initiative, the Bavarian Research Center of Molecular Biosystems and the Deutsche Forschungsgemeinschaft/GRK1721. P.C. was supported by the Deutsche Forschungsgemeinschaft grants SFB646 and GRK1721 (the latter to P.C. and E.V.), the European Research Council Advanced Grant TRANSIT, the Jung-Stiftung, and the Volkswagen Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Cai G, 2012, STRUCTURE, V20, P899, DOI 10.1016/j.str.2012.02.023; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; Cevher MA, 2014, NAT STRUCT MOL BIOL, V21, P1028, DOI 10.1038/nsmb.2914; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chen YX, 2013, J STRUCT BIOL, V182, P235, DOI 10.1016/j.jsb.2013.03.002; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Eibauer M, 2012, J STRUCT BIOL, V180, P488, DOI 10.1016/j.jsb.2012.09.008; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel C, 2013, NATURE, V502, P650, DOI 10.1038/nature12712; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Eswar N., 2006, CURR PROTOCOLS BIOIN, V5, P561; Fishburn J, 2012, MOL CELL BIOL, V32, P12, DOI 10.1128/MCB.06242-11; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Hrabe T, 2012, J STRUCT BIOL, V178, P177, DOI 10.1016/j.jsb.2011.12.003; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Korinek A, 2011, J STRUCT BIOL, V175, P394, DOI 10.1016/j.jsb.2011.06.003; Koschubs T, 2010, NUCLEIC ACIDS RES, V38, P3186, DOI 10.1093/nar/gkq029; Koschubs T, 2009, EMBO J, V28, P69, DOI 10.1038/emboj.2008.254; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lariviere L, 2013, NUCLEIC ACIDS RES, V41, P9266, DOI 10.1093/nar/gkt704; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Lariviere L, 2012, CURR OPIN CELL BIOL, V24, P305, DOI 10.1016/j.ceb.2012.01.007; Lee YC, 1999, MOL CELL BIOL, V19, P2967; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Linder T, 2006, BIOCHEM BIOPH RES CO, V349, P948, DOI 10.1016/j.bbrc.2006.08.099; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Liu Y, 2001, J BIOL CHEM, V276, P7169, DOI 10.1074/jbc.M009586200; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Muhlbacher W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5310; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; Nock A, 2012, MOL CELL, V48, P837, DOI 10.1016/j.molcel.2012.10.009; NONET ML, 1989, GENETICS, V123, P715; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Penczek PA, 2004, J OPT SOC AM A, V21, P499, DOI 10.1364/JOSAA.21.000499; Petrotchenko EV, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-64; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rani PG, 2004, MOL CELL BIOL, V24, P1709, DOI 10.1128/MCB.24.4.1709-1720.2004; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schulz D, 2014, J BIOL CHEM, V289, P17446, DOI 10.1074/jbc.M114.568014; Seizl M, 2011, NUCLEIC ACIDS RES, V39, P6291, DOI 10.1093/nar/gkr229; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sogaard TMM, 2007, J BIOL CHEM, V282, P14113, DOI 10.1074/jbc.M701345200; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Wang XJ, 2014, CELL RES, V24, P796, DOI 10.1038/cr.2014.64; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	87	205	210	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					376	380		10.1038/nature14229	http://dx.doi.org/10.1038/nature14229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25652824				2022-12-28	WOS:000349547400037
J	DeFilippis, AP; Young, R; Carrubba, CJ; McEvoy, JW; Budoff, MJ; Blumenthal, RS; Kronmal, RA; McClelland, RL; Nasir, K; Blaha, MJ				DeFilippis, Andrew P.; Young, Rebekah; Carrubba, Christopher J.; McEvoy, John W.; Budoff, Matthew J.; Blumenthal, Roger S.; Kronmal, Richard A.; McClelland, Robyn L.; Nasir, Khurram; Blaha, Michael J.			An Analysis of Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; FRAMINGHAM; PREDICTION; PREVENTION; ATHEROSCLEROSIS; POPULATION; VALIDATION; GUIDELINES	Background: Accurate risk assessment of atherosclerotic cardiovascular disease (ASCVD) is essential to effectively balance the risks and benefits of therapy for primary prevention. Objective: To compare the calibration and discrimination of the new American Heart Association (AHA) and American College of Cardiology (ACC) ASCVD risk score with alternative risk scores and to explore preventive therapy as a cause of the reported risk overestimation using the AHA-ACC-ASCVD score. Design: Prospective epidemiologic study of ASCVD. Setting: MESA (Multi-Ethnic Study of Atherosclerosis), a community-based, sex-balanced, multiethnic cohort. Patients: 4227 MESA participants aged 50 to 74 years and without diabetes at baseline. Measurements: Observed and expected events for the AHAACC- ASCVD score were compared with 4 commonly used risk scores-and their respective end points-in MESA after a 10.2-year follow-up. Results: The new AHA-ACC-ASCVD and 3 older Framingham-based risk scores overestimated cardiovascular events by 37% to 154% in men and 8% to 67% in women. Overestimation was noted throughout the continuum of risk. In contrast, the Reynolds Risk Score overestimated risk by 9% in men but underestimated risk by 21% in women. Aspirin, lipid-lowering or antihypertensive therapy, and interim revascularization did not explain the overestimation. Limitation: Comparability of MESA with target populations for primary prevention and possibility of missed events in MESA. Conclusion: Of the 5 risk scores, 4, including the new AHAACC- ASCVD score, showed overestimation of risk (25% to 115%) in a modern, multiethnic cohort without baseline clinical ASCVD. If validated, overestimation of ASCVD risk may have substantial implications for individual patients and the health care system.	Univ Louisville, Louisville, KY 40202 USA; Univ Washington, Seattle, WA 98115 USA; Univ Colorado, Boulder, CO 80309 USA; Johns Hopkins Med Ciccarone Ctr Prevent Heart Dis, Baltimore, MD USA; Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; Baptist Hlth Med Grp, Miami, FL 33139 USA	University of Louisville; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	DeFilippis, AP (corresponding author), Univ Louisville, Div Cardiovasc Med, 550 South Jackson St, Louisville, KY 40202 USA.	APDeFi01@louisville.edu	Budoff, Matthew/ABD-5175-2021; Blumenthal, Roger S/H-3223-2018	Budoff, Matthew/0000-0002-9616-1946; Blumenthal, Roger S/0000-0003-1910-3168; McEvoy, John/0000-0001-6530-5479	National Heart, Lung, and Blood Institute [N01-HC-95159, N01-HC-95169]; National Center for Research Resources [UL1-TR-000040, UL1-TR-001079]; National Heart, Lung, and Blood Institute; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095169, N01HC095159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079, UL1TR000040] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL095169, R43HL095169] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.	Bastuji-Garin S, 2002, J HYPERTENS, V20, P1973, DOI 10.1097/00004872-200210000-00016; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Brandle M, 2003, DIABETES CARE, V26, P1796, DOI 10.2337/diacare.26.6.1796; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Calonge N, 2009, ANN INTERN MED, V150, P396; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Erbel R, 2010, J AM COLL CARDIOL, V56, P1397, DOI 10.1016/j.jacc.2010.06.030; Fletcher B, 2005, CIRCULATION, V112, P3184, DOI 10.1161/CIRCULATIONAHA.105.169180; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Gordon WJ, 2010, J GEN INTERN MED, V25, P1145, DOI 10.1007/s11606-010-1454-2; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hoffmann D, 1997, J TOXICOL ENV HEALTH, V50, P307, DOI 10.1080/009841097160393; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Mitchell Aaron P, 2012, BMC Res Notes, V5, P373, DOI 10.1186/1756-0500-5-373; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; Muntner P, 2014, JAMA-J AM MED ASSOC, V311, P1406, DOI 10.1001/jama.2014.2630; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Sacks DB, 2008, CLIN CHEM, V54, P1756, DOI 10.1373/clinchem.2008.113282; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	35	322	327	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4					266	+		10.7326/M14-1281	http://dx.doi.org/10.7326/M14-1281			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686167	Green Accepted			2022-12-28	WOS:000350232500016
J	Eaton, S; Roberts, S; Turner, B				Eaton, Simon; Roberts, Sue; Turner, Bridget			SPOTLIGHT: PATIENT CENTRED CARE Delivering person centred care in long term conditions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SELF-MANAGEMENT; HEALTH-CARE; MULTIMORBIDITY; EPIDEMIOLOGY; SUPPORT		[Eaton, Simon; Roberts, Sue] Northumbria Healthcare NHS Fdn Trust, Year Care Partnerships, North Shields NE29 8NH, Tyne & Wear, England; [Turner, Bridget] Diabet UK, London NW1 7AA, England		Eaton, S (corresponding author), Northumbria Healthcare NHS Fdn Trust, Year Care Partnerships, North Shields NE29 8NH, Tyne & Wear, England.	simon.eaton@northumbria-healthcare.nhs.uk						Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Battersby M, 2007, MILBANK Q, V85, P37, DOI 10.1111/j.1468-0009.2007.00476.x; Blakeman T, 2006, BRIT J GEN PRACT, V56, P407; Bloem BR, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1838; Chew-Graham CA, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-103; Coulter A, 2015, COCHRANE DB SYST REV, V1; Coulter A, 2011, ENGAGING PATIENTS HE; Department of Health, 2012, LONG TERM CONDITIONS; Dixon A., 2013, DELIVERING BETTER SE; Ellins J, 2005, ENGAGED ARE PEOPLE T; Health Foundation, 2011, HELP PEOPL HELP THEM; Healthcare Commission, 2007, MAN DIAB IMPR SERV P; Hibbard JH, 2013, HEALTH AFFAIR, V32, P207, DOI 10.1377/hlthaff.2012.1061; Hibbard Judith H, 2008, Res Brief, P1; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kennedy A, 2007, BMJ-BRIT MED J, V335, P968, DOI 10.1136/bmj.39372.540903.94; Kennedy A, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0129-5; National Voices, 2013, PRINC CAR SUPP PLANN; NESTA, 2013, BUS CAS PEOPL POW HL; NHS England, 2014, ENHANCING QUALITY LI; NHS England, 2014, 5 YEAR FORW VIEW; Richmond Group of Charities, 2012, VIS ACT MAK PAT CTR; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Snow R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003583; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; UN Secretary General, 2011, PREV CONTR NONC DIS; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389; WHO, 2005, PREV CHRON DIS PREP; Year of Care, 2011, REP FIND PIL PROGR	30	82	83	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h181	10.1136/bmj.h181	http://dx.doi.org/10.1136/bmj.h181			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB0LU	25670186	Bronze			2022-12-28	WOS:000349318400004
J	Kamel, KS; Halperin, ML				Kamel, Kamel S.; Halperin, Mitchell L.			Disorders of Fluids and Electrolytes Acid-Base Problems in Diabetic Ketoacidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SERUM ANION GAP; CEREBRAL EDEMA; BICARBONATE THERAPY; METABOLIC-ACIDOSIS; LACTIC-ACIDOSIS; CHILDREN; BRAIN; MECHANISM; HYPOALBUMINEMIA; HYPERGLYCEMIA		Univ Toronto, St Michaels Hosp, Div Renal, Toronto, ON M5B 1W8, Canada; Univ Toronto, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Halperin, ML (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Keenan Res Ctr,Li Ka Shing Knowledge Inst, 30 Bond St,Rm 408, Toronto, ON M5B 1W8, Canada.	mitchell.halperin@utoronto.ca						Adrogue HJ, 1998, NEW ENGL J MED, V338, P26, DOI 10.1056/NEJM199801013380106; ADROGUE HJ, 1982, NEW ENGL J MED, V307, P1603, DOI 10.1056/NEJM198212233072603; Adrogue HJ, 2005, ACID BASE DISORDERS, P313; BALABAN RS, 1980, J PHYSIOL-LONDON, V304, P331, DOI 10.1113/jphysiol.1980.sp013327; BROSNAN JT, 1987, CAN J PHYSIOL PHARM, V65, P489, DOI 10.1139/y87-084; Brown TB, 2004, EMERG MED J, V21, P141, DOI 10.1136/emj.2002.001578; Carlotti APCP, 2009, PEDIATR DIABETES, V10, P522, DOI 10.1111/j.1399-5448.2009.00529.x; Carvounis CP, 2000, AM J NEPHROL, V20, P369, DOI 10.1159/000013618; Chua HR, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-23; DAVIES AO, 1984, J CLIN ENDOCR METAB, V59, P398, DOI 10.1210/jcem-59-3-398; Dunger DB, 2004, PEDIATRICS, V113, P133; Edge JA, 2006, DIABETOLOGIA, V49, P2002, DOI 10.1007/s00125-006-0363-8; Emmett M, 2006, NAT CLIN PRACT NEPHR, V2, P4, DOI 10.1038/ncpneph0073; Feldman M, 2005, J LAB CLIN MED, V146, P317, DOI 10.1016/j.lab.2005.07.008; Figge J, 1998, CRIT CARE MED, V26, P1807, DOI 10.1097/00003246-199811000-00019; FLATT JP, 1972, DIABETES, V21, P50, DOI 10.2337/diab.21.1.50; GAMBA G, 1991, REV INVEST CLIN, V43, P234; GAMBLIN GT, 1986, AM J MED, V80, P758, DOI 10.1016/0002-9343(86)90842-9; Glaser N, 2001, NEW ENGL J MED, V344, P264, DOI 10.1056/NEJM200101253440404; Glaser NS, 2008, J PEDIATR-US, V153, P541, DOI 10.1016/j.jpeds.2008.04.048; GOODKIN DA, 1984, CLIN ENDOCRINOL META, V13, P333, DOI 10.1016/S0300-595X(84)80025-0; Gowrishankar M, 2007, J AM SOC NEPHROL, V18, P2278, DOI 10.1681/ASN.2006121416; HALE PJ, 1984, BMJ-BRIT MED J, V289, P1035, DOI 10.1136/bmj.289.6451.1035; Halperin ML, 2006, PEDIATR DIABETES, V7, P191, DOI 10.1111/j.1399-5448.2006.00190.x; Halperin ML, 2010, J AM SOC NEPHROL, V21, P894, DOI 10.1681/ASN.2009080794; HOFFMAN WH, 1988, AM J NEURORADIOL, V9, P733; Hoorn EJ, 2007, J PEDIATR-US, V150, P467, DOI 10.1016/j.jpeds.2006.11.062; HUANG YG, 1995, BRIT J ANAESTH, V74, P583, DOI 10.1093/bja/74.5.583; JUNGAS RL, 1992, PHYSIOL REV, V72, P419, DOI 10.1152/physrev.1992.72.2.419; Kamel KS, 1998, KIDNEY INT, V53, P531, DOI 10.1046/j.1523-1755.1998.00803.x; Kamel KS, 1996, NEPHRON, V73, P382; KETY SS, 1948, J CLIN INVEST, V27, P500, DOI 10.1172/JCI101997; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; KRANE EJ, 1985, NEW ENGL J MED, V312, P1147, DOI 10.1056/NEJM198505023121803; Kraut JA, 2001, AM J KIDNEY DIS, V38, P703, DOI 10.1053/ajkd.2001.27688; Kraut JA, 2007, CLIN J AM SOC NEPHRO, V2, P162, DOI 10.2215/CJN.03020906; Kraut JA, 2012, NAT REV NEPHROL, V8, P589, DOI 10.1038/nrneph.2012.186; MACGREGOR IL, 1976, GASTROENTEROLOGY, V70, P190; MITCHELL JH, 1972, KIDNEY INT, V1, P375, DOI 10.1038/ki.1972.48; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; MORRIS LR, 1986, ANN INTERN MED, V105, P836, DOI 10.7326/0003-4819-105-6-836; Napolova O, 2003, NEPHROL DIAL TRANSPL, V18, P2674, DOI 10.1093/ndt/gfg419; NARINS RG, 1987, ANN INTERN MED, V106, P615, DOI 10.7326/0003-4819-106-4-615; NOBES CD, 1990, J BIOL CHEM, V265, P12910; OH MS, 1990, NEPHRON, V54, P1, DOI 10.1159/000185800; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; OWEN OE, 1969, J CLIN INVEST, V48, P574, DOI 10.1172/JCI106016; QUANT PA, 1993, BIOCHIM BIOPHYS ACTA, V1156, P135, DOI 10.1016/0304-4165(93)90128-U; Rastegar A, 2007, J AM SOC NEPHROL, V18, P2429, DOI 10.1681/ASN.2006121408; Rolfe DFS, 1997, BIOSCIENCE REP, V17, P9, DOI 10.1023/A:1027327015957; Sabatini S, 2009, J AM SOC NEPHROL, V20, P692, DOI 10.1681/ASN.2007121329; Savage MW, 2011, DIABETIC MED, V28, P508, DOI 10.1111/j.1464-5491.2011.03246.x; Shafiee MA, 2005, KIDNEY INT, V67, P613, DOI 10.1111/j.1523-1755.2005.67117.x; SONNE O, 1981, J BIOL CHEM, V256, P6250; Sperling MA, 2006, PEDIATR DIABETES, V7, P73, DOI 10.1111/j.1399-543X.2006.00157.x; Steele A, 1997, ANN INTERN MED, V126, P20, DOI 10.7326/0003-4819-126-1-199701010-00003; Voet D, 2011, BIOCHEMISTRY-US, P959; WILDENTH.K, 1968, AM J PHYSIOL, V214, P1352, DOI 10.1152/ajplegacy.1968.214.6.1352; Wolfsdorf J, 2009, PEDIATR DIABETES, V10, P118, DOI 10.1111/j.1399-5448.2009.00569.x	60	40	40	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2015	372	6					546	554		10.1056/NEJMra1207788	http://dx.doi.org/10.1056/NEJMra1207788			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CH	25651248				2022-12-28	WOS:000349143600009
J	Saver, JL; Starkman, S; Eckstein, M; Stratton, SJ; Pratt, FD; Hamilton, S; Conwit, R; Liebeskind, DS; Sung, G; Kramer, I; Moreau, G; Goldweber, R; Sanossian, N				Saver, Jeffrey L.; Starkman, Sidney; Eckstein, Marc; Stratton, Samuel J.; Pratt, Franklin D.; Hamilton, Scott; Conwit, Robin; Liebeskind, David S.; Sung, Gene; Kramer, Ian; Moreau, Gary; Goldweber, Robert; Sanossian, Nerses		FAST-MAG Investigators Coordinator	Prehospital Use of Magnesium Sulfate as Neuroprotection in Acute Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE ISCHEMIC-STROKE; HEALTH-CARE PROFESSIONALS; THERAPY; FIELD; TRIALS; METHODOLOGY; GUIDELINES; MANAGEMENT	Background Magnesium sulfate is neuroprotective in preclinical models of stroke and has shown signals of potential efficacy with an acceptable safety profile when delivered early after stroke onset in humans. Delayed initiation of neuroprotective agents has hindered earlier phase 3 trials of neuroprotective agents. Methods We randomly assigned patients with suspected stroke to receive either intravenous magnesium sulfate or placebo, beginning within 2 hours after symptom onset. A loading dose was initiated by paramedics before the patient arrived at the hospital, and a 24-hour maintenance infusion was started on the patient's arrival at the hospital. The primary outcome was the degree of disability at 90 days, as measured by scores on the modified Rankin scale (range, 0 to 6, with higher scores indicating greater disability). Results Among the 1700 enrolled patients (857 in the magnesium group and 843 in the placebo group), the mean (+/- SD) age was 69 +/- 13 years, 42.6% were women, and the mean pretreatment score on the Los Angeles Motor Scale of stroke severity (range, 0 to 10, with higher scores indicating greater motor deficits) was 3.7 +/- 1.3. The final diagnosis of the qualifying event was cerebral ischemia in 73.3% of patients, intracranial hemorrhage in 22.8%, and a stroke-mimicking condition in 3.9%. The median interval between the time the patient was last known to be free of stroke symptoms and the start of the study-drug infusion was 45 minutes (interquartile range, 35 to 62), and 74.3% of patients received the study-drug infusion within the first hour after symptom onset. There was no significant shift in the distribution of 90-day disability outcomes on the global modified Rankin scale between patients in the magnesium group and those in the placebo group (P = 0.28 by the Cochran-Mantel-Haenszel test); mean scores at 90 days did not differ between the magnesium group and the placebo group (2.7 in each group, P = 1.00). No significant between-group differences were noted with respect to mortality (15.4% in the magnesium group and 15.5% in the placebo group, P = 0.95) or all serious adverse events. Conclusions Prehospital initiation of magnesium sulfate therapy was safe and allowed the start of therapy within 2 hours after the onset of stroke symptoms, but it did not improve disability outcomes at 90 days.	[Saver, Jeffrey L.; Starkman, Sidney; Liebeskind, David S.] Univ Calif Los Angeles, David Geffen Sch Med, Comprehens Stroke Ctr, Los Angeles, CA 90095 USA; [Saver, Jeffrey L.; Starkman, Sidney; Liebeskind, David S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Starkman, Sidney; Pratt, Franklin D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Emergency Med, Los Angeles, CA 90095 USA; [Eckstein, Marc] Univ So Calif, Keck Sch Med, Dept Emergency Med, Los Angeles, CA 90033 USA; [Sung, Gene; Sanossian, Nerses] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Eckstein, Marc] Presbyterian Intercommun Hosp, Los Angeles Fire Dept, Los Angeles, CA USA; [Pratt, Franklin D.] Presbyterian Intercommun Hosp, Los Angeles Cty Fire Dept, Los Angeles, CA USA; [Kramer, Ian] Presbyterian Intercommun Hosp, Dept Emergency Med, Los Angeles, CA USA; [Moreau, Gary] Huntington Mem Hosp, Long Beach Mem Med Ctr, Dept Emergency Med, Los Angeles, CA USA; [Goldweber, Robert] Huntington Mem Hosp, Dept Emergency Med, Dept Emergency Med, Los Angeles, CA USA; [Stratton, Samuel J.] Los Angeles Cty Emergency Med Serv EMS Agcy, Torrance, CA USA; [Stratton, Samuel J.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Hamilton, Scott] Stanford Univ, Palo Alto, CA 94304 USA; [Conwit, Robin] Natl Inst Neurol Disorders & Stroke, Bethesda, MD USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of Southern California; University of Southern California; Huntington Memorial Hospital; University of Southern California; Huntington Memorial Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Saver, JL (corresponding author), Univ Calif Los Angeles, Comprehens Stroke Ctr, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	jsaver@mednet.ucla.edu	Lawrence, John/ABF-7076-2020	Lawrence, John/0000-0002-9892-2753; Saver, Jeffrey/0000-0001-9141-2251; Sutter, Gerd/0000-0001-6143-082X; Stratton, Samuel/0000-0002-2505-115X; Schwarzman, Polina/0000-0002-2769-8651; Jacob, Javier/0000-0003-1101-1066; Lotfipour, Shahram/0000-0003-3437-9410; Kamangar, Nader/0000-0002-9206-4954; Niemann, James/0000-0002-2626-7681; grotta, james/0000-0002-3667-4248; Llinas, Rafael/0000-0002-9161-2699; Murray, Joanne/0000-0003-2994-4155	National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS044364, U10NS080377] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the National Institute of Neurological Disorders and Stroke.	Adeoye O, 2011, STROKE, V42, P1952, DOI 10.1161/STROKEAHA.110.612358; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Dube L, 2003, CAN J ANAESTH, V50, P732, DOI 10.1007/BF03018719; Ferguson Katrina N, 2004, J Stroke Cerebrovasc Dis, V13, P109, DOI 10.1016/j.jstrokecerebrovasdis.2004.04.001; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kidwell CS, 2000, STROKE, V31, P71, DOI 10.1161/01.STR.31.1.71; Kidwell CS, 2001, STROKE, V32, P1349, DOI 10.1161/01.STR.32.6.1349; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Muir KW, 2001, CNS DRUGS, V15, P921, DOI 10.2165/00023210-200115120-00002; Ramanujam P, 2009, J EMERG MED, V37, P40, DOI 10.1016/j.jemermed.2007.11.092; Rogalewski A, 2006, STROKE, V37, P1129, DOI 10.1161/01.STR.0000209330.73175.34; Sanossian N, 2009, CEREBROVASC DIS, V28, P539, DOI 10.1159/000247596; Saver JL, 2011, J THROMB HAEMOST, V9, P333, DOI 10.1111/j.1538-7836.2011.04371.x; Saver J.L., 2011, MAGNESIUM CENTRAL NE, P205, DOI DOI 10.1017/UPO9780987073051.016; Saver JL, 2014, INT J STROKE, V9, P215, DOI 10.1111/ijs.12243; Saver JL, 2014, INT J STROKE, V9, P220, DOI 10.1111/ijs.12242; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Saver JL, 2010, STROKE, V41, P1431, DOI 10.1161/STROKEAHA.110.583815; Saver JL, 2010, STROKE, V41, P992, DOI 10.1161/STROKEAHA.109.571364; Saver JL, 2004, STROKE, V35, pE106, DOI 10.1161/01.STR.0000124458.98123.52; Tilley BC, 1996, STROKE, V27, P2136, DOI 10.1161/01.STR.27.11.2136	24	248	267	1	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2015	372	6					528	536		10.1056/NEJMoa1408827	http://dx.doi.org/10.1056/NEJMoa1408827			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CH	25651247	Green Accepted, Green Submitted			2022-12-28	WOS:000349143600007
J	Toutov, AA; Liu, WB; Betz, KN; Fedorov, A; Stoltz, BM; Grubbs, RH				Toutov, Anton A.; Liu, Wen-Bo; Betz, Kerry N.; Fedorov, Alexey; Stoltz, Brian M.; Grubbs, Robert H.			Silylation of C-H bonds in aromatic heterocycles by an Earth-abundant metal catalyst	NATURE			English	Article							FUNCTIONALIZATION; ACTIVATION; CHEMISTRY; ARENES	Heteroaromatic compounds containing carbon-silicon(C-Si) bonds are of great interest in the fields of organic electronics and photonics(1), drug discovery(2), nuclear medicine(3) and complex molecule synthesis(4-6), because these compounds have very useful physicochemical properties. Many of the methods now used to construct heteroaromatic C-Si bonds involve stoichiometric reactions between heteroaryl organometallic species and silicon electrophiles(6,7) or direct, transition metal-catalysed intermolecular carbon-hydrogen (C-H) silylation using rhodium or iridium complexes in the presence of excess hydrogen acceptors(8,9). Both approaches are useful, but their limitations include functional group in compatibility, narrow scope of application, high cost and low availability of the catalysts, and unproven scalability. For this reason, a new and general catalytic approach to heteroaromatic C-Si bond construction that avoids such limitations is highly desirable. Here we report an example of cross-dehydrogenative heteroaromatic C-H functionalization catalysed by an Earth-abundant alkali metal species. We found that readily available and inexpensive potassium tert-butoxide catalyses the direct silylation of aromatic heterocycles with hydrosilanes, furnishing heteroarylsilanes in a single step. The silylation proceeds under mild conditions, in the absence of hydrogen acceptors, ligands or additives, and is scalable to greater than 100 grams under optionally solvent-free conditions. Substrate classes that are difficult to activate with precious metal catalysts are silylated in good yield and with excellent regioselectivity. The derived heteroarylsilane products readily engage in versatile transformations enabling new synthetic strategies for heteroaromatic elaboration, and are useful in their own right in pharmaceutical and materials science applications.	[Toutov, Anton A.; Liu, Wen-Bo; Betz, Kerry N.; Fedorov, Alexey; Stoltz, Brian M.; Grubbs, Robert H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Grubbs, RH (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	stoltz@caltech.edu; rhg@caltech.edu	Fedorov, Alexey/B-2708-2008; LIU, WEN-BO/D-7401-2012	Fedorov, Alexey/0000-0001-9814-6726; 	NSF under the CCI Center for Selective C-H Functionalization [CHE-1205646, CHE-1212767]; BP under the XC2 initiative; Resnick Sustainability Institute at Caltech; Dow Chemical; NSERC; Shanghai Institute of Organic Chemistry (SIOC); Division Of Chemistry [1205646] Funding Source: National Science Foundation	NSF under the CCI Center for Selective C-H Functionalization; BP under the XC2 initiative; Resnick Sustainability Institute at Caltech; Dow Chemical; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Shanghai Institute of Organic Chemistry (SIOC); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the NSF under the CCI Center for Selective C-H Functionalization (CHE-1205646) and under CHE-1212767, and by BP under the XC<SUP>2</SUP> initiative. We thank the Novartis Institutes for Biomedical Research Incorporated for the donation of samples to the CCHF. D. Morton is thanked for a donation of thenalidine. A.A.T. is grateful to the Resnick Sustainability Institute at Caltech and to Dow Chemical for a predoctoral fellowship, and to NSERC for a PGS D fellowship. The Shanghai Institute of Organic Chemistry (SIOC) and S.-L. You are thanked for a postdoctoral fellowship to W.-B.L. We thank S. Virgil and the Caltech Center for Catalysis and Chemical Synthesis for access to analytical equipment. D. Vandervelde is acknowledged for assistance with NMR interpretation. N. Dalleska is thanked for assistance with ICP-MS tracemetal analysis. M. Shahgoli and N. Torian are acknowledged for assistance with high-resolution mass spectrometry.	Ball LT, 2012, SCIENCE, V337, P1644, DOI 10.1126/science.1225709; Cheng C, 2014, SCIENCE, V343, P853, DOI 10.1126/science.1248042; Collins KD, 2013, NAT CHEM, V5, P597, DOI [10.1038/NCHEM.1669, 10.1038/nchem.1669]; Curless LD, 2014, CHEM COMMUN, V50, P5270, DOI 10.1039/c3cc47372d; Denmark SE, 2006, CHEM-EUR J, V12, P4954, DOI 10.1002/chem.200600034; Du W, 2003, BIOORGAN MED CHEM, V11, P451, DOI 10.1016/S0968-0896(02)00437-6; Fedorov A, 2013, CHEM SCI, V4, P1640, DOI 10.1039/c3sc22256j; Franz AK, 2013, J MED CHEM, V56, P388, DOI 10.1021/jm3010114; Furukawa S, 2009, J AM CHEM SOC, V131, P14192, DOI 10.1021/ja906566r; Hansen MM, 2004, SYNLETT, P1351, DOI 10.1055/s-2004-825609; Kakiuchi F, 2004, J AM CHEM SOC, V126, P12792, DOI 10.1021/ja047040d; Klare HFT, 2011, J AM CHEM SOC, V133, P3312, DOI 10.1021/ja111483r; Kuznetsov A, 2013, ORG LETT, V15, P2498, DOI 10.1021/ol400977r; LANGKOPF E, 1995, CHEM REV, V95, P1375, DOI 10.1021/cr00037a011; Lee M, 2000, J AM CHEM SOC, V122, P12011, DOI 10.1021/ja003079g; Li CJ, 2008, P NATL ACAD SCI USA, V105, P13197, DOI 10.1073/pnas.0804348105; Lu B, 2008, ANGEW CHEM INT EDIT, V47, P7508, DOI 10.1002/anie.200802456; Oyamada J, 2011, ANGEW CHEM INT EDIT, V50, P10720, DOI 10.1002/anie.201105636; SAKAKURA T, 1987, CHEM LETT, P2375, DOI 10.1246/cl.1987.2375; Seiple IB, 2010, J AM CHEM SOC, V132, P13194, DOI 10.1021/ja1066459; Seregin IV, 2007, CHEM SOC REV, V36, P1173, DOI 10.1039/b606984n; Showell GA, 2003, DRUG DISCOV TODAY, V8, P551, DOI 10.1016/S1359-6446(03)02726-0; Song JJ, 2007, CHEM SOC REV, V36, P1120, DOI 10.1039/b607868k; Tamao K, 1996, J AM CHEM SOC, V118, P11974, DOI 10.1021/ja962829c; Ting R, 2005, J AM CHEM SOC, V127, P13094, DOI 10.1021/ja053293a; Wang YF, 2006, J AM CHEM SOC, V128, P2536, DOI 10.1021/ja056074y; Weickgenannt A, 2009, CHEM-ASIAN J, V4, P406, DOI 10.1002/asia.200800426; Whisler MC, 2004, ANGEW CHEM INT EDIT, V43, P2206, DOI 10.1002/anie.200300590; Zhang F, 2011, J MATER CHEM, V21, P17590, DOI 10.1039/c1jm12801a; Zhao ZD, 2005, ORG LETT, V7, P2523, DOI 10.1021/ol0506563	30	277	281	16	373	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					80	84		10.1038/nature14126	http://dx.doi.org/10.1038/nature14126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25652999				2022-12-28	WOS:000349098000035
J	Mohammadi, D				Mohammadi, Dara			Matshidiso Moeti: new Director of WHO AFRO	LANCET			English	Biographical-Item																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					411	411		10.1016/S0140-6736(15)60143-X	http://dx.doi.org/10.1016/S0140-6736(15)60143-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	25706967				2022-12-28	WOS:000348509900013
J	Alcorn, T				Alcorn, Ted			Yinghao Sun: leader of research on prostate cancer in China	LANCET			English	Biographical-Item																			0	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					321	321		10.1016/S0140-6736(15)60107-6	http://dx.doi.org/10.1016/S0140-6736(15)60107-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CN	25706842	Bronze			2022-12-28	WOS:000348509000012
J	Moon, C; Baldridge, MT; Wallace, MA; Burnham, CAD; Virgin, HW; Stappenbeck, TS				Moon, Clara; Baldridge, Megan T.; Wallace, Meghan A.; Burnham, Carey-Ann D.; Virgin, Herbert W.; Stappenbeck, Thaddeus S.			Vertically transmitted faecal IgA levels determine extra-chromosomal phenotypic variation	NATURE			English	Article							T-CELL RESPONSES; DEFICIENT MICE; PROTEOLYTIC DEGRADATION; INTESTINAL MICROBIOTA; SECRETORY COMPONENT; IMMUNOGLOBULIN-A; TRANSPORT; BACTERIA; RECEPTOR; DEFENSE	The proliferation of genetically modified mouse models has exposed phenotypic variation between investigators and institutions that has been challenging to control(1-5). In many cases, the microbiota is the presumed cause of the variation. Current solutions to account for phenotypic variability include littermate and maternal controls or defined microbial consortia ingnotobiotic mice(6,7). Inconventionally raised mice, the microbiome is transmitted from the dam(2,8,9). Here we show that microbially driven dichotomous faecal immunoglobulin-A (IgA) levels in wild-type mice within the same facility mimic the effects of chromosomal mutations. We observe in multiple facilities that vertically transmissible bacteria in IgA-low mice dominantly lower faecal IgA levels in IgA-high mice after co-housing or faecal transplantation. In response to injury, IgA-low mice show increased damage that is transferable by faecal transplantation and driven by faecal IgA differences. We find that bacteria from IgA-low mice degrade the secretory component of secretory IgA as well as IgA itself. These data indicate that phenotypic comparisons between mice must take into account the non-chromosomal hereditary variation between different breeders. We propose faecal IgA as one marker of microbial variability and conclude that co-housing and/or faecal transplantation enables analysis of progeny from different dams.	[Moon, Clara; Baldridge, Megan T.; Wallace, Meghan A.; Burnham, Carey-Ann D.; Virgin, Herbert W.; Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu; stappenb@pathology.wustl.edu	Baldridge, Megan/T-7274-2019	Baldridge, Megan/0000-0002-7030-6131; Moon, Clara/0000-0003-2076-9282; Virgin, Herbert/0000-0001-8580-7628	National Institutes of Health (NIH) [AI08488702, DK7161907]; Crohn's & Colitis Foundation of America Genetics Initiative; Rainin Foundation; Helmsley Charitable Trust; NIH [T32AI007163, T32CA009547, P30AR048335, P30DK052574]; W.M. Keck Fellowship from Washington University; NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK097079, R01DK101354, R01DK071619] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011170] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America Genetics Initiative; Rainin Foundation; Helmsley Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Fellowship from Washington University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants AI08488702 and DK7161907, the Crohn's & Colitis Foundation of America Genetics Initiative, the Rainin Foundation, and the Helmsley Charitable Trust. C.M. was supported by NIH training grant T32AI007163, and M.T.B. was supported by NIH training grant T32CA009547 and the W.M. Keck Fellowship from Washington University. We thank H. Miyoshi for technical recommendations, D. Kreamalmeyer for animal care and breeding, and members of the Stappenbeck and Virgin laboratories for discussion. Experimental support was provided by the Speed Congenics Facility of the Rheumatic Diseases Core Center (NIH award number P30AR048335) and the Digestive Disease Research Core Center (NIH award number P30DK052574) of Washington University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blutt SE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00402; BRANDTZAEG P, 1984, NATURE, V311, P71, DOI 10.1038/311071a0; Brandtzaeg P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00222; BROWN WR, 1970, J CLIN INVEST, V49, P1374, DOI 10.1172/JCI106354; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fujiwara R, 2008, BRIT J NUTR, V99, P1174, DOI 10.1017/S0007114507862349; Hao LY, 2013, CURR OPIN GASTROEN, V29, P363, DOI 10.1097/MOG.0b013e32836157a4; Holmdahl R, 2012, EUR J IMMUNOL, V42, P45, DOI 10.1002/eji.201142048; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Kang SS, 2008, PLOS MED, V5, P424, DOI 10.1371/journal.pmed.0050041; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Letran SE, 2011, J IMMUNOL, V186, P5406, DOI 10.4049/jimmunol.1003576; LINDH E, 1975, J IMMUNOL, V114, P284; LOOMES LM, 1990, INFECT IMMUN, V58, P1979, DOI 10.1128/IAI.58.6.1979-1985.1990; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Moon C, 2014, MUCOSAL IMMUNOL, V7, P818, DOI 10.1038/mi.2013.98; Murthy AK, 2006, J GASTROEN HEPATOL, V21, P1372, DOI 10.1111/j.1440-1746.2006.04312.x; PLAUT AG, 1975, SCIENCE, V190, P1103, DOI 10.1126/science.810892; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reikvam DH, 2012, EUR J IMMUNOL, V42, P2959, DOI 10.1002/eji.201242543; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Tsuji M, 2008, SEMIN IMMUNOL, V20, P59, DOI 10.1016/j.smim.2007.12.003; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Wexler HM, 1996, INT J SYST BACTERIOL, V46, P252, DOI 10.1099/00207713-46-1-252; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11	35	160	165	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					90	U209		10.1038/nature14139	http://dx.doi.org/10.1038/nature14139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25686606	Green Accepted			2022-12-28	WOS:000354040900039
J	Gonzalez, E; Billings, SD; Fernandez, AP				Gonzalez, Elena; Billings, Steven D.; Fernandez, Anthony P.			A refractory rash in a seborrheic distribution	LANCET			English	Editorial Material									[Gonzalez, Elena] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Billings, Steven D.; Fernandez, Anthony P.] Cleveland Clin, Dept Pathol, Cleveland, OH 44195 USA; [Billings, Steven D.; Fernandez, Anthony P.] Cleveland Clin, Dept Dermatol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Fernandez, AP (corresponding author), Cleveland Clin, Dept Dermatol, Med Dermatol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	fernana6@ccf.org							0	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1777	1777		10.1016/S0140-6736(14)61902-4	http://dx.doi.org/10.1016/S0140-6736(14)61902-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25652885				2022-12-28	WOS:000353726000033
J	Mirand, A; Peigue-Lafeuille, H				Mirand, Audrey; Peigue-Lafeuille, Helsne			Acute flaccid myelitis and enteroviruses: an ongoing story	LANCET			English	Editorial Material							INFECTION; PARALYSIS; CHILDREN		[Mirand, Audrey; Peigue-Lafeuille, Helsne] CHU Clermont Ferrand, Virol Lab, Natl Reference Ctr Enteroviruses & Parechoviruses, F-63003 Clermont Ferrand, France	CHU Clermont Ferrand	Mirand, A (corresponding author), CHU Clermont Ferrand, Virol Lab, Natl Reference Ctr Enteroviruses & Parechoviruses, F-63003 Clermont Ferrand, France.	amirand@chu-clermontferrand.fr						[Anonymous], 2014, AC FLACC MYEL INT CO; Ayscue P, 2014, MMWR-MORBID MORTAL W, V63, P903; CDC, 2014, SUMM FIND INV AC FLA; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Inamura T, 2014, REV MED VIROL, V2014, DOI [10.1002/rmv.1820, DOI 10.1002/RMV.1820]; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Lang M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.44.20952; Marx A, 2000, EPIDEMIOL REV, V22, P298, DOI 10.1093/oxfordjournals.epirev.a018041; Messacar K, 2015, LANCET; Midgley Claire M, 2014, MMWR Morb Mortal Wkly Rep, V63, P798; Modlin JF, 2007, NEW ENGL J MED, V356, P1204, DOI 10.1056/NEJMp078016; Pastula DM, 2014, MMWR-MORBID MORTAL W, V63, P901; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895	14	8	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1601	1602		10.1016/S0140-6736(15)60121-0	http://dx.doi.org/10.1016/S0140-6736(15)60121-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG6NG	25638661				2022-12-28	WOS:000353418000012
J	West, AP; Khoury-Hanold, W; Staron, M; Tal, MC; Pineda, CM; Lang, SM; Bestwick, M; Duguay, BA; Raimundo, N; MacDuff, DA; Kaech, SM; Smiley, JR; Means, RE; Iwasaki, A; Shadel, GS				West, A. Phillip; Khoury-Hanold, William; Staron, Matthew; Tal, Michal C.; Pineda, Cristiana M.; Lang, Sabine M.; Bestwick, Megan; Duguay, Brett A.; Raimundo, Nuno; MacDuff, Donna A.; Kaech, Susan M.; Smiley, James R.; Means, Robert E.; Iwasaki, Akiko; Shadel, Gerald S.			Mitochondrial DNA stress primes the antiviral innate immune response	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; TRANSCRIPTION FACTOR; VIRUS; HERPES; EXPRESSION; REPLICATION; RECOGNITION; INFECTION; AUTOPHAGY; EFFECTOR	Mitochondrial DNA (mtDNA) is normally present at thousands of copies per cell and is packaged into several hundred higher-order structures termed nudeoids(1). The abundant mtDNA-binding protein TFAM (transcription factor A, mitochondrial) regulates nucleoid architecture, abundance and segregation(2). Complete mtDNA depletion profoundly impairs oxidative phosphorylation, triggering calcium-dependent stress signalling and adaptive metabolic responses'. However, the cellular responses to mtDNA instability, a physiologically relevant stress observed in many human diseases and ageing, remain poorly defined(4). Here we show that moderate mtDNA stress elicited by TFAM deficiency engages cytosolic antiviral signalling to enhance the expression of a subset of interferon-stimulated genes. Mechanistically, we find that aberrant mtDNA packaging promotes escape of mtDNA into the cytosol, where it engages the DNA sensor cGAS (also known as MB21D1) and promotes STING (also known as TMEM173)-IRF3-dependent signalling to elevate interferon-stimulated gene expression, potentiate type I interferon responses and confer broad viral resistance. Furthermore, we demonstrate that herpesviruses induce mtDNA stress, which enhances antiviral signalling and type I interferon responses during infection. Our results further demonstrate that mitochondria are central participants in innate immunity, identify mtDNA stress as a cell-intrinsic trigger of antiviral signalling and suggest that cellular monitoring of mtDNA homeostasis cooperates with canonical virus sensing mechanisms to fully engage antiviral innate immunity.	[West, A. Phillip; Pineda, Cristiana M.; Lang, Sabine M.; Bestwick, Megan; Raimundo, Nuno; Means, Robert E.; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Khoury-Hanold, William; Staron, Matthew; Tal, Michal C.; Kaech, Susan M.; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Duguay, Brett A.; Smiley, James R.] Univ Alberta, Dept Med Microbiol & Immunol, Li Ka Shing Inst Virol, Edmonton, AB T6G 2S2, Canada; [MacDuff, Donna A.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kaech, Susan M.; Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University; University of Alberta; Washington University (WUSTL); Howard Hughes Medical Institute; Yale University	Shadel, GS (corresponding author), Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA.	gerald.shadel@yale.edu	Iwasaki, Akiko/Z-1591-2019; Raimundo, Nuno/AAD-9498-2020; MacDuff, Donna/AAD-2786-2019; West, A. Phillip/W-8171-2019	Iwasaki, Akiko/0000-0002-7824-9856; Raimundo, Nuno/0000-0002-5988-9129; MacDuff, Donna/0000-0002-6183-6827; West, A. Phillip/0000-0003-2884-6895; Bestwick, Megan/0000-0003-3670-5507; Tal, Michal/0000-0003-2550-6246; Smiley, James/0000-0001-9162-4393	United Mitochondrial Disease Foundation; Mitocon; NIH [R01 AG047632, P01 ES011163, R01 A1054359, R01 A1081884, T32 AI055403, F31 AG039163, NRSA F32 DK091042]; Canadian Institutes for Health Research [MOP37995]; Canada Research Chair in Molecular Virology; American Cancer Society [PF-13-035-01-DMC]; Alberta Innovates-Health Solutions; Queen Elizabeth II Graduate Scholarship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081884, R01AI054359, T32AI055403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK091042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047632, F31AG039163] Funding Source: NIH RePORTER	United Mitochondrial Disease Foundation; Mitocon; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Molecular Virology(Canada Research Chairs); American Cancer Society(American Cancer Society); Alberta Innovates-Health Solutions; Queen Elizabeth II Graduate Scholarship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Chandel for Tfam<SUP>fl/fl</SUP> mice, D. Martin for Tfam<SUP>+/-</SUP> MEFs, J. Schoggins and S. Virgin for cGas<SUP>-/-</SUP> MEFs, G. Barber for Sting<SUP>-/-</SUP> MEFs, G. Sen for IFIT3 antibodies,J. Rose for VSV antibodies and recombinant vaccinia virus, K. Bahl and J. Schell for advice with VSV infections, and S. Ding for advice with HSV-1 gene expression analysis. This work was supported by a joint grant from the United Mitochondrial Disease Foundation and Mitocon, NIH R01 AG047632 and P01 ES011163 (G.S.S.), NIH R01 A1054359 and R01 A1081884 (A.I.), Canadian Institutes for Health Research grant MOP37995 and a Canada Research Chair in Molecular Virology (J.R.S.), American Cancer Society Postdoctoral Fellowship PF-13-035-01-DMC (A.P.W.), NIH T32 AI055403 (W.K.-H.), NIH F31 AG039163 (M.C.T.), NIH NRSA F32 DK091042 (M.B.), Alberta Innovates-Health Solutions and a Queen Elizabeth II Graduate Scholarship (B.A.D.), and a United Mitochondrial Disease Foundation Postdoctoral Fellowship (N.R.).	Ablasser A, 2014, J IMMUNOL, V192, P5993, DOI 10.4049/jimmunol.1400737; Atianand MK, 2013, J IMMUNOL, V190, P1911, DOI 10.4049/jimmunol.1203162; Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Cardenas I, 2011, AM J REPROD IMMUNOL, V65, P110, DOI 10.1111/j.1600-0897.2010.00908.x; Corcoran JA, 2009, J VIROL, V83, P2601, DOI 10.1128/JVI.02087-08; Crow MK, 2004, CURR OPIN RHEUMATOL, V16, P541, DOI 10.1097/01.bor.0000135453.70424.1b; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; Dalton KP, 2001, VIROLOGY, V279, P414, DOI 10.1006/viro.2000.0736; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Duguay BA, 2014, J VIROL, V88, P2967, DOI 10.1128/JVI.03129-13; Duguay BA, 2013, J VIROL, V87, P11787, DOI 10.1128/JVI.02306-13; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kasashima K, 2011, EXP CELL RES, V317, P210, DOI 10.1016/j.yexcr.2010.10.008; Khodarev NN, 2007, CANCER RES, V67, P9214, DOI 10.1158/0008-5472.CAN-07-1019; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee HM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3317; Lee HT, 2012, INT J MOL SCI, V13, P8853, DOI 10.3390/ijms13078853; Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027; Pang IK, 2013, P NATL ACAD SCI USA, V110, P13910, DOI 10.1073/pnas.1303275110; PARR MB, 1994, LAB INVEST, V70, P369; Pohjoismaki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saffran HA, 2007, EMBO REP, V8, P188, DOI 10.1038/sj.embor.7400878; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Welsh RM., 2008, CURR PROTOC MICROBIO; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wiedmer A, 2008, J VIROL, V82, P4647, DOI 10.1128/JVI.02198-07; Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003; Yordy B, 2012, CELL HOST MICROBE, V12, P334, DOI 10.1016/j.chom.2012.07.013	49	852	880	16	271	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					553	+		10.1038/nature14156	http://dx.doi.org/10.1038/nature14156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25642965	Green Accepted			2022-12-28	WOS:000353334500046
J	Arner, E; Daub, CO; Vitting-Seerup, K; Andersson, R; Lilje, B; Drablos, F; Lennartsson, A; Ronnerblad, M; Hrydziuszko, O; Vitezic, M; Freeman, TC; Alhendi, AMN; Arner, P; Axton, R; Baillie, JK; Beckhouse, A; Bodega, B; Briggs, J; Brombacher, F; Davis, M; Detmar, M; Ehrlund, A; Endoh, M; Eslami, A; Fagiolini, M; Fairbairn, L; Faulkner, GJ; Ferrai, C; Fisher, ME; Forrester, L; Goldowitz, D; Guler, R; Ha, T; Hara, M; Herlyn, M; Ikawa, T; Kai, CK; Kawamoto, H; Khachigian, LM; Klinken, SP; Kojima, S; Koseki, H; Klein, S; Mejhert, N; Miyaguchi, K; Mizuno, Y; Morimoto, M; Morris, KJ; Mummery, C; Nakachi, Y; Ogishima, S; Okada-Hatakeyama, M; Okazaki, Y; Orlando, V; Ovchinnikov, D; Passier, R; Patrikakis, M; Pombo, A; Qin, XY; Roy, S; Sato, H; Savvi, S; Saxena, A; Schwegmann, A; Sugiyama, D; Swoboda, R; Tanaka, H; Tomoiu, A; Winteringham, LN; Wolvetang, E; Yanagi-Mizuochi, C; Yoneda, M; Zabierowski, S; Zhang, P; Abugessaisa, I; Bertin, N; Diehl, AD; Fukuda, S; Furuno, M; Harshbarger, J; Hasegawa, A; Hori, F; Ishikawa-Kato, S; Ishizu, Y; Itoh, M; Kawashima, T; Kojima, M; Kondo, N; Lizio, M; Meehan, TF; Mungall, CJ; Murata, M; Nishiyori-Sueki, H; Sahin, S; Nagao-Sato, S; Severin, J; de Hoon, MJL; Kawai, J; Kasukawa, T; Lassmann, T; Suzuki, H; Kawaji, H; Summers, KM; Wells, C; Hume, DA; Forrest, ARR; Sandelin, A; Carninci, P; Hayashizaki, Y				Arner, Erik; Daub, Carsten O.; Vitting-Seerup, Kristoffer; Andersson, Robin; Lilje, Berit; Drablos, Finn; Lennartsson, Andreas; Roennerblad, Michelle; Hrydziuszko, Olga; Vitezic, Morana; Freeman, Tom C.; Alhendi, Ahmad M. N.; Arner, Peter; Axton, Richard; Baillie, J. Kenneth; Beckhouse, Anthony; Bodega, Beatrice; Briggs, James; Brombacher, Frank; Davis, Margaret; Detmar, Michael; Ehrlund, Anna; Endoh, Mitsuhiro; Eslami, Afsaneh; Fagiolini, Michela; Fairbairn, Lynsey; Faulkner, Geoffrey J.; Ferrai, Carmelo; Fisher, Malcolm E.; Forrester, Lesley; Goldowitz, Daniel; Guler, Reto; Ha, Thomas; Hara, Mitsuko; Herlyn, Meenhard; Ikawa, Tomokatsu; Kai, Chieko; Kawamoto, Hiroshi; Khachigian, Levon M.; Klinken, S. Peter; Kojima, Soichi; Koseki, Haruhiko; Klein, Sarah; Mejhert, Niklas; Miyaguchi, Ken; Mizuno, Yosuke; Morimoto, Mitsuru; Morris, Kelly J.; Mummery, Christine; Nakachi, Yutaka; Ogishima, Soichi; Okada-Hatakeyama, Mariko; Okazaki, Yasushi; Orlando, Valerio; Ovchinnikov, Dmitry; Passier, Robert; Patrikakis, Margaret; Pombo, Ana; Qin, Xian-Yang; Roy, Sugata; Sato, Hiroki; Savvi, Suzana; Saxena, Alka; Schwegmann, Anita; Sugiyama, Daisuke; Swoboda, Rolf; Tanaka, Hiroshi; Tomoiu, Andru; Winteringham, Louise N.; Wolvetang, Ernst; Yanagi-Mizuochi, Chiyo; Yoneda, Misako; Zabierowski, Susan; Zhang, Peter; Abugessaisa, Imad; Bertin, Nicolas; Diehl, Alexander D.; Fukuda, Shiro; Furuno, Masaaki; Harshbarger, Jayson; Hasegawa, Akira; Hori, Fumi; Ishikawa-Kato, Sachi; Ishizu, Yuri; Itoh, Masayoshi; Kawashima, Tsugumi; Kojima, Miki; Kondo, Naoto; Lizio, Marina; Meehan, Terrence F.; Mungall, Christopher J.; Murata, Mitsuyoshi; Nishiyori-Sueki, Hiromi; Sahin, Serkan; Nagao-Sato, Sayaka; Severin, Jessica; de Hoon, Michiel J. L.; Kawai, Jun; Kasukawa, Takeya; Lassmann, Timo; Suzuki, Harukazu; Kawaji, Hideya; Summers, Kim M.; Wells, Christine; Hume, David A.; Forrest, Alistair R. R.; Sandelin, Albin; Carninci, Piero; Hayashizaki, Yoshihide		FANTOM Consortium	Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells	SCIENCE			English	Article							RNAS	Although it is generally accepted that cellular differentiation requires changes to transcriptional networks, dynamic regulation of promoters and enhancers at specific sets of genes has not been previously studied en masse. Exploiting the fact that active promoters and enhancers are transcribed, we simultaneously measured their activity in 19 human and 14 mouse time courses covering a wide range of cell types and biological stimuli. Enhancer RNAs, then messenger RNAs encoding transcription factors, dominated the earliest responses. Binding sites for key lineage transcription factors were simultaneously overrepresented in enhancers and promoters active in each cellular system. Our data support a highly generalizable model in which enhancer transcription is the earliest event in successive waves of transcriptional change during cellular differentiation or activation.	[Arner, Erik; Daub, Carsten O.; Roy, Sugata; Saxena, Alka; Abugessaisa, Imad; Bertin, Nicolas; Fukuda, Shiro; Furuno, Masaaki; Harshbarger, Jayson; Hasegawa, Akira; Hori, Fumi; Ishikawa-Kato, Sachi; Ishizu, Yuri; Itoh, Masayoshi; Kawashima, Tsugumi; Kojima, Miki; Kondo, Naoto; Lizio, Marina; Murata, Mitsuyoshi; Nishiyori-Sueki, Hiromi; Sahin, Serkan; Nagao-Sato, Sayaka; Severin, Jessica; de Hoon, Michiel J. L.; Kawai, Jun; Kasukawa, Takeya; Lassmann, Timo; Suzuki, Harukazu; Kawaji, Hideya; Forrest, Alistair R. R.; Carninci, Piero; Hayashizaki, Yoshihide] RIKEN Omics Sci Ctr OSC, Tsurumi Ku, 1-7-22 Suehiro cho, Yokohama, Kanagawa 2300045, Japan; [Arner, Erik; Daub, Carsten O.; Roy, Sugata; Saxena, Alka; Abugessaisa, Imad; Bertin, Nicolas; Furuno, Masaaki; Harshbarger, Jayson; Hasegawa, Akira; Hori, Fumi; Ishikawa-Kato, Sachi; Ishizu, Yuri; Itoh, Masayoshi; Kawashima, Tsugumi; Kojima, Miki; Kondo, Naoto; Lizio, Marina; Murata, Mitsuyoshi; Nishiyori-Sueki, Hiromi; Sahin, Serkan; Nagao-Sato, Sayaka; Severin, Jessica; de Hoon, Michiel J. L.; Kasukawa, Takeya; Lassmann, Timo; Suzuki, Harukazu; Kawaji, Hideya; Forrest, Alistair R. R.; Carninci, Piero] RIKEN Ctr Life Sci Technol, Div Genom Technol CLST DGT, Tsurumi Ku, 1-7-22 Suehiro cho, Yokohama, Kanagawa 2300045, Japan; [Itoh, Masayoshi; Kawai, Jun; Kawaji, Hideya; Hayashizaki, Yoshihide] RIKEN Prevent Med & Diag Innovat Program PMI, 2-1 Hirosawa,Wako-shi, Saitama 3510198, Japan; [Mummery, Christine; Passier, Robert] Leiden Univ Med Ctr, Anat & Embryol, Einthovenweg 20,POB 9600, NL-2300 RC Leiden, Netherlands; [Beckhouse, Anthony; Briggs, James; Ovchinnikov, Dmitry; Wolvetang, Ernst; Wells, Christine] Univ Queensland, AIBN, Brisbane, Qld 4072, Australia; [Endoh, Mitsuhiro; Ferrai, Carmelo; Morris, Kelly J.; Pombo, Ana] Berlin Inst Med Syst Biol, Max Delbrueck Ctr, Robert Roessle Str 10, D-13125 Berlin, Germany; [Orlando, Valerio] King Abdullah Univ Sci & Technol KAUST, Biol & Environm Sci & Engn Div, Ibn Al Haytham Bldg-2, Thuwal, Saudi Arabia; [Faulkner, Geoffrey J.] Mater Med Res Inst, Canc Biol Program, Raymond Terrace, South Brisbane, Qld 4101, Australia; [Yanagi-Mizuochi, Chiyo] Kyushu Univ Hosp, Ctr Clin & Translat Reseach, 3-1-1 Maidashi, Higashi Ku, Fukuoka 8128582, Japan; [Alhendi, Ahmad M. N.; Khachigian, Levon M.; Patrikakis, Margaret] Univ New South Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Eslami, Afsaneh; Miyaguchi, Ken; Ogishima, Soichi; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan; [Arner, Erik; Hrydziuszko, Olga] Karolinska Inst, Dept Biosciences & Nutr, SE-14186 Stockholm, Sweden; [Arner, Erik; Hrydziuszko, Olga] Karolinska Inst, Sci Life Lab, SE-14186 Stockholm, Sweden; [Lennartsson, Andreas; Roennerblad, Michelle] Karolinska Inst, Dept Biosciences & Nutr, Ctr Biosciences, Halsovagen 7-9, SE-14183 Huddinge, Sweden; [Sugiyama, Daisuke] Kyushu Univ, Dept Clin Study, Ctr Adv Med Innovat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Goldowitz, Daniel; Ha, Thomas; Zhang, Peter] Univ British Columbia, Child & Family Res Inst, Dept Med Genet, Ctr Mol Med & Therapeut, 950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada; [Arner, Peter; Ehrlund, Anna; Mejhert, Niklas] Karolinska Inst, Dept Med, S-14186 Stockholm, Sweden; [Arner, Peter; Ehrlund, Anna; Mejhert, Niklas] Karolinska Univ Hosp, Ctr Metab & Endocrinol, S-14186 Stockholm, Sweden; [Diehl, Alexander D.] Univ Buffalo, Sch Med & Biomed Sci, Dept Neurol, New York State Ctr Excellence Bioinformat & Life, 701 Ellicott St, Buffalo, NY 14203 USA; [Mizuno, Yosuke; Nakachi, Yutaka; Okazaki, Yasushi] Saitama Med Univ, Div Funct Genom & Syst Med, Res Ctr Genom Med, 1397-1 Yamane, Hidaka, Saitama 3501241, Japan; [Nakachi, Yutaka; Okazaki, Yasushi] Saitama Med Univ, Div Translat Res, Res Ctr Genom Med, 1397-1 Yamane, Hidaka, Saitama 3501241, Japan; [Brombacher, Frank; Guler, Reto; Savvi, Suzana; Schwegmann, Anita] Int Ctr Genet Engn Biotechnol ICGEB Cape Town com, Immunol & Infect Dis, Anzio Rd, Cape Town, South Africa; [Brombacher, Frank; Guler, Reto; Savvi, Suzana; Schwegmann, Anita] Univ Cape Town, Inst Infect Dis & Mol Med IDM, Div Immunol, Anzio Rd, Cape Town, South Africa; [Fagiolini, Michela] Harvard Med Sch, Childrens Hosp, F M Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA; [Mungall, Christopher J.] Lawrence Berkeley Natl Lab, Genom Div, 1 Cyclotron Rd, Berkeley, CA 94720 USA; [Klinken, S. Peter; Winteringham, Louise N.] Univ Western Australia, Harry Perkins Inst Med Res, Nedlands, WA, Australia; [Klinken, S. Peter; Winteringham, Louise N.] Univ Western Australia, Ctr Med Res Ctr, QEII Med Ctr, QQ Block, Nedlands, WA, Australia; [Wells, Christine] Univ Glasgow, Inst Infect Immun & Inflammat, MVLS, Glasgow, Lanark, Scotland; [Detmar, Michael] Inst Pharmaceut Sci, ETH Zurich, Vladimir Prelog Weg 3, CH-8093 Zurich, Switzerland; [Bodega, Beatrice; Orlando, Valerio] IRCCS Fnd Santa Lucia, Via Fosso Fiorano 64, I-00143 Rome, Italy; [Kai, Chieko; Sato, Hiroki; Yoneda, Misako] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Herlyn, Meenhard; Swoboda, Rolf; Zabierowski, Susan] Wistar Inst Anat & Biol, Melanoma Res Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA; [Meehan, Terrence F.] European Mol Biol Lab European Bioinformat Inst, Mouse Informat, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England; [Drablos, Finn] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Fac Med, POB 8905, NO-7491 Trondheim, Norway; [Morimoto, Mitsuru] RIKEN Ctr Dev Biol CDB, Chuo Ku, 2-2-3 Minatojimaminamimachi, Kobe, Hyogo 6500047, Japan; [Endoh, Mitsuhiro; Ikawa, Tomokatsu; Kawamoto, Hiroshi; Koseki, Haruhiko; Okada-Hatakeyama, Mariko] RIKEN Res Ctr Allergy & Immunol RCAI, Tsurumi Ku, 1-7-22 Suehirocho, Yokohama, Kanagawa 2300045, Japan; [Endoh, Mitsuhiro; Ikawa, Tomokatsu; Koseki, Haruhiko; Okada-Hatakeyama, Mariko] RIKEN Ctr Integrat Med Sci, 1-7-22 Suehiro cho, Yokohama, Kanagawa 2300045, Japan; [Hara, Mitsuko; Kojima, Soichi; Qin, Xian-Yang] RIKEN Ctr Life Sci Technol, Div Bio Funct Dynam Imaging CLST DBDI, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Vitting-Seerup, Kristoffer; Andersson, Robin; Lilje, Berit; Vitezic, Morana; Sandelin, Albin] Univ Copenhagen, Dept Biol & Biotech Res & Innovat Ctr BRIC, Bioinformat Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark; [Freeman, Tom C.; Axton, Richard; Baillie, J. Kenneth; Davis, Margaret; Fairbairn, Lynsey; Fisher, Malcolm E.; Forrester, Lesley; Tomoiu, Andru; Summers, Kim M.; Hume, David A.] Univ Edinburgh, Roslin Inst & Royal Dick Sch Vet Studies, Easter Bush, Edinburgh EH25 9RG, Midlothian, Scotland; [Bertin, Nicolas] Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med, 14 Med Dr, Singapore 1201, Singapore; [Ogishima, Soichi] Tohoku Univ, Dept Bioclin Informat, Tohoku Med Megabank Org, Aoba Ku, Seiryo cho 2-1, Sendai shi, Miyagi 9808573, Japan	RIKEN; RIKEN; RIKEN; Leiden University; Leiden University Medical Center (LUMC); University of Queensland; Helmholtz Association; Max Delbruck Center for Molecular Medicine; King Abdullah University of Science & Technology; Mater Research; University of New South Wales Sydney; Tokyo Medical & Dental University (TMDU); Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Kyushu University; Child & Family Research Institute; University of British Columbia; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Saitama Medical University; Saitama Medical University; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; Harvard University; Boston Children's Hospital; Harvard Medical School; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; University of Glasgow; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Tokyo; The Wistar Institute; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Norwegian University of Science & Technology (NTNU); RIKEN; RIKEN; RIKEN; RIKEN; University of Copenhagen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; National University of Singapore; Tohoku University		david.hume@roslin.ed.ac.uk; forrest@gsc.riken.jp; albin@binf.ku.dk; carninci@riken.jp; yosihide@gsc.riken.jp	Diehl, Alexander/G-9883-2016; Baillie, John Kenneth/F-3124-2011; Kawaji, Hideya/N-5116-2015; Kawai, Jun/A-6451-2016; Carninci, Piero/K-1568-2014; Nakachi, Yutaka/M-2446-2013; Sandelin, Albin/G-2881-2011; Arner, Erik/A-1895-2010; Khachigian, Levon/AAZ-7458-2020; Bodega, Beatrice/I-4644-2018; Vitting-Seerup, Kristoffer/C-9008-2015; Itoh, Masayoshi/N-5363-2015; Pombo, Ana/A-1045-2010; Vitezic, Morana/A-6165-2013; Summers, Kim M/M-4086-2015; Baillie, Kenneth/AEK-6650-2022; Beckhouse, Anthony G/A-2601-2010; Abugessaisa, Imad/S-9275-2018; Drablos, Finn/L-4970-2019; Kojima, Soichi/N-7104-2015; Daub, Carsten O/A-7436-2010; Vitting-Seerup, Kristoffer/AAE-4069-2021; Dethlefsen, Olga/AAE-1395-2022; Koseki, Haruhiko/I-3825-2014; Dethlefsen, Olga/I-5163-2012; Qin, Xian-Yang/AAB-5628-2020; Kasukawa, Takeya/N-5070-2015; Faulkner, Geoffrey J/M-3168-2014; Severin, Jessica/AAQ-2723-2020; Bertin, Nicolas/O-9602-2019; Winteringham, Louise/H-6105-2014; Hayashizaki, Yoshihide/N-6590-2015; Ovchinnikov, Dmitry/J-7963-2014; Lassmann, Timo/HCH-4313-2022; Wolvetang, Ernst jurgen/D-6644-2017; Lassmann, Timo/A-8271-2008; de Hoon, Michiel/A-6443-2013; Ferrai, Carmelo/GVS-7378-2022; Mungall, Chris/I-6006-2019; Andersson, Robin/B-5311-2009; Wells, Christine/A-5071-2010; Bertin, Nicolas/C-3025-2008	Diehl, Alexander/0000-0001-9990-8331; Baillie, John Kenneth/0000-0001-5258-793X; Kawaji, Hideya/0000-0002-0575-0308; Carninci, Piero/0000-0001-7202-7243; Nakachi, Yutaka/0000-0003-1964-2495; Sandelin, Albin/0000-0002-7109-7378; Arner, Erik/0000-0003-1225-4908; Bodega, Beatrice/0000-0003-0527-9234; Vitting-Seerup, Kristoffer/0000-0002-6450-0608; Itoh, Masayoshi/0000-0002-1772-318X; Pombo, Ana/0000-0002-7493-6288; Vitezic, Morana/0000-0002-7994-9600; Summers, Kim M/0000-0002-7084-4386; Baillie, Kenneth/0000-0001-5258-793X; Beckhouse, Anthony G/0000-0002-5141-8250; Abugessaisa, Imad/0000-0001-7458-801X; Drablos, Finn/0000-0001-5794-828X; Kojima, Soichi/0000-0002-5252-1612; Daub, Carsten O/0000-0002-3295-8729; Dethlefsen, Olga/0000-0003-0502-1401; Koseki, Haruhiko/0000-0001-8424-5854; Dethlefsen, Olga/0000-0003-0502-1401; Kasukawa, Takeya/0000-0001-5085-0802; Faulkner, Geoffrey J/0000-0001-5769-4494; Severin, Jessica/0000-0003-1274-208X; Ovchinnikov, Dmitry/0000-0001-9603-8385; Lassmann, Timo/0000-0002-0138-2691; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Lassmann, Timo/0000-0002-0138-2691; Mungall, Chris/0000-0002-6601-2165; Andersson, Robin/0000-0003-1516-879X; Freeman, Thomas/0000-0001-5235-8483; Okazaki, Yasushi/0000-0003-3241-5502; Fisher, Malcolm/0000-0003-1074-8103; Wells, Christine/0000-0003-3133-3628; Fukuda, Shiro/0000-0002-0065-662X; Hume, David/0000-0002-2615-1478; Meehan, Terrence/0000-0003-1980-3228; Tomoiu, Andru/0000-0001-8508-4626; Goldowitz, Daniel/0000-0003-4756-4017; Winteringham, Louise/0000-0002-8117-5069; Roy, Sugata/0000-0001-7183-7957; Mejhert, Niklas/0000-0003-1785-833X; Khachigian, Levon/0000-0003-3446-0323; Arner, Peter/0000-0002-6208-6220; Forrest, Alistair/0000-0003-4543-1675; Ferrai, Carmelo/0000-0002-8088-2757; Bertin, Nicolas/0000-0002-9835-9606; Endoh, Mitsuhiro/0000-0003-0715-1701; fagiolini, michela/0000-0003-2807-803X; de Hoon, Michiel/0000-0003-0489-2352	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Research Grants for RIKEN Preventive Medicine and Diagnosis Innovation Program; RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (from the MEXT, Japan); Biotechnology and Biological Sciences Research Council [BBS/E/D/20211550, BB/H008098/1, BBS/E/D/20211552, BBS/E/D/20211551, BBS/E/D/20251969] Funding Source: researchfish; Medical Research Council [MC_U120061476] Funding Source: researchfish; Novo Nordisk Fonden [NNF10SA1016550, NNF12OC1016371] Funding Source: researchfish; BBSRC [BBS/E/D/20211551, BB/H008098/1, BBS/E/D/20251969, BBS/E/D/20211552, BBS/E/D/20211550] Funding Source: UKRI; MRC [MC_U120061476] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24689042] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Grants for RIKEN Preventive Medicine and Diagnosis Innovation Program; RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (from the MEXT, Japan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	For a full list of acknowledgements and contributions, see supplementary text. FANTOM5 was made possible by a Research Grant for RIKEN Omics Science Center from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) to Y. Hayashizaki. It was also supported by Research Grants for RIKEN Preventive Medicine and Diagnosis Innovation Program to Y. Hayashizaki and RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (from the MEXT, Japan). Additional funding is listed in the supplementary text. All CAGE data needed to reproduce the study have been deposited at the DNA Data Bank of Japan (DDBJ) under accession numbers DRA000991, DRA002711, DRA002747, and DRA002748. Additional visualizations of the data are available at http://fantom.gsc.riken.jp/5/. The human induced pluripotent stem cell lines that were subjected to cortical neuronal differentiation can be made available after completion of a materials transfer agreement with the Australian Institute for Bioengineering and Nanotechnology of The University of Queensland.	Andersson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6336; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Hsieh CL, 2014, P NATL ACAD SCI USA, V111, P7319, DOI 10.1073/pnas.1324151111; Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Ronnerblad M, 2014, BLOOD, V123, pE79, DOI 10.1182/blood-2013-02-482893; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Wu H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004610	20	351	357	3	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					1010	1014		10.1126/science.1259418	http://dx.doi.org/10.1126/science.1259418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25678556	Green Published, Green Accepted			2022-12-28	WOS:000349958900043
J	Goyal, S; Zandstra, PW				Goyal, Sidhartha; Zandstra, Peter W.			STEM CELLS Chasing blood	NATURE			English	Editorial Material							DYNAMICS; MICE		[Goyal, Sidhartha] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A7, Canada; [Zandstra, Peter W.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 1A7, Canada	University of Toronto; University of Toronto; University of Toronto	Goyal, S (corresponding author), Univ Toronto, Dept Phys, 60 St George St, Toronto, ON M5S 1A7, Canada.	peter.zandstra@utoronto.ca						Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; HARRISON DE, 1987, BLOOD, V69, P773; MCCULLOCH EA, 1964, SCIENCE, V144, P844, DOI 10.1126/science.144.3620.844; Qiao W, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145141; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824	7	3	3	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					488	490		10.1038/nature14203	http://dx.doi.org/10.1038/nature14203			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25686602				2022-12-28	WOS:000350097300034
J	Perry, JJ; Alyahya, B; Sivilotti, MLA; Bullard, MJ; Emond, M; Sutherland, J; Worster, A; Hohl, C; Lee, JS; Eisenhauer, MA; Pauls, M; Lesiuk, H; Wells, GA; Stiell, IG				Perry, Jeffrey J.; Alyahya, Bader; Sivilotti, Marco L. A.; Bullard, Michael J.; Emond, Marcel; Sutherland, Jane; Worster, Andrew; Hohl, Corinne; Lee, Jacques S.; Eisenhauer, Mary A.; Pauls, Merril; Lesiuk, Howard; Wells, George A.; Stiell, Ian G.			Differentiation between traumatic tap and aneurysmal subarachnoid hemorrhage: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RED-BLOOD-CELLS; CEREBROSPINAL-FLUID; LUMBAR PUNCTURE; EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; XANTHOCHROMIA; DIAGNOSIS; HEADACHE; RULE; SPECTROPHOTOMETRY	OBJECTIVES To describe the findings in cerebrospinal fluid from patients with acute headache that could distinguish subarachnoid hemorrhage from the effects of a traumatic lumbar puncture. DESIGN A substudy of a prospective multicenter cohort study. SETTING 12 Canadian academic emergency departments, from November 2000 to December 2009. PARTICIPANTS Alert patients aged over 15 with an acute non-traumatic headache who underwent lumbar puncture to rule out subarachnoid hemorrhage. MAIN OUTCOME MEASURE Aneurysmal subarachnoid hemorrhage requiring intervention or resulting in death. RESULTS Of the 1739 patients enrolled, 641 (36.9%) had abnormal results on cerebrospinal fluid analysis with > 1 x 10(6)/L red blood cells in the final tube of cerebrospinal fluid and/or xanthochromia in one or more tubes. There were 15 (0.9%) patients with aneurysmal subarachnoid hemorrhage based on abnormal results of a lumbar puncture. The presence of fewer than 2000 x 10(6)/L red blood cells in addition to no xanthochromia excluded the diagnosis of aneurysmal subarachnoid hemorrhage, with a sensitivity of 100% (95% confidence interval 74.7% to 100%) and specificity of 91.2% (88.6% to 93.3%). CONCLUSION No xanthochromia and red blood cell count < 2000 x 10(6)/L reasonably excludes the diagnosis of aneurysmal subarachnoid hemorrhage. Most patients with acute headache who meet this cut off will need no further investigations and aneurysmal subarachnoid hemorrhage can be excluded as a cause of their headache.	[Perry, Jeffrey J.; Alyahya, Bader; Stiell, Ian G.] Univ Ottawa, Ottawa Hosp Res Inst, Dept Emergency Med, Ottawa Hosp, Ottawa, ON K1Y 4E9, Canada; [Sivilotti, Marco L. A.] Univ Ottawa, Dept Emergency Med, Ottawa, ON K1Y 4E9, Canada; [Bullard, Michael J.] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada; [Emond, Marcel] Hop Enfants Jesus, Fac Med, Dept Emergency Med, Quebec City, PQ G1J 1Z4, Canada; [Sutherland, Jane] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Worster, Andrew] McMaster Univ, Dept Emergency Med, Hamilton, ON, Canada; [Hohl, Corinne] Univ British Columbia, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Lee, Jacques S.] Univ Toronto, Div Emergency Med, Toronto, ON, Canada; [Eisenhauer, Mary A.] Univ Western Ontario, Div Emergency Med, London, ON, Canada; [Pauls, Merril] Univ Manitoba, Dept Emergency Med, Winnipeg, MB, Canada; [Lesiuk, Howard] Univ Ottawa, Div Neurosurg, Ottawa, ON K1Y 4E9, Canada; [Wells, George A.] Univ Ottawa, Ottawa Hosp Res Inst, Dept Epidemiol & Community Med, Ottawa, ON K1Y 4E9, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Alberta; Laval University; University of Ottawa; Ottawa Hospital Research Institute; McMaster University; University of British Columbia; University of Toronto; Western University (University of Western Ontario); University of Manitoba; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Perry, JJ (corresponding author), Ottawa Hosp, Clin Epidemiol Unit, F647,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	jperry@ohri.ca	Lee, Jacques/CAF-4380-2022; Hohl, Corinne M/AAY-3325-2021; Sivilotti, Marco L.A./AAR-8892-2020; Emond, Marcel/G-5804-2014	Lee, Jacques/0000-0002-9143-6285; Hohl, Corinne M/0000-0002-9210-7838; Sivilotti, Marco L.A./0000-0001-6641-1118; Emond, Marcel/0000-0001-7158-8110; Stiell, Ian/0000-0002-2583-6408; Perry, Jeffrey/0000-0003-2134-9597; Alyahya, Bader/0000-0002-4869-4852	Canadian Institutes of Health Research [67107, 153742]; Ontario Ministry of Health and Long Term Care; Physician's Services Incorporated Foundation [01-39]; Canadian Institutes of Health Research New Investigator Award; Alberta Innovates [201300690] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Physician's Services Incorporated Foundation; Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This research was funded by the Canadian Institutes of Health Research (grants: 67107, 153742), the Ontario Ministry of Health and Long Term Care, and the physicians of Ontario through the Physician's Services Incorporated Foundation (01-39). JPP is supported by a Canadian Institutes of Health Research New Investigator Award and was previously supported as a career scientist by the Ontario Ministry of Health. IGS is a distinguished professor and university health research chair, University of Ottawa. CH is supported by a Canadian Institutes of Health Research New Investigator Award and was previously supported by a Mentored Clinician Scientist Award from the Vancouver Coastal Health Research Institute.	Arora S, 2010, J EMERG MED, V39, P13, DOI 10.1016/j.jemermed.2007.09.052; Beetham R, 2004, J NEUROL NEUROSUR PS, V75, P528, DOI 10.1136/jnnp.2003.023176; Beetham R, 2009, SCAND J CLIN LAB INV, V69, P1, DOI [10.1080/00365510802651874, 10.1080/00365510802651866]; BURUMA OJS, 1981, J NEUROL NEUROSUR PS, V44, P144, DOI 10.1136/jnnp.44.2.144; Byyny RL, 2008, ANN EMERG MED, V51, P697, DOI 10.1016/j.annemergmed.2007.10.007; Chu K, 2014, ANN EMERG MED, V64, P256, DOI 10.1016/j.annemergmed.2014.01.023; Czuczman AD, 2013, ACAD EMERG MED, V20, P247, DOI 10.1111/acem.12095; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Dupont SA, 2008, MAYO CLIN PROC, V83, P1326, DOI 10.1016/S0025-6196(11)60780-5; Edlow JA, 2002, ARCH PATHOL LAB MED, V126, P413; Edlow JA, 2000, NEW ENGL J MED, V342, P29, DOI 10.1056/NEJM200001063420106; Edlow JA, 2008, ANN EMERG MED, V52, P407, DOI 10.1016/j.annemergmed.2008.07.001; Gorchynski Julie, 2007, Cal J Emerg Med, V8, P3; Greebe P, 2007, STROKE, V38, P1222, DOI 10.1161/01.STR.0000260093.49693.7a; Heasley DC, 2005, AM J NEURORADIOL, V26, P820; Kang DH, 2009, J CLIN NEUROSCI, V16, P904, DOI 10.1016/j.jocn.2008.10.008; LANG DT, 1990, AM J CLIN PATHOL, V93, P403, DOI 10.1093/ajcp/93.3.403; LEBLANC R, 1987, J NEUROSURG, V66, P35, DOI 10.3171/jns.1987.66.1.0035; PAGE KB, 1994, J CLIN PATHOL, V47, P986, DOI 10.1136/jcp.47.11.986; Perry JJ, 2008, ANN EMERG MED, V51, P707, DOI 10.1016/j.annemergmed.2007.10.025; Perry JJ, 2006, STROKE, V37, P2467, DOI 10.1161/01.STR.0000240689.15109.47; Perry JJ, 2013, JAMA-J AM MED ASSOC, V310, P1248, DOI 10.1001/jama.2013.278018; Perry JJ, 2012, CAN J NEUROL SCI, V39, P638, DOI 10.1017/S0317167100015389; Perry JJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4277; Perry JJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5204; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Schull MJ, 1999, ACAD EMERG MED, V6, P131, DOI 10.1111/j.1553-2712.1999.tb01051.x; Schwartz TH, 1996, NEUROSURGERY, V39, P433, DOI 10.1097/00006123-199609000-00001; Thomas LE, 2014, J NEUROSURG, V121, P24, DOI 10.3171/2014.3.JNS132239; VERMEULEN M, 1989, J NEUROL NEUROSUR PS, V52, P826, DOI 10.1136/jnnp.52.7.826; Vermeulen MJ, 2007, STROKE, V38, P1216, DOI 10.1161/01.STR.0000259661.05525.9a; Watson ID, 2008, ANN CLIN BIOCHEM, V45, P189, DOI 10.1258/acb.2007.007043	32	44	44	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2015	350								h568	10.1136/bmj.h568	http://dx.doi.org/10.1136/bmj.h568			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WC	25694274	Green Published, hybrid			2022-12-28	WOS:000349911500005
J	Sokol, DK				Sokol, Daniel K.			How to treat a Piraha: medical ethics and cultural difference	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Sokol, DK (corresponding author), 12 Kings Bench Walk, London, England.	daniel.sokol@talk21.com						Dyer C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h703; Engelhardt Jr. H. T., 2006, GLOBAL BIOETHICS THE; Everett Daniel L., 2008, DONT SLEEP THERE ARE; General Medical Council, 2013, GOOD MED PRACTICE; TURKEWITZ J, 2014, NY TIMES	5	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2015	350								h850	10.1136/bmj.h850	http://dx.doi.org/10.1136/bmj.h850			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WC	25694331				2022-12-28	WOS:000349911500017
J	Eliakim-Raz, N; Leibovici, L				Eliakim-Raz, Noa; Leibovici, Leonard			Some antimicrobials increased admissions and ED visits for hypoglycemia in older users of glipizide or glyburide	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Eliakim-Raz, Noa; Leibovici, Leonard] Rabin Med Ctr, Petah Tiqwa, Israel	Rabin Medical Center	Eliakim-Raz, N (corresponding author), Rabin Med Ctr, Beilinson Campus, Petah Tiqwa, Israel.							Du YF, 2014, CLIN INTERV AGING, V9, P1963, DOI 10.2147/CIA.S53482; Shorr RI, 1997, ARCH INTERN MED, V157, P1681, DOI 10.1001/archinte.157.15.1681; Sinclair AJ, 2011, DIABETES METAB, V37, pS27, DOI 10.1016/S1262-3636(11)70962-4	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4							JC13	10.7326/ACPJC-2015-162-4-013	http://dx.doi.org/10.7326/ACPJC-2015-162-4-013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686188				2022-12-28	WOS:000350232500004
J	Finkelstein, A; Taubman, S				Finkelstein, Amy; Taubman, Sarah			Randomize evaluations to improve health care delivery	SCIENCE			English	Editorial Material							INSURANCE EXPERIMENT; MEDICAID		[Finkelstein, Amy] MIT, Dept Econ, Cambridge, MA 02139 USA; [Finkelstein, Amy; Taubman, Sarah] MIT, J PAL North Amer, Cambridge, MA 02139 USA; [Finkelstein, Amy] Natl Bur Econ Res, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Bureau of Economic Research	Finkelstein, A (corresponding author), MIT, Dept Econ, Cambridge, MA 02139 USA.	afink@mit.edu						Allen H, 2013, J HEALTH POLIT POLIC, V38, P1183, DOI 10.1215/03616878-2373244; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Aron-Dine A, 2013, J ECON PERSPECT, V27, P197, DOI 10.1257/jep.27.1.197; Baicker K, 2014, AM ECON REV, V104, P322, DOI 10.1257/aer.104.5.322; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Chetty R, 2011, Q J ECON, V126, P1593, DOI 10.1093/qje/qjr041; Crepon B, 2013, Q J ECON, V128, P531, DOI 10.1093/qje/qjt001; Douthat R., 2013, NY TIMES; Finkelstein A., 2014, USING RANDOMIZED EVA; Finkelstein A, 2007, Q J ECON, V122, P1, DOI 10.1162/qjec.122.1.1; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Newhouse JP, 1993, FREE ALL LESSONS RAN; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183	13	20	19	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					720	722		10.1126/science.aaa2362	http://dx.doi.org/10.1126/science.aaa2362			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA9DT	25678649				2022-12-28	WOS:000349221300026
J	Meng, QJ; Ji, Q; Zhang, YG; Liu, D; Grossnickle, DM; Luo, ZX				Meng, Qing-Jin; Ji, Qiang; Zhang, Yu-Guang; Liu, Di; Grossnickle, David M.; Luo, Zhe-Xi			An arboreal docodont from the Jurassic and mammaliaform ecological diversification	SCIENCE			English	Article							INTRINSIC HAND PROPORTIONS; LOCOMOTOR BEHAVIOR; MAMMALS; DIVERSITY; ANATOMY	A new docodontan mammaliaform from the Middle Jurassic of China has skeletal features for climbing and dental characters indicative of an omnivorous diet that included plant sap. This fossil expands the range of known locomotor adaptations in docodontans to include climbing, in addition to digging and swimming. It further shows that some docodontans had a diet with a substantial herbivorous component, distinctive from the faunivorous diets previously reported in other members of this clade. This reveals a greater ecological diversity in an early mammaliaform clade at a more fundamental taxonomic level not only between major clades as previously thought.	[Meng, Qing-Jin; Zhang, Yu-Guang; Liu, Di] Beijing Museum Nat Hist, Beijing 100050, Peoples R China; [Ji, Qiang] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Grossnickle, David M.; Luo, Zhe-Xi] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Luo, Zhe-Xi] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	Chinese Academy of Geological Sciences; University of Chicago; University of Chicago	Luo, ZX (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	zxluo@uchicago.edu	Meng, Q./GSI-6185-2022; Luo, Zhe-XI/AAU-2263-2021		Beijing Science and Technology Commission; Ministry of Science and Technology of China; Chinese Academy of Geological Science; University of Chicago	Beijing Science and Technology Commission; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Geological Science; University of Chicago(University of Chicago)	Research supported by Beijing Science and Technology Commission Grant, 2014 First-Class Award in Science and Technology to Q.-J.M., Ministry of Science and Technology of China 973 Project funding and Chinese Academy of Geological Science funding to Q.J., and the University of Chicago to Z.-X.L. We thank A. I. Neander for her superb graphics work. Full acknowledgment to colleagues for supporting our research is in SM (18). Full datasets are in SM (18).	Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Averianov A.O., 2010, Trudy Zoologicheskogo Instituta, V314, P121; Chen M, 2013, J MAMM EVOL, V20, P159, DOI 10.1007/s10914-012-9199-9; Gill PG, 2014, NATURE, V512, P303, DOI 10.1038/nature13622; Hershkovitz P., 1977, NEW WORLD MONKEYS PA; Hu Yao-Ming, 2007, Vertebrata Palasiatica, V45, P173; JENKINS FA, 1976, PHILOS T ROY SOC B, V273, P387, DOI 10.1098/rstb.1976.0022; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; Kirk EC, 2008, J HUM EVOL, V55, P278, DOI 10.1016/j.jhevol.2008.02.008; Lessertisseur J., 1967, TRAITE ZOOL, P587; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2007, NATURE, V450, P93, DOI 10.1038/nature06221; Luo ZX, 2011, ANNU REV ECOL EVOL S, V42, P355, DOI 10.1146/annurev-ecolsys-032511-142302; Luo Zhe-Xi, 2007, Bulletin of Carnegie Museum of Natural History, V39, P27, DOI 10.2992/0145-9058(2007)39[27:AOMSAP]2.0.CO;2; MACLEOD N, 1993, AM J SCI, V293A, P300, DOI 10.2475/ajs.293.A.300; Martin T, 2005, ZOOL J LINN SOC-LOND, V145, P219, DOI 10.1111/j.1096-3642.2005.00187.x; Martin Thomas, 2010, Palaeobiodiversity Palaeoenvironments, V90, P295, DOI 10.1007/s12549-010-0030-4; Meng J, 2006, NATURE, V444, P889, DOI 10.1038/nature05234; Rougier G. W., 2014, J MAMM EVOL; Rougier GW, 2011, NATURE, V479, P98, DOI 10.1038/nature10591; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Sargis EJ, 2004, EVOL ANTHROPOL, V13, P56, DOI 10.1002/evan.10131; Sigogneau-Russell D, 2003, ACTA PALAEONTOL POL, V48, P357; Weisbecker V, 2006, J MORPHOL, V267, P1469, DOI 10.1002/jmor.10495; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429	29	66	74	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					764	768		10.1126/science.1260879	http://dx.doi.org/10.1126/science.1260879			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678661				2022-12-28	WOS:000349221300046
J	Cho, NW; Greenberg, RA				Cho, Nam Woo; Greenberg, Roger A.			Familiar ends with alternative endings	NATURE			English	Editorial Material							REPAIR		[Cho, Nam Woo; Greenberg, Roger A.] Univ Penn, Abramson Family Canc Res Inst, Basser Res Ctr BRCA, Dept Canc Biol,Perelman Sch Med, Philadelphia, PA 19104 USA; [Cho, Nam Woo; Greenberg, Roger A.] Univ Penn, Abramson Family Canc Res Inst, Basser Res Ctr BRCA, Dept Pathol,Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Cho, NW (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Basser Res Ctr BRCA, Dept Canc Biol,Perelman Sch Med, Philadelphia, PA 19104 USA.	rogergr@mail.med.upenn.edu			NCI NIH HHS [R01 CA174904] Funding Source: Medline; NIGMS NIH HHS [R01 GM101149] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA174904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101149] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Kent T., 2015, NATURE STRUCT MOL BI; Marie A, 2010, NUCLEIC ACIDS RES, V38, P5706, DOI 10.1093/nar/gkq379; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020	11	9	34	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					174	176		10.1038/nature14200	http://dx.doi.org/10.1038/nature14200			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8SD	25642961				2022-12-28	WOS:000349190300026
J	Jain, A				Jain, Anita			SPOTLIGHT: PATIENT CENTRED CARE Patient communities reform healthcare in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ajain@bmj.com						Improving Chronic Illness Care, CHRON CAR MOD; Jain A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g4184; MSF, MSF SUPP OPP GIL TEN; Phadke A, 2013, DEV APPROACH SOCIAL; Ramachandran SK, 2015, HINDU           0101; Shukla A, 2014, 27 MUN SERV PROJ; Shukla A, 2013, COMMUNITY BASED MONI; WHO Europe, 1978, DECL ALM AT	8	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h225	10.1136/bmj.h225	http://dx.doi.org/10.1136/bmj.h225			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670187	Bronze			2022-12-28	WOS:000349318400005
J	Jun, M; James, MT; Manns, BJ; Quinn, RR; Ravani, P; Tonelli, M; Perkovic, V; Winkelmayer, WC; Ma, ZH; Hemmelgarn, BR				Jun, Min; James, Matthew T.; Manns, Braden J.; Quinn, Robert R.; Ravani, Pietro; Tonelli, Marcello; Perkovic, Vlado; Winkelmayer, Wolfgang C.; Ma, Zhihai; Hemmelgarn, Brenda R.		Alberta Kidney Dis Network	The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADMINISTRATIVE DATA; RENAL-FUNCTION; HEMODIALYSIS; DISEASE; STROKE; RISK; COMORBIDITIES; COMPLICATIONS; EFFICACY; THERAPY	OBJECTIVE To determine rates of major bleeding by level of kidney function for older adults with atrial fibrillation starting warfarin. DESIGN Retrospective cohort study. SETTING Community based, using province wide laboratory and administrative data in Alberta, Canada. PARTICIPANTS 12 403 adults aged 66 years or more, with atrial fibrillation who started warfarin treatment between 1 May 2003 and 31 March 2010 and had a measure of kidney function at baseline. Kidney function was estimated using the Chronic Kidney Disease Epidemiology Collaboration equation and participants were categorised based on estimated glomerular filtration rate (eGFR): >= 90, 60-89, 45-59, 30-44, 15-29, < 15 ml/min/1.73m(2). We excluded participants with end stage renal disease (dialysis or renal transplant) at baseline. MAIN OUTCOME MEASURES Admission to hospital or visit to an emergency department for major bleeding (intracranial, upper and lower gastrointestinal, or other). RESULTS Of 12 403 participants, 45% had an eGFR < 60 ml/min/1.73m(2). Overall, 1443 (11.6%) experienced a major bleeding episode over a median follow-up of 2.1 (interquartile range: 1.0-3.8) years. During the first 30 days of warfarin treatment, unadjusted and adjusted rates of major bleeding were higher at lower eGFR (P for trend < 0.001 and 0.001, respectively). Adjusted bleeding rates per 100 person years were 63.4 (95% confidence interval 24.9 to 161.6) in participants with eGFR < 15 ml/min/1.73m2 compared with 6.1 (1.9 to 19.4) among those with eGFR > 90 ml/min/1.73m(2) (adjusted incidence rate ratio 10.3, 95% confidence interval 2.3 to 45.5). Similar associations were observed at more than 30 days after starting warfarin, although the magnitude of the increase in rates across eGFR categories was attenuated. Across all eGFR categories, adjusted rates of major bleeding were consistently higher during the first 30 days of warfarin treatment compared with the remainder of follow-up. Increases in major bleeding rates were largely due to gastrointestinal bleeding (3.5-fold greater in eGFR < 15 ml/min/1.73m(2) compared with >= 90 ml/min/1.73m(2)). Intracranial bleeding was not increased with worsening kidney function. CONCLUSIONS Reduced kidney function was associated with an increased risk of major bleeding among older adults with atrial fibrillation starting warfarin; excess risks from reduced eGFR were most pronounced during the first 30 days of treatment. Our results support the need for careful consideration of the bleeding risk relative to kidney function when assessing the risk-benefit ratio of warfarin treatment in people with chronic kidney disease and atrial fibrillation, particularly in the first 30 days of treatment.	[Jun, Min; James, Matthew T.; Manns, Braden J.; Quinn, Robert R.; Ravani, Pietro; Tonelli, Marcello; Ma, Zhihai; Hemmelgarn, Brenda R.] Univ Calgary, Div Nephrol, Dept Med, Calgary, AB T2N 2T9, Canada; [James, Matthew T.; Manns, Braden J.; Quinn, Robert R.; Ravani, Pietro; Hemmelgarn, Brenda R.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 2T9, Canada; [Perkovic, Vlado] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Winkelmayer, Wolfgang C.] Baylor Coll Med, Nephrol Sect, Houston, TX 77030 USA	University of Calgary; University of Calgary; George Institute for Global Health; University of Sydney; Baylor College of Medicine	Hemmelgarn, BR (corresponding author), Univ Calgary, Div Nephrol, Dept Med, Calgary, AB T2N 2T9, Canada.	Brenda.Hemmelgarn@albertahealthservices.ca	Ravani, Pietro/J-3050-2015; Perkovic, Vlado/AAY-1933-2021; Quinn, Robert R/E-7017-2011; Tonelli, Marcello/B-3028-2009	Ravani, Pietro/0000-0001-6973-8570; Tonelli, Marcello/0000-0002-0846-3187; Perkovic, Vlado/0000-0002-4257-7620; Jun, Min/0000-0003-1460-7535	Canadian Institutes of Health Research; Alberta Innovates Health Solutions; National Health and Medical Research Council of Australia; Roy and Vi Baay Chair in Kidney Research; Canada Research Chair; National Institute for Diabetes and Digestive and Kidney Diseases [R01DK095024]; Gordon A Cain Chair in Nephrology at Baylor College of Medicine; Alberta Innovates [201300672] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095024] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Roy and Vi Baay Chair in Kidney Research; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Institute for Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Gordon A Cain Chair in Nephrology at Baylor College of Medicine; Alberta Innovates; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	MJ was supported by postdoctoral fellowships from the Canadian Institutes of Health Research and Alberta Innovates Health Solutions, and an early career fellowship from the National Health and Medical Research Council of Australia. BRH was supported by the Roy and Vi Baay Chair in Kidney Research; MT was supported by a Canada Research Chair. WCW was supported by grant R01DK095024 from the National Institute for Diabetes and Digestive and Kidney Diseases. WCW enjoys salary and research support through the endowed Gordon A Cain Chair in Nephrology at Baylor College of Medicine. The funding organisations had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Aguilar MI, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006186.pub2; Arnason T, 2006, THROMB RES, V118, P253, DOI 10.1016/j.thromres.2005.06.015; Bennett WM, 2006, CLIN J AM SOC NEPHRO, V1, P1357, DOI 10.2215/CJN.01700506; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; Carrero JJ, 2014, JAMA-J AM MED ASSOC, V311, P919, DOI 10.1001/jama.2014.1334; Chan KE, 2009, J AM SOC NEPHROL, V20, P2223, DOI 10.1681/ASN.2009030319; Dublin S, 2006, ARCH INTERN MED, V166, P2322, DOI 10.1001/archinte.166.21.2322; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gomes T, 2013, CAN MED ASSOC J, V185, pE121, DOI 10.1503/cmaj.121218; Harel Z, 2014, J AM SOC NEPHROL, V25, P431, DOI 10.1681/ASN.2013040361; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hijazi Z, 2014, CIRCULATION, V129, P961, DOI 10.1161/CIRCULATIONAHA.113.003628; Hohnloser SH, 2012, EUR HEART J, V33, P2821, DOI 10.1093/eurheartj/ehs274; Holden RM, 2008, CLIN J AM SOC NEPHRO, V3, P105, DOI 10.2215/CJN.01810407; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jalal DI, 2010, SEMIN THROMB HEMOST, V36, P34, DOI 10.1055/s-0030-1248722; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT, V3, P1, DOI [10.1038/kisup.2012.73, DOI 10.1038/KISUP.2012.73]; Kuo CC, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-15; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Limdi NA, 2009, J AM SOC NEPHROL, V20, P912, DOI 10.1681/ASN.2008070802; Luo JC, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.09.010; Mokrzycki MH, 2001, KIDNEY INT, V59, P1935, DOI 10.1046/j.1523-1755.2001.0590051935.x; Ng KP, 2013, AM J KIDNEY DIS, V62, P615, DOI 10.1053/j.ajkd.2013.02.381; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Pavord S, 2011, BLOOD REV, V25, P271, DOI 10.1016/j.blre.2011.07.001; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Shah M, 2014, CIRCULATION, V129, P1196, DOI 10.1161/CIRCULATIONAHA.113.004777; Smith DH, 2004, J AM SOC NEPHROL, V15, P1300, DOI 10.1097/01.ASN.0000125670.64996.BB; Statistics Canada, ETHN PORTR CAN HIGHL; Thijs A, 2008, CLIN NEPHROL, V70, P325; United States Renal Data System, 2005, 2005 ANN DAT REP ATL; Winkelmayer WC, 2011, CLIN J AM SOC NEPHRO, V6, P2662, DOI 10.2215/CJN.04550511; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	39	105	108	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2015	350								h246	10.1136/BMJ.h246	http://dx.doi.org/10.1136/BMJ.h246			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0IL	25647223	hybrid, Green Published			2022-12-28	WOS:000349309100002
J	Malem, A; Farnworth, D				Malem, Andrew; Farnworth, David			Headache, flashing lights, and blurred vision	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERTENSIVE RETINOPATHY; PATHOGENESIS		[Malem, Andrew; Farnworth, David] Queen Alexandra Hosp, Eye Dept, Portsmouth PO6 3LY, Hants, England	Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital	Malem, A (corresponding author), Queen Alexandra Hosp, Eye Dept, Portsmouth PO6 3LY, Hants, England.	andrew.malem@cantab.net						BECHGAARD P, 1956, Acta Med Scand Suppl, V312, P175; Cheung N, 2010, BRAIN, V133, P1987, DOI 10.1093/brain/awq127; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dodson PM, 1996, J HUM HYPERTENS, V10, P93; Duncan BB, 2002, BRIT J OPHTHALMOL, V86, P1002, DOI 10.1136/bjo.86.9.1002; GARNER A, 1975, BRIT J OPHTHALMOL, V59, P3, DOI 10.1136/bjo.59.1.3; KEITH NM, 1974, AM J MED SCI, V268, P336, DOI 10.1097/00000441-197412000-00004; KINCAIDSMITH P, 1958, Q J MED, V27, P117; Lane DA, 2009, AM J HYPERTENS, V22, P1199, DOI 10.1038/ajh.2009.153; McLeod D, 2005, BRIT J OPHTHALMOL, V89, P229, DOI 10.1136/bjo.2004.058347; MCLEOD D, 1977, BRIT J OPHTHALMOL, V61, P177, DOI 10.1136/bjo.61.3.177; MCRAE RP, 1986, MED CLIN N AM, V70, P749; Peacock WF, 2011, CRIT CARE, V15, DOI 10.1186/cc10289; Rodriguez MA, 2010, CARDIOL REV, V18, P102, DOI 10.1097/CRD.0b013e3181c307b7; Royal College of Ophthalmologists, 2012, DIAB RET GUID; SCHEIE HG, 1953, AMA ARCH OPHTHALMOL, V49, P117; Wong TY, 2004, NEW ENGL J MED, V351, P2310, DOI 10.1056/NEJMra032865; Zampaglione B, 1996, HYPERTENSION, V27, P144, DOI 10.1161/01.HYP.27.1.144	18	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2015	350								h446	10.1136/bmj.h446	http://dx.doi.org/10.1136/bmj.h446			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0HO	25645460				2022-12-28	WOS:000349306800002
J	Hawkes, C; Smith, TG; Jewell, J; Wardle, J; Hammond, RA; Friel, S; Thow, AM; Kain, J				Hawkes, Corinna; Smith, Trenton G.; Jewell, Jo; Wardle, Jane; Hammond, Ross A.; Friel, Sharon; Thow, Anne Marie; Kain, Juliana			Smart food policies for obesity prevention	LANCET			English	Article							FRONT-OF-PACKAGE; SCHOOL-BASED INTERVENTIONS; PHYSICAL-ACTIVITY; VEGETABLE INTAKE; EATING BEHAVIOR; PUBLIC-HEALTH; LOW-INCOME; CONSUMER PERCEPTIONS; NUTRITION EDUCATION; PARENTAL INFLUENCE	Prevention of obesity requires policies that work. In this Series paper, we propose a new way to understand how food policies could be made to work more effectively for obesity prevention. Our approach draws on evidence from a range of disciplines (psychology, economics, and public health nutrition) to develop a theory of change to understand how food policies work. We focus on one of the key determinants of obesity: diet. The evidence we review suggests that the interaction between human food preferences and the environment in which those preferences are learned, expressed, and reassessed has a central role. We identify four mechanisms through which food policies can affect diet: providing an enabling environment for learning of healthy preferences, overcoming barriers to the expression of healthy preferences, encouraging people to reassess existing unhealthy preferences at the point-of-purchase, and stimulating a food-systems response. We explore how actions in three specific policy areas (school settings, economic instruments, and nutrition labelling) work through these mechanisms, and draw implications for more effective policy design. We find that effective food-policy actions are those that lead to positive changes to food, social, and information environments and the systems that underpin them. Effective food-policy actions are tailored to the preference, behavioural, socioeconomic, and demographic characteristics of the people they seek to support, are designed to work through the mechanisms through which they have greatest effect, and are implemented as part of a combination of mutually reinforcing actions. Moving forward, priorities should include comprehensive policy actions that create an enabling environment for infants and children to learn healthy food preferences and targeted actions that enable disadvantaged populations to overcome barriers to meeting healthy preferences. Policy assessments should be carefully designed on the basis of a theory of change, using indicators of progress along the various pathways towards the long-term goal of reducing obesity rates.	[Hawkes, Corinna; Jewell, Jo] World Canc Res Fund Int, London WC1B 3HH, England; [Smith, Trenton G.] Univ Otago, Dept Econ, Dunedin, New Zealand; [Wardle, Jane] UCL, Dept Epidemiol & Publ Hlth, Hlth Behav Res Ctr, London, England; [Hammond, Ross A.] Brookings Inst, Ctr Social Dynam & Policy, Washington, DC 20036 USA; [Friel, Sharon] Australian Natl Univ, Regulatory Inst Network, Canberra, ACT, Australia; [Thow, Anne Marie] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW 2006, Australia; [Kain, Juliana] Univ Chile, Inst Nutr & Food Technol, Santiago, Chile	University of Otago; University of London; University College London; Brookings Institution; Australian National University; University of Sydney; Universidad de Chile	Hawkes, C (corresponding author), World Canc Res Fund Int, London WC1B 3HH, England.	c.hawkes@wcrf.org	Smith, Trenton/B-5449-2008	Smith, Trenton/0000-0001-6272-8871; Friel, Sharon/0000-0002-8345-5435; Jewell, Jo/0000-0001-7302-9320	National Collaborative on Childhood Obesity Research (NCCOR) Envision Project from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [1R01HD08023]; National Heart, Lung, and Blood Institute; National Institutes of Health (NIH) Office of Behavioural and Social Science Research [1R01HL115485]; Cancer Research UK; Envision Project of the National Collaborative on Childhood Obesity Research; RWJF [260639, 61468, 66284]; CDC [U48/DP00064-00S1, 1U48DP001946]; Nutrition and Obesity Policy, Research and Evaluation Network; Office of Behavioural and Social Sciences Research of NIH; Cancer Research UK [14133] Funding Source: researchfish; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001946, U48DP000064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115485] Funding Source: NIH RePORTER	National Collaborative on Childhood Obesity Research (NCCOR) Envision Project from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH) Office of Behavioural and Social Science Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Envision Project of the National Collaborative on Childhood Obesity Research; RWJF; CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Nutrition and Obesity Policy, Research and Evaluation Network; Office of Behavioural and Social Sciences Research of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	CH, TS, JJ, SF, AMT, and JK had no funding sources for the purposes of researching and writing this paper. RH is supported by the National Collaborative on Childhood Obesity Research (NCCOR) Envision Project through grant 1R01HD08023 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and by the National Heart, Lung, and Blood Institute and National Institutes of Health (NIH) Office of Behavioural and Social Science Research through grant 1R01HL115485. JW is supported by Cancer Research UK. CH and JJ attended the authors meeting, which was supported by the Envision Project of the National Collaborative on Childhood Obesity Research, which coordinates childhood obesity research across the NIH, Centers for Disease Control and Prevention (CDC), US Department of Agriculture, and the Robert Wood Johnson Foundation (RWJF). This work is supported in part by grants from RWJF (grant numbers 260639, 61468 and 66284), CDC (U48/DP00064-00S1 and 1U48DP001946), including the Nutrition and Obesity Policy, Research and Evaluation Network, and the Office of Behavioural and Social Sciences Research of NIH. The funders had no role in design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson A, 2013, PUBLIC HEALTH NUTR, V16, P968, DOI 10.1017/S1368980013000621; Alaimo K, 2013, CHILD OBES, V9, P509, DOI 10.1089/chi.2013.0052; Amaro S, 2006, EUR J PEDIATR, V165, P630, DOI 10.1007/s00431-006-0153-9; An RP, 2013, PUBLIC HEALTH NUTR, V16, P1215, DOI 10.1017/S1368980012004715; An RP, 2013, AM J HEALTH BEHAV, V37, P56, DOI 10.5993/AJHB.37.1.6; Andreyeva T, 2012, J ACAD NUTR DIET, V112, P850, DOI 10.1016/j.jand.2012.02.019; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; [Anonymous], 1983, FOOD POLICY ANAL; Backholer K, 2014, AM J PUBLIC HEALTH, V104, pE43, DOI 10.2105/AJPH.2014.302066; Bae Sang Geun, 2012, J Prev Med Public Health, V45, P47, DOI 10.3961/jpmph.2012.45.1.47; Ball K, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-86; Barosh L, 2014, AUST NZ J PUBL HEAL, V38, P7, DOI 10.1111/1753-6405.12158; Bartlett S., 2014, EVALUATION HLTH INCE; Bartlett S, 2013, AG3198D090053 USDA A; Bere E, 2010, BRIT J NUTR, V104, P589, DOI 10.1017/S0007114510000814; Birch LL, 1998, P NUTR SOC, V57, P617, DOI 10.1079/PNS19980090; Black AP, 2013, BRIT J NUTR, V110, P2309, DOI 10.1017/S0007114513001700; Black AP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1099; Bleich SN, 2014, AM J PUBLIC HEALTH, V104, P2417, DOI 10.2105/AJPH.2014.302150; Bollinger B, 2010, CALORIE POSTING CHAI; Boyland EJ, 2013, APPETITE, V62, P236, DOI 10.1016/j.appet.2012.01.032; Bronnenberg BJ, 2010, EVOLUTION BRAND PREF; Bruemmer B, 2012, J ACAD NUTR DIET, V112, P1169, DOI 10.1016/j.jand.2012.04.019; Brug J, 2008, BRIT J NUTR, V99, pS7, DOI 10.1017/S0007114508892458; Burns C, 2011, PUBLIC HEALTH NUTR, V14, P1017, DOI 10.1017/S136898001000385X; Butland BJ, 2007, FORESIGHT TACKLING O; Cairns G, 2013, APPETITE, V62, P209, DOI 10.1016/j.appet.2012.04.017; Campos S, 2011, PUBLIC HEALTH NUTR, V14, P1496, DOI 10.1017/S1368980010003290; Chandon P, 2012, NUTR REV, V70, P571, DOI 10.1111/j.1753-4887.2012.00518.x; Chen XL, 2012, PUBLIC HEALTH NUTR, V15, P760, DOI 10.1017/S1368980011002242; Chriqui JF, 2014, JAMA PEDIATR, V168, P279, DOI 10.1001/jamapediatrics.2013.4457; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christian TJ, 2012, J URBAN HEALTH, V89, P746, DOI 10.1007/s11524-012-9678-6; Cohen DA, 2012, OBES REV, V13, P766, DOI 10.1111/j.1467-789X.2012.01001.x; Contento IR, 2008, ASIA PAC J CLIN NUTR, V17, P176; Cullen KW, 2008, AM J PUBLIC HEALTH, V98, P111, DOI 10.2105/AJPH.2007.111765; de Sa J, 2008, EUR J PUBLIC HEALTH, V18, P558, DOI 10.1093/eurpub/ckn061; Dodds P, 2014, APPETITE, V73, P23, DOI 10.1016/j.appet.2013.10.013; Drewnowski A, 1999, AM J CLIN NUTR, V70, P28; Driessen CE, 2014, OBES REV, V15, P968, DOI 10.1111/obr.12224; Elbel B, 2013, OBESITY, V21, P2172, DOI 10.1002/oby.20550; Ellison B, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-21; Emrich TE, 2014, APPL PHYSIOL NUTR ME, V39, P417, DOI 10.1139/apnm-2013-0304; Epstein LH, 2012, AM J CLIN NUTR, V95, P789, DOI 10.3945/ajcn.111.024380; Epstein LH, 2010, PSYCHOL SCI, V21, P406, DOI 10.1177/0956797610361446; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; Evans CEL, 2012, AM J CLIN NUTR, V96, P889, DOI 10.3945/ajcn.111.030270; Evidence Analysis Library Division Center for Nutrition Policy and Promotion U.S. Department of Agriculture, 2012, SER SYST REV EFF NUT; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Fildes A, 2014, AM J CLIN NUTR, V99, P911, DOI 10.3945/ajcn.113.077867; Finegood D.T., 2014, HLTH BEHAV CHANGE PO, P435; Fletcher A, 2014, SOCIOLOGY, V48, P500, DOI 10.1177/0038038513500102; Francis M, 2010, PUBLIC HEALTH NUTR, V13, P738, DOI 10.1017/S1368980010000182; Gardner B., 2014, HLTH PSYCHOL REV, V8, P1, DOI DOI 10.1080/17437199.2013.876238; Gates A., 2011, The Open Nutrition Journal, V5, P1, DOI 10.2174/1874288201105010001; Gillman MW, 2013, NEW ENGL J MED, V369, P2173, DOI 10.1056/NEJMp1310577; Green R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3703; Grunert KG, 2010, J PUBLIC HEALTH-HEID, V18, P261, DOI 10.1007/s10389-009-0307-0; Hammond RA, 2014, ANN NY ACAD SCI, V1331, P34, DOI 10.1111/nyas.12344; Hammond RA, 2012, P NATL ACAD SCI USA, V109, P12356, DOI 10.1073/pnas.0913003109; Hammond RA, 2009, PREV CHRONIC DIS, V6; Hanks AS, 2012, J PUBLIC HEALTH-UK, V34, P370, DOI 10.1093/pubmed/fds003; Harris G, 2008, CURR OPIN CLIN NUTR, V11, P315, DOI 10.1097/MCO.0b013e3282f9e228; Hawkes C., 2002, GLOBALIZATION DIETS; Hawkes C, 2013, SCN NEWS, P40; Hawley KL, 2013, PUBLIC HEALTH NUTR, V16, P430, DOI 10.1017/S1368980012000754; He MZ, 2009, PUBLIC HEALTH NUTR, V12, P2199, DOI 10.1017/S1368980009005801; Hersey JC, 2013, NUTR REV, V71, P1, DOI 10.1111/nure.12000; Hoelscher DM, 2013, J ACAD NUTR DIET, V113, P1375, DOI 10.1016/j.jand.2013.08.004; Huang TT, 2009, PREV CHRONIC DIS, V6; Institute of Medicine, 2011, EARL CHILDH OB PREV; Institute of Medicine, 2012, ACC PROGR OB PREV SO; Institute of Medicine-Committee on Evaluating Progress of Obesity Prevention Efforts Food and Nutrition Board, 2013, EV OB PREV EFF PLAN; Instituto Nacional de Salud Publica, 2014, RES PREL EF IMP PES; International Agency for Research on Cancer, 2011, EFF TAX PRIC POL TOB; Jensen JD, 2013, FOOD POLICY, V42, P18, DOI 10.1016/j.foodpol.2013.06.004; Kain J, 2010, REV MED CHILE, V138, P181, DOI [10.4067/S0034-98872010000200006, /S0034-98872010000200006]; Kain J, 2009, PUBLIC HEALTH NUTR, V12, P1451, DOI 10.1017/S136898000800428X; Kiszko KM, 2014, J COMMUN HEALTH, V39, P1248, DOI 10.1007/s10900-014-9876-0; Kral TVE, 2009, J PEDIATR PSYCHOL, V34, P596, DOI 10.1093/jpepsy/jsn037; Larson N, 2012, J ACAD NUTR DIET, V112, P1216, DOI 10.1016/j.jand.2012.03.035; Ledikwe JH, 2005, J NUTR, V135, P905, DOI 10.1093/jn/135.4.905; Lee JH, 2010, J FOOD SCI, V75, pC647, DOI 10.1111/j.1750-3841.2010.01737.x; Lerner-Geva L, 2014, PUBLIC HEALTH NUTR, V12, P1; Letona P, 2014, INT J OBESITY, V38, P1466, DOI 10.1038/ijo.2014.38; Lobstein T, 2015, LANCET, V385, P2510, DOI 10.1016/S0140-6736(14)61746-3; Macdiarmid JI, 2013, APPETITE, V71, P411, DOI 10.1016/j.appet.2013.09.012; Maillot M, 2010, PUBLIC HEALTH NUTR, V13, P1178, DOI 10.1017/S1368980009993028; McClain AD, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-54; McFadden A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-148; McGinnis Michael, 2006, FOOD MARK CHILDR YOU; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Musaiger AO, 2013, SCI WORLD J, DOI 10.1155/2013/232164; National Institute for Health Development Hungary, 2013, IMP ASS PUBL HLTH PR; Neff RA, 2009, J HUNGER ENVIRON NUT, V4, P282, DOI 10.1080/19320240903337041; Ni Mhurchu C, 2010, AM J CLIN NUTR, V91, P736, DOI 10.3945/ajcn.2009.28742; Nikolaou CK, 2015, INT J OBESITY, V39, P542, DOI 10.1038/ijo.2014.162; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; Oldroyd J, 2008, J EPIDEMIOL COMMUN H, V62, P573, DOI 10.1136/jech.2007.066357; Oliver A, 2013, J SOC POLICY, V42, P685, DOI 10.1017/S0047279413000299; Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277; Reinaerts E, 2008, HEALTH EDUC RES, V23, P987, DOI 10.1093/her/cyn027; Remington A, 2012, AM J CLIN NUTR, V95, P72, DOI 10.3945/ajcn.111.024596; Reyes NR, 2013, J ACAD NUTR DIET, V113, P1175, DOI 10.1016/j.jand.2013.05.014; Richards TJ, 2007, CONTEMP ECON POLICY, V25, P309, DOI 10.1111/j.1465-7287.2007.00047.x; Roberto CA, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120015; Roberts K, 2012, STANDARDS EVALUATION; Robinson TN, 2007, ARCH PEDIAT ADOL MED, V161, P792, DOI 10.1001/archpedi.161.8.792; Rozin P., 1988, SOCIAL LEARNING PSYC, P165; Rozin P, 2006, FRONT NUTR SCI, P19, DOI 10.1079/9780851990323.0019; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Savoie N, 2013, CAN J PUBLIC HEALTH, V104, pE359, DOI 10.17269/cjph.104.4027; Sedibe HM, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-211; Shepherd J, 2006, HEALTH EDUC RES, V21, P239, DOI 10.1093/her/cyh060; Sichieri R, 2009, PUBLIC HEALTH NUTR, V12, P197, DOI 10.1017/S1368980008002644; Skouteris H, 2011, OBES REV, V12, P315, DOI 10.1111/j.1467-789X.2010.00751.x; Smed S, 2007, FOOD POLICY, V32, P624, DOI 10.1016/j.foodpol.2007.03.002; Smith TG, 2004, SOC CHOICE WELFARE, V23, P383, DOI 10.1007/s00355-003-0265-3; Sobal J, 2006, FRONT NUTR SCI, P1, DOI 10.1079/9780851990323.0001; Sonnenberg L, 2013, PREV MED, V57, P253, DOI 10.1016/j.ypmed.2013.07.001; Spence S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078298; Stein D., 2012, UNDERSTANDING THEORY; STIGLER GJ, 1977, AM ECON REV, V67, P76; Strazdins L, 2011, ENVIRON PLANN A, V43, P545, DOI 10.1068/a4360; Sturm R, 2013, AM J PREV MED, V44, P567, DOI 10.1016/j.amepre.2013.02.011; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Taber DR, 2012, ARCH PEDIAT ADOL MED, V166, P256, DOI 10.1001/archpediatrics.2011.200; Thaler RH., 2021, NUDGE FINAL EDITION; Thow AM, 2014, NUTR REV, V72, P551, DOI 10.1111/nure.12123; Triandis HC, 1911, INTERPERSONAL BEHAV; Unnevehr LJ, 2008, FOOD POLICY, V33, P497, DOI 10.1016/j.foodpol.2008.05.006; Van Cauwenberghe E, 2010, BRIT J NUTR, V103, P781, DOI 10.1017/S0007114509993370; van Stralen MM, 2011, INT J OBESITY, V35, P1251, DOI 10.1038/ijo.2011.68; Vemula SR, 2013, PUBLIC HEALTH NUTR, V17, P2104; Ventura AK, 2011, CURR OPIN CLIN NUTR, V14, P379, DOI 10.1097/MCO.0b013e328346df65; Verplanken B, 2006, J PUBLIC POLICY MARK, V25, P90, DOI 10.1509/jppm.25.1.90; Vyth EL, 2011, J AM DIET ASSOC, V111, P131, DOI 10.1016/j.jada.2010.10.003; Vyth EL, 2010, PUBLIC HEALTH NUTR, V13, P1882, DOI 10.1017/S1368980010000637; Vyth EL, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-65; Walker RE, 2010, HEALTH PLACE, V16, P876, DOI 10.1016/j.healthplace.2010.04.013; Wansink, 2006, MINDLESS EATING WHY; Wansink B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077055; Wardle J, 2008, BRIT J NUTR, V99, pS15, DOI 10.1017/S000711450889246X; Young L, 2002, HEALTH PROMOT INT, V17, P13, DOI 10.1093/heapro/17.1.13; Zeng Qingqi, 2013, Wei Sheng Yan Jiu, V42, P600; Zhen C, 2011, AM J AGR ECON, V93, P175, DOI 10.1093/ajae/aaq155	150	444	462	9	316	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2410	2421		10.1016/S0140-6736(14)61745-1	http://dx.doi.org/10.1016/S0140-6736(14)61745-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK1XV	25703109				2022-12-28	WOS:000356003700035
J	Wentzensen, N; Trabert, B				Wentzensen, Nicolas; Trabert, Britton			Hormone therapy: short-term relief, long-term consequences	LANCET			English	Editorial Material							ESTROGEN PLUS PROGESTIN; NIH-AARP DIET; OVARIAN-CANCER; UNITED-STATES; REPLACEMENT THERAPY; ENDOMETRIAL CANCER; BREAST-CANCER; HEALTH; RISK; WOMEN		[Wentzensen, Nicolas; Trabert, Britton] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wentzensen, N (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	wentzenn@mail.nih.gov	Trabert, Britton/F-8051-2015; Wentzensen, Nicolas/AAG-8522-2019	Trabert, Britton/0000-0002-1539-6090; 				Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Brinton LA, 2008, CANCER EPIDEM BIOMAR, V17, P3150, DOI 10.1158/1055-9965.EPI-08-0435; Collaborative Group on Epidemiological Studies of Ovarian Cancer, 2014, LANCET; Lacey JV, 2002, JAMA-J AM MED ASSOC, V288, P334, DOI 10.1001/jama.288.3.334; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Moyer VA, 2013, ANN INTERN MED, V158, P47, DOI 10.7326/0003-4819-158-1-201301010-00553; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Steinkellner AR, 2012, MENOPAUSE, V19, P616, DOI 10.1097/gme.0b013e31824bb039; Trabert B, 2012, BRIT J CANCER, V107, P1181, DOI 10.1038/bjc.2012.397; Trabert B, 2013, INT J CANCER, V132, P417, DOI 10.1002/ijc.27623; WEISS NS, 1976, NEW ENGL J MED, V294, P1259, DOI 10.1056/NEJM197606032942303; Yang HP, 2013, J CLIN ONCOL, V31, P2146, DOI 10.1200/JCO.2012.45.5758	12	14	15	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1806	1808		10.1016/S0140-6736(14)62458-2	http://dx.doi.org/10.1016/S0140-6736(14)62458-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6ZE	25684588	hybrid			2022-12-28	WOS:000354184500005
J	Naggie, S; Kim, AY				Naggie, Susanna; Kim, Arthur Y.			PHOTON-2: hope for patients with HIV and HCV co-infection?	LANCET			English	Editorial Material							HEPATITIS-C; SOFOSBUVIR; RIBAVIRIN		[Naggie, Susanna] Duke Clin Res Inst, Durham, NC USA; [Kim, Arthur Y.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Kim, Arthur Y.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA	Duke University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kim, AY (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	akim1@mgh.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, K23AI096913] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI064518, K23 AI096913] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AbbVie, 2014, VIEK PAK PACK INS; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; American Association for the Study of Liver Diseases and Infectious Diseases Society of America, REC TEST MAN TREAT H; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Dieterich D, 2014, CLIN INFECT DIS, V59, P1579, DOI 10.1093/cid/ciu675; Gilead Sciences, 2014, HARV PACK INS; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Molina J-M, 2015, LANCET; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734; Townsend KS, 2014, AM ASS STUD LIV DIS, P84; United States. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2013, GUID IND CHRON HEP C; Wyles D, 2014, AM ASS STUD LIV DIS, P1939	14	3	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1052	1054		10.1016/S0140-6736(15)60122-2	http://dx.doi.org/10.1016/S0140-6736(15)60122-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25659286	Green Accepted			2022-12-28	WOS:000351270400008
J	McGarr, A; Bekins, B; Burkardt, N; Dewey, J; Earle, P; Ellsworth, W; Ge, S; Hickman, S; Holland, A; Majer, E; Rubinstein, J; Sheehan, A				McGarr, A.; Bekins, B.; Burkardt, N.; Dewey, J.; Earle, P.; Ellsworth, W.; Ge, S.; Hickman, S.; Holland, A.; Majer, E.; Rubinstein, J.; Sheehan, A.			Coping with earthquakes induced by fluid injection	SCIENCE			English	Editorial Material							SEISMICITY; ARKANSAS; OKLAHOMA; SWARM		[McGarr, A.; Ellsworth, W.; Hickman, S.; Rubinstein, J.] US Geol Survey, Earthquake Sci Ctr, Menlo Pk, CA 94025 USA; [Bekins, B.] US Geol Survey, Natl Water Qual Assessment Program, Menlo Pk, CA 94025 USA; [Burkardt, N.] US Geol Survey, Powell Ctr, Ft Collins, CO 80526 USA; [Dewey, J.; Earle, P.] US Geol Survey, Geol Hazards Ctr, Golden, CO 80225 USA; [Ge, S.; Sheehan, A.] Univ Colorado, Boulder, CO 80302 USA; [Holland, A.] Oklahoma Geol Survey, Norman, OK 73069 USA; [Majer, E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	McGarr, A (corresponding author), US Geol Survey, Earthquake Sci Ctr, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	mcgarr@usgs.gov	Sheehan, Anne F/B-3954-2014	Sheehan, Anne F/0000-0002-9629-1687; Rubinstein, Justin/0000-0003-1274-6785				Cypser DA, 1994, J ENV LAW LITIG, V9, P551; Davis S. D., 1993, Seismological Research Letters, V64, P207; Deichmann N, 2009, SEISMOL RES LETT, V80, P784, DOI 10.1785/gssrl.80.5.784; Ellsworth WL, 2013, SCIENCE, V341, P142, DOI 10.1126/science.1225942; Frohlich C, 2012, P NATL ACAD SCI USA, V109, P13934, DOI 10.1073/pnas.1207728109; Gan W, 2013, P NATL ACAD SCI USA, V110, P18786, DOI 10.1073/pnas.1311316110; HAAR LC, 1984, B SEISMOL SOC AM, V74, P2463; HEALY JH, 1968, SCIENCE, V161, P1301, DOI 10.1126/science.161.3848.1301; Holland AA, 2013, B SEISMOL SOC AM, V103, P1784, DOI 10.1785/0120120109; Horton S, 2012, SEISMOL RES LETT, V83, P250, DOI 10.1785/gssrl.83.2.250; HUBBERT MK, 1959, GEOL SOC AM BULL, V70, P115; Keranen KM, 2014, SCIENCE, V345, P448, DOI 10.1126/science.1255802; Keranen K. M., 2013, GEOLOGY, V2013; Llenos AL, 2013, B SEISMOL SOC AM, V103, P2850, DOI 10.1785/0120130017; Majer EL, 2007, GEOTHERMICS, V36, P185, DOI 10.1016/j.geothermics.2007.03.003; McGarr A, 2014, J GEOPHYS RES-SOL EA, V119, P1008, DOI 10.1002/2013JB010597; Olsen, 2014, 20141091 USGS; Rubinstein J. L., 2013, AM GEOPH UN FALL M A; Rubinstein JL, 2014, B SEISMOL SOC AM, V104, P2162, DOI 10.1785/0120140009; Sperry T., 2014, GREELEY TRIBUNE 0624; Zhang YP, 2013, GROUND WATER, V51, P525, DOI 10.1111/gwat.12071; Zoback MD, 2012, P NATL ACAD SCI USA, V109, P10164, DOI 10.1073/pnas.1202473109; Zoback MD, 2012, EARTH MAGAZINE, P38	23	144	146	5	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					830	831		10.1126/science.aaa0494	http://dx.doi.org/10.1126/science.aaa0494			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700505				2022-12-28	WOS:000349761100025
J	Cheskin, LJ; Mullin, GE				Cheskin, Lawrence J.; Mullin, Gerard E.			In obesity with type 2 diabetes, duodenal-jejunal bypass liners improved weight loss and HbA(1c) during treatment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Cheskin, Lawrence J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Mullin, Gerard E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Cheskin, LJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.		Cheskin, Lawrence/AAM-1094-2021; Mullin, Gerry/H-5294-2019	Cheskin, Lawrence/0000-0003-0262-1030; Mullin, Gerry/0000-0001-5317-6788				Samaras K, 2013, DIABETOLOGIA, V56, P2564, DOI 10.1007/s00125-013-3033-7; Zechmeister-Koss I, 2014, OBES SURG, V24, P310, DOI 10.1007/s11695-013-1137-2	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4							JC9	10.7326/ACPJC-2015-162-4-009	http://dx.doi.org/10.7326/ACPJC-2015-162-4-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686196				2022-12-28	WOS:000350232500012
J	Locke, AE; Kahali, B; Berndt, SI; Justice, AE; Pers, TH; Felix, R; Powell, C; Vedantam, S; Buchkovich, ML; Yang, J; Croteau-Chonka, DC; Esko, T; Fall, T; Ferreira, T; Gustafsson, S; Kutalik, Z; Luan, JA; Magi, R; Randall, JC; Winkler, TW; Wood, AR; Workalemahu, T; Faul, JD; Smith, JA; Zhao, JH; Zhao, W; Chen, J; Fehrmann, R; Hedman, AK; Karjalainen, J; Schmidt, EM; Absher, D; Amin, N; Anderson, D; Beekman, M; Bolton, JL; Bragg-Gresham, L; Buyske, S; Demirkan, A; Deng, GH; Ehret, GB; Feenstra, B; Feitosa, MF; Fischer, K; Goel, A; Gong, J; Jackson, AU; Kanoni, S; Kleber, ME; Kristiansson, K; Lim, U; Lotay, V; Mangino, M; Leach, IM; Medina-Gomez, C; Medland, SE; Nalls, MA; Palmer, CD; Pasko, D; Pechlivanis, S; Peters, MJ; Prokopenko, I; Shungin, D; Stancakova, A; Strawbridge, RJ; Sung, YJ; Tanaka, T; Teumer, A; Trompet, S; van der Laan, SW; van Settee, J; Van Vliet-Ostaptchouk, JV; Wang, ZM; Yengo, L; Zhang, WH; Isaacs, A; Albrecht, E; Arnlov, J; Arscott, GM; Attwood, AP; Bandinelli, S; Barrett, A; Bas, IN; Bellis, C; Bennett, AJ; Berne, C; Blagieva, R; Bluher, M; Bohringer, S; Bonnycastle, LL; Bottcher, Y; Boyd, HA; Bruinenberg, M; Caspersen, IH; Chen, YD; Clarke, R; Daw, EW; de Craen, AJM; Delgado, G; Dimitriou, M; Doney, ASF; Eklund, N; Estrada, K; Eury, E; Folkersen, L; Fraser, RM; Garcia, ME; Geller, F; Giedraitis, V; Gigante, B; Go, AS; Golay, A; Goodall, AH; Gordon, SD; Gorski, M; Grabe, HJ; Grallert, H; Grammer, TB; Grassler, J; Gronberg, H; Groves, CJ; Gusto, G; Haessler, J; Hall, P; Haller, T; Hallmans, G; Hartman, CA; Hassinen, M; Hayward, C; Heard-Costa, NL; Helmer, Q; Hengstenberg, C; Holmen, O; Hottenga, JJ; James, AL; Jeff, JM; Johansson, A; Jolley, J; Juliusdottir, T; Kinnunen, L; Koenig, W; Koskenvuo, M; Kratzer, W; Laitinen, J; Lamina, C; Leander, K; Lee, NR; Lichtner, P; Lind, L; Lindstrom, J; Lo, KS; Lobbens, S; Lorbeer, R; Lu, YC; Mach, F; Magnusson, PKE; Mahajan, A; McArdle, WL; McLachlan, S; Menni, C; Merger, S; Mihailov, E; Milani, L; Moayyeri, A; Monda, KL; Morken, MA; Mulas, A; Muller, G; Muller-Nurasyid, M; Musk, AW; Nagaraja, R; Nothen, MM; Nolte, IM; Pilz, S; Rayner, NW; Renstrom, F; Rettig, R; Ried, JS; Ripke, S; Robertson, NR; Rose, LM; Sanna, S; Scharnagl, H; Scholtens, S; Schumacher, FR; Scott, WR; Seufferlein, T; Shi, JX; Smith, AV; Smolonska, J; Stanton, AV; Steinthorsdottir, V; Stirrups, K; Stringham, HM; Sundstrom, J; Swertz, MA; Swift, AJ; Syvanen, AC; Tan, ST; Tayo, BO; Thorand, B; Thorleifsson, G; Tyrer, JP; Uh, HW; Vandenput, L; Verhulst, FC; Vermeulen, SH; Verweij, N; Vonk, JM; Waite, LL; Warren, HR; Waterworth, D; Weedon, MN; Wilkens, LR; Willenborg, C; Wilsgaard, T; Wojczynski, MK; Wong, A; Wrightl, AF; Zhang, QY; Brennan, EP; Choi, M; Dastani, Z; Drong, AW; Eriksson, P; Franco-Cereceda, A; Gadin, JR; Gharavi, AG; Goddard, ME; Handsaker, RE; Huang, JY; Karpe, F; Kathiresan, S; Keildson, S; Kiryluk, K; Kubo, M; Lee, JY; Liang, L; Lifton, RP; Ma, BS; McCarroll, SA; McKnight, AJ; Min, JL; Moffatt, MF; Montgomery, GW; Murabito, JM; Nicholson, G; Nyholt, DR; Okada, Y; Perry, JRB; Dorajoo, R; Reinmaa, E; Salem, RM; Sandholm, N; Scott, RA; Stolk, L; Takahashi, A; Tanaka, T; van 't Hooft, FM; Vinkhuyzen, AAE; Westra, HJ; Zheng, W; Zondervan, KT; Heath, AC; Arveiler, D; Bakker, SJL; Beilby, J; Bergman, RN; Blangero, J; Bovet, P; Campbell, H; Caulfield, MJ; Cesana, G; Chakravarti, A; Chasman, DI; Chines, PS; Collins, FS; Crawford, DC; Cupples, LA; Cusi, D; Danesh, J; de Faire, U; den Ruijter, HM; Dominiczak, AF; Erbel, R; Erdmann, J; Eriksson, JG; Farrall, M; Felix, SB; Ferrannini, E; Ferrieres, J; Ford, I; Forouhi, NG; Forrester, T; Franco, OH; Gansevoort, RT; Gejman, PV; Gieger, C; Gottesman, O; Gudnason, V; Gyllensten, U; Hall, AS; Harris, TB; Hattersley, AT; Hicks, AA; Hindorff, LA; Hingorani, AD; Hofman, A; Homuth, G; Hovingh, GK; Humphries, SE; Hunt, SC; Hypponen, E; Illig, T; Jacobs, KB; Jarvelin, MR; Jockel, KH; Johansen, B; Jousilahti, P; Jukema, JW; Jula, AM; Kaprio, J; Kastelein, JJP; Keinanen-Kiukaanniemi, SM; Kiemeney, LA; Knekt, P; Kooner, JS; Kooperberg, C; Kovacs, P; Kraja, AT; Kumari, M; Kuusisto, J; Lakka, TA; Langenberg, C; Le Marchand, L; Lehtimaki, T; Lyssenko, V; Mannisto, S; Marette, A; Matise, TC; McKenzie, CA; McKnight, B; Moll, FL; Morris, AD; Morris, AP; Murray, JC; Nelis, M; Ohlsson, C; Oldehinkel, AJ; Ong, KK; Madden, PAF; Pasterkamp, G; Peden, JF; Peters, A; Postma, DS; Pramstaller, PP; Price, JF; Qi, L; Raitakari, OT; Rankinen, T; Rao, DC; Rice, TK; Ridker, PM; Rioux, JD; Ritchie, MD; Rudan, I; Salomaa, V; Samani, NJ; Saramines, J; Sarzynski, MA; Schunkert, H; Schwarz, PEH; Sever, P; Shuldiner, AR; Sinisalo, J; Stolk, RP; Strauch, K; Tonjes, A; Tregouet, DA; Tremblay, A; Tremoli, E; Virtamo, J; Vohl, MC; Volker, U; Waeber, G; Willemsen, G; Witteman, JC; Zillikens, MC; Adair, LS; Amouyel, P; Asselbergs, FW; Assimes, TL; Bochud, M; Boehm, BO; Boerwinkle, E; Bornstein, SR; Bottinger, EP; Bouchard, C; Cauchi, S; Chambers, JC; Chanock, SJ; Cooper, RS; de Bakker, PIW; Dedoussis, G; Ferrucci, L; Franks, PW; Froguel, P; Groop, LC; Haiman, CA; Hamsten, A; Hui, JN; Hunter, DJ; Hveem, K; Kaplan, RC; Kivimaki, M; Kuh, D; Laakso, M; Liu, YM; Martin, NG; Marz, W; Melbve, M; Metspalu, A; Moebus, S; Munroe, PB; Njolstad, I; Oostra, BA; Palmer, CNA; Pedersen, NL; Perola, M; Perusse, L; Peters, U; Power, C; Quertermous, T; Rauramaa, R; Rivadeneira, F; Saaristo, TE; Saleheen, D; Sattar, N; Schadt, EE; Schlessinger, D; Slagboom, PE; Snieder, H; Spector, TD; Thorsteinsdottir, UR; Stumvoll, M; Tuomilehto, J; Uitterlinden, AG; Uusitupa, M; van der Harst, P; Walker, M; Wallaschofski, H; Wareham, NJ; Watkins, H; Weir, DR; Wichmann, HE; Wilson, JF; Zanen, P; Borecki, IB; Deloukas, P; Fox, CS; Heid, IM; O'Connell, JR; Strachan, DP; Stefansson, K; van Duijri, CM; Abecasis, GR; Franke, L; Frayling, TM; McCarthy, MI; Visscher, PM; Scherag, A; Willer, CJ; Boehnke, M; Mohlke, KL; Lindgren, CM; Beckmann, JS; Barroso, I; North, KE; Ingelsson, E; Hirschhorn, JN; Loos, RJF; Speliotes, EK				Locke, Adam E.; Kahali, Bratati; Berndt, Sonja I.; Justice, Anne E.; Pers, Tune H.; Day, Felix R.; Powell, Corey; Vedantam, Sailaja; Buchkovich, Martin L.; Yang, Jian; Croteau-Chonka, Damien C.; Esko, Tonu; Fall, Tove; Ferreira, Teresa; Gustafsson, Stefan; Kutalik, Zoltan; Luan, Jian'an; Maegi, Reedik; Randall, Joshua C.; Winkler, Thomas W.; Wood, Andrew R.; Workalemahu, Tsegaselassie; Faul, Jessica D.; Smith, Jennifer A.; Zhao, Jing Hua; Zhao, Wei; Chen, Jin; Fehrmann, Rudolf; Hedman, Asa K.; Karjalainen, Juha; Schmidt, Ellen M.; Absher, Devin; Amin, Najaf; Anderson, Denise; Beekman, Marian; Bolton, Jennifer L.; Bragg-Gresham, L.; Buyske, Steven; Demirkan, Ayse; Deng, Guohong; Ehret, Georg B.; Feenstra, Bjarke; Feitosa, Mary F.; Fischer, Krista; Goel, Anuj; Gong, Jian; Jackson, Anne U.; Kanoni, Stavroula; Kleber, Marcus E.; Kristiansson, Kati; Lim, Unhee; Lotay, Vaneet; Mangino, Massimo; Leach, Irene Mateo; Medina-Gomez, Carolina; Medland, Sarah E.; Nalls, Michael A.; Palmer, Cameron D.; Pasko, Dorota; Pechlivanis, Sonali; Peters, Marjolein J.; Prokopenko, Inga; Shungin, Dmitry; Stancakova, Alena; Strawbridge, Rona J.; Sung, Yun Ju; Tanaka, Toshiko; Teumer, Alexander; Trompet, Stella; van der Laan, Sander W.; van Settee, Jessica; Van Vliet-Ostaptchouk, Jana V.; Wang, Zhaoming; Yengo, Loic; Zhang, Weihua; Isaacs, Aaron; Albrecht, Eva; Arnlov, Johan; Arscott, Gillian M.; Attwood, Antony P.; Bandinelli, Stefania; Barrett, Amy; Bas, Isabelita N.; Bellis, Claire; Bennett, Amanda J.; Berne, Christian; Blagieva, Roza; Blueher, Matthias; Bohringer, Stefan; Bonnycastle, Lori L.; Boettcher, Yvonne; Boyd, Heather A.; Bruinenberg, Marcel; Caspersen, Ida H.; Chen, Yii-Der Ida; Clarke, Robert; Daw, E. Warwick; de Craen, Anton J. M.; Delgado, Graciela; Dimitriou, Maria; Doney, Alex S. F.; Eklund, Niina; Estrada, Karol; Eury, Elodie; Folkersen, Lasse; Fraser, Ross M.; Garcia, Melissa E.; Geller, Frank; Giedraitis, Vilmantas; Gigante, Bruna; Go, Alan S.; Golay, Alain; Goodall, Alison H.; Gordon, Scott D.; Gorski, Mathias; Grabe, Hans-Joergen; Grallert, Harald; Grammer, Tanja B.; Graessler, Jurgen; Gronberg, Henrik; Groves, Christopher J.; Gusto, Gaeelle; Haessler, Jeffrey; Hall, Per; Haller, Toomas; Hallmans, Goran; Hartman, Catharina A.; Hassinen, Maija; Hayward, Caroline; Heard-Costa, Nancy L.; Helmer, Qinta; Hengstenberg, Christian; Holmen, Oddgeir; Hottenga, Jouke-Jan; James, Alan L.; Jeff, Janina M.; Johansson, Asa; Jolley, Jennifer; Juliusdottir, Thorhildur; Kinnunen, Leena; Koenig, Wolfgang; Koskenvuo, Markku; Kratzer, Wolfgang; Laitinen, Jaana; Lamina, Claudia; Leander, Karin; Lee, Nanette R.; Lichtner, Peter; Lind, Lars; Lindstrom, Jaana; Lo, Ken Sin; Lobbens, Stephane; Lorbeer, Roberto; Lu, Yingchang; Mach, Francois; Magnusson, Patrik K. E.; Mahajan, Anubha; McArdle, Wendy L.; McLachlan, Stela; Menni, Cristina; Merger, Sigrun; Mihailov, Evelin; Milani, Lili; Moayyeri, Alireza; Monda, Keri L.; Morken, Mario A.; Mulas, Antonella; Mueller, Gabriele; Mueller-Nurasyid, Martina; Musk, Arthur W.; Nagaraja, Ramaiah; Noethen, Markus M.; Nolte, Ilja M.; Pilz, Stefan; Rayner, Nigel W.; Renstrom, Frida; Rettig, Rainer; Ried, Janina S.; Ripke, Stephan; Robertson, Neil R.; Rose, Lynda M.; Sanna, Serena; Scharnagl, Hubert; Scholtens, Salome; Schumacher, Fredrick R.; Scott, William R.; Seufferlein, Thomas; Shi, Jianxin; Smith, Albert Vernon; Smolonska, Joanna; Stanton, Alice V.; Steinthorsdottir, Valgerdur; Stirrups, Kathleen; Stringham, Heather M.; Sundstrom, Johan; Swertz, Morris A.; Swift, Amy J.; Syvanen, Ann-Christine; Tan, Sian-Tsung; Tayo, Bamidele O.; Thorand, Barbara; Thorleifsson, Gudmar; Tyrer, Jonathan P.; Uh, Hae-Won; Vandenput, Liesbeth; Verhulst, Frank C.; Vermeulen, Sita H.; Verweij, Niek; Vonk, Judith M.; Waite, Lindsay L.; Warren, Helen R.; Waterworth, Dawn; Weedon, Michael N.; Wilkens, Lynne R.; Willenborg, Christina; Wilsgaard, Tom; Wojczynski, Mary K.; Wong, Andrew; Wrightl, Alan F.; Zhang, Qunyuan; Brennan, Eoin P.; Choi, Murim; Dastani, Zari; Drong, Alexander W.; Eriksson, Per; Franco-Cereceda, Anders; Gadin, Jesper R.; Gharavi, Ali G.; Goddard, Michael E.; Handsaker, Robert E.; Huang, Jinyan; Karpe, Fredrik; Kathiresan, Sekar; Keildson, Sarah; Kiryluk, Krzysztof; Kubo, Michiaki; Lee, Jong-Young; Liang, Liming; Lifton, Richard P.; Ma, Baoshan; McCarroll, Steven A.; McKnight, Amy J.; Min, Josine L.; Moffatt, Miriam F.; Montgomery, Grant W.; Murabito, Joanne M.; Nicholson, George; Nyholt, Dale R.; Okada, Yukinori; Perry, John R. B.; Dorajoo, Rajkumar; Reinmaa, Eva; Salem, Rany M.; Sandholm, Niina; Scott, Robert A.; Stolk, Lisette; Takahashi, Atsushi; Tanaka, Toshihiro; van 't Hooft, Ferdinand M.; Vinkhuyzen, Anna A. E.; Westra, Harm-Jan; Zheng, Wei; Zondervan, Krina T.; Heath, Andrew C.; Arveiler, Dominique; Bakker, Stephan J. L.; Beilby, John; Bergman, Richard N.; Blangero, John; Bovet, Pascal; Campbell, Harry; Caulfield, Mark J.; Cesana, Giancarlo; Chakravarti, Aravinda; Chasman, Daniel I.; Chines, Peter S.; Collins, Francis S.; Crawford, Dana C.; Cupples, L. Adrienne; Cusi, Daniele; Danesh, John; de Faire, Ulf; den Ruijter, Hester M.; Dominiczak, Anna F.; Erbel, Raimund; Erdmann, Jeanette; Eriksson, Johan G.; Farrall, Martin; Felix, Stephan B.; Ferrannini, Ele; Ferrieres, Jean; Ford, Ian; Forouhi, Nita G.; Forrester, Terrence; Franco, Oscar H.; Gansevoort, Ron T.; Gejman, Pablo V.; Gieger, Christian; Gottesman, Omri; Gudnason, Vilmundur; Gyllensten, Ulf; Hall, Alistair S.; Harris, Tamara B.; Hattersley, Andrew T.; Hicks, Andrew A.; Hindorff, Lucia A.; Hingorani, Aroon D.; Hofman, Albert; Homuth, Georg; Hovingh, G. Kees; Humphries, Steve E.; Hunt, Steven C.; Hypponen, Elina; Illig, Thomas; Jacobs, Kevin B.; Jarvelin, Marjo-Riitta; Joeckel, Karl-Heinz; Johansen, Berit; Jousilahti, Pekka; Jukema, J. Wouter; Jula, Antti M.; Kaprio, Jaakko; Kastelein, John J. P.; Keinanen-Kiukaanniemi, Sirkka M.; Kiemeney, Lambertus A.; Knekt, Paul; Kooner, Jaspal S.; Kooperberg, Charles; Kovacs, Peter; Kraja, Aldi T.; Kumari, Meena; Kuusisto, Johanna; Lakka, Timo A.; Langenberg, Claudia; Le Marchand, Laic; Lehtimaki, Terho; Lyssenko, Valeriya; Mannisto, Satu; Marette, Andre; Matise, Tara C.; McKenzie, Colin A.; McKnight, Barbara; Moll, Frans L.; Morris, Andrew D.; Morris, Andrew P.; Murray, Jeffrey C.; Nelis, Mari; Ohlsson, Claes; Oldehinkel, Albertine J.; Ong, Ken K.; Madden, Pamela A. F.; Pasterkamp, Gerard; Peden, John F.; Peters, Annette; Postma, Dirkje S.; Pramstaller, Peter P.; Price, Jackie F.; Qi, Lu; Raitakari, Olli T.; Rankinen, Tuomo; Rao, D. C.; Rice, Treva K.; Ridker, Paul M.; Rioux, John D.; Ritchie, Marylyn D.; Rudan, Igor; Salomaa, Veikko; Samani, Nilesh J.; Saramines, Jouko; Sarzynski, Mark A.; Schunkert, Heribert; Schwarz, Peter E. H.; Sever, Peter; Shuldiner, Alan R.; Sinisalo, Juha; Stolk, Ronald P.; Strauch, Konstantin; Toenjes, Anke; Tregouet, David-Alexandre; Tremblay, Angelo; Tremoli, Elena; Virtamo, Jarmo; Vohl, Marie-Claude; Voelker, Uwe; Waeber, Gerard; Willemsen, Gonneke; Witteman, Jacqueline C.; Zillikens, M. Carola; Adair, Linda S.; Amouyel, Philippe; Asselbergs, Folkert W.; Assimes, Themistocles L.; Bochud, Murielle; Boehm, Bernhard O.; Boerwinkle, Eric; Bornstein, Stefan R.; Bottinger, Erwin P.; Bouchard, Claude; Cauchi, Stephane; Chambers, John C.; Chanock, Stephen J.; Cooper, Richard S.; de Bakker, Paul I. W.; Dedoussis, George; Ferrucci, Luigi; Franks, Paul W.; Froguel, Philippe; Groop, Leif C.; Haiman, Christopher A.; Hamsten, Anders; Hui, Jennie; Hunter, David J.; Hveem, Kristian; Kaplan, Robert C.; Kivimaki, Mika; Kuh, Diana; Laakso, Markku; Liu, Yongmei; Martin, Nicholas G.; Maerz, Winfried; Melbve, Mads; Metspalu, Andres; Moebus, Susanne; Munroe, Patricia B.; Njolstad, Inger; Oostra, Ben A.; Palmer, Colin N. A.; Pedersen, Nancy L.; Perola, Markus; Perusse, Louis; Peters, Ulrike; Power, Chris; Quertermous, Thomas; Rauramaa, Rainer; Rivadeneira, Fernando; Saaristo, Timo E.; Saleheen, Danish; Sattar, Naveed; Schadt, Eric E.; Schlessinger, David; Slagboom, P. Eline; Snieder, Harold; Spector, Tim D.; Thorsteinsdottir, Unnu R.; Stumvoll, Michael; Tuomilehto, Jaakko; Uitterlinden, Andre G.; Uusitupa, Matti; van der Harst, Pim; Walker, Mark; Wallaschofski, Henri; Wareham, Nicholas J.; Watkins, Hugh; Weir, David R.; Wichmann, H-Erich; Wilson, James F.; Zanen, Pieter; Borecki, Ingrid B.; Deloukas, Panos; Fox, Caroline S.; Heid, Iris M.; O'Connell, Jeffrey R.; Strachan, David P.; Stefansson, Kari; van Duijri, Cornelia M.; Abecasis, Goncalo R.; Franke, Lude; Frayling, Timothy M.; McCarthy, Mark I.; Visscher, Peter M.; Scherag, Andre; Willer, Cristen J.; Boehnke, Michael; Mohlke, Karen L.; Lindgren, Cecilia M.; Beckmann, Jacques S.; Barroso, Ines; North, Kari E.; Ingelsson, Erik; Hirschhorn, Joel N.; Loos, Ruth J. F.; Speliotes, Elizabeth K.		LifeLines Cohort Study; ADIPOGen Consortium; AGEN-BMI Working Grp; CARDIOGRAMplusC4D Consortium; CKDGen Consortium; GLGC; ICBP; MAGIC Investigators; MuTHER Consortium; MIGen Consortium; PAGE Consortium; ReproGen Consortium; GENIE Consortium; Int Endogene Consortium	Genetic studies of body mass index yield new insights for obesity biology	NATURE			English	Article							GENOME-WIDE ASSOCIATION; PROVIDES INSIGHTS; GLYCEMIC TRAITS; LOCI; METAANALYSIS; VARIANTS; INDIVIDUALS; HIPPOCAMPAL; ARCHITECTURE; TOPIRAMATE	Obesity is heritable and predisposes to many diseases. To understand the genetic basis of obesity better, here we conduct a genome-wide association study and Metabochip meta-analysis of body mass index (BMI), a measure commonly used to define obesity and assess adiposity, in upto 339,224 individuals. This analysis identifies 97 BMI-associated loci (P < 5 x 10(-8)), 56 of which are novel. Five loci demonstrate clear evidence of several independent association signals, and many loci have significant effects on other metabolic phenotypes. The 97 loci account for similar to 2.7% of BMI variation, and genome-wide estimates suggest that common variation accounts for >20% of BMI variation. Pathway analyses provide strong support for a role of the central nervous systemin obesity susceptibility and implicate new genes and pathways, including those related to synaptic function, glutamate signalling, insulin secretion/action, energy metabolism, lipid biology and adipogenesis.	[Locke, Adam E.; Bragg-Gresham, L.; Jackson, Anne U.; Stringham, Heather M.; Abecasis, Goncalo R.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Kahali, Bratati; Powell, Corey; Speliotes, Elizabeth K.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Kahali, Bratati; Powell, Corey; Speliotes, Elizabeth K.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Berndt, Sonja I.; Wang, Zhaoming; Jacobs, Kevin B.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Justice, Anne E.; Monda, Keri L.; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Pers, Tune H.; Vedantam, Sailaja; Esko, Tonu; Palmer, Cameron D.; Salem, Rany M.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Pers, Tune H.; Vedantam, Sailaja; Esko, Tonu; Palmer, Cameron D.; Salem, Rany M.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Pers, Tune H.; Vedantam, Sailaja; Esko, Tonu; Palmer, Cameron D.; Salem, Rany M.; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Pers, Tune H.; Vedantam, Sailaja; Esko, Tonu; Palmer, Cameron D.; Estrada, Karol; Handsaker, Robert E.; Kathiresan, Sekar; McCarroll, Steven A.; Salem, Rany M.; Lindgren, Cecilia M.; Hirschhorn, Joel N.] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA 02142 USA; [Pers, Tune H.; Esko, Tonu; Handsaker, Robert E.; McCarroll, Steven A.; Salem, Rany M.; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Pers, Tune H.] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Day, Felix R.; Luan, Jian'an; Zhao, Jing Hua; Scott, Robert A.; Forouhi, Nita G.; Langenberg, Claudia; Ong, Ken K.; Wareham, Nicholas J.; Loos, Ruth J. F.] Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Inst Metab Sci, Cambridge CB2 0QQ, England; [Buchkovich, Martin L.; Croteau-Chonka, Damien C.; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Yang, Jian; Vinkhuyzen, Anna A. E.; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4012, Australia; [Croteau-Chonka, Damien C.; Qi, Lu; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Esko, Tonu; Maegi, Reedik; Fischer, Krista; Haller, Toomas; Mihailov, Evelin; Milani, Lili; Reinmaa, Eva; Morris, Andrew P.; Nelis, Mari; Metspalu, Andres; Perola, Markus] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Fall, Tove; Gronberg, Henrik; Hall, Per; Magnusson, Patrik K. E.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Fall, Tove; Gustafsson, Stefan; Hedman, Asa K.; Arnlov, Johan; Syvanen, Ann-Christine; Ingelsson, Erik] Uppsala Univ, Sci Life Lab, S-75185 Uppsala, Sweden; [Fall, Tove; Gustafsson, Stefan; Hedman, Asa K.; Arnlov, Johan; Ingelsson, Erik] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden; [Ferreira, Teresa; Maegi, Reedik; Randall, Joshua C.; Hedman, Asa K.; Goel, Anuj; Prokopenko, Inga; Juliusdottir, Thorhildur; Mahajan, Anubha; Rayner, Nigel W.; Robertson, Neil R.; Drong, Alexander W.; Keildson, Sarah; Perry, John R. B.; Zondervan, Krina T.; Farrall, Martin; Morris, Andrew P.; Watkins, Hugh; McCarthy, Mark I.; Lindgren, Cecilia M.; Ingelsson, Erik] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Kutalik, Zoltan] CHU Vaudois, Inst Social & Prevent Med IUMSP, CH-1010 Lausanne, Switzerland; [Kutalik, Zoltan; Beckmann, Jacques S.] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Kutalik, Zoltan; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Randall, Joshua C.; Rayner, Nigel W.; Stirrups, Kathleen; Deloukas, Panos; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Winkler, Thomas W.; Gorski, Mathias; Heid, Iris M.] Univ Regensburg, Inst Epidemiol & Prevent Med, Dept Genet Epidemiol, D-93053 Regensburg, Germany; [Wood, Andrew R.; Pasko, Dorota; Weedon, Michael N.; Perry, John R. B.; Frayling, Timothy M.] Univ Exeter, Univ Exeter Med Sch, Exeter EX1 2LU, Devon, England; [Workalemahu, Tsegaselassie; Qi, Lu; Franks, Paul W.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Faul, Jessica D.; Weir, David R.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI 48104 USA; [Smith, Jennifer A.; Zhao, Wei] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Chen, Jin; Willer, Cristen J.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Fehrmann, Rudolf; Karjalainen, Juha; Smolonska, Joanna; Swertz, Morris A.; Westra, Harm-Jan; van der Harst, Pim; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Schmidt, Ellen M.; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Absher, Devin; Waite, Lindsay L.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Amin, Najaf; Demirkan, Ayse; Isaacs, Aaron; Oostra, Ben A.; van Duijri, Cornelia M.] Erasmus MC Univ Med Ctr, Dept Epidemiol, Genet Epidemiol Unit, NL-3015 GE Rotterdam, Netherlands; [Anderson, Denise] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6008, Australia; [Beekman, Marian; Bohringer, Stefan; Helmer, Qinta; Uh, Hae-Won; Stolk, Lisette; Slagboom, P. Eline] Leiden Univ, Med Ctr, NCHA, NL-2300 RC Leiden, Netherlands; [Beekman, Marian; Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Mol Epidemiol, NL-2300 RC Leiden, Netherlands; [Bolton, Jennifer L.; Fraser, Ross M.; McLachlan, Stela; Campbell, Harry; Price, Jackie F.; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Bragg-Gresham, L.] Univ Michigan, Kidney Epidemiol & Cost Ctr, Ann Arbor, MI 48109 USA; [Buyske, Steven] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ 08854 USA; [Buyske, Steven; Matise, Tara C.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Demirkan, Ayse] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZC Leiden, Netherlands; [Deng, Guohong; Zhang, Weihua; Scott, William R.; Tan, Sian-Tsung; Kooner, Jaspal S.; Chambers, John C.] Ealing Hosp NHS Trust, Southall UB1 3HW, Middx, England; [Deng, Guohong] Univ London Imperial Coll Sci Technol & Med, Dept Gastroenterol & Hepatol, London W2 1PG, England; [Deng, Guohong] Third Mil Med Univ, Southwest Hosp, Inst Infect Dis, Chongqing, Peoples R China; [Ehret, Georg B.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA; [Ehret, Georg B.; Mach, Francois] Univ Hosp Geneva, Dept Specialties Internal Med, CH-1211 Geneva, Switzerland; [Feenstra, Bjarke; Boyd, Heather A.; Geller, Frank] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Feitosa, Mary F.; Daw, E. Warwick; Wojczynski, Mary K.; Zhang, Qunyuan; Kraja, Aldi T.; Rao, D. C.; Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Goel, Anuj; Farrall, Martin; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovacular Med, Oxford OX3 9DU, England; [Gong, Jian; Haessler, Jeffrey; Kooperberg, Charles; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Kanoni, Stavroula; Stirrups, Kathleen; Deloukas, Panos] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Kleber, Marcus E.; Delgado, Graciela; Grammer, Tanja B.; Maerz, Winfried] Heidelberg Univ, Dept Med Nephrol Hypertensiol Endocrinol Diabetol, Med Fac Mannheim, D-68187 Mannheim, Germany; [Kleber, Marcus E.; Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med 2, D-89081 Ulm, Germany; [Kristiansson, Kati; Eklund, Niina; Kinnunen, Leena; Lindstrom, Jaana; Eriksson, Johan G.; Jousilahti, Pekka; Jula, Antti M.; Kaprio, Jaakko; Knekt, Paul; Mannisto, Satu; Salomaa, Veikko; Virtamo, Jarmo; Perola, Markus; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, FI-00271 Helsinki, Finland; [Lim, Unhee; Wilkens, Lynne R.; Le Marchand, Laic] Univ Hawaii, Program Epidemiol, Ctr Canc, Honolulu, HI 96813 USA; [Lotay, Vaneet; Jeff, Janina M.; Lu, Yingchang; Gottesman, Omri; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Mangino, Massimo; Menni, Cristina; Moayyeri, Alireza; Perry, John R. B.; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Leach, Irene Mateo; Verweij, Niek; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [Medina-Gomez, Carolina; Peters, Marjolein J.; Franco, Oscar H.; Hofman, Albert; Zillikens, M. Carola; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Duijri, Cornelia M.] NCHA, NL-3015 GE Rotterdam, Netherlands; [Medina-Gomez, Carolina; Franco, Oscar H.; Hofman, Albert; Witteman, Jacqueline C.; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Duijri, Cornelia M.] Erasmus MC Univ Med Ctr, Dept Epidemiol, NL-3015 GE Rotterdam, Netherlands; [Medina-Gomez, Carolina; Peters, Marjolein J.; Estrada, Karol; Stolk, Lisette; Zillikens, M. Carola; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC Univ Med Ctr, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Medland, Sarah E.; Gordon, Scott D.; Montgomery, Grant W.; Nyholt, Dale R.; Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Nalls, Michael A.] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Pechlivanis, Sonali; Joeckel, Karl-Heinz; Moebus, Susanne; Scherag, Andre] Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol IMIBE, D-45147 Essen, Germany; [Prokopenko, Inga; Barrett, Amy; Bennett, Amanda J.; Groves, Christopher J.; Rayner, Nigel W.; Robertson, Neil R.; Karpe, Fredrik; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Prokopenko, Inga; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London W12 0NN, England; [Shungin, Dmitry; Renstrom, Frida; Franks, Paul W.] Skane Univ Hosp, Dept Clin Sci, Genet & Mol Epidemiol Unit, S-20502 Malmo, Sweden; [Shungin, Dmitry; Franks, Paul W.] Umea Univ, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden; [Shungin, Dmitry] Umea Univ, Dept Odontol, S-90185 Umea, Sweden; [Stancakova, Alena] Univ Eastern Finland, FI-70210 Kuopio, Finland; [Strawbridge, Rona J.; Folkersen, Lasse; Eriksson, Per; Gadin, Jesper R.; van 't Hooft, Ferdinand M.; Hamsten, Anders] Karolinska Inst, Dept Med, Ctr Mol Med, Atherosclerosis Res Unit, S-17176 Stockholm, Sweden; [Sung, Yun Ju; Rao, D. C.; Rice, Treva K.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Translat Gerontol Branch, Baltimore, MD 21225 USA; [Teumer, Alexander; Homuth, Georg; Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, D-17475 Greifswald, Germany; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands; [Trompet, Stella; de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, NL-2300 RC Leiden, Netherlands; [van der Laan, Sander W.; den Ruijter, Hester M.; Pasterkamp, Gerard] Univ Med Ctr Utrecht, Div Heart & Lungs, Expt Cardiol Lab, NL-3584 CX Utrecht, Netherlands; [van Settee, Jessica; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Van Vliet-Ostaptchouk, Jana V.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands; [Wang, Zhaoming; Jacobs, Kevin B.] NCI, Core Genotyping Facil, SAIC Frederick Inc, Frederick, MD 21702 USA; [Yengo, Loic; Eury, Elodie; Lobbens, Stephane; Smith, Albert Vernon; Cauchi, Stephane; Froguel, Philippe] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8199, F-59019 Lille, France; [Yengo, Loic; Eury, Elodie; Lobbens, Stephane; Smith, Albert Vernon; Cauchi, Stephane; Froguel, Philippe] European Genom Inst Diabet, F-59000 Lille, France; [Yengo, Loic; Eury, Elodie; Lobbens, Stephane; Cauchi, Stephane; Froguel, Philippe] Univ Lille 2, F-59000 Lille, France; [Zhang, Weihua; Scott, William R.; Jarvelin, Marjo-Riitta; Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Isaacs, Aaron; Oostra, Ben A.; van Duijri, Cornelia M.] Ctr Med Sytems Biol, NL-2300 RC Leiden, Netherlands; [Albrecht, Eva; Grallert, Harald; Mueller-Nurasyid, Martina; Ried, Janina S.; Gieger, Christian; Strauch, Konstantin; Heid, Iris M.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Studies, SE-79188 Falun, Sweden; [Arscott, Gillian M.; Beilby, John; Hui, Jennie] PathWest Lab Med Western Australia, Nedlands, WA 6009, Australia; [Attwood, Antony P.; Jolley, Jennifer] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Attwood, Antony P.; Jolley, Jennifer] NHS Blood & Transplant, Cambridge CB2 0PT, England; [Bandinelli, Stefania] ASF, Geriatr Unit, I-50125 Florence, Italy; [Bas, Isabelita N.; Lee, Nanette R.] Univ San Carlos, USC Off Populat Studies Fdn Inc, Cebu 6000, Philippines; [Bellis, Claire; Blangero, John] Texas Biomed Res Inst, Dept Genet, San Antonio, TX 78227 USA; [Bellis, Claire] Queensland Univ Technol, Genom Res Ctr, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Berne, Christian] Uppsala Univ, Dept Med Sci Endocrinol Diabet & Metab, S-75185 Uppsala, Sweden; [Blagieva, Roza; Merger, Sigrun] Univ Ulm, Med Ctr, Div Endocrinol Diabet & Metab, D-89081 Ulm, Germany; [Blueher, Matthias; Boettcher, Yvonne; Kovacs, Peter; Stumvoll, Michael] Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04103 Leipzig, Germany; [Blueher, Matthias; Kovacs, Peter; Stumvoll, Michael] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Bohringer, Stefan; Helmer, Qinta; Uh, Hae-Won] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, NL-2300 RC Leiden, Netherlands; [Bonnycastle, Lori L.; Morken, Mario A.; Swift, Amy J.; Chines, Peter S.; Collins, Francis S.] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Bruinenberg, Marcel; Scholtens, Salome] Univ Groningen, Univ Med Ctr Groningen, LifeLines Cohort Study, NL-9700 RB Groningen, Netherlands; [Caspersen, Ida H.; Johansen, Berit] Norwegian Univ Sci & Technol, Dept Biol, N-7491 Trondheim, Norway; [Chen, Yii-Der Ida] Univ Calif Los Angeles, Dept Pediat, Torrance, CA 90502 USA; [Chen, Yii-Der Ida] Los Angeles Biomed Res Inst, Transgen Inst, Torrance, CA 90502 USA; [Clarke, Robert] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Clarke, Robert] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford OX3 7LF, England; [Dimitriou, Maria; Dedoussis, George] Harokopio Univ, Dept Dietet Nutr, Athens 17671, Greece; [Doney, Alex S. F.; Morris, Andrew D.; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Eklund, Niina; Kaprio, Jaakko; Groop, Leif C.; Perola, Markus] Univ Helsinki, Inst Mol Med, FI-00014 Helsinki, Finland; [Estrada, Karol; Ripke, Stephan] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Estrada, Karol; Ripke, Stephan] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Garcia, Melissa E.; Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, NIH, Bethesda, MD 20892 USA; [Giedraitis, Vilmantas] Uppsala Univ, Dept Publ Hlth & Caring Sci, S-75185 Uppsala, Sweden; [Gigante, Bruna; Leander, Karin; de Faire, Ulf] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-17177 Stockholm, Sweden; [Go, Alan S.] Kaiser Permanente, Div Res, Oakland, CA 94612 USA; [Golay, Alain] Univ Hosp Geneva, Serv Therapeut Educ Diabet Obes & Chron Dis, CH-1211 Geneva, Switzerland; [Goodall, Alison H.; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Goodall, Alison H.; Samani, Nilesh J.] Glenfield Gen Hosp, NIHR, Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Gorski, Mathias] Univ Hosp Regensburg, Dept Nephrol, D-93053 Regensburg, Germany; [Grabe, Hans-Joergen] HELIOS Hosp Stralsund, Univ Med Greifswald, Dept Psychiat & Psychotherapy, D-17475 Greifswald, Germany; [Grabe, Hans-Joergen] German Ctr Neurodegenerat Dis DZNE, D-17475 Greifswald, Germany; [Grallert, Harald; Illig, Thomas; Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Grallert, Harald; Thorand, Barbara] German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany; [Graessler, Jurgen; Schwarz, Peter E. H.; Bornstein, Stefan R.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Med 3, D-01307 Dresden, Germany; [Gusto, Gaeelle] Inst Inter Reg Sante, F-37520 La Riche, France; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Unit Nutr Res, S-90187 Umea, Sweden; [Hartman, Catharina A.; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 RB Groningen, Netherlands; [Hassinen, Maija; Lakka, Timo A.; Rauramaa, Rainer] Kuoplo Res Inst Exercise Med, Kuopio 70100, Finland; [Hayward, Caroline; Wrightl, Alan F.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Heard-Costa, Nancy L.; Murabito, Joanne M.; Cupples, L. Adrienne; Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Heard-Costa, Nancy L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Helmer, Qinta] Vrije Univ Amsterdam, Fac Psychol & Educ, NL-1081 BT Amsterdam, Netherlands; [Hengstenberg, Christian; Mueller-Nurasyid, Martina; Peters, Annette; Schunkert, Heribert] Munich Heart Alliance, German Res Ctr Cardiovasc Res, Deutsch Forschungszentrum Herz Kreislauferkrankun, D-80636 Munich, Germany; [Hengstenberg, Christian; Schunkert, Heribert] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80636 Munich, Germany; [Holmen, Oddgeir; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7489 Trondheim, Norway; [Hottenga, Jouke-Jan; Willemsen, Gonneke] Vrije Univ Amsterdam, NL-1081 BT Amsterdam, Netherlands; [James, Alan L.] Dept Pulm Physiol & Sleep Med, Nedlands, WA 6009, Australia; [Johansson, Asa; Gyllensten, Ulf] Univ Western Australia, Sch Med & Pharmacol, Crawley 6009, Australia; [Johansson, Asa; Gyllensten, Ulf] Uppsala Univ, Dept Immunol, SciLifeLab, Rudbeck Lab, SE-75185 Uppsala, Sweden; [Koskenvuo, Markku; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, FI-00014 Helsinki, Finland; [Kratzer, Wolfgang; Seufferlein, Thomas] Univ Ulm, Med Ctr, Dept Internal Med 1, D-89081 Ulm, Germany; [Laitinen, Jaana] Finnish Inst Occupat Hlth, FI-90100 Oulu, Finland; [Lamina, Claudia] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Lichtner, Peter] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; [Lind, Lars; Sundstrom, Johan] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden; [Lo, Ken Sin; Rioux, John D.] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lorbeer, Roberto] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Lu, Yingchang; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [McArdle, Wendy L.; Min, Josine L.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Mihailov, Evelin; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Moayyeri, Alireza] UCL, Farr Inst Hlth Informat Res, London NW1 2DA, England; [Monda, Keri L.] Amgen Inc, Ctr Observat Res, Newbury Pk, CA 91320 USA; [Mulas, Antonella; Sanna, Serena] CNR, IRGB, I-09042 Cagliari, Sardinia, Italy; [Mueller, Gabriele] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Ctr Evidence Based Healthcare, D-01307 Dresden, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, D-81377 Munich, Germany; [Mueller-Nurasyid, Martina; Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Musk, Arthur W.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Nagaraja, Ramaiah; Schlessinger, David] NIA, Lab Genet, Baltimore, MD 21224 USA; [Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Nolte, Ilja M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Pilz, Stefan] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Inst Res Extramural Med, Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands; [Pilz, Stefan] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, A-8036 Graz, Austria; [Rettig, Rainer] Univ Med Greifswald, Inst Physiol, D-17495 Karlsburg, Germany; [Ripke, Stephan; McCarroll, Steven A.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Rose, Lynda M.; Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Scharnagl, Hubert; Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria; [Schumacher, Fredrick R.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Shi, Jianxin] NCI, Bethesda, MD 20892 USA; [Smith, Albert Vernon; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert Vernon; Gudnason, Vilmundur] Univ Iceland, IS-101 Reykjavik, Iceland; [Smolonska, Joanna; Vonk, Judith M.; Stolk, Ronald P.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Stanton, Alice V.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Thorsteinsdottir, Unnu R.; Stefansson, Kari] Amgen Inc, deCODE Genet, IS-101 Reykjavik, Iceland; [Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, S-75144 Uppsala, Sweden; [Tan, Sian-Tsung; Moffatt, Miriam F.; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Tayo, Bamidele O.; Cooper, Richard S.] Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL 61053 USA; [Thorand, Barbara; Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, German Res Ctr Environm Hlth, D-85764 Neuherberg, Germany; [Tyrer, Jonathan P.] Univ Cambridge, Dept Oncol, Cambridge CB2 0QQ, England; [Tyrer, Jonathan P.] Univ Gothenburg, Ctr Bone & Arthrit Res, Dept Internal Med & Clin Nutr, Inst Med,Sahlgrenska Acad, S-41345 Gothenburg, Sweden; [Verhulst, Frank C.] Erasmus MC Univ Med Ctr, Dept Child & Adolescent Psychiat Psychol, NL-3000 CB Rotterdam, Netherlands; [Vermeulen, Sita H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6500 HB Nijmegen, Netherlands; [Vermeulen, Sita H.] Radboud Univ Nijmegen, Med Ctr, Dept Genet, NL-6500 HB Nijmegen, Netherlands; [Warren, Helen R.; Caulfield, Mark J.; Munroe, Patricia B.] Queen Mary Univ London, Dept Clin Pharmacol, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Waterworth, Dawn] GlaxoSmithKline, Genet, King Of Prussia, PA 19406 USA; [Willenborg, Christina; Erdmann, Jeanette] Partner Site Hamburg Lubeck Kiel, German Ctr Cardiovasc Res, D-23562 Lubeck, Germany; [Willenborg, Christina; Erdmann, Jeanette] Med Univ Lubeck, Inst Integrat & Expt Genom, D-23562 Lubeck, Germany; [Wilsgaard, Tom; Njolstad, Inger] UiT, Fac Hlth Sci, Dept Community Med, N-9037 Tromso, Norway; [Wong, Andrew; Ong, Ken K.; Kuh, Diana] UCL, MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England; [Brennan, Eoin P.] Natl Univ Ireland Univ Coll Dublin, Sch Med & Med Sci, Diabet Complicat Res Ctr, Conway Inst, Dublin 4, Ireland; [Choi, Murim] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Dastani, Zari] McGill Univ, Lady Davis Inst, Dept Human Genet, Montreal, PQ H3T 1E2, Canada; [Dastani, Zari] McGill Univ, Lady Davis Inst, Dept Epidemiol, Montreal, PQ H3T 1E2, Canada; [Dastani, Zari] McGill Univ, Lady Davis Inst, Dept Biostat, Montreal, PQ H3T 1E2, Canada; [Franco-Cereceda, Anders] Karolinska Inst, Cardiothoracic Surg Unit, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Gharavi, Ali G.; Kiryluk, Krzysztof] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Bundoora, Vic 3083, Australia; [Goddard, Michael E.] Univ Melbourne, Dept Food & Agr Syst, Melbourne, Vic 3010, Australia; [Huang, Jinyan; Liang, Liming; Ma, Baoshan; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Huang, Jinyan] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Shanghai Inst Hematol, Rui Jin Hosp,Sch Med, Shanghai 200030, Peoples R China; [Karpe, Fredrik] OUH Trust, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LE, England; [Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA USA; [Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa 2300045, Japan; [Lee, Jong-Young] Natl Inst Hlth, Ctr Genome Sci, Chungcheongbuk Do 363951, Chungbuk, South Korea; [Liang, Liming] Harvard Univ, Dept Biostat, Harvard Sch Publ Hlth, Boston, MA 02115 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06520 USA; [Ma, Baoshan] Dalian Maritime Univ, Coll Informat Sci & Technol, Dalian 116026, Liaoning, Peoples R China; [McKnight, Amy J.] Queens Univ Belfast, Ctr Publ Hlth, Belfast BT9 7AB, Down, North Ireland; [Murabito, Joanne M.] Boston Univ, Sch Med, Sect Gen Internal Med, Boston, MA 02118 USA; [Nicholson, George] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Nicholson, George] MRC Harwell, Harwell OX11 0QG, Berks, England; [Nyholt, Dale R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Okada, Yukinori; Takahashi, Atsushi] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa 2300045, Japan; [Okada, Yukinori; Tanaka, Toshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo 1138510, Japan; [Dorajoo, Rajkumar] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore; [Sandholm, Niina] Aalto Univ, Dept Biomed Engn & Computat Sci, Sch Sci, FI-00076 Helsinki, Finland; [Sandholm, Niina] Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, FI-00290 Helsinki, Finland; [Sandholm, Niina] Folkhalsan Res Ctr, Folkhalsan Inst Genet, FI-00290 Helsinki, Finland; [Tanaka, Toshihiro] RIKEN Ctr Integrat Med Sci, Lab Cardiovasc Dis, Yokohama, Kanagawa 2300045, Japan; [Tanaka, Toshihiro] Tokyo Med & Dent Univ, Bioresource Res Ctr, Div Dis Divers, Tokyo 1138510, Japan; [Zheng, Wei] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN 37075 USA; [Zheng, Wei] Vanderbilt Univ, Med Ctr, Vanderbilt Epidemiol Ctr, Nashville, TN 37075 USA; [Zheng, Wei] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37075 USA; [Zondervan, Krina T.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford OX3 7BN, England; [Heath, Andrew C.; Madden, Pamela A. F.; Rao, D. C.; Rice, Treva K.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Arveiler, Dominique] Univ Strasbourg, Fac Med, Dept Epidemiol & Publ Hlth, EA3430, Strasbourg, France; [Bakker, Stephan J. L.; Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands; [Beilby, John; Hui, Jennie] Univ Western Australia, Nedlands, WA 6009, Australia; [Bergman, Richard N.] Cedars Sinai Diabet & Obes Res Inst, Los Angeles, CA 90048 USA; [Bovet, Pascal; Bochud, Murielle] CHU Vaudois, Inst Social & Prevent Med IUMSP, CH-1010 Lausanne, Switzerland; [Bovet, Pascal; Bochud, Murielle] Univ Lausanne, CH-1010 Lausanne, Switzerland; [Bovet, Pascal; Bochud, Murielle] Minist Hlth, Victoria, Seychelles; [Cesana, Giancarlo] Univ Milan, I-20126 Bicocca, Italy; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Crawford, Dana C.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37203 USA; [Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Cusi, Daniele] Univ Milan, Dept Hlth Sci, I-20142 Milan, Italy; [Cusi, Daniele] Fdn Filarete, I-20139 Milan, Italy; [Danesh, John; Saleheen, Danish] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [den Ruijter, Hester M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands; [Dominiczak, Anna F.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Erbel, Raimund] Univ Hosp Essen, Clin Cardiol, West German Heart Ctr, D-45147 Essen, Germany; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, FI-00290 Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, FIN-00290 Helsinki, Finland; [Felix, Stephan B.] Univ Med Greifswald, Dept Internal Med B, D-17475 Greifswald, Germany; [Felix, Stephan B.; Voelker, Uwe; Wallaschofski, Henri] Partner Site Greifswald, DZHK, D-17475 Greifswald, Germany; [Ferrannini, Ele] Univ Pisa, Dept Internal Med, I-56100 Pisa, Italy; [Ferrannini, Ele] Univ Pisa, Inst Clin Physiol, Natl Res Council, I-56124 Pisa, Italy; [Ferrieres, Jean] Toulouse Univ, Sch Med, Ranguell Hosp, Dept Cardiol, F-31400 Toulouse, France; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland; [Forrester, Terrence; McKenzie, Colin A.] Univ W Indies, UWI Solut Developing Countries, Kingston 7, Jamaica; [Gejman, Pablo V.] NorthShore Univ HealthSyst, Evanston, IL 60201 USA; [Gejman, Pablo V.] Univ Chicago, Chicago, IL 60637 USA; [Hall, Alistair S.] Univ Leeds, Leeds MRC Med Bioinformat Ctr, Leeds LS2 9LU, W Yorkshire, England; [Hattersley, Andrew T.] Univ Exeter, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Hicks, Andrew A.; Pramstaller, Peter P.] Bolzano EURAC, European Acad Bozen, Ctr Biomed, I-39100 Bolzano, Italy; [Hicks, Andrew A.; Pramstaller, Peter P.] Inst Univ Lubeck, D-23562 Lubeck, Germany; [Hindorff, Lucia A.] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA; [Hingorani, Aroon D.; Asselbergs, Folkert W.] UCL, Inst Cardiovasc Sci, London WC1E 6BT, England; [Hovingh, G. Kees; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Humphries, Steve E.] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London WC1E 6JJ, England; [Hunt, Steven C.] Univ Utah, Dept Internal Med, Cardiovasc Genet Div, Salt Lake City, UT 84108 USA; [Hypponen, Elina] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5000, Australia; [Hypponen, Elina] Univ S Australia, Sch Populat Hlth, Adelaide, SA 5000, Australia; [Hypponen, Elina] South Australian Hlth & Med Res Inst, Adelaide, SA 5000, Australia; [Hypponen, Elina; Power, Chris] UCL, Inst Child Hlth, London WC1N 1EH, England; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-30625 Hannover, Germany; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, FI-90101 Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, MRC Hlth Protect Agcy HPA, Ctr Environm & Hlth, Sch Publ Hlth, London W2 1PG, England; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, FI-90220 Oulu, Finland; Univ Oulu, Bioctr Oulu, FI-90014 Oulu, Finland; [Jarvelin, Marjo-Riitta; Keinanen-Kiukaanniemi, Sirkka M.] Univ Oulu, Inst Hlth Sci, FI-90014 Oulu, Finland; [Jukema, J. Wouter; Asselbergs, Folkert W.; van der Harst, Pim] Interuniv Cardiol Inst Netherlands ICIN, Durrer Ctr Cardiogenet Res, NL-3501 DG Utrecht, Netherlands; [Jukema, J. Wouter; Asselbergs, Folkert W.; van der Harst, Pim] Interuniv Cardiol Inst Netherlands ICIN, Durrer Ctr Cardiogenet Res, NL-3501 DG Utrecht, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands ICIN, NL-3501 DG Utrecht, Netherlands; [Keinanen-Kiukaanniemi, Sirkka M.] Oulu Univ Hosp, Unit Primary Hlth Care Gen Practice, FI-90220 Oulu, Finland; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; [Kooner, Jaspal S.; Chambers, John C.] Imperial Coll Healthcare NHS Trust, London W12 0HS, England; [Kumari, Meena; Langenberg, Claudia; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Kumari, Meena] Univ Essex, Dept Biol & Social Epidemiol, Colchester CO4 3SQ, Essex, England; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Dept Med, FI-70210 Kuopio, Finland; [Kuusisto, Johanna; Lakka, Timo A.; Laakso, Markku; Rauramaa, Rainer] Univ Eastern Finland, FI-70210 Kuopio, Finland; [Lakka, Timo A.] Univ Eastern Finland, Inst Biomed, Dept Physiol, FI-70211 Kuopio, Finland; [Lakka, Timo A.; Rauramaa, Rainer] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, FI-70210 Kuopio, Finland; [Lehtimaki, Terho] Univ Tampere, Fimlab Labs, Dept Clin Chem, FI-33520 Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, FI-33520 Tampere, Finland; [Lyssenko, Valeriya] Steno Diabet Ctr AS, DK-2820 Gentofte, Denmark; [Lyssenko, Valeriya; Groop, Leif C.] Lund Univ, Lund Univ Diabet Ctr, S-22100 Malmo, Sweden; [Lyssenko, Valeriya; Groop, Leif C.] Lund Univ, Dept Clin Sci, Diabet & Endocrinol Unit, S-22100 Malmo, Sweden; [Marette, Andre] Univ Laval, Fac Med, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ G1V 0A6, Canada; [McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Moll, Frans L.] Univ Med Ctr Utrecht, Dept Surg, NL-3584 CX Utrecht, Netherlands; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3GA, Merseyside, England; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Peden, John F.] Illumina Inc, Cambridge CB10 1XL, England; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Med & TB, Groningen, Netherlands; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FI-20521 Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FI-20521 Turku, Finland; [Rankinen, Tuomo; Sarzynski, Mark A.; Bouchard, Claude] Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA 70808 USA; [Ritchie, Marylyn D.] Penn State Univ, Ctr Syst Genom, University Pk, PA 16802 USA; [Rudan, Igor] Univ Split, Fac Med, Croatian Ctr Global Hlth, Split 21000, Croatia; [Saramines, Jouko] South Carelia Cent Hosp, Lappeenranta 53130, Finland; [Schwarz, Peter E. H.] German Ctr Diabet Res DZD, Paul Langerhans Inst Dresden, D-01307 Dresden, Germany; [Sever, Peter] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London W2 1PG, England; [Shuldiner, Alan R.; O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Shuldiner, Alan R.; O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Program Personalized & Genom Med, Baltimore, MD 21201 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Sinisalo, Juha] Univ Helsinki, Cent Hosp, Heart & Lung Ctr, Dept Med, FI-00290 Helsinki, Finland; [Tregouet, David-Alexandre] Univ Paris 06, Sorbonne Univ, UMR S 1166, F-75013 Paris, France; [Tregouet, David-Alexandre] Univ Paris 06, INSERM, UMR S 1166, Team Genom & Physiopathol Cardiovasc Dis, F-75013 Paris, France; [Tregouet, David-Alexandre] ICAN, F-75013 Paris, France; [Tremblay, Angelo; Perusse, Louis] Univ Laval, Dept Kinesiol, Quebec City, PQ G1V 0A6, Canada; [Tremoli, Elena] Univ Milan, Dipartimento Sci Farmacol & Biomol, I-20133 Milan, Italy; [Tremoli, Elena] Inst Ricoveroe Cura & Carattere Sci, Ctr Cardiol Monzino, I-20133 Milan, Italy; [Vohl, Marie-Claude] Univ Laval, Dept Food Sci & Nutr, Quebec City, PQ G1V 0A6, Canada; [Waeber, Gerard] Univ Hosp CHUV, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Waeber, Gerard] Univ Lausanne, CH-1011 Lausanne, Switzerland; [Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Amouyel, Philippe] Inst Pasteur, F-59000 Lille, France; [Amouyel, Philippe] INSERM, U744, F-59000 Lille, France; [Amouyel, Philippe] Univ Lille 2, F-59000 Lille, France; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, NL-3584 CX Utrecht, Netherlands; [Assimes, Themistocles L.; Melbve, Mads; Quertermous, Thomas] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Boehm, Bernhard O.] Univ London Imperial Coll Sci Technol & Med, Lee Kong Chian Sch Med, Singapore 637553, Singapore; [Boehm, Bernhard O.] Nanyang Technol Univ, Singapore 637553, Singapore; [Boehm, Bernhard O.] Univ Ulm, Med Ctr, Dept Internal Med 1, D-89081 Ulm, Germany; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [de Bakker, Paul I. W.] Harvard Univ, Dept Med, Div Genet, Brigham & Womens Hosp,Med Sch, Boston, MA 02115 USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, NL-3584 CX Utrecht, Netherlands; [Hui, Jennie] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Liu, Yongmei] Wake Forest Sch Med, Div Publ Hlth Sci, Ctr Human Genet, Winston Salem, NC 27157 USA; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, D-68163 Mannheim, Germany; [Melbve, Mads] Univ Copenhagen, Dept Clin Med, DK-2200 Copenhagen, Denmark; [Oostra, Ben A.] Erasmus MC Univ Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Saaristo, Timo E.] Finnish Diabet Assoc, FI-33680 Tampere, Finland; [Saaristo, Timo E.] Pirkanmaa Hosp Dist, FI-33521 Tampere, Finland; [Saleheen, Danish] Ctr Noncommunicable Dis, Karatchi, Pakistan; [Saleheen, Danish] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Div Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Schadt, Eric E.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10580 USA; [Thorsteinsdottir, Unnu R.; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Tuomilehto, Jaakko] Univ Hosp La Paz IdiPaz, Inst Hlth Res, Madrid 28046, Spain; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21589, Saudi Arabia; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, A-3500 Krems, Austria; [Uusitupa, Matti] Univ Eastern Finland, Dept Publ Hlth & Clin Nutr, Kuopio, Finland; [Uusitupa, Matti] Kuopio Univ Hosp, Res Unit, FI-70210 Kuopio, Finland; [Walker, Mark] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wallaschofski, Henri] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Wichmann, H-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, D-85764 Munich, Germany; [Wichmann, H-Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Wichmann, H-Erich] Helmholtz Zentrum Munchen, Inst Epidemiol 1, German Res Ctr Environm Hlth, D-85764 Neuherberg, Germany; [Zanen, Pieter] Univ Med Ctr Utrecht, Dept Pulmonol, NL-3584 CX Utrecht, Netherlands; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21589, Saudi Arabia; [Strachan, David P.] St Georges Univ London, Div Populat Hlth Sci & Educ, London SW17 0RE, England; [McCarthy, Mark I.] Oxford Univ Hosp NHS Trust, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Scherag, Andre] Jena Univ Hosp, Clin Epidemiol Integrated Res & Treatment Ctr, CSCC, D-07743 Jena, Germany; [Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Beckmann, Jacques S.] CHUV Univ Hosp, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Barroso, Ines] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Barroso, Ines] Addenbrookes Hosp, Inst Metab Sci, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Technical University of Denmark; University of North Carolina; University of North Carolina Chapel Hill; University of Queensland; University of Queensland; Harvard University; Brigham & Women's Hospital; University of Tartu; Karolinska Institutet; Uppsala University; Uppsala University; University of Oxford; Wellcome Centre for Human Genetics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; University of Lausanne; Wellcome Trust Sanger Institute; University of Regensburg; University of Exeter; Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Groningen; University of Michigan System; University of Michigan; HudsonAlpha Institute for Biotechnology; Erasmus University Rotterdam; Erasmus MC; Telethon Kids Institute; University of Western Australia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Edinburgh; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Imperial College London; Army Medical University; Johns Hopkins University; University of Geneva; Statens Serum Institut; Washington University (WUSTL); University of Oxford; Fred Hutchinson Cancer Center; University of London; Queen Mary University London; Ruprecht Karls University Heidelberg; Ulm University; Finland National Institute for Health & Welfare; Cancer Research Center of Hawaii; University of Hawaii System; Icahn School of Medicine at Mount Sinai; University of London; King's College London; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; QIMR Berghofer Medical Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Oxford; Imperial College London; Lund University; Skane University Hospital; Umea University; Umea University; University of Eastern Finland; Karolinska Institutet; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Greifswald Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Imperial College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Dalarna University; University of Cambridge; University of San Carlos; Texas Biomedical Research Institute; Queensland University of Technology (QUT); Ulm University; Leipzig University; Leipzig University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Groningen; Norwegian University of Science & Technology (NTNU); University of California System; University of California Los Angeles; University of Oxford; University of Oxford; Harokopio University Athens; University of Dundee; University of Helsinki; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Uppsala University; Karolinska Institutet; Kaiser Permanente; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Regensburg; Greifswald Medical School; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Groningen; University of Edinburgh; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Vrije Universiteit Amsterdam; German Centre for Cardiovascular Research; Munich Heart Alliance; German Heart Centre Munich; Technical University of Munich; Norwegian University of Science & Technology (NTNU); Vrije Universiteit Amsterdam; University of Western Australia; SciLifeLab; Uppsala University; University of Helsinki; Ulm University; Finnish Institute of Occupational Health; Medical University of Innsbruck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Uppsala University; Universite de Montreal; Greifswald Medical School; Icahn School of Medicine at Mount Sinai; University of Bristol; University of Tartu; University of London; University College London; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Munich; University of Munich; University of Western Australia; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Bonn; University of Bonn; University of Groningen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Medical University of Graz; Greifswald Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Medical University of Graz; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Icelandic Heart Association; University of Iceland; University of Groningen; Royal College of Surgeons - Ireland; Imperial College London; Loyola University Chicago; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cambridge; University of Gothenburg; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Radboud University Nijmegen; University of London; Queen Mary University London; GlaxoSmithKline; German Centre for Cardiovascular Research; University of Lubeck; UiT The Arctic University of Tromso; University of London; University College London; University College Dublin; Seoul National University (SNU); Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; Karolinska Institutet; Columbia University; University of Melbourne; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Oxford; Harvard University; Harvard Medical School; Massachusetts General Hospital; RIKEN; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Harvard University; Harvard T.H. Chan School of Public Health; Howard Hughes Medical Institute; Yale University; Dalian Maritime University; Boston University; University of Oxford; MRC Harwell; Queensland University of Technology (QUT); RIKEN; Tokyo Medical & Dental University (TMDU); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Aalto University; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; RIKEN; Tokyo Medical & Dental University (TMDU); Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Oxford; Washington University (WUSTL); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Groningen; University of Western Australia; Cedars Sinai Medical Center; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Milan; Harvard University; Harvard Medical School; Vanderbilt University; Vanderbilt University; Boston University; University of Milan; University of Cambridge; Utrecht University; Utrecht University Medical Center; University of Glasgow; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Greifswald Medical School; German Centre for Cardiovascular Research; University of Pisa; University of Pisa; CHU de Toulouse; Universite de Franche-Comte; Universite Federale Toulouse Midi-Pyrenees (ComUE); University of Glasgow; University West Indies Mona Jamaica; NorthShore University Health System; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; Utah System of Higher Education; University of Utah; University of South Australia; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of London; University College London; Hannover Medical School; Finland National Institute for Health & Welfare; Imperial College London; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Radboud University Nijmegen; Imperial College London; University of London; University College London; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Tampere University; Tampere University; Steno Diabetes Center; Lund University; Laval University; University of Washington; University of Washington Seattle; Utrecht University; Utrecht University Medical Center; University of Liverpool; University of Iowa; Illumina; University of Groningen; Krankenhaus Bozen; University of Turku; University of Turku; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Split; Technische Universitat Dresden; Imperial College London; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Helsinki; Helsinki University Central Hospital; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Laval University; University of Milan; IRCCS Centro Cardiologico Monzino; Laval University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of North Carolina; University of North Carolina Chapel Hill; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Utrecht University; Utrecht University Medical Center; Stanford University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Ulm University; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utrecht University; Utrecht University Medical Center; University of Western Australia; Yeshiva University; Albert Einstein College of Medicine; Wake Forest University; SYNLAB Group; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC; Pirkanmaa Hospital District; University of Pennsylvania; University of Glasgow; Icahn School of Medicine at Mount Sinai; University of Iceland; King Abdulaziz University; Danube University Krems; University of Eastern Finland; Kuopio University Hospital; Newcastle University - UK; Greifswald Medical School; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Utrecht University; Utrecht University Medical Center; King Abdulaziz University; St Georges University London; Oxford University Hospitals NHS Foundation Trust; University of Michigan System; University of Michigan; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of North Carolina; University of North Carolina Chapel Hill; Icahn School of Medicine at Mount Sinai	Speliotes, EK (corresponding author), Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA.	joelh@broadinstitute.org; ruth.loos@mssm.edu; espeliot@med.umich.edu	Medland, Sarah E/C-7630-2013; Trégouët, David-Alexandre/P-9210-2019; Stumvoll, Michael/ABE-1121-2021; Kolcic, Ivana/E-2713-2017; Vohl, Marie-Claude/AAQ-1378-2021; Cazier, Jean-Baptiste/GLR-2949-2022; Fehrmann, Rudolf/E-2551-2011; Rudan, Igor/I-1467-2012; Nyholt, Dale Robert/J-3174-2017; Bouchard, Claude/AAE-2035-2019; Polasek, Ozren/B-6002-2011; Strawbridge, Rona/H-5422-2012; Bovet, Pascal/F-4477-2011; Ramos, Rafel/P-2083-2019; Kronenberg, Florian/B-1736-2008; Barbalić, Maja/E-2161-2017; Study, GoDARTS/K-9448-2016; Schumacher, Fredrick/R-6043-2019; Montgomery, Grant W/B-7148-2008; Mangino, Massimo/F-5134-2011; Dörr, Marcus/F-1919-2010; Ripke, Stephan/AAK-5486-2021; Meitinger, Thomas/O-1318-2015; Charchar, Fadi/I-6656-2017; Hicks, Andrew Anthony/E-9518-2017; Heikkilä, Kauko/E-5578-2019; Dedoussis, George/AAN-7252-2021; Erdmann, Jeanette/A-4417-2009; Leander, Karin/C-7261-2017; Kastelein, John/AAF-7950-2020; Kivimaki, Mika/B-3607-2012; Rioux, John D/A-9599-2015; Raso, Francesco Mattace-/L-2541-2015; Crawford, Dana/O-5578-2019; Arora, Pankaj/F-3437-2011; Vandenput, Liesbeth/AAP-3655-2020; Bochud, Murielle/A-3981-2010; Marmot, M G/Y-3920-2019; Wilson, James F/A-5704-2009; Lim, Unhee/AEA-8591-2022; Tregouet, David-Alexandre/E-3961-2016; Bouchard, Claude/A-7637-2009; Wichmann, Heinz Erich/AAA-5695-2022; Doney, Alexander SF/P-7437-2017; Deloukas, Panos/B-2922-2013; zhang, weihua/GXV-1334-2022; Lopez, Lorna/AAR-4912-2020; Fraser, Ross M/J-9519-2012; Lahti, Jari/P-2283-2019; Zgaga, Lina/Q-9415-2018; Franco, Óscar H/ABE-2305-2020; Moayyeri, Alireza/N-3332-2014; Prokopenko, Inga/AAU-9895-2020; Hveem, Kristian/AFV-4683-2022; Huang, Jiaxing/B-7521-2009; FROGUEL, Philippe/O-6799-2017; Crisponi, Laura/AAC-2642-2019; Fall, Tove/O-7226-2014; Martin, Nicholas/R-9235-2019; Franke, Andre/B-2151-2010; Peyvandi, Flora/AAK-7437-2020; Johansson, Åsa/AAG-6799-2021; Lyytikäinen, Leo-Pekka/C-8544-2016; Boehm, Bernhard Otto/F-8750-2015; Müller-Nurasyid, Martina/I-8735-2018; Franke, Lude/P-7036-2016; Raitakari, Olli/AAQ-7389-2021; Sarzynski, Mark/A-9798-2014; Gudnason, Vilmundur/K-6885-2015; Mulas, Antonella/B-4231-2015; Stathopoulou, Maria/H-7324-2016; Onland-Moret, N. Charlotte/G-9185-2011; Blangero, John/ABA-7175-2021; Matullo, Giuseppe/K-6383-2016; Tanaka, Toshihiro/J-9310-2014; Jukema, J. Wouter/ABD-6503-2021; Bakker, Stephan J. L./J-4023-2015; Ormel, Johan/C-6094-2013; Franks, Paul/AAA-3300-2020; Assimes, Themistocles Leonard/D-9696-2015; Campbell, Harry/E-2959-2010; Stanton, Alice V/F-4697-2012; Wong, Andrew/M-8899-2016; panduru, nicolae mircea/AAB-9885-2021; Zheng, Wei/O-3351-2013; Lamina, Claudia/F-7608-2010; Vandenput, Liesbeth/AAI-4100-2021; Girelli, Domenico/B-1183-2008; Milani, Lili/N-1097-2019; de Bakker, Paul IW/B-8730-2009; Zhu, Xiaofeng/O-6874-2019; Medland, Sarah/AAT-7595-2020; Visscher, Peter/ABB-6151-2020; Staessen, Jan A/A-1065-2011; Gigante, Bruna/I-9252-2012; Boban, Mladen/E-2777-2017; Ripatti, Samuli/H-9446-2014; McKnight, Amy Jayne/ABF-4492-2020; Rankinen, Tuomo/N-1984-2017; Beekman, Marian/L-3004-2019; Gaunt, Tom R/O-3918-2014; Salumets, Andres/J-2278-2015; Dominiczak, Anna F/P-9390-2017; Wood, Andrew R/AAB-3807-2019; Teumer, Alexander/S-7438-2019; McKay, Gareth/AAZ-2601-2020; Palmer, Lyle John/N-1948-2019; Mägi, Reedik/AAJ-9679-2021; Kaprio, Jaakko/A-1820-2008; Hui, Jennie/A-9543-2013; Erdmann, Jeanette/P-7513-2014; Kutalik, Zoltan/HHZ-5697-2022; Sundstrom, Johan/R-2139-2019; Langenberg, Claudia/ABG-9067-2021; Peters, Annette/A-6117-2011; Laan, Maris/A-4100-2011; Njolstad, Inger/X-3784-2019; Hall, Alistair/K-1953-2019; Verweij, Niek/A-4499-2017; Seufferlein, Thomas TW/P-7147-2018; Lehtimäki, Terho/AAD-1094-2022; Drong, Alexander/AAG-1115-2020; Wong, Andrew/AAE-6995-2019; BOUATIA-NAJI, NABILA/D-5863-2013; Grallert, Harald/B-3424-2013; Haller, Toomas/N-3797-2019; Kuh, Diana/L-6019-2014; Hosseini, S. Mohsen/K-7133-2013; Slagboom, P. Eline/R-4790-2016; Ramos, Rafel/D-9627-2016; Belllis, Claire/GYA-5547-2022; Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Verweij, Niek/ABC-6249-2021; Uda, Manuela/AAC-2645-2019; Berndt, Sonja I/J-8423-2016; Magnusson, Patrik KE/C-4458-2017; Johnson, Andrew D/G-6520-2013; Deary, Ian J/C-6297-2009; Colaus, PsyColaus/K-6607-2013; bandinelli, stefania/AAL-4570-2020; Stancakova, Alena/AAN-6723-2020; Ford, Ian/ABE-6145-2020; Yengo, Loic/D-2692-2017; Prokopenko, Inga/H-3241-2014; Ohlsson, Claes/AGP-3544-2022; Hengstenberg, Christian/U-5485-2019; Nelis, Mari/ABG-7775-2020; Kinnunen, Leena/B-7059-2012; Vermeulen, Sita H./L-4716-2015; Stefansson, Kari/AAE-7187-2019; Johansson, Åsa/G-5270-2011; Bush, William/N-1369-2019; Tzoulaki, Ioanna/ABE-6269-2020; Alhenc-Gelas, Francois/F-9511-2017; Lee, Jong-Young/M-6319-2013; Vonk, Judith M/ABA-3009-2020; Smith, Albert Vernon/K-5150-2015; Loos, Ruth/GON-5877-2022; Thorand, Barbara/B-5349-2014; Meisinger, Christine/B-5358-2014; Nato, Alejandro Q/D-9276-2012; EHRET, Georg B/A-9532-2009; Rivadeneira, Fernando/O-5385-2015; Palmer, Lyle John/K-3196-2014; Wang, Zhaoming/R-5527-2018; Boehringer, Stefan/Y-2442-2018; Vonk, Judith/K-8477-2019; Sundström, Johan/A-6286-2009; Prabhakaran, Dorairaj/B-4147-2011; Perusse, Louis/A-3444-2012; Gudnason, Vilmundur/AAE-7126-2019; Go, Alan S./AAE-7745-2019; Kubo, Michiaki/N-7947-2015; Ohlsson, Claes/HIR-6959-2022; Willenborg, Christina/D-2668-2012; Falhammar, Henrik/AAD-4329-2019; Loos, Ruth J F/Q-2862-2016; van der Laan, Sander W./N-1330-2019; Beckmann, Jacques S/A-9772-2008; Kanoni, Stavroula/AAN-7161-2021; DEMIRKAN, AYSE/G-9313-2016; Ramachandran, Vasan/Y-2527-2019; Choi, Murim/AAP-9120-2021; Locke, Adam/K-2000-2019; Medina-Gomez, Carolina/I-1725-2019; Singleton, Andrew B/C-3010-2009; Visser, Jenny A./F-8156-2011; Yang, Jian/A-5852-2010; Karjalainen, Juha/P-8624-2016; Palmer, Colin NA/C-7053-2008; Ärnlöv, Johan/AAF-2746-2019; Kiemeney, Lambertus A./D-3357-2009; Asselbergs, Folkert W./ABD-6752-2021; Feitosa, Mary F/K-8044-2012; Hypponen, Elina/B-2596-2014; Lee, Sang Hong/A-2569-2011; Paterson, Andrew/A-4088-2011; Aulchenko, Yurii/M-8270-2013; Ferrieres, Jean/S-7993-2016; Tiirikainen, Maarit/B-6954-2012; FAVA, Cristiano/K-9590-2015; Evans, David/H-6325-2013; ruggiero, daniela/K-5638-2016; Gauguier, Dominique/G-2190-2016; MacGregor, Stuart/C-6442-2009; Penninx, Brenda WJH/S-7627-2017; Vinkhuyzen, Anna/N-8691-2013; McCarthy, Mark/M-3763-2015; TREMOLI, ELENA/I-8126-2018; Aspelund, Thor/C-5983-2008; Soler Artigas, Maria/L-6529-2013; Warrington, Nicole/P-4868-2014; Okamura, Tomonori/L-1693-2013; Johnson, Paul/O-9695-2014; CASARI, Giorgio/J-3070-2018; Asselta, Rosanna/AAC-2367-2019; Zondervan, Krina/M-1143-2013; Kuznetsova, Tatiana/ABI-5662-2020; Robino, Antonietta/K-9398-2016	Medland, Sarah E/0000-0003-1382-380X; Trégouët, David-Alexandre/0000-0001-9084-7800; Stumvoll, Michael/0000-0001-6225-8240; Kolcic, Ivana/0000-0001-7918-6052; Cazier, Jean-Baptiste/0000-0001-7581-9051; Fehrmann, Rudolf/0000-0002-7516-315X; Rudan, Igor/0000-0001-6993-6884; Nyholt, Dale Robert/0000-0001-7159-3040; Polasek, Ozren/0000-0002-5765-1862; Strawbridge, Rona/0000-0001-8506-3585; Bovet, Pascal/0000-0002-0242-4259; Ramos, Rafel/0000-0001-7970-5537; Kronenberg, Florian/0000-0003-2229-1120; Barbalić, Maja/0000-0001-8914-1691; Schumacher, Fredrick/0000-0002-3073-7463; Montgomery, Grant W/0000-0002-4140-8139; Mangino, Massimo/0000-0002-2167-7470; Dörr, Marcus/0000-0001-7471-475X; Charchar, Fadi/0000-0002-6164-9941; Hicks, Andrew Anthony/0000-0001-6320-0411; Heikkilä, Kauko/0000-0002-9256-8028; Dedoussis, George/0000-0002-7798-6221; Leander, Karin/0000-0002-1404-9222; Kivimaki, Mika/0000-0002-4699-5627; Rioux, John D/0000-0001-7560-8326; Crawford, Dana/0000-0002-6437-6248; Arora, Pankaj/0000-0003-2420-3550; Vandenput, Liesbeth/0000-0002-1712-6131; Bochud, Murielle/0000-0002-5727-0218; Marmot, M G/0000-0002-2431-6419; Wilson, James F/0000-0001-5751-9178; Lim, Unhee/0000-0001-6221-7190; Bouchard, Claude/0000-0002-0048-491X; Doney, Alexander SF/0000-0002-6210-5620; Deloukas, Panos/0000-0001-9251-070X; Lopez, Lorna/0000-0002-0241-9783; Fraser, Ross M/0000-0003-0488-2592; Lahti, Jari/0000-0002-4310-5297; Zgaga, Lina/0000-0003-4089-9703; Franco, Óscar H/0000-0002-4606-4929; Moayyeri, Alireza/0000-0002-9143-2161; FROGUEL, Philippe/0000-0003-2972-0784; Crisponi, Laura/0000-0001-9128-8537; Martin, Nicholas/0000-0003-4069-8020; Franke, Andre/0000-0003-1530-5811; Peyvandi, Flora/0000-0001-7423-9864; Johansson, Åsa/0000-0002-2915-4498; Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Müller-Nurasyid, Martina/0000-0003-3793-5910; Franke, Lude/0000-0002-5159-8802; Gudnason, Vilmundur/0000-0001-5696-0084; Stathopoulou, Maria/0000-0003-4376-2083; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Matullo, Giuseppe/0000-0003-0674-7757; Tanaka, Toshihiro/0000-0001-6201-9784; Jukema, J. Wouter/0000-0002-3246-8359; Bakker, Stephan J. L./0000-0003-3356-6791; Assimes, Themistocles Leonard/0000-0003-2349-0009; Campbell, Harry/0000-0002-6169-6262; Wong, Andrew/0000-0003-2079-4779; Zheng, Wei/0000-0003-1226-070X; Lamina, Claudia/0000-0002-5398-5806; Vandenput, Liesbeth/0000-0002-1712-6131; Girelli, Domenico/0000-0001-9684-1899; Milani, Lili/0000-0002-5323-3102; de Bakker, Paul IW/0000-0001-7735-7858; Medland, Sarah/0000-0003-1382-380X; Visscher, Peter/0000-0002-2143-8760; Staessen, Jan A/0000-0002-3026-1637; Boban, Mladen/0000-0003-1570-9621; Ripatti, Samuli/0000-0002-0504-1202; McKnight, Amy Jayne/0000-0002-7482-709X; Beekman, Marian/0000-0003-0585-6206; Gaunt, Tom R/0000-0003-0924-3247; Salumets, Andres/0000-0002-1251-8160; Dominiczak, Anna F/0000-0003-4913-3608; Wood, Andrew R/0000-0003-1726-948X; Teumer, Alexander/0000-0002-8309-094X; McKay, Gareth/0000-0001-8197-6280; Palmer, Lyle John/0000-0002-1628-3055; Kaprio, Jaakko/0000-0002-3716-2455; Hui, Jennie/0000-0002-1653-2496; Erdmann, Jeanette/0000-0002-4486-6231; Kutalik, Zoltan/0000-0001-8285-7523; Sundstrom, Johan/0000-0003-2247-8454; Langenberg, Claudia/0000-0002-5017-7344; Peters, Annette/0000-0001-6645-0985; Laan, Maris/0000-0002-8519-243X; Lehtimäki, Terho/0000-0002-2555-4427; Wong, Andrew/0000-0003-2079-4779; Haller, Toomas/0000-0002-5069-6523; Kuh, Diana/0000-0001-7386-2857; Hosseini, S. Mohsen/0000-0003-3626-9928; Slagboom, P. Eline/0000-0002-2875-4723; Ramos, Rafel/0000-0001-7970-5537; Belllis, Claire/0000-0001-5073-9610; Verweij, Niek/0000-0002-4303-7685; Uda, Manuela/0000-0002-4890-6456; Magnusson, Patrik KE/0000-0002-7315-7899; Johnson, Andrew D/0000-0001-6369-5178; Deary, Ian J/0000-0002-1733-263X; Stancakova, Alena/0000-0002-1375-0252; Yengo, Loic/0000-0002-4272-9305; Prokopenko, Inga/0000-0003-1624-7457; Ohlsson, Claes/0000-0002-9633-2805; Nelis, Mari/0000-0001-9748-1020; Kinnunen, Leena/0000-0001-8739-4812; Vermeulen, Sita H./0000-0003-4913-8601; Johansson, Åsa/0000-0002-2915-4498; Bush, William/0000-0002-9729-6519; Tzoulaki, Ioanna/0000-0002-4275-9328; Lee, Jong-Young/0000-0002-0092-9958; Vonk, Judith M/0000-0001-7531-4547; Smith, Albert Vernon/0000-0003-1942-5845; Thorand, Barbara/0000-0002-8416-6440; Nato, Alejandro Q/0000-0002-8745-9046; EHRET, Georg B/0000-0002-5730-0675; Rivadeneira, Fernando/0000-0001-9435-9441; Palmer, Lyle John/0000-0002-1628-3055; Wang, Zhaoming/0000-0001-7556-3869; Boehringer, Stefan/0000-0001-9108-9212; Vonk, Judith/0000-0001-7531-4547; Sundström, Johan/0000-0003-2247-8454; Prabhakaran, Dorairaj/0000-0002-3172-834X; Perusse, Louis/0000-0001-6440-9698; Gudnason, Vilmundur/0000-0001-5696-0084; Ohlsson, Claes/0000-0002-9633-2805; Willenborg, Christina/0000-0001-5217-6882; Falhammar, Henrik/0000-0002-5622-6987; Loos, Ruth J F/0000-0002-8532-5087; van der Laan, Sander W./0000-0001-6888-1404; Beckmann, Jacques S/0000-0002-9741-1900; Kanoni, Stavroula/0000-0002-1691-9615; Ramachandran, Vasan/0000-0001-7357-5970; Locke, Adam/0000-0001-6227-198X; Medina-Gomez, Carolina/0000-0001-7999-5538; Yang, Jian/0000-0003-2001-2474; Palmer, Colin NA/0000-0002-6415-6560; Ärnlöv, Johan/0000-0002-6933-4637; Kiemeney, Lambertus A./0000-0002-2368-1326; Asselbergs, Folkert W./0000-0002-1692-8669; Feitosa, Mary F/0000-0002-0933-2410; Hypponen, Elina/0000-0003-3670-9399; Nicholson, George/0000-0001-9588-6075; Ala-Korpela, Mika/0000-0001-5905-1206; ripke, stephan/0000-0003-3622-835X; Cupples, L. Adrienne/0000-0003-0273-7965; Org, Elin/0000-0003-1451-9375; Lagou, Vasiliki/0000-0003-3165-8940; Koenig, Wolfgang/0000-0002-2064-9603; Eriksson, Johan/0000-0002-2516-2060; Adeyemo, Adebowale/0000-0002-3105-3231; Viigimaa, Margus/0000-0001-5575-5978; Whincup, Peter/0000-0002-5589-4107; Lee, Sang Hong/0000-0001-9701-2718; Anderson, Denise/0000-0003-0643-4136; Blangero, John/0000-0001-6250-5723; Ellinghaus, David/0000-0002-4332-6110; Berzuini, Carlo/0000-0001-6056-0489; Goddard, Michael/0000-0001-9917-7946; Pramstaller, Peter P/0000-0002-9831-8302; rossing, peter/0000-0002-1531-4294; Hedman, Asa/0000-0001-5413-204X; Ongen, Halit/0000-0002-4197-5790; Paterson, Andrew/0000-0002-9169-118X; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921; Stanton, Alice/0000-0002-4961-165X; Humphries, Stephen E/0000-0002-8221-6547; Edkins, Sarah/0000-0003-0717-1972; Peters, Marjolein/0000-0003-3167-9063; Gurdasani, Deepti/0000-0001-9996-6929; Aulchenko, Yurii/0000-0002-7899-1575; Wang, Thomas/0000-0003-4063-6508; Goodall, Alison/0000-0002-7883-9645; Vohl, Marie-Claude/0000-0002-7017-5848; Hopewell, Jemma/0000-0002-3870-8018; Lawlor, Debbie A/0000-0002-6793-2262; Scott, William/0000-0001-5467-114X; Preuss, Michael/0000-0001-5266-8465; Ferrieres, Jean/0000-0001-6144-1297; Meitinger, Thomas/0000-0002-8838-8403; Voight, Benjamin/0000-0002-6205-9994; Hattersley, Andrew/0000-0001-5620-473X; Nothen, Markus/0000-0002-8770-2464; Pilz, Stefan/0000-0002-7959-1311; Cesana, Giovanni/0000-0002-0743-478X; Boomsma, Dorret/0000-0002-7099-7972; Lucas, Gavin/0000-0003-4166-9416; Folkersen, Lasse/0000-0003-0708-9530; Marrugat, Jaume/0000-0003-3320-554X; zanen, pieter/0000-0002-5318-8276; Zemunik, Tatijana/0000-0001-8120-2891; Tiirikainen, Maarit/0000-0002-8124-3818; Jones, Lindsay/0000-0002-4219-8356; melbye, mads/0000-0001-8264-6785; Buyske, Steven/0000-0001-8539-5416; Tomaszewski, Maciej/0000-0001-8215-6567; Kleber, Marcus/0000-0003-0663-7275; Goessling, Wolfram/0000-0001-9972-1569; FAVA, Cristiano/0000-0002-8910-7378; Evans, David/0000-0003-0663-4621; Kristiansson, Kati/0000-0003-4688-107X; Tryggvadottir, Laufey/0000-0001-8067-9030; Couper, David/0000-0002-4313-9235; Mattace-Raso, Francesco/0000-0002-1688-6497; Lindgren, Cecilia/0000-0002-4903-9374; Lakatta, Edward/0000-0002-4772-0035; Devuyst, Olivier/0000-0003-3744-4767; Tsoka, Sophia/0000-0001-8403-1282; Sandholm, Niina/0000-0003-4322-6942; Shriner, Daniel/0000-0003-1928-5520; Burri, Andrea/0000-0002-4705-3551; Gigante, Bruna/0000-0003-4508-7990; solinas, emilia/0000-0003-3532-1317; Ohkubo, Takayoshi/0000-0002-3283-8196; Ganna, Andrea/0000-0002-8147-240X; Zhu, Xiaofeng/0000-0003-0037-411X; Kangas, Antti/0000-0001-7492-1732; ruggiero, daniela/0000-0003-3898-7827; Workalemahu, Tsegaselassie/0000-0003-4571-9740; Skorpen, Frank/0000-0001-7093-8000; Forouhi, Nita/0000-0002-5041-248X; Liu, Ching-Ti/0000-0002-0703-0742; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Pechlivanis, Sonali/0000-0002-6181-7044; Brennan, Eoin/0000-0003-4908-5474; Glazer, Nicole/0000-0002-6397-609X; Gauguier, Dominique/0000-0001-6156-9530; MacGregor, Stuart/0000-0001-6731-8142; Stewart, Alexandre/0000-0003-2673-9164; ELOSUA, ROBERTO/0000-0001-8235-0095; Salem, Rany/0000-0001-8816-6862; Penninx, Brenda WJH/0000-0001-7779-9672; Price, Jackie/0000-0003-3251-3970; Gordon, Scott/0000-0001-7623-328X; Wheeler, Eleanor/0000-0002-8616-6444; Faul, Jessica/0000-0002-6969-6478; Kovacs, Peter/0000-0002-0290-5423; Kuulasmaa, Kari/0000-0003-2165-1411; Feenstra, Bjarke/0000-0003-1478-649X; Vinkhuyzen, Anna/0000-0003-3352-0603; Cusi, Daniele/0000-0002-1006-7597; Karpe, Fredrik/0000-0002-2751-1770; Hall, Alistair/0000-0003-0306-7887; Lindstrom, Jaana/0000-0001-9255-020X; Chandak, Giriraj Ratan/0000-0002-3095-9453; Tenesa, Albert/0000-0003-4884-4475; Nikus, Kjell/0000-0002-9345-9851; Rich, Stephen/0000-0003-3872-7793; Hingorani, Aroon/0000-0001-8365-0081; Bergman, Richard/0000-0003-1539-4471; Kumari, Meena/0000-0001-9716-1035; Ferrario, Marco M/0000-0003-2741-7124; Esko, Tonu/0000-0003-1982-6569; Goel, Anuj/0000-0003-2307-4021; Sim, Xueling/0000-0002-1233-7642; Tarnow, Lise/0000-0002-8735-966X; Moebus, Susanne/0000-0002-0072-5410; Frayling, Timothy/0000-0001-8362-2603; Willemsen, Gonneke/0000-0003-3755-0236; McCarroll, Steven/0000-0002-6954-8184; Kessler, Thorsten/0000-0003-3326-1621; McCarthy, Mark/0000-0002-4393-0510; Heard-Costa, Nancy/0000-0001-9730-0306; Randall, Joshua/0000-0003-1540-203X; Karasik, David/0000-0002-8826-0530; van Pelt, Joost/0000-0001-5538-1806; Beilby, John/0000-0002-4915-2254; TREMOLI, ELENA/0000-0002-0929-6106; Munroe, Patricia/0000-0002-4176-2947; Emilsson, Valur/0000-0001-9982-0524; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Dorajoo, Rajkumar/0000-0001-6608-2051; Scholtens, Salome/0000-0002-0651-5203; Tai, E Shyong/0000-0003-2929-8966; Mahajan, Anubha/0000-0001-5585-3420; Uh, Hae-Won/0000-0003-4195-7872; CUCCA, Francesco/0000-0002-7414-1995; Fuchsberger, Christian/0000-0002-5918-8947; Day, Felix/0000-0003-3789-7651; Aspelund, Thor/0000-0002-7998-5433; Volker, Uwe/0000-0002-5689-3448; Asiki, Gershim/0000-0002-9966-1153; Ciullo, Marina/0000-0002-9621-9984; den Ruijter, Hester/0000-0001-9762-014X; Melander, Olle/0000-0002-2581-484X; Magi, Reedik/0000-0002-2964-6011; Tobin, Martin/0000-0002-3596-7874; Org, Elin/0000-0001-8688-9717; Marziliano, Nicola/0000-0001-6800-089X; SCUTERI, ANGELO/0000-0003-4784-5441; Quertermous, Thomas/0000-0002-7645-9067; Lakka, Timo/0000-0002-9199-2871; Elliott, Paul/0000-0002-7511-5684; Soler Artigas, Maria/0000-0002-3213-1107; Graessler, Juergen/0000-0003-3619-8517; Ma, Baoshan/0000-0003-1629-1968; Demirkan, Ayse/0000-0002-7546-0867; Boyd, Heather/0000-0001-6849-9985; Chouraki, Vincent/0000-0002-4698-1794; Menni, Cristina/0000-0001-9790-0571; Geller, Frank/0000-0002-9238-3269; Eriksson, Per/0000-0002-5635-2692; Van Duijn, Cornelia/0000-0002-2374-9204; Terzic, Janos/0000-0003-3228-2076; Pers, Tune/0000-0003-0207-4831; Raychaudhuri, Soumya/0000-0002-1901-8265; Murgia, Federico/0000-0002-3608-845X; Bandinelli, Stefania/0000-0002-6491-0850; Franks, Paul/0000-0002-0520-7604; Taylor, Andrew/0000-0003-4194-7113; Amouyel, Philippe/0000-0001-9088-234X; Marette, Andre/0000-0003-3950-5973; Maxwell, Alexander P./0000-0002-6110-7253; Wild, Philipp/0000-0003-4413-9752; Gasparini, Paolo/0000-0002-0859-0856; Godson, Catherine/0000-0003-0655-1041; Warrington, Nicole/0000-0003-4195-775X; Stolk, Ronald/0000-0002-0518-1205; Gieger, Christian/0000-0001-6986-9554; Sanghera, Dharambir/0000-0001-7203-8655; Ouwehand, Willem/0000-0002-7744-1790; Waeber, Gerard/0000-0003-4193-788X; Chen, Ming-Huei/0000-0003-3551-8726; Martinovic Klaric, Irena/0000-0002-6545-5589; Lunetta, Kathryn/0000-0002-9268-810X; Mulas, Antonella/0000-0002-6856-1483; Broer, Linda/0000-0003-0011-123X; Caulfield, Mark/0000-0001-9295-3594; Schork, Nicholas/0000-0003-0920-5013; Mannisto, Satu/0000-0002-8668-3046; Soranzo, Nicole/0000-0003-1095-3852; Kahali, Bratati/0000-0003-2523-3778; Barroso, Ines/0000-0001-5800-4520; Okamura, Tomonori/0000-0003-0488-0351; Shuldiner, Alan/0000-0001-9921-4305; Johnson, Paul/0000-0001-6663-7520; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Amin, Najaf/0000-0002-8944-1771; CASARI, Giorgio/0000-0002-0115-8980; Caspersen, Ida Henriette/0000-0003-2591-8435; Engert, James/0000-0001-8411-4790; Seshadri, Sudha/0000-0001-6135-2622; Weedon, Michael/0000-0002-6174-6135; bennett, amanda/0000-0003-2140-8710; Wain, Louise/0000-0003-4951-1867; Asselta, Rosanna/0000-0001-5351-0619; Portas, Laura/0000-0003-1789-1893; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Rice, Treva/0000-0001-7452-2600; Schmidt, Ellen/0000-0003-1198-7536; Shungin, Dmitry/0000-0001-7900-5856; Justice, Anne/0000-0002-8903-8712; Zondervan, Krina/0000-0002-0275-9905; Smith, Jennifer Ann/0000-0002-3575-5468; Eyheramendy, Susana/0000-0003-4723-9660; Sinisalo, Juha/0000-0002-0169-5137; Kuznetsova, Tatiana/0000-0003-4293-4576; Kraft, Peter/0000-0002-4472-8103; Robino, Antonietta/0000-0003-2152-2353	Economic and Social Research Council [ES/F02679X/1, ES/J023299/1] Funding Source: researchfish; Lundbeck Foundation [R190-2014-3904] Funding Source: researchfish; Medical Research Council [G0600717B, MC_UU_12012/5/B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10380, NF-SI-0611-10170, NF-SI-0514-10027, NF-SI-0513-10109, NF-SI-0512-10114, NF-SI-0611-10219, NF-SI-0512-10165, NF-SI-0513-10059, NF-SI-0512-10113, NF-SI-0611-10099] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016416, NNF13OC0004839, NNF14OC0010513, NNF13OC0005785, NNF12OC1016467, NNF14OC0009883] Funding Source: researchfish; ESRC [ES/F02679X/1, ES/J023299/1] Funding Source: UKRI; MRC [MR/L003120/1, MC_UU_12015/1, MC_UU_12015/2, G0600717, G1000616, G0902037, MR/N01104X/1, MC_UU_12013/1, MC_PC_U127561128, MC_UU_12019/1, MC_U106179472, MC_UP_A100_1003, G9521010, MR/K013351/1, G0601261, MC_UU_12015/5, MR/K002414/1, G1001799, MC_UU_12012/1] Funding Source: UKRI; British Heart Foundation [BHF_FS/14/55/30806, BHF_RG/08/008/25291, BHF_RG/08/014/24067, RG/10/12/28456, RG/07/008/23674, RG/08/014/24067, BHF_RG/10/12/28456, FS/14/55/30806, RG/08/008/25291] Funding Source: Medline; Cancer Research UK [14136, CRUK_14136] Funding Source: Medline; Medical Research Council [MRC_G0401527, MR/N01104X/1, MC_UU_12013/4, G0600717, MC_UU_12015/5, MRC_MC_UP_A100_1003, MR/L003120/1, MRC_MR/K013351/1, MRC_MC_UU_12012/1, G1000616, MRC_MC_U106179471, MC_UU_12012/1, MC_U106179471, G1001799, MRC_G1001799, MRC_MC_UU_12015/5, MRC_MC_U106179472, G0601261, MC_UP_A100_1003, G0401527, MRC_MR/N01104X/1, MRC_MC_UU_12019/1, MRC_MC_UU_12013/1, MRC_MC_UU_12015/1, MC_U106179472, G19/35, MC_UU_12015/2, MR/K013351/1, MRC_MC_UU_12015/2, G9521010, MC_UU_12013/1, G1000143, G0100222, MR/K006584/1, MRC_MR/L003120/1, MC_PC_U127561128, G8802774, MRC_G0601261, MR/K002414/1, MC_UU_12015/1, MC_UU_12019/1, MRC_G1000143, MRC_G9521010, G0902037, MRC_MC_PC_U127561128, MRC_MR/K006584/1] Funding Source: Medline; NCATS NIH HHS [TL1 TR001066, UL1 TR000124, UL1 TR001067] Funding Source: Medline; NCI NIH HHS [UM1 CA182913, U01 CA164930, UM1 CA182910, P30 CA071789] Funding Source: Medline; NHGRI NIH HHS [U01 HG007416, U01 HG007417, U01 HG007376, U01 HG007419] Funding Source: Medline; NHLBI NIH HHS [R01 HL117626, K01 HL116770, T32 HL007055, R01 HL105756, R01 HL117078, T32 HL007824, R01 HL109946, P30 HL107251] Funding Source: Medline; NIA NIH HHS [R01 AG025941, U01 AG049505, R01 AG041517, U01 AG009740, R01 AG033193, P30 AG010129] Funding Source: Medline; NICHD NIH HHS [P2C HD050924] Funding Source: Medline; NIDA NIH HHS [R21 DA027040] Funding Source: Medline; NIDDK NIH HHS [P30 DK072488, R01 DK078150, R01 DK062370, R01 DK072193, R01 DK089256, P30 DK020572, P30 DK020541, R01 DK075787, P30 DK063491, P30 DK056341, P60 DK020541, R01 DK093757, K23 DK080145, U01 DK062370] Funding Source: Medline; NIGMS NIH HHS [P30 GM103341, T32 GM080178, R25 GM062459, T32 GM007814] Funding Source: Medline; NIMHD NIH HHS [P20 MD006899] Funding Source: Medline; NINDS NIH HHS [R01 NS017950] Funding Source: Medline; Wellcome Trust [097117, 098017, WT098017, 098381, 085235, WT097117, WT085235, 100574, 084766, WT100574, WT098381, WT084766] Funding Source: Medline; Chief Scientist Office [CSO_CZB/4/710, CSO_CZB/4/672, CZB/4/672, CZB/4/710] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA071789, UM1CA182910, U01CA164930, UM1CA182913] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001067, TL1TR001066, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117078, P30HL107251, R01HL117626, T32HL007824, T32HL007055, R01HL109946, R01HL105756, K01HL116770] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007376, U01HG007419, U01HG007416, U01HG007417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK080145, R01DK075787, P30DK020541, R01DK078150, P30DK063491, R01DK093757, R01DK089256, P60DK020541, U01DK062370, P30DK072488, R01DK072193, R01DK062370, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178, T32GM007814, R25GM062459, P30GM103341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740, ZIAAG000675, R01AG033193, R01AG025941, R01AG041517, U01AG049505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027040] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); Chief Scientist Office; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; Bouchonville M, 2014, INT J OBESITY, V38, P423, DOI 10.1038/ijo.2013.122; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fall T, 2014, MOL CELL ENDOCRINOL, V382, P740, DOI 10.1016/j.mce.2012.08.018; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs JW, 2000, EPILEPSIA, V41, pS10; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Kilpelainen TO, 2011, NAT GENET, V43, P753, DOI 10.1038/ng.866; Lee AWS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041537; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Magi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070735; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Poulsen CF, 2004, NEUROCHEM RES, V29, P275, DOI 10.1023/B:NERE.0000010456.92887.3b; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Sandholm N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002921; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shen Y, 2013, J NEUROSCI, V33, P464, DOI 10.1523/JNEUROSCI.3282-12.2013; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Williams WW, 2012, DIABETES, V61, P2187, DOI 10.2337/db11-0751; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	73	2541	2580	31	948	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					197	U401		10.1038/nature14177	http://dx.doi.org/10.1038/nature14177			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25673413	Green Submitted, Green Accepted			2022-12-28	WOS:000349190300031
J	McDermott, DH; Gao, JL; Liu, Q; Siwicki, M; Martens, C; Jacobs, P; Velez, D; Yim, E; Bryke, CR; Hsu, N; Dai, ZY; Marquesen, MM; Stregevsky, E; Kwatemaa, N; Theobald, N; Priel, DAL; Pittaluga, S; Raffeld, MA; Calvo, KR; Maric, I; Desmond, R; Holmes, KL; Kuhns, DB; Balabanian, K; Bachelerie, F; Porcella, SF; Malech, HL; Murphy, PM				McDermott, David H.; Gao, Ji-Liang; Liu, Qian; Siwicki, Marie; Martens, Craig; Jacobs, Paejonette; Velez, Daniel; Yim, Erin; Bryke, Christine R.; Hsu, Nancy; Dai, Zunyan; Marquesen, Martha M.; Stregevsky, Elina; Kwatemaa, Nana; Theobald, Narda; Priel, Debra A. Long; Pittaluga, Stefania; Raffeld, Mark A.; Calvo, Katherine R.; Maric, Irina; Desmond, Ronan; Holmes, Kevin L.; Kuhns, Douglas B.; Balabanian, Karl; Bachelerie, Francoise; Porcella, Stephen F.; Malech, Harry L.; Murphy, Philip M.			Chromothriptic Cure of WHIM Syndrome	CELL			English	Article							CXCR4 ANTAGONIST PLERIXAFOR; CHEMOKINE RECEPTORS; HEMATOPOIETIC STEM; PROGENITOR CELLS; MYELOKATHEXIS; SURVIVAL/ANTIAPOPTOSIS; DESENSITIZATION; NEUTROPENIA; MUTATIONS; MECHANISM	Chromothripsis is a catastrophic cellular event recently described in cancer in which chromosomes undergo massive deletion and rearrangement. Here, we report a case in which chromothripsis spontaneously cured a patient with WHIM syndrome, an autosomal dominant combined immunodeficiency disease caused by gain-of-function mutation of the chemokine receptor CXCR4. In this patient, deletion of the disease allele, CXCR4(R334X), as well as 163 other genes from one copy of chromosome 2 occurred in a hematopoietic stem cell (HSC) that re-populated the myeloid but not the lymphoid lineage. In competitive mouse bone marrow (BM) transplantation experiments, Cxcr4 haploinsufficiency was sufficient to confer a strong long-term engraftment advantage of donor BM over BM from either wildtype or WHIM syndrome model mice, suggesting a potential mechanism for the patient's cure. Our findings suggest that partial inactivation of CXCR4 may have general utility as a strategy to promote HSC engraftment in transplantation.	[McDermott, David H.; Gao, Ji-Liang; Liu, Qian; Siwicki, Marie; Jacobs, Paejonette; Velez, Daniel; Yim, Erin; Murphy, Philip M.] NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Martens, Craig; Porcella, Stephen F.] NIAID, Res Technol Branch, NIH, Hamilton, MT 59840 USA; [Stregevsky, Elina; Holmes, Kevin L.] NIAID, Res Technol Branch, NIH, Bethesda, MD 20892 USA; [Hsu, Nancy; Dai, Zunyan] Quest Diagnost, Chantilly, VA 20151 USA; [Marquesen, Martha M.; Kwatemaa, Nana; Theobald, Narda; Malech, Harry L.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; [Priel, Debra A. Long; Kuhns, Douglas B.] Frederick Natl Lab Canc Res, Leidos Biomed Res, Clin Serv Program, Frederick, MD 21701 USA; [Pittaluga, Stefania; Raffeld, Mark A.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Calvo, Katherine R.; Maric, Irina] NIH, Div Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Desmond, Ronan] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Desmond, Ronan] Tallaght Hosp, Dept Haematol, Dublin 24, Ireland; [Balabanian, Karl; Bachelerie, Francoise] Univ Paris 11, Lab Excellence Res Medicat & Innovat Therapeut, INSERM UMR S996, F-92140 Clamart, France; [Bryke, Christine R.; Hsu, Nancy] Beth Israel Deaconess Med Ctr, Dept Cytogenet, Boston, MA 02215 USA; [Dai, Zunyan] Emory Univ, Sch Med, Dept Human Genet, Decatur, GA 30030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Trinity College Dublin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Beth Israel Deaconess Medical Center; Emory University	Murphy, PM (corresponding author), NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA.	pmm@nih.gov	Balabanian, Karl/S-6250-2019; Balabanian, Karl/I-2990-2016; BACHELERIE, FRANCOISE/F-8823-2013; Gao, Ji-Liang/Y-4397-2019; McDermott, David/AAP-2459-2021	Balabanian, Karl/0000-0002-0534-3198; Balabanian, Karl/0000-0002-0534-3198; BACHELERIE, FRANCOISE/0000-0002-0399-3277; McDermott, David/0000-0001-6978-0867; Malech, Harry/0000-0001-5874-5775	Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases (NIAID), NIH; National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZICBC011079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000645, ZIAAI000988, ZIAAI000644, ZIAAI000615] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090025] Funding Source: NIH RePORTER	Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases (NIAID), NIH; National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	This work was supported by the Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases (NIAID), NIH and was funded in part with federal funds from the National Cancer Institute, NIH under contract HHSN261200800001E. We thank Hongwei Zhang for flow cytometry advice, Carolyn Boscia for help with graphics, and the research subjects for their participation in the study. A provisional patent on CXCR4 knockdown as a method to enhance HSC engraftment has been filed by the US government with D. H. M., Q. L., M. S., J.G., H. L. M., and P. M. M. as inventors.	Al Ustwani O, 2014, BRIT J HAEMATOL, V164, P15, DOI 10.1111/bjh.12574; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Balabanian K, 2012, BLOOD, V119, P5722, DOI 10.1182/blood-2012-01-403378; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Cohen SB, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-71; Dale DC, 2011, BLOOD, V118, P4963, DOI 10.1182/blood-2011-06-360586; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Dotta L, 2011, CURR MOL MED, V11, P317, DOI 10.2174/156652411795677963; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; Jones MJK, 2012, DEV CELL, V23, P908, DOI 10.1016/j.devcel.2012.10.010; Kawai T, 2007, BLOOD, V109, P78, DOI 10.1182/blood-2006-05-025296; Kawai T, 2009, CURR OPIN HEMATOL, V16, P20, DOI 10.1097/MOH.0b013e32831ac557; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; KRILL CE, 1964, NEW ENGL J MED, V270, P973, DOI 10.1056/NEJM196405072701902; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; McDermott DH, 2014, BLOOD, V123, P2308, DOI 10.1182/blood-2013-09-527226; McDermott DH, 2011, BLOOD, V118, P4957, DOI 10.1182/blood-2011-07-368084; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Orelio C, 2009, HAEMATOL-HEMATOL J, V94, P462, DOI 10.3324/haematol.13728; Signoret N, 1998, J CELL SCI, V111, P2819; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tassone L, 2009, J ALLERGY CLIN IMMUN, V123, P1170, DOI 10.1016/j.jaci.2008.12.1133; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; WETZLER M, 1990, AM J MED, V89, P663, DOI 10.1016/0002-9343(90)90187-I; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269; ZUELZER WW, 1964, NEW ENGL J MED, V270, P699, DOI 10.1056/NEJM196404022701402	34	118	128	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					686	699		10.1016/j.cell.2015.01.014	http://dx.doi.org/10.1016/j.cell.2015.01.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25662009	Green Accepted, Bronze			2022-12-28	WOS:000349208800012
J	Gornall, J				Gornall, Jonathan			Sugar's web of influence 3: Why the responsibility deal is a "dead duck" for sugar reduction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						Action on Sugar, 2014, CHILDH OB ACT PLAN; [Anonymous], 2014, SUG RED RESP CHALL; Kantar Worldpanel Usage, 2014, SALT SUG FAT CONS EY; RAVEN R J, 1988, American Museum Novitates, P1; Renton A., 2014, DAILY MAIL; Scientific Advisory Committee on Nutrition, 2014, DRAFT CARB HLTH REP; Taubes G, 2001, SCIENCE, V291, P2536, DOI 10.1126/science.291.5513.2536	7	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2015	350								h219	10.1136/bmj.h219	http://dx.doi.org/10.1136/bmj.h219			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0MG	25672995				2022-12-28	WOS:000349319700002
J	Sartor, C; Gregoire, E; Albanese, J; Fournier, PE				Sartor, Catherine; Gregoire, Emilie; Albanese, Jacques; Fournier, Pierre-Edouard			Invasive Listeria monocytogenes infection after liver transplantation: a life-threatening condition	LANCET			English	Editorial Material									[Sartor, Catherine] Hop Conception, Equipe Operat Hyg Hosp, F-13005 Marseille, France; [Gregoire, Emilie] Hop Conception, Serv Chirurg Digest & Transplantat Hepat, F-13005 Marseille, France; [Albanese, Jacques] Hop Conception, Serv Anesthesie Reanimat, F-13005 Marseille, France; [Fournier, Pierre-Edouard] Aix Marseille Univ, Unite Rech Malad Infect & Tropicales Emergentes, Marseille, France; [Fournier, Pierre-Edouard] Hop St Marguerite, Com Lutte Infect Nosocomiales, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Sartor, C (corresponding author), Hop Conception, Equipe Operat Hyg Hosp, Com Lutte Infect Nosocomiales, 147 Blvd Baille, F-13005 Marseille, France.	catherine.sartor@ap-hm.fr	Albanese, Jacques/AAS-7466-2021; Fournier, Pierre-Edouard/AAC-6155-2021	Fournier, Pierre-Edouard/0000-0001-8463-8885				Ehehalt U, 2010, CASE REP MED, V2010, DOI 10.1155/2010/901894; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Goulet V, 2012, CLIN INFECT DIS, V54, P652, DOI 10.1093/cid/cir902; Ministry of Health France, CARN MAT; Mook P, 2011, EMERG INFECT DIS, V17, P38, DOI 10.3201/eid1701.101174	5	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					200	200		10.1016/S0140-6736(14)61831-6	http://dx.doi.org/10.1016/S0140-6736(14)61831-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY7BI	25706469				2022-12-28	WOS:000347715900027
J	Head, R; Murray, J; Sarrassat, S; Snell, W; Meda, N; Ouedraogo, M; Deboise, L; Cousens, S				Head, Roy; Murray, Joanna; Sarrassat, Sophie; Snell, Will; Meda, Nicolas; Ouedraogo, Moctar; Deboise, Laurent; Cousens, Simon			Can mass media interventions reduce child mortality?	LANCET			English	Editorial Material							ACTIVE TRACHOMA; RISK-FACTORS; HEALTH; CAMPAIGNS; EDUCATION; IMPACT	Many people recognise that mass media is important in promoting public health but there have been few attempts to measure how important. An ongoing trial in Burkina Faso (ClinicalTrials.gov, NCT01517230) is an attempt to bring together the very different worlds of mass media and epidemiology: to measure rigorously, using a cluster-randomised design, how many lives mass media can save in a low-income country, and at what cost. Application of the Lives Saved Tool predicts that saturation-based media campaigns could reduce child mortality by 10-20%, at a cost per disability-adjusted life-year that is as low as any existing health intervention. In this Viewpoint we explain the scientific reasoning behind the trial, while stressing the importance of the media methodology used.	[Head, Roy; Murray, Joanna; Snell, Will] Dev Media Int, London N1 5EW, England; [Sarrassat, Sophie; Cousens, Simon] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Meda, Nicolas; Ouedraogo, Moctar] Ctr Muraz, Bobo Dioulasso, Burkina Faso	University of London; London School of Hygiene & Tropical Medicine; Centre Muraz	Head, R (corresponding author), Dev Media Int, Unit R, Reliance Wharf, Hertford Rd, London N1 5EW, England.	roy@developmentmedia.net	OUEDRAOGO, Moctar/AAH-4179-2020	Sarrassat, Sophie/0000-0001-6872-6455	Wellcome Trust [091367] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 1995, Am J Public Health, V85, P183; Bala M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub2; de Vroome E M, 1990, Int J STD AIDS, V1, P268; Development Media International, ETH TRACH CAMP 2001; DMI Orissa Maternal and Child Helath Campaign 2009, 2009, DMI ORISSA METERNAL; DuboisArber F, 1997, AM J PUBLIC HEALTH, V87, P558, DOI 10.2105/AJPH.87.4.558; Edwards T, 2006, OPHTHALMOLOGY, V113, P548, DOI 10.1016/j.ophtha.2006.01.008; Edwards T, 2008, TROP MED INT HEALTH, V13, P556, DOI 10.1111/j.1365-3156.2008.02034.x; Elder RW, 2004, AM J PREV MED, V27, P57, DOI 10.1016/j.amepre.2004.03.002; FARQUHAR JW, 1990, JAMA-J AM MED ASSOC, V264, P359, DOI 10.1001/jama.264.3.359; Grilli R., 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000389; Hornik R. C., 2002, PUBLIC HLTH COMMUNIC, P1; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P3, DOI 10.1596/978-0-8213-6179-5/Chpt-1; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Levy D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001336; MCDIVITT JA, 1993, STUD FAMILY PLANN, V24, P295, DOI 10.2307/2939223; Murray C., 2012, ACCELERATING PROGR I; Noar SM, 2006, J HEALTH COMMUN, V11, P21, DOI 10.1080/10810730500461059; The US Community Preventive Services Taskforce, 2013, RED TOB US SEC SMOK; United Nations Children's Fund, 2010, FACTS FOR LIF; Viswanath K, 2002, LEA COMMUN SER, P289; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; WORDEN JK, 1988, PREV MED, V17, P531, DOI 10.1016/0091-7435(88)90051-5; World Health Organization, 1996, INV HLTH RES DEV REP; Zimicki S, 2002, LEA COMMUN SER, P197	25	21	21	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					97	100		10.1016/S0140-6736(14)61649-4	http://dx.doi.org/10.1016/S0140-6736(14)61649-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM2OA	25684587				2022-12-28	WOS:000357519400032
J	Ansell, DA; McDonald, EK				Ansell, David A.; McDonald, Edwin K.			Bias, Black Lives, and Academic Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISPARITIES		[Ansell, David A.; McDonald, Edwin K.] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA	Rush University	Ansell, DA (corresponding author), Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA.							Ayanian JZ, 2014, NEW ENGL J MED, V371, P2288, DOI 10.1056/NEJMsa1407273; Castillo-Page L, 2012, DIVERSITY MED ED FAC; Chapman EN, 2013, J GEN INTERN MED, V28, P1504, DOI 10.1007/s11606-013-2441-1; Guevara JP, 2013, JAMA-J AM MED ASSOC, V310, P2297, DOI 10.1001/jama.2013.282116; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875	5	48	48	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1087	1089		10.1056/NEJMp1500832	http://dx.doi.org/10.1056/NEJMp1500832			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD6EZ	25692913				2022-12-28	WOS:000351183600002
J	Kim, MS; Lapkouski, M; Yang, W; Gellert, M				Kim, Min-Sung; Lapkouski, Mikalai; Yang, Wei; Gellert, Martin			Crystal structure of the V(D)J recombinase RAG1-RAG2	NATURE			English	Article							DNA HAIRPIN FORMATION; AMINO-ACID-RESIDUES; SINGLE ACTIVE-SITE; MUTATIONAL ANALYSIS; BINDING DOMAIN; RAG2 PROTEINS; COMPLEX; TRANSPOSITION; CLEAVAGE; RAG1/2	V(D)J recombination in the vertebrate immune system generates a highly diverse population of immunoglobulins and T-cell receptors by combinatorial joining of segments of coding DNA. The RAG1-RAG2 protein complex initiates this site-specific recombination by cutting DNA at specific sites flanking the coding segments. Here we report the crystal structure of the mouse RAG1-RAG2 complex at 3.2A resolution. The 230-kilodalton RAG1-RAG2 heterotetramer is 'Y-shaped', with the amino-terminal domains of the two RAG1 chains forming an intertwined stalk. Each RAG1-RAG2 heterodimer composes one arm of the 'Y', with the active site in the middle and RAG2 at its tip. The RAG1-RAG2 structure rationalizes more than 60 mutations identified in immunodeficient patients, as well as a large body of genetic and biochemical data. The architectural similarity between RAG1 and the hairpin-forming transposases Hermes and Tn5 suggests the evolutionary conservation of these DNA rearrangements.	[Kim, Min-Sung; Lapkouski, Mikalai; Yang, Wei; Gellert, Martin] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Yang, W (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	wei.yang@nih.gov; gellert@helix.nih.gov	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036147, ZIADK036167] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Grundy and S. Ramon-Maiques for the pioneering work that made this study possible, and D. Leahy for editing the manuscript The research was supported by the intramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.	Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Aidinis V, 1999, MOL CELL BIOL, V19, P6532; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Boboila C, 2012, ADV IMMUNOL, V116, P1, DOI 10.1016/B978-0-12-394300-2.00001-6; Callebaut I, 1998, CELL MOL LIFE SCI, V54, P880, DOI 10.1007/s000180050216; CUOMO CA, 1994, NUCLEIC ACIDS RES, V22, P1810, DOI 10.1093/nar/22.10.1810; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Gigi V, 2014, NUCLEIC ACIDS RES, V42, P6352, DOI 10.1093/nar/gku295; Grundy GJ, 2007, P NATL ACAD SCI USA, V104, P3078, DOI 10.1073/pnas.0611293104; Grundy GJ, 2009, MOL CELL, V35, P217, DOI 10.1016/j.molcel.2009.06.022; Gwyn LM, 2009, J MOL BIOL, V390, P863, DOI 10.1016/j.jmb.2009.05.076; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hickman AB, 2014, CELL, V158, P353, DOI 10.1016/j.cell.2014.05.037; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Huye LE, 2002, MOL CELL BIOL, V22, P3460, DOI 10.1128/MCB.22.10.3460-3473.2002; Jones JM, 2001, P NATL ACAD SCI USA, V98, P12926, DOI 10.1073/pnas.221471198; Kim DR, 1998, MOL CELL BIOL, V18, P4679, DOI 10.1128/MCB.18.8.4679; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Ko JE, 2004, J BIOL CHEM, V279, P7715, DOI 10.1074/jbc.M311471200; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; Lee YN, 2014, J ALLERGY CLIN IMMUN, V133, P1099, DOI 10.1016/j.jaci.2013.10.007; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Liu Q, 2011, ACTA CRYSTALLOGR D, V67, P45, DOI 10.1107/S0907444910046573; Lu CP, 2006, NAT STRUCT MOL BIOL, V13, P1010, DOI 10.1038/nsmb1154; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Nesmelova IV, 2010, ADV DRUG DELIVER REV, V62, P1187, DOI 10.1016/j.addr.2010.06.006; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Piirila H, 2006, HUM MUTAT, V27, P1200, DOI 10.1002/humu.20405; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Rodgers KK, 1996, J MOL BIOL, V260, P70, DOI 10.1006/jmbi.1996.0382; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SILVER DP, 1993, P NATL ACAD SCI USA, V90, P6100, DOI 10.1073/pnas.90.13.6100; Steiniger-White M, 2004, CURR OPIN STRUC BIOL, V14, P50, DOI 10.1016/j.sbi.2004.01.008; Swanson PC, 1999, MOL CELL BIOL, V19, P3674; Swanson PC, 2001, MOL CELL BIOL, V21, P449, DOI 10.1128/MCB.21.2.449-458.2001; vanGent DC, 1997, EMBO J, V16, P2665, DOI 10.1093/emboj/16.10.2665; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593	45	109	111	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					507	511		10.1038/nature14174	http://dx.doi.org/10.1038/nature14174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25707801	Green Accepted, Green Submitted			2022-12-28	WOS:000350097300040
J	Bateman, AW; Gunderson, J; Mulder, R				Bateman, Anthony W.; Gunderson, John; Mulder, Roger			Treatment of personality disorder	LANCET			English	Article							COGNITIVE-BEHAVIORAL TREATMENT; 6-YEAR FOLLOW-UP; PHARMACOLOGICAL-TREATMENT; MULTISYSTEMIC THERAPY; ANALYTIC THERAPY; CONTROLLED-TRIAL; BORDERLINE; PSYCHOTHERAPY; ADOLESCENTS; COMORBIDITY	The evidence base for the effective treatment of personality disorders is insufficient. Most of the existing evidence on personality disorder is for the treatment of borderline personality disorder, but even this is limited by the small sample sizes and short follow-up in clinical trials, the wide range of core outcome measures used by studies, and poor control of coexisting psychopathology. Psychological or psychosocial intervention is recommended as the primary treatment for borderline personality disorder and pharmacotherapy is only advised as an adjunctive treatment. The amount of research about the underlying, abnormal, psychological or biological processes leading to the manifestation of a disordered personality is increasing, which could lead to more effective interventions. The synergistic or antagonistic interaction of psychotherapies and drugs for treating personality disorder should be studied in conjunction with their mechanisms of change throughout the development of each.	[Bateman, Anthony W.] Barnet Enfield & Haringey Mental Hlth NHS Trust, London, England; [Bateman, Anthony W.] UCL, London, England; [Bateman, Anthony W.] Anna Freud Ctr, London, England; [Gunderson, John] Harvard Univ, Sch Med, Psychosocial & Personal Res McLean Hosp, Boston, MA USA; [Mulder, Roger] Univ Otago, Dept Psychol Med, Christchurch, New Zealand	University of London; University College London; The Anna Freud Centre; Harvard University; Harvard Medical School; McLean Hospital; University of Otago	Bateman, AW (corresponding author), St Anns Hosp, Halliwick Unit, London N15 3TH, England.	anthony.bateman@ucl.ac.uk						Abraham PF, 2008, J AFFECT DISORDERS, V111, P21, DOI 10.1016/j.jad.2008.01.024; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; American Psychiatric Association Practice Guidelines, 2001, Am J Psychiatry, V158, P1; [Anonymous], J AM ACAD CHILD ADOL; [Anonymous], 1999, TRANSFERENCE FOCUSED; Bamelis LLM, 2014, AM J PSYCHIAT, V171, P305, DOI 10.1176/appi.ajp.2013.12040518; Bandelow B, 2010, PSYCHOL REV, V117, P623, DOI 10.1037/a0018095; Bartz J, 2011, SOC COGN AFFECT NEUR, V6, P556, DOI 10.1093/scan/nsq085; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Bateman A, 1999, AM J PSYCHIAT, V156, P1563, DOI 10.1176/ajp.156.10.1563; Bateman A, 2004, PSYCHOTHERAPY BORDER, DOI 10.1093/med:psych/9780198527664.001.0001; Bateman A, 2008, AM J PSYCHIAT, V165, P631, DOI 10.1176/appi.ajp.2007.07040636; Bateman A, 2013, BRIT J PSYCHIAT, V203, P221, DOI 10.1192/bjp.bp.112.121129; Bateman A, 2009, AM J PSYCHIAT, V166, P1355, DOI 10.1176/appi.ajp.2009.09040539; Bateman AW, 2012, AM J PSYCHIAT, V169, P560, DOI 10.1176/appi.ajp.2012.12030341; Bateman AW, 2004, J PERS DISORD, V18, P36, DOI 10.1521/pedi.18.1.36.32772; Bateman AW., 2013, BORDERLINE PERSONALI; Beck A.T., 2015, COGNITIVE THERAPY PE; Becker DF, 2000, AM J PSYCHIAT, V157, P2011, DOI 10.1176/appi.ajp.157.12.2011; Bender D., 2005, TXB PERSONALITY DISO; Bertsch K, 2013, AM J PSYCHIAT, V170, P1169, DOI 10.1176/appi.ajp.2013.13020263; Black D.W., 2004, J CONTEMP PSYCHOTHER, V34, P193, DOI [DOI 10.1023/B:JOCP.0000036630.25741.83, https://doi.org/10.1023/B:JOCP.0000036630.25741.83]; Chamberlain P, 1998, SOCIAL PROGRAMMES RE, P256; Chanen AM, 2008, BRIT J PSYCHIAT, V193, P477, DOI 10.1192/bjp.bp.107.048934; Chiesa M, 2000, BRIT J PSYCHIAT, V176, P485, DOI 10.1192/bjp.176.5.485; Chiesa M, 2006, J PERS DISORD, V20, P493, DOI 10.1521/pedi.2006.20.5.493; Clarke S, 2013, BRIT J PSYCHIAT, V202, P129, DOI 10.1192/bjp.bp.112.108670; Clarkin JF, 2007, AM J PSYCHIAT, V164, P922, DOI 10.1176/appi.ajp.164.6.922; Corruble E, 1996, J AFFECT DISORDERS, V37, P157, DOI 10.1016/0165-0327(95)00091-7; Crawford MJ, 2009, PERSONAL MENT HEALTH, V3, P165, DOI 10.1002/pmh.85; Davidson KM, 2009, PSYCHOL MED, V39, P569, DOI 10.1017/S0033291708004066; Davidson K. M., 2000, COGNITIVE THERAPY PE; Davidson KM, 2010, BRIT J PSYCHIAT, V197, P456, DOI 10.1192/bjp.bp.109.074286; Doyle M, 2013, J FORENSIC PSYCHI PS, V24, P1, DOI 10.1080/14789949.2012.752519; Duggan C, 2007, PERSONAL MENT HEALTH, V1, P95, DOI 10.1002/pmh.22; Duggan C, 2008, PERSONAL MENT HEALTH, V2, P119, DOI 10.1002/pmh.41; Emmelkamp PMG, 2006, BRIT J PSYCHIAT, V189, P60, DOI 10.1192/bjp.bp.105.012153; Friendship C, 2003, LEGAL CRIMINOL PSYCH, V8, P103, DOI 10.1348/135532503762871273; Gabbard G, 2007, GABBARDS TREATMENT P; Gibbon S., 2010, COCHRANE DB SYST REV, V16; Gunderson JG., 2014, HDB GOOD PSYCHIAT MA; Haigh R, 2002, PSYCHIAT B, V26, P68; Helgeland MI, 2005, AM J PSYCHIAT, V162, P1941, DOI 10.1176/appi.ajp.162.10.1941; Herpertz SC, 2007, WORLD J BIOL PSYCHIA, V8, P212, DOI 10.1080/15622970701685224; Huband N, 2007, BRIT J PSYCHIAT, V190, P307, DOI 10.1192/bjp.bp.106.023341; Joseph N, 2012, CRIM BEHAV MENT HEAL, V22, P210, DOI 10.1002/cbm.1835; Kendall T, 2010, BRIT J PSYCHIAT, V196, P158, DOI 10.1192/bjp.196.2.158; Khalifa N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007667.pub2; Kvarstein EH, 2012, J PERS DISORD, V26, P141, DOI 10.1521/pedi.2012.26.2.141; Leichsenring F, 2003, AM J PSYCHIAT, V160, P1223, DOI 10.1176/appi.ajp.160.7.1223; Leichsenring F, 2008, JAMA-J AM MED ASSOC, V300, P1551, DOI 10.1001/jama.300.13.1551; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; Letourneau EJ, 2009, J FAM PSYCHOL, V23, P89, DOI 10.1037/a0014352; Lieb K, 2010, BRIT J PSYCHIAT, V196, P4, DOI 10.1192/bjp.bp.108.062984; Linehan M., 1993, COGNITIVE BEHAV TREA; LINEHAN MM, 1991, ARCH GEN PSYCHIAT, V48, P1060; McGlashan TH, 2000, ACTA PSYCHIAT SCAND, V102, P256, DOI 10.1034/j.1600-0447.2000.102004256.x; McMain SF, 2012, AM J PSYCHIAT, V169, P650, DOI 10.1176/appi.ajp.2012.11091416; McMain SF, 2009, AM J PSYCHIAT, V166, P1365, DOI 10.1176/appi.ajp.2009.09010039; McMurran M, 2012, PSYCHOLOGIST, V25, P276; Mehlum L, 2014, J AM ACAD CHILD PSY, V53, P1082, DOI 10.1016/j.jaac.2014.07.003; Mercer D, 2009, J PERS DISORD, V23, P156, DOI 10.1521/pedi.2009.23.2.156; MULDER R, 1992, AUST NZ J PSYCHIAT, V26, P364, DOI 10.3109/00048679209072059; Mulder RT, 2011, J PERS DISORD, V25, P364, DOI 10.1521/pedi.2011.25.3.364; National Health and Medical Research Council, 2012, CLIN PRACT UID MAN B; National Institute for Health and Care Excellence (NICE), 2009, ANT PERS DIS TREATM; National Institute for Health and Clinical Excellence (NICE), 2009, BORD PERS DIS TREATM; Neacsiu AD, 2010, BEHAV RES THER, V48, P832, DOI 10.1016/j.brat.2010.05.017; Newton-Howes G, 2014, J PERS DISORD, V28, P577, DOI 10.1521/pedi_2013_27_070; Perry JC, 1999, AM J PSYCHIAT, V156, P1312; Ranger M, 2009, EPIDEMIOL PSICHIAT S, V18, P128, DOI 10.1017/S1121189X00001019; Ripoll LH, 2012, CURR OPIN PSYCHIATR, V25, P52, DOI 10.1097/YCO.0b013e32834c3f19; SIEVER LJ, 1991, AM J PSYCHIAT, V148, P1647; Silk K, 2012, OXFORD HDB PERSONALI, P713; Simon W, 2009, INT J PSYCHIAT CLIN, V13, P153, DOI 10.1080/13651500802570972; Skodol AE, 2005, PSYCHOL MED, V35, P443, DOI 10.1017/S003329170400354X; Soloff PH, 1998, B MENNINGER CLIN, V62, P195; Stanley B, 2010, AM J PSYCHIAT, V167, P24, DOI 10.1176/appi.ajp.2009.09050744; Strauss JL, 2006, J CONSULT CLIN PSYCH, V74, P337, DOI 10.1037/0022-006X.74.2.337; Svartberg M, 2004, AM J PSYCHIAT, V161, P810, DOI 10.1176/appi.ajp.161.5.810; Tyrer P, 2011, INT REV PSYCHIATR, V23, P388, DOI 10.3109/09540261.2011.606540; Tyrer P, 2009, NIDOTHERAPY: HARMONISING THE ENVIRONMENT WITH THE PATIENT, P1; Vennard J, 1997, CHANGING OFFENDERS A, P1; WALLERSTEIN RS, 1989, J CONSULT CLIN PSYCH, V57, P195, DOI 10.1037/0022-006X.57.2.195; Wallerstein RS, 1986, 42 LIVES TREATMNET S; Weinberg I, 2011, CURR PSYCHIAT REP, V13, P60, DOI 10.1007/s11920-010-0167-x; Weiss B, 2013, J CONSULT CLIN PSYCH, V81, P1027, DOI 10.1037/a0033928; WINSTON A, 1994, AM J PSYCHIAT, V151, P190; Young J.E., 2006, SCHEMA THERAPY PRACT, DOI DOI 10.1017/; Zanarini MC, 2012, AM J PSYCHIAT, V169, P476, DOI 10.1176/appi.ajp.2011.11101550; Zanarini MC, 2010, ANN CLIN PSYCHIATRY, V22, P75; Zanarini MC, 2004, AM J PSYCHIAT, V161, P2108, DOI 10.1176/appi.ajp.161.11.2108	93	165	166	0	77	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2015	385	9969					735	743		10.1016/S0140-6736(14)61394-5	http://dx.doi.org/10.1016/S0140-6736(14)61394-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7ED	25706219				2022-12-28	WOS:000349788300030
J	Pearson, AD; Mills, JH; Song, YF; Nasertorabi, F; Han, GW; Baker, D; Stevens, RC; Schultz, PG				Pearson, Aaron D.; Mills, Jeremy H.; Song, Yifan; Nasertorabi, Fariborz; Han, Gye Won; Baker, David; Stevens, Raymond C.; Schultz, Peter G.			Trapping a transition state in a computationally designed protein bottle	SCIENCE			English	Article							INTERNAL-ROTATION; CRYSTAL-STRUCTURE; PERDEUTERATED BIPHENYL; ULTRAFAST DIFFRACTION; GASEOUS STATE; AMINO-ACID; SPECTRA; BARRIER; DERIVATIVES; STABILITY	The fleeting lifetimes of the transition states (TSs) of chemical reactions make determination of their three-dimensional structures by diffraction methods a challenge. Here, we used packing interactions within the core of a protein to stabilize the planar TS conformation for rotation around the central carbon-carbon bond of biphenyl so that it could be directly observed by x-ray crystallography. The computational protein design software Rosetta was used to design a pocket within threonyl-transfer RNA synthetase from the thermophile Pyrococcus abyssi that forms complementary van der Waals interactions with a planar biphenyl. This lattermoiety was introduced biosynthetically as the side chain of the noncanonical amino acid p-biphenylalanine. Through iterative rounds of computational design and structural analysis, we identified a protein in which the side chain of p-biphenylalanine is trapped in the energetically disfavored, coplanar conformation of the TS of the bond rotation reaction.	[Pearson, Aaron D.; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Pearson, Aaron D.; Schultz, Peter G.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Mills, Jeremy H.; Song, Yifan; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Nasertorabi, Fariborz; Han, Gye Won; Stevens, Raymond C.] Univ So Calif, Dept Biol Sci, Bridge Inst, Los Angeles, CA 90089 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Scripps Research Institute; Scripps Research Institute; University of Washington; University of Washington Seattle; University of Southern California; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Schultz, PG (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	schultz@scripps.edu	Stevens, Raymond/K-7272-2015; Baker, David/K-8941-2012; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLQ-8724-2022	Stevens, Raymond/0000-0002-4522-8725; Baker, David/0000-0001-7896-6217; Han, Gye Won/0000-0003-4107-835X; Mills, Jeremy/0000-0003-2017-1846	Defense Threat Reduction Agency [HDTRA1-11-1-0041]; National Institute of General Medical Science of the National Institutes of Health [F32GM099210]; National Institutes of Health [2 R01 GM097206-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097206, F32GM099210] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Institute of General Medical Science of the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank N. P. King and P.-S. Huang for helpful discussions. D.B and J.H.M. were supported by the Defense Threat Reduction Agency (HDTRA1-11-1-0041). J.H.M. was supported by National Institute of General Medical Science of the National Institutes of Health under award F32GM099210. P.G.S. acknowledges support by the National Institutes of Health under award 2 R01 GM097206-05. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health. Structures of BIF_1, BIF_1.1 to BIF_1.4, and BIF_0 have been deposited in the Protein Data Bank under accession numbers 4S02, 4S0J, 4S0L, 4S0I, 4S0K, and 4S03.	ALMENNINGEN A, 1985, J MOL STRUCT, V128, P59, DOI 10.1016/0022-2860(85)85041-9; BASTIANSEN O, 1985, J MOL STRUCT, V128, P115, DOI 10.1016/0022-2860(85)85044-4; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; CARREIRA LA, 1977, J MOL STRUCT, V41, P1, DOI 10.1016/0022-2860(77)80034-3; Ceccacci F, 2003, TETRAHEDRON-ASYMMETR, V14, P3117, DOI 10.1016/S0957-4166(03)00544-5; Chatterjee A, 2014, CHEMBIOCHEM, V15, P1782, DOI 10.1002/cbic.201402104; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Dwivedi S, 2005, NAT STRUCT MOL BIOL, V12, P556, DOI 10.1038/nsmb943; Dwivedi S, 2004, ACTA CRYSTALLOGR D, V60, P1662, DOI 10.1107/S0907444904017321; ELORANTA JK, 1972, Z NATURFORSCH A, VA 27, P1652; Han S, 2014, J ORG CHEM, V79, P8550, DOI 10.1021/jo501625f; Ihee H, 2001, SCIENCE, V291, P458, DOI 10.1126/science.291.5503.458; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; KATON JE, 1959, SPECTROCHIM ACTA, V15, P627, DOI 10.1016/S0371-1951(59)80360-X; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEGRAND SM, 1993, J COMPUT CHEM, V14, P349, DOI 10.1002/jcc.540140309; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; POLLACK SJ, 1986, SCIENCE, V234, P1570, DOI 10.1126/science.3787262; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; ROSE TS, 1988, J CHEM PHYS, V88, P6672, DOI 10.1063/1.454408; SCHULTZ PG, 1995, SCIENCE, V269, P1835, DOI 10.1126/science.7569920; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Srinivasan R, 2005, SCIENCE, V307, P558, DOI 10.1126/science.1107291; SUZUKI H, 1959, B CHEM SOC JPN, V32, P1340, DOI 10.1246/bcsj.32.1340; Tanaka Y, 2005, PROTEINS, V61, P1127, DOI 10.1002/prot.20619; TRAMONTANO A, 1986, SCIENCE, V234, P1566, DOI 10.1126/science.3787261; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Xie JM, 2007, ANGEW CHEM INT EDIT, V46, P9239, DOI 10.1002/anie.200703397; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	32	32	34	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					863	867		10.1126/science.aaa2424	http://dx.doi.org/10.1126/science.aaa2424			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700516	Green Accepted, Green Submitted			2022-12-28	WOS:000349761100041
J	Swain, SM; Baselga, J; Kim, SB; Ro, J; Semiglazov, V; Campone, M; Ciruelos, E; Ferrero, JM; Schneeweiss, A; Heeson, S; Clark, E; Ross, G; Benyunes, MC; Cortes, J				Swain, Sandra M.; Baselga, Jose; Kim, Sung-Bae; Ro, Jungsil; Semiglazov, Vladimir; Campone, Mario; Ciruelos, Eva; Ferrero, Jean-Marc; Schneeweiss, Andreas; Heeson, Sarah; Clark, Emma; Ross, Graham; Benyunes, Mark C.; Cortes, Javier		CLEOPATRA Study Grp	Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-II TRIAL; PLUS DOCETAXEL; DOUBLE-BLIND; RECEPTOR; CLEOPATRA; THERAPY; SURVIVAL; EFFICACY; TOLERABILITY; COMBINATION	BACKGROUND In patients with metastatic breast cancer that is positive for human epidermal growth factor receptor 2 (HER2), progression-free survival was significantly improved after first-line therapy with pertuzumab, trastuzumab, and docetaxel, as compared with placebo, trastuzumab, and docetaxel. Overall survival was significantly improved with pertuzumab in an interim analysis without the median being reached. We report final prespecified overall survival results with a median follow-up of 50 months. METHODS We randomly assigned patients with metastatic breast cancer who had not received previous chemotherapy or anti-HER2 therapy for their metastatic disease to receive the pertuzumab combination or the placebo combination. The secondary end points of overall survival, investigator-assessed progression-free survival, independently assessed duration of response, and safety are reported. Sensitivity analyses were adjusted for patients who crossed over from placebo to pertuzumab after the interim analysis. RESULTS The median overall survival was 56.5 months (95% confidence interval [CI], 49.3 to not reached) in the group receiving the pertuzumab combination, as compared with 40.8 months (95% CI, 35.8 to 48.3) in the group receiving the placebo combination (hazard ratio favoring the pertuzumab group, 0.68; 95% CI, 0.56 to 0.84; P<0.001), a difference of 15.7 months. This analysis was not adjusted for crossover to the pertuzumab group and is therefore conservative. Results of sensitivity analyses after adjustment for crossover were consistent. Median progression-free survival as assessed by investigators improved by 6.3 months in the pertuzumab group (hazard ratio, 0.68; 95% CI, 0.58 to 0.80). Pertuzumab extended the median duration of response by 7.7 months, as independently assessed. Most adverse events occurred during the administration of docetaxel in the two groups, with long-term cardiac safety maintained. CONCLUSIONS In patients with HER2-positive metastatic breast cancer, the addition of pertuzumab to trastuzumab and docetaxel, as compared with the addition of placebo, significantly improved the median overall survival to 56.5 months and extended the results of previous analyses showing the efficacy of this drug combination. (Funded by F. Hoffmann-La Roche and Genentech; CLEOPATRA ClinicalTrials. gov number, NCT00567190.)	[Swain, Sandra M.] MedStar Washington Hosp Ctr, Washington Canc Inst, Washington, DC 20010 USA; [Baselga, Jose] Mem Sloan Kettering Canc Ctr, Mem Hosp, New York, NY 10021 USA; [Kim, Sung-Bae] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Ro, Jungsil] Natl Canc Ctr, Ctr Breast Canc, Goyang, South Korea; [Semiglazov, Vladimir] NN Petrov Res Inst Oncol, St Petersburg, Russia; [Campone, Mario] Ctr Rene Gauducheau, F-44035 Nantes, France; [Ferrero, Jean-Marc] Ctr Antoine Lacassagne, F-06054 Nice, France; [Ciruelos, Eva] 12 Octubre Univ Hosp, Dept Med Oncol, Madrid, Spain; [Cortes, Javier] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain; [Schneeweiss, Andreas] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany; [Heeson, Sarah; Clark, Emma; Ross, Graham] Roche Prod Ltd, Welwyn Garden City, Herts, England; [Benyunes, Mark C.] Genentech Inc, San Francisco, CA 94080 USA	MedStar Washington Hospital Center; Memorial Sloan Kettering Cancer Center; University of Ulsan; Asan Medical Center; National Cancer Center - Korea (NCC); N.N. Petrov Research Institute of Oncology; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); UNICANCER; Centre Antoine Lacassagne; Hospital Universitario 12 de Octubre; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Roche Holding; Roche Holding; Genentech	Swain, SM (corresponding author), MedStar Washington Hosp Ctr, Washington Canc Inst, 110 Irving St, Washington, DC 20010 USA.	sandra.m.swain@medstar.net	Andrade, Jurandyr M/B-2025-2013; de Azevedo, Sergio Jobim/P-5115-2015; MORALES, SERAFIN/L-7216-2019; Schneeweiss, Andreas/HHS-4098-2022; Watanabe, Junichiro/AAI-8481-2021; Yeo, Winnie/R-4792-2018	Andrade, Jurandyr M/0000-0003-3619-0582; MORALES, SERAFIN/0000-0001-7445-4193; Watanabe, Junichiro/0000-0001-9226-895X; Pienkowski, Tadeusz/0000-0002-0110-5950; Swain, Sandra/0000-0002-1320-3830; Ciruelos, Eva/0000-0002-2796-1042; Di Leo, Angelo/0000-0002-3665-9056; Cortes, Javier/0000-0001-7623-1583; Biganzoli, Laura/0000-0001-7989-8658; Yeo, Winnie/0000-0002-0863-8469; Coudert, Bruno/0000-0001-9445-2216	F. Hoffmann-La Roche; Genentech; CLEOPATRA; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	F. Hoffmann-La Roche(Hoffmann-La Roche); Genentech(Roche HoldingGenentech); CLEOPATRA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by F. Hoffmann-La Roche and Genentech; CLEOPATRA ClinicalTrials.gov number, NCT00567190.	Amiri-Kordestani L, 2014, CLIN CANCER RES, V20, P5359, DOI 10.1158/1078-0432.CCR-14-1268; Andersson M, 2011, J CLIN ONCOL, V29, P264, DOI 10.1200/JCO.2010.30.8213; Baselga J, 2014, ANN ONCOL, V25, P592, DOI 10.1093/annonc/mdt543; Baselga J, 2014, J CLIN ONCOL, V32, P3753, DOI 10.1200/JCO.2013.54.5384; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Blackwell KL, 2012, J CLIN ONCOL, V30, P2585, DOI 10.1200/JCO.2011.35.6725; Cortes J, 2013, ANN ONCOL, V24, P2630, DOI 10.1093/annonc/mdt274; Cortes J, 2012, J CLIN ONCOL, V30, P1594, DOI 10.1200/JCO.2011.37.4207; Dang C, 2014, J CLIN ONCOL; Gianni L, 2011, 34 ANN SAN ANT BREAS; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Murthy RK, 2014, CANCER-AM CANCER SOC, V120, P1932, DOI 10.1002/cncr.28689; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Negri E, 2014, ONCOLOGIST, V19, P1209, DOI 10.1634/theoncologist.2014-0227; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; Schneeweiss A, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3690; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X; Swain SM, 2013, ONCOLOGIST, V18, P257, DOI 10.1634/theoncologist.2012-0448; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Valero V, 2011, J CLIN ONCOL, V29, P149, DOI 10.1200/JCO.2010.28.6450; von Minckwitz G, 2009, J CLIN ONCOL, V27, P1999, DOI 10.1200/JCO.2008.19.6618	26	1224	1272	7	161	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					724	734		10.1056/NEJMoa1413513	http://dx.doi.org/10.1056/NEJMoa1413513			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7PB	25693012	Green Accepted, Green Published			2022-12-28	WOS:000349818700006
J	Thurman, RJ; Fitch, RW				Thurman, R. Jason; Fitch, R. Warne			Contagious Ecthyma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Thurman, R. Jason; Fitch, R. Warne] Vanderbilt Univ, Nashville, TN 37235 USA	Vanderbilt University	Thurman, RJ (corresponding author), Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.	jason.thurman@vanderbilt.edu							0	7	8	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					E12	E12		10.1056/NEJMicm1304779	http://dx.doi.org/10.1056/NEJMicm1304779			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7PB	25693031				2022-12-28	WOS:000349818700012
J	Wei, SS; Wiens, DA; Zha, Y; Plank, T; Webb, SC; Blackman, DK; Dunn, RA; Conder, JA				Wei, S. Shawn; Wiens, Douglas A.; Zha, Yang; Plank, Terry; Webb, Spahr C.; Blackman, Donna K.; Dunn, Robert A.; Conder, James A.			Seismic evidence of effects of water on melt transport in the Lau back-arc mantle	NATURE			English	Article							SPREADING CENTERS; BENEATH; BASIN; CONSTRAINTS; OLIVINE; RIDGE; DEFORMATION; SEISMOLOGY; NOISE; ZONE	Processes of melt generation and transport beneath back-arc spreading centres are controlled by two endmember mechanisms: decompression melting similar to that at mid-ocean ridges and flux melting resembling that beneath arcs'. The Lau Basin, with an abundance of spreading ridges at different distances from the subduction zone, provides an opportunity to distinguish the effects of these two different melting processes on magma production and crust formation. Here we present constraints on the three-dimensional distribution of partial melt inferred from seismic velocities obtained from Rayleigh wave tomography using land and ocean-bottom seismographs. Low seismic velocities beneath the Central Lau Spreading Centre and the northern Eastern Lau Spreading Centre extend deeper and westwards into the back-arc, suggesting that these spreading centres are fed by melting along upwelling zones from the west, and helping to explain geochemical differences with the Valu Fa Ridge to the south(2), which has no distinct deep low-seismic-velocity anomalies. A region of low S-wave velocity, interpreted as resulting from high melt content, is imaged in the mantle wedge beneath the Central Lau Spreading Centre and the northeastern Lau Basin, even where no active spreading centre currently exists. This low-seismic-velocity anomaly becomes weaker with distance southward along the Eastern Lau Spreading Centre and the Valu Fa Ridge, in contrast to the inferred increase in magmatic productivity(1). We propose that the anomaly variations result from changes in the efficiency of melt extraction, with the decrease in melt to the south correlating with increased fractional melting and higher water content in the magma. Water released from the slab may greatly reduce the melt viscosity(3) or increase grain size(4), or both, thereby facilitating melt transport.	[Wei, S. Shawn; Wiens, Douglas A.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Zha, Yang; Plank, Terry; Webb, Spahr C.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Blackman, Donna K.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Dunn, Robert A.] Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Conder, James A.] So Illinois Univ, Dept Geol, Carbondale, IL 62901 USA	Washington University (WUSTL); Columbia University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; Southern Illinois University System; Southern Illinois University	Wei, SS (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.	songqiaowei@wustl.edu	Wei, Songqiao/H-8308-2014; Zha, Yang/D-2143-2016; Wiens, Douglas A/J-9259-2016; Dunn, Robert A/L-9892-2014; Conder, James/AAH-8831-2019; Conder, James/AAO-6404-2021	Wei, Songqiao/0000-0002-6217-0545; Zha, Yang/0000-0002-2227-1595; Wiens, Douglas A/0000-0002-5169-4386; Dunn, Robert A/0000-0003-1434-5512; Conder, James/0000-0002-2942-9842; Webb, Spahr/0000-0002-7277-174X; Plank, Terry/0000-0002-1665-0484	Ridge 2000 Program under NSF [OCE-0426408, EAR-0911137, OCE-0426369, OCE-0430463, OCE-0426428]	Ridge 2000 Program under NSF	We thank P. J. Shore, Y. J. Chen and the captains, crew and science parties of the RVs Roger Revelle and Kilo Moana for data collecting; D. W. Forsyth, Y. Yang, G. G. Euler, D. Heeszel, X. Sun and W. Shen for helping with data processing; N. Harmon, C. Rychert, P. Skemer and B. M. Mahan for discussions; and N. Hu for support. IRIS PASSCAL and OBSIP provided land-based seismic instrumentation and OBSs, respectively. This work was supported by the Ridge 2000 Program under NSF grants OCE-0426408 (D.A.W. and J.A.C.), EAR-0911137 (D.A.W.), OCE-0426369 (S.C.W.), OCE-0430463 (D.K.B.) and OCE-0426428 (R.A.D.).	Arai R, 2014, EARTH PLANET SC LETT, V390, P304, DOI 10.1016/j.epsl.2014.01.014; Bell S., 2015, B SEISMOL SOC AM; Conder JA, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001113; Conder JA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015390; Cooper LB, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006367; Crawford WC, 2000, B SEISMOL SOC AM, V90, P952, DOI 10.1785/0119990121; Crawford WC, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001435; Dunn RA, 2011, NATURE, V469, P198, DOI 10.1038/nature09690; Escrig S, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002281; Faul UH, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002407; Forsyth DW, 2005, GEOPHYS MONOGR SER, V157, P81, DOI 10.1029/156GM06; Giordano D, 2008, EARTH PLANET SC LETT, V271, P123, DOI 10.1016/j.epsl.2008.03.038; Hahm D, 2012, GEOCHIM COSMOCHIM AC, V85, P88, DOI 10.1016/j.gca.2012.02.007; Hammond WC, 2000, J GEOPHYS RES-SOL EA, V105, P10987, DOI 10.1029/2000JB900042; Harmon N, 2010, EARTH PLANET SC LETT, V298, P334, DOI 10.1016/j.epsl.2010.08.004; Harmon N, 2009, EARTH PLANET SC LETT, V278, P96, DOI 10.1016/j.epsl.2008.11.025; Hayes GP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008524; Herrmann R.B., 2004, COMPUTER PROGRAMS SE; Hirschmann MM, 2010, PHYS EARTH PLANET IN, V179, P60, DOI 10.1016/j.pepi.2009.12.003; Hirschmann MM, 2009, PHYS EARTH PLANET IN, V176, P54, DOI 10.1016/j.pepi.2009.04.001; Hirschmann MM, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000070; Jackson I, 2010, PHYS EARTH PLANET IN, V183, P151, DOI 10.1016/j.pepi.2010.09.005; Kamenetsky VS, 1997, EARTH PLANET SC LETT, V151, P205, DOI 10.1016/S0012-821X(97)81849-3; KARATO S, 1989, TECTONOPHYSICS, V168, P255, DOI 10.1016/0040-1951(89)90221-7; KARATO S, 1993, GEOPHYS RES LETT, V20, P1623, DOI 10.1029/93GL01767; Karato S.-I, 2004, INSIDE SUBDUCTION FA, P135; Karato SI, 2012, EARTH PLANET SC LETT, V321, P95, DOI 10.1016/j.epsl.2012.01.001; Kelley KA, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003732; Kelley KA, 2009, SCIENCE, V325, P605, DOI 10.1126/science.1174156; Kent AJR, 2002, EARTH PLANET SC LETT, V202, P361, DOI 10.1016/S0012-821X(02)00786-0; Kohlstedt DL, 2009, ANNU REV EARTH PL SC, V37, P561, DOI 10.1146/annurev.earth.031208.100104; Langmuir CH, 2006, GEOPHYS MONOGR SER, V166, P87; Lee CTA, 2009, EARTH PLANET SC LETT, V279, P20, DOI 10.1016/j.epsl.2008.12.020; Lee CTA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002413; Lehnert K, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000026; Lytle ML, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004233; Martinez F, 2002, NATURE, V416, P417, DOI 10.1038/416417a; McCarthy C, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048776; Miller KJ, 2014, EARTH PLANET SC LETT, V388, P273, DOI 10.1016/j.epsl.2013.12.003; NISHIMURA CE, 1989, GEOPHYS J INT, V96, P203, DOI 10.1111/j.1365-246X.1989.tb04446.x; Pearce J.A., 1994, GEOL SOC LOND SPEC P, V81, P53, DOI [10.1144/GSL.SP.1994.081.01.04, DOI 10.1144/GSL.SP.1994.081.01.04]; Pyle ML, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006976; Rau CJ, 2011, GEOLOGY, V39, P975, DOI 10.1130/G32179.1; SHEN Y, 1995, J GEOPHYS RES-SOL EA, V100, P2211, DOI 10.1029/94JB02768; Smith GP, 2001, SCIENCE, V292, P713, DOI 10.1126/science.1058763; Stixrude L, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB002965; Takei Y, 2002, J GEOPHYS RES-SOL EA, V107, DOI [10.1029/2001JB000522, 10.1029/2001jb000522]; Taylor B, 1996, EARTH PLANET SC LETT, V144, P35, DOI 10.1016/0012-821X(96)00148-3; Tenner TJ, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003942; Tian L, 2008, J VOLCANOL GEOTH RES, V178, P657, DOI 10.1016/j.jvolgeores.2008.06.039; Wasylenki LE, 2003, J PETROL, V44, P1163, DOI 10.1093/petrology/44.7.1163; Webb SC, 1999, B SEISMOL SOC AM, V89, P1535; Wei S. S., 2013, AGU 2013 FALL M AM G; Wiens DA, 2006, EARTH PLANET SC LETT, V248, P30, DOI 10.1016/j.epsl.2006.04.011; Yang YJ, 2006, GEOPHYS J INT, V166, P1148, DOI 10.1111/j.1365-246X.2006.02972.x; Zha Y, 2014, EARTH PLANET SC LETT, V408, P194, DOI 10.1016/j.epsl.2014.10.019; Zhao DP, 1997, SCIENCE, V278, P254, DOI 10.1126/science.278.5336.254	57	33	33	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					395	398		10.1038/nature14113	http://dx.doi.org/10.1038/nature14113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25642964				2022-12-28	WOS:000349547400041
J	Kiang, L; Kahana, A				Kiang, Lee; Kahana, Alon			Orbital Varix	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kiang, Lee; Kahana, Alon] Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kiang, L (corresponding author), Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48109 USA.	akahana@umich.edu		Kahana, Alon/0000-0002-5667-2274					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7							e9	10.1056/NEJMicm1314101	http://dx.doi.org/10.1056/NEJMicm1314101			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CK	25671275				2022-12-28	WOS:000349143900010
J	Spergel, D				Spergel, David			The oldest cosmic light	NATURE			English	Editorial Material									Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA	Princeton University	Spergel, D (corresponding author), Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA.	dns@astro.princeton.edu	Spergel, David N/A-4410-2011; Keating, Brian G/J-6063-2017	Spergel, David N/0000-0002-5151-0006; Keating, Brian G/0000-0003-3118-5514					0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					170	171		10.1038/518170a	http://dx.doi.org/10.1038/518170a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8SD	25673407				2022-12-28	WOS:000349190300022
J	Gornall, J				Gornall, Jonathan			Sugar's web of influence 4: Mars and company: sweet heroes or villains?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						[Anonymous], 2014, COULD SMALLER SERVIN; Authority for Television on Demand, 2014, AD ONL UND ACC ONL P; Committee on Food Marketing and the Diets of Children and Youth, 2006, FOOD MARK CHILDR YOU; Credit Suisse Research Institute, 2013, SUG CONS CROSSR; Joseph S., 2014, MARKETING WEEK; Mars, 2012, OUR PRINC ACT; Mars, MARK OUR BRANDS RESP; Mintel, 2014, CARB SOFT DRINKS UK; Montague-Jones G., 2013, GROCER          1213; Nieburg O., 2013, CONFECTIONERY N 0225; Nieburg O., 2013, CONFECTIONERY N 1217; Nieburg O., 2014, CONFECTIONERY N 0922; Pettigrew S, 2013, PUBLIC HEALTH NUTR, V16, P2197, DOI 10.1017/S1368980012005435	13	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2015	350								h220	10.1136/bmj.h220	http://dx.doi.org/10.1136/bmj.h220			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0MG	25673663				2022-12-28	WOS:000349319700003
J	Case, MA; Burwick, HA; Volpp, KG; Patel, MS				Case, Meredith A.; Burwick, Holland A.; Volpp, Kevin G.; Patel, Mitesh S.			Accuracy of Smartphone Applications and Wearable Devices for Tracking Physical Activity Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Case, Meredith A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Burwick, Holland A.] Amherst Coll, Amherst, MA 01002 USA; [Volpp, Kevin G.; Patel, Mitesh S.] Philadelphia VA Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; Amherst College; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Patel, MS (corresponding author), Univ Penn, 13th Floor Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	mpatel@upenn.edu		Volpp, Kevin/0000-0003-1423-4599; Case, Meredith/0000-0002-4496-8975	NATIONAL INSTITUTE ON AGING [RC4AG039114] Funding Source: NIH RePORTER; NIA NIH HHS [RC4 AG039114-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bort-Roig J, 2014, SPORTS MED, V44, P671, DOI 10.1007/s40279-014-0142-5; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Powell AC, 2014, JAMA-J AM MED ASSOC, V311, P1851, DOI 10.1001/jama.2014.2564; Schneider PL, 2004, MED SCI SPORT EXER, V36, P331, DOI 10.1249/01.MSS.0000113486.60548.E9	5	401	409	6	98	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					625	626		10.1001/jama.2014.17841	http://dx.doi.org/10.1001/jama.2014.17841			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25668268	Bronze			2022-12-28	WOS:000349070700024
J	Ekman, I; Hedman, H; Swedberg, K; Wallengren, C				Ekman, Inger; Hedman, Hakan; Swedberg, Karl; Wallengren, Catarina			Commentary: Swedish initiative on person centred care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC HEART-FAILURE		[Ekman, Inger; Swedberg, Karl; Wallengren, Catarina] Gothenburg Univ, Ctr Person Centred Care GPCC, SE-40530 Gothenburg, Sweden; [Ekman, Inger; Swedberg, Karl; Wallengren, Catarina] Univ Gothenburg, Inst Hlth & Care Sci, SE-40530 Gothenburg, Sweden; [Hedman, Hakan] Swedish Kidney Assoc, Stockholm, Sweden	University of Gothenburg; University of Gothenburg	Ekman, I (corresponding author), Gothenburg Univ, Ctr Person Centred Care GPCC, SE-40530 Gothenburg, Sweden.	Inger.Ekman@gu.se	Swedberg, Karl/B-2475-2008					Commonwealth Fund, 2014 INTERNATIONAL H; Dudas K, 2013, EUR J CARDIOVASC NUR, V12, P521, DOI 10.1177/1474515112472270; Ekman I, 2012, EUR HEART J, V33, P1112, DOI 10.1093/eurheartj/ehr306; Jenkinson C, 2002, INT J QUAL HEALTH C, V14, P353, DOI 10.1093/intqhc/14.5.353; King's Fund, 2014, POWER TO THE PEOPLE; Moore Foundation, PATIENT AND FAMILY E; Olsson Lars-Eric, 2006, J Orthop Surg Res, V1, P3, DOI 10.1186/1749-799X-1-3; Olsson LE, 2007, J ADV NURS, V58, P116, DOI 10.1111/j.1365-2648.2007.04209.x; Olsson LE, 2009, J ADV NURS, V65, P1626, DOI 10.1111/j.1365-2648.2009.05017.x; Richards T, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5765	10	52	52	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h160	10.1136/bmj.h160	http://dx.doi.org/10.1136/bmj.h160			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB0LU	25670185	Bronze			2022-12-28	WOS:000349318400003
J	Martinez-Boti, MA; Foster, GL; Chalk, TB; Rohling, EJ; Sexton, PF; Lunt, DJ; Pancost, RD; Badger, MPS; Schmidt, DN				Martinez-Boti, M. A.; Foster, G. L.; Chalk, T. B.; Rohling, E. J.; Sexton, P. F.; Lunt, D. J.; Pancost, R. D.; Badger, M. P. S.; Schmidt, D. N.			Plio-Pleistocene climate sensitivity evaluated using high-resolution CO2 records	NATURE			English	Article							CARBON-DIOXIDE CONCENTRATION; SEA-LEVEL FLUCTUATIONS; BORON ISOTOPE; PLIOCENE WARMTH; ICE VOLUME; TEMPERATURE; EVOLUTION; ATLANTIC; CONSTRAINTS; SEDIMENT	Theory and climate modelling suggest that the sensitivity of Earth's climate to changes in radiative forcing could depend on the background climate. However, palaeoclimate data have thus far been insufficient to provide a conclusive test of this prediction. Here we present atmospheric carbon dioxide (CO2) reconstructions based on multi-site boron-isotope records from the late Pliocene epoch (3.3 to 2.3 million years ago). We find that Earth's climate sensitivity to CO2-based radiative forcing (Earth system sensitivity) was half as strong during the warm Pliocene as during the cold late Pleistocene epoch (0.8 to 0.01 million years ago). Weattribute this difference to the radiative impacts of continental ice-volume changes (the ice-albedo feedback) during the late Pleistocene, because equilibrium climate sensitivity is identical for the two intervals when we account for such impacts using sea-level reconstructions. We conclude that, on a global scale, no unexpected climate feedbacks operated during the warm Pliocene, and that predictions of equilibrium climate sensitivity (excludinglong-termice-albedo feedbacks) forour Pliocene-like future(with CO2 levels up to maximum Pliocene levels of 450 parts per million) are well described by the currently accepted range of an increase of 1.5 K to 4.5 K per doubling of CO2.	[Martinez-Boti, M. A.; Foster, G. L.; Chalk, T. B.; Rohling, E. J.] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Rohling, E. J.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia; [Sexton, P. F.] Open Univ, Ctr Earth Planetary Space & Astron Res, Milton Keynes MK7 6AA, Bucks, England; [Lunt, D. J.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Lunt, D. J.; Pancost, R. D.; Badger, M. P. S.; Schmidt, D. N.] Univ Bristol, Cabot Inst, Bristol BS8 1UJ, Avon, England; [Pancost, R. D.; Badger, M. P. S.] Univ Bristol, Sch Chem, Organ Geochem Unit, Bristol BS8 1TS, Avon, England; [Schmidt, D. N.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England	NERC National Oceanography Centre; University of Southampton; Australian National University; Open University - UK; University of Bristol; University of Bristol; University of Bristol; University of Bristol	Foster, GL (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England.	gavin.foster@noc.soton.ac.uk	Chalk, Thomas/AAA-4964-2022; Rohling, Eelco J/B-9736-2008; Badger, Marcus/A-3607-2014; Foster, Gavin/W-5968-2019; Foster, Gavin/CAF-4654-2022; Lunt, Daniel J/G-9451-2011	Chalk, Thomas/0000-0002-2880-3847; Rohling, Eelco J/0000-0001-5349-2158; Badger, Marcus/0000-0001-8195-5244; Foster, Gavin/0000-0003-3688-9668; Lunt, Daniel J/0000-0003-3585-6928; Pancost, Richard/0000-0003-0298-4026; Schmidt, Daniela/0000-0001-8419-2721	NERC [NE/H006273/1, NE/I006346/1]; European Community; Australian Laureate Fellowship [FL120100050]; Yale University; Natural Environment Research Council [NE/I006346/1, NE/H006273/1, NE/I005714/1] Funding Source: researchfish; NERC [NE/I005714/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Community(European Commission); Australian Laureate Fellowship; Yale University; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study used samples provided by the International Ocean Discovery Program (IODP). We thank A. Milton at the University of Southampton for maintaining the mass spectrometers used in this study. S. Cherry and T. Garlichs are acknowledged for their help with sample preparation and we thank D. Liebrand for his assistance with time series analysis. This study was funded by NERC grants NE/H006273/1 to R.D.P., G.L.F., D.J.L. and D.N.S. (which supported M.A.M.B. and M.P.S.B.) and NE/I006346/1 to P.F.S. and G.L.F. M.A.M.B. was also supported by the European Community through a Marie Curie Fellowship and E.J.R. was supported by 2012 Australian Laureate Fellowship FL120100050. G.L.F. also wishes to acknowledge the support of Yale University (as Visiting Flint Lecturer).	Arrhenius S., 1896, LOND EDINB DUBLIN PH, V41, P237, DOI [10.1080/14786449608620846, DOI 10.1080/14786449608620846]; Badger MPS, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0094; Bailey I, 2013, QUATERNARY SCI REV, V75, P181, DOI 10.1016/j.quascirev.2013.06.004; Balco G, 2010, GEOLOGY, V38, P795, DOI 10.1130/G30946.1; Barker S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000559; Bartoli G, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002055; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; Beerling DJ, 2011, P NATL ACAD SCI USA, V108, P9770, DOI 10.1073/pnas.1102409108; Bolton CT, 2013, NATURE, V500, P558, DOI 10.1038/nature12448; Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; Byrne B, 2014, GEOPHYS RES LETT, V41, P152, DOI 10.1002/2013GL058456; Caballero R, 2013, P NATL ACAD SCI USA, V110, P14162, DOI 10.1073/pnas.1303365110; Catanzaro E. J., 1970, US NBS SPECIAL PUBLI; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Crucifix M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027137; Davis CV, 2013, BIOGEOSCIENCES, V10, P6131, DOI 10.5194/bg-10-6131-2013; DeConto RM, 2008, NATURE, V455, P652, DOI 10.1038/nature07337; Dekens PS, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001394; Dekens PS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000200; DELANEY ML, 1985, GEOCHIM COSMOCHIM AC, V49, P1327, DOI 10.1016/0016-7037(85)90284-4; DICKSON AG, 1990, DEEP-SEA RES, V37, P755, DOI 10.1016/0198-0149(90)90004-F; Dowsett HJ, 2012, NAT CLIM CHANGE, V2, P365, DOI [10.1038/NCLIMATE1455, 10.1038/nclimate1455]; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Etourneau J, 2010, EARTH PLANET SC LETT, V297, P103, DOI 10.1016/j.epsl.2010.06.010; Etourneau J, 2009, GEOLOGY, V37, P871, DOI 10.1130/G25733A.1; Evans D, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002315; Fantle MS, 2006, GEOCHIM COSMOCHIM AC, V70, P3883, DOI 10.1016/j.gca.2006.06.009; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Foster GL, 2008, EARTH PLANET SC LETT, V271, P254, DOI 10.1016/j.epsl.2008.04.015; Foster GL, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003201; Foster GL, 2013, CHEM GEOL, V358, P1, DOI 10.1016/j.chemgeo.2013.08.027; Foster GL, 2012, EARTH PLANET SC LETT, V341, P243, DOI 10.1016/j.epsl.2012.06.007; Hansen J, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005776; Haywood AM, 2013, CLIM PAST, V9, P191, DOI 10.5194/cp-9-191-2013; Haywood AM, 2004, EARTH PLANET SC LETT, V218, P363, DOI 10.1016/S0012-821X(03)00685-X; HEMMING NG, 1992, GEOCHIM COSMOCHIM AC, V56, P537, DOI 10.1016/0016-7037(92)90151-8; HEMMING NG, 1995, GEOCHIM COSMOCHIM AC, V59, P371, DOI 10.1016/0016-7037(95)00288-B; Henehan MJ, 2013, EARTH PLANET SC LETT, V364, P111, DOI 10.1016/j.epsl.2012.12.029; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; Hidy AJ, 2013, QUATERNARY SCI REV, V61, P77, DOI 10.1016/j.quascirev.2012.11.009; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Honisch B, 2005, EARTH PLANET SC LETT, V236, P305, DOI 10.1016/j.epsl.2005.04.027; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; KENNEDY JJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI DOI 10.1029/2010JD015220; Klochko K, 2006, EARTH PLANET SC LETT, V248, P276, DOI 10.1016/j.epsl.2006.05.034; Kohler P, 2010, QUATERNARY SCI REV, V29, P129, DOI 10.1016/j.quascirev.2009.09.026; Kurschner WM, 1996, MAR MICROPALEONTOL, V27, P299, DOI 10.1016/0377-8398(95)00067-4; Lawrence KT, 2013, PALEOCEANOGRAPHY, V28, P740, DOI 10.1002/2013PA002546; Lawrence KT, 2010, EARTH PLANET SC LETT, V300, P329, DOI 10.1016/j.epsl.2010.10.013; Lawrence KT, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001669; Lawrence KT, 2006, SCIENCE, V312, P79, DOI 10.1126/science.1120395; Lemarchand D, 2002, CHEM GEOL, V190, P123, DOI 10.1016/S0009-2541(02)00114-6; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Locarnini R. A., 2013, WORLD OCEAN ATLAS 20, V1; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Lunt DJ, 2008, NATURE, V454, P1102, DOI 10.1038/nature07223; Lunt DJ, 2012, EARTH PLANET SC LETT, V321, P128, DOI 10.1016/j.epsl.2011.12.042; Lunt DJ, 2010, NAT GEOSCI, V3, P60, DOI 10.1038/NGEO706; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; Medina-Elizalde M, 2008, EARTH PLANET SC LETT, V269, P584, DOI 10.1016/j.epsl.2008.03.014; Meraner K, 2013, GEOPHYS RES LETT, V40, P5944, DOI 10.1002/2013GL058118; Miller KG, 2012, GEOLOGY, V40, P407, DOI 10.1130/G32869.1; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Myhre G, 1998, GEOPHYS RES LETT, V25, P2715, DOI 10.1029/98GL01908; Naish TR, 2009, PHILOS T R SOC A, V367, P169, DOI 10.1098/rsta.2008.0223; O'Brien CL, 2014, NAT GEOSCI, V7, P607, DOI 10.1038/NGEO2194; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; R Development Core Team, 2009, R LANG ENV STAT COMP; Rae JWB, 2011, EARTH PLANET SC LETT, V302, P403, DOI 10.1016/j.epsl.2010.12.034; Raitzsch M, 2013, GEOLOGY, V41, P591, DOI 10.1130/G34031.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rohling EJ, 2012, NATURE, V491, P683, DOI 10.1038/nature11574; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Rohling EJ, 2012, J CLIMATE, V25, P1635, DOI 10.1175/2011JCLI4078.1; Rohling EJ, 2009, NAT GEOSCI, V2, P500, DOI 10.1038/ngeo557; Schlitzer R., 2012, OCEAN DATA VIEW; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; SHACKLETON N, 1967, NATURE, V215, P15, DOI 10.1038/215015a0; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Tyrrell T, 2004, GEOCHIM COSMOCHIM AC, V68, P3521, DOI 10.1016/j.gca.2004.02.018; van de Wal RSW, 2011, CLIM PAST, V7, P1459, DOI 10.5194/cp-7-1459-2011; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Williams RG, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052771; Yu JM, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001571; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE; Zhang YG, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0096	92	218	222	10	247	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					49	+		10.1038/nature14145	http://dx.doi.org/10.1038/nature14145			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25652996	Green Accepted, Green Submitted			2022-12-28	WOS:000349098000029
J	Masood, E				Masood, Ehsan			Major biodiversity initiative needs support	NATURE			English	Editorial Material												ehsan.masood@researchresearch.com							0	1	1	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					7	7		10.1038/518007a	http://dx.doi.org/10.1038/518007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7LE	25652961	Bronze			2022-12-28	WOS:000349098000004
J	Merkow, RP; Ju, MH; Chung, JW; Hall, BL; Cohen, ME; Williams, MV; Tsai, TC; Ko, CY; Bilimoria, KY				Merkow, Ryan P.; Ju, Mila H.; Chung, Jeanette W.; Hall, Bruce L.; Cohen, Mark E.; Williams, Mark V.; Tsai, Thomas C.; Ko, Clifford Y.; Bilimoria, Karl Y.			Underlying Reasons Associated With Hospital Readmission Following Surgery in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY IMPROVEMENT PROGRAM; SURGICAL-CARE; MEDICARE BENEFICIARIES; 30-DAY READMISSION; AMERICAN-COLLEGE; PATIENT EXPERIENCE; HEART-FAILURE; RISK-FACTORS; RATES; SITE	IMPORTANCE Financial penalties for readmission have been expanded beyond medical conditions to include surgical procedures. Hospitals are working to reduce readmissions; however, little is known about the reasons for surgical readmission. OBJECTIVE To characterize the reasons, timing, and factors associated with unplanned postoperative readmissions. DESIGN, SETTING, AND PARTICIPANTS Patients undergoing surgery at one of 346 continuously enrolled US hospitals participating in the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) between January 1, 2012, and December 31, 2012, had clinically abstracted information examined. Readmission rates and reasons (ascertained by clinical data abstractors at each hospital) were assessed for all surgical procedures and for 6 representative operations: bariatric procedures, colectomy or proctectomy, hysterectomy, total hip or knee arthroplasty, ventral hernia repair, and lower extremity vascular bypass. MAIN OUTCOMES AND MEASURES Unplanned 30day readmission and reason for readmission. RESULTS The unplanned readmission rate for the 498 875 operations was 5.7%. For the individual procedures, the readmission rate ranged from 3.8% for hysterectomy to 14.9% for lower extremity vascular bypass. The most common reason for unplanned readmission was surgical site infection (SSI) overall (19.5%) and also after colectomy or proctectomy (25.8%), ventral hernia repair (26.5%), hysterectomy (28.8%), arthroplasty (18.8%), and lower extremity vascular bypass (36.4%). Obstruction or ileus was the most common reason for readmission after bariatric surgery (24.5%) and the second most common reason overall (10.3%), after colectomy or proctectomy (18.1%), ventral hernia repair (16.7%), and hysterectomy (13.4%). Only 2.3% of patients were readmitted for the same complication they had experienced during their index hospitalization. Only 3.3% of patients readmitted for SSIs had experienced an SSI during their index hospitalization. There was no time pattern for readmission, and early (<= 7 days postdischarge) and late (> 7 days postdischarge) readmissions were associated with the same 3 most common reasons: SSI, ileus or obstruction, and bleeding. Patient comorbidities, index surgical admission complications, nonhome discharge (hazard ratio [HR], 1.40 [95% CI, 1.351.46]), teaching hospital status (HR, 1.14 [95% CI 1.071.21]), and higher surgical volume (HR, 1.15 [95% CI, 1.071.25]) were associated with a higher risk of hospital readmission. CONCLUSIONS AND RELEVANCE Readmissions after surgery were associated with new postdischarge complications related to the procedure and not exacerbation of prior index hospitalization complications, suggesting that readmissions after surgery are a measure of postdischarge complications. These data should be considered when developing quality indicators and any policies penalizing hospitals for surgical readmission.	[Merkow, Ryan P.; Ju, Mila H.; Hall, Bruce L.; Cohen, Mark E.; Ko, Clifford Y.; Bilimoria, Karl Y.] Amer Coll Surg, Div Res & Optimal Patient Care, Chicago, IL USA; [Merkow, Ryan P.; Ju, Mila H.; Chung, Jeanette W.; Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, Dept Surg, SOQIC, Chicago, IL 60611 USA; [Merkow, Ryan P.; Ju, Mila H.; Chung, Jeanette W.; Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, Ctr Healthcare Studies, Chicago, IL 60611 USA; [Merkow, Ryan P.; Ju, Mila H.; Chung, Jeanette W.; Bilimoria, Karl Y.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Northwestern Inst Comparat Effectiveness Res Onco, SOQIC, Chicago, IL 60611 USA; [Merkow, Ryan P.] Univ Chicago, Dept Surg, Div Biol Sci, Chicago, IL 60637 USA; [Hall, Bruce L.] Washington Univ, Sch Med, Dept Surg, Barnes Jewish Hosp, St Louis, MO 63110 USA; [Hall, Bruce L.] Washington Univ, Ctr Hlth Policy, Olin Business Sch, St Louis, MO USA; [Hall, Bruce L.] John Cochran Vet Affairs Med Ctr, Dept Surg, St Louis, MO USA; [Hall, Bruce L.] BJC Healthcare, St Louis, MO USA; [Williams, Mark V.] Univ Kentucky, Dept Internal Med, Ctr Hlth Serv Res, Lexington, KY 40506 USA; [Tsai, Thomas C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Tsai, Thomas C.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Ko, Clifford Y.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA; [Ko, Clifford Y.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	American College of Surgeons; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Barnes-Jewish Hospital; Washington University (WUSTL); Washington University (WUSTL); University of Kentucky; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Bilimoria, KY (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, SOQIC, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA.	k-bilimoria@northwestern.edu	Hall, Bruce/HGV-0612-2022	Williams, Mark V/0000-0001-6107-0457	American College of Surgeons Clinical Scholars in Residence Program; Northwestern Institute for Comparative Effectiveness Research in Oncology (NICER-Onc); National Institutes of Health (NIH) [5T32HL094293]; NIH; Agency for Healthcare Research and Quality; American Cancer Society; National Comprehensive Cancer Network; American College of Surgeons; American Board of Surgery; Accreditation Council for Graduate Medical Education; Health Care Services Corporation; Robert H. Lurie Cancer Center of Northwestern University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094293] Funding Source: NIH RePORTER	American College of Surgeons Clinical Scholars in Residence Program; Northwestern Institute for Comparative Effectiveness Research in Oncology (NICER-Onc); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); American Cancer Society(American Cancer Society); National Comprehensive Cancer Network; American College of Surgeons; American Board of Surgery; Accreditation Council for Graduate Medical Education; Health Care Services Corporation; Robert H. Lurie Cancer Center of Northwestern University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Merkow is supported by the American College of Surgeons Clinical Scholars in Residence Program and the Northwestern Institute for Comparative Effectiveness Research in Oncology (NICER-Onc). Dr Ju is supported by the American College of Surgeons Clinical Scholars in Residence Program and National Institutes of Health (NIH) grant 5T32HL094293. Dr Hall is a consultant to the American College of Surgeons. Dr Bilimoria reported support from the NIH, Agency for Healthcare Research and Quality, American Cancer Society, National Comprehensive Cancer Network, American College of Surgeons, American Board of Surgery, Accreditation Council for Graduate Medical Education, Health Care Services Corporation, and the Robert H. Lurie Cancer Center of Northwestern University.	Alper J., 2014, FACILITATING PATIENT; American College of Surgeons, 2012, NAT SURG QUAL IMPR P; American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP), 2013, ACS NSQIP OP MAN; American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP), ACS NSQIP IT WORKS; American Medical Association, 2013, CPT 2013 CURR PROC T; Berenson RA, 2012, NEW ENGL J MED, V366, P1364, DOI 10.1056/NEJMp1201268; Bilimoria KY, 2013, JAMA-J AM MED ASSOC, V310, P1482, DOI 10.1001/jama.2013.280048; Bilimoria KY, 2009, J CLIN ONCOL, V27, P4177, DOI 10.1200/JCO.2008.21.7018; Brand CA, 2012, INT J QUAL HEALTH C, V24, P483, DOI 10.1093/intqhc/mzs044; Chatterjee P, 2012, ARCH INTERN MED, V172, P1204, DOI 10.1001/archinternmed.2012.3158; Cohen ME, 2013, J AM COLL SURGEONS, V217, P336, DOI 10.1016/j.jamcollsurg.2013.02.027; Cowen ME, 1998, MED CARE, V36, P1108, DOI 10.1097/00005650-199807000-00016; Curran T, 2014, J VASC SURG, V60, P1315, DOI 10.1016/j.jvs.2014.05.050; Detsky AS, 2014, JAMA-J AM MED ASSOC, V311, P2169, DOI 10.1001/jama.2014.3695; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Duffy SQ, 1996, AHCPR PUBLICATION; Fontanarosa PB, 2013, JAMA-J AM MED ASSOC, V309, P398, DOI 10.1001/jama.2013.42; Fox JP, 2013, ANN THORAC SURG, V96, P96, DOI 10.1016/j.athoracsur.2013.03.091; Friese CR, 2010, SURGERY, V147, P602, DOI 10.1016/j.surg.2009.03.014; Girotti ME, 2014, J AM COLL SURGEONS, V218, P423, DOI 10.1016/j.jamcollsurg.2013.12.004; Hawn MT, 2011, ANN SURG, V254, P494, DOI 10.1097/SLA.0b013e31822c6929; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Hospital Compare, HOSP COMP SURV PAT E; Ingraham AM, 2010, J AM COLL SURGEONS, V211, P705, DOI 10.1016/j.jamcollsurg.2010.09.006; Ingraham Angela M, 2010, Adv Surg, V44, P251; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Khuri SF, 2008, ANN SURG, V248, P329, DOI 10.1097/SLA.0b013e3181823485; Khuri SF, 2007, J AM COLL SURGEONS, V204, P1089, DOI 10.1016/j.jamcollsurg.2007.03.028; Lehrman WG, 2010, MED CARE RES REV, V67, P38, DOI 10.1177/1077558709341323; McCarthy D, 2013, JAMA-J AM MED ASSOC, V309, P351, DOI 10.1001/jama.2013.1; National Quality Foundation (NQF), 2014, VEN THROMB WARF DISC; National Quality Foundation (NQF), 2014, HEART FAIL DET DISCH; QualityNet, OV READM MEAS PUBL R; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Sacks GD, 2014, JAMA SURG, V149, P759, DOI 10.1001/jamasurg.2014.18; Schmaltz SP, 2011, J HOSP MED, V6, P454, DOI 10.1002/jhm.905; Sellers MM, 2013, J AM COLL SURGEONS, V216, P420, DOI 10.1016/j.jamcollsurg.2012.11.013; Sharma G, 2010, ARCH INTERN MED, V170, P1664, DOI 10.1001/archinternmed.2010.345; Stulberg JJ, 2010, JAMA-J AM MED ASSOC, V303, P2479, DOI 10.1001/jama.2010.841; Tillman M, 2013, J SURG RES, V184, P150, DOI 10.1016/j.jss.2013.03.048; Tsai TC, 2015, JAMA SURG, V150, P59, DOI 10.1001/jamasurg.2014.2071; Tsai TC, 2014, ANN SURG, V259, P1086, DOI 10.1097/SLA.0000000000000326; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Wick EC, 2011, DIS COLON RECTUM, V54, P1475, DOI 10.1097/DCR.0b013e31822ff8f0; Zhang JQ, 2014, J VASC SURG, V59, P1331, DOI 10.1016/j.jvs.2013.12.032	48	506	506	2	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					483	495		10.1001/jama.2014.18614	http://dx.doi.org/10.1001/jama.2014.18614			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AV	25647204				2022-12-28	WOS:000349070300012
J	Elgar, FJ; Pfortner, TK; Moor, I; De Clercq, B; Stevens, GWJM; Currie, C				Elgar, Frank J.; Pfoertner, Timo-Kolja; Moor, Irene; De Clercq, Bart; Stevens, Gonneke W. J. M.; Currie, Candace			Socioeconomic inequalities in adolescent health 2002-2010: a time-series analysis of 34 countries participating in the Health Behaviour in School-aged Children study	LANCET			English	Article							INCOME INEQUALITY; TRENDS; DETERMINANTS; MORTALITY; WEIGHT; PART	Background Information about trends in adolescent health inequalities is scarce, especially at an international level. We examined secular trends in socioeconomic inequality in five domains of adolescent health and the association of socioeconomic inequality with national wealth and income inequality. Methods We undertook a time-series analysis of data from the Health Behaviour in School-aged Children study, in which cross-sectional surveys were done in 34 North American and European countries in 2002, 2006, and 2010 (pooled n 492 788). We used individual data for socioeconomic status (Health Behaviour in School-aged Children Family Affluence Scale) and health (days of physical activity per week, body-mass index Z score [zBMI], frequency of psychological and physical symptoms on 0-5 scale, and life satisfaction scored 0-10 on the Cantril ladder) to examine trends in health and socioeconomic inequalities in health. We also investigated whether international differences in health and health inequalities were associated with per person income and income inequality. Findings From 2002 to 2010, average levels of physical activity (3.90 to 4.08 days per week; p<0.0001), body mass (zBMI -0.08 to 0.03; p<0.0001), and physical symptoms (3.06 to 3.20, p<0.0001), and life satisfaction (7.58 to 7.61; p=0.0034) slightly increased. Inequalities between socioeconomic groups increased in physical activity (-0.79 to -0.83 days per week difference between most and least affluent groups; p=0.0008), zBMI (0.15 to 0.18; p<0.0001), and psychological (0.58 to 0.67; p=0.0360) and physical (0.21 to 0.26; p=0.0018) symptoms. Only in life satisfaction did health inequality fall during this period (-0.98 to -0.95; p=0.0198). Internationally, the higher the per person income, the better and more equal health was in terms of physical activity (0.06 days per SD increase in income; p< 0.0001), psychological symptoms (-0.09; p< 0.0001), and life satisfaction (0.08; p< 0.0001). However, higher income inequality uniquely related to fewer days of physical activity (-0.05 days; p=0.0295), higher zBMI (0.06; p< 0.0001), more psychological (0.18; p< 0.0001) and physical (0.16; p< 0.0001) symptoms, and larger health inequalities between socioeconomic groups in psychological (0.13; p=0.0080) and physical (0.07; p=0.0022) symptoms, and life satisfaction (-0.10; p=0.0092). Interpretation Socioeconomic inequality has increased in many domains of adolescent health. These trends coincide with unequal distribution of income between rich and poor people. Widening gaps in adolescent health could predict future inequalities in adult health and need urgent policy action.	[Elgar, Frank J.] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ H3A 1A3, Canada; [Elgar, Frank J.] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ H3A 1A3, Canada; [Pfoertner, Timo-Kolja] Univ Cologne, Inst Med Sociol Hlth Serv Res & Rehabil Sci, D-50931 Cologne, Germany; [Moor, Irene] Univ Halle Wittenberg, Inst Med Sociol, D-06108 Halle, Saale, Germany; [De Clercq, Bart] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Stevens, Gonneke W. J. M.] Univ Utrecht, Utrecht Ctr Child & Adolescent Studies, Utrecht, Netherlands; [Currie, Candace] Univ St Andrews, Sch Med, Child & Adolescent Hlth Res Unit, St Andrews, Fife, Scotland	McGill University; McGill University; University of Cologne; Martin Luther University Halle Wittenberg; Ghent University; Utrecht University; University of St Andrews	Elgar, FJ (corresponding author), McGill Univ, Inst Hlth & Social Policy, Montreal, PQ H3A 1A3, Canada.	frank.elgar@mcgill.ca	Elgar, Frank/GSN-3521-2022; Pförtner, Timo-Kolja/AAE-1765-2021; M., Irene/AFN-1005-2022; Elgar, Frank/ABE-7450-2020; Stevens, Gonneke/AAU-7716-2020	M., Irene/0000-0003-3245-5176; Pfortner, Timo-Kolja/0000-0002-8188-894X; Stevens, Gonneke/0000-0001-9929-7972	Canadian Institutes of Health Research; Social Sciences and Humanities Research Council of Canada; Canada Research Chairs programme	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs programme(Canada Research Chairs)	Funding Canadian Institutes of Health Research.; The study was supported by research grants from the Canadian Institutes for Health Research, the Social Sciences and Humanities Research Council of Canada, and the Canada Research Chairs programme awarded to FJE. The Health Behaviour in School-aged Children study is a WHO collaborative study and funded by public sources in each member country. The Health Behaviour in School-aged Children International Coordinating Centre is located at St Andrew's University, and the databank is managed at the University of Bergen.	[Anonymous], 2008, CLOS GAP GEN HLTH EQ; BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Cantril H, 1965, PATTTERN HUMAN CONCE; Collishaw S, 2010, J CHILD PSYCHOL PSYC, V51, P885, DOI 10.1111/j.1469-7610.2010.02252.x; Costanza R, 2014, NATURE, V505, P283, DOI 10.1038/505283a; Currie C., 2012, SOCIAL DETERMINANTS; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Dorling D, 2007, BMJ-BRIT MED J, V335, P873, DOI 10.1136/bmj.39349.507315.DE; Elgar FJ, 2005, J ADOLESCENT HEALTH, V37, P371, DOI 10.1016/j.jadohealth.2004.07.014; Elgar FJ, 2013, SOC SCI MED, V91, P25, DOI 10.1016/j.socscimed.2013.04.030; Goesling B, 2004, POPUL DEV REV, V30, P131, DOI 10.1111/j.1728-4457.2004.00006.x; Hargreaves DS, 2013, ARCH DIS CHILD, V98, P850, DOI 10.1136/archdischild-2012-303403; Haugland S, 2001, J ADOLESCENCE, V24, P611, DOI 10.1006/jado.2000.0393; Houweling TAJ, 2005, INT J EPIDEMIOL, V34, P1257, DOI 10.1093/ije/dyi190; King NB, 2010, AM J PUBLIC HEALTH, V100, P2014, DOI 10.2105/AJPH.2010.203232; Moor I, 2012, GESUNDHEITSWESEN, V74, pS49, DOI 10.1055/s-0032-1312633; Organisation for Economic Co-operation and Development, 2001, DIV WE STAND WHY IN; Pickett W, 2013, PEDIATRICS, V131, pE18, DOI 10.1542/peds.2012-1614; Rajmil L, 2014, INT J PUBLIC HEALTH, V59, P95, DOI 10.1007/s00038-013-0479-9; Regidor E, 2004, J EPIDEMIOL COMMUN H, V58, P900, DOI 10.1136/jech.2004.023036; Roberts C, 2009, INT J PUBLIC HEALTH, V54, P140, DOI 10.1007/s00038-009-5405-9; Shaw M, 2000, SOC SCI MED, V50, P1047, DOI 10.1016/S0277-9536(99)00354-8; Shaw M, 1999, WIDENING GAP HLTH IN; Singh GK, 2006, INT J EPIDEMIOL, V35, P969, DOI 10.1093/ije/dyl083; Solt F, 2009, SOC SCI QUART, V90, P231, DOI 10.1111/j.1540-6237.2009.00614.x; Spencer N, 2004, CHILD CARE HLTH DEV, V30, P699, DOI 10.1111/j.1365-2214.2004.00485.x; Starfield B, 2002, J EPIDEMIOL COMMUN H, V56, P354, DOI 10.1136/jech.56.5.354; The World Bank, GNI PER CAP ATL METH; Torsheim T, 2004, SOC SCI MED, V59, P1, DOI 10.1016/j.socscimed.2003.09.032; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; West P, 1997, SOC SCI MED, V44, P833, DOI 10.1016/S0277-9536(96)00188-8; WHO, 2007, WHO METH DEV; Wilkinson Richard, 2009, SPIRIT LEVEL WHY MOR	33	267	273	9	114	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2088	2095		10.1016/S0140-6736(14)61460-4	http://dx.doi.org/10.1016/S0140-6736(14)61460-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI7XK	25659283	Green Submitted			2022-12-28	WOS:000354979100028
J	Cirulli, ET; Lasseigne, BN; Petrovski, S; Sapp, PC; Dion, PA; Leblond, CS; Couthouis, J; Lu, YF; Wang, QL; Krueger, BJ; Ren, Z; Keebler, J; Han, YJ; Levy, SE; Boone, BE; Wimbish, JR; Waite, LL; Jones, AL; Carulli, JP; Day-Williams, AG; Staropoli, JF; Xin, WW; Chesi, A; Raphael, AR; McKenna-Yasek, D; Cady, J; de Jong, JMBV; Kenna, KP; Smith, BN; Topp, S; Miller, J; Gkazi, A; Al-Chalabi, A; van den Berg, LH; Veldink, J; Silani, V; Ticozzi, N; Shaw, CE; Baloh, RH; Appel, S; Simpson, E; Lagier-Tourenne, C; Pulst, SM; Gibson, S; Trojanowski, JQ; Elman, L; McCluskey, L; Grossman, M; Shneider, NA; Chung, WK; Ravits, JM; Glass, JD; Sims, KB; Van Deerlin, VM; Maniatis, T; Hayes, SD; Ordureau, A; Swarup, S; Landers, J; Baas, F; Allen, AS; Bedlack, RS; Harper, JW; Gitler, AD; Rouleau, GA; Brown, R; Harms, MB; Cooper, GM; Harris, T; Myers, RM; Goldstein, DB				Cirulli, Elizabeth T.; Lasseigne, Brittany N.; Petrovski, Slave; Sapp, Peter C.; Dion, Patrick A.; Leblond, Claire S.; Couthouis, Julien; Lu, Yi-Fan; Wang, Quanli; Krueger, Brian J.; Ren, Zhong; Keebler, Jonathan; Han, Yujun; Levy, Shawn E.; Boone, Braden E.; Wimbish, Jack R.; Waite, Lindsay L.; Jones, Angela L.; Carulli, John P.; Day-Williams, Aaron G.; Staropoli, John F.; Xin, Winnie W.; Chesi, Alessandra; Raphael, Alya R.; McKenna-Yasek, Diane; Cady, Janet; de Jong, J. M. B. Vianney; Kenna, Kevin P.; Smith, Bradley N.; Topp, Simon; Miller, Jack; Gkazi, Athina; Al-Chalabi, Ammar; van den Berg, Leonard H.; Veldink, Jan; Silani, Vincenzo; Ticozzi, Nicola; Shaw, Christopher E.; Baloh, Robert H.; Appel, Stanley; Simpson, Ericka; lagier-Tourenne, ClotilDe; Pulst, Stefan M.; Gibson, Summer; Trojanowski, John Q.; Elman, Lauren; McCluskey, Leo; Grossman, Murray; Shneider, Neil A.; Chung, Wendy K.; Ravits, John M.; Glass, Jonathan D.; Sims, Katherine B.; Van Deerlin, Vivianna M.; Maniatis, Tom; Hayes, Sebastian D.; Ordureau, Alban; Swarup, Sharan; Landers, John; Baas, Frank; Allen, Andrew S.; Bedlack, Richard S.; Harper, J. Wade; Gitler, Aaron D.; Rouleau, Guy A.; Brown, Robert; Harms, Matthew B.; Cooper, Gregory M.; Harris, Tim; Myers, Richard M.; Goldstein, David B.		FALS Sequencing Consortium	Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways	SCIENCE			English	Article							AUTOPHAGY RECEPTOR; SPASTIN GENE; D-SERINE; OPTINEURIN; MUTATIONS; ALS; GRANULES; BINDING; PROTEIN; ROLES	Amyotrophic lateral sclerosis (ALS) is a devastating neurological disease with no effective treatment. We report the results of a moderate-scale sequencing study aimed at increasing the number of genes known to contribute to predisposition for ALS. We performed whole-exome sequencing of 2869 ALS patients and 6405 controls. Several known ALS genes were found to be associated, and TBK1 (the gene encoding TANK-binding kinase 1) was identified as an ALS gene. TBK1 is known to bind to and phosphorylate a number of proteins involved in innate immunity and autophagy, including optineurin (OPTN) and p62 (SQSTM1/sequestosome), both of which have also been implicated in ALS. These observations reveal a key role of the autophagic pathway in ALS and suggest specific targets for therapeutic intervention.	[Cirulli, Elizabeth T.] Duke Univ, Sch Med, Ctr Appl Genom & Precis Med, Durham, NC 27708 USA; [Lasseigne, Brittany N.; Levy, Shawn E.; Boone, Braden E.; Wimbish, Jack R.; Waite, Lindsay L.; Jones, Angela L.; Cooper, Gregory M.; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Petrovski, Slave; Lu, Yi-Fan; Wang, Quanli; Krueger, Brian J.; Ren, Zhong; Goldstein, David B.] Columbia Univ, Inst Genom Med, New York, NY 10032 USA; [Sapp, Peter C.; McKenna-Yasek, Diane; Landers, John; Brown, Robert] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA; [Dion, Patrick A.; Leblond, Claire S.; Rouleau, Guy A.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Couthouis, Julien; Chesi, Alessandra; Raphael, Alya R.; Gitler, Aaron D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Keebler, Jonathan; Han, Yujun] Duke Univ, Sch Med, Durham, NC 27708 USA; [Carulli, John P.; Day-Williams, Aaron G.; Staropoli, John F.; Hayes, Sebastian D.; Harris, Tim] Biogen Inc, Cambridge, MA 02142 USA; [Xin, Winnie W.; Sims, Katherine B.] Massachusetts Gen Hosp, Dept Neurol, Ctr Human Genet Res, Neurogenet DNA Diagnost Lab, Boston, MA 02114 USA; [Cady, Janet; Harms, Matthew B.] Washington Univ, Sch Med, Neurol, St Louis, MO 63110 USA; [de Jong, J. M. B. Vianney; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Kenna, Kevin P.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Acad Unit Neurol, Dublin, Ireland; [Smith, Bradley N.; Topp, Simon; Miller, Jack; Gkazi, Athina; Al-Chalabi, Ammar; Shaw, Christopher E.] Kings Coll London, Dept Basic & Clin Neurosci, Inst Psychiat, London SE5 8AF, England; [van den Berg, Leonard H.; Veldink, Jan] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, NL-3508 GA Utrecht, Netherlands; [Silani, Vincenzo; Ticozzi, Nicola] IRCCS Ist Auxol ltaliano, Dept Neurol, I-20149 Milan, Italy; [Silani, Vincenzo; Ticozzi, Nicola] IRCCS Ist Auxol ltaliano, Lab Neurosci, I-20149 Milan, Italy; [Silani, Vincenzo; Ticozzi, Nicola] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy; [Baloh, Robert H.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Appel, Stanley; Simpson, Ericka] Houston Methodist Hosp, Houston, TX 77030 USA; [Appel, Stanley; Simpson, Ericka] Cornell Univ, Weill Cornell Med Coll, New York, NY 10065 USA; [lagier-Tourenne, ClotilDe] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [lagier-Tourenne, ClotilDe; Ravits, John M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Pulst, Stefan M.; Gibson, Summer] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84112 USA; [Trojanowski, John Q.; Van Deerlin, Vivianna M.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Elman, Lauren; McCluskey, Leo] Univ Penn, Perelman Sch Med, Penn ALS Ctr, Dept Neurol, Philadelphia, PA 19104 USA; [Grossman, Murray] Univ Penn, Perelman Sch Med, Penn Frontotemporal Degenerat Ctr, Dept Neurol, Philadelphia, PA 19104 USA; [Shneider, Neil A.] Columbia Univ, Ctr Motor Neuron Biol & Dis, Dept Neurol, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Dept Pediat & Med, New York, NY 10032 USA; [Glass, Jonathan D.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Maniatis, Tom] Columbia Univ, Dept Biochem Mol Biophys, New York, NY 10027 USA; [Hayes, Sebastian D.; Ordureau, Alban; Swarup, Sharan; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Allen, Andrew S.] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC 27708 USA; [Bedlack, Richard S.] Duke ALS Clin, Durham, NC 27708 USA; [Bedlack, Richard S.] Durham VA Med Ctr, Durham, NC 27708 USA	Duke University; HudsonAlpha Institute for Biotechnology; Columbia University; University of Massachusetts System; University of Massachusetts Worcester; McGill University; Stanford University; Duke University; Biogen; Harvard University; Massachusetts General Hospital; Washington University (WUSTL); University of Amsterdam; Academic Medical Center Amsterdam; Trinity College Dublin; University of London; King's College London; Utrecht University; Utrecht University Medical Center; University of Milan; Cedars Sinai Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Columbia University; Columbia University; Emory University; Columbia University; Harvard University; Harvard Medical School; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Harris, T (corresponding author), Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	tim.harris@biogenidec.com	colombrita, claudia/A-3295-2009; Ticozzi, Nicola/K-8094-2016; lagier-Tourenne, Clotilde/ABE-6303-2020; Goldstein, David/AAY-8125-2020; COUTHOUIS, Julien/G-3895-2012; CEREDA, CRISTINA/G-8208-2011; Troakes, Claire/K-4346-2015; ceroni, mauro/G-7080-2011; Shneider, Neil/ABF-5751-2020; Vance, Caroline/C-3047-2012; Hardiman, Orla/Y-3441-2019; Williams, Kelly L/A-5545-2010; lauria, giuseppe/AAN-5371-2020; Silani, Vincenzo/P-4421-2017; Ordureau, Alban/C-7558-2012; Gellera, Cinzia/J-7887-2016; Gagliardi, Stella/D-6905-2018; CASTELLOTTI, BARBARA/J-4939-2016; Chesi, Alessandra/AAT-8248-2020; Baas, Frank/F-9574-2010; Pensato, Viviana/J-6533-2016; Al-Chalabi, Ammar/E-5361-2010; Taroni, Franco/N-3879-2013; Cooper, Gregory/D-6914-2011; D'Alfonso, Sandra/K-7295-2014; Duga, Stefano/F-8173-2014; Chesi, Alessandra/N-7693-2017	colombrita, claudia/0000-0001-6567-8910; Ticozzi, Nicola/0000-0001-5963-7426; lagier-Tourenne, Clotilde/0000-0002-3058-8322; COUTHOUIS, Julien/0000-0002-2378-4595; CEREDA, CRISTINA/0000-0001-9571-0862; ceroni, mauro/0000-0002-8947-5007; Shneider, Neil/0000-0002-3223-7366; Vance, Caroline/0000-0001-5780-6951; Hardiman, Orla/0000-0003-2610-1291; Williams, Kelly L/0000-0001-6319-9473; lauria, giuseppe/0000-0001-9773-020X; Silani, Vincenzo/0000-0002-7698-3854; Ordureau, Alban/0000-0002-4924-8520; Gellera, Cinzia/0000-0002-3582-665X; CASTELLOTTI, BARBARA/0000-0002-9098-3041; Baas, Frank/0000-0003-3912-5428; Pensato, Viviana/0000-0001-9798-2669; Al-Chalabi, Ammar/0000-0002-4924-7712; Jones, Lindsay/0000-0002-4219-8356; Taroni, Franco/0000-0002-2420-5233; Smith, Bradley/0000-0002-6980-2453; Cirulli Rogers, Liz/0000-0001-7808-2809; Shaw, Pamela/0000-0002-8925-2567; Rapa, Anna/0000-0002-5523-5224; Cooper, Gregory/0000-0001-5509-9923; D'Alfonso, Sandra/0000-0002-3983-9925; HAYES, SEBASTIAN/0000-0002-2383-9461; Bedlack, Richard/0000-0003-4666-7495; Gitler, Aaron/0000-0001-8603-1526; putchakatla, venkateswarlu/0000-0002-5045-9819; Petrovski, Slave/0000-0002-1527-961X; Soraru, Gianni/0000-0001-9691-6328; Wu, Zheyang/0000-0003-0641-0791; Veldink, Jan/0000-0001-5572-9657; Danielson, Eric/0000-0002-5442-0460; Talbot, Kevin/0000-0001-5490-1697; Lasseigne, Brittany/0000-0002-1642-8904; Gkazi, Soragia Athina/0000-0002-6385-368X; Duga, Stefano/0000-0003-3457-1410; Harper, Jeffrey/0000-0002-6944-7236; Allen, Andrew/0000-0002-7232-2143; Blair, Ian/0000-0003-3083-0075; topp, simon/0000-0002-5200-3284; McLaughlin, Russell/0000-0003-3915-2135; Chesi, Alessandra/0000-0002-0954-7446; Esteban-Perez, Jesus/0000-0002-3424-7357; Morrison, Karen Elaine/0000-0003-0216-5717; Troakes, Claire/0000-0002-1790-7376; Turner, Martin/0000-0003-0267-3180; Nicholson, Garth/0000-0001-9694-066X; Landers, John/0000-0001-8084-5043; Shaw, Christopher/0000-0003-0251-0146; Levy, Shawn/0000-0002-1369-5740	National Institute for Health Research [NF-SI-0512-10082] Funding Source: researchfish; Motor Neurone Disease Association [Turner/Jan13/944-795] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001066, UL1TR001067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS083524, K08NS075094, R01NS073873, R37NS033123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688, P01AG032953, P01AG017586] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [1309960] Funding Source: National Science Foundation; MRC [MC_G1000733, G0500289, G0900688, MR/K01014X/1, MR/L016397/1, MR/L021803/1, G9318379, G1100695] Funding Source: UKRI; Medical Research Council [MR/L016397/1, G0900688, G9318379, MR/K01014X/1, G1100695, G0500289, MC_G1000733, MR/L501529/1, MR/L021803/1] Funding Source: Medline; NCATS NIH HHS [UL1 TR001067, TL1 TR001066] Funding Source: Medline; NIA NIH HHS [P01 AG017586, P50 AG025688, P01 AG032953] Funding Source: Medline; NIGMS NIH HHS [T32 GM007754] Funding Source: Medline; NINDS NIH HHS [K08 NS075094, R37 NS033123, R37 NS083524, R01 NS073873] Funding Source: Medline; Wellcome Trust [089701] Funding Source: Medline; Motor Neurone Disease Association [TURNER/JAN13/944-795] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Motor Neurone Disease Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); Motor Neurone Disease Association		Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Cady J, 2015, ANN NEUROL, V77, P100, DOI 10.1002/ana.24306; Chaussenot A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.07.022; Chen S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-28; Chesi A, 2013, NAT NEUROSCI, V16, P851, DOI 10.1038/nn.3412; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Couthouis J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004704; Daoud H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.012; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Iida A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.037; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Kachaner D, 2012, CELL CYCLE, V11, P2808, DOI 10.4161/cc.20946; Kaneb HM, 2015, HUM MOL GENET, V24, P1363, DOI 10.1093/hmg/ddu545; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Keller BA, 2012, ACTA NEUROPATHOL, V124, P733, DOI 10.1007/s00401-012-1035-z; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Li JJ, 2014, INT J CANCER, V134, P1972, DOI 10.1002/ijc.28507; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Maruyama H, 2013, GERIATR GERONTOL INT, V13, P528, DOI 10.1111/ggi.12022; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Meyer T, 2005, NEUROLOGY, V65, P141, DOI 10.1212/01.wnl.0000167130.31618.0a; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Munch C, 2008, AMYOTROPH LATERAL SC, V9, P251, DOI 10.1080/17482960801900172; Neumann M, 2013, REV NEUROL-FRANCE, V169, P793, DOI 10.1016/j.neurol.2013.07.019; Paul P, 2012, AMINO ACIDS, V43, P1823, DOI 10.1007/s00726-012-1385-9; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Poppe L, 2014, EXP NEUROL, V262, P138, DOI 10.1016/j.expneurol.2014.07.001; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Rea SL, 2014, EXP CELL RES, V325, P27, DOI 10.1016/j.yexcr.2014.01.020; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Sasabe J, 2007, EMBO J, V26, P4149, DOI 10.1038/sj.emboj.7601840; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Smith BN, 2014, NEURON, V84, P324, DOI 10.1016/j.neuron.2014.09.027; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Thomas M, 2013, BRAIN, V136, P1345, DOI 10.1093/brain/awt030; Thompson M, 2012, J NEUROCHEM, V120, P598, DOI 10.1111/j.1471-4159.2011.07601.x; van Blitterswijk M., 2012, NEUROBIOL AGING, V33; Van Damme P, 2013, CURR OPIN NEUROL, V26, P466, DOI 10.1097/WCO.0b013e328364c063; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	52	622	633	1	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1436	1441		10.1126/science.aaa3650	http://dx.doi.org/10.1126/science.aaa3650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25700176	Green Accepted, Green Published			2022-12-28	WOS:000352136400031
J	Campbell, BCV; Mitchell, PJ; Kleinig, TJ; Dewey, HM; Churilov, L; Yassi, N; Yan, B; Dowling, RJ; Parsons, MW; Oxley, TJ; Wu, TY; Brooks, M; Simpson, MA; Miteff, F; Levi, CR; Krause, M; Harrington, TJ; Faulder, KC; Steinfort, BS; Priglinger, M; Ang, T; Scroop, R; Barber, PA; McGuinness, B; Wijeratne, T; Phan, TG; Chong, W; Chandra, RV; Bladin, CF; Badve, M; Rice, H; de Villiers, L; Ma, H; Desmond, PM; Donnan, GA; Davis, SM				Campbell, B. C. V.; Mitchell, P. J.; Kleinig, T. J.; Dewey, H. M.; Churilov, L.; Yassi, N.; Yan, B.; Dowling, R. J.; Parsons, M. W.; Oxley, T. J.; Wu, T. Y.; Brooks, M.; Simpson, M. A.; Miteff, F.; Levi, C. R.; Krause, M.; Harrington, T. J.; Faulder, K. C.; Steinfort, B. S.; Priglinger, M.; Ang, T.; Scroop, R.; Barber, P. A.; McGuinness, B.; Wijeratne, T.; Phan, T. G.; Chong, W.; Chandra, R. V.; Bladin, C. F.; Badve, M.; Rice, H.; de Villiers, L.; Ma, H.; Desmond, P. M.; Donnan, G. A.; Davis, S. M.		EXTEND-IA Investigators	Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED-TRIAL; ASSUMPTION-FREE; BLOOD-FLOW; T-PA; INFARCT; THROMBOLYSIS; TIME; CT; REVASCULARIZATION; ALTEPLASE	BACKGROUND Trials of endovascular therapy for ischemic stroke have produced variable results. We conducted this study to test whether more advanced imaging selection, recently developed devices, and earlier intervention improve outcomes. METHODS We randomly assigned patients with ischemic stroke who were receiving 0.9 mg of alteplase per kilogram of body weight less than 4.5 hours after the onset of ischemic stroke either to undergo endovascular thrombectomy with the Solitaire FR (Flow Restoration) stent retriever or to continue receiving alteplase alone. All the patients had occlusion of the internal carotid or middle cerebral artery and evidence of salvageable brain tissue and ischemic core of less than 70 ml on computed tomographic (CT) perfusion imaging. The coprimary outcomes were reperfusion at 24 hours and early neurologic improvement (>= 8-point reduction on the National Institutes of Health Stroke Scale or a score of 0 or 1 at day 3). Secondary outcomes included the functional score on the modified Rankin scale at 90 days. RESULTS The trial was stopped early because of efficacy after 70 patients had undergone randomization (35 patients in each group). The percentage of ischemic territory that had undergone reperfusion at 24 hours was greater in the endovascular-therapy group than in the alteplase-only group (median, 100% vs. 37%; P<0.001). Endovascular therapy, initiated at a median of 210 minutes after the onset of stroke, increased early neurologic improvement at 3 days (80% vs. 37%, P = 0.002) and improved the functional outcome at 90 days, with more patients achieving functional independence (score of 0 to 2 on the modified Rankin scale, 71% vs. 40%; P = 0.01). There were no significant differences in rates of death or symptomatic intracerebral hemorrhage. CONCLUSIONS In patients with ischemic stroke with a proximal cerebral arterial occlusion and salvageable tissue on CT perfusion imaging, early thrombectomy with the Solitaire FR stent retriever, as compared with alteplase alone, improved reperfusion, early neurologic recovery, and functional outcome.	[Campbell, B. C. V.; Yassi, N.; Yan, B.; Oxley, T. J.; Wu, T. Y.; Davis, S. M.] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Neurol, Melbourne Brain Ctr, Parkville, Vic, Australia; [Mitchell, P. J.; Dowling, R. J.; Desmond, P. M.] Univ Melbourne, Dept Radiol, Parkville, Vic 3052, Australia; [Churilov, L.; Oxley, T. J.; Ma, H.; Donnan, G. A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Kleinig, T. J.; Scroop, R.] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Dewey, H. M.; Brooks, M.; Simpson, M. A.] Austin Hlth, Heidelberg, Vic, Australia; [Parsons, M. W.; Miteff, F.; Levi, C. R.; Ang, T.] Univ Newcastle, Prior Res Ctr Brain & Mental Hlth Res, John Hunter Hosp, Newcastle, NSW 2300, Australia; [Krause, M.; Priglinger, M.] Univ Sydney, Royal N Shore Hosp, Dept Neurol, St Leonards, NSW 2065, Australia; [Krause, M.; Priglinger, M.] Univ Sydney, Kolling Inst, St Leonards, NSW, Australia; [Miteff, F.; Harrington, T. J.; Faulder, K. C.; Steinfort, B. S.] Royal N Shore Hosp, Dept Radiol, St Leonards, NSW 2065, Australia; [Wijeratne, T.] Western Hosp, Footscray, Vic, Australia; [Phan, T. G.; Chong, W.; Chandra, R. V.; Ma, H.] Monash Univ, Monash Med Ctr, Clayton, Vic, Australia; [Bladin, C. F.] Monash Univ, Box Hill Hosp, Box Hill, Vic, Australia; [Dewey, H. M.] Monash Univ, Eastern Clin Sch, Fac Med Nursing & Hlth Sci, Box Hill, Vic, Australia; [Badve, M.; Rice, H.; de Villiers, L.] Gold Coast Univ Hosp, Southport, Qld, Australia; [Barber, P. A.] Univ Auckland, Ctr Brain Res, Auckland City Hosp, Auckland 1, New Zealand; [McGuinness, B.] Auckland City Hosp, Auckland, New Zealand	Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Adelaide Hospital; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; John Hunter Hospital; University of Newcastle; Royal North Shore Hospital; University of Sydney; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; Western Hospital; Monash University; Box Hill Hospital; Monash University; Monash University; Gold Coast University Hospital; Auckland City Hospital; University of Auckland; Auckland City Hospital	Campbell, BCV (corresponding author), Royal Melbourne Hosp, Dept Neurol, Grattan St, Parkville, Vic 3050, Australia.	bruce.campbell@mh.org.au	Demchuk, Andrew M/E-1103-2012; Wu, Teddy/AAD-7864-2020; Spratt, Neil J/K-4208-2012; Coulthard, Alan/C-3649-2011; FRACP, Tissa Wijeratne MD PhD/I-2086-2019; Badve, Monica/W-2187-2017; Campbell, Bruce/J-1220-2019; Chandra, Ronil/GPK-0357-2022; Davis, Stephen/L-5260-2013; Desmond, Patricia/D-1966-2014	Demchuk, Andrew M/0000-0002-4930-7789; Wu, Teddy/0000-0003-1845-1769; Spratt, Neil J/0000-0002-9023-6177; Coulthard, Alan/0000-0003-1110-9207; FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; Badve, Monica/0000-0002-1115-6719; Campbell, Bruce/0000-0003-3632-9433; Yassi, Nawaf/0000-0002-0685-0060; Barber, P Alan/0000-0003-2469-9023; Davis, Stephen/0000-0003-0962-2300; Yan, Bernard/0000-0001-8802-9606; Dowling, Richard/0000-0002-4082-8676; Desmond, Patricia/0000-0002-4803-6323; Steinfort, Brendan/0000-0002-6627-7972; Oxley, Thomas/0000-0002-5569-3612; Chandra, Ronil/0000-0001-7555-2297; Levi, Christopher/0000-0002-9474-796X; MA, HENRY/0000-0002-0510-8059; Donnan, Geoffrey/0000-0001-6324-3403; kleinig, Timothy/0000-0003-4430-3276	Australian National Health and Medical Research Council; Alberta Innovates [201300690] Funding Source: researchfish	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Alberta Innovates	Funded by the Australian National Health and Medical Research Council and others; EXTEND-IA ClinicalTrials.gov number, NCT01492725, and Australian New Zealand Clinical Trials Registry number, ACTRN12611000969965	Bang OY, 2011, STROKE, V42, P693, DOI 10.1161/STROKEAHA.110.595256; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bivard A, 2013, RADIOLOGY, V267, P543, DOI 10.1148/radiol.12120971; Bivard A, 2011, BRAIN, V134, P3408, DOI 10.1093/brain/awr257; Broderick JP, 2013, NEW ENGL J MED, V368, P1265; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BCV, 2015, INT J STROKE, V10, P51, DOI 10.1111/ijs.12381; Campbell BCV, 2014, INT J STROKE, V9, P126, DOI 10.1111/ijs.12206; Campbell BCV, 2013, J CEREBR BLOOD F MET, V33, P1168, DOI 10.1038/jcbfm.2013.77; Campbell BCV, 2012, STROKE, V43, P2648, DOI 10.1161/STROKEAHA.112.660548; Campbell BCV, 2011, STROKE, V42, P3435, DOI 10.1161/STROKEAHA.111.618355; Churilov L, 2014, INT J STROKE, V9, P999, DOI 10.1111/ijs.12364; Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; HOLM S, 1979, SCAND J STAT, V6, P65; Howard G, 2012, STROKE, V43, P664, DOI 10.1161/STROKEAHA.111.632935; Inoue M, 2012, STROKE, V43, P2494, DOI 10.1161/STROKEAHA.112.653329; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kimura K, 2008, J NEUROL SCI, V270, P48, DOI 10.1016/j.jns.2008.01.013; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Menezes NM, 2007, STROKE, V38, P194, DOI 10.1161/01.STR.0000251792.76080.45; Meretoja A, 2013, NEUROLOGY, V81, P1071, DOI 10.1212/WNL.0b013e3182a4a4d2; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Pereira VM, 2013, STROKE, V44, P2802, DOI 10.1161/STROKEAHA.113.001232; Quinn TJ, 2008, STROKE, V39, P231, DOI 10.1161/STROKEAHA.107.493320; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Straka M, 2010, J MAGN RESON IMAGING, V32, P1024, DOI 10.1002/jmri.22338; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wintermark M, 2013, STROKE, V44, P2628, DOI 10.1161/STROKEAHA.113.002015; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	30	3597	3825	10	265	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					1009	1018		10.1056/NEJMoa1414792	http://dx.doi.org/10.1056/NEJMoa1414792			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD0XK	25671797				2022-12-28	WOS:000350797300005
J	Nunez, JK; Lee, ASY; Engelman, A; Doudna, JA				Nunez, James K.; Lee, Amy S. Y.; Engelman, Alan; Doudna, Jennifer A.			Integrase-mediated spacer acquisition during CRISPR-Cas adaptive immunity	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SHORT PALINDROMIC REPEATS; TOPOISOMERASE-I MUTANTS; DNA STRAND TRANSFER; ESCHERICHIA-COLI; ACQUIRED-RESISTANCE; BACTERIAL IMMUNITY; GYRASE GENES; SEQUENCE; SYSTEM	Bacteria and archaea insert spacer sequences acquired from foreign DNAs into CRISPR loci to generate immunological memory. The Escherichia coli Cas1-Cas2 complex mediates spacer acquisition in vivo, but the molecular mechanism of this process is unknown. Here we show that the purified Cas1-Cas2 complex integrates oligonucleotide DNA substrates into acceptor DNA to yield products similar to those generated by retroviral integrases and transposases. Cas1 is the catalytic subunit and Cas2 substantially increases integration activity. Protospacer DNA with free 3'-OH ends and supercoiled target DNA are required, and integration occurs preferentially at the ends of CRISPR repeats and at sequences adjacent to cruciform structures abutting AT-rich regions, similar to the CRISPR leader sequence. Our results demonstrate the Cas1-Cas2 complex to be the minimal machinery that catalyses spacer DNA acquisition and explain the significance of CRISPR repeats in providing sequence and structural specificity for Cas1-Cas2-mediated adaptive immunity.	[Nunez, James K.; Lee, Amy S. Y.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Lee, Amy S. Y.; Doudna, Jennifer A.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Engelman, Alan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Engelman, Alan] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu			US National Science Foundation [1244557]; NIH [AI070042]; NIH S10 Instrumentation Grants [S10RR029668, S10RR027303]; US National Science Foundation Graduate Research Fellowship; UC Berkeley Chancellor's Graduate Fellowship; American Cancer Society [PF-14-108-01-RMC]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027303, S10RR029668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH S10 Instrumentation Grants; US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); UC Berkeley Chancellor's Graduate Fellowship; American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to M. Chung, P. J. Kranzusch and A.V. Wright for technical assistance and members of the Doudna laboratory and J. Cate for discussions. This project was funded by US National Science Foundation grant no. 1244557 to J.A.D. and by NIH grant AI070042 to A.E. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 Instrumentation Grants S10RR029668 and S10RR027303. J.K.N. is supported by a US National Science Foundation Graduate Research Fellowship and a UC Berkeley Chancellor's Graduate Fellowship. A.S.Y.L. is supported as an American Cancer Society Postdoctoral Fellow (PF-14-108-01-RMC). J.A.D. is an Investigator of the Howard Hughes Medical Institute and a member of the Center for RNA Systems Biology.	Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Au TK, 2004, EMBO J, V23, P3408, DOI 10.1038/sj.emboj.7600344; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; DINARDO S, 1982, CELL, V31, P43, DOI 10.1016/0092-8674(82)90403-2; ENGELMAN A, 1995, J VIROL, V69, P5908, DOI 10.1128/JVI.69.9.5908-5911.1995; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Goren MG, 2012, J MOL BIOL, V423, P14, DOI 10.1016/j.jmb.2012.06.037; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim TY, 2013, BIOCHEM BIOPH RES CO, V441, P720, DOI 10.1016/j.bbrc.2013.10.122; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nam KH, 2012, J BIOL CHEM, V287, P35943, DOI 10.1074/jbc.M112.382598; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; PALECEK E, 1991, CRIT REV BIOCHEM MOL, V26, P151, DOI 10.3109/10409239109081126; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; PRUSS GJ, 1982, CELL, V31, P35, DOI 10.1016/0092-8674(82)90402-0; Samai P, 2010, ACTA CRYSTALLOGR F, V66, P1552, DOI 10.1107/S1744309110039801; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; SHEFLIN LG, 1985, NUCLEIC ACIDS RES, V13, P6137, DOI 10.1093/nar/13.17.6137; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Yang JY, 1996, CELL, V85, P447, DOI 10.1016/S0092-8674(00)81122-8; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	49	212	227	8	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					193	+		10.1038/nature14237	http://dx.doi.org/10.1038/nature14237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25707795	Green Accepted, Green Submitted			2022-12-28	WOS:000350770500030
J	Gardner, MR; Kattenhorn, LM; Kondur, HR; von Schaewen, M; Dorfman, T; Chiang, JJ; Haworth, KG; Decker, JM; Alpert, MD; Bailey, CC; Neale, ES; Fellinger, CH; Joshi, VR; Fuchs, SP; Martinez-Navio, JM; Quinlan, BD; Yao, AY; Mouquet, H; Gorman, J; Zhang, BS; Poignard, P; Nussenzweig, MC; Burton, DR; Kwong, PD; Piatak, M; Lifson, JD; Gao, GP; Desrosiers, RC; Evans, DT; Hahn, BH; Ploss, A; Cannon, PM; Seaman, MS; Farzan, M				Gardner, Matthew R.; Kattenhorn, Lisa M.; Kondur, Hema R.; von Schaewen, Markus; Dorfman, Tatyana; Chiang, Jessica J.; Haworth, Kevin G.; Decker, Julie M.; Alpert, Michael D.; Bailey, Charles C.; Neale, Ernest S., Jr.; Fellinger, Christoph H.; Joshi, Vinita R.; Fuchs, Sebastian P.; Martinez-Navio, Jose M.; Quinlan, Brian D.; Yao, Annie Y.; Mouquet, Hugo; Gorman, Jason; Zhang, Baoshan; Poignard, Pascal; Nussenzweig, Michel C.; Burton, Dennis R.; Kwong, Peter D.; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Gao, Guangping; Desrosiers, Ronald C.; Evans, David T.; Hahn, Beatrice H.; Ploss, Alexander; Cannon, Paula M.; Seaman, Michael S.; Farzan, Michael			AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FUSION INHIBITOR T-20; TYROSINE SULFATION; N-TERMINUS; POTENT NEUTRALIZATION; ENVELOPE GLYCOPROTEIN; BINDING-SITE; SOLUBLE CD4; HIV-1 GP120; ANTIBODY	Long-term in vivo expression of a broad and potent entry inhibitor could circumvent the need for a conventional vaccine for HIV-1. Adeno-associated virus (AAV) vectors can stably express HIV-1 broadly neutralizing antibodies (bNAbs)(1,2). However, even the best bNAbs neutralize 10-50% of HIV-1 isolates inefficiently (80% inhibitory concentration (IC80) > 5 mu g ml(-1)), suggesting that high concentrations of these antibodies would be necessary to achieve general protection(3-6). Here we show that eCD4-Ig, a fusion ofCD4-Ig with a small CCR5-mimetic sulfopeptide, binds avidly and cooperatively to the HIV-1 envelope glycoprotein (Env) and is more potent than the best bNAbs (geometric mean half-maximum inhibitory concentration (IC50), 0.05 mu g ml(-1)). Because eCD4-Ig binds only conserved regions of Env, it is also much broader than any bNAb. For example, eCD4-Ig efficiently neutralized 100% of a diverse panel of neutralization-resistant HIV-1, HIV-2 and simian immunodeficiency virus isolates, including a comprehensive set of isolates resistant to the CD4-binding site bNAbs VRC01, NIH45-46 and 3BNC117. Rhesus macaques inoculated with an AAV vector stably expressed 17-77 mu g ml(-1) of fully functional rhesuseCD4-Ig for more than 40 weeks, and these macaques were protected from several infectious challenges with SHIV-AD8. Rhesus eCD4-Ig was also markedly less immunogenic than rhesus forms of four well-characterized bNAbs. Our data suggest that AAV-delivered eCD4-Ig can function like an effective HIV-1 vaccine.	[Gardner, Matthew R.; Kondur, Hema R.; Dorfman, Tatyana; Bailey, Charles C.; Fellinger, Christoph H.; Joshi, Vinita R.; Quinlan, Brian D.; Farzan, Michael] Scripps Res Inst, Dept Infect Dis, Jupiter, FL 33458 USA; [Kattenhorn, Lisa M.; Chiang, Jessica J.; Alpert, Michael D.; Neale, Ernest S., Jr.; Yao, Annie Y.; Desrosiers, Ronald C.] Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Comparat Pathol, Southborough, MA 01772 USA; [von Schaewen, Markus; Ploss, Alexander] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Haworth, Kevin G.; Cannon, Paula M.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Decker, Julie M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Decker, Julie M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Alpert, Michael D.] Immunathon Inc, Cambridge, MA 02141 USA; [Fuchs, Sebastian P.; Martinez-Navio, Jose M.; Desrosiers, Ronald C.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Mouquet, Hugo; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Mouquet, Hugo] Inst Pasteur, Dept Immunol, F-75015 Paris, France; [Gorman, Jason; Zhang, Baoshan; Kwong, Peter D.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Nussenzweig, Michel C.] Howard Hughes Med Inst, New York, NY 10065 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Gao, Guangping] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA 01655 USA; [Evans, David T.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53711 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Scripps Research Institute; Harvard University; Princeton University; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Miami; Rockefeller University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Massachusetts System; University of Massachusetts Worcester; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Beth Israel Deaconess Medical Center	Farzan, M (corresponding author), Scripps Res Inst, Dept Infect Dis, Jupiter, FL 33458 USA.	mfarzan@scripps.edu	Fellinger, Christoph/M-9981-2017; poignard, pascal/N-6678-2013; poignard, pascal/AAB-4613-2020; Nussenzweig, Michel/AAE-7292-2019; Ploss, Alexander/ABG-2330-2020; Mouquet, Hugo/M-2750-2014; Gorman, Jason/AGG-9417-2022	Fellinger, Christoph/0000-0003-0242-9161; Ploss, Alexander/0000-0001-9322-7252; Mouquet, Hugo/0000-0002-4230-610X; Gorman, Jason/0000-0002-3775-6560; Gardner, Matthew/0000-0003-2872-7597; Farzan, Michael/0000-0002-2990-5319; Martinez-Navio, Jose/0000-0003-0560-5407; Hahn, Beatrice/0000-0002-9400-9887; Joshi, Vinita/0000-0002-3032-137X; Poignard, Pascal/0000-0002-0021-7192; Bailey, Charles/0000-0003-0200-3523	National Institutes of Health (NIH) [R01 AI091476, R01 AI080324, P01 AI100263, RR000168, RO1 AI058715]; Vaccine Research Center, NIAID, NIH; National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168, K26RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080324, R01AI091476, P30AI073961, R01AI095098, P01AI100263, R01AI058715, P30AI045008, R37AI095098, R01AI098485, UM1AI100663] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by National Institutes of Health (NIH) grants R01 AI091476 and RO1 AI080324 (M.F.), P01 AI100263 (G.G., R.C.D., M.F.), RR000168 (M.R.G., L.M.K., D.T.E., R.C.D., M.F.), R01 AI058715 (B.H.H.), by the Intramural Research program of the Vaccine Research Center, NIAID, NIH (J.G., B.Z., P.D.K.), and by federal funds from the National Cancer Institute, NIH under contract no. HHSN261200800001E. The authors would like to thank H. Choe and M. Martin for critical advice.	Alpert MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002890; Alpert MD, 2012, J VIROL, V86, P12039, DOI 10.1128/JVI.01650-12; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Chiang JJ, 2012, J VIROL, V86, P12417, DOI 10.1128/JVI.00967-12; Choe H, 1998, J VIROL, V72, P6113, DOI 10.1128/JVI.72.7.6113-6118.1998; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Choe H, 2003, CELL, V114, P161, DOI 10.1016/S0092-8674(03)00508-7; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Dorfman T, 2006, J BIOL CHEM, V281, P28529, DOI 10.1074/jbc.M602732200; Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; Fletcher CV, 2007, J ALLERGY CLIN IMMUN, V119, P747, DOI 10.1016/j.jaci.2006.10.045; Greig JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112268; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Humes D, 2012, J VIROL, V86, P12472, DOI 10.1128/JVI.02176-12; HUSSEY RE, 1988, NATURE, V331, P78, DOI 10.1038/331078a0; Jacobson JM, 2000, J INFECT DIS, V182, P326, DOI 10.1086/315698; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Kwong JA, 2011, J VIROL, V85, P7563, DOI 10.1128/JVI.00630-11; Lagenaur LA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-11; Lewis AD, 2002, J VIROL, V76, P8769, DOI 10.1128/JVI.76.17.8769-8775.2002; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; MOEBIUS U, 1992, J EXP MED, V176, P507, DOI 10.1084/jem.176.2.507; Morner A, 1999, J VIROL, V73, P2343; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Quinlan BD, 2013, J BIOL CHEM, V288, P18803, DOI 10.1074/jbc.M113.452839; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sullivan N, 1998, J VIROL, V72, P6332, DOI 10.1128/JVI.72.8.6332-6338.1998; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	50	202	211	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					87	U173		10.1038/nature14264	http://dx.doi.org/10.1038/nature14264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25707797	Green Accepted, Green Submitted			2022-12-28	WOS:000350304000041
J	Harel, I; Benayoun, BA; Machado, B; Singh, PP; Hu, CK; Pech, MF; Valenzano, DR; Zhang, E; Sharp, SC; Artandi, SE; Brunet, A				Harel, Itamar; Benayoun, Berenice A.; Machado, Ben; Singh, Param Priya; Hu, Chi-Kuo; Pech, Matthew F.; Valenzano, Dario Riccardo; Zhang, Elisa; Sharp, Sabrina C.; Artandi, Steven E.; Brunet, Anne			A Platform for Rapid Exploration of Aging and Diseases in a Naturally Short-Lived Vertebrate	CELL			English	Article							FISH NOTHOBRANCHIUS-FURZERI; TELOMERASE; GENOME; GENETICS; MODEL; BIOLOGY; LONGEVITY; CANCER; RATS; LIFE	Aging is a complex process that affects multiple organs. Modeling aging and age-related diseases in the lab is challenging because classical vertebrate models have relatively long lifespans. Here, we develop the first platform for rapid exploration of age-dependent traits and diseases in vertebrates, using the naturally short-lived African turquoise killifish. We provide an integrative genomic and genome-editing toolkit in this organism using our de-novo-assembled genome and the CRISPR/Cas9 technology. We mutate many genes encompassing the hallmarks of aging, and for a subset, we produce stable lines within 2-3 months. As a proof of principle, we show that fish deficient for the protein subunit of telomerase exhibit the fastest onset of telomere-related pathologies among vertebrates. We further demonstrate the feasibility of creating specific genetic variants. This genome-to-phenotype platform represents a unique resource for studying vertebrate aging and disease in a high-throughput manner and for investigating candidates arising from human genome-wide studies.	[Harel, Itamar; Benayoun, Berenice A.; Machado, Ben; Singh, Param Priya; Hu, Chi-Kuo; Valenzano, Dario Riccardo; Zhang, Elisa; Sharp, Sabrina C.; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Pech, Matthew F.; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Pech, Matthew F.; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Artandi, Steven E.; Brunet, Anne] Glenn Labs Biol Aging Stanford, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Brunet, A (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	abrunet1@stanford.edu	Benayoun, Bérénice A./K-7048-2012; Singh, Param P/AAU-7841-2020	Benayoun, Bérénice A./0000-0002-7401-4777; Singh, Param Priya/0000-0002-3325-8767; Harel, Itamar/0000-0001-9749-8279; Valenzano, Dario Riccardo/0000-0002-8761-8289	NIH [DP1AG044848]; Glenn Laboratories for the Biology of Aging; Damon Runyon fellowship; HFSP fellowship; Dean's fellowship, Stanford; Rothschild fellowship; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [DP1AG044848, K99AG049934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Laboratories for the Biology of Aging; Damon Runyon fellowship; HFSP fellowship; Dean's fellowship, Stanford; Rothschild fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Summer Thyme, John Geisinger, Franklin Zhong, and Michael Bassik for stimulating scientific discussion and members of the Brunet lab, especially Lauren Booth and Ashley Webb, for critical discussion and feedback on the manuscript. We thank Brock Martin and Andrew Connolly for histology advice and Elizabeth Pollina for help with the epigenomic data set. We thank Tessa Montague, Eivind Valen, and James Gagnon for incorporating the genome into the CHOPCHOP search engine. This work was supported by NIH DP1AG044848 and the Glenn Laboratories for the Biology of Aging (A.B.), the Damon Runyon, Rothschild, and HFSP fellowships (I.H.), and the Dean's fellowship, Stanford (B.A.B.).	Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anchelin M, 2013, DIS MODEL MECH, V6, P1101, DOI 10.1242/dmm.011635; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Austad SN, 2010, INTEGR COMP BIOL, V50, P783, DOI 10.1093/icb/icq131; Batista LFZ, 2013, CURR OPIN GENET DEV, V23, P526, DOI 10.1016/j.gde.2013.07.006; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bessler M, 2010, FEBS LETT, V584, P3831, DOI 10.1016/j.febslet.2010.05.019; Bolker J, 2012, NATURE, V491, P31, DOI 10.1038/491031a; Boonekamp JJ, 2013, AGING CELL, V12, P330, DOI 10.1111/acel.12050; Di Cicco E, 2011, EXP GERONTOL, V46, P249, DOI 10.1016/j.exger.2010.10.011; Fernald RD, 2012, ANNU REV NEUROSCI, V35, P133, DOI 10.1146/annurev-neuro-062111-150520; Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x; Gomes NMV, 2010, FEBS LETT, V584, P3741, DOI 10.1016/j.febslet.2010.07.031; Gorbunova V, 2014, NAT REV GENET, V15, P531, DOI 10.1038/nrg3728; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; Hartmann N, 2012, DEV DYNAM, V241, P1133, DOI 10.1002/dvdy.23789; Hartmann N, 2009, MECH AGEING DEV, V130, P290, DOI 10.1016/j.mad.2009.01.003; Henriques CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003214; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kirschner J, 2012, AGING CELL, V11, P252, DOI 10.1111/j.1474-9726.2011.00780.x; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024; OKAMOTO A, 1995, CANCER RES, V55, P1448; Parry EM, 2011, BLOOD, V117, P5607, DOI 10.1182/blood-2010-11-322149; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Raices M, 2005, PLOS GENET, V1, P295, DOI 10.1371/journal.pgen.0010030; Reichwald K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r16; Rhinn H, 2013, NATURE, V500, P45, DOI 10.1038/nature12415; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Savage SA, 2009, HEMATOL ONCOL CLIN N, V23, P215, DOI 10.1016/j.hoc.2009.01.003; Schartl M, 2014, DIS MODEL MECH, V7, P181, DOI 10.1242/dmm.012245; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Terzibasi E, 2009, AGING CELL, V8, P88, DOI 10.1111/j.1474-9726.2009.00455.x; Terzibasi E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003866; Trancikova A, 2011, PROG MOL BIOL TRANSL, V100, P419, DOI 10.1016/B978-0-12-384878-9.00012-1; Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x; Valenzano DR, 2011, G3-GENES GENOM GENET, V1, P531, DOI 10.1534/g3.111.001271; Zucchero T, 2006, EXP GERONTOL, V41, P992, DOI 10.1016/j.exger.2006.06.057	49	128	131	1	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					1013	1026		10.1016/j.cell.2015.01.038	http://dx.doi.org/10.1016/j.cell.2015.01.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25684364	Green Accepted, Bronze			2022-12-28	WOS:000351116100022
J	Menche, J; Sharma, A; Kitsak, M; Ghiassian, SD; Vidal, M; Loscalzo, J; Barabasi, AL				Menche, Joerg; Sharma, Amitabh; Kitsak, Maksim; Ghiassian, Susan Dina; Vidal, Marc; Loscalzo, Joseph; Barabasi, Albert-Laszlo			Uncovering disease-disease relationships through the incomplete interactome	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; PROTEIN-INTERACTION NETWORKS; INTERACTION DATASETS; MOLECULAR NETWORKS; CANDIDATE GENES; CELIAC-DISEASE; GWAS DATA; MEDICINE; BIOLOGY; DISORDERS	According to the diseasemodule hypothesis, the cellular components associated with a disease segregate in the same neighborhood of the human interactome, themap of biologically relevant molecular interactions. Yet, given the incompleteness of the interactome and the limited knowledge of disease-associated genes, it is not obvious if the available data have sufficient coverage to map out modules associated with each disease. Here we derive mathematical conditions for the identifiability of disease modules and show that the network-based location of each disease module determines its pathobiological relationship to other diseases. For example, diseases with overlapping network modules show significant coexpression patterns, symptom similarity, and comorbidity, whereas diseases residing in separated network neighborhoods are phenotypically distinct. These tools represent an interactome-based platform to predict molecular commonalities between phenotypically related diseases, even if they do not share primary disease genes.	[Menche, Joerg; Sharma, Amitabh; Kitsak, Maksim; Ghiassian, Susan Dina; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Networks Res, Dana Res Ctr 111, Boston, MA 02115 USA; [Menche, Joerg; Sharma, Amitabh; Kitsak, Maksim; Ghiassian, Susan Dina; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Dana Res Ctr 111, Boston, MA 02115 USA; [Menche, Joerg; Sharma, Amitabh; Kitsak, Maksim; Ghiassian, Susan Dina; Vidal, Marc; Barabasi, Albert-Laszlo] Dana Farber Canc Inst, CCSB, Boston, MA 02215 USA; [Menche, Joerg; Sharma, Amitabh; Kitsak, Maksim; Ghiassian, Susan Dina; Vidal, Marc; Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Menche, Joerg; Barabasi, Albert-Laszlo] Cent European Univ, Ctr Network Sci, H-1051 Budapest, Hungary; [Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Loscalzo, Joseph; Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA	Northeastern University; Northeastern University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Central European University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Barabasi, AL (corresponding author), Northeastern Univ, Ctr Complex Networks Res, Dana Res Ctr 111, 110 Forsyth St, Boston, MA 02115 USA.	alb@neu.edu	Loscalzo, Joseph/ABD-8980-2021; Menche, Jörg/G-3994-2015; Vidal, Marc/Y-2466-2019; Menche, Jörg/AAB-7008-2021; Barabasi, Albert-Laszlo/S-6474-2017	Menche, Jörg/0000-0002-1583-6404; Vidal, Marc/0000-0003-3391-5410; Menche, Jörg/0000-0002-1583-6404; Kitsak, Maksim/0000-0002-6862-6021; Barabasi, Albert/0000-0002-4028-3522	NIH from NHGRI [P50-HG004233, U01-HG001715, UO1-HG007690]; NIH from NHLBI [PO1-HL083069, R37-HL061795, RC2-HL101543, U01-HL108630]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL083069, RC2HL101543, R37HL061795, U01HL108630] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007690, P50HG004233, U41HG001715, U01HG001715] Funding Source: NIH RePORTER	NIH from NHGRI; NIH from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank A.-R. Carvunis, S. Pevzner, and T. Rolland for providing invaluable insights into the y2h data set; J. Bagrow and F. Simini for many discussions on the network methods; and G. Musella for figure design. This work was supported by NIH grants P50-HG004233, U01-HG001715, and UO1-HG007690 from NHGRI and PO1-HL083069, R37-HL061795, RC2-HL101543, and U01-HL108630 from NHLBI.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Bauer A, 2005, ACTA CARDIOL, V60, P551, DOI 10.2143/AC.60.5.2004979; Bornholdt S., 2003, HDB GRAPHS NETWORKS, V2; Buchanan M., 2010, NETWORKS CELL BIOL; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cohen R., 2010, COMPLEX NETWORKS STR; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Krauthammer M, 2004, P NATL ACAD SCI USA, V101, P15148, DOI 10.1073/pnas.0404315101; Kuhn M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.10; Lage K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.36; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Mestres J, 2009, MOL BIOSYST, V5, P1051, DOI 10.1039/b905821b; Mosca R, 2013, CURR OPIN STRUC BIOL, V23, P929, DOI 10.1016/j.sbi.2013.07.005; Mottaz A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S3; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pawson T, 2008, FEBS LETT, V582, P1266, DOI 10.1016/j.febslet.2008.02.011; Pilette Charles, 2004, Proc Am Thorac Soc, V1, P125, DOI 10.1513/pats.2306032; Ramos EM, 2014, EUR J HUM GENET, V22, P144, DOI 10.1038/ejhg.2013.96; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Singh-Blom UM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058977; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van der Windt DAWM, 2010, JAMA-J AM MED ASSOC, V303, P1738, DOI 10.1001/jama.2010.549; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wass MN, 2011, CURR OPIN STRUC BIOL, V21, P382, DOI 10.1016/j.sbi.2011.03.013; Wheelock CE, 2009, MOL BIOSYST, V5, P588, DOI 10.1039/b902356a; Wuchty S, 2010, J BIOMED INFORM, V43, P945, DOI 10.1016/j.jbi.2010.08.011; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212	50	785	803	12	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224							1257601	10.1126/science.1257601	http://dx.doi.org/10.1126/science.1257601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700523	Green Accepted			2022-12-28	WOS:000349761100035
J	Lehuen, A				Lehuen, Agnes			A Double-Edged Sword against Type 1 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CROSSTALK		[Lehuen, Agnes] Univ Paris 05, Hop Cochin Port Royal, INSERM, U1016,Inst Cochin, Paris, France; [Lehuen, Agnes] Univ Sorbonne Paris Cite, Lab Excellence INFLAMEX, Hop Cochin, Dept Hosp Univ Malad Hormonales & Autoimmunes, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Lehuen, A (corresponding author), Univ Paris 05, Hop Cochin Port Royal, INSERM, U1016,Inst Cochin, Paris, France.			Lehuen, Agnes/0000-0002-0450-3321				Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Fu WX, 2014, ELIFE, V3, DOI 10.7554/eLife.04631; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589	5	5	5	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					778	780		10.1056/NEJMcibr1414708	http://dx.doi.org/10.1056/NEJMcibr1414708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7PB	25693020				2022-12-28	WOS:000349818700016
J	Kalk, WJ				Kalk, W. John			Guantanamo force feeding trial: the US is wrong to medicalize hunger striking	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Medway Maritime Hosp, Gillingham ME7 5NY, Kent, England	Medway Maritime Hospital	Kalk, WJ (corresponding author), Medway Maritime Hosp, Gillingham ME7 5NY, Kent, England.	wjohnkalk@gmail.com						Annas GJ, 2013, NEW ENGL J MED, V369, P101, DOI 10.1056/NEJMp1306065; [Anonymous], 1991, Lancet, V337, P647; [Anonymous], 2014, GUARDIAN; KALK WJ, 1993, S AFR MED J, V83, P391; KALK WJ, 1991, LANCET, V337, P660, DOI 10.1016/0140-6736(91)92465-E; Keller A, 2014, DOING HARM HLTH PROF; Nicholl DJ, 2007, LANCET, V370, P823, DOI 10.1016/S0140-6736(07)61402-0; Steyn Johan, 2004, INT COMP LAW Q, V53, P1, DOI DOI 10.1093/iclq/53.1.1; World Medical Association, 1975, WORLD MED J, V22, P87; World Medical Association, 2006, WORLD MED ASS DECL M	10	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2015	350								h669	10.1136/bmj.h669	http://dx.doi.org/10.1136/bmj.h669			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0MG	25673236				2022-12-28	WOS:000349319700012
J	Gordon, A; Oliver, D				Gordon, Adam; Oliver, David			SPOTLIGHT: PATIENT CENTRED CARE Commentary: Frameworks for long term conditions must take account of needs of frail older people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gordon, Adam; Oliver, David] British Geriatr Soc, London, England; [Oliver, David] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Oliver, David] Royal Berkshire NHS Fdn Trust, Reading, Berks, England	Nottingham University Hospital NHS Trust; Royal Berkshire Hospital	Gordon, A (corresponding author), British Geriatr Soc, London, England.	adam.gordon@nottingham.ac.uk	Gordon, Adam/C-3934-2018	Gordon, Adam/0000-0003-1676-9853				British Geriatrics Society, 2014, FIT FRAILT; Eaton S, 2014, BMJ-BRIT MED J, V350, ph181; Fuller G, 2014, BMJ-BRIT MED J, V348, P2865; Nolan M, 2006, QUAL AGEING OLDER AD, V7, P5, DOI 10.1108/14717794200600015; Oakley R, 2014, AGE AGEING, V43, P442, DOI 10.1093/ageing/afu077; Oliver D., 2014, MAKING OUR HLTH CARE; Welsh TJ, 2014, INT J CLIN PRACT, V68, P290, DOI 10.1111/ijcp.12313	7	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h370	10.1136/bmj.h370	http://dx.doi.org/10.1136/bmj.h370			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670195	Bronze			2022-12-28	WOS:000349318400013
J	Ard, J				Ard, Jamy			Obesity in the US: what is the best role for primary care?	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LIFE-STYLE INTERVENTION; DIABETES PREVENTION PROGRAM; RANDOMIZED CONTROLLED-TRIAL; WEIGHT-LOSS INTERVENTIONS; PHYSICAL-ACTIVITY; CARDIOMETABOLIC RISK; SUPPORT PROGRAM; UNITED-STATES; MANAGEMENT; REDUCTION	The increasing prevalence of obesity together with projected increases in diabetes over the next 20-30 years will put a substantial strain on the finances and resources of the US healthcare system. The best opportunity for broad scale treatment of obesity may lie in the primary care setting. This review assesses the evidence on the efficacy of treatment for obesity delivered in primary care in the United States. It summarizes an earlier systematic review, recent obesity treatment guidelines, and subsequent US based trials with a minimum follow-up of six months in which at least one member of a primary care team helped deliver comprehensive behavioral obesity treatment to adults with overweight or obesity. Overall, the evidence suggests that obesity treatment delivered in primary care has limited effectiveness. Questions remain about the optimal role of the primary care provider in the treatment of obesity and the prevention of weight gain, as well as potential systems approaches to the treatment of obesity.	Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center	Ard, J (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	jard@wakehealth.edu		Ard, Jamy/0000-0002-1643-6795	Nestle Healthcare Nutrition; Vivus; Novo Nordisk; Eisai pharmaceutical	Nestle Healthcare Nutrition(Nestle SA); Vivus; Novo Nordisk(Novo Nordisk); Eisai pharmaceutical	I have read and understood BMJ policy on declaration of interests and declare the following interests: I receive research support and am a consultant medical director for Nestle Healthcare Nutrition; I have also received research support and consultant fees from Vivus and consultant fees from Novo Nordisk and Eisai pharmaceutical.	Alexander SC, 2011, FAM MED, V43, P179; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1169; Appel LJ, 2011, NEW ENGL J MED, V365, P1959, DOI 10.1056/NEJMoa1108660; Ashley JM, 2001, ARCH INTERN MED, V161, P1599, DOI 10.1001/archinte.161.13.1599; Azar Kristen M J, 2013, Biomed Res Int, V2013, P191209, DOI 10.1155/2013/191209; Bennett GG, 2013, JAMA INTERN MED, V173, P1770, DOI 10.1001/jamainternmed.2013.9263; Bennett GG, 2012, ARCH INTERN MED, V172, P565, DOI 10.1001/archinternmed.2012.1; Bennett GG, 2010, OBESITY, V18, P308, DOI 10.1038/oby.2009.242; Bennett WL, 2014, J GEN INTERN MED, V29, P50, DOI 10.1007/s11606-013-2562-6; Boutelle K N, 2005, Eat Weight Disord, V10, pe1; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Centers for Disease Control and Prevention, 2014, NATIONAL DIABETES ST; Centers for Disease Control and Prevention, AMBULATORY CARE USE; Centers for Disease Control and Prevention, NATIONAL AMBULATORY; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1066; Centers for Medicare and Medicaid Services, 2011, DECISION MEMO FOR IN; Christian JG, 2008, ARCH INTERN MED, V168, P141, DOI 10.1001/archinternmed.2007.13; Christian JG, 2011, J AM DIET ASSOC, V111, P75, DOI 10.1016/j.jada.2010.10.006; Cohen M D, 1991, Fam Med, V23, P25; Colman E, 2005, ANN INTERN MED, V143, P380, DOI 10.7326/0003-4819-143-5-200509060-00013; Donnelly JE, 2013, CONTEMP CLIN TRIALS, V36, P116, DOI 10.1016/j.cct.2013.06.007; Drieling RL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-98; Duncan JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-223; Economic Research Service, 2014, FOOD AVAILABILITY PE; Ely AC, 2008, J RURAL HEALTH, V24, P125, DOI 10.1111/j.1748-0361.2008.00148.x; Foster GD, 2003, OBES RES, V11, P1168, DOI 10.1038/oby.2003.161; Gorin AA, 2013, HEALTH PSYCHOL, V32, P128, DOI 10.1037/a0026959; Greaney ML, 2009, OBES WEIGHT MANAG, V5, P222, DOI DOI 10.1089/OBE.2009.0507; Gregg E. W., 2009, Morbidity and Mortality Weekly Report, V58, P1259; Haas WC, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.039; Hauptman J, 2000, ARCH FAM MED, V9, P160, DOI 10.1001/archfami.9.2.160; Jakicic JM, 2012, JAMA-J AM MED ASSOC, V307, P2617, DOI 10.1001/jama.2012.6866; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Jolly K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6500; Katula JA, 2011, DIABETES CARE, V34, P1451, DOI 10.2337/dc10-2115; Katula JA, 2010, CONTEMP CLIN TRIALS, V31, P71, DOI 10.1016/j.cct.2009.09.002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kumanyika S, 2011, CONTEMP CLIN TRIALS, V32, P215, DOI 10.1016/j.cct.2010.11.002; Kumanyika SK, 2012, OBESITY, V20, P1249, DOI 10.1038/oby.2011.329; KUSHNER RF, 1995, PREV MED, V24, P546, DOI 10.1006/pmed.1995.1087; Lambourne K, 2012, CONTEMP CLIN TRIALS, V33, P1044, DOI 10.1016/j.cct.2012.05.014; Lean M, 2006, BMJ-BRIT MED J, V333, P959, DOI 10.1136/bmj.333.7575.959; LeBlanc E, 2011, PUBLICATION; LeBlanc ES, 2011, ANN INTERN MED, V155, P434, DOI 10.7326/0003-4819-155-7-201110040-00006; Logue E, 2005, OBES RES, V13, P917, DOI 10.1038/oby.2005.106; Lutes LD, 2013, CONTEMP CLIN TRIALS, V34, P161, DOI 10.1016/j.cct.2012.09.007; Ma J, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-71; Martin PD, 2008, OBESITY, V16, P2462, DOI 10.1038/oby.2008.399; Martin PD, 2006, OBESITY, V14, P1412, DOI 10.1038/oby.2006.160; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; Nicklas JM, 2012, AM J PREV MED, V42, P481, DOI 10.1016/j.amepre.2012.01.005; Obesity Expert Panel, 2013, MANAGING OVERWEIGHT; Ockene IS, 1999, ARCH INTERN MED, V159, P725, DOI 10.1001/archinte.159.7.725; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ortman J. M., 2014, AGING NATION OLDER P, P25; Pellegrini CA, 2014, CONTEMP CLIN TRIALS, V38, P251, DOI 10.1016/j.cct.2014.05.007; Poston WSC, 2006, J INTERN MED, V260, P388, DOI 10.1111/j.1365-2796.2006.01702.x; Ryan DH, 2010, ARCH INTERN MED, V170, P146, DOI 10.1001/archinternmed.2009.508; Sarwer DB, 2013, INT J OBESITY, V37, pS25, DOI 10.1038/ijo.2013.93; Schuster RJ, 2008, J NUTR HEALTH AGING, V12, p764S; Shaw RJ, 2013, AM J MED, V126, P1002, DOI 10.1016/j.amjmed.2013.07.001; Shuger SL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-41; ter Bogt NCW, 2009, AM J PREV MED, V37, P270, DOI 10.1016/j.amepre.2009.06.011; Tsai AG, 2012, OBESITY, V20, P1838, DOI 10.1038/oby.2011.193; Tsai AG, 2010, OBESITY, V18, P1614, DOI 10.1038/oby.2009.457; Tsai AG, 2009, J GEN INTERN MED, V24, P1073, DOI 10.1007/s11606-009-1042-5; US Census Bureau, 2012, US CENSUS BUREAU PRO; Vetter ML, 2013, INT J OBESITY, V37, pS19, DOI 10.1038/ijo.2013.92; Volger S, 2013, INT J OBESITY, V37, pS12, DOI 10.1038/ijo.2013.91; Wadden TA, 2013, INT J OBESITY, V37, pS3, DOI 10.1038/ijo.2013.90; Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156; Wadden TA, 2011, NEW ENGL J MED, V365, P1969, DOI 10.1056/NEJMoa1109220; Warner ET, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-192; Whittemore R, 2009, NURS RES, V58, P2, DOI 10.1097/NNR.0b013e31818fcef3; Wolf AM, 2004, DIABETES CARE, V27, P1570, DOI 10.2337/diacare.27.7.1570; Yank V, 2013, CONTEMP CLIN TRIALS, V34, P126, DOI 10.1016/j.cct.2012.10.007	79	20	21	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2015	350								g7846	10.1136/bmj.g7846	http://dx.doi.org/10.1136/bmj.g7846			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0JX	25656059				2022-12-28	WOS:000349313100025
J	Roman, BR				Roman, Benjamin R.			On Marginal Health Care - Probability Inflation and the Tragedy of the Commons	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Roman, Benjamin R.] Univ Penn, Robert Wood Johnson Fdn, Clin Scholars Program, Philadelphia, PA 19104 USA; [Roman, Benjamin R.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Robert Wood Johnson Foundation (RWJF); University of Pennsylvania; Memorial Sloan Kettering Cancer Center	Roman, BR (corresponding author), Univ Penn, Robert Wood Johnson Fdn, Clin Scholars Program, Philadelphia, PA 19104 USA.							ASCH DA, 1995, ANN INTERN MED, V122, P846, DOI 10.7326/0003-4819-122-11-199506010-00007; ASCH DA, 1990, MED DECIS MAKING, V10, P47, DOI 10.1177/0272989X9001000108; DeKay ML, 1998, MED DECIS MAKING, V18, P19, DOI 10.1177/0272989X9801800105; Emanuel E. J., 2012, NY TIMES; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HIATT HH, 1975, NEW ENGL J MED, V293, P235, DOI 10.1056/NEJM197507312930506; Institute of Medicine, 2012, BEST CAR LOW COST PA; National Research Council, 2002, DRAMA COMMONS; Ostrom E, 2010, AM ECON REV, V100, P641, DOI 10.1257/aer.100.3.641; REDELMEIER DA, 1990, NEW ENGL J MED, V322, P1162, DOI 10.1056/NEJM199004193221620; Roman BR, 2014, ANN INTERN MED, V161, P149, DOI 10.7326/M14-0212; Rottenstreich Y, 2001, PSYCHOL SCI, V12, P185, DOI 10.1111/1467-9280.00334; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574	15	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2015	372	6					572	575		10.1056/NEJMms1407446	http://dx.doi.org/10.1056/NEJMms1407446			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA8CH	25651255				2022-12-28	WOS:000349143600017
J	Rajaram, R; Barnard, C; Bilimoria, KY				Rajaram, Ravi; Barnard, Cynthia; Bilimoria, Karl Y.			Concerns About Using the Patient Safety Indicator-90 Composite in Pay-for-Performance Programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VALIDITY		[Rajaram, Ravi] Northwestern Univ, Feinberg Sch Med, SOQIC, Chicago, IL 60611 USA; [Rajaram, Ravi] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA; [Rajaram, Ravi] Northwestern Univ, Feinberg Sch Med, Ctr Healthcare Studies, Chicago, IL 60611 USA; [Barnard, Cynthia] NW Mem Hosp, Dept Qual Strategies, Chicago, IL 60611 USA; [Bilimoria, Karl Y.] NW Mem Hosp, Feinberg Sch Med, SOQIC, Chicago, IL USA; [Bilimoria, Karl Y.] NW Mem Hosp, Feinberg Sch Med, Dept Surg, Chicago, IL USA; [Bilimoria, Karl Y.] NW Mem Hosp, Feinberg Sch Med, Ctr Healthcare Studies, Chicago, IL USA; [Bilimoria, Karl Y.] Northwestern Univ, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern Memorial Hospital; Northwestern Memorial Hospital; Northwestern University; Feinberg School of Medicine; Northwestern Memorial Hospital; Northwestern University; Feinberg School of Medicine; Northwestern Memorial Hospital; Northwestern University; Feinberg School of Medicine; Northwestern University	Bilimoria, KY (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, Surg Outcomes & Qual Improvement Ctr, 633 N St Clair St,Floor 20, Chicago, IL 60611 USA.	k-bilimoria@northwestern.edu						Agency for Healthcare Research Quality, PAT SAF IND PSI PAR; [Anonymous], 2014, ACS NSQIP SEM REP JU; Bilimoria KY, 2013, JAMA-J AM MED ASSOC, V310, P1482, DOI 10.1001/jama.2013.280048; Dixon-Woods M, 2012, MILBANK Q, V90, P548, DOI 10.1111/j.1468-0009.2012.00674.x; Kaafarani HMA, 2011, J AM COLL SURGEONS, V212, P924, DOI 10.1016/j.jamcollsurg.2010.07.007; Meddings JA, 2013, ANN INTERN MED, V159, P505, DOI 10.7326/0003-4819-159-8-201310150-00003; Paruch JL, 2014, JAMA SURG, V149, P887, DOI 10.1001/jamasurg.2013.5237; RTI International, METHODOLOGY; University HealthSystem Consortium, QUAL ACC METH; Utter GH, 2009, ANN SURG, V250, P1041, DOI 10.1097/SLA.0b013e3181afe095	10	68	68	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					897	898		10.1001/jama.2015.52	http://dx.doi.org/10.1001/jama.2015.52			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25654581				2022-12-28	WOS:000350231800010
J	Busch, K; Klapproth, K; Barile, M; Flossdorf, M; Holland-Letz, T; Schlenner, SM; Reth, M; Hofer, T; Rodewald, HR				Busch, Katrin; Klapproth, Kay; Barile, Melania; Flossdorf, Michael; Holland-Letz, Tim; Schlenner, Susan M.; Reth, Michael; Hoefer, Thomas; Rodewald, Hans-Reimer			Fundamental properties of unperturbed haematopoiesis from stem cells in vivo	NATURE			English	Article							CLONAL ANALYSIS; RECONSTITUTION; EXPRESSION; RECEPTOR; MARROW; MOUSE; GENE	Haematopoietic stem cells (HSCs) are widely studied by HSC transplantation into immune- and blood-cell-depleted recipients. Single HSCs can rebuild the system after transplantation(1-5). Chromosomal marking', viral integration(7-9) and barcoding' of transplanted HSCs suggest that very low numbers of HSCs perpetuate a continuous stream of differentiating cells. However, the numbers of productive HSCs during normal haematopoiesis, and the flux of differentiating progeny remain unknown. Here we devise a mouse model allowing inducible genetic labelling of the most primitive Tie(2+) HSCs in bone marrow, and quantify label progression along haematopoietic development by limiting dilution analysis and data-driven modelling. During maintenance of the haematopoietic system, at least 30% or 5,000 HSCs are productive in the adult mouse after label induction. However, the time to approach equilibrium between labelled HSCs and their progeny is surprisingly long, a time scale that would exceed the mouse's life. Indeed, we find that adult haematopoiesis is largely 'sustained by previously designated 'short-term' stem cells downstream of HSCs that nearly fully self-renew, and receive rare but polydonal HSC input. By contrast, in fetal and early postnatal life, HSCs are rapidly used to establish the immune and blood system. In the adult mouse, 5-fluoruracil-induced leukopenia enhances the output of HSCs and of downstream compartments, thus accelerating haematopoietic flux. Label tracing also identifies a strong lineage bias in adult mice, with several-hundred-fold larger myeloid than lymphoid output, which is only marginally accentuated with age. Finally, we show that transplantation imposes severe constraints on HSC engraftment, consistent with the previously observed oligodonal HSC activity under these conditions. Thus, we uncover fundamental differences between the normal maintenance of the haematopoietic system, its regulation by challenge, and its re-establishment after transplantation. HSC fate mapping and its linked modelling provide a quantitative framework for studying in situ the regulation of haematopoiesis in health and disease.	[Busch, Katrin; Klapproth, Kay; Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany; [Barile, Melania; Flossdorf, Michael; Hoefer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany; [Holland-Letz, Tim] German Canc Res Ctr, Div Biostat, D-69120 Heidelberg, Germany; [Schlenner, Susan M.] Univ Leuven, Dept Microbiol & Immunol, B-3000 Leuven, Belgium; [Schlenner, Susan M.] VIB, Autoimmune Genet Lab, B-3000 Leuven, Belgium; [Reth, Michael] Univ Freiburg, Ctr Biol Signaling Studies, BIOSS, D-79104 Freiburg, Germany; [Reth, Michael] Univ Freiburg, Fac Biol, Dept Mol Immunol, D-79108 Freiburg, Germany; [Reth, Michael] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); KU Leuven; Flanders Institute for Biotechnology (VIB); University of Freiburg; University of Freiburg; Max Planck Society	Rodewald, HR (corresponding author), German Canc Res Ctr, Div Cellular Immunol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	thoefer@dkfz.de; hr.rodewald@dkfz.de	Höfer, Thomas/G-5665-2013; Schlenner, Susan/P-7905-2017	Höfer, Thomas/0000-0003-3560-8780; Schlenner, Susan/0000-0002-8553-3388	International Graduate School in Molecular Medicine, Ulm; DFG [EXC294, TRR130, SFB746, SFB 873, SFB 938]; BMBF [Fkz 031614]; EU-FP7 Marie Curie ITN Quantitative T cell immunology (QuanTI); ERC [233074]; Helmholtz Alliance on preclinical cancer models (PCCC)	International Graduate School in Molecular Medicine, Ulm; DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); EU-FP7 Marie Curie ITN Quantitative T cell immunology (QuanTI); ERC(European Research Council (ERC)European Commission); Helmholtz Alliance on preclinical cancer models (PCCC)	We thank C. Blum for blastocyst injections, T. Arnsperger, N. Maltry and S. Schafer for technical assistance, and the animal facility at the DKFZ for expert mouse husbandry. We are grateful to N. Dietlein, H. J. Fehling, T. Feyerabend, C. Opitz, J. Rodewald, A. Roers, K. Rajewslw and A. Trumpp for discussions. K.B. was initially funded through the International Graduate School in Molecular Medicine, Ulm. M.R. was supported by the DFG through EXC294, TRR130 and SFB746. T.H. is a member of CellNetworks, and was supported by BMBF e:Bio grant T-Sys (Fkz 031614) and EU-FP7 Marie Curie ITN Quantitative T cell immunology (QuanTI). H.-R.R. was supported by DFG-SFB 873-project B11, DFG-SFB 938 project L, ERC Advanced Grant no. 233074, and the Helmholtz Alliance on preclinical cancer models (PCCC).	ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; BOGGS DR, 1984, AM J HEMATOL, V16, P277, DOI 10.1002/ajh.2830160309; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Gomez Perdiguero E., 2014, NATURE; HARRISON DE, 1987, BLOOD, V69, P773; Hsu HC, 2000, BLOOD, V96, P3757, DOI 10.1182/blood.V96.12.3757.h8003757_3757_3762; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Waskow C, 2009, NAT METHODS, V6, P267, DOI [10.1038/nmeth.1309, 10.1038/NMETH.1309]; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yano M, 1997, BLOOD, V89, P4317, DOI 10.1182/blood.V89.12.4317; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	24	424	427	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					542	546		10.1038/nature14242	http://dx.doi.org/10.1038/nature14242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25686605				2022-12-28	WOS:000350097300048
J	Romanoski, CE; Glass, CK				Romanoski, Casey E.; Glass, Christopher K.			Epigenomics Roadmap for regulation	NATURE			English	Editorial Material									[Romanoski, Casey E.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Romanoski, CE (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	cromanoski@ucsd.edu; ckg@ucsd.edu	Glass, Christopher/AAI-3933-2021; Almouzni, Genevieve/ABG-1029-2021	Glass, Christopher/0000-0003-4344-3592; Almouzni, Genevieve/0000-0001-5570-0723; Romanoski, Casey/0000-0002-0149-225X	NATIONAL CANCER INSTITUTE [R01CA173903] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL123485, R00HL123485] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA173903] Funding Source: Medline; NHLBI NIH HHS [K99 HL123485, R00 HL123485] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))			0	136	136	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					314	316		10.1038/518314a	http://dx.doi.org/10.1038/518314a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25693562	Bronze			2022-12-28	WOS:000349547400025
J	Kamper, SJ; Apeldoorn, AT; Chiarotto, A; Smeets, RJEM; Ostelo, RWJG; Guzman, J; van Tulder, MW				Kamper, Steven J.; Apeldoorn, A. T.; Chiarotto, A.; Smeets, R. J. E. M.; Ostelo, R. W. J. G.; Guzman, J.; van Tulder, M. W.			Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COGNITIVE-BEHAVIORAL TREATMENT; FUNCTION-CENTERED REHABILITATION; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; FUNCTIONAL RESTORATION; PHYSICAL-THERAPY; PRIMARY-CARE; COST-EFFECTIVENESS; GRADED ACTIVITY; COPING SKILLS	Objective To assess the long term effects of multidisciplinary biopsychosocial rehabilitation for patients with chronic low back pain. Design Systematic review and random effects meta-analysis of randomised controlled trials. Data sources Electronic searches of Cochrane Back Review Group Trials Register, CENTRAL, Medline, Embase, PsycINFO, and CINAHL databases up to February 2014, supplemented by hand searching of reference lists and forward citation tracking of included trials. Study selection criteria Trials published in full; participants with low back pain for more than three months; multidisciplinary rehabilitation involved a physical component and one or both of a psychological component or a social or work targeted component; multidisciplinary rehabilitation was delivered by healthcare professionals from at least two different professional backgrounds; multidisciplinary rehabilitation was compared with a non-multidisciplinary intervention. Results Forty one trials included a total of 6858 participants with a mean duration of pain of more than one year who often had failed previous treatment. Sixteen trials provided moderate quality evidence that multidisciplinary rehabilitation decreased pain (standardised mean difference 0.21, 95% confidence interval 0.04 to 0.37; equivalent to 0.5 points in a 10 point pain scale) and disability (0.23, 0.06 to 0.40; equivalent to 1.5 points in a 24 point Roland-Morris index) compared with usual care. Nineteen trials provided low quality evidence that multidisciplinary rehabilitation decreased pain (standardised mean difference 0.51, -0.01 to 1.04) and disability (0.68, 0.16 to 1.19) compared with physical treatments, but significant statistical heterogeneity across trials was present. Eight trials provided moderate quality evidence that multidisciplinary rehabilitation improves the odds of being at work one year after intervention (odds ratio 1.87, 95% confidence interval 1.39 to 2.53) compared with physical treatments. Seven trials provided moderate quality evidence that multidisciplinary rehabilitation does not improve the odds of being at work (odds ratio 1.04, 0.73 to 1.47) compared with usual care. Two trials that compared multidisciplinary rehabilitation with surgery found little difference in outcomes and an increased risk of adverse events with surgery. Conclusions Multidisciplinary biopsychosocial rehabilitation interventions were more effective than usual care (moderate quality evidence) and physical treatments (low quality evidence) in decreasing pain and disability in people with chronic low back pain. For work outcomes, multidisciplinary rehabilitation seems to be more effective than physical treatment but not more effective than usual care.	[Kamper, Steven J.] Univ Sydney, George Inst, Musculoskeletal Div, Sydney, NSW 2050, Australia; [Kamper, Steven J.; Apeldoorn, A. T.; Chiarotto, A.; Ostelo, R. W. J. G.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, NL-1081 BT Amsterdam, Netherlands; [Kamper, Steven J.; Apeldoorn, A. T.; Chiarotto, A.; Ostelo, R. W. J. G.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, NL-1081 BT Amsterdam, Netherlands; [Smeets, R. J. E. M.] Maastricht Univ, Med Ctr, Dept Rehabil Med, NL-6200 MD Maastricht, Netherlands; [Ostelo, R. W. J. G.; van Tulder, M. W.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, NL-1081 HV Amsterdam, Netherlands; [Guzman, J.] Univ British Columbia, Vancouver, BC V6T 1Z3, Canada	University of Sydney; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; Vrije Universiteit Amsterdam; University of British Columbia	Kamper, SJ (corresponding author), POB M201 Missenden Rd, Camperdown, NSW 2050, Australia.	skamper@george.org.au	Harding, Richard/G-9729-2012; Smeets, Rob JEM/D-1522-2011; van Tulder, Maurits/AAB-9785-2022; Chiarotto, Alessandro/X-5526-2019; Ostelo, Raymond/GSE-2602-2022	Smeets, Rob JEM/0000-0002-9503-366X; van Tulder, Maurits/0000-0002-7589-8471; Guzman, Jaime/0000-0001-8977-2581; Ostelo, Raymond/0000-0001-7679-7210; Chiarotto, Alessandro/0000-0003-2350-9945; Kamper, Steven/0000-0003-3012-5499	National Health and Medical Research Council of Australia; Scientific College of Physiotherapy (Wetenschappelijk College Fysiotherapie) of the Royal Dutch Association for Physiotherapy; Health Care Insurance Board (College voor zorgverzekeringen); Royal Dutch Physiotherapy Association	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Scientific College of Physiotherapy (Wetenschappelijk College Fysiotherapie) of the Royal Dutch Association for Physiotherapy; Health Care Insurance Board (College voor zorgverzekeringen); Royal Dutch Physiotherapy Association	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: SJK has received grants from the National Health and Medical Research Council of Australia; RJEMS is a member of a scientific advisory board for Philips Pain Management; RWJGO has received grants from the Scientific College of Physiotherapy (Wetenschappelijk College Fysiotherapie) of the Royal Dutch Association for Physiotherapy and from the Health Care Insurance Board (College voor zorgverzekeringen); MWvT has received grants from the Royal Dutch Physiotherapy Association.	Abbasi M, 2012, EUR J PAIN, V16, P1033, DOI 10.1002/j.1532-2149.2011.00097.x; ALARANTA H, 1994, SPINE, V19, P1339, DOI 10.1097/00007632-199406000-00007; Basler HD, 1997, PATIENT EDUC COUNS, V31, P113, DOI 10.1016/S0738-3991(97)00996-8; Bendix A E, 1998, Eur Spine J, V7, P111, DOI 10.1007/s005860050040; Bendix AF, 1996, CLEV CLIN J MED, V63, P62, DOI 10.3949/ccjm.63.1.62; Bendix AF, 1995, EUROPEAN SPINE J, V4, P149; Bendix T, 2000, SPINE, V25, P2494, DOI 10.1097/00007632-200010010-00012; Bosmans JE, 2010, BMJ-BRIT MED J, V341, pd6414; Chou R, 2009, SPINE, V34, P1094, DOI 10.1097/BRS.0b013e3181a105fc; Cochrane Back Review Group, 2011, CRIT JUDG RISK BIAS; Coole C, 2013, CLIN REHABIL, V27, P40, DOI 10.1177/0269215512446839; Costa LDM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3829; Dagenais S, 2010, SPINE J, V10, P514, DOI 10.1016/j.spinee.2010.03.032; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fairbank J, 2005, BMJ-BRIT MED J, V330, P1233, DOI 10.1136/bmj.38441.620417.8F; Foster NE, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-108; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Guzman J, 2001, BMJ-BRIT MED J, V322, P1511, DOI 10.1136/bmj.322.7301.1511; Guzman J, 2002, COCHRANE DB SYST REV, V1; Hancock M, 2009, PHYS THER, V89, P698, DOI 10.2522/ptj.20080351; HARKAPAA K, 1989, SCAND J REHABIL MED, V21, P81; Hellum C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2786; Henchoz Y, 2010, SWISS MED WKLY, V140, P1; Henschke Nicholas, 2008, BMJ, V337, pa171, DOI 10.1136/bmj.a171; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Jackel WH, 1990, REHABILITATION STUTT, V29, P219; Jousset N, 2004, SPINE, V29, P487, DOI 10.1097/01.BRS.0000102320.35490.43; Kaapa EH, 2006, SPINE, V31, P371; Kamper SJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000963.pub3; Kamper SJ, 2010, BEST PRACT RES CL RH, V24, P181, DOI 10.1016/j.berh.2009.11.003; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kole-Snijders AMJ, 1999, J CONSULT CLIN PSYCH, V67, P931, DOI 10.1037/0022-006X.67.6.931; Kool J, 2007, ARCH PHYS MED REHAB, V88, P1089, DOI 10.1016/j.apmr.2007.05.022; Kool JP, 2005, ARCH PHYS MED REHAB, V86, P857, DOI 10.1016/j.apmr.2004.10.044; Lambeek LC, 2010, BMJ-BRIT MED J, V340, pd750; Lambeek LC, 2011, SPINE, V36, P1050, DOI 10.1097/BRS.0b013e3181e70488; Leeuw M, 2008, PAIN, V138, P192, DOI 10.1016/j.pain.2007.12.009; Linton SJ, 2005, CLIN J PAIN, V21, P109, DOI 10.1097/00002508-200503000-00001; Lukinmaa A., 1990, KANSANELAKELAITOKSEN, VML, P1; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Machado LAC, 2009, RHEUMATOLOGY, V48, P520, DOI 10.1093/rheumatology/ken470; Mangels M, 2009, CLIN J PAIN, V25, P356, DOI 10.1097/AJP.0b013e3181925791; Mansell G, 2013, BEST PRACT RES CL RH, V27, P685, DOI 10.1016/j.berh.2013.10.001; Meng K, 2011, CLIN J PAIN, V27, P248, DOI 10.1097/AJP.0b013e3181ffbfaf; MITCHELL RI, 1994, SPINE, V19, P633, DOI 10.1097/00007632-199403001-00001; Moix J, 2003, DOLOR, V18, P149; Monticone M, 2013, CLIN J PAIN, V29, P929, DOI 10.1097/AJP.0b013e31827fef7e; Morone G, 2011, EUR J PHYS REHAB MED, V47, P533; Morone G, 2012, CLIN REHABIL, V26, P339, DOI 10.1177/0269215511414443; NICHOLAS MK, 1991, BEHAV RES THER, V29, P225, DOI 10.1016/0005-7967(91)90112-G; NICHOLAS MK, 1992, PAIN, V48, P339, DOI 10.1016/0304-3959(92)90082-M; Norlund A, 2009, J REHABIL MED, V41, P115, DOI 10.2340/16501977-0297; Ravenek MJ, 2010, WORK, V35, P349, DOI 10.3233/WOR-2010-0995; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Roche G, 2007, ARCH PHYS MED REHAB, V88, P1229, DOI 10.1016/j.apmr.2007.07.014; Roche-Leboucher G, 2011, SPINE, V36, P2235, DOI 10.1097/BRS.0b013e3182191e13; Schweikert B, 2006, J RHEUMATOL, V33, P2519; Skouen JS, 2002, SPINE, V27, P901, DOI 10.1097/00007632-200205010-00002; Smeets RJEM, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-5; Smeets RJEM, 2006, J PAIN, V7, P261, DOI 10.1016/j.jpain.2005.10.011; Smeets RJEM, 2008, PAIN, V134, P263, DOI 10.1016/j.pain.2007.04.021; Stanton TR, 2009, SPINE, V34, pE316, DOI 10.1097/BRS.0b013e318198d073; Strand LI, 2001, SPINE, V26, P800, DOI 10.1097/00007632-200104010-00022; Streilbelt M, 2009, PHYS MED REHAB KUROR, V19, P34, DOI 10.1055/s-0028-1093331; Tavafian SS, 2008, SPINE, V33, P1617, DOI 10.1097/BRS.0b013e31817bd31c; Tavafian SS, 2011, CLIN J PAIN, V27, P811, DOI 10.1097/AJP.0b013e31821e7930; TURNER JA, 1990, J CONSULT CLIN PSYCH, V58, P573, DOI 10.1037/0022-006X.58.5.573; van den Hout JHC, 2003, CLIN J PAIN, V19, P87, DOI 10.1097/00002508-200303000-00003; van Geen JW, 2007, SPINE, V32, P249, DOI 10.1097/01.brs.0000251745.00674.08; van Tulder MW, 2009, SPINE, V34, P1685, DOI 10.1097/BRS.0b013e3181ab6a78; Vollenbroek-Hutten MMR, 2004, CLIN REHABIL, V18, P566, DOI 10.1191/0269215504cr772oa; Von Korff M, 2005, PAIN, V113, P323, DOI 10.1016/j.pain.2004.11.007; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Waddell G, 2004, BACK PAIN REVOLUTION; Waterschoot FPC, 2014, PAIN, V155, P179, DOI 10.1016/j.pain.2013.10.006	79	490	504	10	111	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2015	350								h444	10.1136/bmj.h444	http://dx.doi.org/10.1136/bmj.h444			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WC	25694111	hybrid, Green Published			2022-12-28	WOS:000349911500002
J	Karsch-Volk, M; Barrett, B; Linde, K				Karsch-Voelk, Marlies; Barrett, Bruce; Linde, Klaus			Echinacea for Preventing and Treating the Common Cold	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Karsch-Voelk, Marlies; Linde, Klaus] Tech Univ Munich, Klinikum Rechts Isar, Inst Gen Practice, D-81667 Munich, Germany; [Barrett, Bruce] Univ Wisconsin, Dept Family Med, Madison, WI 53706 USA	Technical University of Munich; University of Wisconsin System; University of Wisconsin Madison	Karsch-Volk, M (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Gen Practice, Orleansstr 47, D-81667 Munich, Germany.	karsch@tum.de		Linde, Klaus/0000-0002-2902-970X	National Center for Complementary & Integrative Health [K24AT006543] Funding Source: NIH RePORTER; NCCIH NIH HHS [K24 AT006543] Funding Source: Medline	National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		[Anonymous], TREATM GUID UPP RESP; Barrett B, 2003, PHYTOMEDICINE, V10, P66, DOI 10.1078/094471103321648692; Karsch-Volk M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000530.pub3; National Institute for Health and Care Excellence, CLIN KNOWL SUMM COMM; Pratter MR, 2006, CHEST, V129, p72S, DOI 10.1378/chest.129.1_suppl.72S	5	25	25	0	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					618	619		10.1001/jama.2014.17145	http://dx.doi.org/10.1001/jama.2014.17145			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25668266	Green Accepted			2022-12-28	WOS:000349070700022
J	Marrazzo, JM; Ramjee, G; Richardson, BA; Gomez, K; Mgodi, N; Nair, G; Palanee, T; Nakabiito, C; van der Straten, A; Noguchi, L; Hendrix, CW; Dai, JY; Ganesh, S; Mkhize, B; Taljaard, M; Parikh, UM; Piper, J; Masse, B; Grossman, C; Rooney, J; Schwartz, JL; Watts, H; Marzinke, MA; Hillier, SL; McGowan, IM; Chirenje, ZM				Marrazzo, Jeanne M.; Ramjee, Gita; Richardson, Barbra A.; Gomez, Kailazarid; Mgodi, Nyaradzo; Nair, Gonasagrie; Palanee, Thesla; Nakabiito, Clemensia; van der Straten, Ariane; Noguchi, Lisa; Hendrix, Craig W.; Dai, James Y.; Ganesh, Shayhana; Mkhize, Baningi; Taljaard, Marthinette; Parikh, Urvi M.; Piper, Jeanna; Masse, Benoit; Grossman, Cynthia; Rooney, James; Schwartz, Jill L.; Watts, Heather; Marzinke, Mark A.; Hillier, Sharon L.; McGowan, Ian M.; Chirenje, Z. Mike		VOICE Study Team	Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; PREVENTION; TRIALS; TRANSMISSION; MICROBICIDE; ADHERENCE; GEL	BACKGROUND Reproductive-age women need effective interventions to prevent the acquisition of human immunodeficiency virus type 1 (HIV-1) infection. METHODS We conducted a randomized, placebo-controlled trial to assess daily treatment with oral tenofovir disoproxil fumarate (TDF), oral tenofovir-emtricitabine (TDF-FTC), or 1% tenofovir (TFV) vaginal gel as preexposure prophylaxis against HIV-1 infection in women in South Africa, Uganda, and Zimbabwe. HIV-1 testing was performed monthly, and plasma TFV levels were assessed quarterly. RESULTS Of 12,320 women who were screened, 5029 were enrolled in the study. The rate of retention in the study was 91% during 5509 person-years of follow-up. A total of 312 HIV-1 infections occurred; the incidence of HIV-1 infection was 5.7 per 100 personyears. In the modified intention-to-treat analysis, the effectiveness was -49.0% with TDF (hazard ratio for infection, 1.49; 95% confidence interval [CI], 0.97 to 2.29), -4.4% with TDF-FTC (hazard ratio, 1.04; 95% CI, 0.73 to 1.49), and 14.5% with TFV gel (hazard ratio, 0.85; 95% CI, 0.61 to 1.21). In a random sample, TFV was detected in 30%, 29%, and 25% of available plasma samples from participants randomly assigned to receive TDF, TDF-FTC, and TFV gel, respectively. Independent predictors of TFV detection included being married, being older than 25 years of age, and being multiparous. Detection of TFV in plasma was negatively associated with characteristics predictive of HIV-1 acquisition. Elevations of serum creatinine levels were seen more frequently among participants randomly assigned to receive oral TDF-FTC than among those assigned to receive oral placebo (1.3% vs. 0.2%, P = 0.004). We observed no significant differences in the frequencies of other adverse events. CONCLUSIONS None of the drug regimens we evaluated reduced the rates of HIV-1 acquisition in an intention-to-treat analysis. Adherence to study drugs was low.	[Marrazzo, Jeanne M.] Univ Washington, Seattle, WA 98104 USA; [Richardson, Barbra A.; Dai, James Y.; Masse, Benoit] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Ramjee, Gita; Ganesh, Shayhana] MRC, HIV Prevent Res Unit, Durban, South Africa; [Nair, Gonasagrie] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Palanee, Thesla] Witwatersrand Reprod Hlth & HIV Res Inst, Johannesburg, South Africa; [Mkhize, Baningi] Perinatal HIV Res Unit, Johannesburg, South Africa; [Taljaard, Marthinette] AURUM Inst, Klerksdorp, South Africa; [Gomez, Kailazarid] FHI 360, Durham, NC USA; [Mgodi, Nyaradzo; Chirenje, Z. Mike] Univ Zimbabwe Univ Calif San Francisco Res Progra, Harare, Zimbabwe; [Nakabiito, Clemensia] Makerere Univ Johns Hopkins Univ Res Collaborat, Kampala, Uganda; [van der Straten, Ariane] Res Triangle Inst RTI Int, Womens Global Hlth Imperat, San Francisco, CA USA; [Noguchi, Lisa; Parikh, Urvi M.; Hillier, Sharon L.; McGowan, Ian M.] Univ Pittsburgh, Med Ctr, Magee Womens Res Inst, Pittsburgh, PA USA; [Hendrix, Craig W.; Marzinke, Mark A.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Piper, Jeanna] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Grossman, Cynthia] NIMH, NIH, Bethesda, MD 20892 USA; [Watts, Heather] Eunice Shriver Kennedy Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Rooney, James] Gilead Sci Inc, Foster City, CA 94404 USA; [Schwartz, Jill L.] CONRAD, Arlington, VA USA; [Masse, Benoit] Univ Montreal, Ctr Hosp Univ St Justine, Montreal, PQ, Canada	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; FHI 360; Makerere University; Research Triangle Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Gilead Sciences; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Marrazzo, JM (corresponding author), Univ Washington, Harborview Med Ctr, Div Infect Dis, 325 9th Ave,Mailbox 359932, Seattle, WA 98104 USA.	jmm2@uw.edu	Hendrix, Craig W/G-4182-2014; M, Ian/AAP-1032-2021; M, i/HCI-9242-2022; Palanee-Phillips, Thesla/ABD-2449-2020	Hendrix, Craig W/0000-0002-5696-8665; M, Ian/0000-0002-6470-8476; van der Straten, Ariane/0000-0001-8536-648X; Marrazzo, Jeanne/0000-0002-9277-7364; Masse, Benoit/0000-0002-4944-8098; Cranston, Ross/0000-0002-2687-6217	Gilead Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068633, UM1AI069436, UM1AI069530, UM1AI069469, UM1AI069422, UM1AI068615, P30AI094189, UM1AI069463, UM1AI106707] Funding Source: NIH RePORTER	Gilead Sciences(Gilead Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Hendrix reports receiving grant support from Gilead Sciences, and Dr. Rooney, being an employee of and holding stock options in Gilead Sciences. Dr. Rooney also reports pending patents related to the use of tenofovir for prevention of genital herpes simplex virus infection (US 13/700,710 and WO 2011/156416).	Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lu M, 2008, AIDS BEHAV, V12, P86, DOI 10.1007/s10461-007-9261-4; Lumley T., 2010, COMPLEX SURVEYS GUID, DOI [10.1002/9780470580066, DOI 10.1002/9780470580066]; Mensch BS, 2012, CURR OPIN HIV AIDS, V7, P534, DOI 10.1097/COH.0b013e3283590632; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Richardson BA, 2013, JAIDS-J ACQ IMM DEF, V63, P120, DOI 10.1097/QAI.0b013e31828607c5; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b	19	880	897	0	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2015	372	6					509	518		10.1056/NEJMoa1402269	http://dx.doi.org/10.1056/NEJMoa1402269			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CH	25651245	Green Published, Green Accepted			2022-12-28	WOS:000349143600005
J	Hiscock, H; Sciberras, E; Mensah, F; Gerner, B; Efron, D; Khano, S; Oberklaid, F				Hiscock, Harriet; Sciberras, Emma; Mensah, Fiona; Gerner, Bibi; Efron, Daryl; Khano, Sonia; Oberklaid, Frank			Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEFICIT/HYPERACTIVITY DISORDER; PSYCHOMETRIC PROPERTIES; ADHD; ADOLESCENTS; PREVALENCE; CHILDHOOD; MELATONIN; OUTCOMES	Objective To examine whether behavioural strategies designed to improve children's sleep problems could also improve the symptoms, behaviour, daily functioning, and working memory of children with attention deficit hyperactivity disorder (ADHD) and the mental health of their parents. Design Randomised controlled trial. Setting 21 general paediatric practices in Victoria, Australia. Participants 244 children aged 5-12 years with ADHD attending the practices between 2010 and 2012. Intervention Sleep hygiene practices and standardised behavioural strategies delivered by trained psychologists or trainee paediatricians during two fortnightly consultations and a follow-up telephone call. Children in the control group received usual clinical care. Main outcome measures At three and six months after randomisation: severity of ADHD symptoms (parent and teacher ADHD rating scale IV-primary outcome), sleep problems (parent reported severity, children's sleep habits questionnaire, actigraphy), behaviour (strengths and difficulties questionnaire), quality of life (pediatric quality of life inventory 4.0), daily functioning (daily parent rating of evening and morning behavior), working memory (working memory test battery for children, six months only), and parent mental health (depression anxiety stress scales). Results Intervention compared with control families reported a greater decrease in ADHD symptoms at three and six months (adjusted mean difference for change in symptom severity -2.9, 95% confidence interval -5.5 to -0.3, P=0.03, effect size -0.3, and -3.7, -6.1 to -1.2, P=0.004, effect size -0.4, respectively). Compared with control children, intervention children had fewer moderate-severe sleep problems at three months (56% v 30%; adjusted odds ratio 0.30, 95% confidence interval 0.16 to 0.59; P<0.001) and six months (46% v 34%; 0.58, 0.32 to 1.0; P=0.07). At three months this equated to a reduction in absolute risk of 25.7% (95% confidence interval 14.1% to 37.3%) and an estimated number needed to treat of 3.9. At six months the number needed to treat was 7.8. Approximately a half to one third of the beneficial effect of the intervention on ADHD symptoms was mediated through improved sleep, at three and six months, respectively. Intervention families reported greater improvements in all other child and family outcomes except parental mental health. Teachers reported improved behaviour of the children at three and six months. Working memory (backwards digit recall) was higher in the intervention children compared with control children at six months. Daily sleep duration measured by actigraphy tended to be higher in the intervention children at three months (mean difference 10.9 minutes, 95% confidence interval -19.0 to 40.8 minutes, effect size 0.2) and six months (9.9 minutes, -16.3 to 36.1 minutes, effect size 0.3); however, this measure was only completed by a subset of children (n=54 at three months and n=37 at six months). Conclusions A brief behavioural sleep intervention modestly improves the severity of ADHD symptoms in a community sample of children with ADHD, most of whom were taking stimulant medications. The intervention also improved the children's sleep, behaviour, quality of life, and functioning, with most benefits sustained to six months post-intervention. The intervention may be suitable for use in primary and secondary care.	[Hiscock, Harriet; Sciberras, Emma; Mensah, Fiona; Gerner, Bibi; Efron, Daryl; Khano, Sonia; Oberklaid, Frank] Royal Childrens Hosp, Ctr Community Child Hlth, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Hiscock, Harriet; Sciberras, Emma; Mensah, Fiona; Gerner, Bibi; Efron, Daryl; Khano, Sonia; Oberklaid, Frank] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Mensah, Fiona] Royal Childrens Hosp, Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Hiscock, H (corresponding author), Royal Childrens Hosp, Ctr Community Child Hlth, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	harriet.hiscock@rch.org.au	Mensah, Fiona K/G-3382-2018; Hiscock, Harriet/M-6882-2013	Mensah, Fiona K/0000-0002-6951-9949; Oberklaid, Frank/0000-0002-9024-111X; Hiscock, Harriet/0000-0003-3017-2770; Sciberras, Emma/0000-0003-2812-303X	Australian National Health and Medical Research Council (NHMRC) [607362]; NHMRC early career fellowships in population health [1037159, 1037449]; NHMRC career development award [607351]; NHMRC population health capacity building grant [436914]; Victorian Government	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC early career fellowships in population health(National Health and Medical Research Council (NHMRC) of Australia); NHMRC career development award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC population health capacity building grant(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	The study was supported by a project grant (No 607362) from the Australian National Health and Medical Research Council (NHMRC). ES's and FM's positions are funded by NHMRC early career fellowships in population health (No 1037159 and No 1037449). HH's position is funded by an NHMRC career development award (No 607351). HH, ES, and FM were also supported by an NHMRC population health capacity building grant (No 436914) during the conduct of the trial. Murdoch Childrens Research Institute is supported by the Victorian Government's operational infrastructure support programme. The NHMRC had no role in the study design, the collection, analysis, and interpretation of the data, the drafting of the manuscript, or the decision to submit this paper for publication. All researchers worked independently from the funder.	American Academy of Sleep Medicine, 2001, INT CLASSIFICATION S; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Australian Bureau of Statistics, 2018, CENSUS POPULATION HO; Barbaresi WJ, 2007, J DEV BEHAV PEDIATR, V28, P265, DOI 10.1097/DBP.0b013e31811ff87d; Barkley RA, 2006, J AM ACAD CHILD PSY, V45, P192, DOI 10.1097/01.chi.0000189134.97436.e2; Brown RT, 2005, PEDIATRICS, V115, pE749, DOI 10.1542/peds.2004-2560; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cortese S, 2013, J AM ACAD CHILD PSY, V52, P784, DOI 10.1016/j.jaac.2013.06.001; Doshi JA, 2012, J AM ACAD CHILD PSY, V51, P990, DOI 10.1016/j.jaac.2012.07.008; DuPaul G. J., 1998, ADHD RATING SCALE 4; Gillberg C, 2004, EUR CHILD ADOLES PSY, V13, P80, DOI 10.1007/s00787-004-1008-4; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Gringras P, 2010, BMJ-BRIT MED J, V345, pe6664; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Kelsey DK, 2004, PEDIATRICS, V114, pE1, DOI 10.1542/peds.114.1.e1; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lyneham HJ, 2005, J AM ACAD CHILD PSY, V44, P274, DOI 10.1097/00004583-200503000-00012; Meltzer LJ, 2011, SLEEP MED, V12, P793, DOI 10.1016/j.sleep.2011.03.011; Mindell JA, 2010, CLIN GUIDE PEDIAT SL; Owens JA, 2000, SLEEP, V23, P1043; Pickering S., 2001, WORKING MEMORY TEST; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Quach J, 2011, PEDIATRICS, V128, P692, DOI 10.1542/peds.2011-0409; Reiersen AM, 2007, J CHILD PSYCHOL PSYC, V48, P464, DOI 10.1111/j.1469-7610.2006.01720.x; Schachter HA, 2001, CAN MED ASSOC J, V165, P1475; Sciberras E, 2011, SLEEP MED, V12, P932, DOI 10.1016/j.sleep.2011.02.006; Sciberras E, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-101; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; StataCorp, 2011, STAT STAT SOFTW REL; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Sung V, 2008, ARCH PEDIAT ADOL MED, V162, P336, DOI 10.1001/archpedi.162.4.336; Van Der Heijden KB, 2007, J AM ACAD CHILD PSY, V46, P233, DOI 10.1097/01.chi.0000246055.76167.0d; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Weiss MD, 2006, J AM ACAD CHILD PSY, V45, P512, DOI [10.1097/01.chi.0000205706.78818.ef, 10.1097/01 chi.0000205706.78818.ef]; Yoon SYR, 2012, SLEEP MED REV, V16, P371, DOI 10.1016/j.smrv.2011.07.001; Yoshimasu K, 2012, J CHILD PSYCHOL PSYC, V53, P1036, DOI 10.1111/j.1469-7610.2012.02567.x	39	160	163	1	62	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2015	350								h68	10.1136/bmj.h68	http://dx.doi.org/10.1136/bmj.h68			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ7ZB	25646809	Green Published, hybrid			2022-12-28	WOS:000348433200028
J	Mohammadi, D				Mohammadi, Dara			Monica Roa: legal champion of abortion rights	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					221	221		10.1016/S0140-6736(15)60046-0	http://dx.doi.org/10.1016/S0140-6736(15)60046-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ2DL	25706699	Bronze			2022-12-28	WOS:000348044800014
J	Kieny, MP; Dovlo, D				Kieny, Marie Paule; Dovlo, Delanyo			Beyond Ebola: a new agenda for resilient health systems	LANCET			English	Editorial Material									[Kieny, Marie Paule; Dovlo, Delanyo] WHO, Hlth Syst & Innovat, CH-1202 Geneva, Switzerland	World Health Organization	Kieny, MP (corresponding author), WHO, Hlth Syst & Innovat, CH-1202 Geneva, Switzerland.	kienym@who.int	Kieny, Marie-Paule/N-3914-2017; Kieny, Marie-Paule/Q-1238-2019	Kieny, Marie-Paule/0000-0002-5943-6488; 	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2014, LANCET, V383, P1946, DOI 10.1016/S0140-6736(14)60938-7; Evans DB, 2010, B WORLD HEALTH ORGAN, V88, P402, DOI 10.2471/BLT.10.078741; Kasolo F, 2013, BIOSECUR BIOTERROR, V11, P163, DOI 10.1089/bsp.2013.0032; Kilmarx PH, 2014, MMWR-MORBID MORTAL W, V63, P1168; Nam SL, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6837; World Bank Group, UPD EC IMP 2014 EB E	6	65	66	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					91	92		10.1016/S0140-6736(14)62479-X	http://dx.doi.org/10.1016/S0140-6736(14)62479-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY7BI	25706456	Green Accepted			2022-12-28	WOS:000347715900004
J	Dobson, J; Whitley, RJ; Pocock, S; Monto, AS				Dobson, Joanna; Whitley, Richard J.; Pocock, Stuart; Monto, Arnold S.			Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials	LANCET			English	Article							RESPIRATORY-TRACT COMPLICATIONS; NEURAMINIDASE; CHILDREN; EFFICACY; IMPACT; INHIBITORS; INFECTION; OUTCOMES; ILLNESS; SAFETY	Background Despite widespread use, questions remain about the efficacy of oseltamivir in the treatment of influenza. We aimed to do an individual patient data meta-analysis for all clinical trials comparing oseltamivir with placebo for treatment of seasonal influenza in adults regarding symptom alleviation, complications, and safety. Methods We included all published and unpublished Roche-sponsored randomised placebo-controlled, double-blind trials of 75 mg twice a day oseltamivir in adults. Trials of oseltamivir for treatment of naturally occurring influenza-like illness in adults reporting at least one of the study outcomes were eligible. We also searched Medline, PubMed, Embase, the Cochrane Central Register of Controlled Trials, and the ClinicalTrials.gov trials register for other relevant trials published before Jan 1, 2014 (search last updated on Nov 27, 2014). We analysed intention-to-treat infected, intention-to-treat, and safety populations. The primary outcome was time to alleviation of all symptoms analysed with accelerated failure time methods. We used risk ratios and Mantel-Haenszel methods to work out complications, admittances to hospital, and safety outcomes. Findings We included data from nine trials including 4328 patients. In the intention-to-treat infected population, we noted a 21% shorter time to alleviation of all symptoms for oseltamivir versus placebo recipients (time ratio 0.79, 95% CI 0.74-0.85; p<0.0001). The median times to alleviation were 97.5 h for oseltamivir and 122>7 h for placebo groups (difference -25.2 h, 95% CI -36.2 to -16.0). For the intention-to-treat population, the estimated treatment effect was attenuated (time ratio 0>85) but remained highly significant (median difference -17>8 h). In the intention-to-treat infected population, we noted fewer lower respiratory tract complications requiring antibiotics more than 48 h after randomisation (risk ratio [RR] 0.56, 95% CI 0.42-0.75; p=0.0001; 4.9% oseltamivir vs 8>7% placebo, risk difference -3.8%, 95% CI -5.0 to -2.2) and also fewer admittances to hospital for any cause (RR 0.37, 95% CI 0.17-0.81; p=0.013; 0.6% oseltamivir, 1.7% placebo, risk difference -1.1%, 95% CI -1.4 to -0.3). Regarding safety, oseltamivir increased the risk of nausea (RR 1.60, 95% CI 1.29-1.99; p<0.0001; 9.9% oseltamivir vs 6.2% placebo, risk difference 3.7%, 95% CI 1.8-6.1) and vomiting (RR 2.43, 95% CI 1.83-3.23; p<0.0001; 8.0% oseltamivir vs 3.3% placebo, risk difference 4.7%, 95% CI 2.7-7.3). We recorded no effect on neurological or psychiatric disorders or serious adverse events. Interpretation Our findings show that oseltamivir in adults with influenza accelerates time to clinical symptom alleviation, reduces risk of lower respiratory tract complications, and admittance to hospital, but increases the occurrence of nausea and vomiting.	[Dobson, Joanna; Pocock, Stuart] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Whitley, Richard J.] Univ Alabama Birmingham, Dept Pediat Microbiol Med & Neurosurg, Birmingham, AL USA; [Monto, Arnold S.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of London; London School of Hygiene & Tropical Medicine; University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan	Monto, AS (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, 1415 Washington Hts, Ann Arbor, MI 48109 USA.	asmonto@umich.edu			Multiparty Group for Advice on Science (MUGAS) foundation; Multiparty Group for Advice on Science (MUGAS) Foundation from Roche Pharmaceuticals	Multiparty Group for Advice on Science (MUGAS) foundation; Multiparty Group for Advice on Science (MUGAS) Foundation from Roche Pharmaceuticals	Multiparty Group for Advice on Science (MUGAS) foundation.; This study was funded by the Multiparty Group for Advice on Science (MUGAS) Foundation through an unrestricted grant from Roche Pharmaceuticals. Neither party had a role in analysis, interpretation, reporting or the decision to submit for publication. We thank Roche for providing the data and answering data specific queries.	Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Collett, 2003, MODELLING SURVIVAL D; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Dharan NJ, 2012, INFLUENZA OTHER RESP, V6, P153, DOI 10.1111/j.1750-2659.2011.00312.x; EGGER M, 2001, SYSTEMATIC REV HEALT; Fry AM, 2014, LANCET INFECT DIS, V14, P109, DOI 10.1016/S1473-3099(13)70267-6; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; Heinonen S, 2010, CLIN INFECT DIS, V51, P887, DOI 10.1086/656408; Hernan MA, 2011, CLIN INFECT DIS, V53, P277, DOI 10.1093/cid/cir400; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Johnston SL, 2005, PEDIATR INFECT DIS J, V24, P225, DOI 10.1097/01.inf.0000154322.38267.ce; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Kaiser L, 2000, ARCH INTERN MED, V160, P3234, DOI 10.1001/archinte.160.21.3234; Kashiwagi S, 2000, Kansenshogaku Zasshi, V74, P1044; Li LY, 2003, CHINESE MED J-PEKING, V116, P44; Lipsitch M, 2013, CLIN INFECT DIS, V57, P1368, DOI 10.1093/cid/cit481; Martin C, 2001, INT CONGR SER, V1219, P807, DOI 10.1016/S0531-5131(01)00359-4; Monto AS, 2005, NEW ENGL J MED, V352, P323, DOI 10.1056/NEJMp048343; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Muthuri SG, 2013, J INFECT DIS, V207, P553, DOI 10.1093/infdis/jis726; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Saiedabadi NWP., 2000, 9 INT C INF DIS APR; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Treanor JohnJ., 2000, 38 ANN M INF DIS SOC; USA. Center for Drug Evaluation and Research (CDER), 2011, GUID IND INFL DEV DR; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002	31	344	358	5	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1729	1737		10.1016/S0140-6736(14)62449-1	http://dx.doi.org/10.1016/S0140-6736(14)62449-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25640810				2022-12-28	WOS:000353726000028
J	Park, SY; Peterson, FC; Mosquna, A; Yao, J; Volkman, BF; Cutler, SR				Park, Sang-Youl; Peterson, Francis C.; Mosquna, Assaf; Yao, Jin; Volkman, Brian F.; Cutler, Sean R.			Agrochemical control of plant water use using engineered abscisic acid receptors	NATURE			English	Article							DROUGHT TOLERANCE; SELECTIVE ACTIVATION; STRUCTURAL BASIS; GENE-EXPRESSION; ABA RECEPTORS; SNRK2 KINASES; MECHANISM; PROTEINS; LIGAND; TRANSFORMATION	Rising temperatures and lessening fresh water supplies are threatening agricultural productivity and have motivated efforts to improve plant water use and drought tolerance. During water deficit, plants produce elevated levels of abscisic acid (ABA), which improves water consumption and stress tolerance by controlling guard cell aperture and other protective responses(1,2). One attractive strategy for controlling water use is to develop compounds that activate ABA receptors, but agonists approved for use have yet to be developed. In principle, an engineered ABA receptor that can be activated by an existing agrochemical could achieve this goal. Here we describe a variant of the ABA receptor PYRABACTIN RESISTANCE 1 (PYR1) that possesses nanomolar sensitivity to the agrochemical mandipropamid and demonstrate its efficacy for controlling ABA responses and drought tolerance in transgenic plants. Furthermore, crystallographic studies provide a mechanistic basis for its activity and demonstrate the relative ease with which the PYR1 ligand-binding pocket can be altered to accommodate new ligands. Thus, we have successfully repurposed an agrochemical for a new application using receptor engineering. We anticipate that this strategy will be applied to other plant receptors and represents a new avenue for crop improvement.	[Park, Sang-Youl; Mosquna, Assaf; Yao, Jin; Cutler, Sean R.] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Park, Sang-Youl; Mosquna, Assaf; Yao, Jin; Cutler, Sean R.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Park, Sang-Youl; Mosquna, Assaf; Yao, Jin; Cutler, Sean R.] Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Peterson, Francis C.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; Medical College of Wisconsin	Cutler, SR (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	sean.cutler@ucr.edu	Volkman, Brian F./ABE-7306-2020; Volkman, Brian F./ABE-7312-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Cutler, Sean/0000-0002-8593-0885	National Science Foundation [IOS 1258175, MCB 1022378]; Syngenta Corporation; United States-Israel Binational Agricultural Research and Development Postdoctoral Fellowship [F1-440-2010]; Direct For Biological Sciences [1258175] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1022378] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Syngenta Corporation(Syngenta); United States-Israel Binational Agricultural Research and Development Postdoctoral Fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank N. Chen for technical assistance constructing the K59R pocket library, J. Mandal for RNA-seq library preparation, D. Jensen for protein production, J. Bailey-Serres for comments on the manuscript and M. Nuccio, M. Nina and F. Early for suggestions regarding candidate agrochemicals. This work was supported in part by the National Science Foundation(IOS 1258175, MCB 1022378 to S.R.C.), Syngenta Corporation (S.R.C. and F.P.), and a United States-Israel Binational Agricultural Research and Development Postdoctoral Fellowship F1-440-2010 (to A.M.).	BELSHAW PJ, 1995, ANGEW CHEM INT EDIT, V34, P2129, DOI 10.1002/anie.199521291; Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; Cao MJ, 2013, CELL RES, V23, P1043, DOI 10.1038/cr.2013.95; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; DeSantis G, 2003, J AM CHEM SOC, V125, P11476, DOI 10.1021/ja035742h; Johnson GT, 2011, STRUCTURE, V19, P293, DOI 10.1016/j.str.2010.12.023; Kim H, 2014, J EXP BOT, V65, P453, DOI 10.1093/jxb/ert397; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Melcher K, 2010, NAT STRUCT MOL BIOL, V17, P1102, DOI 10.1038/nsmb.1887; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyakawa T, 2013, TRENDS PLANT SCI, V18, P259, DOI 10.1016/j.tplants.2012.11.002; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mosquna A, 2011, P NATL ACAD SCI USA, V108, P20838, DOI 10.1073/pnas.1112838108; Muller KM, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni116; Ng LM, 2011, P NATL ACAD SCI USA, V108, P21259, DOI 10.1073/pnas.1118651109; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Okamoto M, 2013, P NATL ACAD SCI USA, V110, P12132, DOI 10.1073/pnas.1305919110; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peterson FC, 2010, NAT STRUCT MOL BIOL, V17, P1109, DOI 10.1038/nsmb.1898; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Sun HJ, 2006, PLANT CELL PHYSIOL, V47, P426, DOI 10.1093/pcp/pci251; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang Y, 2005, PLANT J, V43, P413, DOI 10.1111/j.1365-313X.2005.02463.x; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Yuan XQ, 2010, J BIOL CHEM, V285, P28953, DOI 10.1074/jbc.M110.160192	31	155	163	7	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					545	+		10.1038/nature14123	http://dx.doi.org/10.1038/nature14123			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25652827				2022-12-28	WOS:000353334500044
J	Bassett, MT				Bassett, Mary T.			#BlackLivesMatter - A Challenge to the Medical and Public Health Communities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									New York City Dept Hlth & Mental Hyg, Off Commissioner, New York, NY 11101 USA	New York City Department of Health & Mental Hygiene	Bassett, MT (corresponding author), New York City Dept Hlth & Mental Hyg, Off Commissioner, New York, NY 11101 USA.							Association of American Medical Colleges, 2014, DIV PHYS WORKF FACTS; Harper S, 2014, HEALTH AFFAIR, V33, P1375, DOI 10.1377/hlthaff.2013.1273; Krieger N, 2014, SOCIAL EPIDEMIOLOGY, P63, DOI [DOI 10.1093/MED/9780195377903.001.0001, DOI 10.1093/MED/9780195377903.003.0003]; Washington H. A., 2006, DOUBLEDAY	4	66	66	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1085	1087		10.1056/NEJMp1500529	http://dx.doi.org/10.1056/NEJMp1500529			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD6EZ	25692912				2022-12-28	WOS:000351183600001
J	Joura, EA; Giuliano, AR; Iversen, OE; Bouchard, C; Mao, C; Mehlsen, J; Moreira, ED; Ngan, Y; Petersen, LK; Lazcano-Ponce, E; Pitisuttithum, P; Restrepo, JA; Stuart, G; Woelber, L; Yang, YC; Cuzick, J; Garland, SM; Huh, W; Kjaer, SK; Bautista, OM; Chan, ISF; Chen, J; Gesser, R; Moeller, E; Ritter, M; Vuocolo, S; Luxembourg, A				Joura, E. A.; Giuliano, A. R.; Iversen, O-E; Bouchard, C.; Mao, C.; Mehlsen, J.; Moreira, E. D., Jr.; Ngan, Y.; Petersen, L. K.; Lazcano-Ponce, E.; Pitisuttithum, P.; Restrepo, J. A.; Stuart, G.; Woelber, L.; Yang, Y. C.; Cuzick, J.; Garland, S. M.; Huh, W.; Kjaer, S. K.; Bautista, O. M.; Chan, I. S. F.; Chen, J.; Gesser, R.; Moeller, E.; Ritter, M.; Vuocolo, S.; Luxembourg, A.		Broad Spectrum HPV Vaccine Study	A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; GENITAL WARTS; PARTICLE VACCINE; YOUNG-WOMEN; CERVICAL ABNORMALITIES; GENOTYPE ATTRIBUTION; SAFETY; EFFICACY; IMPACT; PREVALENCE	BACKGROUND The investigational 9-valent viruslike particle vaccine against human papillomavirus (HPV) includes the HPV types in the quadrivalent HPV (qHPV) vaccine (6, 11, 16, and 18) and five additional oncogenic types (31, 33, 45, 52, and 58). Here we present the results of a study of the efficacy and immunogenicity of the 9vHPV vaccine in women 16 to 26 years of age. METHODS We performed a randomized, international, double-blind, phase 2b-3 study of the 9vHPV vaccine in 14,215 women. Participants received the 9vHPV vaccine or the qHPV vaccine in a series of three intramuscular injections on day 1 and at months 2 and 6. Serum was collected for analysis of antibody responses. Swabs of labial, vulvar, perineal, perianal, endocervical, and ectocervical tissue were obtained and used for HPV DNA testing, and liquid-based cytologic testing (Papanicolaou testing) was performed regularly. Tissue obtained by means of biopsy or as part of definitive therapy (including a loop electrosurgical excision procedure and conization) was tested for HPV. RESULTS The rate of high-grade cervical, vulvar, or vaginal disease irrespective of HPV type (i.e., disease caused by HPV types included in the 9vHPV vaccine and those not included) in the modified intention-to-treat population (which included participants with and those without prevalent infection or disease) was 14.0 per 1000 person-years in both vaccine groups. The rate of high-grade cervical, vulvar, or vaginal disease related to HPV-31, 33, 45, 52, and 58 in a prespecified per-protocol efficacy population (susceptible population) was 0.1 per 1000 person-years in the 9vHPV group and 1.6 per 1000 person-years in the qHPV group (efficacy of the 9vHPV vaccine, 96.7%; 95% confidence interval, 80.9 to 99.8). Antibody responses to HPV-6, 11, 16, and 18 were noninferior to those generated by the qHPV vaccine. Adverse events related to injection site were more common in the 9vHPV group than in the qHPV group. CONCLUSIONS The 9vHPV vaccine prevented infection and disease related to HPV-31, 33, 45, 52, and 58 in a susceptible population and generated an antibody response to HPV-6, 11, 16, and 18 that was noninferior to that generated by the qHPV vaccine. The 9vHPV vaccine did not prevent infection and disease related to HPV types beyond the nine types covered by the vaccine. (Funded by Merck; ClinicalTrials.gov number, NCT00543543).	[Joura, E. A.] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria; [Giuliano, A. R.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Iversen, O-E] Univ Bergen, Dept Clin Med, Haukeland Univ Hosp, Bergen, Norway; [Bouchard, C.] Univ Laval, Quebec City, PQ, Canada; [Stuart, G.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Mao, C.] Univ Washington, Seattle, WA 98195 USA; [Mehlsen, J.] Univ Copenhagen, Frederiksberg Hosp, Coordinating Res Ctr, Copenhagen, Denmark; [Kjaer, S. K.] Rigshosp, Danish Canc Soc Res Ctr, DK-2100 Copenhagen, Denmark; [Kjaer, S. K.] Rigshosp, Dept Gynecol, DK-2100 Copenhagen, Denmark; [Moreira, E. D., Jr.] Brazilian Minist Hlth, Assoc Obras Sociais Irma Dulce, Salvador, BA, Brazil; [Moreira, E. D., Jr.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Salvador, BA, Brazil; [Ngan, Y.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Petersen, L. K.] Aarhus Univ Hosp, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark; [Lazcano-Ponce, E.] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Pitisuttithum, P.] Mahidol Univ, Fac Trop Med, Nakhon Pathom, Thailand; [Restrepo, J. A.] Invest Clin, Medellin, Colombia; [Woelber, L.] Univ Med Ctr Hamburg Eppendorf, Dept Gynecol, Hamburg, Germany; [Yang, Y. C.] Mackay Mem Hosp, Taipei, Taiwan; [Cuzick, J.] Wolfson Inst Prevent Med, London, England; [Garland, S. M.] Univ Melbourne, Royal Womens Hosp, Parkville, Vic 3052, Australia; [Garland, S. M.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Huh, W.] Univ Alabama Birmingham, Div Gynecol Oncol, Birmingham, AL USA; [Bautista, O. M.; Chan, I. S. F.; Chen, J.; Gesser, R.; Moeller, E.; Ritter, M.; Vuocolo, S.; Luxembourg, A.] Merck, Whitehouse Stn, NJ USA	Medical University of Vienna; H Lee Moffitt Cancer Center & Research Institute; University of Bergen; Haukeland University Hospital; Laval University; University of British Columbia; University of Washington; University of Washington Seattle; University of Copenhagen; Danish Cancer Society; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Fundacao Oswaldo Cruz; University of Hong Kong; Aarhus University; Instituto Nacional de Salud Publica; Mahidol University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Mackay Memorial Hospital; University of London; Queen Mary University London; University of Melbourne; Murdoch Children's Research Institute; University of Alabama System; University of Alabama Birmingham; Merck & Company	Joura, EA (corresponding author), Med Univ Vienna, Dept Gynecol & Obstet, Wahringer Gurtel 18-20, Vienna, Austria.	elmar.joura@meduniwien.ac.at	Mehlsen, Jesper/AAA-5848-2022; Bouchard, Celine/ABE-5810-2021; Petersen, Lone Kjeld/R-6025-2017; Moreira, Edson D/J-1758-2012; Kong, Tae-Wook/AAF-3036-2021; Moreira Jr, Edson Duarte/GRF-5620-2022; Lally, Michelle/I-4865-2016	Bouchard, Celine/0000-0003-2258-058X; Petersen, Lone Kjeld/0000-0002-1424-6170; Moreira, Edson D/0000-0002-7081-8348; Kong, Tae-Wook/0000-0002-9007-565X; Moreira Jr, Edson Duarte/0000-0002-7081-8348; Lally, Michelle/0000-0003-0716-4668; Chu, Tang-Yuan/0000-0003-2717-2681; Kjaer, Susanne/0000-0002-8347-1398; McNeil, Shelly/0000-0001-5444-4166	Merck; Cancer Research UK [16891] Funding Source: researchfish	Merck(Merck & Company); Cancer Research UK(Cancer Research UK)	Funded by Merck; ClinicalTrials.gov number, NCT00543543	Arnheim-Dahlstom L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5906; Baandrup L, 2013, SEX TRANSM DIS, V40, P130, DOI 10.1097/OLQ.0b013e31827bd66b; Baldur-Felskov B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt460; Bauer HM, 2012, AM J PUBLIC HEALTH, V102, P833, DOI 10.2105/AJPH.2011.300465; Block SL, 2010, PEDIATR INFECT DIS J, V29, P95, DOI 10.1097/INF.0b013e3181b77906; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Chao C, 2012, J INTERN MED, V271, P193, DOI 10.1111/j.1365-2796.2011.02467.x; Chaturvedi AK, 2010, J ADOLESCENT HEALTH, V46, pS20, DOI 10.1016/j.jadohealth.2010.01.016; Christensen Neil D, 2005, Expert Opin Emerg Drugs, V10, P5, DOI 10.1517/14728214.10.1.5; Crowe E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1458; de Sanjose S, 2013, EUR J CANCER, V49, P3450, DOI 10.1016/j.ejca.2013.06.033; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2009, J INFECT DIS, V199, P805, DOI 10.1086/597071; Gee J, 2011, VACCINE, V29, P8279, DOI 10.1016/j.vaccine.2011.08.106; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Grimaldi-Bensouda L, 2014, J INTERN MED, V275, P398, DOI 10.1111/joim.12155; Hatch KD, 2006, INT J GYNECOL OBSTET, V94, pS40, DOI 10.1016/S0020-7292(07)60008-3; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Joura EA, 2014, CANCER EPIDEM BIOMAR, V23, P1997, DOI 10.1158/1055-9965.EPI-14-0410; Joura EA, 2008, VACCINE, V26, P6844, DOI 10.1016/j.vaccine.2008.09.073; Kahn JA, 2012, PEDIATRICS, V130, pE249, DOI 10.1542/peds.2011-3587; Kjaer SK, 2007, J INFECT DIS, V196, P1447, DOI 10.1086/522863; Klein NP, 2012, ARCH PEDIAT ADOL MED, V166, P1140, DOI 10.1001/archpediatrics.2012.1451; Leval A, 2012, J INFECT DIS, V206, P860, DOI 10.1093/infdis/jis405; Macartney KK, 2013, DRUG SAFETY, V36, P393, DOI 10.1007/s40264-013-0039-5; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Nsouli-Maktabi Hala, 2013, MSMR, V20, P17; Nygard M, 2013, EUROGIN 2013 FLOR IT; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Palefsky JM, 1999, J ACQ IMMUN DEF SYND, V21, pS42; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Picconi MA, 2000, J MED VIROL, V61, P65, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;65::AID-JMV10&gt;3.0.CO;2-Z; Powell SE, 2012, VACCINE, V31, P109, DOI 10.1016/j.vaccine.2012.10.092; Read TRH, 2011, SEX TRANSM INFECT, V87, P544, DOI 10.1136/sextrans-2011-050234; Roberts C, 2014, HUM VACC IMMUNOTHER, V10, P2168, DOI 10.4161/hv.29205; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Serrano B, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-38; Slade BA, 2009, JAMA-J AM MED ASSOC, V302, P750, DOI 10.1001/jama.2009.1201; Srodon M, 2006, AM J SURG PATHOL, V30, P1513, DOI 10.1097/01.pas.0000213291.96401.48; Tabrizi SN, 2012, J INFECT DIS, V206, P1645, DOI 10.1093/infdis/jis590; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309	46	828	886	8	177	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					711	723		10.1056/NEJMoa1405044	http://dx.doi.org/10.1056/NEJMoa1405044			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7PB	25693011	Green Published			2022-12-28	WOS:000349818700005
J	Leung, D; Jung, I; Rajagopal, N; Schmitt, A; Selvaraj, S; Lee, AY; Yen, CA; Lin, S; Lin, YI; Qiu, YJ; Xie, W; Yue, F; Hariharan, M; Ray, P; Kuan, S; Edsall, L; Yang, HB; Chi, NC; Zhang, MQ; Ecker, JR; Ren, B				Leung, Danny; Jung, Inkyung; Rajagopal, Nisha; Schmitt, Anthony; Selvaraj, Siddarth; Lee, Ah Young; Yen, Chia-An; Lin, Shin; Lin, Yiing; Qiu, Yunjiang; Xie, Wei; Yue, Feng; Hariharan, Manoj; Ray, Pradipta; Kuan, Samantha; Edsall, Lee; Yang, Hongbo; Chi, Neil C.; Zhang, Michael Q.; Ecker, Joseph R.; Ren, Bing			Integrative analysis of haplotype-resolved epigenomes across human tissues	NATURE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; ENHANCERS; GENOME; TRANSCRIPTION; PROMOTERS; LANDSCAPE; BRAIN; ATLAS; STATE	Allelic differences between the two homologous chromosomes can affect the propensity of inheritance in humans; however, the extent of such differences in the human genome has yet to be fully explored. Here we delineate allelic chromatin modifications and transcriptomes among a broad set of human tissues, enabled by a chromosome-spanning haplotype reconstruction strategy(1). The resulting large collection of haplotype-resolved epigenomic maps reveals extensive allelic biases in both chromatin state and transcription, which show considerable variation across tissues and between individuals, and allow us to investigate cis-regulatory relationships between genes and their control sequences. Analyses of histone modification maps also uncover intriguing characteristics of cis-regulatory elements and tissue-restricted activities of repetitive elements. The rich data sets described here will enhance our understanding of the mechanisms by which cis-regulatory elements control gene expression programs.	[Leung, Danny; Jung, Inkyung; Rajagopal, Nisha; Schmitt, Anthony; Selvaraj, Siddarth; Lee, Ah Young; Yen, Chia-An; Qiu, Yunjiang; Kuan, Samantha; Edsall, Lee; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Lin, Shin; Lin, Yiing] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lin, Shin] Stanford Univ, Dept Cardiovasc Med, Stanford, CA 94304 USA; [Lin, Yiing] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Xie, Wei] Tsinghua Univ, Tsinghua Univ Peking Univ Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Yue, Feng] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA; [Hariharan, Manoj; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Ray, Pradipta; Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Richardson, TX 75080 USA; [Yang, Hongbo; Chi, Neil C.] Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Chi, Neil C.; Ren, Bing] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Zhang, Michael Q.] Tsinghua Univ, TNLIST Tsinghua Natl Lab Informat Sci & Technol, Bioinformat Div, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China; [Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; Stanford University; Stanford University; Washington University (WUSTL); Tsinghua University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Howard Hughes Medical Institute; Salk Institute; University of Texas System; University of Texas Dallas; University of California System; University of California San Diego; University of California System; University of California San Diego; Tsinghua University; University of California System; University of California San Diego; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	biren@ucsd.edu	Ecker, Joseph R/B-9144-2008; Qiu, Yunjiang/AAC-1395-2019; Hariharan, Manoj/N-2855-2015; Jung, Inkyung/CAJ-5773-2022; Xie, Wei/J-1380-2017	Ecker, Joseph R/0000-0001-5799-5895; Hariharan, Manoj/0000-0002-1006-5372; Xie, Wei/0000-0003-2126-3849; Leung, Danny Chi Yeu/0000-0002-2472-894X; Lin, Yiing/0000-0002-0317-7608; Lin, Shin/0000-0003-0118-0413; Jung, Inkyung/0000-0002-5885-2754; Edsall, Lee Elizabeth/0000-0002-0326-2829; Ray, Pradipta/0000-0003-0931-4201; Qiu, Yunjiang/0000-0002-0539-9714	NIH Epigenome Roadmap Project [U01 ES017166]; CIRM [RN2-00905-1]; NIH [ES017166, F32HL110473, K99HL119617]; NSFC [91019016]; NBRPC [2012CB316503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL119617, F32HL110473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024984, U01ES017166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER	NIH Epigenome Roadmap Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); NBRPC(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the NIH Epigenome Roadmap Project (U01 ES017166), CIRM RN2-00905-1, NIH ES017166, NSFC 91019016, NBRPC 2012CB316503 and NIH Fellowship Grants F32HL110473 and K99HL119617. We thank A. Kulkarni and J. Wu for help with processing RNA-seq data sets, and Y. He and M. Schultz for discussions regarding allelic analyses of RNA-seq data sets. We also thank members of the Ren laboratory for comments.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fang F, 2012, P NATL ACAD SCI USA, V109, P7332, DOI 10.1073/pnas.1201310109; Flandez M, 2014, GUT, V63, P647, DOI 10.1136/gutjnl-2012-304381; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Hirai H, 2005, BLOOD, V106, P1948, DOI 10.1182/blood-2004-12-4872; Hwang DH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-117; Jahan I, 2010, CELL TISSUE RES, V341, P95, DOI 10.1007/s00441-010-0984-6; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Moya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030014; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Xie MC, 2013, NAT GENET, V45, P836, DOI 10.1038/ng.2649; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	30	119	122	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					350	354		10.1038/nature14217	http://dx.doi.org/10.1038/nature14217			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25693566	Green Accepted, hybrid			2022-12-28	WOS:000349547400032
J	Wang, DW; Gouhier, TC; Menge, BA; Ganguly, AR				Wang, Daiwei; Gouhier, Tarik C.; Menge, Bruce A.; Ganguly, Auroop R.			Intensification and spatial homogenization of coastal upwelling under climate change	NATURE			English	Article							CALIFORNIA CURRENT; FUTURE; TRENDS; ECOSYSTEM; PACIFIC; IMPACTS; NORTH	The timing and strength of wind-driven coastal upwelling along the eastern margins of major ocean basins regulate the productivity of critical fisheries and marine ecosystems by bringing deep and nutrient-rich waters to the sunlit surface, where photosynthesis can occur(1-3). How coastal upwelling regimes might change in a warming climate is therefore a question of vital importance(4,5). Although enhanced land-ocean differential heating due to greenhouse warming has been proposed to intensify coastal upwelling by strengthening alongshore winds', analyses of observations and previous climate models have provided little consensus on historical and projected trends in coastal upwelling(7-13). Here we show that there are strong and consistent changes in the timing, intensity and spatial heterogeneity of coastal upwelling in response to future warming in most Eastern Boundary Upwelling Systems (EBUSs). An ensemble of climate models shows that by the end of the twenty-first century the upwelling season will start earlier, end later and become more intense at high but not low latitudes. This projected increase in upwelling intensity and duration at high latitudes will result in a substantial reduction of the existing latitudinal variation in coastal upwelling. These patterns are consistent across three of the four EBUSs (Canary, Benguela and Humboldt, but not California). The lack of upwelling intensification and greater uncertainty associated with the California EBUS may reflect regional controls associated with the atmospheric response to climate change. Given the strong linkages between upwelling and marine ecosystems(14,15), the projected changes in the intensity, timing and spatial structure of coastal upwelling may influence the geographical distribution of marine biodiversity.	[Wang, Daiwei; Ganguly, Auroop R.] Northeastern Univ, Dept Civil & Environm Engn, Sustainabil & Data Sci Lab, Boston, MA 02115 USA; [Gouhier, Tarik C.] Northeastern Univ, Ctr Marine Sci, Dept Marine & Environm Sci, Nahant, MA 01908 USA; [Menge, Bruce A.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA	Northeastern University; Northeastern University; Oregon State University	Wang, DW (corresponding author), Northeastern Univ, Dept Civil & Environm Engn, Sustainabil & Data Sci Lab, Boston, MA 02115 USA.	dw2116@gmail.com	Menge, Bruce/I-6571-2012; Wang, Daiwei/E-4265-2015; Gouhier, Tarik/C-3611-2009	Wang, Daiwei/0000-0003-3685-1416; Gouhier, Tarik/0000-0002-9537-7358	Northeastern University's Interdisciplinary Research Program; US National Science Foundation's Expeditions in Computing program [1029711]; Div Of Information & Intelligent Systems [1029711] Funding Source: National Science Foundation	Northeastern University's Interdisciplinary Research Program; US National Science Foundation's Expeditions in Computing program; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was funded by grants from Northeastern University's Interdisciplinary Research Program and the US National Science Foundation's Expeditions in Computing program (award no. 1029711). We acknowledge the World Climate Research Program's Working Group on Coupled Modeling, which is responsible for CMIP5, and we thank the climate modelling groups for producing and making available their model output. For CMIP5 the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led the development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Barth JA, 2007, P NATL ACAD SCI USA, V104, P3719, DOI 10.1073/pnas.0700462104; Barton ED, 2013, PROG OCEANOGR, V116, P167, DOI 10.1016/j.pocean.2013.07.007; Belmadani A, 2014, CLIM DYNAM, V43, P1893, DOI 10.1007/s00382-013-2015-2; Blanchette CA, 2008, J BIOGEOGR, V35, P1593, DOI 10.1111/j.1365-2699.2008.01913.x; Bograd SJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035933; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Chenillat F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049966; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Cropper TE, 2014, DEEP-SEA RES PT I, V86, P94, DOI 10.1016/j.dsr.2014.01.007; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Fenberg PB, 2015, ECOGRAPHY, V38, P83, DOI 10.1111/ecog.00880; Garcia-Reyes M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005576; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Gutierrez D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046324; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Iles AC, 2012, GLOBAL CHANGE BIOL, V18, P783, DOI 10.1111/j.1365-2486.2011.02567.x; Jacox MG, 2014, GEOPHYS RES LETT, V41, P3189, DOI 10.1002/2014GL059589; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lemos RT, 2004, INT J CLIMATOL, V24, P511, DOI 10.1002/joc.1009; McGregor HV, 2007, SCIENCE, V315, P637, DOI 10.1126/science.1134839; Menge BA, 2013, ECOL MONOGR, V83, P283, DOI 10.1890/12-1706.1; Mote PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016086; Narayan N, 2010, OCEAN SCI, V6, P815, DOI 10.5194/os-6-815-2010; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pickett MH, 2006, FISH OCEANOGR, V15, P256, DOI 10.1111/j.1365-2419.2005.00400.x; Pickett MH, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001902; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Rykaczewski RR, 2008, P NATL ACAD SCI USA, V105, P1965, DOI 10.1073/pnas.0711777105; Santos F, 2012, CONT SHELF RES, V34, P79, DOI 10.1016/j.csr.2011.12.004; Schwing FB, 2002, PROG OCEANOGR, V54, P459, DOI 10.1016/S0079-6611(02)00064-2; Schwing FB, 1996, NOAATMNMFSSWFSC231 U; Schwing FB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026911; Snyder MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017647; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tebaldi C, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049863; TRENBERTH KE, 1990, J PHYS OCEANOGR, V20, P1742, DOI 10.1175/1520-0485(1990)020<1742:TMACIG>2.0.CO;2; Wang MY, 2010, J MARINE SYST, V79, P258, DOI 10.1016/j.jmarsys.2008.11.028	41	247	262	19	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					390	394		10.1038/nature14235	http://dx.doi.org/10.1038/nature14235			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25693571				2022-12-28	WOS:000349547400040
J	Kintisch, E				Kintisch, Eli			The science of schmoozing	SCIENCE			English	Editorial Material																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					798	798		10.1126/science.347.6223.798	http://dx.doi.org/10.1126/science.347.6223.798			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA9DT	25678666				2022-12-28	WOS:000349221300053
J	LeBoeuf, NR; McDermott, S; Harris, NL				LeBoeuf, Nicole R.; McDermott, Shaunagh; Harris, Nancy L.			Case 5-2015: A 69-Year-Old Woman with Recurrent Skin Lesions after Treatment for Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CD30(+) LYMPHOPROLIFERATIVE DISORDERS; T-CELL LEUKEMIA/LYMPHOMA; PAPULOSIS; CLASSIFICATION; INVOLVEMENT; EXPRESSION; DIAGNOSIS; DISEASE; EORTC		[LeBoeuf, Nicole R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [LeBoeuf, Nicole R.] Harvard Univ, Dana Farber Brigham & Womens Canc Ctr, Ctr Cutaneous Oncol, Sch Med, Boston, MA 02115 USA; [McDermott, Shaunagh] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Harris, Nancy L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [LeBoeuf, Nicole R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [McDermott, Shaunagh] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Harris, Nancy L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	LeBoeuf, NR (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA.				Harvard Medical School Department of Continuing Education	Harvard Medical School Department of Continuing Education	This case was presented at the Harvard Medical School postgraduate course "Dermatopathology Update," directed by Lyn M. Duncan, M.D., Mai P. Hoang, M.D., Martin C. Mihm, Jr., M.D., George F. Murphy, M.D., and Steven R. Tahan, M.D., and sponsored by the Harvard Medical School Department of Continuing Education.	Asano H, 2010, INT J HEMATOL, V92, P550, DOI 10.1007/s12185-010-0675-9; Barbosa HS, 1999, J ACQ IMMUN DEF SYND, V21, P65, DOI 10.1097/00126334-199905010-00009; Bekkenk MW, 2000, BLOOD, V95, P3653, DOI 10.1182/blood.V95.12.3653.012k23_3653_3661; Benner MF, 2009, ARCH DERMATOL, V145, P1399, DOI 10.1001/archdermatol.2009.280; Bittencourt A, 2009, ACTA ONCOL, V48, P598, DOI 10.1080/02841860802657235; Castellar ERP, 2014, BLOOD, V124, P1473, DOI 10.1182/blood-2014-04-571091; Duvic M, 2013, 55 ANN M AM SOC HEM; Eberle FC, 2012, AM J SURG PATHOL, V36, P716, DOI 10.1097/PAS.0b013e3182487158; ERPAIBOON P, 1991, Journal of Dermatology (Tokyo), V18, P580; Feldman AL, 2011, BLOOD, V117, P915, DOI 10.1182/blood-2010-08-303305; Gallardo F, 2002, J CUTAN PATHOL, V29, P368, DOI 10.1034/j.1600-0560.2002.290608.x; Gascoyne RD, 1999, BLOOD, V93, P3913, DOI 10.1182/blood.V93.11.3913.411k22_3913_3921; HORN TD, 1989, ARCH DERMATOL, V125, P1512, DOI 10.1001/archderm.125.11.1512; Kempf W, 2006, J CUTAN PATHOL, V33, P58, DOI 10.1111/j.0303-6987.2006.00548.x; Kempf W, 2011, BLOOD, V118, P4024, DOI 10.1182/blood-2011-05-351346; Lai CM, 2013, EXPERT REV HEMATOL, V6, P361, DOI 10.1586/17474086.2013.814434; Liu HL, 2003, J AM ACAD DERMATOL, V49, P1049, DOI 10.1016/S0190-9622(03)02484-8; MACAULAY WL, 1968, ARCH DERMATOL, V97, P23, DOI 10.1001/archderm.97.1.23; Magro CM, 2006, APPL IMMUNOHISTO M M, V14, P7, DOI 10.1097/01.pai.0000143347.58174.91; Magro CM, 2003, HUM PATHOL, V34, P119, DOI 10.1053/hupa.2003.4; Massi D, 2004, AM J DERMATOPATH, V26, P234, DOI 10.1097/00000372-200406000-00013; National Comprehensive Cancer Network, 2014, NONH LYMPH VERS 5; Pro B, 2012, J CLIN ONCOL, V30, P2190, DOI 10.1200/JCO.2011.38.0402; SIOUTOS N, 1994, AM J DERMATOPATH, V16, P2, DOI 10.1097/00000372-199402000-00002; Terao H, 2000, J Dermatol, V27, P170; Wada DA, 2011, MODERN PATHOL, V24, P596, DOI 10.1038/modpathol.2010.225; WHITE RM, 1985, CANCER, V55, P1136, DOI 10.1002/1097-0142(19850301)55:5<1136::AID-CNCR2820550532>3.0.CO;2-T; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502	28	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7					650	659		10.1056/NEJMcpc1314241	http://dx.doi.org/10.1056/NEJMcpc1314241			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CK	25671258				2022-12-28	WOS:000349143900011
J	Knott, CS; Coombs, N; Stamatakis, E; Biddulph, JP				Knott, Craig S.; Coombs, Ngaire; Stamatakis, Emmanuel; Biddulph, Jane P.			All cause mortality and the case for age specific alcohol consumption guidelines: pooled analyses of up to 10 population based cohorts	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; BLOOD ETHANOL CONCENTRATIONS; LIFETIME ABSTAINERS; MARITAL-STATUS; RISK; METAANALYSIS; MEN; HEALTH; ASSOCIATION; DRINKING	OBJECTIVES To examine the suitability of age specific limits for alcohol consumption and to explore the association between alcohol consumption and mortality in different age groups. DESIGN Population based data from Health Survey for England 1998-2008, linked to national mortality registration data and pooled for analysis using proportional hazards regression. Analyses were stratified by sex and age group (50-64 and >= 65 years). SETTING Up to 10 waves of the Health Survey for England, which samples the non-institutionalised general population resident in England. PARTICIPANTS The derivation of two analytical samples was based on the availability of comparable alcohol consumption data, covariate data, and linked mortality data among adults aged 50 years or more. Two samples were used, each utilising a different variable for alcohol usage: self reported average weekly consumption over the past year and self reported consumption on the heaviest day in the past week. In fully adjusted analyses, the former sample comprised Health Survey for England years 1998-2002, 18 368 participants, and 4102 deaths over a median follow-up of 9.7 years, whereas the latter comprised Health Survey for England years 1999-2008, 34 523 participants, and 4220 deaths over a median follow-up of 6.5 years. MAIN OUTCOME MEASURE All cause mortality, defined as any death recorded between the date of interview and the end of data linkage on 31 March 2011. RESULTS In unadjusted models, protective effects were identified across a broad range of alcohol usage in all age-sex groups. These effects were attenuated across most use categories on adjustment for a range of personal, socioeconomic, and lifestyle factors. After the exclusion of former drinkers, these effects were further attenuated. Compared with self reported never drinkers, significant protective associations were limited to younger men (50-64 years) and older women (>= 65 years). Among younger men, the range of protective effects was minimal, with a significant reduction in hazards present only among those who reported consuming 15.1-20.0 units/average week (hazard ratio 0.49, 95% confidence interval 0.26 to 0.91) or 0.1-1.5 units on the heaviest day (0.43, 0.21 to 0.87). The range of protective effects was broader but lower among older women, with significant reductions in hazards present <= 10.0 units/average week and across all levels of heaviest day use. Supplementary analyses found that most protective effects disappeared where calculated in comparison with various definitions of occasional drinkers. CONCLUSIONS Beneficial associations between low intensity alcohol consumption and all cause mortality may in part be attributable to inappropriate selection of a referent group and weak adjustment for confounders. Compared with never drinkers, age stratified analyses suggest that beneficial dose-response relations between alcohol consumption and all cause mortality may be largely specific to women drinkers aged 65 years or more, with little to no protection present in other age-sex groups. These protective associations may, however, be explained by the effect of selection biases across age-sex strata.	[Knott, Craig S.; Biddulph, Jane P.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Coombs, Ngaire; Stamatakis, Emmanuel] UCL, Dept Epidemiol & Publ Hlth, Phys Activ Res Grp, London, England; [Coombs, Ngaire] Univ Southampton, Dept Social Stat & Demog, Southampton, Hants, England; [Stamatakis, Emmanuel] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Stamatakis, Emmanuel] Univ Sydney, Fac Hlth Sci, Exercise Hlth & Performance Fac Res Grp, Sydney, NSW 2006, Australia	University of London; University College London; University of London; University College London; University of Southampton; University of Sydney; University of Sydney	Knott, CS (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	craig.knott.10@ucl.ac.uk	Stamatakis, Emmanuel/C-4958-2009	Stamatakis, Emmanuel/0000-0001-7323-3225	Department of Health; NHS Information Centre for Health and Social Care; European Research Council	Department of Health; NHS Information Centre for Health and Social Care; European Research Council(European Research Council (ERC)European Commission)	The Health Survey for England was initially funded by the Department of Health. Since April 2005, the Health Survey for England has been funded by the NHS Information Centre for Health and Social Care. The developers and funders of the Health Survey for England do not bear any responsibility for the analyses or interpretations presented here. The views expressed in this article are those of the authors and do not necessarily reflect those of the funders. CSK is supported by a three year PhD studentship from the European Research Council.	Alcohol Concern, 2002, ALC MIS OLD PEOPL AC; Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; British Medical Association, 2008, ALC MIS TACKL UK EP; Britton A, 2001, J EPIDEMIOL COMMUN H, V55, P383, DOI 10.1136/jech.55.6.383; Britton A, 2010, ADDICTION, V105, P639, DOI 10.1111/j.1360-0443.2009.02832.x; Caldwell TM, 2006, ALCOHOL ALCOHOLISM, V41, P650, DOI 10.1093/alcalc/agl088; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Crome I, 2011, OUR INVISIBLE ADDICT; Davis CG, 2010, ADDICT BEHAV, V35, P302, DOI 10.1016/j.addbeh.2009.11.001; Department of Health, 2008, COST ALC HARM NHS EN; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Doll R, 2005, INT J EPIDEMIOL, V34, P199, DOI 10.1093/ije/dyh369; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dufour M C, 1992, Clin Geriatr Med, V8, P127; Emberson JR, 2006, VASC HEALTH RISK MAN, V2, P239, DOI 10.2147/vhrm.2006.2.3.239; Erens B, 2003, HLTH SURVEY ENGLAND; Falaschetti E, 2002, GEN HLTH OLDER PEOPL; Fat LN, 2014, J EPIDEMIOL COMMUN H, V68, P71, DOI 10.1136/jech-2013-202576; Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005; Fink A, 1996, ARCH INTERN MED, V156, P1150, DOI 10.1001/archinte.156.11.1150; Forster L E, 1993, J Community Health, V18, P225, DOI 10.1007/BF01324433; Fuller E, 2009, HLTH SURVEY ENGLAND, V1; Gartner U, 1996, Z GASTROENTEROL, V34, P675; Goddard E., 2007, ESTIMATING ALCOHOL; GOLDBERG RJ, 1994, CIRCULATION, V89, P651, DOI 10.1161/01.CIR.89.2.651; Graham K, 1998, ADDICT RES, V6, P473, DOI 10.3109/16066359809004366; Health and Social Care Information Centre, 2013, HLTH SURV ENGL 2012; Health and Social Care Information Centre, 2012, STAT ALC ENGL 2012; Holman CDJ, 1996, MED J AUSTRALIA, V164, P141, DOI 10.5694/j.1326-5377.1996.tb122011.x; House of Commons Science and Technology Committee, 2012, 11 HOUS COMM SCI TEC, V1; Howie Erin K, 2011, J Aging Res, V2011, P805062, DOI 10.4061/2011/805062; Hurcombe R, 2010, ETHNICITY ALCOHOL RE; Lister G., 2007, P NAT SOC MARK CTR; Lucey MR, 1999, J STUD ALCOHOL, V60, P103, DOI 10.15288/jsa.1999.60.103; Luo Y, 2012, SOC SCI MED, V74, P907, DOI 10.1016/j.socscimed.2011.11.028; Makela P, 1999, ADDICTION, V94, P867, DOI 10.1046/j.1360-0443.1999.94686710.x; Makela P, 1997, BRIT MED J, V315, P211, DOI 10.1136/bmj.315.7102.211; Marschner IC, 2007, AM J EPIDEMIOL, V166, P824, DOI 10.1093/aje/kwm145; Meier P, 2008, CURR OPIN CLIN NUTR, V11, P21, DOI 10.1097/MCO.0b013e3282f30564; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Murray RP, 1999, J STUD ALCOHOL, V60, P740, DOI 10.15288/jsa.1999.60.740; Nakamura Y, 2009, ALCOHOL, V43, P635, DOI 10.1016/j.alcohol.2009.06.005; National Treatment Agency for Substance Misuse, 2013, ALC TREATM ENGL 2011; Office for National Statistics, 2014, DEATH REG SUMM TABL; Office for National Statistics Geography GIS and Mapping Unit, 2011, REG THEIR CONS COUNT; Pednekar MS, 2012, ALCOHOL, V46, P139, DOI 10.1016/j.alcohol.2011.08.006; Prescott CA, 2001, J STUD ALCOHOL, V62, P589, DOI 10.15288/jsa.2001.62.589; Prime Minister's Strategy Unit, 2003, STRAT UN ALC HARM RE; Rafferty A, 2011, INTRO COMPLEX SAMPLE; Rehm J, 2008, AM J EPIDEMIOL, V168, P866, DOI 10.1093/aje/kwn093; REHM J, 1995, ADDICTION, V90, P471, DOI 10.1046/j.1360-0443.1995.9044712.x; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rossow I, 2001, ADDICTION, V96, pS77; Sayon-Orea C, 2011, NUTR REV, V69, P419, DOI 10.1111/j.1753-4887.2011.00403.x; Shaper AG, 2000, HEART, V83, P394, DOI 10.1136/heart.83.4.394; SHAPER AG, 1990, BRIT J ADDICT, V85, P837; SHAPER AG, 1988, LANCET, V2, P1267; Shelton N, 2011, HEALTH PLACE, V17, P784, DOI 10.1016/j.healthplace.2011.02.004; Sher KJ, 2011, J ABNORM PSYCHOL, V120, P322, DOI 10.1037/a0021813; Skog OJ, 2001, ADDICTION, V96, pS35; STACK S, 1993, J MARRIAGE FAM, V55, P1018, DOI 10.2307/352781; StataCorp, 2013, SURV AN EP TABL REF; Stockwell T, 2013, INT J EPIDEMIOL, V42, P1792, DOI 10.1093/ije/dyt217; Tsubono Y, 2001, JAMA-J AM MED ASSOC, V286, P1177, DOI 10.1001/jama.286.10.1177; WANNAMETHEE G, 1988, INT J EPIDEMIOL, V17, P307, DOI 10.1093/ije/17.2.307; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424	69	133	135	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h384	10.1136/BMJ.h384	http://dx.doi.org/10.1136/BMJ.h384			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB0LU	25670624	Green Published, hybrid			2022-12-28	WOS:000349318400014
J	Luxford, K; Newell, S				Luxford, Karen; Newell, Stephanie			SPOTLIGHT: PATIENT CENTRED CARE New South Wales mounts "patient based care" challenge	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Luxford, Karen; Newell, Stephanie] Clin Excellence Commiss, Sydney, NSW 2000, Australia		Luxford, K (corresponding author), Clin Excellence Commiss, 227 Elizabeth St, Sydney, NSW 2000, Australia.	karen.luxford@cec.health.nsw.gov.au						Australian Commission on Safety and Quality in Health Care, 2012, AUSTR SAF QUAL GOALS; Australian Commission on Safety and Quality in Health Care, 2020, NAT SAF QUAL HLTH SE; Australian Commission on Safety and Quality in Healthcare, 2010, PAT CTR CAR IMPR QUA; Balik B, 2011, ACHIEVING EXCEPTIONA; Charmel PA, 2008, HEALTHCARE FINAN MAR, P1; Clinical Excellence Commission, 2010, GUID PAT BAS CAR CHA; Clinical Excellence Commission, 2010, PAT BAS CAR CHALL; Clinical Excellence Commission, 2014, SAF SYST BETT CAR QU; Delbanco T, 2001, Health Expect, V4, P144, DOI 10.1046/j.1369-6513.2001.00145.x; Department of Health, 2008, HIGH QUALITY CARE AL; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Greene Sarah M, 2012, Perm J, V16, P49; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jenkinson C, 2002, INT J QUAL HEALTH C, V14, P353, DOI 10.1093/intqhc/14.5.353; King's Fund, 2012, VIS ACT MAK PAT CTR; Kotter JohnP., 1996, LEADING CHANGE; Luxford K, 2012, INT J QUAL HEALTH C, V24, P439, DOI 10.1093/intqhc/mzs053; Luxford K, 2011, INT J QUAL HEALTH C, V23, P510, DOI 10.1093/intqhc/mzr024; Scott KW, 2014, NEW ENGL J MED, V371, P3, DOI 10.1056/NEJMp1402157; Shaller D., 2007, PATIENT CTR CARE WHA; World Health Organization, 2010, PEOPL CTR CAR LOW MI	21	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								g7582	10.1136/bmj.g7582	http://dx.doi.org/10.1136/bmj.g7582			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB0LU	25670177	Bronze			2022-12-28	WOS:000349318400027
J	Stagnaro-Green, A				Stagnaro-Green, Alex			Screening Pregnant Women for Overt Thyroid Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPLICATING PREGNANCY; DYSFUNCTION; POSTPARTUM; MANAGEMENT; UNIVERSAL		Univ Illinois, Coll Med Rockford, Rockford, IL 61107 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford	Stagnaro-Green, A (corresponding author), Univ Illinois, Coll Med Rockford, 1601 Parkview Ave, Rockford, IL 61107 USA.	asg@uic.edu		Stagnaro-Green, Alex/0000-0003-2434-3852				Abalovich M, 2002, THYROID, V12, P63, DOI 10.1089/105072502753451986; Blatt AJ, 2012, J CLIN ENDOCR METAB, V97, P777; DAVIS LE, 1989, AM J OBSTET GYNECOL, V160, P63, DOI 10.1016/0002-9378(89)90088-4; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Dosiou C, 2012, J CLIN ENDOCR METAB, V97, P1536, DOI 10.1210/jc.2011-2884; Lazarus JH, 2012, NEW ENGL J MED, V366, P493, DOI 10.1056/NEJMoa1106104; Mannisto T, 2013, J CLIN ENDOCR METAB, V98, P2725, DOI 10.1210/jc.2012-4233; Negro R, 2006, J CLIN ENDOCR METAB, V91, P2587, DOI 10.1210/jc.2005-1603; Negro R, 2010, J CLIN ENDOCR METAB, V95, P1699, DOI 10.1210/jc.2009-2009; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087	10	7	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					565	566		10.1001/jama.2014.17226	http://dx.doi.org/10.1001/jama.2014.17226			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25668257				2022-12-28	WOS:000349070700011
J	Harris, MS; Chawdhary, G				Harris, Mark S.; Chawdhary, Gaurav			PICTURE QUIZ A swollen right eye in a child	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Harris, Mark S.] Northampton Gen Hosp, Northampton NN1 5BD, England; [Chawdhary, Gaurav] Royal Berkshire Hosp, Reading RG1 5AN, Berks, England	Royal Berkshire Hospital	Harris, MS (corresponding author), Northampton Gen Hosp, Northampton NN1 5BD, England.	mh8481@my.bristol.ac.uk						Baring DEC, 2011, CLIN OTOLARYNGOL, V36, P57, DOI 10.1111/j.1749-4486.2011.02258.x; Buchanan MA, 2012, PAEDIAT CHILD HLTH, V22, P72, DOI DOI 10.1016/J.PAED.2011.12.002; Clarke William N, 2004, Paediatr Child Health, V9, P471; Fanella S, 2011, CAN J INFECT DIS MED, V22, P97, DOI 10.1155/2011/626809; Howe L, 2004, CLIN OTOLARYNGOL, V29, P725, DOI 10.1111/j.1365-2273.2004.00889.x; Jain A, 2001, INT OPHTHALMOL CLIN, V41, P71, DOI 10.1097/00004397-200110000-00009; Soong J, 2012, CLIN MED, V12, P276, DOI 10.7861/clinmedicine.12-3-276; Standring S, 2008, GRAYS ANATOMY ANATOM, P655	8	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2015	350								h554	10.1136/bmj.h554	http://dx.doi.org/10.1136/bmj.h554			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0JX	25655276				2022-12-28	WOS:000349313100007
J	Osborne, NH; Nicholas, LH; Ryan, AM; Thumma, JR; Dimick, JB				Osborne, Nicholas H.; Nicholas, Lauren H.; Ryan, Andrew M.; Thumma, Jyothi R.; Dimick, Justin B.			Association of Hospital Participation in a Quality Reporting Program With Surgical Outcomes and Expenditures for Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIFFERENCE-IN-DIFFERENCES; IMPROVEMENT PROGRAM; OPERATIVE MORTALITY; ADMINISTRATIVE DATA; BARIATRIC SURGERY; CLAIMS DATA; COMPLICATIONS; PERFORMANCE; RISK; CARE	IMPORTANCE The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) provides feedback to hospitals on risk-adjusted outcomes. It is not known if participation in the program improves outcomes and reduces costs relative to nonparticipating hospitals. OBJECTIVE To evaluate the association of enrollment and participation in the ACS NSQIP with outcomes and Medicare payments compared with control hospitals that did not participate in the program. DESIGN, SETTING, AND PARTICIPANTS Quasi-experimental study using national Medicare data (2003-2012) for a total of 1 226 479 patients undergoing general and vascular surgery at 263 hospitals participating in ACS NSQIP and 526 nonparticipating hospitals. A difference-in-differences analytic approach was used to evaluate whether participation in ACS NSQIP was associated with improved outcomes and reduced Medicare payments compared with nonparticipating hospitals that were otherwise similar. Control hospitals were selected using propensity score matching (2 control hospitals for each ACS NSQIP hospital). MAIN OUTCOMES AND MEASURES Thirty-day mortality, serious complications (eg, pneumonia, myocardial infarction, or acute renal failure and a length of stay >75th percentile), reoperation, and readmission within 30 days. Hospital costs were assessed using price-standardized Medicare payments during hospitalization and 30 days after discharge. RESULTS After accounting for patient factors and preexisting time trends toward improved outcomes, there were no statistically significant improvements in outcomes at 1, 2, or 3 years after (vs before) enrollment in ACS NSQIP. For example, in analyses comparing outcomes at 3 years after (vs before) enrollment, there were no statistically significant differences in risk-adjusted 30-day mortality (4.3% after enrollment vs 4.5% before enrollment; relative risk [RR], 0.96 [95% CI, 0.89 to 1.03]), serious complications (11.1% after enrollment vs 11.0% before enrollment; RR, 0.96 [95% CI, 0.91 to 1.00]), reoperations (0.49% after enrollment vs 0.45% before enrollment; RR, 0.97 [95% CI, 0.77 to 1.16]), or readmissions (13.3% after enrollment vs 12.8% before enrollment; RR, 0.99 [95% CI, 0.96 to 1.03]). There were also no differences at 3 years after (vs before) enrollment in mean total Medicare payments ($40 [95% CI, -$268 to $348]), or payments for the index admission (-$11 [95% CI, -$278 to 257]), hospital readmission ($245 [95% CI, -$231 to $721]), or outliers (-$86 [95% CI, -$1666 to $1495]). CONCLUSIONS AND RELEVANCE With time, hospitals had progressively better surgical outcomes but enrollment in a national quality reporting program was not associated with the improved outcomes or lower Medicare payments among surgical patients. Feedback on outcomes alone may not be sufficient to improve surgical outcomes.	[Osborne, Nicholas H.; Ryan, Andrew M.; Thumma, Jyothi R.; Dimick, Justin B.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Osborne, Nicholas H.] Univ Michigan, Ctr Clin Management Res, Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48109 USA; [Nicholas, Lauren H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Ryan, Andrew M.; Dimick, Justin B.] Univ Michigan, Sch Publ Hlth, Dept Hlth Policy & Management, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Michigan System; University of Michigan	Osborne, NH (corresponding author), Ctr Cardiovasc 5168, Vasc Surg Sect, 1500 E Med Ctr Dr,SPC 5867, Ann Arbor, MI 48109 USA.	nichosbo@umich.edu			National Institute on Aging [R01AG039434]; NATIONAL INSTITUTE ON AGING [K01AG041763, R01AG039434] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a grant R01AG039434 from the National Institute on Aging (Drs Dimick, Osborne, and Nicholas).	Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Best WR, 2002, J AM COLL SURGEONS, V194, P257, DOI 10.1016/S1072-7515(01)01183-8; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2010, HEALTH SERV RES, V45, P1783, DOI 10.1111/j.1475-6773.2010.01150.x; Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; Dimick JB, 2006, J AM COLL SURGEONS, V202, P933, DOI 10.1016/j.jamcollsurg.2006.02.015; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Dimick JB, 2013, JAMA-J AM MED ASSOC, V309, P792, DOI 10.1001/jama.2013.755; Donald SG, 2007, REV ECON STAT, V89, P221, DOI 10.1162/rest.89.2.221; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ellner Scott J, 2011, Bull Am Coll Surg, V96, P9; Fink AS, 2002, ANN SURG, V236, P344, DOI 10.1097/00000658-200209000-00011; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Glickson Jeannie, 2013, Bull Am Coll Surg, V98, P66; Gottlieb DJ, 2010, HEALTH AFFAIR, V29, P537, DOI 10.1377/hlthaff.2009.0609; Hall BL, 2009, ANN SURG, V250, P363, DOI 10.1097/SLA.0b013e3181b4148f; Hannan EL, 2003, MED CARE, V41, P1164, DOI 10.1097/01.MLR.0000088452.82637.40; Hibbard JH, 2005, HEALTH AFFAIR, V24, P1150, DOI 10.1377/hlthaff.24.4.1150; IEZZONI LI, 1994, INQUIRY-J HEALTH CAR, V31, P40; IEZZONI LI, 1994, MED CARE, V32, P700, DOI 10.1097/00005650-199407000-00004; Ingraham Angela M, 2010, Adv Surg, V44, P251; Khuri SF, 2008, ANN SURG, V248, P329, DOI 10.1097/SLA.0b013e3181823485; Lawson EH, 2012, ANN SURG, V256, P973, DOI 10.1097/SLA.0b013e31826b4c4f; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Little R.J.A., 2002, STAT ANAL MISSING DA; Livingston EH, 2004, AM J SURG, V188, P105, DOI 10.1016/j.amjsurg.2004.03.001; Miller DC, 2011, HEALTH AFFAIR, V30, P2107, DOI 10.1377/hlthaff.2011.0783; Morris AM, 2007, ANN SURG, V245, P73, DOI 10.1097/01.sla.0000231797.37743.9f; Neumayer L, 2000, J SURG RES, V88, P58, DOI 10.1006/jsre.1999.5791; Rosenthal MB, 2008, NEW ENGL J MED, V359, P1197, DOI 10.1056/NEJMp0804658; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Rowell KS, 2007, J AM COLL SURGEONS, V204, P1293, DOI 10.1016/j.jamcollsurg.2007.03.024; Ryan AM, 2015, HEALTH SERV RES, V50, P1211, DOI 10.1111/1475-6773.12270; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; Schilling PL, 2008, J AM COLL SURGEONS, V207, P698, DOI 10.1016/j.jamcollsurg.2008.06.138; Schilling PL, 2010, SURG INNOV, V17, P127, DOI 10.1177/1553350610363595; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Walshe K, 2002, QUAL SAF HEALTH CARE, V11, P85, DOI 10.1136/qhc.11.1.85; Weingart SN, 2000, MED CARE, V38, P796, DOI 10.1097/00005650-200008000-00004; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	45	215	215	1	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					496	504		10.1001/jama.2015.25	http://dx.doi.org/10.1001/jama.2015.25			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA7AV	25647205	Green Accepted, Bronze			2022-12-28	WOS:000349070300013
J	Chang, E				Chang, Eugene			Preterm birth and the role of neuroprotection	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DEVELOPMENTAL COORDINATION DISORDER; AMNIOTIC-FLUID INFECTION; UMBILICAL-CORD PLASMA; MAGNESIUM-SULFATE; CEREBRAL-PALSY; WHITE-MATTER; NEURODEVELOPMENTAL OUTCOMES; ANTENATAL CORTICOSTEROIDS; OLIGODENDROCYTE PROGENITORS; OXIDATIVE STRESS	Preterm birth remains a common complication of pregnancy and causes substantial neonatal morbidity and mortality. As improvements in the care of preterm neonates have outpaced efforts to prevent preterm birth, the numbers of survivors with neurologic sequelae that affect quality of life have increased. The main strategies to reduce the impact of neurologic complications of prematurity include prevention of preterm birth and protection of the developing fetal brain through antenatal administration of drugs. These strategies rely on a basic understanding of the intertwined pathophysiology of spontaneous preterm labor and perinatal brain injury, which will be reviewed here. The review will outline current methods for the prevention of prematurity and neuroprotection. The use of magnesium sulfate as a neuroprotective compound will be discussed, including concerns over its association with increased pediatric mortality and abnormalities in bone density.	Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29492 USA	Medical University of South Carolina	Chang, E (corresponding author), Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29492 USA.	changey@musc.edu						Ali H, 2010, ACTA NEUROBIOL EXP, V70, P316; Allen MC, 2008, CURR OPIN NEUROL, V21, P123, DOI 10.1097/WCO.0b013e3282f88bb4; Allen MC, 2011, CLIN PERINATOL, V38, P441, DOI 10.1016/j.clp.2011.06.011; American College of Obstetricians and Gynecologists Committee on Obstetric Practice Society for Maternal-Fetal Medicine, 2013, Obstet Gynecol, V122, P727, DOI 10.1097/01.AOG.0000433994.46087.85; Antenatal Magnesium Sulphate for Neuroprotection Guideline Development Panel, 2010, ANT MAGN SULF PRIOR; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 1998, J NEUROSCI, V18, P6241; Bakiri Y, 2009, NEUROSCIENCE, V158, P266, DOI 10.1016/j.neuroscience.2008.01.015; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Beaino G, 2010, DEV MED CHILD NEUROL, V52, pE119, DOI 10.1111/j.1469-8749.2010.03612.x; Behrman RE, 2007, PRETERM BIRTH CAUSES; Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bolisetty S, 2014, PEDIATRICS, V133, P55, DOI 10.1542/peds.2013-0372; Bos AF, 2013, DEV MED CHILD NEUROL, V55, P1, DOI 10.1111/dmcn.12297; Brunton PJ, 2014, PROG NEUROBIOL, V113, P106, DOI 10.1016/j.pneurobio.2013.08.005; Burd I, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.022; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Castillo-Melendez M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00194; Chang EY, 2011, J MATERN-FETAL NEO M, V24, P732, DOI 10.3109/14767058.2010.528089; Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X; Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032; Conde-Agudelo A, 2009, AM J OBSTET GYNECOL, V200, P595, DOI 10.1016/j.ajog.2009.04.005; Costantine MM, 2009, OBSTET GYNECOL, V114, P354, DOI 10.1097/AOG.0b013e3181ae98c2; COX SM, 1990, AM J OBSTET GYNECOL, V163, P767, DOI 10.1016/0002-9378(90)91065-K; Crowther CA, 2003, JAMA-J AM MED ASSOC, V290, P2669, DOI 10.1001/jama.290.20.2669; Davis NM, 2007, DEV MED CHILD NEUROL, V49, P325, DOI 10.1111/j.1469-8749.2007.00325.x; De Nicola AF, 2013, J NEUROENDOCRINOL, V25, P1095, DOI 10.1111/jne.12043; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Dodd JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004947.pub3; Doyle LW, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004661.pub3; Doyle LW, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e2; Dribben WH, 2009, NEONATOLOGY, V96, P23, DOI 10.1159/000201327; Fleiss B, 2012, BRAIN RES, V1433, P9, DOI 10.1016/j.brainres.2011.11.035; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; Gitto E, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/980374; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Hayes EJ, 2008, OBSTET GYNECOL, V111, P921, DOI 10.1097/AOG.0b013e318169ce2d; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Husson I, 2002, ANN NEUROL, V51, P82, DOI 10.1002/ana.10072; Jenkins DD, 2009, J CHILD NEUROL, V24, P1212, DOI 10.1177/0883073809338412; Jones MW, 2007, J PEDIATR HEALTH CAR, V21, P146, DOI DOI 10.1016/J.PEDHC.2006.06.007; Karadottir R, 2007, NEUROSCIENCE, V145, P1426, DOI 10.1016/j.neuroscience.2006.08.070; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; KNOX IC, 1950, AM J OBSTET GYNECOL, V59, P190, DOI 10.1016/0002-9378(50)90370-X; Kumral A, 2005, DEV BRAIN RES, V160, P146, DOI 10.1016/j.devbrainres.2005.08.006; Kusters Cynthia D J, 2013, Ned Tijdschr Geneeskd, V157, pA5449; Kuzniewicz MW, 2014, J PEDIATR-US, V164, P20, DOI 10.1016/j.jpeds.2013.09.021; Larsen RF, 2013, DEV MED CHILD NEUROL, V55, P1016, DOI 10.1111/dmcn.12223; Lekic T, 2011, ACTA NEUROCHIR SUPPL, V111, P201, DOI 10.1007/978-3-7091-0693-8_34; Leveno KJ, 1998, LANCET, V351, P291, DOI 10.1016/S0140-6736(05)78240-4; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Magee L, 2011, J OBSTET GYNAECOL CA, V33, P516, DOI 10.1016/S1701-2163(16)34886-1; Manning SM, 2008, J NEUROSCI, V28, P6670, DOI 10.1523/JNEUROSCI.1702-08.2008; Marlow N, 2007, PEDIATRICS, V120, P793, DOI 10.1542/peds.2007-0440; Marret S, 2008, GYNECOL OBSTET FERTI, V36, P278, DOI 10.1016/j.gyobfe.2008.01.012; Marret S, 2007, BJOG-INT J OBSTET GY, V114, P310, DOI 10.1111/j.1471-0528.2006.01162.x; Marret S, 2007, OBSTET GYNECOL, V110, P72, DOI 10.1097/01.AOG.0000267498.95402.bd; Marret S, 2013, HAND CLINIC, V111, P169, DOI 10.1016/B978-0-444-52891-9.00016-6; Mayo JC, 2005, J NEUROIMMUNOL, V165, P139, DOI 10.1016/j.jneuroim.2005.05.002; McPherson RJ, 2008, INT J DEV NEUROSCI, V26, P103, DOI 10.1016/j.ijdevneu.2007.08.012; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; MENENDEZPELAEZ A, 1993, J PINEAL RES, V15, P59, DOI 10.1111/j.1600-079X.1993.tb00511.x; Merchant NM, 2013, BRIT J CLIN PHARMACO, V76, P725, DOI 10.1111/bcp.12092; Mittendorf R, 1997, LANCET, V350, P1517, DOI 10.1016/S0140-6736(97)24047-X; Moore Tamanna, 2012, BMJ, V345, pe7961, DOI 10.1136/bmj.e7961; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Nagae LM, 2007, AM J NEURORADIOL, V28, P1213, DOI 10.3174/ajnr.A0534; NELSON KB, 1995, PEDIATRICS, V95, P263; O'Callaghan ME, 2011, OBSTET GYNECOL, V118, P576, DOI 10.1097/AOG.0b013e31822ad2dc; O'Shea T M, 2001, Semin Neonatol, V6, P293, DOI 10.1053/siny.2001.0065; Oskoui M, 2013, DEV MED CHILD NEUROL, V55, P509, DOI 10.1111/dmcn.12080; Paintlia MK, 2008, J NEUROCHEM, V105, P956, DOI 10.1111/j.1471-4159.2007.05199.x; Paintlia MK, 2004, J NEUROSCI RES, V78, P347, DOI 10.1002/jnr.20261; Reiter RJ, 2009, CRIT REV BIOCHEM MOL, V44, P175, DOI 10.1080/10409230903044914; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Rose S, 2011, BRAIN CONNECT, V1, P309, DOI 10.1089/brain.2011.0034; Rouse DJ, 2008, NEW ENGL J MED, V359, P895, DOI 10.1056/NEJMoa0801187; Royal College of Obstetricians and Gynaecologists, 2012, 29 ROYAL COLL OBST G, P1; Salmeen Kirsten E, 2014, F1000Prime Rep, V6, P6, DOI 10.12703/P6-6; Scheck SM, 2012, DEV MED CHILD NEUROL, V54, P684, DOI 10.1111/j.1469-8749.2012.04332.x; Schiariti V, 2008, J PERINATOL, V28, P566, DOI 10.1038/jp.2008.34; Schiariti V, 2007, J DEV BEHAV PEDIATR, V28, P9, DOI 10.1097/01.DBP.0000257516.52459.33; Sommer C, 2007, KLIN PADIATR, V219, P23, DOI 10.1055/s-2006-921341; Son SM, 2007, NEUROSCI LETT, V420, P34, DOI 10.1016/j.neulet.2007.04.054; US Food and Drug Administration, 2013, FDA DRUG SAF COMM FD; van Velthoven CTJ, 2013, STROKE, V44, P1426, DOI 10.1161/STROKEAHA.111.000326; VITTE PA, 1988, J PINEAL RES, V5, P437, DOI 10.1111/j.1600-079X.1988.tb00787.x; Volpe JJ., 2008, NEUROLOGY NEWBORN, P279; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; WATTS DH, 1992, OBSTET GYNECOL, V79, P351; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1124, DOI 10.1067/mob.2000.109035; Yoon BH, 1996, AM J OBSTET GYNECOL, V174, P1433, DOI 10.1016/S0002-9378(96)70585-9; Yoshida S, 2011, RADIOLOGY, V260, P511, DOI 10.1148/radiol.11101783; Yoshida S, 2010, DEV MED CHILD NEUROL, V52, P935, DOI 10.1111/j.1469-8749.2010.03669.x; Zhang J, 2014, J CLIN NEUROSCI, V21, P1283, DOI 10.1016/j.jocn.2013.10.040	99	35	39	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2015	350								g6661	10.1136/bmj.g6661	http://dx.doi.org/10.1136/bmj.g6661			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZB	25646630				2022-12-28	WOS:000348433200001
J	Kelly, H; Cowling, BJ				Kelly, Heath; Cowling, Benjamin J.			Influenza: the rational use of oseltamivir	LANCET			English	Editorial Material							NEURAMINIDASE INHIBITORS; MORTALITY; CHILDREN; ADULTS		[Kelly, Heath] Victorian Infect Dis Reference Lab, North Melbourne, Vic, Australia; [Kelly, Heath] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Cowling, Benjamin J.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Hong Kong, Peoples R China	Victorian Infectious Diseases Reference Laboratory; Australian National University; University of Hong Kong; World Health Organization	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009	Cowling, Benjamin John/0000-0002-6297-7154				[Anonymous], LANCET; [Anonymous], 2010, WHO GUID PHARM MAN P; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Brammer L, 2011, CLIN INFECT DIS, V52, pS27, DOI 10.1093/cid/ciq009; Doshi P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7898; Dunn AG, 2014, ANN INTERN MED, V161, P513, DOI 10.7326/M14-0933; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2263; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5313; Lyman Gary H, 2005, BMC Med Res Methodol, V5, P14, DOI 10.1186/1471-2288-5-14; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Pebody RG, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.22.20823; Sutter DE, 2012, J MED VIROL, V84, P1699, DOI 10.1002/jmv.23374	15	20	21	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1700	1702		10.1016/S0140-6736(15)60074-5	http://dx.doi.org/10.1016/S0140-6736(15)60074-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25640811				2022-12-28	WOS:000353726000005
J	Aieta, F; Kats, MA; Genevet, P; Capasso, F				Aieta, Francesco; Kats, Mikhail A.; Genevet, Patrice; Capasso, Federico			Multiwavelength achromatic metasurfaces by dispersive phase compensation	SCIENCE			English	Article							OPTICAL ANTENNA METASURFACES; FLAT OPTICS; LIGHT; DISCONTINUITIES; NANOANTENNAS; REFLECTION; REFRACTION; LENSES	The replacement of bulk refractive optical elements with diffractive planar components enables the miniaturization of optical systems. However, diffractive optics suffers from large chromatic aberrations due to the dispersion of the phase accumulated by light during propagation. We show that this limitation can be overcome with an engineered wavelength-dependent phase shift imparted by a metasurface, and we demonstrate a design that deflects three wavelengths by the same angle. A planar lens without chromatic aberrations at three wavelengths is also presented. Our designs are based on low-loss dielectric resonators, which introduce a dense spectrum of optical modes to enable dispersive phase compensation. The suppression of chromatic aberrations in metasurface-based planar photonics will find applications in lightweight collimators for displays, as well as chromatically corrected imaging systems.	[Aieta, Francesco; Kats, Mikhail A.; Genevet, Patrice; Capasso, Federico] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University	Capasso, F (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	capasso@seas.harvard.edu	Genevet, Patrice/HGB-7010-2022; Genevet, Patrice/AAE-6936-2019; Kats, Mikhail A./G-6022-2011	Genevet, Patrice/0000-0003-0216-3885; Kats, Mikhail A./0000-0003-4897-4720	Air Force Office of Scientific Research [FA9550-12-1-0389]; Draper Laboratory [SC001-0000000731]; NSF [ECCS-1347251]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Draper Laboratory; NSF(National Science Foundation (NSF))	We acknowledge partial financial support from the Air Force Office of Scientific Research under grant FA9550-12-1-0389 (Multidisciplinary University Initiative), Draper Laboratory under program SC001-0000000731, and the NSF under program ECCS-1347251 (EAGER). We thank B. Kress (Google) for insightful remarks and suggestions; S. Kalchmair, R. Khorasaninejad, and J. P. Laine (Draper Laboratory) for helpful discussions; and E. Hu for the supercontinuum laser (NKT "SuperK"). The fabrication was performed at the Harvard Center for Nanoscale Systems, which is a member of the National Nanotechnology Infrastructure Network. The thin-film characterization of the amorphous silicon was done by Accurion.	Aieta F, 2012, NANO LETT, V12, P4932, DOI 10.1021/nl302516v; Aieta F, 2012, NANO LETT, V12, P1702, DOI 10.1021/nl300204s; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Chen WT, 2014, NANO LETT, V14, P225, DOI 10.1021/nl403811d; Hecht E., 1997, OPTICS, V3; Kats MA, 2012, P NATL ACAD SCI USA, V109, P12364, DOI 10.1073/pnas.1210686109; Kildishev AV, 2013, SCIENCE, V339, DOI 10.1126/science.1232009; Krasnok AE, 2012, OPT EXPRESS, V20, P20599, DOI 10.1364/OE.20.020599; Kress BC., 2009, APPL DIGITAL OPTICS; Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213; Mercado RI, 1998, P SOC PHOTO-OPT INS, V3482, P321, DOI 10.1117/12.322019; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; Pedrotti F. L., 1987, INTRO OPTICS; Pors A, 2013, NANO LETT, V13, P829, DOI 10.1021/nl304761m; Saeidi C, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4892560; van de Hulst H.C., 1981, LIGHT SCATTERING SMA; Vo S, 2014, IEEE PHOTONIC TECH L, V26, P1375, DOI 10.1109/LPT.2014.2325947; Yang BA, 2013, OPT LETT, V38, P679, DOI 10.1364/OL.38.000679; Yu NF, 2014, NAT MATER, V13, P139, DOI [10.1038/nmat3839, 10.1038/NMAT3839]; Yu NF, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2013.2241399; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	21	741	788	67	836	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1342	1345		10.1126/science.aaa2494	http://dx.doi.org/10.1126/science.aaa2494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25700175	Green Submitted			2022-12-28	WOS:000351219600036
J	Clayton, EW				Clayton, Ellen Wright			Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome An IOM Report on Redefining an Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Clayton, Ellen Wright] Vanderbilt Univ, Ctr Biomed Eth & Soc, Nashville, TN 37203 USA	Vanderbilt University	Clayton, EW (corresponding author), Vanderbilt Univ, Pediat, 2525 W End Ave,Ste 400, Nashville, TN 37203 USA.	ellen.clayton@vanderbilt.edu						Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; JASON LA, 2005, CFIDS CHRONICLE, P16; Marshall Rebecca, 2011, Physiotherapy Theory and Practice, V27, P373, DOI 10.3109/09593985.2010.502554	4	139	146	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1101	1102		10.1001/jama.2015.1346	http://dx.doi.org/10.1001/jama.2015.1346			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25668027				2022-12-28	WOS:000351102500007
J	Newton-Howes, G; Clark, LA; Chanen, A				Newton-Howes, Giles; Clark, Lee Anna; Chanen, Andrew			Personality disorder across the life course	LANCET			English	Article							DIMENSIONAL REPRESENTATIONS; TRAITS; AGE; BORDERLINE; CLASSIFICATION; ADULTHOOD; COMMUNITY; METAANALYSIS; CHILDHOOD; HEALTH	The pervasive effect of personality disorder is often overlooked in clinical practice, both as an important moderator of mental state and physical disorders, and as a disorder that should be recognised and managed in its own right. Contemporary research has shown that maladaptive personality (when personality traits are extreme and associated with clinical distress or psychosocial impairment) is common, can be recognised early in life, evolves continuously across the lifespan, and is more plastic than previously believed. These new insights off er opportunities to intervene to support more adaptive development than before, and research shows that such intervention can be effective. Further research is needed to improve classification, assessment, and diagnosis of personality disorder across the lifespan; to understand the complex interplay between changes in personality traits and clinical presentation over time; and to promote more effective intervention at the earliest possible stage of the disorder than is done at present. Recognition of how personality disorder relates to age and developmental stage can improve care of all patients.	[Newton-Howes, Giles] Univ Otago, Wellington 6242, New Zealand; [Newton-Howes, Giles] Univ London Imperial Coll Sci Technol & Med, London, England; [Clark, Lee Anna] Univ Notre Dame, Notre Dame, IN 46556 USA; [Chanen, Andrew] Natl Ctr Excellence, Youth Mental Hlth, Melbourne, Vic, Australia; [Chanen, Andrew] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia	University of Otago; Imperial College London; University of Notre Dame; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne	Newton-Howes, G (corresponding author), Univ Otago, Mein St, Wellington 6242, New Zealand.	giles.newton-howes@otago.ac.nz	Howes, Giles Newton/AAK-6427-2020	Chanen, Andrew/0000-0003-4468-622X; Newton-Howes, Giles/0000-0002-5167-1213				Agrawal A, 2013, PERSONAL DISORD, V4, P55, DOI 10.1037/a0030224; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Bahorik AL, 2010, SCHIZOPHR RES, V124, P29, DOI 10.1016/j.schres.2010.09.005; Balsis S, 2007, PSYCHOL AGING, V22, P171, DOI 10.1037/0882-7974.22.1.171; Bastiaansen L, 2013, PERSONAL DISORD, V4, P293, DOI 10.1037/per0000018; Bernstein DP, 2007, J PERS DISORD, V21, P536, DOI 10.1521/pedi.2007.21.5.536; Blashfield RK, 2000, AM J PSYCHIAT, V157, P472, DOI 10.1176/appi.ajp.157.3.472; CASPI A, 1995, CHILD DEV, V66, P486, DOI 10.2307/1131592; Caspi A, 2001, PSYCHOL INQ, V12, P49, DOI 10.1207/S15327965PLI1202_01; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Chan W, 2012, J PERS SOC PSYCHOL, V103, P1050, DOI 10.1037/a0029712; Chanen Andrew M, 2013, Br J Psychiatry Suppl, V54, ps24, DOI 10.1192/bjp.bp.112.119180; Chanen AM, 2008, CURR PSYCHIATRY REV, V4, P48, DOI 10.2174/157340008783743820; Chanen AM, 2008, PERSONAL MENT HEALTH, V2, P35, DOI 10.1002/pmh.28; Clark LA, 1997, J PERS DISORD, V11, P205, DOI 10.1521/pedi.1997.11.3.205; Clark LA, 2005, J ABNORM PSYCHOL, V114, P505, DOI 10.1037/0021-843X.114.4.505; Clark LA, 2007, ANNU REV PSYCHOL, V58, P227, DOI 10.1146/annurev.psych.57.102904.190200; Cohen P, 2005, J PERS DISORD, V19, P466, DOI 10.1521/pedi.2005.19.5.466; Cohen P, 2008, PSYCHIAT CLIN N AM, V31, P477, DOI 10.1016/j.psc.2008.03.005; Cooper LD, 2014, J PERS DISORD, V28, P151, DOI 10.1521/pedi.2014.28.1.151; De Bolle M, 2009, CHILD PSYCHIAT HUM D, V40, P269, DOI 10.1007/s10578-009-0125-1; De Fruyt F, 2006, J PERS SOC PSYCHOL, V91, P538, DOI 10.1037/0022-3514.91.3.538; De Fruyt F, 2014, ANNU REV CLIN PSYCHO, V10, P449, DOI 10.1146/annurev-clinpsy-032813-153634; Duberstein PR, 2011, PSYCHOL AGING, V26, P351, DOI 10.1037/a0021377; Ferguson CJ, 2010, J PERS SOC PSYCHOL, V98, P659, DOI 10.1037/a0018770; Fok MLY, 2012, J PSYCHOSOM RES, V73, P104, DOI 10.1016/j.jpsychores.2012.05.001; Gleason MEJ, 2014, J PERS, V82, P493, DOI 10.1111/jopy.12068; Glinski K, 2010, BEHAV CHANGE, V27, P42, DOI 10.1375/bech.27.1.42; Gratz KL, 2010, EMOTION REGULATION M, P107; Gruhn D, 2011, DEV PSYCHOL, V47, P376, DOI 10.1037/a0021315; Gutierrez F, 2012, J PERS DISORD, V26, P763, DOI 10.1521/pedi.2012.26.5.763; Hallquist MN, 2013, J ABNORM PSYCHOL, V122, P138, DOI 10.1037/a0030060; James W, 1950, PRINCIPLES PSYCHOL; Johnson JG, 2000, ACTA PSYCHIAT SCAND, V102, P265, DOI 10.1034/j.1600-0447.2000.102004265.x; Kendler KS, 2007, PSYCHOL MED, V37, P655, DOI 10.1017/S0033291706009755; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P1438, DOI 10.1001/archpsyc.65.12.1438; Krueger RF, 2008, J PERS, V76, P1485, DOI 10.1111/j.1467-6494.2008.00529.x; Krueger RF, 2007, INT J METH PSYCH RES, V16, pS65, DOI 10.1002/mpr.212; Lenzenweger MF, 2007, J ABNORM PSYCHOL, V116, P684, DOI 10.1037/0021-843X.116.4.684; LIVESLEY WJ, 1994, J ABNORM PSYCHOL, V103, P6, DOI 10.1037/0021-843X.103.1.6; Livesley WJ, 1998, CAN J PSYCHIAT, V43, P137, DOI 10.1177/070674379804300202; Markon KE, 2005, J PERS SOC PSYCHOL, V88, P139, DOI 10.1037/0022-3514.88.1.139; McGlashan TH, 2005, AM J PSYCHIAT, V162, P883, DOI 10.1176/appi.ajp.162.5.883; Mervielde I, 2005, J PERS DISORD, V19, P171, DOI 10.1521/pedi.19.2.171.62627; Moffitt TE, 2008, J CHILD PSYCHOL PSYC, V49, P3, DOI 10.1111/j.1469-7610.2007.01823.x; Morey LC, 2012, PSYCHOL MED, V42, P1705, DOI 10.1017/S0033291711002601; Newton-Howes G, 2006, BRIT J PSYCHIAT, V188, P13, DOI 10.1192/bjp.188.1.13; Newton-Howes G, 2008, AUST NZ J PSYCHIAT, V42, P572, DOI 10.1080/00048670802119739; O'Connor BP, 2002, J PERS SOC PSYCHOL, V83, P962, DOI 10.1037//0022-3514.83.4.962; Powers AD, 2013, PERSONAL DISORD, V4, P152, DOI 10.1037/a0028709; Powers AD, 2012, J PERS DISORD, V26, P524, DOI 10.1521/pedi.2012.26.4.524; Reichborn-Kjennerud T, 2007, PSYCHOL MED, V37, P645, DOI 10.1017/S0033291706009548; Ritchie CW, 2011, INT PSYCHOGERIATR, V23, P299, DOI 10.1017/S1041610210001742; Roberts BW, 2008, CURR DIR PSYCHOL SCI, V17, P31, DOI 10.1111/j.1467-8721.2008.00543.x; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Samuel DB, 2008, CLIN PSYCHOL REV, V28, P1326, DOI 10.1016/j.cpr.2008.07.002; Schulenberg JE, 2004, DEV PSYCHOPATHOL, V16, P799, DOI 10.1017/S0954579404040015; Seivewright H, 2002, LANCET, V359, P2253, DOI 10.1016/S0140-6736(02)09266-8; Skodol AE, 2005, J PERS DISORD, V19, P487, DOI 10.1521/pedi.2005.19.5.487; Skodol AE, 2008, PSYCHIAT CLIN N AM, V31, P495, DOI 10.1016/j.psc.2008.03.010; Srivastava S, 2003, J PERS SOC PSYCHOL, V84, P1041, DOI 10.1037/0022-3514.84.5.1041; Stevenson J, 2011, AUST NZ J PSYCHIAT, V45, P771, DOI 10.3109/00048674.2011.595685; Stoffers JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005652.pub2; Torgersen S, 2008, PSYCHOL MED, V38, P1617, DOI 10.1017/S0033291708002924; Trull TJ, 2005, ANNU REV CLIN PSYCHO, V1, P355, DOI 10.1146/annurev.clinpsy.1.102803.144009; Tyrer Peter, 2015, Lancet, V385, P717, DOI 10.1016/S0140-6736(14)61995-4; Tyrer P, 2011, PERSONAL MENT HEALTH, V5, P246, DOI 10.1002/pmh.190; Tyrer P, 2011, LANCET, V377, P1814, DOI 10.1016/S0140-6736(10)61926-5; Verheul R, 2004, J PERS DISORD, V18, P309, DOI 10.1521/pedi.2004.18.4.309; Warner MB, 2004, J ABNORM PSYCHOL, V113, P217, DOI 10.1037/0021-843X.113.2.217; Widiger TA, 2007, AM PSYCHOL, V62, P71, DOI 10.1037/0003-066X.62.2.71; Wong CCY, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12226; Yamagata S, 2006, J PERS SOC PSYCHOL, V90, P987, DOI 10.1037/0022-3514.90.6.987; Zanarini MC, 2007, AM J PSYCHIAT, V164, P929, DOI 10.1176/appi.ajp.164.6.929; Zanarini MC, 2012, PSYCHIAT ANN, V42, P53, DOI 10.3928/00485713-20120124-05; ZIMMERMAN M, 1994, ARCH GEN PSYCHIAT, V51, P225; Zimmerman M, 2008, PSYCHIAT CLIN N AM, V31, P405, DOI 10.1016/j.psc.2008.03.015	79	120	121	0	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2015	385	9969					727	734		10.1016/S0140-6736(14)61283-6	http://dx.doi.org/10.1016/S0140-6736(14)61283-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB7ED	25706218				2022-12-28	WOS:000349788300029
J	Mitja, O; Houinei, W; Moses, P; Kapa, A; Paru, R; Hays, R; Lukehart, S; Godornes, C; Bieb, SV; Grice, T; Siba, P; Mabey, D; Sanz, S; Alonso, PL; Asiedu, K; Bassat, Q				Mitja, Oriol; Houinei, Wendy; Moses, Penias; Kapa, August; Paru, Raymond; Hays, Russell; Lukehart, Sheila; Godornes, Charmie; Bieb, Sibauk Vivaldo; Grice, Tim; Siba, Peter; Mabey, David; Sanz, Sergi; Alonso, Pedro L.; Asiedu, Kingsley; Bassat, Quique			Mass Treatment with Single-Dose Azithromycin for Yaws	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAPUA-NEW-GUINEA; TREPONEMA-PALLIDUM; CHILDREN	BACKGROUND Mass treatment with azithromycin is a central component of the new World Health Organization (WHO) strategy to eradicate yaws. Empirical data on the effectiveness of the strategy are required as a prerequisite for worldwide implementation of the plan. METHODS We performed repeated clinical surveys for active yaws, serologic surveys for latent yaws, and molecular analyses to determine the cause of skin ulcers and identify macrolide-resistant mutations before and 6 and 12 months after mass treatment with azithromycin on a Papua New Guinean island on which yaws was endemic. Primary-outcome indicators were the prevalence of serologically confirmed active infectious yaws in the entire population and the prevalence of latent yaws with high-titer seroreactivity in a subgroup of children 1 to 15 years of age. RESULTS At baseline, 13,302 of 16,092 residents (82.7%) received one oral dose of azithromycin. The prevalence of active infectious yaws was reduced from 2.4% before mass treatment to 0.3% at 12 months (difference, 2.1 percentage points; P<0.001). The prevalence of high-titer latent yaws among children was reduced from 18.3% to 6.5% (difference, 11.8 percentage points; P<0.001) with a near-absence of high-titer seroreactivity in children 1 to 5 years of age. Adverse events identified within 1 week after administration of the medication occurred in approximately 17% of the participants, included nausea, diarrhea, and vomiting, and were mild in severity. No evidence of emergence of resistance to macrolides against Treponema pallidum subspecies pertenue was seen. CONCLUSIONS The prevalence of active and latent yaws infection fell rapidly and substantially 12 months after high-coverage mass treatment with azithromycin, with the reduction perhaps aided by subsequent activities to identify and treat new cases of yaws. Our results support the WHO strategy for the eradication of yaws. (Funded by Newcrest Mining and International SOS; YESA-13 ClinicalTrials.gov number, NCT01955252.)	[Mitja, Oriol; Moses, Penias; Kapa, August; Paru, Raymond] Lihir Med Ctr, Int SOS, Lihir Isl, New Ireland Pro, Papua N Guinea; [Houinei, Wendy; Bieb, Sibauk Vivaldo] Natl Dept Hlth, Dis Control Branch, Port Moresby, Papua N Guinea; [Siba, Peter] Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea; [Mitja, Oriol; Sanz, Sergi; Alonso, Pedro L.; Bassat, Quique] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Hays, Russell] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Cairns, Qld, Australia; [Grice, Tim] Univ Queensland, Sustainable Minerals Inst, Ctr Social Responsibil Min, Brisbane, Qld, Australia; [Lukehart, Sheila; Godornes, Charmie] Univ Washington, Dept Med, Seattle, WA USA; [Lukehart, Sheila] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Mabey, David] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Asiedu, Kingsley] WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland	PNG Institute Of Medical Research; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; James Cook University; University of Queensland; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Mitja, O (corresponding author), Lihir Med Ctr, Dept Community Hlth, POB 34, Lihir Isl, New Ireland Pro, Papua N Guinea.	oriolmitja@hotmail.com	Bassat, Quique/P-2341-2016; Alonso, Pedro L/AAZ-3645-2020; Sanz, Sergi/AAY-7211-2020; Mitjà, Oriol/W-4181-2018	Bassat, Quique/0000-0003-0875-7596; Alonso, Pedro L/0000-0003-3292-3443; Mitjà, Oriol/0000-0003-3266-8868; Sanz Bravo, Sergi/0000-0001-5010-4527; Mitja, Oriol/0000-0002-6469-529X; Mabey, David/0000-0002-0031-8276	Newcrest Mining and International SOS;  [YESA-13]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042143] Funding Source: NIH RePORTER	Newcrest Mining and International SOS; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by Newcrest Mining and International SOS; YESA-13 ClinicalTrials.gov number, NCT01955252.	[Anonymous], 2013, WHO GLOBAL HLTH OBSE; [Anonymous], 1957, J TROP MED HYG, V60, P62; [Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P189; Centurion-Lara A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002222; CenturionLara A, 1997, J CLIN MICROBIOL, V35, P1348, DOI 10.1128/JCM.35.6.1348-1352.1997; HACKETT C J, 1960, Bull World Health Organ, V23, P739; HACKETT C J, 1956, Bull World Health Organ, V15, P869; HILL K R, 1953, Bull World Health Organ, V8, P17; LI H Y, 1955, Bull World Health Organ, V12, P905; Lukehart SA, 2004, NEW ENGL J MED, V351, P154, DOI 10.1056/NEJMoa040216; Mabey D, 2012, LANCET, V379, P295, DOI 10.1016/S0140-6736(11)61842-4; Marra CM, 2010, J INFECT DIS, V202, P1380, DOI 10.1086/656533; Meheus A., 1992, World Health Statistics Quarterly, V45, P228; Mitja O, 2014, LANCET GLOB HEALTH, V2, pE235, DOI 10.1016/S2214-109X(14)70019-1; Mitja O, 2013, LANCET, V381, P763, DOI 10.1016/S0140-6736(12)62130-8; Mitja O, 2012, LANCET, V379, P342, DOI 10.1016/S0140-6736(11)61624-3; Mitja O, 2011, EMERG INFECT DIS, V17, P1083, DOI [10.3201/eid1706.101575, 10.3201/eid/1706.101575]; SAMAME G E, 1956, Bull World Health Organ, V15, P897; WHO, 2012, SUMM REP CONS ER YAW; World Health Organization, 2013, YAWS REC BOOKL COMM; ZAHRA A, 1956, Bull World Health Organ, V15, P911	21	75	75	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					703	710		10.1056/NEJMoa1408586	http://dx.doi.org/10.1056/NEJMoa1408586			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7PB	25693010	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000349818700004
J	Sussman, JB; Kent, DM; Nelson, JP; Hayward, RA				Sussman, Jeremy B.; Kent, David M.; Nelson, Jason P.; Hayward, Rodney A.			Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INDIVIDUAL PATIENTS; CLINICAL-TRIALS; PREDICTION; MODELS; REGRESSION; HETEROGENEITY; GUIDELINES; MELLITUS	Objective To determine whether some participants in the Diabetes Prevention Program were more or less likely to benefit from metformin or a structured lifestyle modification program. Design Post hoc analysis of the Diabetes Prevention Program, a randomized controlled trial. Setting Ambulatory care patients. Participants 3060 people without diabetes but with evidence of impaired glucose metabolism. Intervention Intervention groups received metformin or a lifestyle modification program with the goals of weight loss and physical activity. Main outcome measure Development of diabetes, stratified by the risk of developing diabetes according to a diabetes risk prediction model. Results Of the 3081 participants with impaired glucose metabolism at baseline, 655 (21%) progressed to diabetes over a median 2.8 years' follow-up. The diabetes risk model had good discrimination (C statistic=0.73) and calibration. Although the lifestyle intervention provided a sixfold greater absolute risk reduction in the highest risk quarter than in the lowest risk quarter, patients in the lowest risk quarter still received substantial benefit (three year absolute risk reduction 4.9% v 28.3% in highest risk quarter; numbers needed to treat of 20.4 and 3.5, respectively). The benefit of metformin, however, was seen almost entirely in patients in the top quarter of risk of diabetes. No benefit was seen in the lowest risk quarter. Participants in the highest risk quarter averaged a 21.4% three year absolute risk reduction (number needed to treat 4.6). Conclusions Patients at high risk of diabetes have substantial variation in their likelihood of receiving benefit from diabetes prevention treatments. Using this knowledge could decrease overtreatment and make prevention of diabetes far more efficient, effective, and patient centered, provided that decision making is based on an accurate risk prediction tool.	[Sussman, Jeremy B.; Hayward, Rodney A.] Dept Vet Affairs Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Sussman, Jeremy B.; Hayward, Rodney A.] Univ Michigan, Div Gen Internal Med, NCRC, Ann Arbor, MI 48109 USA; [Kent, David M.; Nelson, Jason P.] Tufts Med Ctr, Predict Analyt & Comparat Effectiveness Ctr, Boston, MA 02111 USA; [Hayward, Rodney A.] Univ Michigan, RWJ Fdn Clin Scholars Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Tufts Medical Center; University of Michigan System; University of Michigan	Sussman, JB (corresponding author), 2800 Plymouth Rd,North Campus Res Complex,Bldg 1, Ann Arbor, MI 48109 USA.	jeremysu@med.umich.edu	Sussman, Jeremy/W-3394-2019	Sussman, Jeremy/0000-0002-2158-3618	Patient-Centered Outcomes Research Institute [PCORI: 1IP2PI000722]; National Institute of Neurological Disorders and Stroke [U01 AA022802]; Department of Veterans Affairs Quality Enhancement Research Initiative [QUERI DIB 98-001]; Michigan Center for Diabetes Translational Research (National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health) [P60 DK-20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS086294] Funding Source: NIH RePORTER	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs Quality Enhancement Research Initiative(US Department of Veterans Affairs); Michigan Center for Diabetes Translational Research (National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this study was provided by the Patient-Centered Outcomes Research Institute (PCORI: 1IP2PI000722). Additional support was provided by the National Institute of Neurological Disorders and Stroke (U01 AA022802), the Department of Veterans Affairs Quality Enhancement Research Initiative (QUERI DIB 98-001), and the Michigan Center for Diabetes Translational Research (National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (P60 DK-20572)).	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Bellows J, 2014, J AM MED INFORM ASSN, V21, P432, DOI 10.1136/amiajnl-2012-001595; Bray GA, 1999, DIABETES CARE, V22, P623; Burke JF, 2014, CIRC-CARDIOVASC QUAL, V7, P163, DOI 10.1161/CIRCOUTCOMES.113.000497; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Dorresteijn JAN, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5888; Hayward RA, 2005, HEALTH AFFAIR, V24, P1571, DOI 10.1377/hlthaff.24.6.1571; Hayward RA, 2014, CIRC-CARDIOVASC QUAL, V7, P311, DOI 10.1161/CIRCOUTCOMES.114.000876; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Herman WH, 2012, DIABETES CARE, V35, P723, DOI 10.2337/dc11-1468; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Ioannidis JPA, 1997, J CLIN EPIDEMIOL, V50, P1089, DOI 10.1016/S0895-4356(97)00149-2; Karve A, 2010, DIABETES CARE, V33, P2355, DOI 10.2337/dc09-1957; Kennedy EH, 2013, MED CARE, V51, P251, DOI 10.1097/MLR.0b013e31827da594; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Knowler WC, 2003, DIABETES CARE, V26, P977; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Mann DM, 2010, AM J EPIDEMIOL, V171, P980, DOI 10.1093/aje/kwq030; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Sussman JB, 2011, CIRC-CARDIOVASC QUAL, V4, P268, DOI 10.1161/CIRCOUTCOMES.110.959239; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	25	61	62	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2015	350								h454	10.1136/bmj.h454	http://dx.doi.org/10.1136/bmj.h454			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WD	25697494	Green Published, hybrid			2022-12-28	WOS:000349911600002
J	Milo, A; Neel, AJ; Toste, FD; Sigman, MS				Milo, Anat; Neel, Andrew J.; Toste, F. Dean; Sigman, Matthew S.			A data-intensive approach to mechanistic elucidation applied to chiral anion catalysis	SCIENCE			English	Article							HIGH-THROUGHPUT DISCOVERY; PI-PI INTERACTIONS; STERIC PARAMETERS; CHEMISTRY; BENZENE; HYDROGENATION; DESIGN; ACIDS; DIMER	Knowledge of chemical reaction mechanisms can facilitate catalyst optimization, but extracting that knowledge from a complex system is often challenging. Here, we present a data-intensive method for deriving and then predictively applying a mechanistic model of an enantioselective organic reaction. As a validating case study, we selected an intramolecular dehydrogenative C-N coupling reaction, catalyzed by chiral phosphoric acid derivatives, in which catalyst-substrate association involves weak, noncovalent interactions. Little was previously understood regarding the structural origin of enantioselectivity in this system. Catalyst and substrate substituent effects were probed by means of systematic physical organic trend analysis. Plausible interactions between the substrate and catalyst that govern enantioselectivity were identified and supported experimentally, indicating that such an approach can afford an efficient means of leveraging mechanistic insight so as to optimize catalyst design.	[Milo, Anat; Sigman, Matthew S.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Neel, Andrew J.; Toste, F. Dean] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Neel, Andrew J.; Toste, F. Dean] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Toste, FD (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA.	fdtoste@berkeley.edu; sigman@chem.utah.edu	milo, anat/C-3255-2015; Toste, F. Dean/Y-2556-2019	milo, anat/0000-0003-1552-8193; Toste, F. Dean/0000-0001-8018-2198; Neel, Andrew/0000-0003-2872-5292	NSF [CHE-0749506, CHE-1361296]; National Institute of General Medical Sciences [R01 GM104534]; Center for High Performance Computing at the University of Utah; Amgen Fellowship in Organic Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104534] Funding Source: NIH RePORTER; Division Of Chemistry [1361296] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Center for High Performance Computing at the University of Utah; Amgen Fellowship in Organic Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the NSF (CHE-0749506 and CHE-1361296) and the National Institute of General Medical Sciences (R01 GM104534) for partial support of this work. The support and resources from the Center for High Performance Computing at the University of Utah are gratefully acknowledged. A.J.N. gratefully acknowledges an Amgen Fellowship in Organic Chemistry for funding and Jorg Hehn for early contributions to this work.	Akiyama T, 2007, CHEM REV, V107, P5744, DOI 10.1021/cr068374j; [Anonymous], 2010, SYNTHESIS, DOI DOI 10.1055/S-0029-1218801; Anslyn E. V., 2006, MODERN PHYS ORGANIC; Bobbitt J. M., 2004, ORGANIC REACTIONS; Collins KD, 2014, NAT CHEM, V6, P859, DOI [10.1038/NCHEM.2062, 10.1038/nchem.2062]; COZZI F, 1992, J AM CHEM SOC, V114, P5729, DOI 10.1021/ja00040a036; Curtin D. Y., 1954, REC CHEM PROG, V15, P110; Friedfeld MR, 2013, SCIENCE, V342, P1076, DOI 10.1126/science.1243550; HALPERN J, 1982, SCIENCE, V217, P401, DOI 10.1126/science.217.4558.401; Harper KC, 2012, NAT CHEM, V4, P366, DOI [10.1038/nchem.1297, 10.1038/NCHEM.1297]; Harper KC, 2011, P NATL ACAD SCI USA, V108, P2179, DOI 10.1073/pnas.1013331108; Heider PL, 2014, ORG PROCESS RES DEV, V18, P402, DOI 10.1021/op400294z; Hohenstein EG, 2009, J PHYS CHEM A, V113, P878, DOI 10.1021/jp809062x; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Knowles RR, 2010, P NATL ACAD SCI USA, V107, P20678, DOI 10.1073/pnas.1006402107; Krenske EH, 2013, ACCOUNTS CHEM RES, V46, P979, DOI 10.1021/ar3000794; Li CJ, 2009, ACCOUNTS CHEM RES, V42, P335, DOI 10.1021/ar800164n; Lima Manuel, 2013, VISUAL COMPLEXITY MA; Mancheno OG, 2013, SYNTHESIS-STUTTGART, V45, P1602, DOI 10.1055/s-0033-1338480; Martinez CR, 2012, CHEM SCI, V3, P2191, DOI 10.1039/c2sc20045g; McNally A, 2011, SCIENCE, V334, P1114, DOI 10.1126/science.1213920; Metola P, 2014, CHEM SCI, V5, P4278, DOI 10.1039/c4sc01641f; Milo A, 2014, NATURE, V507, P210, DOI 10.1038/nature13019; Neel AJ, 2013, J AM CHEM SOC, V135, P14044, DOI 10.1021/ja407410b; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Parmar D, 2014, CHEM REV, V114, P9047, DOI 10.1021/cr5001496; Parrish RM, 2014, J AM CHEM SOC, V136, P17386, DOI 10.1021/ja5101245; Reetz MT, 2002, ANGEW CHEM INT EDIT, V41, P1335, DOI 10.1002/1521-3773(20020415)41:8<1335::AID-ANIE1335>3.0.CO;2-A; Riley KE, 2013, ACCOUNTS CHEM RES, V46, P927, DOI 10.1021/ar300083h; Robbins DW, 2011, SCIENCE, V333, P1423, DOI 10.1126/science.1207922; Santanilla AB, 2015, SCIENCE, V347, P49, DOI 10.1126/science.1259203; Schmink JR, 2013, ALDRICHIM ACTA, V46, P71; Shchegolev B. F., 2013, Biofizika, V58, P461; Sherrill CD, 2013, ACCOUNTS CHEM RES, V46, P1020, DOI 10.1021/ar3001124; Silver Nate, 2012, SIGNAL NOISE WHY SO; Tidwell T. T., 1997, PURE APPL CHEM, V69, P1; Verloop A., 1977, PHARMACOCHEM LIB, V2, P63; Wheeler SE, 2008, J AM CHEM SOC, V130, P10854, DOI 10.1021/ja802849j; Wheeler SE, 2013, ACCOUNTS CHEM RES, V46, P1029, DOI 10.1021/ar300109n; Yeung CS, 2011, CHEM REV, V111, P1215, DOI 10.1021/cr100280d	40	154	153	6	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					737	743		10.1126/science.1261043	http://dx.doi.org/10.1126/science.1261043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678656	Green Accepted			2022-12-28	WOS:000349221300040
J	Krupic, J; Bauza, M; Burton, S; Barry, C; O'Keefe, J				Krupic, Julija; Bauza, Marius; Burton, Stephen; Barry, Caswell; O'Keefe, John			Grid cell symmetry is shaped by environmental geometry	NATURE			English	Article							ENTORHINAL CORTEX; SPATIAL MAP; RATS; NAVIGATION; REPRESENTATION; LOCATION; MEMORY; THETA; MODEL	Grid cells represent an animal's location by firing in multiple fields arranged in a striking hexagonal array(1). Such an impressive and constant regularity prompted suggestions that grid cells represent a universal and environmental-invariant metric for navigation(1,2). Originally the properties of grid patterns were believed to be independent of the shape of the environment and this notion has dominated almost all theoretical grid cell models(3-6). However, several studies indicate that environmental boundaries influence grid firing(7-10), though the strength, nature and longevity of this effect is unclear. Here we show that grid orientation, scale, symmetry and homogeneity are strongly and permanently affected by environmental geometry. We found that grid patterns orient to the walls of polarized enclosures such as squares, but not circles. Furthermore, the hexagonal grid symmetry is permanently broken in highly polarized environments such as trapezoids, the pattern being more elliptical and less homogeneous. Our results provide compelling evidence for the idea that environmental boundaries compete with the internal organization of the grid cell system to drive grid firing. Notably, grid cell activity is more local than previously thought and as a consequence cannot provide a universal spatial metric in all environments.	[Krupic, Julija; Bauza, Marius; Burton, Stephen; Barry, Caswell; O'Keefe, John] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [O'Keefe, John] UCL, Sainsbury Wellcome Ctr, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Krupic, J (corresponding author), UCL, Dept Cell & Dev Biol, Mortimer St, London WC1E 6BT, England.	j.krupic@ucl.ac.uk	Bauza, Marius/AAB-6403-2019	Bauza, Marius/0000-0003-3514-8382; Krupic, Julija/0000-0001-6299-1629; Burton, Stephen/0000-0002-0788-1897; O'Keefe, John/0000-0001-5697-4881	Wellcome Trust; Gatsby Charitable Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation	We thank J. Poort for discussions. The research was supported by grants from the Wellcome Trust and the Gatsby Charitable Foundation. J.K. is a Wellcome Trust Sir Henry Welcome Fellow. C.B. is a Royal Society and Wellcome Trust Sir Henry Dale Fellow. This work was conducted in accordance with the UK Animals (Scientific Procedures) Act (1986).	Barry C, 2006, REV NEUROSCIENCE, V17, P71; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Barry C, 2012, P NATL ACAD SCI USA, V109, P17687, DOI 10.1073/pnas.1209918109; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Fiete IR, 2008, J NEUROSCI, V28, P6858, DOI 10.1523/JNEUROSCI.5684-07.2008; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Gallistel C.R., 2013, ORG ACTION NEW SYNTH; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Kelly JW, 2008, COGNITION, V109, P281, DOI 10.1016/j.cognition.2008.09.001; Krupic J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0188; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Skaggs W.E., 1993, INFORM THEORETIC APP, P1030, DOI DOI 10.5555/2987061.2987188; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; TAUBE JS, 1990, J NEUROSCI, V10, P420; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224	23	169	172	4	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					232	U199		10.1038/nature14153	http://dx.doi.org/10.1038/nature14153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25673417	Green Accepted			2022-12-28	WOS:000349190300038
J	Roth, RB; Hess, E; Kaminsky, AF				Roth, Russell B.; Hess, Elmer; Kaminsky, Anthony F.			Of Fires and Frying Pans (Reprinted from vol 155, pg 302, 1954)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint											Roth, RB (corresponding author), 501 Commerce Bldg, Erie, PA USA.							ROTH RB, 1954, JAMA-J AM MED ASSOC, V155, P302, DOI 10.1001/jama.1954.03690210080021	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					632	632		10.1001/jama.2014.11576	http://dx.doi.org/10.1001/jama.2014.11576			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25668278				2022-12-28	WOS:000349070700033
J	Bradbury, A; Pluckthun, A				Bradbury, Andrew; Plueckthun, Andreas			Standardize antibodies used in research	NATURE			English	Editorial Material							REPRODUCIBILITY; PROTEINS		[Bradbury, Andrew] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87454 USA; [Plueckthun, Andreas] Univ Zurich, Dept Biochem, CH-8006 Zurich, Switzerland	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Zurich	Bradbury, A (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87454 USA.	amb@lanl.gov	Chalmers, Andrew/D-4103-2009; Plückthun, Andreas/C-2746-2009	Chalmers, Andrew/0000-0003-4182-6717; Plückthun, Andreas/0000-0003-4191-5306; Bradbury, Andrew/0000-0002-5567-8172				Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Gold L, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003582; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Slaastad H, 2011, PROTEOMICS, V11, P4578, DOI 10.1002/pmic.201000744; Vasilevsky NA, 2013, PEERJ, V1, DOI 10.7717/peerj.148; Voskuil Jla, 2014, F1000Res, V3, P232, DOI 10.12688/f1000research.4966.1	10	416	431	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					27	29		10.1038/518027a	http://dx.doi.org/10.1038/518027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25652980	Bronze			2022-12-28	WOS:000349098000013
J	Pandolfi, JM				Pandolfi, John M.			Deep and complex ways to survive bleaching	NATURE			English	Editorial Material							CORAL-REEF; CLIMATE-CHANGE		[Pandolfi, John M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Pandolfi, John M.] Univ Queensland, Australian Res Council, Ctr Excellence Coral Reef Studies, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Pandolfi, JM (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia.	j.pandolfi@uq.edu.au	Pandolfi, John M/A-3121-2009	Pandolfi, John M/0000-0003-3047-6694				Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Munday PL, 2013, ECOL LETT, V16, P1488, DOI 10.1111/ele.12185; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Smith JE, 2010, OECOLOGIA, V163, P497, DOI 10.1007/s00442-009-1546-z; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Wilkinson C., 1998, 1997 1998 MASS BLEAC	10	2	2	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					43	44		10.1038/nature14196	http://dx.doi.org/10.1038/nature14196			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25652993				2022-12-28	WOS:000349098000026
J	Dickson, DR; Dickson, CCL; Farnell, R				Dickson, David Robin; Dickson, Claire C. L.; Farnell, Robert			10-MINUTE CONSULTATION Pain at the base of the thumb	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dickson, David Robin; Farnell, Robert] Leeds Gen Infirm, Hand Unit, Leeds LS1 3EX, W Yorkshire, England; [Dickson, Claire C. L.] Wetherby Surg, Wetherby, W Yorkshire, England	Leeds General Infirmary; University of Leeds	Dickson, DR (corresponding author), Leeds Gen Infirm, Hand Unit, Leeds LS1 3EX, W Yorkshire, England.	davidrdickson@hotmail.com						Anakwe RE, 2011, BMJ-BRIT MED J, V343, P1160; Berggren M, 2001, SCAND J PLAST RECONS, V35, P415; Dziedzic K, 2015, ANN RHEUM DIS, V74, P108, DOI 10.1136/annrheumdis-2013-203938; Maarse W, 2009, J HAND SURG-ASIAN-PA, V14, P99, DOI 10.1142/S0218810409004311; National Institute for Health and Care Excellence, 2014, 177 CG NAT I HLTH CA, V177	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2015	350								h182	10.1136/bmj.h182	http://dx.doi.org/10.1136/bmj.h182			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0IL	25647321				2022-12-28	WOS:000349309100001
J	Saver, BG				Saver, Barry G.			Should C Be a Passing Grade for the USPSTF?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SHARED DECISION-MAKING; CANCER		Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Saver, BG (corresponding author), Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA 01655 USA.	barry.saver@umassmed.edu						Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Hoffman RM, 2014, AM J PREV MED, V47, P251, DOI 10.1016/j.amepre.2014.04.011; Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; Kahneman D., 2011, THINKING FAST AND SL; Kamerow D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4270; SLOVIC P, 1995, AM PSYCHOL, V50, P364, DOI 10.1037/0003-066X.50.5.364; Sommers BD, 2008, CANCER, V113, P2058, DOI 10.1002/cncr.23807; U.S. Preventive Services Task Force, 2009, AHRQ PUBLICATION	8	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					465	466		10.1001/jama.2014.17082	http://dx.doi.org/10.1001/jama.2014.17082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA7AV	25647200				2022-12-28	WOS:000349070300008
J	Zhelev, Z; Hyde, C; Youngman, E; Rogers, M; Fleming, S; Slade, T; Coelho, H; Jones-Hughes, T; Nikolaou, V				Zhelev, Zhivko; Hyde, Christopher; Youngman, Emily; Rogers, Morwenna; Fleming, Simon; Slade, Toby; Coelho, Helen; Jones-Hughes, Tracey; Nikolaou, Vasilis			Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-ARTERY-DISEASE; EARLY RULE-OUT; CARDIAC TROPONIN; RELATIVE CHANGES; RAPID RULE; COPEPTIN; PERFORMANCE; ABSOLUTE; PROTEIN; UTILITY	Objective To obtain summary estimates of the accuracy of a single baseline measurement of the Elecsys Troponin T high-sensitive assay (Roche Diagnostics) for the diagnosis of acute myocardial infarction in patients presenting to the emergency department. Design Systematic review and meta-analysis of diagnostic test accuracy studies. Data sources Medline, Embase, and other relevant electronic databases were searched for papers published between January 2006 and December 2013. Study selection Studies were included if they evaluated the diagnostic accuracy of a single baseline measurement of Elecsys Troponin T high-sensitive assay for the diagnosis of acute myocardial infarction in patients presenting to the emergency department with suspected acute coronary syndrome. Study appraisal and data synthesis The first author screened all titles and abstracts identified through the searches and selected all potentially relevant papers. The screening of the full texts, the data extraction, and the methodological quality assessment, using the adapted QUADAS-2 tool, were conducted independently by two reviewers with disagreements being resolved through discussion or arbitration. If appropriate, meta-analysis was conducted using the hierarchical bivariate model. Results Twenty three studies reported the performance of the evaluated assay at presentation. The results for 14 ng/L and 3-5 ng/L cut-off values were pooled separately. At 14 ng/L (20 papers), the summary sensitivity was 89.5% (95% confidence interval 86.3% to 92.1%) and the summary specificity was 77.1% (68.7% to 83.7%). At 3-5 ng/L (six papers), the summary sensitivity was 97.4% (94.9% to 98.7%) and the summary specificity was 42.4% (31.2% to 54.5%). This means that if 21 of 100 consecutive patients have the target condition (21%, the median prevalence across the studies), 2 (95% confidence interval 2 to 3) of 21 patients with acute myocardial infarction will be missed (false negatives) if 14 ng/L is used as a cut-off value and 18 (13 to 25) of 79 patients without acute myocardial infarction will test positive (false positives). If the 3-5 ng/L cut-off value is used, < 1 (0 to 1) patient with acute myocardial infarction will be missed and 46 (36 to 54) patients without acute myocardial infarction will test positive. Conclusions The results indicate that a single baseline measurement of the Elecsys Troponin T high-sensitive assay could be used to rule out acute myocardial infarction if lower cut-off values such as 3 ng/L or 5 ng/L are used. However, this method should be part of a comprehensive triage strategy and may not be appropriate for patients who present less than three hours after symptom onset. Care must also be exercised because of the higher imprecision of the evaluated assay and the greater effect of lot-to-lot reagent variation at low troponin concentrations. Systematic review registration PROSPERO registration number CRD42013003926.	[Zhelev, Zhivko; Hyde, Christopher; Youngman, Emily; Rogers, Morwenna; Coelho, Helen; Jones-Hughes, Tracey; Nikolaou, Vasilis] Univ Exeter, Sch Med, Inst Hlth Res, Exeter, Devon EX2 4SG, England; [Fleming, Simon] Royal Cornwall Hosp, Truro TQ1 3LQ, England; [Slade, Toby] Royal Cornwall Hosp, Emergency Dept, Truro TQ1 3LQ, England	University of Exeter; Royal Cornwall Hospital; Royal Cornwall Hospital	Zhelev, Z (corresponding author), Univ Exeter, Sch Med, Inst Hlth Res, Exeter, Devon EX2 4SG, England.	Z.Zhelev@exeter.ac.uk	Nikolaou, Vasilis/AAC-3174-2020	Nikolaou, Vasilis/0000-0002-2768-5340; Christopher, Hyde/0000-0002-7349-0616; Zhelev, Zhivko/0000-0002-0106-2401; Rogers, Morwenna/0000-0002-6039-238X	South West Academic Health Science Network (AHSN); National Institute for Health Research (NIHR) Collaboration for Leadership for Applied Health Research and Care for the South West Peninsula	South West Academic Health Science Network (AHSN); National Institute for Health Research (NIHR) Collaboration for Leadership for Applied Health Research and Care for the South West Peninsula	This research was funded by the South West Academic Health Science Network (AHSN) and the National Institute for Health Research (NIHR) Collaboration for Leadership for Applied Health Research and Care for the South West Peninsula. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. The AHSN and the NIHR had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Aldous S, 2012, EMERG MED J, V29, P805, DOI 10.1136/emermed-2011-200222; Aldous SJ, 2012, CLIN CHEM LAB MED, V50, P727, DOI [10.1515/CCLM.2011.830, 10.1515/cclm.2011.830]; Aldous SJ, 2012, CAN MED ASSOC J, V184, pE260, DOI 10.1503/cmaj.110773; Aldous SJ, 2011, CLIN CHEM, V57, P1154, DOI 10.1373/clinchem.2010.161166; Aldous SJ, 2011, ANN CLIN BIOCHEM, V48, P241, DOI 10.1258/acb.2010.010219; Apple FS, 2012, CLIN CHEM, V58, P1599, DOI 10.1373/clinchem.2012.194985; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Bahrmann P, 2013, J AM MED DIR ASSOC, V14, P409, DOI 10.1016/j.jamda.2012.12.005; Bahrmann P, 2013, CLIN CHEM LAB MED, V51, P1307, DOI 10.1515/cclm-2012-0401; Balmelli C, 2013, AM HEART J, V166, P30, DOI 10.1016/j.ahj.2013.03.014; Biener Moritz, 2013, Int J Cardiol, V167, P1134, DOI 10.1016/j.ijcard.2012.09.122; Body R, 2014, EMERG MED J, V31, P872, DOI 10.1136/emermed-2014-203832; Body R, 2011, J AM COLL CARDIOL, V58, P1333, DOI 10.1016/j.jacc.2011.06.026; Chenevier-Gobeaux C, 2013, AM J CARDIOL, V111, P1701, DOI 10.1016/j.amjcard.2013.02.024; Christ M, 2010, AM J MED, V123, P1134, DOI 10.1016/j.amjmed.2010.07.015; Cochrane Collaboration, DIAGN TEST ACC WORK; Collinson PO, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17150; Eggers KM, 2012, CLIN CHIM ACTA, V413, P1135, DOI 10.1016/j.cca.2012.03.011; Freund Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10270; Giannitsis E, 2011, CLIN CHEM, V57, P1452, DOI 10.1373/clinchem.2010.161265; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Gimenez MR, 2013, INT J CARDIOL, V168, P3896, DOI 10.1016/j.ijcard.2013.06.049; Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; Haaf P, 2012, CIRCULATION, V126, P31, DOI 10.1161/CIRCULATIONAHA.112.100867; Hallermayer K, 2013, CLIN CHEM, V59, P572, DOI 10.1373/clinchem.2012.197103; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hammerer-Lercher A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000204; Harbord RM, 2009, STATA J, V9, P211, DOI 10.1177/1536867X0900900203; Hoeller R, 2013, HEART, V99, P1567, DOI 10.1136/heartjnl-2013-303643; Inoue K, 2011, CIRC J, V75, P2813, DOI 10.1253/circj.CJ-11-0598; Invernizzi L, 2013, BIOCHIM CLIN, V37, P36; Irfan A, 2013, AM J MED, V126, P781, DOI 10.1016/j.amjmed.2013.02.031; Khan DA, 2011, KOREAN J LAB MED, V31, P172, DOI 10.3343/kjlm.2011.31.3.172; Kurz K, 2011, CLIN RES CARDIOL, V100, P209, DOI 10.1007/s00392-010-0230-y; Lotze U, 2011, VASC HEALTH RISK MAN, V7, P509, DOI 10.2147/VHRM.S21753; Melki D, 2011, SCAND CARDIOVASC J, V45, P198, DOI 10.3109/14017431.2011.565792; Meune C, 2013, INT J CARDIOL, V168, P3752, DOI 10.1016/j.ijcard.2013.06.011; MIDAS, 2007, MIDAS STAT MOD MET I; Mueller M, 2012, CLIN CHEM, V58, P209, DOI 10.1373/clinchem.2011.171827; National Institute for Health and Care Excellence, 2014, MYOC INF AC EARL RUL; Niska Richard, 2010, Natl Health Stat Report, P1; Normann J, 2012, AM HEART J, V164, P698, DOI 10.1016/j.ahj.2012.08.003; Olivieri F, 2012, MECH AGEING DEV, V133, P300, DOI 10.1016/j.mad.2012.03.005; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Potocki M, 2012, HEART, V98, P558, DOI 10.1136/heartjnl-2011-301269; Pry, 2008, CLIN BIOCHEM REV, V29, pS49; Reichlin T, 2012, ARCH INTERN MED, V172, P1211, DOI 10.1001/archinternmed.2012.3698; Reichlin T, 2011, CIRCULATION, V124, P136, DOI 10.1161/CIRCULATIONAHA.111.023937; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Reiter M, 2012, EUR HEART J, V33, P988, DOI 10.1093/eurheartj/ehr376; Reiter M, 2011, EUR HEART J, V32, P1379, DOI 10.1093/eurheartj/ehr033; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Roche Diagnostics, 2014, EL TROP T HIGH SENS; Saenger AK, 2011, CLIN CHIM ACTA, V412, P748, DOI 10.1016/j.cca.2010.12.034; Santalo M, 2013, AM J MED, V126, P709, DOI 10.1016/j.amjmed.2013.03.003; Sebbane M, 2013, AM J EMERG MED, V31, P1302, DOI 10.1016/j.ajem.2013.04.033; Takwoingi Y., 2013, MET TEST ACC STUD ST; Thelin J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-42; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Westwood M, 2014, HIGH SENSITIVITY TRO; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	61	128	133	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2015	350								h15	10.1136/bmj.h15	http://dx.doi.org/10.1136/bmj.h15			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZG	25646632	hybrid, Green Published			2022-12-28	WOS:000348433700005
J	Supek, F; Lehner, B				Supek, Fran; Lehner, Ben			Differential DNA mismatch repair underlies mutation rate variation across the human genome	NATURE			English	Article							COMPREHENSIVE MOLECULAR CHARACTERIZATION; RNA-SEQ DATA; CANCER GENOMES; SOMATIC MUTATIONS; EXCISION-REPAIR; REPLICATION; ORGANIZATION; LANDSCAPES; SIGNATURES; REGIONS	Cancer genome sequencing has revealed considerable variation in somatic mutation rates across the human genome, with mutation rates elevated inheterochromatic late replicating regionsand reduced in early replicating euchromatin(1-5). Multiple mechanisms have been suggested to underlie this(2,6-10), but the actual cause is unknown. Here we identify variable DNA mismatch repair (MMR) as the basis of this variation. Analysing similar to 17 million single-nucleotide variants from the genomes of 652 tumours, we show that regional autosomal mutation rates at megabase resolution are largely stable across cancer types, with differences related to changes in replication timing and gene expression. However, mutations arising after the inactivation of MMR are no longer enriched in late replicating heterochromatin relative to early replicating euchromatin. Thus, differential DNA repair and not differential mutation supply is the primary cause of the large-scale regional mutation rate variation across the human genome.	[Supek, Fran; Lehner, Ben] CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain; [Supek, Fran; Lehner, Ben] UPF, Barcelona 08003, Spain; [Supek, Fran] Rudjer Boskovic Inst, Div Elect, Zagreb 10000, Croatia; [Lehner, Ben] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Rudjer Boskovic Institute; ICREA	Lehner, B (corresponding author), CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain.	ben.lehner@crg.eu	Lehner, Ben/ABH-6562-2020; Supek, Fran/B-2359-2012; Lehner, Ben/L-3413-2014	Lehner, Ben/0000-0002-8817-1124; Supek, Fran/0000-0002-7811-6711; Lehner, Ben/0000-0002-8817-1124	Spanish Ministry of Economy and Competitiveness [BFU2011-26206]; Spanish Ministry of Economy and Competitiveness (Centro de Excelencia Severo Ochoa) [SEV-2012-0208]; European Research Council Consolidator grant IR-DC [616434]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR); EMBO Young Investigator Program; EMBL-CRG Systems Biology Program; FP7 project 4DCellFate [277899]; FP7 project MAESTRA [ICT-2013-612944]; Marie Curie Actions; ICREA Funding Source: Custom	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Economy and Competitiveness (Centro de Excelencia Severo Ochoa)(Spanish Government); European Research Council Consolidator grant IR-DC; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); EMBL-CRG Systems Biology Program; FP7 project 4DCellFate; FP7 project MAESTRA; Marie Curie Actions(European Commission); ICREA(ICREA)	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (BFU2011-26206 and 'Centro de Excelencia Severo Ochoa 2013-2017' SEV-2012-0208), a European Research Council Consolidator grant IR-DC (616434), Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), the EMBO Young Investigator Program, the EMBL-CRG Systems Biology Program, FP7 project 4DCellFate (277899), FP7 project MAESTRA (ICT-2013-612944) and by Marie Curie Actions.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Amouroux R, 2010, NUCLEIC ACIDS RES, V38, P2878, DOI 10.1093/nar/gkp1247; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Chaudhuri S, 2009, NUCLEIC ACIDS RES, V37, P1690, DOI 10.1093/nar/gkp003; Chen CL, 2010, GENOME RES, V20, P447, DOI 10.1101/gr.098947.109; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Edelbrock MA, 2009, MUTAT RES-FUND MOL M, V662, P59, DOI 10.1016/j.mrfmmm.2008.12.006; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hodgkinson A, 2012, HUM MUTAT, V33, P136, DOI 10.1002/humu.21616; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; HSU TC, 1975, GENETICS, V79, P137; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jager N, 2013, CELL, V155, P567, DOI 10.1016/j.cell.2013.09.042; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2502; Lubelsky Y, 2014, GENOME RES, V24, P1102, DOI 10.1101/gr.160010.113; Mebane W. R., 2010, J STAT SOFTW, V42, P473; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pawlik TM, 2004, DIS MARKERS, V20, P199, DOI 10.1155/2004/368680; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Roberts ND, 2013, BIOINFORMATICS, V29, P2223, DOI 10.1093/bioinformatics/btt375; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Sima J, 2014, CURR OPIN GENET DEV, V25, P93, DOI 10.1016/j.gde.2013.11.022; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Thurman RE, 2007, GENOME RES, V17, P917, DOI 10.1101/gr.6081407; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Waters LS, 2006, P NATL ACAD SCI USA, V103, P8971, DOI 10.1073/pnas.0510167103; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982	40	202	204	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					81	U173		10.1038/nature14173	http://dx.doi.org/10.1038/nature14173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25707793	Green Accepted			2022-12-28	WOS:000354040900037
J	Ganiats, TG				Ganiats, Theodore G.			Redefining the Chronic Fatigue Syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ganiats, Theodore G.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	University of Miami	Ganiats, TG (corresponding author), Univ Miami, Miller Sch Med, Dept Family Med & Community Hlth, 1801 NW 9th Ave 470, Miami, FL 33136 USA.							Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Fletcher MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010817; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gerrity TR, 2002, NEUROIMMUNOMODULAT, V10, P134, DOI 10.1159/000067176; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Jason LA, 2006, CFIDS CHRONICLE; Keller BA, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-104; Lerner AM, 2004, IN VIVO, V18, P101; U.S. Food and Drug Administration, 2013, VOIC PAT CHRON FAT S	10	11	12	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					653	U250		10.7326/M15-0357	http://dx.doi.org/10.7326/M15-0357			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6AZ	25668185				2022-12-28	WOS:000354119100011
J	Yosef, I; Qimron, U				Yosef, Ido; Qimron, Udi			MICROBIOLOGY How bacteria get spacers from invaders	NATURE			English	Editorial Material							CRISPR; SYSTEM; PROKARYOTES; IMMUNITY; DEFENSE		[Yosef, Ido; Qimron, Udi] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Yosef, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel.	ehudq@post.tau.ac.il	Gazit, Ehud/AHE-9332-2022	Qimron, Udi/0000-0003-2169-5270				Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	10	4	4	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					166	167		10.1038/nature14204	http://dx.doi.org/10.1038/nature14204			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25707799				2022-12-28	WOS:000350770500024
J	Koch, M; Varela, L; Kim, JG; Kim, JD; Hernandez-Nuno, F; Simonds, SE; Castorena, CM; Vianna, CR; Elmquist, JK; Morozov, YM; Rakic, P; Bechmann, I; Cowley, MA; Szigeti-Buck, K; Dietrich, MO; Gao, XB; Diano, S; Horvath, TL				Koch, Marco; Varela, Luis; Kim, Jae Geun; Kim, Jung Dae; Hernandez-Nuno, Francisco; Simonds, Stephanie E.; Castorena, Carlos M.; Vianna, Claudia R.; Elmquist, Joel K.; Morozov, Yury M.; Rakic, Pasko; Bechmann, Ingo; Cowley, Michael A.; Szigeti-Buck, Klara; Dietrich, Marcelo O.; Gao, Xiao-Bing; Diano, Sabrina; Horvath, Tamas L.			Hypothalamic POMC neurons promote cannabinoid-induced feeding	NATURE			English	Article							UNCOUPLING PROTEIN-2; FOOD-INTAKE; MITOCHONDRIAL DYNAMICS; ENDOCANNABINOID SYSTEM; NEUROPEPTIDE-Y; NEUROENDOCRINE; NUCLEUS; OBESITY; LOCALIZATION; CIRCUITS	Hypothalamic pro-opiomelanocortin (POMC) neurons promote satiety. Cannabinoid receptor 1 (CB1R) is critical for the central regulation of food intake. Here we test whether CB1R-controlled feeding in sated mice is paralleled by decreased activity of POMC neurons. We show that chemical promotion of CB1R activity increases feeding, and notably, CB1R activation also promotes neuronal activity of POMC cells. This paradoxical increase in POMC activity was crucial for CB1R-induced feeding, because designer-receptors-exclusively-activated-by-designer-drugs (DREADD)-mediated inhibition of POMC neurons diminishes, whereas DREADD-mediated activation of POMC neurons enhances CB1R-driven feeding. The Pomc gene encodes both the anorexigenic peptide alpha-melanocyte-stimulating hormone, and the opioid peptide beta-endorphin. CB1R activation selectively increases beta-endorphin but not alpha-melanocyte-stimulating hormone release in the hypothalamus, and systemic or hypothalamic administration of the opioid receptor antagonist naloxone blocks acute CB1R-induced feeding. These processes involve mitochondrial adaptations that, when blocked, abolish CB1R-induced cellular responses and feeding. Together, these results uncover a previously unsuspected role of POMC neurons in the promotion of feeding by cannabinoids.	[Koch, Marco; Varela, Luis; Kim, Jae Geun; Kim, Jung Dae; Hernandez-Nuno, Francisco; Szigeti-Buck, Klara; Dietrich, Marcelo O.; Gao, Xiao-Bing; Diano, Sabrina; Horvath, Tamas L.] Yale Univ, Sch Med, Sect Comparat Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Koch, Marco; Bechmann, Ingo] Univ Leipzig, Inst Anat, D-04103 Leipzig, Germany; [Kim, Jung Dae; Diano, Sabrina; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Simonds, Stephanie E.; Cowley, Michael A.] Monash Univ, Dept Physiol, Obes & Diabet Inst, Clayton, Vic 3800, Australia; [Castorena, Carlos M.; Vianna, Claudia R.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Endocrinol & Metab, Dallas, TX 75390 USA; [Morozov, Yury M.; Rakic, Pasko; Dietrich, Marcelo O.; Diano, Sabrina; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Rakic, Pasko; Horvath, Tamas L.] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA	Yale University; Leipzig University; Yale University; Monash University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Yale University	Horvath, TL (corresponding author), Yale Univ, Sch Med, Sect Comparat Med, Program Integrat Cell Signaling & Neurobiol Metab, 333 Cedar St, New Haven, CT 06520 USA.	tamas.horvath@yale.edu	Gao, Xiao-Bing/C-3121-2011; Varela, Luis/ABG-7581-2020; Dietrich, Marcelo/A-9928-2009; Cowley, Michael A/B-9428-2008	Gao, Xiao-Bing/0000-0002-2035-4936; Varela, Luis/0000-0001-7794-7241; Dietrich, Marcelo/0000-0001-9781-2221; Cowley, Michael A/0000-0001-7811-134X; Morozov, Yury/0000-0002-3679-6819; Kim, Jung Dae/0000-0002-4750-6856; SIMONDS, STEPHANIE/0000-0003-1590-6190	US National Institutes of Health [DP1 DK098058, R01 DK097566, R01 AG040236, P01 NS062686]; American Diabetes Association; Klarmann Family Foundation; Helmholtz Society (ICEMED); Deutsche Forschungsgemeinschaft [SFB 1052/1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053301, R01DK097566, DP1DK098058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS062686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023999] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Klarmann Family Foundation; Helmholtz Society (ICEMED); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank M. Shanabrough and J. Bober for technical support and R. Jakab for assisting with the illustrations. This work was supported by the US National Institutes of Health (DP1 DK098058, R01 DK097566, R01 AG040236 and P01 NS062686), the American Diabetes Association, The Klarmann Family Foundation, the Helmholtz Society (ICEMED) and the Deutsche Forschungsgemeinschaft SFB 1052/1 (Obesity Mechanisms).	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Andrews ZB, 2009, J NEUROSCI, V29, P14057, DOI 10.1523/JNEUROSCI.3890-09.2009; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Bakkali-Kassemi L, 2011, BRIT J NUTR, V105, P654, DOI 10.1017/S0007114510004095; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Dietrich MO, 2013, TRENDS NEUROSCI, V36, P65, DOI 10.1016/j.tins.2012.12.005; Dietrich MO, 2012, NAT NEUROSCI, V15, P1108, DOI 10.1038/nn.3147; DiPatrizio NV, 2012, TRENDS NEUROSCI, V35, P403, DOI 10.1016/j.tins.2012.04.006; Dores RM, 2011, ANN NY ACAD SCI, V1220, P34, DOI 10.1111/j.1749-6632.2010.05928.x; DUBE MG, 1994, PHYSIOL BEHAV, V56, P811, DOI 10.1016/0031-9384(94)90247-X; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; FOLTIN RW, 1986, PHARMACOL BIOCHEM BE, V25, P577, DOI 10.1016/0091-3057(86)90144-9; GREENBERG I, 1976, PSYCHOPHARMACOLOGY, V49, P79; Hebert-Chatelain E, 2014, MOL METAB, V3, P495, DOI 10.1016/j.molmet.2014.03.007; Hebert-Chatelain E, 2014, MOL METAB, V3, P339, DOI 10.1016/j.molmet.2014.03.008; Hentges ST, 2007, J NEUROPHYSIOL, V97, P3298, DOI 10.1152/jn.00051.2007; Hentges ST, 2005, J NEUROSCI, V25, P9746, DOI 10.1523/JNEUROSCI.2769-05.2005; Ho J, 2007, PHYSIOL BEHAV, V92, P507, DOI 10.1016/j.physbeh.2007.04.028; Horvath TL, 1999, J NEUROSCI, V19, P10417; HORVATH TL, 1992, ENDOCRINOLOGY, V131, P2461, DOI 10.1210/en.131.5.2461; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Bermudez-Silva FJ, 2012, J PSYCHOPHARMACOL, V26, P114, DOI 10.1177/0269881111408458; Kalra SP, 1998, ANN NY ACAD SCI, V863, P236, DOI 10.1111/j.1749-6632.1998.tb10698.x; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Landry M, 2003, EUR J NEUROSCI, V17, P579, DOI 10.1046/j.1460-9568.2003.02472.x; LEIBOWITZ SF, 1982, PEPTIDES, V3, P421, DOI 10.1016/0196-9781(82)90102-4; LEIBOWITZ SF, 1985, PSYCHOPHARMACOL BULL, V21, P412; Moreira PI, 2011, J STEROID BIOCHEM, V123, P8, DOI 10.1016/j.jsbmb.2010.09.004; Morozov YM, 2014, MOL METAB, V3, P338, DOI 10.1016/j.molmet.2014.03.006; Morozov YM, 2013, EUR J NEUROSCI, V38, P2341, DOI 10.1111/ejn.12237; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nasrallah CM, 2014, NAT REV ENDOCRINOL, V10, P650, DOI 10.1038/nrendo.2014.160; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Sinnayah P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002202; Soria-Gomez E, 2014, NAT NEUROSCI, V17, P407, DOI 10.1038/nn.3647; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Zhan C, 2013, J NEUROSCI, V33, P3624, DOI 10.1523/JNEUROSCI.2742-12.2013; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	54	252	256	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					45	U72		10.1038/nature14260	http://dx.doi.org/10.1038/nature14260			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25707796	Green Accepted			2022-12-28	WOS:000350304000032
J	Jones, MR; Seeman, NC; Mirkin, CA				Jones, Matthew R.; Seeman, Nadrian C.; Mirkin, Chad A.			Programmable materials and the nature of the DNA bond	SCIENCE			English	Review							SINGLE-STRANDED-DNA; NANOPARTICLE SUPERLATTICES; GOLD NANOPARTICLES; ASYMMETRIC FUNCTIONALIZATION; NANOSCALE SHAPES; FOLDING DNA; ARRAYS; PROTEIN; NANOSTRUCTURES; CONSTRUCTION	For over half a century, the biological roles of nucleic acids as catalytic enzymes, intracellular regulatory molecules, and the carriers of genetic information have been studied extensively. More recently, the sequence-specific binding properties of DNA have been exploited to direct the assembly of materials at the nanoscale. Integral to any methodology focused on assembling matter from smaller pieces is the idea that final structures have well-defined spacings, orientations, and stereo-relationships. This requirement can be met by using DNA-based constructs that present oriented nanoscale bonding elements from rigid core units. Here, we draw analogy between such building blocks and the familiar chemical concepts of "bonds" and "valency" and review two distinct but related strategies that have used this design principle in constructing new configurations of matter.	[Jones, Matthew R.; Mirkin, Chad A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Seeman, Nadrian C.] NYU, Dept Chem, New York, NY 10003 USA; [Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA	Northwestern University; New York University; Northwestern University; Northwestern University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	ned.seeman@nyu.edu; chadnano@northwestern.edu	Mirkin, Chad A/E-3911-2010	Mirkin, Chad/0000-0002-6634-7627; Jones, Matthew/0000-0002-9289-291X	Air Force Office of Scientific Research [FA9550-11-1-0275]; Office of Naval Research [N000141110729, N000140911118]; National Science Foundation (NSF) [CMMI-1120890, EFRI-1332411, CCF-1117210]; Multidisciplinary University Research Initiative from the Army Research Office [W911NF-11-1-0024]; U.S. Department of Energy [DE-SC0007991]; Gordon and Betty Moore Foundation [3849]; NSF	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)); Multidisciplinary University Research Initiative from the Army Research Office; U.S. Department of Energy(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF))	C.A.M. thanks the Air Force Office of Scientific Research under award FA9550-11-1-0275. N.C.S. thanks the following grants: N000141110729 and N000140911118 from the Office of Naval Research; grants CMMI-1120890, EFRI-1332411, and CCF-1117210 from the National Science Foundation (NSF); Multidisciplinary University Research Initiative W911NF-11-1-0024 from the Army Research Office; DE-SC0007991 from the U.S. Department of Energy for partial salary support; and grant 3849 from the Gordon and Betty Moore Foundation. C.A.M. and M.R.J. thank E. Auyeung, J. Cutler, and J. Wu for providing the tomographic reconstruction of the AB<INF>6</INF> nanoparticle superlattice provided in Fig. 5A. M.R.J. thanks NSF for a Graduate Research Fellowship. The authors acknowledge the following patents based on the work described in this document: C.A.M., R. L. Letsinger, R. C. Mucic, J. J. Storhoff, R. Elghanian (Nanosphere), Nanoparticles having oligonucleotides attached thereto and uses therefor, W.O. Patent 1998004740, February 5, 1998; C.A.M., R. L. Letsinger, R. C. Mucic, J. J. Storhoff, R. Elghanian (Nanosphere), Nanoparticles having oligonucleotides attached thereto and uses therefor, U.S. Patent 8,323,888, December 4, 2012; N.C.S., X. Li, X. Yang, J. Qi (New York University), Nanoconstructions of geometrical objects and lattices from antiparallel nucleic acid double crossover molecules, W.O. Patent 1997041142, November 6, 1997; N.C.S., E. Winfree, F. Liu, L. W. Savin (New York University), Polynucleotide lattice for use as tools in genetic engineering, U.S. Patent 6,255,469, July 3, 2001.	Acuna GP, 2012, SCIENCE, V338, P506, DOI 10.1126/science.1228638; Aldaye FA, 2006, ANGEW CHEM INT EDIT, V45, P2204, DOI 10.1002/anie.200502481; Aldaye FA, 2008, SCIENCE, V321, P1795, DOI 10.1126/science.1154533; Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Auyeung E, 2014, NATURE, V505, P73, DOI 10.1038/nature12739; Auyeung E, 2012, ADV MATER, V24, P5181, DOI 10.1002/adma.201202069; Auyeung E, 2012, NAT NANOTECHNOL, V7, P24, DOI [10.1038/nnano.2011.222, 10.1038/NNANO.2011.222]; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Constantinou PE, 2006, ORG BIOMOL CHEM, V4, P3414, DOI 10.1039/b605212f; Cutler JI, 2012, J AM CHEM SOC, V134, P1376, DOI 10.1021/ja209351u; DESIRAJU GR, 1995, ANGEW CHEM INT EDIT, V34, P2311, DOI 10.1002/anie.199523111; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Ding BQ, 2010, J AM CHEM SOC, V132, P3248, DOI 10.1021/ja9101198; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Dreyfus R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.048301; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Feng L, 2013, SOFT MATTER, V9, P9816, DOI 10.1039/c3sm51586a; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Gu HZ, 2010, NATURE, V465, P202, DOI 10.1038/nature09026; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Herne TM, 1997, J AM CHEM SOC, V119, P8916, DOI 10.1021/ja9719586; Hill HD, 2006, NAT PROTOC, V1, P324, DOI 10.1038/nprot.2006.51; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Huo FW, 2006, ADV MATER, V18, P2304, DOI 10.1002/adma.200601178; Jin RC, 2003, J AM CHEM SOC, V125, P1643, DOI 10.1021/ja021096v; Jones MR, 2013, ANGEW CHEM INT EDIT, V52, P2886, DOI 10.1002/anie.201209504; Jones MR, 2012, NATURE, V491, P42, DOI 10.1038/491042a; Jones MR, 2011, J AM CHEM SOC, V133, P18865, DOI 10.1021/ja206777k; Jones MR, 2011, CHEM REV, V111, P3736, DOI 10.1021/cr1004452; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; KALLENBACH NR, 1983, NATURE, V305, P829, DOI 10.1038/305829a0; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Kim Y, 2013, J AM CHEM SOC, V135, P10342, DOI 10.1021/ja405988r; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; LaBean TH, 2000, J AM CHEM SOC, V122, P1848, DOI 10.1021/ja993393e; Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+; Li HY, 2004, J AM CHEM SOC, V126, P418, DOI 10.1021/ja0383367; Li XJ, 1996, J AM CHEM SOC, V118, P6131, DOI 10.1021/ja960162o; Lin CX, 2012, NAT CHEM, V4, P832, DOI 10.1038/NCHEM.1451; LIU B, 1994, NANOBIOLOGY, V3, P177; Liu D, 2004, J AM CHEM SOC, V126, P2324, DOI 10.1021/ja031754r; Liu WY, 2011, ANGEW CHEM INT EDIT, V50, P264, DOI 10.1002/anie.201005911; Lytton-Jean AKR, 2005, J AM CHEM SOC, V127, P12754, DOI 10.1021/ja052255o; Macfarlane RJ, 2013, SCIENCE, V341, P1222, DOI 10.1126/science.1241402; Macfarlane RJ, 2013, ANGEW CHEM INT EDIT, V52, P5688, DOI 10.1002/anie.201209336; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Macfarlane RJ, 2009, P NATL ACAD SCI USA, V106, P10493, DOI 10.1073/pnas.0900630106; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398; Martinez-Veracoechea FJ, 2013, SOFT MATTER, V9, P3213, DOI 10.1039/c3sm27766f; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Maye MM, 2010, NAT NANOTECHNOL, V5, P116, DOI [10.1038/NNANO.2009.378, 10.1038/nnano.2009.378]; Maye MM, 2009, NAT MATER, V8, P388, DOI [10.1038/NMAT2421, 10.1038/nmat2421]; Millstone JE, 2008, SMALL, V4, P2176, DOI 10.1002/smll.200800931; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Mucic RC, 1998, J AM CHEM SOC, V120, P12674, DOI 10.1021/ja982721s; NIEMEYER CM, 1994, NUCLEIC ACIDS RES, V22, P5530, DOI 10.1093/nar/22.25.5530; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Pal S, 2011, J AM CHEM SOC, V133, P17606, DOI 10.1021/ja207898r; Park DJ, 2015, P NATL ACAD SCI USA, V112, P977, DOI 10.1073/pnas.1422649112; Park SJ, 2001, ANGEW CHEM INT EDIT, V40, P2909, DOI 10.1002/1521-3773(20010803)40:15<2909::AID-ANIE2909>3.0.CO;2-O; Park SJ, 2004, J PHYS CHEM B, V108, P12375, DOI 10.1021/jp040242b; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; PETRILLO ML, 1988, BIOPOLYMERS, V27, P1337, DOI 10.1002/bip.360270902; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/NNANO.2011.187, 10.1038/nnano.2011.187]; Rinker S, 2008, NAT NANOTECHNOL, V3, P418, DOI 10.1038/nnano.2008.164; Rogers WB, 2015, SCIENCE, V347, P639, DOI 10.1126/science.1259762; Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sa-Ardyen P, 2003, BIOPHYS J, V84, P3829, DOI 10.1016/S0006-3495(03)75110-8; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schreiber R, 2014, NAT NANOTECHNOL, V9, P74, DOI [10.1038/nnano.2013.253, 10.1038/NNANO.2013.253]; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seferos DS, 2007, J AM CHEM SOC, V129, P15477, DOI 10.1021/ja0776529; Senesi AJ, 2013, ANGEW CHEM INT EDIT, V52, P6624, DOI 10.1002/anie.201301936; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Sobczak JPJ, 2012, SCIENCE, V338, P1458, DOI 10.1126/science.1229919; Sun DZ, 2011, J AM CHEM SOC, V133, P5252, DOI 10.1021/ja111542t; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; van der Meulen SAJ, 2013, J AM CHEM SOC, V135, P15129, DOI 10.1021/ja406226b; Wang F, 2014, CHEM REV, V114, P2881, DOI 10.1021/cr400354z; Wang T, 2012, J AM CHEM SOC, V134, P1606, DOI 10.1021/ja207976q; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Xu LG, 2012, J AM CHEM SOC, V134, P1699, DOI 10.1021/ja2088713; Xu XY, 2006, J AM CHEM SOC, V128, P9286, DOI 10.1021/ja061980b; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yan H, 2003, P NATL ACAD SCI USA, V100, P8103, DOI 10.1073/pnas.1032954100; Yang H, 2008, ANGEW CHEM INT EDIT, V47, P2443, DOI 10.1002/anie.200703741; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang C, 2013, NAT MATER, V12, P741, DOI [10.1038/NMAT3647, 10.1038/nmat3647]; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532; Zhang JP, 2006, NANO LETT, V6, P248, DOI 10.1021/nl052210l; Zhang XP, 2002, J AM CHEM SOC, V124, P12940, DOI 10.1021/ja026973b; Zhang YG, 2013, NAT NANOTECHNOL, V8, P865, DOI [10.1038/nnano.2013.209, 10.1038/NNANO.2013.209]; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c	108	908	937	42	1015	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224							1260901	10.1126/science.1260901	http://dx.doi.org/10.1126/science.1260901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700524				2022-12-28	WOS:000349761100034
J	Nordstrom, P; Gustafson, Y; Michaelsson, K; Nordstrom, A				Nordstrom, Peter; Gustafson, Yngve; Michaelsson, Karl; Nordstrom, Anna			Length of hospital stay after hip fracture and short term risk of death after discharge: a total cohort study in Sweden	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MORTALITY; INTERVENTION; THERAPY; COMPLICATIONS; OUTCOMES; IMPACT	Objective To investigate relation between inpatient length of stay after hip fracture and risk of death after hospital discharge. Setting Population >= 50 years old living in Sweden as of 31 December 2005 with a first hip fracture the years 2006-12. Participants 116 111 patients with an incident hip fracture from a closed nationwide cohort. Main outcome measure Death within 30 days of hospital discharge in relation to hospital length of stay after adjustment for multiple covariates. Results Mean inpatient length of stay after a hip fracture decreased from 14.2 days in 2006 to 11.6 days in 2012 (P<0.001). The association between length of stay and risk of death after discharge was non-linear (P<0.001), with a threshold for this non-linear effect of about 10 days. Thus, for patients with length of stay of <= 10 days (n=59 154), each 1-day reduction in length of stay increased the odds of death within 30 days of discharge by 8% in 2006 (odds ratio 1.08 (95% confidence interval 1.04 to 1.12)), which increased to16% in 2012 (odds ratio 1.16 (1.12 to 1.20)). In contrast, for patients with a length of stay of >= 11 days (n=56 957), a 1-day reduction in length of stay was not associated with an increased risk of death after discharge during any of the years of follow up. Limitations No accurate evaluation of the underlying cause of death could be performed. Conclusion Shorter length of stay in hospital after hip fracture is associated with increased risk of death after hospital discharge, but only among patients with length of stay of 10 days or less. This association remained robust over consecutive years.	[Nordstrom, Peter; Gustafson, Yngve] Umea Univ, Dept Community Med & Rehabil, SE-91087 Umea, Sweden; [Michaelsson, Karl] Uppsala Univ, Sect Orthoped, Dept Surg Sci, SE-75185 Uppsala, Sweden; [Nordstrom, Anna] Umea Univ, SE-91087 Umea, Sweden	Umea University; Uppsala University; Umea University	Nordstrom, P (corresponding author), Umea Univ, Dept Community Med & Rehabil, SE-91087 Umea, Sweden.	peter.nordstrom@germed.umu.se	Nordström, Anna/F-2238-2010; Nordström, Anna/O-2504-2018; Michaelsson, Karl/AAM-9094-2021	Nordström, Anna/0000-0003-3534-456X; Nordström, Anna/0000-0003-3534-456X; Michaelsson, Karl/0000-0003-2815-1217; Nordstrom, Peter/0000-0003-2924-508X	Swedish research council	Swedish research council(Swedish Research CouncilEuropean Commission)	The present study was funded by the Swedish research council. The researchers conducted this study totally independent of the funding bodies.	Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Aiken LH, 2014, LANCET, V383, P1824, DOI 10.1016/S0140-6736(13)62631-8; Bloom DE, 2011, GLOBAL EC BURDEN NON, DOI DOI 10.1192/BJP.184.5.393; Centers for Medicare & Medicaid Services, 2013, NAT HLTH EXP PROJ 20; Clarke A, 2001, EUR J PUBLIC HEALTH, V11, P166, DOI 10.1093/eurpub/11.2.166; Ellis G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006211.pub2; Gedeborg R, 2009, CRIT CARE MED, V37, P449, DOI 10.1097/CCM.0b013e318194b164; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; HOLLINGWORTH W, 1993, BRIT MED J, V307, P903, DOI 10.1136/bmj.307.6909.903; Kaboli PJ, 2012, ANN INTERN MED, V157, P837, DOI 10.7326/0003-4819-157-12-201212180-00003; Karinkanta S, 2010, NAT REV ENDOCRINOL, V6, P396, DOI 10.1038/nrendo.2010.70; Kondo A, 2010, DISABIL REHABIL, V32, P826, DOI 10.3109/09638280903314051; Koster M, 2013, NEUROEPIDEMIOLOGY, V40, P240, DOI 10.1159/000345953; Lawrence VA, 2002, ARCH INTERN MED, V162, P2053, DOI 10.1001/archinte.162.18.2053; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lundstrom M, 2005, J AM GERIATR SOC, V53, P622, DOI 10.1111/j.1532-5415.2005.53210.x; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Michaelsson K, 1998, BMJ-BRIT MED J, V316, P1858; Michaelsson K, 2014, J BONE MINER RES, V29, P424, DOI 10.1002/jbmr.2029; OECD, 2012, HLTH GLANC EUR 2012, P154; Parker M, 2006, BMJ-BRIT MED J, V333, P27, DOI 10.1136/bmj.333.7557.27; Qureshi A, 2003, AGE AGEING, V32, P8, DOI 10.1093/ageing/32.1.8; Rafferty AM, 2007, INT J NURS STUD, V44, P175, DOI 10.1016/j.ijnurstu.2006.08.003; ROCHE J, 2005, BMJ-BRIT MED J, V331, P1374, DOI DOI 10.1136/BMJ.38643.663843.55; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Statistics Sweden Database, 2014, OFF POP STAT; Swedish Association of Local Authorities and Regions, 2013, QUAL EFF SWED HLTH C; United Nation, 2013, WORLD POP PROSP 2012; Vidan M, 2005, J AM GERIATR SOC, V53, P1476, DOI 10.1111/j.1532-5415.2005.53466.x	30	98	99	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2015	350								h696	10.1136/bmj.h696	http://dx.doi.org/10.1136/bmj.h696			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB8WF	25700551	Green Published, hybrid			2022-12-28	WOS:000349911800005
J	Wilson, C; Agafonov, RV; Hoemberger, M; Kutter, S; Zorba, A; Halpin, J; Buosi, V; Otten, R; Waterman, D; Theobald, DL; Kern, D				Wilson, C.; Agafonov, R. V.; Hoemberger, M.; Kutter, S.; Zorba, A.; Halpin, J.; Buosi, V.; Otten, R.; Waterman, D.; Theobald, D. L.; Kern, D.			Using ancient protein kinases to unravel a modern cancer drug's mechanism	SCIENCE			English	Article							C-SRC; RESURRECTED PROTEINS; CRYSTAL-STRUCTURE; TYROSINE KINASES; ABL KINASE; EVOLUTION; RECONSTRUCTION; CONFORMATION; INHIBITORS; IMATINIB	Macromolecular function is rooted in energy landscapes, where sequence determines not a single structure but an ensemble of conformations. Hence, evolution modifies a protein's function by altering its energy landscape. Here, we recreate the evolutionary pathway between two modern human oncogenes, Src and Abl, by reconstructing their common ancestors. Our evolutionary reconstruction combined with x-ray structures of the common ancestor and pre-steady-state kinetics reveals a detailed atomistic mechanism for selectivity of the successful cancer drug Gleevec. Gleevec affinity is gained during the evolutionary trajectory toward Abl and lost toward Src, primarily by shifting an induced-fit equilibrium that is also disrupted in the clinical T315I resistance mutation. This work reveals the mechanism of Gleevec specificity while offering insights into how energy landscapes evolve.	[Wilson, C.; Agafonov, R. V.; Hoemberger, M.; Kutter, S.; Zorba, A.; Halpin, J.; Buosi, V.; Otten, R.; Waterman, D.; Kern, D.] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02452 USA; [Wilson, C.; Agafonov, R. V.; Hoemberger, M.; Kutter, S.; Zorba, A.; Halpin, J.; Buosi, V.; Otten, R.; Waterman, D.; Theobald, D. L.; Kern, D.] Brandeis Univ, Dept Biochem, Waltham, MA 02452 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University	Kern, D (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02452 USA.	dkern@brandeis.edu	Theobald, Douglas L/F-3514-2013; Hoemberger, Marc/AAM-5435-2021	Theobald, Douglas L/0000-0002-2695-8343; Hoemberger, Marc/0000-0003-2515-1094; Halpin, Jackson/0000-0003-4085-1064; Kutter, Steffen/0000-0002-0349-8161; Otten, Renee/0000-0001-7342-6131; Wilson, Christopher/0000-0002-8012-2440; Hadzipasic, Adelajda/0000-0002-4452-8419	Howard Hughes Medical Institute (HHMI); Office of Basic Energy Sciences; Catalysis Science Program; U.S. Dept. of Energy [DE-FG02-05ER15699]; NIH [GM100966-01, GM096053, GM094468]; National Institutes of Health; National Institute of General Medical Sciences; HHMI; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094468, T32GM007122, R01GM096053, R01GM100966, T32GM007596] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Office of Basic Energy Sciences(United States Department of Energy (DOE)); Catalysis Science Program; U.S. Dept. of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHMI(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (HHMI), the Office of Basic Energy Sciences, Catalysis Science Program, U.S. Dept. of Energy, award DE-FG02-05ER15699, and NIH (GM100966-01) to D.K and NIH (GM096053 and GM094468) to D.L.T. R.O. is an HHMI Fellow of the Damon Runyon Cancer Research Foundation, DRG-2114-12. We thank the Advanced Light Source (ALS), Berkeley, CA, USA, for access to beamline BL8.2.2. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the HHMI. The ALS is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231. D.K. is the inventor on a patent applied for by Brandeis University that describes a biophysical platform for drug development based on energy landscapes The Protein Data Bank accession codes are 4CSV (ANC-AS.Gleevec) and 4UEU (ANC-AS.AMPPCP).	Agafonov RV, 2014, NAT STRUCT MOL BIOL, V21, P848, DOI 10.1038/nsmb.2891; Aleksandrov A, 2010, J BIOL CHEM, V285, P13807, DOI 10.1074/jbc.M110.109660; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; ECKHART W, 1979, CELL, V18, P925, DOI 10.1016/0092-8674(79)90205-8; Field SF, 2010, MOL BIOL EVOL, V27, P225, DOI 10.1093/molbev/msp230; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Harms MJ, 2013, NAT REV GENET, V14, P559, DOI 10.1038/nrg3540; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ingles-Prieto A, 2013, STRUCTURE, V21, P1690, DOI 10.1016/j.str.2013.06.020; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Krishnan NM, 2004, MOL BIOL EVOL, V21, P1871, DOI 10.1093/molbev/msh198; Liberles DA., 2007, ANCESTRAL SEQUENCE R; Lin YL, 2013, P NATL ACAD SCI USA, V110, P1664, DOI 10.1073/pnas.1214330110; Lovera S, 2012, J AM CHEM SOC, V134, P2496, DOI 10.1021/ja210751t; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Nagar B, 2002, CANCER RES, V62, P4236; PAULING L, 1963, ACTA CHEM SCAND, V17, pS9; Perez-Jimenez R, 2011, NAT STRUCT MOL BIOL, V18, P592, DOI 10.1038/nsmb.2020; Redelings BD, 2005, SYST BIOL, V54, P401, DOI 10.1080/10635150590947041; Richter DJ, 2013, ANNU REV GENET, V47, P509, DOI 10.1146/annurev-genet-111212-133456; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069	33	98	102	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					882	886		10.1126/science.aaa1823	http://dx.doi.org/10.1126/science.aaa1823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700521	Green Accepted			2022-12-28	WOS:000349761100046
J	Reid, MC; Eccleston, C; Pillemer, K				Reid, M. Carrington; Eccleston, Christopher; Pillemer, Karl			Management of chronic pain in older adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PRIMARY-CARE; MUSCULOSKELETAL PAIN; EXERCISE PROGRAM; CHRONIC DISEASE; HEALTH; PREVALENCE; OSTEOARTHRITIS; OUTCOMES; ARTHRITIS; PATIENT		[Reid, M. Carrington] Weill Cornell Med Coll, Dis Geriatr & Palliat Med, New York, NY 10065 USA; [Eccleston, Christopher] Univ Bath, Ctr Pain Res, Bath BA2 7AY, Avon, England; [Pillemer, Karl] Cornell Univ, Dept Human Dev, Ithaca, NY USA	Cornell University; University of Bath; Cornell University	Reid, MC (corresponding author), Weill Cornell Med Coll, Dis Geriatr & Palliat Med, New York, NY 10065 USA.	mcr2004@med.cornell.edu		Pillemer, Karl/0000-0002-7700-3563; Eccleston, Christopher/0000-0003-0698-1543	National Institute on Ageing [P30AG022845]; Agency for Healthcare Quality and Research [R01HS020648]; Howard and Phyllis Schwartz Philanthropic Fund; Endo Pharmaceuticals; UK National Institute for Health Research Cochrane Program; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS020648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG022845] Funding Source: NIH RePORTER	National Institute on Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Healthcare Quality and Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Howard and Phyllis Schwartz Philanthropic Fund; Endo Pharmaceuticals; UK National Institute for Health Research Cochrane Program; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We have read and understood the BMJ policy on declaration of interests and declare that: MCR has received funding from the National Institute on Ageing (P30AG022845), the Agency for Healthcare Quality and Research (R01HS020648), Howard and Phyllis Schwartz Philanthropic Fund, and Endo Pharmaceuticals. KP has received research funding from the National Institute on Ageing (P30AG022845). CE has received a grant from the UK National Institute for Health Research Cochrane Program.	Abdulla A, 2013, AGE AGEING, V42, pI1, DOI 10.1093/ageing/afs200; Azevedo LF, 2013, MED CARE, V51, P859, DOI 10.1097/MLR.0b013e3182a53e4e; Broderick JE, 2014, PAIN, V155, P1743, DOI 10.1016/j.pain.2014.05.024; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Cooper G, 2013, MEDSCAPE OVERVIEW OS; Dansie EJ, 2013, BRIT J ANAESTH, V111, P19, DOI 10.1093/bja/aet124; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; Draguns JG, 2013, PSYCHOLOGIA, V56, P74; Du SZ, 2011, PATIENT EDUC COUNS, V85, pE299, DOI 10.1016/j.pec.2011.02.021; Eccleston C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010152.pub2; Enck RE, 2010, AM J HOSP PALLIAT ME, V27, P301, DOI 10.1177/1049909110369530; Ferrell B, 2002, J AM GERIATR SOC, V50, pS205, DOI 10.1046/j.1532-5415.50.6s.1.x; Ferrell B, 2009, J AM GERIATR SOC, V57, P1331, DOI 10.1111/j.1532-5415.2009.02376.x; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Guillory J, 2015, CLIN J PAIN; Hadjistavropoulos T, 2007, CLIN J PAIN, V23, pS1, DOI 10.1097/AJP.0b013e31802be869; Henderson JV, 2013, PAIN MED, V14, P1346, DOI 10.1111/pme.12195; Herr K, 2011, PAIN MANAG NURS, V12, P230, DOI 10.1016/j.pmn.2011.10.002; Institute of Medicine (US) Committee on Advancing Pain Research Care and Education, 2011, REL PAIN AM BLUEPR T; International Association for the Study of Pain, 2012, IASP TAX; Jackson T, 2014, CLIN J PAIN, V30, P346, DOI 10.1097/AJP.0b013e31829ea1e3; Keefe FJ, 2004, PAIN, V110, P539, DOI 10.1016/j.pain.2004.03.022; Kroenke K, 2014, JAMA-J AM MED ASSOC, V312, P240, DOI 10.1001/jama.2014.7689; Leadley R M, 2012, J Pain Palliat Care Pharmacother, V26, P310, DOI 10.3109/15360288.2012.736933; Levy SS, 2012, DISABIL HEALTH J, V5, P305, DOI 10.1016/j.dhjo.2012.07.003; Lin EHB, 2003, JAMA-J AM MED ASSOC, V290, P2428, DOI 10.1001/jama.290.18.2428; Lunde LH, 2009, J CLIN PSYCHOL MED S, V16, P254, DOI 10.1007/s10880-009-9162-y; Makris UE, 2014, JAMA-J AM MED ASSOC, V312, P825, DOI 10.1001/jama.2014.9405; Mallen CD, 2013, JAMA INTERN MED, V173, P1119, DOI 10.1001/jamainternmed.2013.962; Martire Lynn M, 2008, Fam Syst Health, V26, P185; McGuire BE, 2014, CURR OPIN PSYCHIATR, V27, P380, DOI 10.1097/YCO.0000000000000090; Messier SP, 2013, JAMA-J AM MED ASSOC, V310, P1263, DOI 10.1001/jama.2013.277669; Morley S, 2013, PAIN, V154, P1929, DOI 10.1016/j.pain.2013.05.049; Nicholas MK, 2013, PAIN, V154, P824, DOI 10.1016/j.pain.2013.02.009; Papaleontiou M, 2010, J AM GERIATR SOC, V58, P1353, DOI 10.1111/j.1532-5415.2010.02920.x; Patel KV, 2013, PAIN, V154, P2649, DOI 10.1016/j.pain.2013.07.029; Reid MC, 2008, PAIN MED, V9, P409, DOI 10.1111/j.1526-4637.2008.00428.x; Reid MC, 2010, PAIN MED, V11, P1063, DOI 10.1111/j.1526-4637.2010.00883.x; Richardson JE, 2013, PAIN MED, V14, P1621, DOI 10.1111/pme.12206; Riddle DL, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-149; Royal College of Physicians British Geriatrics Society and British Pain Society, 2007, CONC GUID GOOD PRACT, V8; Smith AK, 2010, ANN INTERN MED, V153, P563, DOI 10.7326/0003-4819-153-9-201011020-00005; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; Tobias KR, 2014, PAIN MANAG NURS, V15, P760, DOI 10.1016/j.pmn.2013.07.013; Towheed TE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004257.pub2; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Tsang A, 2008, J PAIN, V9, P883, DOI 10.1016/j.jpain.2008.05.005; Tse MMY, 2013, J CLIN NURS, V22, P1843, DOI 10.1111/j.1365-2702.2012.04317.x; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; Wyldea V, 2011, PAIN, V152, P457	52	197	201	1	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2015	350								h532	10.1136/bmj.h532	http://dx.doi.org/10.1136/bmj.h532			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0MZ	25680884	Green Published			2022-12-28	WOS:000349321700001
J	Muller, E; Barday, Z; Mendelson, M; Kahn, D				Muller, Elmi; Barday, Zunaid; Mendelson, Marc; Kahn, Delawir			HIV-Positive-to-HIV-Positive Kidney Transplantation - Results at 3 to 5 Years	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; RENAL-TRANSPLANTATION; RESISTANCE MUTATIONS; CYTOCHROME-P450 3A4; DRUG-RESISTANCE; NAIVE PATIENTS; CAPE-TOWN; DISEASE	BACKGROUND The outcome of kidney transplantation in human immunodeficiency virus (HIV)-positive patients who receive organs from HIV-negative donors has been reported to be similar to the outcome in HIV-negative recipients. We report the outcomes at 3 to 5 years in HIV-positive patients who received kidneys from HIV-positive deceased donors. METHODS We conducted a prospective, nonrandomized study of kidney transplantation in HIV-infected patients who had a CD4 T-cell count of 200 per cubic millimeter or higher and an undetectable plasma HIV RNA level. All the patients were receiving antiretroviral therapy (ART). The patients received kidneys from deceased donors who tested positive for HIV with the use of fourth-generation enzyme-linked immunosorbent assay at the time of referral. All the donors either had received no ART previously or had received only first-line ART. RESULTS From September 2008 through February 2014, a total of 27 HIV-positive patients underwent kidney transplantation. Survivors were followed for a median of 2.4 years. The rate of survival among the patients was 84% at 1 year, 84% at 3 years, and 74% at 5 years. The corresponding rates of graft survival were 93%, 84%, and 84%. (If a patient died with a functioning graft, the calculation was performed as if the graft had survived.) Rejection rates were 8% at 1 year and 22% at 3 years. HIV infection remained well controlled, with undetectable virus in blood after the transplantation. CONCLUSIONS Kidney transplantation from an HIV-positive donor appears to be an additional treatment option for HIV-infected patients requiring renal-replacement therapy. (Funded by Sanofi South Africa and the Roche Organ Transplantation Research Foundation.)	[Muller, Elmi] Univ Cape Town, Dept Surg, Groote Schuur Hosp, Transplant Unit, ZA-7925 Cape Town, South Africa; [Barday, Zunaid] Univ Cape Town, Dept Med, Groote Schuur Hosp, Div Nephrol, ZA-7925 Cape Town, South Africa; [Mendelson, Marc] Univ Cape Town, Dept Med, Groote Schuur Hosp, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Kahn, Delawir] Univ Cape Town, Dept Surg, Groote Schuur Hosp, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Muller, E (corresponding author), Univ Cape Town Surg, Groote Schuur Hosp Observ Cape Town, ZA-7925 Cape Town, South Africa.	elmi.muller@uct.ac.za	Muller, Elmi/I-3258-2014	Muller, Elmi/0000-0003-4891-5296; Mendelson, Marc/0000-0001-6668-3893	Sanofi South Africa; Roche Organ Transplantation Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI116061] Funding Source: NIH RePORTER	Sanofi South Africa(Sanofi-Aventis); Roche Organ Transplantation Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by Sanofi South Africa and the Roche Organ Transplantation Research Foundation.	Canaud G, 2014, J AM SOC NEPHROL, V25, P407, DOI 10.1681/ASN.2013050564; Fenner L, 2013, TROP MED INT HEALTH, V18, P194, DOI 10.1111/tmi.12026; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Iordanskiy S, 2013, VIROLOGY, V443, P208, DOI 10.1016/j.virol.2013.05.023; Jacobs GB, 2008, AIDS RES HUM RETROV, V24, P1009, DOI 10.1089/aid.2008.0028; Laurinavicius A, 1999, KIDNEY INT, V56, P2203, DOI 10.1046/j.1523-1755.1999.00769.x; Levison JH, 2013, CLIN INFECT DIS, V56, P587, DOI 10.1093/cid/cis887; Levison JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032144; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; Mengel M, 2012, AM J TRANSPLANT, V12, P563, DOI 10.1111/j.1600-6143.2011.03926.x; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; Muller E, 2010, NEW ENGL J MED, V362, P2336, DOI 10.1056/NEJMc0900837; Nwobegahay J, 2012, J MED VIROL, V84, P1839, DOI 10.1002/jmv.23348; Nwobegahay JM, 2011, J HEALTH POPUL NUTR, V29, P303, DOI 10.3329/jhpn.v29i4.8444; Okpechi I, 2011, NEPHROL DIAL TRANSPL, V26, P1853, DOI 10.1093/ndt/gfq655; Parboosing R, 2011, J MED VIROL, V83, P1508, DOI 10.1002/jmv.22143; Peters PJ, 2008, KIDNEY INT, V74, P925, DOI 10.1038/ki.2008.305; Roland ME, 2003, TRANSPLANTATION, V75, P425, DOI 10.1097/01.TP.0000046943.35335.18; Stock PG, 2011, NEW ENGL J MED, V364, P1082; Stock PG, 2007, TRANSPLANTATION, V84, P563, DOI 10.1097/01.tp.0000279190.96029.77; Stock PG, 2010, NEW ENGL J MED, V363, P2004, DOI 10.1056/NEJMoa1001197; Streeck H, 2008, J EXP MED, V205, P1789, DOI 10.1084/jem.20080281; Waters L, 2012, CURR OPIN INFECT DIS, V25, P42, DOI 10.1097/QCO.0b013e32834ef5af; Wearne N, 2012, NEPHROL DIAL TRANSPL, V27, P4109, DOI 10.1093/ndt/gfr702; Winston J, 2008, CLIN INFECT DIS, V47, P1449, DOI 10.1086/593099; Wyatt Christina M, 2006, Curr Infect Dis Rep, V8, P76, DOI 10.1007/s11908-006-0038-0; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4; Zhou SF, 2005, CLIN PHARMACOKINET, V44, P279, DOI 10.2165/00003088-200544030-00005; Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664	29	130	135	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7					613	620		10.1056/NEJMoa1408896	http://dx.doi.org/10.1056/NEJMoa1408896			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CK	25671253	Green Accepted			2022-12-28	WOS:000349143900005
J	Bruce, DJ; Whitwell, D; Pandit, H				Bruce, David J.; Whitwell, Duncan; Pandit, Hemant			Joint pain in hereditary multiple exostoses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE; OSTEOCHONDROMA; EXT1		[Bruce, David J.] John Radcliffe Hosp, Oxford OX3 9DU, England; [Whitwell, Duncan; Pandit, Hemant] Nuffield Orthopaed Ctr, Oxford OX3 7LD, England	University of Oxford; Nuffield Orthopaedic Centre	Bruce, DJ (corresponding author), John Radcliffe Hosp, Oxford OX3 9DU, England.	davebruce@doctors.org.uk		Pandit, Hemant/0000-0001-7392-8561				Bottner F, 2003, J BONE JOINT SURG BR, V85B, P1161, DOI 10.1302/0301-620X.85B8.14059; de Andrea CE, 2012, ONCOGENE, V31, P1095, DOI 10.1038/onc.2011.311; Dootjes E, 2012, J BONE JOINT S B S14, V94-B, P8; Jacobson JA, 2008, RADIOLOGY, V248, P737, DOI 10.1148/radiol.2483062112; Kok HK, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130398; Matsumoto K, 2010, P NATL ACAD SCI USA, V107, P10932, DOI 10.1073/pnas.0914642107; Mavrogenis AF, 2008, ORTHOPEDICS, V31, P1018, DOI 10.3928/01477447-20110525-01; Mesfin A, 2012, ORTHOPEDICS, V35, pE1807, DOI 10.3928/01477447-20121120-29; Murphey MD, 2000, RADIOGRAPHICS, V20, P1407, DOI 10.1148/radiographics.20.5.g00se171407; Porter DE, 2004, J BONE JOINT SURG BR, V86B, P1041, DOI 10.1302/0301-620X.86B7.14815; Sandell LJ, 2009, J BONE JOINT SURG AM, V91A, P58, DOI 10.2106/JBJS.I.00391; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; Wuyts W, 2000, HUM MUTAT, V15, P220, DOI 10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K; Wuyts W, 2013, GENEREVIEWS; Zuntini M, 2010, CLIN GENET, V78, P507, DOI 10.1111/j.1399-0004.2010.01490.x	15	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2015	350								h656	10.1136/bmj.h656	http://dx.doi.org/10.1136/bmj.h656			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0MG	25673003				2022-12-28	WOS:000349319700010
J	Jones, DS				Jones, David S.			The Puzzle of Positive Results - Myocardial Revascularization	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEART; OPERATION; DISEASE		[Jones, David S.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02163 USA; [Jones, David S.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Jones, DS (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02163 USA.							BECK CS, 1958, JAMA-J AM MED ASSOC, V168, P2110, DOI 10.1001/jama.1958.03000160024007; Beck CS, 1943, ANN SURG, V119, P788; BROFMAN BL, 1956, JAMA-J AM MED ASSOC, V162, P1603, DOI 10.1001/jama.1956.02970350019005; Gross L, 1937, J EXP MED, V65, P91, DOI 10.1084/jem.65.1.91; VANSANT JH, 1960, AM J SURG, V100, P572, DOI 10.1016/0002-9610(60)90323-8	5	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2015	372	6					501	503		10.1056/NEJMp1414157	http://dx.doi.org/10.1056/NEJMp1414157			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CH	25651243	Green Published			2022-12-28	WOS:000349143600002
J	Rastan, S				Rastan, Sohaila			Mary F. Lyon (1925-2014) OBITUARY	NATURE			English	Biographical-Item									[Rastan, Sohaila] Act Hearing Loss, London, England; [Rastan, Sohaila] MRC Radiobiol Unit, Harwell, Berks, England		Rastan, S (corresponding author), Act Hearing Loss, London, England.	sohaila@rastan.fsnet.co.uk							0	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					36	36		10.1038/518036a	http://dx.doi.org/10.1038/518036a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25652989	Bronze			2022-12-28	WOS:000349098000021
J	Collier, S; Scally, G				Collier, Stephen; Scally, Gabriel			Can private providers be trusted to run NHS hospitals after Hinchingbrooke?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Collier, Stephen] NHS Partners Network, London SW1H ODB, England		Collier, S (corresponding author), NHS Partners Network, London SW1H ODB, England.	stephen.collier1@nhs.net; gabriel.scally@btinternet.com						Care Quality Commission, CHIEF INSP HOSP REC; Care Quality Commission, 2012, LEARN DIS SERV INSP; Francis R, 2013, REPORT MIDSTAFFORDSH, V1; Hoskin P, 2012, WILL HINCHINGBROOKE; House of Commons Public Administration Select Committee, 2002, PUBL SERV ETH 7 REP; Ministry of Justice, 2012, FREED INF GUID EX GU; National Audit Office, 2014, FIN SUST NHS BOD; NHS Confederation, 2014, THER IS ALW BETT WAY; NHS Confederation, 2014, IND SECT PROV CAR NH; NHS England, 2014, 5 YEAR FORW VIEW; RIVETT G, NATL HLTH SERVICE HI; Roebuck C, 2011, DEV EFFECTIVE LEADER; Simon HA, 1947, ADM BEHAV STUDY DECI	13	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2015	350								h289	10.1136/bmj.h289	http://dx.doi.org/10.1136/bmj.h289			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZB	25646837				2022-12-28	WOS:000348433200013
J	Edelstein, M; Angelides, P; Heymann, DL				Edelstein, Michael; Angelides, Philip; Heymann, David L.			Ebola: the challenging road to recovery	LANCET			English	Editorial Material									[Edelstein, Michael; Angelides, Philip; Heymann, David L.] Royal Inst Int Affairs, Ctr Global Hlth Secur, London SW1Y 4LE, England		Edelstein, M (corresponding author), Royal Inst Int Affairs, Ctr Global Hlth Secur, Chatham House, London SW1Y 4LE, England.	medelstein@chathamhouse.org	Edelstein, Michael/GQY-7219-2022	Edelstein, Michael/0000-0002-7323-0806; Angelides, Philip/0000-0002-1003-6221				Christensen J, 2014, CNN             1210; Fofana L, 2014, INTERPRESS SERV 1201; Hayden EC, 2014, NATURE, V514, P15, DOI 10.1038/514015a; Integrated Regional Information Networks (UNOCHA), 2014, EB HAMP HIV AIDS CAR; Lazuta J, 2014, VOICE AM        0924; Medecins Sans Frontieres, 2014, SIERR LEON 1 5 MILL; Powell A., 2014, HARVARD GAZETEE 0815; Stone-Brown K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7375; The World Bank, OP DAT PHYS PER 1000; Tottham J, 2014, AL JAZEERA AM   1229; UNAIDS, 2014, HIV EB UPD 2014; UNICEF, 2015, UNICEF HELPS REST ME; United Nations Development Program, 2014, ASS SOC IMP EB VIR D; United Nations Development Programme, 2014, COMM VOL LIB AR LIM; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2015, EB SIT REP; World Health Organization, DENS NURS MIDW PERS; World Health Organization, 2015, WHO COUNTR PROF	18	13	13	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2234	2235		10.1016/S0140-6736(15)60203-3	http://dx.doi.org/10.1016/S0140-6736(15)60203-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25678357				2022-12-28	WOS:000355943500009
J	Ohto, U; Shibata, T; Tanji, H; Ishida, H; Krayukhina, E; Uchiyama, S; Miyake, K; Shimizu, T				Ohto, Umeharu; Shibata, Takuma; Tanji, Hiromi; Ishida, Hanako; Krayukhina, Elena; Uchiyama, Susumu; Miyake, Kensuke; Shimizu, Toshiyuki			Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9	NATURE			English	Article							HEMI-METHYLATED DNA; BACTERIAL-DNA; SRA DOMAIN; HUMAN TLR9; ACTIVATION; BINDING; UHRF1; RESPONSIVENESS; LIGANDS; PROTEIN	Innate immunity serves as the first line of defence against invading pathogens such as bacteria and viruses'. Toll-like receptors (TLRs) are examples of innate immune receptors, which sense specific molecular patterns from pathogens and activate immune responses'. TLR9 recognizes bacterial and viral DNA containing the cytosinephosphate-guanine (CpG) dideoxynucleotide moth". The molecular basis by which CpG-containing DNA (CpG-DNA) elicits immunostimulatory activity via TLR9 remains to be elucidated. Here we show the crystal structures of three forms of TLR9: unliganded, bound to agonistic CpG-DNA, and bound to inhibitory DNA (iDNA). AgonisticCpG-DNA-bound TLR9 formed a symmetric TLR9-CpG-DNA complex with 2:2 stoichiometry, whereas iDNA-bound TLR9 was a monomer. CpG-DNA was recognized by both protomers in the dimer, in particular by the amino-terminal fragment (LRRNT-LRR10) from one protomer and the carboxy-terminal fragment (LRR2O-LRR22) from the other. The iDNA, which formed a stem-loop structure suitable for binding by intramolecular base pairing, bound to the concave surface from LRR2-LRR 1 O. This structure serves as an important basis for improving our understanding of the functional mechanisms of TLR9.	[Ohto, Umeharu; Tanji, Hiromi; Ishida, Hanako; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shibata, Takuma; Miyake, Kensuke] Univ Tokyo, Dept Microbiol & Immunol, Ctr Expt Med & Syst Biol, Div Innate Immun,Lab Innate Immun,Inst Med Sci,Mi, Tokyo 1088639, Japan; [Shibata, Takuma; Shimizu, Toshiyuki] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Krayukhina, Elena; Uchiyama, Susumu] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Krayukhina, Elena] U Med Corp, Suita, Osaka 5650871, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Osaka University	Shimizu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp	Shibata, Takuma/M-8196-2019; UCHIYAMA, Susumu/F-9590-2017	UCHIYAMA, Susumu/0000-0002-5181-179X	Japanese Ministry of Education, Culture, Sports, Science, and Technology; JSPS Japanese-German Graduate Externship; Senri-Life Science Foundation; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research [25253032] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS Japanese-German Graduate Externship; Senri-Life Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the beamline staff members at the Photon Factory and SPring-8 for their assistance with data collection. This work was supported by a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (U.O., S.U., K.M. and T.S.); the JSPS-Japanese German Graduate Externship (S.U.); the Senri-Life Science Foundation (S.U.); the Takeda Science Foundation (U.O. and T.S.); and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (U.O.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Kubarenko AV, 2010, J BIOL CHEM, V285, P36486, DOI 10.1074/jbc.M110.117200; Lenert PS, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/986596; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muta T, 2001, EUR J BIOCHEM, V268, P4580, DOI 10.1046/j.1432-1327.2001.02385.x; Onji M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2949; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peter ME, 2009, J IMMUNOL, V182, P7690, DOI 10.4049/jimmunol.0900819; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584	34	222	236	5	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					702	U303		10.1038/nature14138	http://dx.doi.org/10.1038/nature14138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25686612				2022-12-28	WOS:000353689700055
J	Prestmo, A; Hagen, G; Sletvold, O; Helbostad, JL; Thingstad, P; Taraldsen, K; Lydersen, S; Halsteinli, V; Saltnes, T; Lamb, SE; Johnsen, LG; Saltvedt, I				Prestmo, Anders; Hagen, Gunhild; Sletvold, Olav; Helbostad, Jorunn L.; Thingstad, Pernille; Taraldsen, Kristin; Lydersen, Stian; Halsteinli, Vidar; Saltnes, Turi; Lamb, Sarah E.; Johnsen, Lars G.; Saltvedt, Ingvild			Comprehensive geriatric care for patients with hip fractures: a prospective, randomised, controlled trial	LANCET			English	Article							MINI-MENTAL-STATE; IMPORTANT DIFFERENCE; ORTHOGERIATRIC CARE; PERFORMANCE; SCALE; RESPONSIVENESS; DISABILITY; STANDARD; SERVICE; VERSION	Background Most patients with hip fractures are characterised by older age (>70 years), frailty, and functional deterioration, and their long-term outcomes are poor with increased costs. We compared the effectiveness and costeffectiveness of giving these patients comprehensive geriatric care in a dedicated geriatric ward versus the usual orthopaedic care. Methods We did a prospective, single-centre, randomised, parallel-group, controlled trial. Between April 18, 2008, and Dec 30, 2010, we randomly assigned home-dwelling patients with hip-fractures aged 70 years or older who were able to walk 10 m before their fracture, to either comprehensive geriatric care or orthopaedic care in the emergency department, to achieve the required sample of 400 patients. Randomisation was achieved via a web-based, computer-generated, block method with unknown block sizes. The primary outcome, analysed by intention to treat, was mobility measured with the Short Physical Performance Battery (SPPB) 4 months after surgery for the fracture. The type of treatment was not concealed from the patients or staff delivering the care, and assessors were only partly masked to the treatment during follow-up. This trial is registered with ClinicalTrials.gov, number NCT00667914. Findings We assessed 1077 patients for eligibility, and excluded 680, mainly for not meeting the inclusion criteria such as living in a nursing home or being aged less than 70 years. Of the remaining patients, we randomly assigned 198 to comprehensive geriatric care and 199 to orthopaedic care. At 4 months, 174 patients remained in the comprehensive geriatric care group and 170 in the orthopaedic care group; the main reason for dropout was death. Mean SPPB scores at 4 months were 5.12 (SE 0.20) for comprehensive geriatric care and 4.38 (SE 0.20) for orthopaedic care (between-group difference 0.74, 95% CI 0.18-1.30, p= 0.010). Interpretation Immediate admission of patients aged 70 years or more with a hip fracture to comprehensive geriatric care in a dedicated ward improved mobility at 4 months, compared with the usual orthopaedic care. The results suggest that the treatment of older patients with hip fractures should be organised as orthogeriatric care.	[Prestmo, Anders; Sletvold, Olav; Helbostad, Jorunn L.; Thingstad, Pernille; Taraldsen, Kristin; Johnsen, Lars G.; Saltvedt, Ingvild] Norwegian Univ Sci & Technol, Dept Neurosci, N-7491 Trondheim, Norway; [Hagen, Gunhild; Halsteinli, Vidar] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7491 Trondheim, Norway; [Lydersen, Stian] Norwegian Univ Sci & Technol, Reg Ctr Child & Youth Mental Hlth & Child Welf, N-7491 Trondheim, Norway; [Prestmo, Anders; Sletvold, Olav; Saltvedt, Ingvild] Univ Trondheim Hosp, St Olav Hosp, Dept Geriatr, Trondheim, Norway; [Helbostad, Jorunn L.] Univ Trondheim Hosp, St Olav Hosp, Dept Clin Serv, Trondheim, Norway; [Johnsen, Lars G.] Univ Trondheim Hosp, St Olav Hosp, Dept Orthopaed, Trondheim, Norway; [Halsteinli, Vidar] Cent Norway Reg Hlth Author, Stjordal, Norway; [Saltnes, Turi] Norwegian Directorate Hlth, Trondheim, Norway; [Lamb, Sarah E.] Univ Oxford, Oxford Clin Trials Res Unit, Oxford, England	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oxford	Prestmo, A (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Neurosci, Post Box 8905, N-7491 Trondheim, Norway.	ingvild.saltvedt@ntnu.no; ingvild.saltvedt@ntnu.no	Saltvedt, Ingvild/AAD-9674-2022; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022	Saltvedt, Ingvild/0000-0002-7897-9808; Lamb, Sarah/0000-0003-4349-7195; Hagen, Gunhild/0000-0001-7464-9652	Norwegian Research Council; Central Norway Regional Health Authority; St Olav Hospital Trust; Fund for Research and Innovation; Liaison Committee; Norwegian University of Science and Technology; Department of Neuroscience at the Norwegian University of Science and Technology; Foundation for Scientific and Industrial Research at the Norwegian Institute of Technology (SINTEF); Municipality of Trondheim	Norwegian Research Council(Research Council of NorwayEuropean Commission); Central Norway Regional Health Authority; St Olav Hospital Trust; Fund for Research and Innovation; Liaison Committee; Norwegian University of Science and Technology; Department of Neuroscience at the Norwegian University of Science and Technology; Foundation for Scientific and Industrial Research at the Norwegian Institute of Technology (SINTEF)(SINTEF); Municipality of Trondheim	Norwegian Research Council, Central Norway Regional Health Authority, St Olav Hospital Trust and Fund for Research and Innovation, Liaison Committee between Central Norway Regional Health Authority and the Norwegian University of Science and Technology, the Department of Neuroscience at the Norwegian University of Science and Technology, Foundation for Scientific and Industrial Research at the Norwegian Institute of Technology (SINTEF), and the Municipality of Trondheim.	Adunsky A, 2005, DISABIL REHABIL, V27, P1123, DOI 10.1080/09638280500056030; Auais M, 2013, OSTEOPOROSIS INT, V24, P2713, DOI 10.1007/s00198-013-2390-x; Bentler SE, 2009, AM J EPIDEMIOL, V170, P1290, DOI 10.1093/aje/kwp266; Bertram M, 2011, INJURY PREV, V17, P365, DOI 10.1136/ip.2010.029579; Brazier J, 2016, MEASURING VALUING HL; British Orthopedic Association and British Geriatrics Society, 2007, CAR PAT FRAG FRACT; Cheng SY, 2011, OSTEOPOROSIS INT, V22, P2575, DOI 10.1007/s00198-011-1596-z; Cook J, 2004, STAT METHODS MED RES, V13, P157, DOI 10.1191/0962280204sm359ra; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Ellis G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006211.pub2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ginsberg G, 2013, HIP INT, V23, P570, DOI 10.5301/hipint.5000080; Giusti A, 2011, EUR J PHYS REHAB MED, V47, P281; GLADMAN JRF, 1993, AGE AGEING, V22, P419, DOI 10.1093/ageing/22.6.419; Glick H A, 2001, Expert Rev Pharmacoecon Outcomes Res, V1, P25, DOI 10.1586/14737167.1.1.25; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; Hauer KA, 2011, GERONTOLOGY, V57, P462, DOI 10.1159/000320054; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Kammerlander C, 2010, OSTEOPOROSIS INT, V21, pS637, DOI 10.1007/s00198-010-1396-x; Kempen GIJM, 2008, AGE AGEING, V37, P45, DOI 10.1093/ageing/afm157; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Liem IS, 2013, INJURY, V44, P1403, DOI 10.1016/j.injury.2013.06.018; MAHONEY F I, 1965, Md State Med J, V14, P61; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; Nikitovic M, 2013, OSTEOPOROSIS INT, V24, P659, DOI 10.1007/s00198-012-2034-6; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; Peasgood T, 2009, OSTEOPOROSIS INT, V20, P853, DOI 10.1007/s00198-009-0844-y; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Saltvedt Ingvild, 2012, BMC Res Notes, V5, P355, DOI 10.1186/1756-0500-5-355; Shyu YIL, 2010, J AM GERIATR SOC, V58, P1081, DOI 10.1111/j.1532-5415.2010.02882.x; Sletvold O, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-18; Stein J, 2012, ACTA PSYCHIAT SCAND, V126, P208, DOI 10.1111/j.1600-0447.2012.01850.x; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Taraldsen K, 2014, J GERONTOL A-BIOL, V69, P338, DOI 10.1093/gerona/glt097; Twisk JWR, 2008, EUR J EPIDEMIOL, V23, P655, DOI 10.1007/s10654-008-9279-6; Volpato S, 2008, J GERONTOL A-BIOL, V63, P1393, DOI 10.1093/gerona/63.12.1393; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Watne LO, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-63; Wu CY, 2011, ARCH PHYS MED REHAB, V92, P1281, DOI 10.1016/j.apmr.2011.03.008; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709	41	324	338	4	77	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1623	1633		10.1016/S0140-6736(14)62409-0	http://dx.doi.org/10.1016/S0140-6736(14)62409-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG6NG	25662415	Green Submitted			2022-12-28	WOS:000353418000035
J	Rowhani-Rahbar, A; Zatzick, D; Wang, J; Mills, BM; Simonetti, JA; Fan, MD; Rivara, FP				Rowhani-Rahbar, Ali; Zatzick, Douglas; Wang, Jin; Mills, Brianna M.; Simonetti, Joseph A.; Fan, Mary D.; Rivara, Frederick P.			Firearm-Related Hospitalization and Risk for Subsequent Violent Injury, Death, or Crime Perpetration A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; UNITED-STATES; HOMICIDE OFFENDERS; PSYCHIATRIC-DISORDERS; COLLABORATIVE CARE; TRIAL; TRAUMA; BEHAVIORS; MORTALITY; SURVIVORS	Background: Risk for violent victimization or crime perpetration after firearm-related hospitalization (FRH) must be determined to inform the need for future interventions. Objective: To compare the risk for subsequent violent injury, death, or crime perpetration among patients with an FRH, those hospitalized for noninjury reasons, and the general population. Design: Retrospective cohort study. Setting: All hospitals in Washington. Patients: Patients with an FRH and a random sample of those with a non-injury-related hospitalization in 2006 to 2007 (index hospitalization). Measurements: Primary outcomes included subsequent FRH, firearm-related death, and the combined outcome of firearm-or violence-related arrest ascertained through 2011. Results: Among patients with an index FRH (n = 613), rates of subsequent FRH, firearm-related death, and firearm-or violencerelated arrest were 329 (95% CI, 142 to 649), 100 (CI, 21 to 293), and 4221 (CI, 3352 to 5246) per 100 000 person-years, respectively. Compared with the general population, standardized incidence ratios among patients with an index FRH were 30.1 (CI, 14.9 to 61.0) for a subsequent FRH and 7.3 (CI, 2.4 to 22.9) for firearm-related death. In survival analyses that accounted for competing risks, patients with an index FRH were at greater risk for subsequent FRH (subhazard ratio [sHR], 21.2 [CI, 7.0 to 64.0]), firearm-related death (sHR, 4.3 [CI, 1.3 to 14.1]), and firearm- or violence-related arrest (sHR, 2.7 [CI, 2.0 to 3.5]) than those with a non-injury-related index hospitalization. Limitation: Lack of information on whether patients continued to reside in Washington during follow-up may have introduced outcome misclassification. Conclusion: Hospitalization for a firearm-related injury is associated with a heightened risk for subsequent violent victimization or crime perpetration. Further research at the intersection of clinical care, the criminal justice system, and public health to evaluate the effectiveness of interventions delivered to survivors of firearm-related injury is warranted.	Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Rowhani-Rahbar, A (corresponding author), Univ Washington, Dept Epidemiol, Box 357236, Seattle, WA 98195 USA.			Rowhani-Rahbar, Ali/0000-0002-2705-4485; Mills, Brianna/0000-0002-6632-9592	Seattle City Council; University of Washington Royalty Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007543] Funding Source: NIH RePORTER	Seattle City Council; University of Washington Royalty Research Fund(University of Washington); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	By the Seattle City Council and the University of Washington Royalty Research Fund.	[Anonymous], NCVS VICT AN TOOL; [Anonymous], 2007, CRIMINOL PUBLIC POL, DOI DOI 10.1111/J.1745-9133.2007.00429.X; [Anonymous], 2014, INJ PREV CONTR DAT S; Broidy LM, 2006, HOMICIDE STUD, V10, P155, DOI 10.1177/1088767906288577; Centers for Disease Control and Prevention, 2014, NAT VIOL DEATH REP S; Cherry D, 1998, ANN EMERG MED, V32, P51, DOI 10.1016/S0196-0644(98)70099-X; Cook PJ, 2005, JAMA-J AM MED ASSOC, V294, P598, DOI 10.1001/jama.294.5.598; Cook PJ, 1999, JAMA-J AM MED ASSOC, V282, P447, DOI 10.1001/jama.282.5.447; Corrigan PW, 2005, PSYCHIAT RES, V136, P153, DOI 10.1016/j.psychres.2005.06.005; Cunningham R, 2009, ANN EMERG MED, V53, P490, DOI 10.1016/j.annemergmed.2008.11.014; DeLisi M, 2006, CRIM JUSTICE BEHAV, V33, P367, DOI 10.1177/0093854806286193; DiScala C, 2004, PEDIATRICS, V113, P1306, DOI 10.1542/peds.113.5.1306; Dowd MD, 1996, AM J PUBLIC HEALTH, V86, P929, DOI 10.2105/AJPH.86.7.929; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Farrington DP, 2012, HOMICIDE STUD, V16, P99, DOI 10.1177/1088767912439398; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Galea S, 2010, AM J PUBLIC HEALTH, V100, P1745, DOI 10.2105/AJPH.2009.179697; Gostin LO, 2011, JAMA-J AM MED ASSOC, V305, P2108, DOI 10.1001/jama.2011.688; Greenspan AI, 2002, J TRAUMA, V53, P709, DOI 10.1097/00005373-200210000-00015; Gubler KD, 1996, J TRAUMA, V41, P952, DOI 10.1097/00005373-199612000-00002; Hawkins JD, 2014, JAMA PEDIATR, V168, P122, DOI 10.1001/jamapediatrics.2013.4009; Howard G, 2000, ANN EPIDEMIOL, V10, P214, DOI 10.1016/S1047-2797(00)00038-7; Kalesan B, 2014, AM J EPIDEMIOL, V179, P303, DOI 10.1093/aje/kwt255; Kellermann AL, 1996, NEW ENGL J MED, V335, P1438, DOI 10.1056/NEJM199611073351906; Lauritsen JL, 2009, CRIMINOLOGY, V47, P361, DOI 10.1111/j.1745-9125.2009.00149.x; Lee J, 2014, SURGERY, V155, P894, DOI 10.1016/j.surg.2014.02.011; Loeber R, 2011, LONG RES SOC BEH SCI, P1, DOI 10.1007/978-1-4419-9949-8; Lustenberger T, 2011, WORLD J SURG, V35, P528, DOI 10.1007/s00268-010-0920-7; Metzl JM, 2011, LANCET, V377, P2172, DOI 10.1016/S0140-6736(11)60950-1; Miller T, 2012, COST FIREARM VIOLENC; Piquero AR, 2003, CRIME JUSTICE, V30, P359, DOI 10.1086/652234; Planty M., 2013, FIREARM VIOLENCE 199; Pulay AJ, 2008, J CLIN PSYCHIAT, V69, P12, DOI 10.4088/JCP.v69n0103; Purtle J, 2013, J TRAUMA ACUTE CARE, V75, P331, DOI 10.1097/TA.0b013e318294f518; RESNICK MD, 2004, J HLTH EC, V0035; RIVARA FP, 1993, JAMA-J AM MED ASSOC, V270, P1962, DOI 10.1001/jama.270.16.1962; Sampson R.J., 2005, RACE CRIME JUSTICE R, P177; Washington State Department of Health, WASH STAT COMPR HOSP; WEISBESKI D, 1989, J TRAUMA, V29, P940, DOI 10.1097/00005373-198907000-00006; Wintemute GJ, 2001, JAMA-J AM MED ASSOC, V285, P1019, DOI 10.1001/jama.285.8.1019; Worrell SS, 2006, J TRAUMA, V60, P379, DOI 10.1097/01.ta.0000203549.15373.7b; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zatzick D, 2014, JAMA PEDIATR, V168, P532, DOI 10.1001/jamapediatrics.2013.4784; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313; [No title captured]	45	70	70	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2015	162	7					492	U167		10.7326/M14-2362	http://dx.doi.org/10.7326/M14-2362			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG4UT	25706337				2022-12-28	WOS:000353283400004
J	Santander-Garcia, M; Rodriguez-Gil, P; Corradi, RLM; Jones, D; Miszalski, B; Boffin, HMJ; Rubio-Diez, MM; Kotze, MM				Santander-Garcia, M.; Rodriguez-Gil, P.; Corradi, R. L. M.; Jones, D.; Miszalski, B.; Boffin, H. M. J.; Rubio-Diez, M. M.; Kotze, M. M.			The double-degenerate, super-Chandrasekhar nucleus of the planetary nebula Henize 2-428	NATURE			English	Article							BINARY CENTRAL STARS; ORBITAL-PERIOD; EVOLUTION; COMPANION; MERCATOR; LIGHT	The planetary nebula stage is the ultimate fate of stars with masses one to eight times that of the Sun (M-circle dot). The origin of their complex morphologies is poorly understood(1), although several mechanisms involving binary interaction have been proposed(2,3). In close binary systems, the orbital separation is short enough for the primary star to overfill its Roche lobe as the star expands during the asymptotic giant branch phase. The excess gas eventually forms a common envelope surrounding both stars. Drag forces then result in the envelope being ejected into a bipolar planetary nebula whose equator is coincident with the orbital plane of the system. Systems in which both stars have ejected their envelopes and are evolving towards the white dwarf stage are said to be double degenerate. Here we report that Henize 2-428 has a double-degenerate core with a combined mass of similar to 1.76M(circle dot), which is above the Chandrasekhar limit (the maximum mass of a stable white dwarf) of 1.4M(circle dot). This, together with its short orbital period (4.2 hours), suggests that the system should merge in 700 million years, triggering a type Ia supernova event. This supports the hypothesis of the double-degenerate, super-Chandrasekhar evolutionary pathway for the formation of type Ia supernovae(4).	[Santander-Garcia, M.] Observ Astron Nacl, E-28803 Alcala De Henares, Spain; [Santander-Garcia, M.] CSIC, Inst Ciencia Mat Madrid, E-28049 Madrid, Spain; [Rodriguez-Gil, P.; Corradi, R. L. M.; Jones, D.] Inst Astrofis Canarias, E-38200 Tenerife, Spain; [Rodriguez-Gil, P.; Corradi, R. L. M.; Jones, D.] Univ La Laguna, Dept Astrofis, E-38205 Tenerife, Spain; [Miszalski, B.; Kotze, M. M.] South African Astron Observ, ZA-7935 Observatory, South Africa; [Miszalski, B.] Southern African Large Telescope Fdn, ZA-7935 Observatory, South Africa; [Boffin, H. M. J.] European So Observ, Santiago 19001, Chile; [Rubio-Diez, M. M.] INTA, CSIC, Ctr Astrobiol, E-28850 Torrejon De Ardoz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); Instituto de Astrofisica de Canarias; Universidad de la Laguna; National Research Foundation - South Africa; South African Astronomical Observatory; European Southern Observatory; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Santander-Garcia, M (corresponding author), Observ Astron Nacl, Apartado Correos 112, E-28803 Alcala De Henares, Spain.	m.santander@oan.es	Jones, David/G-8109-2014; Rodriguez-Gil, Pablo/H-7709-2015	Jones, David/0000-0003-3947-5946; Rodriguez-Gil, Pablo/0000-0002-4717-5102; Kotze, Marissa/0000-0003-2711-051X; Santander-Garcia, Miguel/0000-0002-7338-0986	Spanish MINECO [CSD2009-00038, AYA2012-35330, RYC-2010-05762, AYA 2012-38700]	Spanish MINECO(Spanish Government)	This work is based on observations made with the 1 m SAAO (South Africa Astronomical Observatory), the 1.2 m Mercator, the 2.5 m INT (Isaac Newton Telescope), the 4.2 m WHT (William Herschel Telescope), the 8.2 m VLT and the 10.4 m GTC telescopes. We are grateful to T. Marsh for the use of the PAMELA and MOLLY codes, to T. Hillwig, O. Pals and J. Alcolea for their comments and to J. Garcia-Rojas and C. Zurita for the INT/WFC (Wide Field Camera) service observations. This work was partially supported by the Spanish MINECO within grants CSD2009-00038, AYA2012-35330, RYC-2010-05762 and AYA 2012-38700.	Balick B, 2002, ANNU REV ASTRON ASTR, V40, P439, DOI 10.1146/annurev.astro.40.060401.093849; BLOCKER T, 1995, ASTRON ASTROPHYS, V299, P755; Boffin HMJ, 2011, ASTR SOC P, V447, P159; Bruch A, 2001, ASTRON ASTROPHYS, V377, P898, DOI 10.1051/0004-6361:20011092; Castelli F., 2004, PREPRINT; Chen XF, 2008, MON NOT R ASTRON SOC, V387, P1416, DOI 10.1111/j.1365-2966.2008.13334.x; Claret A, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201116451; Corradi RLM, 2014, MON NOT R ASTRON SOC, V441, P2799, DOI 10.1093/mnras/stu703; Davignon G, 2004, P SOC PHOTO-OPT INS, V5492, P871, DOI 10.1117/12.550773; De Marco O, 2009, PUBL ASTRON SOC PAC, V121, P316, DOI 10.1086/597765; Fitzpatrick E.L., 2004, ASTRONOMICAL SOC PAC, V309, P33; Garcia-Arrendondo F, 2004, ASTROPHYS J, V600, P992, DOI 10.1086/379821; Hillwig TC, 2013, ASTR SOC P, V469, P277; Hillwig TC, 2010, ASTRON J, V140, P319, DOI 10.1088/0004-6256/140/2/319; Howell DA, 2006, NATURE, V443, P308, DOI 10.1038/nature05103; Jones D, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322797; Jones D., 2014, P AS PLAN NEB 6 C 4, P43; Miszalski B, 2009, ASTRON ASTROPHYS, V505, P249, DOI 10.1051/0004-6361/200912176; PACZYNSKI B, 1971, ANNU REV ASTRON ASTR, V9, P183, DOI 10.1146/annurev.aa.09.090171.001151; Prsa A., 2011, **DATA OBJECT**; Raskin G, 2004, P SOC PHOTO-OPT INS, V5492, P830, DOI 10.1117/12.550191; Rodriguez M, 2001, ASTRON ASTROPHYS, V377, P1042, DOI 10.1051/0004-6361:20011123; Rodriguez-Gil P, 2010, MON NOT R ASTRON SOC, V407, pL21, DOI 10.1111/j.1745-3933.2010.00895.x; Schaefer BE, 2012, NATURE, V481, P164, DOI 10.1038/nature10692; SchwarzenbergCzerny A, 1996, ASTROPHYS J, V460, pL107, DOI 10.1086/309985; Shapiro S.L., 1983, BLACK HOLES WHITE DW; Stanghellini L, 2002, ASTROPHYS J, V576, P285, DOI 10.1086/341340; Stroeer A, 2007, ASTRON ASTROPHYS, V462, P269, DOI 10.1051/0004-6361:20065564; Tovmassian G, 2010, ASTROPHYS J, V714, P178, DOI 10.1088/0004-637X/714/1/178; Weidemann V, 2000, ASTRON ASTROPHYS, V363, P647; WILSON RE, 1979, ASTROPHYS J, V234, P1054, DOI 10.1086/157588	32	58	58	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					63	U12		10.1038/nature14124	http://dx.doi.org/10.1038/nature14124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25686608	Green Submitted			2022-12-28	WOS:000350304000035
J	Kling, J				Kling, Jim			MEASURE FOR MEASURE	NATURE			English	Editorial Material																		Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Chattopadhyay PK, 2012, CYTOM PART A, V81A, P456, DOI 10.1002/cyto.a.22043; Gaudilliere B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009701; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702	5	10	10	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					439	443		10.1038/518439a	http://dx.doi.org/10.1038/518439a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3SA	25693572	Bronze			2022-12-28	WOS:000349547400051
J	Lamichhaney, S; Berglund, J; Almen, MS; Maqbool, K; Grabherr, M; Martinez-Barrio, A; Promerova, M; Rubin, CJ; Wang, C; Zamani, N; Grant, BR; Grant, PR; Webster, MT; Andersson, L				Lamichhaney, Sangeet; Berglund, Jonas; Almen, Markus Sallman; Maqbool, Khurram; Grabherr, Manfred; Martinez-Barrio, Alvaro; Promerova, Marta; Rubin, Carl-Johan; Wang, Chao; Zamani, Neda; Grant, B. Rosemary; Grant, Peter R.; Webster, Matthew T.; Andersson, Leif			Evolution of Darwin's finches and their beaks revealed by genome sequencing	NATURE			English	Article							FRONTONASAL DYSPLASIA; GEOSPIZA-DIFFICILIS; ADAPTIVE RADIATION; SPECIATION; GALAPAGOS; ALIGNMENT; GENE; ASSOCIATION; POPULATIONS; MORPHOLOGY	Darwin's finches, inhabiting the Galapagos archipelago and Cocos Island, constitute an iconic model for studies of speciation and adaptive evolution. Here we report the results of whole-genome re-sequencing of 120 individuals representing all of the Darwin's finch species and two close relatives' Phylogenetic analysis reveals important discrepancies with the phenotype-based taxonomy. We find extensive evidence for interspecific gene flow throughout the radiation. Hybridization has given rise to species of mixed ancestry. A 240 kilobase haplotype encompassing the ALX1 gene that encodes a transcription factor affecting craniofacial. development is strongly associated with beak shape diversity across Darwin's finch species as well as within the medium ground finch (Geospiza fortis) a species that has undergone rapid evolution of beak shape in response to environmental changes. The ALX1 haplotype has contributed to diversification of beak shapes among the Darwin's finches and thereby, to an expanded utilization of food resources.	[Lamichhaney, Sangeet; Berglund, Jonas; Almen, Markus Sallman; Grabherr, Manfred; Martinez-Barrio, Alvaro; Promerova, Marta; Rubin, Carl-Johan; Wang, Chao; Zamani, Neda; Webster, Matthew T.; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Maqbool, Khurram; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75007 Uppsala, Sweden; [Zamani, Neda] Umea Univ, Dept Plant Physiol, SE-90187 Umea, Sweden; [Grant, B. Rosemary; Grant, Peter R.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Andersson, Leif] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	Uppsala University; Swedish University of Agricultural Sciences; Umea University; Princeton University; Texas A&M University System; Texas A&M University College Station	Andersson, L (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden.	leif.andersson@imbim.uu.se	Grant, Peter/HIR-3733-2022	Rubin, Carl-Johan/0000-0001-8238-5052; Maqbool, Khurram/0000-0003-2981-2582; Sallman Almen, Markus/0000-0001-9591-9228; Grabherr, Manfred/0000-0001-8792-6508; Webster, Matthew/0000-0003-1141-2863	National Science Foundation (USA); Knut and Alice Wallenberg Foundation; Uppsala University and Hospital, SciLifeLab; Swedish Research Council [80576801, 70374401]	National Science Foundation (USA)(National Science Foundation (NSF)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Uppsala University and Hospital, SciLifeLab; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The National Science Foundation (USA) funded the collection of material under permits from the Galapagos and Costa Rica National Parks Services, and in accordance with protocols of Princeton University's Animal Welfare Committee. The map and images of finch heads are reproduced with permission from Princeton University Press. The project was supported by the Knut and Alice Wallenberg Foundation. Sequencing was performed by the SNP&SEQ Technology Platform, supported by Uppsala University and Hospital, SciLifeLab and Swedish Research Council (80576801 and 70374401). Computer resources were supplied by UPPMAX.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Ali JR, 2014, J BIOGEOGR, V41, P1227, DOI 10.1111/jbi.12313; Andersson L, 2013, CURR OPIN GENET DEV, V23, P295, DOI 10.1016/j.gde.2013.02.014; Balakrishnan CN, 2009, GENETICS, V181, P645, DOI 10.1534/genetics.108.094250; BOAG PT, 1984, J ZOOL, V204, P413, DOI 10.1111/j.1469-7998.1984.tb02380.x; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Brugmann SA, 2010, HUM MOL GENET, V19, P920, DOI 10.1093/hmg/ddp559; Burns KJ, 2014, MOL PHYLOGENET EVOL, V75, P41, DOI 10.1016/j.ympev.2014.02.006; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Dee CT, 2013, HUM MOL GENET, V22, P239, DOI 10.1093/hmg/dds423; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellegren H, 2013, ANNU REV ECOL EVOL S, V44, P239, DOI 10.1146/annurev-ecolsys-110411-160327; Farrington HL, 2014, EVOLUTION, V68, P2932, DOI 10.1111/evo.12484; Geist DJ, 2014, GEOPHYS MONOGR SER, V204, P145; Grant P.R., 1999, RECOGNITION STATES L, V2; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grant P. R., 2014, 40 YEARS EVOLUTION D, DOI DOI 10.2307/J.CTT5HHNCC; GRANT PR, 1985, BIOL J LINN SOC, V25, P1, DOI 10.1111/j.1095-8312.1985.tb00384.x; Grant PR, 2000, BIOL J LINN SOC, V69, P287, DOI 10.1006/bijl.1999.0382; GRANT PR, 1992, ECOLOGY, V73, P766, DOI 10.2307/1940156; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; HOLM S, 1979, SCAND J STAT, V6, P65; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lack D., 1947, DARWINS FINCHES; Lack David, 1945, OCCAS PAPERS CALIFORNIA ACAD SCI, V21, P1; Li B., 2012, GENOME DARWINS FINCH, DOI [10.5524/100040, DOI 10.5524/100040]; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mallarino R, 2011, P NATL ACAD SCI USA, V108, P4057, DOI 10.1073/pnas.1011480108; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; NEI M, 1987, MOL EVOLUTIONARY GEN, P276; Petren K, 2005, MOL ECOL, V14, P2943, DOI 10.1111/j.1365-294X.2005.02632.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qvarnstrom A, 2009, HEREDITY, V102, P4, DOI 10.1038/hdy.2008.93; Rabosky DL, 2013, ANNU REV ECOL EVOL S, V44, P481, DOI 10.1146/annurev-ecolsys-110512-135800; Rands CM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-95; Rivera-Perez JA, 1999, DEVELOPMENT, V126, P3811; ROWE A, 1991, DEVELOPMENT, V111, P1007; SCHLUTER D, 1984, EVOLUTION, V38, P856, DOI 10.1111/j.1558-5646.1984.tb00357.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sommer P, 2006, DEV GROWTH DIFFER, V48, P297, DOI 10.1111/j.1440-169x.2006.00866.x; SWARTH HARRY S., 1931, OCC PAPERS CALIFORNIA ACAD SCI, V18, P1; Uz E, 2010, AM J HUM GENET, V86, P789, DOI 10.1016/j.ajhg.2010.04.002; Van der Auwera G. A., 2002, CURR PROTOC BIOINFOR, V43, p11 101; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x	59	528	541	30	828	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					371	375		10.1038/nature14181	http://dx.doi.org/10.1038/nature14181			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25686609				2022-12-28	WOS:000349547400036
J	Skipper, M; Eccleston, A; Gray, N; Heemels, T; Le Bot, N; Marte, B; Weiss, U				Skipper, Magdalena; Eccleston, Alex; Gray, Noah; Heemels, Therese; Le Bot, Nathalie; Marte, Barbara; Weiss, Ursula			EPIGENOME ROADMAP	NATURE			English	Editorial Material														Gray, Noah/0000-0002-4672-7403					0	20	21	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					313	313		10.1038/518313a	http://dx.doi.org/10.1038/518313a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB7IL	25693561	Bronze			2022-12-28	WOS:000416862800001
J	Chapman, S				Chapman, Sarah			"How can I help you hear?" The transforming power of six little words	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2015	350								h184	10.1136/bmj.h184	http://dx.doi.org/10.1136/bmj.h184			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WC	25694114	Green Published, Bronze			2022-12-28	WOS:000349911500001
J	Ravanelli, NM; Hodder, SG; Havenith, G; Jay, O				Ravanelli, Nicholas M.; Hodder, Simon G.; Havenith, George; Jay, Ollie			Heart Rate and Body Temperature Responses to Extreme Heat and Humidity With and Without Electric Fans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MEN		[Ravanelli, Nicholas M.] Univ Sydney, Thermal Ergon Lab, Sydney, NSW 2006, Australia; [Hodder, Simon G.; Havenith, George] Univ Loughborough, Environm Ergon Res Ctr, Loughborough, Leics, England; [Jay, Ollie] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia	University of Sydney; Loughborough University; University of Sydney	Jay, O (corresponding author), Univ Sydney, Fac Hlth Sci, 75 East St, Lidcombe, NSW 2141, Australia.	ollie.jay@sydney.edu.au	Jay, Ollie/AAD-8009-2020; Havenith, George/B-8579-2008; Ravanelli, Nicholas/AAB-5255-2020	Havenith, George/0000-0001-6223-4265; Ravanelli, Nicholas/0000-0002-4894-9552; Hodder, Simon/0000-0002-3554-3609; Jay, Ollie/0000-0002-6076-6337				Gupta S, 2012, COCHRANE DB SYST REV, V7; INOUE Y, 1991, J APPL PHYSIOL, V71, P2453, DOI 10.1152/jappl.1991.71.6.2453; Kenney WL, 2002, J APPL PHYSIOL, V92, P2256, DOI 10.1152/japplphysiol.01040.2001; Patz JA, 2014, JAMA-J AM MED ASSOC, V312, P1565, DOI 10.1001/jama.2014.13186; US Environmental Protection Agency, EXC HEAT EV GUID; World Health Organization, PUBL HLTH ADV PREV H	6	53	53	3	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					724	725		10.1001/jama.2015.153	http://dx.doi.org/10.1001/jama.2015.153			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25688786	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000349476100020
J	Torres, A; Sibila, O; Ferrer, M; Polverino, E; Menendez, R; Mensa, J; Gabarrus, A; Sellares, J; Restrepo, MI; Anzueto, A; Niederman, MS; Agusti, C				Torres, Antoni; Sibila, Oriol; Ferrer, Miguel; Polverino, Eva; Menendez, Rosario; Mensa, Josep; Gabarrus, Albert; Sellares, Jacobo; Restrepo, Marcos I.; Anzueto, Antonio; Niederman, Michael S.; Agusti, Caries			Effect of Corticosteroids on Treatmmt Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HYDROCORTISONE THERAPY; RISK; PROGNOSIS; OUTCOMES; GLUCOCORTICOIDS; DEXAMETHASONE; PREDICTION; GUIDELINES; MORTALITY; PATTERNS	IMPORTANCE In patients with severe community-acquired pneumonia, treatment failure is associated with excessive inflammatory response and worse outcomes. Corticosteroids may modulate cytokine release in these patients, but the benefit of this adjunctive therapy remains controversial. OBJECTIVE To assess the effect of corticosteroids in patients with severe community-acquired pneumonia and high associated inflammatory response. DESIGN, SETTING, AND PARTICIPANTS Multicenter, randomized, double-blind, placebo-controlled trial conducted in 3 Spanish teaching hospitals involving patients with both severe community-acquired pneumonia and a high inflammatory response, which was defined as a level of C-reactive protein greater than 150 mg/L at admission. Patients were recruited and followed up from June 2004 through February 2012. INTERVENTIONS Patients were randomized to receive either an intravenous bolus of 0.5 mg/kg per 12 hours of methylprednisolone (n = 61) or placebo (n = 59) for 5 days started within 36 hours of hospital admission. MAIN OUTCOMES AND MEASURES The primary outcome was treatment failure (composite outcome of early treatment failure defined as [1] clinical deterioration indicated by development of shock, [2] need for invasive mechanical ventilation not present at baseline, or [3] death within 72 hours of treatment; or composite outcome of late treatment failure defined as [1] radiographic progression, [2] persistence of severe respiratory failure, [3] development of shock, [4] need for invasive mechanical ventilation not present at baseline, or [5] death between 72 hours and 120 hours after treatment initiation; or both early and late treatment failure). In-hospital mortality was a secondary outcome and adverse events were assessed. RESULTS There was less treatment failure among patients from the methylprednisolone group (8 patients [13%]) compared with the placebo group (18 patients [31%]) (P = .02), with a difference between groups of 18% (95% CI, 3% to 32%). Corticosteroid treatment reduced the risk of treatment failure (odds ratio, 0.34 [95% CI, 0.14 to 0.87]; P = .02). In-hospital mortality did not differ between the 2 groups (6 patients [10%] in the methylprednisolone group vs 9 patients [15%] in the placebo group; P = .37); the difference between groups was 5% (95% CI, -6% to 17%). Hyperglycemia occurred in 11 patients (18%) in the methylprednisolone group and in 7 patients (12%) in the placebo group (P = .34). CONCLUSIONS AND RELEVANCE Among patients with severe community-acquired pneumonia and high initial inflammatory response, the acute use of methylprednisolone compared with placebo decreased treatment failure. If replicated, these findings would support the use of corticosteroids as adjunctive treatment in this clinical population.	[Torres, Antoni; Ferrer, Miguel; Polverino, Eva; Gabarrus, Albert; Sellares, Jacobo; Agusti, Caries] Hosp Clin Barcelona, Serv Pneumol, Inst Clin Torax, E-08036 Barcelona, Spain; [Torres, Antoni; Ferrer, Miguel; Polverino, Eva; Mensa, Josep; Gabarrus, Albert; Sellares, Jacobo; Agusti, Caries] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Torres, Antoni; Ferrer, Miguel; Polverino, Eva; Menendez, Rosario; Gabarrus, Albert; Sellares, Jacobo; Agusti, Caries] Ctr Invest Biomed Red Enfermedades Resp, Islas Baleares, Spain; [Torres, Antoni] Univ Barcelona, Barcelona, Spain; [Sibila, Oriol] Hosp Santa Creu & Sant Pau, Serv Pneumol, Barcelona, Spain; [Sibila, Oriol] Inst Invest Biomed St Pau, Barcelona, Spain; [Menendez, Rosario] Hosp Univ La Fe, Serv Neumol, Valencia, Spain; [Mensa, Josep] Hosp Clin Barcelona, Serv Malalties Infeccioses, E-08036 Barcelona, Spain; [Restrepo, Marcos I.; Anzueto, Antonio] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Restrepo, Marcos I.; Anzueto, Antonio] South Texas Vet Hlth Care Syst, Audie L Murphy Div, San Antonio, TX USA; [Restrepo, Marcos I.] VERDICT, San Antonio, TX USA; [Niederman, Michael S.] Winthrop Univ Hosp, Mineola, NY 11501 USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital of Santa Creu i Sant Pau; Hospital Universitari i Politecnic La Fe; University of Barcelona; Hospital Clinic de Barcelona; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Winthrop University Hospital	Torres, A (corresponding author), Hosp Clin Barcelona, Serv Pneumol, C Villarroel 170, E-08036 Barcelona, Spain.	atorres@ub.edu	Torres, Antonio/AAI-3334-2021; Menéndez, Rosario/G-9723-2016; POLVERINO, eva/AAI-6053-2021; Sibila, Oriol/T-4366-2017; Sellares, Jacobo/AAN-3250-2020; Torres, Antoni/H-6128-2017	Torres, Antonio/0000-0002-8643-2167; Menéndez, Rosario/0000-0002-3592-3839; Sibila, Oriol/0000-0002-4833-6713; Torres, Antoni/0000-0002-8643-2167; Ferrer, Miguel/0000-0001-8171-6673; Sellares, Jacobo/0000-0001-6047-1670; Polverino, Eva/0000-0002-4058-5109; Gabarrus, Albert/0000-0003-3492-1310	Sociedad Espanola de Neumologia; Societat Catalana de Pneumologia; Fundacio Catalana de Pneumologia; Grup de Recerca de Qualitat de la Generalitat de Catalunya [SGR-2011]; Fondo de Investigacion Sanitaria [PI030113]; Institut dInvestigacions Biomediques August Pi i Sunyer; Centro de Investigacion Biomedica En Red-Enfermedades Respiratorias [CB06/06/0028]	Sociedad Espanola de Neumologia; Societat Catalana de Pneumologia; Fundacio Catalana de Pneumologia; Grup de Recerca de Qualitat de la Generalitat de Catalunya; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Institut dInvestigacions Biomediques August Pi i Sunyer; Centro de Investigacion Biomedica En Red-Enfermedades Respiratorias	This study was supported by the Sociedad Espanola de Neumologia, the Societat Catalana de Pneumologia, the Fundacio Catalana de Pneumologia, the Grup de Recerca de Qualitat de la Generalitat de Catalunya (grant SGR-2011), the Fondo de Investigacion Sanitaria (grant PI030113), the Institut dInvestigacions Biomediques August Pi i Sunyer, and the Centro de Investigacion Biomedica En Red-Enfermedades Respiratorias (grant CB06/06/0028).	Alvarez-Lerma Francisco, 2004, Curr Opin Crit Care, V10, P369; Cilloniz C, 2011, CRIT CARE, V15, DOI 10.1186/cc10444; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Confalonieri M, 2013, CURR INFECT DIS REP, V15, P158, DOI 10.1007/s11908-013-0322-8; Ewig S, 1998, AM J RESP CRIT CARE, V158, P1102, DOI 10.1164/ajrccm.158.4.9803114; Fernandez-Serrano S, 2003, CLIN DIAGN LAB IMMUN, V10, P813, DOI 10.1128/CDLI.10.5.813-820.2003; Fernandez-Serrano S, 2011, CRIT CARE, V15, DOI 10.1186/cc10103; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Garcia-Vidal C, 2007, EUR RESPIR J, V30, P951, DOI 10.1183/09031936.00027607; Halm EA, 1998, JAMA-J AM MED ASSOC, V279, P1452, DOI 10.1001/jama.279.18.1452; Li Y, 2008, INTENS CARE MED, V34, P568, DOI 10.1007/s00134-007-0921-7; Lisboa T, 2009, CHEST, V135, P165, DOI 10.1378/chest.08-1216; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martinez R, 2011, EUR RESPIR J, V37, P393, DOI 10.1183/09031936.00040710; Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7; Menendez R, 2008, THORAX, V63, P447, DOI 10.1136/thx.2007.086785; Menendez R, 2004, THORAX, V59, P960, DOI 10.1136/thx.2003.017756; Menendez R, 2009, THORAX, V64, P587, DOI 10.1136/thx.2008.105312; Nawab QUA, 2011, INTENS CARE MED, V37, P1553, DOI 10.1007/s00134-011-2274-5; Nie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047926; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; PUREN AJ, 1995, CHEST, V107, P1342, DOI 10.1378/chest.107.5.1342; Ramirez P, 2011, CRIT CARE MED, V39, P2211, DOI 10.1097/CCM.0b013e3182257445; Remmelts HHF, 2012, J INFECTION, V65, P25, DOI 10.1016/j.jinf.2012.03.008; Restrepo MI, 2008, CHEST, V133, P610, DOI 10.1378/chest.07-1456; Restrepo MI, 2010, CHEST, V137, P552, DOI 10.1378/chest.09-1547; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Roson B, 2004, ARCH INTERN MED, V164, P502, DOI 10.1001/archinte.164.5.502; Salluh JIF, 2011, J CRIT CARE, V26, P193, DOI 10.1016/j.jcrc.2010.07.014; Sibila O, 2008, EUR RESPIR J, V32, P1037, DOI 10.1183/09031936.00009208; Sibila O, 2007, EUR RESPIR J, V30, P1167, DOI 10.1183/09031936.00053607; Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; STUCK AE, 1989, REV INFECT DIS, V11, P954; Talbot GH, 2012, CLIN INFECT DIS, V55, P1114, DOI 10.1093/cid/cis566; Valencia M, 2007, CHEST, V132, P515, DOI 10.1378/chest.07-0306	37	324	356	2	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					677	686		10.1001/jama.2015.88	http://dx.doi.org/10.1001/jama.2015.88			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25688779	Green Published, Bronze			2022-12-28	WOS:000349476100013
J	Coventry, P; Lovell, K; Dickens, C; Bower, P; Chew-Graham, C; McElvenny, D; Hann, M; Cherrington, A; Garrett, C; Gibbons, CJ; Baguley, C; Roughley, K; Adeyemi, I; Reeves, D; Waheed, W; Gask, L				Coventry, Peter; Lovell, Karina; Dickens, Chris; Bower, Peter; Chew-Graham, Carolyn; McElvenny, Damien; Hann, Mark; Cherrington, Andrea; Garrett, Charlotte; Gibbons, Chris J.; Baguley, Clare; Roughley, Kate; Adeyemi, Isabel; Reeves, David; Waheed, Waquas; Gask, Linda			Integrated primary care for patients with mental and physical multimorbidity: cluster randomised controlled trial of collaborative care for patients with depression comorbid with diabetes or cardiovascular disease	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; INTERVENTIONS; PEOPLE; MANAGEMENT; QUESTIONNAIRE; CIRCULATION; EDUCATION; COINCIDE; RECOVERY; OUTCOMES	OBJECTIVE To test the effectiveness of an integrated collaborative care model for people with depression and long term physical conditions. DESIGN Cluster randomised controlled trial. SETTING 36 general practices in the north west of England. PARTICIPANTS 387 patients with a record of diabetes or heart disease, or both, who had depressive symptoms (>= 10 on patient health questionaire-9 (PHQ-9)) for at least two weeks. Mean age was 58.5 (SD 11.7). Participants reported a mean of 6.2 (SD 3.0) long term conditions other than diabetes or heart disease; 240 (62%) were men; 360 (90%) completed the trial. INTERVENTIONS Collaborative care included patient preference for behavioural activation, cognitive restructuring, graded exposure, and/or lifestyle advice, management of drug treatment, and prevention of relapse. Up to eight sessions of psychological treatment were delivered by specially trained psychological wellbeing practitioners employed by Improving Access to Psychological Therapy services in the English National Health Service; integration of care was enhanced by two treatment sessions delivered jointly with the practice nurse. Usual care was standard clinical practice provided by general practitioners and practice nurses. MAIN OUTCOME MEASURES The primary outcome was reduction in symptoms of depression on the self reported symptom checklist-13 depression scale (SCL-D13) at four months after baseline assessment. Secondary outcomes included anxiety symptoms (generalised anxiety disorder 7), self management (health education impact questionnaire), disability (Sheehan disability scale), and global quality of life (WHOQOL-BREF). RESULTS 19 general practices were randomised to collaborative care and 20 to usual care; three practices withdrew from the trial before patients were recruited. 191 patients were recruited from practices allocated to collaborative care, and 196 from practices allocated to usual care. After adjustment for baseline depression score, mean depressive scores were 0.23 SCL-D13 points lower (95% confidence interval -0.41 to -0.05) in the collaborative care arm, equal to an adjusted standardised effect size of 0.30. Patients in the intervention arm also reported being better self managers, rated their care as more patient centred, and were more satisfied with their care. There were no significant differences between groups in quality of life, disease specific quality of life, self efficacy, disability, and social support. CONCLUSIONS Collaborative care that incorporates brief low intensity psychological therapy delivered in partnership with practice nurses in primary care can reduce depression and improve self management of chronic disease in people with mental and physical multimorbidity. The size of the treatment effects were modest and were less than the prespecified effect but were achieved in a trial run in routine settings with a deprived population with high levels of mental and physical multimorbidity.	[Coventry, Peter; McElvenny, Damien; Adeyemi, Isabel] NIHR Collaborat Leadership Appl Hlth Res & Care, Manchester, England; [Coventry, Peter; Lovell, Karina; Bower, Peter; McElvenny, Damien; Hann, Mark; Garrett, Charlotte; Adeyemi, Isabel; Reeves, David; Gask, Linda] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England; [Lovell, Karina] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester M13 9PL, Lancs, England; [Dickens, Chris] Univ Exeter, Sch Med, Inst Hlth Serv Res, Exeter EX1 2LU, Devon, England; [Bower, Peter; Reeves, David] Univ Manchester, NIHR Sch Primary Care Res, Manchester M13 9PL, Lancs, England; [Chew-Graham, Carolyn; Cherrington, Andrea] Keele Univ, Res Inst, Keele ST5 5BG, Staffs, England; [Chew-Graham, Carolyn] Keele Univ, NIHR Collaborat Leadership Appl Hlth Res & Care W, Keele ST5 5BG, Staffs, England; [Hann, Mark] Univ Manchester, Ctr Biostat, Manchester M13 9PL, Lancs, England; [Garrett, Charlotte; Gask, Linda] Univ Manchester, Ctr Primary Care, Manchester M13 9PL, Lancs, England; [Gibbons, Chris J.] Univ Manchester, Manchester Ctr Hlth Psychol, Manchester M13 9PL, Lancs, England; [Baguley, Clare] NHS Hlth Educ North West, Manchester M1 3BN, Lancs, England; [Roughley, Kate] Univ Liverpool, Div Clin Psychol, Liverpool L69 3GB, Merseyside, England; [Waheed, Waquas] Lancashire Care NHS Fdn Trust, Preston PR5 6AW, Lancs, England	University of Manchester; University of Manchester; University of Exeter; University of Manchester; Keele University; Keele University; University of Manchester; University of Manchester; University of Manchester; University of Liverpool	Coventry, P (corresponding author), NIHR Collaborat Leadership Appl Hlth Res & Care, Manchester, England.	peter.a.coventry@manchester.ac.uk	Coventry, Peter/AAA-9344-2019; Bower, Peter/A-1508-2011; Coventry, Peter/H-6714-2014; Lovell, Karina S E/E-6410-2012; Reeves, David/H-6203-2014; Sidey-Gibbons, Chris/G-3101-2014	Coventry, Peter/0000-0003-0625-3829; Bower, Peter/0000-0001-9558-3349; Coventry, Peter/0000-0003-0625-3829; Lovell, Karina S E/0000-0001-8821-895X; Reeves, David/0000-0001-6377-6859; Sidey-Gibbons, Chris/0000-0002-4732-7305; Dickens, Chris/0000-0001-6326-7544; Adeyemi, Isabel/0000-0003-4912-9385	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Greater Manchester	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Greater Manchester	This trial was funded by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Greater Manchester. The views expressed in this article are those of the authors and not necessarily those of the NIHR, NHS, or the Department of Health.	Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bayliss EA, 2009, J CLIN EPIDEMIOL, V62, P550, DOI 10.1016/j.jclinepi.2008.05.002; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Briddon J, 2008, J MENT HEALTH TRAIN, V3, P12, DOI 10.1108/17556228200800003; Brockmeier LL, 2003, MULT LINEAR REGRESSI, V29, P8; Brown S, 2005, STAT MED, V24, P3715, DOI 10.1002/sim.2391; Campbell Marion K, 2012, BMJ, V345, pe5661, DOI 10.1136/bmj.e5661; Cape J, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-38; Carney RM, 2004, PSYCHOSOM MED, V66, P799, DOI 10.1097/01.psy.0000146795.38162.b1; Chalder M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2758; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Coventry PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108114; Coventry PA, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-136; Coventry PA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-139; DCCT Res Grp, 1988, DIABETES CARE, V11, P725; Department for Communities and Local Government, 2011, ENGL IND DEPR 2010; Department of Health, 2011, NO HLTH MENT HLTH CR; DEROGATIS LR, 1977, J CLIN PSYCHOL, V33, P981, DOI 10.1002/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0; Dickens C, 2012, J PSYCHOSOM RES, V73, P334, DOI 10.1016/j.jpsychores.2012.08.018; Gibbons CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081852; Gilbody S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002792.pub2; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Gunn J, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-88; Hjerl K, 2003, PSYCHOSOMATICS, V44, P24, DOI 10.1176/appi.psy.44.1.24; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042; Knowles SE, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-110; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lin EHB, 2000, ARCH FAM MED, V9, P1052, DOI 10.1001/archfami.9.10.1052; Lorig K., 1996, OUTCOME MEASURES HLT, VVol. 2019; Lovell K, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-91; Mercer SW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5559; Mercer SW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4152; Mitchell Pamela H, 2003, J Cardiopulm Rehabil, V23, P398, DOI 10.1097/00008483-200311000-00001; Morgan MAJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002171; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Myles P, 2007, COMPLETE GUIDE PRIMA; National Institute for Health and Care Excellence, 2009, DEPR AD CHRON PHYS H; Naylor C., 2012, LONG TERM CONDITIONS; NICE, 2010, DEPR TREATM MAN DEPR; NICE, 2010, DEPR AD CHRON PHYS H; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Richards DA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4913; Rick J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-293; Salisbury C, 2012, LANCET, V380, P7, DOI 10.1016/S0140-6736(12)60482-6; Sharpe M, 2014, LANCET, V384, P1099, DOI 10.1016/S0140-6736(14)61231-9; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Strong V, 2008, LANCET, V372, P40, DOI 10.1016/S0140-6736(08)60991-5; Sun X, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1553; Turpin G, 2011, IAPT SUPERVISION GUI; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Von Korff Michael, 2011, BMJ, V343, pd6612, DOI 10.1136/bmj.d6612; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; World Health Organization, 2005, MENT HLTH FAC CHALL	62	156	160	5	79	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2015	350								h638	10.1136/bmj.h638	http://dx.doi.org/10.1136/bmj.h638			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB8WA	25687344	hybrid, Green Published			2022-12-28	WOS:000349911300001
J	Greenblum, S; Carr, R; Borenstein, E				Greenblum, Sharon; Carr, Rogan; Borenstein, Elhanan			Extensive Strain-Level Copy-Number Variation across Human Gut Microbiome Species	CELL			English	Article							COMPARATIVE GENOMICS; METABOLIC SYNDROME; ESCHERICHIA-COLI; OXIDATIVE STRESS; GENE LOSS; DIVERSITY; BACTERIA; MICE; COLONIZATION; VIRULENCE	Within each bacterial species, different strains may vary in the set of genes they encode or in the copy number of these genes. Yet, taxonomic characterization of the human microbiota is often limited to the species level or to previously sequenced strains, and accordingly, the prevalence of intra-species variation, its functional role, and its relation to host health remain unclear. Here, we present a comprehensive large-scale analysis of intra-species copy-number variation in the gut microbiome, introducing a rigorous computational pipeline for detecting such variation directly from shotgun metagenomic data. We uncover a large set of variable genes in numerous species and demonstrate that this variation has significant functional and clinically relevant implications. We additionally infer intra-species compositional profiles, identifying population structure shifts and the presence of yet uncharacterized variants. Our results highlight the complex relationship between microbiome composition and functional capacity, linking metagenome-level compositional shifts to strain-level variation.	[Greenblum, Sharon; Carr, Rogan; Borenstein, Elhanan] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Engn & Sci, Seattle, WA 98195 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Santa Fe Institute	Borenstein, E (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	elbo@uw.edu			New Innovator Award [DP2 AT 007802-01]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [DP2AT007802] Funding Source: NIH RePORTER	New Innovator Award; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	We thank Peter Turnbaugh, Jay Shendure, Phil Green, Colin Manoil, two anonymous reviewers, and the members of the Borenstein Lab for support and helpful discussions. This work was supported by a New Innovator Award DP2 AT 007802-01 to EB.	AlMamun AAM, 1997, J BACTERIOL, V179, P4493, DOI 10.1128/jb.179.14.4493-4500.1997; Borziak K, 2013, J BACTERIOL, V195, P3596, DOI 10.1128/JB.00421-13; Brown CT, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-30; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; Fitzsimons MS, 2013, GENOME RES, V23, P878, DOI 10.1101/gr.142208.112; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gevers D, 2004, TRENDS MICROBIOL, V12, P148, DOI 10.1016/j.tim.2004.02.007; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Han XY, 2008, J BACTERIOL, V190, P3323, DOI 10.1128/JB.01807-07; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; Hoffman LR, 2014, CLIN INFECT DIS, V58, P396, DOI 10.1093/cid/cit715; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Kraal L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097279; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Langsjoen PH, 2014, CLIN PHARM DRUG DEV, V3, P13, DOI 10.1002/cpdd.73; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lee MC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002651; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Neville BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068919; Pimenta AL, 2005, J BACTERIOL, V187, P7471, DOI 10.1128/JB.187.21.7471-7480.2005; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Siezen RJ, 2010, ENVIRON MICROBIOL, V12, P758, DOI 10.1111/j.1462-2920.2009.02119.x; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Sohet FM, 2009, BIOCHEM PHARMACOL, V78, P1391, DOI 10.1016/j.bcp.2009.07.008; Solheim M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-194; SONTI RV, 1989, GENETICS, V123, P19; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Zaneveld JR, 2010, NUCLEIC ACIDS RES, V38, P3869, DOI 10.1093/nar/gkq066; ZUNINO P, 1994, MICROB PATHOGENESIS, V16, P379, DOI 10.1006/mpat.1994.1038	42	146	149	1	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					583	594		10.1016/j.cell.2014.12.038	http://dx.doi.org/10.1016/j.cell.2014.12.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25640238	Bronze, Green Accepted			2022-12-28	WOS:000349208800004
J	Lee, N; Moss, WN; Yario, TA; Steitz, JA				Lee, Nara; Moss, Walter N.; Yario, Therese A.; Steitz, Joan A.			EBV Noncoding RNA Binds Nascent RNA to Drive Host PAX5 to Viral DNA	CELL			English	Article							EPSTEIN-BARR-VIRUS; B-LYMPHOCYTES; LYTIC CYCLE; RIBOSOMAL-RNA; EBER GENES; CELL-LINE; PROTEIN; TRANSCRIPTION; SEQUENCE; LYMPHOMAGENESIS	EBER2 is an abundant nuclear noncoding RNA expressed by the Epstein-Barr virus (EBV). Probing its possible chromatin localization by CHART revealed EBER2's presence at the terminal repeats (TRs) of the latent EBV genome, overlapping previously identified binding sites for the B cell transcription factor PAX5. EBER2 interacts with PAX5 and is required for the localization of PAX5 to the TRs. EBER2 knockdown phenocopies PAX5 depletion in upregulating the expression of LMP2A/B and LMP1, genes nearest the TRs. Knockdown of EBER2 also decreases EBV lytic replication, underscoring the essential role of the TRs in viral replication. Recruitment of the EBER2-PAX5 complex is mediated by base-pairing between EBER2 and nascent transcripts from the TR locus. The interaction is evolutionarily conserved in the related primate herpesvirus CeHV15 despite great sequence divergence. Using base-pairing with nascent RNA to guide an interacting transcription factor to its DNA target site is a previously undescribed function for a trans-acting noncoding RNA.	[Lee, Nara; Moss, Walter N.; Yario, Therese A.; Steitz, Joan A.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu	Moss, Walter/H-8096-2019	Moss, Walter/0000-0001-6419-5570	National Cancer Institute [CA16038]; NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. George Miller (Yale), Ayman El- Guindy (Yale), and Nancy Raab-Traub (University of North Carolina) for EBV reagents and discussions, Matthew Simon (Yale), Paul Lieberman (Wistar), Tom Cech (UC Boulder), Thomas Jenuwein (MPI Freiburg), Sandra Weller (UConn Health), and Joel Rozowsky (Yale) for advice, and Jessica Brown, Kazimierz Tycowski, and Mingyi Xie for helpful comments. This work was supported by a grant from the National Cancer Institute (CA16038). J.A.S. is an investigator of the Howard Hughes Medical Institute.	Arvey A, 2012, CELL HOST MICROBE, V12, P233, DOI 10.1016/j.chom.2012.06.008; BROWN NA, 1988, J VIROL, V62, P962, DOI 10.1128/JVI.62.3.962-969.1988; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chiu SH, 2014, J VIROL, V88, P4962, DOI 10.1128/JVI.00063-14; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Cozma D, 2007, J CLIN INVEST, V117, P2602, DOI 10.1172/JCI30842; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Feederle R, 2005, J VIROL, V79, P7641, DOI 10.1128/JVI.79.12.7641-7647.2005; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gregorovic G, 2011, J VIROL, V85, P3535, DOI 10.1128/JVI.02086-10; Greifenegger N, 1998, J VIROL, V72, P9323, DOI 10.1128/JVI.72.11.9323-9328.1998; Houmani JL, 2009, J VIROL, V83, P9844, DOI 10.1128/JVI.01014-09; HOWE JG, 1988, J VIROL, V62, P2790, DOI 10.1128/JVI.62.8.2790-2798.1988; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ideue T, 2009, RNA, V15, P1578, DOI 10.1261/rna.1657609; Katsumura KR, 2012, J MED VIROL, V84, P504, DOI 10.1002/jmv.23208; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Komano J, 1999, J VIROL, V73, P9827, DOI 10.1128/JVI.73.12.9827-9831.1999; Lacoste V, 2010, INFECT GENET EVOL, V10, P1, DOI 10.1016/j.meegid.2009.10.009; Lee N, 2012, RNA, V18, P2073, DOI 10.1261/rna.034900.112; Lejeune E, 2010, COLD SH Q B, V75, P275, DOI 10.1101/sqb.2010.75.024; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; LINDAHL T, 1976, J MOL BIOL, V102, P511, DOI 10.1016/0022-2836(76)90331-4; Ma SD, 2011, J VIROL, V85, P165, DOI 10.1128/JVI.01512-10; Malone CD, 2009, COLD SH Q B, V74, P225, DOI 10.1101/sqb.2009.74.052; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; MILLER CL, 1994, P NATL ACAD SCI USA, V91, P772, DOI 10.1073/pnas.91.2.772; Miller G, 2007, ADV CANCER RES, V97, P81, DOI 10.1016/S0065-230X(06)97004-3; Moss WN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-543; Muckstein U, 2006, BIOINFORMATICS, V22, P1177, DOI 10.1093/bioinformatics/btl024; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; RAABTRAUB N, 1986, CELL, V47, P883, DOI 10.1016/0092-8674(86)90803-2; Ragoczy T, 1998, J VIROL, V72, P7978, DOI 10.1128/JVI.72.10.7978-7984.1998; Repellin CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009092; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Rivailler P, 2002, J VIROL, V76, P12055, DOI 10.1128/JVI.76.23.12055-12068.2002; Rivailler P, 2002, J VIROL, V76, P421, DOI 10.1128/JVI.76.1.421-426.2002; Rovedo M, 2007, J VIROL, V81, P84, DOI 10.1128/JVI.01302-06; Rowe M, 2009, SEMIN CANCER BIOL, V19, P377, DOI 10.1016/j.semcancer.2009.07.004; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Simon Matthew D, 2013, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2125s101; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; SUGDEN B, 1979, J VIROL, V31, P590, DOI 10.1128/JVI.31.3.590-595.1979; SWAMINATHAN S, 1991, P NATL ACAD SCI USA, V88, P1546, DOI 10.1073/pnas.88.4.1546; TOCZYSKI DP, 1994, P NATL ACAD SCI USA, V91, P3463, DOI 10.1073/pnas.91.8.3463; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Yajima M, 2005, J VIROL, V79, P4298, DOI 10.1128/JVI.79.7.4298-4307.2005; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; ZIMMERMANN J, 1995, J VIROL, V69, P3147, DOI 10.1128/JVI.69.5.3147-3155.1995	56	102	108	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					607	618		10.1016/j.cell.2015.01.015	http://dx.doi.org/10.1016/j.cell.2015.01.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25662012	Bronze, Green Accepted			2022-12-28	WOS:000349208800006
J	Frosch, DL				Frosch, Dominick L.			SPOTLIGHT: PATIENT CENTRED CARE The patient is the most important member of the team	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SELF-EFFICACY; EDUCATION		[Frosch, Dominick L.] Gordon & Betty Moore Fdn, Palo Alto, CA 94304 USA; [Frosch, Dominick L.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Frosch, DL (corresponding author), Gordon & Betty Moore Fdn, Page Mill Rd, Palo Alto, CA 94304 USA.	Dominick.frosch@moore.org						Ahola AJ, 2013, DIABETIC MED, V30, P413, DOI 10.1111/dme.12105; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576; Marks R, 2005, HEALTH PROMOT PRACT, V6, P148, DOI 10.1177/1524839904266792; Muhlhauser I, 2002, DIABETOLOGIA, V45, P1723, DOI 10.1007/s00125-002-0987-2; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64	7	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								g7767	10.1136/bmj.g7767	http://dx.doi.org/10.1136/bmj.g7767			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB0LU	25670181	Bronze			2022-12-28	WOS:000349318400031
J	Ceschia, A				Ceschia, Audrey			FGM: the mutilation of girls and young women must stop	LANCET			English	Editorial Material							FEMALE GENITAL MUTILATION		Lancet, London EC2Y 5AS, England		Ceschia, A (corresponding author), Lancet, London EC2Y 5AS, England.							Adam T, 2010, B WORLD HEALTH ORGAN, V88, P281, DOI 10.2471/BLT.09.064808; European Institute for Gender Equality, CURR SIT FEM GEN MUT; Foldes P, 2012, LANCET, V380, P134, DOI 10.1016/S0140-6736(12)60400-0; UNICEF, 2013, FEM GEN MUT CUTT STA; WHO, 2014, FEM GEN MUT FACH SHE	5	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					483	484						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AV	25705831				2022-12-28	WOS:000349213600005
J	Linn, MC; Palmer, E; Baranger, A; Gerard, E; Stone, E				Linn, Marcia C.; Palmer, Erin; Baranger, Anne; Gerard, Elizabeth; Stone, Elisa			Undergraduate research experiences: Impacts and opportunities	SCIENCE			English	Review							RESEARCH PROGRAMS; SCIENCE RESEARCH; CAREER CHOICES; STUDENTS; FACULTY; GAINS; SCIENTISTS; COLLEGE; PARTICIPATION; PERCEPTIONS	Most undergraduates give high ratings to research experiences. Studies report that these experiences improve participation and persistence, often by strengthening students' views of themselves as scientists. Yet, the evidence for these claims is weak. More than half the 60 studies reviewed rely on self-report surveys or interviews. Rather than introducing new images of science, research experiences may reinforce flawed images especially of research practices and conceptual understanding. The most convincing studies show benefits for mentoring and for communicating the nature of science, but the ideas that students learn are often isolated or fragmented rather than integrated and coherent. Rigorous research is needed to identify ways to design research experiences so that they promote integrated understanding. These studies need powerful and generalizable assessments that can document student progress, help distinguish effective and ineffective aspects of the experiences, and illustrate how students interpret the research experiences they encounter. To create research experiences that meet the needs of interested students and make effective use of scarce resources, we encourage systematic, iterative studies with multiple indicators of success.	[Linn, Marcia C.; Palmer, Erin; Baranger, Anne; Gerard, Elizabeth; Stone, Elisa] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Linn, MC (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	mclinn@berkeley.edu			National Science Foundation [DRL-1119670, DRL-0918743, DRL-0822388]; Direct For Education and Human Resources [1119670, 0918743] Funding Source: National Science Foundation; Division Of Research On Learning [1418423] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); Division Of Research On Learning(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	This material is based upon work supported by the National Science Foundation under grant nos. DRL-1119670, DRL-0918743, and DRL-0822388. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	AAAS, 2011, VIS CHANG UND BIOL E; Adedokun O., 2012, J COLL SCI TEACH, V42, P82; Adedokun OA, 2014, CBE-LIFE SCI EDUC, V13, P139, DOI 10.1187/cbe.13-03-0045; Adedokun OA, 2013, J RES SCI TEACH, V50, P940, DOI 10.1002/tea.21102; Ainsworth S. E., 2008, CURR PERSP CONG LEAR; Auchincloss LC, 2014, CBE-LIFE SCI EDUC, V13, P29, DOI 10.1187/cbe.14-01-0004; Behar-Horenstein L. S., 2010, PARTNERSHIP LEARNING, V18, P269, DOI DOI 10.1080/13611267.2010.492945; Bransford J. D, 1999, PEOPLE LEARN BRAIN M; Brownell S.E., 2012, J COLL SCI TEACH, V41, P36; Burnette JM, 2013, GENETICS, V193, P367, DOI 10.1534/genetics.112.147355; Carter FD, 2009, EDUC EVAL POLICY AN, V31, P441, DOI 10.3102/0162373709348584; Cartrette DP, 2012, RES SCI EDUC, V42, P1073, DOI 10.1007/s11165-011-9235-4; Chang MJ, 2014, J RES SCI TEACH, V51, P555, DOI 10.1002/tea.21146; Collins A., 1989, ED RES, V18, P32; Craney C, 2011, J HIGH EDUC-UK, V82, P92, DOI 10.1353/jhe.2011.0000; Critcher CR, 2009, J PERS SOC PSYCHOL, V97, P931, DOI 10.1037/a0017452; Dasgupta AP, 2014, CBE-LIFE SCI EDUC, V13, P265, DOI 10.1187/cbe.13-09-0192; Dolan E, 2009, J SCI EDUC TECHNOL, V18, P487, DOI 10.1007/s10956-009-9165-3; Dolan EL, 2010, CBE-LIFE SCI EDUC, V9, P543, DOI 10.1187/cbe.10-03-0052; Duschl R. A., 2007, TAKING SCI SCH LEARN, DOI DOI 10.17226/11625; Eagan MK, 2013, AM EDUC RES J, V50, P683, DOI 10.3102/0002831213482038; Eagan MK, 2011, RES HIGH EDUC, V52, P151, DOI 10.1007/s11162-010-9189-9; Edwards TM, 2011, BIOSCIENCE, V61, P301, DOI 10.1525/bio.2011.61.4.10; Espinosa LL, 2011, HARVARD EDUC REV, V81, P209, DOI 10.17763/haer.81.2.92315ww157656k3u; Fechheimer M, 2011, CBE-LIFE SCI EDUC, V10, P156, DOI 10.1187/cbe.10-10-0130; Feldman A, 2013, SCI EDUC, V97, P218, DOI 10.1002/sce.21051; Finn K., 2011, J COLL SCI TEACH, V40, P38; Gormally C, 2012, CBE-LIFE SCI EDUC, V11, P364, DOI 10.1187/cbe.12-03-0026; Graham MJ, 2013, SCIENCE, V341, P1455, DOI 10.1126/science.1240487; Grunert ML, 2011, CHEM EDUC RES PRACT, V12, P420, DOI 10.1039/c1rp90050a; Hanauer DI, 2012, CBE-LIFE SCI EDUC, V11, P378, DOI 10.1187/cbe.12-04-0043; Harrison M, 2011, CBE-LIFE SCI EDUC, V10, P279, DOI 10.1187/cbe.10-12-0151; Harsh J.A., 2011, J COLL SCI TEACH, V41, P84; Harsh JA, 2012, J CHEM EDUC, V89, P1364, DOI 10.1021/ed200581m; Hernandez PR, 2013, J EDUC PSYCHOL, V105, P89, DOI 10.1037/a0029691; Ing M., 2013, J STEM ED, V14, P16; John J, 2011, STUD HIGH EDUC, V36, P781, DOI 10.1080/03075071003777708; Jones MT, 2010, J HIGH EDUC-UK, V81, P82, DOI 10.1353/jhe.0.0082; Junge B, 2010, CBE-LIFE SCI EDUC, V9, P119, DOI 10.1187/cbe.09-08-0057; Kardash CM, 2012, INSTR SCI, V40, P875, DOI 10.1007/s11251-011-9195-0; Khoukhi A, 2013, J SCI EDUC TECHNOL, V22, P630, DOI 10.1007/s10956-012-9419-3; Laursen S., 2012, CHANGE MAGAZINE HIGH, V44, P30, DOI [10.1080/00091383.2012.655217, DOI 10.1080/00091383.2012.655217]; Lederman NG, 2002, J RES SCI TEACH, V39, P497, DOI 10.1002/tea.10034; Linn M. C., 2011, SCI LEARNING INSTRUC; Linn MC., 1995, J SCI EDUC TECHNOL, V4, P103, DOI [10.1007/BF02214052, DOI 10.1007/BF02214052]; Lopatto David, 2007, CBE Life Sci Educ, V6, P297, DOI 10.1187/cbe.07-06-0039; Lopatto David, 2004, Cell Biol Educ, V3, P270, DOI 10.1187/cbe.04-07-0045; National Academy of Sciences National Academy of Engineering Institute of Medicine, 1997, ADV TEACH ROL MOD FR; National Research Council, 2001, KNOWING WHAT STUDENT; National Research Council, 2005, AM LAB REP INV HIGH, DOI [10.17226/11311, DOI 10.17226/11311]; Osborne J, 2010, SCIENCE, V328, P463, DOI 10.1126/science.1183944; Ovink SM, 2011, RES HIGH EDUC, V52, P370, DOI 10.1007/s11162-010-9198-8; Pacifici L. B., 2011, J COLL SCI TEACH, V41, P54; Pacifici LB, 2011, CBE-LIFE SCI EDUC, V10, P199, DOI 10.1187/cbe.11-01-0005; Packard BW, 2004, J COLL STUDENT RETEN, V6, P289, DOI [DOI 10.2190/RUKP-XGVY-8LG0-75VH, 10.2190/RUKP-XGVY-8LG0-75VH.]; Pawson R., 2004, 21 ESRC UK CTR EV BA; Prunuske AJ, 2013, CBE-LIFE SCI EDUC, V12, P403, DOI 10.1187/cbe.13-02-0043; Russell CB, 2011, CHEM EDUC RES PRACT, V12, P57, DOI 10.1039/C1RP90008K; Sadler TD, 2010, J RES SCI TEACH, V47, P235, DOI 10.1002/tea.20326; Sandoval WA, 2005, SCI EDUC, V89, P634, DOI 10.1002/sce.20065; Schultz PW, 2011, EDUC EVAL POLICY AN, V33, P95, DOI 10.3102/0162373710392371; Schwartz J, 2012, SCI EDUC, V96, P527, DOI 10.1002/sce.21004; Shaffer CD, 2014, CBE-LIFE SCI EDUC, V13, P111, DOI 10.1187/cbe-13-08-0152; Slovacek S, 2012, J RES SCI TEACH, V49, P199, DOI 10.1002/tea.20451; Stevens LM, 2014, CBE-LIFE SCI EDUC, V13, P224, DOI 10.1187/cbe.13-12-0239; Strawn C., 2012, J COLL SCI TEACH, V41, P47; Szteinberg G. A, 2012, LONG TERM EFFECTS CO; Szteinberg GA, 2013, CHEM EDUC RES PRACT, V14, P23, DOI 10.1039/c2rp20115a; Taraban R, 2012, J EDUC PSYCHOL, V104, P499, DOI 10.1037/a0026851; Thiry H, 2012, CBE-LIFE SCI EDUC, V11, P260, DOI 10.1187/cbe.11-11-0098; Thiry H, 2011, J HIGH EDUC-UK, V82, P357, DOI 10.1080/00221546.2011.11777209; Thiry H, 2011, J SCI EDUC TECHNOL, V20, P771, DOI 10.1007/s10956-010-9271-2; White R., 1992, PROBING UNDERSTANDIN; Wilson A, 2013, STUD HIGH EDUC, V38, P1562, DOI 10.1080/03075079.2011.633163	74	318	327	23	317	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222							1261757	10.1126/science.1261757	http://dx.doi.org/10.1126/science.1261757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CX	25657254				2022-12-28	WOS:000349145200034
J	Hermann, B; Kern, M; La Pietra, L; Simon, J; Einsle, O				Hermann, Bianca; Kern, Melanie; La Pietra, Luigi; Simon, Joerg; Einsle, Oliver			The octahaem MccA is a haem c-copper sulfite reductase	NATURE			English	Article							DESULFOVIBRIO-VULGARIS HILDENBOROUGH; CYTOCHROME-C; NITRITE REDUCTASE; WOLINELLA-SUCCINOGENES; HYDROXYLAMINE OXIDOREDUCTASE; NITROSOMONAS-EUROPAEA; CRYSTAL-STRUCTURES; PACKING MOTIFS; RESOLUTION; BINDING	The six-electron reduction of sulfite to sulfide is the pivot point of the biogeochemical cycle of the element sulfur'. The octahaem cytochrome c MccA (also known as SirA) catalyses this reaction for dissimilatory sulfite utilization by various bacteria. It is distinct from known sulfite reductases because it has a substantially higher catalytic activity and a relatively low reactivity towards nitrite. The mechanistic reasons for the increased efficiency of MccA remain to be elucidated. Here we show that anoxically purified MccA exhibited a 2- to 5.5-fold higher specific sulfite reductase activity than the enzyme isolated under oxic conditions2. We determined the threedimensional structure of MccA to 2.2 A resolution by single-wavelength anomalous dispersion. We find a homotrimer with an unprecedented fold and haem arrangement, as well as a haem bound to a CX15CH motif'. The heterobimetallic active-site haem 2 has a Cu(I) ion juxtaposed to a haem cat a Fe-Cu distance of 4.4 A. While the combination of metals is reminiscent of respiratory haem-copper oxidases, the oxidation-labile Cu(I) centre of MccA did not seem to undergo a redox transition during catalysis. Intact MccA tightly bound SO2 at haem 2, a dehydration product of the substrate sulfite that was partially turned over due to photoreduction by X-ray irradiation, yielding the reaction intermediate SO. Our data show the biometal copper in a new context and function and provide a chemical rationale for the comparatively high catalytic activity of MccA.	[Hermann, Bianca; Einsle, Oliver] Univ Freiburg, Inst Biochem, Lehrstuhl Biochem, D-79104 Freiburg, Germany; [Kern, Melanie; La Pietra, Luigi; Simon, Joerg] Tech Univ Darmstadt, Dept Biol, Microbial Energy Convers & Biotechnol, D-64287 Darmstadt, Germany; [Einsle, Oliver] BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; Technical University of Darmstadt	Einsle, O (corresponding author), Univ Freiburg, Inst Biochem, Lehrstuhl Biochem, Albertstr 21, D-79104 Freiburg, Germany.	simon@bio.tu-darmstadt.de; einsle@biochemie.uni-freiburg.de	Simon, Jörg/F-2355-2016	Simon, Jörg/0000-0003-0214-3745; Einsle, Oliver/0000-0001-8722-2893; La Pietra, Luigi/0000-0003-2321-6990	Deutsche Forschungsgemeinschaft [El 520/5, SI 848/7]; BIOSS Centre for Biological Signaling Studies at Albert-Ludwigs-Universitat Freiburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BIOSS Centre for Biological Signaling Studies at Albert-Ludwigs-Universitat Freiburg	This work was supported by the Deutsche Forschungsgemeinschaft (El 520/5 to O.E. and SI 848/7 to J.S.) and the BIOSS Centre for Biological Signaling Studies at Albert-Ludwigs-Universitat Freiburg. We thank S. Andrade for assistance with stopped-flow spectrometry, P. Kroneck, T. Clarke and D. Richardson for stimulating discussions, and the beamline staff at the Swiss Light Source, Villigen, Switzerland, for assistance with data collection.	Aoyama H, 2009, P NATL ACAD SCI USA, V106, P2165, DOI 10.1073/pnas.0806391106; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cedervall P, 2013, BIOCHEMISTRY-US, V52, P6211, DOI 10.1021/bi400960w; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Einsle O, 2000, J BIOL CHEM, V275, P39608, DOI 10.1074/jbc.M006188200; Einsle O, 1999, NATURE, V400, P476, DOI 10.1038/22802; Einsle O, 2011, METHOD ENZYMOL, V496, P399, DOI 10.1016/B978-0-12-386489-5.00016-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Hartshorne RS, 2007, MOL MICROBIOL, V64, P1049, DOI 10.1111/j.1365-2958.2007.05712.x; Hartshorne S, 2006, BIOCHEM SOC T, V34, P146, DOI 10.1042/BST0340146; Igarashi N, 1997, NAT STRUCT BIOL, V4, P276, DOI 10.1038/nsb0497-276; Iverson TM, 1998, NAT STRUCT BIOL, V5, P1005, DOI 10.1038/2975; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kemp GL, 2010, BIOCHEM J, V431, P73, DOI 10.1042/BJ20100866; Kern M, 2011, MOL MICROBIOL, V82, P1515, DOI 10.1111/j.1365-2958.2011.07906.x; Kern M, 2011, METHOD ENZYMOL, V486, P429, DOI [10.1016/S0076-6879(11)86019-2, 10.1016/B978-0-12-381294-0.00019-5]; Kern M, 2010, MOL MICROBIOL, V75, P122, DOI 10.1111/j.1365-2958.2009.06965.x; Klotz MG, 2008, ENVIRON MICROBIOL, V10, P3150, DOI 10.1111/j.1462-2920.2008.01733.x; Lukat P, 2008, BIOCHEMISTRY-US, V47, P2080, DOI 10.1021/bi7021415; Mowat CG, 2004, NAT STRUCT MOL BIOL, V11, P1023, DOI 10.1038/nsmb827; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pereira IAC, 2000, BBA-PROTEIN STRUCT M, V1481, P119, DOI 10.1016/S0167-4838(00)00111-4; Polyakov KM, 2009, J MOL BIOL, V389, P846, DOI 10.1016/j.jmb.2009.04.037; Schiffer A, 2008, J MOL BIOL, V379, P1063, DOI 10.1016/j.jmb.2008.04.027; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shirodkar S, 2011, ENVIRON MICROBIOL, V13, P108, DOI 10.1111/j.1462-2920.2010.02313.x; Simon J, 2013, ADV MICROB PHYSIOL, V62, P45, DOI 10.1016/B978-0-12-410515-7.00002-0; Simon J, 2011, FEBS J, V278, P4179, DOI 10.1111/j.1742-4658.2011.08374.x; STEUBER J, 1995, EUR J BIOCHEM, V233, P873, DOI 10.1111/j.1432-1033.1995.873_3.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	37	38	40	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					706	U318		10.1038/nature14109	http://dx.doi.org/10.1038/nature14109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25642962				2022-12-28	WOS:000353689700056
J	Tashkin, DP				Tashkin, Donald P.			Dual anti-inflammatory agents prevent COPD exacerbations	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CLINICAL-TRIALS; ROFLUMILAST		Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Tashkin, DP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA.	dtashkin@mednet.ucla.edu						Bateman ED, 2011, EUR RESPIR J, V38, P553, DOI 10.1183/09031936.00178710; Calverley PMA, 2009, LANCET, V374, P685, DOI 10.1016/S0140-6736(09)61255-1; Donaldson GC, 2005, CHEST, V128, P1995, DOI 10.1378/chest.128.4.1995; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2015, GLOB STRAT DIAGN MAN; Gunen H, 2005, EUR RESPIR J, V26, P234, DOI 10.1183/09031936.05.00024804; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Martinez FJ, 2015, LANCET; Perera PN, 2012, COPD, V9, P131, DOI 10.3109/15412555.2011.650239; Rennard SI, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-18; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Wedzicha JA, 2013, CHEST, V143, P1302, DOI 10.1378/chest.12-1489	12	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					832	834		10.1016/S0140-6736(15)60212-4	http://dx.doi.org/10.1016/S0140-6736(15)60212-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC6CB	25684589				2022-12-28	WOS:000350451100009
J	Lane, R				Lane, Richard			Profile Henry Marsh: telling the stories of neurosurgery	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					597	597		10.1016/S0140-6736(15)60223-9	http://dx.doi.org/10.1016/S0140-6736(15)60223-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AZ	25706073				2022-12-28	WOS:000349214000016
J	Banks-Leite, C; Pardini, R; Tambosi, LR; Pearse, WD; Bueno, AA; Bruscagin, RT; Condez, TH; Dixo, M; Igari, AT; Martensen, AC; Metzger, JP				Banks-Leite, Cristina; Pardini, Renata; Tambosi, Leandro R.; Pearse, William D.; Bueno, Adriana A.; Bruscagin, Roberta T.; Condez, Thais H.; Dixo, Marianna; Igari, Alexandre T.; Martensen, Alexandre C.; Metzger, Jean Paul			Response to Comment on "Using ecological thresholds to evaluate the costs and benefits of set-asides in a biodiversity hotspot"	SCIENCE			English	Editorial Material								Finney claims that we did not include transaction costs while assessing the economic costs of a set-aside program in Brazil and that accounting for them could potentially render large payments for environmental services (PES) projects unfeasible. We agree with the need for a better understanding of transaction costs but provide evidence that they do not alter the feasibility of the set-aside scheme we proposed.	[Banks-Leite, Cristina] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Banks-Leite, Cristina; Tambosi, Leandro R.; Bruscagin, Roberta T.; Dixo, Marianna; Metzger, Jean Paul] Univ Sao Paulo, Inst Biociencias, Dept Ecol, BR-05508090 Sao Paulo, Brazil; [Pardini, Renata] Univ Sao Paulo, Inst Biociencias, Dept Zool, BR-05508090 Sao Paulo, Brazil; [Pearse, William D.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Bueno, Adriana A.] Fundacao Florestal, BR-02377000 Sao Paulo, Brazil; [Condez, Thais H.] Univ Estadual Paulista, Inst Biociencias, Dept Zool, BR-13506900 Rio Claro, SP, Brazil; [Igari, Alexandre T.] Univ Sao Paulo, Curso Gestao Ambiental, Escola Artes Ciencias & Humanidades, BR-03828000 Sao Paulo, Brazil; [Martensen, Alexandre C.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada	Imperial College London; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Minnesota System; University of Minnesota Twin Cities; Universidade Estadual Paulista; University of Toronto	Banks-Leite, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	c.banks@imperial.ac.uk	Martensen, Alexandre Camargo/H-3180-2012; Banks-Leite, Cristina/D-3075-2011; Metzger, Jean Paul/C-2514-2012; Pardini, Renata/C-4095-2012; Tambosi, Leandro Reverberi/ABH-7869-2020; Tambosi, Leandro R/B-2359-2013; IGARI, ALEXANDRE/P-1998-2014	Martensen, Alexandre Camargo/0000-0001-9017-7480; Banks-Leite, Cristina/0000-0002-0091-2857; Metzger, Jean Paul/0000-0002-0087-5240; Pardini, Renata/0000-0002-3769-8401; Tambosi, Leandro Reverberi/0000-0001-5486-7310; Tambosi, Leandro R/0000-0001-5486-7310; IGARI, ALEXANDRE/0000-0002-1382-5031				Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; Banks-Leite C, 2011, J APPL ECOL, V48, P706, DOI 10.1111/j.1365-2664.2011.01966.x; Finney C, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0916	3	2	2	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223								10.1126/science.aaa1602	http://dx.doi.org/10.1126/science.aaa1602			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA9DT	25678655				2022-12-28	WOS:000349221300037
J	Anderson, DM; Anderson, KM; Chang, CL; Makarewich, CA; Nelson, BR; McAnally, JR; Kasaragod, P; Shelton, JM; Liou, J; Bassel-Duby, R; Olson, EN				Anderson, Douglas M.; Anderson, Kelly M.; Chang, Chi-Lun; Makarewich, Catherine A.; Nelson, Benjamin R.; McAnally, John R.; Kasaragod, Prasad; Shelton, John M.; Liou, Jen; Bassel-Duby, Rhonda; Olson, Eric N.			A Micropeptide Encoded by a Putative Long Noncoding RNA Regulates Muscle Performance	CELL			English	Article							RETICULUM CA2+ ATPASE; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; PHOSPHOLAMBAN ABLATION; CARDIAC CONTRACTILITY; PROTEIN EXPRESSION; HEART-FAILURE; MESSENGER-RNA; CALCIUM-PUMP; SARCOLIPIN	Functional micropeptides can be concealed within RNAs that appear to be noncoding. We discovered a conserved micropeptide, which we named myoregulin (MLN), encoded by a skeletal muscle-specific RNA annotated as a putative long noncoding RNA. MLN shares structural and functional similarity with phospholamban (PLN) and sarcolipin (SLN), which inhibit SERCA, the membrane pump that controls muscle relaxation by regulating Ca2+ uptake into the sarcoplasmic reticulum (SR). MLN interacts directly with SERCA and impedes Ca2+ uptake into the SR. In contrast to PLN and SLN, which are expressed in cardiac and slow skeletal muscle in mice, MLN is robustly expressed in all skeletal muscle. Genetic deletion of MLN in mice enhances Ca2+ handling in skeletal muscle and improves exercise performance. These findings identify MLN as an important regulator of skeletal muscle physiology and highlight the possibility that additional micropeptides are encoded in the many RNAs currently annotated as noncoding.	[Anderson, Douglas M.; Anderson, Kelly M.; Makarewich, Catherine A.; Nelson, Benjamin R.; McAnally, John R.; Kasaragod, Prasad; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chang, Chi-Lun; Liou, Jen] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Shelton, John M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Anderson, Douglas M.; Anderson, Kelly M.; Makarewich, Catherine A.; Nelson, Benjamin R.; McAnally, John R.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Liou, Jen/AAN-1105-2021; Chang, Chi-Lun/Z-1891-2019	Chang, Chi-Lun/0000-0003-0017-2243	NIH [HL-077439, HL-111665, HL-093039, DK-099653, U01-HL-100401]; Fondation Leducq Networks of Excellence; Robert A. Welch Foundation [1-0025, I-1789]; American Heart Association post-doctoral fellowship [13POST14570050]; American Heart Association predoctoral fellowship [14PRE19830031]; NIH Training grant [1F30AR067094-01]; Sigrid Juselius Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100401, R01HL093039, R01HL111665, R01HL053351, R01HL077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F30AR067094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099653] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq Networks of Excellence; Robert A. Welch Foundation(The Welch Foundation); American Heart Association post-doctoral fellowship(American Heart Association); American Heart Association predoctoral fellowship(American Heart Association); NIH Training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigrid Juselius Foundation(Sigrid Juselius Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Tobias Meyer at Stanford University Medical Center for generously providing the pcDNA-T1ER vector and Dr. David H. MacLennan at University of Toronto for generously providing the Serca1 (A52) antibody. This work was supported by grants from the NIH (HL-077439, HL-111665, HL-093039, DK-099653, and U01-HL-100401), Fondation Leducq Networks of Excellence, and the Robert A. Welch Foundation (grant 1-0025 to E.N.O.; I-1789 to J.L.). D.M.A. was supported by an American Heart Association post-doctoral fellowship (13POST14570050). K.M.A. was supported by an American Heart Association predoctoral fellowship (14PRE19830031). B.R.N. was supported by an NIH Training grant (1F30AR067094-01), and P.K. was supported by a postdoctoral grant from the Sigrid Juselius Foundation.	Abell E, 2011, P NATL ACAD SCI USA, V108, P14485, DOI 10.1073/pnas.1018266108; Allen DG, 2010, CAN J PHYSIOL PHARM, V88, P83, DOI 10.1139/Y09-058; Anderson DM, 2012, J BIOL CHEM, V287, P35351, DOI 10.1074/jbc.M112.399386; Anderson DM, 2009, DEV DYNAM, V238, P572, DOI 10.1002/dvdy.21873; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; ANGER M, 1994, J MOL CELL CARDIOL, V26, P539, DOI 10.1006/jmcc.1994.1064; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; BRIGGS FN, 1992, J BIOL CHEM, V267, P26056; Chu GX, 1998, ANN NY ACAD SCI, V853, P49, DOI 10.1111/j.1749-6632.1998.tb08256.x; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Dorn GW, 2004, CIRCULATION, V109, P150, DOI 10.1161/01.CIR.0000111581.15521.F5; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fajardo VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084304; Fong AP, 2012, DEV CELL, V22, P721, DOI 10.1016/j.devcel.2012.01.015; Goonasekera SA, 2011, J CLIN INVEST, V121, P1044, DOI 10.1172/JCI43844; Holemans Tine, 2014, Cold Spring Harb Protoc, V2014, P876, DOI 10.1101/pdb.prot076893; Kirchberber M A, 1975, Recent Adv Stud Cardiac Struct Metab, V5, P103; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267; Lu BD, 1999, DEV BIOL, V216, P312, DOI 10.1006/dbio.1999.9488; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; MacLennan DH, 2003, ANN NY ACAD SCI, V986, P472, DOI 10.1111/j.1749-6632.2003.tb07231.x; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Mattiazzi A, 2006, BRAZ J MED BIOL RES, V39, P563, DOI 10.1590/S0100-879X2006000500001; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Minamisawa S, 2003, J BIOL CHEM, V278, P9570, DOI 10.1074/jbc.M213132200; Nelson BR, 2013, P NATL ACAD SCI USA, V110, P11881, DOI 10.1073/pnas.1310571110; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Pan Y, 2003, J BIOL CHEM, V278, P13367, DOI 10.1074/jbc.M213228200; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Reyon Deepak, 2012, Curr Protoc Mol Biol, VChapter 12, DOI 10.1002/0471142727.mb1215s100; Rossi AE, 2006, MUSCLE NERVE, V33, P715, DOI 10.1002/mus.20512; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Shelton JM, 2000, J LIPID RES, V41, P532; Slack JP, 1997, AM J PHYSIOL-CELL PH, V273, pC1, DOI 10.1152/ajpcell.1997.273.1.C1; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Tsai FC, 2014, NAT CELL BIOL, V16, P133, DOI 10.1038/ncb2906; Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	54	708	768	12	145	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					595	606		10.1016/j.cell.2015.01.009	http://dx.doi.org/10.1016/j.cell.2015.01.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25640239	Bronze, Green Accepted			2022-12-28	WOS:000349208800005
J	Ceccaldi, R; Liu, JC; Amunugama, R; Hajdu, I; Primack, B; Petalcorin, MIR; O'Connor, KW; Konstantinopoulos, PA; Elledge, SJ; Boulton, SJ; Yusufzai, T; D'Andrea, AD				Ceccaldi, Raphael; Liu, Jessica C.; Amunugama, Ravindra; Hajdu, Ildiko; Primack, Benjamin; Petalcorin, Mark I. R.; O'Connor, Kevin W.; Konstantinopoulos, Panagiotis A.; Elledge, Stephen J.; Boulton, Simon J.; Yusufzai, Timur; D'Andrea, Alan D.			Homologous-recombination-deficient tumours are dependent on Pol theta-mediated repair	NATURE			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE; OVARIAN-CANCER; GENOMIC INSTABILITY; HEMATOPOIETIC STEM; FANCONI-ANEMIA; HUMAN-CELLS; POLYMERASE; PATHWAY; CHEMOTHERAPY	Large-scale genomic studies have shown that half of epithelial ovarian cancers (EOCs) have alterations in genes regulating homologous recombination (HR) repair(1). Loss of HR accounts for the genomic instability of EOCs and for their cellular hyper-dependence on alternative poly-ADP ribose polymerase (PARP)-mediated DNA repair mechanisms(2-5). Previous studies have implicated the DNA polymerase theta (Pol theta also known as POLQ, encoded by POLQ) 6 in a pathway required for the repair of DNA double-strand breaks(7-9), referred to as the error-prone microhomology-mediated end-joining (MMEJ) pathway(10-13). Whether Pol theta interacts with canonical DNA repair pathways to prevent genomic instability remains unknown. Here we report an inverse correlation between HR activity and Pol theta expression in EOCs. Knockdown of Pol theta in HR-proficient cells upregulates HR activity and RAD51 nucleofilament assembly, while knockdown of Pol theta in HR-deficient EOCs enhances cell death. Consistent with these results, genetic inactivation of an HR gene (Fancd2) and Polq in mice results in embryonic lethality. Moreover, Pol theta contains RAD51 binding motifs and it blocks RAD51-mediated recombination. Our results reveal a synthetic lethal relationship between the HR pathway and Pol theta-mediated repair in EOCs, and identify Pol theta as a novel druggable target for cancer therapy.	[Ceccaldi, Raphael; Liu, Jessica C.; Primack, Benjamin; O'Connor, Kevin W.; Yusufzai, Timur; D'Andrea, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Liu, Jessica C.; Yusufzai, Timur] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; [Liu, Jessica C.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Amunugama, Ravindra] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; [Hajdu, Ildiko; Elledge, Stephen J.] Brigham & Womens Hosp, Howard Hughes Med Inst, Div Genet, Boston, MA 02215 USA; [Petalcorin, Mark I. R.; Boulton, Simon J.] London Res Inst, Canc Res UK, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Konstantinopoulos, Panagiotis A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Med Gynecol Oncol Program, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Cancer Research UK; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	D'Andrea, AD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA.	alan_dandrea@dfci.harvard.edu		O'Connor, Kevin/0000-0001-5121-623X; Petalcorin, Mark/0000-0001-8211-9440	Philippe Foundation; Ovarian Cancer Research Fellowship (OCRF); NIH [P50CA168504, R01HL52725]; OCRF; BCRF; Cancer Research UK [11581] Funding Source: researchfish; Wellcome Trust [104558/Z/14/Z] Funding Source: researchfish; The Francis Crick Institute [10048, 10267] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA168504] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044664] Funding Source: NIH RePORTER	Philippe Foundation; Ovarian Cancer Research Fellowship (OCRF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OCRF; BCRF; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Shima, D. Chowdhury, G. Shapiro, J. Walter, D. Kozono, J. Ablain, M. Delord, J.-B. Lazaro and members of the D'Andrea laboratory for discussions. We also thank H. Kim for providing DNA constructs, L. Moldovan for providing GST tagged RAD51, S. Johnson for providing MDA-MB 436 cells, A. Y. Li for technical assistance, L. Moreau for chromosomal breakage analysis, and K. Mouw for critical reading of the manuscript. We thank H. Zhang for providing access to shRNA screening data shown in Extended Data Fig. 6i. We thank C. Cazaux and J.-S. Hoffmann for providing pcDNA Flag-tagged Pol theta. R.C. received support from the Philippe Foundation and is a recipient of the Ovarian Cancer Research Fellowship (OCRF). This work was supported by NIH grants P50CA168504 and R01HL52725 and by grants from OCRF and BCRF.	Aggarwal M, 2011, P NATL ACAD SCI USA, V108, P1525, DOI 10.1073/pnas.1006423108; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Amunugama R, 2013, DNA REPAIR, V12, P723, DOI 10.1016/j.dnarep.2013.05.005; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Chan SH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001005; Chiruvella KK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012757; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hu YD, 2014, CANCER DISCOV, V4, P1430, DOI 10.1158/2159-8290.CD-13-0891; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kang J, 2012, JNCI-J NATL CANCER I, V104, P670, DOI 10.1093/jnci/djs177; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koole W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4216; Lemee F, 2010, P NATL ACAD SCI USA, V107, P13390, DOI 10.1073/pnas.0910759107; Marie A, 2010, NUCLEIC ACIDS RES, V38, P5706, DOI 10.1093/nar/gkq379; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Muzzini DM, 2008, DNA REPAIR, V7, P941, DOI 10.1016/j.dnarep.2008.03.021; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Parmar K, 2010, STEM CELLS, V28, P1186, DOI 10.1002/stem.437; Pitroda SP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008291; Seki M, 2004, EMBO J, V23, P4484, DOI 10.1038/sj.emboj.7600424; Seki M, 2003, NUCLEIC ACIDS RES, V31, P6117, DOI 10.1093/nar/gkg814; Seki M, 2008, DNA REPAIR, V7, P119, DOI 10.1016/j.dnarep.2007.08.005; Shima N, 2004, MOL CELL BIOL, V24, P10381, DOI 10.1128/MCB.24.23.10381-10389.2004; Ward JD, 2010, MOL CELL, V37, P259, DOI 10.1016/j.molcel.2009.12.026; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456; Yoshimura M, 2006, MOL CELL, V24, P115, DOI 10.1016/j.molcel.2006.07.032; Yousefzadeh MJ, 2013, DNA REPAIR, V12, P1, DOI 10.1016/j.dnarep.2012.10.004; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Zhang Y, 2011, NAT STRUCT MOL BIOL, V18, P80, DOI 10.1038/nsmb.1940	39	460	499	2	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					258	U306		10.1038/nature14184	http://dx.doi.org/10.1038/nature14184			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25642963	Green Accepted, Green Submitted			2022-12-28	WOS:000349190300044
J	Liu, YJ; Le Berre, M; Lautenschlaeger, F; Maiuri, P; Callan-Jones, A; Heuze, M; Takaki, T; Voituriez, R; Piel, M				Liu, Yan-Jun; Le Berre, Mael; Lautenschlaeger, Franziska; Maiuri, Paolo; Callan-Jones, Andrew; Heuze, Melina; Takaki, Tohru; Voituriez, Raphael; Piel, Matthieu			Confinement and Low Adhesion Induce Fast Amoeboid Migration of Slow Mesenchymal Cells	CELL			English	Article							MOLECULAR-MECHANISMS; INVASION; MODES; CONTRACTILITY; TRANSITION; BLEBS	The mesenchymal-amoeboid transition (MAT) was proposed as a mechanism for cancer cells to adapt their migration mode to their environment. While the molecular pathways involved in this transition are well documented, the role of the microenvironment in the MAT is still poorly understood. Here, we investigated how confinement and adhesion affect this transition. We report that, in the absence of focal adhesions and under conditions of confinement, mesenchymal cells can spontaneously switch to a fast amoeboid migration phenotype. We identified two main types of fast migration-one involving a local protrusion and a second involving a myosin-II-dependent mechanical instability of the cell cortex that leads to a global cortical flow. Interestingly, transformed cells are more prone to adopt this fast migration mode. Finally, we propose a generic model that explains migration transitions and predicts a phase diagram of migration phenotypes based on three main control parameters: confinement, adhesion, and contractility.	[Liu, Yan-Jun; Le Berre, Mael; Lautenschlaeger, Franziska; Maiuri, Paolo; Heuze, Melina; Piel, Matthieu] Inst Curie, CNRS UMR 144, F-75005 Paris, France; [Voituriez, Raphael] Univ Paris 06, CNRS, Lab Jean Perrin, F-75005 Paris, France; [Voituriez, Raphael] Univ Paris 06, CNRS, Lab Phys Theor Mat Condensee, F-75005 Paris, France; [Lautenschlaeger, Franziska] Univ Saarland, D-66123 Saarbrucken, Germany; [Takaki, Tohru] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Callan-Jones, Andrew] Univ Paris Diderot, CNRS, Lab Mat & Syst Complexes, UMR 7057, F-75204 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Saarland University; Cancer Research UK; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite	Le Berre, M (corresponding author), Inst Curie, CNRS UMR 144, 26 Rue Ulm, F-75005 Paris, France.	mael.leberre@curie.fr; matthieu.piel@curie.fr	Le Berre, Maël/E-3538-2010; Lautenschläger, Franziska/L-3484-2016; voituriez, raphael/V-3418-2017; 刘, 严君/GZL-5764-2022; liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022	Le Berre, Maël/0000-0002-2293-3659; Lautenschläger, Franziska/0000-0001-8263-3386; Maiuri, Paolo/0000-0001-5079-445X; Heuze, Melina/0000-0002-4271-2706; voituriez, raphael/0000-0001-8746-5713	Vivatech; ARC	Vivatech; ARC(Australian Research Council)	The authors acknowledge the Nikon Imaging Centre at the Institut Curie-CNRS and Vincent Fraisier from the PICT-IBiSA Lhomond Imaging facility of Institut Curie for their help with the microscopy, and Timo Betz for kindly sharing his software for PIV analysis. We thank Stephanie Miserey-Lenkei and Nicolas Carpi for their help with western blots. Vivatech and ARC are acknowledged for their financial support to Y.-J.L. and M.L.B., ANR-09-PIRI-0027 and InNaBioSante to R.V. and M.P., and ERC 311205-PROMICO to M.P.	Alessandri K, 2013, P NATL ACAD SCI USA, V110, P14843, DOI 10.1073/pnas.1309482110; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Callan-Jones AC, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025022; Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Hawkins RJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058103; Hawkins RJ, 2011, BIOPHYS J, V101, P1041, DOI 10.1016/j.bpj.2011.07.038; Heuze ML, 2013, IMMUNOL REV, V256, P240, DOI 10.1111/imr.12108; Hung WC, 2013, J CELL BIOL, V202, P807, DOI 10.1083/jcb.201302132; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Le Berre M, 2012, INTEGR BIOL-UK, V4, P1406, DOI 10.1039/c2ib20056b; Lorentzen A, 2011, J CELL SCI, V124, P1256, DOI 10.1242/jcs.074849; Malawista SE, 2000, CELL MOTIL CYTOSKEL, V46, P183, DOI 10.1002/1097-0169(200007)46:3<183::AID-CM3>3.3.CO;2-U; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Petrie RJ, 2014, SCIENCE, V345, P1062, DOI 10.1126/science.1256965; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Ruprecht V, 2015, CELL, V160, P673, DOI 10.1016/j.cell.2015.01.008; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Trache A., 2008, CURRENT PROTOCOLS MI; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Wilson K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3896; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yoshida K, 2001, J CELL SCI, V114, P2155	34	425	431	14	165	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					659	672		10.1016/j.cell.2015.01.007	http://dx.doi.org/10.1016/j.cell.2015.01.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25679760	Bronze			2022-12-28	WOS:000349208800010
J	Gornall, J				Gornall, Jonathan			Sugar's web of influence 2: Biasing the science	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIETARY SUGAR; BODY-WEIGHT; EPIDEMIC; OBESITY; CRISIS					jgornall@mac.com						Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085; Crowe K., 2013, CBC NEWS; Goldman G., 2014, ADDED SUGAR SUBTRACT; James M, 2014, CARELESS EATING COST; Kahn R, 2014, DIABETES CARE, V37, P957, DOI 10.2337/dc13-2506; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Murphy MM, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-53; Sugar Association, 1977, ANN M BOARD DIR MAY; Taubes G, 2012, MOTHER JONES; World Sugar Research Organisation, SUG WEIGHT MAN; Yudkin J., 2012, WHITE DEADLY SUGAR I	12	2	2	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2015	350								h215	10.1136/bmj.h215	http://dx.doi.org/10.1136/bmj.h215			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0MG	25673131				2022-12-28	WOS:000349319700001
J	Kieboom, JK; Verkade, HJ; Burgerhof, JG; Bierens, JJ; van Rheenen, PF; Kneyber, MC; Albers, MJ				Kieboom, J. K.; Verkade, H. J.; Burgerhof, J. G.; Bierens, J. J.; van Rheenen, P. F.; Kneyber, M. C.; Albers, M. J.			Outcome after resuscitation beyond 30 minutes in drowned children with cardiac arrest and hypothermia: Dutch nationwide retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACCIDENTAL HYPOTHERMIA; WATER TEMPERATURE; CARDIOPULMONARY BYPASS; SUBMERSION; EPIDEMIOLOGY; GUIDELINES; ASSOCIATION; MANAGEMENT; RESCUE	OBJECTIVES To evaluate the outcome of drowned children with cardiac arrest and hypothermia, and to determine distinct criteria for termination of cardiopulmonary resuscitation in drowned children with hypothermia and absence of spontaneous circulation. DESIGN Nationwide retrospective cohort study. SETTING Emergency departments and paediatric intensive care units of the eight university medical centres in the Netherlands. PARTICIPANTS Children aged up to 16 with cardiac arrest and hypothermia after drowning, who presented at emergency departments and/or were admitted to intensive care. MAIN OUTCOME MEASURE Survival and neurological outcome one year after the drowning incident. Poor outcome was defined as death or survival in a vegetative state or with severe neurological disability (paediatric cerebral performance category (PCPC) >= 4). RESULTS From 1993 to 2012, 160 children presented with cardiac arrest and hypothermia after drowning. In 98 (61%) of these children resuscitation was performed for more than 30 minutes (98/160, median duration 60 minutes), of whom 87 (89%) died (95% confidence interval 83% to 95%; 87/98). Eleven of the 98 children survived (11%, 5% to 17%), but all had a PCPC score >= 4. In the 62 (39%) children who did not require prolonged resuscitation, 17 (27%, 16% to 38%) survived with a PCPC score <= 3 after one year: 10 (6%) had a good neurological outcome (score 1), five (3%) had mild neurological disability (score 2), and two (1%) had moderate neurological disability (score 3). From the original 160 children, only 44 were alive at one year with any outcome. CONCLUSIONS Drowned children in whom return of spontaneous circulation is not achieved within 30 minutes of advanced life support have an extremely poor outcome. Good neurological outcome is more likely when spontaneous circulation returns within 30 minutes of advanced life support, especially when the drowning incident occurs in winter. These findings question the therapeutic value of resuscitation beyond 30 minutes in drowned children with cardiac arrest and hypothermia.	[Kieboom, J. K.; Verkade, H. J.; van Rheenen, P. F.; Kneyber, M. C.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Paediat, NL-9700 AB Groningen, Netherlands; [Burgerhof, J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 AB Groningen, Netherlands; [Albers, M. J.] St Elizabeth Hosp, Dept Paediat, Tilburg, Netherlands	University of Groningen; University of Groningen; Elisabeth-TweeSteden Ziekenhuis (ETZ)	Kieboom, JK (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Paediat, NL-9700 AB Groningen, Netherlands.	j.k.w.kieboom@umcg.nl	Bierens, Joost/AAW-8332-2020; Kneyber, Martin/AAV-8437-2020; Burgerhof, Johannes G/B-2455-2013	Bierens, Joost/0000-0003-4467-8211; Kneyber, Martin/0000-0002-6008-3376; Burgerhof, Johannes G/0000-0003-3827-9601; Verkade, Henkjan J/0000-0002-7034-2861; /0000-0003-3867-2665				Atkins DL, 2009, CIRCULATION, V119, P1484, DOI 10.1161/CIRCULATIONAHA.108.802678; BIERENS JJLM, 1990, ANN EMERG MED, V19, P1390, DOI 10.1016/S0196-0644(05)82604-6; Bierens Joost J L M, 2002, Curr Opin Crit Care, V8, P578, DOI 10.1097/00075198-200212000-00016; Bierens JJLM, 2013, RESUSCITATION, V84, P1467, DOI 10.1016/j.resuscitation.2013.09.005; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; Brown DJA, 2012, NEW ENGL J MED, V367, P1930, DOI 10.1056/NEJMra1114208; Brugger H, 2001, RESUSCITATION, V51, P7, DOI 10.1016/S0300-9572(01)00383-5; Corneli HM, 2012, PEDIATR EMERG CARE, V28, P475, DOI 10.1097/PEC.0b013e3182539098; Donoghue AJ, 2005, ANN EMERG MED, V46, P512, DOI 10.1016/j.annemergmed.2005.05.028; Dutch Government, LAWS REG; Dutch Ministry of Infrastructure and the Environment, DAT QUAL DUTCH SURF; Eich C, 2005, RESUSCITATION, V67, P145, DOI 10.1016/j.resuscitation.2005.05.002; Eich C, 2007, RESUSCITATION, V75, P42, DOI 10.1016/j.resuscitation.2007.03.013; Fallat ME, 2014, ANN EMERG MED, V63, P504, DOI 10.1016/j.annemergmed.2014.01.013; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Giesbrecht GG, 2000, AVIAT SPACE ENVIR MD, V71, P733; GRAF WD, 1995, ANN EMERG MED, V26, P312, DOI 10.1016/S0196-0644(95)70079-X; Idris AH, 2003, RESUSCITATION, V59, P45, DOI 10.1016/j.resuscitation.2003.09.003; KUISMA M, 1995, RESUSCITATION, V30, P141, DOI 10.1016/0300-9572(95)00888-Z; KYRIACOU DN, 1994, PEDIATRICS, V94, P137; Laosee Orapin C., 2012, Morbidity and Mortality Weekly Report, V61, P344; Layon AJ, 2009, ANESTHESIOLOGY, V110, P1390, DOI 10.1097/ALN.0b013e3181a4c3b8; Lee LK, 2006, ACAD EMERG MED, V13, P308, DOI 10.1197/j.aem.2005.10.012; Nitta M, 2013, RESUSCITATION, V84, P1568, DOI 10.1016/j.resuscitation.2013.06.017; ORLOWSKI JP, 1979, JACEP-J AM COLL EMER, V8, P176, DOI 10.1016/S0361-1124(79)80121-5; ORLOWSKI JP, 1987, PEDIATR CLIN N AM, V34, P75; ORLOWSKI JP, 1988, JAMA-J AM MED ASSOC, V260, P390, DOI 10.1001/jama.260.3.390; QUAN L, 1992, PEDIATRICS, V90, P909; Quan LD, 2014, RESUSCITATION, V85, P790, DOI 10.1016/j.resuscitation.2014.02.024; Royal Netherlands Meteorological Institute, CLIM SCEN; Ruttmann E, 2007, J THORAC CARDIOV SUR, V134, P594, DOI 10.1016/j.jtcvs.2007.03.049; Salomez F, 2004, RESUSCITATION, V63, P261, DOI 10.1016/j.resuscitation.2004.06.007; Sirbaugh PE, 1999, ANN EMERG MED, V33, P174, DOI 10.1016/S0196-0644(99)70391-4; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Suominen P, 2002, RESUSCITATION, V52, P247, DOI 10.1016/S0300-9572(01)00478-6; Suominen PK, 1997, RESUSCITATION, V35, P111, DOI 10.1016/S0300-9572(97)00036-1; Szpilman D, 2012, NEW ENGL J MED, V366, P2102, DOI 10.1056/NEJMra1013317; Tipton MJ, 2011, RESUSCITATION, V82, P819, DOI 10.1016/j.resuscitation.2011.02.021; Tipton M, 2013, RESUSCITATION, V84, pE31, DOI 10.1016/j.resuscitation.2012.08.339; Topjian AA, 2012, NEUROCRIT CARE, V17, P441, DOI 10.1007/s12028-012-9747-4; Veenhuizen L, 1994, Ned Tijdschr Geneeskd, V138, P906; Venema AM, 2010, RESUSCITATION, V81, P434, DOI 10.1016/j.resuscitation.2010.01.005; Wanscher M, 2012, RESUSCITATION, V83, P1078, DOI 10.1016/j.resuscitation.2012.05.009; World Health Organization, FACTSH DROWN	44	68	76	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h418	10.1136/bmj.h418	http://dx.doi.org/10.1136/bmj.h418			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670715	Green Published, hybrid			2022-12-28	WOS:000349318400017
J	Pinsky, PF; Gierada, DS; Black, W; Munden, R; Nath, H; Aberle, D; Kazerooni, E				Pinsky, Paul F.; Gierada, David S.; Black, William; Munden, Reginald; Nath, Hrudaya; Aberle, Denise; Kazerooni, Ella			Performance of Lung-RADS in the National Lung Screening Trial A Retrospective Assessment	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER; MANAGEMENT; STATEMENT; CT	Background: Lung cancer screening with low-dose computed tomography (LDCT) has been recommended, based primarily on the results of the NLST (National Lung Screening Trial). The American College of Radiology recently released Lung-RADS, a classification system for LDCT lung cancer screening. Objective: To retrospectively apply the Lung-RADS criteria to the NLST. Design: Secondary analysis of a group from a randomized trial. Setting: 33 U.S. screening centers. Patients: Participants were randomly assigned to the LDCT group of the NLST, were aged 55 to 74 years, had at least a 30-pack-year history of smoking, and were current smokers or had quit within the past 15 years. Intervention: 3 annual LDCT lung cancer screenings. Measurements: Lung-RADS classifications for LDCT screenings. Lung-RADS categories 1 to 2 constitute negative screening results, and categories 3 to 4 constitute positive results. Results: Of 26 722 LDCT group participants, 26 455 received a baseline screening; 48 671 screenings were done after baseline. At baseline, the false-positive result rate (1 minus the specificity rate) for Lung-RADS was 12.8% (95% CI, 12.4% to 13.2%) versus 26.6% (CI, 26.1% to 27.1%) for the NLST; after baseline, the falsepositive result rate was 5.3% (CI, 5.1% to 5.5%) for Lung-RADS versus 21.8% (CI, 21.4% to 22.2%) for the NLST. Baseline sensitivity was 84.9% (CI, 80.8% to 89.0%) for Lung-RADS versus 93.5% (CI, 90.7% to 96.3%) for the NLST, and sensitivity after baseline was 78.6% (CI, 74.6% to 82.6%) for Lung-RADS versus 93.8% (CI, 91.4% to 96.1%) for the NLST. Limitation: Lung-RADS criteria were applied retrospectively. Conclusion: Lung-RADS may substantially reduce the falsepositive result rate; however, sensitivity is also decreased. The effect of using Lung-RADS criteria in clinical practice must be carefully studied.	[Pinsky, Paul F.] NCI, Bethesda, MD 20892 USA; Washington Univ, Sch Med, St Louis, MO USA; Geisel Sch Med Dartmouth, Hanover, NH USA; Houston Methodist Hosp, Houston, TX USA; Univ Alabama Birmingham, Birmingham, AL USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Michigan, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); Dartmouth College; The Methodist Hospital System; The Methodist Hospital - Houston; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan	Pinsky, PF (corresponding author), NCI, 9609 Med Ctr Dr,Room 5E108, Bethesda, MD 20892 USA.	pp4f@nih.gov	Aberle, Denise R./D-5699-2014	Aberle, Denise R./0000-0002-8858-3401	 [U01-CA-80098];  [U01-CA-79778];  [N01-CN-25522];  [N01-CN-25511];  [N01-CN-25512];  [N01-CN-25513];  [N01-CN-25514];  [N01-CN-25515];  [N01-CN-25516];  [N01-CN-25518];  [N01-CN-25524];  [N01-CN-75022];  [N01-CN-25476];  [N02-CN-63300]; NATIONAL CANCER INSTITUTE [U01CA080098, N01CA025516, N01CA025524, N01CA075022, N01CA025513, N01CA025512, U10CA079778, N01CA025515, N01CA025514, N01CA025522, N01CA025511, N01CA025518, U01CA079778, UG1CA189828] Funding Source: NIH RePORTER	; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The NLST was supported by the following grants and contracts: U01-CA-80098, U01-CA-79778, N01-CN-25522, N01-CN-25511, N01-CN-25512, N01-CN-25513, N01-CN-25514, N01-CN-25515, N01-CN-25516, N01-CN-25518, N01-CN-25524, N01-CN-75022, N01-CN-25476, and N02-CN-63300.	Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; American College of Radiology, LUNG CT SCREEN REP D; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gierada DS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju284; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Horeweg N, 2013, EUR RESPIR J, V42, P1659, DOI 10.1183/09031936.00197712; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Moskowitz CS, 2006, CLIN TRIALS, V3, P272, DOI 10.1191/1740774506cn147oa; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; National Comprehensive Cancer Network, 2013, LUNG CANC SCREEN VER; Saeki H, 2011, STAT MED, V30, P3313, DOI 10.1002/sim.4364	14	288	300	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2015	162	7					485	U154		10.7326/M14-2086	http://dx.doi.org/10.7326/M14-2086			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4UT	25664444	Green Accepted			2022-12-28	WOS:000353283400003
J	Sulkowski, MS; Eron, JJ; Wyles, D; Trinh, R; Lalezari, J; Wang, C; Slim, J; Bhatti, L; Gathe, J; Ruane, PJ; Elion, R; Bredeek, F; Brennan, R; Blick, G; Khatri, A; Gibbons, K; Hu, YBR; Fredrick, L; Schnell, G; Pilot-Matias, T; Tripathi, R; Da Silva-Tillmann, B; McGovern, B; Campbell, AL; Podsadecki, T				Sulkowski, Mark S.; Eron, Joseph J.; Wyles, David; Trinh, Roger; Lalezari, Jay; Wang, Chia; Slim, Jihad; Bhatti, Laveeza; Gathe, Joseph; Ruane, Peter J.; Elion, Richard; Bredeek, Fritz; Brennan, Robert; Blick, Gary; Khatri, Amit; Gibbons, Krystal; Hu, Yiran B.; Fredrick, Linda; Schnell, Gretja; Pilot-Matias, Tami; Tripathi, Rakesh; Da Silva-Tillmann, Barbara; McGovern, Barbara; Campbell, Andrew L.; Podsadecki, Thomas			Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1 A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; ALPHA-2A PLUS RIBAVIRIN; GENOTYPE 1 INFECTION; PEGYLATED INTERFERON; HCV; THERAPY; ABT-450/R-OMBITASVIR; VIREMIA; COINFECTION; PREVALENCE	IMPORTANCE Patients co-infected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are at high risk for liver disease progression. However, interferon-based treatments for HCV infection have significant toxicities, limiting treatment uptake. OBJECTIVE To assess the all-oral 3 direct-acting antiviral (3D) regimen of ombitasvir, paritaprevir (co-dosed with ritonavir [paritaprevir/r]), dasabuvir, and ribavirin in HCV genotype 1-infected adults with HIV-1 co-infection, including patients with cirrhosis. DESIGN, SETTING, AND PARTICIPANTS TURQUOISE-I is a randomized, open-label study. Part 1a of this pilot study was conducted at 17 sites in the United States and Puerto Rico between September 2013 and August 2014 and included 63 patients with HCV genotype 1 and HIV-1 co-infection who were HCV treatment-naive or had history of prior treatment failure with peginterferon plus ribavirin therapy. The study allowed enrollment of patients, including those with cirrhosis, with a CD4+ count of 200/mm(3) or greater or CD4+ percentage of 14% or more and plasma HIV-1 RNA suppressed while taking a stable atazanavir-or raltegravir-inclusive antiretroviral regimen. INTERVENTIONS Ombitasvir/paritaprevir/r, dasabuvir, and ribavirin for 12 or 24 weeks of treatment as randomized. MAIN OUTCOMES AND MEASURES The primary assessment was the proportion of patients with sustained virologic response (HCV RNA < 25 IU/mL) at posttreatment week 12 (SVR12). RESULTS Among patients receiving 12 or 24 weeks of 3D and ribavirin, SVR12 was achieved by 29 of 31 (94%; 95% CI, 79%-98%) and 29 of 32 patients (91%; 95% CI, 76%-97%), respectively. Of the 5 patients who did not achieve SVR, 1 withdrew consent, 2 had confirmed virologic relapse or breakthrough, and 2 patients had clinical history and phylogenetic evidence consistent with HCV reinfection. The most common treatment-emergent adverse events were fatigue (48%), insomnia (19%), nausea (18%), and headache (16%). Adverse events were generally mild, with none reported as serious or leading to discontinuation. No patient had a confirmed HIV-1 breakthrough of 200 copies/mL or greater during treatment. CONCLUSIONS AND RELEVANCE In this open-label, randomized uncontrolled study, treatment with the all-oral, interferon-free 3D-plus-ribavirin regimen resulted in high SVR rates among patients co-infected with HCV genotype 1 and HIV-1 whether treated for 12 or 24 weeks. Further phase 3 studies of this regimen are warranted in patients with co-infection.	[Sulkowski, Mark S.] Johns Hopkins Univ, Baltimore, MD 21287 USA; [Eron, Joseph J.] Univ N Carolina, Chapel Hill, NC USA; [Wyles, David] Univ Calif San Diego, La Jolla, CA 92093 USA; [Trinh, Roger; Khatri, Amit; Gibbons, Krystal; Hu, Yiran B.; Fredrick, Linda; Schnell, Gretja; Pilot-Matias, Tami; Tripathi, Rakesh; Da Silva-Tillmann, Barbara; McGovern, Barbara; Campbell, Andrew L.; Podsadecki, Thomas] AbbVie, N Chicago, IL USA; [Lalezari, Jay] Quest Clin Res, San Francisco, CA USA; [Wang, Chia] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [Slim, Jihad] St Michaels Hosp, Newark, NJ USA; [Bhatti, Laveeza] AIDS Healthcare Fdn, Beverly Hills, CA USA; [Gathe, Joseph] Cure C Consortium, Houston, TX USA; [Ruane, Peter J.] Ruane Med & Liver Hlth Inst, Los Angeles, CA USA; [Elion, Richard] Whitman Walker Hlth, Washington, DC USA; [Bredeek, Fritz] Metropolis Med Grp, San Francisco, CA USA; [Brennan, Robert] Infect Dis Associates Cent Virginia, Lynchburg, VA USA; [Blick, Gary] Circle Care Ctr, Norwalk, CT USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; AbbVie; Virginia Mason Medical Center	Sulkowski, MS (corresponding author), Johns Hopkins Univ, Dept Med, Sch Med, 600 N Wolfe St,1830 Bldg,Room 445, Baltimore, MD 21287 USA.	msulkowski@jhmi.edu			AbbVie	AbbVie(AbbVie)	This trial was funded by AbbVie.	Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; Bodenheimer HC, 1997, HEPATOLOGY, V26, P473, DOI 10.1002/hep.510260231; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Khatri A, 2014, 54 INT C ANT AG CHEM; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844; Maieron A, 2014, AM COLL GASTR 79 ANN; Martin TCS, 2013, AIDS, V27, P2551, DOI 10.1097/QAD.0b013e32836381cc; Molina JM, 2015, LANCET, V385, P1098, DOI 10.1016/S0140-6736(14)62483-1; Novoa SR, 2006, CLIN INFECT DIS, V42, P291, DOI 10.1086/499056; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Puoti M, 2013, DIGEST LIVER DIS, V45, pS355, DOI 10.1016/j.dld.2013.09.001; Re III VL, 2014, ANN INTERN MED, V160, P369; Rodriguez-Torres M, 2013, IDWEEK OCT 2 6 SAN F; Rodriguez-Torres M, 2012, HIV CLIN TRIALS, V13, P142, DOI 10.1310/hct1303-142; Sklar PA, 2002, AIDS, V16, P2035, DOI 10.1097/00002030-200210180-00008; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski M, 2015, LANCET, V385, P1087, DOI 10.1016/S0140-6736(14)61793-1; Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Sulkowski MS, 2013, LIVER INT, V33, P63, DOI 10.1111/liv.12082; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744; Zhang S, 2010, ANTIVIR THER, V15, P555, DOI 10.3851/IMP1564	31	256	268	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1223	1231		10.1001/jama.2015.1328	http://dx.doi.org/10.1001/jama.2015.1328			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25706092	Bronze			2022-12-28	WOS:000351435500021
J	Dantzer, B				Dantzer, Ben			Mothers shape ecological communities	SCIENCE			English	Editorial Material							RANGE EXPANSION; DISPERSAL; DYNAMICS		[Dantzer, Ben] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Dantzer, Ben] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dantzer, B (corresponding author), Univ Michigan, Dept Psychol, 580 Union Dr, Ann Arbor, MI 48109 USA.	dantzer@umich.edu	Dantzer, Ben/E-9779-2011	Dantzer, Ben/0000-0002-3058-265X				Cowles H.C., 1899, BOT GAZ, V27, P95, DOI [DOI 10.1086/327796, 10.1086/327796]; Dantzer B, 2013, SCIENCE, V340, P1215, DOI 10.1126/science.1235765; Duckworth RA, 2008, AM NAT, V172, pS4, DOI 10.1086/588289; Duckworth RA, 2007, P NATL ACAD SCI USA, V104, P15017, DOI 10.1073/pnas.0706174104; Duckworth RA, 2015, SCIENCE, V347, P875, DOI 10.1126/science.1260154; Duckworth RA, 2009, PHILOS T R SOC B, V364, P1075, DOI 10.1098/rstb.2008.0294; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; McAdam AG, 2004, P ROY SOC B-BIOL SCI, V271, P75, DOI 10.1098/rspb.2003.2572; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Plaistow SJ, 2009, PHILOS T R SOC B, V364, P1049, DOI 10.1098/rstb.2008.0251; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2	13	2	2	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					822	823		10.1126/science.aaa6480	http://dx.doi.org/10.1126/science.aaa6480			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700499				2022-12-28	WOS:000349761100019
J	Kalil, AC; Sandkovsky, US				Kalil, Andre C.; Sandkovsky, Uriel S.			Review: Oral antiviral drugs reduce clinical recurrence in recurrent genital herpes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kalil, Andre C.; Sandkovsky, Uriel S.] Univ Nebraska Med Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Kalil, AC (corresponding author), Univ Nebraska Med Ctr, Omaha, NE 68198 USA.								0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4							JC7	10.7326/ACPJC-2015-162-4-007	http://dx.doi.org/10.7326/ACPJC-2015-162-4-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686194				2022-12-28	WOS:000350232500010
J	Buchanan, M				Buchanan, Mark			Trading at the speed of light	NATURE			English	Editorial Material												buchanan.mark@gmail.com						Cliff D., 2010, GLOBAL FINANCIAL MAR; Fricke D., 2015, PREPRINT; Gerig A, 2012, PREPRINT; Hendershott T, 2011, J FINANC, V66, P1, DOI 10.1111/j.1540-6261.2010.01624.x; Johnson N., 2012, PREPRINT; Patterson S., 2014, WALL STREET J; Salmon Felix, 2012, REUTERS; Stiglitz J. E., 2014, 2014 FIN MARK C; Wissner-Gross AD, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056104	9	20	20	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					161	163		10.1038/518161a	http://dx.doi.org/10.1038/518161a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8SD	25673397	Bronze			2022-12-28	WOS:000349190300014
J	Kuhn, CD; Wilusz, JE; Zheng, YX; Beal, PA; Joshua-Tor, L				Kuhn, Claus-D.; Wilusz, Jeremy E.; Zheng, Yuxuan; Beal, Peter A.; Joshua-Tor, Leemor			On-Enzyme Refolding Permits Small RNA and tRNA Surveillance by the CCA-Adding Enzyme	CELL			English	Article							NONCODING RNA; SECONDARY STRUCTURE; STRUCTURAL BASIS; DNA-REPLICATION; POLYMERIZATION; END	Transcription in eukaryotes produces a number of long noncoding RNAs (lncRNAs). Two of these, MALAT1 and Men beta, generate a tRNA-like small RNA in addition to the mature lncRNA. The stability of these tRNA-like small RNAs and bona fide tRNAs is monitored by the CCA-adding enzyme. Whereas CCA is added to stable tRNAs and tRNA-like transcripts, a second CCA repeat is added to certain unstable transcripts to initiate their degradation. Here, we characterize how these two scenarios are distinguished. Following the first CCA addition cycle, nucleotide binding to the active site triggers a clockwise screw motion, producing torque on the RNA. This ejects stable RNAs, whereas unstable RNAs are refolded while bound to the enzyme and subjected to a second CCA catalytic cycle. Intriguingly, with the CCA-adding enzyme acting as a molecular vise, the RNAs proofread themselves through differential responses to its interrogation between stable and unstable substrates.	[Kuhn, Claus-D.; Joshua-Tor, Leemor] Cold Spring Harbor Lab, Howard Hughes Med Inst, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; [Wilusz, Jeremy E.] Univ Penn, Perelman Sch Med, Dept Biophys & Biochem, Philadelphia, PA 19104 USA; [Zheng, Yuxuan; Beal, Peter A.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Davis	Joshua-Tor, L (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu	Kuhn, Claus D./U-3438-2019; Wilusz, Jeremy/AAG-4628-2020	Kuhn, Claus D./0000-0002-4244-3219; Wilusz, Jeremy/0000-0001-6929-8755; Joshua-Tor, Leemor/0000-0001-8185-8049	Jane Coffin Childs Memorial Fund for Medical Research; NIH [R01-GM34277, R01-CA133404, R00-GM104166, R01-GM61115]; Robertson Research Fund of Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory Women in Science Award; Department of Energy, Office of Basic Energy Sciences; NATIONAL CANCER INSTITUTE [P30CA045508, R01CA133404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061115, R01GM034277, R00GM104166, P41GM111244] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robertson Research Fund of Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory Women in Science Award; Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Annie Heroux for help with data collection at beamline X25 at the National Synchrotron Light Source, which is supported by the Department of Energy, Office of Basic Energy Sciences, Andrei Laikhter from ChemGenes for RNA synthesis, Alan Weiner for the AfCCA expression plasmid, and Phillip Sharp and members of the L.J. laboratory for discussions and advice. We thank J. Jansen for comments on the manuscript. C.-D.K. was supported by a Postdoctoral Fellowship from the Jane Coffin Childs Memorial Fund for Medical Research. Early stages of this research were performed at MIT by J.E.W. supported in part by NIH grants R01-GM34277 and R01-CA133404 to P.S. This work was supported by NIH grants R00-GM104166 (to J.E.W), R01-GM61115 (to P.A.B), the Robertson Research Fund of Cold Spring Harbor Laboratory and the Cold Spring Harbor Laboratory Women in Science Award (to L.J.). L.J. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cho HD, 2005, J BIOL CHEM, V280, P9555, DOI 10.1074/jbc.M412594200; Cho HDD, 2004, J BIOL CHEM, V279, P40130, DOI 10.1074/jbc.M405518200; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; DEUTSCHER MP, 1982, ENZYMES, V15, P183, DOI DOI 10.1016/S1874-6047(08)60279-6; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; HOPFIELD JJ, 1980, P NATL ACAD SCI-BIOL, V77, P5248, DOI 10.1073/pnas.77.9.5248; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; KANERVA PA, 1981, ACTA CHEM SCAND B, V35, P379, DOI 10.3891/acta.chem.scand.35b-0379; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pan BC, 2010, SCIENCE, V330, P937, DOI 10.1126/science.1194985; Peacock H, 2011, BIOORG MED CHEM LETT, V21, P5002, DOI 10.1016/j.bmcl.2011.04.136; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Shi PY, 1998, RNA, V4, P276; Sprinzl M, 1979, Prog Nucleic Acid Res Mol Biol, V22, P1, DOI 10.1016/S0079-6603(08)60798-9; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Sydow JF, 2009, CURR OPIN STRUC BIOL, V19, P732, DOI 10.1016/j.sbi.2009.10.009; Toh Y, 2008, EMBO J, V27, P1944, DOI 10.1038/emboj.2008.124; Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712; Tomita K, 2006, NATURE, V443, P956, DOI 10.1038/nature05204; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; Wilusz JE, 2011, SCIENCE, V334, P817, DOI 10.1126/science.1213671; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	52	55	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					644	658		10.1016/j.cell.2015.01.005	http://dx.doi.org/10.1016/j.cell.2015.01.005			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25640237	Bronze, Green Accepted			2022-12-28	WOS:000349208800009
J	Sanders, J				Sanders, Justin			Finding the Right Words at the Right Time - High-Value Advance Care Planning	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTERVENTIONS		[Sanders, Justin] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA; [Sanders, Justin] Ariadne Labs, Serious Illness Care Program, Boston, MA USA; [Sanders, Justin] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Sanders, J (corresponding author), Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA.			Sanders, Justin/0000-0001-8928-4051				Auriemma CL, 2014, JAMA INTERN MED, V174, P1085, DOI 10.1001/jamainternmed.2014.1183; Billings JA, 2014, JAMA INTERN MED, V174, P620, DOI 10.1001/jamainternmed.2013.14384; Block SD, 2014, LANCET, V383, P1699, DOI 10.1016/S0140-6736(13)62676-8; Boyd K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3699; Institute of Medicine, 2014, DYING AM IMPR QUAL H	5	17	17	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7					598	599		10.1056/NEJMp1411717	http://dx.doi.org/10.1056/NEJMp1411717			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA8CK	25671251				2022-12-28	WOS:000349143900003
J	Buzsaki, G				Buzsaki, Gyoergy			Our skewed sense of space	SCIENCE			English	Editorial Material							HIPPOCAMPUS		NYU, Langone Ctr, Neurosci Inst, New York, NY 10016 USA	New York University	Buzsaki, G (corresponding author), NYU, Langone Ctr, Neurosci Inst, 550 1St Ave, New York, NY 10016 USA.	gyorgy.buzsaki@nyumc.org		Buzsaki, Gyorgy/0000-0002-3100-4800				Alme CB, 2014, P NATL ACAD SCI USA, V111, P18428, DOI 10.1073/pnas.1421056111; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Markov NT, 2013, SCIENCE, V342, P578, DOI 10.1126/science.1238406; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mizuseki K, 2013, CELL REP, V4, P1010, DOI 10.1016/j.celrep.2013.07.039; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Rich PD, 2014, SCIENCE, V345, P814, DOI 10.1126/science.1255635	9	8	8	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					612	613		10.1126/science.aaa6505	http://dx.doi.org/10.1126/science.aaa6505			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657232				2022-12-28	WOS:000349145200023
J	Savee, JD; Papajak, E; Rotavera, B; Huang, HF; Eskola, AJ; Welz, O; Sheps, L; Taatjes, CA; Zador, J; Osborn, DL				Savee, John D.; Papajak, Ewa; Rotavera, Brandon; Huang, Haifeng; Eskola, Arkke J.; Welz, Oliver; Sheps, Leonid; Taatjes, Craig A.; Zador, Judit; Osborn, David L.			Direct observation and kinetics of a hydroperoxyalkyl radical (QOOH)	SCIENCE			English	Article							LOW-TEMPERATURE COMBUSTION; HYDROCARBON AUTOIGNITION; ATMOSPHERIC OXIDATION; ORGANIC AEROSOL; CHEMISTRY; ISOPRENE; MECHANISM; O-2; PHOTOOXIDATION; ISOMERIZATION	Oxidation of organic compounds in combustion and in Earth's troposphere is mediated by reactive species formed by the addition of molecular oxygen (O-2) to organic radicals. Among the most crucial and elusive of these intermediates are hydroperoxyalkyl radicals, often denoted "QOOH." These species and their reactions with O-2 are responsible for the radical chain branching that sustains autoignition and are implicated in tropospheric autoxidation that can form low-volatility, highly oxygenated organic aerosol precursors. We report direct observation and kinetics measurements of a QOOH intermediate in the oxidation of 1,3-cycloheptadiene, a molecule that offers insight into both resonance-stabilized and nonstabilized radical intermediates. The results establish that resonance stabilization dramatically changes QOOH reactivity and, hence, that oxidation of unsaturated organics can produce exceptionally long-lived QOOH intermediates.	[Savee, John D.; Papajak, Ewa; Rotavera, Brandon; Huang, Haifeng; Eskola, Arkke J.; Welz, Oliver; Sheps, Leonid; Taatjes, Craig A.; Zador, Judit; Osborn, David L.] Sandia Natl Labs, Combust Res Facil, Livermore, CA 94551 USA	United States Department of Energy (DOE); Sandia National Laboratories	Osborn, DL (corresponding author), Sandia Natl Labs, Combust Res Facil, Mail Stop 9055, Livermore, CA 94551 USA.	dlosbor@sandia.gov	Welz, Oliver/C-1165-2013; Rotavera, Brandon/F-9529-2011; Osborn, David/A-2627-2009; Zador, Judit/A-7613-2008	Welz, Oliver/0000-0003-1978-2412; Osborn, David/0000-0003-4304-8218; Zador, Judit/0000-0002-9123-8238; Taatjes, Craig/0000-0002-9271-0282	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES); National Nuclear Security Administration [DE-AC04-94AL85000]; Office of Science, BES/DOE [DE-AC02-05CH11231]	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES)(United States Department of Energy (DOE)); National Nuclear Security Administration(National Nuclear Security Administration); Office of Science, BES/DOE(United States Department of Energy (DOE))	Additional details of the experiments, calculations, and kinetic model are available in the supplementary materials. We thank H. Johnsen and the staff at the Chemical Dynamics Beamline of the Advanced Light Source (ALS) for technical support. This material is based on work supported by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES). Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the National Nuclear Security Administration under contract DE-AC04-94AL85000. This research used resources of the ALS, which is a DOE Office of Science User Facility. The ALS is supported by the Director, Office of Science, BES/DOE, under contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the DOE.	Andersen A, 2008, MOL PHYS, V106, P367, DOI 10.1080/00268970701837008; Archibald AT, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046520; Asatryan R, 2010, J PHYS CHEM A, V114, P8302, DOI 10.1021/jp104828a; Asatryan R, 2010, J PHYS CHEM A, V114, P7693, DOI 10.1021/jp101159h; Battin-Leclerc F, 2008, PROG ENERG COMBUST, V34, P440, DOI 10.1016/j.pecs.2007.10.002; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; Crounse JD, 2013, J PHYS CHEM LETT, V4, P3513, DOI 10.1021/jz4019207; Crounse JD, 2011, PHYS CHEM CHEM PHYS, V13, P13607, DOI 10.1039/c1cp21330j; Dec JE, 2009, P COMBUST INST, V32, P2727, DOI 10.1016/j.proci.2008.08.008; DeSain JD, 2001, FARADAY DISCUSS, V119, P101, DOI 10.1039/b102237g; Edwards PM, 2013, ATMOS CHEM PHYS, V13, P9497, DOI 10.5194/acp-13-9497-2013; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; Ezell MJ, 2002, PHYS CHEM CHEM PHYS, V4, P5813, DOI 10.1039/b207529f; Fernandes RX, 2009, PHYS CHEM CHEM PHYS, V11, P1320, DOI 10.1039/b819825j; Glowacki DR, 2012, SCIENCE, V337, P1066, DOI 10.1126/science.1224106; Goldsmith CF, 2012, J PHYS CHEM A, V116, P3325, DOI 10.1021/jp210722w; Herbinet O, 2010, COMBUST FLAME, V157, P893, DOI 10.1016/j.combustflame.2009.10.013; Husson B, 2012, COMBUST FLAME, V159, P1399, DOI 10.1016/j.combustflame.2011.12.006; Kalafut-Pettibone AJ, 2013, J PHYS CHEM A, V117, P14141, DOI 10.1021/jp4094996; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; Orlando JJ, 2012, CHEM SOC REV, V41, P6294, DOI 10.1039/c2cs35166h; Paulot F, 2009, SCIENCE, V325, P730, DOI 10.1126/science.1172910; Peeters J, 2009, PHYS CHEM CHEM PHYS, V11, P5935, DOI 10.1039/b908511d; Peeters J, 2014, J PHYS CHEM A, V118, P8625, DOI 10.1021/jp5033146; Perrin O, 1998, INT J CHEM KINET, V30, P875, DOI 10.1002/(SICI)1097-4601(1998)30:12<875::AID-KIN2>3.0.CO;2-8; Scheer AM, 2014, PHYS CHEM CHEM PHYS, V16, P13027, DOI 10.1039/c3cp55468f; Tunved P, 2006, SCIENCE, V312, P261, DOI 10.1126/science.1123052; Vereecken L, 2007, PHYS CHEM CHEM PHYS, V9, P5241, DOI 10.1039/b708023a; Vereecken L, 2012, PHYS CHEM CHEM PHYS, V14, P3802, DOI 10.1039/c2cp23711c; Vereecken L, 2012, CHEM SOC REV, V41, P6259, DOI 10.1039/c2cs35070j; Zador J, 2013, PHYS CHEM CHEM PHYS, V15, P10753, DOI 10.1039/c3cp51185e; Zador J, 2011, PROG ENERG COMBUST, V37, P371, DOI 10.1016/j.pecs.2010.06.006; Zhang F, 2011, J PHYS CHEM A, V115, P655, DOI 10.1021/jp1111839	33	105	108	4	251	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					643	646		10.1126/science.aaa1495	http://dx.doi.org/10.1126/science.aaa1495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657245	Green Submitted			2022-12-28	WOS:000349145200040
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Intention to treat analysis versus per protocol analysis of trial data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Buszewicz M, 2006, BMJ-BRIT MED J, V333, P879, DOI 10.1136/bmj.38965.375718.80; Marston L, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4656; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6694	3	64	66	2	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2015	350								h681	10.1136/bmj.h681	http://dx.doi.org/10.1136/bmj.h681			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0KK	25663096				2022-12-28	WOS:000349314500003
J	Lakhani, M				Lakhani, Mayur			IF I RULED THE NHS Palliative care for everyone with advanced progressive incurable illness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Natl Council Palliat Care, Alexandria, VA 22314 USA		Lakhani, M (corresponding author), Natl Council Palliat Care, Alexandria, VA 22314 USA.	mk.lakhani@gp-c82644.nhs.uk							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2015	350								h605	10.1136/bmj.h605	http://dx.doi.org/10.1136/bmj.h605			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0JX	25654997				2022-12-28	WOS:000349313100013
J	Lewis, S				Lewis, Steven			A System in Name Only - Access, Variation, and Reform in Canada's Provinces	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Access Consulting, Saskatoon, SK, Canada		Lewis, S (corresponding author), Access Consulting, Saskatoon, SK, Canada.			Lewis, Steven/0000-0002-4247-674X				Beall RF, 2014, OPEN MED; Davies K, 2014, MIRROR MIRROR WALL P; Epp J., 1986, ACHIEVING HLTH ALL F; Gagnon Marc-Andre, 2010, EC CASE UNIVERSAL PH; Lalonde M, 1974, NEW PERSPECTIVE HLTH	5	33	33	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2015	372	6					497	500		10.1056/NEJMp1414409	http://dx.doi.org/10.1056/NEJMp1414409			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA8CH	25651242				2022-12-28	WOS:000349143600001
J	Stern, TA; Henrys, SA; Okaya, D; Louie, JN; Savage, MK; Lamb, S; Sato, H; Sutherland, R; Iwasaki, T				Stern, T. A.; Henrys, S. A.; Okaya, D.; Louie, J. N.; Savage, M. K.; Lamb, S.; Sato, H.; Sutherland, R.; Iwasaki, T.			A seismic reflection image for the base of a tectonic plate	NATURE			English	Article							LITHOSPHERE-ASTHENOSPHERE BOUNDARY; NEW-ZEALAND; UPPER-MANTLE; SUBDUCTION ZONE; NORTH-ISLAND; MELT; VELOCITY; WATER; EVOLUTION; BENEATH	Plate tectonics successfully describes the surface of Earth as a mosaic of moving lithospheric plates. But it is not clear what happens at the base of the plates, the lithosphere-asthenosphere boundary (LAB). The LAB has been well imaged with converted teleseismic waves(1,2), whose 10-40-kilometre wavelength controls the structural resolution. Here we use explosion-generated seismic waves (of about 0.5-kilometre wavelength) to form a high-resolution image for the base of an oceanic plate that is subducting beneath North Island, New Zealand. Our 80-kilometre-wide image is based on P-wave reflections and shows an approximately 15 degrees dipping, abrupt, seismic wave-speed transition (less than 1 kilometre thick) at a depth of about 100 kilometres. The boundary is parallel to the top of the plate and seismic attributes indicate a P-wave speed decrease of at least 8 +/- 3 per cent across it. A parallel reflection event approximately 10 kilometres deeper shows that the decrease in P-wave speed is confined to a channel at the base of the plate, which we interpret as a sheared zone of ponded partial melts or volatiles. This is independent, high-resolution evidence for a low-viscosity channel at the LAB that decouples plates from mantle flow beneath, and allows plate tectonics to work.	[Stern, T. A.; Savage, M. K.; Lamb, S.; Sutherland, R.] Victoria Univ Wellington, Inst Geophys, Wellington 6140, New Zealand; [Henrys, S. A.; Sutherland, R.] Inst Geol & Nucl Sci, Lower Hutt 5010, New Zealand; [Okaya, D.] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90210 USA; [Louie, J. N.] Univ Nevada, Seismol Observ, Reno, NV USA; [Sato, H.; Iwasaki, T.] Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan	Victoria University Wellington; GNS Science - New Zealand; University of Southern California; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Tokyo	Stern, TA (corresponding author), Victoria Univ Wellington, Inst Geophys, Salamanca Rd, Wellington 6140, New Zealand.	tim.stern@vuw.ac.nz	Louie, John/AAI-1547-2021; Sutherland, Rupert/Y-9290-2019; Henrys, Stuart/ABD-7378-2020; Louie, John Nikolai/AAO-4390-2020; Savage, Martha K/F-1857-2011	Louie, John/0000-0003-2118-5115; Sutherland, Rupert/0000-0001-7430-0055; Henrys, Stuart/0000-0002-7164-5274; Louie, John Nikolai/0000-0003-2118-5115; Savage, Martha K/0000-0002-2080-0676	Government of New Zealand; Japanese Science and Technology Agency; National Science Foundation [NSF OCE-1061557]; Directorate For Geosciences [1061557] Funding Source: National Science Foundation	Government of New Zealand; Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The SAHKE project was supported by public research funding from the Government of New Zealand, the Japanese Science and Technology Agency, and the National Science Foundation (NSF OCE-1061557). Explosives and technical support was provided by Orica New Zealand Ltd. Individual land owners, Greater Wellington Regional Council, Transpower, and forestry companies allowed us onto their land. The IRIS/Passcal instrument pool provided the land instruments and technical support. We thank colleagues E. Smith and W. Stratford for comments on initial versions of this paper.	Badley ME, 1985, PRACTICAL SEISMIC IN; Bostock MG, 1999, GEOPHYS J INT, V138, P747, DOI 10.1046/j.1365-246x.1999.00902.x; DUNCAN G, 1995, GEOPHYS PROSPECT, V43, P329, DOI 10.1111/j.1365-2478.1995.tb00256.x; Eberhart-Phillips D, 2005, GEOPHYS J INT, V162, P270, DOI [10.1111/j.1365-246X.2005.02530.x, 10.1111/j.1365-246X.2005.02500.x]; Fischer KM, 2010, ANNU REV EARTH PL SC, V38, P551, DOI 10.1146/annurev-earth-040809-152438; Gripp AE, 2002, GEOPHYS J INT, V150, P321, DOI 10.1046/j.1365-246X.2002.01627.x; Hacker BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001127; Hall CE, 2000, GEOPHYS RES LETT, V27, P9, DOI 10.1029/1999GL008393; Hammond WC, 2000, J GEOPHYS RES-SOL EA, V105, P10975, DOI 10.1029/2000JB900041; Henrys S, 2013, GEOCHEM GEOPHY GEOSY, V14, P2063, DOI 10.1002/ggge.20136; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Jarchow C M, 1990, LEADING EDGE TULSA O, V9, P12; Kawakatsu H, 2009, SCIENCE, V324, P499, DOI 10.1126/science.1169499; Lamb S, 2011, TECTONOPHYSICS, V509, P135, DOI 10.1016/j.tecto.2011.06.005; LIE JE, 1990, NATURE, V346, P165, DOI 10.1038/346165a0; MENKE W, 1995, GEOPHYS J INT, V122, P175, DOI 10.1111/j.1365-246X.1995.tb03545.x; Naif S, 2013, NATURE, V495, P356, DOI 10.1038/nature11939; Olugboji TM, 2013, GEOCHEM GEOPHY GEOSY, V14, P880, DOI 10.1002/ggge.20086; PARSONS B, 1978, J GEOPHYS RES, V83, P4485, DOI 10.1029/JB083iB09p04485; Reyners M, 2006, GEOPHYS J INT, V165, P565, DOI 10.1111/j.1365-246X.2006.02897.x; RICHARDSON RM, 1992, J GEOPHYS RES-SOL EA, V97, P11739, DOI 10.1029/91JB00475; Rychert CA, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004619; Sakamaki T, 2013, NAT GEOSCI, V6, P1041, DOI [10.1038/NGEO1982, 10.1038/ngeo1982]; Savage MK, 2007, GEOPHYS J INT, V168, P1034, DOI 10.1111/j.1365-246X.2006.03086.x; Schultz C. A, 1995, UCRLMA121792 LAWR LI; Seward A., 2011, 201150 GNS SCI; Sheriff R. E., 1995, EXPLORATION SEISMOLO; Steer DN, 1998, TECTONOPHYSICS, V286, P111, DOI 10.1016/S0040-1951(97)00258-8; Taylor J. R., 1997, INTRO ERROR ANAL; WARNER M, 1987, GEOPHYS J INT, V89, P223; Warner M, 2004, J GEOPHYS ENG, V1, P88, DOI 10.1088/1742-2132/1/1/012; Watts A.B., 2001, ISOSTASY FLEXURE LIT; Williams CA, 2013, SEISMOL RES LETT, V84, P1066, DOI 10.1785/0220130035; Yamamoto J, 2014, GEOLOGY, V42, P967, DOI 10.1130/G35944.1; Zhou H.W., 2014, PRACTICAL SEISMIC DA	35	79	81	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					85	+		10.1038/nature14146	http://dx.doi.org/10.1038/nature14146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25653000				2022-12-28	WOS:000349098000036
J	Verheye, S; Jolicoeur, EM; Behan, MW; Pettersson, T; Sainsbury, P; Hill, J; Vrolix, M; Agostoni, P; Engstrom, T; Labinaz, M; de Silva, R; Schwartz, M; Meyten, N; Uren, NG; Doucet, S; Tanguay, JF; Lindsay, S; Henry, TD; White, CJ; Edelman, ER; Banai, S				Verheye, Stefan; Jolicoeur, E. Marc; Behan, Miles W.; Pettersson, Thomas; Sainsbury, Paul; Hill, Jonathan; Vrolix, Mathias; Agostoni, Pierfrancesco; Engstrom, Thomas; Labinaz, Marino; de Silva, Ranil; Schwartz, Marc; Meyten, Nathalie; Uren, Neal G.; Doucet, Serge; Tanguay, Jean-Francois; Lindsay, Steven; Henry, Timothy D.; White, Christopher J.; Edelman, Elazer R.; Banai, Shmuel			Efficacy of a Device to Narrow the Coronary Sinus in Refractory Angina	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTERY-DISEASE; CONTROLLED-TRIAL; BECK OPERATION; PLACEBO; REVASCULARIZATION; PECTORIS; REDUCER; MANAGEMENT; ISCHEMIA; SURGERY	BACKGROUND Many patients with coronary artery disease who are not candidates for revascularization have refractory angina despite standard medical therapy. The balloon-expandable, stainless steel, hourglass-shaped, coronary-sinus reducing device creates a focal narrowing and increases pressure in the coronary sinus, thus redistributing blood into ischemic myocardium. METHODS We randomly assigned 104 patients with Canadian Cardiovascular Society (CCS) class III or IV angina (on a scale from I to IV, with higher classes indicating greater limitations on physical activity owing to angina) and myocardial ischemia, who were not candidates for revascularization, to implantation of the device (treatment group) or to a sham procedure (control group). The primary end point was the proportion of patients with an improvement of at least two CCS angina classes at 6 months. RESULTS A total of 35% of the patients in the treatment group (18 of 52 patients), as compared with 15% of those in the control group (8 of 52), had an improvement of at least two CCS angina classes at 6 months (P = 0.02). The device was also associated with improvement of at least one CCS angina class in 71% of the patients in the treatment group (37 of 52 patients), as compared with 42% of those in the control group (22 of 52) (P = 0.003). Quality of life as assessed with the use of the Seattle Angina Questionnaire was significantly improved in the treatment group, as compared with the control group (improvement on a 100-point scale, 17.6 vs. 7.6 points; P = 0.03). There were no significant between-group differences in improvement in exercise time or in the mean change in the wall-motion index as assessed by means of dobutamine echocardiography. At 6 months, 1 patient in the treatment group had had a myocardial infarction; in the control group, 1 patient had died and 3 had had a myocardial infarction. CONCLUSIONS In this small clinical trial, implantation of the coronary-sinus reducing device was associated with significant improvement in symptoms and quality of life in patients with refractory angina who were not candidates for revascularization.	[Verheye, Stefan; Meyten, Nathalie] Ziekenhuis Netwerk Antwerpen Middelheim, Antwerp Cardiovasc Ctr, Antwerp, Belgium; [Vrolix, Mathias] Limburg Hosp, Ziekenhuis Oost, Genk, Belgium; [Jolicoeur, E. Marc; Doucet, Serge; Tanguay, Jean-Francois] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Labinaz, Marino] Ottawa Heart Inst, Ottawa, ON, Canada; [Schwartz, Marc] Neovasc, Richmond, BC, Canada; [Behan, Miles W.; Uren, Neal G.] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland; [Sainsbury, Paul; Lindsay, Steven] Bradford Royal Infirm, Bradford BD9 6RJ, W Yorkshire, England; [Hill, Jonathan] Kings Coll Hosp London, London, England; [de Silva, Ranil] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [de Silva, Ranil] Royal Brompton & Harefield NHS Fdn Trust, Natl Inst Hlth Res, Cardiovasc Biomed Res Unit, London, England; [Pettersson, Thomas] Kristianstad Cent Hosp, Kristianstad, Sweden; [Agostoni, Pierfrancesco] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Engstrom, Thomas] Rigshosp, DK-2100 Copenhagen, Denmark; [Henry, Timothy D.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [White, Christopher J.] Univ Queensland, Ochsner Clin Sch, John Ochsner Heart & Vasc Inst, New Orleans, LA USA; [Edelman, Elazer R.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Edelman, Elazer R.] Harvard Univ, Brigham & Womens Hosp, Cardiovasc Div, Sch Med, Boston, MA 02115 USA; [Banai, Shmuel] Tel Aviv Univ, Sch Med, Tel Aviv Med Ctr, IL-69978 Tel Aviv, Israel	East Limburg Hospital; Universite de Montreal; University of Ottawa; University of Ottawa Heart Institute; Royal Infirmary of Edinburgh; University of Edinburgh; Bradford Royal Infirmary; King's College Hospital NHS Foundation Trust; King's College Hospital; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Utrecht University; Utrecht University Medical Center; Rigshospitalet; University of Copenhagen; Cedars Sinai Medical Center; Ochsner Health System; University of Queensland; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tel Aviv University; Sackler Faculty of Medicine	Banai, S (corresponding author), Tel Aviv Med Ctr & Sch Med, 6 Weizman St, IL-64239 Tel Aviv, Israel.	banais@netvision.net.il	Agostoni, Pierfrancesco/A-3681-2008; White, Christopher J/J-6686-2012	Agostoni, Pierfrancesco/0000-0002-1505-9369; White, Christopher J/0000-0001-8618-7539; Edelman, Elazer/0000-0002-7832-7156	Neovasc	Neovasc	Supported by Neovasc.	Banai S, 2010, J AM COLL CARDIOL S, V55, pA98, DOI DOI 10.1016/S0735-1097(10)60928-X; Banai S, 2007, J AM COLL CARDIOL, V49, P1783, DOI 10.1016/j.jacc.2007.01.061; BECK CS, 1954, JAMA-J AM MED ASSOC, V156, P1226, DOI 10.1001/jama.1954.02950130006002; BECK CS, 1955, JAMA-J AM MED ASSOC, V159, P1264, DOI 10.1001/jama.1955.02960300008003; BEECHER HK, 1961, JAMA-J AM MED ASSOC, V176, P1102, DOI 10.1001/jama.1961.63040260007008; Bienenfeld L, 1996, AM HEART J, V132, P1207, DOI 10.1016/S0002-8703(96)90465-2; BROFMAN BL, 1956, JAMA-J AM MED ASSOC, V162, P1603, DOI 10.1001/jama.1956.02970350019005; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; CHAITMAN BR, 1995, J AM COLL CARDIOL, V26, P585, DOI 10.1016/0735-1097(95)00013-T; Collins M, 1999, J AM SOC ECHOCARDIOG, V12, P7, DOI 10.1016/S0894-7317(99)70167-7; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Frolicher VF, 2007, MANUAL EXERCISE TEST; Henry TD, 2014, NAT REV CARDIOL, V11, P78, DOI 10.1038/nrcardio.2013.200; Henry TD, 2013, EUR HEART J, V34, P2683, DOI 10.1093/eurheartj/eht165; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Ido A, 2001, AM J PHYSIOL-HEART C, V280, pH1361, DOI 10.1152/ajpheart.2001.280.3.H1361; JOHNSON AG, 1994, LANCET, V344, P1140, DOI 10.1016/S0140-6736(94)90637-8; Jolicoeur EM, 2008, AM HEART J, V155, P418, DOI 10.1016/j.ahj.2007.12.004; Jolicoeur EM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-46; Jolicoeur EM, 2012, CAN J CARDIOL, V28, pS50, DOI 10.1016/j.cjca.2011.10.015; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Konigstein M, 2014, EUROINTERVENTION, V9, P1158, DOI 10.4244/EIJV9I10A196; Leon MB, 2005, J AM COLL CARDIOL, V46, P1812, DOI 10.1016/j.jacc.2005.06.079; Mannheimer C, 2002, EUR HEART J, V23, P355, DOI 10.1053/euhj.2001.2706; McGillion M, 2012, CAN J CARDIOL, V28, pS20, DOI 10.1016/j.cjca.2011.07.007; Mohl W, 2008, NAT CLIN PRACT CARD, V5, P528, DOI 10.1038/ncpcardio1298; Mohl Werner, 2005, Interact Cardiovasc Thorac Surg, V4, P66, DOI 10.1510/icvts.2004.095364; Paz Y, 2009, NAT CLIN PRACT CARD, V6, DOI 10.1038/ncpcardio1475; SANDLER G, 1967, THORAX, V22, P34, DOI 10.1136/thx.22.1.34; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Syeda B, 2004, J THORAC CARDIOV SUR, V127, P1703, DOI 10.1016/j.jtcvs.2004.01.036; Williams B, 2010, CATHETER CARDIO INTE, V75, P886, DOI 10.1002/ccd.22431; WISING PJ, 1963, ACTA MED SCAND, V174, P93	33	158	161	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2015	372	6					519	527		10.1056/NEJMoa1402556	http://dx.doi.org/10.1056/NEJMoa1402556			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CH	25651246	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000349143600006
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Meet the Robodocs: resilient automatons who do as they're told	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Appleby J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1563; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; Keogh B, 2013, REV QUALITY CARE TRE; Neville S, 2015, FINANCIAL TIMES	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2015	350								h566	10.1136/bmj.h566	http://dx.doi.org/10.1136/bmj.h566			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0HO	25646004	Bronze			2022-12-28	WOS:000349306800015
J	Pang, T; Chia, KS; Chong, YS; Liu, E; Mahbubani, K; Wong, J; Yeoh, KG				Pang, Tikki; Chia, Kee Seng; Chong, Yap Seng; Liu, Eugene; Mahbubani, Kishore; Wong, John; Yeoh, Khay Guan			Human wellbeing and security: a whole of planet approach	LANCET			English	Editorial Material									[Pang, Tikki; Mahbubani, Kishore] Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore 25972, Singapore; [Chia, Kee Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 25972, Singapore; [Chong, Yap Seng; Liu, Eugene; Wong, John; Yeoh, Khay Guan] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 25972, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Pang, T (corresponding author), Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore 25972, Singapore.	spptep@nus.edu.sg		Chong, Yap Seng/0000-0002-7232-8473				Acemoglu D., 2012, WHY NATIONS FAIL; [Anonymous], 2014, LANCET, V384, P1641; Gawande A., 2014, BIENG MORTALPENGUIN; Haines A, 2014, LANCET, V384, P1073, DOI 10.1016/S0140-6736(14)61659-7; High-Level Panel of Eminent Persons on the Post-2015 Development Agenda, 2013, HIGH LEV PAN EM PERS; Horton R, 2002, LANCET, V360, P582, DOI 10.1016/S0140-6736(02)09809-4; Horton R, 2013, LANCET, V382, P1012, DOI 10.1016/S0140-6736(13)61936-4; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; The Economist, 2014, ECONOMIST, V413, P8; The Economist, 2014, ECONOMIST, V413, P51; The Economist, 2014, ECONOMIST, V413, P68; World Health Organization, 2004, WORLD REP KNOWL BETT; Yong PL, 2010, HEALTHCARE IMPERATIV	13	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					395	396		10.1016/S0140-6736(14)62346-1	http://dx.doi.org/10.1016/S0140-6736(14)62346-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ9CT	25706963				2022-12-28	WOS:000348509900004
J	Jamison, DT				Jamison, Dean T.			Disease Control Priorities, 3rd edition: improving health and reducing poverty	LANCET			English	Editorial Material							MIDDLE-INCOME COUNTRIES; GLOBAL HEALTH; CARE		[Jamison, Dean T.] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle	Jamison, DT (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA.	djamison@uw.edu			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	I declare no competing interests. The Bill & Melinda Gates Foundation provides funding for DCP3 as an element of its Disease Control Priorities Network grant to the University of Washington. I wish to acknowledge two institutions that have played key roles in DCP3: the World Bank, original home for the DCP series and publisher of its products; and the Inter-Academy Medical Panel (IAMP) and its US affiliate, the Institute of Medicine of the National Academy of Sciences, that organised a peer review process to cover each chapter in the nine volumes and they established an Advisory Committee to the Editors, chaired by Anne Mills.	[Anonymous], [No title captured]; BOBADILLA JL, 1993, DIS CONTROL PRIORITI, P51; Frenk J., 1989, Health Policy and Planning, V4, P29, DOI 10.1093/heapol/4.1.29; Hsiao M, 2013, LANCET, V381, P993, DOI 10.1016/S0140-6736(13)60707-2; Jamison D., 2008, OXFORD TXB PUBLIC HL, P903; Jamison D.T., 1993, DIS CONTROL PRIORITI; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jha P., 2009, CHOOSING HLTH ENTITL; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Mock CN, DIS CONTROL IN PRESS, V1; Mock CN, 2015, LANCET; Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9; PLOS Medicine, 2014, PLOS MED, V11; Smith PC, 2013, HEALTH ECON, V22, P180, DOI 10.1002/hec.2774; UN, 2015, SUSTAINABLE DEV GOAL; Verguet S, LANCET GLOB IN PRESS; Verguet S, 2015, HEALTH ECON, V24, P318, DOI 10.1002/hec.3019; WHO, 2010, WOR HEALT REP, P1	19	22	22	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					E11	E14		10.1016/S0140-6736(15)60097-6	http://dx.doi.org/10.1016/S0140-6736(15)60097-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ4TP	25662416				2022-12-28	WOS:000427585100002
J	Stueken, EE; Buick, R; Guy, BM; Koehler, MC				Stueeken, Eva E.; Buick, Roger; Guy, Bradley M.; Koehler, Matthew C.			Isotopic evidence for biological nitrogen fixation by molybdenum-nitrogenase from 3.2 Gyr	NATURE			English	Article							OCEAN; FRACTIONATION; OXYGENATION; LIMITATION; CHEMISTRY; AMMONIA; NITRATE	Nitrogen is an essential nutrient for all organisms that must have been available since the origin of life. Abiotic processes including hydrothermal reduction', photochemical reactions', or lightning disc(h)arge' could have converted atmospheric Ny into assimilable NH4, HCN, or NO species, collectively termed fixed nitrogen. But these sources may have been small on the early Earth, severely limiting the size of the primordial biosphere'. The evolution of the nitrogenfixing enzyme nitrogenase, which reduces atmospheric Ny to organic NH4, thus represented a major breakthrough in the radiation of life, but its timing is uncertain'''. Here we present nitrogen isotope ratios with a mean of 0.0 1.2%0 from marine and fluvial sedimentary rocks of prehnite-pumpellyite to greenschist metamorphic grade between 3.2 and 2.75 billion years ago. These data cannot readily be explained by abiotic processes and therefore suggest biological nitrogen fixation, most probably using molybdenum-based nitrogenase as opposed to other variants that impart significant negative fractionations'. Our data place a minimum age constraint of 3.2 billion years on the origin of biological nitrogen fixation and suggest that molybdenum was bioavailable in the mid-Archaean ocean long before the Great Oxidation Event.	[Stueeken, Eva E.; Buick, Roger; Koehler, Matthew C.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Stueeken, Eva E.; Buick, Roger; Koehler, Matthew C.] Univ Washington, Astrobiol Program, Seattle, WA 98195 USA; [Guy, Bradley M.] Univ Johannesburg, Dept Geol, ZA-2006 Auckland Pk, South Africa	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Johannesburg	Stueken, EE (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	evast@uw.edu	Stüeken, Eva/HCH-7013-2022	Stüeken, Eva/0000-0001-6861-2490; Buick, Roger/0000-0003-0139-1659	Virtual Planetary Laboratory at the University of Washington; Geological Society of America; Agouron Institute; Directorate For Geosciences [1338810] Funding Source: National Science Foundation	Virtual Planetary Laboratory at the University of Washington; Geological Society of America; Agouron Institute(Pfizer); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by the Virtual Planetary Laboratory at the University of Washington, a Geological Society of America graduate student research grant to E.E.S., and by an Agouron Institute grant to R.B. We thank N. J. Beukes for access to the Witwatersrand samples, and the University of Washington Isolab for technical support.	Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; BEAUMONT V, 1994, ANAL CHEM, V66, P2187, DOI 10.1021/ac00085a039; Boyd ES, 2011, GEOBIOLOGY, V9, P221, DOI 10.1111/j.1472-4669.2011.00278.x; Boyd ES, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00205; Brandes JA, 1998, NATURE, V395, P365, DOI 10.1038/26450; Brauer K, 2005, CHEM GEOL, V218, P361, DOI 10.1016/j.chemgeo.2005.01.004; Crowe SA, 2013, NATURE, V501, P535, DOI 10.1038/nature12426; Dos Santos PC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-162; Galbraith ED, 2013, NAT GEOSCI, V6, P579, DOI [10.1038/NGEO1832, 10.1038/ngeo1832]; Garvin J, 2009, SCIENCE, V323, P1045, DOI 10.1126/science.1165675; Glass JB, 2010, LIMNOL OCEANOGR, V55, P667, DOI 10.4319/lo.2009.55.2.0667; Godfrey LV, 2009, NAT GEOSCI, V2, P725, DOI 10.1038/NGEO633; Guy BM, 2012, PRECAMBRIAN RES, V216, P208, DOI 10.1016/j.precamres.2012.06.018; HOERING T, 1957, GEOCHIM COSMOCHIM AC, V12, P97, DOI 10.1016/0016-7037(57)90021-2; Kasting JF, 2001, NATURE, V412, P26, DOI 10.1038/35083660; Kuga M, 2014, EARTH PLANET SC LETT, V393, P2, DOI 10.1016/j.epsl.2014.02.037; Liermann LJ, 2005, CHEM GEOL, V220, P285, DOI 10.1016/j.chemgeo.2005.04.013; Marty B, 2013, SCIENCE, V342, P101, DOI 10.1126/science.1240971; MOORE H, 1977, ATMOS ENVIRON, V11, P1239, DOI 10.1016/0004-6981(77)90102-0; Navarro-Gonzalez R, 2001, NATURE, V412, P61, DOI 10.1038/35083537; Nishizawa M, 2014, GEOCHIM COSMOCHIM AC, V138, P117, DOI 10.1016/j.gca.2014.04.021; Papineau D, 2009, PRECAMBRIAN RES, V171, P37, DOI 10.1016/j.precamres.2009.03.005; Philippot P., 2012, SCI REP-UK, V2, P1; Planavsky NJ, 2014, NAT GEOSCI, V7, P283, DOI 10.1038/ngeo2122; Qi HP, 2003, RAPID COMMUN MASS SP, V17, P2483, DOI 10.1002/rcm.1219; Quan TM, 2009, GEOBIOLOGY, V7, P124, DOI 10.1111/j.1472-4669.2008.00182.x; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; ROBL TL, 1993, ORG GEOCHEM, V20, P249, DOI 10.1016/0146-6380(93)90042-A; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; Schoepfer SD, 2012, PALAEOGEOGR PALAEOCL, V313, P181, DOI 10.1016/j.palaeo.2011.10.019; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Straub M, 2013, NATURE, V501, P200, DOI 10.1038/nature12397; Stueken EE, 2013, GEOCHIM COSMOCHIM AC, V120, P121, DOI 10.1016/j.gca.2013.06.002; Taylor SR., 2001, ENCYCL PHYS SCI TECH, V312, P697; Thomazo C, 2013, ELEMENTS, V9, P345, DOI 10.2113/gselements.9.5.345; Tian F, 2011, EARTH PLANET SC LETT, V308, P417, DOI 10.1016/j.epsl.2011.06.011; Zerkle AL, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000651; Zhang XN, 2014, P NATL ACAD SCI USA, V111, P4782, DOI 10.1073/pnas.1402976111	38	150	152	5	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					666	U178		10.1038/nature14180	http://dx.doi.org/10.1038/nature14180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25686600				2022-12-28	WOS:000353689700047
J	Zeisel, A; Munoz-Manchado, AB; Codeluppi, S; Lonnerberg, P; La Manno, G; Jureus, A; Marques, S; Munguba, H; He, LQ; Betsholtz, C; Rolny, C; Castelo-Branco, G; Hjerling-Leffler, J; Linnarsson, S				Zeisel, Amit; Munoz-Manchado, Ana B.; Codeluppi, Simone; Lonnerberg, Peter; La Manno, Gioele; Jureus, Anna; Marques, Sueli; Munguba, Hermany; He, Liqun; Betsholtz, Christer; Rolny, Charlotte; Castelo-Branco, Goncalo; Hjerling-Leffler, Jens; Linnarsson, Sten			Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq	SCIENCE			English	Article							CEREBRAL-CORTEX; MACROPHAGES; EXPRESSION; BRAIN; STEP; CA1	The mammalian cerebral cortex supports cognitive functions such as sensorimotor integration, memory, and social behaviors. Normal brain function relies on a diverse set of differentiated cell types, including neurons, glia, and vasculature. Here, we have used large-scale single-cell RNA sequencing (RNA-seq) to classify cells in the mouse somatosensory cortex and hippocampal CA1 region. We found 47 molecularly distinct subclasses, comprising all known major cell types in the cortex. We identified numerous marker genes, which allowed alignment with known cell types, morphology, and location. We found a layer I interneuron expressing Pax6 and a distinct postmitotic oligodendrocyte subclass marked by Itpr2. Across the diversity of cortical cell types, transcription factors formed a complex, layered regulatory code, suggesting a mechanism for the maintenance of adult cell type identity.	[Zeisel, Amit; Munoz-Manchado, Ana B.; Codeluppi, Simone; Lonnerberg, Peter; La Manno, Gioele; Jureus, Anna; Marques, Sueli; Munguba, Hermany; Castelo-Branco, Goncalo; Hjerling-Leffler, Jens; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden; [He, Liqun; Betsholtz, Christer] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden; [Betsholtz, Christer] Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Rolny, Charlotte] Karolinska Inst, Dept Oncol Pathol, S-17176 Stockholm, Sweden	Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska Institutet	Linnarsson, S (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden.	jens.hjerling-leffler@ki.se; sten.linnarsson@ki.se	Rolny, Charlotte/AET-0493-2022; Castelo-Branco, Gonçalo/O-9162-2019; La Manno, Gioele/AAC-7968-2022; Castelo-Branco, Goncalo/A-8357-2015; Linnarsson, Sten/HCH-3909-2022; Manchado, Ana Munoz/AAB-6399-2019; codeluppi, simone/I-4143-2012; Hjerling Leffler, Jens/E-3775-2012	Castelo-Branco, Gonçalo/0000-0003-2247-9393; La Manno, Gioele/0000-0003-1428-8757; Marques, Sueli/0000-0003-3368-4392; Munguba, Hermany/0000-0002-8480-8423; codeluppi, simone/0000-0002-7053-0520; Munoz Manchado, Ana/0000-0002-1121-6072; Rolny, Charlotte/0000-0003-4979-9266; Hjerling Leffler, Jens/0000-0002-4539-1776; He, Liqun/0000-0003-2127-7597	European Research Council [261063, BRAINCELL, 294556, BBBARRIER]; Swedish Research Council (STARGET); Human Frontier Science Program; Karolinska Institutet (BRECT); Swedish Cancer Society [CAN2013/852]; Swedish Research Council; European Union (FP7/Marie Curie Integration Grant EPIOPC); Ake Wiberg Foundation; Karolinska Institutet Research Foundations; Svenska Lakaresallskapet; Clas Groschinskys Minnesfond; Hjarnfonden; European Union [FP7/Marie Curie Actions] [322304]; StratNeuro Foundation; Jeanssons Foundation; Ake Wibergs Foundation; Magnus Bergvalls Foundation; Knut and Alice Wallenberg Scholar Grant; Swedish Cancer Society	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council (STARGET)(Swedish Research Council); Human Frontier Science Program(Human Frontier Science Program); Karolinska Institutet (BRECT); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union (FP7/Marie Curie Integration Grant EPIOPC); Ake Wiberg Foundation; Karolinska Institutet Research Foundations(Karolinska Institutet); Svenska Lakaresallskapet; Clas Groschinskys Minnesfond; Hjarnfonden; European Union [FP7/Marie Curie Actions]; StratNeuro Foundation; Jeanssons Foundation; Ake Wibergs Foundation; Magnus Bergvalls Foundation; Knut and Alice Wallenberg Scholar Grant; Swedish Cancer Society(Swedish Cancer Society)	The raw data have been deposited with the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) under accession, code GSE60361. Annotated data are available at http://linnarssonlab.org/cortex. We thank P. Ernfors, K. Harris; and R. Sandberg for useful comments on the manuscript; F. Ginhoux for helpful discussions on microglia and macrophages; A. Johnsson for laboratory management and support; ALM/SciLite (H. G. Blom) for technical support; and Fluidigm Inc. (R. C. Jones and M. Lynch) for generous technical and instrument support. Si. was supported by the European Research Council (261063, BRAINCELL) and the Swedish Research Council (STARGET); A.Z. was supported by the Human Frontier Science Program; A.B.M.-M. was supported by the Karolinska Institutet (BRECT); C.R. was supported by the Swedish Cancer Society (CAN2013/852); G.C.-B. was supported by the Swedish Research Council, the European Union (FP7/Marie Curie Integration Grant EPIOPC), the Ake Wiberg Foundation, the Karolinska Institutet Research Foundations, Svenska Lakaresallskapet, Clas Groschinskys Minnesfond, and Hjarnfonden; J.H.-L. was supported by the Swedish Research Council, the European Union [FP7/Marie Curie Actions (322304, Adolescent Development)], StratNeuro, and the Jeanssons, Ake Wibergs, and Magnus Bergvalls Foundations; C.B. was supported by the European Research Council (294556, BBBARRIER), a Knut and Alice Wallenberg Scholar Grant, the Swedish Cancer Society, and Swedish Research Council. Supplementary materials contain additional data.	Brooks ER, 2014, CURR BIOL, V24, pR973, DOI 10.1016/j.cub.2014.08.047; Chung MI, 2014, ELIFE, V3, DOI 10.7554/eLife.01439; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Galea I, 2005, GLIA, V49, P375, DOI 10.1002/glia.20124; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kann O, 2011, BRAIN, V134, P345, DOI 10.1093/brain/awq333; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Mizuseki K, 2011, NAT NEUROSCI, V14, P1174, DOI 10.1038/nn.2894; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Thomas J, 2010, BIOL CELL, V102, P499, DOI 10.1042/BC20100035; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; Tsafrir D, 2005, BIOINFORMATICS, V21, P2301, DOI 10.1093/bioinformatics/bti329; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	26	1668	1695	28	444	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1138	1142		10.1126/science.aaa1934	http://dx.doi.org/10.1126/science.aaa1934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25700174				2022-12-28	WOS:000350354200053
J	Taylor, JS				Taylor, John-Stephen			The dark side of sunlight and melanoma	SCIENCE			English	Editorial Material							ULTRAVIOLET		Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL)	Taylor, JS (corresponding author), Washington Univ, Dept Chem, St Louis, MO 63130 USA.	taylor@wustl.edu	Taylor, John-Stephen/AAA-3218-2020	Taylor, John-Stephen/0000-0002-8615-7257				Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; LAMOLA AA, 1971, BIOCHEM BIOPH RES CO, V43, P893, DOI 10.1016/0006-291X(71)90701-7; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Napolitano A, 2014, PIGM CELL MELANOMA R, V27, P721, DOI 10.1111/pcmr.12262; Noonan FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1893; Premi S, 2015, SCIENCE, V347, P842, DOI 10.1126/science.1256022	6	24	24	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					824	824		10.1126/science.aaa6578	http://dx.doi.org/10.1126/science.aaa6578			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700500				2022-12-28	WOS:000349761100020
J	Polak, P; Karlic, R; Koren, A; Thurman, R; Sandstrom, R; Lawrence, MS; Reynolds, A; Rynes, E; Vlahovicek, K; Stamatoyannopoulos, JA; Sunyaev, SR				Polak, Paz; Karlic, Rosa; Koren, Amnon; Thurman, Robert; Sandstrom, Richard; Lawrence, Michael S.; Reynolds, Alex; Rynes, Eric; Vlahovicek, Kristian; Stamatoyannopoulos, John A.; Sunyaev, Shamil R.			Cell-of-origin chromatin organization shapes the mutational landscape of cancer	NATURE			English	Article							SOMATIC MUTATIONS; GENOME; ADENOCARCINOMA; SIGNATURES	Cancer is a disease potentiated by mutations in somatic cells. Cancer mutations are not distributed uniformly along the human genome. Instead, different human genomic regions vary by up to fivefold in the local density of cancer somatic mutations', posing a fundamental problem for statistical methods used in cancer genomics. Epigenomic organization has been proposed as a major determinant of the cancer mutational landscape(1-5). However, both somatic mutagenesis and epigenomic features are highly cell-type-specific(6-7). We investigated the distribution of mutations in multiple independent samples of diverse cancer types and compared them to cell-type-specific epigenomic features. Here we show that chromatin accessibility and modification, together with replication timing, explain up to 86% of the variance in mutation rates along cancer genomes. The best predictors of local somatic mutation density are epigenomic features derived from the most likely cell type of origin of the corresponding malignancy. Moreover, we find that cell-of-origin chromatin features are much stronger determinants of cancer mutation profiles than chromatin features of matched cancer cell lines. Furthermore, we show that the cell type of origin of a cancer can be accurately determined based on the distribution of mutations along its genome. Thus, the DNA sequence of a cancer genome encompasses a wealth of information about the identity and epigenomic features of its cell of origin.	[Polak, Paz; Sunyaev, Shamil R.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Polak, Paz; Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Polak, Paz; Koren, Amnon; Lawrence, Michael S.; Sunyaev, Shamil R.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Karlic, Rosa; Vlahovicek, Kristian] Univ Zagreb, Bioinformat Grp, Dept Mol Biol, Div Biol,Fac Sci, Zagreb 10000, Croatia; [Koren, Amnon] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Thurman, Robert; Sandstrom, Richard; Reynolds, Alex; Rynes, Eric; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Vlahovicek, Kristian] Univ Oslo, Dept Informat, NO-0316 Oslo, Norway; [Stamatoyannopoulos, John A.] Univ Washington, Div Oncol, Dept Med, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Zagreb; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Oslo; University of Washington; University of Washington Seattle	Sunyaev, SR (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	jstam@u.washington.edu; ssunyaev@rics.bwh.harvard.edu	Polak, Paz/AAH-9380-2020; Vlahoviček, Kristian/D-9661-2011; Lawrence, Michael/AAC-8202-2020	Vlahoviček, Kristian/0000-0002-5705-2464; Karlic, Rosa/0000-0002-1291-2897; Sandstrom, Richard/0000-0002-3356-1547	NIH [R01 MH101244, U54 CA143874, U01 ES017156, P01 HL53750, U54 HG007010]; Integra-Life Seventh Framework Program [315997]; EMBO [1431/2006]; NATIONAL CANCER INSTITUTE [U54CA143874] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053750] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integra-Life Seventh Framework Program; EMBO(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants R01 MH101244, U54 CA143874 to S.R.S. and U01 ES017156, P01 HL53750, U54 HG007010 to J.A.S. R.K and K.V. acknowledge the Integra-Life Seventh Framework Program (grant number 315997) and the EMBO Young Investigator Program (Installation grant 1431/2006 to K.V.).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hodgkinson A, 2012, HUM MUTAT, V33, P136, DOI 10.1002/humu.21616; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2502; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	28	317	322	0	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					360	364		10.1038/nature14221	http://dx.doi.org/10.1038/nature14221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25693567	hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000349547400034
J	Woolston, C				Woolston, Chris			WORKPLACE SAFETY Risky encounters	NATURE			English	Editorial Material																		Clancy KBH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102172	1	2	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					445	446		10.1038/nj7539-445a	http://dx.doi.org/10.1038/nj7539-445a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3SA	25699307	Bronze			2022-12-28	WOS:000349547400052
J	Anderson, AH; Yang, W; Townsend, RR; Pan, Q; Chertow, GM; Kusek, JW; Charleston, J; He, J; Kallem, R; Lash, JP; Miller, ER; Rahman, M; Steigerwalt, S; Weir, M; Wright, JT; Feldman, HI				Anderson, Amanda H.; Yang, Wei; Townsend, Raymond R.; Pan, Qiang; Chertow, Glenn M.; Kusek, John W.; Charleston, Jeanne; He, Jiang; Kallem, RadhaKrishna; Lash, James P.; Miller, Edgar R., III; Rahman, Mahboob; Steigerwalt, Susan; Weir, Matthew; Wright, Jackson T., Jr.; Feldman, Harold I.		Chronic Renal Insufficiency Cohort	Time-Updated Systolic Blood Pressure and the Progression of Chronic Kidney Disease A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							RENAL-INSUFFICIENCY COHORT; CONVERTING ENZYME-INHIBITION; MARGINAL STRUCTURAL MODELS; BASE-LINE CHARACTERISTICS; HYPERTENSION; RISK; ASSOCIATION; VARIABILITY; MORTALITY; SURVIVAL	Background: Previous reports of the longitudinal association between achieved blood pressure (BP) and end-stage renal disease (ESRD) among patients with chronic kidney disease (CKD) have not incorporated time-updated BP with appropriate covariate adjustment. Objective: To assess the association between baseline and time-updated systolic blood pressure (SBP) with CKD progression. Design: Observational, prospective cohort study. (ClinicalTrials.gov: NCT00304148) Setting: 7 U.S. clinical centers. Patients: Patients in the Chronic Renal Insufficiency Cohort Study (n = 3708) followed for a median of 5.7 years (25th to 75th percentile, 4.6 to 6.7 years). Measurements: The mean of 3 seated SBP measurements made up the visit-specific SBP. Time-updated SBP was the mean of that and all previous visits. Outcomes were ESRD and the composite end point of ESRD or halving of the estimated glomerular filtration rate. Analyses investigating baseline and time-updated SBP used Cox proportional hazards models and marginal structural models, respectively. Results: Systolic blood pressure was 130 mm Hg or greater at all visits in 19.2% of patients. The hazard ratio for ESRD among patients with SBP of was 1.46 (95% CI, 1.13 to 1.88) using only baseline data and 2.37 (CI, 1.48 to 3.80) using time-updated data. Among patients with SBP of 140 mm Hg or greater, corresponding hazard ratios were 1.46 (CI, 1.18 to 1.88) and 3.37 (CI, 2.26 to 5.03) for models using only baseline data and those using time-updated data, respectively. Limitation: Blood pressure was measured once annually, and the cohort was not a random sample. Conclusion: Time-updated SBP greater than 130 mm Hg was more strongly associated with CKD progression than analyses based on baseline SBP.	[Anderson, Amanda H.; Yang, Wei; Pan, Qiang; Feldman, Harold I.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Townsend, Raymond R.] Univ Penn, Perelman Sch Med, Renal Hypertens Div, Philadelphia, PA 19104 USA; [Chertow, Glenn M.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Kusek, John W.] NIDDK, Div Kidney Urol & Hematol Dis, NIH, Bethesda, MD 20892 USA; [Charleston, Jeanne] Johns Hopkins Univ ProHlth, Baltimore, MD 21207 USA; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA; [Kallem, RadhaKrishna] Univ Penn, Perelman Sch Med, Smilow Ctr Translat Res, Renal Hypertens Div, Philadelphia, PA 19104 USA; [Lash, James P.] Univ Illinois, Dept Med, Med Ctr, Nephrol Sect, Chicago, IL 60612 USA; [Miller, Edgar R., III] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Rahman, Mahboob; Wright, Jackson T., Jr.] Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Div Nephrol & Hypertens, Cleveland, OH 44106 USA; [Steigerwalt, Susan] Renaissance Renal Res Inst, Detroit, MI 48336 USA; [Weir, Matthew] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University; Johns Hopkins Medicine; Tulane University; University of Pennsylvania; Pennsylvania Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Johns Hopkins Medicine; Case Western Reserve University; University Hospitals of Cleveland; University System of Maryland; University of Maryland Baltimore	Anderson, AH (corresponding author), Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, 819 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	andersah@mail.med.upenn.edu	He, Jiang/AAF-5303-2020; Weir, Matthew R/ABC-3654-2021	He, Jiang/0000-0002-8286-9652; Weir, Matthew R/0000-0001-8820-5702; Chertow, Glenn/0000-0002-7599-0534	National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439, UL1TR000433, UL1TR000003, UL1TR000424] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879, UL1RR024131, M01RR016500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060902, U01DK060990, U01DK060963, U01DK060980, K01DK092353, U01DK060984, U01DK061021, U01DK061022, U01DK061028, K24DK002651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of Diabetes and Digestive and Kidney Diseases.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Anderson AH, 2012, AM J KIDNEY DIS, V60, P250, DOI 10.1053/j.ajkd.2012.04.012; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Bangalore S, 2011, CIRCULATION, V123, P2799, DOI 10.1161/CIRCULATIONAHA.110.016337; Brunelli SM, 2008, CLIN J AM SOC NEPHRO, V3, P777, DOI 10.2215/CJN.04281007; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Davis EM, 2011, HYPERTENSION, V57, P1061, DOI 10.1161/HYPERTENSIONAHA.111.169367; Estacio RO, 2000, DIABETES CARE, V23, pB54; Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Fischer MJ, 2011, AM J KIDNEY DIS, V58, P214, DOI 10.1053/j.ajkd.2011.05.010; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2008, EPIDEMIOLOGY, V19, P766, DOI 10.1097/EDE.0b013e3181875e61; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Joffe M, 2010, AM J NEPHROL, V31, P426, DOI 10.1159/000296250; JOFFE MM, 1995, STAT MED, V14, P2131, DOI 10.1002/sim.4780141907; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Lash JP, 2009, CLIN J AM SOC NEPHRO, V4, P1302, DOI 10.2215/CJN.00070109; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lewis JB, 1999, AM J KIDNEY DIS, V34, P809, DOI 10.1016/S0272-6386(99)70036-3; Lv JC, 2013, CAN MED ASSOC J, V185, P949, DOI 10.1503/cmaj.121468; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5; Sarnak MJ, 2005, ANN INTERN MED, V142, P342, DOI 10.7326/0003-4819-142-5-200503010-00009; Sim JJ, 2014, J AM COLL CARDIOL, V64, P588, DOI 10.1016/j.jacc.2014.04.065; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; U.S. Renal Data System, 2013, 2013 USRDS ANN DAT R; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Wuhl E, 2009, NEW ENGL J MED, V361, P1639, DOI 10.1056/NEJMoa0902066; Yang W, 2014, AM J KIDNEY DIS, V63, P236, DOI 10.1053/j.ajkd.2013.08.028; Yang W, 2012, PHARMACOEPIDEM DR S, V21, P241, DOI 10.1002/pds.2306	37	100	105	2	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4					258	+		10.7326/M14-0488	http://dx.doi.org/10.7326/M14-0488			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686166	Green Accepted			2022-12-28	WOS:000350232500015
J	Cole, TB				Cole, Thomas B.			House and Street	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					650	651		10.1001/jama.2014.11583	http://dx.doi.org/10.1001/jama.2014.11583			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25688767				2022-12-28	WOS:000349476100001
J	Fernandez, LM; Girdler, RV; Wright, RB; Harper, DM				Fernandez, Luz M.; Girdler, Renee V.; Wright, R. Brent; Harper, Diane M.			IIV3 reduced flu in HIV- pregnant women and infants, and in HIV plus pregnant women but not their infants	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Fernandez, Luz M.; Girdler, Renee V.; Wright, R. Brent; Harper, Diane M.] Univ Louisville, Louisville, KY 40292 USA	University of Louisville	Fernandez, LM (corresponding author), Univ Louisville, Louisville, KY 40292 USA.		Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X				Jackson LA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-71; Jefferson T, 2014, COCHRANE DB SYST REV, V3; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; *WHO, 2001, REP COMM MACR HLTH	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4							JC6	10.7326/ACPJC-2015-162-4-006	http://dx.doi.org/10.7326/ACPJC-2015-162-4-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686193				2022-12-28	WOS:000350232500009
J	Chen, A; Koehler, AN				Chen, Andrew; Koehler, Angela N.			Tying up a transcription factor	SCIENCE			English	Editorial Material							CBF-BETA-SMMHC; RUNX1; INHIBITION; PROTEINS		[Chen, Andrew; Koehler, Angela N.] MIT, Koch Inst Integrat Canc Res, Dept Biol Engn, Cambridge, MA 02139 USA; [Koehler, Angela N.] Broad Inst MIT & Harvard, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Chen, A (corresponding author), MIT, Koch Inst Integrat Canc Res, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	koehler@mit.edu						Adya N, 2000, SEMIN CELL DEV BIOL, V11, P361, DOI 10.1006/scdb.2000.0189; Berg T, 2008, CURR OPIN CHEM BIOL, V12, P464, DOI 10.1016/j.cbpa.2008.07.023; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Erba HP, 2015, LEUKEMIA RES, V39, P183, DOI 10.1016/j.leukres.2014.11.027; Gorczynski MJ, 2007, CHEM BIOL, V14, P1186, DOI 10.1016/j.chembiol.2007.09.006; Illendula A, 2015, SCIENCE, V347, P779, DOI 10.1126/science.aaa0314; Koehler AN, 2010, CURR OPIN CHEM BIOL, V14, P331, DOI 10.1016/j.cbpa.2010.03.022; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kumar C Chandra, 2011, Genes Cancer, V2, P95, DOI 10.1177/1947601911408076; Lukasik SM, 2002, NAT STRUCT BIOL, V9, P674, DOI 10.1038/nsb831; Majmudar CY, 2005, CURR OPIN CHEM BIOL, V9, P467, DOI 10.1016/j.cbpa.2005.08.012; Marr MT, 2006, GENE DEV, V20, P1458, DOI 10.1101/gad.1418806; Orlowski RJ, 2015, CURR OPIN HEMATOL, V22, P97, DOI 10.1097/MOH.0000000000000115; Zhang L, 2003, BLOOD CELL MOL DIS, V30, P147, DOI 10.1016/S1079-9796(03)00022-6	14	4	5	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					713	714		10.1126/science.aaa6119	http://dx.doi.org/10.1126/science.aaa6119			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678644				2022-12-28	WOS:000349221300021
J	Dittmann, M; Hoffmann, HH; Scull, MA; Gilmore, RH; Bell, KL; Ciancanelli, M; Wilson, SJ; Crotta, S; Yu, YP; Flatley, B; Xiao, JW; Casanova, JL; Wack, A; Bieniasz, PD; Rice, CM				Dittmann, Meike; Hoffmann, Hans-Heinrich; Scull, Margaret A.; Gilmore, Rachel H.; Bell, Kierstin L.; Ciancanelli, Michael; Wilson, Sam J.; Crotta, Stefania; Yu, Yingpu; Flatley, Brenna; Xiao, Jing W.; Casanova, Jean-Laurent; Wack, Andreas; Bieniasz, Paul D.; Rice, Charles M.			A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation	CELL			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; PROTEOLYTIC CLEAVAGE; PROPROTEIN CONVERTASE; PROTEASE INHIBITOR; HEMAGGLUTININ; TMPRSS2; FURIN; GLYCOPROTEIN; TRYPSIN; MICE	Interferon-stimulated genes (ISGs) act in concert to provide a tight barrier against viruses. Recent studies have shed light on the contribution of individual ISG effectors to the antiviral state, but most have examined those acting on early, intracellular stages of the viral life cycle. Here, we applied an image-based screen to identify ISGs inhibiting late stages of influenza A virus (IAV) infection. We unraveled a directly antiviral function for the gene SERPINE1, encoding plasminogen activator inhibitor 1 (PAI-1). By targeting extracellular airway proteases, PAI-1 inhibits IAV glycoprotein cleavage, thereby reducing infectivity of progeny viruses. This was biologically relevant for IAV restriction in vivo. Further, partial PAI-1 deficiency, attributable to a polymorphism in human SERPINE1, conferred increased susceptibility to IAV in vitro. Together, our findings reveal that manipulating the extracellular environment to inhibit the last step in a virus life cycle is an important mechanism of the antiviral response.	[Dittmann, Meike; Hoffmann, Hans-Heinrich; Scull, Margaret A.; Gilmore, Rachel H.; Bell, Kierstin L.; Yu, Yingpu; Flatley, Brenna; Xiao, Jing W.; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [Ciancanelli, Michael; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Wilson, Sam J.; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, Lab Retrovirol, Howard Hughes Med Inst, New York, NY 10065 USA; [Wilson, Sam J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Crotta, Stefania; Wack, Andreas] Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA; [Casanova, Jean-Laurent] INSERM, Imagine Inst, Necker Branch, Lab Human Genet Infect Dis, F-75015 Paris, France; [Casanova, Jean-Laurent] Paris Descartes Univ, F-75015 Paris, France; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Hematol Immunol Unit, F-75015 Paris, France	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Glasgow; MRC National Institute for Medical Research; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Rice, CM (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.	ricec@rockefeller.edu	Casanova, Jean-Laurent/I-3418-2017; Scull, Margaret/K-9963-2019; Dittmann, Meike/M-5045-2017	Wilson, Sam/0000-0002-6065-0895; Casanova, Jean-Laurent/0000-0002-7782-4169; Dittmann, Meike/0000-0002-1741-7916; Wack, Andreas/0000-0001-5226-2991; Scull, Margaret/0000-0002-6860-2468; Ciancanelli, Michael/0000-0002-4623-852X; Crotta, Stefania/0000-0003-4676-8616	National Institutes of Health (NIH) [R01-AI091707, U54-AI057158]; MRC [MR/K024752/1, MC_U117597139, G0801822] Funding Source: UKRI; Medical Research Council [G0801822, MR/K024752/1, MC_U117597139] Funding Source: researchfish; The Francis Crick Institute [10206] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI091707] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank all Rice lab members but especially M. Hsu, M. Saeed, and Z. Ozair, for critical reading and helpful comments on the manuscript; Jeanne Chiaravalli-Giganti at the Rockefeller High-Throughput and Spectroscopy Resource Center and Sebastien Monettes at the Tri-Institutional Laboratory of Comparative Pathology for technical advice and support; Margaret MacDonald for VSV strain Indiana; Adolfo Garcia-Sastre for the gift of 2G9 a-HA antibody; Peter Palese for influenza viruses A/Puerto Rico/8/1934, A/ Vietnam/1203/2004(HALo), A/California/04/2009, and A/sw/Texas/4199-2/ 1998; D. Steinhauer and S. Galloway for both the gift of pCAGGS-HA plasmids and for technical advice on the cleavage assay; Gary Whittaker for the gift of HAT and TMPRSS2 expression plasmids; and Sharmila Nair for advice with VSV in vivo experiments. This work was supported by National Institutes of Health (NIH) grant R01-AI091707 (C.M.R.), U54-AI057158 (I. Lipkin, Northeast Biodefense Center, subcontract to C.M.R.), the German Research Foundation and the Rockefeller Women and Science Fellowship (M.D.), Medical Research Council Grants U117597139 (to A.W. and S.C.), NIH grant 8UL1TR000043from the National Center for Translational Sciences (NCATS; J.-L. C.), and the St. Giles Foundation (J.-L.C.). Additional funding was provided by the Greenberg Medical Research Institute, the Starr Foundation, and anonymous donors.	Beppu Y, 1997, J BIOCHEM-TOKYO, V121, P309; BERKENPAS MB, 1995, EMBO J, V14, P2969, DOI 10.1002/j.1460-2075.1995.tb07299.x; Bernot D, 2011, J CELL SCI, V124, P1224, DOI 10.1242/jcs.079889; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; BOSCH FX, 1981, VIROLOGY, V113, P725, DOI 10.1016/0042-6822(81)90201-4; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; BRODY BA, 1992, P NATL ACAD SCI USA, V89, P3443, DOI 10.1073/pnas.89.8.3443; Carlson CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001136; Declerck PJ, 2013, SEMIN THROMB HEMOST, V39, P356, DOI 10.1055/s-0033-1334487; Fay WP, 1997, BLOOD, V90, P204; Galloway SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003151; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Hartshorn KL, 2006, J IMMUNOL, V176, P6962, DOI 10.4049/jimmunol.176.11.6962; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; He WC, 2010, J BIOL CHEM, V285, P24665, DOI 10.1074/jbc.M109.091256; HORIMOTO T, 1994, J VIROL, V68, P6074, DOI 10.1128/JVI.68.9.6074-6078.1994; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Keller TT, 2006, CIRC RES, V99, P1261, DOI 10.1161/01.RES.0000250834.29108.1a; Kido H, 2012, BBA-PROTEINS PROTEOM, V1824, P186, DOI 10.1016/j.bbapap.2011.07.001; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; Komissarov AA, 2005, J BIOL CHEM, V280, P1482, DOI 10.1074/jbc.M408608200; LAWRENCE DA, 1994, J BIOL CHEM, V269, P27657; LAZAROWITZ SG, 1975, VIROLOGY, V68, P440, DOI 10.1016/0042-6822(75)90285-8; LAZAROWITZ SG, 1973, VIROLOGY, V56, P172, DOI 10.1016/0042-6822(73)90296-1; Lee MG, 1996, ARCH VIROL, V141, P1979, DOI 10.1007/BF01718208; LEE WM, 1993, J VIROL, V67, P2110, DOI 10.1128/JVI.67.4.2110-2122.1993; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Mangeat B, 2012, J BIOL CHEM, V287, P22015, DOI 10.1074/jbc.M111.319996; Medcalf RL, 2007, J THROMB HAEMOST, V5, P132, DOI 10.1111/j.1538-7836.2007.02464.x; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; NY T, 1986, P NATL ACAD SCI USA, V83, P6776, DOI 10.1073/pnas.83.18.6776; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; SKEHEL JJ, 1975, P NATL ACAD SCI USA, V72, P93, DOI 10.1073/pnas.72.1.93; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Steinhauer DA, 2012, P NATL ACAD SCI USA, V109, P16404, DOI 10.1073/pnas.1214903109; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13; TASHIRO M, 1992, J VIROL, V66, P7211, DOI 10.1128/JVI.66.12.7211-7216.1992; TASHIRO M, 1987, J GEN VIROL, V68, P2039, DOI 10.1099/0022-1317-68-7-2039; Turner J, 2009, BIOCHEM SOC T, V37, P877, DOI 10.1042/BST0370877; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Watanabe R, 2011, VIROLOGY, V417, P50, DOI 10.1016/j.virol.2011.05.006; Yondola MA, 2011, J VIROL, V85, P2480, DOI 10.1128/JVI.02188-10; Zhirnov Oleg P., 2011, Antiviral Chemistry & Chemotherapy, V21, P169, DOI 10.3851/IMP1715; Zi YZ, 2005, BLOOD COAGUL FIBRIN, V16, P79, DOI 10.1097/00001721-200501000-00013	53	93	93	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					631	643		10.1016/j.cell.2015.01.040	http://dx.doi.org/10.1016/j.cell.2015.01.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25679759	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000349208800008
J	Stensola, T; Stensola, H; Moser, MB; Moser, EI				Stensola, Tor; Stensola, Hanne; Moser, May-Britt; Moser, Edvard I.			Shearing-induced asymmetry in entorhinal grid cells	NATURE			English	Article							SPATIAL REPRESENTATION; PATH-INTEGRATION; CORTEX; MAP; FIELDS; MODEL	Grid cells are neurons with periodic spatial receptive fields (grids) that tile two-dimensional space in a hexagonal pattern. To provide useful information about location, grids must be stably anchored to an external reference frame. The mechanisms underlying this anchoring process have remained elusive. Here we show in differently sized familiar square enclosures that the axes of the grids are offset from the walls by an angle that minimizes symmetry with the borders of the environment. This rotational offset is invariably accompanied by an elliptic distortion of the grid pattern. Reversing the ellipticity analytically by a shearing transformation removes the angular offset. This, together with the near-absence of rotation in novel environments, suggests that the rotation emerges through non-coaxial strain as a function of experience. The systematic relationship between rotation and distortion of the grid pattern points to shear forces arising from anchoring to specific geometric reference points as key elements of the mechanism for alignment of grid patterns to the external world.	[Stensola, Tor; Stensola, Hanne; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7491 Trondheim, Norway; [Stensola, Tor; Stensola, Hanne; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Neural Computat, N-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Stensola, T (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Olav Kyrres Gate 9, N-7491 Trondheim, Norway.	tor.stensola@ntnu.no; edvard.moser@ntnu.no		Stensola, Hanne/0000-0002-5823-944X; Stensola, Tor/0000-0002-5485-6141	European Research Council [232608, 338865]; European Commission [600725]; Kavli Foundation; Louis-Jeantet Prize for Medicine; Centre of Excellence funding scheme of the Research Council of Norway (Centre for the Biology of Memory) [145993]; Centre of Excellence funding scheme of the Research Council of Norway (Centre for Neural Computation) [223262]	European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Kavli Foundation; Louis-Jeantet Prize for Medicine; Centre of Excellence funding scheme of the Research Council of Norway (Centre for the Biology of Memory); Centre of Excellence funding scheme of the Research Council of Norway (Centre for Neural Computation)	We thank M. Morreaunet, T. Solstad, B. Dunn, Y. Roudi, A. Treves and A. Witoelar for discussions. The work was supported by two Advanced Investigator Grants from the European Research Council ('CIRCUIT',grant agreement number 232608; 'GRIDCODE', grant agreement number 338865), the European Commission's FP7 FET Proactive programme on Neuro-Bio-Inspired Systems (grant agreement 600725), the Kavli Foundation, the Louis-Jeantet Prize for Medicine, and the Centre of Excellence funding scheme of the Research Council of Norway (Centre for the Biology of Memory, grant number 145993; Centre for Neural Computation, grant number 223262).	Barry C, 2006, REV NEUROSCIENCE, V17, P71; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Barry C, 2012, P NATL ACAD SCI USA, V109, P17687, DOI 10.1073/pnas.1209918109; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Krupic J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0188; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Mase G., 1970, CONTINUUM MECH, P44; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Moser EI, 2014, NAT REV NEUROSCI, V15, P466, DOI 10.1038/nrn3766; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; Yoon KJ, 2013, NAT NEUROSCI, V16, P1077, DOI 10.1038/nn.3450	24	111	112	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					207	U425		10.1038/nature14151	http://dx.doi.org/10.1038/nature14151			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25673414				2022-12-28	WOS:000349190300032
J	Tang, ZJ; Dai, SY; He, YS; Doty, RA; Shultz, LD; Sampson, SB; Dai, CK				Tang, Zijian; Dai, Siyuan; He, Yishu; Doty, Rosalinda A.; Shultz, Leonard D.; Sampson, Stephen Byers; Dai, Chengkai			MEK Guards Proteome Stability and Inhibits Tumor-Suppressive Amyloidogenesis via HSF1	CELL			English	Article							HEAT-SHOCK FACTOR-1; KINASE KINASE MEK1; AMYLOID OLIGOMERS; ERK INHIBITOR; GROWTH; DISEASE; HSP90; CARCINOGENESIS; IDENTIFICATION; HOMEOSTASIS	Signaling through RAS/MAP kinase pathway is central to biology. ERK has long been perceived as the only substrate for MEK. Here, we report that HSF1, the master regulator of the proteotoxic stress response, is a new MEK substrate. Beyond mediating cell-environment interactions, the MEK-HSF1 regulation impacts malignancy. In tumor cells, MEK blockade inactivates HSF1 and thereby provokes proteomic chaos, presented as protein destabilization, aggregation, and, strikingly, amyloidogenesis. Unlike their non-transformed counterparts, tumor cells are particularly susceptible to proteomic perturbation and amyloid induction. Amyloidogenesis is tumor suppressive, reducing in vivo melanoma growth and contributing to the potent anti-neoplastic effects of proteotoxic stressors. Our findings unveil a key biological function of the oncogenic RAS-MEK signaling in guarding proteostasis and suppressing amyloidogenesis. Thus, proteomic instability is an intrinsic feature of malignant state, and disrupting the fragile tumor proteostasis to promote amyloidogenesis may be a feasible therapeutic strategy.	[Tang, Zijian; Dai, Siyuan; He, Yishu; Doty, Rosalinda A.; Shultz, Leonard D.; Sampson, Stephen Byers; Dai, Chengkai] Jackson Lab, Bar Harbor, ME 04609 USA; [Tang, Zijian] Univ Maine, Dept Mol & Biomed Sci, Grad Programs, Orono, ME 04469 USA	Jackson Laboratory; University of Maine System; University of Maine Orono	Dai, CK (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	chengkai.dai@jax.org			Jackson Laboratory Cancer Center [3P30CA034196]; NIH [1DP2OD007070]; Ellison Medical Foundation [AG-NS-0599-09]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007070] Funding Source: NIH RePORTER	Jackson Laboratory Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Luke Whitesell for cell lines, Pete Finger for technical assistance, and members of the C. D. laboratory for discussions. This work was supported in part by The Jackson Laboratory Cancer Center Support Grant (3P30CA034196), and grants from NIH (1DP2OD007070) and the Ellison Medical Foundation (AG-NS-0599-09) to C.D.	AHN NG, 1991, J BIOL CHEM, V266, P4220; Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BRUNET A, 1994, FEBS LETT, V346, P299, DOI 10.1016/0014-5793(94)00475-7; BRUNET A, 1994, ONCOGENE, V9, P3379; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Clausson CM, 2011, NAT METHODS, V8, P892, DOI 10.1038/nmeth.1743; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai CK, 2012, J CLIN INVEST, V122, P3742, DOI 10.1172/JCI62727; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150	39	102	105	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					729	744		10.1016/j.cell.2015.01.028	http://dx.doi.org/10.1016/j.cell.2015.01.028			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25679764	Green Accepted, Bronze			2022-12-28	WOS:000349208800015
J	Vindenes, T; McQuillen, D				Vindenes, Tine; McQuillen, Daniel			Acute Lymphangitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vindenes, Tine] Tufts Med Ctr, Boston, MA 02116 USA; [McQuillen, Daniel] Lahey Clin & Med Ctr, Burlington, MA USA	Tufts Medical Center; Lahey Hospital & Medical Center	Vindenes, T (corresponding author), Tufts Med Ctr, Boston, MA 02116 USA.	tinevindenes@gmail.com							0	4	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7					649	649		10.1056/NEJMicm1406569	http://dx.doi.org/10.1056/NEJMicm1406569			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CK	25671257				2022-12-28	WOS:000349143900009
J	Robert, G; Cornwell, J; Locock, L; Purushotham, A; Sturmey, G; Gager, M				Robert, Glenn; Cornwell, Jocelyn; Locock, Louise; Purushotham, Arnie; Sturmey, Gordon; Gager, Melanie			SPOTLIGHT: PATIENT CENTRED CARE Patients and staff as codesigners of healthcare services	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXPERIENCE; DESIGN; GAP		[Robert, Glenn] Kings Coll London, Florence Nightingale Fac Nursing & Midwifery, London WC2R 2LS, England; [Cornwell, Jocelyn] Point Care Fdn, London, England; [Locock, Louise] Univ Oxford, Oxford, England; [Purushotham, Arnie] Kings Coll London, London WC2R 2LS, England; [Gager, Melanie] Royal Berkshire NHS Fdn Trust, Intens Care Unit, Reading, Berks, England	University of London; King's College London; University of Oxford; University of London; King's College London; Royal Berkshire Hospital	Robert, G (corresponding author), Kings Coll London, Florence Nightingale Fac Nursing & Midwifery, London WC2R 2LS, England.	glenn.robert@kcl.ac.uk	Robert, Glenn/ABD-6477-2021	Purushotham, Arnie/0000-0001-8577-9655; Robert, Glenn/0000-0001-8781-6675				Adams M, 2014, IMPROVING PATIENT CT; Bate P, 2007, ORG QUALITY IMPROVEM; Berwick DM, 2003, QUAL SAF HEALTH CARE, V12, P448, DOI 10.1136/qhc.12.6.448; Bowen S, 2013, CODESIGN, V9, P230, DOI 10.1080/15710882.2013.846384; Coughlan Peter., 2007, J APPL BEHAV SCI, V43, P122, DOI [10.1177/0021886306297722, DOI 10.1177/0021886306297722]; Coulter A, 2014, BMJ-BRIT MED J, V348, pg2225; Donetto S, DESIGN J IN PRESS; Grocott P, 2013, WOUNDS UK, V9, P23; Grocott P, 2013, INT WOUND J, V10, P265, DOI 10.1111/j.1742-481X.2012.00972.x; Howard J., 2007, ORIGIN TOUCHPOINTS; Iedema R, 2010, J APPL BEHAV SCI, V46, P73, DOI 10.1177/0021886309357544; Johansson-Skoldberg U, 2014, CREAT INNOV MANAG, V22, P121; Locock L, 2014, HLTH SERV DELIV RES, V2; Lord L, 2014, J HEALTH ORGAN MANAG, V28, P714, DOI 10.1108/JHOM-08-2013-0160; Maben J, 2012, INT J OLDER PEOPLE N, V7, P83, DOI 10.1111/j.1748-3743.2012.00326.x; NESTA, 2013, US US POW COD COD; Palmer V, BMJ OPEN IN PRESS; Ream E, 2013, ENHANCING CARERS OUT; Reeves R, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-259; Robert G, 2013, J HEALTH SERV RES PO, V18, P67, DOI 10.1177/1355819612473583; Rozenblum R, 2013, BMJ QUAL SAF, V22, P242, DOI 10.1136/bmjqs-2012-001045; Sangiorgi D, 2014, MAPPING DEV SERVICE; Sangiorgi D, 2011, INT J DES, V5, P29; Thomson A, BMC HLTH SE IN PRESS; Tsianakas V, 2012, SUPPORT CARE CANCER, V20, P2639, DOI 10.1007/s00520-012-1470-3	25	195	196	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								g7714	10.1136/bmj.g7714	http://dx.doi.org/10.1136/bmj.g7714			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670179	Green Published, Bronze			2022-12-28	WOS:000349318400029
J	Silverstein, A				Silverstein, Alex			SPOTLIGHT: PATIENT CENTRED CARE Patient commentary: What I need to self manage my care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Int Diabet Federat Young Leaders Diabet Program, Manama, Bahrain		Silverstein, A (corresponding author), Int Diabet Federat Young Leaders Diabet Program, Manama, Bahrain.	alexsdiabetes@gmail.com							0	2	2	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h248	10.1136/bmj.h248	http://dx.doi.org/10.1136/bmj.h248			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670188				2022-12-28	WOS:000349318400006
J	Colliex, C				Colliex, Christian			Taking temperature at the nanoscale	SCIENCE			English	Editorial Material							ENERGY		Univ Paris 11, CNRS, UMR 8502, Lab Phys Solides, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay	Colliex, C (corresponding author), Univ Paris 11, CNRS, UMR 8502, Lab Phys Solides, Bldg 510, F-91405 Orsay, France.	christian.colliex@u-psud.fr						ABE H, 1992, J ELECTRON MICROSC, V41, P465; Argentero G, 2015, ULTRAMICROSCOPY, V151, P23, DOI 10.1016/j.ultramic.2014.11.031; Hartmann M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.080402; Krivanek OL, 2014, NATURE, V514, P209, DOI 10.1038/nature13870; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; Mecklenburg M, 2015, SCIENCE, V347, P629, DOI 10.1126/science.aaa2433; SEAH MP, 1986, J MATER SCI, V21, P1305, DOI 10.1007/BF00553268; WATANABE H, 1956, J PHYS SOC JPN, V11, P112, DOI 10.1143/JPSJ.11.112	8	3	3	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					611	612		10.1126/science.aaa5311	http://dx.doi.org/10.1126/science.aaa5311			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657231				2022-12-28	WOS:000349145200022
J	Lea, DW				Lea, David W.			Climate sensitivity in a warmer world	NATURE			English	Editorial Material									Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Lea, DW (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	lea@geol.ucsb.edu			Division Of Ocean Sciences [1260696] Funding Source: National Science Foundation	Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Brigham-Grette J, 2013, SCIENCE, V340, P1421, DOI 10.1126/science.1233137; Colman R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036268; Dowsett HJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02013; Kutzbach JE, 2013, GEOPHYS RES LETT, V40, P3721, DOI 10.1002/grl.50724; Lunt DJ, 2010, NAT GEOSCI, V3, P60, DOI 10.1038/NGEO706; Martinez-Boti MA, 2015, NATURE, V518, P49, DOI 10.1038/nature14145; Meraner K, 2013, GEOPHYS RES LETT, V40, P5944, DOI 10.1002/2013GL058118; Otto A, 2013, NAT GEOSCI, V6, P415, DOI 10.1038/ngeo1836; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Zhang YG, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0096	10	2	2	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					46	47		10.1038/518046b	http://dx.doi.org/10.1038/518046b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25652995				2022-12-28	WOS:000349098000028
J	Baum, M				Baum, Michael			Saatchi is right to promote medical innovation but his bill is wrong way to do it	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Baum, M (corresponding author), UCL, London WC1E 6BT, England.	baum.michael3@gmail.com						ABE O, 1995, NEW ENGL J MED, V333, P1444; Autier P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3620; Clarke M, 1998, LANCET, V351, P1451; Dyer C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h495; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Peedell C, 2014, TIMES; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	7	3	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2015	350								h531	10.1136/bmj.h531	http://dx.doi.org/10.1136/bmj.h531			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0IP	25652261				2022-12-28	WOS:000349309500002
J	Cereda, E; Klersy, C; Serioli, M; Crespi, A; D'Andrea, F				Cereda, Emanuele; Klersy, Catherine; Serioli, Marcella; Crespi, Aldo; D'Andrea, Federico		OligoElement Sore Trial Study Grp	A Nutritional Formula Enriched With Arginine, Zinc, and Antioxidants for the Healing of Pressure Ulcers A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ENTERAL NUTRITION; RISK; PREVENTION; GUIDELINES; SUPPORT	Background: Trials on specific nutritional supplements for the treatment of pressure ulcers (PUs) have been small, inconsistent in their formulations, or unsuccessful in controlling for total supplement calorie or protein content. Objective: To evaluate whether supplementation with arginine, zinc, and antioxidants within a high-calorie, high-protein formula improves PU healing. Design: Multicenter, randomized, controlled, blinded trial. (ClinicalTrials.gov: NCT01107197) Setting: Long-term care and home care services. Patients: 200 adult malnourished patients with stage II, III, and IV PUs. Interventions: An energy-dense, protein-rich oral formula enriched with arginine, zinc, and antioxidants (400 mL/d) or an equal volume of an isocaloric, isonitrogenous formula for 8 weeks. Measurements: The primary end point was the percentage of change in PU area at 8 weeks. Secondary end points included complete healing, reduction in the PU area of 40% or greater, incidence of wound infections, the total number of dressings at 8 weeks, and the percentage of change in area at 4 weeks. Results: Supplementation with the enriched formula (n = 101) resulted in a greater reduction in PU area (mean reduction, 60.9% [95% CI, 54.3% to 67.5%]) than with the control formula (n = 99) (45.2% [CI, 38.4% to 52.0%]) (adjusted mean difference, 18.7% [CI, 5.7% to 31.8%]; P = 0.017). A more frequent reduction in area of 40% or greater at 8 weeks was also seen (odds ratio, 1.98 [CI, 1.12 to 3.48]; P = 0.018). No difference was found in terms of the other secondary end points. Limitation: Participation was restricted to patients who were malnourished, were able to drink oral supplements, and were living in long-term care institutions or receiving home care services. Conclusion: Among malnourished patients with PU, 8 weeks of supplementation with an oral nutritional formula enriched with arginine, zinc, and antioxidants improved PU healing.	[Cereda, Emanuele; Klersy, Catherine] Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, Serv Dietet & Nutr Clin, I-27100 Pavia, Italy; Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, Serv Biometria & Stat, I-27100 Pavia, Italy; [Serioli, Marcella; D'Andrea, Federico] Azienda Osped Univ Maggiore Carita, Struttura Complessa Direz Osped Dietet & Nutr Cli, I-28100 Novara, Italy; [Crespi, Aldo] Azienda Sanit Locale Novara ASL NO, I-28100 Novara, Italy	IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; Azienda Ospedaliera Maggiore della Carita di Novara; University of Eastern Piedmont Amedeo Avogadro	Cereda, E (corresponding author), Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, Serv Dietet & Nutr Clin, Viale Golgi 19, I-27100 Pavia, Italy.	e.cereda@smatteo.pv.it	klersy, catherine/AAA-3003-2019; Cereda, Emanuele/AAA-2247-2019; Perna, Simone/Y-8892-2018; Caccialanza, Riccardo/J-1904-2015	klersy, catherine/0000-0003-0314-8548; Cereda, Emanuele/0000-0002-0747-1951; Perna, Simone/0000-0002-2720-1473; Caccialanza, Riccardo/0000-0002-9379-3569; Chiarotto, Alessandro/0000-0003-2350-9945	Azienda Ospedaliera Universitaria Maggiore della Carita	Azienda Ospedaliera Universitaria Maggiore della Carita	By the Azienda Ospedaliera Universitaria Maggiore della Carita	Agency for Healthcare Research and Quality, 2006, AHRQ QUAL IND GUID P; [Anonymous], 2006, CLIN NUTR, V25, P175; Benati G, 2001, ARCH GERONTOL GERIAT, P43, DOI 10.1016/S0167-4943(01)00120-0; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; BRANDEIS GH, 1990, JAMA-J AM MED ASSOC, V264, P2905, DOI 10.1001/jama.264.22.2905; Carnovale E, 2000, TABELLE COMPOSIZIONE; Cereda E, 2011, J AM DIET ASSOC, V111, P1868, DOI 10.1016/j.jada.2011.09.005; Cereda E, 2011, J AM MED DIR ASSOC, V12, P174, DOI 10.1016/j.jamda.2010.11.013; Cereda E, 2009, CURR OPIN CLIN NUTR, V12, P1, DOI 10.1097/MCO.0b013e3283186f59; Cereda E, 2009, J AM GERIATR SOC, V57, P1395, DOI 10.1111/j.1532-5415.2009.02351.x; Chow O, 2014, ADV WOUND CARE, V3, P46, DOI 10.1089/wound.2012.0415; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Desneves KJ, 2005, CLIN NUTR, V24, P979, DOI 10.1016/j.clnu.2005.06.011; Doley J, 2010, NUTR CLIN PRACT, V25, P50, DOI 10.1177/0884533609359294; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Frias Soriano L, 2004, J Wound Care, V13, P319; Gengenbacher M, 2002, AGING CLIN EXP RES, V14, P420; Haesler E., 2019, PREVENTION TREATMENT; Hubbard GP, 2012, CLIN NUTR, V31, P293, DOI 10.1016/j.clnu.2011.11.020; Iizaka S, 2010, WOUND REPAIR REGEN, V18, P31, DOI 10.1111/j.1524-475X.2009.00564.x; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Morello M, 2009, NUTR CLIN PRACT, V24, P635, DOI 10.1177/0884533609342439; Pancorbo-Hidalgo PL, 2006, J ADV NURS, V54, P94, DOI 10.1111/j.1365-2648.2006.03794.x; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Reddy M, 2008, JAMA-J AM MED ASSOC, V300, P2647, DOI 10.1001/jama.2008.778; Shahin ESM, 2010, NUTRITION, V26, P886, DOI 10.1016/j.nut.2010.01.016; SMITH DM, 1995, ANN INTERN MED, V123, P433, DOI 10.7326/0003-4819-123-6-199509150-00008; Smith MEB, 2013, ANN INTERN MED, V159, P39, DOI 10.7326/0003-4819-159-1-201307020-00007; Stechmiller JK, 2010, NUTR CLIN PRACT, V25, P61, DOI 10.1177/0884533609358997; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sugama J, 2007, J CLIN NURS, V16, P1265, DOI 10.1111/j.1365-2702.2007.01790.x; Teno JM, 2012, ARCH INTERN MED, V172, P697, DOI 10.1001/archinternmed.2012.1200; Thomas DR, 2001, NUTRITION, V17, P121, DOI 10.1016/S0899-9007(00)00514-1; van Anholt RD, 2010, NUTRITION, V26, P867, DOI 10.1016/j.nut.2010.05.009; Wolfe RR, 2008, CLIN NUTR, V27, P675, DOI 10.1016/j.clnu.2008.06.008	37	61	66	0	53	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2015	162	3					167	U44		10.7326/M14-0696	http://dx.doi.org/10.7326/M14-0696			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NP	25643304				2022-12-28	WOS:000350108100002
J	Singer, AE; Meeker, D; Teno, JM; Lynn, J; Lunney, JR; Lorenz, KA				Singer, Adam E.; Meeker, Daniella; Teno, Joan M.; Lynn, Joanne; Lunney, June R.; Lorenz, Karl A.			Symptom Trends in the Last Year of Life From 1998 to 2010 A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ADVANCED CANCER; MULTIPLE IMPUTATION; SUPPORTIVE CARE; PALLIATIVE CARE; OF-LIFE; QUALITY; END; HEALTH; PREVALENCE; DYSPNEA	Background: Calls for improvement in end-of-life care have focused attention on the management of pain and other troubling symptoms at the end of life. Objective: To describe changes in pain intensity and symptom prevalence during the last year of life from 1998 to 2010. Design: Observational study. Setting: The HRS (Health and Retirement Study), a nationally representative longitudinal survey of community-dwelling U. S. residents aged 51 years or older. Participants: 7204 HRS participants who died while enrolled in the study and their family respondents. Measurements: Proxy-reported pain during the last year of life and other symptoms for at least 1 month during the last year of life. Trends in pain intensity and symptom prevalence were analyzed for all decedents and within the categories of sudden death, cancer, congestive heart failure or chronic lung disease, and frailty. Results: Between 1998 and 2010, proxy reports of the prevalence of any pain increased for all decedents from 54.3% (95% CI, 51.6% to 57.1%) to 60.8% (CI, 58.2% to 63.4%), an increase of 11.9% (CI, 3.1% to 21.4%). Reported prevalences of depression and periodic confusion also increased for all decedents by 26.6% (CI, 14.5% to 40.1%) and 31.3% (CI, 18.6% to 45.1%), respectively. Individual symptoms increased in prevalence among specific decedent categories, except in cancer, which showed no significant changes. The prevalence of moderate or severe pain did not change among all decedents or in any specific decedent category. Limitation: Use of proxy reports and limited information about some patient and surrogate variables. Conclusion: Despite national efforts to improve end-of-life care, proxy reports of pain and other alarming symptoms in the last year of life increased from 1998 to 2010.	[Singer, Adam E.] RAND Corp, Pardee RAND Grad Sch, Santa Monica, CA 90407 USA; Univ So Calif, Los Angeles, CA 90089 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; Brown Univ, Providence, RI 02912 USA; Altarum Inst, Washington, DC USA; [Lunney, June R.] Hosp & Palliat Nurses Assoc, Pittsburgh, PA 15276 USA	RAND Corporation; Pardee RAND Graduate School; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Brown University	Singer, AE (corresponding author), RAND Corp, Pardee RAND Grad Sch, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA.	asinger@rand.org	Meeker, Daniella/AAV-5953-2020	Meeker, Daniella/0000-0002-1034-7628	National Institute of Nursing Research [R01 NR013372]; Medical Scientist Training Program at the University of California, Los Angeles [T32 GM008042]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024968] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Medical Scientist Training Program at the University of California, Los Angeles; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Institute of Nursing Research (grant R01 NR013372; Dr. Lorenz); Mr. Singer received support from grant T32 GM008042 as a member of the Medical Scientist Training Program at the University of California, Los Angeles.	[Anonymous], 2004, NIH Consens State Sci Statements, V21, P1; [Anonymous], 2011, PRIORITIES NATL QUAL; [Anonymous], 2012, NATL VOLUNTARY CONSE; Barbera L, 2010, CANCER-AM CANCER SOC, V116, P5767, DOI 10.1002/cncr.25681; Ben-Aharon I, 2012, ACTA ONCOL, V51, P996, DOI 10.3109/0284186X.2012.709638; Centers for Medicare & Medicaid Services, 2014, HOSP EXP CAR SURV; Currow DC, 2010, J PAIN SYMPTOM MANAG, V39, P680, DOI 10.1016/j.jpainsymman.2009.09.017; Dy SM, 2012, IMPROVING HLTH CARE; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Field MJ, 1997, APPROACHING DEATH IM; Fine Robert L, 2007, Proc (Bayl Univ Med Cent), V20, P5; Foley KM, 2001, IMPROVING PALLIATIVE; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Langley PC, 2010, VALUE HEALTH, V13, pA395; Lorenz KA, 2001, ANN INTERN MED, V134, P854, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00009; Lorenz KA, 2008, ANN INTERN MED, V148, P147, DOI 10.7326/0003-4819-148-2-200801150-00010; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lunney JR, 2002, J AM GERIATR SOC, V50, P1108, DOI 10.1046/j.1532-5415.2002.50268.x; Malin JL, 2011, J PALLIAT MED, V14, P573, DOI 10.1089/jpm.2010.0464; McPherson CJ, 2003, SOC SCI MED, V56, P95, DOI 10.1016/S0277-9536(02)00011-4; Morrison RS, 2011, J PALLIAT MED, V14, P1094, DOI 10.1089/jpm.2011.9634; Morss S, 2011, J PALLIAT MED, V14, P451, DOI 10.1089/jpm.2010.0434; National Hospice and Palliative Care Organization, 2013, NHPCO FACTS FIG HOSP; Reyes-Gibby CC, 2006, J PAIN SYMPTOM MANAG, V32, P118, DOI 10.1016/j.jpainsymman.2006.01.008; Royston P, 2009, STATA J, V9, P466, DOI 10.1177/1536867X0900900308; Smith AK, 2010, ANN INTERN MED, V153, P563, DOI 10.7326/0003-4819-153-9-201011020-00005; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; Steffick DE, 2000, DOCUMENTATION AFFECT; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Ulmer C, 2010, FUTURE DIRECTIONS NA; University of Michigan, 2008, HLTH RETIREMENT STUD; Walling AM, 2013, JAMA INTERN MED, V173, P2071, DOI 10.1001/jamainternmed.2013.10797; Walling AM, 2012, SUPPORT CARE CANCER, V20, P2189, DOI 10.1007/s00520-012-1462-3; Walling AM, 2010, ARCH INTERN MED, V170, P1057, DOI 10.1001/archinternmed.2010.175	39	84	85	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2015	162	3					175	U58		10.7326/M13-1609	http://dx.doi.org/10.7326/M13-1609			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NP	25643305	Green Accepted			2022-12-28	WOS:000350108100003
J	Martinez, FJ; Calverley, PMA; Goehring, UM; Brose, M; Fabbri, LM; Rabe, KF				Martinez, Fernando J.; Calverley, Peter M. A.; Goehring, Udo-Michael; Brose, Manja; Fabbri, Leonardo M.; Rabe, Klaus F.			Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial	LANCET			English	Article							INHALED CORTICOSTEROIDS; INHIBITOR ROFLUMILAST; N-ACETYLCYSTEINE; DOUBLE-BLIND; COPD; PREVENTION; MODERATE; PLACEBO; BRONCHODILATORS; PROPIONATE	Background Roflumilast reduces exacerbations in patients with severe chronic obstructive pulmonary disease. Its effect in patients using fixed combinations of inhaled corticosteroids and longacting beta(2) agonists is unknown. We postulated that roflumilast would reduce exacerbations in patients with severe chronic obstructive pulmonary disease at risk for exacerbations, even in combination with inhaled corticosteroid and longacting beta(2) agonist treatment. Methods For this 1-year double-blind, placebo-controlled, parallel group, multicentre, phase 3-4 trial, the Roflumilast and Exacerbations in patients receiving Appropriate Combination Therapy (REACT) study, we enrolled patients with severe chronic obstructive pulmonary disease from 203 centres (outpatient clinics, hospitals, specialised pulmonologists, and family doctors) in 21 countries. Eligible patients were 40 years of age or older with a smoking history of at least 20 pack-years and a diagnosis of chronic obstructive pulmonary disease with severe airflow limitation, symptoms of chronic bronchitis, and at least two exacerbations in the previous year. We used a computerised central randomisation system to randomly assign patients in a 1:1 ratio to the two treatment groups: roflumilast 500 mu g or placebo given orally once daily together with a fixed inhaled corticosteroid and longacting beta(2) agonist combination. Background tiotropium treatment was allowed. All patients and investigators were masked to group assignment. The primary outcome was the rate of moderate to severe chronic obstructive pulmonary disease exacerbations per patient per year, analysed by intention to treat. This study is registered with ClinicalTrials. gov, number NCT01329029. Findings Between April 3, 2011, and May 27, 2014, we enrolled 1945 eligible participants and randomly assigned 973 to the roflumilast group and 972 to the placebo group. The rate of moderate-to-severe chronic obstructive pulmonary disease exacerbations was 13.2% lower in the roflumilast group than in the placebo group according to a Poisson regression analysis (roflumilast 0.805 vs placebo 0.927; rate ratio [RR] 0.868 [95% CI 0.753-1.002], p=0.0529), and 14.2% lower according to a predefined sensitivity analysis using negative binomial regression (0.823 vs 0.959; 0.858 [0.740-0.995], p=0.0424). Adverse events were reported by 648 (67%) of 968 patients receiving roflumilast and by 572 (59%) of 967 patients in the placebo group; adverse event-associated patient withdrawal from the study was also more common in the roflumilast group (104/968 [11%]) than in the placebo group (52/967 [5%]). The most frequently reported serious adverse events were chronic obstructive pulmonary disease exacerbations and pneumonia, and 17 (1.8%) deaths occurred in the roflumilast group compared with 18 (1.9%) in the placebo group. Interpretation Our findings suggest that roflumilast reduces exacerbations and hospital admissions in patients with severe chronic obstructive pulmonary disease and chronic bronchitis who are at risk of frequent and severe exacerbations despite inhaled corticosteroid and longacting beta(2) agonist therapy, even in combination with tiotropium.	[Martinez, Fernando J.] Weill Cornell Med Coll, New York, NY USA; [Martinez, Fernando J.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Calverley, Peter M. A.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England; [Goehring, Udo-Michael] Takeda Dev Ctr Europe Ltd, London, England; [Brose, Manja] Takeda Pharmaceut Int GmbH, Zurich, Switzerland; [Fabbri, Leonardo M.] Univ Modena & Reggio Emilia, Modena, Italy; [Rabe, Klaus F.] LungenClin Grosshansdorf, Airway Res Ctr North, Grosshansdorf, Germany; [Rabe, Klaus F.] Univ Kiel, Dept Med, Kiel, Germany	Cornell University; University of Michigan System; University of Michigan; University of Liverpool; Takeda Pharmaceutical Company Ltd; Takeda Development Centre Europe Ltd.; Universita di Modena e Reggio Emilia; Grosshansdorf Hospital; University of Kiel	Martinez, FJ (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Med, 525 East 68th St,Room M-522 Box 130, New York, NY 10065 USA.	fmartine@med.umich.edu	Fabbri, Leonardo M/I-4055-2012; Rabe, Klaus F./AAW-6296-2021	Fabbri, Leonardo M/0000-0001-8894-1689; Rabe, Klaus F./0000-0002-7020-1401	Takeda	Takeda(Takeda Pharmaceutical Company Ltd)	We thank all the investigators who recruited and treated patients at the 203 centres involved in the REACT study. We also thank Alexander Kroll of Synergy Vision, London, UK (supported by Takeda) for editorial assistance with the preparation of this report.	Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Bateman ED, 2011, EUR RESPIR J, V38, P553, DOI 10.1183/09031936.00178710; Beghe B, 2013, AM J RESP CRIT CARE, V188, P271, DOI 10.1164/rccm.201301-0021PP; Calverley PMA, 2010, RESP MED, V104, P1858, DOI 10.1016/j.rmed.2010.09.008; Calverley PMA, 2007, AM J RESP CRIT CARE, V176, P154, DOI 10.1164/rccm.200610-1563OC; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2012, INT J CHRONIC OBSTR, V7, P375, DOI 10.2147/COPD.S31100; Calverley PMA, 2009, LANCET, V374, P685, DOI 10.1016/S0140-6736(09)61255-1; Criner GJ, 2014, NEW ENGL J MED, V370, P2201, DOI 10.1056/NEJMoa1403086; Cyr MC, 2008, BRIT J CLIN PHARMACO, V65, P40, DOI 10.1111/j.1365-2125.2007.02977.x; Decramer M, 2005, LANCET, V365, P1552, DOI 10.1016/S0140-6736(05)66456-2; Dransfield MT, 2013, LANCET RESP MED, V1, P210, DOI 10.1016/S2213-2600(13)70040-7; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Finney L, 2014, LANCET RESP MED, V2, P919, DOI 10.1016/S2213-2600(14)70169-9; Hurst JR, 2009, AM J RESP CRIT CARE, V179, P369, DOI 10.1164/rccm.200807-1067OC; Jones PW, 2013, EUR RESPIR J, V42, P647, DOI 10.1183/09031936.00125612; Jones PW, 2013, COPD, V10, P269, DOI 10.3109/15412555.2013.776920; Jones PW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-161; Keene ON, 2007, PHARM STAT, V6, P89, DOI 10.1002/pst.250; Muellerova H, 2015, CHEST, V147, P999, DOI 10.1378/chest.14-0655; O'Donnell DE, 2012, EUR RESPIR J, V39, P1104, DOI 10.1183/09031936.00096511; O'Reilly J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3134; Rabe KF, 2005, LANCET, V366, P563, DOI 10.1016/S0140-6736(05)67100-0; Rennard SI, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-18; Spina D, 2014, CURR OPIN PULM MED, V20, P73, DOI 10.1097/MCP.0000000000000012; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Wedzicha JA, 2013, CHEST, V143, P1302, DOI 10.1378/chest.12-1489; White WB, 2013, CHEST, V144, P758, DOI 10.1378/chest.12-2332; Wouters EFM, 2012, J CLIN ENDOCR METAB, V97, pE1720, DOI 10.1210/jc.2011-2886; Zervas E, 2013, CURR DRUG TARGETS, V14, P192, DOI 10.2174/1389450111314020006; Zheng JP, 2014, LANCET RESP MED, V2, P187, DOI 10.1016/S2213-2600(13)70286-8	33	252	267	2	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					857	866		10.1016/S0140-6736(14)62410-7	http://dx.doi.org/10.1016/S0140-6736(14)62410-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC6CB	25684586				2022-12-28	WOS:000350451100033
J	Nicholson, D				Nicholson, David			Universal health coverage: reaching a consensus	LANCET			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London SW7 2AZ, England	Imperial College London	Nicholson, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London SW7 2AZ, England.	nicholson7062@gmail.com						[Anonymous], [No title captured]; The World Bank, 2013, COMMUNICATION   0521	2	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					838	838		10.1016/S0140-6736(15)60129-5	http://dx.doi.org/10.1016/S0140-6736(15)60129-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC6CB	25698552				2022-12-28	WOS:000350451100012
J	Nienaber, CA; Clough, RE				Nienaber, Christoph A.; Clough, Rachel E.			Management of acute aortic dissection	LANCET			English	Article							GROWTH-FACTOR-BETA; INTERNATIONAL REGISTRY; FALSE LUMEN; ENDOVASCULAR TREATMENT; B DISSECTION; THORACIC AORTA; D-DIMER; COMPUTED-TOMOGRAPHY; NEUROLOGIC DEFICIT; DESCENDING AORTA	A new appraisal of the management of acute aortic dissection is timely because of recent developments in diagnostic strategies (including biomarkers and imaging), endograft design, and surgical treatment, which have led to a better understanding of the epidemiology, risk factors, and molecular nature of aortic dissection. Although open surgery is the main treatment for proximal aortic repair, use of endovascular management is now established for complicated distal dissection and distal arch repair, and has recently been discussed as a pre-emptive measure to avoid late complications by inducing aortic remodelling.	[Nienaber, Christoph A.] Univ Rostock, Univ Heart Ctr Rostock, D-18055 Rostock, Germany; [Clough, Rachel E.] Kings Coll London, Cardiovasc Imaging Dept, London WC2R 2LS, England	University of Rostock; University of London; King's College London	Nienaber, CA (corresponding author), Univ Rostock, Heart Ctr Rostock, Dept Internal Med 1, D-18055 Rostock, Germany.	christoph.nienaber@med.uni-rostock.de			Academy of Medical Sciences (AMS) [AMS-SGCL9-Clough] Funding Source: researchfish	Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))		Abcarian PW, 2004, AM J ROENTGENOL, V182, P1377, DOI 10.2214/ajr.182.6.1821377; Acosta S, 2006, J VASC SURG, V44, P237, DOI 10.1016/j.jvs.2006.04.037; Akin I, 2009, EUR J VASC ENDOVASC, V37, P289, DOI 10.1016/j.ejvs.2008.12.004; [Anonymous], 2010, CARDIOVASC COMPUT TO; Attias D, 2009, CIRCULATION, V120, P2541, DOI 10.1161/CIRCULATIONAHA.109.887042; Augoustides JGT, 2012, J CARDIOTHOR VASC AN, V26, P1139, DOI 10.1053/j.jvca.2012.06.024; Baguet JP, 2012, J HYPERTENS, V30, P440, DOI 10.1097/HJH.0b013e32834f867a; Bernard Y, 2001, AM J CARDIOL, V87, P1378, DOI 10.1016/S0002-9149(01)01556-9; Booher AM, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.01.020; Booher AM, 2011, AM J CARDIOL, V107, P315, DOI 10.1016/j.amjcard.2010.09.020; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Canaud L, 2013, J THORAC CARDIOV SUR, V145, P1431, DOI 10.1016/j.jtcvs.2013.02.060; Cheng Z, 2013, J VASC SURG, V57, p35S, DOI 10.1016/j.jvs.2012.07.061; Chikwe J, 2013, ANN THORAC SURG, V95, P1563, DOI 10.1016/j.athoracsur.2013.02.039; Chung JW, 2000, RADIOLOGY, V214, P87, DOI 10.1148/radiology.214.1.r00ja3287; CIGARROA JE, 1993, NEW ENGL J MED, V328, P35, DOI 10.1056/NEJM199301073280107; Clough RE, 2013, EUR J VASC ENDOVASC, V46, P191, DOI 10.1016/j.ejvs.2013.05.009; Clough RE, 2012, J VASC SURG, V55, P914, DOI 10.1016/j.jvs.2011.11.005; Clough RE, 2011, J VASC SURG, V54, P1580, DOI 10.1016/j.jvs.2011.07.034; Clough RE, 2011, J VASC SURG, V54, P1251, DOI 10.1016/j.jvs.2011.05.022; Clouse WD, 2004, MAYO CLIN PROC, V79, P176, DOI 10.4065/79.2.176; Coady MA, 2010, CIRCULATION, V121, P2780, DOI 10.1161/CIR.0b013e3181e4d033; Collins JS, 2004, CIRCULATION, V110, pII237, DOI 10.1161/01.CIR.0000138219.67028.2a; CREGLER LL, 1992, AM HEART J, V124, P1665, DOI 10.1016/0002-8703(92)90109-9; Dake MD, 2013, EUR J VASC ENDOVASC, V46, P175, DOI 10.1016/j.ejvs.2013.04.029; Das D, 2012, J AM COLL CARDIOL, V60, P775, DOI 10.1016/j.jacc.2012.04.027; Divchev D, 2014, J INTERV CARDIOL, V27, P334, DOI 10.1111/joic.12110; Eid-Lidt G, 2013, CATHETER CARDIO INTE, V82, pE898, DOI 10.1002/ccd.24725; Estrera AL, 2003, J THORAC CARDIOV SUR, V126, P1288, DOI 10.1016/S0022-5223(03)00962-0; Evangelista A, 2012, CIRCULATION, V125, P3133, DOI 10.1161/CIRCULATIONAHA.111.090266; Fattori R, 2013, JACC-CARDIOVASC INTE, V6, P876, DOI 10.1016/j.jcin.2013.05.003; Fattori R, 2008, JACC-CARDIOVASC INTE, V1, P395, DOI 10.1016/j.jcin.2008.04.009; Fattouch K, 2009, ANN THORAC SURG, V88, P1244, DOI 10.1016/j.athoracsur.2009.06.055; Feldman M, 2009, ANN THORAC CARDIOVAS, V15, P286; Gaul C, 2007, STROKE, V38, P292, DOI 10.1161/01.STR.0000254594.33408.b1; Gilon D, 2009, AM J CARDIOL, V103, P1029, DOI 10.1016/j.amjcard.2008.12.013; Golledge J, 2008, LANCET, V372, P55, DOI 10.1016/S0140-6736(08)60994-0; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Harris KM, 2011, CIRCULATION, V124, P1911, DOI 10.1161/CIRCULATIONAHA.110.006320; Hazui H, 2006, CIRC J, V70, P1598, DOI 10.1253/circj.70.1598; Hiratzka Loren F, 2010, Catheter Cardiovasc Interv, V76, pE43; Howard DPJ, 2013, CIRCULATION, V127, P2031, DOI 10.1161/CIRCULATIONAHA.112.000483; Immer FF, 2005, CIRCULATION, V112, pI249, DOI 10.1161/CIRCULATIONAHA.104.525733; Jia X, 2013, J VASC SURG, V57, P406, DOI 10.1016/j.jvs.2012.08.064; Jonker FHW, 2012, ANN THORAC SURG, V94, P1223, DOI 10.1016/j.athoracsur.2012.05.040; Karmonik C, 2011, EUR J VASC ENDOVASC, V42, P172, DOI 10.1016/j.ejvs.2011.04.008; Kato K, 2010, J NUCL MED, V51, P674, DOI 10.2967/jnumed.109.065227; Ketelsen D, 2011, ACTA RADIOL, V52, P762, DOI 10.1258/ar.2010.100274; Klompas M, 2002, JAMA-J AM MED ASSOC, V287, P2262, DOI 10.1001/jama.287.17.2262; Kurihara T, 2012, CIRCULATION, V126, P3070, DOI 10.1161/CIRCULATIONAHA.112.097097; Lai DT, 2002, CIRCULATION, V106, pI218, DOI 10.1161/01.cir.000032890.55215.27; Lansman SL, 2002, ANN THORAC SURG, V74, pS1833, DOI 10.1016/S0003-4975(02)04134-6; LARSON EW, 1984, AM J CARDIOL, V53, P849, DOI 10.1016/0002-9149(84)90418-1; Liu Jin-cheng, 2008, Int J Surg, V6, P151, DOI 10.1016/j.ijsu.2008.02.004; Lombardi JV, 2012, J VASC SURG, V55, P629, DOI 10.1016/j.jvs.2011.10.022; Lu QS, 2013, J AM COLL CARDIOL, V61, P1917, DOI 10.1016/j.jacc.2012.08.994; Manfredini R, 2004, J VASC SURG, V40, P382, DOI 10.1016/j.jvs.2004.04.019; Marcheix B, 2008, JACC-CARDIOVASC INTE, V1, P673, DOI 10.1016/j.jcin.2008.10.005; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; Mehta RH, 2002, CIRCULATION, V106, P1110, DOI 10.1161/01.CIR.0000027568.39540.4B; Meredith EL, 2009, EUR J ECHOCARDIOGR, V10, pI31, DOI 10.1093/ejechocard/jen251; Meszaros I, 2000, CHEST, V117, P1271, DOI 10.1378/chest.117.5.1271; Miller DC, 2002, ANN THORAC SURG, V74, pS1857, DOI 10.1016/S0003-4975(02)04263-7; Moon MC, 2011, J VASC SURG, V53, P942, DOI 10.1016/j.jvs.2010.10.067; Nagaoka K, 2010, INTERNAL MED, V49, P1943, DOI 10.2169/internalmedicine.49.3770; Nienaber C A, 1999, Cardiol Rev, V7, P332, DOI 10.1097/00045415-199911000-00011; Nienaber CA, 2004, CIRCULATION, V109, P3014, DOI 10.1161/01.CIR.0000130644.78677.2C; Nienaber CA, 2005, AM HEART J, V149, P592, DOI 10.1016/j.ahj.2004.05.060; Nienaber CA, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001404; Nienaber CA, 2013, CIRC-CARDIOVASC INTE, V6, P407, DOI 10.1161/CIRCINTERVENTIONS.113.000463; Nienaber CA, 2012, EUR HEART J, V33, P26, DOI 10.1093/eurheartj/ehr186; Nienaber CA, 2011, SEMIN VASC SURG, V24, P167, DOI 10.1053/j.semvascsurg.2011.10.003; Nienaber CA, 2011, J VASC SURG, V54, P1529, DOI 10.1016/j.jvs.2011.06.099; Nienaber CA, 2009, CIRCULATION, V120, P2519, DOI 10.1161/CIRCULATIONAHA.109.886408; Nordon IM, 2012, EUR J VASC ENDOVASC, V44, P406, DOI 10.1016/j.ejvs.2012.07.018; Nordon IM, 2009, J VASC SURG, V50, P987, DOI 10.1016/j.jvs.2009.05.056; Nozato T, 2013, INT J CARDIOL, V168, P4267, DOI 10.1016/j.ijcard.2013.04.211; Office for National Statistics, NAT POP PROJ AG SEX; Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400; Olsson C, 2013, HEART, V99, P1030, DOI 10.1136/heartjnl-2013-303654; Parker JD, 2008, ANN THORAC SURG, V86, P1707, DOI 10.1016/j.athoracsur.2008.06.074; Patterson B, 2013, CIRCULATION, V127, P24, DOI 10.1161/CIRCULATIONAHA.112.110056; Prakash SK, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000323; Qin YL, 2012, J VASC SURG, V56, P1232, DOI 10.1016/j.jvs.2012.04.019; Ramanath VS, 2009, MAYO CLIN PROC, V84, P465, DOI 10.1016/S0025-6196(11)60566-1; Ranasinghe AM, 2010, J AM COLL CARDIOL, V56, P1535, DOI 10.1016/j.jacc.2010.01.076; Regalado ES, 2011, CIRC RES, V109, P680, DOI 10.1161/CIRCRESAHA.111.248161; Richens D, 2003, EUR J CARDIO-THORAC, V23, P143, DOI 10.1016/S1010-7940(02)00720-0; ROBERTS CS, 1991, ANN SURG, V213, P356, DOI 10.1097/00000658-199104000-00011; Rogers AM, 2011, CIRCULATION, V123, DOI 10.1161/CIRCULATIONAHA.110.988568; Rogers IS, 2011, AM J CARDIOL, V107, P643, DOI 10.1016/j.amjcard.2010.10.039; Safi HJ, 2005, ANN THORAC SURG, V80, P2173, DOI 10.1016/j.athoracsur.2005.05.060; Sakalihazan N, EUR HEART J IN PRESS; Shah BN, 2012, EUR J EMERG MED, V19, P277, DOI 10.1097/MEJ.0b013e328354729d; Shiga T, 2006, ARCH INTERN MED, V166, P1350, DOI 10.1001/archinte.166.13.1350; Shinohara T, 2003, ARTERIOSCL THROM VAS, V23, P1839, DOI 10.1161/01.ATV.0000085016.02363.80; Sobocinski J, 2011, EUR J VASC ENDOVASC, V42, P442, DOI 10.1016/j.ejvs.2011.04.037; Song JM, 2007, J AM COLL CARDIOL, V50, P799, DOI 10.1016/j.jacc.2007.03.064; Steuer J, 2013, EUR J VASC ENDOVASC, V45, P627, DOI 10.1016/j.ejvs.2013.03.013; Sueyoshi E, 2013, RADIOLOGY, V267, P368, DOI 10.1148/radiol.12121274; Suzuki T, 2003, CIRCULATION, V108, P312, DOI 10.1161/01.cir.0000087386.07204.09; Suzuki T, 1996, CIRCULATION, V93, P1244, DOI 10.1161/01.CIR.93.6.1244; Suzuki T, 2012, AM J CARDIOL, V109, P122, DOI 10.1016/j.amjcard.2011.08.012; Suzuki T, 2011, J AM COLL CARDIOL, V58, P775, DOI 10.1016/j.jacc.2010.01.079; Suzuki T, 2009, CIRCULATION, V119, P2702, DOI 10.1161/CIRCULATIONAHA.108.833004; Svensson LG, 2008, ANN THORAC SURG, V85, pS1, DOI 10.1016/j.athoracsur.2007.10.099; Thrumurthy SG, 2012, BMJ-BRIT MED J, V344, pd8290; Tolenaar JL, 2013, ANN THORAC SURG, V96, P39, DOI 10.1016/j.athoracsur.2013.03.087; Trimarchi S, 2006, CIRCULATION, V114, pI357, DOI 10.1161/CIRCULATIONAHA.105.000620; Trimarchi S, 2011, J THORAC CARDIOV SUR, V142, pE101, DOI 10.1016/j.jtcvs.2010.12.032; Trimarchi S, 2010, CIRCULATION, V122, P1283, DOI 10.1161/CIRCULATIONAHA.109.929422; Tsai TT, 2008, J VASC SURG, V47, P844, DOI 10.1016/j.jvs.2007.11.059; Tsai TT, 2006, CIRCULATION, V114, pI350, DOI 10.1161/CIRCULATIONAHA.105.000497; Tsai TT, 2005, CIRCULATION, V112, P3802, DOI 10.1161/CIRCULATIONAHA.105.534198; Ullery BW, 2012, J VASC SURG, V56, P1510, DOI 10.1016/j.jvs.2012.05.086; Ulug P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006512.pub2; Wen D, 2011, CLIN CHIM ACTA, V412, P688, DOI 10.1016/j.cca.2010.12.039; White RA, 2011, J VASC SURG, V53, P1082, DOI 10.1016/j.jvs.2010.11.124; Wilkinson DA, 2013, ANN THORAC SURG, V96, P23, DOI 10.1016/j.athoracsur.2013.01.041; Williams JB, 2012, J VASC SURG, V55, P1255, DOI 10.1016/j.jvs.2011.11.063	120	310	369	12	87	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					800	811		10.1016/S0140-6736(14)61005-9	http://dx.doi.org/10.1016/S0140-6736(14)61005-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC0UD	25662791				2022-12-28	WOS:000350051700035
J	Holmes, D				Holmes, David			Francoise Meunier: building an EORTC for the future	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2015	385	9969					679	679		10.1016/S0140-6736(15)60274-4	http://dx.doi.org/10.1016/S0140-6736(15)60274-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7ED	25706207	Bronze			2022-12-28	WOS:000349788300012
J	Jason, H; Douglas, A				Jason, Hilliard; Douglas, Andrew			Are the conditions right for a 21st-century medical school?	LANCET			English	Editorial Material							EDUCATION; AMBIGUITY; TOLERANCE; STUDENTS		[Jason, Hilliard; Douglas, Andrew] Int New Sch Med, London SW1Y 5NQ, England		Jason, H (corresponding author), Int New Sch Med, London SW1Y 5NQ, England.	h.jason@insomed.org						Bloom CP, 1998, FACILITATING DEV USE; Caulfield M, 2014, ACAD MED, V89, P1526, DOI 10.1097/ACM.0000000000000485; Cooke M, 2010, ED PHYS CALL REFORM; Crisp N, 2014, NEW ENGL J MED, V370, P950, DOI 10.1056/NEJMra1111610; Eichbaum Q, 2014, LANCET GLOB HEALTH, V2, pE689, DOI 10.1016/S2214-109X(14)70334-1; Flexner A., 1910, FLEXNER REPORT; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; GELLER G, 1990, SOC SCI MED, V31, P619, DOI 10.1016/0277-9536(90)90098-D; Irby DM, 2010, ACAD MED, V85, P220, DOI 10.1097/ACM.0b013e3181c88449; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Min, 2011, HLTH MEDICAL TECHNOL; OECD Health Policy Studies, 2014, GEOGR VAR HLTH CAR W; Ryan RM, 2013, HDB SELF DETERMINATI	13	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2015	385	9969					672	673		10.1016/S0140-6736(14)62480-6	http://dx.doi.org/10.1016/S0140-6736(14)62480-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB7ED	25706205				2022-12-28	WOS:000349788300008
J	Bach, RG				Bach, Richard G.			Review: Periprocedural high-dose statins reduce contrast-induced acute kidney injury after coronary angiography	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INDUCED NEPHROPATHY; SODIUM-BICARBONATE; PREVENTION; ACETYLCYSTEINE; INTERVENTION; TRIAL		Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Bach, RG (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.		Bach, Richard/AAI-2515-2021; Bach, Richard G/G-9764-2011					Berwanger O, 2011, CIRCULATION, V124, P1250, DOI 10.1161/CIRCULATIONAHA.111.038943; Maioli M, 2008, J AM COLL CARDIOL, V52, P599, DOI 10.1016/j.jacc.2008.05.026; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Thayssen P, 2014, CIRC-CARDIOVASC INTE, V7, P216, DOI 10.1161/CIRCINTERVENTIONS.113.000653	5	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4							JC4	10.7326/ACPJC-2015-162-4-004	http://dx.doi.org/10.7326/ACPJC-2015-162-4-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686191				2022-12-28	WOS:000350232500007
J	Li, TJ; Vedula, SS; Hadar, N; Parkin, C; Lau, J; Dickersin, K				Li, Tianjing; Vedula, S. Swaroop; Hadar, Nira; Parkin, Christopher; Lau, Joseph; Dickersin, Kay			Innovations in Data Collection, Management, and Archiving for Systematic Reviews	ANNALS OF INTERNAL MEDICINE			English	Article							DATA EXTRACTION; ERRORS; METAANALYSES	Data abstraction is a key step in conducting systematic reviews because data collected from study reports form the basis of appropriate conclusions. Recent methodological standards and expectations highlight several principles for data collection. To support implementation of these standards, this article provides a step-by-step tutorial for selecting data collection tools; constructing data collection forms; and abstracting, managing, and archiving data for systematic reviews. Examples are drawn from recent experience using the Systematic Review Data Repository for data collection and management. If it is done well, data collection for systematic reviews only needs to be done by 1 team and placed into a publicly accessible database for future use. Technological innovations, such as the Systematic Review Data Repository, will contribute to finding trustworthy answers for many health and health care questions.	[Li, Tianjing; Vedula, S. Swaroop; Hadar, Nira; Parkin, Christopher; Lau, Joseph; Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Li, TJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 North Wolfe St,E6011, Baltimore, MD 21205 USA.	tli@jhsph.edu		Li, Tianjing/0000-0001-5371-4558	National Eye Institute, National Institutes of Health [1 RC1 EY020140]; Agency for Healthcare Research and Quality [HHSA 290-2007-10055-I, HHSA 290-2012-00012-I]; NATIONAL EYE INSTITUTE [RC1EY020140] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	By the National Eye Institute, National Institutes of Health (grant 1 RC1 EY020140). The SRDR was initially developed by the Tufts University Evidence-based Practice Center and is now maintained by the Brown University Evidence-based Practice Center under contract with the Agency for Healthcare Research and Quality (contract no. HHSA 290-2007-10055-I and HHSA 290-2012-00012-I).	[Anonymous], 2009, SYSTEMATIC REV CRDS; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Buscemi N, 2006, J CLIN EPIDEMIOL, V59, P697, DOI 10.1016/j.jclinepi.2005.11.010; Chandler J., 2013, COCHRANE UNIT; CL Meinert, 1986, CLIN TRIALS DESIGN C, P140; Clarke M, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-39; Cochrane Collaboration, 2012, METH STAND REP COCHR; COMET Initiative, 2013, AB COMET; Eden J, 2011, FINDING WHAT WORKS IN HEALTH CARE: STANDARDS FOR SYSTEMATIC REVIEWS, P1; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Gresham G, 2014, 35 SOC CLIN TRIALS A; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Horton J, 2010, J CLIN EPIDEMIOL, V63, P289, DOI 10.1016/j.jclinepi.2009.04.007; Ip S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-15; Jones AP, 2005, J CLIN EPIDEMIOL, V58, P741, DOI 10.1016/j.jclinepi.2004.11.024; Kiritchenko S, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-56; McFadden E, 1997, MANAGEMENT DATA CLIN; Meinert C L, 2012, CLIN TRIALS HDB DESI; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Olsen L, 2011, LEARNING WHAT WORKS; Saldanha IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109400; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Wallace BC, 2012, GENET MED, V14, P663, DOI 10.1038/gim.2012.7; Wallace BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-55; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132	25	60	60	1	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4					287	294		10.7326/M14-1603	http://dx.doi.org/10.7326/M14-1603			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686168				2022-12-28	WOS:000350232500018
J	Allen, KA				Allen, Katherine A.			When carbon escaped from the sea	NATURE			English	Editorial Material							ATMOSPHERIC CO2; OCEAN; PH; PROXY		Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Allen, KA (corresponding author), Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08901 USA.	kat.allen@rutgers.edu						Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Henehan MJ, 2013, EARTH PLANET SC LETT, V364, P111, DOI 10.1016/j.epsl.2012.12.029; Honisch B, 2005, EARTH PLANET SC LETT, V236, P305, DOI 10.1016/j.epsl.2005.04.027; Martinez-Boti MA, 2015, NATURE, V518, P219, DOI 10.1038/nature14155; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Palmer MR, 2003, SCIENCE, V300, P480, DOI 10.1126/science.1080796; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Sanyal A, 2001, PALEOCEANOGRAPHY, V16, P515, DOI 10.1029/2000PA000547; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009	9	1	1	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					176	177		10.1038/518176a	http://dx.doi.org/10.1038/518176a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8SD	25673410				2022-12-28	WOS:000349190300027
J	Wang, S; Mata-Fink, J; Kriegsman, B; Hanson, M; Irvine, DJ; Eisen, HN; Burton, DR; Wittrup, KD; Kardar, M; Chakraborty, AK				Wang, Shenshen; Mata-Fink, Jordi; Kriegsman, Barry; Hanson, Melissa; Irvine, Darrell J.; Eisen, Herman N.; Burton, Dennis R.; Wittrup, K. Dane; Kardar, Mehran; Chakraborty, Arup K.			Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies	CELL			English	Article							GP120 ENVELOPE GLYCOPROTEIN; GERMINAL-CENTERS; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSE; B-CELLS; SOMATIC HYPERMUTATION; STRUCTURAL INSIGHTS; VACCINE; MUTATION; ANTIGEN	Generation of potent antibodies by a mutation-selection process called affinity maturation is a key component of effective immune responses. Antibodies that protect against highly mutable pathogens must neutralize diverse strains. Developing effective immunization strategies to drive their evolution requires understanding how affinity maturation happens in an environment where variants of the same antigen are present. We present an in silico model of affinity maturation driven by antigen variants which reveals that induction of cross-reactive antibodies often occurs with low probability because conflicting selection forces, imposed by different antigen variants, can frustrate affinity maturation. We describe how variables such as temporal pattern of antigen administration influence the outcome of this frustrated evolutionary process. Our calculations predict, and experiments in mice with variant gp120 constructs of the HIV envelope protein confirm, that sequential immunization with antigen variants is preferred over a cocktail for induction of cross-reactive antibodies focused on the shared CD4 binding site epitope.	[Wang, Shenshen; Mata-Fink, Jordi; Irvine, Darrell J.; Burton, Dennis R.; Chakraborty, Arup K.] MGH MIT & Harvard, Ragon Inst, Cambridge, MA 02139 USA; [Wang, Shenshen; Mata-Fink, Jordi; Kriegsman, Barry; Wittrup, K. Dane; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Wang, Shenshen; Kardar, Mehran; Chakraborty, Arup K.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Hanson, Melissa; Irvine, Darrell J.; Wittrup, K. Dane; Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Institute Med Engn & Sci, Cambridge, MA 02139 USA; [Irvine, Darrell J.; Eisen, Herman N.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Eisen, Herman N.] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Scripps Research Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chakraborty, AK (corresponding author), MGH MIT & Harvard, Ragon Inst, Cambridge, MA 02139 USA.	arupc@mit.edu		Hanson, Melissa/0000-0003-3270-8460; /0000-0003-2398-5896	Ragon Institute of MGH; Ragon Institute of MIT; Ragon Institute of Harvard; International AIDS Vaccine Initiative (IAVI) through the Neutralizing Antibody Consortium [SFP1849]; NIH [R01 AI033292]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery grant [UM1AI100663]; NATIONAL CANCER INSTITUTE [R01CA174795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292, UM1AI100663] Funding Source: NIH RePORTER	Ragon Institute of MGH; Ragon Institute of MIT; Ragon Institute of Harvard; International AIDS Vaccine Initiative (IAVI) through the Neutralizing Antibody Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support provided by the Ragon Institute of MGH, MIT, and Harvard (AKC, SW, MK, KDW, JMF) and the International AIDS Vaccine Initiative (IAVI) through the Neutralizing Antibody Consortium SFP1849 (DRB); NIH grants R01 AI033292 (DRB), and Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery grant UM1AI100663 (DRB, AKC). We are grateful to Kevin Kaczorowski and Dariusz Murakowski for helpful discussions and comments.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Deem MW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.068101; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; GOIDL EA, 1968, J IMMUNOL, V100, P371; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kelsoe G, 1996, Semin Immunol, V8, P179, DOI 10.1006/smim.1996.0022; KEPLER TB, 1993, J THEOR BIOL, V164, P37, DOI 10.1006/jtbi.1993.1139; Kepler TB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00170; Kesmir C, 2003, J THEOR BIOL, V222, P9, DOI 10.1016/S0022-5193(03)00010-9; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Malherbe DC, 2011, J VIROL, V85, P5262, DOI 10.1128/JVI.02419-10; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Meyer-Hermann M, 2002, J THEOR BIOL, V216, P273, DOI 10.1006/jtbi.2002.2550; Meyer-Hermann ME, 2006, MATH MED BIOL, V23, P255, DOI 10.1093/imammb/dql012; NIEUWENHUIS P, 1984, AM J ANAT, V170, P421, DOI 10.1002/aja.1001700315; Oprea M, 1997, J IMMUNOL, V158, P5155; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Pissani F, 2012, VACCINE, V30, P5519, DOI 10.1016/j.vaccine.2012.06.042; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Shlomchik MJ, 2012, IMMUNOL REV, V247, P5, DOI 10.1111/j.1600-065X.2012.01125.x; Shlomchik MJ, 1998, CURR TOP MICROBIOL, V229, P173; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Swerdlin N, 2008, P IEEE, V96, P1421, DOI 10.1109/JPROC.2008.925435; THALI M, 1992, J VIROL, V66, P5635, DOI 10.1128/JVI.66.9.5635-5641.1992; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742; Zhang JS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000800; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	52	111	113	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					785	797		10.1016/j.cell.2015.01.027	http://dx.doi.org/10.1016/j.cell.2015.01.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25662010	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000349208800019
J	Horwitz, LI; Lin, ZQ; Herrin, J; Bernheim, S; Drye, EE; Krumholz, HM; Ross, JS				Horwitz, Leora I.; Lin, Zhenqiu; Herrin, Jeph; Bernheim, Susannah; Drye, Elizabeth E.; Krumholz, Harlan M.; Ross, Joseph S.			Association of hospital volume with readmission rates: a retrospective cross-sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BARIATRIC SURGERY; MORTALITY; CARE; QUALITY; OUTCOMES; PROGRAM	OBJECTIVE To examine the association of hospital volume (a marker of quality of care) with hospital readmission rates. DESIGN Retrospective cross-sectional study. SETTING 4651US acute care hospitals. STUDY DATA 6 916 644 adult discharges, excluding patients receiving psychiatric or medical cancer treatment. MAIN OUTCOME MEASURES We used Medicare fee-for-service data from 1 July 2011 to 30 June 2012 to calculate observed-to-expected, unplanned, 30 day, standardized readmission rates for hospitals and for specialty cohorts medicine, surgery/gynecology, cardiorespiratory, cardiovascular, and neurology. We assessed the association of hospital volume by quintiles with 30 day, standardized readmission rates, with and without adjustment for hospital characteristics (safety net status, teaching status, geographic region, urban/rural status, nurse to bed ratio, ownership, and cardiac procedure capability. We also examined associations with the composite outcome of 30 day, standardized readmission or mortality rates. RESULTS Mean 30 day, standardized readmission rate among the fifth of hospitals with the lowest volume was 14.7 (standard deviation 5.3) compared with 15.9 (1.7) among the fifth of hospitals with the highest volume (P < 0.001). We observed the same pattern of lower readmission rates in the lowest versus highest volume hospitals in the specialty cohorts for medicine (16.6 v 17.4, P < 0.001), cardiorespiratory (18.5 v 20.5, P < 0.001), and neurology (13.2 v 14.0, p = 0.01) cohorts; the cardiovascular cohort, however, had an inverse association (14.6 v 13.7, P < 0.001). These associations remained after adjustment for hospital characteristics except in the cardiovascular cohort, which became non-significant, and the surgery/gynecology cohort, in which the lowest volume fifth of hospitals had significantly higher standardized readmission rates than the highest volume fifth (difference 0.63 percentage points (95% confidence interval 0.10 to 1.17), P = 0.02). Mean 30 day, standardized mortality or readmission rate was not significantly different between highest and lowest volume fifths (20.4 v 20.2, P = 0.19) and was highest in the middle fifth of hospitals (range 20.6-20.8). CONCLUSIONS Standardized readmission rates are lowest in the lowest volume hospitals-opposite from the typical association of greater hospital volume with better outcomes. This association was independent of hospital characteristics and was only partially attenuated by examining mortality and readmission together. Our findings suggest that readmissions are associated with different aspects of care than mortality or complications.	[Horwitz, Leora I.] NYU, Div Healthcare Delivery Sci, Dept Populat Hlth, Langone Med Ctr, New York, NY 10012 USA; [Horwitz, Leora I.] NYU, Sch Med, Ctr Healthcare Innovat & Delivery Sci, New York, NY USA; [Lin, Zhenqiu; Bernheim, Susannah; Drye, Elizabeth E.; Krumholz, Harlan M.; Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Herrin, Jeph; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Herrin, Jeph] Hlth Res & Educ Trust, Chicago, IL USA; [Bernheim, Susannah; Ross, Joseph S.] Yale Univ, Sch Med, Dept Med, Sect Gen Internal Med, New Haven, CT 06510 USA; [Drye, Elizabeth E.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Univ, Sect Hlth Policy & Adm, Sch Epidemiol & Publ Hlth, New Haven, CT USA	New York University; NYU Langone Medical Center; New York University; Yale University; Yale University; Yale University; Yale University; Yale University	Horwitz, LI (corresponding author), NYU, Div Healthcare Delivery Sci, Dept Populat Hlth, Langone Med Ctr, New York, NY 10012 USA.	leora.horwitz@nyumc.org	Horwitz, Leora/ABD-1292-2020; , Harlan/AAI-2875-2020; Horwitz, Leora/A-6959-2009	Ross, Joseph/0000-0002-9218-3320; Horwitz, Leora/0000-0003-1800-6040	Center for Medicare & Medicaid Services, an agency of the US Department of Health and Human Services [HHSM-500-2013-13018I, HHSM-500-T0001]; Agency for Healthcare Research and Quality [R01 HS022882]; National Institute on Aging [K08 AG038336, K08 AG032886]; American Federation for Aging Research; National Heart, Lung, and Blood Institute [U01 HL105270-03]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS022882] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG038336, K08AG032886] Funding Source: NIH RePORTER	Center for Medicare & Medicaid Services, an agency of the US Department of Health and Human Services; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was performed under contract HHSM-500-2013-13018I, Task Order HHSM-500-T0001, funded by the Center for Medicare & Medicaid Services, an agency of the US Department of Health and Human Services. This work was also supported by the Agency for Healthcare Research and Quality (R01 HS022882). LIH and JSR are supported by the National Institute on Aging (K08 AG038336 and K08 AG032886, respectively) and by the American Federation for Aging Research through the Paul B Beeson Career Development Award Program. HMK is supported by grant U01 HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. No funding source had any role in the study design; in the collection, analysis, and interpretation of data; or in the writing of the report. The Center for Medicare & Medicaid Services reviewed and approved the use of its data for this work and approved submission of the manuscript.	Agency for Healthcare Research and Quality, 2013, INP QUAL IND TECHN S; Agency for Healthcare Research and Quality, 2013, PED QUAL IND TECHN S; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Borenstein SH, 2005, J PEDIATR SURG, V40, P75, DOI 10.1016/j.jpedsurg.2004.09.002; Burns EM, 2011, BRIT J SURG, V98, P408, DOI 10.1002/bjs.7312; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Conover M., 2012, HOSP WIDE ALL CAUSE; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Fischer JP, 2013, PLAST RECONSTR SURG, V132, P666, DOI 10.1097/PRS.0b013e31829acc8c; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Goodney PP, 2003, ANN SURG, V238, P161, DOI 10.1097/01.SLA.0000081094.66659.c3; Gooiker GA, 2011, BRIT J SURG, V98, P485, DOI 10.1002/bjs.7413; Gooiker G A, 2010, Eur J Surg Oncol, V36 Suppl 1, pS27, DOI 10.1016/j.ejso.2010.06.024; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Holt PJE, 2007, BRIT J SURG, V94, P395, DOI 10.1002/bjs.5710; Horwitz LI, 2014, ANN INTERN MED, V161, pS66, DOI 10.7326/M13-3000; Horwitz LI, 2013, CTR MEDICARE MED SER; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Joynt KE, 2011, CIRC-CARDIOVASC QUAL, V4, P53, DOI 10.1161/CIRCOUTCOMES.110.950964; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Magid DJ, 2000, JAMA-J AM MED ASSOC, V284, P3131, DOI 10.1001/jama.284.24.3131; Mayer EK, 2011, BJU INT, V108, pE258, DOI 10.1111/j.1464-410X.2010.10010.x; National Center for Health Statistics, 2006, NCHS URB RUR CLASS S; Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24; Normand SLT, 2007, STAT SCI, V22, P206, DOI 10.1214/088342307000000096; PHIBBS CS, 1996, JAMA-J AM MED ASSOC, V276, P1054; Pose PN, 2010, EUR HEART J, V31, P1985, DOI 10.1093/eurheartj/ehq151; Reames BN, 2014, ANN SURG, V260, P244, DOI 10.1097/SLA.0000000000000375; Ross JS, 2007, HEALTH AFFAIR, V26, P238, DOI 10.1377/hlthaff.26.1.238; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Roy CL, 2009, J GEN INTERN MED, V24, P374, DOI 10.1007/s11606-008-0848-x; The Leapfrog Group, 2008, EV BAS HOSP REF FACT; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; Urbach DR, 2004, BRIT MED J, V328, P737, DOI 10.1136/bmj.38030.642963.AE; Weller WE, 2007, J AM COLL SURGEONS, V204, P383, DOI 10.1016/j.jamcollsurg.2006.12.031; Wouters MWJM, 2012, CANCER-AM CANCER SOC, V118, P1754, DOI 10.1002/cncr.26383; Zevin B, 2012, ANN SURG, V256, P60, DOI 10.1097/SLA.0b013e3182554c62	39	41	41	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2015	350								h447	10.1136/BMJ.h447	http://dx.doi.org/10.1136/BMJ.h447			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LA	25665806	Green Published, hybrid			2022-12-28	WOS:000349316200001
J	Battle, A; Khan, Z; Wang, SH; Mitrano, A; Ford, MJ; Pritchard, JK; Gilad, Y				Battle, Alexis; Khan, Zia; Wang, Sidney H.; Mitrano, Amy; Ford, Michael J.; Pritchard, Jonathan K.; Gilad, Yoav			Impact of regulatory variation from RNA to protein	SCIENCE			English	Article							GENE-EXPRESSION; YEAST; ABUNDANCE; IDENTIFICATION; TRANSCRIPTOME; HUMANS	The phenotypic consequences of expression quantitative trait loci (eQTLs) are presumably due to their effects on protein expression levels. Yet the impact of genetic variation, including eQTLs, on protein levels remains poorly understood. To address this, we mapped genetic variants that are associated with eQTLs, ribosome occupancy (rQTLs), or protein abundance (pQTLs). We found that most QTLs are associated with transcript expression levels, with consequent effects on ribosome and protein levels. However, eQTLs tend to have significantly reduced effect sizes on protein levels, which suggests that their potential impact on downstream phenotypes is often attenuated or buffered. Additionally, we identified a class of cis QTLs that affect protein abundance with little or no effect on messenger RNA or ribosome levels, which suggests that they may arise from differences in posttranslational regulation.	[Battle, Alexis; Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Battle, Alexis; Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Khan, Zia; Wang, Sidney H.; Mitrano, Amy; Gilad, Yoav] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ford, Michael J.] MS Bioworks LLC, Ann Arbor, MI 48108 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Chicago; Stanford University	Pritchard, JK (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	pritch@stanford.edu; gilad@uchicago.edu		Khan, Zia/0000-0002-7859-3489	NIH [GM077959, HG007036, MH084703]; Howard Hughes Medical Institute;  [F32HG006972]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG006972, U01HG007036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084703] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Stephens, T. Flutre, and members of the Pritchard and Gilad labs for helpful discussions. This work was supported by NIH grants GM077959, HG007036, and MH084703. A.B. and J.K.P. were supported by the Howard Hughes Medical Institute. Z.K. was supported by F32HG006972. The proteomics data are available at ProteomeXchange (accession PXD001406). The ribosome profiling data are available at GEO (accession GSE61742). J.K.P. is on the Senior Advisory Board for 23andMe and DNAnexus and holds stock in both. A.B. holds stock in Google, Inc.	Albert FW, 2014, NATURE, V506, P494, DOI 10.1038/nature12904; Artieri CG, 2014, GENOME RES, V24, P411, DOI 10.1101/gr.165522.113; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Garge N, 2010, MOL CELL PROTEOMICS, V9, P1383, DOI 10.1074/mcp.M900378-MCP200; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hause RJ, 2014, AM J HUM GENET, V95, P194, DOI 10.1016/j.ajhg.2014.07.005; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; McManus CJ, 2014, GENOME RES, V24, P422, DOI 10.1101/gr.164996.113; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Picotti P, 2013, NATURE, V494, P266, DOI 10.1038/nature11835; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Stadler M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003739; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002	24	253	255	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					664	667		10.1126/science.1260793	http://dx.doi.org/10.1126/science.1260793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657249	Green Accepted			2022-12-28	WOS:000349145200045
J	Podgornaia, AI; Laub, MT				Podgornaia, Anna I.; Laub, Michael T.			Pervasive degeneracy and epistasis in a protein-protein interface	SCIENCE			English	Article							SEQUENCE SPACE; EVOLUTION; SPECIFICITY	Mapping protein sequence space is a difficult problem that necessitates the analysis of 20(N) combinations for sequences of length N. We systematically mapped the sequence space of four key residues in the Escherichia coli protein kinase PhoQ that drive recognition of its substrate PhoP. We generated a library containing all 160,000 variants of PhoQ at these positions and used a two-step selection coupled to next-generation sequencing to identify 1659 functional variants. Our results reveal extensive degeneracy in the PhoQ-PhoP interface and epistasis, with the effect of individual substitutions often highly dependent on context. Together, epistasis and the genetic code create a pattern of connectivity of functional variants in sequence space that likely constrains PhoQ evolution. Consequently, the diversity of PhoQ orthologs is substantially lower than that of functional PhoQ variants.	[Podgornaia, Anna I.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Podgornaia, Anna I.; Laub, Michael T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Laub, Michael T.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Laub, MT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	laub@mit.edu		Podgornaia, Anna/0000-0002-7163-7901; Laub, Michael/0000-0002-8288-7607	Human Frontier Science Program; Office of Naval Research; NSF	Human Frontier Science Program(Human Frontier Science Program); Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF))	We thank B. Fiske, A. Murray, B. Sauer, and the Laub laboratory for discussions. Supported by Human Frontier Science Program and Office of Naval Research grants (M.T.L.) and an NSF Graduate Fellowship (A.I.P.). Author contributions: A.I.P. and M.T.L. conceived the approach, analyzed data, and wrote the paper. A.I.P. performed all experiments.	Bank C, 2014, GENETICS, V196, P841, DOI 10.1534/genetics.113.156190; Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Capra EJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001220; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Harms MJ, 2013, NAT REV GENET, V14, P559, DOI 10.1038/nrg3540; Hietpas RT, 2011, P NATL ACAD SCI USA, V108, P7896, DOI 10.1073/pnas.1016024108; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Melamed D, 2013, RNA, V19, P1537, DOI 10.1261/rna.040709.113; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Weinreich DM, 2013, CURR OPIN GENET DEV, V23, P700, DOI 10.1016/j.gde.2013.10.007; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165	21	101	101	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					673	677		10.1126/science.1257360	http://dx.doi.org/10.1126/science.1257360			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657251	Green Published			2022-12-28	WOS:000349145200047
J	Yu, Q; Qi, L; Tsuru, T; Traylor, R; Rugg, D; Morris, JW; Asta, M; Chrzan, DC; Minor, AM				Yu, Qian; Qi, Liang; Tsuru, Tomohito; Traylor, Rachel; Rugg, David; Morris, J. W., Jr.; Asta, Mark; Chrzan, D. C.; Minor, Andrew M.			Origin of dramatic oxygen solute strengthening effect in titanium	SCIENCE			English	Article							STACKING-FAULT ENERGY; DISLOCATION; ALUMINUM; TI	Structural alloys are often strengthened through the addition of solute atoms. However, given that solute atoms interact weakly with the elastic fields of screw dislocations, it has long been accepted that solution hardening is only marginally effective in materials with mobile screw dislocations. By using transmission electron microscopy and nanomechanical characterization, we report that the intense hardening effect of dilute oxygen solutes in pure a-Ti is due to the interaction between oxygen and the core of screw dislocations that mainly glide on prismatic planes. First-principles calculations reveal that distortion of the interstitial sites at the screw dislocation core creates a very strong but short-range repulsion for oxygen that is consistent with experimental observations. These results establish a highly effective mechanism for strengthening by interstitial solutes.	[Yu, Qian; Qi, Liang; Traylor, Rachel; Morris, J. W., Jr.; Asta, Mark; Chrzan, D. C.; Minor, Andrew M.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Yu, Qian; Minor, Andrew M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Natl Ctr Electon Microscopy, Berkeley, CA 94720 USA; [Tsuru, Tomohito] Japan Atom Energy, Nucl Sci & Engn Directorate, Tokai, Ibaraki, Japan; [Rugg, David] Rolls Royce PLC, Derby DE24 8BJ, England	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Japan Atomic Energy Agency; Rolls-Royce Holding Group	Minor, AM (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.	aminor@berkeley.edu	Qi, Liang/A-3851-2010	Qi, Liang/0000-0002-0201-9333; Tsuru, Tomohito/0000-0002-2160-0588	U.S. Office of Naval Research [N00014-12-1-0413]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Grants-in-Aid for Scientific Research [22102007] Funding Source: KAKEN	U.S. Office of Naval Research(Office of Naval Research); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We gratefully acknowledge funding from the U.S. Office of Naval Research under grant N00014-12-1-0413. Work at the Molecular Foundry was supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231. T.T. acknowledges the financial support of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant-in-Aid for Scientific Research in Innovative Areas "Bulk Nanostructured Materials." We thank J. Kacher for dislocation tomography training and Timet (Exton, PA) for the production of the high-purity model alloys used in this study.	[Anonymous], 1990, METALS HDB, V2; CONRAD H, 1981, PROG MATER SCI, V26, P123, DOI 10.1016/0079-6425(81)90001-3; Ghazisaeidi M, 2014, ACTA MATER, V76, P82, DOI 10.1016/j.actamat.2014.05.025; Ghazisaeidi M, 2012, ACTA MATER, V60, P1287, DOI 10.1016/j.actamat.2011.11.024; Hirth J. P., 1972, THEORY DISLOCATIONS; Jos B, 1997, PHYS REV LETT, V78, P266; Kibey S, 2006, ACTA MATER, V54, P2991, DOI 10.1016/j.actamat.2006.02.048; Kisielowski C, 2008, MICROSC MICROANAL, V14, P469, DOI 10.1017/S1431927608080902; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Leyson GPM, 2010, NAT MATER, V9, P750, DOI [10.1038/NMAT2813, 10.1038/nmat2813]; Lu G, 2000, PHYS REV B, V62, P3099, DOI 10.1103/PhysRevB.62.3099; NEUHAUSER H, 1993, PHYS SCRIPTA, VT49B, P412, DOI 10.1088/0031-8949/1993/T49B/005; ROSI FD, 1953, T AM I MIN MET ENG, V197, P257; TYSON WR, 1969, SCRIPTA METALL MATER, V3, P917, DOI 10.1016/0036-9748(69)90241-5; VITEK V, 1968, PHILOS MAG, V18, P773, DOI 10.1080/14786436808227500; Wasz ML, 1996, INT MATER REV, V41, P1, DOI 10.1179/095066096790151330; Williams GLaJC., 2007, TITANIUM, V2nd; Wu HH, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.045504; Wu XZ, 2010, APPL SURF SCI, V256, P3409, DOI 10.1016/j.apsusc.2009.12.042; Yasi JA, 2010, ACTA MATER, V58, P5704, DOI 10.1016/j.actamat.2010.06.045	20	195	204	29	381	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					635	639		10.1126/science.1260485	http://dx.doi.org/10.1126/science.1260485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657243				2022-12-28	WOS:000349145200038
J	Kim, SH; Kim, H; Kim, NJ				Kim, Sang-Heon; Kim, Hansoo; Kim, Nack J.			Brittle intermetallic compound makes ultrastrong low-density steel with large ductility	NATURE			English	Article							DUAL-PHASE STEELS; MECHANICAL-PROPERTIES; FRACTURE-TOUGHNESS; TITANIUM-ALLOYS; TENSILE; BEHAVIOR; PLASTICITY; TI-6AL-4V	Although steel has been the workhorse of the automotive industry since the 1920s, the share by weight of steel and iron in an average light vehicle is now gradually decreasing, from 68.1 per cent in 1995 to 60.1 per cent in 2011 (refs 1, 2). This has been driven by the low strength-to-weight ratio (specific strength) of iron and steel, and the desire to improve such mechanical properties with other materials. Recently, high-aluminium low-density steels have been actively studied as a means of increasing the specific strength of an alloy by reducing its density(3-5). But with increasing aluminium content a problem is encountered: brittle intermetallic compounds can formin the resulting alloys, leading to poor ductility. Here we show that an FeAl-type brittle but hard intermetallic compound (B2) can be effectively used as a strengthening second phase in high-aluminiumlow-density steel, while alleviating its harmful effect on ductility by controlling its morphology and dispersion. The specific tensile strength and ductility of the developed steel improve on those of the lightest and strongest metallic materials known, titanium alloys. We found that alloying of nickel catalyses the precipitation of nanometre-sized B2 particles in the face-centred cubic matrix of high-aluminiumlow-density steel during heat treatment of cold-rolled sheet steel. Our results demonstrate how intermetallic compounds can be harnessed in the alloy design of lightweight steels for structural applications and others.	[Kim, Sang-Heon; Kim, Hansoo; Kim, Nack J.] POSTECH, Grad Inst Ferrous Technol, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH)	Kim, H (corresponding author), POSTECH, Grad Inst Ferrous Technol, Pohang 790784, South Korea.	hansoo-kim@postech.ac.kr		Kim, Hansoo/0000-0003-1989-7703; Kim, Nack J./0000-0001-7822-8134	Steel Innovation Program of POSCO	Steel Innovation Program of POSCO	We thank J.-S. Lee and Y.-U. Heo for discussions. The press hardening steel was obtained from POSCO. This work was supported by the Steel Innovation Program of POSCO.	[Anonymous], CORROSION FATIGUE EN; BOWEN AW, 1979, MATER SCI ENG, V40, P31, DOI 10.1016/0025-5416(79)90006-5; Breuer J, 2001, METALL MATER TRANS B, V32, P913, DOI 10.1007/s11663-001-0077-8; Cao GH, 2007, ACTA MATER, V55, P3765, DOI 10.1016/j.actamat.2007.02.025; Choi K, 2010, SCRIPTA MATER, V63, P1028, DOI 10.1016/j.scriptamat.2010.07.036; Chumak I, 2008, J PHASE EQUILIB DIFF, V29, P300, DOI 10.1007/s11669-008-9319-7; DAVIES RG, 1978, METALL TRANS A, V9, P671, DOI 10.1007/BF02659924; Davis S., 2013, TRANSPORTATION ENERG, P4; Dursun T, 2014, MATER DESIGN, V56, P862, DOI 10.1016/j.matdes.2013.12.002; Fan DW, 2009, STEEL RES INT, V80, P241; Frommeyer G, 2006, STEEL RES INT, V77, P627, DOI 10.1002/srin.200606440; Gil FJ, 2003, MAT SCI ENG A-STRUCT, V349, P150, DOI 10.1016/S0921-5093(02)00784-0; Gschneidner K, 2003, NAT MATER, V2, P587, DOI 10.1038/nmat958; Gutierrez-Urrutia I, 2013, SCRIPTA MATER, V68, P343, DOI 10.1016/j.scriptamat.2012.08.038; Kim H, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/014205; Kuc D, 2009, MATER CHARACT, V60, P1185, DOI 10.1016/j.matchar.2009.03.020; Leslie W. C., 1981, PHYSICAL METALLURGY, P43; Liu CT, 1997, INTERMETALLICS, V5, P579, DOI 10.1016/S0966-9795(97)00045-9; Marmy P, 2001, J NUCL MATER, V296, P155, DOI 10.1016/S0022-3115(01)00564-5; Militzer M, 2002, SCIENCE, V298, P975, DOI 10.1126/science.1078210; Richeton T, 2005, NAT MATER, V4, P465, DOI 10.1038/nmat1393; Stoloff NS, 2000, INTERMETALLICS, V8, P1313, DOI 10.1016/S0966-9795(00)00077-7; Suh DW, 2013, SCRIPTA MATER, V68, P337, DOI 10.1016/j.scriptamat.2012.11.037; Sutou Y, 2010, ISIJ INT, V50, P893, DOI 10.2355/isijinternational.50.893; Tahtinen S, 2002, J NUCL MATER, V307, P416, DOI 10.1016/S0022-3115(02)01010-3; Thomser C, 2009, STEEL RES INT, V80, P582, DOI 10.2374/SRI09SP046; Yoo JD, 2008, MAT SCI ENG A-STRUCT, V496, P417, DOI 10.1016/j.msea.2008.05.042; Zargaran A, 2014, SCRIPTA MATER, V89, P37, DOI 10.1016/j.scriptamat.2014.06.018	28	387	407	42	587	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					77	+		10.1038/nature14144	http://dx.doi.org/10.1038/nature14144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25652998				2022-12-28	WOS:000349098000034
J	Lewis, JA; Ahn, BY				Lewis, Jennifer A.; Ahn, Bok Y.			Three-dimensional printed electronics	NATURE			English	Editorial Material							LIGHT-EMITTING-DIODES; NANOCRYSTALS; POLYMER		[Lewis, Jennifer A.; Ahn, Bok Y.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Lewis, Jennifer A.; Ahn, Bok Y.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lewis, JA (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	jalewis@seas.harvard.edu	Lewis, Jennifer/HCH-4635-2022	Lewis, Jennifer/0000-0002-0280-2774				Adams JJ, 2011, ADV MATER, V23, P1335, DOI 10.1002/adma.201003734; Ahn BY, 2009, SCIENCE, V323, P1590, DOI 10.1126/science.1168375; Coe S, 2002, NATURE, V420, P800, DOI 10.1038/nature01217; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; Dai XL, 2014, NATURE, V515, P96, DOI 10.1038/nature13829; Hu H, 2006, J PHYS CHEM B, V110, P7090, DOI 10.1021/jp0609232; Kong YL, 2014, NANO LETT, V14, P7017, DOI 10.1021/nl5033292; Ladd C, 2013, ADV MATER, V25, P5081, DOI 10.1002/adma.201301400; Lewis JA, 2006, ADV FUNCT MATER, V16, P2193, DOI 10.1002/adfm.200600434; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI 10.1038/nphoton.2012.328; Smay JE, 2002, LANGMUIR, V18, P5429, DOI 10.1021/la0257135; Sun K, 2013, ADV MATER, V25, P4539, DOI 10.1002/adma.201301036; Wood V, 2009, ADV MATER, V21, P2151, DOI 10.1002/adma.200803256	13	171	182	6	259	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					42	43		10.1038/518042a	http://dx.doi.org/10.1038/518042a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25652992				2022-12-28	WOS:000349098000025
J	Varraso, R; Chiuve, SE; Fung, TT; Barr, RG; Hu, FB; Willett, WC; Camargo, CA				Varraso, Raphaelle; Chiuve, Stephanie E.; Fung, Teresa T.; Barr, R. Graham; Hu, Frank B.; Willett, Walter C.; Camargo, Carlos A.			Alternate Healthy Eating Index 2010 and risk of chronic obstructive pulmonary disease among US women and men: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CURED MEAT CONSUMPTION; DIETARY PATTERNS; LUNG-FUNCTION; VALIDATION; MORTALITY; QUALITY; CANCER; COHORT	OBJECTIVE To investigate the association between the Alternate Healthy Eating Index 2010 (AHEI-2010)-a measure of diet quality-and the risk of chronic obstructive pulmonary disease (COPD). DESIGN Prospective cohort study. SETTING Participants in the Nurses' Health Study and the Health Professionals Follow-up Study, United States. PARTICIPANTS 73 228 female nurses from 1984 to 2000 and 47 026 men from 1986 to 1998, who completed biennial questionnaires. MAIN OUTCOME MEASURES The primary outcome was the self report of newly diagnosed COPD. Multivariable Cox proportional hazards models were adjusted for age, physical activity, body mass index, total energy intake, smoking, second hand tobacco exposure (only in the Nurses' Health Study), race/ethnicity, physician visits, US region, spouse's highest educational attainment (only in the Nurses' Health Study), and menopausal status (only in the Nurses' Health Study). RESULTS Over the study period, 723 cases of newly diagnosed COPD occurred in women and 167 in men. In the pooled analysis, a significant negative association was seen between the risk of newly diagnosed COPD and fifths of the AHEI-2010: hazard ratios were 0.81 (95% confidence interval 0.51 to 1.29) for the second fifth, 0.98 (0.80 to 1.18) for the third fifth, 0.74 (0.59 to 0.92) for the fourth fifth, and 0.67 (0.53 to 0.85) for participants who ate the healthiest diet according to the AHEI-2010 (that is, were in the highest fifth), compared with those who ate the less healthy diet (participants in the lowest fifth). Similar findings were observed among ex-smokers and current smokers. CONCLUSIONS A higher AHEI-2010 diet score (reflecting high intakes of whole grains, polyunsaturated fatty acids, nuts, and long chain omega-3 fats and low intakes of red/processed meats, refined grains, and sugar sweetened drinks) was associated with a lower risk of COPD in both women and men. These findings support the importance of a healthy diet in multi-interventional programs to prevent COPD.	[Varraso, Raphaelle] INSERM, U1168, VIMA Aging & Chron Dis Epidemiol & Publ Hlth Appr, F-94807 Villejuif, France; [Varraso, Raphaelle] Univ Versailles St Quentin En Yvelines, UMR S 1168, UVSQ, Versailles, France; [Chiuve, Stephanie E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02215 USA; [Chiuve, Stephanie E.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Chiuve, Stephanie E.; Fung, Teresa T.; Hu, Frank B.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Fung, Teresa T.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA; [Barr, R. Graham] Columbia Univ, Div Gen Med, Dept Med, Med Ctr, New York, NY 10032 USA; [Barr, R. Graham] Columbia Univ, Dept Epidemiol, Med Ctr, New York, NY 10032 USA; [Hu, Frank B.; Willett, Walter C.; Camargo, Carlos A.] Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA 02115 USA; [Hu, Frank B.; Willett, Walter C.; Camargo, Carlos A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hu, Frank B.; Willett, Walter C.; Camargo, Carlos A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Camargo, Carlos A.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Simmons University; Columbia University; Columbia University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Varraso, R (corresponding author), INSERM, U1168, VIMA Aging & Chron Dis Epidemiol & Publ Hlth Appr, 16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	raphaelle.varraso@inserm.fr	Camargo, Carlos A./C-2145-2008; Varraso, Raphaelle/R-8740-2016	Camargo, Carlos A./0000-0002-5071-7654; Varraso, Raphaelle/0000-0002-3338-7825; Chiuve, Stephanie/0000-0002-3524-8917	National Institutes of Health (Bethesda, MD, USA) [CA-87969, CA-167552, HL-63841, AI-52338]; NATIONAL CANCER INSTITUTE [U01CA167552, UM1CA167552, P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075476, R01HL063841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI052338] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants CA-87969, CA-167552, HL-63841, and AI-52338 from the National Institutes of Health (Bethesda, MD, USA). The design, conduct, and reporting were entirely the responsibility of the authors, independent from funders.	Barr RG, 2002, AM J EPIDEMIOL, V155, P965, DOI 10.1093/aje/155.10.965; Boggs DA, 2013, J NUTR, V143, P1636, DOI 10.3945/jn.113.179002; Bosire C, 2013, AM J EPIDEMIOL, V177, P504, DOI 10.1093/aje/kws261; Butler LM, 2006, AM J RESP CRIT CARE, V173, P264, DOI 10.1164/rccm.200506-901OC; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Clini EM, 2013, AM J RESP CRIT CARE, V187, P668, DOI 10.1164/rccm.201302-0230ED; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; COLDITZ GA, 1991, AM J CARDIOL, V67, P933, DOI 10.1016/0002-9149(91)90163-F; Dai ZL, 2014, J NUTR, V144, P511, DOI 10.3945/jn.113.187955; de Batlle J, 2012, EUR RESPIR J, V40, P555, DOI 10.1183/09031936.00116911; Decramer M, 2013, LANCET RESP MED, V1, P73, DOI 10.1016/S2213-2600(12)70060-7; Fransen HP, 2008, CURR OPIN CLIN NUTR, V11, P559, DOI 10.1097/MCO.0b013e32830a49db; Hanson C, 2013, TRANSL RES, V162, P219, DOI 10.1016/j.trsl.2013.04.004; Hole DJ, 1996, BRIT MED J, V313, P711; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jensen KO, 1999, EUR J CLIN NUTR, V53, P351, DOI 10.1038/sj.ejcn.1600767; Jiang R, 2008, AM J CLIN NUTR, V87, P1002, DOI 10.1093/ajcn/87.4.1002; Jiang R, 2007, AM J RESP CRIT CARE, V175, P798, DOI 10.1164/rccm.200607-969OC; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McKeever TM, 2010, AM J CLIN NUTR, V92, P408, DOI 10.3945/ajcn.2009.29021; Okubo H, 2014, EUR RESPIR J, V43, P972, DOI 10.1183/09031936.00109513; Reedy J, 2014, J NUTR, V144, P881, DOI 10.3945/jn.113.189407; Samieri C, 2013, ANN INTERN MED, V159, P584, DOI 10.7326/0003-4819-159-9-201311050-00004; Shaheen SO, 2010, EUR RESPIR J, V36, P277, DOI 10.1183/09031936.00114709; Tam A, 2013, EXPERT REV RESP MED, V7, P197, DOI [10.1586/ers.13.22, 10.1586/ERS.13.22]; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Varraso R, 2007, THORAX, V62, P786, DOI 10.1136/thx.2006.074534; Varraso R, 2007, AM J EPIDEMIOL, V166, P1438, DOI 10.1093/aje/kwm235; Varraso R, 2007, AM J CLIN NUTR, V86, P488, DOI 10.1093/ajcn/86.2.488; Willett W, 2012, NUTRITIONAL EPIDEMIO	33	99	101	2	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2015	350								h286	10.1136/bmj.h286	http://dx.doi.org/10.1136/bmj.h286			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0IL	25649042	hybrid, Green Published			2022-12-28	WOS:000349309100003
J	Burki, T				Burki, Talha			MULTIMORBIDITY Why India should worry about a coepidemic of diabetes and tuberculosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												talhakburki@gmail.com						Kumar A, 2013, TROP MED INT HEALTH, V18, P646, DOI 10.1111/tmi.12083; Lonnroth K, 2014, LANCET DIABETES ENDO, V2, P730, DOI 10.1016/S2213-8587(14)70109-3; WHO, TB COUNTR PROF IND; World Diabetes Foundation International Union Against Tuberculosis and Lung Disease, 2014, LOOM COEP TB DIAB CA	4	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2015	350								h111	10.1136/bmj.h111	http://dx.doi.org/10.1136/bmj.h111			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZB	25647583				2022-12-28	WOS:000348433200003
J	Bond, M; Tejedor, MF; Campbell, KE; Chornogubsky, L; Novo, N; Francisco, G				Bond, Mariano; Tejedor, Marcelo F.; Campbell, Kenneth E., Jr.; Chornogubsky, Laura; Novo, Nelson; Francisco Goin			Eocene primates of South America and the African origins of New World monkeys	NATURE			English	Article							LATE MIDDLE EOCENE; EVOLUTION	The platyrrhine primates, or New World monkeys, are immigrant mammals whose fossil record comes from Tertiary and Quaternary sediments of South America and the Caribbean Greater Antilles(1,2). The time and place of platyrrhine origins are some of the most controversial issues in primate palaeontology, although an African Palaeogene ancestry has been presumed by most primatologists(3,4). Until now, the oldest fossil records of New World monkeys have come from Salla, Bolivia(5,6), and date to approximately 26 million years ago(7), or the Late Oligocene epoch. Here we report the discovery of new primates from the ? Late Eocene epoch of Amazonian Peru, which extends the fossil record of primates in South America back approximately 10 million years. The new specimens are important for understanding the origin and early evolution of modern platyrrhine primates because they bear little resemblance to any extinct or living South American primate, but they do bear striking resemblances to Eocene African anthropoids, and our phylogenetic analysis suggests a relationship with African taxa. The discovery of these new primates brings the first appearance datum of caviomorph rodents and primates in South America back into close correspondence, but raises new questions about the timing and means of arrival of these two mammalian groups.	Consejo Nacl Invest Cient & Tecn, Museo Ciencias Nat La Plata, Div Paleontol Vertebrados, La Plata, Buenos Aires, Argentina; Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, RA-9120 Puerto Madryn, Chubut, Argentina; Fac Ciencias Nat, Sede Trelew, Argentina; Univ Nacl Patagonia San Juan Bosco, RA-9100 Trelew, Chubut, Argentina; Nat Hist Museum Los Angeles Cty, Vertebrate Zool, Los Angeles, CA 90007 USA; Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat Bernardino Rivadavia, Secc Paleontol Vertebrados, Buenos Aires, DF, Argentina; Univ Nacl Lujan, Dept Ciencias Basicas, RA-6700 Lujan, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de la Patagonia San Juan Bosco; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Universidad Nacional de Lujan	Campbell, KE (corresponding author), Nat Hist Museum Los Angeles Cty, Vertebrate Zool, Los Angeles, CA 90007 USA.	kcampbell@nhm.org	Tejedor, Marcelo/AAU-4189-2021	Tejedor, Marcelo/0000-0003-3465-673X	National Geographic Society; National Science Foundation [DBI-0216506]	National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF))	INGEMMET, Lima, has been a partner and supporter of the field work in Amazonia led by K.E.C. and C.D. Frailey, especially H. Rivera-Mantilla and O. Palacios. M. Aldana and the late L. Romero-Pittman., both of INGEMMET, and C. D. Frailey provided assistance in the field expeditions. Funding in support of the Santa Rosa expeditions was provided by the National Geographic Society and J. G. Wigmore (1995 discovery expedition), and J. G. Wigmore, W. Rhodes, and R. Seaver (1998 collecting expedition). A. Stenger provided funding to support the picking of matrix by C. Suarez-Gomez. G.-A. Kung provided assistance in operating the scanning electron microscope at LACM, an instrument funded by National Science Foundation Major Research Instrumentation grant DBI-0216506; F. Tricarico assisted with scanning electron microscope operations at the Museo Argentino de Ciencias Naturales (MACN); and M. Tomeo assisted with development of figures. We thank K. C. Beard, Biodiversity Institute and Natural History Museum, University of Kansas, for providing epoxy casts of Talahpithecus, A. Kramarz for access to the palaeontology collections at MACN, D. Flores and L. Lucero for access to the mammalogy collections of the MACN, and CONICET (Argentina, PIP 0361).	Antoine PO, 2012, P ROY SOC B-BIOL SCI, V279, P1319, DOI 10.1098/rspb.2011.1732; Bauer K, 1997, BIOL J LINN SOC, V60, P1; Campbell, 2004, NATURAL HIST MUSEUM, V40, P1; Campbell Kenneth E. Jr, 2004, Natural History Museum of Los Angeles County Science Series, V40, P3; Campbell Kenneth E. Jr, 2004, Natural History Museum of Los Angeles County Science Series, V40, pi; Chaimanee Y, 2012, P NATL ACAD SCI USA, V109, P10293, DOI 10.1073/pnas.1200644109; de Oliveira Felipe Bandoni, 2009, P55, DOI 10.1007/978-0-387-78705-3_3; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1; Fleagle JG, 2002, CAM S BIO EVOL ANTHR, V33, P161; Gamble T, 2011, J EVOLUTION BIOL, V24, P231, DOI 10.1111/j.1420-9101.2010.02184.x; Hartwig WC, 2002, CAM S BIO EVOL ANTHR, V33, P175; Hoffstetter R., 1969, CR HEBD ACAD SCI, V69, P434; Houle Alain, 1998, Diversity and Distributions, V4, P201; Jaeger JJ, 2010, NATURE, V467, P1096, DOI 10.1038/nature09425; Kay RF, 1998, J VERTEBR PALEONTOL, V18, P189, DOI 10.1080/02724634.1998.10011043; Kay RF, 2008, J HUM EVOL, V54, P323, DOI 10.1016/j.jhevol.2007.09.002; Kay RF, 2015, MOL PHYLOGENET EVOL, V82, P358, DOI 10.1016/j.ympev.2013.12.002; Marivaux L, 2014, AM J PHYS ANTHROPOL, V154, P387, DOI 10.1002/ajpa.22523; Mayr G, 2011, NATURWISSENSCHAFTEN, V98, P961, DOI 10.1007/s00114-011-0849-1; Queiroz de, 2014, THE MONKEYS VOYAGE; Rosenberger A. L., 2009, S AM PRIMATES TESTIN, V16, P69; Rosenberger AL, 2010, J HUM EVOL, V59, P214, DOI 10.1016/j.jhevol.2010.03.003; Seiffert ER, 2012, EVOL ANTHROPOL, V21, P239, DOI 10.1002/evan.21335; Seiffert ER, 2010, P NATL ACAD SCI USA, V107, P9712, DOI 10.1073/pnas.1001393107; SIMONS EL, 1989, P NATL ACAD SCI USA, V86, P9956, DOI 10.1073/pnas.86.24.9956; Takai M, 2000, AM J PHYS ANTHROPOL, V111, P263, DOI 10.1002/(SICI)1096-8644(200002)111:2<263::AID-AJPA10>3.3.CO;2-Y; Tejedor Marcelo F., 2013, Revista del Museo de La Plata Seccion Zoologia, V20, P20	27	113	116	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					538	+		10.1038/nature14120	http://dx.doi.org/10.1038/nature14120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25652825				2022-12-28	WOS:000353334500042
J	Webster, DP; Klenerman, P; Dusheiko, GM				Webster, Daniel P.; Klenerman, Paul; Dusheiko, Geoffrey M.			Hepatitis C	LANCET			English	Article							TREATMENT-NAIVE PATIENTS; GENOTYPE 1 INFECTION; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT-EXPERIENCED PATIENTS; INTERFERON-ALPHA-2B PLUS RIBAVIRIN; HUMAN-IMMUNODEFICIENCY-VIRUS; FIXED-DOSE COMBINATION; HIV-POSITIVE MEN; PEGYLATED INTERFERON; NATURAL-HISTORY	Hepatitis C virus (HCV) infection is a major health problem worldwide. The effects of chronic infection include cirrhosis, end-stage liver disease, and hepatocellular carcinoma. As a result of shared routes of transmission, co-infection with HIV is a substantial problem, and individuals infected with both viruses have poorer outcomes than do peers infected with one virus. No effective vaccine exists, although persistent HCV infection is potentially curable. The standard of care has been subcutaneous interferon alfa and oral ribavirin for 24-72 weeks. This treatment results in a sustained virological response in around 50% of individuals, and is complicated by clinically significant adverse events. In the past 10 years, advances in HCV cell culture have enabled an improved understanding of HCV virology, which has led to development of many new direct-acting antiviral drugs that target key components of virus replication. These direct-acting drugs allow for simplified and shortened treatments for HCV that can be given as oral regimens with increased tolerability and efficacy than interferon and ribavirin. Remaining obstacles include access to appropriate care and treatment, and development of a vaccine.	[Webster, Daniel P.] Royal Free London NHS Fdn Trust, Dept Virol, London NW3 2QG, England; [Klenerman, Paul] Univ Oxford, Natl Inst Hlth Res, Biomed Res Ctr, Oxford, England; [Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Oxford, England; [Dusheiko, Geoffrey M.] UCL, Inst Liver & Digest Hlth, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; University of Oxford; University of Oxford; University of London; University College London	Webster, DP (corresponding author), Royal Free London NHS Fdn Trust, Dept Virol, London NW3 2QG, England.	daniel.webster@ucl.ac.uk		klenerman, paul/0000-0003-4307-9161	Bristol-Myers Squibb; Gilead; Janssen; Viiv; Abbott Molecular; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0510-10204] Funding Source: researchfish	Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Viiv; Abbott Molecular; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute for Health Research(National Institute for Health Research (NIHR))	DPW has received travel grants or lecture fees from Bristol-Myers Squibb, Gilead, Janssen, Viiv, and Abbott Molecular. PK declares no competing interests. GMD has acted as an adviser for Janssen, Gilead Sciences, AbbVie, Merck, and Bristol-Myers Squibb.	Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Albert M, 2011, AIDS, V25, P399, DOI 10.1097/QAD.0b013e328343443b; Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; Antaki N, 2010, LIVER INT, V30, P342, DOI 10.1111/j.1478-3231.2009.02188.x; Asselah T, 2013, LIVER INT, V33, P93, DOI 10.1111/liv.12076; Avo AP, 2013, J MED VIROL, V85, P815, DOI 10.1002/jmv.23545; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Batty EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066129; Bedimo R, 2010, HIV MED, V11, P462, DOI 10.1111/j.1468-1293.2009.00815.x; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Beinhardt S, 2013, J HEPATOL, V59, P972, DOI 10.1016/j.jhep.2013.06.028; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Bezemer G, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-11; Bourliere M, 2014, HEPATOLOGY S, V60, pLB6; Brown R, 2014, ANN M AM ASS STUD LI; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Castera L, 2009, J HEPATOL, V50, P59, DOI 10.1016/j.jhep.2008.08.018; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; Charlton M, 2015, GASTROENTEROLOGY, V148, P108, DOI 10.1053/j.gastro.2014.10.001; Charlton M, 2011, HEPATOLOGY, V54, P3, DOI 10.1002/hep.24470; Chastain CA, 2013, CURR HIV-AIDS REP, V10, P408, DOI 10.1007/s11904-013-0182-8; Chevaliez S, 2011, CLIN RES HEPATOL GAS, V35, pS31, DOI [10.1016/S2210-7401(11)70005-5, 10.1016/S2210-7401(11)70007-9]; Cobb B, 2013, AM J GASTROENTEROL, V108, P471, DOI 10.1038/ajg.2012.248; Coilly A, 2014, J HEPATOL, V60, P78, DOI 10.1016/j.jhep.2013.08.018; Collin F, 2009, AIDS, V23, P1021, DOI 10.1097/QAD.0b013e3283292195; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Curry MP, 2013, 64 ANN M AM ASS STUD; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; Danta M, 2011, CURR OPIN HIV AIDS, V6, P451, DOI 10.1097/COH.0b013e32834b4974; Ponde RAD, 2013, EUR J CLIN MICROBIOL, V32, P985, DOI 10.1007/s10096-013-1857-1; Deterding K, 2013, LANCET INFECT DIS, V13, P497, DOI 10.1016/S1473-3099(13)70059-8; Dieterich D, 2014, HEPATOLOGY, V60, p220A; Dore GJ, 2013, J HEPATOL, V58, pS570, DOI 10.1016/S0168-8278(13)61417-8; Duggal P, 2013, ANN INTERN MED, V158, P235, DOI 10.7326/0003-4819-158-4-201302190-00003; Everson G, 2014, J HEPATOL S, V60; Everson GT, 2013, 64 ANN M AM ASS STUD; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Fierer DS, 2014, CLIN INFECT DIS, V58, P873, DOI 10.1093/cid/cit799; Fitzmaurice K, 2011, GUT, V60, P1563, DOI 10.1136/gut.2010.228403; Flamm SL, 2014, HEPATOLOGY, V60, p320A; Forns X, 2014, GASTROENTEROLOGY, V146, P1669, DOI 10.1053/j.gastro.2014.02.051; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gane EJ, 2014, J HEPATOL, V60, pS3, DOI 10.1016/S0168-8278(14)60008-8; Garimella T, 2014, J INT AIDS SOC, V17, P92, DOI 10.7448/IAS.17.4.19628; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Gilleece YC, 2005, JAIDS-J ACQ IMM DEF, V40, P41, DOI 10.1097/01.qai.0000174930.64145.a9; Gonzalez V, 2013, J CLIN VIROL, V58, P249, DOI 10.1016/j.jcv.2013.05.005; Gray RR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002656; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Halliday J, 2011, EXPERT REV VACCINES, V10, P659, DOI [10.1586/erv.11.55, 10.1586/ERV.11.55]; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hassanein T, 2014, 49 ANN M EUR ASS STU; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; Hezode C, 2014, 49 ANN M EUR ASS STU; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Hinkin CH, 2008, J ADDICT DIS, V27, P11, DOI 10.1300/J069v27n02_02; Hsu CS, 2013, NEW ENGL J MED, V369, P678, DOI 10.1056/NEJMc1307641; Jacobson IM, 2012, J VIRAL HEPATITIS, V19, P1, DOI 10.1111/j.1365-2893.2012.01590.x; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2012, HEPATOLOGY, V56, P567, DOI 10.1002/hep.25865; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jain S, 2007, AM J PERINAT, V24, P251, DOI 10.1055/s-2007-970181; Jensen DM, 2014, HEPATOLOGY, V60, p219A; Kapoor A, 2013, MBIO, V4, DOI 10.1128/mBio.00216-13; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kiser JJ, 2013, NAT REV GASTRO HEPAT, V10, P596, DOI 10.1038/nrgastro.2013.106; Klenerman P, 2007, PLOS MED, V4, P1608, DOI 10.1371/journal.pmed.0040240; Klevens RM, 2012, CLIN INFECT DIS, V55, pS3, DOI 10.1093/cid/cis393; Kohli A, 2013, 64 ANN M AM ASS STUD; Kong L, 2012, J VIROL, V86, P13085, DOI 10.1128/JVI.01939-12; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Kwo PY, 2014, NEW ENGL J MED, V371, P2375, DOI 10.1056/NEJMoa1408921; Lacombe K, 2013, AIDS, V27, P1356, DOI 10.1097/QAD.0b013e32836138d0; Lawitz E., 2013, 64 ANN M AM ASS STUD; Lawitz E, 2014, LANCET; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Loomba R, 2011, ALIMENT PHARM THER, V33, P559, DOI 10.1111/j.1365-2036.2010.04549.x; Lopez-Dieguez M, 2011, AIDS, V25, P899, DOI 10.1097/QAD.0b013e3283454174; Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1; Lyons S, 2012, EMERG INFECT DIS, V18, P1976, DOI 10.3201/eid1812.120498; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9; Manns MP, 2014, GASTROENTEROLOGY, V147, P366, DOI 10.1053/j.gastro.2014.04.006; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Martin TCS, 2013, AIDS, V27, P2551, DOI 10.1097/QAD.0b013e32836381cc; McIntyre PG, 2006, COCHRANE DB SYST REV, V4; McPhee F, 2013, J HEPATOL, V58, pS492, DOI 10.1016/S0168-8278(13)61211-8; Membreno FE, 2011, CLIN LIVER DIS, V15, P611, DOI 10.1016/j.cld.2011.05.003; Meredith LW, 2012, REV MED VIROL, V22, P182, DOI 10.1002/rmv.723; Moreno C, 2015, J HEPATOL, V62, P1047, DOI 10.1016/j.jhep.2014.12.031; Muir A, 2014, HEPATOLOOGY S, V60; Nelson DR, 2014, 65 ANN M AM ASS STUD; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Osinusi A, 2014, 49 ANN M EUR ASS STU; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pianko S, 2014, HEPATOLOGY, V60, p297A; Plaza Z, 2012, ANTIVIR THER, V17, P921, DOI 10.3851/IMP2091; Pol S, 2012, LANCET INFECT DIS, V12, P671, DOI 10.1016/S1473-3099(12)70138-X; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Prasad MR, 2013, AM J PERINAT, V30, P149, DOI 10.1055/s-0033-1334459; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Racanelli V, 2003, TRENDS IMMUNOL, V24, P456, DOI 10.1016/S1471-4906(03)00178-9; Reddy R, 2014, HEPATOLOGY S, V60, p49A; Rockstroh JK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-234; Ruane PJ, 2013, 64 ANN M AM ASS STUD; Serpaggi J, 2006, AIDS, V20, P233, DOI 10.1097/01.aids.0000200541.40633.56; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Shulla A, 2012, CURR OPIN VIROL, V2, P725, DOI 10.1016/j.coviro.2012.09.013; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Sulkowski M, 2013, 64 ANN M AM ASS STUD; Sulkowski M, 2015, LANCET; Sulkowski MS, 2013, J HEPATOL, V58, pS570, DOI 10.1016/S0168-8278(13)61416-6; Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Sulkowski MS, 2013, HEPATOLOGY, V57, P2143, DOI 10.1002/hep.26276; Sulkowski MS, 2013, J INFECT DIS, V207, pS26, DOI 10.1093/infdis/jis764; Szabo E, 2003, PATHOL ONCOL RES, V9, P215, DOI 10.1007/BF02893380; Terrault NA, 2013, HEPATOLOGY, V57, P881, DOI 10.1002/hep.26164; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Thomson EC, 2011, J GEN VIROL, V92, P2227, DOI 10.1099/vir.0.033910-0; Thomson EC, 2011, GUT, V60, P837, DOI 10.1136/gut.2010.217166; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; TOVO Cristiane Valle, 2013, Arq. Gastroenterol., V50, P19, DOI 10.1590/S0004-28032013000100005; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; van Heeswijk R, 2013, ANTIMICROB AGENTS CH, V57, P2304, DOI 10.1128/AAC.02262-12; Wahid A, 2013, J VIRAL HEPATITIS, V20, P369, DOI 10.1111/jvh.12094; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Webster DP, 2013, INT J STD AIDS, V24, P179, DOI 10.1177/0956462412472317; Wiegand J, 2006, HEPATOLOGY, V43, P250, DOI 10.1002/hep.21043; Wyatt CA, 2008, AIDS, V22, P1799, DOI 10.1097/QAD.0b013e32830e0152; Zaltron S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-S2-S2; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zou SM, 2010, TRANSFUSION, V50, P1495, DOI 10.1111/j.1537-2995.2010.02622.x	156	353	365	0	80	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1124	1135		10.1016/S0140-6736(14)62401-6	http://dx.doi.org/10.1016/S0140-6736(14)62401-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25687730	Green Accepted			2022-12-28	WOS:000351270400031
J	Adler, NE; Stead, WW				Adler, Nancy E.; Stead, William W.			Patients in Context - EHR Capture of Social and Behavioral Determinants of Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Adler, Nancy E.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Stead, William W.] Vanderbilt Univ, Med Ctr, Nashville, TN USA	University of California System; University of California San Francisco; Vanderbilt University	Adler, NE (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.			STEAD, WILLIAM/0000-0002-5048-9540				Behforouz HL, 2014, NEW ENGL J MED, V371, P1277, DOI 10.1056/NEJMp1404846; Franks P, 2010, ANN FAM MED, V8, P447, DOI 10.1370/afm.1167; Institute of Medicine, 2014, CAPT SOC BEH DOM MEA; Institute of Medicine, 2012, PRIM CAR PUBL HLTH E; Pantell M, 2013, AM J PUBLIC HEALTH, V103, P2056, DOI 10.2105/AJPH.2013.301261	5	174	175	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					698	701		10.1056/NEJMp1413945	http://dx.doi.org/10.1056/NEJMp1413945			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB7PB	25693009				2022-12-28	WOS:000349818700003
J	Dunn, AS				Dunn, Andrew S.			After initial anticoagulation for a first unprovoked venous thromboembolism, aspirin reduced recurrence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mt Sinai Hlth Syst, New York, NY 10019 USA	Icahn School of Medicine at Mount Sinai	Dunn, AS (corresponding author), Mt Sinai Hlth Syst, New York, NY 10019 USA.							Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201	2	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4							JC5	10.7326/ACPJC-2015-162-4-005	http://dx.doi.org/10.7326/ACPJC-2015-162-4-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686192				2022-12-28	WOS:000350232500008
J	Martinez-Boti, MA; Marino, G; Foster, GL; Ziveri, P; Henehan, MJ; Rae, JWB; Mortyn, PG; Vance, D				Martinez-Boti, M. A.; Marino, G.; Foster, G. L.; Ziveri, P.; Henehan, M. J.; Rae, J. W. B.; Mortyn, P. G.; Vance, D.			Boron isotope evidence for oceanic carbon dioxide leakage during the last deglaciation	NATURE			English	Article							WESTERN EQUATORIAL PACIFIC; PLANKTONIC-FORAMINIFERA; SOUTHERN-OCEAN; ATMOSPHERIC CO2; DEEP-OCEAN; GLOBIGERINOIDES-SACCULIFER; SEASONAL-CHANGES; ATLANTIC SECTOR; SURFACE WATERS; NORTH PACIFIC	Atmospheric CO2 fluctuations over glacial-interglacial cycles remain a major challenge to our understanding of the carbon cycle and the climate system. Leading hypotheses put forward to explain glacial-interglacial atmospheric CO2 variations invoke changes in deep-ocean carbon storage(1,2), probably modulated by processes in the Southern Ocean, where much of the deep ocean is ventilated(3). A central aspect of such models is that, during deglaciations, an isolated glacial deep-ocean carbon reservoir is reconnected with the atmosphere, driving the atmospheric CO2 rise observed in ice-core records(4-6). However, direct documentation of changes in surface ocean carbon content and the associated transfer of carbon to the atmosphere during deglaciations has been hindered by the lack of proxy reconstructions that unambiguously reflect the oceanic carbonate system. Radiocarbon activity tracks changes in ocean ventilation(6), but not in ocean carbon content, whereas proxies that record increased deglacial upwelling(4,7) do not constrain the proportion of upwelled carbon that is degassed relative to that which is taken up by the biological pump. Here we apply the boron isotope pH proxy in planktic foraminifera to two sediment cores from the sub-Antarctic Atlantic and the eastern equatorial Pacific as a more direct tracer of oceanic CO2 outgassing. We show that surface waters at both locations, which partly derive from deep water upwelled in the Southern Ocean(8,9), became a significant source of carbon to the atmosphere during the last deglaciation, when the concentration of atmospheric CO2 was increasing. This oceanic CO2 outgassing supports the view that the ventilation of a deep-ocean carbon reservoir in the Southern Ocean had a key role in the deglacial CO2 rise, although our results allow for the possibility that processes operating in other regions may also have been important for the glacial-interglacial ocean-atmosphere exchange of carbon.	[Martinez-Boti, M. A.; Foster, G. L.; Henehan, M. J.] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Marino, G.; Ziveri, P.; Mortyn, P. G.] Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, Bellaterra 08193, Catalonia, Spain; [Marino, G.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia; [Ziveri, P.] ICREA, Barcelona 08010, Catalonia, Spain; [Ziveri, P.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Earth Sci, Earth & Climate Cluster, NL-1081 HV Amsterdam, Netherlands; [Henehan, M. J.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [Rae, J. W. B.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Rae, J. W. B.] Univ St Andrews, Dept Earth & Environm Sci, St Andrews KY16 9AL, Fife, Scotland; [Mortyn, P. G.] Univ Autonoma Barcelona, Dept Geog, Bellaterra 08193, Catalonia, Spain; [Vance, D.] ETH, Dept Earth Sci, Inst Geochem & Petrol, CH-8092 Zurich, Switzerland	NERC National Oceanography Centre; University of Southampton; Autonomous University of Barcelona; Australian National University; ICREA; Vrije Universiteit Amsterdam; Yale University; California Institute of Technology; University of St Andrews; Autonomous University of Barcelona; Swiss Federal Institutes of Technology Domain; ETH Zurich	Martinez-Boti, MA (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Waterfront Campus, Southampton SO14 3ZH, Hants, England.	m.a.martinez-boti@noc.soton.ac.uk; gianluca.marino@anu.edu.au	Rae, James/R-3812-2017; Foster, Gavin/CAF-4654-2022; Marino, Gianluca/AAN-3969-2020; Henehan, Michael J./AAY-8536-2020; Ziveri, Patrizia/I-3856-2015; Foster, Gavin/W-5968-2019; Mortyn, P. Graham/I-3860-2015	Rae, James/0000-0003-3904-2526; Foster, Gavin/0000-0003-3688-9668; Marino, Gianluca/0000-0001-9795-5337; Henehan, Michael J./0000-0003-4706-1233; Ziveri, Patrizia/0000-0002-5576-0301; Mortyn, P. Graham/0000-0002-9473-4309	European Community; Universitat Autonoma de Barcelona; Spanish Ministry of Science and Innovation (PROCARSO) [CGL2009-10806]; NERC [NE/D00876/X2]; NOAA/UCAR Climate and Global Change Postdoctoral Fellowship; Australian Laureate Fellowship [FL120100050]; ICREA Funding Source: Custom	European Community(European Commission); Universitat Autonoma de Barcelona; Spanish Ministry of Science and Innovation (PROCARSO); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NOAA/UCAR Climate and Global Change Postdoctoral Fellowship; Australian Laureate Fellowship; ICREA(ICREA)	We thank the International Ocean Drilling Program for providing samples from ODP Leg 202, R. Gersonde and A. Mackensen for the PS2498-1 core material, J. F. McManus for sharing his unpublished benthic isotope data for ODP1238, and E. J. Rohling, M. P. Hain and C. Beaulieu for discussions. For the calibration of G. bulloides, we thank M. Kucera for providing core-top samples from the archives at the University of Tubingen, H. C. Bostock for samples from the National Institute for Water and Atmospheric Research, Wellington, and B. J. Marshall and R. Thunell for samples from the Cariaco Basin sediment trap time series. J. A. Milton, M. J. Cooper and A. Michalik provided assistance during ICP-MS analyses and sample preparation in the laboratory. C. Alt and M. T. Horigome helped with foraminifera picking. We thank the other members of 'The B-Team' at the National Oceanography Centre Southampton for their contributions. Financial support was provided by the European Community through a Marie Curie Intra-European Fellowship for Career Development to M.A.M.-B., the Universitat Autonoma de Barcelona through a Postdoctoral Research Grant to G.M., the Spanish Ministry of Science and Innovation (PROCARSO project CGL2009-10806) to G.M., P.Z. and P.G.M., a NERC PhD studentship awarded to M.J.H., a NOAA/UCAR Climate and Global Change Postdoctoral Fellowship to J.W.B.R., and NERC grant NE/D00876/X2 to G.L.F. G.M. was also supported by the Australian Laureate Fellowship project FL120100050 (E J. Rohling).	Anand P, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000846; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Arbuszewski JA, 2013, NAT GEOSCI, V6, P959, DOI [10.1038/NGEO1961, 10.1038/ngeo1961]; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Barker S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000559; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; BE AWH, 1980, MAR MICROPALEONTOL, V5, P283, DOI 10.1016/0377-8398(80)90014-6; BOYLE EA, 1985, EARTH PLANET SC LETT, V76, P135, DOI 10.1016/0012-821X(85)90154-2; Bradtmiller LI, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001282; Burke A, 2012, SCIENCE, V335, P557, DOI 10.1126/science.1208163; CARON DA, 1990, MAR MICROPALEONTOL, V16, P93, DOI 10.1016/0377-8398(90)90031-G; Catanzaro E. J., 1970, NBS SPEC PUBL, V260; Chandler R.E., 2011, STAT METHODS TREND D; CURRY WB, 1983, EARTH PLANET SC LETT, V64, P33, DOI 10.1016/0012-821X(83)90050-X; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; DICKSON AG, 1990, DEEP-SEA RES, V37, P755, DOI 10.1016/0198-0149(90)90004-F; Doss W, 2013, EARTH PLANET SC LETT, V377, P43, DOI 10.1016/j.epsl.2013.07.019; Douville E, 2010, BIOGEOSCIENCES, V7, P2445, DOI 10.5194/bg-7-2445-2010; Dubois N, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2009PA001781; FAIRBANKS RG, 1982, NATURE, V298, P841, DOI 10.1038/298841a0; Faul KL, 2000, J FORAMIN RES, V30, P110, DOI 10.2113/0300110; FINE RA, 1994, J GEOPHYS RES-OCEANS, V99, P25063, DOI 10.1029/94JC02277; Foster GL, 2008, EARTH PLANET SC LETT, V271, P254, DOI 10.1016/j.epsl.2008.04.015; Foster GL, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003201; Foster GL, 2013, CHEM GEOL, V358, P1, DOI 10.1016/j.chemgeo.2013.08.027; Foster GL, 2012, EARTH PLANET SC LETT, V341, P243, DOI 10.1016/j.epsl.2012.06.007; Gersonde R, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000809; Gloor M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015594; Gonzalez-Davila M, 2011, BIOGEOSCIENCES, V8, P1401, DOI 10.5194/bg-8-1401-2011; Goodman PJ, 2005, J PHYS OCEANOGR, V35, P2134, DOI 10.1175/JPO2825.1; Hain M.P., 2014, TREATISE GEOCHEMISTR, V2nd, P485, DOI DOI 10.1016/B978-0-08-095975-7.00618-5; Hain MP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003790; HEMMING NG, 1992, GEOCHIM COSMOCHIM AC, V56, P537, DOI 10.1016/0016-7037(92)90151-8; HEMMING NG, 1995, GEOCHIM COSMOCHIM AC, V59, P371, DOI 10.1016/0016-7037(95)00288-B; Henehan M. J., 2013, THESIS U SOUTHAMPTON; Henehan MJ, 2013, EARTH PLANET SC LETT, V364, P111, DOI 10.1016/j.epsl.2012.12.029; Honisch B, 2005, EARTH PLANET SC LETT, V236, P305, DOI 10.1016/j.epsl.2005.04.027; Keeling RF, 2001, NATURE, V412, P605, DOI 10.1038/35088129; Key R. M., 2010, EARTH SYST SCI DATA, V2, P105, DOI [DOI 10.5194/ESSD-2-105-2010, 10.5194/essd-2-105-2010]; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Klochko K, 2006, EARTH PLANET SC LETT, V248, P276, DOI 10.1016/j.epsl.2006.05.034; Kohler P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002345; Koutavas A, 2004, ADV GLOB CHANGE RES, V21, P347, DOI 10.1007/978-1-4020-2944-8_12; Kubota K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05261; Lea DW, 2006, QUATERNARY SCI REV, V25, P1152, DOI 10.1016/j.quascirev.2005.11.010; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Lee K, 2010, GEOCHIM COSMOCHIM AC, V74, P1801, DOI 10.1016/j.gca.2009.12.027; Liu ZY, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016492; Lourantou A, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003545; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; LUKAS R, 1986, PROG OCEANOGR, V16, P63, DOI 10.1016/0079-6611(86)90007-8; Mackensen A, 2001, GLOBAL PLANET CHANGE, V30, P197, DOI 10.1016/S0921-8181(01)00102-3; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Marshall J, 2012, NAT GEOSCI, V5, P171, DOI [10.1038/ngeo1391, 10.1038/NGEO1391]; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; Mashiotta TA, 1999, EARTH PLANET SC LETT, V170, P417, DOI 10.1016/S0012-821X(99)00116-8; McGee D, 2007, EARTH PLANET SC LETT, V257, P215, DOI 10.1016/j.epsl.2007.02.033; Menviel L, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002224; Mix A., 2003, P ODP INITIAL REPORT, V202; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Mortyn PG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000637; Niebler H. S., 2004, STABLE ISOTOPES MEAS; Niebler HS, 1998, MAR MICROPALEONTOL, V34, P213, DOI 10.1016/S0377-8398(98)00009-7; Ninnemann US, 1997, PALEOCEANOGRAPHY, V12, P560, DOI 10.1029/97PA01032; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Palmer MR, 2003, SCIENCE, V300, P480, DOI 10.1126/science.1080796; Palter JB, 2010, BIOGEOSCIENCES, V7, P3549, DOI 10.5194/bg-7-3549-2010; Pena LD, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001620; Pichevin LE, 2009, NATURE, V459, P1114, DOI 10.1038/nature08101; Prebble JG, 2013, MAR MICROPALEONTOL, V101, P33, DOI 10.1016/j.marmicro.2013.04.004; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rae JWB, 2014, PALEOCEANOGRAPHY, V29, P645, DOI 10.1002/2013PA002570; Rae JWB, 2011, EARTH PLANET SC LETT, V302, P403, DOI 10.1016/j.epsl.2010.12.034; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Sadekov AY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3692; SANYAL A, 1995, NATURE, V373, P234, DOI 10.1038/373234a0; Sanyal A, 2001, PALEOCEANOGRAPHY, V16, P515, DOI 10.1029/2000PA000547; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Schmidt GA, 1999, PALEOCEANOGRAPHY, V14, P422, DOI 10.1029/1999PA900008; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Siani G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3758; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Spero HJ, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000814; Spero HJ, 2002, SCIENCE, V296, P522, DOI 10.1126/science.1069401; Stocker TF, 1998, SCIENCE, V282, P61, DOI 10.1126/science.282.5386.61; Stott L, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001690; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Stuiver M., 2005, CALIB RADIOCARBON CA; Takahashi T, 2009, DEEP-SEA RES PT I, V56, P2075, DOI 10.1016/j.dsr.2009.07.007; THUNELL RC, 1984, MICROPALEONTOLOGY, V30, P243, DOI 10.2307/1485688; THUNELL RC, 1983, EARTH PLANET SC LETT, V64, P44, DOI 10.1016/0012-821X(83)90051-1; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; TOGGWEILER JR, 1991, J GEOPHYS RES-OCEANS, V96, P20467, DOI 10.1029/91JC02063; TSUCHIYA M, 1989, PROG OCEANOGR, V23, P101, DOI 10.1016/0079-6611(89)90012-8; Van Heuven, 2011, ORNLCDIAC105B USDA C; Yu JM, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001571; Yu JM, 2010, SCIENCE, V330, P1084, DOI 10.1126/science.1193221; Yu JM, 2010, EARTH PLANET SC LETT, V293, P114, DOI 10.1016/j.epsl.2010.02.029; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE	101	132	135	3	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					219	U154		10.1038/nature14155	http://dx.doi.org/10.1038/nature14155			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25673416	Green Accepted			2022-12-28	WOS:000349190300035
J	Barnes, T; Winfrow, M; Laboi, P; Wilkie, M				Barnes, Tania; Winfrow, Michael; Laboi, Paul; Wilkie, Martin			Commentary: Supporting patient independence in long term haemodialysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Barnes, Tania; Wilkie, Martin] Sheffield Teaching Hosp, Sheffield, S Yorkshire, England; [Laboi, Paul] York Teaching Hosp, York, N Yorkshire, England	University of Sheffield	Wilkie, M (corresponding author), Sheffield Teaching Hosp, Sheffield, S Yorkshire, England.	martin.wilkie@sth.nhs.uk						Cavanaugh KL, 2010, J AM SOC NEPHROL, V21, P1979, DOI 10.1681/ASN.2009111163; Glidewell L, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-118; Nitsch D, 2011, NEPHROL DIAL TRANSPL, V26, P1670, DOI 10.1093/ndt/gfq561	3	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h252	10.1136/bmj.h252	http://dx.doi.org/10.1136/bmj.h252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670189	Bronze			2022-12-28	WOS:000349318400007
J	Hannan, A				Hannan, Amir			Commentary: UK general practice moves to open notes to patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Haughton Thornley Med Ctr, Hyde, England		Hannan, A (corresponding author), Haughton Thornley Med Ctr, Hyde, England.	amir.hannan@nhs.net						Hannan A, 2007, STUD HEALTH TECHNOL, V127, P108; Shah SGS, 2015, INT J MED INFORM, V84, P111, DOI 10.1016/j.ijmedinf.2014.10.005	2	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h266	10.1136/bmj.h266	http://dx.doi.org/10.1136/bmj.h266			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670191	Bronze			2022-12-28	WOS:000349318400009
J	Rychert, CA				Rychert, Catherine A.			The slippery base of a tectonic plate	NATURE			English	Editorial Material							LITHOSPHERE-ASTHENOSPHERE BOUNDARY; SEISMIC ANISOTROPY; UPPER-MANTLE; HEAT-FLOW; MELT; ORIGIN; WATER		Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	NERC National Oceanography Centre; University of Southampton	Rychert, CA (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England.	c.rychert@soton.ac.uk		Rychert, Catherine/0000-0001-5071-793X				Becker TW, 2014, EARTH PLANET SC LETT, V401, P236, DOI 10.1016/j.epsl.2014.06.014; Beghein C, 2014, SCIENCE, V343, P1237, DOI 10.1126/science.1246724; Burgos G, 2014, J GEOPHYS RES-SOL EA, V119, P1079, DOI 10.1002/2013JB010528; Gaherty JB, 1999, PHYS EARTH PLANET IN, V110, P21, DOI 10.1016/S0031-9201(98)00132-0; Green DH, 2010, NATURE, V467, P448, DOI 10.1038/nature09369; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Jackson I, 2006, MAT SCI ENG A-STRUCT, V442, P170, DOI 10.1016/j.msea.2006.01.136; Karato SI, 2012, EARTH PLANET SC LETT, V321, P95, DOI 10.1016/j.epsl.2012.01.001; Kawakatsu H, 2009, SCIENCE, V324, P499, DOI 10.1126/science.1169499; Kodaira S, 2014, NAT GEOSCI, V7, P371, DOI [10.1038/ngeo2121, 10.1038/NGEO2121]; MCKENZIE DP, 1967, J GEOPHYS RES, V72, P6261, DOI 10.1029/JZ072i024p06261; Naif S, 2013, NATURE, V495, P356, DOI 10.1038/nature11939; PARSONS B, 1977, J GEOPHYS RES, V82, P803, DOI 10.1029/JB082i005p00803; Rychert CA, 2005, NATURE, V436, P542, DOI 10.1038/nature03904; Rychert CA, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004194; Rychert CA, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008070; Sakamaki T, 2013, NAT GEOSCI, V6, P1041, DOI [10.1038/NGEO1982, 10.1038/ngeo1982]; Stern TA, 2015, NATURE, V518, P85, DOI 10.1038/nature14146	18	1	1	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					39	40		10.1038/518039a	http://dx.doi.org/10.1038/518039a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25652991				2022-12-28	WOS:000349098000023
J	Huang, TTK; Cawley, JH; Ashe, M; Costa, SA; Frerichs, LM; Zwicker, L; Rivera, JA; Levy, D; Hammond, RA; Lambert, EV; Kumanyika, SK				Huang, Terry T-K; Cawley, John H.; Ashe, Marice; Costa, Sergio A.; Frerichs, Leah M.; Zwicker, Lindsey; Rivera, Juan A.; Levy, David; Hammond, Ross A.; Lambert, Estelle V.; Kumanyika, Shiriki K.			Mobilisation of public support for policy actions to prevent obesity	LANCET			English	Article							CHILDHOOD OBESITY; NONCOMMUNICABLE DISEASES; HEALTH BEHAVIOR; SOCIAL-CHANGE; BODY-IMAGE; NUTRITION; LESSONS; FOOD; CAMPAIGNS; FRAMEWORK	Public mobilisation is needed to enact obesity-prevention policies and to mitigate reaction against their implementation. However, approaches in public health focus mainly on dialogue between public health professionals and political leaders. Strategies to increase popular demand for obesity-prevention policies include refinement and streamlining of public information, identification of effective obesity frames for each population, strengthening of media advocacy, building of citizen protest and engagement, and development of a receptive political environment with change agents embedded across organisations and sectors. Long-term support and investment in collaboration between diverse stakeholders to create shared value is also important. Each actor in an expanded coalition for obesity prevention can make specific contributions to engaging, mobilising, and coalescing the public. The shift from a top-down to a combined and integrated bottom-up and top-down approach would need an overhaul of current strategies and reprioritisation of resources.	[Huang, Terry T-K; Costa, Sergio A.] CUNY, Sch Publ Hlth, New York, NY 10019 USA; [Huang, Terry T-K; Costa, Sergio A.; Frerichs, Leah M.] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE USA; [Cawley, John H.] Cornell Univ, Dept Policy & Management, Ithaca, NY USA; [Cawley, John H.] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA; [Ashe, Marice; Zwicker, Lindsey] ChangeLab Solut, Oakland, CA USA; [Rivera, Juan A.] Natl Publ Hlth Inst, Cuernavaca, Morelos, Mexico; [Levy, David] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Hammond, Ross A.] Brookings Inst, Ctr Social Dynam & Policy, Washington, DC 20036 USA; [Lambert, Estelle V.] Univ Cape Town, MRC Res Unit Exercise Sci & Sports Med, ZA-7700 Rondebosch, South Africa; [Kumanyika, Shiriki K.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	City University of New York (CUNY) System; University of Nebraska System; University of Nebraska Medical Center; Cornell University; Cornell University; Georgetown University; Brookings Institution; University of Cape Town; University of Pennsylvania; Pennsylvania Medicine	Huang, TTK (corresponding author), CUNY, Sch Publ Hlth, New York, NY 10019 USA.	terry.huang@sph.cuny.edu	Lambert, Estelle/ABF-1268-2020; Cawley, John/E-6734-2010; Levy, David/GPS-4945-2022	Lambert, Estelle/0000-0003-4315-9153; Cawley, John/0000-0002-4805-9883; Costa, Sergio/0000-0002-2795-7705; Huang, Terry/0000-0001-5544-5187				Baumgartner F.R., 2009, AGENDAS INSTABILITY, V2nd; Bernier NF, 2011, HEALTH PROMOT INT, V26, P109, DOI 10.1093/heapro/daq079; Bhatta BP, 2013, J REVENUE PRICING MA, V12, P103, DOI 10.1057/rpm.2012.47; Birkland T., 2010, INTRO POLICY PROCESS, V4th ed., DOI [10.4324/9781315717371, DOI 10.4324/9781315717371]; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Brecher C, 2010, J PUBL ADM RES THEOR, V20, P335, DOI 10.1093/jopart/mup008; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Cawley J, 2010, HEALTH AFFAIR, V29, P364, DOI 10.1377/hlthaff.2009.0721; Chadwick A, 2007, POLIT COMMUN, V24, P283, DOI 10.1080/10584600701471666; Chester J., 2007, INTERACTIVE FOOD BEV; Christens BD, 2011, YOUTH SOC, V43, P528, DOI 10.1177/0044118X10383647; Commission on Youth Voting and Civic Knowledge, 2013, ALL TOG NOW COLL INN; Committee on Accelerating Progress in Obesity Prevention, 2012, ACCELERATING PROGR O; Cugelman B, 2011, J MED INTERNET RES, V13, P84, DOI 10.2196/jmir.1367; de Leeuw E, 1999, HEALTH PROMOT INT, V14, P261, DOI 10.1093/heapro/14.3.261; Dillon L, 2012, WHAT BOB FILNER DID; DOWNS A, 1972, PUBLIC INTEREST, P38; Dreier P, 2010, LESSONS HLTH CARE WA; Economos CD, 2001, NUTR REV, V59, pS40; Eriksen M, 2005, LESSONS LEARNED PUBL; Evans WD, 2010, OBESITY, V18, pS23, DOI 10.1038/oby.2009.428; Federal Register, 2013, INC NOND WELLN PROGR; Finegood DT., 2011, HDB SOCIAL SCI OBESI, P208, DOI DOI 10.1093/OXFORDHB/9780199736362.013.0013; Freeland-Graves JH, 2013, J ACAD NUTR DIET, V113, P307, DOI 10.1016/j.jand.2012.12.013; Frerichs L, PREV CHRONI IN PRESS; Frerichs L, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120095; Gollust SE, 2013, AM J PUBLIC HEALTH, V103, pE96, DOI 10.2105/AJPH.2013.301271; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Grebe E, 2011, J S AFR STUD, V37, P849, DOI 10.1080/03057070.2011.608271; Green D.P., 2008, GET OUT VOTE INCREAS, V2nd ed.; Hank Johnston, 2005, FRAMES PROTEST SOCIA, P1; Hanna R, 2011, BUS HORIZONS, V54, P265, DOI 10.1016/j.bushor.2011.01.007; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Hawkes C, 2015, LANCET; Hersey JC, 2013, NUTR REV, V71, P1, DOI 10.1111/nure.12000; Heywood D, 2004, MULTIPRONGED APPROAC; Heywood M, 2009, J HUM RIGHTS PRACT, V1, P14, DOI 10.1093/jhuman/hun006; Hinrichsen GA, 2010, GERONTOLOGIST, V50, P735, DOI 10.1093/geront/gnq034; Hinyard LJ, 2007, HEALTH EDUC BEHAV, V34, P777, DOI 10.1177/1090198106291963; Holdsworth M, 2013, HEALTH POLICY PLANN, V28, P858, DOI 10.1093/heapol/czs125; Horton R, 2013, LANCET, V381, P509, DOI 10.1016/S0140-6736(13)60100-2; Jaffe E, 2012, BOOK BURNING CAMPAIG; Kerin L, 2010, CHILDHOOD AD LIKENS; Kersh R, 2002, HEALTH AFFAIR, V21, P142, DOI 10.1377/hlthaff.21.6.142; Khayesi M, 2011, J TRANSP GEOGR, V19, P1547, DOI 10.1016/j.jtrangeo.2011.06.012; Kingdon J.W., 2002, AGENDAS ALTERNATIVES, V2nd; Kraak V.I, 2006, FOOD MARK CHILDR YOU; Kugelberg S, 2012, HEALTH POLICY, V107, P91, DOI 10.1016/j.healthpol.2012.06.005; Kumanyika S, 2012, PREV MED, V55, P542, DOI 10.1016/j.ypmed.2012.09.010; Kumanyika SK, 2010, BRIDGING THE EVIDENCE GAP IN OBESITY PREVENTION: A FRAMEWORK TO INFORM DECISION MAKING, P1; Lefebvre RC, 2012, J SOC MARKET, V2, P118, DOI 10.1108/20426761211243955; LEFEBVRE RC, 1988, HEALTH EDUC QUART, V15, P299; LegiStorm, 2011, FORM LOBB WORK C OUT; Longest B., 2015, HLTH POLICYMAKING US; Lopez R, 2012, NEW TUNE GAY MARRIAG; Maibach EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-299; Mchiza ZJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-433; McKinnon R, 2007, J NUTR EDUC BEHAV, V39, pS53, DOI 10.1016/j.jneb.2006.08.012; Mendelson R, 2007, APPL PHYSIOL NUTR ME, V32, P495, DOI 10.1139/H07-003; Millstein RA, 2011, TRANSL BEHAV MED, V1, P497, DOI 10.1007/s13142-011-0060-0; Moffett T, 2013, C DANCE GUN CONTROL; Montgomery KC, 2009, J ADOLESCENT HEALTH, V45, pS18, DOI 10.1016/j.jadohealth.2009.04.006; Morain S, 2013, HEALTH AFFAIR, V32, P486, DOI 10.1377/hlthaff.2012.0609; NESTLE M, 2013, FOOD POLITICS FOOD I; Patrick, 2008, EMORY LAW J, V58, P249; Puoane T, 2010, ETHNIC DIS, V20, P29; Randolph W, 2004, ANNU REV PUBL HEALTH, V25, P419, DOI 10.1146/annurev.publhealth.25.101802.123046; Rich Andrew, 2005, THINK TANKS PUBLIC P; Roberto CA, 2015, LANCET; Robinson TN, 2010, OBESITY, V18, pS17, DOI 10.1038/oby.2009.427; Sabatier P.A., 2006, POLICY CHANGE LEARNI; Siddique H., 2013, GUARDIAN; Smith M, 2007, SOC LEGAL STUD, V16, P5, DOI 10.1177/0964663907073444; Stead M, 2007, HEALTH EDUC, V107, P126, DOI 10.1108/09654280710731548; Swinburn B, 2005, OBES REV, V6, P23, DOI 10.1111/j.1467-789X.2005.00184.x; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; Tarrow SidneyG., 1994, POWER MOVEMENT; Thow AM, 2011, HEALTH PROMOT INT, V26, P55, DOI 10.1093/heapro/daq057; Walmsley A, 2010, NEW MEDIA NEEDS NEW; Waqa G, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-74; World Cancer Research Fund/American Institute for Cancer Research, 2009, POL ACT CANC PREV FO; World Health Organization, 2013, WHO FRAM CONV TOB CO; World Health Organization, 2012, POP BAS APPR CHILDH; Worsham J, 2006, POLICY STUD J, V34, P437, DOI 10.1111/j.1541-0072.2006.00181.x; Yeung R. M. W., 2001, British Food Journal, V103, P170, DOI 10.1108/00070700110386728	86	111	111	1	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2422	2431		10.1016/S0140-6736(14)61743-8	http://dx.doi.org/10.1016/S0140-6736(14)61743-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK1XV	25703113	Green Submitted			2022-12-28	WOS:000356003700036
J	Kleinert, S; Horton, R				Kleinert, Sabine; Horton, Richard			Rethinking and reframing obesity	LANCET			English	Editorial Material									[Kleinert, Sabine; Horton, Richard] The Lancet, London EC2Y 5AS, England		Kleinert, S (corresponding author), The Lancet, London EC2Y 5AS, England.							[Anonymous], 2011, LANCET, V378, P741, DOI 10.1016/S0140-6736(11)61356-1; [Anonymous], 2015, DAILY TELEGRAPH; Chan M., 2015, COMMUNICATION   0113; Dietz WH, 2015, LANCET, V385, P2521, DOI 10.1016/S0140-6736(14)61748-7; Ekelund U, 2015, AM J CLIN NUTR, V101, P613, DOI 10.3945/ajcn.114.100065; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hawkes C, 2015, LANCET; Huang TTK, 2015, LANCET, V385, P2422, DOI 10.1016/S0140-6736(14)61743-8; Lobstein T, 2015, LANCET; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Roberto CA, 2015, LANCET; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; World Health Organization, 2013, GLOB ACT PLAN PREV C	16	54	57	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2326	2328		10.1016/S0140-6736(15)60163-5	http://dx.doi.org/10.1016/S0140-6736(15)60163-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK1XV	25703115				2022-12-28	WOS:000356003700006
J	Lane, R				Lane, Richard			Profile: Christina Roberto: taking a broad view on combating obesity	LANCET			English	Biographical-Item																			0	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2345	2345		10.1016/S0140-6736(15)60257-4	http://dx.doi.org/10.1016/S0140-6736(15)60257-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	25703110	Bronze			2022-12-28	WOS:000356003700015
J	Jan, E				Jan, Eric			MOLECULAR BIOLOGY Signals across domains of life	NATURE			English	Editorial Material							RIBOSOME; RECRUITMENT; INITIATION; SITE; RNA	Signal sequences on messenger RNA that initiate protein synthesis are not thought to be interchangeable between life's domains. The finding that a signal from an arthropod virus can function in bacteria questions this idea. SEE LETTER P.110	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Jan, E (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	ej@mail.ubc.ca	Jan, Eric/O-1923-2019					Bonning BC, 2010, ANNU REV ENTOMOL, V55, P129, DOI 10.1146/annurev-ento-112408-085457; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Colussi TM, 2015, NATURE, V519, P110, DOI 10.1038/nature14219; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Malys N, 2011, CELL MOL LIFE SCI, V68, P991, DOI 10.1007/s00018-010-0588-z; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nishiyama T, 2007, NUCLEIC ACIDS RES, V35, P1514, DOI 10.1093/nar/gkl1121; Pfingsten JS, 2006, SCIENCE, V314, P1450, DOI 10.1126/science.1133281; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6	10	2	3	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					40	41		10.1038/nature14202	http://dx.doi.org/10.1038/nature14202			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25652822				2022-12-28	WOS:000350304000029
J	Premi, S; Wallisch, S; Mano, CM; Weiner, AB; Bacchiocchi, A; Wakamatsu, K; Bechara, EJH; Halaban, R; Douki, T; Brash, DE				Premi, Sanjay; Wallisch, Silvia; Mano, Camila M.; Weiner, Adam B.; Bacchiocchi, Antonella; Wakamatsu, Kazumasa; Bechara, Etelvino J. H.; Halaban, Ruth; Douki, Thierry; Brash, Douglas E.			Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure	SCIENCE			English	Article							ULTRAVIOLET; DEGRADATION; INDUCTION; PATHWAY; REPAIR; RISK; ACTS	Mutations in sunlight-induced melanoma arise from cyclobutane pyrimidine dimers (CPDs), DNA photoproducts that are typically created picoseconds after an ultraviolet (UV) photon is absorbed at thymine or cytosine. We found that in melanocytes, CPDs are generated for > 3 hours after exposure to UVA, a major component of the radiation in sunlight and in tanning beds. These "dark CPDs" constitute the majority of CPDs and include the cytosine-containing CPDs that initiate UV-signature C -> T mutations. Dark CPDs arise when UV-induced reactive oxygen and nitrogen species combine to excite an electron in fragments of the pigment melanin. This creates a quantum triplet state that has the energy of a UV photon but induces CPDs by energy transfer to DNA in a radiation-independent manner. Melanin may thus be carcinogenic as well as protective against cancer. These findings also validate the long-standing suggestion that chemically generated excited electronic states are relevant to mammalian biology.	[Premi, Sanjay; Wallisch, Silvia; Mano, Camila M.; Weiner, Adam B.; Brash, Douglas E.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Mano, Camila M.; Bechara, Etelvino J. H.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil; [Bacchiocchi, Antonella; Halaban, Ruth] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Wakamatsu, Kazumasa] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Toyoake, Aichi 4701192, Japan; [Bechara, Etelvino J. H.] Univ Fed Sao Carlos, Dept Ciencias Exatas & Terra, BR-09972270 Sao Paulo, Brazil; [Halaban, Ruth; Brash, Douglas E.] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06520 USA; [Douki, Thierry] CEA Grenoble, INAC, LCIB UMR CEA UJF E3, F-38054 Grenoble 9, France	Yale University; Universidade de Sao Paulo; Yale University; Fujita Health University; Universidade Federal de Sao Carlos; Yale University; CEA	Brash, DE (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	douglas.brash@yale.edu	Bechara, Etelvino JH/AAN-1136-2021; Bechara, Etelvino JH/M-6251-2013; Wakamatsu, Kazumasa/AAZ-5877-2020; Premi, Sanjay/ABB-1423-2020; Thierry, Douki/H-2108-2018	Bechara, Etelvino JH/0000-0001-9526-2529; Bechara, Etelvino JH/0000-0001-9526-2529; Wakamatsu, Kazumasa/0000-0003-1748-9001; Premi, Sanjay/0000-0002-5492-5469; Thierry, Douki/0000-0002-5022-071X; Weiner, Adam/0000-0002-1912-042X	Department of Defense CDMRP [CA093473P1, CA093473]; NIH [2 P50 CA121974, P30 DK34989]; University of Veterinary Medicine, Vienna; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/02062-8]; FAPESP [06/56530-4]; INCT-Processos Redox em Biomedicina; Grants-in-Aid for Scientific Research [15K09794] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER	Department of Defense CDMRP(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Veterinary Medicine, Vienna; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INCT-Processos Redox em Biomedicina; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Bosenberg and V. Muthusamy for UVA-irradiated mouse skin; the Yale Office of Environmental Health and Safety for the single-photon liquid scintillation counter; A. Bommakanti for photography; and D. Mitchell and A. Mennone for helpful discussions. Supported by Department of Defense CDMRP grants CA093473P1 and CA093473 (D.E.B. and R.H.); NIH grant 2 P50 CA121974 (R.H. and D.E.B.); a postgraduate fellowship from the University of Veterinary Medicine, Vienna (S.W.); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) doctoral fellowship 09/02062-8 (C.M.M.); and FAPESP grant 06/56530-4 and the INCT-Processos Redox em Biomedicina (E.J.H.B.). Confocal support was provided by NIH grant P30 DK34989 to the Yale Liver Center.	ADAM W, 1988, FREE RADICAL RES COM, V5, P253, DOI 10.3109/10715768909074708; BEECHAM EJ, 1991, MOL CELL BIOL, V11, P3095, DOI 10.1128/MCB.11.6.3095; BRASH DE, 1987, P NATL ACAD SCI USA, V84, P3782, DOI 10.1073/pnas.84.11.3782; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Carrier W., 1982, SCI PHOTOMEDICINE, P91; CHEDEKEL MR, 1978, P NATL ACAD SCI USA, V75, P5395, DOI 10.1073/pnas.75.11.5395; Cilento G., 1982, CHEM BIOL GENERATION, P277; Douki T, 2003, BIOCHEMISTRY-US, V42, P9221, DOI 10.1021/bi034593c; Gordon-Thomson Clare, 2012, Photochem Photobiol Sci, V11, P1837, DOI 10.1039/c2pp25202c; Halaban R, 2000, P NATL ACAD SCI USA, V97, P5889, DOI 10.1073/pnas.97.11.5889; HATTA S, 1988, J INVEST DERMATOL, V91, P181, DOI 10.1111/1523-1747.ep12464454; Hochberg M, 2006, BIOMED PHARMACOTHER, V60, P233, DOI 10.1016/j.biopha.2006.04.008; Kayatz P, 2001, INVEST OPHTH VIS SCI, V42, P241; Knudsen FS, 2000, CHEM RES TOXICOL, V13, P317, DOI 10.1021/tx990176i; KOLLIAS N, 1991, J PHOTOCH PHOTOBIO B, V9, P135, DOI 10.1016/1011-1344(91)80147-A; KRAEMER KH, 1975, P NATL ACAD SCI USA, V72, P59, DOI 10.1073/pnas.72.1.59; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; LAMOLA AA, 1971, BIOCHEM BIOPH RES CO, V43, P893, DOI 10.1016/0006-291X(71)90701-7; Lazovich D, 2010, CANCER EPIDEM BIOMAR, V19, P1557, DOI 10.1158/1055-9965.EPI-09-1249; Munoz-Munoz JL, 2009, BBA-PROTEINS PROTEOM, V1794, P1017, DOI 10.1016/j.bbapap.2009.04.002; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Noonan FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1893; RomeroGraillet C, 1996, J BIOL CHEM, V271, P28052, DOI 10.1074/jbc.271.45.28052; SAITO I, 1979, J AM CHEM SOC, V101, P4757, DOI 10.1021/ja00510a068; Schreier WJ, 2007, SCIENCE, V315, P625, DOI 10.1126/science.1135428; SLAWINSKA D, 1982, PHYSIOL CHEM PHYS M, V14, P363; Takeuchi S, 2004, P NATL ACAD SCI USA, V101, P15076, DOI 10.1073/pnas.0403994101; Valencia A, 2008, J INVEST DERMATOL, V128, P214, DOI 10.1038/sj.jid.5700960; Velosa AC, 2007, CHEM RES TOXICOL, V20, P1162, DOI 10.1021/tx700074n; Wakamatsu K, 2012, PIGM CELL MELANOMA R, V25, P434, DOI 10.1111/j.1755-148X.2012.01011.x; WHITE EH, 1974, ANGEW CHEM INT EDIT, V13, P229, DOI 10.1002/anie.197402291; Williams PF, 2011, INT J CANCER, V129, P1730, DOI 10.1002/ijc.25804; Ye T, 2006, PHOTOCHEM PHOTOBIOL, V82, P733, DOI 10.1562/2006-01-02-RA-762	34	299	302	12	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					842	847		10.1126/science.1256022	http://dx.doi.org/10.1126/science.1256022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700512	Green Accepted			2022-12-28	WOS:000349761100036
J	Hernanz, M				Hernanz, Margarita			ASTROPHYSICS A lithium-rich stellar explosion	NATURE			English	Editorial Material							GAMMA-RAY LINES; GIANT STARS; LI-7; NOVAE; BE-7; ELEMENTS; DECAY		CSIC, IEEC, ICE, Inst Space Sci, Barcelona 08193, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona	Hernanz, M (corresponding author), CSIC, IEEC, ICE, Inst Space Sci, Barcelona 08193, Spain.	hernanz@ice.csic.es	Hernanz, Margarita/K-1770-2014	Hernanz, Margarita/0000-0002-8651-7910				BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; CAMERON AGW, 1955, ASTROPHYS J, V121, P144, DOI 10.1086/145970; CAMERON AGW, 1971, ASTROPHYS J, V164, P111, DOI 10.1086/150821; HARRIS MJ, 1991, ASTROPHYS J, V375, P216, DOI 10.1086/170183; Romano D, 1999, ASTRON ASTROPHYS, V352, P117; STARRFIELD S, 1978, ASTROPHYS J, V222, P600, DOI 10.1086/156175; Tajitsu A, 2015, NATURE, V518, P381, DOI 10.1038/nature14161	11	6	6	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					307	308		10.1038/518307a	http://dx.doi.org/10.1038/518307a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25693557				2022-12-28	WOS:000349547400022
J	Kim, KH; Kim, JG; Nozawa, S; Sato, T; Oang, KY; Kim, T; Ki, H; Jo, J; Park, S; Song, C; Sato, T; Ogawa, K; Togashi, T; Tono, K; Yabashi, M; Ishikawa, T; Kim, J; Ryoo, R; Kim, J; Ihee, H; Adachi, S				Kim, Kyung Hwan; Kim, Jong Goo; Nozawa, Shunsuke; Sato, Tokushi; Oang, Key Young; Kim, Taewu; Ki, Hosung; Jo, Junbeom; Park, Sungjun; Song, Changyong; Sato, Takahiro; Ogawa, Kanade; Togashi, Tadashi; Tono, Kensuke; Yabashi, Makina; Ishikawa, Tetsuya; Kim, Joonghan; Ryoo, Ryong; Kim, Jeongho; Ihee, Hyotcherl; Adachi, Shin-ichi			Direct observation of bond formation in solution with femtosecond X-ray scattering	NATURE			English	Article							FREE-ELECTRON LASER; SPIN-CROSSOVER DYNAMICS; REAL-TIME OBSERVATION; EXCITED-STATE; 100 PS; OLIGOMERS; GOLD; SPECTROSCOPY; AU(CN)(2)(-); TRACKING	The making and breaking of atomic bonds are essential processes in chemical reactions. Although the ultrafast dynamics of bond breaking have been studied intensively using time-resolved techniques(1-3),, it is very difficult to study the structural dynamics of bond making, mainly because of its bimolecular nature. It is especially difficult to initiate and follow diffusion-limited bond formation in solution with ultrahigh time resolution. Here we use femtosecond time-resolved X-ray solution scattering to visualize the formation of a gold trimer complex, [Au(CN)(2)(-)](3) in real time without the limitation imposed by slow diffusion. This photoexcited gold trimer, which has weakly bound gold atoms in the ground state(4-6), undergoes a sequence of structural changes, and our experiments probe the dynamics of individual reaction steps, including covalent bond formation, the bent-to-linear transition, bond contraction and tetramer formation with a time resolution of 500 femtoseconds. We also determined the three-dimensional structures of reaction intermediates with sub-angstrom spatial resolution. This work demonstrates that it is possible to track in detail and in real time the structural changes that occur during a chemical reaction in solution using X-ray free-electron lasers' and advanced analysis of time-resolved solution scattering data.	[Kim, Kyung Hwan; Kim, Jong Goo; Oang, Key Young; Kim, Taewu; Ki, Hosung; Jo, Junbeom; Park, Sungjun; Ryoo, Ryong; Ihee, Hyotcherl] Inst for Basic Sci Korea, Ctr Nanomat & Chem React, Taejon 305701, South Korea; [Kim, Kyung Hwan; Kim, Jong Goo; Oang, Key Young; Kim, Taewu; Ki, Hosung; Jo, Junbeom; Park, Sungjun; Ryoo, Ryong; Ihee, Hyotcherl] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Nozawa, Shunsuke; Sato, Tokushi; Adachi, Shin-ichi] High Energy Accelerator Res Org, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan; [Song, Changyong; Sato, Takahiro; Ogawa, Kanade; Yabashi, Makina; Ishikawa, Tetsuya] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Togashi, Tadashi; Tono, Kensuke] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Kim, Joonghan] Catholic Univ Korea, Dept Chem, Puchon 420743, South Korea; [Kim, Jeongho] Inha Univ, Dept Chem, Inchon 402751, South Korea; [Adachi, Shin-ichi] Grad Univ Adv Studies, Dept Mat Struct Sci, Sch High Energy Accelerator Sci, Tsukuba, Ibaraki 3050801, Japan	Institute for Basic Science - Korea (IBS); Korea Advanced Institute of Science & Technology (KAIST); High Energy Accelerator Research Organization (KEK); RIKEN; Japan Synchrotron Radiation Research Institute; Catholic University of Korea; Inha University; Graduate University for Advanced Studies - Japan	Ihee, H (corresponding author), Inst for Basic Sci Korea, Ctr Nanomat & Chem React, Taejon 305701, South Korea.	hyotcherl.ihee@kaist.ac.kr; shinichi.adachi@kek.jp	Kim, Jeongho/AAK-8380-2020; Sato, Takahiro/C-2306-2017; Ishikawa, Tetsuya/I-4775-2012; Ihee, Hyotcherl/C-1614-2011; Ryoo, Ryong/B-1090-2009; Yabashi, Makina/A-2832-2015; Ki, Hosung/AAK-6201-2020; Kim, Joonghan/M-2162-2019	Kim, Jeongho/0000-0003-4085-293X; Ishikawa, Tetsuya/0000-0002-6906-9909; Yabashi, Makina/0000-0002-2472-1684; Ryoo, Ryong/0000-0003-0047-3329; Ki, Hosung/0000-0001-8273-6596; Nozawa, Shunsuke/0000-0003-4977-6849; Kim, Kyung Hwan/0000-0002-0482-9786; Adachi, Shin-ichi/0000-0002-3676-1165	X-ray Free Electron Laser Priority Strategic Program of MEXT, Japan; PRESTO/JST; Innovative Areas 'Artificial Photosynthesis (AnApple)' from Japan Society for the Promotion of Science [25107527]; Basic Science Research Program through National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF-2014R1A1A1002511];  [IBS-R004-G2]; Grants-in-Aid for Scientific Research [26102014] Funding Source: KAKEN	X-ray Free Electron Laser Priority Strategic Program of MEXT, Japan; PRESTO/JST(Japan Science & Technology Agency (JST)); Innovative Areas 'Artificial Photosynthesis (AnApple)' from Japan Society for the Promotion of Science; Basic Science Research Program through National Research Foundation of Korea - Ministry of Science, ICT & Future Planning; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Iwamura and K. Nozaki for discussions. This work was supported by IBS-R004-G2; the X-ray Free Electron Laser Priority Strategic Program of MEXT, Japan; PRESTO/JST; the Innovative Areas 'Artificial Photosynthesis (AnApple)' (no. 25107527) grant from the Japan Society for the Promotion of Science; and the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Science, ICT & Future Planning (NRF-2014R1A1A1002511). The experiments were performed at beamline BL3 of SACLA with the approval of the Japan Synchrotron Radiation Research Institute (proposal nos 2012A8030, 2012A8038, 201288029, 201288043, 2013A8053, 201388036, 201388059, 2014A8042 and 2014A8022) and at beamline NW14A of KEK with the approval of the Photon Factory Program Advisory Committee (proposal nos 2011G655, 2012G778 and 2012G779).	Arnlund D, 2014, NAT METHODS, V11, P923, DOI [10.1038/nmeth.3067, 10.1038/NMETH.3067]; Bressler C, 2009, SCIENCE, V323, P489, DOI 10.1126/science.1165733; Christensen M, 2009, J AM CHEM SOC, V131, P502, DOI 10.1021/ja804485d; Coppens P, 2011, J PHYS CHEM LETT, V2, P616, DOI 10.1021/jz200050x; Cui GL, 2013, ANGEW CHEM INT EDIT, V52, P10281, DOI 10.1002/anie.201305487; Davidsson J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.245503; Fritz DM, 2007, SCIENCE, V315, P633, DOI 10.1126/science.1135009; Haldrup K, 2009, ANGEW CHEM INT EDIT, V48, P4180, DOI 10.1002/anie.200900741; HARRIS AL, 1988, ANNU REV PHYS CHEM, V39, P341, DOI 10.1146/annurev.physchem.39.1.341; Ichiyanagi K, 2009, J SYNCHROTRON RADIAT, V16, P391, DOI 10.1107/S0909049509005986; Ihee H, 2005, SCIENCE, V309, P1223, DOI [10.1126/science.1114782, 10.1126/scheme.1114782]; Ihee H, 2009, ACCOUNTS CHEM RES, V42, P356, DOI 10.1021/ar800168v; Inubushi Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.144801; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; Iwamura M, 2013, J AM CHEM SOC, V135, P538, DOI 10.1021/ja310004z; JONAS DM, 1995, J PHYS CHEM-US, V99, P2594, DOI 10.1021/j100009a018; Jun S, 2010, PHYS CHEM CHEM PHYS, V12, P11536, DOI 10.1039/c002004d; Kim KH, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.165505; Kim KH, 2012, J AM CHEM SOC, V134, P7001, DOI 10.1021/ja210856v; Kim TK, 2009, CHEMPHYSCHEM, V10, P1958, DOI 10.1002/cphc.200900154; Kirchner FO, 2014, NAT PHOTONICS, V8, P52, DOI [10.1038/NPHOTON.2013.315, 10.1038/nphoton.2013.315]; Lemke HT, 2013, J PHYS CHEM A, V117, P735, DOI 10.1021/jp312559h; Miller RJD, 2014, ANNU REV PHYS CHEM, V65, P583, DOI 10.1146/annurev-physchem-040412-110117; Miller TA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2385; Plech A, 2006, NAT PHYS, V2, P44, DOI 10.1038/nphys191; Pyykko P, 2004, ANGEW CHEM INT EDIT, V43, P4412, DOI 10.1002/anie.200300624; Rawashdeh-Omary MA, 2000, J AM CHEM SOC, V122, P10371, DOI 10.1021/ja001545w; Rawashdeh-Omary MA, 2001, J AM CHEM SOC, V123, P11237, DOI 10.1021/ja011176j; Rini M, 2003, SCIENCE, V301, P349, DOI 10.1126/science.1085762; Rosspeintner A, 2013, ANNU REV PHYS CHEM, V64, P247, DOI 10.1146/annurev-physchem-040412-110146; Schmidbaur H, 2008, CHEM SOC REV, V37, P1931, DOI 10.1039/b708845k; Sokolowski-Tinten K, 2003, NATURE, V422, P287, DOI 10.1038/nature01490; Tamasaku K, 2014, NAT PHOTONICS, V8, P313, DOI [10.1038/NPHOTON.2014.10, 10.1038/nphoton.2014.10]; Wang SG, 2004, J AM CHEM SOC, V126, P1266, DOI 10.1021/ja035097e; ZEWAIL AH, 1988, SCIENCE, V242, P1645, DOI 10.1126/science.242.4886.1645; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135; Zhang WK, 2014, NATURE, V509, P345, DOI 10.1038/nature13252	37	166	168	4	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					385	389		10.1038/nature14163	http://dx.doi.org/10.1038/nature14163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25693570				2022-12-28	WOS:000349547400039
J	Scholl, B; Priebe, NJ				Scholl, Benjamin; Priebe, Nicholas J.			NEUROSCIENCE The cortical connection	NATURE			English	Editorial Material							SILENT SYNAPSES; LTP		[Scholl, Benjamin; Priebe, Nicholas J.] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Scholl, B (corresponding author), Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA.	nico@austin.utexas.edu			NEI NIH HHS [R01 EY025102] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY025102] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLARD T, 1991, J NEUROPHYSIOL, V66, P1048, DOI 10.1152/jn.1991.66.3.1048; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kleinfeld D, 2011, J NEUROSCI, V31, P16125, DOI 10.1523/JNEUROSCI.4077-11.2011; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008	10	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					306	307		10.1038/nature14201	http://dx.doi.org/10.1038/nature14201			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25652821	Green Accepted			2022-12-28	WOS:000349547400021
J	Schmitt, BP				Schmitt, Brian P.			In HF, angiotensin-neprilysin inhibition reduced mortality and HF hospitalization compared with enalapril	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Edward Hines Jr VA Hosp, Hines, IL 60141 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Schmitt, BP (corresponding author), Edward Hines Jr VA Hosp, Hines, IL 60141 USA.							Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Troughton RW, 2014, EUR HEART J, V35, P1559, DOI 10.1093/eurheartj/ehu090	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4							JC2	10.7326/ACPJC-2015-162-4-002	http://dx.doi.org/10.7326/ACPJC-2015-162-4-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686189				2022-12-28	WOS:000350232500005
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Female genital mutilation: a wise doctor and a foolish prosecution	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Laville S., 2014, GUARDIAN; UK Government, 2003, FEMALE GENITAL MUTIL	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2015	350								h815	10.1136/bmj.h815	http://dx.doi.org/10.1136/bmj.h815			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WA	25687441	Bronze			2022-12-28	WOS:000349911300004
J	Carnall, R; Farrar, C				Carnall, Ruth; Farrar, Carnall			Support doctors who lead change programmes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Carnall, Ruth; Farrar, Carnall] NHS London, London, England		Carnall, R (corresponding author), NHS London, London, England.	ruth.carnall@carnallfarrar.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2015	350								h704	10.1136/bmj.h704	http://dx.doi.org/10.1136/bmj.h704			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0MN	25678529				2022-12-28	WOS:000349320500001
J	Chen, YH; Du, WL; Hagemeijer, MC; Takvorian, PM; Pau, C; Cali, A; Brantner, CA; Stempinski, ES; Connelly, PS; Ma, HC; Jiang, P; Wimmer, E; Altan-Bonnet, G; Altan-Bonnet, N				Chen, Ying-Han; Du, WenLi; Hagemeijer, Marne C.; Takvorian, Peter M.; Pau, Cyrilla; Cali, Ann; Brantner, Christine A.; Stempinski, Erin S.; Connelly, Patricia S.; Ma, Hsin-Chieh; Jiang, Ping; Wimmer, Eckard; Altan-Bonnet, Gregoire; Altan-Bonnet, Nihal			Phosphatidylserine Vesicles Enable Efficient En Bloc Transmission of Enteroviruses	CELL			English	Article							VIRUS ENTRY; PROTEIN; RECOGNITION; AUTOPHAGOSOMES; REPLICATION; PARTICLES; RECEPTORS; MECHANISM; FORM	A central paradigm within virology is that each viral particle largely behaves as an independent infectious unit. Here, we demonstrate that clusters of enteroviral particles are packaged within phosphatidylserine (PS) lipid-enriched vesicles that are non-lytically released from cells and provide greater infection efficiency than free single viral particles. We show that vesicular PS lipids are co-factors to the relevant enterovirus receptors in mediating subsequent infectivity and transmission, in particular to primary human macrophages. We demonstrate that clustered packaging of viral particles within vesicles enables multiple viral RNA genomes to be collectively transferred into single cells. This study reveals a novel mode of viral transmission, where enteroviral genomes are transmitted from cell-to-cell en bloc in membrane-bound PS vesicles instead of as single independent genomes. This has implications for facilitating genetic cooperativity among viral quasispecies as well as enhancing viral replication.	[Chen, Ying-Han; Du, WenLi; Hagemeijer, Marne C.; Altan-Bonnet, Nihal] NHLBI, Lab Host Pathogen Dynam, NIH, Bethesda, MD 20892 USA; [Chen, Ying-Han; Takvorian, Peter M.; Pau, Cyrilla; Cali, Ann] Rutgers State Univ, Federated Dept Biol Sci, Newark, NJ 07102 USA; [Brantner, Christine A.; Stempinski, Erin S.; Connelly, Patricia S.] NHLBI, Electron Microscopy Core Facil, NIH, Bethesda, MD 20892 USA; [Ma, Hsin-Chieh; Jiang, Ping; Wimmer, Eckard] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Altan-Bonnet, Gregoire] Mem Sloan Kettering Canc Ctr, Program Computat Biol & Immunol, New York, NY 10065 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Rutgers State University Newark; Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center	Altan-Bonnet, N (corresponding author), NHLBI, Lab Host Pathogen Dynam, NIH, Bethesda, MD 20892 USA.	nihal.altan-bonnet@nih.gov		Altan-Bonnet, Gregoire/0000-0002-7283-3162; Brantner, Christine/0000-0001-8172-901X	NIH;  [AI091985-01A1];  [AI083408];  [AI15122]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015122, R01AI083408, R37AI015122, R56AI083408, R01AI091985] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank Yasmine Belkaid, Konstantin Chumakov, Ana Maria Cuervo, James Hogle, Gerald Feldman, Jennifer Jones, Jennifer Lippincott-Schwartz, Sanford Simon, Radek Dobrowolski, Wilma Friedman, Ellie Ehrenfeld and members of the Altan-Bonnet lab for fruitful discussions. The authors would like to especially thank Wen-Chin Tseng for help in constructing the graphical cartoons. The authors also thank Frank Macaluso and Geoffrey Perumal of the Albert Einstein College of Medicine Analytical Imaging facility for technical support. A.C., P.T., and C.P. were supported by grant AI091985-01A1; G.A.B. was supported by grant AI083408; H.M., P.J., and E.W. were supported by grant AI15122; and Y.C., W.D., M.H., C.B., P.C., E.S., and N.A.B. were supported by intramural NIH funds.	Baddeley D, 2009, BIOPHYS J, V96, pL22, DOI 10.1016/j.bpj.2008.11.002; Barton DJ, 1997, J VIROL, V71, P8482, DOI 10.1128/JVI.71.11.8482-8489.1997; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bird SW, 2014, P NATL ACAD SCI USA, V111, P13081, DOI 10.1073/pnas.1401437111; Borderia AV, 2011, CURR OPIN VIROL, V1, P643, DOI 10.1016/j.coviro.2011.09.012; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; Brandenburg B, 2007, PLOS BIOL, V5, P1543, DOI 10.1371/journal.pbio.0050183; Chen ZC, 2013, P NATL ACAD SCI USA, V110, P20242, DOI 10.1073/pnas.1320041110; Chen ZC, 2011, J VIROL, V85, P4354, DOI 10.1128/JVI.02553-10; Clark MR, 2011, NAT IMMUNOL, V12, P373, DOI 10.1038/ni.2024; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/nmeth.1768, 10.1038/NMETH.1768]; den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; EHRENFELD E, 1970, VIROLOGY, V40, P840, DOI 10.1016/0042-6822(70)90129-7; FADOK VA, 1992, J IMMUNOL, V148, P2207; Feng ZD, 2015, J CLIN INVEST, V125, P169, DOI 10.1172/JCI77527; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Flint S.J., 2020, PRINCIPLES VIROLOGY, V2; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Ilnytska O, 2013, CELL HOST MICROBE, V14, P281, DOI 10.1016/j.chom.2013.08.002; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Lev S., 2012, COLD SPRING HARB PER, V4, P1; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Liu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001066; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13; Nchoutmboube JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003401; Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161; Owens RJ, 2004, J VIROL, V78, P6649, DOI 10.1128/JVI.78.12.6649-6656.2004; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Robinson SM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004045; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Shaffer SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075120; Strauss M, 2013, J VIROL, V87, P3903, DOI 10.1128/JVI.03209-12; Strazynski M, 2002, INT J FOOD MICROBIOL, V74, P73, DOI 10.1016/S0168-1605(01)00708-5; Sui L, 2006, INT J MOL MED, V17, P1093; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; Takahashi M, 2008, ARCH VIROL, V153, P657, DOI 10.1007/s00705-008-0045-6; Taylor MP, 2009, J VIROL, V83, P6599, DOI 10.1128/JVI.01819-08; Termini CM, 2014, MOL BIOL CELL, V25, P1560, DOI 10.1091/mbc.E13-11-0660; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Vianuzzi M., 2006, NATURE, V439, P344	49	268	276	4	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					619	630		10.1016/j.cell.2015.01.032	http://dx.doi.org/10.1016/j.cell.2015.01.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25679758	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000349208800007
J	Pizzo, PA; Walker, DM				Pizzo, Philip A.; Walker, David M.			Should We Practice What We Profess? Care near the End of Life	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pizzo, Philip A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University								Gallo JJ, 2003, J AM GERIATR SOC, V51, P961, DOI 10.1046/j.1365-2389.2003.51309.x; Institute of Medicine, 2014, DYING AM IMPR QUAL H; Periyakoil VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098246; Smith TJ, 2012, J CLIN ONCOL, V30, P880, DOI 10.1200/JCO.2011.38.5161; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624	5	14	14	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7					595	598		10.1056/NEJMp1413167	http://dx.doi.org/10.1056/NEJMp1413167			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA8CK	25671250				2022-12-28	WOS:000349143900002
J	Gadalla, SM; Wang, T; Haagenson, M; Spellman, SR; Lee, SJ; Williams, KM; Wong, JY; De Vivo, I; Savage, SA				Gadalla, Shahinaz M.; Wang, Tao; Haagenson, Michael; Spellman, Stephen R.; Lee, Stephanie J.; Williams, Kirsten M.; Wong, Jason Y.; De Vivo, Immaculata; Savage, Sharon A.			Association Between Donor Leukocyte Telomere Length and Survival After Unrelated Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; RISK-FACTORS; CHILDREN; SENESCENCE; PATHOPHYSIOLOGY; RECIPIENTS; FAILURE; PROGRAM; AGE	IMPORTANCE Telomeres protect chromosome ends and are markers of cellular aging and replicative capacity. OBJECTIVE To evaluate the association between recipient and donor pretransplant leukocyte telomere length with outcomes after unrelated donor allogeneic hematopoietic cell transplantation (HCT) for patients with severe aplastic anemia. DESIGN, PARTICIPANTS, AND SETTING The study included 330 patients (235 acquired, 85 Fanconi anemia, and 10 Diamond-Blackfan anemia) and their unrelated donors who had pre-HCT blood samples and clinical and outcome data available at the Center for International Blood and Marrow Transplant Research. Patients underwent HCT between 1989 and 2007 in 84 centers and were followed-up to March 2013. EXPOSURES Recipient and donor pre-HCT leukocyte telomere length classified into long (third tertile) and short (first and second tertiles combined) based on donor telomere length distribution. MAIN OUTCOMES AND MEASURES Overall survival, neutrophil recovery, and acute and chronic graft-vs-host disease, as ascertained by transplant centers through regular patient follow-up. RESULTS Longer donor leukocyte telomere length was associated with higher survival probability (5-year overall survival, 56%; number at risk, 57; cumulative deaths, 50) than shorter donor leukocyte telomere length (5-year overall survival, 40%; number at risk, 71; cumulative deaths, 128; P = .009). The association remained statistically significant after adjusting for donor age, disease subtype, Karnofsky performance score, graft type, HLA matching, prior aplastic anemia therapy, race/ethnicity, and calendar year of transplant (hazard ratio [HR], 0.61; 95% CI, 0.44-0.86). Similar results were noted in analyses stratified on severe aplastic anemia subtype, recipient age, HLA matching, calendar year of transplant, and conditioning regimen. There was no association between donor telomere length and neutrophil engraftment at 28 days (cumulative incidence, 86% vs 85%; HR, 0.94; 95% CI, 0.73-1.22), acute graft-vs-host disease grades III-IV at 100 days (cumulative incidence, 22% vs 28%; HR, 0.77; 95% CI, 0.48-1.23), or chronic graft-vs-host disease at 1-year (cumulative incidence, 28% vs 30%; HR, 0.81; 95% CI, 0.53-1.24) for long vs short, respectively. Pretransplant leukocyte telomere length in the recipients was not associated with posttransplant survival (HR, 0.91; 95% CI, 0.64-1.30). CONCLUSIONS AND RELEVANCE Longer donor leukocyte telomere length was associated with increased 5-year survival in patients who received HCT for severe aplastic anemia. Patient leukocyte telomere length was not associated with survival. The results of this observational study suggest that donor leukocyte telomere length may have a role in long-term posttransplant survival. Copyright 2015 American Medical Association. All rights reserved.	[Gadalla, Shahinaz M.; Savage, Sharon A.] NCI, Clin Genet Branch, NIH, Rockville, MD 20850 USA; [Wang, Tao; Lee, Stephanie J.] Med Coll Wisconsin, Ctr Int Blood & Marrow Transplant hRes, Milwaukee, WI 53226 USA; [Wang, Tao; Lee, Stephanie J.] Med Coll Wisconsin, Div Biostat, Milwaukee, WI 53226 USA; [Haagenson, Michael; Spellman, Stephen R.] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA; [Lee, Stephanie J.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Williams, Kirsten M.] George Washington Univ, Med Ctr, Div Blood & Marrow Transplantat, Ctr Canc & Blood Disorders,Childrens Natl Med Ctr, Washington, DC 20037 USA; [Williams, Kirsten M.] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Wong, Jason Y.; De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Wong, Jason Y.; De Vivo, Immaculata] Harvard Univ, Sch Med, Boston, MA USA; [Wong, Jason Y.; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for International Blood & Marrow Transplant Research; Medical College of Wisconsin; Medical College of Wisconsin; Center for International Blood & Marrow Transplant Research; Fred Hutchinson Cancer Center; Children's National Health System; George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Gadalla, SM (corresponding author), NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, 9609 Med Ctr Dr,Room 6E-534, Rockville, MD 20850 USA.	gadallas@mail.nih.gov	Savage, Sharon/AAB-5160-2019; Savage, Sharon A/B-9747-2015; Gadalla, Shahinaz/U-2848-2019; Gadalla, Shahinaz M/C-4005-2015	Savage, Sharon/0000-0001-6006-0740; Savage, Sharon A/0000-0001-6006-0740; Gadalla, Shahinaz M/0000-0002-3255-8143; De Vivo, Immaculata/0000-0002-7185-7402; Wong, Jason/0000-0002-8167-540X	Public Health Service from the National Cancer Institute [U24-CA76518]; National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases, Health Resources; Services Administration [HHSH234200637015C]; Office of Naval Research [N00014-13-1-0039, N00014-14-1-0028]; National Institutes of Health [2R01 CA082838]; Intramural Research Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA082838, ZIACP010190, U24CA076518] Funding Source: NIH RePORTER	Public Health Service from the National Cancer Institute; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases, Health Resources; Services Administration; Office of Naval Research(Office of Naval Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by Public Health Service grant U24-CA76518 from the National Cancer Institute, the National Heart, Lung, and Blood Institute and the National Institute of Allergy and Infectious Diseases, Health Resources (Drs Wang and Lee and Messrs Haagenson and Spellman), and grant HHSH234200637015C from the Services Administration, grants N00014-13-1-0039 and N00014-14-1-0028 from the Office of Naval Research (Dr Wang and Messrs Haagenson and Spellman), grant 2R01 CA082838 from the National Institutes of Health (Dr De Vivo), and the Intramural Research Program of the National Cancer Institute (Drs Gadalla and Savage).	Aini W, 2012, TRANSPL INT, V25, P956, DOI 10.1111/j.1432-2277.2012.01523.x; Akiyama M, 1998, BONE MARROW TRANSPL, V21, P167, DOI 10.1038/sj.bmt.1701060; Akiyama M, 2000, BONE MARROW TRANSPL, V25, P441, DOI 10.1038/sj.bmt.1702144; Akkina SK, 2012, LIVER TRANSPLANT, V18, P395, DOI 10.1002/lt.23398; Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Baerlocher GM, 2009, BLOOD, V114, P219, DOI 10.1182/blood-2009-03-209833; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Davies SM, 2000, BLOOD, V96, P4096; de Latour RP, 2012, BLOOD, V120, P3353, DOI 10.1182/blood-2012-01-403337; Deeg HJ, 2006, BLOOD, V108, P1485, DOI 10.1182/blood-2006-03-005041; Flowers MED, 1999, HEMATOL ONCOL CLIN N, V13, P1091, DOI 10.1016/S0889-8588(05)70111-8; Gadalla SM, 2011, BLOOD REV, V25, P261, DOI 10.1016/j.blre.2011.06.004; Greim H, 2014, ANN NY ACAD SCI, V1310, P7, DOI 10.1111/nyas.12362; Gross TG, 1999, BONE MARROW TRANSPL, V23, P251, DOI 10.1038/sj.bmt.1701554; Khincha PP, 2013, SEMIN HEMATOL, V50, P333, DOI 10.1053/j.seminhematol.2013.09.002; Kojima S, 2002, BLOOD, V100, P799, DOI 10.1182/blood.V100.3.799; Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; Lee JJ, 1999, BONE MARROW TRANSPL, V24, P411, DOI 10.1038/sj.bmt.1701923; Lin JG, 2014, DNA REPAIR, V20, P142, DOI 10.1016/j.dnarep.2014.01.012; Mangerini R, 2009, ANN HEMATOL, V88, P1029, DOI 10.1007/s00277-009-0712-z; Maury S, 2007, HAEMATOL-HEMATOL J, V92, P589, DOI 10.3324/haematol.10899; McGlynn LM, 2009, AGING CELL, V8, P45, DOI 10.1111/j.1474-9726.2008.00447.x; Perez-Albuerne ED, 2008, BRIT J HAEMATOL, V141, P216, DOI 10.1111/j.1365-2141.2008.07030.x; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Scheinberg P, 2012, HEMATOL-AM SOC HEMAT, P292, DOI 10.1182/asheducation-2012.1.292; Scheinberg P, 2010, JAMA-J AM MED ASSOC, V304, P1358, DOI 10.1001/jama.2010.1376; SCHULTZ KR, 1994, BLOOD, V84, P3212; Szpecht D, 2012, ARCH IMMUNOL THER EX, V60, P225, DOI 10.1007/s00005-012-0174-1; Viollier R, 2008, BONE MARROW TRANSPL, V41, P45, DOI 10.1038/sj.bmt.1705894; Widmann TA, 2005, EXP HEMATOL, V33, P1257, DOI 10.1016/j.exphem.2005.05.019; Wong JYY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087348; Young NS, 2013, HEMATOL-AM SOC HEMAT, P76, DOI 10.1182/asheducation-2013.1.76	36	60	65	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					594	602		10.1001/jama.2015.7	http://dx.doi.org/10.1001/jama.2015.7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25668263	Green Accepted, Bronze			2022-12-28	WOS:000349070700019
J	Nelson, EC; Eftimovska, E; Lind, C; Hager, A; Wasson, JH; Lindblad, S				Nelson, Eugene C.; Eftimovska, Elena; Lind, Cristin; Hager, Andreas; Wasson, John H.; Lindblad, Staffan			SPOTLIGHT: PATIENT CENTRED CARE Patient reported outcome measures in practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IMPACT		[Nelson, Eugene C.; Wasson, John H.] Dartmouth Coll, Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Nelson, Eugene C.] Dartmouth Hitchcock Hlth, Lebanon, NH USA; [Eftimovska, Elena; Lindblad, Staffan] Karolinska Inst, Dept Learning Informat Management & Eth, S-10401 Stockholm, Sweden; [Lind, Cristin] Rare Dis Sweden, Stockholm, Sweden; [Hager, Andreas] Genia, Stockholm, Sweden; [Hager, Andreas] Hansen Law, Stockholm, Sweden; [Lindblad, Staffan] Qual Register Ctr, Stockholm, Sweden	Dartmouth College; Karolinska Institutet	Nelson, EC (corresponding author), Dartmouth Coll, Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, 35 Centerra Pkwy,Suite 300, Lebanon, NH 03766 USA.	eugene.c.nelson@gmail.com	Eftimovska, Elena/B-6115-2015	Eftimovska, Elena/0000-0001-8662-3847				Ahles TA, 2006, ANN FAM MED, V4, P341, DOI 10.1370/afm.527; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Chen J, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-211; Crandall W, 2011, INFLAMM BOWEL DIS, V17, P450, DOI 10.1002/ibd.21394; Dawson J, 2010, BMJ-BRIT MED J, V340, pc186; Devlin N., 2010, GETTING MOST OUT PRO; Devlin NJ, 2010, HEALTH ECON, V19, P886, DOI 10.1002/hec.1608; Haverman L, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-3; Hvitfeldt Helena, 2009, Qual Manag Health Care, V18, P247, DOI 10.1097/QMH.0b013e3181bee32e; Marshall S, 2006, J EVAL CLIN PRACT, V12, P559, DOI 10.1111/j.1365-2753.2006.00650.x; NELSON E, 1983, JAMA-J AM MED ASSOC, V249, P3331, DOI 10.1001/jama.249.24.3331; Nelson EC, 2012, USING PATIENT REPORT; Nelson EC, 2011, ENG LEARNING HEALTHC, P149; PINCUS T, 1983, ARTHRITIS RHEUM-US, V26, P1346, DOI 10.1002/art.1780261107; Santana MJ, 2014, QUAL LIFE RES, V23, P1505, DOI 10.1007/s11136-013-0596-1; Svensk Reumatologis Kvalitetsregister, 2013, ARSR 2012 SWED RHEUM; Taylor W, 2013, NAT QUAL C SACR CA 4; Valderas JM, 2008, QUAL LIFE RES, V17, P179, DOI 10.1007/s11136-007-9295-0; Wasson J H, 1999, Eff Clin Pract, V2, P1; Wasson JH, 2011, J AMBUL CARE MANAG, V34, P38, DOI 10.1097/JAC.0b013e3181fff641	20	363	368	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								g7818	10.1136/bmj.g7818	http://dx.doi.org/10.1136/bmj.g7818			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB0LU	25670183	Bronze			2022-12-28	WOS:000349318400033
J	Smith, JM				Smith, Jeanette M.			Portia in a Pink Blouse Guy Pene du Bois	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					550	551		10.1001/jama.2014.11569	http://dx.doi.org/10.1001/jama.2014.11569			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25668246				2022-12-28	WOS:000349070700001
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Cancer strategy should be led by evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Cancer Research UK, OUR POL BOW CANC SCR; Cancer Research UK, WHAT BREAST SCREEN R; Kumar H., 2015, CANC RES UK SCI 0111; McCartney M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5155; National Institute for Health and Care Excellence, 2014, SUSP CANC REC MAN SU; National Institute for Health and Care Excellence, 2010, OV CANC REC IN MAN O; Ohuma E, IMPROVING DIAGNOSIS; TATE JJT, 1990, BRIT J SURG, V77, P523, DOI 10.1002/bjs.1800770516	8	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2015	350								h735	10.1136/bmj.h735	http://dx.doi.org/10.1136/bmj.h735			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LA	25665898	Bronze			2022-12-28	WOS:000349316200005
J	Grepin, KA				Grepin, Karen A.			International donations to the Ebola virus outbreak: too little, too late?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DONOR		NYU, New York, NY 10012 USA	New York University	Grepin, KA (corresponding author), NYU, New York, NY 10012 USA.	kag12@nyu.edu	Grepin, Karen Ann/P-1248-2018	Grepin, Karen Ann/0000-0003-4368-0045				[Anonymous], 2014, PBS             0828; [Anonymous], 2014, REUTERS; [Anonymous], 2014, NY TIMES; Birrell I, 2014, INDEPENDENT; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; Glassman A, 2014, MUCH IS ACTUALLY BEI; Global Humanitarian Assistance Team, GLOB HUM ASS REP 201; Grepin KA, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0084-6; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; Gulland A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h460; Strom S, 2014, NY TIMES; UN OCHA, 2014, DEF PLEDG COMM CONTR; WHO AFRO, 2014, WHO SUPPL ARR GUIN S; WHO AFRO, 2014, EB VIR DIS GUIN; WHO Guinea Liberia Sierra Leone, 2014, EB VIR DIS OUTB RESP	15	25	25	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2015	350								h376	10.1136/bmj.h376	http://dx.doi.org/10.1136/bmj.h376			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0IL	25649057	Bronze			2022-12-28	WOS:000349309100004
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Who's measuring the harm caused by the new benefits system?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], MARM REV; Capita, 2012, CAP SIGNS PIP CONTR; Department for Work and Pensions, 2014, FRAUD ERR BEN SYST 2; Gray P., 2013, INDEPENDENT REV PERS; Plimmer G., 2014, FINANCIAL TIMES; Public Accounts Committee, 2014, IMPL PERS IND PAYM N; Work and Pensions Committee, 2014, MON PERF DEP WORK PE	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2015	350								h280	10.1136/bmj.h280	http://dx.doi.org/10.1136/bmj.h280			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZB	25646761	Bronze			2022-12-28	WOS:000348433200008
J	Hentzien, M; Lambert, D; Limelette, A; N'Guyen, Y; Robbins, A; Lebrun, D; Jaussaud, R; Bani-Sadr, F				Hentzien, Maxime; Lambert, Dorothee; Limelette, Anne; N'Guyen, Yohan; Robbins, Ailsa; Lebrun, Delphine; Jaussaud, Roland; Bani-Sadr, Firouze			Macroscopic amoxicillin crystalluria	LANCET			English	Editorial Material									[Hentzien, Maxime; Lambert, Dorothee; N'Guyen, Yohan; Robbins, Ailsa; Lebrun, Delphine; Jaussaud, Roland; Bani-Sadr, Firouze] Ctr Hosp Univ Robert Debre, Serv Med Interne Malad Infect, Immunol Clin, F-51092 Reims, France; [Limelette, Anne] Ctr Hosp Univ Robert Debre, Lab Bacteriol, Labs Centraux, F-51092 Reims, France	CHU de Reims; CHU de Reims	Hentzien, M (corresponding author), Ctr Hosp Univ Robert Debre, Serv Med Interne Malad Infect, Immunol Clin, Ave Gen Koenig, F-51092 Reims, France.	mhentzien@chu-reims.fr	Hentzien, Maxime/H-8730-2019; Robbins, Ailsa/AAG-3200-2021	Hentzien, Maxime/0000-0003-2729-9420; N'Guyen, Yohan/0000-0001-9092-5071					0	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2296	2296		10.1016/S0140-6736(14)62001-8	http://dx.doi.org/10.1016/S0140-6736(14)62001-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25680270	Green Submitted			2022-12-28	WOS:000355943500032
J	Vahedi, G; Kanno, Y; Furumoto, Y; Jiang, K; Parker, SCJ; Erdos, MR; Davis, SR; Roychoudhuri, R; Restifo, NP; Gadina, M; Tang, ZH; Ruan, YJ; Collins, FS; Sartorelli, V; O'Shea, JJ				Vahedi, Golnaz; Kanno, Yuka; Furumoto, Yasuko; Jiang, Kan; Parker, Stephen C. J.; Erdos, Michael R.; Davis, Sean R.; Roychoudhuri, Rahul; Restifo, Nicholas P.; Gadina, Massimo; Tang, Zhonghui; Ruan, Yijun; Collins, Francis S.; Sartorelli, Vittorio; O'Shea, John J.			Super-enhancers delineate disease-associated regulatory nodes in T cells	NATURE			English	Article							GENETIC ARCHITECTURE; SUSCEPTIBILITY LOCI; IDENTITY GENES; RISK LOCI; IDENTIFICATION; TRANSCRIPTION; METAANALYSIS; EXPRESSION; DIFFERENTIATION; DOMAINS	Enhancers regulate spatiotemporal gene expression and impart cellspecific transcriptional outputs that drive cell identity'. Super-enhancers (SEs), also known as stretch-enhancers, are a subset of enhancers especially important for genes associated with cell identity and genetic risk of disease(2-6). CD4(+) T cells are critical for host defence and autoimmunity. Here we analysed maps of mouse T-cell SEs as a non-biased means of identifying key regulatory nodes involved in cell specification. We found that cytokines and cytokine receptors were the dominant class of genes exhibiting SE architecture in T cells. Nonetheless, the locus encoding Bach2, a key negative regulator of effector differentiation, emerged as the most prominent T-cell SE, revealing a network in which SE-associated genes critical for T-cell biology are repressed by BACH2. Disease-associated single-nucleotide polymorphisms for immune-mediated disorders, including rheumatoid arthritis, were highly enriched for T-cell SEs versus typical enhancers or SEs in other cell lineages'. Intriguingly, treatment of T cells with the Janus kinase (JAK) inhibitor tofacitinib disproportionately altered the expression of rheumatoid arthritis risk genes with SE structures. Together, these results indicate that genes with SE architecture in T cells encompass a variety of cytokines and cytokine receptors but are controlled by a 'guardian' transcription factor, itself endowed with an SE. Thus, enumeration of SEs allows the unbiased determination of key regulatory nodes in T cells, which are preferentially modulated by pharmacological intervention.	[Vahedi, Golnaz; Kanno, Yuka; Jiang, Kan; O'Shea, John J.] NIAMSD, Lymphocyte Cell Biol Sect, NIH, Bethesda, MD 20892 USA; [Furumoto, Yasuko; Gadina, Massimo] NIAMS, Translat Immunol Sect, NIH, Bethesda, MD 20892 USA; [Parker, Stephen C. J.; Erdos, Michael R.; Collins, Francis S.] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Davis, Sean R.; Roychoudhuri, Rahul; Restifo, Nicholas P.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Tang, Zhonghui; Ruan, Yijun] Univ Connecticut, Jackson Lab Genom Med, Farmington, CT 06030 USA; [Tang, Zhonghui; Ruan, Yijun] Univ Connecticut, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Sartorelli, Vittorio] NIAMS, La Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Jackson Laboratory; University of Connecticut; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Vahedi, G (corresponding author), NIAMSD, Lymphocyte Cell Biol Sect, NIH, Bethesda, MD 20892 USA.	vahedig@mail.nih.gov; osheaj@arb.niams.nih.gov	Gadina, Massimo/R-4195-2019; Restifo, Nicholas Phillip/Z-1614-2019; Kanno, Yuka/B-5802-2013; Roychoudhuri, Rahul/A-7442-2010; Parker, Stephen/ABF-1063-2021; Restifo, Nicholas Phillip/M-6549-2019; Davis, Sean/AAD-1801-2021	Kanno, Yuka/0000-0001-5668-9319; Roychoudhuri, Rahul/0000-0002-5392-1853; Davis, Sean/0000-0002-8991-6458; Tang, Zhonghui/0000-0003-2907-3986; Restifo, Nicholas P./0000-0003-4229-4580; Sartorelli, Vittorio/0000-0002-9284-3675	Sir Henry Dale Fellowship - Wellcome Trust [105663/Z/14/Z]; Sir Henry Dale Fellowship - Royal Society [105663/Z/14/Z]; Intramural Research Program of NIAMS; NCI [R01 CA186714]; NATIONAL CANCER INSTITUTE [R01CA186714, ZIABC010763] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI112570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041181, ZIGAR041168, ZIAAR041106, ZIAAR041159, ZICAR041169, ZIAAR041126] Funding Source: NIH RePORTER	Sir Henry Dale Fellowship - Wellcome Trust; Sir Henry Dale Fellowship - Royal Society; Intramural Research Program of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank B. Afzali, A. Nussenzweig, A. Poholek, S. Canna, A. Richard and E. Mathe for critically reading this manuscript. We are grateful to R. Faryabi, H.-Y. Shih, W. Resch, M. Ombrello, Z. Deng and E. Remmers for their contributions to experimental and analytical components of this study. We also thank H. Sun, G. Gutierrez-Cruz, J. Simone, J. Lay and K. Tinsley for their excellent technical support. This study used the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health. R.R. is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant number 105663/Z/14/Z). This work was supported by the Intramural Research Program of NIAMS and by NCI grant R01 CA186714.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Hawkins RD, 2013, IMMUNITY, V38, P1271, DOI 10.1016/j.immuni.2013.05.011; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; McAllister K, 2013, ARTHRITIS RHEUM-US, V65, P3058, DOI 10.1002/art.38183; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	32	247	253	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					558	+		10.1038/nature14154	http://dx.doi.org/10.1038/nature14154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25686607	Green Accepted			2022-12-28	WOS:000353334500047
J	Lander, ES				Lander, Eric S.			Cutting the Gordian Helix - Regulating Genomic Testing in the Era of Precision Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lander, Eric S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Lander, Eric S.] Council Advisors Sci & Technol, Washington, DC USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Lander, ES (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.							ClinGen, CLIN GEN RES HOM PAG; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; FDA, OPT FDAS REG OV NEXT	3	44	48	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2015	372	13					1185	1186		10.1056/NEJMp1501964	http://dx.doi.org/10.1056/NEJMp1501964			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE1QD	25689017				2022-12-28	WOS:000351585900002
J	Caplan, AL				Caplan, Arthur L.			Morality in a time of Ebola	LANCET			English	Editorial Material									NYU, Langone Med Ctr, Div Med Eth, Dept Populat Hlth, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Caplan, AL (corresponding author), NYU, Langone Med Ctr, Div Med Eth, Dept Populat Hlth, 550 1St Ave, New York, NY 10016 USA.	arthur.caplan@nyumc.org						Caplan AL, WHY DO 2 WHITE AM GE; Caplan AL, RESC ME CHALL COMP U; Holan AD, 2014 LIE YEAR EXAGGE; Kanapathipillai R, 2014, NEW ENGL J MED, V371, P2249, DOI 10.1056/NEJMp1412166; Rid A, 2014, LANCET, V384, P1896, DOI 10.1016/S0140-6736(14)61315-5; Rotella C., THIS IS NOT ZOMBIE A; Szabo L., EBOLA OUTBREAK RACIN; Weintraub K., MISTAKES REVERSALS S; WHO Ethics Working Group Meeting, ETH ISS REL STUD DES; World Health Organization (WHO), FREQ ASK QUEST EB VI; Zezima K., EBOLA OUTBREAK OUT C	11	16	16	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					E16	E17		10.1016/S0140-6736(14)61653-6	http://dx.doi.org/10.1016/S0140-6736(14)61653-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC6CB	25703457				2022-12-28	WOS:000350451100001
J	Rosenbaum, L				Rosenbaum, Lisa			Being like Mike - Fear, Trust, and the Tragic Death of Michael Davidson	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Crimaldi L, 2015, BOSTON GLOBE    0122; Dowd Maureen, 2012, NY TIMES; Kelen GD, 2012, ANN EMERG MED, V60, P790, DOI 10.1016/j.annemergmed.2012.08.012; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Kowalenko T, 2005, ANN EMERG MED, V46, P142, DOI 10.1016/j.annemergmed.2004.10.010	5	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2015	372	9					798	799		10.1056/NEJMp1501253	http://dx.doi.org/10.1056/NEJMp1501253			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB8SQ	25651078				2022-12-28	WOS:000349901700003
J	Goginashvili, A; Zhang, ZR; Erbs, E; Spiegelhalter, C; Kessler, P; Mihlan, M; Pasquier, A; Krupina, K; Schieber, N; Cinque, L; Morvan, J; Sumara, I; Schwab, Y; Settembre, C; Ricci, R				Goginashvili, Alexander; Zhang, Zhirong; Erbs, Eric; Spiegelhalter, Coralie; Kessler, Pascal; Mihlan, Michael; Pasquier, Adrien; Krupina, Ksenia; Schieber, Nicole; Cinque, Laura; Morvan, Joelle; Sumara, Izabela; Schwab, Yannick; Settembre, Carmine; Ricci, Romeo			Insulin secretory granules control autophagy in pancreatic beta cells	SCIENCE			English	Article							PROTEIN; LC3; PHOSPHORYLATION; BIOGENESIS; MATURATION; LYSOSOMES; SITE; AMPK	Pancreatic beta cells lower insulin release in response to nutrient depletion. The question of whether starved beta cells induce macroautophagy, a predominant mechanism maintaining energy homeostasis, remains poorly explored. We found that, in contrast to many mammalian cells, macroautophagy in pancreatic beta cells was suppressed upon starvation. Instead, starved beta cells induced lysosomal degradation of nascent secretory insulin granules, which was controlled by protein kinase D (PKD), a key player in secretory granule biogenesis. Starvation-induced nascent granule degradation triggered lysosomal recruitment and activation of mechanistic target of rapamycin that suppressed macroautophagy. Switching from macroautophagy to insulin granule degradation was important to keep insulin secretion low upon fasting. Thus, beta cells use a PKD-dependent mechanism to adapt to nutrient availability and couple autophagy flux to secretory function.	[Goginashvili, Alexander; Zhang, Zhirong; Erbs, Eric; Spiegelhalter, Coralie; Kessler, Pascal; Mihlan, Michael; Pasquier, Adrien; Krupina, Ksenia; Morvan, Joelle; Sumara, Izabela; Ricci, Romeo] Univ Strasbourg, CNRS, INSERM, IGBMC, F-67404 Illkirch Graffenstaden, France; [Schieber, Nicole; Schwab, Yannick] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Cinque, Laura; Settembre, Carmine] Dulbecco Telethon Inst, I-80131 Naples, Italy; [Cinque, Laura; Settembre, Carmine] Telethon Inst Genet & Med TIGEM, I-80131 Naples, Italy; [Settembre, Carmine] Univ Naples Federico II, Dept Med & Translat Sci Unit, I-80131 Naples, Italy; [Ricci, Romeo] Univ Strasbourg, Nouvel Hop Civil, Lab Biochim & Biol Mol, F-67091 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; European Molecular Biology Laboratory (EMBL); Fondazione Telethon; Dulbecco Telethon Institute (DTI); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ricci, R (corresponding author), Univ Strasbourg, CNRS, INSERM, IGBMC, F-67404 Illkirch Graffenstaden, France.	romeo.ricci@igbmc.fr	ZHANG, Zhirong/A-3422-2015; Goginashvili, Alexander/HGB-5860-2022; Settembre, Carmine/AIA-9170-2022; Ricci, Romeo/K-3009-2013; Kessler, Pascal/ABF-6615-2021	ZHANG, Zhirong/0000-0002-7331-783X; Ricci, Romeo/0000-0002-9766-4369; Spiegelhalter, Coralie/0000-0001-6372-1647; Mihlan, Michael/0000-0002-3946-6583; SETTEMBRE, Carmine/0000-0002-5829-8589; Schwab, Yannick/0000-0001-8027-1836; Goginashvili, Alexander/0000-0002-3305-5898; Sumara, Izabela/0000-0002-5968-3358; Cinque, Laura/0000-0002-8497-3939	European Research Council (ERC) starting grant (ERC-StG) [281271-STRESSMETABOL]; European Foundation for the Study of Diabetes/Lilly European Diabetes Research Programme grant; ERC grant; Deutsche Forschungsgemeinschaft; IGBMC Ph.D. fellowship; Bourse Regionale de Recherche from region Alsace; INSERM; Action Thematique et Incitative sur Programme (ATIP)-Avenir program; Telethon Grant; EMBL; European Foundation for the Study of Diabetes [Lilly 2014_7] Funding Source: researchfish	European Research Council (ERC) starting grant (ERC-StG)(European Research Council (ERC)); European Foundation for the Study of Diabetes/Lilly European Diabetes Research Programme grant; ERC grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IGBMC Ph.D. fellowship; Bourse Regionale de Recherche from region Alsace(Region Grand-Est); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Action Thematique et Incitative sur Programme (ATIP)-Avenir program; Telethon Grant(Fondazione Telethon); EMBL; European Foundation for the Study of Diabetes	We thank H. de F. Magliarelli, H. Gehart, O. Sumara, G. Sumara, N. Djouder, E. Hafen, R. J. Loewith, J. Klumperman, E. Polishchuk, R. Polishchuk, and all current members of the Ricci laboratory for critical scientific inputs. We thank A. Hausser for providing G-PKDrep-live, G. Rutter for providing Phogrin-GFP, J. Hutton (deceased) and H. Davidson for an antibody against Phogrin, and J. Klumperman for an antibody against Lamp1. We thank M. Koch, N. Messaddeq, and C. Ruhlmann for support in imaging; N. Mizushima for providing GFP-LC3 transgenic mice; and P. Halban and J.-I. Miyazaki for sharing the MIN6B1 cell line. This work was supported by a European Research Council (ERC) starting grant (ERC-2011-StG, 281271-STRESSMETABOL) and a European Foundation for the Study of Diabetes/Lilly European Diabetes Research Programme grant. A. G. and Z.Z. were supported by the ERC grant, M. M. was supported by a fellowship of the Deutsche Forschungsgemeinschaft, A. P. was supported by an IGBMC Ph.D. fellowship, K.K. was supported by a fellowship (Bourse Regionale de Recherche from region Alsace and INSERM), I.S. was supported by the Action Thematique et Incitative sur Programme (ATIP)-Avenir program, L.C. and C. Spiegelhalter were supported by a Telethon Grant, and N.S. and Y.S. were supported by EMBL internal funding. A. G. and R. R. have applied for a patent that protects autophagy-inducing molecules to increase insulin release.	Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; GOLD G, 1982, SCIENCE, V218, P56, DOI 10.1126/science.6181562; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Lee MS, 2014, TRENDS ENDOCRIN MET, V25, P620, DOI 10.1016/j.tem.2014.08.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; SMITH RE, 1966, J CELL BIOL, V31, P319, DOI 10.1083/jcb.31.2.319; STEINER DF, 1967, SCIENCE, V157, P697, DOI 10.1126/science.157.3789.697; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	28	96	103	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					878	882		10.1126/science.aaa2628	http://dx.doi.org/10.1126/science.aaa2628			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700520				2022-12-28	WOS:000349761100045
J	Leyshon, S; McAdam, S				Leyshon, Stephen; McAdam, Stephen			SPOTLIGHT: PATIENT CENTRED CARE Scene setter: the importance of taking a systems approach to person centred care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Boyle D, 2009, THE CHALLENGE OF CO; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; Foot C, 2014, PEOPLE IN CONTROL OF; Hibbard JH, 2013, HEALTH AFFAIR, V32, P216, DOI 10.1377/hlthaff.2012.1064; Rasmussen E, 2014, MONDAY MORNING SUSTA; Stewart M, 2003, PATIENT CENTERED MED	7	9	9	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2015	350								h985	10.1136/bmj.h985	http://dx.doi.org/10.1136/bmj.h985			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WF	25701152	Bronze			2022-12-28	WOS:000349911800017
J	Gjoneska, E; Pfenning, AR; Mathys, H; Quon, G; Kundaje, A; Tsai, LH; Kellis, M				Gjoneska, Elizabeta; Pfenning, Andreas R.; Mathys, Hansruedi; Quon, Gerald; Kundaje, Anshul; Tsai, Li-Huei; Kellis, Manolis			Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease	NATURE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; ELEMENTS; ENCODE; ACTIVATION; DISCOVERY; MICROGLIA; DATABASE; BINDING	Alzheimer's disease (AD) is a severe(1) age-related neurodegenerative disorder characterized by accumulation of amyloid-beta plaques and neurofibrillary tangles, synaptic and neuronal loss, and cognitive decline. Several genes have been implicated in AD, but chromatin state alterations during neurodegeneration remain uncharacterized. Here we profile transcriptional and chromatin state dynamics across early and late pathology in the hippocampus of an inducible mouse model of AD-like neurodegeneration. We find a coordinated down-regulation of synaptic plasticity genes and regulatory regions, and upregulation of immune response genes and regulatory regions, which are targeted by factors that belong to the ETS family of transcriptional regulators, including PU.1. Human regions orthologous to increasing-level enhancers show immune-cell-specific enhancer signatures as well as immune cell expression quantitative trait loci, while decreasing-level enhancer orthologues show fetal-brain-specific enhancer activity. Notably, AD-associated genetic variants are specifically enriched in increasing-level enhancer orthologues, implicating immune processes in AD predisposition. Indeed, increasing enhancers overlap known AD loci lacking protein-altering variants, and implicate additional loci that do not reach genome-wide significance. Our results reveal new insights into the mechanisms of neurodegeneration and establish the mouse as a useful model for functional studies of AD regulatory regions.	[Gjoneska, Elizabeta; Mathys, Hansruedi; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Gjoneska, Elizabeta; Pfenning, Andreas R.; Quon, Gerald; Kundaje, Anshul; Tsai, Li-Huei; Kellis, Manolis] Broad Inst Harvard Univ & Massachusetts Inst Tech, Cambridge, MA 02142 USA; [Pfenning, Andreas R.; Quon, Gerald; Kundaje, Anshul; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Kundaje, Anshul] Stanford Univ, Dept Genet, Dept Comp Sci, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Stanford University	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu; manoli@mit.edu	Kundaje, Anshul/Y-2598-2019; Kundaje, Anshul/Y-2739-2019; Kellis, Manolis/ABE-7385-2020	Kundaje, Anshul/0000-0003-3084-2287; Kundaje, Anshul/0000-0003-3084-2287; Kellis, Manolis/0000-0001-7113-9630; /0000-0002-3447-9801; Quon, Gerald/0000-0002-1716-0153	Belfer Neurodegeneration Consortium; NIH/NINDS/NIA [RO1NS078839]; Swiss National Science Foundation [P2BSP3_151885]; NIH/NHGRI [R01HG004037-07, RC1HG005334]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, RC1HG005334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078839] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation	Belfer Neurodegeneration Consortium; NIH/NINDS/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Mungenast for critical reading and editing of the manuscript and discussions about the project, M. Taylor for mouse colony maintenance, and X. Zhang, R. lssner, H. Whitton and C. Epstein for technical assistance with ChIP-seq library preparation. We thank P. Kheradpour for the transcription factor binding site motif scan of the mouse genome. This work was partially supported by the Belfer Neurodegeneration Consortium funding and NIH/NINDS/NIA (RO1NS078839) to L-HT, Early Postdoc Mobility fellowship from the Swiss National Science Foundation (P2BSP3_151885) to H.M., and NIH/NHGRI (R01HG004037-07 and RC1HG005334) to M.K.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004; Association A.s., 2010, ALZHEIMERS DEMENT, P158, DOI [10.1016/j.jalz.2010.01.009, DOI 10.1016/J.JALZ.2010.01.009]; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blalock EM, 2011, J CHEM NEUROANAT, V42, P118, DOI 10.1016/j.jchemneu.2011.06.007; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Guez-Barber D, 2012, J NEUROSCI METH, V203, P10, DOI 10.1016/j.jneumeth.2011.08.045; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jantaratnotai N, 2013, J ALZHEIMERS DIS, V37, P367, DOI 10.3233/JAD-122191; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Lam PY, 2012, J CELL SCI, V125, P4973, DOI 10.1242/jcs.106625; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyons MR, 2011, PROG NEUROBIOL, V94, P259, DOI 10.1016/j.pneurobio.2011.05.003; May G, 2013, CELL STEM CELL, V13, P754, DOI 10.1016/j.stem.2013.09.003; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reed-Geaghan EG, 2010, J NEUROSCI, V30, P15369, DOI 10.1523/JNEUROSCI.2637-10.2010; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	57	338	348	1	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					365	369		10.1038/nature14252	http://dx.doi.org/10.1038/nature14252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25693568	Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000349547400035
J	Harris, RP				Harris, Russell P.			Starting a New Discussion About Lung Cancer Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; HARMS	IMPORTANCE Screening for lung cancer has the potential to reduce mortality, but in addition to detecting aggressive tumors, screening will also detect indolent tumors that otherwise may not cause clinical symptoms. These overdiagnosis cases represent an important potential harm of screening because they incur additional cost, anxiety, and morbidity associated with cancer treatment. OBJECTIVE To estimate overdiagnosis in the National Lung Screening Trial (NLST). DESIGN, SETTING, AND PARTICIPANTS We used data from the NLST, a randomized trial comparing screening using low-dose computed tomography (LDCT) vs chest radiography (CXR) among 53 452 persons at high risk for lung cancer observed for 6.4 years, to estimate the excess number of lung cancers in the LDCT arm of the NLST compared with the CXR arm. J. MAIN OUTCOMES AND MEASURES We calculated 2 measures of overdiagnosis: the probability that a lung cancer detected by screening with LDCT is an overdiagnosis (PS), defined as the excess lung cancers detected by LDCT divided by all lung cancers detected by screening in the LDCT arm; and the number of cases that were considered overdiagnosis relative to the number of persons needed to screen to prevent 1 death from lung cancer. RESULTS During follow-up, 1089 lung cancers were reported in the LDCT arm and 969 in the CXR arm of the NLST. The probability is 18.5% (95% Cl, 5.4%-30.6%) that any lung cancer detected by screening with LDCT was an overdiagnosis, 22.5% (95% Cl, 9.7%-34.3%) that a non-small cell lung cancer detected by LDCT was an overdiagnosis, and 78.9% (95% Cl, 62.2%-93.5%) that a bronchioalveolar lung cancer detected by LDCT was an overdiagnosis. The number of cases of overdiagnosis found among the 320 participants who would need to be screened in the NLST to prevent 1 death from lung cancer was 1.38. CONCLUSIONS AND RELEVANCE More than 18% of all lung cancers detected by LDCT in the NLST seem to be indolent, and overdiagnosis should be considered when describing the risks of LDCT screening for lung cancer.	Univ N Carolina, UNC Ctr Excellence Clin Prevent Serv, Cecil G Sheps Ctr Hlth Serv Res, 725 Martin Luther King Blvd,CB 7590, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Harris, RP (corresponding author), Univ N Carolina, UNC Ctr Excellence Clin Prevent Serv, Cecil G Sheps Ctr Hlth Serv Res, 725 Martin Luther King Blvd,CB 7590, Chapel Hill, NC 27599 USA.	rharris@med.unc.edu						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Cole HM, 2014, JAMA-J AM MED ASSOC, V311, P131, DOI 10.1001/jama.2013.280767; Harris RP, 2014, JAMA INTERN MED, V174, P281, DOI 10.1001/jamainternmed.2013.12745; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Moolgavkar SH, 2012, JNCI-J NATL CANCER I, V104, P541, DOI 10.1093/jnci/djs136; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Pinsky PF, 2012, J MED SCREEN, V19, P154, DOI 10.1258/jms.2012.012010; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635	10	4	6	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					717	+		10.1001/jama.2014.14769	http://dx.doi.org/10.1001/jama.2014.14769			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25688783				2022-12-28	WOS:000349476100017
J	Lopez-Ayala, JM; Oliva-Sandoval, MJ; Sanchez-Munoz, JJ; Gimeno, JR				Maria Lopez-Ayala, Jose; Jose Oliva-Sandoval, Maria; Jose Sanchez-Munoz, Juan; Ramon Gimeno, Juan			Arrhythmogenic right ventricular cardiomyopathy	LANCET			English	Editorial Material							TASK-FORCE CRITERIA; DIAGNOSIS		[Maria Lopez-Ayala, Jose] Los Arcos Mar Menor Univ Hosp, Dept Cardiol, Murcia, Spain; [Jose Oliva-Sandoval, Maria; Jose Sanchez-Munoz, Juan; Ramon Gimeno, Juan] Virgen de la Arrixaca Univ Hosp, Dept Cardiol, Murcia, Spain; [Ramon Gimeno, Juan] Univ Murcia, Sch Med, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia	Gimeno, JR (corresponding author), Univ Hosp Virgen Arrixaca, Inherited Cardiac Dis Unit, Murcia 30120, Spain.	jgimeno@secardiologia.es	Blanes, Juan R Gimeno/I-4269-2015; Muñoz, Juan Jose Sanchez/Z-5426-2019	Blanes, Juan R Gimeno/0000-0001-5818-1754; Lopez-Ayala, Jose Maria/0000-0002-6119-5732				Basso C, 2009, LANCET, V373, P1289, DOI 10.1016/S0140-6736(09)60256-7; Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210; Corrado D, 2010, CIRCULATION, V122, P1144, DOI 10.1161/CIRCULATIONAHA.109.913871; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Quarta G, 2011, CIRCULATION, V123, P2701, DOI 10.1161/CIRCULATIONAHA.110.976936	5	5	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					662	662		10.1016/S0140-6736(14)62461-2	http://dx.doi.org/10.1016/S0140-6736(14)62461-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AZ	25706084				2022-12-28	WOS:000349214000035
J	Maxwell, SRJ; Cameron, IT; Webb, DJ				Maxwell, Simon R. J.; Cameron, Iain T.; Webb, David J.			Prescribing safety: ensuring that new graduates are prepared	LANCET			English	Editorial Material									[Maxwell, Simon R. J.; Webb, David J.] Univ Edinburgh, Western Gen Hosp, Clin Res Ctr, Clin Pharmacol Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Maxwell, Simon R. J.] Prescribing Safety Assessment, London, England; [Cameron, Iain T.] Med Sch Council, London, England; [Cameron, Iain T.] Univ Southampton, Southampton, Hants, England; [Webb, David J.] British Pharmacol Soc, London, England	University of Edinburgh; University of Southampton	Maxwell, SRJ (corresponding author), Univ Edinburgh, Western Gen Hosp, Clin Res Ctr, Clin Pharmacol Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	s.maxwell@ed.ac.uk		Maxwell, Simon/0000-0002-3032-7237				Avery T, 2012, INVESTIGATING PREVAL; General Medical Council, STAT MED ED PRACT UK; General Medical Council, NAT LIC EX; Heaton A, 2008, BRIT J CLIN PHARMACO, V66, P128, DOI 10.1111/j.1365-2125.2008.03197.x; Lechler R, 2007, OUTCOMES MED SCH COU; Maxwell SRJ, 2006, LANCET, V367, P799, DOI 10.1016/S0140-6736(06)68316-5; McManus IC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2621; Ryan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079802; T Dornan, 2009, DEPTH INVESTIGATION; The Lancet, 2009, LANCET, V374, P1495; US Institute of Medicine, 2007, PREV MED ERR	11	27	27	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					579	581		10.1016/S0140-6736(14)62339-4	http://dx.doi.org/10.1016/S0140-6736(14)62339-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AZ	25706071				2022-12-28	WOS:000349214000006
J	Carter, BD; Abnet, CC; Feskanich, D; Freedman, ND; Hartge, P; Lewis, CE; Ockene, JK; Prentice, RL; Speizer, FE; Thun, MJ; Jacobs, EJ				Carter, Brian D.; Abnet, Christian C.; Feskanich, Diane; Freedman, Neal D.; Hartge, Patricia; Lewis, Cora E.; Ockene, Judith K.; Prentice, Ross L.; Speizer, Frank E.; Thun, Michael J.; Jacobs, Eric J.			Smoking and Mortality - Beyond Established Causes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER RISK; CIGARETTE-SMOKING; PROSTATE-CANCER; PROSPECTIVE COHORT; NURSES HEALTH; RENAL-FAILURE; UNITED-STATES; ASSOCIATION; ALCOHOL; DISEASE	BACKGROUND Mortality among current smokers is 2 to 3 times as high as that among persons who never smoked. Most of this excess mortality is believed to be explained by 21 common diseases that have been formally established as caused by cigarette smoking and are included in official estimates of smoking-attributable mortality in the United States. However, if smoking causes additional diseases, these official estimates may significantly underestimate the number of deaths attributable to smoking. METHODS We pooled data from five contemporary U.S. cohort studies including 421,378 men and 532,651 women 55 years of age or older. Participants were followed from 2000 through 2011, and relative risks and 95% confidence intervals were estimated with the use of Cox proportional-hazards models adjusted for age, race, educational level, daily alcohol consumption, and cohort. RESULTS During the follow-up period, there were 181,377 deaths, including 16,475 among current smokers. Overall, approximately 17% of the excess mortality among current smokers was due to associations with causes that are not currently established as attributable to smoking. These included associations between current smoking and deaths from renal failure (relative risk, 2.0; 95% confidence interval [CI], 1.7 to 2.3), intestinal ischemia (relative risk, 6.0; 95% CI, 4.5 to 8.1), hypertensive heart disease (relative risk, 2.4; 95% CI, 1.9 to 3.0), infections (relative risk, 2.3; 95% CI, 2.0 to 2.7), various respiratory diseases (relative risk, 2.0; 95% CI, 1.6 to 2.4), breast cancer (relative risk, 1.3; 95% CI, 1.2 to 1.5), and prostate cancer (relative risk, 1.4; 95% CI, 1.2 to 1.7). Among former smokers, the relative risk for each of these outcomes declined as the number of years since quitting increased. CONCLUSIONS A substantial portion of the excess mortality among current smokers between 2000 and 2011 was due to associations with diseases that have not been formally established as caused by smoking. These associations should be investigated further and, when appropriate, taken into account when the mortality burden of smoking is investigated. (Funded by the American Cancer Society.)	[Carter, Brian D.; Thun, Michael J.; Jacobs, Eric J.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30303 USA; [Abnet, Christian C.; Freedman, Neal D.; Hartge, Patricia] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Feskanich, Diane; Speizer, Frank E.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Feskanich, Diane; Speizer, Frank E.] Harvard Univ, Sch Med, Boston, MA USA; [Lewis, Cora E.] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, Worcester, MA USA; [Prentice, Ross L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	American Cancer Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; University of Massachusetts System; University of Massachusetts Worcester; Fred Hutchinson Cancer Center	Carter, BD (corresponding author), Amer Canc Soc, Natl Home Off, 250 Williams St NW, Atlanta, GA 30303 USA.	brian.carter@cancer.org	Freedman, Neal David/B-9741-2015; Abnet, Christian C/C-4111-2015	Freedman, Neal David/0000-0003-0074-1098; Abnet, Christian C/0000-0002-3008-7843; Pedone, Claudio/0000-0003-1847-9032; Carter, Brian/0000-0003-1166-6521; Antonelli Incalzi, Raffaele/0000-0003-2100-2075	American Cancer Society; NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the American Cancer Society.	Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7; [Anonymous], 2004, HLTH CONS SMOK REP S; [Anonymous], 2014, HLTH CONSMOK 50 YE; [Anonymous], 2014, HOW TOBACCO SMOKE CA; [Anonymous], 2010, AM FAM LIV ARR 2010; [Anonymous], 2010, CDC NCHS NAT HOSP DI; [Anonymous], 2010, CURR POP SURV 2010 C; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; BELANGER CF, 1978, AM J NURS, V78, P1039, DOI 10.2307/3462013; Braithwaite D, 2012, BREAST CANCER RES TR, V136, P521, DOI 10.1007/s10549-012-2276-1; Bryan L, 2014, NICOTINE TOB RES, V16, P1183, DOI 10.1093/ntr/ntu047; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Egan KM, 2002, EPIDEMIOLOGY, V13, P138, DOI 10.1097/00001648-200203000-00007; Ejerblad E, 2004, J AM SOC NEPHROL, V15, P2178, DOI 10.1097/01.ASN.0000135048.35659.10; FRIEDMAN GD, 1974, NEW ENGL J MED, V290, P469, DOI 10.1056/NEJM197402282900901; Gaudet MM, 2013, JNCI-J NATL CANCER I, V105, P515, DOI 10.1093/jnci/djt023; Giovannucci E, 1999, CANCER EPIDEM BIOMAR, V8, P277; Huncharek M, 2010, AM J PUBLIC HEALTH, V100, P693, DOI 10.2105/AJPH.2008.150508; Kenfield SA, 2011, JAMA-J AM MED ASSOC, V305, P2548, DOI 10.1001/jama.2011.879; Lip GYH, 2000, EUR HEART J, V21, P1653, DOI 10.1053/euhj.2000.2339; Lowenfels Albert B, 2009, Curr Gastroenterol Rep, V11, P97; Luo JH, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1016; Moreira DM, 2014, CANCER-AM CANCER SOC, V120, P197, DOI 10.1002/cncr.28423; Murphy SL, 2013, NATL VITAL STAT REPO; Nyante SJ, 2014, BRIT J CANCER, V110, P2339, DOI 10.1038/bjc.2014.132; Orth SR, 1998, KIDNEY INT, V54, P926, DOI 10.1046/j.1523-1755.1998.00067.x; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Sadr-Azodi O, 2012, GUT, V61, P262, DOI 10.1136/gutjnl-2011-300566; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; Thun MJ, 2000, JAMA-J AM MED ASSOC, V284, P706, DOI 10.1001/jama.284.6.706; Unal B, 2004, J ULTRAS MED, V23, P647, DOI 10.7863/jum.2004.23.5.647; Zhang L, 2012, CURR MED CHEM, V19, P63, DOI 10.2174/092986712803413926	37	437	451	0	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7					631	640		10.1056/NEJMsa1407211	http://dx.doi.org/10.1056/NEJMsa1407211			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA8CK	25671255				2022-12-28	WOS:000349143900007
J	Ortmann, CA; Kent, DG; Nangalia, J; Silber, Y; Wedge, DC; Grinfeld, J; Baxter, EJ; Massie, CE; Papaemmanuil, E; Menon, S; Godfrey, AL; Dimitropoulou, D; Guglielmelli, P; Bellosillo, B; Besses, C; Dohner, K; Harrison, CN; Vassiliou, GS; Vannucchi, A; Campbell, PJ; Green, AR				Ortmann, Christina A.; Kent, David G.; Nangalia, Jyoti; Silber, Yvonne; Wedge, David C.; Grinfeld, Jacob; Baxter, E. Joanna; Massie, Charles E.; Papaemmanuil, Elli; Menon, Suraj; Godfrey, Anna L.; Dimitropoulou, Danai; Guglielmelli, Paola; Bellosillo, Beatriz; Besses, Carles; Dohner, Konstanze; Harrison, Claire N.; Vassiliou, George S.; Vannucchi, Alessandro; Campbell, Peter J.; Green, Anthony R.			Effect of Mutation Order on Myeloproliferative Neoplasms	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; POLYCYTHEMIA-VERA; SOMATIC MUTATIONS; CLONAL EVOLUTION; SELF-RENEWAL; MOUSE MODEL; CANCER; TET2; ALPHA; JAK2	BACKGROUND Cancers result from the accumulation of somatic mutations, and their properties are thought to reflect the sum of these mutations. However, little is known about the effect of the order in which mutations are acquired. METHODS We determined mutation order in patients with myeloproliferative neoplasms by genotyping hematopoietic colonies or by means of next-generation sequencing. Stem cells and progenitor cells were isolated to study the effect of mutation order on mature and immature hematopoietic cells. RESULTS The age at which a patient presented with a myeloproliferative neoplasm, acquisition of JAK2 V617F homozygosity, and the balance of immature progenitors were all influenced by mutation order. As compared with patients in whom the TET2 mutation was acquired first (hereafter referred to as "TET2-first patients"), patients in whom the Janus kinase 2 (JAK2) mutation was acquired first ("JAK2-first patients") had a greater likelihood of presenting with polycythemia vera than with essential thrombocythemia, an increased risk of thrombosis, and an increased sensitivity of JAK2-mutant progenitors to ruxolitinib in vitro. Mutation order influenced the proliferative response to JAK2 V617F and the capacity of double-mutant hematopoietic cells and progenitor cells to generate colony-forming cells. Moreover, the hematopoietic stem-and-progenitor-cell compartment was dominated by TET2 single-mutant cells in TET2-first patients but by JAK2-TET2 double-mutant cells in JAK2-first patients. Prior mutation of TET2 altered the transcriptional consequences of JAK2 V617F in a cell-intrinsic manner and prevented JAK2 V617F from up-regulating genes associated with proliferation. CONCLUSIONS The order in which JAK2 and TET2 mutations were acquired influenced clinical features, the response to targeted therapy, the biology of stem and progenitor cells, and clonal evolution in patients with myeloproliferative neoplasms. (Funded by Leukemia and Lymphoma Research and others.)	[Ortmann, Christina A.; Kent, David G.; Nangalia, Jyoti; Silber, Yvonne; Grinfeld, Jacob; Baxter, E. Joanna; Massie, Charles E.; Godfrey, Anna L.; Dimitropoulou, Danai; Green, Anthony R.] Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Ortmann, Christina A.; Kent, David G.; Nangalia, Jyoti; Silber, Yvonne; Grinfeld, Jacob; Baxter, E. Joanna; Massie, Charles E.; Godfrey, Anna L.; Dimitropoulou, Danai; Green, Anthony R.] Wellcome Trust Res Labs, MRC, Stem Cell Inst, Cambridge, England; [Ortmann, Christina A.; Kent, David G.; Nangalia, Jyoti; Silber, Yvonne; Grinfeld, Jacob; Baxter, E. Joanna; Massie, Charles E.; Godfrey, Anna L.; Dimitropoulou, Danai; Vassiliou, George S.; Campbell, Peter J.; Green, Anthony R.] Dept Hematol, Cambridge, England; [Ortmann, Christina A.; Nangalia, Jyoti; Grinfeld, Jacob; Baxter, E. Joanna; Godfrey, Anna L.; Vassiliou, George S.; Campbell, Peter J.; Green, Anthony R.] Univ Cambridge, Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England; [Wedge, David C.; Papaemmanuil, Elli; Vassiliou, George S.; Campbell, Peter J.] Wellcome Trust Res Labs, Sanger Inst, Cambridge, England; [Menon, Suraj] Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England; [Harrison, Claire N.] Guys & St Thomas Natl Hlth Serv Fdn Trust, Guys Hosp, London, England; [Guglielmelli, Paola; Vannucchi, Alessandro] Univ Florence, Dipartimento Med Sperimentale & Clin, Florence, Italy; [Bellosillo, Beatriz] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Besses, Carles] Hosp del Mar, Dept Hematol, Barcelona, Spain; [Dohner, Konstanze] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany	University of Cambridge; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Cancer Research UK; CRUK Cambridge Institute; Guy's & St Thomas' NHS Foundation Trust; University of Florence; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Ulm University	Kent, DG (corresponding author), Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	dgk23@cam.ac.uk; arg1000@cam.ac.uk	Guglielmelli, Paola/K-7509-2016; Wedge, David/AAC-4977-2021; Kent, David/AAZ-4916-2021	Guglielmelli, Paola/0000-0003-1809-284X; Kent, David/0000-0001-7871-8811; Massie, Charlie/0000-0003-2314-4843; Vassiliou, George/0000-0003-4337-8022; Baxter, Elizabeth Joanna/0000-0002-5946-5238; Green, Anthony/0000-0002-9795-0218; Wedge, David/0000-0002-7572-3196	Leukemia and Lymphoma Research; Cancer Research UK [22310, 12765] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10079] Funding Source: researchfish	Leukemia and Lymphoma Research; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Leukemia and Lymphoma Research and others.	Abbas T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012914; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Chen E, 2010, CANCER CELL, V18, P524, DOI 10.1016/j.ccr.2010.10.013; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Floyd S, 2008, CURR BIOL, V18, P1649, DOI 10.1016/j.cub.2008.09.058; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hasan S, 2013, BLOOD, V122, P1464, DOI 10.1182/blood-2013-04-498956; Heyer J, 2010, NAT REV CANCER, V10, P470, DOI 10.1038/nrc2877; Hu CM, 2007, J BIOMED SCI, V14, P491, DOI 10.1007/s11373-007-9175-1; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kent DG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001576; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Kubovcakova L, 2013, BLOOD, V121, P1188, DOI 10.1182/blood-2012-03-415646; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Lundberg P, 2014, BLOOD, V123, P2220, DOI 10.1182/blood-2013-11-537167; Mohr F, 2011, EXP HEMATOL, V39, P272, DOI 10.1016/j.exphem.2010.12.004; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Mullally A, 2013, BLOOD, V121, P3692, DOI 10.1182/blood-2012-05-432989; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Petzer AL, 1996, J EXP MED, V183, P2551, DOI 10.1084/jem.183.6.2551; Saint-Martin C, 2009, BLOOD, V114, P1628, DOI 10.1182/blood-2009-01-197525; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317	38	335	346	7	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7					601	612		10.1056/NEJMoa1412098	http://dx.doi.org/10.1056/NEJMoa1412098			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CK	25671252	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000349143900004
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			Invokamet and Xigduo XR - Two New Combinations for Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint													Pflomm, Jean-Marie/HDO-0765-2022					[Anonymous], 2014, Treat Guidel Med Lett, V12, P17; [Anonymous], 2014, MED LETT DRUGS THER, V56, P13; [Anonymous], 2013, MED LETT DRUGS THER, V55, P5	3	1	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					620	621		10.1001/jama.2015.349	http://dx.doi.org/10.1001/jama.2015.349			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25668267				2022-12-28	WOS:000349070700023
J	Schneiderman, H				Schneiderman, Henry			Efficacy at the Bedside	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TEAM		[Schneiderman, Henry] St Francis Hosp & Med Ctr, Sect Palliat Med, Hartford, CT 06105 USA; [Schneiderman, Henry] Univ Connecticut, Sch Med, Farmington, CT USA; [Schneiderman, Henry] Yale Univ, Sch Nursing, New Haven, CT 06536 USA	Saint Francis Hospital & Medical Center; University of Connecticut; Yale University	Schneiderman, H (corresponding author), St Francis Hosp & Med Ctr, Sect Palliat Med, Hartford, CT 06105 USA.	heschnei@stfranciscare.org						Butler K., 2014, KNOCKING ON HEAVENS, P269; Dentzer S., 2013, HEALTH AFFAIR, V32, P6; Elder A, 2013, JAMA-J AM MED ASSOC, V310, P799, DOI 10.1001/jama.2013.227195; Golden A, 2013, ANN INTERN MED, V159, P642, DOI 10.7326/0003-4819-159-9-201311050-00714; Grey Margaret, 2013, Conn Med, V77, P113; Reisman A, 2013, ANN INTERN MED, V159, P640, DOI 10.7326/0003-4819-159-9-201311050-00713; Resnick B, 2013, J AM GERIATR SOC, V61, P1019, DOI 10.1111/jgs.12272; Schneiderman H., 1994, CONSULTANT, V34, P1041; Schneiderman H., 2009, CONSULTANT, V49, P361; Schneiderman H., 2009, CONSULTANT, V49, P270; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461	11	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					569	570		10.1001/jama.2014.13720	http://dx.doi.org/10.1001/jama.2014.13720			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25668258				2022-12-28	WOS:000349070700013
J	Sondak, VK; Glass, LF; Geller, AC				Sondak, Vernon K.; Glass, L. Frank; Geller, Alan C.			Risk-Stratified Screening for Detection of Melanoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								Detection of Primary Melanoma in Individuals at Extreme High Risk: A Prospective 5-Year Follow-up Study Fergal J. Moloney, MD; Pascale Guitera, MD, PhD; Elliot Coates, MB, BS; Nikolas K. Haass, MD, PhD; Kenneth Ho, MB, BS; Ritta Khoury, BMedSci; Rachel L. O'Connell, PhD; Leo Raudonikis; Helen Schmid, MPH; Graham J. Mann, MB, BS, PhD; ScottW. Menzies, MB, BS, PhD IMPORTANCE The clinical phenotype and certain predisposing genetic mutations that confer increased melanoma risk are established; however, no consensus exists regarding optimal screening for such individuals. Early identification remains the most important intervention in reducing melanoma mortality. OBJECTIVE To evaluate the impact of full-body examinations every 6 months supported by dermoscopy and total-body photography (TBP) on all patients and sequential digital dermoscopy imaging (SDDI), when indicated, on detecting primary melanoma in an extreme-risk population. DESIGN, SETTING, AND PARTICIPANTS Prospective observational study from February 2006 to February 2011, with patients recruited from Sydney Melanoma Diagnostic Centre and Melanoma Institute Australia who had a history of invasive melanoma and dysplastic nevus syndrome, history of invasive melanoma and at least 3 first-degree or second-degree relatives with prior melanoma, history of at least 2 primary invasive melanomas, or a CDKN2A or CDK4 gene mutation. EXPOSURES Six-month full-body examination compared with TBP. For equivocal lesions, SDDI short term (approximately 3 months) or long term (>= 6 months), following established criteria, was performed. Atypical lesions were excised. MAIN OUTCOMES AND MEASURES New primary melanoma numbers, characteristics, and cumulative incidence in each patient subgroup; effect of diagnostic aids on new melanoma identification. RESULTS In 311 patients with a median (interquartile range [IQR]) follow-up of 3.5 (2.4-4.2) years, 75 primary melanomas were detected, 14 at baseline visit. Median (IQR) Breslow thickness of postbaseline incident melanomas was in situ (in situ to 0.60 mm). Thirty-eight percent were detected using TBP and 39% with SDDI. Five melanomas were greater than 1mmBreslow thickness, 3 of which were histologically desmoplastic; the other 2 had nodular components. The benign to malignant excision ratio was 1.6: 1 for all lesions excised and 4.4: 1 for melanocytic lesions. Cumulative risk of developing a novel primary melanoma was 12.7% by year 2, with new primary melanoma incidence during the final 3 years of follow-up half of that observed during the first 2 years (incidence density ratio, 0.43 [95% CI, 0.25-0.74]; P = .002). CONCLUSIONS AND RELEVANCE Monitoring patients at extreme risk with TBP and SDDI assisted with early diagnosis of primary melanoma. Hypervigilance for difficult-to-detect thick melanoma subtypes is crucial. JAMA Dermatol. 2014;150(8):819-827. doi: 10.1001/jamadermatol.2014.514.	[Sondak, Vernon K.; Glass, L. Frank] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA; [Geller, Alan C.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	H Lee Moffitt Cancer Center & Research Institute; Harvard University; Harvard T.H. Chan School of Public Health	Sondak, VK (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	vernon.sondak@moffitt.org						Calonge N, 2009, ANN INTERN MED, V150, P188, DOI 10.7326/0003-4819-150-3-200902030-00020; Geller AC, 2006, ARCH DERMATOL, V142, P504, DOI 10.1001/archderm.142.4.504; Halpern AC, 2014, JAMA DERMATOL, V150, P815, DOI 10.1001/jamadermatol.2014.513; Katalinic A, 2012, CANCER-AM CANCER SOC, V118, P5395, DOI 10.1002/cncr.27566; Moloney FJ, 2014, JAMA DERMATOL, V150, P819, DOI 10.1001/jamadermatol.2014.514; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Swetter SM, 2009, ARCH DERMATOL, V145, P397, DOI 10.1001/archdermatol.2008.603; Waldmann A, 2012, ARCH DERMATOL, V148, P903, DOI 10.1001/archdermatol.2012.893	9	10	10	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					616	+		10.1001/jama.2014.13813	http://dx.doi.org/10.1001/jama.2014.13813			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25668265				2022-12-28	WOS:000349070700021
J	Walker, J; Meltsner, M; Delbanco, T				Walker, Jan; Meltsner, Michael; Delbanco, Tom			SPOTLIGHT: PATIENT CENTRED CARE US experience with doctors and patients sharing clinical notes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INVITING PATIENTS; RECORDS; READ		[Walker, Jan; Delbanco, Tom] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Meltsner, Michael] Northeastern Univ, Sch Law, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Northeastern University	Walker, J (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA.	jwalker1@bidmc.harvard.edu						BALDRY M, 1986, BRIT MED J, V292, P596, DOI 10.1136/bmj.292.6520.596; Delbanco T, 2012, ANN INTERN MED, V157, P461, DOI 10.7326/0003-4819-157-7-201210020-00002; Earnest MA, 2004, J AM MED INFORM ASSN, V11, P410, DOI 10.1197/jamia.M1479; Elias P., 2014, COMMUNICATION   0731; GOLODETZ A, 1976, ARCH PHYS MED REHAB, V57, P78; Guest JA, 2013, JAMA-J AM MED ASSOC, V310, P1939, DOI 10.1001/jama.2013.282000; Hannan Amir, 2010, Inform Prim Care, V18, P41; Hibbard JH, 2007, HEALTH SERV RES, V42, P1443, DOI 10.1111/j.1475-6773.2006.00669.x; Homer CSE, 1999, AUST NZ J OBSTET GYN, V39, P54, DOI 10.1111/j.1479-828X.1999.tb03445.x; Kahn MW, 2014, JAMA-J AM MED ASSOC, V311, P1291, DOI 10.1001/jama.2014.1824; Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219; Kuhn T, 2015, ANN INTERN MED, V162, P301, DOI 10.7326/M14-2128; MCFARLANE WJG, 1980, CAN J PSYCHIAT, V25, P497, DOI 10.1177/070674378002500606; Nazi KM, 2014, J AM MED INFORM ASS; NHS England, 2014, 5 YEAR FORW VIEW; Reti SR, 2009, J AM MED INFORM ASSN, V16, P14, DOI 10.1197/jamia.M2854; Shyder G, 2014, COMMUNICATION   0501; Tierney WM, 2015, J GEN INTERN MED, V30, pS31, DOI 10.1007/s11606-014-3053-0; Tiik M, 2010, STUD HEALTH TECHNOL, V156, P171, DOI 10.3233/978-1-60750-565-5-171; Walker J, 2011, ANN INTERN MED, V155, P811, DOI 10.7326/0003-4819-155-12-201112200-00003; Wielawski I, 2014, IMPROVE HLTH HLTH CA, VXVI	21	64	64	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								g7785	10.1136/bmj.g7785	http://dx.doi.org/10.1136/bmj.g7785			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB0LU	25670182	Bronze			2022-12-28	WOS:000349318400032
J	Fan, HC; Fu, GK; Fodor, SPA				Fan, H. Christina; Fu, Glenn K.; Fodor, Stephen P. A.			Combinatorial labeling of single cells for gene expression cytometry	SCIENCE			English	Article							POLYMERASE-CHAIN-REACTION; RNA-SEQ; CELLULAR HETEROGENEITY; FLOW-CYTOMETRY; MOLECULE; IMMUNE; IDENTIFICATION; SIGNATURES; PHENOTYPE; FREQUENCY	We present a technically simple approach for gene expression cytometry combining next-generation sequencing with stochastic barcoding of single cells. A combinatorial library of beads bearing cell-and molecular-barcoding capture probes is used to uniquely label transcripts and reconstruct the digital gene expression profile of thousands of individual cells in a single experiment without the need for robotics or automation. We applied the technology to dissect the human hematopoietic system and to characterize heterogeneous response to in vitro stimulation. High sensitivity is demonstrated by detection of low-abundance transcripts and rare cells. Under current implementation, the technique can analyze a few thousand cells simultaneously and can readily scale to 10,000s or 100,000s of cells.	[Fan, H. Christina; Fu, Glenn K.; Fodor, Stephen P. A.] Cellular Res Inc, Palo Alto, CA 94304 USA		Fodor, SPA (corresponding author), Cellular Res Inc, 3183 Porter Dr, Palo Alto, CA 94304 USA.	sfodor@cellular-research.com						Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bratke K, 2005, EUR J IMMUNOL, V35, P2608, DOI 10.1002/eji.200526122; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chtanova T, 2005, J IMMUNOL, V175, P7837, DOI 10.4049/jimmunol.175.12.7837; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Dimov IK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4451; Eastburn DJ, 2013, ANAL CHEM, V85, P8016, DOI 10.1021/ac402057q; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fu GK, 2014, ANAL CHEM, V86, P2867, DOI 10.1021/ac500459p; Fu GK, 2014, P NATL ACAD SCI USA, V111, P1891, DOI 10.1073/pnas.1323732111; Fu GK, 2011, P NATL ACAD SCI USA, V108, P9026, DOI 10.1073/pnas.1017621108; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Maecker HT, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-9; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Perkins Archibald S, 2008, Hematology Am Soc Hematol Educ Program, P341, DOI 10.1182/asheducation-2008.1.341; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Sanchez-Freire V, 2012, NAT PROTOC, V7, P829, DOI 10.1038/nprot.2012.021; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Shen Yulei, 2004, BMC Immunology, V5; Smith RD, 2000, NUCLEIC ACIDS RES, V28, P4998, DOI 10.1093/nar/28.24.4998; Streets AM, 2014, NAT BIOTECHNOL, V32, P1005, DOI 10.1038/nbt.3039; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Truchetet ME, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3486; Weinstein JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067624; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Zhang HF, 2012, ANAL CHEM, V84, P3599, DOI 10.1021/ac2033084	46	251	306	12	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222							1258367	10.1126/science.1258367	http://dx.doi.org/10.1126/science.1258367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657253				2022-12-28	WOS:000349145200035
J	Owen, J				Owen, Jonathan			The coordination chemistry of nanocrystal surfaces	SCIENCE			English	Editorial Material							CDSE NANOCRYSTALS; LIGAND-EXCHANGE; QUANTUM DOTS		Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Owen, J (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	jso2115@columbia.edu		Owen, Jonathan/0000-0001-5502-3267	Direct For Mathematical & Physical Scien [1151172] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Anderson NC, 2013, J AM CHEM SOC, V135, P18536, DOI 10.1021/ja4086758; Bullen C, 2006, LANGMUIR, V22, P3007, DOI 10.1021/la051898e; Chuang CHM, 2014, NAT MATER, V13, P796, DOI [10.1038/nmat3984, 10.1038/NMAT3984]; GREEN MLH, 1995, J ORGANOMET CHEM, V500, P127, DOI 10.1016/0022-328X(95)00508-N; Hines MA, 1996, J PHYS CHEM-US, V100, P468, DOI 10.1021/jp9530562; Kalyuzhny G, 2005, J PHYS CHEM B, V109, P7012, DOI 10.1021/jp045352x; Moreels I, 2007, CHEM MATER, V19, P6101, DOI 10.1021/cm071410q; Munro AM, 2007, J PHYS CHEM C, V111, P6220, DOI 10.1021/jp068733e; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Nagpal P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1492; Owen JS, 2008, J AM CHEM SOC, V130, P12279, DOI 10.1021/ja804414f; Zherebetskyy D, 2014, SCIENCE, V344, P1380, DOI 10.1126/science.1252727	12	251	254	18	393	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					615	616		10.1126/science.1259924	http://dx.doi.org/10.1126/science.1259924			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657234				2022-12-28	WOS:000349145200025
J	Sackley, CM; Walker, MF; Burton, CR; Watkins, CL; Mant, J; Roalfe, AK; Wheatley, K; Sheehan, B; Sharp, L; Stant, KE; Fletcher-Smith, J; Steel, K; Wilde, K; Irvine, L; Peryer, G				Sackley, Catherine M.; Walker, Marion F.; Burton, Christopher R.; Watkins, Caroline L.; Mant, Jonathan; Roalfe, Andrea K.; Wheatley, Keith; Sheehan, Bart; Sharp, Leslie; Stant, Katie E.; Fletcher-Smith, Joanna; Steel, Kerry; Wilde, Kate; Irvine, Lisa; Peryer, Guy		OTCH Trial Investigators	An occupational therapy intervention for residents with stroke related disabilities in UK care homes (OTCH): cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FALLS; REHABILITATION; DEPRESSION; FACILITIES; RISK	OBJECTIVE To evaluate the clinical efficacy of an established programme of occupational therapy in maintaining functional activity and reducing further health risks from inactivity in care home residents living with stroke sequelae. DESIGN Pragmatic, parallel group, cluster randomised controlled trial. SETTING 228 care homes (> 10 beds each), both with and without the provision of nursing care, local to 11 trial administrative centres across the United Kingdom. PARTICIPANTS 1042 care home residents with a history of stroke or transient ischaemic attack, including those with language and cognitive impairments, not receiving end of life care. 114 homes (n = 568 residents, 64% from homes providing nursing care) were allocated to the intervention arm and 114 homes (n = 474 residents, 65% from homes providing nursing care) to standard care (control arm). Participating care homes were randomised between May 2010 and March 2012. INTERVENTION Targeted three month programme of occupational therapy, delivered by qualified occupational therapists and assistants, involving patient centred goal setting, education of care home staff, and adaptations to the environment. MAIN OUTCOME MEASURES Primary outcome at the participant level: scores on the Barthel index of activities of daily living at three months post-randomisation. Secondary outcome measures at the participant level: Barthel index scores at six and 12 months post-randomisation, and scores on the Rivermead mobility index, geriatric depression scale-15, and EuroQol EQ-5D-3L questionnaire, at all time points. RESULTS 64% of the participants were women and 93% were white, with a mean age of 82.9 years. Baseline characteristics were similar between groups for all measures, personal characteristics, and diagnostic tests. Overall, 2538 occupational therapy visits were made to 498 participants in the intervention arm (mean 5.1 visits per participant). No adverse events attributable to the intervention were recorded. 162 (11%) died before the primary outcome time point, and 313 (30%) died over the 12 months of the trial. The primary outcome measure did not differ significantly between the treatment arms. The adjusted mean difference in Barthel index score at three months was 0.19 points higher in the intervention arm (95% confidence interval -0.33 to 0.70, P = 0.48). Secondary outcome measures also showed no significant differences at all time points. CONCLUSIONS This large phase III study provided no evidence of benefit for the provision of a routine occupational therapy service, including staff training, for care home residents living with stroke related disabilities. The established three month individualised course of occupational therapy targeting stroke related disabilities did not have an impact on measures of functional activity, mobility, mood, or health related quality of life, at all observational time points. Providing and targeting ameliorative care in this clinically complex population strategies.	[Sackley, Catherine M.] Kings Coll London, Dept Physiotherapy, London WC2R 2LS, England; [Walker, Marion F.; Fletcher-Smith, Joanna] Univ Nottingham, Div Rehabil & Ageing, Fac Med & Hlth Sci, Nottingham NG7 2RD, England; [Burton, Christopher R.] Bangor Univ, Sch Healthcare Sci, Bangor, Gwynedd, Wales; [Watkins, Caroline L.] UCLan, Sch Hlth, Preston, Lancs, England; [Mant, Jonathan] Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England; [Roalfe, Andrea K.; Stant, Katie E.] Univ Birmingham, Birmingham, W Midlands, England; [Wheatley, Keith] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England; [Sheehan, Bart] John Radcliffe Hosp, Directorate Acute Med & Rehabil, Oxford OX3 9DU, England; [Sharp, Leslie; Wilde, Kate; Irvine, Lisa; Peryer, Guy] Univ E Anglia, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England; [Steel, Kerry] Queen Elizabeth Hosp Birmingham, Birmingham, W Midlands, England	University of London; King's College London; University of Nottingham; Bangor University; University of Central Lancashire; University of Birmingham; Cancer Research UK; University of Birmingham; University of Oxford; University of East Anglia; University of Birmingham	Peryer, G (corresponding author), Univ E Anglia, Fac Med & Hlth Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	g.peryer@uea.ac.uk	Irvine, Lisa/ABH-5953-2020	Burton, Christopher/0000-0003-1159-1494; Logan, Philippa/0000-0002-6657-2381; Peryer, Guy/0000-0003-0425-6911; Walker, Marion/0000-0002-3534-591X; Irvine, Lisa/0000-0003-1936-3584; sackley, catherine/0000-0002-8580-6622; Dawes, Helen/0000-0002-2933-5213	UK National Institute for Health Research [08/14/30]; National Institute for Health Research [NF-SI-0510-10024, 08/14/30, NF-SI-0508-10243, NF-SI-0512-10092] Funding Source: researchfish	UK National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The OTCH study was funded by the UK National Institute for Health Research Health Technology Assessment programme (08/14/30). The results will be published in full in Health Technology Assessment. All researchers acted independently to the funding body. The funding body had no role in designing the study, data collection, analysing and interpreting the data, or writing the report. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the funding body, the NHS, or the Department of Health. The research team acknowledge the support of the NIHR, through the Comprehensive Clinical Research Network, in particular, Jacqueline Briggs and Rhian Hughes. The corresponding author (GP) confirms full access to all the data in the study and had final responsibility for the decision to submit for publication.	Barodawala S, 2001, CLIN REHABIL, V15, P607, DOI 10.1191/0269215501cr454oa; Bray H, 2008, POPULATION TRENDS, V131, P8; Care Quality Commission, 2012, HLTH CAR CAR HOM SPE; Centre for Policy and Aging, 2012, PROF RES BUP CAR HOM; Collen F M, 1991, Int Disabil Stud, V13, P50; Collin C, 1988, Int Disabil Stud, V10, P61; Crocker T, 2013, AGE AGEING, V42, P682, DOI 10.1093/ageing/aft133; Damian J, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-6; Department of Health, 2006, OPD NEW AMB OLD AG N; Dworzynski K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3615; Fletcher-Smith JC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010116.pub2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Folstein MF, 2001, MINI MENTAL STATE EX; Gage H, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-71; Gompertz P., 1994, CLIN REHABIL, V8, P233, DOI [DOI 10.1177/026921559400800308, 10.1177/026921559400800308]; Hankey GJ, 2013, LANCET GLOB HEALTH, V1, pE239, DOI 10.1016/S2214-109X(13)70095-0; Harwood RH, 2004, AGE AGEING, V33, P529, DOI 10.1093/ageing/afh191; Hsieh YW, 2007, NEUROREHAB NEURAL RE, V21, P233, DOI 10.1177/1545968306294729; Kerse N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1445; Legg L, 2007, BMJ-BRIT MED J, V335, P922, DOI 10.1136/bmj.39343.466863.55; Lievesley N, 2011, CHANGING ROLE CARE H; Macdonald A, 2007, AGE AGEING, V36, P16, DOI 10.1093/ageing/afl126; MAHONEY F I, 1965, Md State Med J, V14, P61; Masterson-Algar P, 2014, J EVAL CLIN PRACT, V20, P445, DOI 10.1111/jep.12174; National Institute for Health and Care Excellence, 2013, STROK REH LONG TERM; Paterson M, 2006, BRIT J OCCUPATIONAL, V69, P115, DOI DOI 10.1177/030802260606900304; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; Rapp K, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.06.011; Sackley C, 2009, BMJ-BRIT MED J, V339, P670; Sackley C, 2006, INT J THER REHABIL, V13, P370, DOI 10.12968/ijtr.2006.13.8.370; Sackley CM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-52; Sackley C, 2006, STROKE, V37, P2336, DOI 10.1161/01.STR.0000237124.20596.92; Sackley C, 2008, STROKE, V39, P3329, DOI 10.1161/STROKEAHA.108.518563; Sackley CM, 2008, CLIN REHABIL, V22, P714, DOI 10.1177/0269215508089058; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Syder D, 1993, SHEFFIELD SCREENING; Underwood M, 2013, LANCET, V382, P41, DOI 10.1016/S0140-6736(13)60649-2; van den Berg Maayken, 2006, Nurs Times, V102, P32; van Wijk I, 2006, J NEUROL NEUROSUR PS, V77, P1238, DOI 10.1136/jnnp.2006.089391; Walker MF, 2004, STROKE, V35, P2226, DOI 10.1161/01.STR.0000137766.17092.fb; Whitney J, 2012, J AM MED DIR ASSOC, V13, P535, DOI 10.1016/j.jamda.2012.03.009; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organization, 2001, INT CLASS FUNCT DIS	43	26	26	3	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2015	350								h468	10.1136/bmj.h468	http://dx.doi.org/10.1136/bmj.h468			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0JX	25657106	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000349313100005
J	Wallace, E; Salisbury, C; Guthrie, B; Lewis, C; Fahey, T; Smith, SM				Wallace, Emma; Salisbury, Chris; Guthrie, Bruce; Lewis, Cliona; Fahey, Tom; Smith, Susan M.			Managing patients with multimorbidity in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ADVERSE DRUG EVENTS; OLDER PERSONS PRESCRIPTIONS; STOPP SCREENING TOOL; LONG-TERM CONDITIONS; HEALTH-CARE; HOSPITAL ADMISSIONS; COST-EFFECTIVENESS; ALERT DOCTORS; EXPERIENCES; CONTINUITY		[Wallace, Emma; Lewis, Cliona; Fahey, Tom; Smith, Susan M.] Royal Coll Surgeons Ireland, Sch Med, HRB Ctr Primary Care Res, Dublin 2, Ireland; [Salisbury, Chris] Univ Bristol, Ctr Acad Primary Care, Bristol, Avon, England; [Guthrie, Bruce] Univ Dundee, Qual Safety & Informat Res Grp, Dundee, Scotland	Health Research Board - Ireland; Royal College of Surgeons - Ireland; University of Bristol; University of Dundee	Wallace, E (corresponding author), Royal Coll Surgeons Ireland, Sch Med, HRB Ctr Primary Care Res, Dublin 2, Ireland.	emmawallace@rcsi.ie	Guthrie, Bruce/HHM-9696-2022; Fahey, Tom/C-9367-2012; Salisbury, Chris/C-6724-2008	Fahey, Tom/0000-0002-5896-5783; Salisbury, Chris/0000-0002-4378-3960; Guthrie, Bruce/0000-0003-4191-4880; wallace, emma/0000-0002-9315-2956; Smith, Susan/0000-0001-6027-2727				Aboulghate A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X653624; [Anonymous], 2014, TOOLS SHAR DEC MAK; Avery AJ, 2012, LANCET, V379, P1310, DOI 10.1016/S0140-6736(11)61817-5; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bayliss Elizabeth A, 2004, Health Qual Life Outcomes, V2, P47, DOI 10.1186/1477-7525-2-47; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Brilleman SL, 2013, FAM PRACT, V30, P172, DOI 10.1093/fampra/cms060; Cahir C, 2014, BRIT J CLIN PHARMACO, V77, P201, DOI 10.1111/bcp.12161; Campbell SM, 2010, ANN FAM MED, V8, P499, DOI 10.1370/afm.1145; Condelius A, 2008, ARCH GERONTOL GERIAT, V46, P41, DOI 10.1016/j.archger.2007.02.005; Cooper JA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0484-6; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Da Silva D, 2012, HELPING PEOPLE SHARE; Drewes YM, 2011, AGE AGEING, V40, P352, DOI 10.1093/ageing/afr010; Duerden M., 2013, POLYPHARMACY MED OPT; Elwyn G, 2010, BMJ-BRIT MED J, V341, pc5146; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Fiscella K, 2008, ARCH INTERN MED, V168, P1843, DOI 10.1001/archinte.168.17.1843; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2004, HEALTH QUAL LIFE OUT, V2, P51, DOI [10.1186/1477-7525-2-51, DOI 10.1186/1477-7525-2-51]; Fortin M, 2006, ANN FAM MED, V4, P417, DOI 10.1370/afm.528; Foster G, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD005108.PUB2; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gallagher P, 2009, AGE AGEING, V38, P603, DOI 10.1093/ageing/afp058; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gitlin LN, 2009, J AM GERIATR SOC, V57, P476, DOI 10.1111/j.1532-5415.2008.02147.x; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Gunn JM, 2012, SOC PSYCH PSYCH EPID, V47, P175, DOI 10.1007/s00127-010-0330-z; Guthrie B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a867; Guthrie Bruce, 2011, BMJ, V342, pd3514, DOI 10.1136/bmj.d3514; Haggerty JL, 2012, BMJ, V345; Hamilton H, 2011, ARCH INTERN MED, V171, P1013, DOI 10.1001/archinternmed.2011.215; Harrison C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004694; Holland R, 2005, BMJ-BRIT MED J, V330, P293, DOI 10.1136/bmj.38338.674583.AE; Holland R, 2008, BRIT J CLIN PHARMACO, V65, P303, DOI 10.1111/j.1365-2125.2007.03071.x; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Hussey PS, 2014, JAMA INTERN MED, V174, P742, DOI 10.1001/jamainternmed.2014.245; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Kennedy A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2882; Lin EHB, 2003, JAMA-J AM MED ASSOC, V290, P2428, DOI 10.1001/jama.290.18.2428; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; MAY C, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B2803; Mercer SW, 2007, BRIT J GEN PRACT, V57, P960, DOI 10.3399/096016407782604910; Mercer SW, 2007, ANN FAM MED, V5, P503, DOI 10.1370/afm.778; Muth C, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0223-1; National Institute for Health and Care Excellence, 2009, DEPR AD CHRON PHYS H; Nyweide DJ, 2013, JAMA INTERN MED, V173, P1879, DOI 10.1001/jamainternmed.2013.10059; O'Brien R, 2011, CHRONIC ILLN, V7, P45, DOI 10.1177/1742395310382461; Payne RA, 2014, EUR J CLIN PHARMACOL, V70, P575, DOI 10.1007/s00228-013-1639-9; Roland M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2510; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285; Sharma G, 2009, JAMA-J AM MED ASSOC, V301, P1671, DOI 10.1001/jama.2009.517; Sinnott C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003610; Smith SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006560.pub2; Smith SM, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X514756; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Wilson AD, 2006, COCHRANE DB SYST REV, V1, DOI [10.1002/14651858.CD003540.pub.2, DOI 10.1002/14651858.CD003540.PUB.2]; Wyatt KD, 2014, MED CARE, V52, pS92, DOI 10.1097/MLR.0b013e3182a51b3d	63	334	339	6	57	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2015	350								h176	10.1136/bmj.h176	http://dx.doi.org/10.1136/bmj.h176			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ7ZB	25646760	Green Published			2022-12-28	WOS:000348433200004
J	Manson, JE; Bassuk, SS				Manson, JoAnn E.; Bassuk, Shari S.			Vitamin D Research and Clinical Practice At a Crossroads	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FORCE RECOMMENDATION STATEMENT; D DEFICIENCY; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; CANCER; SUPPLEMENTS; TRIAL		[Manson, JoAnn E.; Bassuk, Shari S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Manson, JE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA138962] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA138962, CA138962] Funding Source: Medline; NHLBI NIH HHS [R01 HL034594] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bolland MJ, 2014, LANCET DIABETES ENDO, V2, P307, DOI 10.1016/S2213-8587(13)70212-2; Greider K., 2012, AARP B; Heaney RP, 2015, ANN INTERN MED, V162, P144, DOI 10.7326/M14-2573; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Institute of Medicine, 2011, DIETARY REFERENCE IN; LeFevre ML, 2015, ANN INTERN MED, V162, P133, DOI 10.7326/M14-2450; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Moyer VA, 2014, ANN INTERN MED, V160, P558, DOI 10.7326/M14-0198	8	82	83	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1311	1312		10.1001/jama.2015.1353	http://dx.doi.org/10.1001/jama.2015.1353			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25695911				2022-12-28	WOS:000352315900012
J	Gostin, LO				Gostin, Lawrence O.			Law, Ethics, and Public Health in the Vaccination Debates Politics of the Measles Outbreak	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				CDC Health Alert Network, 2015, US MULT MEAS OUTBR; Healy J, 2015, NY TIMES, pA1; National Conference of State Legislatures, 2015, STAT REL PHIL EX SCH; Omer SB, 2012, NEW ENGL J MED, V367, P1170, DOI 10.1056/NEJMc1209037; Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342; Peters JW, 2015, NY TIMES, pA1; van Panhuis WG, 2013, NEW ENGL J MED, V369, P2152, DOI 10.1056/NEJMms1215400; Yang YT, 2015, JAMA-J AM MED ASSOC, V313, P247, DOI 10.1001/jama.2014.16286	8	54	55	0	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1099	1100		10.1001/jama.2015.1518	http://dx.doi.org/10.1001/jama.2015.1518			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25675396				2022-12-28	WOS:000351102500006
J	Haigwood, NL				Haigwood, Nancy L.			HIV Tied down by its own receptor	NATURE			English	Editorial Material							SIV INFECTION; RETROVIRUS	An engineered protein that binds to the envelope of HIV viruses protects monkeys against infection with a simian-human virus that causes AIDS. This gene-therapy approach might provide an alternative to elusive HIV vaccines. SEE LETTER P.87	Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR 97006 USA	Oregon Health & Science University; Oregon National Primate Research Center	Haigwood, NL (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR 97006 USA.	haigwoon@ohsu.edu	Haigwood, Nancy Logan/AAV-7484-2020	Haigwood, Nancy/0000-0002-1477-9575	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER; NIH HHS [P51 OD011092] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492	8	0	0	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					36	37		10.1038/nature14205	http://dx.doi.org/10.1038/nature14205			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25707798				2022-12-28	WOS:000350304000026
J	Heim, NA; Knope, ML; Schaal, EK; Wang, SC; Payne, JL				Heim, Noel A.; Knope, Matthew L.; Schaal, Ellen K.; Wang, Steve C.; Payne, Jonathan L.			Cope's rule in the evolution of marine animals	SCIENCE			English	Article							BODY-SIZE EVOLUTION; SELECTION; INCREASE; MAMMALS; TRENDS; OXYGEN; BIRDS	Cope's rule proposes that animal lineages evolve toward larger body size over time. To test this hypothesis across all marine animals, we compiled a data set of body sizes for 17,208 genera of marine animals spanning the past 542 million years. Mean biovolume across genera has increased by a factor of 150 since the Cambrian, whereas minimum biovolume has decreased by less than a factor of 10, and maximum biovolume has increased by more than a factor of 100,000. Neutral drift from a small initial value cannot explain this pattern. Instead, most of the size increase reflects differential diversification across classes, indicating that the pattern does not reflect a simple scaling-up of widespread and persistent selection for larger size within populations.	[Heim, Noel A.; Knope, Matthew L.; Schaal, Ellen K.; Payne, Jonathan L.] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Wang, Steve C.] Swarthmore Coll, Dept Math & Stat, Swarthmore, PA 19081 USA	Stanford University; Swarthmore College	Heim, NA (corresponding author), Stanford Univ, Dept Geol & Environm Sci, 450 Serra Mall, Stanford, CA 94305 USA.	naheim@stanford.edu	Heim, Noel A,/GRO-2700-2022; Payne, Jonathan L/A-1240-2007; Wang, Steve C./R-8145-2019	Payne, Jonathan L/0000-0002-9601-3310; Wang, Steve C./0000-0002-8953-285X; Heim, Noel/0000-0002-4528-345X	NSF [EAR-1151022]; Stanford School of Earth Sciences; Swarthmore College James Michener Faculty Fellowship; Directorate For Geosciences [1151022] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Stanford School of Earth Sciences; Swarthmore College James Michener Faculty Fellowship; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank G. Griggs, M. Faerber, M. Laws, S. Sanghvi, L. Taylor, and the many undergraduate and high-school students for making body size measurements. J. Saltzman helped recruit high-school students. G. Hunt assisted with time series analysis. A. Clauset and M. A. Etnier kindly made their body size data on extant marine mammals available. Funding was provided by NSF grant EAR-1151022, the Stanford School of Earth Sciences, and the Swarthmore College James Michener Faculty Fellowship. Raw data files used for all analyses are permanently archived in the Stanford Digital Repository (http://purl.stanford.edu/rf761bx8302). This is Paleobiology Database publication 217.	Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; ARNOLD AJ, 1995, J PALEONTOL, V69, P203, DOI 10.1017/S0022336000034557; BAMBACH RK, 1993, PALEOBIOLOGY, V19, P372, DOI 10.1017/S0094837300000336; Brown J.H., 1995, MACROECOLOGY; Butler RJ, 2008, J EVOLUTION BIOL, V21, P1673, DOI 10.1111/j.1420-9101.2008.01594.x; Cope E.D., 1896, PRIMARY FACTORS ORGA, DOI DOI 10.5962/BHL.TITLE.2068; COPE E. D, 1885, AM NAT, V19, P234; Dahl TW, 2010, P NATL ACAD SCI USA, V107, P17911, DOI 10.1073/pnas.1011287107; Deperet C.J.J., 1909, TRANSFORMATIONS ANIM; GOULD SJ, 1988, J PALEONTOL, V62, P319, DOI 10.1017/S0022336000059126; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Hone DWE, 2005, J EVOLUTION BIOL, V18, P587, DOI 10.1111/j.1420-9101.2004.00870.x; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; Kingsolver JG, 2004, EVOLUTION, V58, P1608; Knouft JH, 2003, AM NAT, V161, P413, DOI 10.1086/346133; Laurin M, 2004, SYST BIOL, V53, P594, DOI 10.1080/10635150490445706; Maurer BA, 1998, EVOL ECOL, V12, P925, DOI 10.1023/A:1006512121434; Moen DS, 2006, J EVOLUTION BIOL, V19, P1210, DOI 10.1111/j.1420-9101.2006.01082.x; Monroe MJ, 2010, J EVOLUTION BIOL, V23, P2017, DOI 10.1111/j.1420-9101.2010.02051.x; NEWELL ND, 1949, EVOLUTION, V3, P103, DOI 10.2307/2405545; Novack-Gottshall PM, 2008, P NATL ACAD SCI USA, V105, P5430, DOI 10.1073/pnas.0709645105; Pauly D., 2019, GASPING FISH PANTING, V2nd ed.; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; RENSCH B, 1948, EVOLUTION, V2, P218, DOI 10.1111/j.1558-5646.1948.tb02742.x; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Sperling EA, 2013, P NATL ACAD SCI USA, V110, P13446, DOI 10.1073/pnas.1312778110; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251	29	109	110	21	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					867	870		10.1126/science.1260065	http://dx.doi.org/10.1126/science.1260065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700517	Green Published			2022-12-28	WOS:000349761100042
J	Young, LJ; Barrett, CE				Young, Larry J.; Barrett, Catherine E.			Can oxytocin treat autism?	SCIENCE			English	Editorial Material							SPECTRUM DISORDERS; CHILDREN; OXTR		[Young, Larry J.; Barrett, Catherine E.] Emory Univ, Silvio O Conte Ctr Oxytocin & Social Cognit, Dept Psychiat, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA	Emory University	Young, LJ (corresponding author), Emory Univ, Silvio O Conte Ctr Oxytocin & Social Cognit, Dept Psychiat, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.	lyoun03@emory.edu	Young, Larry/HGE-5031-2022	Barrett, Catherine/0000-0002-2692-4194	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096983, P50MH100023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS096050] Funding Source: NIH RePORTER; NCRR NIH HHS [P51 RR000165] Funding Source: Medline; NIMH NIH HHS [P50 MH100023, R01 MH096983] Funding Source: Medline; NINDS NIH HHS [T32 NS096050] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anagnostou E, 2014, BRAIN RES, V1580, P188, DOI 10.1016/j.brainres.2014.01.049; Aoki Y, 2014, BRAIN, V137, P3073, DOI 10.1093/brain/awu231; Barrett CE, 2014, NEUROPHARMACOLOGY, V85, P357, DOI 10.1016/j.neuropharm.2014.05.041; Freeman SM, 2014, PSYCHONEUROENDOCRINO, V45, P128, DOI 10.1016/j.psyneuen.2014.03.023; Gordon I, 2013, P NATL ACAD SCI USA, V110, P20953, DOI 10.1073/pnas.1312857110; Guastella AJ, 2015, J CHILD PSYCHOL PSYC, V56, P444, DOI 10.1111/jcpp.12305; Huang HP, 2014, NEUROPSYCHOPHARMACOL, V39, P1102, DOI 10.1038/npp.2013.310; LoParo D, 2015, MOL PSYCHIATR, V20, P640, DOI 10.1038/mp.2014.77; Modi ME, 2015, NEUROPSYCHOPHARMACOL, V40, P1856, DOI 10.1038/npp.2015.35; Owen SF, 2013, NATURE, V500, P458, DOI 10.1038/nature12330; Parker KJ, 2014, P NATL ACAD SCI USA, V111, P12258, DOI 10.1073/pnas.1402236111; Penagarikano O, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010257; Skuse DH, 2014, P NATL ACAD SCI USA, V111, P1987, DOI 10.1073/pnas.1302985111; Teng BL, 2013, NEUROPHARMACOLOGY, V72, P187, DOI 10.1016/j.neuropharm.2013.04.038; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190	15	140	142	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					825	826		10.1126/science.aaa8120	http://dx.doi.org/10.1126/science.aaa8120			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700501	Green Accepted			2022-12-28	WOS:000349761100021
J	Fitzgibbons, RJ; Forse, A				Fitzgibbons, Robert J., Jr.; Forse, Armour			Groin Hernias in Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INGUINAL-HERNIA; SOCIETY GUIDELINES; RISK-FACTORS; CHRONIC PAIN; REPAIR; METAANALYSIS; SURGERY; MEN	A 67-year-old man presents with a bulge in his right groin, which he recently noticed while in the shower. He is easily able to push it back completely, but it reappears intermittently. He says it is not painful and that he has not altered his activity level because of it. Physical examination confirms the presence of a right inguinal hernia. How should his case be managed?	[Fitzgibbons, Robert J., Jr.; Forse, Armour] Creighton Univ, Sch Med, Dept Surg, Omaha, NE 68131 USA	Creighton University	Fitzgibbons, RJ (corresponding author), Creighton Univ, Sch Med, Dept Surg, 601 N 30th St,Suite 3520, Omaha, NE 68131 USA.	fitzjr@creighton.edu	, Robert/A-2904-2019	, Robert/0000-0002-3652-7686				Ahmad G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006583.pub2; Amato B, 2012, COCHRANE DB SYST REV, V4, P1, DOI DOI 10.1002/14651858.CD001543.PUB4; [Anonymous], 2007, SSAT PAT CAR GUID SU; Bay-Nielsen Morten, 2006, Hernia, V10, P30, DOI 10.1007/s10029-005-0029-3; Bittner R, 2011, SURG ENDOSC, V25, P2773, DOI 10.1007/s00464-011-1799-6; Burcharth J, 2013, HERNIA, V17, P183, DOI 10.1007/s10029-013-1060-4; Burcharth J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054367; Cavazzola LT, 2013, SURG CLIN N AM, V93, P1269, DOI 10.1016/j.suc.2013.06.013; Chung L, 2011, BRIT J SURG, V98, P596, DOI 10.1002/bjs.7355; Dahlstrand U, 2009, ANN SURG, V249, P672, DOI 10.1097/SLA.0b013e31819ed943; El-Dhuwaib Y, 2013, SURG ENDOSC, V27, P936, DOI 10.1007/s00464-012-2538-3; Fitzgibbons RJ, 2006, JAMA-J AM MED ASSOC, V295, P285, DOI 10.1001/jama.295.3.285; Fitzgibbons RJ, 2013, ANN SURG, V258, P508, DOI 10.1097/SLA.0b013e3182a19725; Hair A, 2001, J AM COLL SURGEONS, V193, P125, DOI 10.1016/S1072-7515(01)00983-8; Hakeem A, 2011, WORLD J GASTRO SURG, V3, P73, DOI 10.4240/wjgs.v3.i6.73; Kehlet H, 2005, WORLD J SURG, V29, P1058, DOI 10.1007/s00268-005-7969-8; Kingsnorth A, 2003, LANCET, V362, P1561, DOI 10.1016/S0140-6736(03)14746-0; Koch A, 2005, BRIT J SURG, V92, P1553, DOI 10.1002/bjs.5156; Lau H, 2007, SURGERY, V141, P262, DOI 10.1016/j.surg.2006.04.014; Li JS, 2014, AM J SURG, V207, P602, DOI 10.1016/j.amjsurg.2013.05.008; McCormack K, 2005, HEALTH TECHNOL ASSES, V9, P1; McCormack K, 2003, Cochrane Database Syst Rev, pCD001785, DOI 10.1002/14651858.CD001785; Miller J, 2014, JAMA SURG, V149, P1077, DOI 10.1001/jamasurg.2014.484; Miserez M, 2014, HERNIA, V18, P151, DOI 10.1007/s10029-014-1236-6; National Insititute for Health and Care Excellence, 2004, LAP SURG ING HERN RE; Nilsson E, 1997, EUR J SURG, V163, P823; Nilsson H, 2007, ANN SURG, V245, P656, DOI 10.1097/01.sla.0000251364.32698.4b; O'Dwyer PJ, 2006, ANN SURG, V244, P167, DOI 10.1097/01.sla.0000217637.69699.ef; O'Reilly EA, 2012, ANN SURG, V255, P846, DOI 10.1097/SLA.0b013e31824e96cf; Poelman MM, 2013, SURG ENDOSC, V27, P3505, DOI 10.1007/s00464-013-3001-9; Poobalan AS, 2003, CLIN J PAIN, V19, P48, DOI 10.1097/00002508-200301000-00006; Primatesta P, 1996, INT J EPIDEMIOL, V25, P835, DOI 10.1093/ije/25.4.835; Rosenberg Jacob, 2011, Dan Med Bull, V58, pC4243; Ruhl CE, 2007, AM J EPIDEMIOL, V165, P1154, DOI 10.1093/aje/kwm011; Schouten N, 2012, HERNIA, V16, P387, DOI 10.1007/s10029-012-0904-7; Scott NW., 2002, COCHRANE DB SYST REV, pCD002197, DOI [10.1002/14651858, DOI 10.1002/14651858, DOI 10.1002/14651858.CD002197]; Simons MP, 2009, HERNIA, V13, P343, DOI 10.1007/s10029-009-0529-7; Smigielski J, 2011, EUR J CLIN INVEST, V41, P584, DOI 10.1111/j.1365-2362.2010.02445.x; Svendsen SW, 2013, SCAND J WORK ENV HEA, V39, P5, DOI 10.5271/sjweh.3305; Thompson JS, 2008, AM J SURG, V195, P89, DOI 10.1016/j.amjsurg.2007.07.021; Treadwell J., 2012, WORLD MALARIA REPORT, V70, P1; van den Berg JC, 1999, INVEST RADIOL, V34, P739, DOI 10.1097/00004424-199912000-00002; Zacest AC, 2010, J NEUROSURG, V112, P784, DOI 10.3171/2009.8.JNS09533; Zhu X, 2014, SURG-J R COLL SURG E, V12, P94, DOI 10.1016/j.surge.2013.11.018	44	96	103	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					756	763		10.1056/NEJMcp1404068	http://dx.doi.org/10.1056/NEJMcp1404068			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7PB	25693015				2022-12-28	WOS:000349818700009
J	Leaute-Labreze, C; Hoeger, P; Mazereeuw-Hautier, J; Guibaud, L; Baselga, E; Posiunas, G; Phillips, RJ; Caceres, H; Gutierrez, JCL; Ballona, R; Friedlander, SF; Powell, J; Perek, D; Metz, B; Barbarot, S; Maruani, A; Szalai, ZZ; Krol, A; Boccara, O; Foelster-Holst, R; Bosch, MIF; Su, J; Buckova, H; Torrelo, A; Cambazard, F; Grantzow, R; Wargon, O; Wyrzykowski, D; Roessler, J; Bernabeu-Wittel, J; Valencia, AM; Przewratil, P; Glick, S; Pope, E; Birchall, N; Benjamin, L; Mancini, AJ; Vabres, P; Souteyrand, P; Frieden, IJ; Berul, CI; Mehta, CR; Prey, S; Boralevi, F; Morgan, CC; Heritier, S; Delarue, A; Voisard, JJ				Leaute-Labreze, C.; Hoeger, P.; Mazereeuw-Hautier, J.; Guibaud, L.; Baselga, E.; Posiunas, G.; Phillips, R. J.; Caceres, H.; Lopez Gutierrez, J. C.; Ballona, R.; Friedlander, S. F.; Powell, J.; Perek, D.; Metz, B.; Barbarot, S.; Maruani, A.; Szalai, Z. Z.; Krol, A.; Boccara, O.; Foelster-Holst, R.; Febrer Bosch, M. I.; Su, J.; Buckova, H.; Torrelo, A.; Cambazard, F.; Grantzow, R.; Wargon, O.; Wyrzykowski, D.; Roessler, J.; Bernabeu-Wittel, J.; Valencia, A. M.; Przewratil, P.; Glick, S.; Pope, E.; Birchall, N.; Benjamin, L.; Mancini, A. J.; Vabres, P.; Souteyrand, P.; Frieden, I. J.; Berul, C. I.; Mehta, C. R.; Prey, S.; Boralevi, F.; Morgan, C. C.; Heritier, S.; Delarue, A.; Voisard, J-J			A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TREATMENT SELECTION; NATURAL-HISTORY; INFANCY; CORTICOSTEROIDS; MANAGEMENT; ANOMALIES; CHILDREN; THERAPY; DESIGNS	BACKGROUND Oral propranolol has been used to treat complicated infantile hemangiomas, although data from randomized, controlled trials to inform its use are limited. METHODS We performed a multicenter, randomized, double-blind, adaptive, phase 2-3 trial assessing the efficacy and safety of a pediatric-specific oral propranolol solution in infants 1 to 5 months of age with proliferating infantile hemangioma requiring systemic therapy. Infants were randomly assigned to receive placebo or one of four propranolol regimens (1 or 3 mg of propranolol base per kilogram of body weight per day for 3 or 6 months). A preplanned interim analysis was conducted to identify the regimen to study for the final efficacy analysis. The primary end point was success (complete or nearly complete resolution of the target hemangioma) or failure of trial treatment at week 24, as assessed by independent, centralized, blinded evaluations of standardized photographs. RESULTS Of 460 infants who underwent randomization, 456 received treatment. On the basis of an interim analysis of the first 188 patients who completed 24 weeks of trial treatment, the regimen of 3 mg of propranolol per kilogram per day for 6 months was selected for the final efficacy analysis. The frequency of successful treatment was higher with this regimen than with placebo (60% vs. 4%, P<0.001). A total of 88% of patients who received the selected propranolol regimen showed improvement by week 5, versus 5% of patients who received placebo. A total of 10% of patients in whom treatment with propranolol was successful required systemic retreatment during follow-up. Known adverse events associated with propranolol (hypoglycemia, hypotension, bradycardia, and bronchospasm) occurred infrequently, with no significant difference in frequency between the placebo group and the groups receiving propranolol. CONCLUSIONS This trial showed that propranolol was effective at a dose of 3 mg per kilogram per day for 6 months in the treatment of infantile hemangioma. (Funded by Pierre Fabre Dermatologie; ClinicalTrials.gov number, NCT01056341.)	[Leaute-Labreze, C.; Prey, S.; Boralevi, F.] Ctr Hosp Univ CHU, Hop Pellegrin Enfants, Bordeaux, France; [Mazereeuw-Hautier, J.] Hop Enfants, Toulouse, France; [Guibaud, L.] CHU Lyon Est, Hop Femme Mere Enfant, Lyon, France; [Barbarot, S.] CHU Nantes, F-44035 Nantes 01, France; [Barbarot, S.] INSERM, Ctr Invest Clin CIC 004, Nantes, France; [Maruani, A.] Univ Tours, INSERM CIC 1415, Ctr Hosp Reg Univ CHRU Tours, Tours, France; [Boccara, O.] Hop Necker Enfants Malad, Paris, France; [Morgan, C. C.] Cardinal Syst, Paris, France; [Cambazard, F.] Hop Nord St Etienne, CHU St Etienne, St Etienne, France; [Vabres, P.] CHU Dijon, Hop Bocage, Dijon, France; [Souteyrand, P.] CHR Univ Clermont Ferrand, Hotel Dieu, Clermont Ferrand, France; [Delarue, A.; Voisard, J-J] Pierre Fabre Dermatol, Lavaur, France; [Hoeger, P.] Kinderkrankenhaus Wilhelmstift, Hamburg, Germany; [Foelster-Holst, R.] Univ Klinikum Schleswig Holstein, Kiel, Germany; [Grantzow, R.] Univ Munich, Kinderchirurg Klin, Munich, Germany; [Roessler, J.] Univ Klinikum Freiburg, Zentrum Kinderheilkunde & Jugendmed, Freiburg, Germany; [Baselga, E.] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Lopez Gutierrez, J. C.] Hosp La Paz, Madrid, Spain; [Torrelo, A.] Hosp Nino Jesus, Madrid, Spain; [Febrer Bosch, M. I.] Hosp Gen Univ Valencia, Valencia, Spain; [Bernabeu-Wittel, J.] Hosp Univ Virgen Rocio, Seville, Spain; [Valencia, A. M.] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico; [Posiunas, G.] Vilnius Univ Hosp, Childrens Hosp, Vilnius, Lithuania; [Phillips, R. J.] Monash Univ, Royal Childrens Hosp, Melbourne, Vic 3004, Australia; [Su, J.] Monash Univ, Box Hill Hosp, Melbourne, Vic 3004, Australia; [Heritier, S.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Wargon, O.] Sydney Childrens Hosp, Sydney, NSW, Australia; [Buckova, H.] Hosp Brno, Pediat Clin Fac, Brno, Czech Republic; [Ballona, R.] Clin Int, Lima, Peru; [Caceres, H.] Inst Nacl Salud Nino, Lima, Peru; [Friedlander, S. F.] Rady Childrens Hosp, San Diego, CA USA; [Powell, J.] CHU St Justine, Montreal, PQ, Canada; [Perek, D.] Inst Pomnik Ctr Zdrowia Dziecka, Warsaw, Poland; [Wyrzykowski, D.] Gdansk Med Univ, Copernicus Hosp, Gdansk, Poland; [Przewratil, P.] M Komopnickiej Uniwersytetu, Szpital Klin, Lodz, Poland; [Metz, B.] Univ Calif Irvine, Irvine, CA USA; [Szalai, Z. Z.] Borgyogyaszati Ozrtaly, Heim Pal Gyermekkorhaz, Budapest, Hungary; Oregon Hlth & Sci Univ, Portland, OR USA; [Glick, S.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Pope, E.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Birchall, N.] Auckland Dermatol, Auckland, New Zealand; [Benjamin, L.] Stanford Univ, Sch Med, Lucile Packard Childrens Hosp, Stanford, CA 94305 USA; [Mancini, A. J.] Ann & Robert H Lurie Childrens Hosp, Chicago, IL USA; [Frieden, I. J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Berul, C. I.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Mehta, C. R.] Cytel, Cambridge, MA USA	CHU Bordeaux; CHU de Toulouse; CHU Lyon; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne; CHU Dijon Bourgogne; University of Kiel; Schleswig Holstein University Hospital; University of Munich; University of Freiburg; Hospital of Santa Creu i Sant Pau; Hospital Universitario La Paz; Hospital Clinic Universitari de Valencia; Virgen del Rocio University Hospital; Hospital Infantil de Mexico Federico Gomez; Vilnius University Hospital Santariskiu Klinikos; Monash University; Royal Children's Hospital Melbourne; Box Hill Hospital; Monash University; Monash University; University of Sydney; Rady Childrens Hospital San Diego; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Children's Memorial Health Institute; Fahrenheit Universities; Medical University Gdansk; University of California System; University of California Irvine; Oregon Health & Science University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Lucile Packard Children's Hospital (LPCH); Stanford University; Ann & Robert H. Lurie Children's Hospital of Chicago; University of California System; University of California San Francisco; Children's National Health System	Leaute-Labreze, C (corresponding author), Hop Pellegrin Enfants, Unite Dermatol Pediat, Pl Amelie Raba Leon, F-33076 Bordeaux, France.	christine.labreze@chu-bordeaux.fr	Lopez-Gutierrez, Juan Carlos/AAF-1417-2021; Su, John/AAH-9042-2019; Wargon, Orli/D-6204-2015; Glick, Sharon A./AAQ-3810-2021; Mancini, Anthony J./AAE-1583-2022; Su, John C/E-6040-2017; Vabres, Pierre/V-3850-2019; Vabres, Pierre/D-3906-2011; Maruani, annabel/L-9017-2015; IBIS, DERMATOLOGIA/H-7489-2016	Lopez-Gutierrez, Juan Carlos/0000-0003-0445-6796; Su, John/0000-0002-4021-5423; Wargon, Orli/0000-0002-4466-6985; Su, John C/0000-0002-4021-5423; Vabres, Pierre/0000-0001-8693-3183; Vabres, Pierre/0000-0001-8693-3183; Rossler, Jochen/0000-0003-4022-4917; Maruani, Annabel/0000-0003-3734-810X; Barbarot, Sebastien/0000-0002-6629-9100; Mancini, Anthony J/0000-0003-0903-7734; Frieden, Ilona/0000-0001-7305-5940; Valencia, Adriana/0000-0001-5421-4176; boralevi, franck/0000-0002-0477-5909; Przewratil, Przemyslaw/0000-0003-4581-8853	Pierre Fabre Dermatologie	Pierre Fabre Dermatologie	Funded by Pierre Fabre Dermatologie; ClinicalTrials.gov number, NCT01056341.	Ahogo CK, 2013, BRIT J DERMATOL, V169, P1252, DOI 10.1111/bjd.12432; Barrio Victoria R, 2005, Dermatol Ther, V18, P151, DOI 10.1111/j.1529-8019.2005.05018.x; Bauland CG, 2011, PLAST RECONSTR SURG, V127, P1643, DOI 10.1097/PRS.0b013e318208d2ac; Bertrand J, 2011, PEDIATR DERMATOL, V28, P649, DOI 10.1111/j.1525-1470.2011.01551.x; BOWERS RE, 1960, ARCH DERMATOL, V82, P667, DOI 10.1001/archderm.1960.01580050009002; Chang LC, 2008, PEDIATRICS, V122, P360, DOI 10.1542/peds.2007-2767; Drolet BA, 2013, PEDIATRICS, V131, P128, DOI 10.1542/peds.2012-1691; ENJOLRAS O, 1990, PEDIATRICS, V85, P491; Enjoras O, 2004, ARCH PEDIATRIE, V11, P99, DOI 10.1016/j.arcped.2003.10.014; EZEKOWITZ A, 1995, NEW ENGL J MED, V333, P595, DOI 10.1056/NEJM199508313330913; EZEKOWITZ RAB, 1994, NEW ENGL J MED, V330, P300; EZEKOWITZ RAB, 1992, NEW ENGL J MED, V326, P1456, DOI 10.1056/NEJM199205283262203; Frieden IJ, 1997, J AM ACAD DERMATOL, V37, P631, DOI 10.1016/S0190-9622(97)70183-X; Frieden Ilona J, 2005, Pediatr Dermatol, V22, P383, DOI 10.1111/j.1525-1470.2005.00102.x; Fuchsmann C, 2011, ARCH OTOLARYNGOL, V137, P471, DOI 10.1001/archoto.2011.55; Haggstrom AN, 2007, J PEDIATR-US, V150, P291, DOI 10.1016/j.jpeds.2006.12.003; Haider KM, 2010, J AAPOS, V14, P251, DOI 10.1016/j.jaapos.2010.05.002; Heritier S, 2011, STAT MED, V30, P1541, DOI 10.1002/sim.4179; Hermans DJJ, 2011, J AM ACAD DERMATOL, V64, P833, DOI 10.1016/j.jaad.2011.01.025; Hogeling M, 2011, PEDIATRICS, V128, pE259, DOI 10.1542/peds.2010-0029; Hoornweg M J, 2005, Ned Tijdschr Geneeskd, V149, P2455; Izadpanah A, 2013, PLAST RECONSTR SURG, V131, P601, DOI 10.1097/PRS.0b013e31827c6fab; Jennison C, 2007, J BIOPHARM STAT, V17, P1135, DOI 10.1080/10543400701645215; Kilcline C, 2008, PEDIATR DERMATOL, V25, P168, DOI 10.1111/j.1525-1470.2008.00626.x; Leaute-Labreze C, 2013, BRIT J DERMATOL, V169, P181, DOI 10.1111/bjd.12217; Leaute-Labreze C, 2008, NEW ENGL J MED, V358, P2649, DOI 10.1056/NEJMc0708819; Lister WA, 1938, LANCET, V1, P1429; Mabeta P, 2011, INT J DEV BIOL, V55, P431, DOI 10.1387/ijdb.103221pm; Mazereeuw-Hautier J, 2010, J PEDIATR-US, V157, P340, DOI 10.1016/j.jpeds.2010.04.003; Metry D, 2013, PEDIATR DERMATOL, V30, P71, DOI 10.1111/j.1525-1470.2012.01879.x; Munden A, 2014, BRIT J DERMATOL, V170, P907, DOI 10.1111/bjd.12804; Phillips RJ, 2012, J PAEDIATR CHILD H, V48, P902, DOI 10.1111/j.1440-1754.2012.02521.x; Posch M, 2005, STAT MED, V24, P3697, DOI 10.1002/sim.2389; Price CJ, 2011, ARCH DERMATOL, V147, P1371, DOI 10.1001/archdermatol.2011.203; Saint-Jean M, 2011, J AM ACAD DERMATOL, V64, P827, DOI 10.1016/j.jaad.2010.12.040; Sans V, 2009, PEDIATRICS, V124, pE423, DOI 10.1542/peds.2008-3458; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Snir M, 2011, EYE, V25, P1627, DOI 10.1038/eye.2011.233; ZAREM HA, 1967, PLAST RECONSTR SURG, V39, P76, DOI 10.1097/00006534-196701000-00010	39	400	429	6	108	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2015	372	8					735	746		10.1056/NEJMoa1404710	http://dx.doi.org/10.1056/NEJMoa1404710			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7PB	25693013				2022-12-28	WOS:000349818700007
J	Gordon, LM; Cohen, MJ; MacRenaris, KW; Pasteris, JD; Seda, T; Joester, D				Gordon, Lyle M.; Cohen, Michael J.; MacRenaris, Keith W.; Pasteris, Jill D.; Seda, Takele; Joester, Derk			Amorphous intergranular phases control the properties of rodent tooth enamel	SCIENCE			English	Article							FERRIHYDRITE; TOMOGRAPHY; MAGNESIUM	Dental enamel, a hierarchical material composed primarily of hydroxylapatite nanowires, is susceptible to degradation by plaque biofilm-derived acids. The solubility of enamel strongly depends on the presence of Mg2+, F-, and CO32-. However, determining the distribution of these minor ions is challenging. We show-using atom probe tomography, x-ray absorption spectroscopy, and correlative techniques-that in unpigmented rodent enamel, Mg2+ is predominantly present at grain boundaries as an intergranular phase of Mg-substituted amorphous calcium phosphate (Mg-ACP). In the pigmented enamel, a mixture of ferrihydrite and amorphous iron-calcium phosphate replaces the more soluble Mg-ACP, rendering it both harder and more resistant to acid attack. These results demonstrate the presence of enduring amorphous phases with a dramatic influence on the physical and chemical properties of the mature mineralized tissue.	[Gordon, Lyle M.; Cohen, Michael J.; Joester, Derk] Northwestern Univ, Evanston, IL 60208 USA; [MacRenaris, Keith W.] Northwestern Univ, QBIC, Evanston, IL 60208 USA; [Pasteris, Jill D.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Seda, Takele] Western Washington Univ, Dept Phys & Astron, Bellingham, WA 98225 USA	Northwestern University; Northwestern University; Washington University (WUSTL); Western Washington University	Joester, D (corresponding author), Northwestern Univ, 2220 Campus Dr, Evanston, IL 60208 USA.	d-joester@northwestern.edu	Joester, Derk/B-7525-2009	Gordon, Lyle/0000-0001-8335-0126; Pasteris, Jill/0000-0001-7041-6966	National Science Foundation [NSF DMR-0805313, DMR-1106208, DMR-1341391]; Northwestern University Materials Research Center [NSF-Materials Research and Engineering Center (MRSEC)] [DMR-1121262]; International Institute for Nanotechnology; Institute for Sustainability and Energy at Northwestern (ISEN); ACS; Canadian National Sciences and Engineering Research Council; NIH [T32GM008449]; U.S. DOE [DE-AC02-06CH11357]; E. I. DuPont de Nemours Co.; Dow Chemical Company; Northwestern University; Natural Sciences and Engineering Research Council of Canada; National Research Council of Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NSF-MRI [DMR-0420532]; ONR-DURIP [N00014-0400798, N00014-0610539, N00014-0910781]; NSF-MRSEC [DMR-1121262]; NASA Ames Research Center [NNA06CB93G]; NSF-NSEC [EEC-0118025/003]; Keck Foundation; State of Illinois; Direct For Mathematical & Physical Scien [1106208] Funding Source: National Science Foundation; Division Of Materials Research [1341391] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008449] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Northwestern University Materials Research Center [NSF-Materials Research and Engineering Center (MRSEC)](National Science Foundation (NSF)); International Institute for Nanotechnology; Institute for Sustainability and Energy at Northwestern (ISEN); ACS(American Cancer Society); Canadian National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. DOE(United States Department of Energy (DOE)); E. I. DuPont de Nemours Co.; Dow Chemical Company; Northwestern University; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NSF-MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); ONR-DURIP(Office of Naval Research); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NASA Ames Research Center(National Aeronautics & Space Administration (NASA)); NSF-NSEC(National Science Foundation (NSF)); Keck Foundation(W.M. Keck Foundation); State of Illinois; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Science Foundation (NSF DMR-0805313, DMR-1106208, and DMR-1341391), the Northwestern University Materials Research Center [NSF-Materials Research and Engineering Center (MRSEC) DMR-1121262], the International Institute for Nanotechnology, the Institute for Sustainability and Energy at Northwestern (ISEN), and the Petroleum Research Fund of the ACS in part supported this work. The Canadian National Sciences and Engineering Research Council in part supported L.M.G. The NIH predoctoral Biotechnology Training Grant T32GM008449 in part supported M.J.C. Portions of this work were performed at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) and the Canadian Light Source (CLS). DND-CAT is located at Sector 5 of the Advanced Photon Source (APS), an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory supported by the U.S. DOE under contract DE-AC02-06CH11357. E. I. DuPont de Nemours & Co., The Dow Chemical Company, and Northwestern University support DND-CAT. The Natural Sciences and Engineering Research Council of Canada, the National Research Council of Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan support CLS. This work made use of the Northwestern University Center for Atom Probe Tomography (NUCAPT) supported by NSF-MRI (DMR-0420532) and ONR-DURIP (N00014-0400798, N00014-0610539, N00014-0910781); the Optical Microscopy and Metallography Facility; the J. B. Cohen X-Ray Diffraction Facility supported by the NSF-MRSEC (DMR-1121262); the Northwestern University Quantitative Bioelemental Imaging Center supported by NASA Ames Research Center NNA06CB93G; the Northwestern University Atomic and Nanoscale Characterization and Experimental Center (NUANCE), Electron Probe Instrumentation Center (EPIC), and the Northwestern Nanoscale Integrated Fabrication, Testing, and Instrumentation Facility (NIFTI) supported by NSF-NSEC (EEC-0118025/003), NSF-MRSEC (DMR-1121262), the Keck Foundation, the State of Illinois, and Northwestern University. We thank Q. Ma and T. Regier for assistance with x-ray absorption spectroscopy; B. Myers for assistance with TEM sample preparation; C. Phatak for performing correlative TEM of APT samples; C. Whyne and M. Akens for supplying rat incisors; and C. Newcomb, S. Sur, and A. Deymier-Black for supplying mouse incisors. The supplementary materials contain additional data. L.M.G., J.D.P., and D.J. designed experiments, analyzed the data, and prepared the manuscript. L.M.G., M.J.C., K.W.M., J.D.P., and T.S. performed experiments.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Addadi L, 2012, Z KRIST-CRYST MATER, V227, P711, DOI 10.1524/zkri.2012.1524; American Dental Association, 2014, US DENT SPEND REM FL; Bechtle S, 2010, BIOMATERIALS, V31, P375, DOI 10.1016/j.biomaterials.2009.09.050; Bowen WH, 2013, ODONTOLOGY, V101, P9, DOI 10.1007/s10266-012-0091-0; CLARKE DR, 1987, J AM CERAM SOC, V70, P15, DOI 10.1111/j.1151-2916.1987.tb04846.x; Cuy JL, 2002, ARCH ORAL BIOL, V47, P281, DOI 10.1016/S0003-9969(02)00006-7; Dumont M, 2014, J STRUCT BIOL, V186, P38, DOI 10.1016/j.jsb.2014.02.006; Featherstone J D, 2012, Adv Dent Res, V24, P28, DOI 10.1177/0022034512452885; Gordon LM, 2012, ACS NANO, V6, P10667, DOI 10.1021/nn3049957; Gordon LM, 2011, NATURE, V469, P194, DOI 10.1038/nature09686; GORECKI G, 1992, CORROSION, V48, P613, DOI 10.5006/1.3315980; Hellman OC, 2000, MICROSC MICROANAL, V6, P437, DOI 10.1007/s100050010051; HOLT C, 1988, J CRYST GROWTH, V92, P239, DOI 10.1016/0022-0248(88)90455-1; HUGHES JM, 1989, AM MINERAL, V74, P870; Ingram G S, 1990, J Dent Res, V69 Spec No, P581; Laurencin D, 2011, BIOMATERIALS, V32, P1826, DOI 10.1016/j.biomaterials.2010.11.017; LeGeros R Z, 1996, Adv Dent Res, V10, P225; Li D, 1999, CAN MINERAL, V37, P199; MADSEN MB, 1986, HYPERFINE INTERACT, V29, P1431, DOI 10.1007/BF02399503; Martin T., 1999, ZOOLOGISCHE REIHE, V75, P257; Michel FM, 2010, P NATL ACAD SCI USA, V107, P2787, DOI 10.1073/pnas.0910170107; Moinichen CB, 1996, J ANAT, V189, P325; Nanci A, 2012, DEV STRUCTURE FUNCTI, V8; Politi Y, 2010, CHEM MATER, V22, P161, DOI 10.1021/cm902674h; Robinson C, 2000, CRIT REV ORAL BIOL M, V11, P481, DOI 10.1177/10454411000110040601; Rose J, 1997, LANGMUIR, V13, P1827, DOI 10.1021/la961039d; SILVERSTONE LM, 1975, CARIES RES, V9, P373, DOI 10.1159/000260179; Taubman MA, 2006, NAT REV IMMUNOL, V6, P555, DOI 10.1038/nri1857; TERPSTRA RA, 1986, CALCIFIED TISSUE INT, V39, P348, DOI 10.1007/BF02555203; Thompson K, 2007, ULTRAMICROSCOPY, V107, P131, DOI 10.1016/j.ultramic.2006.06.008; VOGEL P, 1984, REV SUISSE ZOOL, V91, P699, DOI 10.5962/bhl.part.81575; World Health Organization, 2012, ORAL HLTH; ZHAO JM, 1994, CLAY CLAY MINER, V42, P737, DOI 10.1346/CCMN.1994.0420610	34	145	148	6	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					746	750		10.1126/science.1258950	http://dx.doi.org/10.1126/science.1258950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678658				2022-12-28	WOS:000349221300042
J	Lu, TX; Wheeler, SE				Lu, Tongxiang; Wheeler, Steven E.			Harnessing weak interactions for enantioselective catalysis	SCIENCE			English	Editorial Material							SMALL-MOLECULE CATALYSTS; NONCOVALENT INTERACTIONS		[Lu, Tongxiang; Wheeler, Steven E.] Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA	Texas A&M University System; Texas A&M University College Station	Lu, TX (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA.	wheeler@chem.tamu.edu	Wheeler, Steven E/G-5834-2011; Lu, Tongxiang/K-7457-2014	Wheeler, Steven E/0000-0001-7824-6906; Lu, Tongxiang/0000-0003-3425-0959				Houk KN, 2008, NATURE, V455, P309, DOI 10.1038/nature07368; Houk KN, 2014, DAEDALUS-US, V143, P49, DOI 10.1162/DAED_a_00305; Knowles RR, 2010, P NATL ACAD SCI USA, V107, P20678, DOI 10.1073/pnas.1006402107; Krenske EH, 2013, ACCOUNTS CHEM RES, V46, P979, DOI 10.1021/ar3000794; Mahlau M, 2013, ANGEW CHEM INT EDIT, V52, P518, DOI 10.1002/anie.201205343; Milo A, 2015, SCIENCE, V347, P737, DOI 10.1126/science.1261043; Milo A, 2014, NATURE, V507, P210, DOI 10.1038/nature13019; Neel AJ, 2013, J AM CHEM SOC, V135, P14044, DOI 10.1021/ja407410b; Wheeler SE, 2014, J PHYS CHEM A, V118, P6133, DOI 10.1021/jp504415p	9	16	16	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					719	720		10.1126/science.aaa5624	http://dx.doi.org/10.1126/science.aaa5624			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678648				2022-12-28	WOS:000349221300025
J	Kratter, KM				Kratter, Kaitlin M.			Sibling rivalry begins at birth	NATURE			English	Editorial Material							SOLAR-TYPE STARS; STELLAR; MULTIPLICITY		Univ Arizona, Dept Astron, Tucson, AZ 85721 USA	University of Arizona	Kratter, KM (corresponding author), Univ Arizona, Dept Astron, Tucson, AZ 85721 USA.	kkratter@email.arizona.edu		Kratter, Kaitlin/0000-0001-5253-1338				Bate MR, 2012, MON NOT R ASTRON SOC, V419, P3115, DOI 10.1111/j.1365-2966.2011.19955.x; BODENHEIMER P, 1995, ANNU REV ASTRON ASTR, V33, P199; Bonnell IA, 2001, MON NOT R ASTRON SOC, V323, P785, DOI 10.1046/j.1365-8711.2001.04270.x; Crutcher RM, 2012, ANNU REV ASTRON ASTR, V50, P29, DOI 10.1146/annurev-astro-081811-125514; Duchene G, 2013, ANNU REV ASTRON ASTR, V51, P269, DOI 10.1146/annurev-astro-081710-102602; DUQUENNOY A, 1991, ASTRON ASTROPHYS, V248, P485; Fisher RT, 2004, ASTROPHYS J, V600, P769, DOI 10.1086/380111; MATHIEU RD, 1994, ANNU REV ASTRON ASTR, V32, P465, DOI 10.1146/annurev.aa.32.090194.002341; Offner SSR, 2010, ASTROPHYS J, V725, P1485, DOI 10.1088/0004-637X/725/2/1485; Pineda JE, 2015, NATURE, V518, P213, DOI 10.1038/nature14166; Raghavan D, 2010, ASTROPHYS J SUPPL S, V190, P1, DOI 10.1088/0067-0049/190/1/1; Reipurth B., 2014, PROTOSTARS PLANETS, P267, DOI DOI 10.2458/AZUUAPRESS9780816531240-CH012	12	0	0	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					173	174		10.1038/518173a	http://dx.doi.org/10.1038/518173a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8SD	25673408				2022-12-28	WOS:000349190300025
J	Pineda, JE; Offner, SSR; Parker, RJ; Arce, HG; Goodman, AA; Caselli, P; Fuller, GA; Bourke, TL; Corder, SA				Pineda, Jaime E.; Offner, Stella S. R.; Parker, Richard J.; Arce, Hector G.; Goodman, Alyssa A.; Caselli, Paola; Fuller, Gary A.; Bourke, Tyler L.; Corder, Stuartt A.			The formation of a quadruple star system with wide separation	NATURE			English	Article							STELLAR MULTIPLICITY; PROTOSTELLAR OUTFLOW; EMBEDDED PROTOSTARS; MOLECULAR CLOUDS; MASS FUNCTION; BINARY STARS; DENSE CORES; LARGE ARRAY; EVOLUTION; FRAGMENTATION	The initial multiplicity of stellar systems is highly uncertain. A number of mechanisms have been proposed to explain the origin of binary and multiple star systems, including core fragmentation, disk fragmentation and stellar capture(1-3). Observations show that protostellar and pre-main-sequence multiplicity is higher than the multiplicity found in field stars(4-7), which suggests that dynamical interactions occur early, splitting up multiple systems and modifying the initial stellar separations(8,9). Without direct, high-resolution observations of forming systems, however, it is difficult to determine the true initial multiplicity and the dominant binary formation mechanism. Here we report observations of a wide-separation (greater than 1,000 astronomical units) quadruple system composed of a young protostar and three gravitationally bound dense gas condensations. These condensations are the result of fragmentation of dense gas filaments, and each condensation is expected to forma star on a time-scale of 40,000 years. We determine that the closest pair will form a bound binary, while the quadruple stellar system itself is bound but unstable on timescales of 500,000 years (comparable to the lifetime of the embedded protostellar phase(10)). These observations suggest that filament fragmentation on length scales of about 5,000 astronomical units offers a viable pathway to the formation of multiple systems.	[Pineda, Jaime E.] ETH, Inst Astron, CH-8093 Zurich, Switzerland; [Offner, Stella S. R.; Arce, Hector G.] Yale Univ, Dept Astron, New Haven, CT 06520 USA; [Offner, Stella S. R.] Univ Massachusetts, Dept Astron, Amherst, MA 01003 USA; [Parker, Richard J.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool L3 5RF, Merseyside, England; [Goodman, Alyssa A.; Bourke, Tyler L.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Caselli, Paola] Max Planck Inst Extraterr Phys MPE, D-85741 Garching, Germany; [Fuller, Gary A.] Univ Manchester, Sch Phys & Astron, Jodrell Bank Ctr Astrophys, UK ARC Node, Manchester M13 9PL, Lancs, England; [Bourke, Tyler L.] Jodrell Bank Observ, SKA Org, Macclesfield SK11 9DL, Cheshire, England; [Corder, Stuartt A.] Joint ALMA Observ, Santiago, Chile; [Corder, Stuartt A.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Yale University; University of Massachusetts System; University of Massachusetts Amherst; Liverpool John Moores University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Max Planck Society; University of Manchester; Jodrell Bank Centre for Astrophysics; University of Manchester; Jodrell Bank Centre for Astrophysics; National Radio Astronomy Observatory (NRAO)	Pineda, JE (corresponding author), ETH, Inst Astron, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland.	jpineda@mpe.mpg.de	Pineda, Jaime/AAX-3157-2021; Goodman, Alyssa A/A-6007-2010	Pineda, Jaime/0000-0002-3972-1978; Goodman, Alyssa A/0000-0003-1312-0477; Caselli, Paola/0000-0003-1481-7911; Fuller, Gary/0000-0001-8509-1818	Swiss National Science Foundation [CRSII2_141880]; NSF CAREER award [AST-0845619]; NSF [AST-0908159]; ERC [PALs 320620]; NASA [NNX09AB89G, 51311.01, NAS 5-26555]; Space Telescope Science Institute; Royal Astronomical Society; Canada Foundation for Innovation; Science and Technology Facilities Council [ST/L000768/1] Funding Source: researchfish; STFC [ST/L000768/1] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); ERC(European Research Council (ERC)European Commission); NASA(National Aeronautics & Space Administration (NASA)); Space Telescope Science Institute(Space Telescope Science Institute); Royal Astronomical Society; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank K. Todorov for discussions and comments that improved the paper. We acknowledge support from the Swiss National Science Foundation project CRSII2_141880 (J.E.P.), NSF CAREER award AST-0845619 (H.G.A.), NSF grant AST-0908159 (A.A.G.), ERC project PALs 320620 (P.C.) and NASA grant NNX09AB89G (T.L.B.). S.S.R.O. acknowledges support from NASA through Hubble Fellowship grant 51311.01 awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS 5-26555. R.J.P. acknowledges support from the Royal Astronomical Society through a research fellowship. This research made use of astrodendro (http://www.dendrograms.org), Astropy, and APLpy (http://aplpy.github.com). The James Clerk Maxwell Telescope is operated by the Joint Astronomy Centre on behalf of the Science and Technology Facilities Council of the UK, the National Research Council of Canada, and (up to 31 March 2013) the Netherlands Organisation for Scientific Research. Additional funds for the construction of SCUBA-2 were provided by the Canada Foundation for Innovation. The National Radio Astronomy Observatory is a facility of the NSF operated under cooperative agreement by Associated Universities, Inc.	Alves J, 2007, ASTRON ASTROPHYS, V462, pL17, DOI 10.1051/0004-6361:20066389; Andre P., 2014, PREPRINT; Brassfield E., 2011, BAAS, V43; Chen XP, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/110; Connelley MS, 2008, ASTRON J, V135, P2526, DOI 10.1088/0004-6256/135/6/2526; Connelley MS, 2008, ASTRON J, V135, P2496, DOI 10.1088/0004-6256/135/6/2496; Duchene G, 2013, ANNU REV ASTRON ASTR, V51, P269, DOI 10.1146/annurev-astro-081710-102602; Evans NJ, 2009, ASTROPHYS J SUPPL S, V181, P321, DOI 10.1088/0067-0049/181/2/321; FULLER GA, 1991, ASTROPHYS J, V376, P135, DOI 10.1086/170262; Goodman AA, 1998, ASTROPHYS J, V504, P223, DOI 10.1086/306045; Kamazaki T, 2001, ASTROPHYS J, V548, P278, DOI 10.1086/318668; Kirk H, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/115; Lada CJ, 2006, ASTROPHYS J, V640, pL63, DOI 10.1086/503158; Machida MN, 2013, MON NOT R ASTRON SOC, V431, P1719, DOI 10.1093/mnras/stt291; Matzner CD, 2000, ASTROPHYS J, V545, P364, DOI 10.1086/317785; Moeckel N, 2010, MON NOT R ASTRON SOC, V404, P721, DOI 10.1111/j.1365-2966.2010.16347.x; Motte F, 1998, ASTRON ASTROPHYS, V336, P150; Nakamura F, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/2/L25; Offner SSR, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/61; Offner SSR, 2010, ASTROPHYS J, V725, P1485, DOI 10.1088/0004-637X/725/2/1485; Parker RJ, 2013, MON NOT R ASTRON SOC, V436, P650, DOI 10.1093/mnras/stt1603; Peretto N, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321318; Perley RA, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/1/L1; Pineda JE, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/1/L2; Pineda JE, 2010, ASTROPHYS J LETT, V712, pL116, DOI 10.1088/2041-8205/712/1/L116; Reipurth B., 2014, PREPRINT; Reipurth B, 2012, NATURE, V492, P221, DOI 10.1038/nature11662; Rosolowsky EW, 2008, ASTROPHYS J, V679, P1338, DOI 10.1086/587685; Stamatellos D, 2009, MON NOT R ASTRON SOC, V392, P413, DOI 10.1111/j.1365-2966.2008.14069.x; Tohline JE, 2002, ANNU REV ASTRON ASTR, V40, P349, DOI 10.1146/annurev.astro.40.060401.093810	30	79	79	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					213	U447		10.1038/nature14166	http://dx.doi.org/10.1038/nature14166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25673415				2022-12-28	WOS:000349190300033
J	Snow, R				Snow, Rosamund			Patient commentary: Direct access would beat receiving test results with the receptionist's interpretation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rsnow@bmj.com						O'Kane M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h673	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2015	350								h797	10.1136/bmj.h797	http://dx.doi.org/10.1136/bmj.h797			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0MG	25673249	Green Submitted			2022-12-28	WOS:000349319700026
J	Mesko, B				Mesko, Bertalan			SPOTLIGHT: PATIENT CENTRED CARE Commentary: we need to be better prepared for a technological future	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												berci@medicalfuturist.com						Broudway I, 2014, BUSINESSWEEK	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h279	10.1136/bmj.h279	http://dx.doi.org/10.1136/bmj.h279			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670194	Bronze			2022-12-28	WOS:000349318400012
J	Montori, VM; Tabini, CC				Montori, Victor M.; Tabini, Claudia C.			Commentary: Opening access to the medical record calls for other reforms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Montori, Victor M.] Mayo Clin, KER Unit, Rochester, MN 55905 USA	Mayo Clinic	Montori, VM (corresponding author), Mayo Clin, KER Unit, Rochester, MN 55905 USA.	montori.victor@mayo.edu		Montori, Victor/0000-0003-0595-2898	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Mair FS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6680; Rocca WA, 2012, MAYO CLIN PROC, V87, P1202, DOI 10.1016/j.mayocp.2012.08.012; Walker J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7785	3	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h271	10.1136/bmj.h271	http://dx.doi.org/10.1136/bmj.h271			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670193	Green Published, Bronze			2022-12-28	WOS:000349318400011
J	Parish, E				Parish, Emma			SPOTLIGHT: PATIENT CENTRED CARE BMJ roundtable debate: How can we get better at providing patient centred care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												eparish@bmj.com							0	15	15	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h412	10.1136/bmj.h412	http://dx.doi.org/10.1136/bmj.h412			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670196	Bronze			2022-12-28	WOS:000349318400016
J	Holcomb, JB; Tilley, BC; Baraniuk, S; Fox, EE; Wade, CE; Podbielski, JM; del Junco, DJ; Brasel, KJ; Bulger, EM; Callcut, RA; Cohen, MJ; Cotton, BA; Fabian, TC; Inaba, K; Kerby, JD; Muskat, P; O'Keeffe, T; Rizoli, S; Robinson, BRH; Scalea, TM; Schreiber, MA; Stein, DM; Weinberg, JA; Callum, JL; Hess, JR; Matijevic, N; Miller, CN; Pittet, JF; Hoyt, DB; Pearson, GD; Leroux, B; van Belle, G				Holcomb, John B.; Tilley, Barbara C.; Baraniuk, Sarah; Fox, Erin E.; Wade, Charles E.; Podbielski, Jeanette M.; del Junco, Deborah J.; Brasel, Karen J.; Bulger, Eileen M.; Callcut, Rachael A.; Cohen, Mitchell Jay; Cotton, Bryan A.; Fabian, Timothy C.; Inaba, Kenji; Kerby, Jeffrey D.; Muskat, Peter; O'Keeffe, Terence; Rizoli, Sandro; Robinson, Bryce R. H.; Scalea, Thomas M.; Schreiber, Martin A.; Stein, Deborah M.; Weinberg, Jordan A.; Callum, Jeannie L.; Hess, John R.; Matijevic, Nena; Miller, Christopher N.; Pittet, Jean-Francois; Hoyt, David B.; Pearson, Gail D.; Leroux, Brian; van Belle, Gerald		PROPPR Study Grp	Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma The PROPPR Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DAMAGE CONTROL RESUSCITATION; MULTIPLE-ORGAN FAILURE; FRESH-FROZEN PLASMA; MASSIVE TRANSFUSION; MAJOR TRAUMA; PRODUCTS; MULTICENTER; SURVIVAL; RISK; COAGULOPATHY	IMPORTANCE Severely injured patients experiencing hemorrhagic shock often require massive transfusion. Earlier transfusion with higher blood product ratios (plasma, platelets, and red blood cells), defined as damage control resuscitation, has been associated with improved outcomes; however, there have been no large multicenter clinical trials. OBJECTIVE To determine the effectiveness and safety of transfusing patients with severe trauma and major bleeding using plasma, platelets, and red blood cells in a 1:1:1 ratio compared with a 1:1:2 ratio. DESIGN, SETTING, AND PARTICIPANTS Pragmatic, phase 3, multisite, randomized clinical trial of 680 severely injured patients who arrived at 1 of 12 level I trauma centers in North America directly from the scene and were predicted to require massive transfusion between August 2012 and December 2013. INTERVENTIONS Blood product ratios of 1:1:1 (338 patients) vs 1:1:2 (342 patients) during active resuscitation in addition to all local standard-of-care interventions (uncontrolled). MAIN OUTCOMES AND MEASURES Primary outcomes were 24-hour and 30-day all-cause mortality. Prespecified ancillary outcomes included time to hemostasis, blood product volumes transfused, complications, incidence of surgical procedures, and functional status. RESULTS No significant differences were detected in mortality at 24 hours (12.7% in 1:1:1 group vs 17.0% in 1:1:2 group; difference, -4.2%[95% CI, -9.6% to 1.1%]; P=.12) or at 30 days (22.4% vs 26.1%, respectively; difference, -3.7%[95% CI, -10.2% to 2.7%]; P=.26). Exsanguination, which was the predominant cause of death within the first 24 hours, was significantly decreased in the 1:1:1 group (9.2% vs 14.6% in 1:1:2 group; difference, -5.4%[95% CI, -10.4% to -0.5%]; P=.03). More patients in the 1:1:1 group achieved hemostasis than in the 1:1:2 group (86% vs 78%, respectively; P=.006). Despite the 1:1:1 group receiving more plasma (median of 7Uvs5U, P<.001) and platelets (12 U vs 6 U, P<.001) and similar amounts of red blood cells (9 U) over the first 24 hours, no differences between the 2 groups were found for the 23 prespecified complications, including acute respiratory distress syndrome, multiple organ failure, venous thromboembolism, sepsis, and transfusion-related complications. CONCLUSIONS AND RELEVANCE Among patients with severe trauma and major bleeding, early administration of plasma, platelets, and red blood cells in a 1:1:1 ratio compared with a 1:1:2 ratio did not result in significant differences in mortality at 24 hours or at 30 days. However, more patients in the 1:1:1 group achieved hemostasis and fewer experienced death due to exsanguination by 24 hours. Even though there was an increased use of plasma and platelets transfused in the 1:1:1 group, no other safety differenceswere identified between the 2 groups.	[Holcomb, John B.; Fox, Erin E.; Wade, Charles E.; Podbielski, Jeanette M.; del Junco, Deborah J.; Cotton, Bryan A.; Matijevic, Nena] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Div Acute Care Surg, Sch Med,Dept Surg, Houston, TX 77030 USA; [Tilley, Barbara C.; Baraniuk, Sarah] Univ Texas Hlth Sci Ctr Houston, Div Biostat, Sch Publ Hlth, Houston, TX 77030 USA; [Brasel, Karen J.] Med Coll Wisconsin, Div Trauma & Crit Care, Dept Surg, Milwaukee, WI 53226 USA; [Bulger, Eileen M.] Univ Washington, Sch Med, Dept Surg, Div Trauma & Crit Care, Seattle, WA 98195 USA; [Callcut, Rachael A.; Cohen, Mitchell Jay] Univ Calif San Francisco, Sch Med, Dept Surg, Div Gen Surg, San Francisco, CA 94143 USA; [Fabian, Timothy C.; Weinberg, Jordan A.] Univ Tennessee, Ctr Hlth Sci, Coll Med, Div Trauma & Surg Crit Care,Dept Surg, Memphis, TN 38163 USA; [Inaba, Kenji] Univ So Calif, Div Trauma & Crit Care, Los Angeles, CA USA; [Kerby, Jeffrey D.] Univ Alabama Birmingham, Sch Med, Dept Surg, Div Trauma Burns & Surg Crit Care, Birmingham, AL USA; [Muskat, Peter; Robinson, Bryce R. H.] Univ Cincinnati, Coll Med, Dept Surg, Div Trauma Crit Care, Cincinnati, OH USA; [O'Keeffe, Terence] Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, Tucson, AZ USA; [Rizoli, Sandro] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada; [Scalea, Thomas M.; Stein, Deborah M.] Univ Maryland, Sch Med, Program Trauma, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Schreiber, Martin A.] Oregon Hlth & Sci Univ, Sch Med, Div Trauma Crit Care & Acute Care Surg, Portland, OR 97201 USA; [Callum, Jeannie L.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Dept Clin Pathol, Toronto, ON M4N 3M5, Canada; [Hess, John R.] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Miller, Christopher N.] Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA; [Pittet, Jean-Francois] Univ Alabama Birmingham, Sch Med, Dept Anesthesiol, Div Crit Care & Perioperat Med, Birmingham, AL USA; [Hoyt, David B.] Amer Coll Surg, Chicago, IL USA; [Pearson, Gail D.] NHLBI, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA; [Leroux, Brian; van Belle, Gerald] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [van Belle, Gerald] Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Medical College of Wisconsin; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of Tennessee System; University of Tennessee Health Science Center; University of Southern California; University of Alabama System; University of Alabama Birmingham; University System of Ohio; University of Cincinnati; University of Arizona; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University System of Maryland; University of Maryland Baltimore; Oregon Health & Science University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Washington; University of Washington Seattle; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Birmingham; American College of Surgeons; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Holcomb, JB (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, 6410 Fannin St, Houston, TX 77030 USA.	john.holcomb@uth.tmc.edu	Callcut, Rachael/ABE-1484-2021; Wong, Monica D/D-9016-2017; Leroux, Brian G/H-2254-2015	Wong, Monica D/0000-0001-7041-9518; Galvagno, Samuel/0000-0001-5563-4092; holcomb, john/0000-0001-8312-9157; Stein, Deborah/0000-0003-3683-3963	US National Heart, Lung, and Blood Institute [U01HL077863]; US Department of Defense; Defence Research and Development Canada; Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health [CRR-120612]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074902] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Defense(United States Department of Defense); Defence Research and Development Canada; Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported with grant U01HL077863 from the US National Heart, Lung, and Blood Institute and funding from the US Department of Defense, the Defence Research and Development Canada in partnership with the Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health (grant CRR-120612).	Amer Soc Anesthesiologists Task Fo, 2006, ANESTHESIOLOGY, V105, P198; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baraniuk S, 2014, INJURY, V45, P1287, DOI 10.1016/j.injury.2014.06.001; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Cotton BA, 2011, ANN SURG, V254, P598, DOI 10.1097/SLA.0b013e318230089e; del Junco DJ, 2013, J TRAUMA ACUTE CARE, V75, pS24, DOI 10.1097/TA.0b013e31828fa3b9; del Junco DJ, 2013, J TRAUMA ACUTE CARE, V75, pS97, DOI 10.1097/TA.0b013e318298b0a4; Duchesne JC, 2008, J TRAUMA, V65, P272, DOI 10.1097/TA.0b013e31817e5166; Dutton R, 2009, CLIN TRIALS, V6, P467, DOI 10.1177/1740774509344102; Dzik WH, 2011, CRIT CARE, V15, DOI 10.1186/cc10498; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Ho AMH, 2005, AM J SURG, V190, P479, DOI 10.1016/j.amjsurg.2005.03.034; Ho AMH, 2012, ANESTHESIOLOGY, V116, P716, DOI 10.1097/ALN.0b013e318245c47b; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Holcomb JB, 2011, J TRAUMA, V71, pS318, DOI 10.1097/TA.0b013e318227edbb; Holcomb JB, 2011, SHOCK, V35, P107, DOI 10.1097/SHK.0b013e3181f7fd01; Hollis S, 2002, STAT MED, V21, P3823, DOI 10.1002/sim.1276; HOYT DB, 1994, J TRAUMA, V37, P426, DOI 10.1097/00005373-199409000-00016; Huber-Wagner S, 2007, VOX SANG, V92, P69, DOI 10.1111/j.1423-0410.2006.00858.x; Johansson PI, 2009, VOX SANG, V96, P111, DOI 10.1111/j.1423-0410.2008.01130.x; Johansson PI, 2013, TRANSFUSION, V53, P3088, DOI 10.1111/trf.12214; Johansson PI, 2014, BLOOD, V124, P3052, DOI 10.1182/blood-2014-05-575340; Johnson JL, 2010, ARCH SURG-CHICAGO, V145, P973, DOI 10.1001/archsurg.2010.216; Kautza BC, 2012, J TRAUMA ACUTE CARE, V72, P106, DOI 10.1097/TA.0b013e3182410a3c; Kelly JM, 2013, EXPERT REV HEMATOL, V6, P631, DOI 10.1586/17474086.2013.859520; Klein JP, 2003, SURVIVAL ANALYSIS TE; Langan NR, 2014, JAMA SURG, V149, P904, DOI 10.1001/jamasurg.2014.940; Moore EE, 2009, J AM COLL SURGEONS, V208, P1, DOI 10.1016/j.jamcollsurg.2008.09.023; Nascimento B, 2013, CMAJ, V185, P583; Nunez TC, 2009, J TRAUMA, V66, P346, DOI 10.1097/TA.0b013e3181961c35; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OBRIEN PC, 1983, BIOMETRICS, V39, P787, DOI 10.2307/2531110; Park PK, 2013, J TRAUMA ACUTE CARE, V75, pS238, DOI 10.1097/TA.0b013e31829a8c71; Perkins JG, 2009, J TRAUMA, V66, pS77, DOI 10.1097/TA.0b013e31819d8936; Pieracci FM, 2012, TRAUMA, P216; Radwan ZA, 2013, JAMA SURG, V148, P170, DOI 10.1001/jamasurgery.2013.414; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Roback JD, 2010, TRANSFUSION, V50, P1227, DOI 10.1111/j.1537-2995.2010.02632.x; Robinson BRH, 2013, J TRAUMA ACUTE CARE, V75, pS61, DOI 10.1097/TA.0b013e31828fa408; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Sauaia A, 2014, J TRAUMA ACUTE CARE, V76, P582, DOI 10.1097/TA.0000000000000147; Savage SA, 2013, J TRAUMA ACUTE CARE, V74, P396, DOI 10.1097/TA.0b013e31827a3639; Scalea TM, 2008, ANN SURG, V248, P578, DOI 10.1097/SLA.0b013e31818990ed; Shaz BH, 2010, TRANSFUSION, V50, P493, DOI 10.1111/j.1537-2995.2009.02414.x; Silverman T, 2005, TRANSFUSION, V45, p14S, DOI 10.1111/j.0041-1132.2005.00157.x; Snyder CW, 2009, J TRAUMA, V66, P358, DOI 10.1097/TA.0b013e318196c3ac; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Tisherman SA., 2014, ANN SURG, DOI [10.1097/SLA.0b013e3181df0401, DOI 10.1097/SLA.0B013E3181DF0401]; US Army Institute of Surgical Research, 2014, JOINT THEATER TRAUMA; US Centers for Disease Control and Prevention, 2012, INJURY PREVENTION AN; US Department of Health and Human Services; US Food and Drug Administration, 2013, GUIDANCE FOR INSTITU; US Food and Drug Administration, 2010, PRODUCT DEVELOPMENT; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; Watson GA, 2009, J TRAUMA, V67, P221, DOI 10.1097/TA.0b013e3181ad5957	60	1240	1276	6	83	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					471	482		10.1001/jama.2015.12	http://dx.doi.org/10.1001/jama.2015.12			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AV	25647203	Bronze, Green Accepted			2022-12-28	WOS:000349070300011
J	Koser, CU; Javid, B; Liddell, K; Ellington, MJ; Feuerriegel, S; Niemann, S; Brown, NM; Burman, WJ; Abubakar, I; Ismail, NA; Moore, D; Peacock, SJ; Torok, ME				Koeser, Claudio U.; Javid, Babak; Liddell, Kathleen; Ellington, Matthew J.; Feuerriegel, Silke; Niemann, Stefan; Brown, Nicholas M.; Burman, William J.; Abubakar, Ibrahim; Ismail, Nazir A.; Moore, David; Peacock, Sharon J.; Toeroek, M. Estee			Drug-resistance mechanisms and tuberculosis drugs	LANCET			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; ATP SYNTHASE; SUSCEPTIBILITY; BEDAQUILINE; DIVERSITY; REGIMENS; COMPLEX		[Koeser, Claudio U.; Javid, Babak; Peacock, Sharon J.; Toeroek, M. Estee] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QW, England; [Javid, Babak] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Liddell, Kathleen] Univ Cambridge, Fac Law, Cambridge CB2 0QW, England; [Ellington, Matthew J.; Brown, Nicholas M.; Peacock, Sharon J.; Toeroek, M. Estee] Publ Hlth England, Clin Microbiol & Publ Hlth Lab, Cambridge, England; [Feuerriegel, Silke; Niemann, Stefan] Res Ctr Borstel, Borstel, Germany; [Feuerriegel, Silke] German Ctr Infect Res, Borstel, Germany; [Burman, William J.] Denver Publ Hlth, Denver, CO USA; [Abubakar, Ibrahim] Publ Hlth England, Ctr Infect Dis Surveillance & Control, TB Sect, London, England; [Abubakar, Ibrahim] UCL, Res Dept Infect & Populat Hlth, London, England; [Ismail, Nazir A.] Natl Inst Communicable Dis, Ctr TB, Johannesburg, South Africa; [Moore, David] London Sch Hyg & Trop Med, TB Ctr, London WC1, England; [Moore, David] Univ Peruana Cayetano Heredia, Lab Invest Enfermedades Infecciosa, Lima, Peru; [Peacock, Sharon J.; Toeroek, M. Estee] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Peacock, Sharon J.] Wellcome Trust Sanger Inst, Hinxton, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Tsinghua University; University of Cambridge; Public Health England; Forschungszentrum Borstel; German Center for Infection Research; Public Health England; University of London; University College London; National Institute for Communicable Diseases (NICD); University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia; University of Cambridge; Wellcome Trust Sanger Institute	Koser, CU (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QW, England.	cuk21@cam.ac.uk	Peacock, Sharon J/ABE-6331-2020; Ellington, Matthew/ABH-7978-2020; Niemann, Stefan/C-9327-2011; Köser, Claudio/I-3740-2013	Köser, Claudio/0000-0002-0232-846X; Niemann, Stefan/0000-0002-6604-0684; Torok, Mili Estee/0000-0001-9098-8590; Abubakar, Ibrahim/0000-0002-0370-1430; Peacock, Sharon/0000-0002-1718-2782; Brown, Nicholas/0000-0002-6657-300X	Academy of Medical Sciences (AMS) [AMS-CSF4-Torok] Funding Source: researchfish; Wellcome Trust [098600] Funding Source: Medline; Department of Health [HICF-T5-342] Funding Source: Medline	Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Wellcome Trust(Wellcome Trust); Department of Health		Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Andries K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102135; [Anonymous], 2014, NATURE, V513, P143; Cook-Deegan R, 2013, EUR J HUM GENET, V21, P585, DOI 10.1038/ejhg.2012.217; de Carvalho LPS, 2009, J MED CHEM, V52, P5789, DOI 10.1021/jm9010719; Diacon AH, 2014, NEW ENGL J MED, V371, P2436, DOI 10.1056/NEJMc1412235; Feuerriegel S, 2011, ANTIMICROB AGENTS CH, V55, P5718, DOI 10.1128/AAC.05500-11; Food and Drug Administration, GUID IND ANT PROD DE; Food and Drug Administration. Guidance for Industry, 2007, GUID IND ROL HIV RES; Hartkoorn RC, 2014, ANTIMICROB AGENTS CH, V58, P2979, DOI 10.1128/AAC.00037-14; Huitric E, 2010, ANTIMICROB AGENTS CH, V54, P1022, DOI 10.1128/AAC.01611-09; Kesselheim AS, 2013, NEW ENGL J MED, V369, P869, DOI 10.1056/NEJMhle1308199; Koser CU, 2012, ANTIMICROB AGENTS CH, V56, P6080, DOI 10.1128/AAC.01641-12; Matthijs G, 2013, NAT BIOTECHNOL, V31, P704, DOI 10.1038/nbt.2644; Outterson K, 2014, NEW BUSINESS MODELS; Russell DG, 2013, NATURE, V502, pS7, DOI 10.1038/502S7a; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Shafer RW, 2005, J ANTIMICROB CHEMOTH, V55, P817, DOI 10.1093/jac/dki127; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Somoskovi A, 2015, EUR RESPIR J, V45, P554, DOI [10.1183/09031936.00142914, 10]; Wells WA, 2013, LANCET INFECT DIS, V13, P449, DOI 10.1016/S1473-3099(13)70025-2; Zumla AI, 2014, LANCET INFECT DIS, V14, P327, DOI 10.1016/S1473-3099(13)70328-1	22	22	23	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					305	307						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ9CN	25706840	Green Submitted, Green Accepted			2022-12-28	WOS:000348509000004
J	Dietz, WH; Baur, LA; Hall, K; Puhl, RM; Taveras, EM; Uauy, R; Kopelman, P				Dietz, William H.; Baur, Louise A.; Hall, Kevin; Puhl, Rebecca M.; Taveras, Elsie M.; Uauy, Ricardo; Kopelman, Peter			Management of obesity: improvement of health-care training and systems for prevention and care	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; WEIGHT-LOSS; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; BARIATRIC SURGERY; ADAPTIVE THERMOGENESIS; ADOLESCENT OVERWEIGHT; MEDICAL-SCHOOLS; NATIONAL-SURVEY	Although the caloric deficits achieved by increased awareness, policy, and environmental approaches have begun to achieve reductions in the prevalence of obesity in some countries, these approaches are insufficient to achieve weight loss in patients with severe obesity. Because the prevalence of obesity poses an enormous clinical burden, innovative treatment and care-delivery strategies are needed. Nonetheless, health professionals are poorly prepared to address obesity. In addition to biases and unfounded assumptions about patients with obesity, absence of training in behaviour-change strategies and scarce experience working within interprofessional teams impairs care of patients with obesity. Modalities available for the treatment of adult obesity include clinical counselling focused on diet, physical activity, and behaviour change, pharmacotherapy, and bariatric surgery. Few options, few published reports of treatment, and no large randomised trials are available for paediatric patients. Improved care for patients with obesity will need alignment of the intensity of therapy with the severity of disease and integration of therapy with environmental changes that reinforce clinical strategies. New treatment strategies, such as the use of technology and innovative means of health-care delivery that rely on health professionals other than physicians, represent promising options, particularly for patients with overweight and patients with mild to moderate obesity. The co-occurrence of undernutrition and obesity in low-income and middle-income countries poses unique challenges that might not be amenable to the same strategies as those that can be used in high-income countries.	[Dietz, William H.] George Washington Univ, Sumner M Redstone Global Ctr Prevent & Wellness, Washington, DC 20052 USA; [Baur, Louise A.] Childrens Hosp Westmead, Sch Clin, Weight Management Serv, Westmead, NSW, Australia; [Hall, Kevin] NIDDK, Lab Biol Modeling, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Puhl, Rebecca M.] Yale Univ, Ctr Food Policy & Obes, New Haven, CT USA; [Taveras, Elsie M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp Children, Div Gen Acad Pediat, Boston, MA USA; [Uauy, Ricardo] Univ Catolica Chile, Div Pediat, Escuela Med, Santiago, Chile; [Kopelman, Peter] St Georges Univ London, London, England	George Washington University; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Yale University; Harvard University; Harvard Medical School; Pontificia Universidad Catolica de Chile; Universidad Catolica del Norte; St Georges University London	Dietz, WH (corresponding author), George Washington Univ, Sumner M Redstone Global Ctr Prevent & Wellness, Washington, DC 20052 USA.	dietzwcd4@gmail.com	Hall, Kevin/F-2383-2010; Baur, Louise/AAE-3413-2021; Puhl, Rebecca/ABE-9260-2021	Hall, Kevin/0000-0003-4062-3133; 	JPB Foundation; Institute of Medicine; Cardinal Health Foundation; State of Kansas; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013036] Funding Source: NIH RePORTER	JPB Foundation; Institute of Medicine; Cardinal Health Foundation; State of Kansas; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	WHD declares consulting fees and travel reimbursement from the JPB Foundation, the Institute of Medicine, the Cardinal Health Foundation, and the State of Kansas: and honoraria and travel support from the Kansas Health Foundation, Case Western Reserve University, Cleveland Town Hall, and the National Institute for Health Care Management. KH has a patent pending for the personalised dynamic feedback control of body weight. LAB, RMP, EMT, RU, and PK declare no competing interests.	Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; ADAMS CH, 1993, WOMEN HEALTH, V20, P45, DOI 10.1300/J013v20n02_04; Adams KM, 2010, ACAD MED, V85, P1537, DOI 10.1097/ACM.0b013e3181eab71b; Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; American Academy of Pediatrics, COMM PED TRAIN IN; Amy NK, 2006, INT J OBESITY, V30, P147, DOI 10.1038/sj.ijo.0803105; Andersen RE, 1999, JAMA-J AM MED ASSOC, V281, P335, DOI 10.1001/jama.281.4.335; Appel LJ, 2011, NEW ENGL J MED, V365, P1959, DOI 10.1056/NEJMoa1108660; Armstrong MJ, 2011, OBES REV, V12, P709, DOI 10.1111/j.1467-789X.2011.00892.x; Arterburn DE, 2005, INT J OBESITY, V29, P334, DOI 10.1038/sj.ijo.0802896; Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1; Association of American Medical Colleges, 2007, 7 ASS AM MED COLL; Astrup A, 2012, INT J OBESITY, V36, P843, DOI 10.1038/ijo.2011.158; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Bertakis KD, 2005, OBES RES, V13, P1615, DOI 10.1038/oby.2005.198; Bleich SN, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001871; Bleich SN, 2012, OBESITY, V20, P999, DOI 10.1038/oby.2011.402; Block JP, 2003, PREV MED, V36, P669, DOI 10.1016/S0091-7435(03)00055-0; Borys JM, 2012, OBES REV, V13, P299, DOI 10.1111/j.1467-789X.2011.00950.x; British Obesity and Metabolic Surgery Society, 2014, COMM FUID WEIGHT ASS; C.S. Mott Children's Hospital, 2013, C S MOTT CHILDR HOSP; Catenacci VA, 2011, OBESITY, V19, P1163, DOI 10.1038/oby.2010.264; Center for Drug Evaluation and Research Food and Drug Administration US Department of Health and Human Services, 2007, GUID IND DEV PROD WE; Centers for Disease Control and Prevention, NAT DIAB PREV PROGR; Conway PH, 2009, JAMA-J AM MED ASSOC, V301, P763, DOI 10.1001/jama.2009.103; Cook S, 2005, PEDIATRICS, V116, P112, DOI 10.1542/peds.2004-1517; Crabtree BF, 2011, MED CARE, V49, pS28, DOI 10.1097/MLR.0b013e3181cad65c; Das P, 2012, LANCET, V380, P189, DOI 10.1016/S0140-6736(12)61024-1; Dietz W, 2007, HEALTH AFFAIR, V26, P430, DOI 10.1377/hlthaff.26.2.430; Dorsey KB, 2005, ARCH PEDIAT ADOL MED, V159, P632, DOI 10.1001/archpedi.159.7.632; Doucet E, 2003, CLIN SCI, V105, P89, DOI 10.1042/CS20020252; Doucet E, 2001, BRIT J NUTR, V85, P715, DOI 10.1079/BJN2001348; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Durant NH, 2013, OBES REV, V14, P532, DOI 10.1111/obr.12038; Eckstein KC, 2006, PEDIATRICS, V117, P681, DOI 10.1542/peds.2005-0910; European Medicines Agency. Committee on Clinical Evaluation of Medicinal Products Used in Weight Control, 2007, COMM CLIN EV MED PRO; Flodgren G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000984.pub2; Foster GD, 2003, OBES RES, V11, P1168, DOI 10.1038/oby.2003.161; Foster GD, 1997, J CONSULT CLIN PSYCH, V65, P79, DOI 10.1037/0022-006X.65.1.79; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Garmendia ML, 2013, EUR J CLIN NUTR, V67, P513, DOI 10.1038/ejcn.2012.190; Garvey WT, 2012, AM J CLIN NUTR, V95, P297, DOI 10.3945/ajcn.111.024927; Gerner B, 2010, MED EDUC, V44, P706, DOI 10.1111/j.1365-2923.2010.03686.x; Hall KD, 2012, ANNU REV NUTR, V32, P35, DOI 10.1146/annurev-nutr-071811-150705; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hayden MJ, 2006, MED J AUSTRALIA, V185, P293, DOI 10.5694/j.1326-5377.2006.tb00568.x; Heal DJ, 2012, NEUROPHARMACOLOGY, V63, P132, DOI 10.1016/j.neuropharm.2012.01.017; Hebl MR, 2003, INT J OBESITY, V27, P269, DOI 10.1038/sj.ijo.802231; Hills AP, 2010, OBES REV, V11, P740, DOI 10.1111/j.1467-789X.2009.00692.x; Huizinga MM, 2010, OBESITY, V18, P1932, DOI 10.1038/oby.2010.35; Inge TH, 2004, PEDIATRICS, V114, P217, DOI 10.1542/peds.114.1.217; Institute of Medicine, 2012, PRIM CAR PUBL HLTH E; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; King LA, 2007, BRIT J GEN PRACT, V57, P124; Klein JD, 2010, PEDIATRICS, V125, P265, DOI 10.1542/peds.2008-2985; Koletzko B, 2009, AM J CLIN NUTR, V89, P1836, DOI 10.3945/ajcn.2008.27091; Kushner RF, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-53; Marvasti FF, 2012, NEW ENGL J MED, V367, P889, DOI 10.1056/NEJMp1206230; Masica AL, 2009, MAYO CLIN PROC, V84, P1062, DOI 10.4065/mcp.2009.0657; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; National Confidential Enquiry into Patient Outcome and Death. National confidential enquiry into patient outcome and death (NCEPOD), 2012, TOO LEAN SERV REV CA; National Institute for Children's Healthcare Quality, BE OUR VOIC; National Obesity Observatory, 2010, BAR SURG OB; Nguyen B, 2011, OBES REV, V12, pe298, DOI 10.1111/j.1467-789X.2010.00830.x; Nicklas JM, 2012, AM J PREV MED, V42, P481, DOI 10.1016/j.amepre.2012.01.005; North Carolina Prevntion Partners, HLTH NC HOSP RED APP; O'Brien KS, 2010, OBESITY, V18, P2138, DOI 10.1038/oby.2010.79; Orexigen Therapeutics Inc, 2010, CONTR NALTR SR BUPR; Pedersen PJ, 2009, J AM COLL HEALTH, V57, P465, DOI 10.3200/JACH.57.4.471-480; Perrin EM, 2012, ARCH PEDIAT ADOL MED, V166, P317, DOI 10.1001/archpediatrics.2011.1135; Polacsek M, 2009, PEDIATRICS, V123, pS258, DOI 10.1542/peds.2008-2780C; Puhl R, 2013, INT J OBESITY, V37, P612, DOI 10.1038/ijo.2012.110; Puhl RM, 2011, PEDIATRICS, V128, pE786, DOI 10.1542/peds.2010-3841; Rattay KT, 2009, PEDIATRICS, V123, pS100, DOI 10.1542/peds.2008-1755J; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Ross J, SHUT DOWN MCDONALDS; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Ryan DH, 2010, ARCH INTERN MED, V170, P146, DOI 10.1001/archinternmed.2009.508; Sacher PM, 2010, OBESITY, V18, pS62, DOI 10.1038/oby.2009.433; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schwartz MB, 2003, OBES RES, V11, P1033, DOI 10.1038/oby.2003.142; Scottish Intercollegiate Guidelines Network, MAN OB; Sharma AM, 2009, INT J OBESITY, V33, P289, DOI 10.1038/ijo.2009.2; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Taveras EM, 2013, CONTEMP CLIN TRIALS, V34, P101, DOI 10.1016/j.cct.2012.10.005; Taveras EM, 2011, MATERN CHILD HLTH J, V15, P1217, DOI 10.1007/s10995-010-0696-2; Thorndike AN, 2012, AM J PUBLIC HEALTH, V102, P527, DOI 10.2105/AJPH.2011.300391; Tong EK, 2010, NICOTINE TOB RES, V12, P724, DOI 10.1093/ntr/ntq071; Tsigos C, 2011, OBESITY FACTS, V4, P329, DOI 10.1159/000331236; Uauy R, 2006, J PEDIATR GASTR NUTR, V43, pS26, DOI 10.1097/01.mpg.0000255848.84658.52; Vitolins MZ, 2012, TEACH LEARN MED, V24, P267, DOI 10.1080/10401334.2012.692286; Wadden TA, 2014, OBESITY, V22, P5, DOI 10.1002/oby.20662; Wadden TA, 2012, CIRCULATION, V125, P1157, DOI 10.1161/CIRCULATIONAHA.111.039453; Wake M, 2013, ARCH DIS CHILD, V98, P3, DOI 10.1136/archdischild-2012-301659; Wake M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-39; Wake M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3308; Wang YC, 2012, AM J PREV MED, V42, P437, DOI 10.1016/j.amepre.2012.01.018; Wang YC, 2011, INT J PEDIATR OBES, V6, P12, DOI 10.3109/17477161003587774; Wear D, 2006, ACAD MED, V81, P454, DOI 10.1097/01.ACM.0000222277.21200.a1; Weinsier RL, 2000, AM J CLIN NUTR, V72, P1088; White House Task Force on Childhood Obesity Report to the President, 2010, SOLV PROBL CHILD OB; Whitlock EP, 2010, PEDIATRICS, V125, pE396, DOI 10.1542/peds.2009-1955; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S; Woolford SJ, 2010, J TELEMED TELECARE, V16, P458, DOI 10.1258/jtt.2010.100207; Zhuo XH, 2012, HEALTH AFFAIR, V31, P50, DOI 10.1377/hlthaff.2011.1115	114	220	226	2	112	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2521	2533		10.1016/S0140-6736(14)61748-7	http://dx.doi.org/10.1016/S0140-6736(14)61748-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK9AR	25703112				2022-12-28	WOS:000356532500027
J	Ghanima, W; Khelif, A; Waage, A; Michel, M; Tjonnfjord, GE; Ben Romdhan, N; Kahrs, J; Darne, B; Holme, PA				Ghanima, Waleed; Khelif, Abderrahim; Waage, Anders; Michel, Marc; Tjonnfjord, Geir E.; Ben Romdhan, Neila; Kahrs, Johannes; Darne, Bernadette; Holme, Pal Andre		RITP Study Grp	Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							DEXAMETHASONE MONOTHERAPY; SPLENECTOMY; PURPURA; THERAPY; RESPONSES; EFFICACY; SAFETY; COHORT	Background Immune thrombocytopenia is characterised by immune-mediated destruction and suboptimum production of platelets. Despite the absence of supporting evidence, rituximab is frequently used off-label in patients with immune thrombocytopenia. We aimed to assess the efficacy of rituximab as compared with placebo as a splenectomy-sparing treatment in patients who were previously treated with corticosteroids. Methods In this multicentre, randomised, double-masked, placebo-controlled trial, we enrolled corticosteroid unresponsive adult patients (aged >= 18 years) with primary immune thrombocytopenia and a platelet count of less than 30 x 10(9) platelets per L. Patients were randomly assigned (1: 1) to four weekly infusions of 375 mg/m(2) rituximab or placebo. Concurrent treatment with corticosteroids only was allowed during the study. The primary endpoint was rate of treatment failure within 78 weeks-a composite of splenectomy or meeting criteria for splenectomy after week 12 if splenectomy was not done, assessed in all patients who received at least one dose of study treatment. Secondary endpoints were response rates, relapse rates, and duration of response. Efficacy endpoints were assessed with the Kaplan-Meier method. Safety endpoints were assessed in all patients who received at least one dose. This trial is registered with ClinicalTrials.gov, number NCT00344149. Findings Between Aug 17, 2006, and June 30, 2011, we enrolled 112 patients. 32 (58%) of 55 patients in the rituximab group and 37 (69%) of 54 patients in the placebo group had treatment failure within 78 weeks (Kaplan-Meier cumulative incidence 46% for rituximab vs 52% for placebo (hazard ratio [HR] 0.89, 95% CI 0.55-1.45; p=0.65). The cumulative incidence of overall response was 81% in the rituximab group versus 73% in the placebo group (p=0.15) and complete response was 58% in the rituximab group versus 50% in the placebo group (p=0.12). Of those achieving an overall response, 68% relapsed in the rituximab group and 78% relapsed in the placebo group, and of those achieving complete response, 50% relapsed in the rituximab group and 62% relapsed in the placebo group. Time to relapse in the rituximab group was longer in patients who achieved overall response (36 vs 7 weeks; p=0.01) but not complete response (76 vs 49 weeks; p=0.19). Rates of bleeding were similar in the two groups (21 [38%] in the rituximab group vs 27 [50%] in the placebo group; p=0.08) as were rates of infection (22 [40%] vs 13 [24%]; p=0.09). Interpretation Despite no reduction in the rate of long-term treatment failure with rituximab, a small benefit cannot be ruled out, as suggested by an apparently longer duration of response and numerically higher response rates with rituximab.	[Ghanima, Waleed; Kahrs, Johannes] Ostfold Hosp Trust, Dept Med, N-1603 Fredrikstad, Norway; [Khelif, Abderrahim] Farhat Hached Hosp, Dept Med, Sousse, Tunisia; [Waage, Anders] St Olav Hosp, Dept Med, Trondheim, Norway; [Michel, Marc] Univ Paris Est Creteil, Henri Mondor Hosp, Dept Med, Creteil, France; [Ben Romdhan, Neila] La Rabta Hosp, Dept Med, Tunis, Tunisia; [Ghanima, Waleed; Tjonnfjord, Geir E.; Holme, Pal Andre] Oslo Univ Hosp, Dept Haematol, Oslo, Norway; [Ghanima, Waleed; Tjonnfjord, Geir E.; Holme, Pal Andre] Univ Oslo, Inst Clin Med, Oslo, Norway; [Darne, Bernadette] Monitoring Force, Maisons Laffitte, France	Universite de Sousse; Hopital Farhat Hached; Norwegian University of Science & Technology (NTNU); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite de Tunis-El-Manar; Hopital La Rabta; University of Oslo; University of Oslo	Ghanima, W (corresponding author), Ostfold Hosp Trust, Dept Med, N-1603 Fredrikstad, Norway.	waleed.ghanima@so-hf.no	St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Tjønnfjord, Geir Erland/AAH-8739-2020; Wisloff, Ulrik/K-2899-2012	Ghanima, Waleed/0000-0003-2225-6165; Schjesvold, Fredrik/0000-0003-1096-0569	South-East Regional Health Authority, Norway; Ostfold Hospital, Norway; Roche, France; Roche, Norway	South-East Regional Health Authority, Norway; Ostfold Hospital, Norway; Roche, France(Roche Holding); Roche, Norway	South-East Regional Health Authority and Ostfold Hospital, Norway; Roche, France; and Roche, Norway.	Arnold DM, 2007, ANN INTERN MED, V146, P25, DOI 10.7326/0003-4819-146-1-200701020-00006; Arnold DM, 2012, BLOOD, V119, P1356, DOI 10.1182/blood-2011-08-374777; Bussel JB, 2014, HAEMATOLOGICA, V99, P1264, DOI 10.3324/haematol.2013.103291; Cheng YF, 2003, NEW ENGL J MED, V349, P831, DOI 10.1056/NEJMoa030254; Cines DB, 2009, BLOOD, V113, P6511, DOI 10.1182/blood-2009-01-129155; Cooper N, 2004, BRIT J HAEMATOL, V125, P232, DOI 10.1111/j.1365-2141.2004.04889.x; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; Ghanima W, 2012, BLOOD, V120, P960, DOI 10.1182/blood-2011-12-309153; Gudbrandsdottir S, 2013, BLOOD, V121, P1976, DOI 10.1182/blood-2012-09-455691; Health UNCIo, 2006, COMM TERM CRIT ADV E; Khellaf M, 2005, HAEMATOLOGICA, V90, P829; Kojouri K, 2004, BLOOD, V104, P2623, DOI 10.1182/blood-2004-03-1168; Kristinsson SY, 2014, HAEMATOLOGICA, V99, P392, DOI 10.3324/haematol.2013.092460; Li ZY, 2011, INT J HEMATOL, V93, P91, DOI 10.1007/s12185-010-0753-z; Mazzucconi MG, 2007, BLOOD, V109, P1401, DOI 10.1182/blood-2005-12-015222; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Neylon AJ, 2003, BRIT J HAEMATOL, V122, P966, DOI 10.1046/j.1365-2141.2003.04547.x; Patel VL, 2012, BLOOD, V119, P5989, DOI 10.1182/blood-2011-11-393975; Portielje JEA, 2001, BLOOD, V97, P2549, DOI 10.1182/blood.V97.9.2549; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Rodeghiero F, 2008, AM J HEMATOL, V83, P91, DOI 10.1002/ajh.21109; Sailer T, 2006, HAEMATOLOGICA, V91, P1041; Zaja F, 2006, EXP HEMATOL, V34, P571, DOI 10.1016/j.exphem.2006.02.009; Zaja F, 2010, BLOOD, V115, P2755, DOI 10.1182/blood-2009-07-229815	24	123	129	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1653	1661		10.1016/S0140-6736(14)61495-1	http://dx.doi.org/10.1016/S0140-6736(14)61495-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG6NG	25662413				2022-12-28	WOS:000353418000038
J	Messacar, K; Schreiner, TL; Maloney, JA; Wallace, A; Ludke, J; Oberste, MS; Nix, WA; Robinson, CC; Glode, MP; Abzug, MJ; Dominguez, SR				Messacar, Kevin; Schreiner, Teri L.; Maloney, John A.; Wallace, Adam; Ludke, Jan; Oberste, M. Stephen; Nix, W. Allan; Robinson, Christine C.; Glode, Mary P.; Abzug, Mark J.; Dominguez, Samuel R.			A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA	LANCET			English	Article							POLIOMYELITIS-LIKE ILLNESS; MYELITIS; DISEASE; PCR	Background Clusters of acute flaccid paralysis or cranial nerve dysfunction in children are uncommon. We aimed to assess a cluster of children with acute flaccid paralysis and cranial nerve dysfunction geographically and temporally associated with an outbreak of enterovirus-D68 respiratory disease. Methods We defined a case of neurological disease as any child admitted to Children's Hospital Colorado (Aurora, CO, USA) with acute flaccid paralysis with spinal-cord lesions involving mainly grey matter on imaging, or acute cranial nerve dysfunction with brainstem lesions on imaging, who had onset of neurological symptoms between Aug 1, 2014, and Oct 31, 2014. We used Poisson regression to assess whether the numbers of cases during the outbreak period were significantly greater than baseline case numbers from a historical control period (July 31, 2010, to July 31, 2014). Findings 12 children met the case definition (median age 11.5 years [IQR 6.75-15]). All had a prodromal febrile illness preceding neurological symptoms by a median of 7 days (IQR 5.75-8). Neurological deficits included flaccid limb weakness (n=10; asymmetric n=7), bulbar weakness (n=6), and cranial nerve VI (n=3) and VII (n=2) dysfunction. Ten (83%) children had confluent, longitudinally extensive spinal-cord lesions of the central grey matter, with predominant anterior horn-cell involvement, and nine (75%) children had brainstem lesions. Ten (91%) of 11 children had cerebrospinal fluid pleocytosis. Nasopharyngeal specimens from eight (73%) of 11 children were positive for rhinovirus or enterovirus. Viruses from five (45%) of 11 children were typed as enterovirus D68. Enterovirus PCR of cerebrospinal fluid, blood, and rectal swabs, and tests for other causes, were negative. Improvement of cranial nerve dysfunction has been noted in three (30%) of ten children. All ten children with limb weakness have residual deficits. Interpretation We report the first geographically and temporally defined cluster of acute flaccid paralysis and cranial nerve dysfunction in children associated with an outbreak of enterovirus-D68 respiratory illness. Our findings suggest the possibility of an association between enterovirus D68 and neurological disease in children. If enterovirus-D68 infections continue to happen in an endemic or epidemic pattern, development of effective antiviral or immunomodulatory therapies and vaccines should become scientific priorities.	[Messacar, Kevin; Glode, Mary P.; Abzug, Mark J.; Dominguez, Samuel R.] Childrens Hosp Colorado, Dept Pediat Infect Dis, Aurora, CO 80045 USA; [Messacar, Kevin] Childrens Hosp Colorado, Hosp Med, Aurora, CO 80045 USA; [Schreiner, Teri L.; Wallace, Adam; Ludke, Jan] Childrens Hosp Colorado, Dept Child Neurol, Aurora, CO 80045 USA; [Maloney, John A.] Childrens Hosp Colorado, Dept Radiol, Aurora, CO 80045 USA; [Robinson, Christine C.] Childrens Hosp Colorado, Dept Pathol & Lab Med, Aurora, CO 80045 USA; Univ Colorado, Sch Med, Aurora, CO 80045 USA; [Oberste, M. Stephen; Nix, W. Allan] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Children's Hospital Colorado; Children's Hospital Colorado; Children's Hospital Colorado; Children's Hospital Colorado; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Centers for Disease Control & Prevention - USA	Dominguez, SR (corresponding author), Childrens Hosp Colorado, Dept Pediat Infect Dis, Aurora, CO 80045 USA.	samuel.dominguez@childrenscolorado.org	Messacar, Kevin/H-4834-2019	Messacar, Kevin/0000-0001-5830-3491	National Center for Advancing Translational Sciences, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	National Center for Advancing Translational Sciences, National Institutes of Health.	ARITA J, 1995, PEDIATR NEUROL, V13, P263, DOI 10.1016/0887-8994(95)00181-E; Ayscue P, 2014, MMWR-MORBID MORTAL W, V63, P903; Centers for Disease Control and Prevention, 2014, INV AC FLACC MYEL US; Gaensbauer JT, 2014, PEDIATRICS, V134, pE642, DOI 10.1542/peds.2014-0498; Haq A, 2006, ARCH NEUROL-CHICAGO, V63, P778, DOI 10.1001/archneur.63.5.778; HOPKINS IJ, 1974, AUST PAEDIATR J, V10, P273; HORSTMANN DM, 1949, AM J MED, V6, P592, DOI 10.1016/0002-9343(49)90132-1; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Imamura Tadatsugu, 2011, Morbidity and Mortality Weekly Report, V60, P1301; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kimura J, 2001, ELECTRODIAGNOSIS DIS; Kincaid O, 2006, CURR NEUROL NEUROSCI, V6, P469, DOI 10.1007/s11910-006-0048-1; Knipe D.M.H., 2013, PETER FIELDS VIROLOG, V6th; Kost CB, 2007, J CLIN MICROBIOL, V45, P1081, DOI 10.1128/JCM.01718-06; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Krupp LB, 2007, NEUROLOGY, V68, pS7, DOI 10.1212/01.wnl.0000259422.44235.a8; Lang M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.44.20952; Midgley Claire M, 2014, MMWR Morb Mortal Wkly Rep, V63, P798; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; Poritz MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026047; Rhoades RE, 2011, VIROLOGY, V411, P288, DOI 10.1016/j.virol.2010.12.014; Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; TOP FH, 1958, PEDIATRICS, V21, P106; Tsai JD, 2014, JPN J INFECT DIS, V67, P333, DOI 10.7883/yoken.67.333; van Vliet KE, 1998, J CLIN MICROBIOL, V36, P2652, DOI 10.1128/JCM.36.9.2652-2657.1998; Wassilak Steve, 2012, Morbidity and Mortality Weekly Report, V61, P353; Wolf VL, 2012, J CHILD NEUROL, V27, P1426, DOI 10.1177/0883073812452916; Yeung SCM, 2010, PEDIATR NEUROL, V42, P133, DOI 10.1016/j.pediatrneurol.2009.09.013	31	206	214	3	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1662	1671		10.1016/S0140-6736(14)62457-0	http://dx.doi.org/10.1016/S0140-6736(14)62457-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG6NG	25638662				2022-12-28	WOS:000353418000039
J	McKee, M; Stuckler, D				McKee, Martin; Stuckler, David			Realising an election manifesto for public health in the UK	LANCET			English	Editorial Material									[McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1H 9SH, England; [Stuckler, David] Univ Oxford, Dept Sociol, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	McKee, M (corresponding author), London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1H 9SH, England.	martin.mckee@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Stuckler, David/0000-0002-1288-8401				Hastings R., 2012, INDEPENDENT; Kickbusch I, 2012, HEALTH PROMOT INT, V27, P427, DOI 10.1093/heapro/das057; Krugman Paul., 2014, NEW YORK TIMES; Mackenbach JP., 2013, SUCCESSES FAILURES H; Marmot M, 2010, FAIR SOC HLTH LIVES; McKee M, 2012, CLIN MED, V12, P346, DOI 10.7861/clinmedicine.12-4-346; Mindell JS, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8082; Panjwani C, 2014, HEALTH POLICY, V114, P163, DOI 10.1016/j.healthpol.2013.11.002; Stuckler DB, 2013, THE BODY EC; [No title captured]; [No title captured]; [No title captured]; [No title captured]	13	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2015	385	9969					665	666		10.1016/S0140-6736(15)60268-9	http://dx.doi.org/10.1016/S0140-6736(15)60268-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB7ED	25706204				2022-12-28	WOS:000349788300004
J	Nardini, E; Reeves, JN; Gofford, J; Harrison, FA; Risaliti, G; Braito, V; Costa, MT; Matzeu, GA; Walton, DJ; Behar, E; Boggs, SE; Christensen, FE; Craig, WW; Hailey, CJ; Matt, G; Miller, JM; O'Brien, PT; Stern, D; Turner, TJ; Ward, MJ				Nardini, E.; Reeves, J. N.; Gofford, J.; Harrison, F. A.; Risaliti, G.; Braito, V.; Costa, M. T.; Matzeu, G. A.; Walton, D. J.; Behar, E.; Boggs, S. E.; Christensen, F. E.; Craig, W. W.; Hailey, C. J.; Matt, G.; Miller, J. M.; O'Brien, P. T.; Stern, D.; Turner, T. J.; Ward, M. J.			Black hole feedback in the luminous quasar PDS 456	SCIENCE			English	Article							RADIO-QUIET AGNS; HOST GALAXIES; SIGMA RELATION; OUTFLOWS; WIND; ABSORBER; LOCATION	The evolution of galaxies is connected to the growth of supermassive black holes in their centers. During the quasar phase, a huge luminosity is released as matter falls onto the black hole, and radiation-driven winds can transfer most of this energy back to the host galaxy. Over five different epochs, we detected the signatures of a nearly spherical stream of highly ionized gas in the broadband x-ray spectra of the luminous quasar PDS 456. This persistent wind is expelled at relativistic speeds from the inner accretion disk, and its wide aperture suggests an effective coupling with the ambient gas. The outflow's kinetic power larger than 1046 ergs per second is enough to provide the feedback required by models of black hole and host galaxy coevolution.	[Nardini, E.; Reeves, J. N.; Gofford, J.; Costa, M. T.; Matzeu, G. A.] Keele Univ, Astrophys Grp, Sch Phys & Geog Sci, Keele ST5 5BG, Staffs, England; [Reeves, J. N.; Gofford, J.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Harrison, F. A.; Walton, D. J.] CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91125 USA; [Risaliti, G.] Osserv Astrofis Arcetri, Ist Nazl Astrofis, I-50125 Florence, Italy; [Risaliti, G.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Braito, V.] Osserv Astron Brera, INAF, I-23807 Merate, LC, Italy; [Walton, D. J.; Stern, D.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Behar, E.] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Boggs, S. E.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Christensen, F. E.] Tech Univ Denmark, Space Natl Space Inst, DK-2800 Lyngby, Denmark; [Craig, W. W.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Hailey, C. J.] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Matt, G.] Univ Rome Tre, Dipartimento Matemat & Fis, I-00146 Rome, Italy; [Miller, J. M.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [O'Brien, P. T.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Turner, T. J.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Turner, T. J.] Eureka Sci Inc, Oakland, CA 94602 USA; [Ward, M. J.] Univ Durham, Dept Phys, Durham DH1 3LE, England	Keele University; University System of Maryland; University of Maryland Baltimore County; California Institute of Technology; Istituto Nazionale Astrofisica (INAF); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Istituto Nazionale Astrofisica (INAF); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Technion Israel Institute of Technology; University of California System; University of California Berkeley; Technical University of Denmark; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Columbia University; Roma Tre University; University of Michigan System; University of Michigan; University of Leicester; University System of Maryland; University of Maryland Baltimore County; Eureka Scientific; Durham University	Nardini, E (corresponding author), Keele Univ, Astrophys Grp, Sch Phys & Geog Sci, Keele ST5 5BG, Staffs, England.	e.nardini@keele.ac.uk	Boggs, Steven E/E-4170-2015; christensen, finn/AAB-8622-2020; Matzeu, Gabriele/AAL-5530-2021	Boggs, Steven E/0000-0001-9567-4224; Matzeu, Gabriele/0000-0003-1994-5322; Ward, Martin/0000-0003-1810-0889; Nardini, Emanuele/0000-0001-9226-8992; O'Brien, Paul/0000-0002-5128-1899; Miller, Jon/0000-0003-2869-7682; Matt, Giorgio/0000-0002-2152-0916; Braito, Valentina/0000-0002-2629-4989; Stern, Daniel/0000-0003-2686-9241; Risaliti, Guido/0000-0002-3556-977X	U.K. Science and Technology Facilities Council [ST/J001384/1]; ESA member states; National Aeronautics and Space Administration; NASA [NNX11AJ57G, NNG08FD60C]; Italian Space Agency [ASI-INAF I/037/12/0]; Italian National Institute for Astrophysics [PRIN-INAF 2012]; I-CORE program of the Planning and Budgeting Committee; Israel Science Foundation [1937/12, 1163/10]; Israel's Ministry of Science and Technology; Science and Technology Facilities Council [ST/L00075X/1, ST/J001384/1, 1227522, ST/K001000/1, ST/H001972/1] Funding Source: researchfish; STFC [ST/H001972/1, ST/J001384/1, ST/L00075X/1, ST/K001000/1] Funding Source: UKRI	U.K. Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); ESA member states(European Space Agency); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); Italian Space Agency(Agenzia Spaziale Italiana (ASI)); Italian National Institute for Astrophysics; I-CORE program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); Israel's Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This research was supported under the U.K. Science and Technology Facilities Council grant ST/J001384/1 and is based on x-ray observations obtained with the XMM-Newton and NuSTAR satellites. XMM-Newton is a European Space Agency (ESA) science mission with instruments and contributions directly funded by ESA member states and the National Aeronautics and Space Administration. The NuSTAR mission is a project led by the California Institute of Technology, managed by the Jet Propulsion Laboratory, and funded by NASA. We thank the NuSTAR Operations, Software, and Calibration teams for support with execution and analysis of these observations. We also acknowledge financial support from the Italian Space Agency under grant ASI-INAF I/037/12/0 (G.R. and G.M.); the Italian National Institute for Astrophysics under grant PRIN-INAF 2012 (G.R.); the I-CORE program of the Planning and Budgeting Committee, the Israel Science Foundation under grants 1937/12 and 1163/10, Israel's Ministry of Science and Technology (E.B.); and NASA under grants NNX11AJ57G and NNG08FD60C (T.J.T.). The data are stored in the science archives of the two x-ray observatories involved and will become publicly available on 25 March 2015 (XMM-Newton) and with the upcoming DR6 data release (NuSTAR).	Arav N, 2013, MON NOT R ASTRON SOC, V436, P3286, DOI 10.1093/mnras/stt1812; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; Done C, 2007, MON NOT R ASTRON SOC, V374, pL15, DOI 10.1111/j.1745-3933.2006.00255.x; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Gallo LC, 2013, MON NOT R ASTRON SOC, V434, pL66, DOI 10.1093/mnrasl/slt080; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Gofford J, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/77; Gofford J, 2013, MON NOT R ASTRON SOC, V430, P60, DOI 10.1093/mnras/sts481; Hopkins PF, 2010, MON NOT R ASTRON SOC, V401, P7, DOI 10.1111/j.1365-2966.2009.15643.x; Jahnke K, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/92; Kaastra JS, 2014, SCIENCE, V345, P64, DOI 10.1126/science.1253787; King A, 2003, ASTROPHYS J, V596, pL27, DOI 10.1086/379143; King AR, 2010, MON NOT R ASTRON SOC, V402, P1516, DOI 10.1111/j.1365-2966.2009.16013.x; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Krongold Y, 2007, ASTROPHYS J, V659, P1022, DOI 10.1086/512476; McQuillin RC, 2013, MON NOT R ASTRON SOC, V434, P1332, DOI 10.1093/mnras/stt1101; Pounds KA, 2009, MON NOT R ASTRON SOC, V397, P249, DOI 10.1111/j.1365-2966.2009.14971.x; Proga D, 2000, ASTROPHYS J, V543, P686, DOI 10.1086/317154; Reeves JN, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/45; Reeves JN, 2009, ASTROPHYS J, V701, P493, DOI 10.1088/0004-637X/701/1/493; Reeves JN, 2003, ASTROPHYS J, V593, pL65, DOI 10.1086/378218; Silk J, 1998, ASTRON ASTROPHYS, V331, pL1; Tombesi F, 2012, MON NOT R ASTRON SOC, V422, pL1, DOI 10.1111/j.1745-3933.2012.01221.x; Tombesi F, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/200913440; Zubovas K, 2012, ASTROPHYS J LETT, V745, DOI 10.1088/2041-8205/745/2/L34	26	156	156	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					860	863		10.1126/science.1259202	http://dx.doi.org/10.1126/science.1259202			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700515	Green Accepted, Green Submitted			2022-12-28	WOS:000349761100040
J	O'Loughlin, A; Dinneen, SF				O'Loughlin, Aonghus; Dinneen, Sean F.			The Ipswich Touch Test at home had 78% sensitivity and 94% specificity for detecting loss of foot sensation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DIABETIC FOOT		[O'Loughlin, Aonghus] Galway Univ Hosp, Galway, Ireland; NUI Galway, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	O'Loughlin, A (corresponding author), Galway Univ Hosp, Galway, Ireland.			Dinneen, Sean/0000-0002-6636-0493				Arad Y, 2011, DIABETES CARE, V34, P1041, DOI 10.2337/dc10-1666; Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021; Dorresteijn JAN, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001488.pub3; Monteiro-Soares M, 2012, DIABETES-METAB RES, V28, P574, DOI 10.1002/dmrr.2319	4	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4							JC10	10.7326/ACPJC-2015-162-4-010	http://dx.doi.org/10.7326/ACPJC-2015-162-4-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686185				2022-12-28	WOS:000350232500001
J	Jambeck, JR; Geyer, R; Wilcox, C; Siegler, TR; Perryman, M; Andrady, A; Narayan, R; Law, KL				Jambeck, Jenna R.; Geyer, Roland; Wilcox, Chris; Siegler, Theodore R.; Perryman, Miriam; Andrady, Anthony; Narayan, Ramani; Law, Kara Lavender			Plastic waste inputs from land into the ocean	SCIENCE			English	Article							SUBTROPICAL GYRE; DEBRIS; ACCUMULATION	Plastic debris in the marine environment is widely documented, but the quantity of plastic entering the ocean from waste generated on land is unknown. By linking worldwide data on solid waste, population density, and economic status, we estimated the mass of land-based plastic waste entering the ocean. We calculate that 275 million metric tons (MT) of plastic waste was generated in 192 coastal countries in 2010, with 4.8 to 12.7 million MT entering the ocean. Population size and the quality of waste management systems largely determine which countries contribute the greatest mass of uncaptured waste available to become plastic marine debris. Without waste management infrastructure improvements, the cumulative quantity of plastic waste available to enter the ocean from land is predicted to increase by an order of magnitude by 2025.	[Jambeck, Jenna R.; Perryman, Miriam] Univ Georgia, Coll Engn, Athens, GA 30602 USA; [Geyer, Roland] Univ Calif, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Wilcox, Chris] Commonwealth Sci & Ind Res Org, Oceans & Atmosphere Flagship, Hobart, Tas 7000, Australia; [Siegler, Theodore R.] DSM Environm Serv, Windsor, VT 05089 USA; [Andrady, Anthony] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Narayan, Ramani] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Law, Kara Lavender] Sea Educ Assoc, Woods Hole, MA 02543 USA	University System of Georgia; University of Georgia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of North Carolina; North Carolina State University; Michigan State University	Jambeck, JR (corresponding author), Univ Georgia, Coll Engn, 412 Driftmier Engn Ctr, Athens, GA 30602 USA.	jjambeck@uga.edu	Jambeck, Jenna/C-3357-2018	Jambeck, Jenna/0000-0003-1248-7218; Law, Kara/0000-0002-5298-6751; Andrady, Anthony/0000-0001-8683-9998	Ocean Conservancy	Ocean Conservancy	We thank M. A. Barlaz and N. Starr for critical discussions and L. Amaral-Zettler, M. G. Chapman, G. Leonard, and R. Williams for helpful reading of the manuscript. We also thank the anonymous reviewers for their constructive comments. This work was conducted within the Marine Debris Working Group at the National Center for Ecological Analysis and Synthesis, University of California, Santa Barbara, with support from the Ocean Conservancy. Our data and model can be found at http://jambeck.engr.uga.edu/landplasticinput and in the supplementary materials.	[Anonymous], 2012, PROB PROJ TOT POP ME; [Anonymous], MUN SOL WAST GEN REC; [Anonymous], 2013, 2013 RES REV; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Braungart M, 2013, NATURE, V494, P174, DOI 10.1038/494174b; Carson HS, 2013, MAR ENVIRON RES, V84, P76, DOI 10.1016/j.marenvres.2012.12.002; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Goldstein MC, 2013, PEERJ, V1, DOI 10.7717/peerj.184; Hoornweg D., 2012, WHAT WASTE GLOBAL RE; Hoornweg D, 2013, NATURE, V502, P615, DOI 10.1038/502615a; International Maritime Organization, 1988, INT CONV PREV POLL S; Law KL, 2014, ENVIRON SCI TECHNOL, V48, P4732, DOI 10.1021/es4053076; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lechner A, 2014, ENVIRON POLLUT, V188, P177, DOI 10.1016/j.envpol.2014.02.006; Lindhqvist T, 1990, MODELLER FORLANGT PR, P7; Marshall RE, 2013, WASTE MANAGE, V33, P988, DOI 10.1016/j.wasman.2012.12.023; National Research Council (U.S.) Study Panel on Assessing Potential Ocean Pollutants, 1975, ASS POT OC POLL REP; Obbard RW, 2014, EARTHS FUTURE, V2, P315, DOI 10.1002/2014EF000240; PlasticsEurope, 2013, PLAST FACTS 2013; Thompson RC, 2009, PHILOS T R SOC B, V364, P2153, DOI 10.1098/rstb.2009.0053	21	4847	5052	383	3353	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					768	771		10.1126/science.1260352	http://dx.doi.org/10.1126/science.1260352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678662				2022-12-28	WOS:000349221300047
J	Luo, ZX; Meng, QJ; Ji, Q; Liu, D; Zhang, YG; Neander, AI				Luo, Zhe-Xi; Meng, Qing-Jin; Ji, Qiang; Liu, Di; Zhang, Yu-Guang; Neander, April I.			Evolutionary development in basal mammaliaforms as revealed by a docodontan	SCIENCE			English	Article							MAMMAL NECROLESTES; JOINT FORMATION; DIVERSIFICATION	A new Late Jurassic docodontan shows specializations for a subterranean lifestyle. It is similar to extant subterranean golden moles in having reduced digit segments as compared to the ancestral phalangeal pattern of mammaliaforms and extant mammals. The reduction of digit segments can occur in mammals by fusion of the proximal and intermediate phalangeal precursors, a developmental process for which a gene and signaling network have been characterized in mouse and human. Docodontans show a positional shift of thoracolumbar ribs, a developmental variation that is controlled by Hox9 and Myf5 genes in extant mammals. We argue that these morphogenetic mechanisms of modern mammals were operating before the rise of modern mammals, driving the morphological disparity in the earliest mammaliaform diversification.	[Luo, Zhe-Xi; Neander, April I.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Meng, Qing-Jin; Liu, Di; Zhang, Yu-Guang] Beijing Museum Nat Hist, Beijing 100050, Peoples R China; [Ji, Qiang] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China	University of Chicago; Chinese Academy of Geological Sciences	Luo, ZX (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	zxluo@uchicago.edu; mengqingjin@bmnh.org.cn	Luo, Zhe-XI/AAU-2263-2021; Meng, Q./GSI-6185-2022	Neander, April/0000-0001-6816-2872	Beijing Science and Technology Commission; Ministry of Science and Technology of China; University of Chicago	Beijing Science and Technology Commission; Ministry of Science and Technology of China(Ministry of Science and Technology, China); University of Chicago(University of Chicago)	We thank A. Tabrum and R. Masek for fossil preparation; R. Rudolph, B. Smith, and L. Leoni for CT scanning; L. Heaney and W. Stanley (Field Museum) and J. Wible and S. McLaren (Carnegie Museum) for collections access; T. Martin, J. Wible, A. Crompton, J. Hopson, and D. Grossnickle for discussion on the fossil; and M. Shapiro, K. Sears, and G. Wagner for discussion on development. Support was provided by the Beijing Science and Technology Commission "Building of Innovative Team Plan Program," 2014 First-Class Award In Science and Technology (Q.-J.M.), Ministry of Science and Technology of China 973 Project funding (Q.J.), and the University of Chicago (Z.-X.L.). Full acknowledgement to colleagues is in the supplementary materials.	Asher RJ, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3546[1:NARNAP]2.0.CO;2; Averianov A.O., 2010, Trudy Zoologicheskogo Instituta, V314, P121; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Buchholtz EA, 2014, ZOOLOGY, V117, P64, DOI 10.1016/j.zool.2013.09.001; Chen M, 2013, J MAMM EVOL, V20, P159, DOI 10.1007/s10914-012-9199-9; Chimento Nicolás R, 2012, Rev. Mus. Argent. Cienc. Nat., V14, P261; Galis F, 2014, P NATL ACAD SCI USA, V111, P11401, DOI 10.1073/pnas.1401392111; Guerreiro I, 2013, P NATL ACAD SCI USA, V110, P10682, DOI 10.1073/pnas.1300592110; Hildebrand M., 1985, P89; Hopson JA, 1995, J VERTEBR PALEONTOL, V15, P615, DOI 10.1080/02724634.1995.10011252; Hou SL, 2014, CHINESE SCI BULL, V59, P546, DOI 10.1007/s11434-013-0088-2; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Kindahl M., 1949, Acta Zoologica Stockholm, V30, P133; Kley Nathan J., 2007, P284; Lessertisseur J., 1967, TRAITE ZOOLOGIE, P709; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; Martin T, 2005, ZOOL J LINN SOC-LOND, V145, P219, DOI 10.1111/j.1096-3642.2005.00187.x; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Meng QJ, 2015, SCIENCE, V347, P764, DOI 10.1126/science.1260879; Narita Y, 2005, J EXP ZOOL PART B, V304B, P91, DOI 10.1002/jez.b.21029; Rougier GW, 2012, P NATL ACAD SCI USA, V109, P20053, DOI 10.1073/pnas.1212997109; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; Stricker S, 2011, DEV DYNAM, V240, P990, DOI 10.1002/dvdy.22565; Sues Hans-Dieter, 2006, P114	30	57	63	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					760	764		10.1126/science.1260880	http://dx.doi.org/10.1126/science.1260880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678660				2022-12-28	WOS:000349221300045
J	Pompon, J; Garcia-Blanco, MA				Pompon, Julien; Garcia-Blanco, Mariano A.			RNA: Jack of All Trades and Master of All	CELL			English	Editorial Material							VIRUS; HOST	Noncoding RNAs have regulatory capabilities that evolution harnesses to fulfill diverse functions. Lee et al. show that a noncoding RNA from Epstein-Barr virus recruits a host transcription factor to silence virus gene expression and propose that it does this through base-pairing with nascent viral transcripts.	[Pompon, Julien; Garcia-Blanco, Mariano A.] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore; [Garcia-Blanco, Mariano A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	National University of Singapore; University of Texas System; University of Texas Medical Branch Galveston	Pompon, J (corresponding author), Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore.	julien.pompon@duke-nus.edu.sg; maragarc@utmb.edu	Pompon, Julien/AAA-4463-2021	Pompon, Julien/0000-0003-1110-9039				Arvey A, 2012, CELL HOST MICROBE, V12, P233, DOI 10.1016/j.chom.2012.06.008; Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Lee N, 2015, CELL, V160, P607, DOI 10.1016/j.cell.2015.01.015; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3	9	2	2	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					579	580		10.1016/j.cell.2015.01.047	http://dx.doi.org/10.1016/j.cell.2015.01.047			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25679756	Bronze			2022-12-28	WOS:000349208800002
J	Shungin, D; Winkler, TW; Croteau-Chonka, DC; Ferreira, T; Lockes, AE; Magi, R; Strawbridge, RJ; Pers, TH; Fischer, K; Justice, AE; Workalemahu, T; Wu, JMW; Buchkovich, ML; Heard-Costa, NL; Roman, TS; Drong, AW; Song, C; Gustafsson, S; Day, FR; Esko, T; Fall, T; Kutalik, Z; Luan, JA; Randall, JC; Scherag, A; Vedantam, S; Wood, AR; Chen, J; Fehrmann, R; Karjalainen, J; Kahali, B; Liu, CT; Schmidt, EM; Absher, D; Amin, N; Anderson, D; Beekman, M; Bragg-Gresham, JL; Buyske, S; Demirkan, A; Ehret, GB; Feitosa, MF; Goel, A; Jackson, AU; Johnson, T; Kleber, ME; Kristiansson, K; Mangino, M; Leach, IM; Medina-Gomez, C; Palmer, CD; Pasko, D; Pechlivaniss, S; Peters, MJ; Prokopenko, I; Stancakova, A; Sung, YJ; Tanakam, T; Teumer, A; Van Vliet-Ostaptchouk, JV; Yengo, L; Zhang, WH; Albrecht, E; Arnlov, J; Arscott, GM; Bandinelli, S; Barrett, A; Bellis, C; Bennett, AJ; Berne, C; Bluher, M; Buhringer, S; Bonnet, F; Bottcher, Y; Bruinenberg, M; Carba, DB; Caspersen, IH; Clarke, R; Daw, EW; Deelen, J; Deelman, E; Delgado, G; Doney, ASF; Eklund, N; Erdos, MR; Estrada, K; Eury, E; Friedrichs, N; Garcia, ME; Giedraitis, V; Gigante, B; Go, AS; Golay, A; Grallert, H; Grammer, TB; Grassler, J; Grewal, J; Groves, CJ; Haller, T; Hallmans, G; Hartman, CA; Hassinen, M; Hayward, C; Heikkila, K; Herzig, KH; Helmer, Q; Hillege, HL; Holmen, O; Hunt, SC; Isaacs, A; Ittermann, T; James, AL; Johansson, I; Juliusdottir, T; Kalafati, IP; Kinnunen, L; Koenig, W; Kooner, IK; Kratzer, W; Lamina, C; Leander, K; Lee, NR; Lichtner, P; Lind, L; Lindstrom, J; Lobbens, S; Lorentzon, M; Mach, F; Magnusson, PKE; Mahajan, A; McArdle, WL; Menni, C; Merger, S; Mihailov, E; Milani, L; Mills, R; Moayyeri, A; Monda, KL; Mooijaart, SP; Muhleisen, TW; Mulas, A; Muller, G; Muller-Nurasyid, M; Nagaraja, R; Nalls, MA; Narisu, N; Glorioso, N; Nolte, IM; Olden, M; Rayner, NW; Renstrom, F; Ried, JS; Robertson, NR; Rose, LM; Sanna, S; Scharnagl, H; Scholtens, S; Sennblad, B; Seufferlein, T; Sitlani, CM; Smith, AV; Stirrups, K; Stringhams, HM; Sundstrom, J; Swertz, MA; Swift, AJ; Syvanen, AC; Tayo, BO; Thorand, B; Thorleifsson, G; Tomaschitz, A; Troffa, C; van Oort, FVA; Verweij, N; Vonk, JM; Waite, LL; Wennauer, R; Wilsgaard, T; Wojczynski, MK; Wong, A; Zhang, QY; Zhao, JH; Brennan, EP; Choi, M; Eriksson, P; Folkersen, L; Franco-Cereceda, A; Gharavi, AG; Hedman, AK; Hivert, MF; Huang, JY; Kanoni, S; Karpe, F; Keildson, S; Kiryluk, K; Liang, LM; Lifton, RP; Ma, BS; McKnight, AJ; McPherson, R; Metspalu, A; Min, JL; Moffatt, MF; Montgomery, GW; Murabito, JM; Nicholson, G; Nyholt, DR; Olsson, C; Perry, JRB; Reinmaa, E; Salem, RM; Sandholm, N; Schadt, EE; Scott, R; Stolk, L; Vallejo, EE; Westra, HJ; Zondervan, KT; Amouyel, P; Arveiler, D; Bakker, SJL; Beilby, J; Bergman, RN; Blangero, J; Brown, MJ; Burnier, M; Campbell, H; Chakravarti, A; Chiness, PS; Claudi-Boehmi, S; Collins, FS; Crawford, DC; Danesh, J; de Faire, U; de Geusl, EJC; Dorr, M; Erbel, R; Eriksson, JG; Farrall, M; Ferrannini, E; Ferrieres, J; Forouhi, NG; Forrester, T; Franco, OH; Gansevoort, RT; Gieger, C; Gudnason, V; Haiman, CA; Harris, TB; Hattersley, AT; Heliovaara, M; Hicks, AA; Hingorani, AD; Hoffmann, W; Hofman, A; Homuth, G; Humphries, SE; Hypponen, E; Illig, T; Jarvelin, MR; Johansen, B; Jousilahti, P; Jula, AM; Kaprio, J; Kee, F; Keinanen-Kiukaanniemi, SM; Kooner, JS; Kooperberg, C; Kovacs, P; Kraja, AT; Kumari, M; Kuulasmaa, K; Kuusisto, J; Lakka, TA; Langenberg, C; Le Marchand, L; Lehtimaki, T; Lyssenko, V; Mannisto, S; Marette, A; Matise, TC; McKenzie, CA; McKnight, B; Musk, AW; Mohlenkamp, S; Morris, AD; Nelis, M; Ohlsson, C; Oldehinkel, AJ; Ong, KK; Palmer, LJ; Penninx, BW; Peters, A; Pramstaller, PP; Raitakari, OT; Rankinen, T; Rao, DC; Rice, TK; Ridker, PM; Ritchie, MD; Rudan, I; Salomaa, V; Samani, NJ; Saramies, J; Sarzynski, MA; Schwarz, PEH; Shuldiner, AR; Staessen, JA; Steinthorsdottir, V; Stolk, RP; Strauch, K; Tonjes, A; Tremblay, A; Tremoli, E; Vohl, MC; Volker, U; Vollenweider, P; Wilson, JF; Witteman, JC; Adair, LS; Bochud, M; Boehm, BO; Bornstein, SR; Bouchard, C; Cauchi, S; Caulfield, MJ; Chambers, JC; Chasman, DI; Cooper, RS; Dedoussis, G; Ferrucci, L; Froguel, P; Grabe, HJ; Hamsten, A; Hui, JN; Hveem, K; Jockel, KH; Kivimaki, M; Kuh, D; Laakso, M; Liu, YM; Marz, W; Munroe, PB; Njolstad, I; Oostra, BA; Palmer, CNA; Pedersen, NL; Perola, M; Perusse, L; Peters, U; Power, C; Quertermous, T; Rauramaa, R; Rivadeneira, F; Saaristo, TE; Saleheen, D; Sinisalo, J; Slagboom, PE; Snieder, H; Spector, TD; Thorsteinsdottir, UR; Stumvoll, M; Tuomilehto, J; Uitterlinden, AG; Uusitupa, M; van der Harst, P; Veronesi, G; Walker, M; Wareham, NJ; Watkins, H; Wichmann, HE; Abecasis, GR; Assimes, TL; Berndt, SI; Boehnkes, M; Borecki, IB; Deloukas, P; Franke, L; Frayling, TM; Groop, LC; Hunter, DJ; Kaplan, RC; O'Connell, JR; Qi, L; Schlessinger, D; Strachan, DP; Stefansson, K; van Dujin, CM; Willer, CJ; Visscher, PM; Yang, J; Hirschhorn, JN; Zillikens, MC; McCarthy, MI; Speliotes, EK; North, KE; Fox, CS; Barroso, I; Franks, PW; Ingelsson, E; Heid, IM; Loos, RJF; Cupples, LA; Morris, AP; Lindgren, CM; Mohlke, KL				Shungin, Dmitry; Winkler, Thomas W.; Croteau-Chonka, Damien C.; Ferreira, Teresa; Lockes, Adam E.; Maegi, Reedik; Strawbridge, Rona J.; Pers, Tune H.; Fischer, Krista; Justice, Anne E.; Workalemahu, Tsegaselassie; Wu, Joseph M. W.; Buchkovich, Martin L.; Heard-Costa, Nancy L.; Roman, Tamara S.; Drong, Alexander W.; Song, Ci; Gustafsson, Stefan; Day, Felix R.; Esko, Tonu; Fall, Tove; Kutalik, Zoltan; Luan, Jian'an; Randall, Joshua C.; Scherag, Andre; Vedantam, Sailaja; Wood, Andrew R.; Chen, Jin; Fehrmann, Rudolf; Karjalainen, Juha; Kahali, Bratati; Liu, Ching-Ti; Schmidt, Ellen M.; Absher, Devin; Amin, Najaf; Anderson, Denise; Beekman, Marian; Bragg-Gresham, Jennifer L.; Buyske, Steven; Demirkan, Ayse; Ehret, Georg B.; Feitosa, Mary F.; Goel, Anuj; Jackson, Anne U.; Johnson, Toby; Kleber, Marcus E.; Kristiansson, Kati; Mangino, Massimo; Leach, Irene Mateo; Medina-Gomez, Carolina; Palmer, Cameron D.; Pasko, Dorota; Pechlivaniss, Sonali; Peters, Marjolein J.; Prokopenko, Inga; Stancakova, Alena; Sung, Yun Ju; Tanakam, Toshiko; Teumer, Alexander; Van Vliet-Ostaptchouk, Jana V.; Yengo, Loic; Zhang, Weihua; Albrecht, Eva; Arnlov, Johan; Arscott, Gillian M.; Bandinelli, Stefania; Barrett, Amy; Bellis, Claire; Bennett, Amanda J.; Berne, Christian; Blueher, Matthias; Buhringer, Stefan; Bonnet, Fabrice; Boettcher, Yvonne; Bruinenberg, Marcel; Carba, Delia B.; Caspersen, Ida H.; Clarke, Robert; Daw, E. Warwick; Deelen, Joris; Deelman, Ewa; Delgado, Graciela; Doney, Alex S. F.; Eklund, Niina; Erdos, Michael R.; Estrada, Karol; Eury, Elodie; Friedrichs, Nele; Garcia, Melissa E.; Giedraitis, Vilmantas; Gigante, Bruna; Go, Alan S.; Golay, Alain; Grallert, Harald; Grammer, Tanja B.; Graessler, Juergen; Grewal, Jagvir; Groves, Christopher J.; Haller, Toomas; Hallmans, Goran; Hartman, Catharina A.; Hassinen, Maija; Hayward, Caroline; Heikkila, Kauko; Herzig, Karl-Heinz; Helmer, Quinta; Hillege, Hans L.; Holmen, Oddgeir; Hunt, Steven C.; Isaacs, Aaron; Ittermann, Till; James, Alan L.; Johansson, Ingegerd; Juliusdottir, Thorhildur; Kalafati, Ioanna-Panagiota; Kinnunen, Leena; Koenig, Wolfgang; Kooner, Ishminder K.; Kratzer, Wolfgang; Lamina, Claudia; Leander, Karin; Lee, Nanette R.; Lichtner, Peter; Lind, Lars; Lindstrom, Jaana; Lobbens, Stephane; Lorentzon, Mattias; Mach, Francois; Magnusson, Patrik K. E.; Mahajan, Anubha; McArdle, Wendy L.; Menni, Cristina; Merger, Sigrun; Mihailov, Evelin; Milani, Lili; Mills, Rebecca; Moayyeri, Alireza; Monda, Ken L.; Mooijaart, Simon P.; Muehleisen, Thomas W.; Mulas, Antonella; Mueller, Gabriele; Mueller-Nurasyid, Martina; Nagaraja, Ramaiah; Nalls, Michael A.; Narisu, Narisu; Glorioso, Nicola; Nolte, Ilja M.; Olden, Matthias; Rayner, Nigel W.; Renstrom, Frida; Ried, Janina S.; Robertson, Neil R.; Rose, Lynda M.; Sanna, Serena; Scharnagl, Hubert; Scholtens, Salome; Sennblad, Bengt; Seufferlein, Thomas; Sitlani, Colleen M.; Smith, Albert Vernon; Stirrups, Kathleen; Stringham, Heather M.; Sundstrom, Johan; Swertz, Morris A.; Swift, Amy J.; Syvanen, Ann-Christine; Tayo, Bamidele O.; Thorand, Barbara; Thorleifsson, Gudmar; Tomaschitz, Andreas; Troffa, Chiara; van Oort, Floor V. A.; Verweij, Niek; Vonk, Judith M.; Waite, Lindsay L.; Wennauer, Roman; Wilsgaard, Tom; Wojczynski, Mary K.; Wong, Andrew; Zhang, Qunyuan; Zhao, Jing Hua; Brennan, Eoin P.; Choi, Murim; Eriksson, Per; Folkersen, Lasse; Franco-Cereceda, Anders; Gharavi, Ali G.; Hedman, Asa K.; Hivert, Marie-France; Huang, Jinyan; Kanoni, Stavroula; Karpe, Fredrik; Keildson, Sarah; Kiryluk, Krzysztof; Liang, Liming; Lifton, Richard P.; Ma, Baoshan; McKnight, Amy J.; McPherson, Ruth; Metspalu, Andres; Min, Josine L.; Moffatt, Miriam F.; Montgomery, Grant W.; Murabito, Joanne M.; Nicholson, George; Nyholt, Dale R.; Olsson, Christian; Perry, John R. B.; Reinmaa, Eva; Salem, Rany M.; Sandholm, Niina; Schadt, Eric E.; Scott, Robert A.; Stolk, Lisette; Vallejo, Edgar E.; Westra, Harm-Jan; Zondervan, Krina T.; Amouyel, Philippe; Arveiler, Dominique; Bakker, Stephan J. L.; Beilby, John; Bergman, Richard N.; Blangero, John; Brown, Morris J.; Burnier, Michel; Campbell, Harry; Chakravarti, Aravinda; Chiness, Peter S.; Claudi-Boehmi, Simone; Collins, Francis S.; Crawford, Dana C.; Danesh, John; de Faire, Ulf; de Geusl, Eco J. C.; Doerr, Marcus; Erbel, Raimund; Eriksson, Johan G.; Farrall, Martin; Ferrannini, Ele; Ferrieres, Jean; Forouhi, Nita G.; Forrester, Terrence; Franco, Oscar H.; Gansevoort, Ron T.; Gieger, Christian; Gudnason, Vilmundur; Haiman, Christopher A.; Harris, Tamara B.; Hattersley, Andrew T.; Heliovaara, Markku; Hicks, Andrew A.; Hingorani, Aroon D.; Hoffmann, Wolfgang; Hofman, Albert; Homuth, Georg; Humphries, Steve E.; Hyppoenen, Elina; Illig, Thomas; Jarvelin, Marjo-Riitta; Johansen, Berit; Jousilahti, Pekka; Jula, Antti M.; Kaprio, Jaakko; Kee, Frank; Keinanen-Kiukaanniemi, Sirkka M.; Kooner, Jaspal S.; Kooperberg, Charles; Kovacs, Peter; Kraja, Aldi T.; Kumari, Meena; Kuulasmaa, Kari; Kuusisto, Johanna; Lakka, Timo A.; Langenberg, Claudia; Le Marchand, Loic; Lehtimaki, Terho; Lyssenko, Valeriya; Mannisto, Satu; Marette, Andre; Matise, Tara C.; McKenzie, Colin A.; McKnight, Barbara; Musk, Arthur W.; Mohlenkamp, Stefan; Morris, Andrew D.; Nelis, Mari; Ohlsson, Claes; Oldehinkel, Albertine J.; Ong, Ken K.; Palmer, Lyle J.; Penninx, Brenda W.; Peters, Annette; Pramstaller, Peter P.; Raitakari, Olli T.; Rankinen, Tuomo; Rao, D. C.; Rice, Treva K.; Ridker, Paul M.; Ritchie, Marylyn D.; Rudan, Igor; Salomaa, Veikko; Samani, Nilesh J.; Saramies, Jouko; Sarzynski, Mark A.; Schwarz, Peter E. H.; Shuldiner, Alan R.; Staessen, Jan A.; Steinthorsdottir, Valgerdur; Stolk, Ronald P.; Strauch, Konstantin; Toenjes, Anke; Tremblay, Angelo; Tremoli, Elena; Vohl, Marie-Claude; Voelker, Uwe; Vollenweider, Peter; Wilson, James F.; Witteman, Jacqueline C.; Adair, Linda S.; Bochud, Murielle; Boehm, Bernhard O.; Bornstein, Stefan R.; Bouchard, Claude; Cauchi, Stephane; Caulfield, Mark J.; Chambers, John C.; Chasman, Daniel I.; Cooper, Richard S.; Dedoussis, George; Ferrucci, Luigi; Froguel, Philippe; Grabe, Hans-Joergen; Hamsten, Anders; Hui, Jennie; Hveem, Kristian; Joeckel, Karl-Heinz; Kivimaki, Mika; Kuh, Diana; Laakso, Markku; Liu, Yongmei; Maerz, Winfried; Munroe, Patricia B.; Njolstad, Inger; Oostra, Ben A.; Palmer, Colin N. A.; Pedersen, Nancy L.; Perola, Markus; Perusse, Louis; Peters, Ulrike; Power, Chris; Quertermous, Thomas; Rauramaa, Rainer; Rivadeneira, Fernando; Saaristo, Timo E.; Saleheen, Danish; Sinisalo, Juha; Slagboom, P. Eline; Snieder, Harold; Spector, Tim D.; Thorsteinsdottir, Unnur R.; Stumvoll, Michael; Tuomilehto, Jaakko; Uitterlinden, Andre G.; Uusitupa, Math; van der Harst, Pim; Veronesi, Giovanni; Walker, Mark; Wareham, Nicholas J.; Watkins, Hugh; Wichmann, H-Erich; Abecasis, Goncalo R.; Assimes, Themistocles L.; Berndt, Sonja I.; Boehnkes, Michael; Borecki, Ingrid B.; Deloukas, Panos; Franke, Lude; Frayling, Timothy M.; Groop, Leif C.; Hunter, David J.; Kaplan, Robert C.; O'Connell, Jeffrey R.; Qi, Lu; Schlessinger, David; Strachan, David P.; Stefansson, Kari; van Dujin, Cornelia M.; Willer, Cristen J.; Visscher, Peter M.; Yang, Jian; Hirschhorn, Joel N.; Zillikens, M. Carola; McCarthy, Mark I.; Speliotes, Elizabeth K.; North, Kari E.; Fox, Caroline S.; Barroso, Ines; Franks, Paul W.; Ingelsson, Erik; Heid, Iris M.; Loos, Ruth J. F.; Cupples, L. Adrienne; Morris, Andrew P.; Lindgren, Cecilia M.; Mohlke, Karen L.		ADIPOGEN Consortium; CARDIOGRAMplusC4D Consortium; CKDGen Consortium; GEFOS Consortium; GENIE Consortium; GLGC; ICBP; Int Endogene Consortium; LifeLines Cohort Study; MAGIC Investigators; MuTHER Consortium; PAGE Consortium; ReproGen Consortium	New genetic loci link adipose and insulin biology to body fat distribution	NATURE			English	Article							GENOME-WIDE ASSOCIATION; ADIPOGENIC DIFFERENTIATION; ABDOMINAL ADIPOSITY; SEXUAL-DIMORPHISM; GLYCEMIC TRAITS; FALSE DISCOVERY; COMMON SNPS; METAANALYSIS; VARIANTS; RISK	Body fat distribution is a heritable trait and a well-established predictor of adverse metabolic outcomes, independent of overall adiposity. To increase our understanding of the genetic basis of body fat distribution and its molecular links to cardiometabolic traits, here we conduct genome-wide association meta-analyses of traits related to waist and hip circumferences in up to 224,459 individuals. We identify 49 loci (33 new) associated with waist-to-hip ratio adjusted for body mass index (BMI), and an additional 19 loci newly associated with related waist and hip circumference measures (P < 5 x 10(-8)). In total, 20 of the 49 waist-to-hip ratio adjusted for BMI loci show significant sexual dimorphism, 19 of which display a stronger effect in women. The identified loci were enriched for genes expressed in adipose tissue and for putative regulatory elements in adipocytes. Pathway analyses implicated adipogenesis, angiogenesis, transcriptional regulation and insulin resistance as processes affecting fat distribution, providing insight into potential pathophysiological mechanisms.	[Shungin, Dmitry; Franks, Paul W.] Umea Univ, Med Unit, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden; [Shungin, Dmitry; Renstrom, Frida; Franks, Paul W.] Lund Univ, Ctr Diabet, Skane Univ Hosp, Dept Clin Sci,Genet & Mol Epidemiol Unit, S-20502 Malmo, Sweden; [Shungin, Dmitry; Johansson, Ingegerd] Umea Univ, Dept Oncol, S-90185 Umea, Sweden; [Winkler, Thomas W.; Olden, Matthias; Heid, Iris M.] Univ Regensburg, Inst Epidemiol & Prevent Med, Dept Genet Epidemiol, D-93053 Regensburg, Germany; [Croteau-Chonka, Damien C.; Buchkovich, Martin L.; Roman, Tamara S.; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Croteau-Chonka, Damien C.; Hunter, David J.; Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Croteau-Chonka, Damien C.; Estrada, Karol; Ridker, Paul M.; Chasman, Daniel I.; Hunter, David J.; Qi, Lu] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ferreira, Teresa; Maegi, Reedik; Drong, Alexander W.; Randall, Joshua C.; Goel, Anuj; Prokopenko, Inga; Juliusdottir, Thorhildur; Mahajan, Anubha; Rayner, Nigel W.; Robertson, Neil R.; Hedman, Asa K.; Keildson, Sarah; Perry, John R. B.; Zondervan, Krina T.; Farrall, Martin; Watkins, Hugh; McCarthy, Mark I.; Ingelsson, Erik; Morris, Andrew P.; Lindgren, Cecilia M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Lockes, Adam E.; Bragg-Gresham, Jennifer L.; Jackson, Anne U.; Stringham, Heather M.; Abecasis, Goncalo R.; Boehnkes, Michael] Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; [Maegi, Reedik; Fischer, Krista; Esko, Tonu; Haller, Toomas; Mihailov, Evelin; Milani, Lili; Metspalu, Andres; Reinmaa, Eva; Nelis, Mari; Perola, Markus; Morris, Andrew P.] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Strawbridge, Rona J.; Sennblad, Bengt; Eriksson, Per; Folkersen, Lasse; Hamsten, Anders] Karolinska Inst, Dept Med, Ctr Mol Med, Atherosclerosis Res Unit, S-17176 Stockholm, Sweden; [Pers, Tune H.; Esko, Tonu; Vedantam, Sailaja; Palmer, Cameron D.; Salem, Rany M.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Pers, Tune H.; Esko, Tonu; Vedantam, Sailaja; Palmer, Cameron D.; Salem, Rany M.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Pers, Tune H.; Esko, Tonu; Vedantam, Sailaja; Palmer, Cameron D.; Salem, Rany M.; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Pers, Tune H.; Esko, Tonu; Vedantam, Sailaja; Palmer, Cameron D.; Estrada, Karol; Salem, Rany M.; Hirschhorn, Joel N.; Lindgren, Cecilia M.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Pers, Tune H.; Esko, Tonu; Vedantam, Sailaja; Palmer, Cameron D.; Estrada, Karol; Salem, Rany M.; Hirschhorn, Joel N.; Lindgren, Cecilia M.] Harvard Univ, Cambridge, MA 02142 USA; [Pers, Tune H.; Esko, Tonu; Salem, Rany M.; Hirschhorn, Joel N.] Harvard Univ, Dept Genet, Boston, MA 02115 USA; [Pers, Tune H.] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Justice, Anne E.; Monda, Ken L.; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Workalemahu, Tsegaselassie; Hunter, David J.; Qi, Lu; Franks, Paul W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Wu, Joseph M. W.; Liu, Ching-Ti; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Heard-Costa, Nancy L.; Murabito, Joanne M.; Fox, Caroline S.; Cupples, L. Adrienne] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Heard-Costa, Nancy L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Song, Ci; Fall, Tove; Magnusson, Patrik K. E.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Song, Ci; Gustafsson, Stefan; Fall, Tove; Arnlov, Johan; Syvanen, Ann-Christine; Hedman, Asa K.; Ingelsson, Erik] Uppsala Univ, Sci Life Lab, S-75185 Uppsala, Sweden; [Song, Ci; Gustafsson, Stefan; Fall, Tove; Arnlov, Johan; Hedman, Asa K.; Ingelsson, Erik] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden; [Day, Felix R.; Luan, Jian'an; Zhao, Jing Hua; Scott, Robert A.; Forouhi, Nita G.; Langenberg, Claudia; Ong, Ken K.; Wareham, Nicholas J.; Loos, Ruth J. F.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Kutalik, Zoltan] CHU Vaudois, Inst Social & Prevent Med IUMSP, CH-1010 Lausanne, Switzerland; [Kutalik, Zoltan; Johnson, Toby] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Kutalik, Zoltan; Johnson, Toby] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Randall, Joshua C.; Rayner, Nigel W.; Stirrups, Kathleen; Deloukas, Panos; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Scherag, Andre; Pechlivaniss, Sonali; Joeckel, Karl-Heinz] Univ Hosp Essen, IMIBE, D-45147 Essen, Germany; [Scherag, Andre] Jena Univ Hosp, CSCC, Clin Epidemiol Integrated Res & Treatment Ctr, D-07743 Jena, Germany; [Wood, Andrew R.; Pasko, Dorota; Perry, John R. B.; Frayling, Timothy M.] Univ Exeter, Sch Med, Exeter EX1 2LU, Devon, England; [Chen, Jin; Willer, Cristen J.] Univ Michigan, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Fehrmann, Rudolf; Karjalainen, Juha; Swertz, Morris A.; Westra, Harm-Jan; van der Harst, Pim; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Kahali, Bratati; Speliotes, Elizabeth K.] Univ Michigan, Div Gastroenterol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kahali, Bratati; Schmidt, Ellen M.; Willer, Cristen J.; Speliotes, Elizabeth K.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Absher, Devin; Waite, Lindsay L.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Amin, Najaf; Demirkan, Ayse; Isaacs, Aaron; Oostra, Ben A.; van Dujin, Cornelia M.] Erasmus MC Univ Med Ctr, Dept Epidemiol, Genet Epidemiol Unit, NL-3015 GE Rotterdam, Netherlands; [Anderson, Denise] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6008, Australia; [Beekman, Marian; Buhringer, Stefan; Deelen, Joris; Helmer, Quinta; Mooijaart, Simon P.; Stolk, Lisette; Slagboom, P. Eline] Leiden Univ, Med Ctr, NCHA, NL-2300 RC Leiden, Netherlands; [Beekman, Marian; Deelen, Joris; Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Mol Epidemiol, NL-2300 RC Leiden, Netherlands; [Bragg-Gresham, Jennifer L.] Univ Michigan, Kidney Epidemiol & Cost Ctr, Ann Arbor, MI 48109 USA; [Buyske, Steven] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ 08854 USA; [Buyske, Steven; Matise, Tara C.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Demirkan, Ayse] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZC Leiden, Netherlands; [Ehret, Georg B.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet c Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA; [Ehret, Georg B.] Univ Hosp Geneva, Dept Specialties Internal Med, CH-1211 Geneva, Switzerland; [Feitosa, Mary F.; Daw, E. Warwick; Zhang, Qunyuan; Kraja, Aldi T.; Rao, D. C.; Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Goel, Anuj; Farrall, Martin; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford OX3 9DU, England; [Johnson, Toby] Univ Lausanne, CHUV, Univ Inst Social & Preventat Med, CH-1005 Lausanne, Switzerland; [Kleber, Marcus E.; Delgado, Graciela; Grammer, Tanja B.; Smith, Albert Vernon; Maerz, Winfried] Heidelberg Univ, Dept Med Nephrol Hypertensiol Endocrinol Diabetol, Med Fac Mannheim, D-68187 Mannheim, Germany; [Kleber, Marcus E.; Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med 2, D-89081 Ulm, Germany; [Kristiansson, Kati; Eklund, Niina; Kinnunen, Leena; Lindstrom, Jaana; Eriksson, Johan G.; Heliovaara, Markku; Jousilahti, Pekka; Jula, Antti M.; Kaprio, Jaakko; Kuulasmaa, Kari; Mannisto, Satu; Salomaa, Veikko; Perola, Markus; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, FI-00271 Helsinki, Finland; [Mangino, Massimo; Menni, Cristina; Moayyeri, Alireza; Perry, John R. B.; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Leach, Irene Mateo; Hillege, Hans L.; Verweij, Niek; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [Medina-Gomez, Carolina; Peters, Marjolein J.; Franco, Oscar H.; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Dujin, Cornelia M.; Zillikens, M. Carola] NCHA, NL-3015 GE Rotterdam, Netherlands; [Medina-Gomez, Carolina; Franco, Oscar H.; Hofman, Albert; Witteman, Jacqueline C.; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Dujin, Cornelia M.] Erasmus MC Univ Med Ctr, Dept Epidemiol, NL-3015 GE Rotterdam, Netherlands; [Medina-Gomez, Carolina; Peters, Marjolein J.; Estrada, Karol; Stolk, Lisette; Rivadeneira, Fernando; Uitterlinden, Andre G.; Zillikens, M. Carola] Erasmus MC Univ Med Ctr, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Prokopenko, Inga; Barrett, Amy; Bennett, Amanda J.; Groves, Christopher J.; Rayner, Nigel W.; Robertson, Neil R.; Karpe, Fredrik; McCarthy, Mark I.] Univ Oxford, Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Prokopenko, Inga; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, Hammersmith Hosp, London W12 0NN, England; [Stancakova, Alena] Univ Eastern Finland, FI-70210 Kuopio, Finland; [Sung, Yun Ju; Rao, D. C.; Rice, Treva K.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Tanakam, Toshiko; Ferrucci, Luigi] NIA, Translat Gerontol Branch, Baltimore, MD 21225 USA; [Teumer, Alexander; Homuth, Georg; Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, D-17475 Greifswald, Germany; [Van Vliet-Ostaptchouk, Jana V.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands; [Yengo, Loic; Eury, Elodie; Lobbens, Stephane; Cauchi, Stephane; Froguel, Philippe] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8199, F-59019 Lille, France; [Yengo, Loic; Eury, Elodie; Lobbens, Stephane; Cauchi, Stephane; Froguel, Philippe] European Genom Inst Diabet, F-59000 Lille, France; [Yengo, Loic; Eury, Elodie; Lobbens, Stephane; Cauchi, Stephane; Froguel, Philippe] Univ Lille 2, F-59000 Lille, France; [Zhang, Weihua; Grewal, Jagvir; Kooner, Ishminder K.; Mills, Rebecca; Kooner, Jaspal S.; Chambers, John C.] Ealing Hosp NHS Trust, Southall UB1 3HW, Middx, England; [Zhang, Weihua; Grewal, Jagvir; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Albrecht, Eva; Grallert, Harald; Mueller-Nurasyid, Martina; Ried, Janina S.; Gieger, Christian; Strauch, Konstantin; Heid, Iris M.] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Studies, SE-79188 Falun, Sweden; [Arscott, Gillian M.; Beilby, John; Hui, Jennie] PathWest Lab Med Western Australia, Nedlands, WA 6009, Australia; [Bandinelli, Stefania] ASF, Geriatr Unit, I-50125 Florence, Italy; [Bellis, Claire; Blangero, John] Texas Biomed Res Inst, Dept Genet, San Antonio, TX 78227 USA; [Bellis, Claire] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, Brisbane, Qld 4001, Australia; [Berne, Christian] Uppsala Univ, Dept Med Sci Endocrinol Diabet & Metab, S-75185 Uppsala, Sweden; [Blueher, Matthias; Boettcher, Yvonne; Kovacs, Peter; Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04103 Leipzig, Germany; [Blueher, Matthias; Kovacs, Peter; Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Buhringer, Stefan; Helmer, Quinta] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Bonnet, Fabrice] Univ Rennes, Dept Endocrinol, INSERM, UMR991, F-35000 Rennes, France; [Bruinenberg, Marcel; Scholtens, Salome] Univ Groningen, Univ Med Ctr Groningen, LifeLines Cohort Study, NL-9700 RB Groningen, Netherlands; [Carba, Delia B.; Lee, Nanette R.] Univ San Carlos, USC Off Populat Studies Fdn Inc, Cebu 6000, Philippines; [Caspersen, Ida H.; Johansen, Berit] Norwegian Univ Sci & Technol, Dept Biol, N-7491 Trondheim, Norway; [Clarke, Robert] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Clarke, Robert] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford OX3 7LF, England; [Deelman, Ewa] Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA; [Doney, Alex S. F.; Morris, Andrew D.; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Eklund, Niina; Kaprio, Jaakko; Perola, Markus; Groop, Leif C.] Univ Helsinki, Inst Mol Med, FI-00014 Helsinki, Finland; [Erdos, Michael R.; Narisu, Narisu; Swift, Amy J.; Chiness, Peter S.; Collins, Francis S.] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Estrada, Karol] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Friedrichs, Nele] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Garcia, Melissa E.; Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, NIH, Bethesda, MD 20892 USA; [Giedraitis, Vilmantas] Uppsala Univ, Dept Publ Hlth & Caring Sci, S-75185 Uppsala, Sweden; [Gigante, Bruna; Leander, Karin; de Faire, Ulf] Karolinska Inst, Div Cardiovasc Epidemiol, Inst Environm Med, S-17177 Stockholm, Sweden; [Go, Alan S.] Kaiser Permanente, Div Res, Oakland, CA 94612 USA; [Golay, Alain] Univ Hosp Geneva, Serv Therapeut Educ Diabet Obes & Chron Dis, CH-1211 Geneva, Switzerland; [Grallert, Harald; Illig, Thomas; Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Grallert, Harald; Thorand, Barbara] German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany; [Graessler, Juergen; Schwarz, Peter E. H.; Bornstein, Stefan R.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Med 3, D-01307 Dresden, Germany; [Hallmans, Goran] Umea Univ, Unit Nutr Res, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden; [Hartman, Catharina A.; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 RB Groningen, Netherlands; [Hassinen, Maija; Lakka, Timo A.; Rauramaa, Rainer] Kuoplo Res Inst Exercise Med, FI-70100 Kuopio, Finland; [Hayward, Caroline] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Heikkila, Kauko; Kaprio, Jaakko] Univ Helsinki, Hjelt Inst, Dept Publ Hlth, FI-00014 Helsinki, Finland; [Herzig, Karl-Heinz] Univ Oulu, Inst Biomed, FI-90014 Oulu, Finland; [Herzig, Karl-Heinz] Med Res Ctr Oulu, FI-90014 Oulu, Finland; [Herzig, Karl-Heinz] Oulu Univ Hosp, FI-90014 Oulu, Finland; [Herzig, Karl-Heinz; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, FI-90014 Oulu, Finland; [Helmer, Quinta] Vrije Univ Amsterdam, Fac Psychol & Educ, NL-1081 BT Amsterdam, Netherlands; [Hillege, Hans L.; Nolte, Ilja M.; Vonk, Judith M.; Stolk, Ronald P.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Holmen, Oddgeir; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7489 Trondheim, Norway; [Hunt, Steven C.] Univ Utah, Cardiovasc Genet Div, Dept Internal Med, Salt Lake City, UT 84108 USA; [Isaacs, Aaron; Oostra, Ben A.; van Dujin, Cornelia M.] Ctr Med Sytems Biol, NL-2300 RC Leiden, Netherlands; [Ittermann, Till; Hoffmann, Wolfgang] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [James, Alan L.] Dept Pulm Physiol & Sleep Med, Nedlands, WA 6009, Australia; [James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA 6009, Australia; [Kalafati, Ioanna-Panagiota; Dedoussis, George] Harokopio Univ, Dept Dietet Nutr, Athens 17671, Greece; [Kratzer, Wolfgang; Seufferlein, Thomas] Univ Ulm, Med Ctr, Dept Internal Med 1, D-89081 Ulm, Germany; [Lamina, Claudia] Med Univ Innsbruck, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Lichtner, Peter] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; [Lind, Lars; Sundstrom, Johan] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden; [Lorentzon, Mattias; Ohlsson, Claes] Univ Gothenburg, Ctr Bone & Arthrit Res, Dept Internal Med & Clin Nutr, Inst Med,Sahlgrenska Acad, S-41345 Gothenburg, Sweden; [McArdle, Wendy L.; Min, Josine L.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Merger, Sigrun; Claudi-Boehmi, Simone] Univ Ulm, Med Ctr, Div Endocrinol Diabet & Metab, D-89081 Ulm, Germany; [Mihailov, Evelin; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Moayyeri, Alireza] UCL, Farr Inst Hlth Informat Res, London NW1 2DA, England; [Monda, Ken L.] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA 91320 USA; [Mooijaart, Simon P.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, NL-2300 RC Leiden, Netherlands; [Muehleisen, Thomas W.] Univ Bonn, Life Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Muehleisen, Thomas W.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Mulas, Antonella; Sanna, Serena] CNR, IRGB, I-09042 Cagliari, Sardinia, Italy; [Mueller, Gabriele] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Ctr Evidence Based Healthcare, D-01307 Dresden, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, D-81377 Munich, Germany; [Mueller-Nurasyid, Martina; Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat, D-81377 Munich, Germany; [Mueller-Nurasyid, Martina; Peters, Annette] Munich HeartAlliance, German Res Ctr Cardiovasc Res, Deutsch Forschungszentrum Herz Kreislauferkrankun, D-80636 Munich, Germany; [Nagaraja, Ramaiah; Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Nalls, Michael A.] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Glorioso, Nicola; Troffa, Chiara] Univ Sassari, Sch Med, Hypertens & Related Dis Ctr AOU, I-07100 Sassari, Italy; [Rose, Lynda M.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Scharnagl, Hubert; Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria; [Sennblad, Bengt] Karolinska Inst, Sci Life Lab, S-17165 Stockholm, Sweden; [Sitlani, Colleen M.] Univ Washington, Dept Med, Seattle, WA 98101 USA; [Smith, Albert Vernon; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert Vernon; Gudnason, Vilmundur] Univ Iceland, IS-101 Reykjavik, Iceland; [Stirrups, Kathleen; Kanoni, Stavroula; Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, S-75144 Uppsala, Sweden; [Tayo, Bamidele O.; Cooper, Richard S.] Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL 61053 USA; [Thorand, Barbara; Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Thorleifsson, Gudmar; Steinthorsdottir, Valgerdur; Thorsteinsdottir, Unnur R.; Stefansson, Kari] Amgen Inc, deCODE Genet, IS-101 Reykjavik, Iceland; [Tomaschitz, Andreas] Med Univ Graz, Dept Cardiol, A-8036 Graz, Austria; [van Oort, Floor V. A.] Erasmus MC Univ Med Ctr, Dept Child & Adolescent Psychiat, NL-3000 CB Rotterdam, Netherlands; [Wennauer, Roman] Univ Ulm, Med Ctr, Dept Clin Chem, D-89081 Ulm, Germany; [Wilsgaard, Tom; Njolstad, Inger] UiT, Fac Hlth Sci, Dept Community Med, N-9037 Tromso, Norway; [Wong, Andrew; Ong, Ken K.; Kuh, Diana] UCL, MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England; [Brennan, Eoin P.] Natl Univ Ireland Univ Coll Dublin, Diabet Complicat Res Ctr, Conway Inst, Sch Med & Med Sci, Dublin 4, Ireland; [Choi, Murim] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Franco-Cereceda, Anders; Olsson, Christian] Karolinska Inst, Cardlothorac Surg Unit, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Gharavi, Ali G.; Kiryluk, Krzysztof] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Hivert, Marie-France] Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA 02215 USA; [Hivert, Marie-France] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Huang, Jinyan] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, Shanghai 200025, Peoples R China; [Huang, Jinyan; Liang, Liming; Ma, Baoshan; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Karpe, Fredrik] OUH Trust, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LE, England; [Liang, Liming] Harvard Univ, Harvard Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06520 USA; [Ma, Baoshan] Dalian Maritime Univ, Coll Informat Sci & Technol, Dalian 116026, Liaoning, Peoples R China; [McKnight, Amy J.] Queens Univ Belfast, Ctr Publ Hlth, Belfast BT9 7AB, Down, North Ireland; [McPherson, Ruth] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Moffatt, Miriam F.; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Montgomery, Grant W.; Nyholt, Dale R.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Murabito, Joanne M.] Boston Univ, Sch Med, Sect Gen Internal Med, Boston, MA 02118 USA; [Nicholson, George] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Nicholson, George] MRC Harwell, Harwell OX11 0QG, Berks, England; [Nyholt, Dale R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Sandholm, Niina] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, FI-00076 Helsinki, Finland; [Sandholm, Niina] Univ Helsinki, Cent Hosp, Div Nephrol, Dept Med, FI-00290 Helsinki, Finland; [Sandholm, Niina] Folkhalsan Inst Genet, Folkhalsan Res Ctr, FI-00290 Helsinki, Finland; [Schadt, Eric E.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10580 USA; [Vallejo, Edgar E.] Tecnol Monterrey, Dept Comp Sci, Atizapan De Zaragoza 52926, Mexico; [Zondervan, Krina T.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford OX3 7BN, England; [Amouyel, Philippe] Univ Lille 2, Inst Pasteur Lille, INSERM, U744, F-59000 Lille, France; [Arveiler, Dominique] Univ Strasbourg, Fac Med, EA3430, Dept Epidemiol & Publ Hlth, Strasbourg, France; [Bakker, Stephan J. L.; Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands; [Beilby, John; Hui, Jennie] Univ Western Australia, Perth, WA 6009, Australia; [Bergman, Richard N.] Cedars Sinai Diabet & Obes Res Inst, Los Angeles, CA 90048 USA; [Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Burnier, Michel] Lausanne Univ Hosp CHUV, Dept Med, Serv Nephrol, CH-1005 Lausanne, Switzerland; [Campbell, Harry; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Crawford, Dana C.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37203 USA; [Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Danesh, John; Saleheen, Danish] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [de Geusl, Eco J. C.] Vrije Univ Amsterdam, NL-1081 BT Amsterdam, Netherlands; [de Geusl, Eco J. C.; Penninx, Brenda W.] Vrije Univ Amsterdam, Inst Hlth & Care Res, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands; [Doerr, Marcus] Univ Med Greifswald, Dept Internal Med B, D-17475 Greifswald, Germany; [Doerr, Marcus; Hoffmann, Wolfgang; Voelker, Uwe] Partner Site Greifswald, DZHK, D-17475 Greifswald, Germany; [Erbel, Raimund; Mohlenkamp, Stefan] Univ Hosp Essen, West German Heart Ctr, Clin Cardiol, D-45122 Essen, Germany; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth, FI-00290 Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, FI-00290 Helsinki, Finland; [Ferrannini, Ele] Univ Pisa, Dept Internal Med, I-56100 Pisa, Italy; [Ferrieres, Jean] Toulouse Univ, Sch Med, Rangueil Hosp, Dept Cardiol, F-31400 Toulouse, France; [Forrester, Terrence; McKenzie, Colin A.] Univ W Indies, UWI Solut Developing Countries, Kingston 7, Jamaica; [Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Hattersley, Andrew T.] Univ Exeter, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Hicks, Andrew A.; Pramstaller, Peter P.] Bolzano EURAC, European Acad Bozen, Ctr Biomed, I-39100 Bolzano, Italy; [Hicks, Andrew A.; Pramstaller, Peter P.] Inst Univ Lubeck, D-23562 Lubeck, Germany; [Hingorani, Aroon D.] UCL, Inst Cardiovasc Sci, London WC1E 6BT, England; [Humphries, Steve E.] UCL, Ctr Cardiovasc Genet, Inst Cardiovasc Sci, London WC1E 6JJ, England; [Hyppoenen, Elina] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5000, Australia; [Hyppoenen, Elina] Univ S Australia, Sch Populat Hlth, Adelaide, SA 5000, Australia; [Hyppoenen, Elina] South Australian Hlth & Med Res Inst, Adelaide, SA 5000, Australia; [Hyppoenen, Elina; Power, Chris] UCL, Inst Child Hlth, London WC1N 1EH, England; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-30625 Hannover, Germany; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, FI-90101 Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC Hlth Protect Agcy HPA Ctr Environ & Hlth, London W2 1PG, England; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, FI-90014 Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, FI-90014 Oulu, Finland; [Kee, Frank] Queens Univ Belfast, UK Clin Res Collaborat Ctr Excellence Publ Hlth N, Belfast BT7 1NN, Antrim, North Ireland; [Keinanen-Kiukaanniemi, Sirkka M.] Univ Oulu, Inst Hlth Sci, Fac Med, FI-90014 Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka M.] Oulu Univ Hosp, Unit Primary Hlth Care Gen Practice, FI-90220 Oulu, Finland; [Kooner, Jaspal S.] Imperial Coll Healthcare NHS Trust, London W12 0HS, England; [Kooperberg, Charles; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Kumari, Meena; Langenberg, Claudia; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Kumari, Meena] Univ Essex, Dept Biol & Social Epidemiol, Colchester CO4 3SQ, Essex, England; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Dept Med, FI-70210 Kuopio, Finland; [Kuusisto, Johanna; Lakka, Timo A.; Laakso, Markku; Rauramaa, Rainer] Univ Eastern Finland, FI-70210 Kuopio, Finland; [Lakka, Timo A.] Univ Eastern Finland, Inst Biomed, Dept Physiol, FI-70211 Kuopio, Finland; [Lakka, Timo A.; Rauramaa, Rainer] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, FI-70210 Kuopio, Finland; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Epidemiol Program, Honolulu, HI 96813 USA; [Lehtimaki, Terho] Univ Tampere, Fimlab Labs, Dept Clin Chem, FI-33520 Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, FI-33520 Tampere, Finland; [Lyssenko, Valeriya] Steno Diabet Ctr AS, DK-2820 Gentofte, Denmark; [Lyssenko, Valeriya; Groop, Leif C.] Lund Univ, Lund Univ Diabet Ctr, S-22100 Malmo, Sweden; [Lyssenko, Valeriya; Groop, Leif C.] Lund Univ, Dept Clin Sci, Diabet & Endocrinol Unit, S-22100 Malmo, Sweden; [Marette, Andre] Univ Laval, Fac Med, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ G1V 0A6, Canada; [Marette, Andre; Vohl, Marie-Claude; Perusse, Louis] Univ Laval, Inst Nutr & Funct Foods, Quebec City, PQ G1V 0A6, Canada; [Musk, Arthur W.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Musk, Arthur W.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Palmer, Lyle J.] Univ Toronto, Toronto, ON M5G 1E2, Canada; [Lakka, Timo A.; Rauramaa, Rainer] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Penninx, Brenda W.] Vrije Univ Amsterdam, Dept Psychiat, NL-1081 BT Amsterdam, Netherlands; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FI-20521 Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FI-20521 Turku, Finland; [Rankinen, Tuomo; Sarzynski, Mark A.; Bouchard, Claude] Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA 70808 USA; [Rao, D. C.; Rice, Treva K.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Ritchie, Marylyn D.] Penn State Univ, Ctr Syst Genom, University Pk, PA 16802 USA; [Rudan, Igor] Univ Split, Croatian Ctr Global Hlth, Fac Med, Split 21000, Croatia; [Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Samani, Nilesh J.] Glenfield Gen Hosp, Natl Inst Hlth Res NIHR Leicester Cardiovasc Biom, Leicester LE3 9QP, Leics, England; [Saramies, Jouko] South Carelia Cent Hosp, Lappeenranta 53130, Finland; [Schwarz, Peter E. H.] Paul Langerhans Inst Dresden, German Ctr Diabet Res DZD, D-01307 Dresden, Germany; [Shuldiner, Alan R.; O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Divis Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Shuldiner, Alan R.; O'Connell, Jeffrey R.] Univ Maryland, Program Personalized & Genom Med, Sch Med, Baltimore, MD 21201 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Staessen, Jan A.] Maastricht Univ, Dept Epidemiol, NL-6229 HA Maastricht, Netherlands; [Staessen, Jan A.] Univ Leuven, KU Leuven Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, B-3000 Louvain, Belgium; [Tremblay, Angelo; Perusse, Louis] Univ Laval, Dept Kinesiol, Quebec City, PQ G1V 0A6, Canada; [Tremoli, Elena] Univ Milan, Dipartimento Sci Farmacol & Biomol, I-20133 Milan, Italy; [Tremoli, Elena] Inst Ricovero & Cura Carattere Sci, Ctr Cardiol Monzi, I-20133 Milan, Italy; [Vohl, Marie-Claude] Univ Laval, Dept Food Sci & Nutr, Quebec City, PQ G1V 0A6, Canada; [Vollenweider, Peter] Univ Hosp CHUV, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Vollenweider, Peter; Bochud, Murielle] Univ Lausanne, CH-1011 Lausanne, Switzerland; [Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Bochud, Murielle] CHU Vaudois, Inst Social & Prevent Med IUMSP, CH-1010 Lausanne, Switzerland; [Boehm, Bernhard O.] Imperial Coll London, Lee Kong Chian Sch Med, Singapore 637553, Singapore; [Boehm, Bernhard O.] Nanyang Technol Univ, Singapore 637553, Singapore; [Boehm, Bernhard O.] Univ Ulm, Med Ctr, Dept Internal Med 1, D-89081 Ulm, Germany; [Caulfield, Mark J.; Munroe, Patricia B.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Dept Clin Pharmacol, London EC1M 6BQ, England; [Grabe, Hans-Joergen] HELIOS Hosp Stralsund, Univ Med Greifswald, Dept Psychiat & Psychotherapy, D-17475 Greifswald, Germany; [Grabe, Hans-Joergen] German Ctr Neurodegenerat Dis DZNE, D-17475 Greifswald, Germany; [Hui, Jennie] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [Liu, Yongmei] Wake Forest Sch Med, Div Publ Hlth Sci, Ctr Human Genet, Winston Salem, NC 27157 USA; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, D-68163 Mannheim, Germany; [Oostra, Ben A.] Erasmus MC Univ Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Quertermous, Thomas; Assimes, Themistocles L.] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Saaristo, Timo E.] Finnish Diabet Assoc, FI-33680 Tampere, Finland; [Saaristo, Timo E.] Pirkanmaa Hosp Dist, FI-33521 Tampere, Finland; [Saleheen, Danish] Ctr Noncommunicable Dis, Karatchi, Pakistan; [Saleheen, Danish] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Sinisalo, Juha] Univ Helsinki, Cent Hosp, Heart & Lung Ctr, Dept Med, FI-00290 Helsinki, Finland; [Thorsteinsdottir, Unnur R.; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Tuomilehto, Jaakko] Hosp Univ LaPaz IdiPAZ, Inst Invest Sanitaria, Madrid 28046, Spain; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21589, Saudi Arabia; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, A-3500 Krems, Austria; [Uusitupa, Math] Univ Eastern Finland, Dept Publ Hlth & Clin Nutr, FI-70211 Kuopio, Finland; [van der Harst, Pim] Interuniv Cardiol Inst Netherlands, Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, NL-3501 DG Utrecht, Netherlands; [Veronesi, Giovanni] Univ Insubria, EPIMED Res Ctr, Dept Clin & Expt Med, I-21100 Varese, Italy; [Walker, Mark] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wichmann, H-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, D-85764 Munich, Germany; [Wichmann, H-Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Wichmann, H-Erich] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, D-85764 Neuherberg, Germany; [Berndt, Sonja I.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21589, Saudi Arabia; [Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Strachan, David P.] St Georges Univ London, Div Populat Hlth Sci & Educ, London SW17 0RE, England; [Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Visscher, Peter M.; Yang, Jian] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Visscher, Peter M.; Yang, Jian] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4012, Australia; [McCarthy, Mark I.] Oxford Univ Hosp NHS Trust, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Barroso, Ines] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge CB2 OQQ, England; [Barroso, Ines] Addenbrookes Hosp, Inst Metab Sci, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 OQQ, England; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3GA, Merseyside, England	Lund University; Skane University Hospital; Umea University; University of Regensburg; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Oxford; Wellcome Centre for Human Genetics; University of Michigan System; University of Michigan; University of Tartu; Karolinska Institutet; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Technical University of Denmark; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Karolinska Institutet; Uppsala University; Uppsala University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; University of Lausanne; Wellcome Trust Sanger Institute; University of Exeter; University of Michigan System; University of Michigan; University of Groningen; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; HudsonAlpha Institute for Biotechnology; Erasmus University Rotterdam; Erasmus MC; Telethon Kids Institute; University of Western Australia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Johns Hopkins University; University of Geneva; Washington University (WUSTL); University of Oxford; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Ruprecht Karls University Heidelberg; Ulm University; Finland National Institute for Health & Welfare; University of London; King's College London; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Oxford; Imperial College London; University of Eastern Finland; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Greifswald Medical School; University of Groningen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Imperial College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Dalarna University; Texas Biomedical Research Institute; Queensland University of Technology (QUT); Leipzig University; Leipzig University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; University of Groningen; University of San Carlos; Norwegian University of Science & Technology (NTNU); University of Oxford; University of Oxford; University of Southern California; University of Dundee; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Massachusetts General Hospital; Greifswald Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Uppsala University; Karolinska Institutet; Kaiser Permanente; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Groningen; University of Edinburgh; University of Helsinki; University of Oulu; University of Oulu; University of Oulu; Vrije Universiteit Amsterdam; University of Groningen; Norwegian University of Science & Technology (NTNU); Utah System of Higher Education; University of Utah; Greifswald Medical School; University of Western Australia; Harokopio University Athens; Ulm University; Medical University of Innsbruck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Uppsala University; University of Gothenburg; University of Bristol; Ulm University; University of Tartu; University of London; University College London; Amgen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bonn; University of Bonn; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Munich; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Sassari; Harvard University; Brigham & Women's Hospital; Medical University of Graz; Karolinska Institutet; University of Washington; University of Washington Seattle; Icelandic Heart Association; University of Iceland; University of London; Queen Mary University London; Loyola University Chicago; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Medical University of Graz; Erasmus University Rotterdam; Erasmus MC; Ulm University; UiT The Arctic University of Tromso; University of London; University College London; University College Dublin; Seoul National University (SNU); Karolinska Institutet; Columbia University; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Chinese Academy of Sciences; Shanghai Jiao Tong University; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health; Howard Hughes Medical Institute; Yale University; Dalian Maritime University; University of Ottawa; University of Ottawa Heart Institute; Imperial College London; QIMR Berghofer Medical Research Institute; Boston University; University of Oxford; MRC Harwell; Queensland University of Technology (QUT); Aalto University; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Icahn School of Medicine at Mount Sinai; Tecnologico de Monterrey; University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Groningen; University of Western Australia; Cedars Sinai Medical Center; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Edinburgh; Vanderbilt University; Vanderbilt University; University of Cambridge; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Greifswald Medical School; German Centre for Cardiovascular Research; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Pisa; CHU de Toulouse; Universite de Franche-Comte; Universite Federale Toulouse Midi-Pyrenees (ComUE); University West Indies Mona Jamaica; University of Southern California; University of London; University College London; University of London; University College London; University of South Australia; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of London; University College London; Hannover Medical School; Finland National Institute for Health & Welfare; Imperial College London; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Imperial College London; Fred Hutchinson Cancer Center; University of London; University College London; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Cancer Research Center of Hawaii; University of Hawaii System; Tampere University; Tampere University; Steno Diabetes Center; Lund University; Laval University; Laval University; University of Washington; University of Washington Seattle; University of Western Australia; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Vrije Universiteit Amsterdam; Krankenhaus Bozen; University of Turku; University of Turku; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Split; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Technische Universitat Dresden; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Maastricht University; Laval University; University of Milan; Laval University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of North Carolina; University of North Carolina Chapel Hill; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Ulm University; University of London; Queen Mary University London; Greifswald Medical School; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Western Australia; Wake Forest University; SYNLAB Group; Erasmus University Rotterdam; Erasmus MC; Stanford University; Pirkanmaa Hospital District; University of Pennsylvania; University of Helsinki; Helsinki University Central Hospital; University of Iceland; King Abdulaziz University; Danube University Krems; University of Eastern Finland; University of Insubria; Newcastle University - UK; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); King Abdulaziz University; Yeshiva University; Albert Einstein College of Medicine; St Georges University London; University of Michigan System; University of Michigan; University of Queensland; University of Queensland; Oxford University Hospitals NHS Foundation Trust; University of North Carolina; University of North Carolina Chapel Hill; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Liverpool	Mohlke, KL (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	celi@well.ox.ac.uk; mohlke@med.unc.edu	d'Adamo, Adamo Pio/G-4064-2011; Leander, Karin/C-7261-2017; Strawbridge, Rona/H-5422-2012; Palmer, Lyle John/K-3196-2014; Hicks, Andrew Anthony/E-9518-2017; Dörr, Marcus/F-1919-2010; Zheng, Wei/O-3351-2013; Möhlenkamp, Stefan/AGG-1320-2022; Polasek, Ozren/B-6002-2011; Milani, Lili/N-1097-2019; Yang, Jian/A-5852-2010; Stancakova, Alena/AAN-6723-2020; Stathopoulou, Maria/H-7324-2016; Yengo, Loic/D-2692-2017; Vohl, Marie-Claude/AAQ-1378-2021; Nelis, Mari/ABG-7775-2020; Heikkilä, Kauko/E-5578-2019; Kronenberg, Florian/B-1736-2008; Ohlsson, Claes/AGP-3544-2022; Deloukas, Panos/B-2922-2013; BOUATIA-NAJI, NABILA/D-5863-2013; Lorentzon, Mattias/W-7878-2019; Boehm, Bernhard Otto/F-8750-2015; Marmot, M G/Y-3920-2019; Smith, Albert Vernon/K-5150-2015; Franke, Andre/B-2151-2010; Hivert, Marie-France/GWN-0455-2022; de Geus, Eco J.C./M-9318-2015; Zgaga, Lina/Q-9415-2018; Ormel, Johan/C-6094-2013; Vonk, Judith M/ABA-3009-2020; Kalafati, Ioanna-Panagiota/AAJ-2287-2020; Bakker, Stephan J. L./J-4023-2015; Study, GoDARTS/K-9448-2016; sanna, serena/H-3009-2019; Karjalainen, Juha/P-8624-2016; zhang, weihua/GXV-1334-2022; Franco, Óscar H/ABE-2305-2020; Tregouet, David-Alexandre/E-3961-2016; Johnson, Andrew D/G-6520-2013; Kutalik, Zoltan/HHZ-5697-2022; Hosseini, S. Mohsen/K-7133-2013; Verweij, Niek/A-4499-2017; Hui, Jennie/A-9543-2013; Peters, Annette/A-6117-2011; Bonnet, Fabrice/G-4255-2017; Beekman, Marian/L-3004-2019; Arora, Pankaj/F-3437-2011; Schumacher, Fredrick/R-6043-2019; Palmer, Colin NA/C-7053-2008; Olsson, Christian/AAW-2769-2021; Sundström, Johan/A-6286-2009; Wichmann, Heinz Erich/AAA-5695-2022; Hveem, Kristian/AFV-4683-2022; Blangero, John/ABA-7175-2021; Drong, Alexander/AAG-1115-2020; Grallert, Harald/B-3424-2013; Loos, Ruth/GON-5877-2022; Njolstad, Inger/X-3784-2019; Hypponen, Elina/B-2596-2014; Lyytikäinen, Leo-Pekka/C-8544-2016; Ohlsson, Claes/HIR-6959-2022; Veronesi, Giovanni/E-3859-2010; Rivadeneira, Fernando/O-5385-2015; Wilson, James F/A-5704-2009; Crawford, Dana/O-5578-2019; Lahti, Jari/P-2283-2019; Wood, Andrew R/AAB-3807-2019; Meisinger, Christine/B-5358-2014; Trégouët, David-Alexandre/P-9210-2019; DEMIRKAN, AYSE/G-9313-2016; Kuh, Diana/L-6019-2014; Bouchard, Claude/AAE-2035-2019; Matullo, Giuseppe/K-6383-2016; EHRET, Georg B/A-9532-2009; Prabhakaran, Dorairaj/B-4147-2011; Kinnunen, Leena/B-7059-2012; Gudnason, Vilmundur/AAE-7126-2019; Prokopenko, Inga/AAU-9895-2020; Medina-Gomez, Carolina/I-1725-2019; Montgomery, Grant W/B-7148-2008; Teumer, Alexander/S-7438-2019; Gigante, Bruna/I-9252-2012; Narisu, Narisu/T-6908-2019; Fall, Tove/O-7226-2014; McKnight, Amy Jayne/ABF-4492-2020; Mulas, Antonella/B-4231-2015; Cauley, Jane A/N-4836-2015; Seufferlein, Thomas TW/P-7147-2018; Campbell, Harry/E-2959-2010; Fehrmann, Rudolf/E-2551-2011; Haller, Toomas/N-3797-2019; Bochud, Murielle/A-3981-2010; Feitosa, Mary F/K-8044-2012; Dominiczak, Anna F/P-9390-2017; Veronesi, Giovanni/O-5678-2019; Balcells, Susana/C-5222-2017; Franks, Paul/AAA-3300-2020; Raso, Francesco Mattace-/L-2541-2015; Ramachandran, Vasan/Y-2527-2019; Stumvoll, Michael/ABE-1121-2021; Erdmann, Jeanette/P-7513-2014; Wong, Andrew/AAE-6995-2019; Loos, Ruth J F/Q-2862-2016; Sarzynski, Mark/A-9798-2014; Deary, Ian J/C-6297-2009; Khusnutdinova, Elza Kamilevna/A-4810-2013; Ripatti, Samuli/H-9446-2014; Crisponi, Laura/AAC-2642-2019; Wong, Andrew/M-8899-2016; Meitinger, Thomas/O-1318-2015; Staessen, Jan A/A-1065-2011; Magnusson, Patrik KE/C-4458-2017; Gudnason, Vilmundur/K-6885-2015; Nyholt, Dale Robert/J-3174-2017; Gaunt, Tom R/O-3918-2014; Müller-Nurasyid, Martina/I-8735-2018; Dedoussis, George/AAN-7252-2021; Bush, William/N-1369-2019; Rankinen, Tuomo/N-1984-2017; Bouchard, Claude/A-7637-2009; Choi, Murim/AAP-9120-2021; Franke, Lude/P-7036-2016; Berndt, Sonja I/J-8423-2016; bandinelli, stefania/AAL-4570-2020; Kolcic, Ivana/E-2713-2017; Assimes, Themistocles Leonard/D-9696-2015; Zheng, Houfeng/K-4424-2012; Salumets, Andres/J-2278-2015; Thorand, Barbara/B-5349-2014; Verweij, Niek/ABC-6249-2021; Onland-Moret, N. Charlotte/G-9185-2011; Singleton, Andrew B/C-3010-2009; Palmer, Lyle John/N-1948-2019; Laan, Maris/A-4100-2011; Sundstrom, Johan/R-2139-2019; FROGUEL, Philippe/O-6799-2017; Brown, Matthew A/E-5749-2010; Vonk, Judith/K-8477-2019; Medland, Sarah E/C-7630-2013; Nato, Alejandro Q/D-9276-2012; panduru, nicolae mircea/AAB-9885-2021; Lamina, Claudia/F-7608-2010; Uda, Manuela/AAC-2645-2019; Kanoni, Stavroula/AAN-7161-2021; Ärnlöv, Johan/AAF-2746-2019; Tzoulaki, Ioanna/ABE-6269-2020; Prokopenko, Inga/H-3241-2014; Raitakari, Olli/AAQ-7389-2021; Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Zhu, Xiaofeng/O-6874-2019; Evangelou, Evangelos/C-3033-2013; Moayyeri, Alireza/N-3332-2014; Lopez, Lorna/AAR-4912-2020; Charchar, Fadi/I-6656-2017; Langenberg, Claudia/ABG-9067-2021; Lehtimäki, Terho/AAD-1094-2022; Penninx, Brenda WJH/S-7627-2017; Alhenc-Gelas, Francois/F-9511-2017; Falhammar, Henrik/AAD-4329-2019; Mooijaart, Simon P./A-5306-2008; Slagboom, P. Eline/R-4790-2016; Doney, Alexander SF/P-7437-2017; Bovet, Pascal/F-4477-2011; Belllis, Claire/GYA-5547-2022; Boban, Mladen/E-2777-2017; Visscher, Peter/ABB-6151-2020; Meulenbelt, Ingrid/F-4756-2011; Kaprio, Jaakko/A-1820-2008; Garcia-Giralt, Natalia/AAA-7588-2021; Kivimaki, Mika/B-3607-2012; Mangino, Massimo/F-5134-2011; Visser, Jenny A./F-8156-2011; Mägi, Reedik/AAJ-9679-2021; McKay, Gareth/AAZ-2601-2020; Barbalić, Maja/E-2161-2017; Stefansson, Kari/AAE-7187-2019; Perusse, Louis/A-3444-2012; Urreizti, Roser/M-6402-2014; Rudan, Igor/I-1467-2012; Vallejo, Edgar/M-3179-2018; Cazier, Jean-Baptiste/GLR-2949-2022; Colaus, PsyColaus/K-6607-2013; Go, Alan S./AAE-7745-2019; Deelen, Joris/H-3201-2019; Boehringer, Stefan/Y-2442-2018; ruggiero, daniela/K-5638-2016; FAVA, Cristiano/K-9590-2015; TREMOLI, ELENA/I-8126-2018; Luben, Robert/H-5519-2015; Okamura, Tomonori/L-1693-2013; Ferrieres, Jean/S-7993-2016; Lee, Sang Hong/A-2569-2011; McCarthy, Mark/M-3763-2015; Robino, Antonietta/K-9398-2016; Pennell, Craig/C-5190-2011; Nicholson, Geoffrey/F-1901-2010; Aulchenko, Yurii/M-8270-2013; Wood, Lekki/B-8053-2010; Soler Artigas, Maria/L-6529-2013; Zondervan, Krina/M-1143-2013; Aspelund, Thor/C-5983-2008; Duncan, Bruce/L-4140-2016; Bidulescu, Aurelian/N-2617-2014; Paterson, Andrew/A-4088-2011; MacGregor, Stuart/C-6442-2009; Vandenput, Liesbeth/AAP-3655-2020; Johnson, Paul/O-9695-2014; Evans, David/H-6325-2013; Warrington, Nicole/P-4868-2014; Tiirikainen, Maarit/B-6954-2012	d'Adamo, Adamo Pio/0000-0001-9367-4909; Leander, Karin/0000-0002-1404-9222; Strawbridge, Rona/0000-0001-8506-3585; Palmer, Lyle John/0000-0002-1628-3055; Hicks, Andrew Anthony/0000-0001-6320-0411; Dörr, Marcus/0000-0001-7471-475X; Zheng, Wei/0000-0003-1226-070X; Polasek, Ozren/0000-0002-5765-1862; Milani, Lili/0000-0002-5323-3102; Yang, Jian/0000-0003-2001-2474; Stancakova, Alena/0000-0002-1375-0252; Stathopoulou, Maria/0000-0003-4376-2083; Yengo, Loic/0000-0002-4272-9305; Nelis, Mari/0000-0001-9748-1020; Heikkilä, Kauko/0000-0002-9256-8028; Kronenberg, Florian/0000-0003-2229-1120; Ohlsson, Claes/0000-0002-9633-2805; Deloukas, Panos/0000-0001-9251-070X; Lorentzon, Mattias/0000-0003-0749-1431; Marmot, M G/0000-0002-2431-6419; Smith, Albert Vernon/0000-0003-1942-5845; Franke, Andre/0000-0003-1530-5811; de Geus, Eco J.C./0000-0001-6022-2666; Zgaga, Lina/0000-0003-4089-9703; Vonk, Judith M/0000-0001-7531-4547; Bakker, Stephan J. L./0000-0003-3356-6791; sanna, serena/0000-0002-3768-1749; Franco, Óscar H/0000-0002-4606-4929; Johnson, Andrew D/0000-0001-6369-5178; Kutalik, Zoltan/0000-0001-8285-7523; Hosseini, S. Mohsen/0000-0003-3626-9928; Hui, Jennie/0000-0002-1653-2496; Peters, Annette/0000-0001-6645-0985; Bonnet, Fabrice/0000-0001-9255-8228; Beekman, Marian/0000-0003-0585-6206; Arora, Pankaj/0000-0003-2420-3550; Schumacher, Fredrick/0000-0002-3073-7463; Palmer, Colin NA/0000-0002-6415-6560; Olsson, Christian/0000-0002-5677-0747; Sundström, Johan/0000-0003-2247-8454; Hypponen, Elina/0000-0003-3670-9399; Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Ohlsson, Claes/0000-0002-9633-2805; Veronesi, Giovanni/0000-0002-4119-6615; Rivadeneira, Fernando/0000-0001-9435-9441; Wilson, James F/0000-0001-5751-9178; Crawford, Dana/0000-0002-6437-6248; Lahti, Jari/0000-0002-4310-5297; Wood, Andrew R/0000-0003-1726-948X; Trégouët, David-Alexandre/0000-0001-9084-7800; Kuh, Diana/0000-0001-7386-2857; Matullo, Giuseppe/0000-0003-0674-7757; EHRET, Georg B/0000-0002-5730-0675; Prabhakaran, Dorairaj/0000-0002-3172-834X; Kinnunen, Leena/0000-0001-8739-4812; Gudnason, Vilmundur/0000-0001-5696-0084; Medina-Gomez, Carolina/0000-0001-7999-5538; Montgomery, Grant W/0000-0002-4140-8139; Teumer, Alexander/0000-0002-8309-094X; McKnight, Amy Jayne/0000-0002-7482-709X; Cauley, Jane A/0000-0003-0752-4408; Campbell, Harry/0000-0002-6169-6262; Fehrmann, Rudolf/0000-0002-7516-315X; Haller, Toomas/0000-0002-5069-6523; Bochud, Murielle/0000-0002-5727-0218; Feitosa, Mary F/0000-0002-0933-2410; Dominiczak, Anna F/0000-0003-4913-3608; Veronesi, Giovanni/0000-0002-4119-6615; Balcells, Susana/0000-0003-1211-1907; Ramachandran, Vasan/0000-0001-7357-5970; Stumvoll, Michael/0000-0001-6225-8240; Erdmann, Jeanette/0000-0002-4486-6231; Wong, Andrew/0000-0003-2079-4779; Loos, Ruth J F/0000-0002-8532-5087; Deary, Ian J/0000-0002-1733-263X; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Ripatti, Samuli/0000-0002-0504-1202; Crisponi, Laura/0000-0001-9128-8537; Wong, Andrew/0000-0003-2079-4779; Staessen, Jan A/0000-0002-3026-1637; Magnusson, Patrik KE/0000-0002-7315-7899; Gudnason, Vilmundur/0000-0001-5696-0084; Nyholt, Dale Robert/0000-0001-7159-3040; Gaunt, Tom R/0000-0003-0924-3247; Müller-Nurasyid, Martina/0000-0003-3793-5910; Dedoussis, George/0000-0002-7798-6221; Bush, William/0000-0002-9729-6519; Bouchard, Claude/0000-0002-0048-491X; Franke, Lude/0000-0002-5159-8802; Kolcic, Ivana/0000-0001-7918-6052; Assimes, Themistocles Leonard/0000-0003-2349-0009; Zheng, Houfeng/0000-0001-5681-8598; Salumets, Andres/0000-0002-1251-8160; Thorand, Barbara/0000-0002-8416-6440; Verweij, Niek/0000-0002-4303-7685; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Palmer, Lyle John/0000-0002-1628-3055; Laan, Maris/0000-0002-8519-243X; Sundstrom, Johan/0000-0003-2247-8454; FROGUEL, Philippe/0000-0003-2972-0784; Brown, Matthew A/0000-0003-0538-8211; Vonk, Judith/0000-0001-7531-4547; Medland, Sarah E/0000-0003-1382-380X; Nato, Alejandro Q/0000-0002-8745-9046; Lamina, Claudia/0000-0002-5398-5806; Uda, Manuela/0000-0002-4890-6456; Kanoni, Stavroula/0000-0002-1691-9615; Ärnlöv, Johan/0000-0002-6933-4637; Tzoulaki, Ioanna/0000-0002-4275-9328; Prokopenko, Inga/0000-0003-1624-7457; Evangelou, Evangelos/0000-0002-5488-2999; Moayyeri, Alireza/0000-0002-9143-2161; Lopez, Lorna/0000-0002-0241-9783; Charchar, Fadi/0000-0002-6164-9941; Langenberg, Claudia/0000-0002-5017-7344; Lehtimäki, Terho/0000-0002-2555-4427; Penninx, Brenda WJH/0000-0001-7779-9672; Falhammar, Henrik/0000-0002-5622-6987; Mooijaart, Simon P./0000-0003-3106-3568; Slagboom, P. Eline/0000-0002-2875-4723; Doney, Alexander SF/0000-0002-6210-5620; Bovet, Pascal/0000-0002-0242-4259; Belllis, Claire/0000-0001-5073-9610; Boban, Mladen/0000-0003-1570-9621; Visscher, Peter/0000-0002-2143-8760; Meulenbelt, Ingrid/0000-0001-7786-7081; Kaprio, Jaakko/0000-0002-3716-2455; Garcia-Giralt, Natalia/0000-0001-6507-0147; Kivimaki, Mika/0000-0002-4699-5627; Mangino, Massimo/0000-0002-2167-7470; McKay, Gareth/0000-0001-8197-6280; Barbalić, Maja/0000-0001-8914-1691; Perusse, Louis/0000-0001-6440-9698; Urreizti, Roser/0000-0003-3617-7134; Rudan, Igor/0000-0001-6993-6884; Vallejo, Edgar/0000-0003-2805-7132; Cazier, Jean-Baptiste/0000-0001-7581-9051; Deelen, Joris/0000-0003-4483-3701; Boehringer, Stefan/0000-0001-9108-9212; Randall, Joshua/0000-0003-1540-203X; Eriksson, Per/0000-0002-5635-2692; van Schoor, Natasja/0000-0002-0870-0795; ruggiero, daniela/0000-0003-3898-7827; Amin, Najaf/0000-0002-8944-1771; Bandinelli, Stefania/0000-0002-6491-0850; Terzic, Janos/0000-0003-3228-2076; FAVA, Cristiano/0000-0002-8910-7378; rossing, peter/0000-0002-1531-4294; marc, janja/0000-0001-6013-9758; Nogues, Xavier/0000-0002-5537-1859; Vohl, Marie-Claude/0000-0002-7017-5848; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Mattace-Raso, Francesco/0000-0002-1688-6497; van Meurs, Joyce/0000-0001-6245-2123; Godson, Catherine/0000-0003-0655-1041; Sandholm, Niina/0000-0003-4322-6942; Whincup, Peter/0000-0002-5589-4107; Eyheramendy, Susana/0000-0003-4723-9660; Sanghera, Dharambir/0000-0001-7203-8655; Kuulasmaa, Kari/0000-0003-2165-1411; Blangero, John/0000-0001-6250-5723; Caulfield, Mark/0000-0001-9295-3594; Wild, Philipp/0000-0003-4413-9752; Menni, Cristina/0000-0001-9790-0571; Asiki, Gershim/0000-0002-9966-1153; Nicholson, George/0000-0001-9588-6075; Taylor, Andrew/0000-0003-4194-7113; Gieger, Christian/0000-0001-6986-9554; TREMOLI, ELENA/0000-0002-0929-6106; Luben, Robert/0000-0002-5088-6343; Ganna, Andrea/0000-0002-8147-240X; Shuldiner, Alan/0000-0001-9921-4305; Johnson, Toby/0000-0002-5998-3270; Graessler, Juergen/0000-0003-3619-8517; Demirkan, Ayse/0000-0002-7546-0867; Rich, Stephen/0000-0003-3872-7793; Stewart, Alexandre/0000-0003-2673-9164; Okamura, Tomonori/0000-0003-0488-0351; Ferrieres, Jean/0000-0001-6144-1297; Kita, Yoshikuni/0000-0002-2366-1106; Lee, Sang Hong/0000-0001-9701-2718; Brennan, Eoin/0000-0003-4908-5474; Center, Jacqueline/0000-0002-5278-4527; Lindgren, Cecilia/0000-0002-4903-9374; Ma, Baoshan/0000-0003-1629-1968; Tai, E Shyong/0000-0003-2929-8966; Uh, Hae-Won/0000-0003-4195-7872; Geller, Frank/0000-0002-9238-3269; Kraft, Peter/0000-0002-4472-8103; Mulas, Antonella/0000-0002-6856-1483; Heard-Costa, Nancy/0000-0001-9730-0306; Gurdasani, Deepti/0000-0001-9996-6929; Barroso, Ines/0000-0001-5800-4520; Tomaszewski, Maciej/0000-0001-8215-6567; Scollen, Serena/0000-0002-9311-1337; McCarthy, Mark/0000-0002-4393-0510; Weedon, Michael/0000-0002-6174-6135; Forouhi, Nita/0000-0002-5041-248X; Pettersson Kymmer, Ulrika/0000-0002-0557-9803; Karasik, David/0000-0002-8826-0530; Liu, Ching-Ti/0000-0002-0703-0742; Workalemahu, Tsegaselassie/0000-0003-4571-9740; Schork, Nicholas/0000-0003-0920-5013; Van Hul, Wim/0000-0002-5065-7858; Beilby, John/0000-0002-4915-2254; Song, Ci/0000-0002-0947-9068; Skorpen, Frank/0000-0001-7093-8000; Koromila, Theodora/0000-0001-5504-1369; Day, Felix/0000-0003-3789-7651; Munroe, Patricia/0000-0002-4176-2947; Soranzo, Nicole/0000-0003-1095-3852; Robino, Antonietta/0000-0003-2152-2353; Volker, Uwe/0000-0002-5689-3448; Pennell, Craig/0000-0002-0937-6165; Emilsson, Valur/0000-0001-9982-0524; Gasparini, Paolo/0000-0002-0859-0856; Quertermous, Thomas/0000-0002-7645-9067; Nicholson, Geoffrey/0000-0002-0152-1153; Aulchenko, Yurii/0000-0002-7899-1575; Wood, Lekki/0000-0001-7616-2119; Caspersen, Ida Henriette/0000-0003-2591-8435; Wilson, Scott/0000-0002-0357-1373; Tryggvadottir, Laufey/0000-0001-8067-9030; Sinisalo, Juha/0000-0002-0169-5137; Soler Artigas, Maria/0000-0002-3213-1107; Devuyst, Olivier/0000-0003-3744-4767; Lakka, Timo/0000-0002-9199-2871; Locke, Adam/0000-0001-6227-198X; Ohkubo, Takayoshi/0000-0002-3283-8196; Lindstrom, Jaana/0000-0001-9255-020X; ELOSUA, ROBERTO/0000-0001-8235-0095; CUCCA, Francesco/0000-0002-7414-1995; Ciullo, Marina/0000-0002-9621-9984; Elliott, Paul/0000-0002-7511-5684; Hingorani, Aroon/0000-0001-8365-0081; Zondervan, Krina/0000-0002-0275-9905; Org, Elin/0000-0001-8688-9717; Tarnow, Lise/0000-0002-8735-966X; Rice, Treva/0000-0001-7452-2600; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Goel, Anuj/0000-0003-2307-4021; Meitinger, Thomas/0000-0002-8838-8403; Aspelund, Thor/0000-0002-7998-5433; Duncan, Bruce/0000-0002-7491-2630; Jones, Lindsay/0000-0002-4219-8356; Olmos, Jose M./0000-0002-7765-0891; Waeber, Gerard/0000-0003-4193-788X; Hattersley, Andrew/0000-0001-5620-473X; Ouwehand, Willem/0000-0002-7744-1790; Pers, Tune/0000-0003-0207-4831; Bidulescu, Aurelian/0000-0001-8211-8309; Seshadri, Sudha/0000-0001-6135-2622; Viigimaa, Margus/0000-0001-5575-5978; Sim, Xueling/0000-0002-1233-7642; Kessler, Thorsten/0000-0003-3326-1621; Kleber, Marcus/0000-0003-0663-7275; Mellstrom, Dan/0000-0003-2761-3723; Wang, Thomas/0000-0003-4063-6508; Kristiansson, Kati/0000-0003-4688-107X; Org, Elin/0000-0003-1451-9375; Shriner, Daniel/0000-0003-1928-5520; Pramstaller, Peter P/0000-0002-9831-8302; Chen, Ming-Huei/0000-0003-3551-8726; Buyske, Steven/0000-0001-8539-5416; Kovacs, Peter/0000-0002-0290-5423; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Ellinghaus, David/0000-0002-4332-6110; Folkersen, Lasse/0000-0003-0708-9530; Hughes, Rebecca/0000-0003-2110-5234; Burri, Andrea/0000-0002-4705-3551; Chouraki, Vincent/0000-0002-4698-1794; Bergman, Richard/0000-0003-1539-4471; Paterson, Andrew/0000-0002-9169-118X; Lawlor, Debbie A/0000-0002-6793-2262; Zemunik, Tatijana/0000-0001-8120-2891; Shrine, Nick/0000-0003-3641-4371; Amouyel, Philippe/0000-0001-9088-234X; MacGregor, Stuart/0000-0001-6731-8142; Kangas, Antti/0000-0001-7492-1732; Vandenput, Liesbeth/0000-0002-1712-6131; Goessling, Wolfram/0000-0001-9972-1569; Kumari, Meena/0000-0001-9716-1035; Melander, Olle/0000-0002-2581-484X; Raychaudhuri, Soumya/0000-0002-1901-8265; Humphries, Stephen E/0000-0002-8221-6547; Mahajan, Anubha/0000-0001-5585-3420; Glazer, Nicole/0000-0002-6397-609X; Scholtens, Salome/0000-0002-0651-5203; Franks, Paul/0000-0002-0520-7604; Peters, Marjolein/0000-0003-3167-9063; Ballantyne, Christie/0000-0002-6432-1730; Murgia, Federico/0000-0002-3608-845X; Lunetta, Kathryn/0000-0002-9268-810X; Schmidt, Ellen/0000-0003-1198-7536; Wain, Louise/0000-0003-4951-1867; Eriksson, Johan/0000-0002-2516-2060; Maxwell, Alexander P./0000-0002-6110-7253; Justice, Anne/0000-0002-8903-8712; Anderson, Denise/0000-0003-0643-4136; Couper, David/0000-0002-4313-9235; Magi, Reedik/0000-0002-2964-6011; brandi, maria luisa/0000-0002-8741-0592; SCUTERI, ANGELO/0000-0003-4784-5441; Tobin, Martin/0000-0002-3596-7874; Wheeler, Eleanor/0000-0002-8616-6444; Lakatta, Edward/0000-0002-4772-0035; Johnson, Paul/0000-0001-6663-7520; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Chandak, Giriraj Ratan/0000-0002-3095-9453; Koenig, Wolfgang/0000-0002-2064-9603; Lucas, Gavin/0000-0003-4166-9416; Kahali, Bratati/0000-0003-2523-3778; Fuchsberger, Christian/0000-0002-5918-8947; Tenesa, Albert/0000-0003-4884-4475; Nogues, Xavier/0000-0001-8201-9933; Semple, Robert Kenneth/0000-0001-6539-3069; Voight, Benjamin/0000-0002-6205-9994; Ferrario, Marco M/0000-0003-2741-7124; bennett, amanda/0000-0003-2140-8710; Edkins, Sarah/0000-0003-0717-1972; Price, Jackie/0000-0003-3251-3970; Kammerer, Candace M/0000-0002-2841-4761; Evans, David/0000-0003-0663-4621; Ala-Korpela, Mika/0000-0001-5905-1206; Warrington, Nicole/0000-0003-4195-775X; Shungin, Dmitry/0000-0001-7900-5856; Van Duijn, Cornelia/0000-0002-2374-9204; Stolk, Ronald/0000-0002-0518-1205; Adeyemo, Adebowale/0000-0002-3105-3231; Hedman, Asa/0000-0001-5413-204X; Tsoka, Sophia/0000-0001-8403-1282; Pechlivanis, Sonali/0000-0002-6181-7044; Cupples, L. Adrienne/0000-0003-0273-7965; Tiirikainen, Maarit/0000-0002-8124-3818; Karpe, Fredrik/0000-0002-2751-1770; Martinovic Klaric, Irena/0000-0002-6545-5589; Esko, Tonu/0000-0003-1982-6569; Portas, Laura/0000-0003-1789-1893; Zhu, Xiaofeng/0000-0003-0037-411X; melbye, mads/0000-0001-8264-6785; Marette, Andre/0000-0003-3950-5973; Mannisto, Satu/0000-0002-8668-3046; Hopewell, Jemma/0000-0002-3870-8018; Ongen, Halit/0000-0002-4197-5790; Zarrabeitia, Maria T./0000-0002-2836-7766; Gigante, Bruna/0000-0003-4508-7990; Nikus, Kjell/0000-0002-9345-9851; Hocking, Lynne J/0000-0002-2414-2826; Salem, Rany/0000-0001-8816-6862	British Heart Foundation [RG/13/2/30098, FS/14/55/30806, BHF_RG/08/014/24067, BHF_RG/13/2/30098, BHF_FS/14/55/30806, RG/07/008/23674, BHF_RG/10/12/28456, RG/08/008/25291, RG/10/12/28456, BHF_RG/08/008/25291, RG/08/014/24067] Funding Source: Medline; Cancer Research UK [CRUK_14136, 14136] Funding Source: Medline; Diabetes UK [12/0004470, DUK_12/0004470] Funding Source: Medline; Intramural NIH HHS [Z01 HG000024-14] Funding Source: Medline; Medical Research Council [MRC_MC_PC_U127561128, G0902037, MC_UU_12011/1, G1001799, MR/L003120/1, G0100222, MRC_MC_UU_12012/1, MC_UP_A100_1003, MRC_MC_UU_12015/1, MRC_G1001799, G0601463, MC_UU_12015/1, MRC_G9521010, G0400491, MR/K006584/1, MC_U147585819, MC_UU_12013/1, MRC_G0401527, MRC_MC_UU_12015/5, MRC_MR/K011480/1, MRC_MR/K006584/1, MRC_G0601261, MRC_MC_UU_12019/1, MC_U147585824, MRC_MC_UU_12011/1, MC_U106179471, MR/K013351/1, MRC_MR/L003120/1, MRC_G1000143, G19/35, G8802774, MC_UU_12013/4, MC_UU_12015/5, MRC_MR/K013351/1, G1000616, MRC_MC_U106179471, MC_UU_12012/1, MC_U147585827, MRC_G0601463, MRC_MC_U106179472, G0601261, MRC_MR/N01104X/1, MRC_MC_UU_12013/1, MR/K011480/1, MRC_MC_UP_A620_1014, G1000143, G0600717, G9521010, MC_U106179472, MC_PC_U127561128, MRC_MC_UP_A100_1003, G0401527, MC_UU_12019/1, MR/N01104X/1, MC_UU_12015/2, MC_UP_A620_1014, MRC_MC_UU_12015/2] Funding Source: Medline; NCI NIH HHS [P30 CA071789, UM1 CA182913, UM1 CA182910] Funding Source: Medline; NHGRI NIH HHS [U01 HG007416, U01 HG007417, U01 HG007419, U01 HG007376] Funding Source: Medline; NHLBI NIH HHS [R01 HL105756, R01 HL109946, T32 HL007055, R01 HL117626, T32 HL069768, R00 HL094535, R01 HL117078, K01 HL116770, R01 HL120393] Funding Source: Medline; NIA NIH HHS [R01 AG033193, R01 AG025941, R01 AG041517, U01 AG049505] Funding Source: Medline; NICHD NIH HHS [U54 HD083211] Funding Source: Medline; NIDA NIH HHS [R21 DA027040] Funding Source: Medline; NIDDK NIH HHS [K23 DK080145, U01 DK062370, R01 DK089256, R01 DK093757, P30 DK056341, R01 DK078150, R01 DK107437, R01 DK062370, P30 DK020572, P30 DK040561, R01 DK072193, P30 DK072488, P60 DK020541, P30 DK079637, R01 DK075787, P30 DK020541] Funding Source: Medline; NIGMS NIH HHS [P30 GM103341, T32 GM067553, T32 GM007092] Funding Source: Medline; NIMHD NIH HHS [P20 MD006899] Funding Source: Medline; Wellcome Trust [WT098017, 098498, 097117, WT085235, WT100574, WT098381, 098381, 085235, WT098498, 098017, WT097117, WT084766, 084766, 100574] Funding Source: Medline; Chief Scientist Office [CSO_CZB/4/710, CZB/4/710] Funding Source: Medline; ESRC [ES/F02679X/1, ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1, MC_UU_12019/1, G0400491, G0601463, MR/L003120/1, MC_UU_12015/1, MC_UP_A100_1003, MC_UU_12012/1, G1001799, G1000616, MR/N01104X/1, MC_PC_U127561128, G0600717, MC_U147585827, MC_UU_12015/5, MC_UU_12013/1, MC_U106179472, G9521010, G0902037, G0601261, MC_UU_12015/2, MC_U147585819] Funding Source: UKRI; Economic and Social Research Council [ES/J023299/1, ES/F02679X/1] Funding Source: researchfish; Lundbeck Foundation [R190-2014-3904] Funding Source: researchfish; Medical Research Council [G0600717B, MC_CF023241, U1475000001, MC_UU_12012/5/B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10170, NF-SI-0512-10165, NF-SI-0611-10219, NF-SI-0512-10135, NF-SI-0513-10109, NF-SI-0512-10114, NF-SI-0512-10113, NF-SI-0508-10082, NF-SI-0514-10027, NF-SI-0611-10099, NF-SI-0507-10380, NF-SI-0513-10085] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1016167, NNF11OC1014855, NNF14OC0010513, NNF13OC0005781, NNF15OC0016416, NNF12OC1016467, NNF13OC0005785] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [UM1CA182913, UM1CA182910, P30CA071789] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768, ZIAHL006094, R01HL109946, R01HL117078, R01HL117626, R01HL120393, K01HL116770, R01HL105756, T32HL007055, R00HL094535] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007416, ZIAHG000024, U01HG007417, U01HG007376, U01HG007419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, K23DK080145, P30DK079637, R01DK107437, P30DK020572, P30DK072488, P60DK020541, R01DK078150, R01DK075787, R01DK089256, P30DK040561, R01DK062370, R01DK072193, U01DK062370, R01DK093757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067553, P30GM103341, T32GM007092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033193, R01AG041517, R01AG025941, U01AG049505, ZIAAG007390, ZIAAG000675, ZIAAG001050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027040] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Diabetes UK(Diabetes UK); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Wellcome Trust(Wellcome Trust); Chief Scientist Office; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 1999, MOL CELL ENDOCRINOL; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; Bult CJ, 2000, IEEE INTERNATIONAL SYMPOSIUM ON BIO-INFORMATICS AND BIOMEDICAL ENGINEERING, PROCEEDINGS, P29, DOI 10.1109/BIBE.2000.889586; Buyske S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035651; Canoy D, 2008, CURR OPIN CARDIOL, V23, P591, DOI 10.1097/HCO.0b013e328313133a; Cao YH, 2013, CELL METAB, V18, P478, DOI 10.1016/j.cmet.2013.08.008; Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Elias I, 2013, ADIPOCYTE, V2, P109, DOI 10.4161/adip.22880; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; FALCONER DS, 1990, INTRO QUANTITATIVE G; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002705; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Goossens GH, 2012, MOL IMMUNOL, V50, P142, DOI 10.1016/j.molimm.2012.01.005; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hindorff LA, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoopes SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045261; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Jaager K, 2011, STEM CELLS DEV, V20, P1327, DOI 10.1089/scd.2010.0258; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Li HL, 2013, STEM CELL RES, V10, P313, DOI 10.1016/j.scr.2012.11.007; Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mason C, 2008, OBESITY, V16, P2690, DOI 10.1038/oby.2008.438; Maynard LM, 2001, PEDIATRICS, V107, P344, DOI 10.1542/peds.107.2.344; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Mori M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001314; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nakagami H, 2013, DIABETES METAB J, V37, P85, DOI 10.4093/dmj.2013.37.2.85; Neale MC, 1992, METHODOLOGY GENETIC; Need AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/hmg/ddp413; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Pal A, 2012, NEW ENGL J MED, V367, P1002, DOI 10.1056/NEJMoa1113966; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033	94	893	905	10	446	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					187	U378		10.1038/nature14132	http://dx.doi.org/10.1038/nature14132			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25673412	Green Accepted, Green Submitted			2022-12-28	WOS:000349190300030
J	Emdin, CA; Rahimi, K; Neal, B; Callender, T; Perkovic, V; Patel, A				Emdin, Connor A.; Rahimi, Kazem; Neal, Bruce; Callender, Thomas; Perkovic, Vlado; Patel, Anushka			Blood Pressure Lowering in Type 2 Diabetes A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CARDIOVASCULAR MORBIDITY; MYOCARDIAL-INFARCTION; MICROVASCULAR COMPLICATIONS; RANDOMIZED-TRIAL; RECURRENT STROKE; OLDER PATIENTS; HEART-FAILURE; MORTALITY; HYPERTENSION	IMPORTANCE Lowering blood pressure (BP) is widely used to reduce vascular risk in individuals with diabetes. OBJECTIVE To determine the associations between BP-lowering treatment and vascular disease in type 2 diabetes. . DATA SOURCES AND STUDY SELECTION We searched MEDLINE for large-scale randomized controlled trials of BP-lowering treatment including patients with diabetes, published between January 1966 and October 2014. DATA EXTRACTION AND SYNTHESIS Two reviewers independently extracted study characteristics and vascular outcome data. Estimates were stratified by baseline BP and achieved BP, and pooled using fixed-effects meta-analysis. MAIN OUTCOMES AND MEASURES All-cause mortality, cardiovascular events, coronary heart disease events, stroke, heart failure, retinopathy, new or worsening albuminuria, and renal failure. RESULTS Forty trials judged to be of low risk of bias (100 354 participants) were included. Each 10-mm Hg lower systolic BP was associated with a significantly lower risk of mortality (relative risk [RR], 0.87; 95% CI, 0.78-0.96); absolute risk reduction (ARR) in events per 1000 patient-years (3.16; 95% CI, 0.90-5.22), cardiovascular events (RR, 0.89 [95% CI, 0.83-0.95]; ARR, 3.90 [95% CI, 1.57-6.06]), coronary heart disease (RR, 0.88 [95% CI, 0.80-0.98]; ARR, 1.81 [95% CI, 0.35-3.11]), stroke (RR, 0.73 [95% CI, 0.64-0.83]; ARR, 4.06 [95% CI, 2.53-5.40]), albuminuria (RR, 0.83 [95% CI, 0.79-0.87]; ARR, 9.33 [95% CI, 7.13-11.37]), and retinopathy (RR, 0.87 [95% CI, 0.76-0.99]; ARR, 2.23 [95% CI, 0.15-4.04]). When trials were stratified by mean baseline systolic BP at greater than or less than 140 mmHg, RRs for outcomes other than stroke, retinopathy, and renal failure were lower in studies with greater baseline systolic BP (P interaction <0.1). The associations between BP-lowering treatments and outcomes were not significantly different, irrespective of drug class, except for stroke and heart failure. Estimates were similar when all trials, regardless of risk of bias, were included. CONCLUSIONS AND RELEVANCE Among patients with type 2 diabetes, BP lowering was associated with improved mortality and other clinical outcomes with lower RRs observed among those with baseline BP of 140 mmHg and greater. These findings support the use of medications for BP lowering in these patients. Copyright 2015 American Medical Association. All rights reserved.	[Emdin, Connor A.; Rahimi, Kazem; Callender, Thomas] Univ Oxford, George Inst Global Hlth, Oxford OX1 3DB, England; [Neal, Bruce; Perkovic, Vlado; Patel, Anushka] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia	University of Oxford; George Institute for Global Health; University of Sydney	Rahimi, K (corresponding author), Univ Oxford, George Inst Global Hlth, Oxford Martin Sch, 34 Broad St, Oxford OX1 3DB, England.	kazem.rahimi@georgeinstitute.ox.ac.uk	Dagdelen, Selcuk/A-9432-2017; Rahimi, Kazem/Q-1279-2015; Perkovic, Vlado/AAY-1933-2021; Rahimi, Kazem/AAA-4250-2022; Emdin, Connor/B-6746-2015	Dagdelen, Selcuk/0000-0002-0513-1750; Rahimi, Kazem/0000-0002-4807-4610; Patel, Anushka/0000-0003-3825-4092; Callender, Thomas/0000-0001-8440-9433; Neal, Bruce/0000-0002-0490-7465; Perkovic, Vlado/0000-0002-4257-7620; Emdin, Connor/0000-0002-2385-8259	Australian Research Council Future Fellowship; NHMRC of Australia Senior Research Fellowships; NHMRC program grant; NIHR Oxford Biomedical Research Centre; NIHR Career Development Fellowship; Rhodes Trust; Oxford Martin School; National Institute for Health Research [CDF-2013-06-012] Funding Source: researchfish	Australian Research Council Future Fellowship(Australian Research Council); NHMRC of Australia Senior Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); NHMRC program grant(National Health and Medical Research Council (NHMRC) of Australia); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Career Development Fellowship; Rhodes Trust; Oxford Martin School; National Institute for Health Research(National Institute for Health Research (NIHR))	The George Institute for Global Health has received grants from several pharmaceutical companies to conduct clinical trials in patients with diabetes. Dr Neal is supported by an Australian Research Council Future Fellowship. Drs Neal, Perkovic, and Patel are supported by NHMRC of Australia Senior Research Fellowships and hold an NHMRC program grant. Dr Rahimi is supported by the NIHR Oxford Biomedical Research Centre and NIHR Career Development Fellowship. Mr Emdin is supported by the Rhodes Trust. The work of the George Institute is supported by the Oxford Martin School.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; [Anonymous], 1991, OPHTHALMOLOGY, V98, P823; [Anonymous], 1985, PREV MED, V14, P312; Baigent C, 2010, OXFORD TXB MED, P31; Bakris GL, 2004, HYPERTENSION, V44, P637, DOI 10.1161/01.HYP.0000143851.23721.26; Bangalore S, 2011, CIRCULATION, V123, P2799, DOI 10.1161/CIRCULATIONAHA.110.016337; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Berl T, 2003, ANN INTERN MED, V138, P542, DOI 10.7326/0003-4819-138-7-200304010-00010; Berthet K, 2004, BLOOD PRESSURE, V13, P7, DOI 10.1080/08037050410029605; Bilous R, 2009, ANN INTERN MED, V151, P11, DOI 10.7326/0003-4819-151-1-200907070-00120; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Daly CA, 2005, EUR HEART J, V26, P1369, DOI 10.1093/eurheartj/ehi225; de Galan BE, 2009, J AM SOC NEPHROL, V20, P883, DOI 10.1681/ASN.2008070667; Deedwania PC, 2005, AM HEART J, V149, P159, DOI 10.1016/j.ahj.2004.05.056; Domanski M, 2003, J AM COLL CARDIOL, V42, P914, DOI 10.1016/S0735-1097(03)00856-8; Erdmann E, 2001, EUR J HEART FAIL, V3, P469, DOI 10.1016/S1388-9842(01)00174-X; Estacio RO, 2000, DIABETES CARE, V23, pB54; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gerstein HC, 2000, LANCET, V355, P253; GUNDERSEN T, 1983, DIABETES CARE, V6, P285, DOI 10.2337/diacare.6.3.285; Gustafsson I, 1999, J AM COLL CARDIOL, V34, P83, DOI 10.1016/S0735-1097(99)00146-1; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hjalmarson A, 1999, LANCET, V353, P2001; Hollaway LC, 2008, WOODHEAD PUBL MATER, P1; JAMES PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kengne AP, 2007, J HYPERTENS, V25, P1205; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lindholm LH, 2000, J HYPERTENS, V18, P1671, DOI 10.1097/00004872-200018110-00020; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Mancia G, 2003, HYPERTENSION, V41, P431, DOI 10.1161/01.HYP.0000057420.27692.AD; Marre M, 2004, BMJ-BRIT MED J, V328, P495; MOYE LA, 1994, EUR HEART J, V15, P2, DOI 10.1093/eurheartj/15.suppl_B.2; Nakao K, 2010, HYPERTENS RES, V33, P600, DOI 10.1038/hr.2010.38; Niskanen L, 2001, DIABETES CARE, V24, P2091, DOI 10.2337/diacare.24.12.2091; Ostergren J, 2008, J HYPERTENS, V26, P2103, DOI 10.1097/HJH.0b013e328310e0d9; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Pechere-Bertschi A, 2005, BLOOD PRESSURE, V14, P337, DOI 10.1080/08037050500340018; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; SCHRADER J, 2006, J CLIN BASIC CARD S1, V9, P2; Schrier RW, 2007, NAT CLIN PRACT NEPHR, V3, P428, DOI 10.1038/ncpneph0559; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Schrier RW, 2000, NEW ENGL J MED, V343, P1969, DOI 10.1056/NEJM200012283432614; Shindler DM, 1996, AM J CARDIOL, V77, P1017, DOI 10.1016/S0002-9149(97)89163-1; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; SWEDBERG K, 1992, NEW ENGL J MED, V327, P678, DOI 10.1056/NEJM199209033271002; Tillin T, 2011, J HYPERTENS, V29, P1457, DOI 10.1097/HJH.0b013e3283480db9; Trenkwalder P, 2005, BLOOD PRESSURE, V14, P31, DOI 10.1080/08037050510008823; Tuomilehto J, 1999, NEW ENGL J MED, V340, P677, DOI 10.1056/NEJM199903043400902; TURNER RC, 1993, J HYPERTENS, V11, P309; Weber MA, 2010, J AM COLL CARDIOL, V56, P77, DOI 10.1016/j.jacc.2010.02.046; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Woodward M, 2003, DIABETES CARE, V26, P360; Wright RA, 1979, JAMA-J AM MED ASSOC, V277, P157; Yui Y, 2004, HYPERTENS RES, V27, P449, DOI 10.1291/hypres.27.449; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S., 1992, NEW ENGL J MED, V327, P685, DOI [DOI 10.1056/NEJM199209033271003, 10.1056/NEJM199209033271003.Erratumin]; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593; Zhang YQ, 2011, EUR HEART J, V32, P1500, DOI 10.1093/eurheartj/ehr039	83	484	530	3	64	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					603	615		10.1001/jama.2014.18574	http://dx.doi.org/10.1001/jama.2014.18574			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25668264				2022-12-28	WOS:000349070700020
J	Hawkes, N				Hawkes, Nigel			SPOTLIGHT: PATIENT CENTRED CARE Seeing things from the patients' view: what will it take?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Al-Ubaydli M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5575; Centers for Medicare and Medicaid Services, MEAN US STAG 1; Goodrich J, 2012, J ROY SOC MED, V105, P117, DOI 10.1258/jrsm.2011.110183; Greenfield G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6422; King's Fund, 2014, PEOPL CONTR THEIR OW; Lewis-Barned N, IMPLEMENTING SHARED; National Information Board, 2014, PERS HLTH CAR 2020; Smith R, 2014, BMJ BLOG        0214	8	10	10	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								g7757	10.1136/bmj.g7757	http://dx.doi.org/10.1136/bmj.g7757			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670180	Bronze			2022-12-28	WOS:000349318400030
J	Brock, AS; Cook, JL; Ranney, N; Rockey, DC				Brock, Andrew S.; Cook, Jennifer L.; Ranney, Nathaniel; Rockey, Don C.			A Not-So-Obscure Cause of Gastrointestinal Bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VENTRICULAR ASSIST DEVICES; ENTEROSCOPY; LESIONS	A 66-year-old man was admitted to the hospital with a 2-day history of fatigue, dizziness on standing, and bright red blood from the rectum that transitioned to black, tarry stools. He reported no abdominal pain, nausea, vomiting, or weight loss. He had a history of several myocardial infarctions and subsequent ischemic cardiomyopathy (ejection fraction, approximately 20%); a HeartMate II left ventricular assist device (LVAD) had been placed 2.5 months earlier as destination therapy (i.e., permanent therapy for a patient who is not a candidate for heart transplantation). He also had chronic atrial fibrillation. Medications included warfarin (target international normalized ratio [INR], 2.0 to 3.0), low-dose aspirin, amiodarone, and metoprolol. On physical examination, the patient's skin and conjunctiva were pale. The heart rate and blood pressure (measured by automated sphygmomanometry) were 74 beats per minute and 117/99 mm Hg, respectively. A continuous hum from the LVAD was heard in the precordial region. The abdomen was soft, with normoactive bowel sounds. Melena was noted in the patient's bed. There were no stigmata of chronic liver disease.	[Brock, Andrew S.; Cook, Jennifer L.; Ranney, Nathaniel; Rockey, Don C.] Med Univ S Carolina, Dept Internal Med, Charleston, SC 29425 USA	Medical University of South Carolina	Rockey, DC (corresponding author), Med Univ S Carolina, Dept Internal Med, 96 Jonathan Lucas St,Suite 803, Charleston, SC 29425 USA.	rockey@musc.edu						BOLEY SJ, 1977, GASTROENTEROLOGY, V72, P650; Crow S, 2009, J THORAC CARDIOV SUR, V137, P208, DOI 10.1016/j.jtcvs.2008.07.032; Douard R, 2000, AM J SURG, V180, P181, DOI 10.1016/S0002-9610(00)00447-5; Ge ZZ, 2011, GASTROENTEROLOGY, V141, P1629, DOI 10.1053/j.gastro.2011.07.018; Gerson LB, 2009, CLIN GASTROENTEROL H, V7, P664, DOI 10.1016/j.cgh.2009.01.021; Islam S, 2013, CLIN CARDIOL, V36, P190, DOI 10.1002/clc.22096; Kushnir VM, 2012, GASTROINTEST ENDOSC, V75, P973, DOI 10.1016/j.gie.2011.12.014; Letsou GV, 2005, J HEART LUNG TRANSPL, V24, P105, DOI 10.1016/j.healun.2003.10.018; Lopez MJ, 1996, ARCH SURG-CHICAGO, V131, P272; MAY A, 2012, ENDOSCOPY, V44, P304; Raju Gottumukkala S, 2007, Gastroenterology, V133, P1697, DOI 10.1053/j.gastro.2007.06.007; Samaha E, 2012, AM J GASTROENTEROL, V107, P240, DOI 10.1038/ajg.2011.325; Suarez J, 2011, CIRC-HEART FAIL, V4, P779, DOI 10.1161/CIRCHEARTFAILURE.111.962613; Veyradier A, 2001, GASTROENTEROLOGY, V120, P346, DOI 10.1053/gast.2001.21204; WARKENTIN TE, 1992, LANCET, V340, P35, DOI 10.1016/0140-6736(92)92434-H	15	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2015	372	6					556	561		10.1056/NEJMcps1302223	http://dx.doi.org/10.1056/NEJMcps1302223			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CH	25651250				2022-12-28	WOS:000349143600012
J	Pavan, M; Ventura, G; Maschio, M; Ventura, A				Pavan, Matteo; Ventura, Giovanna; Maschio, Massimo; Ventura, Alessandro			Extremely large air distension of the bowel	LANCET			English	Editorial Material									[Pavan, Matteo; Ventura, Giovanna; Ventura, Alessandro] Univ Trieste, I-34137 Trieste, Italy; [Maschio, Massimo] IRCCS Burlo Garofolo Trieste, Inst Maternal & Child Hlth, Trieste, Italy	University of Trieste; IRCCS Burlo Garofolo	Pavan, M (corresponding author), Univ Trieste, Via Istria 65-1, I-34137 Trieste, Italy.	matteo_pavan@hotmail.it		Pavan, Matteo/0000-0002-9409-9720; Ventura, Alessandro/0000-0002-4657-1760					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2399	2399		10.1016/S0140-6736(14)61901-2	http://dx.doi.org/10.1016/S0140-6736(14)61901-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	25703456				2022-12-28	WOS:000356003700033
J	Lopez, EMJ; Ghetmiri, E; Gettle, LM; Reed, MF; McAllister, BP				Lopez, Eric Mark J.; Ghetmiri, Ehsan; Gettle, Lori M.; Reed, Michael F.; McAllister, Brian P.			Encephalopathy and high anion gap metabolic acidosis: an unusual herald of buried bumper syndrome	LANCET			English	Editorial Material									[Lopez, Eric Mark J.; Ghetmiri, Ehsan; McAllister, Brian P.] Penn State Coll Med, Penn State Milton S Hershey Med Ctr, Dept Med, Hershey, PA 17033 USA; [Gettle, Lori M.] Penn State Coll Med, Penn State Milton S Hershey Med Ctr, Dept Radiol, Hershey, PA 17033 USA; [Reed, Michael F.] Penn State Coll Med, Penn State Milton S Hershey Med Ctr, Dept Surg, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	McAllister, BP (corresponding author), Penn State Coll Med, Milton S Hershey Med Ctr, 500 Univ Dr,POB 850, Hershey, PA 17033 USA.	bmcallister@hmc.psu.edu		Reed, Michael/0000-0001-8478-8605				Bertolini R, 2014, WORLD J GASTROENTERO, V20, P11439, DOI 10.3748/wjg.v20.i32.11439; Biswas Saptarshi, 2014, Case Rep Crit Care, V2014, P634953, DOI 10.1155/2014/634953; Kang Kyung Pyo, 2006, Electrolyte Blood Press, V4, P53, DOI 10.5049/EBP.2006.4.1.53; NGHIEM CH, 1988, WESTERN J MED, V148, P332; Rahnemai-Azar AA, 2014, WORLD J GASTROENTERO, V20, P7739, DOI 10.3748/wjg.v20.i24.7739	5	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2015	385	9969					744	744		10.1016/S0140-6736(15)60030-7	http://dx.doi.org/10.1016/S0140-6736(15)60030-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7ED	25706220				2022-12-28	WOS:000349788300031
J	Senussi, MH; Surath, H; Mireles-Cabodevila, E				Senussi, Mourad H.; Surath, Hemantha; Mireles-Cabodevila, Eduardo			Shortness of Breath After a Choking Incident Negative-pressure pulmonary edema	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AIRWAY		[Senussi, Mourad H.; Mireles-Cabodevila, Eduardo] Cleveland Clin, Resp Inst, Cleveland, OH 44195 USA; [Surath, Hemantha] St Joseph Hosp, Dept Internal Med, Chicago, IL USA	Cleveland Clinic Foundation	Senussi, MH (corresponding author), Cleveland Clin, Resp Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	senussm@ccf.org	Senussi, Mourad H/L-1725-2019	Mireles-Cabodevila, Eduardo/0000-0002-7822-8529				Adolph M D, 1994, Ear Nose Throat J, V73, P324; BARTLETT JG, 1975, CHEST, V68, P560, DOI 10.1378/chest.68.4.560; Bhaskar B, 2011, SAUDI J ANAESTH, V5, P308, DOI 10.4103/1658-354X.84108; CAPITANIO MA, 1973, RADIOLOGY, V107, P159, DOI 10.1148/107.1.159; DEPASO WJ, 1991, CLIN CHEST MED, V12, P269; Koch SM, 1996, CAN J ANAESTH, V43, P73, DOI 10.1007/BF03015962; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Nam YS, 2001, ACTA ANAESTH SCAND, V45, P911; OSWALT CE, 1977, JAMA-J AM MED ASSOC, V238, P1833, DOI 10.1001/jama.238.17.1833; Patel Alpesh R, 2006, Crit Care Resusc, V8, P115	10	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					721	722		10.1001/jama.2014.17182	http://dx.doi.org/10.1001/jama.2014.17182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25688785				2022-12-28	WOS:000349476100019
J	Finney, C				Finney, Christopher			Comment on "Using ecological thresholds to evaluate the costs and benefits of set-asides in a biodiversity hotspot"	SCIENCE			English	Editorial Material							ENVIRONMENTAL SERVICES; CONSERVATION; PAYMENTS	Banks-Leite et al. (Reports, 29 August 2014, p. 1041) conclude that a large-scale program to restore the Brazilian Atlantic Forest using payments for environmental services (PES) is economically feasible. They do not analyze transaction costs, which are quantified infrequently and incompletely in the literature. Transaction costs can exceed 20% of total project costs and should be included in future research.	Nature Conservancy, Atlantic Forest & Cent Savannas Conservat Program, BR-01311300 Sao Paulo, Brazil		Finney, C (corresponding author), Nature Conservancy, Atlantic Forest & Cent Savannas Conservat Program, Ave Paulista 2439 Conj 91, BR-01311300 Sao Paulo, Brazil.	cfinney@tnc.org		Pearse, William D/0000-0002-6241-3164				Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; COASE RH, 1960, J LAW ECON, V3, P1, DOI 10.1086/466560; Guedes F.B., 2011, PSA MATA ATLANTICA S; Guedes F. B., 2011, PSA MATA ATLANTICA S, P55; Naidoo R, 2006, PLOS BIOL, V4, P2153, DOI 10.1371/journal.pbio.0040360; Perrot-Mautre D., 2006, VITTEL PAYMENTS ECOS; The Nature Conservancy, 2011, PROJ CONS AG PASS PA; Veiga F, 2011, PAGAMENTOS SERVICOS, V42, P123; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x	10	6	6	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223								10.1126/science.aaa0916	http://dx.doi.org/10.1126/science.aaa0916			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA9DT	25678654				2022-12-28	WOS:000349221300036
J	Gornall, J				Gornall, Jonathan			Sugar: spinning a web of influence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@bmj.com						Ahern AL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-434; Capewell S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3428; Haddock CK, 2014, BRIT J NUTR, V111, P372, DOI 10.1017/S0007114513002377; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; PepsiCo Inc., 2013, FORM 10 K FISC YEAR; Renton A., 2014, DAILY MAIL; Scientific Advisory Committee on Nutrition, ANN REP 2001 2012; Scientific Advisory Committee on Nutrition, 2014, DRAFT CARB HLTH REP; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Universities UK, 2014, RES POSTGR RES TRAIN; Yudkin J., 2012, WHITE AND DEADLY	12	31	31	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2015	350								h231	10.1136/bmj.h231	http://dx.doi.org/10.1136/bmj.h231			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0MG	25673325				2022-12-28	WOS:000349319700004
J	Rogers, WB; Manoharan, VN				Rogers, W. Benjamin; Manoharan, Vinothan N.			Programming colloidal phase transitions with DNA strand displacement	SCIENCE			English	Article							NANOPARTICLE SUPERLATTICES; CRYSTALLIZATION; SYSTEMS; TEMPERATURE; HANDSHAKING; DESIGN	DNA-grafted nanoparticles have been called "programmable atom-equivalents": Like atoms, they form three-dimensional crystals, but unlike atoms, the particles themselves carry information (the sequences of the grafted strands) that can be used to "program" the equilibrium crystal structures. We show that the programmability of these colloids can be generalized to the full temperature-dependent phase diagram, not just the crystal structures themselves. We add information to the buffer in the form of soluble DNA strands designed to compete with the grafted strands through strand displacement. Using only two displacement reactions, we program phase behavior not found in atomic systems or other DNA-grafted colloids, including arbitrarily wide gas-solid coexistence, reentrant melting, and even reversible transitions between distinct crystal phases.	[Rogers, W. Benjamin; Manoharan, Vinothan N.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Manoharan, Vinothan N.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Manoharan, VN (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	vnm@seas.harvard.edu	Manoharan, Vinothan N/C-1292-2008; Rogers, William/L-8941-2016	Manoharan, Vinothan N/0000-0003-0370-6095; Rogers, William/0000-0001-8587-8215	Harvard MRSEC through NSF [DMR-0820484]; NSF [DMR-1435964]; Alfred P. Sloan Research Fellowship	Harvard MRSEC through NSF; NSF(National Science Foundation (NSF)); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation)	We thank S. Magkiriadou, J. Collins, Z. Zeravcic, and M. Brenner for helpful discussions. Supported by the Harvard MRSEC through NSF grant DMR-0820484, NSF grant DMR-1435964, and an Alfred P. Sloan Research Fellowship. See the supplementary materials for additional data.	Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Angioletti-Uberti S, 2012, NAT MATER, V11, P518, DOI [10.1038/NMAT3314, 10.1038/nmat3314]; Baker BA, 2013, SOFT MATTER, V9, P11160, DOI 10.1039/c3sm52157e; Biancaniello PL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058302; Casey MT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2206; Di Michele L, 2013, PHYS CHEM CHEM PHYS, V15, P3115, DOI 10.1039/c3cp43841d; Dreyfus R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.048301; Frenkel D, 2002, SCIENCE, V296, P65, DOI 10.1126/science.1070865; Halverson JD, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062310; KING J, 1974, NATURE, V251, P112, DOI 10.1038/251112a0; Li TING, 2013, J AM CHEM SOC, V135, P8535, DOI 10.1021/ja312644h; Macfarlane RJ, 2013, SCIENCE, V341, P1222, DOI 10.1126/science.1241402; Macfarlane RJ, 2013, ANGEW CHEM INT EDIT, V52, P5688, DOI 10.1002/anie.201209336; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Maye MM, 2010, NAT NANOTECHNOL, V5, P116, DOI [10.1038/NNANO.2009.378, 10.1038/nnano.2009.378]; McGinley JT, 2013, SOFT MATTER, V9, P9119, DOI 10.1039/c3sm50950h; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Mognetti BM, 2012, SOFT MATTER, V8, P2213, DOI 10.1039/c2sm06635a; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Rogers WB, 2012, P NATL ACAD SCI USA, V109, pE380, DOI 10.1073/pnas.1121102109; Rogers WB, 2011, P NATL ACAD SCI USA, V108, P15687, DOI 10.1073/pnas.1109853108; Roldan-Vargas S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02451; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Scarlett RT, 2011, SOFT MATTER, V7, P1912, DOI 10.1039/c0sm00370k; Tison CK, 2007, LANGMUIR, V23, P9728, DOI 10.1021/la700601j; Varilly P, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4748100; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zeravcic Z, 2014, P NATL ACAD SCI USA, V111, P15918, DOI 10.1073/pnas.1411765111; Zhang DY, 2011, NAT CHEM, V3, P103, DOI 10.1038/NCHEM.957	31	154	155	3	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					639	642		10.1126/science.1259762	http://dx.doi.org/10.1126/science.1259762			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657244	Green Submitted			2022-12-28	WOS:000349145200039
J	McNamara, M; Batur, P; DeSapri, KT				McNamara, Megan; Batur, Pelin; DeSapri, Kristi Tough			Perimenopause	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	12	13	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2015	162	3								10.7326/AITC201502030	http://dx.doi.org/10.7326/AITC201502030			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV9ZT	25643316				2022-12-28	WOS:000364649000002
J	Lobstein, T; Jackson-Leach, R; Moodie, ML; Hall, KD; Gortmaker, SL; Swinburn, BA; James, WPT; Wang, YF; McPherson, K				Lobstein, Tim; Jackson-Leach, Rachel; Moodie, Marjory L.; Hall, Kevin D.; Gortmaker, Steven L.; Swinburn, Boyd A.; James, W. Philip T.; Wang, Youfa; McPherson, Klim			Child and adolescent obesity: part of a bigger picture	LANCET			English	Article							ASSESSING COST-EFFECTIVENESS; PRIMARY-SCHOOL CHILDREN; BODY-MASS INDEX; QUALITY-OF-LIFE; ACTIVE-TRANSPORT; OVERWEIGHT; FOOD; PREVENTION; INTERVENTIONS; HEALTH	The prevalence of childhood overweight and obesity has risen substantially worldwide in less than one generation. In the USA, the average weight of a child has risen by more than 5 kg within three decades, to a point where a third of the country's children are overweight or obese. Some low-income and middle-income countries have reported similar or more rapid rises in child obesity, despite continuing high levels of undernutrition. Nutrition policies to tackle child obesity need to promote healthy growth and household nutrition security and protect children from inducements to be inactive or to overconsume foods of poor nutritional quality. The promotion of energy-rich and nutrient-poor products will encourage rapid weight gain in early childhood and exacerbate risk factors for chronic disease in all children, especially those showing poor linear growth. Whereas much public health effort has been expended to restrict the adverse marketing of breastmilk substitutes, similar effort now needs to be expanded and strengthened to protect older children from increasingly sophisticated marketing of sedentary activities and energy-dense, nutrient-poor foods and beverages. To meet this challenge, the governance of food supply and food markets should be improved and commercial activities subordinated to protect and promote children's health.	[Lobstein, Tim; Jackson-Leach, Rachel; James, W. Philip T.] World Obes Federat, London WC1N 2JU, England; [Moodie, Marjory L.] Deakin Univ, Deakin Hlth Econ, Melbourne, Vic, Australia; [Swinburn, Boyd A.] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Melbourne, Vic, Australia; [Swinburn, Boyd A.] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Hall, Kevin D.] NIDDK, NIH, Bethesda, MD 20892 USA; [Gortmaker, Steven L.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Wang, Youfa] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Epidemiol & Environm Hlth, Buffalo, NY 14260 USA; [McPherson, Klim] Univ Oxford, New Coll, Oxford, England	Deakin University; Deakin University; World Health Organization; University of Auckland; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Harvard T.H. Chan School of Public Health; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Oxford	Lobstein, T (corresponding author), World Obes Federat, Charles Darwin House, London WC1N 2JU, England.	tlobstein@worldobesity.org	james, william/H-4289-2013; Hall, Kevin/F-2383-2010	james, william/0000-0002-2506-1198; Hall, Kevin/0000-0003-4062-3133	World Obesity Federation; US National Collaborative on Childhood Obesity Research; RWJF [260639]; CDC [U48/DP00064]; NIH [1R01HD064685-01A1, U54HD070725]; Nutrition and Obesity Policy, Research and Evaluation Network; Office of Behavioural and Social Sciences Research of NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD070725, R01HD064685] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013036] Funding Source: NIH RePORTER	World Obesity Federation; US National Collaborative on Childhood Obesity Research; RWJF; CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutrition and Obesity Policy, Research and Evaluation Network; Office of Behavioural and Social Sciences Research of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work for this paper was supported by the World Obesity Federation, formerly the International Association for the Study of Obesity (IASO). Additional work was done in part for the Envision Project, supported by the US National Collaborative on Childhood Obesity Research, which coordinates childhood obesity research across the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), US Department of Agriculture, and the Robert Wood Johnson Foundation (RWJF). The work was also supported in part by grants from RWJF (grant 260639), CDC (U48/DP00064) and NIH (1R01HD064685-01A1, U54HD070725), including the Nutrition and Obesity Policy, Research and Evaluation Network, and the Office of Behavioural and Social Sciences Research of NIH. We thank Faten Ben Abdelaziz of WHO Regional Office for the Eastern Mediterranean for comments and advice on the manuscript and for regional media advertising data. We thank Caroline Hancock for sharing her MSc in Public Health dissertation. We thank Jaap Seidell and Carolyn Summerbell for their comments on an earlier version of the manuscript, and to the anonymous reviewers of the submitted drafts.	Alexander E, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-26; Ananthapavan J, 2010, SURG OBES RELAT DIS, V6, P377, DOI 10.1016/j.soard.2010.02.040; [Anonymous], 2007, PARC YB 2007; [Anonymous], 2013, BRAZIL SOFT DRINKS; [Anonymous], 2013, GLOBAL SOFT DRINKS; [Anonymous], 2012, SOFT DRINKKS IND IND; Nguyen BKL, 2013, BRIT J NUTR, V110, pS45, DOI 10.1017/S0007114513002080; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Brown HS, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-47; Cawley J, 2007, ARCH PEDIAT ADOL MED, V161, P611, DOI 10.1001/archpedi.161.6.611; Coleman-Jensen A., 2012, 141 USDAERS; Dahl-Regis M, 2002, ANN REPORT CHIEF MED; Darapheak Chau, 2013, Int Arch Med, V6, P29, DOI 10.1186/1755-7682-6-29; del Rio-Navarro BE, 2004, OBES RES, V12, P215, DOI 10.1038/oby.2004.28; Del-Rio-Navarro BE, 2007, EUR J CLIN NUTR, V61, P963, DOI 10.1038/sj.ejcn.1602612; Department of Health Victoria Australia, 2006, ACE OB ASS COST EFF; Dixon B, 2012, ADV NUTR, V3, P73, DOI 10.3945/an.111.000919; El-Zanaty F., 2009, EGYPT DEMOGRAPHIC HL, DOI DOI 10.1177/0049475514561330; Flynn MAT, 2006, OBES REV, V7, P7, DOI 10.1111/j.1467-789X.2006.00242.x; Galbraith-Emami S, 2013, OBES REV, V14, P960, DOI 10.1111/obr.12060; Goldfield GS, 2001, INT J OBESITY, V25, P1843, DOI 10.1038/sj.ijo.0801838; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Haby MM, 2006, INT J OBESITY, V30, P1463, DOI 10.1038/sj.ijo.0803469; Hall KD, 2013, LANCET DIABETES ENDO, V1, P97, DOI 10.1016/S2213-8587(13)70051-2; Hall KD, 2012, ANNU REV NUTR, V32, P35, DOI 10.1146/annurev-nutr-071811-150705; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hancock C., 2013, THESIS OXFORD BROOKE; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Hollingworth W, 2012, INT J OBESITY, V36, P559, DOI 10.1038/ijo.2011.272; Huang TTK, 2015, LANCET, V385, P2422, DOI 10.1016/S0140-6736(14)61743-8; Internal Markets Bureau, 2011, GLOB PATHF REP BAB F; John J, 2012, NUTRITION, V28, P829, DOI 10.1016/j.nut.2011.11.016; Kalavainen M, 2009, PEDIATR INT, V51, P606, DOI 10.1111/j.1442-200X.2009.02810.x; Keating CL, 2011, INT J PEDIATR OBES, V6, P434, DOI 10.3109/17477166.2011.590197; Keating CL, 2011, VALUE HEALTH, V14, P752, DOI 10.1016/j.jval.2011.02.1181; Keen YJ, 2010, BREAKING RULESA STRE; Kelly B, 2010, AM J PUBLIC HEALTH, V100, P1730, DOI 10.2105/AJPH.2009.179267; Khadilkar VV, 2009, INDIAN PEDIATR, V46, P477; Khambalia AZ, 2012, OBES REV, V13, P214, DOI 10.1111/j.1467-789X.2011.00947.x; Larson N, 2011, J AM DIET ASSOC, V111, P1343, DOI 10.1016/j.jada.2011.06.007; Levinson FJ., 2013, ADDRESSING MALNUTRIT; Limon G, 2009, HIGHLY PATHOGENIC AV; Lin BH, 2011, ECON HUM BIOL, V9, P329, DOI 10.1016/j.ehb.2011.08.007; Lobstein T, 2005, OBES REV, V6, P203, DOI 10.1111/j.1467-789X.2005.00191.x; Lobstein T., 2007, GLOBAL PERSPECTIVES, P125, DOI [10.1007/978-0-387-70974-1_9, DOI 10.1007/978-0-387-70974-1_9]; Magnus A, 2009, INT J OBESITY, V33, P1094, DOI 10.1038/ijo.2009.156; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; McAuley KA, 2010, OBESITY, V18, P131, DOI 10.1038/oby.2009.148; McDowell Margaret A, 2008, Natl Health Stat Report, P1; Menon P, 2015, MATERN CHILD NUTR, V11, P73, DOI 10.1111/mcn.12036; Moodie M, 2010, COMMUNITY BASED OBES; Moodie M, 2011, J PHYS ACT HEALTH, V8, P503, DOI 10.1123/jpah.8.4.503; Moodie M, 2008, ECON HUM BIOL, V6, P363, DOI 10.1016/j.ehb.2008.06.001; Moodie M, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-63; Moodie ML, 2013, OBESITY, V21, P2072, DOI 10.1002/oby.20472; Moodie ML, 2010, OBESITY, V18, P1585, DOI 10.1038/oby.2009.401; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Martinez PM, 2011, GAC SANIT, V25, P198, DOI 10.1016/j.gaceta.2010.11.003; National Institute for Health and Care Excellence (NICE), 2011, WHOL SYST APPR OB PR; National Institute for Health and Care Excellence (NICE), 2007, OB FULL GUID SECT 6; Nixon CA, 2012, OBES REV, V13, P106, DOI 10.1111/j.1467-789X.2011.00962.x; Ogden Cynthia L, 2004, Adv Data, P1; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Roberto CA, 2015, LANCET, V385, P2400, DOI 10.1016/S0140-6736(14)61744-X; Santika O, 2009, J NUTR, V139, P135, DOI 10.3945/jn.108.092270; SAWAYA AL, 1995, OBES RES, V3, pS107, DOI 10.1002/j.1550-8528.1995.tb00453.x; Smith J, 2013, AUST NZ J PUBL HEAL, V37, P337, DOI 10.1111/1753-6405.12081; Spencer J., 2012, GETTING JUNK FOOD MA; Steyn K, 1998, E AFR MED J, V75, P35; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Swinburn B, 2013, OBES REV, V14, P1, DOI 10.1111/obr.12087; Uauy R, 2008, ANN MED, V40, P11, DOI 10.1080/07853890701704683; USDA (U. S. Department of Agriculture), 2012, EN INT PERC EN PROT; Wang LY, 2008, J SCHOOL HEALTH, V78, P619, DOI 10.1111/j.1746-1561.2008.00357.x; Wang LY, 2003, OBES RES, V11, P1313, DOI 10.1038/oby.2003.178; Wang Y, 2013, COMP EFFECTIVENESS R, V115; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; *WHO, 2010, SET REC MARK FOODS N; WHO, 2013, MARK FOOD HIGH FAT S; WHO, 2013, 1 M WHO SCI TECHN AD; Working Group on Infant and Young Child Feeding Indicators, 2006, DEV VAL SIMPL IND DI; World Health Organisation, 2012, FRAM IMPL SET REC MA; World Health Organization, 2013, GROWTH REF DAT 5 19; World Health Organization, 1981, INT COD MARK BREAST; World Health Organization, 2013, GLOB SCH BAS STUD HL	89	637	653	13	327	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2510	2520		10.1016/S0140-6736(14)61746-3	http://dx.doi.org/10.1016/S0140-6736(14)61746-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK9AR	25703114	Green Accepted			2022-12-28	WOS:000356532500026
J	Gapstur, SM; Patel, AV; Banks, E; Dal Maso, L; Talamini, R; Chetrit, A; Hirsh-Yechezkel, G; Lubin, F; Sadetzki, S; Beral, V; Bull, D; Cairns, B; Crossley, B; Gaitskell, K; Goodill, A; Green, J; Hermon, C; Key, T; Moser, K; Reeves, G; Sitas, F; Collins, R; Peto, R; Gonzalez, CA; Lee, N; Marchbanks, P; Ory, HW; Peterson, HB; Wingo, PA; Martin, N; Silpisornkosol, S; Theetranont, C; Boosiri, B; Chutivongse, S; Jimakorn, P; Virutamasen, P; Wongsrichanalai, C; Goodman, MT; Lidegaard, O; Kjaer, SK; Morch, LS; Tjonneland, A; Byers, T; Rohan, T; Mosgaard, B; Vessey, M; Yeates, D; Freudenheim, JL; Titus, LJ; Chang-Claude, J; Kaaks, R; Anderson, KE; Lazovich, D; Robien, K; Hampton, J; Newcomb, PA; Rossing, MA; Thomas, DB; Weiss, NS; Lokkegaard, E; Riboli, E; Clavel-Chapelon, F; Cramer, D; Hankinson, SE; Tamimi, RM; Tworoger, SS; Franceschi, S; La Vecchia, C; Negri, E; Adami, HO; Magnusson, C; Riman, T; Weiderpass, E; Wolk, A; Schouten, LJ; van den Brandt, PA; Chantarakul, N; Koetsawang, S; Rachawat, D; Palli, D; Black, A; Brinton, LA; Freedman, DM; Hartge, P; Hsing, AW; Jnr, JVL; Lissowska, J; Hoover, RN; Schairer, C; Babb, C; Urban, M; Graff-Iversen, S; Selmer, R; Bain, CJ; Green, AC; Purdie, DM; Siskind, V; Webb, PM; Moysich, K; McCann, SE; Hannaford, P; Kay, C; Binns, CW; Lee, AH; Zhang, M; Ness, RB; Nasca, P; Coogan, PF; Palmer, JR; Rosenberg, L; Whittemore, A; Katsouyanni, K; Trichopoulou, A; Trichopoulos, D; Tzonou, A; Dabancens, A; Martinez, L; Molina, R; Salas, O; Lurie, G; Carney, ME; Wilkens, LR; Hartman, L; Manjer, J; Olsson, H; Kumle, M; Grisso, JA; Morgan, M; Wheeler, JE; Edwards, RP; Kelley, JL; Modugno, F; Onland-Moret, NC; Peeters, PHM; Casagrande, J; Pike, MC; Wu, AH; Canfell, K; Miller, AB; Gram, IT; Lund, E; McGowan, L; Shu, XO; Zheng, W; Farley, TMM; Holck, S; Meirik, O; Risch, HA				Gapstur, S. M.; Patel, A. V.; Banks, E.; Dal Maso, L.; Talamini, R.; Chetrit, A.; Hirsh-Yechezkel, G.; Lubin, F.; Sadetzki, S.; Beral, V.; Bull, D.; Cairns, B.; Crossley, B.; Gaitskell, K.; Goodill, A.; Green, J.; Hermon, C.; Key, T.; Moser, K.; Reeves, G.; Sitas, F.; Collins, R.; Peto, R.; Gonzalez, C. A.; Lee, N.; Marchbanks, P.; Ory, H. W.; Peterson, H. B.; Wingo, P. A.; Martin, N.; Silpisornkosol, S.; Theetranont, C.; Boosiri, B.; Chutivongse, S.; Jimakorn, P.; Virutamasen, P.; Wongsrichanalai, C.; Goodman, M. T.; Lidegaard, O.; Kjaer, S. K.; Morch, L. S.; Tjonneland, A.; Byers, T.; Rohan, T.; Mosgaard, B.; Vessey, M.; Yeates, D.; Freudenheim, J. L.; Titus, L. J.; Chang-Claude, J.; Kaaks, R.; Anderson, K. E.; Lazovich, D.; Robien, K.; Hampton, J.; Newcomb, P. A.; Rossing, M. A.; Thomas, D. B.; Weiss, N. S.; Lokkegaard, E.; Riboli, E.; Clavel-Chapelon, F.; Cramer, D.; Hankinson, S. E.; Tamimi, R. M.; Tworoger, S. S.; Franceschi, S.; La Vecchia, C.; Negri, E.; Adami, H. O.; Magnusson, C.; Riman, T.; Weiderpass, E.; Wolk, A.; Schouten, L. J.; van den Brandt, P. A.; Chantarakul, N.; Koetsawang, S.; Rachawat, D.; Palli, D.; Black, A.; Brinton, L. A.; Freedman, D. M.; Hartge, P.; Hsing, A. W.; Jnr, J. V. Lacey; Lissowska, J.; Hoover, R. N.; Schairer, C.; Babb, C.; Urban, M.; Graff-Iversen, S.; Selmer, R.; Bain, C. J.; Green, A. C.; Purdie, D. M.; Siskind, V.; Webb, P. M.; Moysich, K.; McCann, S. E.; Hannaford, P.; Kay, C.; Binns, C. W.; Lee, A. H.; Zhang, M.; Ness, R. B.; Nasca, P.; Coogan, P. F.; Palmer, J. R.; Rosenberg, L.; Whittemore, A.; Katsouyanni, K.; Trichopoulou, A.; Trichopoulos, D.; Tzonou, A.; Dabancens, A.; Martinez, L.; Molina, R.; Salas, O.; Lurie, G.; Carney, M. E.; Wilkens, L. R.; Hartman, L.; Manjer, J.; Olsson, H.; Kumle, M.; Grisso, J. A.; Morgan, M.; Wheeler, J. E.; Edwards, R. P.; Kelley, J. L.; Modugno, F.; Onland-Moret, N. C.; Peeters, P. H. M.; Casagrande, J.; Pike, M. C.; Wu, A. H.; Canfell, K.; Miller, A. B.; Gram, I. T.; Lund, E.; McGowan, L.; Shu, X. O.; Zheng, W.; Farley, T. M. M.; Holck, S.; Meirik, O.; Risch, H. A.		Collaborative Grp Epidemiological	Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies	LANCET			English	Article							THERAPY	Background Half the epidemiological studies with information about menopausal hormone therapy and ovarian cancer risk remain unpublished, and some retrospective studies could have been biased by selective participation or recall. We aimed to assess with minimal bias the effects of hormone therapy on ovarian cancer risk. Methods Individual participant datasets from 52 epidemiological studies were analysed centrally. The principal analyses involved the prospective studies (with last hormone therapy use extrapolated forwards for up to 4 years). Sensitivity analyses included the retrospective studies. Adjusted Poisson regressions yielded relative risks (RRs) versus never-use. Findings During prospective follow-up, 12 110 postmenopausal women, 55% (6601) of whom had used hormone therapy, developed ovarian cancer. Among women last recorded as current users, risk was increased even with <5 years of use (RR 1.43, 95% CI 1.31-1.56; p<0.0001). Combining current-or-recent use (any duration, but stopped <5 years before diagnosis) resulted in an RR of 1.37 (95% CI 1.29-1.46; p<0.0001); this risk was similar in European and American prospective studies and for oestrogen-only and oestrogen-progestagen preparations, but differed across the four main tumour types (heterogeneity p<0.0001), being definitely increased only for the two most common types, serous (RR 1.53, 95% CI 1.40-1.66; p<0.0001) and endometrioid (1.42, 1.20-1.67; p<0.0001). Risk declined the longer ago use had ceased, although about 10 years after stopping long-duration hormone therapy use there was still an excess of serous or endometrioid tumours (RR 1.25, 95% CI 1.07-1.46, p=0.005). Interpretation The increased risk may well be largely or wholly causal; if it is, women who use hormone therapy for 5 years from around age 50 years have about one extra ovarian cancer per 1000 users and, if its prognosis is typical, about one extra ovarian cancer death per 1700 users.	[Gapstur, S. M.; Patel, A. V.] Amer Canc Soc, Atlanta, GA 30329 USA; [Banks, E.] Australian Natl Univ, Caberra, ACT, Australia; [Dal Maso, L.; Talamini, R.] Aviano Canc Ctr, I-33081 Aviano, Italy; [Chetrit, A.; Hirsh-Yechezkel, G.; Lubin, F.; Sadetzki, S.] Gertner Inst, Tel Hashomer, Israel; [Beral, V.; Bull, D.; Cairns, B.; Crossley, B.; Gaitskell, K.; Goodill, A.; Green, J.; Hermon, C.; Key, T.; Moser, K.; Reeves, G.] Canc Epidemiol Unit, Oxford, England; [Sitas, F.] NSW Canc Council, Woolloomooloo, NSW, Australia; [Collins, R.; Peto, R.] Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; [Collins, R.; Peto, R.] Epidemiol Studies Unit CTSU, Oxford, England; [Gonzalez, C. A.] Catalan Inst Oncol, Barcelona, Spain; [Lee, N.; Marchbanks, P.; Ory, H. W.; Peterson, H. B.; Wingo, P. A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Martin, N.; Silpisornkosol, S.; Theetranont, C.] Chiang Mai Univ, Chiang Mai, Thailand; [Boosiri, B.; Chutivongse, S.; Jimakorn, P.; Virutamasen, P.; Wongsrichanalai, C.] Chulalongkorn Univ, Bangkok, Thailand; [Goodman, M. T.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Lidegaard, O.; Kjaer, S. K.; Morch, L. S.] Copenhagen Univ Hosp, Copenhagen, Denmark; [Kjaer, S. K.; Tjonneland, A.] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Byers, T.] Colorado Sch Publ Hlth, Denver, CO USA; [Rohan, T.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Mosgaard, B.] Herlev Univ Hosp, Copenhagen, Denmark; [Vessey, M.; Yeates, D.] Dept Publ Hlth, Oxford, England; [Freudenheim, J. L.] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Titus, L. J.] Geisel Sch Med Dartmouth, Hanover, NH USA; [Chang-Claude, J.; Kaaks, R.] German Canc Res Ctr, Heidelberg, Germany; [Anderson, K. E.; Lazovich, D.; Robien, K.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Hampton, J.; Newcomb, P. A.; Rossing, M. A.; Thomas, D. B.; Weiss, N. S.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Lokkegaard, E.] Univ Copenhagen, Hillerod Hosp, DK-1168 Copenhagen, Denmark; [Riboli, E.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Clavel-Chapelon, F.] INSERM, U1018, Villejuif, France; [Clavel-Chapelon, F.] Paris South Univ, Inst Gustave Roussy, Villejuif, France; [Cramer, D.; Hankinson, S. E.; Tamimi, R. M.; Tworoger, S. S.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Franceschi, S.] Int Agcy Res Canc, F-69372 Lyon, France; [La Vecchia, C.; Negri, E.] Univ Milan, Ist Ric Farmacol Mario Negri, I-20122 Milan, Italy; [Adami, H. O.; Magnusson, C.; Riman, T.; Weiderpass, E.; Wolk, A.] Karolinska Inst, Stockholm, Sweden; [Schouten, L. J.; van den Brandt, P. A.] Maastricht Univ, NL-6200 MD Maastricht, Netherlands; [Chantarakul, N.; Koetsawang, S.; Rachawat, D.] Mahidol Univ, Bangkok 10700, Thailand; [Palli, D.] Canc Res & Prevent Inst, Florence, Italy; [Black, A.; Brinton, L. A.; Freedman, D. M.; Hartge, P.; Hsing, A. W.; Jnr, J. V. Lacey; Lissowska, J.; Hoover, R. N.; Schairer, C.] NCI, Bethesda, MD 20892 USA; [Babb, C.; Urban, M.] MRC, Canc Epidemiol Res Grp, Natl Hlth Lab Serv, Johannesburg, South Africa; [Graff-Iversen, S.; Selmer, R.] Norwegian Inst Publ Hlth, Oslo, Norway; [Bain, C. J.; Green, A. C.; Purdie, D. M.; Siskind, V.; Webb, P. M.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Bain, C. J.; Green, A. C.; Purdie, D. M.; Siskind, V.; Webb, P. M.] Univ Queensland, Brisbane, Qld, Australia; [Moysich, K.; McCann, S. E.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Hannaford, P.; Kay, C.] Royal Coll Gen Practitioners Oral Contracept Stud, London, England; [Binns, C. W.; Lee, A. H.; Zhang, M.] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Ness, R. B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Nasca, P.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Boston, MA 02125 USA; [Coogan, P. F.; Palmer, J. R.; Rosenberg, L.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Whittemore, A.] Stanford Univ, Stanford, CA 94305 USA; [Katsouyanni, K.; Trichopoulou, A.; Trichopoulos, D.; Tzonou, A.] Univ Athens, Sch Med, GR-11527 Athens, Greece; [Dabancens, A.; Martinez, L.; Molina, R.; Salas, O.] Univ Chile, Santiago, Chile; [Lurie, G.; Carney, M. E.; Wilkens, L. R.] Univ Hawaii, Honolulu, HI 96822 USA; [Hartman, L.; Manjer, J.; Olsson, H.] Univ Lund Hosp, S-22185 Lund, Sweden; [Kumle, M.] Univ Hosp North Norway, Tromso, Norway; [Grisso, J. A.; Morgan, M.; Wheeler, J. E.] Univ Penn, Philadelphia, PA 19104 USA; [Edwards, R. P.; Kelley, J. L.; Modugno, F.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Onland-Moret, N. C.; Peeters, P. H. M.] Univ Med Ctr, Utrecht, Netherlands; [Casagrande, J.; Pike, M. C.; Wu, A. H.] Univ So Calif, Los Angeles, CA USA; [Canfell, K.] Univ New S Wales, Sydney, NSW 2052, Australia; [Miller, A. B.] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Gram, I. T.; Lund, E.] Arctic Univ Tromso, Tromso, Norway; [McGowan, L.] George Washington Univ, Washington, DC USA; [Shu, X. O.; Zheng, W.] Vanderbilt Univ, Nashville, TN 37235 USA; [Farley, T. M. M.; Holck, S.; Meirik, O.] WHO, CH-1211 Geneva, Switzerland; [Risch, H. A.] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA	American Cancer Society; Australian National University; University of Oxford; Cancer Council New South Wales; Radcliffe Infirmary; University of Oxford; University of Oxford; Catalan Institute of Oncology; Centers for Disease Control & Prevention - USA; Chiang Mai University; Chulalongkorn University; Cedars Sinai Medical Center; University of Copenhagen; Danish Cancer Society; Colorado School of Public Health; Yeshiva University; Albert Einstein College of Medicine; University of Copenhagen; Herlev & Gentofte Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Dartmouth College; Helmholtz Association; German Cancer Research Center (DKFZ); University of Minnesota System; University of Minnesota Twin Cities; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Copenhagen; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Harvard University; World Health Organization; International Agency for Research on Cancer (IARC); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; Karolinska Institutet; Maastricht University; Mahidol University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Health Laboratory Service; Norwegian Institute of Public Health (NIPH); QIMR Berghofer Medical Research Institute; University of Queensland; Roswell Park Cancer Institute; Curtin University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Massachusetts System; University of Massachusetts Boston; Boston University; Stanford University; Athens Medical School; National & Kapodistrian University of Athens; Universidad de Chile; University of Hawaii System; Lund University; Skane University Hospital; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utrecht University; Utrecht University Medical Center; University of Southern California; University of New South Wales Sydney; University of Toronto; UiT The Arctic University of Tromso; George Washington University; Vanderbilt University; World Health Organization; Yale University	Gapstur, SM (corresponding author), NDPH, Canc Epidemiol Unit, Richard Doll Bldg, Oxford OX3 7LF, England.	collaborations@ceu.ox.ac.uk	de Villiers, Chantal Babb/AAL-3787-2021; Onland-Moret, N. Charlotte/G-9185-2011; dal maso, luigino/J-3616-2018; Green, Adele C/P-2736-2014; Katsouyanni, Klea/D-4856-2014; Brinton, Louise A/G-7486-2015; Weiderpass, Elisabete/AAP-2747-2021; Negri, Eva Vanna Lorenza/AAC-5698-2019; Webb, Penelope/D-5736-2013; Lissowska, Jolanta/AAH-3252-2020; franceschi, silvia/M-2452-2014; Green, Adele C/B-5324-2011; Weiderpass, Elisabete/M-4029-2016; Schouten, Leo J/AAB-2275-2019	de Villiers, Chantal Babb/0000-0003-1334-1819; Onland-Moret, N. Charlotte/0000-0002-2360-913X; dal maso, luigino/0000-0001-6163-200X; Green, Adele C/0000-0002-2753-4841; Katsouyanni, Klea/0000-0002-0132-9575; Brinton, Louise A/0000-0003-3853-8562; Weiderpass, Elisabete/0000-0003-2237-0128; Negri, Eva Vanna Lorenza/0000-0001-9712-8526; Webb, Penelope/0000-0003-0733-5930; Lissowska, Jolanta/0000-0003-2695-5799; franceschi, silvia/0000-0003-4181-8071; Weiderpass, Elisabete/0000-0003-2237-0128; Schouten, Leo J/0000-0003-3361-7560; Magnusson, Cecilia/0000-0002-8567-6725; Lokkegaard, Ellen/0000-0003-4149-5663; van den Brandt, Piet/0000-0001-8781-8099; Morch, Lina/0000-0001-6506-2569; Goodman, Marc/0000-0002-4839-3021; Olsson, Hakan/0000-0002-8794-9635; La Vecchia, Carlo/0000-0003-1441-897X; Riboli, Elio/0000-0001-6795-6080; Kjaer, Susanne/0000-0002-8347-1398	Medical Research Council, Cancer Research UK; Cancer Research UK; UK Medical Research Council; MRC [MC_U137686850] Funding Source: UKRI; Cancer Research UK [16896, 16491] Funding Source: researchfish; Medical Research Council [MC_U137686850] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011645] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [UM1CA182910, P30CA071789] Funding Source: NIH RePORTER	Medical Research Council, Cancer Research UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Cancer Research UK); Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Medical Research Council, Cancer Research UK.r The chief acknowledgment is to the participants and to the investigators in these studies. Data checking and analysis in the Oxford Cancer Epidemiology Unit was supported by Cancer Research UK and the UK Medical Research Council. Adrian Goodill drew the graphs.	Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Beral V, 2012, LANCET ONCOL, V13, P946, DOI [10.1016/S1470-2045(12)70322-4, 10.1016/S1470-2045(12)70365-0]; Beral V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001200; Beral V, 2007, LANCET, V369, P1703, DOI 10.1016/S0140-6736(07)60534-0; de Villiers TJ, 2013, CLIMACTERIC, V16, P316, DOI 10.3109/13697137.2013.795683; European Medicines Agency, GUID CLIN INV MED PR; Fritz APC., 2013, INT CLASSIFICATION D; International Agency for Research on Cancer, 2007, INT AG RES CANC MON, V91; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Medicines and Healthcare products Regulatory Agency (MHRA), HORM REPL THER SAF U; Morch LS, 2009, JAMA-J AM MED ASSOC, V302, P289; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Rodriguez C, 2001, JAMA-J AM MED ASSOC, V285, P1460, DOI 10.1001/jama.285.11.1460; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; US Food and Drug Administration, ESTR ESTR PROG THER	16	230	242	3	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1835	1842		10.1016/S0140-6736(14)61687-1	http://dx.doi.org/10.1016/S0140-6736(14)61687-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6ZE	25684585	hybrid, Green Published			2022-12-28	WOS:000354184500027
J	Zorzatto, C; Machado, JPB; Lopes, KVG; Nascimento, KJT; Pereira, WA; Brustolini, OJB; Reis, PAB; Calil, IP; Deguchi, M; Sachetto-Martins, G; Gouveia, BC; Loriato, VAP; Silva, MAC; Silva, FF; Santos, AA; Chory, J; Fontes, EPB				Zorzatto, Cristiane; Machado, Joao Paulo B.; Lopes, Kenia V. G.; Nascimento, Kelly J. T.; Pereira, Welison A.; Brustolini, Otavio J. B.; Reis, Pedro A. B.; Calil, Iara P.; Deguchi, Michihito; Sachetto-Martins, Gilberto; Gouveia, Bianca C.; Loriato, Virgilio A. P.; Silva, Marcos A. C.; Silva, Fabyano F.; Santos, Anesia A.; Chory, Joanne; Fontes, Elizabeth P. B.			NIK1-mediated translation suppression functions as a plant antiviral immunity mechanism	NATURE			English	Article							NUCLEAR SHUTTLE PROTEIN; DIFFERENTIAL EXPRESSION ANALYSIS; PUTATIVE TUMOR-SUPPRESSOR; GEMINIVIRUS; KINASE; ARABIDOPSIS; DEFENSE; STRESS; NIK; SEQUENCES	Plants and plant pathogens are subject to continuous co-evolutionary pressure for dominance, and the outcomes of these interactions can substantially impact agriculture and food security'. In virusplant interactions, one of the major mechanisms for plant antiviral immunity relies on RNA silencing, which is often suppressed by co-evolving virus suppressors, thus enhancing viral pathogenicity in susceptible hosts'. In addition, plants use the nucleotide-binding and leucine-rich repeat (NB-LRR) domain-containing resistance proteins, which recognize viral effectors to activate effector-triggered immunity in a defence mechanism similar to that employed in nonviral infections'''. Unlike most eukaryotic organisms, plants are not known to activate mechanisms of host global translation suppression to fight viruses'''. Here we demonstrate in Arabidopsis that the constitutive activation of NIK1, a leucine-rich repeat receptor-like kinase (LRR-RLK) identified as a virulence target of the begomovirus nuclear shuttle protein (NSP)(4-6), leads to global translation suppression and translocation of the downstream component RPL 10 to the nucleus, where it interacts with a newly identified MYB-like protein, Lb-INTERACTING MYB DOMAIN-CONTAINING PROTEIN (LIMYB), to downregulate translational machinery genes fully. LIMYB overexpression represses ribosomal protein genes at the transcriptional level, resulting in protein synthesis inhibition, decreased viral messenger RNA association with polysome fractions and enhanced tolerance to begomovirus. By contrast, the loss of LIMYB function releases the repression of translation-related genes and increases susceptibility to virus infection. Therefore, LIMYB links immune receptor LRR-RLK activation to global translation suppression as an antiviral immunity strategy in plants.	[Zorzatto, Cristiane; Machado, Joao Paulo B.; Lopes, Kenia V. G.; Nascimento, Kelly J. T.; Pereira, Welison A.; Brustolini, Otavio J. B.; Reis, Pedro A. B.; Calil, Iara P.; Deguchi, Michihito; Gouveia, Bianca C.; Loriato, Virgilio A. P.; Fontes, Elizabeth P. B.] Univ Fed Vicosa, Bioagro, Natl Inst Sci & Technol Plant Pest Interact, Dept Bioquim & Biol Mol, BR-36570000 Vicosa, MG, Brazil; [Zorzatto, Cristiane; Machado, Joao Paulo B.; Lopes, Kenia V. G.; Nascimento, Kelly J. T.; Pereira, Welison A.; Brustolini, Otavio J. B.; Reis, Pedro A. B.; Calil, Iara P.; Deguchi, Michihito; Sachetto-Martins, Gilberto; Gouveia, Bianca C.; Loriato, Virgilio A. P.; Silva, Marcos A. C.; Santos, Anesia A.; Chory, Joanne; Fontes, Elizabeth P. B.] Univ Fed Vicosa, Bioagro, Natl Inst Sci & Technol Plant Pest Interact, BR-36570000 Vicosa, MG, Brazil; [Sachetto-Martins, Gilberto] Univ Fed Rio de Janeiro, Dept Genet, BR-21944970 Rio De Janeiro, Brazil; [Silva, Fabyano F.] Univ Fed Vicosa, Dept Zootecnia, BR-36570000 Vicosa, MG, Brazil; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal do Rio de Janeiro; Universidade Federal de Vicosa; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Fontes, EPB (corresponding author), Univ Fed Vicosa, Bioagro, Natl Inst Sci & Technol Plant Pest Interact, Dept Bioquim & Biol Mol, BR-36570000 Vicosa, MG, Brazil.	bbfontes@ufv.br	Sachetto-Martins, Gilberto/AAT-4095-2021; Silva, Fabyano Fonseca/D-8158-2017; Silva, Fabyano/Y-9223-2019; Reis, Pedro Augusto Braga/U-4103-2019; Sachetto-Martins, Gilberto/AAN-6328-2020; Fontes, Elizabeth/K-3159-2012	Reis, Pedro Augusto Braga/0000-0003-2396-3662; Araujo Castro e Silva, Marcos/0000-0002-9873-3717; Fontes, Elizabeth/0000-0002-7986-1369	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [573600/2008-2, 470287/2011-0]; FAPEMIG [CBB-APQ-00070-09]; US National Institutes of Health [5R01-GM94428]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPq; CAPES; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094428] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was financially supported by the following grants from Brazilian government agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grants 573600/2008-2 and 470287/2011-0 (to E.P.B.F.) and FAPEMIG grant CBB-APQ-00070-09 (to E.P.B.F.); and by the US National Institutes of Health grant 5R01-GM94428 (to J.C.). O.J.B.B. was supported by a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) graduate fellowship; C.Z., K.V.G.L., J.P.B.M., I.P.C., B.C.G. and P.A.B.R. were supported by CNPq graduate fellowships; K.J.T.N., W.A.P. and M.D. were supported by postdoctoral fellowships from CNPq. A.A.S. was supported by postdoctoral fellowships from CAPES; and MACS. was the recipient of an undergraduate scholarship from CNPq. J.C. is an Investigator of the Howard Hughes Medical Institute.	Carvalho CM, 2008, PLANT J, V55, P869, DOI 10.1111/j.1365-313X.2008.03556.x; Carvalho CM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000247; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Costa MDL, 2008, J BIOL CHEM, V283, P20209, DOI 10.1074/jbc.M802654200; Delu-Filho N, 2000, PLANT PHYSIOL BIOCH, V38, P353, DOI 10.1016/S0981-9428(00)00752-X; DiCiccio TJ, 1996, STAT SCI, V11, P189; Florentino LH, 2006, J VIROL, V80, P6648, DOI 10.1128/JVI.00173-06; Fontes EPB, 2004, GENE DEV, V18, P2545, DOI 10.1101/gad.1245904; Hanley-Bowdoin L, 2013, NAT REV MICROBIOL, V11, P777, DOI 10.1038/nrmicro3117; Imafuku I, 1999, J CELL BIOL, V147, P121, DOI 10.1083/jcb.147.1.121; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawaguchi R, 2004, PLANT J, V38, P823, DOI 10.1111/j.1365-313X.2004.02090.x; Kawaguchi R, 2003, PLANT CELL ENVIRON, V26, P221, DOI 10.1046/j.1365-3040.2003.00952.x; Kim TH, 2004, PLANT CELL, V16, P3341, DOI 10.1105/tpc.104.026880; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mandadi KK, 2013, PLANT CELL, V25, P1489, DOI 10.1105/tpc.113.111658; Mariano AC, 2004, VIROLOGY, V318, P24, DOI 10.1016/j.virol.2003.09.038; MONTECLARO FS, 1993, P NATL ACAD SCI USA, V90, P6726, DOI 10.1073/pnas.90.14.6726; Oh HS, 2002, J BIOL CHEM, V277, P36489, DOI 10.1074/jbc.M201859200; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rocha CS, 2008, VIROLOGY, V380, P165, DOI 10.1016/j.virol.2008.08.005; Sakamoto T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-229; Santos Anesia A., 2008, V451, P563, DOI 10.1007/978-1-59745-102-4_39; Santos AA, 2010, J EXP BOT, V61, P3839, DOI 10.1093/jxb/erq219; Santos AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005781; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	33	128	135	4	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					679	U227		10.1038/nature14171	http://dx.doi.org/10.1038/nature14171			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25707794	Green Accepted, Green Published			2022-12-28	WOS:000353689700050
J	Stanczyk, NM; Behrens, RH; Chen-Hussey, V; Stewart, SA; Logan, JG				Stanczyk, Nina M.; Behrens, Ron H.; Chen-Hussey, Vanessa; Stewart, Sophie A.; Logan, James G.			Mosquito repellents for travellers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INSECT REPELLENTS; PERSONAL PROTECTION; EFFICACY; SAFETY; DEET; SUNSCREEN; CHILDREN		[Stanczyk, Nina M.; Behrens, Ron H.; Chen-Hussey, Vanessa; Logan, James G.] Univ London London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England; [Behrens, Ron H.] Hosp Trop Dis, London NW1 0PE, England; [Chen-Hussey, Vanessa; Stewart, Sophie A.; Logan, James G.] London Sch Hyg & Trop Med, Arthropod Control Prod Test Ctr, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Logan, JG (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England.	James.Logan@lshtm.ac.uk		Behrens, Ron/0000-0002-8166-2633				Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Chen-Hussey V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-173; Goodyer LI, 2010, J TRAVEL MED, V17, P182, DOI 10.1111/j.1708-8305.2010.00402.x; Ives AR, 2005, J AM MOSQUITO CONTR, V21, P213, DOI 10.2987/8756-971X(2005)21[213:TVBAAH]2.0.CO;2; Koren G, 2003, CAN MED ASSOC J, V169, P209; Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005; Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11; McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285; Menon KS, 2005, AM J IND MED, V47, P91, DOI 10.1002/ajim.20114; Montemarano AD, 1997, LANCET, V349, P1670, DOI 10.1016/S0140-6736(05)62637-2; Murphy ME, 2000, J AM ACAD DERMATOL, V43, P219, DOI 10.1067/mjd.2000.107960; Rajan TV, 2005, MED VET ENTOMOL, V19, P84, DOI 10.1111/j.0269-283X.2005.00544.x; Revay EE, 2013, ACTA TROP, V125, P226, DOI 10.1016/j.actatropica.2012.10.009; United States Environmental Protection Agency, 2004, SCI REV SUPP REG CLA; US Food and Drug Administration, 2012, INS REP US SAF CHILD; Webb CE, 2009, AUST NZ J PUBL HEAL, V33, P485, DOI 10.1111/j.1753-6405.2009.00435.x; WHO, 2004, IC WHO SPEC EV PUBL; WHO, 2009, GUID EFF TEST MOSQ R; WHO, 2006, ETH BUT IR3535 WHO S	19	15	15	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2015	350								h99	10.1136/bmj.h99	http://dx.doi.org/10.1136/bmj.h99			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WD	25698775	Green Accepted			2022-12-28	WOS:000349911600016
J	Ly, DP; Seabury, SA; Jena, AB				Ly, Dan P.; Seabury, Seth A.; Jena, Anupam B.			Divorce among physicians and other healthcare professionals in the United States: analysis of census survey data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BURNOUT; DOCTORS; SATISFACTION; CONFLICT; EARNINGS; GENDER; TRENDS; WOMEN	OBJECTIVES To estimate the prevalence and incidence of divorce among US physicians compared with other healthcare professionals, lawyers, and non-healthcare professionals, and to analyze factors associated with divorce among physicians. DESIGN Retrospective analysis of nationally representative surveys conducted by the US census, 2008-13. SETTING United States. PARTICIPANTS 48 881 physicians, 10 086 dentists, 13 883 pharmacists, 159 044 nurses, 18 920 healthcare executives, 59 284 lawyers, and 6 339 310 other non-healthcare professionals. MAIN OUTCOME MEASURES Logistic models of divorce adjusted for age, sex, race, annual income, weekly hours worked, number of years since marriage, calendar year, and state of residence. Divorce outcomes included whether an individual had ever been divorced (divorce prevalence) or became divorced in the past year (divorce incidence). RESULTS After adjustment for covariates, the probability of being ever divorced (or divorce prevalence) among physicians evaluated at the mean value of other covariates was 24.3% (95% confidence interval 23.8% to 24.8%); dentists, 25.2% (24.1% to 26.3%); pharmacists, 22.9% (22.0% to 23.8%); nurses, 33.0% (32.6% to 33.3%); healthcare executives, 30.9% (30.1% to 31.8%); lawyers, 26.9% (26.4% to 27.4%); and other non-healthcare professionals, 35.0% (34.9% to 35.1%). Similarly, physicians were less likely than those in most other occupations to divorce in the past year. In multivariable analysis among physicians, divorce prevalence was greater among women (odds ratio 1.51, 95% confidence interval 1.40 to 1.63). In analyses stratified by physician sex, greater weekly work hours were associated with increased divorce prevalence only for female physicians. CONCLUSIONS Divorce among physicians is less common than among non-healthcare workers and several health professions. Female physicians have a substantially higher prevalence of divorce than male physicians, which may be partly attributable to a differential effect of hours worked on divorce.	[Ly, Dan P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Seabury, Seth A.] Univ So Calif, Dept Emergency Med, Los Angeles, CA USA; [Seabury, Seth A.] Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; [Jena, Anupam B.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Cambridge, MA USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; University of Southern California; University of Southern California; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research	Jena, AB (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	jena@hcp.med.harvard.edu			Office of the Director, National Institutes of Health; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Office of the Director, National Institutes of Health.	Barnett RC, 2005, J WOMENS HEALTH, V14, P146, DOI 10.1089/jwh.2005.14.146; Bureau USC, 2005, NUMB TIM DUR MARR DI; Calnan M, 2001, SOC SCI MED, V52, P499, DOI 10.1016/S0277-9536(00)00155-6; Centers for Disease Control and Prevention, 2014, NAT MARR DIV RAT TRE; DERDEYN AP, 1979, INT J PSYCHIAT MED, V9, P297, DOI 10.2190/KMEA-3NBH-YMRT-GTYD; DOHERTY WJ, 1989, JAMA-J AM MED ASSOC, V261, P2374, DOI 10.1001/jama.261.16.2374; Dyrbye LN, 2011, ARCH INTERN MED, V171, P1207, DOI 10.1001/archinternmed.2011.289; Dyrbye LN, 2011, ARCH SURG-CHICAGO, V146, P211, DOI 10.1001/archsurg.2010.310; Dyrbye LN, 2010, J AM COLL SURGEONS, V211, P663, DOI 10.1016/j.jamcollsurg.2010.03.032; GABBARD GO, 1987, AM J PSYCHIAT, V144, P567; Innstrand ST, 2011, INT ARCH OCC ENV HEA, V84, P813, DOI 10.1007/s00420-011-0667-y; Johnson J, 2004, TOP EC ANAL POLICY, V4; Lambert TW, 1998, MED EDUC, V32, P533, DOI 10.1046/j.1365-2923.1998.00244.x; Langballe EM, 2011, STRESS HEALTH, V27, P73, DOI 10.1002/smi.1321; Linzer Mark, 2002, J Am Med Womens Assoc (1972), V57, P191; Myers M F, 1998, Med Econ, V75, P100; MYERS MF, 1984, AM J PSYCHIAT, V141, P1386; Myers MF, 2001, WESTERN J MED, V174, P30, DOI 10.1136/ewjm.174.1.30; Myers MF, 1998, MED ECON, V75, p[100, 09]; Orton P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000274; Panagopoulou E, 2006, EUR J INTERN MED, V17, P195, DOI 10.1016/j.ejim.2005.11.013; RAMIREZ AJ, 1995, BRIT J CANCER, V71, P1263, DOI 10.1038/bjc.1995.244; RELMAN AS, 1989, NEW ENGL J MED, V321, P1540, DOI 10.1056/NEJM198911303212209; Ro KEI, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2004; Rollman BL, 1997, NEW ENGL J MED, V336, P800, DOI 10.1056/NEJM199703133361112; ROSE KD, 1972, CALIF MED, V116, P95; Schroen AT, 2004, ACAD MED, V79, P310, DOI 10.1097/00001888-200404000-00006; Seabury SA, 2013, JAMA INTERN MED, V173, P1748; Seabury SA, 2012, JAMA-J AM MED ASSOC, V308, P2083, DOI 10.1001/jama.2012.14552; Shanafelt TD, 2013, MAYO CLIN PROC, V88, P216, DOI 10.1016/j.mayocp.2012.11.021; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; Sobecks NW, 1999, ANN INTERN MED, V130, P312, DOI 10.7326/0003-4819-130-4-199902160-00017; Soler JK, 2008, FAM PRACT, V25, P245, DOI 10.1093/fampra/cmn038; SPANIER GB, 1979, J SEX MARITAL THER, V5, P288, DOI 10.1080/00926237908403734; US Census Bureau, 2014, FACT SHEET DIFF CPS; VAILLANT GE, 1972, NEW ENGL J MED, V287, P372, DOI 10.1056/NEJM197208242870802; Warde CM, 1999, J GEN INTERN MED, V14, P157, DOI 10.1046/j.1525-1497.1999.00307.x	37	38	38	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2015	350								h706	10.1136/bmj.h706	http://dx.doi.org/10.1136/bmj.h706			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB8WC	25694110	hybrid, Green Published			2022-12-28	WOS:000349911500006
J	Ma, YS; Olendzki, BC; Wang, JS; Persuitte, GM; Li, WJ; Fang, H; Merriam, PA; Wedick, NM; Ockene, IS; Culver, AL; Schneider, KL; Olendzki, GF; Carmody, J; Ge, TJ; Zhang, ZY; Pagoto, SL				Ma, Yunsheng; Olendzki, Barbara C.; Wang, Jinsong; Persuitte, Gioia M.; Li, Wenjun; Fang, Hua; Merriam, Philip A.; Wedick, Nicole M.; Ockene, Ira S.; Culver, Annie L.; Schneider, Kristin L.; Olendzki, Gin-Fei; Carmody, James; Ge, Tingjian; Zhang, Zhiying; Pagoto, Sherry L.			Single-Component Versus Multicomponent Dietary Goals for the Metabolic Syndrome A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SEASONAL-VARIATION; PHYSICAL-ACTIVITY; BEHAVIOR CHANGES; NATIONAL-HEALTH; FIBER; ASSOCIATION; RISK; INTERVENTION; PREVENTION; MANAGEMENT	Background: Few studies have compared diets to determine whether a program focused on 1 dietary change results in collateral effects on other untargeted healthy diet components. Objective: To evaluate a diet focused on increased fiber consumption versus the multicomponent American Heart Association (AHA) dietary guidelines. Design: Randomized, controlled trial from June 2009 to January 2014. (ClinicalTrials.gov: NCT00911885) Setting: Worcester, Massachusetts. Participants: 240 adults with the metabolic syndrome. Intervention: Participants engaged in individual and group sessions. Measurements: Primary outcome was weight change at 12 months. Results: At 12 months, mean change in weight was -2.1 kg (95% CI, -2.9 to -1.3 kg) in the high-fiber diet group versus -2.7 kg (CI, -3.5 to -2.0 kg) in the AHA diet group. The mean between-group difference was 0.6 kg (CI, -0.5 to 1.7 kg). During the trial, 12 (9.9%) and 15 (12.6%) participants dropped out of the high-fiber and AHA diet groups, respectively (P = 0.55). Eight participants developed diabetes (hemoglobin A(1c) level >= 6.5%) during the trial: 7 in the high-fiber diet group and 1 in the AHA diet group (P = 0.066). Limitations: Generalizability is unknown. Maintenance of weight loss after cessation of group sessions at 12 months was not assessed. Definitive conclusions cannot be made about dietary equivalence because the study was powered for superiority. Conclusion: The more complex AHA diet may result in up to 1.7 kg more weight loss; however, a simplified approach to weight reduction emphasizing only increased fiber intake may be a reasonable alternative for persons with difficulty adhering to more complicated diet regimens.	[Ma, Yunsheng; Olendzki, Barbara C.; Persuitte, Gioia M.; Li, Wenjun; Merriam, Philip A.; Wedick, Nicole M.; Culver, Annie L.; Olendzki, Gin-Fei; Carmody, James; Zhang, Zhiying; Pagoto, Sherry L.] Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, Worcester, MA 01655 USA; [Wang, Jinsong] Yangzhou Univ, Coll Med, Dept Prevent Med, Yangzhou 225001, Jiangsu, Peoples R China; [Fang, Hua] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Div Biostat, Worcester, MA 01655 USA; [Fang, Hua] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Hlth Serv Res, Worcester, MA 01655 USA; [Ockene, Ira S.] Univ Massachusetts, Sch Med, Div Cardiovasc Med, Dept Med, Worcester, MA 01655 USA; [Schneider, Kristin L.] Univ Med & Sci, Dept Psychol, N Chicago, IL 60064 USA; [Ge, Tingjian] Univ Massachusetts, Dept Comp Sci, Lowell, MA 01854 USA	University of Massachusetts System; University of Massachusetts Worcester; Yangzhou University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Lowell	Ma, YS (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, 55 Lake Ave North, Worcester, MA 01655 USA.	Yunsheng.Ma@umassmed.edu	Olendzki, Barbara/K-1067-2019; Olendzki, Barbara/AAQ-9077-2020; Li, Wenjun/F-5634-2015; Ma, Yunsheng/D-9665-2016	Olendzki, Barbara/0000-0003-4307-5187; Li, Wenjun/0000-0001-5335-7386; Ma, Yunsheng/0000-0003-2317-3716	National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL124366, R01HL094575] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.	Ajani UA, 2004, J NUTR, V134, P1181, DOI 10.1093/jn/134.5.1181; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; BLOCK G, 1992, J AM DIET ASSOC, V92, P969; Carpenter JR, 2013, J BIOPHARM STAT, V23, P1352, DOI 10.1080/10543406.2013.834911; Chuwa EWL, 2006, BRIT J SURG, V93, P3, DOI 10.1002/bjs.5249; Feldeisen SE, 2007, APPL PHYSIOL NUTR ME, V32, P46, DOI [10.1139/H06-101, 10.1139/h06-101]; Feng CY, 2013, STAT MED, V32, P230, DOI 10.1002/sim.5486; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; King DE, 2003, AM J CARDIOL, V92, P1335, DOI 10.1016/j.amjcard.2003.08.020; Lappalainen R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-310; Lichtenstein A, 2006, CIRCULATION, V114, pE629, DOI 10.1161/CIRCULATIONAHA.106.180281; Ma Y, 2006, EUR J CLIN NUTR, V60, P519, DOI 10.1038/sj.ejcn.1602346; Ma YS, 2006, AM J CLIN NUTR, V83, P760, DOI 10.1093/ajcn/83.4.760; Ma YS, 2008, NUTRITION, V24, P941, DOI 10.1016/j.nut.2008.04.005; Marlett JA, 2002, J AM DIET ASSOC, V102, P993, DOI 10.1016/S0002-8223(02)90228-2; Matthews CE, 2000, MED SCI SPORT EXER, V32, P976; Matthews CE, 2001, AM J EPIDEMIOL, V153, P172, DOI 10.1093/aje/153.2.172; Matthews CE, 2001, AM J EPIDEMIOL, V153, P987, DOI 10.1093/aje/153.10.987; McCullough ML, 2006, PUBLIC HEALTH NUTR, V9, P152, DOI 10.1079/PHN2005938; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Merriam PA, 1999, J BIOL RHYTHM, V14, P330, DOI 10.1177/074873099129000669; Merriam PA, 2012, J ACAD NUTR DIET, V112, P621, DOI 10.1016/j.jand.2012.01.024; Ockene IS, 2012, AM J PUBLIC HEALTH, V102, P336, DOI 10.2105/AJPH.2011.300357; Ockene IS, 2002, J AM COLL CARDIOL, V40, P630, DOI 10.1016/S0735-1097(02)02078-8; Pagoto S, 2007, HLTH PSYCHOL S1, V27, pS91; Pagoto SL, 2013, JAMA-J AM MED ASSOC, V310, P687, DOI 10.1001/jama.2013.8601; Park Y, 2005, JAMA-J AM MED ASSOC, V294, P2849, DOI 10.1001/jama.294.22.2849; Pearson TA, 2013, CIRCULATION, V127, P1730, DOI 10.1161/CIR.0b013e31828f8a94; Roger JH, 2014, SAS CODE SENSITIVITY; Ryan P., 1999, STATA TECHNICAL B, V50, P36; Spring B, 2012, ARCH INTERN MED, V172, P789, DOI 10.1001/archinternmed.2012.1044; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	36	28	30	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4					248	+		10.7326/M14-0611	http://dx.doi.org/10.7326/M14-0611			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686165	Green Accepted			2022-12-28	WOS:000350232500014
J	March, L				March, Lyn			Review: In knee or hip OA, opioids reduce pain and improve function but increase adverse events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[March, Lyn] Univ Sydney, Inst Bone & Joint Res, St Leonards, NSW, Australia; [March, Lyn] Royal N Shore Hosp, St Leonards, NSW 2065, Australia	University of Sydney; Royal North Shore Hospital	March, L (corresponding author), Univ Sydney, Inst Bone & Joint Res, St Leonards, NSW, Australia.								0	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4							JC8	10.7326/ACPJC-2015-162-4-008	http://dx.doi.org/10.7326/ACPJC-2015-162-4-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686195				2022-12-28	WOS:000350232500011
J	Sedgwick, P				Sedgwick, Philip			Standard deviation or the standard error of the mean	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2010, BMJ-BRIT MED J, V340, pc1116; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5721; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5310; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1343; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7534; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6533; Walsh Jennifer M, 2012, BMJ, V345, pe5605, DOI 10.1136/bmj.e5605	7	4	4	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2015	350								h831	10.1136/bmj.h831	http://dx.doi.org/10.1136/bmj.h831			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WB	25691433				2022-12-28	WOS:000349911400010
J	Szummer, K; Oldgren, J; Lindhagen, L; Carrero, JJ; Evans, M; Spaak, J; Edfors, R; Jacobson, SH; Andel, P; Wallentin, L; Jernberg, T				Szummer, Karolina; Oldgren, Jonas; Lindhagen, Lars; Carrero, Juan Jesus; Evans, Marie; Spaak, Jonas; Edfors, Robert; Jacobson, Stefan H.; Andel, Pontus; Wallentin, Lars; Jernberg, Tomas			Association Between the Use of Fondaparinux vs Low-Molecular-Weight Heparin and Clinical Outcomes in Patients With Non-ST-Segment Elevation Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; ENOXAPARIN; EQUATION; SAFETY; DRONEDARONE; EFFICACY; IMPACT; DIET	IMPORTANCE Fondaparinux was associated with reduced major bleeding events and improved survival compared with low-molecular-weight heparin (LMWH) in a large randomized clinical trial involving patients with non-ST-segment elevation myocardial infarction (NSTEMI). Large-scale experience of the use of fondaparinux vs LMWH in a nontrial setting is lacking. OBJECTIVE To study the association between the use of fondaparinux vs LMWH and outcomes in patients with NSTEMI in Sweden. DESIGN, SETTING, AND PATIENTS Prospective multicenter cohort study from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies registry involving 40 616 consecutive patients with NSTEMI who received fondaparinux or LMWH between September 1, 2006, through June 30, 2010, with the last follow-up on December 31, 2010. EXPOSURES In-hospital treatment with fondaparinux or LMWH during the hospital stay. MAIN OUTCOMES AND MEASURES In-hospital severe bleeding events and death and 30- and 180-day death, MI, stroke, and major bleeding events. Logistic regression models adjusted for calendar time, admitting hospital, baseline characteristics, and in-hospital revascularization. RESULTS In total, 14 791 patients (36.4%) were treated with fondaparinux and 25 825 (63.6%) with LMWH. One hundred sixty-five patients (1.1%) in the fondaparinux group vs 461 patients (1.8%) in the LMWH group experienced in-hospital bleeding events (adjusted odds ratio [OR], 0.54; 95% CI, 0.42-0.70). A total of 394 patients (2.7%) in the fondaparinux group died while in the hospital vs 1022(4.0%) in the LMWH group (adjusted OR, 0.75; 95% CI, 0.63-0.89). The differences in major bleeding events and mortality between the 2 treatments were similar at 30 and 180 days. There were no significant differences in the number of recurrent MI and stroke events at 30 or 180 days among the 2 treatment groups. CONCLUSIONS AND RELEVANCE In routine clinical care of patients with NSTEMI, fondaparinux was associated with lower odds than LMWH of major bleeding events and death both in-hospital and up to 180 days afterward.	[Szummer, Karolina; Edfors, Robert; Jernberg, Tomas] Dept Med, Cardiol Sect, Huddinge, Sweden; [Szummer, Karolina; Edfors, Robert; Jernberg, Tomas] Karolinska Inst, Karolinska Univ Hosp, S-14186 Huddinge, Sweden; [Oldgren, Jonas; Lindhagen, Lars; Wallentin, Lars] Uppsala Clin Res Ctr, Uppsala, Sweden; [Oldgren, Jonas; Wallentin, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Carrero, Juan Jesus; Evans, Marie] Karolinska Inst, CLINTEC, Div Renal Med, S-14186 Stockholm, Sweden; [Spaak, Jonas] Karolinska Inst, Danderyd Hosp, Div Cardiovasc Med, S-14186 Stockholm, Sweden; [Jacobson, Stefan H.] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Nephrol, S-14186 Stockholm, Sweden; [Andel, Pontus] Lund Univ, Dept Cardiol, Lund, Sweden	Karolinska Institutet; Karolinska University Hospital; Uppsala University; Uppsala University; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Lund University	Szummer, K (corresponding author), Karolinska Univ Hosp, Dept Med, Dept Cardiol, Huddinge, Sweden.	karolina.szummer@karolinska.se	Edfors, Robert Lars/GQQ-1419-2022; Andell, Pontus/N-9979-2014	Andell, Pontus/0000-0002-2759-1379; Jernberg, Tomas/0000-0003-1695-379X; Evans, Marie/0000-0001-8650-5795; Carrero, Juan Jesus/0000-0003-4763-2024; Edfors, Robert/0000-0003-2377-436X	Swedish Foundation for Strategic Research; Swedish Heart and Lung Foundation; ALF Medicin; Swedish Medical Research Council	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); ALF Medicin; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This work was supported by a grant from the Swedish Foundation for Strategic Research, the Swedish Heart and Lung Foundation, ALF Medicin (the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet; Drs Szummer, Evans, Carrero), the Swedish Medical Research Council (Dr Carrero).	Anderson JAM, 2010, J THROMB HAEMOST, V8, P243, DOI 10.1111/j.1538-7836.2009.03705.x; Anderson JL, 2013, J AM COLL CARDIOL, V61, pE179, DOI 10.1016/j.jacc.2013.01.014; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Fox KAA, 2007, ANN INTERN MED, V147, P304, DOI 10.7326/0003-4819-147-5-200709040-00005; Fraser SGaM, 2009, PROP SCOR AN STAT ME; Friberg L, 2014, J AM COLL CARDIOL, V63, P2376, DOI 10.1016/j.jacc.2014.02.601; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hohnloser SH, 2014, J AM COLL CARDIOL, V63, P2385, DOI 10.1016/j.jacc.2014.03.024; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Mehran R, 2010, J AM COLL CARDIOL, V55, P2556, DOI 10.1016/j.jacc.2009.09.076; Mehta SR, 2007, J AM COLL CARDIOL, V50, P1742, DOI 10.1016/j.jacc.2007.07.042; Rao SV, 2005, AM J CARDIOL, V96, P1200, DOI 10.1016/j.amjcard.2005.06.056; Santopinto JJ, 2003, HEART, V89, P1003, DOI 10.1136/heart.89.9.1003; Skali H, 2011, AM HEART J, V162, P548, DOI 10.1016/j.ahj.2011.06.006; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yusuf S, 2006, NEW ENGL J MED, V354, P1464	20	25	28	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					707	716		10.1001/jama.2015.517	http://dx.doi.org/10.1001/jama.2015.517			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25688782				2022-12-28	WOS:000349476100016
J	Suda, M; Kato, R; Yamamoto, HM				Suda, Masayuki; Kato, Reizo; Yamamoto, Hiroshi M.			Light-induced superconductivity using a photoactive electric double layer	SCIENCE			English	Article							INSULATOR; DEVICES; TRANSISTORS; INTERFACES; GRAPHENE; FILM	Electric double layers (EDLs) of ionic liquids have been used in superconducting field-effect transistors as nanogap capacitors. Because of the freezing of the ionic motion below similar to 200 kelvin, modulations of the carrier density have been limited to the high-temperature regime. Here we observe carrier-doping-induced superconductivity in an organic Mott insulator with a photoinduced EDL based on a photochromic spiropyran monolayer. Because the spiropyran can isomerize reversibly between nonionic and zwitterionic isomers through photochemical processes, two distinct built-in electric fields can modulate the carrier density even at cryogenic conditions.	[Suda, Masayuki; Yamamoto, Hiroshi M.] Natl Inst Nat Sci, Inst Mol Sci, Res Ctr Integrat Mol Syst CIMoS, Okazaki, Aichi 4448585, Japan; [Suda, Masayuki; Kato, Reizo; Yamamoto, Hiroshi M.] RIKEN, Wako, Saitama 3510198, Japan	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); RIKEN	Suda, M (corresponding author), Natl Inst Nat Sci, Inst Mol Sci, Res Ctr Integrat Mol Syst CIMoS, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	msuda@ims.ac.jp; yhiroshi@ims.ac.jp	Suda, Masayuki/H-6233-2016; Yamamoto, Hiroshi/T-5955-2019; Yamamoto, Hiroshi/F-3839-2012; Kato, Reizo/I-1073-2014	Suda, Masayuki/0000-0003-0869-2366; Yamamoto, Hiroshi/0000-0002-5686-5156; Yamamoto, Hiroshi/0000-0002-5686-5156; Kato, Reizo/0000-0002-2606-4657	Japan Society for the Promotion of Science (JSPS) [22224006]; Grants-in-Aid for Scientific Research [22224006] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this work was provided by Grants-in-Aid for Scientific Research (S) (no. 22224006) from the Japan Society for the Promotion of Science (JSPS).	Ashkenasy G, 2002, ACCOUNTS CHEM RES, V35, P121, DOI 10.1021/ar990047t; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Cahen D, 2005, ADV FUNCT MATER, V15, P1571, DOI 10.1002/adfm.200500187; Campbell IH, 1997, APPL PHYS LETT, V71, P3528, DOI 10.1063/1.120381; Carmeli I, 2012, ANGEW CHEM INT EDIT, V51, P7162, DOI 10.1002/anie.201201606; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Fujimoto T, 2013, PHYS CHEM CHEM PHYS, V15, P8983, DOI 10.1039/c3cp50755f; Ikegami A, 2010, ANGEW CHEM INT EDIT, V49, P372, DOI 10.1002/anie.200904548; Ishii H, 1999, ADV MATER, V11, P605, DOI 10.1002/(SICI)1521-4095(199906)11:8<605::AID-ADMA605>3.0.CO;2-Q; Jang AR, 2012, ACS NANO, V6, P9207, DOI 10.1021/nn303539y; Kanoda K, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.051007; KATO R, 1987, CHEM LETT, P507, DOI 10.1246/cl.1987.507; Kawasugi Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.116801; Kawasugi Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2949316; Kim M, 2012, NANO LETT, V12, P182, DOI 10.1021/nl2032734; Minkin VI, 2004, CHEM REV, V104, P2751, DOI 10.1021/cr020088u; Ono S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3079401; Orgiu E, 2014, ADV MATER, V26, P1827, DOI 10.1002/adma.201304695; Schmickler W, 1996, CHEM REV, V96, P3177, DOI 10.1021/cr940408c; Shinaoka H, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.034701; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Suzuki M, 2002, PHYS CHEM CHEM PHYS, V4, P185, DOI 10.1039/b108108j; Tamai N, 2000, CHEM REV, V100, P1875, DOI 10.1021/cr9800816; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Ueno K, 2011, NAT NANOTECHNOL, V6, P408, DOI [10.1038/nnano.2011.78, 10.1038/NNANO.2011.78]; Yamamoto HM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3379; Ye JT, 2012, SCIENCE, V338, P1193, DOI 10.1126/science.1228006; Ye JT, 2010, NAT MATER, V9, P125, DOI [10.1038/NMAT2587, 10.1038/nmat2587]; Zhang HT, 2011, NANO LETT, V11, P4939, DOI 10.1021/nl2028798	29	66	66	9	334	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					743	746		10.1126/science.1256783	http://dx.doi.org/10.1126/science.1256783			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678657				2022-12-28	WOS:000349221300041
J	Hanack, C; Moroni, M; Lima, WC; Wende, H; Kirchner, M; Adelfinger, L; Schrenk-Siemens, K; Tappe-Theodor, A; Wetzel, C; Kuich, PH; Gassmann, M; Roggenkamp, D; Bettler, B; Lewin, GR; Selbach, M; Siemens, J				Hanack, Christina; Moroni, Mirko; Lima, Wanessa C.; Wende, Hagen; Kirchner, Marieluise; Adelfinger, Lisa; Schrenk-Siemens, Katrin; Tappe-Theodor, Anke; Wetzel, Christiane; Kuich, P. Henning; Gassmann, Martin; Roggenkamp, Dennis; Bettler, Bernhard; Lewin, Gary R.; Selbach, Matthias; Siemens, Jan			GABA Blocks Pathological but Not Acute TRPV1 Pain Signals	CELL			English	Article							DORSAL-ROOT GANGLIA; NERVE GROWTH-FACTOR; CAPSAICIN RECEPTOR; THERMAL HYPERALGESIA; INFLAMMATORY PAIN; SENSORY NEURONS; SPINAL-CORD; PROTEIN; SENSITIZATION; SUBUNITS	Sensitization of the capsaicin receptor TRPV1 is central to the initiation of pathological forms of pain, and multiple signaling cascades are known to enhance TRPV1 activity under inflammatory conditions. How might detrimental escalation of TRPV1 activity be counteracted? Using a genetic-proteomic approach, we identify the GABA(B1) receptor subunit as bona fide inhibitor of TRPV1 sensitization in the context of diverse inflammatory settings. We find that the endogenous GABAB agonist, GABA, is released from nociceptive nerve terminals, suggesting an autocrine feedback mechanism limiting TRPV1 sensitization. The effect of GABAB on TRPV1 is independent of canonical G protein signaling and rather relies on close juxtaposition of the GABA(B1) receptor subunit and TRPV1. Activating the GABA(B1) receptor subunit does not attenuate normal functioning of the capsaicin receptor but exclusively reverts its sensitized state. Thus, harnessing this mechanism for anti-pain therapy may prevent adverse effects associated with currently available TRPV1 blockers.	[Hanack, Christina; Lima, Wanessa C.; Wende, Hagen; Schrenk-Siemens, Katrin; Tappe-Theodor, Anke; Siemens, Jan] Heidelberg Univ, Dept Pharmacol, D-69120 Heidelberg, Germany; [Hanack, Christina; Moroni, Mirko; Kirchner, Marieluise; Wetzel, Christiane; Kuich, P. Henning; Lewin, Gary R.; Selbach, Matthias] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Adelfinger, Lisa; Gassmann, Martin; Bettler, Bernhard] Univ Basel, Dept Biomed, CH-4056 Basel, Switzerland; [Roggenkamp, Dennis] Beiersdorf AG, Res & Dev, D-20245 Hamburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Basel; Beiersdorf AG	Siemens, J (corresponding author), Heidelberg Univ, Dept Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	jan.siemens@pharma.uni-heidelberg.de	Moroni, Mirko/Q-1524-2018; Lewin, Gary R/B-8028-2011; bettler, bernhard/AAO-8018-2020	Wende, Hagen/0000-0002-9168-8095; Bettler, Bernhard/0000-0003-0842-8207; Siemens, Jan/0000-0001-9051-9217; Wetzel, Christiane/0000-0003-0587-8018; Lewin, Gary/0000-0002-2890-6352; Gassmann, Martin/0000-0001-6201-3032	European Research Council [ERC-2011-StG-280565, ERC-2011-AdG-294678]; Alexander von Humboldt Foundation/BMBF; National Center for Competences in Research "Synapsy, Synaptic Bases of Mental Health Disease'' Swiss National Science Foundation [3100A0-117816]	European Research Council(European Research Council (ERC)European Commission); Alexander von Humboldt Foundation/BMBF; National Center for Competences in Research "Synapsy, Synaptic Bases of Mental Health Disease'' Swiss National Science Foundation	We thank David Julius, Rohini Kuner, Thomas Muller, Bjorn Schroder, Christoph Stein, Gerd Zolles, and Bernd Fakler for critical tools and reagents. We also thank Jana Rossius and Christina Steinmeyer-Stannek for expert technical support and Christopher Bohlen for helpful criticism and reading of the manuscript. This work was supported by the European Research Council (ERC-2011-StG-280565 to J.S. and ERC-2011-AdG-294678 to G.R.L.) and the Alexander von Humboldt Foundation/BMBF to M.M. and J.S. Additional support came from the National Center for Competences in Research "Synapsy, Synaptic Bases of Mental Health Disease'' Swiss National Science Foundation (3100A0-117816) to B.B. Dr. Roggenkamp is an employee of Beiersdorf AG.	Adelfinger L, 2014, BIOCHEM PHARMACOL, V91, P369, DOI 10.1016/j.bcp.2014.07.013; Ayoub MA, 2010, CURR OPIN PHARMACOL, V10, P44, DOI 10.1016/j.coph.2009.09.012; Binet V, 2004, J BIOL CHEM, V279, P29085, DOI 10.1074/jbc.M400930200; Bonnington JK, 2003, J PHYSIOL-LONDON, V551, P433, DOI 10.1113/jphysiol.2003.039990; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Casanova E, 2009, GENESIS, V47, P595, DOI 10.1002/dvg.20535; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Charles KJ, 2001, NEUROSCIENCE, V106, P447, DOI 10.1016/S0306-4522(01)00296-2; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Fischer MJM, 2013, J NEUROSCI, V33, P7407, DOI 10.1523/JNEUROSCI.3721-12.2013; Forster AB, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-17; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Gu QH, 2003, J NEUROPHYSIOL, V89, P1985, DOI 10.1152/jn.00748.2002; Haller C, 2004, GENESIS, V40, P125, DOI 10.1002/gene.20073; Huang JH, 2006, CURR NEUROPHARMACOL, V4, P197, DOI 10.2174/157015906778019554; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Laffray S, 2007, EUR J NEUROSCI, V25, P1402, DOI 10.1111/j.1460-9568.2007.05398.x; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Loo L, 2012, J NEUROSCI, V32, P11942, DOI 10.1523/JNEUROSCI.1330-12.2012; Lopshire JC, 1998, J NEUROSCI, V18, P6081; Lu FF, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-41; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Miller KE, 2011, PHARMACOL THERAPEUT, V130, P283, DOI 10.1016/j.pharmthera.2011.01.005; Moriyama T, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-3; Padgett CL, 2010, ADV PHARMACOL, V58, P123, DOI 10.1016/S1054-3589(10)58006-2; Pagano A, 2001, J NEUROSCI, V21, P1189; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Por ED, 2012, J BIOL CHEM, V287, P37552, DOI 10.1074/jbc.M112.391847; Rutter AR, 2005, NEUROREPORT, V16, P1735, DOI 10.1097/01.wnr.0000185958.03841.0f; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sokal DM, 2003, BRAIN RES, V987, P67, DOI 10.1016/S0006-8993(03)03255-4; Sudo Y, 2012, SYNAPSE, V66, P759, DOI 10.1002/syn.21565; Szallasi A, 2012, EXPERT OPIN INV DRUG, V21, P1351, DOI 10.1517/13543784.2012.704021; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Towers S, 2000, EUR J NEUROSCI, V12, P3201, DOI 10.1046/j.1460-9568.2000.00237.x; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Woolf CJ, 2010, NAT MED, V16, P1241, DOI 10.1038/nm.2230	47	88	92	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					759	770		10.1016/j.cell.2015.01.022	http://dx.doi.org/10.1016/j.cell.2015.01.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25679765	Bronze			2022-12-28	WOS:000349208800017
J	Krull, W				Krull, Wilhelm			Hubert Markl (1938-2015) OBITUARY	NATURE			English	Biographical-Item									Volkswagen Fdn, Hannover, Germany	Volkswagen; Volkswagen Germany	Krull, W (corresponding author), Volkswagen Fdn, Hannover, Germany.	krull@volkswagenstiftung.de						MARKL H, PUBLICATION LIST	1	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					168	168		10.1038/518168a	http://dx.doi.org/10.1038/518168a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25673406	Bronze			2022-12-28	WOS:000349190300021
J	Pineda, CT; Ramanathan, S; Tacer, KF; Weon, JL; Potts, MB; Ou, YH; White, MA; Potts, PR				Pineda, Carlos T.; Ramanathan, Saumya; Tacer, Klementina Fon; Weon, Jenny L.; Potts, Malia B.; Ou, Yi-Hung; White, Michael A.; Potts, Patrick Ryan			Degradation of AMPK by a Cancer-Specific Ubiquitin Ligase	CELL			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-SUPPRESSOR LKB1; MAGE-A; CANCER/TESTIS ANTIGENS; BREAST-CANCER; ENERGY SENSOR; PHOSPHORYLATION; METABOLISM; AUTOPHAGY; GROWTH	AMP-activated protein kinase (AMPK) is a master sensor and regulator of cellular energy status. Upon metabolic stress, AMPK suppresses anabolic and promotes catabolic processes to regain energy homeostasis. Cancer cells can occasionally suppress the growth-restrictive AMPK pathway by mutation of an upstream regulatory kinase. Here, we describe a widespread mechanism to suppress AMPK through its ubiquitination and degradation by the cancer-specific MAGE-A3/6-TRIM28 ubiquitin ligase. MAGE-A3 and MAGE-A6 are highly similar proteins normally expressed only in the male germline but frequently re-activated in human cancers. MAGE-A3/6 are necessary for cancer cell viability and are sufficient to drive tumorigenic properties of non-cancerous cells. Screening for targets of MAGE-A3/6-TRIM28 revealed that it ubiquitinates and degrades AMPK alpha 1. This leads to inhibition of autophagy, activation of mTOR signaling, and hypersensitization to AMPK agonists, such as metformin. These findings elucidate a germline mechanism commonly hijacked in cancer to suppress AMPK.	[Pineda, Carlos T.; Ramanathan, Saumya; Tacer, Klementina Fon; Weon, Jenny L.; Potts, Patrick Ryan] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Potts, Malia B.; Ou, Yi-Hung; White, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Potts, Patrick Ryan] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Potts, Patrick Ryan] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Potts, PR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	ryan.potts@utsouthwestern.edu	Weon, Jenny/GWQ-5772-2022; Potts, Patrick R/P-4707-2018; 高, 雨莉/HGU-8187-2022; Potts, Malia B/N-8130-2018	Potts, Patrick R/0000-0002-2024-8885; Potts, Malia B/0000-0002-8308-1963; Weon, Jenny/0000-0002-4815-6659; Ou, Yi-Hung/0000-0002-9909-7791	NIH Pharmacological Sciences Training Grant [GM007062]; Michael L. Rosenberg Scholar in Medical Research fund; DOD Discovery Award [W81XWH-12-1-0446]; WELCH Foundation [I-1821]; CPRIT [R1117]; NATIONAL CANCER INSTITUTE [R01CA071443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062] Funding Source: NIH RePORTER	NIH Pharmacological Sciences Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael L. Rosenberg Scholar in Medical Research fund; DOD Discovery Award; WELCH Foundation(The Welch Foundation); CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Potts lab for helpful discussions and critical reading of the manuscript. We also thank Drs. Ralph Deberardinis, Beth Levine, John Minna, Jerry Shay, and Hongtao Yu for guidance and critical reagents. This work was supported by NIH Pharmacological Sciences Training Grant GM007062 (C. T. P.), Michael L. Rosenberg Scholar in Medical Research fund (P. R. P.), CPRIT R1117 (P. R. P.), DOD Discovery Award W81XWH-12-1-0446 (P. R. P.), and WELCH Foundation I-1821 (P.R.P.).	Barnes K, 2002, J CELL SCI, V115, P2433; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Chomez P, 2001, CANCER RES, V61, P5544; Chou CC, 2014, CANCER RES, V74, P4783, DOI 10.1158/0008-5472.CAN-14-0135; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Esteve-Puig R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004771; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Feng Y, 2011, PROTEIN CELL, V2, P7, DOI 10.1007/s13238-011-1002-9; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hadad S, 2011, BREAST CANCER RES TR, V128, P783, DOI 10.1007/s10549-011-1612-1; Hadad SM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-307; Hao YH, 2013, CELL, V152, P1051, DOI 10.1016/j.cell.2013.01.051; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jang SJ, 2001, CANCER RES, V61, P7959; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Laderoute KR, 2014, J BIOL CHEM, V289, P22850, DOI 10.1074/jbc.M114.576371; Landgraf RR, 2013, STRUCTURE, V21, P1942, DOI 10.1016/j.str.2013.08.023; Lee CW, 2012, CANCER RES, V72, P4394, DOI 10.1158/0008-5472.CAN-12-0429; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liu W, 2008, CANCER RES, V68, P8104, DOI 10.1158/0008-5472.CAN-08-2132; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; NAKAMURA M, 1984, AM J PHYSIOL, V247, pE234, DOI 10.1152/ajpendo.1984.247.2.E234; Niraula S, 2012, BREAST CANCER RES TR, V135, P821, DOI 10.1007/s10549-012-2223-1; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Quinn BJ, 2013, TRENDS ENDOCRIN MET, V24, P469, DOI 10.1016/j.tem.2013.05.004; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Shantha Kumara H M C, 2012, Cancer Immun, V12, P16; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; WEBER J, 1994, CANCER RES, V54, P1766; Weber P, 2002, DEVELOPMENT, V129, P2329; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026; Zheng LY, 2013, CLIN CANCER RES, V19, P5372, DOI 10.1158/1078-0432.CCR-13-0203	59	213	230	3	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					715	728		10.1016/j.cell.2015.01.034	http://dx.doi.org/10.1016/j.cell.2015.01.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25679763	Green Accepted, Bronze			2022-12-28	WOS:000349208800014
J	Debronkart, D				deBronkart, Dave			SPOTLIGHT: PATIENT CENTRED CARE From patient centred to people powered: autonomy on the rise	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Soc Participatory Med, Nashua, NH 03063 USA		Debronkart, D (corresponding author), Soc Participatory Med, 17 Grasmere Lane, Nashua, NH 03063 USA.	dave@epatientdave.com						Arbesman S, 2012, CURRENT; Dawson N, 2014, CASE AUTONOMY END PA; Debronkart D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1990; Freeman-Daily J, LUNG CANC EPATIENT S; Institute of Medicine, 2012, BEST CAR LOW COST PA; Kuhn Thomas S., 1962, STRUCTURE SCI REVOLU; Lee J, 2014, SOCIAL MEDIA GOOGLE; Richards T, 2014, DOCTORS PATIENTS DIS; Snow R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003583	9	40	41	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h148	10.1136/bmj.h148	http://dx.doi.org/10.1136/bmj.h148			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670184	Bronze			2022-12-28	WOS:000349318400002
J	Greene, A				Greene, Amanda			SPOTLIGHT: PATIENT CENTRED CARE Patient commentary: social media provides patients with support, information, and friendship	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												lalupuslady@gmail.com							0	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2015	350								h256	10.1136/bmj.h256	http://dx.doi.org/10.1136/bmj.h256			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0LU	25670190	Bronze			2022-12-28	WOS:000349318400008
J	Kiss, JE; Brambilla, D; Glynn, SA; Mast, AE; Spencer, BR; Stone, M; Kleinman, SH; Cable, RG				Kiss, Joseph E.; Brambilla, Donald; Glynn, Simone A.; Mast, Alan E.; Spencer, Bryan R.; Stone, Mars; Kleinman, Steven H.; Cable, Ritchard G.		Natl Heart Lung Blood Inst NHLBI	Oral Iron Supplementation After Blood Donation A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STATUS EVALUATION RISE; RESTLESS LEGS SYNDROME; SERUM FERRITIN; LOW HEMOGLOBIN; DONORS; DEFICIENCY; WOMEN; RECOVERY; STORES; PICA	IMPORTANCE Although blood donation is allowed every 8 weeks in the United States, recovery of hemoglobin to the currently accepted standard (12.5 g/dL) is frequently delayed, and some donors become anemic. OBJECTIVE To determine the effect of oral iron supplementation on hemoglobin recovery time (days to recovery of 80% of hemoglobin removed) and recovery of iron stores in iron-depleted ("low ferritin," <= 26 ng/mL) and iron-replete ("higher ferritin," >26 ng/mL) blood donors. DESIGN, SETTING, AND PARTICIPANTS Randomized, nonblinded clinical trial of blood donors stratified by ferritin level, sex, and age conducted in 4 regional blood centers in the United States in 2012. Included were 215 eligible participants aged 18 to 79 years who had not donated whole blood or red blood cells within 4 months. INTERVENTIONS One tablet of ferrous gluconate (37.5mg of elemental iron) daily or no iron for 24 weeks (168 days) after donating a unit of whole blood (500 mL). MAIN OUTCOMES AND MEASURES Time to recovery of 80% of the postdonation decrease in hemoglobin and recovery of ferritin level to baseline as a measure of iron stores. RESULTS The mean baseline hemoglobin levels were comparable in the iron and no-iron groups and declined from a mean (SD) of 13.4 (1.1) g/dL to 12.0 (1.2) g/dL after donation in the low-ferritin group and from 14.2 (1.1) g/dL to 12.9 (1.2) g/dL in the higher-ferritin group. Compared with participants who did not receive iron supplementation, those who received iron supplementation had shortened time to 80% hemoglobin recovery in both the low-ferritin and higher-ferritin groups. Recovery of iron stores in all participants who received supplements took a median of 76 days (IQR, 20-126); for participants not taking iron, median recovery time was longer than 168 days (IQR, 147-> 168 days; P < .001). Without iron supplements, 67% of participants did not recover iron stores by 168 days. 168) [GRAPHICS] CONCLUSIONS AND RELEVANCE Among blood donors with normal hemoglobin levels, low-dose iron supplementation, compared with no supplementation, reduced time to 80% recovery of the postdonation decrease in hemoglobin concentration in donors with low ferritin (<= 26 ng/mL) or higher ferritin (>26 ng/mL). Copyright 2015 American Medical Association. All rights reserved.	[Kiss, Joseph E.] Inst Transfus Med, Pittsburgh, PA 15213 USA; [Brambilla, Donald] RTI, Rockville, MD USA; [Glynn, Simone A.] NHLBI, Bethesda, MD 20892 USA; [Mast, Alan E.] BloodCtr Wisconsin, Milwaukee, WI USA; [Spencer, Bryan R.] Amer Red Cross, Dedham, MA USA; [Stone, Mars] Blood Syst Res Inst, San Francisco, CA USA; [Kleinman, Steven H.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Cable, Ritchard G.] Amer Red Cross, Farmington, CT USA	Institute for Transfusion Medicine; Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Versiti Blood Center of Wisconsin; American Red Cross; Vitalant; Vitalant Research Institute; University of British Columbia; American Red Cross	Kiss, JE (corresponding author), Inst Transfus Med, 3636 Blvd Allies, Pittsburgh, PA 15213 USA.	jkiss@itxm.org	Spencer, Bryan/AAF-4896-2019	Spencer, Bryan/0000-0002-9008-9154; Brambilla, Donald/0000-0002-7276-4689	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100001I, HHSN268201100002I, HHSN268201100003I, HHSN268201100004I, HHSN268201100005I, HHSN268201100006I]	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute (NHLBI) contracts HHSN268201100001I, HHSN268201100002I, HHSN268201100003I, HHSN268201100004I, HHSN268201100005I, and HHSN268201100006I.	[Anonymous], 2010, BLOOD PRODUCTS ADVIS; Baart AM, 2013, TRANSFUSION, V53, P1670, DOI 10.1111/j.1537-2995.2012.03956.x; Brownlie T, 2004, AM J CLIN NUTR, V79, P437; Bryant BJ, 2013, TRANSFUSION, V53, P1637, DOI 10.1111/trf.12061; Cable RG, 2012, TRANSFUSION, V52, P1031, DOI 10.1111/j.1537-2995.2011.03389.x; Cable RG, 2012, TRANSFUSION, V52, P702, DOI 10.1111/j.1537-2995.2011.03401.x; Cable RG, 2011, TRANSFUSION, V51, P511, DOI 10.1111/j.1537-2995.2010.02865.x; DOT D, 1992, ARCH PATHOL LAB MED, V116, P825; Eder A, 2008, PAPER PRESENTED AT 9; Falkingham M, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-4; FOWLER WILLIS M., 1942, JOUR AMER MED ASSOC, V118, P421; Karp JK, 2010, TRANSFUSION, V50, P507, DOI 10.1111/j.1537-2995.2009.02392.x; Kiss JE, 2013, TRANSFUSION, V53, P2766, DOI 10.1111/trf.12209; Krayenbuehl PA, 2011, BLOOD, V118, P3222, DOI 10.1182/blood-2011-04-346304; Mast AE, 2010, TRANSFUSION, V50, P1794, DOI 10.1111/j.1537-2995.2010.02649.x; Murray-Kolb LE, 2007, AM J CLIN NUTR, V85, P778, DOI 10.1093/ajcn/85.3.778; Pottgiesser T, 2008, TRANSFUSION, V48, P1390, DOI 10.1111/j.1537-2995.2008.01719.x; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Radtke H, 2004, TRANSFUSION, V44, P1427, DOI 10.1111/j.1537-2995.2004.04074.x; SIMON TL, 1981, JAMA-J AM MED ASSOC, V245, P2038, DOI 10.1001/jama.245.20.2038; Smith GA, 2014, COCHRANE DB SYST REV, V7; Spencer BR, 2013, TRANSFUSION, V53, P1645, DOI 10.1111/trf.12260; WADSWORTH GR, 1955, J PHYSIOL-LONDON, V129, P583, DOI 10.1113/jphysiol.1955.sp005380; Whitaker BI, 2011, 2011 NATIONAL BLOOD	24	98	101	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					575	583		10.1001/jama.2015.119	http://dx.doi.org/10.1001/jama.2015.119			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25668261	Bronze, Green Accepted			2022-12-28	WOS:000349070700017
J	Rader, C				Rader, Christoph			How to minimalize antibodies	NATURE			English	Editorial Material							MOLECULES; BINDING		[Rader, Christoph] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Rader, Christoph] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	Rader, C (corresponding author), Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	crader@scripps.edu		Rader, Christoph/0000-0001-9955-3454				Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Frankel SR, 2013, CURR OPIN CHEM BIOL, V17, P385, DOI 10.1016/j.cbpa.2013.03.029; Kodadek T, 2010, CURR OPIN CHEM BIOL, V14, P713, DOI 10.1016/j.cbpa.2010.07.001; McEnaney PJ, 2014, J AM CHEM SOC, V136, P18034, DOI 10.1021/ja509513c; McEnaney PJ, 2012, ACS CHEM BIOL, V7, P1139, DOI 10.1021/cb300119g; Rader C, 2014, TRENDS BIOTECHNOL, V32, P186, DOI 10.1016/j.tibtech.2014.02.003; Reichert JM, 2015, MABS-AUSTIN, V7, P1, DOI 10.4161/19420862.2015.988944	7	11	11	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					38	39		10.1038/518038a	http://dx.doi.org/10.1038/518038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25652990				2022-12-28	WOS:000349098000022
J	VanWagner, LB; Green, RM				VanWagner, Lisa B.; Green, Richard M.			Evaluating Elevated Bilirubin Levels in Asymptomatic Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GILBERTS-SYNDROME; RISK; DISEASE		[VanWagner, Lisa B.; Green, Richard M.] Northwestern Univ, Feinberg Sch Med, Div Gastroenterol & Hepatol, Dept Med, Chicago, IL 60611 USA; [VanWagner, Lisa B.] Univ Chicago, Feinberg Sch Med, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Chicago	VanWagner, LB (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Gastroenterol & Hepatol, 680 N Lake Shore Dr,Ste 1400,14-079K, Chicago, IL 60611 USA.	lvw@northwestern.edu		VanWagner, Lisa/0000-0002-6264-2573	NHLBI NIH HHS [F32 HL116151, 1 F32 HL116151-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL116151] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Bulmer AC, 2008, ATHEROSCLEROSIS, V199, P390, DOI 10.1016/j.atherosclerosis.2007.11.022; Centers for Medicare and Medicaid Services, MED FEE SCHED; Claridge LC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2293; Fretzayas A, 2012, EUR J PEDIATR, V171, P11, DOI 10.1007/s00431-011-1641-0; Gold HT, 2009, CANCER-AM CANCER SOC, V115, P3858, DOI 10.1002/cncr.24428; Horsfall LJ, 2013, J GASTROEN HEPATOL, V28, P1643, DOI 10.1111/jgh.12279; Stender S, 2013, J INTERN MED, V273, P59, DOI 10.1111/j.1365-2796.2012.02576.x; Stender S, 2013, JAMA INTERN MED, V173, P1222, DOI 10.1001/jamainternmed.2013.6465; Strassburg CP, 2008, PHARMACOGENOMICS, V9, P703, DOI 10.2217/14622416.9.6.703	10	21	31	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					516	517		10.1001/jama.2014.12835	http://dx.doi.org/10.1001/jama.2014.12835			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AV	25647209	Green Accepted			2022-12-28	WOS:000349070300017
J	Santelli, JS; Baldwin, W; Heitel, J				Santelli, John S.; Baldwin, Wendy; Heitel, Jennifer			Rising wealth, improving health? Adolescents and inequality	LANCET			English	Editorial Material									[Santelli, John S.; Heitel, Jennifer] Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY 10032 USA	Columbia University	Santelli, JS (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY 10032 USA.	js2637@columbia.edu	Santelli, John/AAG-3046-2021		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R13HD081897] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2002, ED STAND; Currie C., 2012, SOCIAL DETERMINANTS; Elgar FJ, 2014, LANCET; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Nestle M, 2013, FOOD POLITICS FOOD I, DOI DOI 10.1525/9780520955066/HTML; Patton GC, 2014, LANCET, V383, P385, DOI 10.1016/S0140-6736(14)60039-8; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Shakespeare W., 2004, THE WINTERS TALE; Torsheim T, 2006, J EPIDEMIOL COMMUN H, V60, P156, DOI 10.1136/jech.2005.037655; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4	11	5	5	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2026	2028		10.1016/S0140-6736(14)61892-4	http://dx.doi.org/10.1016/S0140-6736(14)61892-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI7XK	25659284				2022-12-28	WOS:000354979100009
J	Patel, S; Cone, RD				Patel, Sachin; Cone, Roger D.			NEUROSCIENCE A cellular basis for the munchies	NATURE			English	Editorial Material							FOOD-INTAKE; ENDOCANNABINOID SYSTEM; HYPOTHALAMUS; PROOPIOMELANOCORTIN; STIMULATION; ANATOMY; NEURONS; BRAIN	How does marijuana cause the irresistible hunger pangs known as the munchies? Paradoxically, the answer seems to involve an unusual mode of activation of a brain circuit best known for suppressing appetite. SEE ARTICLE P.45	[Patel, Sachin; Cone, Roger D.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Patel, S (corresponding author), Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	roger.cone@vanderbilt.edu	Patel, Sachin/E-5608-2012					[Anonymous], WORLD DRUG REP 2014; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Appleyard SM, 2003, ENDOCRINOLOGY, V144, P1753, DOI 10.1210/en.2002-221096; Bagnol D, 1999, J NEUROSCI, V19; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Koch M, 2015, NATURE, V519, P45, DOI 10.1038/nature14260; Marks DL, 2006, PEPTIDES, V27, P259, DOI 10.1016/j.peptides.2005.01.025; Ohno-Shosaku T, 2014, CURR OPIN NEUROBIOL, V29, P1, DOI 10.1016/j.conb.2014.03.017; Soria-Gomez E, 2014, NAT NEUROSCI, V17, P407, DOI 10.1038/nn.3647; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Zhan C, 2013, J NEUROSCI, V33, P3624, DOI 10.1523/JNEUROSCI.2742-12.2013	15	6	7	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					38	40		10.1038/nature14206	http://dx.doi.org/10.1038/nature14206			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25707800				2022-12-28	WOS:000350304000028
J	Chen, YM; Lin, YC; Kuo, TW; Knight, ZA				Chen, Yiming; Lin, Yen-Chu; Kuo, Tzu-Wei; Knight, Zachary A.			Sensory Detection of Food Rapidly Modulates Arcuate Feeding Circuits	CELL			English	Article							MELANOCORTIN RECEPTORS; AGRP NEURONS; POMC NEURONS; IN-VIVO; DYNAMICS; NUCLEUS; OBESITY; ACTIVATION; BEHAVIOR	Hunger is controlled by specialized neural circuits that translate homeostatic needs into motivated behaviors. These circuits are under chronic control by circulating signals of nutritional state, but their rapid dynamics on the timescale of behavior remain unknown. Here, we report optical recording of the natural activity of two key cell types that control food intake, AgRP and POMC neurons, in awake behaving mice. We find unexpectedly that the sensory detection of food is sufficient to rapidly reverse the activation state of these neurons induced by energy deficit. This rapid regulation is cell-type specific, modulated by food palatability and nutritional state, and occurs before any food is consumed. These data reveal that AgRP and POMC neurons receive real-time information about the availability of food in the external world, suggesting a primary role for these neurons in controlling appetitive behaviors such as foraging that promote the discovery of food.	[Chen, Yiming; Lin, Yen-Chu; Kuo, Tzu-Wei; Knight, Zachary A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Knight, ZA (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	zachary.knight@ucsf.edu		Knight, Zachary/0000-0001-7621-1478	New York Stem Cell Foundation; Rita Allen Foundation; McKnight Foundation; Alfred P. Sloan Foundation; NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation; Esther A. and Joseph Klingenstein Foundation; Program for Breakthrough Biomedical Research; UCSF Diabetes Center Obesity Pilot program [U01 DK089541]; NIH [R00-DK083531]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089541, P30DK063720, R00DK083531] Funding Source: NIH RePORTER	New York Stem Cell Foundation; Rita Allen Foundation; McKnight Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation(NARSAD); Esther A. and Joseph Klingenstein Foundation; Program for Breakthrough Biomedical Research; UCSF Diabetes Center Obesity Pilot program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Z.A.K. is a New York Stem Cell Foundation-Robertson Investigator. This research was supported by the New York Stem Cell Foundation, the Rita Allen Foundation, the McKnight Foundation, the Alfred P. Sloan Foundation, a NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation, the Esther A. and Joseph Klingenstein Foundation, the Program for Breakthrough Biomedical Research, the UCSF Diabetes Center Obesity Pilot program (U01 DK089541) and NIH R00-DK083531 (Z.A.K.). We thank Jennifer Garrison, Nirao Shah, Kevan Shokat, and members of the Z.A.K. laboratory for comments on the manuscript and Anthony Lee and Scott Owen for technical advice on photometry.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; CLARK JT, 1985, ENDOCRINOLOGY, V117, P2435, DOI 10.1210/endo-117-6-2435; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Friedman J, 2014, J ENDOCRINOL, V223, pT1, DOI 10.1530/JOE-14-0405; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hetherington AW, 1939, P SOC EXP BIOL MED, V41, P465; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	32	350	354	5	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					829	841		10.1016/j.cell.2015.01.033	http://dx.doi.org/10.1016/j.cell.2015.01.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25703096	Green Accepted, Bronze			2022-12-28	WOS:000351116100007
J	Kemp, BM; Lindo, J; Bolnick, DA; Malhi, RS; Chatters, JC				Kemp, Brian M.; Lindo, John; Bolnick, Deborah A.; Malhi, Ripan S.; Chatters, James C.			Response to Comment on "Late Pleistocene human skeleton and mtDNA link Paleoamericans and modern Native Americans"	SCIENCE			English	Editorial Material							ANCIENT DNA; SEQUENCE	Prufer and Meyer raise concerns over the mitochondrial DNA (mtDNA) results we reported for the Hoyo Negro individual, citing failure of a portion of these data to conform to their expectations of ancient DNA (aDNA). Because damage patterns in aDNA vary, outright rejection of our findings on this basis is unwarranted, especially in light of our other observations.	[Kemp, Brian M.] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA; [Kemp, Brian M.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Lindo, John; Malhi, Ripan S.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Bolnick, Deborah A.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Bolnick, Deborah A.] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA; [Malhi, Ripan S.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Chatters, James C.] Appl Paleosci, Bothell, WA 98011 USA; [Chatters, James C.] DirectAMS, Bothell, WA 98011 USA	Washington State University; Washington State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Illinois System; University of Illinois Urbana-Champaign	Kemp, BM (corresponding author), Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA.	bmkemp@wsu.edu; paleosci@gmail.com	Lindo, John/R-5833-2019	Malhi, Ripan/0000-0002-1484-0292				Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Barta JL, 2013, FORENSIC SCI INT, V231, P340, DOI 10.1016/j.forsciint.2013.06.004; Chatters JC, 2014, SCIENCE, V344, P750, DOI 10.1126/science.1252619; Cooper A, 2000, SCIENCE, V289, P1139; Garcia-Garcera M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024161; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Jenkins DL, 2012, SCIENCE, V337, P223, DOI 10.1126/science.1218443; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Prufer K, 2015, SCIENCE, V347, DOI 10.1126/science.1260617; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Seguin-Orlando A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078575	14	4	4	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224								10.1126/science.1261188	http://dx.doi.org/10.1126/science.1261188			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700511				2022-12-28	WOS:000349761100033
J	Fosque, BF; Sun, Y; Dana, H; Yang, CT; Ohyama, T; Tadross, MR; Patel, R; Zlatic, M; Kim, DS; Ahrens, MB; Jayaraman, V; Looger, LL; Schreiter, ER				Fosque, Benjamin F.; Sun, Yi; Dana, Hod; Yang, Chao-Tsung; Ohyama, Tomoko; Tadross, Michael R.; Patel, Ronak; Zlatic, Marta; Kim, Douglas S.; Ahrens, Misha B.; Jayaraman, Vivek; Looger, Loren L.; Schreiter, Eric R.			Labeling of active neural circuits in vivo with designed calcium integrators	SCIENCE			English	Article							NEURONAL-ACTIVITY; GENE-EXPRESSION; VISUAL-CORTEX; DROSOPHILA; BRAIN; PROTEIN; POPULATIONS; SENSOR; CELLS	The identification of active neurons and circuits in vivo is a fundamental challenge in understanding the neural basis of behavior. Genetically encoded calcium (Ca2+) indicators (GECIs) enable quantitative monitoring of cellular-resolution activity during behavior. However, such indicators require online monitoring within a limited field of view. Alternatively, post hoc staining of immediate early genes (IEGs) indicates highly active cells within the entire brain, albeit with poor temporal resolution. We designed a fluorescent sensor, CaMPARI, that combines the genetic targetability and quantitative link to neural activity of GECIs with the permanent, large-scale labeling of IEGs, allowing a temporally precise "activity snapshot" of a large tissue volume. CaMPARI undergoes efficient and irreversible green-to-red conversion only when elevated intracellular Ca2+ and experimenter-controlled illumination coincide. We demonstrate the utility of CaMPARI in freely moving larvae of zebrafish and flies, and in head-fixed mice and adult flies.	[Fosque, Benjamin F.; Sun, Yi; Dana, Hod; Yang, Chao-Tsung; Ohyama, Tomoko; Tadross, Michael R.; Patel, Ronak; Zlatic, Marta; Kim, Douglas S.; Ahrens, Misha B.; Jayaraman, Vivek; Looger, Loren L.; Schreiter, Eric R.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Schreiter, ER (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	schreitere@janelia.hhmi.org	PATEL, RONAK/J-5736-2019	PATEL, RONAK/0000-0002-6945-6466; Dana, Hod/0000-0002-8093-2363; Kim, Douglas/0000-0001-9029-314X; Ohyama, Tomoko/0000-0003-1697-1138; Sun, Yi/0000-0002-1746-0404; Schreiter, Eric/0000-0002-2864-7469; Zlatic, Marta/0000-0002-3149-2250	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; BAKER PF, 1971, J PHYSIOL-LONDON, V218, P709, DOI 10.1113/jphysiol.1971.sp009641; Chen JL, 2013, J NEUROSCI, V33, P17631, DOI 10.1523/JNEUROSCI.3255-13.2013; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Fields RD, 1997, J NEUROSCI, V17, P7252; Freeman J, 2014, NAT METHODS, V11, P941, DOI [10.1038/NMETH.3041, 10.1038/nmeth.3041]; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hoi H, 2013, J AM CHEM SOC, V135, P46, DOI 10.1021/ja310184a; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Lin AC, 2014, NAT NEUROSCI, V17, P559, DOI 10.1038/nn.3660; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071706; Riemensperger T, 2012, BBA-GEN SUBJECTS, V1820, P1169, DOI 10.1016/j.bbagen.2012.02.013; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; SHENG HZ, 1993, J NEUROSCI RES, V35, P459, DOI 10.1002/jnr.490350502; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Tian Lin, 2012, Cold Spring Harb Protoc, V2012, P647, DOI 10.1101/pdb.top069609; Tsien RY, 2013, P NATL ACAD SCI USA, V110, P12456, DOI 10.1073/pnas.1310158110; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Yao ZP, 2012, J NEUROPHYSIOL, V108, P684, DOI 10.1152/jn.00110.2012	32	243	253	9	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					755	760		10.1126/science.1260922	http://dx.doi.org/10.1126/science.1260922			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678659				2022-12-28	WOS:000349221300044
J	Illendula, A; Pulikkan, JA; Zong, HL; Grembecka, J; Xue, LT; Sen, S; Zhou, YP; Boulton, A; Kuntimaddi, A; Gao, Y; Rajewski, RA; Guzman, ML; Castilla, LH; Bushweller, JH				Illendula, Anuradha; Pulikkan, John A.; Zong, Hongliang; Grembecka, Jolanta; Xue, Liting; Sen, Siddhartha; Zhou, Yunpeng; Boulton, Adam; Kuntimaddi, Aravinda; Gao, Yan; Rajewski, Roger A.; Guzman, Monica L.; Castilla, Lucio H.; Bushweller, John H.			A small-molecule inhibitor of the aberrant transcription factor CBF beta-SMMHC delays leukemia in mice	SCIENCE			English	Article							ACUTE MYELOID-LEUKEMIA; BINDING; CBFB-MYH11; RELAPSE; FUSION; GENES; RUNX1; RAS; IDENTIFICATION; MUTATIONS	Acute myeloid leukemia (AML) is the most common form of adult leukemia. The transcription factor fusion CBF beta-SMMHC (core binding factor beta and the smooth-muscle myosin heavy chain), expressed in AML with the chromosome inversion inv(16)(p13q22), outcompetes wild-type CBF beta for binding to the transcription factor RUNX1, deregulates RUNX1 activity in hematopoiesis, and induces AML. Current inv(16) AML treatment with nonselective cytotoxic chemotherapy results in a good initial response but limited long-term survival. Here, we report the development of a protein-protein interaction inhibitor, AI-10-49, that selectively binds to CBF beta-SMMHC and disrupts its binding to RUNX1. AI-10-49 restores RUNX1 transcriptional activity, displays favorable pharmacokinetics, and delays leukemia progression in mice. Treatment of primary inv(16) AML patient blasts with AI-10-49 triggers selective cell death. These data suggest that direct inhibition of the oncogenic CBF beta-SMMHC fusion protein may be an effective therapeutic approach for inv(16) AML, and they provide support for transcription factor targeted therapy in other cancers.	[Illendula, Anuradha; Zhou, Yunpeng; Boulton, Adam; Kuntimaddi, Aravinda; Gao, Yan; Bushweller, John H.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Pulikkan, John A.; Xue, Liting; Castilla, Lucio H.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Zong, Hongliang; Sen, Siddhartha; Guzman, Monica L.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10065 USA; [Grembecka, Jolanta] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Rajewski, Roger A.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA	University of Virginia; University of Massachusetts System; University of Massachusetts Worcester; Cornell University; University of Michigan System; University of Michigan; University of Kansas	Castilla, LH (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	Lucio.Castilla@umassmed.edu; jhb4v@virginia.edu	Sen, Siddhartha/GLV-4511-2022	PULIKKAN, JOHN ANTO/0000-0001-7995-6942; Bushweller, John/0000-0002-5386-1758	National Cancer Institute, NIH [R01 CA140398, R01 CA096983]; Leukemia and Lymphoma Society [SCOR 7006]; Leukemia & Lymphoma Society [1334-08]; American Society of Hematology; NIH [1 DP2 OD007399-01]; NATIONAL CANCER INSTITUTE [R01CA140398, R01CA096983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080186, T32GM008136] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007399] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); American Society of Hematology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. Bradley for assisting in the linker-length analyses in cell lines, R. Delwel for providing patient AML cells, and L. Zhu for performing the statistical analysis of mouse transplantation studies. This work was supported by grants from the National Cancer Institute, NIH (R01 CA140398), to J.H.B., L.H.C., and R.A.R.; (R01 CA096983) to L.H.C.; and a Specialized Center of Research grant from the Leukemia and Lymphoma Society to J.H.B. (SCOR 7006). L.H.C. is the recipient of a Scholar Award from the Leukemia & Lymphoma Society (grant 1334-08) and J.A.P. of a Scholar Award from the American Society of Hematology. M.L.G. is funded by the NIH through the NIH Director's New Innovator Award Program, 1 DP2 OD007399-01. J.H.B., A.I., and J.G. are coinventors on a U.S. patent (US8748618 B2) for AI-10-49 and related analogs. A patent application (10775546.4) has also been filed in Europe.	Adya N, 2000, SEMIN CELL DEV BIOL, V11, P361, DOI 10.1006/scdb.2000.0189; Cao WS, 1997, ONCOGENE, V15, P1315, DOI 10.1038/sj.onc.1201305; Castilla LH, 1999, NAT GENET, V23, P144, DOI 10.1038/13776; Castilla LH, 2004, P NATL ACAD SCI USA, V101, P4924, DOI 10.1073/pnas.0400930101; Cheng CK, 2008, BLOOD, V112, P3391, DOI 10.1182/blood-2008-02-137083; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gorczynski MJ, 2007, CHEM BIOL, V14, P1186, DOI 10.1016/j.chembiol.2007.09.006; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; Haferlach C, 2010, LEUKEMIA, V24, P1065, DOI 10.1038/leu.2010.22; Heilman SA, 2006, CANCER RES, V66, P11214, DOI 10.1158/0008-5472.CAN-06-0959; Hessels D, 2013, CURR UROL REP, V14, P214, DOI 10.1007/s11934-013-0321-1; Huang XM, 1999, NAT STRUCT BIOL, V6, P624; Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794; Kottaridis PD, 2002, BLOOD, V100, P2393, DOI 10.1182/blood-2002-02-0420; Kumar C Chandra, 2011, Genes Cancer, V2, P95, DOI 10.1177/1947601911408076; Kuo YH, 2006, CANCER CELL, V9, P57, DOI 10.1016/j.ccr.2005.12.014; LADANYI M, 1995, DIAGN MOL PATHOL, V4, P162, DOI 10.1097/00019606-199509000-00003; Leroux FR, 2008, BEILSTEIN J ORG CHEM, V4, DOI 10.3762/bjoc.4.13; LIU P, 1993, SCIENCE, V261, P1041, DOI 10.1126/science.8351518; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lukasik SM, 2002, NAT STRUCT BIOL, V9, P674, DOI 10.1038/nsb831; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Manteau B, 2010, J FLUORINE CHEM, V131, P140, DOI 10.1016/j.jfluchem.2009.09.009; Markus J, 2007, CANCER RES, V67, P992, DOI 10.1158/0008-5472.CAN-06-2964; Nakano Y, 1999, BRIT J HAEMATOL, V104, P659, DOI 10.1046/j.1365-2141.1999.01256.x; Ravandi F, 2007, CANCER-AM CANCER SOC, V110, P1900, DOI 10.1002/cncr.23000; Shih LY, 2008, LEUKEMIA, V22, P303, DOI 10.1038/sj.leu.2404995; Xue LT, 2014, BLOOD, V124, P426, DOI 10.1182/blood-2013-12-541730; ZHANG DE, 1994, MOL CELL BIOL, V14, P8085, DOI 10.1128/MCB.14.12.8085	30	77	86	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					779	784		10.1126/science.aaa0314	http://dx.doi.org/10.1126/science.aaa0314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678665	Green Accepted, Green Submitted			2022-12-28	WOS:000349221300050
J	Politi, Y; Weaver, JC				Politi, Yael; Weaver, James C.			Built for tough conditions	SCIENCE			English	Editorial Material							MECHANISM; CALCITE		[Politi, Yael] Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany; [Weaver, James C.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Max Planck Society; Harvard University	Politi, Y (corresponding author), Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany.	yael.politi@mpikg.mpg.de	Weaver, James C./AAE-7870-2019					Addadi L, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/9/098003; Baumgartner J, 2013, P NATL ACAD SCI USA, V110, P14883, DOI 10.1073/pnas.1307119110; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776; Gal A, 2014, ADV FUNCT MATER, V24, P5420, DOI 10.1002/adfm.201400676; Gordon LM, 2015, SCIENCE, V347, P746, DOI 10.1126/science.1258950; Kababya S, 2015, J AM CHEM SOC, V137, P990, DOI 10.1021/ja511869g; Nassif N, 2005, P NATL ACAD SCI USA, V102, P12653, DOI 10.1073/pnas.0502577102; Pokroy B, 2006, ADV MATER, V18, P2363, DOI 10.1002/adma.200600714; Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105; Seto J, 2012, P NATL ACAD SCI USA, V109, P3699, DOI 10.1073/pnas.1109243109; Wang RZ, 1997, PHILOS T R SOC B, V352, P469, DOI 10.1098/rstb.1997.0034	12	7	7	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					712	713		10.1126/science.aaa5245	http://dx.doi.org/10.1126/science.aaa5245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678643				2022-12-28	WOS:000349221300020
J	Brockington, SF; Moyroud, E; Sayou, C; Monniaux, M; Nanao, MH; Thevenon, E; Chahtane, H; Warthmann, N; Melkonian, M; Zhang, Y; Wong, GKS; Weigel, D; Dumas, R; Parcy, F				Brockington, Samuel F.; Moyroud, Edwige; Sayou, Camille; Monniaux, Marie; Nanao, Max H.; Thevenon, Emmanuel; Chahtane, Hicham; Warthmann, Norman; Melkonian, Michael; Zhang, Yong; Wong, Gane Ka-Shu; Weigel, Detlef; Dumas, Renaud; Parcy, Francois			Response to Comment on "A promiscuous intermediate underlies the evolution of LEAFY DNA binding specificity"	SCIENCE			English	Editorial Material							LAND PLANTS; PHYLOGENY; BRYOPHYTES; ORIGIN	Brunkard et al. propose that the identification of novel LEAFY sequences contradicts our model of evolution through promiscuous intermediates. Based on the debate surrounding land plant phylogeny and on our analysis of these interesting novel sequences, we explain why there is no solid evidence to disprove our model.	[Brockington, Samuel F.; Moyroud, Edwige] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Sayou, Camille] Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Monniaux, Marie] Max Planck Inst Plant Breeding Res, Dept Comparat Dev & Genet, D-50829 Cologne, Germany; [Nanao, Max H.] EMBL, F-38042 Grenoble, France; [Nanao, Max H.] Univ Grenoble Alpes, CNRS, UMI 3265, Unit Virus Host Cell Interact,EMBL, F-38042 Grenoble 9, France; [Thevenon, Emmanuel; Chahtane, Hicham; Dumas, Renaud; Parcy, Francois] CNRS, LPCV, UMR 5168, F-38054 Grenoble, France; [Thevenon, Emmanuel; Chahtane, Hicham; Dumas, Renaud; Parcy, Francois] UGA, LPCV, F-38054 Grenoble, France; [Thevenon, Emmanuel; Chahtane, Hicham; Dumas, Renaud; Parcy, Francois] Inst Rech Technol & Sci Vivant, Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, LPCV, F-38054 Grenoble, France; [Thevenon, Emmanuel; Chahtane, Hicham; Dumas, Renaud; Parcy, Francois] INRA, LPCV, F-38054 Grenoble, France; [Warthmann, Norman] Australian Natl Univ, Res Sch Biol, Acton, ACT 0200, Australia; [Melkonian, Michael] Univ Cologne, Biozentrum Koln, Lehrstuhl 1, Bot Inst, D-50674 Cologne, Germany; [Zhang, Yong; Wong, Gane Ka-Shu] Beijing Genom Inst, Shenzhen 518083, Peoples R China; [Wong, Gane Ka-Shu] Univ Alberta, Dept Med, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	University of Cambridge; Max Planck Society; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Australian National University; University of Cologne; Beijing Genomics Institute (BGI); University of Alberta; Max Planck Society	Nanao, MH (corresponding author), EMBL, 6 Rue Jules Horowitz,BP 181, F-38042 Grenoble, France.	mnanao@embl.fr; francois.parcy@cea.fr	Moyroud, Edwige/GPX-8552-2022; Weigel, Detlef/C-1418-2008; Sayou, Camille/AAX-6377-2020; Chahtane, Hicham/P-7853-2018; Brockington, Samuel/K-7819-2013; WONG, Gane Ka-Shu/G-5784-2013; Dumas, Renaud/E-1835-2011; Monniaux, Marie/AAI-8165-2021; Weigel, Detlef/GSJ-0799-2022; Parcy, François/G-9177-2011; Nanao, Max/ABA-9292-2021; Weigel, Detlef/AAR-3312-2021; Sayou, Camille/E-8145-2019; Warthmann, Norman/E-1069-2011	Moyroud, Edwige/0000-0001-7908-3205; Weigel, Detlef/0000-0002-2114-7963; Sayou, Camille/0000-0002-8226-7272; Chahtane, Hicham/0000-0002-0976-1186; Brockington, Samuel/0000-0003-1216-219X; WONG, Gane Ka-Shu/0000-0001-6108-5560; Monniaux, Marie/0000-0001-6847-3902; Weigel, Detlef/0000-0002-2114-7963; Parcy, François/0000-0003-2191-500X; Sayou, Camille/0000-0002-8226-7272; Warthmann, Norman/0000-0002-1178-8409; dumas, renaud/0000-0003-1404-3274	NERC [NE/K009303/1] Funding Source: UKRI; Natural Environment Research Council [NE/K009303/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bomblies K, 2003, DEVELOPMENT, V130, P2385, DOI 10.1242/dev.00457; Brunkard JO, 2015, SCIENCE, V347, DOI 10.1126/science.1255437; Cooper ED, 2014, TRENDS PLANT SCI, V19, P576, DOI 10.1016/j.tplants.2014.06.006; Cox CJ, 2014, SYST BIOL, V63, P272, DOI 10.1093/sysbio/syt109; Finet C, 2010, CURR BIOL, V20, P2217, DOI 10.1016/j.cub.2010.11.035; Karol KG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-321; Li FW, 2014, P NATL ACAD SCI USA, V111, P6672, DOI 10.1073/pnas.1319929111; Nakagawa S, 2013, P NATL ACAD SCI USA, V110, P12349, DOI 10.1073/pnas.1310430110; Nishiyama T, 1999, MOL BIOL EVOL, V16, P1027, DOI 10.1093/oxfordjournals.molbev.a026192; Nishiyama T, 2004, MOL BIOL EVOL, V21, P1813, DOI 10.1093/molbev/msh203; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Sayou C, 2014, SCIENCE, V343, P645, DOI 10.1126/science.1248229; Vazquez-Lobo A, 2007, EVOL DEV, V9, P446, DOI 10.1111/j.1525-142X.2007.00182.x; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104	14	4	6	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222								10.1126/science.1256011	http://dx.doi.org/10.1126/science.1256011			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657241	Green Published			2022-12-28	WOS:000349145200033
J	Dharmarajan, K; Hsieh, AF; Kulkarni, VT; Lin, ZQ; Ross, JS; Horwitz, LI; Kim, N; Suter, LG; Lin, HQ; Normand, SLT; Krumholz, HM				Dharmarajan, Kumar; Hsieh, Angela F.; Kulkarni, Vivek T.; Lin, Zhenqiu; Ross, Joseph S.; Horwitz, Leora I.; Kim, Nancy; Suter, Lisa G.; Lin, Haiqun; Normand, Sharon-Lise T.; Krumholz, Harlan M.			Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CAUSE READMISSION RATES; STANDARDIZED MORTALITY; MEDICARE BENEFICIARIES; 30-DAY READMISSION; PERFORMANCE; MODEL; CARE; REHOSPITALIZATION; INTERVENTION; VALIDATION	OBJECTIVE To characterize the absolute risks for older patients of readmission to hospital and death in the year after hospitalization for heart failure, acute myocardial infarction, or pneumonia. DESIGN Retrospective cohort study. SETTING 4767 hospitals caring for Medicare fee for service beneficiaries in the United States, 2008-10. PARTICIPANTS More than 3 million Medicare fee for service beneficiaries, aged 65 years or more, surviving hospitalization for heart failure, acute myocardial infarction, or pneumonia. MAIN OUTCOME MEASURES Daily absolute risks of first readmission to hospital and death for one year after discharge. To illustrate risk trajectories, we identified the time required for risks of readmission to hospital and death to decline 50% from maximum values after discharge; the time required for risks to approach plateau periods of minimal day to day change, defined as 95% reductions in daily changes in risk from maximum daily declines after discharge; and the extent to which risks are higher among patients recently discharged from hospital compared with the general elderly population. RESULTS Within one year of hospital discharge, readmission to hospital and death, respectively, occurred following 67.4% and 35.8% of hospitalizations for heart failure, 49.9% and 25.1% for acute myocardial infarction, and 55.6% and 31.1% for pneumonia. Risk of first readmission had declined 50% by day 38 after hospitalization for heart failure, day 13 after hospitalization for acute myocardial infarction, and day 25 after hospitalization for pneumonia; risk of death declined 50% by day 11, 6, and 10, respectively. Daily change in risk of first readmission to hospital declined 95% by day 45, 38, and 45; daily change in risk of death declined 95% by day 21, 19, and 21. After hospitalization for heart failure, acute myocardial infarction, or pneumonia, the magnitude of the relative risk for hospital admission over the first 90 days was 8, 6, and 6 times greater than that of the general older population; the relative risk of death was 11, 8, and 10 times greater. CONCLUSIONS Risk declines slowly for older patients after hospitalization for heart failure, acute myocardial infarction, or pneumonia and is increased for months. Specific risk trajectories vary by discharge diagnosis and outcome. Patients should remain vigilant for deterioration in health for an extended time after discharge. Health providers can use knowledge of absolute risks and their changes over time to better align interventions designed to reduce adverse outcomes after discharge with the highest risk periods for patients.	[Dharmarajan, Kumar] Columbia Univ, Med Ctr, Dept Internal Med, New York, NY 10027 USA; [Hsieh, Angela F.; Kulkarni, Vivek T.; Lin, Zhenqiu; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Ross, Joseph S.; Horwitz, Leora I.; Kim, Nancy] Yale Univ, Sch Med, Sect Gen Internal Med, New Haven, CT 06510 USA; [Suter, Lisa G.] Yale Univ, Sch Med, Sect Rheumatol, New Haven, CT 06510 USA; [Lin, Haiqun] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06510 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Columbia University; Yale University; Yale University; Yale University; Yale University; Harvard University; Harvard T.H. Chan School of Public Health	Dharmarajan, K (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, 333 Cedar St, New Haven, CT 06510 USA.	kumar.dharmarajan@yale.edu	, Harlan/AAI-2875-2020; Horwitz, Leora/ABD-1292-2020; Horwitz, Leora/A-6959-2009	Lin, Haiqun/0000-0002-3114-9671; Ross, Joseph/0000-0002-9218-3320; Normand, Sharon-Lise/0000-0001-7027-4769; Horwitz, Leora/0000-0003-1800-6040	National Institute on Aging [K23AG048331, K08AG032886, K08AG038336]; American Federation for Aging Research; National Heart, Lung, and Blood Institute [1U01HL105270-04]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG038336, K08AG032886, K23AG048331] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	KD, JSR, and LIH are supported by grants K23AG048331, K08AG032886, and K08AG038336, respectively, from the National Institute on Aging and American Federation for Aging Research through the Paul B Beeson career development award program. HMK is supported by grant 1U01HL105270-04 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the American Federation for Aging Research.	Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Braunstein JB, 2003, J AM COLL CARDIOL, V42, P1226, DOI 10.1016/S0735-1097(03)00947-1; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; Capelastegui A, 2009, CHEST, V136, P1079, DOI 10.1378/chest.08-2950; Centers for Medicare & Medicaid Services, 2013, PLANN READM ALG VERS; Chun S, 2012, CIRC-HEART FAIL, V5, P414, DOI 10.1161/CIRCHEARTFAILURE.111.964791; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Cutler DM, 2012, NEW ENGL J MED, V366, P1075, DOI 10.1056/NEJMp1113361; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Dodson JA, 2013, AM J MED, V126, P120, DOI 10.1016/j.amjmed.2012.05.029; DONOVAN M, 1987, PAIN, V30, P69, DOI 10.1016/0304-3959(87)90084-4; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gasser T., 1979, LECT NOTES MATH, V757, P23, DOI 10.1007/bfb0098489; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Krumholz HM, 1997, ARCH INTERN MED, V157, P99, DOI 10.1001/archinte.157.1.99; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; McManus David D, 2012, Clin Epidemiol, V4, P115, DOI 10.2147/CLEP.S30883; Network for Excellence in Health Innovation, 2012, IMPR MED ADH RED REA; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; Skull SA, 2008, EPIDEMIOL INFECT, V136, P232, DOI 10.1017/S0950268807008564; Sochalski J, 2009, HEALTH AFFAIR, V28, P179, DOI 10.1377/hlthaff.28.1.179; STEVENSON WG, 1989, AM HEART J, V118, P1182, DOI 10.1016/0002-8703(89)90007-0; Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013; Teng THK, 2012, INT J CARDIOL, V158, P405, DOI 10.1016/j.ijcard.2011.01.061; Teno J, 1997, J AM GERIATR SOC, V45, P500, DOI 10.1111/j.1532-5415.1997.tb05178.x; Yoder JC, 2012, ARCH INTERN MED, V172, P68, DOI 10.1001/archinternmed.2011.603	48	135	137	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2015	350								h411	10.1136/bmj.h411	http://dx.doi.org/10.1136/bmj.h411			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0KK	25656852	Green Published, hybrid			2022-12-28	WOS:000349314500002
J	Guzman, J; Stern, S				Guzman, Jorge; Stern, Scott			Where is Silicon Valley?	SCIENCE			English	Editorial Material							ENTREPRENEURSHIP		[Guzman, Jorge; Stern, Scott] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02142 USA; [Stern, Scott] Natl Bur Econ Res, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); National Bureau of Economic Research	Guzman, J (corresponding author), MIT, Alfred P Sloan Sch Management, Cambridge, MA 02142 USA.	sstern@mit.edu						Acs Zoltan J., 1990, INNOVATION SMALL FIR; Amors J.E., 2014, GLOBAL ENTREPRENEURS; [Anonymous], 2007, GOOD CAPITALISM BAD, DOI DOI 10.2139/SSRN.985843; Belenzon S., 2014, EPONYMOUS ENTREPRENE; Cabral LMB, 2003, AM ECON REV, V93, P1075, DOI 10.1257/000282803769206205; Decker R, 2014, J ECON PERSPECT, V28, P3, DOI 10.1257/jep.28.3.3; Delgado M., 2014, 20375 NBER; Fairlie, 2014, KAUFMAN INDEX ENTREP; Guzman J., 2014, NOWCASTING PLACECAST; Henrekson M, 2014, P NATL ACAD SCI USA, V111, P1760, DOI 10.1073/pnas.1307204111; Hurst E, 2011, BROOKINGS PAP ECO AC, P73; Kaplan S, 2010, RES SOCIOL ORGAN-RES, V29, P107, DOI 10.1108/S0733-558X(2010)0000029013; Klapper L., 2010, INT DIFFERENCES ENTR, P130; Lerner J, 2009, KAUFF FOUND SER, P1; Samila S, 2010, RES POLICY, V39, P1348, DOI 10.1016/j.respol.2010.08.006; Shane S, 2000, ACAD MANAGE REV, V25, P217, DOI 10.5465/amr.2000.2791611	16	76	77	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					606	609		10.1126/science.aaa0201	http://dx.doi.org/10.1126/science.aaa0201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CX	25657229				2022-12-28	WOS:000349145200020
J	Cotton, D				Cotton, Deborah			Celebrating the ACP Centennial: From the Annals Archive	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		Committee on Approaching Death: Addressing Key End of Life Issues, 2014, DYING AM IMPR QUAL H; Halpern SD, 2015, ANN INTERN MED, V162, P224, DOI 10.7326/M14-2476; MARSHALL JR, 1969, ANN INTERN MED, V70, P615, DOI 10.7326/0003-4819-70-3-615; Ness DL, 2015, ANN INTERN MED, V162, P226, DOI 10.7326/M14-2537; Pizzo PA, 2015, ANN INTERN MED, V162, P228, DOI 10.7326/M14-2399; Rao JK, 2015, ANN INTERN MED, V162, P230, DOI 10.7326/M14-2479; Singer AE, 2015, ANN INTERN MED, V162, P175, DOI 10.7326/M13-1609	7	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2015	162	3					232	232		10.7326/M14-2865	http://dx.doi.org/10.7326/M14-2865			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NP	25643307				2022-12-28	WOS:000350108100012
J	Pemovska, T; Johnson, E; Kontro, M; Repasky, GA; Chen, J; Wells, P; Cronin, CN; McTigue, M; Kallioniemi, O; Porkka, K; Murray, BW; Wennerberg, K				Pemovska, Tea; Johnson, Eric; Kontro, Mika; Repasky, Gretchen A.; Chen, Jeffrey; Wells, Peter; Cronin, Ciaran N.; McTigue, Michele; Kallioniemi, Olli; Porkka, Kimmo; Murray, Brion W.; Wennerberg, Krister			Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation	NATURE			English	Article							CHRONIC MYELOID-LEUKEMIA; PATIENTS RECEIVING IMATINIB; BCR-ABL INHIBITOR; TYROSINE KINASE; T315I MUTANT; FOLLOW-UP; MECHANISM; CELLS; RESISTANCE; PONATINIB	The BCR-ABL1 fusion gene is a driver oncogene in chronic myeloid leukaemia and 30-50% of cases of adult acute lymphoblastic leukaemia(1). Introduction of ABL1 kinase inhibitors (for example, imatinib) has markedly improved patient survival(2), but acquired drug resistance remains a challenge(3-5). Point mutations in the ABL1 kinase domain weaken inhibitor binding(6) and represent the most common clinical resistance mechanism. The BCR-ABLI kinase domain gatekeeper mutation Thr315Ile (T315I) confers resistance to all approved ABL1 inhibitors except ponatinib(7,8), which has toxicity limitations. Here we combine comprehensive drug sensitivity and resistance profiling of patient cells ex vivo with structural analysis to establish the VEGFR tyrosine kinase inhibitor axitinib as a selective and effective inhibitor for T315I-mutant BCR-ABL1-driven leukaemia. Axitinib potently inhibited BCR-ABL1(T315I), at both biochemical and cellular levels, by binding to the active form of ABL1 (T315I) in a mutation-selective binding mode. These findings suggest that the T315I mutation shifts the conformational equilibrium of the kinase in favour of an active (DFG-in) A-loop conformation, which has more optimal binding interactions with axitinib. Treatment of a T315I chronic myeloid leukaemia patient with axitinib resulted in a rapid reduction of T315I-positive cells from bone marrow. Taken together, our findings demonstrate an unexpected opportunity to repurpose axitinib, an anti-angiogenic drug approved for renal cancer, as an inhibitor for ABL1 gatekeeper mutant drug-resistant leukaemia patients. This study shows that wild-type proteins do not always sample the conformations available to disease-relevant mutant proteins and that comprehensive drug testing of patient-derived cells can identify unpredictable, clinically significant drug-repositioning opportunities.	[Pemovska, Tea; Repasky, Gretchen A.; Kallioniemi, Olli; Wennerberg, Krister] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00290 Helsinki, Finland; [Johnson, Eric; Chen, Jeffrey; Wells, Peter; Cronin, Ciaran N.; McTigue, Michele; Murray, Brion W.] Pfizer Worldwide Res & Dev, La Jolla Labs, San Diego, CA 92121 USA; [Kontro, Mika; Porkka, Kimmo] Univ Helsinki, Hematol Res Unit Helsinki, FIN-00290 Helsinki, Finland; [Kontro, Mika; Porkka, Kimmo] Helsinki Univ Hosp, Dept Hematol, Ctr Comprehens Canc, Helsinki 00290, Finland	University of Helsinki; Pfizer; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Wennerberg, K (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00290 Helsinki, Finland.	brion.murray@pfizer.com; krister.wennerberg@fimm.fi	Wennerberg, Krister/AAH-2919-2022; /AAO-3123-2020; Pemovska, Tea/AGO-4754-2022; Kallioniemi, Olli P/H-5111-2011; Wennerberg, Krister/AFM-0539-2022; He, Liye/C-8843-2015; Porkka, Kimmo/O-2323-2016	Wennerberg, Krister/0000-0002-1352-4220; /0000-0003-2951-4905; Pemovska, Tea/0000-0003-2951-4905; Kallioniemi, Olli P/0000-0002-3231-0332; Wennerberg, Krister/0000-0002-1352-4220; He, Liye/0000-0002-6632-2112; Repasky, Gretchen/0000-0001-6466-6467; Johnson, Eric/0000-0002-2909-865X; Kontro, Mika/0000-0001-6353-0664; Porkka, Kimmo/0000-0003-4112-5902	Jane and Aatos Erkko Foundation; Academy of Finland; Finnish Cancer Societies; Sigrid Juselius Foundation; Instrumentarium Foundation; FinPharma Doctoral Program-Drug Discovery section	Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); Finnish Cancer Societies; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Instrumentarium Foundation; FinPharma Doctoral Program-Drug Discovery section	We would like to thank the patients and their families for participating in this study and donating their samples for research. We acknowledge the High Throughput Biomedicine Unit at the Institute for Molecular Medicine Finland (FIMM)for technical assistance,the laboratory of C. Gambacorti-Passerini (University of Milano-Bicocca) for engineered Ba/F3 cell mutant panel profiling data, and T. Lundan (Department of Clinical Chemistry and TYKSLAB, Turku University Central Hospital, University of Turku) for the BCR-ABL1(T315I) transcript-level quantification. This work was supported by the Jane and Aatos Erkko Foundation (to K.W.), Academy of Finland (K.W. and O.K.), Finnish Cancer Societies (O.K. and K.P.), Sigrid Juselius Foundation (O.K.), Instrumentarium Foundation (M.K.), and FinPharma Doctoral Program-Drug Discovery section (T.P.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bracarda S, 2014, EXPERT OPIN DRUG SAF, V13, P497, DOI 10.1517/14740338.2014.888413; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Chan WW, 2011, CANCER CELL, V19, P556, DOI 10.1016/j.ccr.2011.03.003; Chen Y, 2013, CLIN PHARMACOKINET, V52, P713, DOI 10.1007/s40262-013-0068-3; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gibbons DL, 2014, P NATL ACAD SCI USA, V111, P3550, DOI 10.1073/pnas.1321173111; Gontarewicz A, 2008, BLOOD, V111, P4355, DOI 10.1182/blood-2007-09-113175; Gross-Goupil M, 2013, CLIN MED INSIGHTS-ON, V7, P269, DOI 10.4137/CMO.S10594; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hochhaus A, 2007, BLOOD, V109, P2303, DOI 10.1182/blood-2006-09-047266; Josephs DH, 2013, THER DRUG MONIT, V35, P562, DOI 10.1097/FTD.0b013e318292b931; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McTigue M, 2012, P NATL ACAD SCI USA, V109, P18281, DOI 10.1073/pnas.1207759109; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Hare T, 2013, CANCER RES, V73, P3356, DOI 10.1158/0008-5472.CAN-12-3904; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Pemovska T, 2013, CANCER DISCOV, V3, P1416, DOI 10.1158/2159-8290.CD-13-0350; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Senior M, 2014, NAT BIOTECHNOL, V32, P9, DOI 10.1038/nbt0114-9a; Shah NP, 2008, CANCER CELL, V14, P485, DOI 10.1016/j.ccr.2008.11.001; Solowiej J, 2013, ACS CHEM BIOL, V8, P978, DOI 10.1021/cb400040z; Solowiej J, 2009, BIOCHEMISTRY-US, V48, P7019, DOI 10.1021/bi900522y; Verzoni E, 2014, PHARMACOGEN PERS MED, V7, P107, DOI 10.2147/PGPM.S37098; Yadav B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05193; Zabriskie MS, 2014, CANCER CELL, V26, P428, DOI 10.1016/j.ccr.2014.07.006; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x	38	159	166	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					102	U225		10.1038/nature14119	http://dx.doi.org/10.1038/nature14119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25686603				2022-12-28	WOS:000350304000044
J	Yan, SN; Wen, JD; Bustamante, C; Tinoco, I				Yan, Shannon; Wen, Jin-Der; Bustamante, Carlos; Tinoco, Ignacio, Jr.			Ribosome Excursions during mRNA Translocation Mediate Broad Branching of Frameshift Pathways	CELL			English	Article							INTERMEDIATE STATES; BACTERIAL RIBOSOME; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; MOVEMENT; SUBUNIT; MECHANISM; STEPS; HEAD	Programmed ribosomal frameshifting produces alternative proteins from a single transcript. -1 frameshifting occurs on Escherichia coli's dnaX mRNA containing a slippery sequence AAAAAAG and peripheral mRNA structural barriers. Here, we reveal hidden aspects of the frameshifting process, including its exact location on the mRNA and its timing within the translation cycle. Mass spectrometry of translated products shows that ribosomes enter the -1 frame from not one specific codon but various codons along the slippery sequence and slip by not just -1 but also -4 or +2 nucleotides. Single-ribosome translation trajectories detect distinctive codon-scale fluctuations in ribosome-mRNA displacement across the slippery sequence, representing multiple ribosomal translocation attempts during frameshifting. Flanking mRNA structural barriers mechanically stimulate the ribosome to undergo back-and-forth translocation excursions, broadly exploring reading frames. Both experiments reveal aborted translation around mutant slippery sequences, indicating that subsequent fidelity checks on newly adopted codon position base pairings lead to either resumed translation or early termination.	[Yan, Shannon; Bustamante, Carlos; Tinoco, Ignacio, Jr.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wen, Jin-Der] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10617, Taiwan; [Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; National Taiwan University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tinoco, I (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	intinoco@lbl.gov	Wen, Jin-Der/A-3159-2014	Wen, Jin-Der/0000-0001-8317-4329; Bustamante, Carlos/0000-0002-2970-0073; Yan, Shannon/0000-0001-7994-9427	National Institutes of Health [GM10840]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010840, R37GM010840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. S.B. Smith for help with the optical tweezers instrument, Dr. T. Iavarone (QB3/Chemistry Mass Spectrometry Facility) for assistance on MS data collection and analysis, Dr. L. Lancaster and Prof. H. Noller for expertise in sample preparations, Dr. C.L. Hetherington for comments on the manuscript, and members of the Tinoco and Bustamante labs for discussions. This work was supported by grants from the National Institutes of Health (GM10840 to I.T.).	Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; Belew AT, 2014, NATURE, V512, P265, DOI 10.1038/nature13429; BRETSCHER MS, 1968, NATURE, V218, P675, DOI 10.1038/218675a0; Caliskan N, 2014, CELL, V157, P1619, DOI 10.1016/j.cell.2014.04.041; Chen J, 2014, NATURE, V512, P328, DOI 10.1038/nature13428; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Ermolenko DN, 2011, NAT STRUCT MOL BIOL, V18, P457, DOI 10.1038/nsmb.2011; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Guo ZJ, 2012, P NATL ACAD SCI USA, V109, P20391, DOI 10.1073/pnas.1218999109; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Jenner L, 2007, EMBO REP, V8, P846, DOI 10.1038/sj.embor.7401044; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; Kim HK, 2014, P NATL ACAD SCI USA, V111, P5538, DOI 10.1073/pnas.1403457111; Liao PY, 2011, NUCLEIC ACIDS RES, V39, P300, DOI 10.1093/nar/gkq761; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Moffitt JR, 2010, P NATL ACAD SCI USA, V107, P15739, DOI 10.1073/pnas.1006997107; Ohashi H, 2010, CURR PHARM BIOTECHNO, V11, P267, DOI 10.2174/138920110791111889; Pulk A, 2013, SCIENCE, V340, P1544, DOI 10.1126/science.1235970; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Ramrath DJF, 2013, P NATL ACAD SCI USA, V110, P20964, DOI 10.1073/pnas.1320387110; Ramrath DJF, 2012, NATURE, V485, P526, DOI 10.1038/nature11006; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 2011, BIOCHEM SOC T, V39, P658, DOI 10.1042/BST0390658; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Stahl G, 2002, TRENDS BIOCHEM SCI, V27, P178, DOI 10.1016/S0968-0004(02)02064-9; Tinoco I, 2013, BIOPOLYMERS, V99, P1147, DOI 10.1002/bip.22293; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; TSUCHIHASHI Z, 1992, GENE DEV, V6, P511, DOI 10.1101/gad.6.3.511; WEISS RB, 1987, COLD SPRING HARB SYM, V52, P687, DOI 10.1101/SQB.1987.052.01.078; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086; Zhou J, 2012, RNA, V18, P230, DOI 10.1261/rna.031187.111	48	72	73	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					870	881		10.1016/j.cell.2015.02.003	http://dx.doi.org/10.1016/j.cell.2015.02.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25703095	Green Accepted, Bronze			2022-12-28	WOS:000351116100010
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC The safety and quality agenda could smother genuine innovation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Deloittes, 2014, EV 2015 16 NAT TAR E; Iacobucci G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h571; Iacobucci G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6430	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2015	350								h561	10.1136/bmj.h561	http://dx.doi.org/10.1136/bmj.h561			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WF	25701293				2022-12-28	WOS:000349911800004
J	Sambles, JR				Sambles, J. R.			Structured photons take it slow	SCIENCE			English	Editorial Material									Univ Exeter, Sch Phys & Astron, Exeter EX4 4QL, Devon, England	University of Exeter	Sambles, JR (corresponding author), Univ Exeter, Sch Phys & Astron, Exeter EX4 4QL, Devon, England.	j.r.Sambles@exeter.ac.uk	Sambles, John Roy/X-8675-2019	SAMBLES, John/0000-0003-2721-0692				Alexeev I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.073901; Giovannini D, 2015, SCIENCE, V347, P857, DOI 10.1126/science.aaa3035; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Kuntz KB, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.043802; Milonni PW, 2002, J PHYS B-AT MOL OPT, V35, pR31, DOI 10.1088/0953-4075/35/6/201; Mugnai D, 2000, PHYS REV LETT, V84, P4830, DOI 10.1103/PhysRevLett.84.4830	6	5	5	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					828	828		10.1126/science.aaa6931	http://dx.doi.org/10.1126/science.aaa6931			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25700503				2022-12-28	WOS:000349761100023
J	Ashton, JR				Ashton, John R.			We need a Public Health Act fit for 21st century	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Johnrashton@blueyonder.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2015	350								h616	10.1136/bmj.h616	http://dx.doi.org/10.1136/bmj.h616			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WD	25697391				2022-12-28	WOS:000349911600003
J	Day, E; Copello, A; Hull, M				Day, Ed; Copello, Alex; Hull, Martyn			Assessment and management of alcohol use disorders	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DEFINING SUBSTANCE USE; SELF-HELP GROUPS; CONTROLLED-TRIAL; RECOMMENDATIONS; INTERVENTION; CARE; NEED		[Day, Ed] Kings Coll London, Inst Psychiat Psychol & Neurosci, Addict Dept, London SE5 8AF, England; [Copello, Alex] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Hull, Martyn] Ridgacre Med Ctr, Birmingham, W Midlands, England	University of London; King's College London; University of Birmingham	Day, E (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Addict Dept, London SE5 8AF, England.	Edward.Day@kcl.ac.uk	Day, Ed/E-2798-2015; Rao, Rahul/P-7158-2014	Day, Ed/0000-0002-7106-7013; Copello, Alex/0000-0003-3788-7197	Medical Research Council (MRC); National Institute for Health Research (NIHR); NIHR Health Technology Assessment [13/86/03]; HTA [11/60/01]; SMMGP by Lundbeck	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Health Technology Assessment; HTA; SMMGP by Lundbeck(Lundbeck Corporation)	We have read and understood the BMJ policy on declaration of interests and declare: ED is a member of the Addictions Department at the Institute of Psychiatry, Psychology and Neuroscience, King's College London. The department is in receipt of or has received grants from the Medical Research Council (MRC) and the National Institute for Health Research (NIHR) to research both drug and psychosocial treatments for alcohol use disorders. He is currently a coinvestigator on NIHR Health Technology Assessment grant (13/86/03) to investigate the effectiveness of adjunctive medication management and contingency management in enhancing adherence to drugs for relapse prevention in alcohol dependence. He is a trustee of the charities Action on Addiction and Changes UK. AC is an honorary member of the School of Psychology at the University of Birmingham, and his department is in receipt or has received grants from the MRC and the NIHR to research psychosocial treatments for alcohol use disorders. He is chief investigator on a randomised controlled trial of a family and social network intervention for young people who misuse alcohol and drugs (HTA grant 11/60/01) and principal investigator on a pilot study to assess the feasibility and impact of a motivational intervention on problem drug and alcohol use in adult mental health inpatient units (NIHR-PB-PG-1010-23138). He is an expert advisor to the charity Action on Addiction. MH is a member of SMMGP (Substance Misuse Management in General Practice) and has been funded through SMMGP by Lundbeck to complete and tutor on the SMMGP advanced certificate in the community management of alcohol disorders.	Al-Kubaisy W, 2012, PROCD SOC BEHV, V38, P59, DOI 10.1016/j.sbspro.2012.03.324; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Babor T.F., 2010, ALCOHOL NO ORDINARY, DOI 10.1093/acprof:oso/9780199551149.001.0001; Center for Substance Abuse Treatment, 2001, ALC US AM OLD AD POC; Drummond C, 2004, ALCOHOL NEEDS ASSESS, P1; Drummond C, 2007, CLIN TOPICS ADDICTIO, P113; Dunstan S, 2011, GEN LIF SURV OV REP; Funk M, 2005, J STUD ALCOHOL, V66, P379, DOI 10.15288/jsa.2005.66.379; Hasin DS, 2013, AM J PSYCHIAT, V170, P834, DOI 10.1176/appi.ajp.2013.12060782; Health and Social Care Information Centre, 2013, STAT ALC ENGL 2013; Heather N, 2013, ALCOHOL ALCOHOLISM, V48, P646, DOI 10.1093/alcalc/agt153; House of Commons Science and Technology Committee, 2012, 11 REP SESS 2010 201; Jackson R, 2010, SCREENING BRIEF INTE; Jonas DE, 2014, JAMA-J AM MED ASSOC, V311, P1889, DOI 10.1001/jama.2014.3628; Kaner E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8501; Lingford-Hughes AR, 2012, J PSYCHOPHARMACOL, V26, P899, DOI 10.1177/0269881112444324; Marlatt GA., 2005, RELAPSE PREVENTION M; Moos RH, 2006, J CLIN PSYCHOL, V62, P735, DOI 10.1002/jclp.20259; *NAT COLL CTR MENT, 2011, ALC US DIS NICE GUID; National Institute for Health and Care Excellence, 2010, PUBL HLTH GUID; National Institute for Health and Care Excellence, 2014, TECHN APPR GUID; National Institute for Health and Care Excellence, 2010, CIN GUID; Public Health England, 2014, YOUNG PEOPL HOSP ALC; Raistrick D, 2006, REV EFFECTIVENESS TR; Rehm J, 2013, ALCOHOL ALCOHOLISM, V48, P633, DOI 10.1093/alcalc/agt127; Rice P, 2012, BRIT J PSYCHIAT, V201, P169, DOI 10.1192/bjp.bp.111.105601; Rollnick S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1900; Timko C, 2007, DRUG ALCOHOL DEPEN, V90, P270, DOI 10.1016/j.drugalcdep.2007.04.007; Wall R, 2014, EUR ADDICT RES, V20, P241, DOI 10.1159/000357940; WHO, 2001, AUDIT ALCOHOL USE DI; World Health Organization, 1992, ICD 10 CLASS MENT BE, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P	31	15	15	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2015	350								h715	10.1136/bmj.h715	http://dx.doi.org/10.1136/bmj.h715			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WD	25698774	Green Submitted, Green Published			2022-12-28	WOS:000349911600004
J	Dixon, JR; Jung, I; Selvaraj, S; Shen, Y; Antosiewicz-Bourget, JE; Lee, AY; Ye, Z; Kim, A; Rajagopal, N; Xie, W; Diao, YR; Liang, J; Zhao, HM; Lobanenkov, VV; Ecker, JR; Thomson, JA; Ren, B				Dixon, Jesse R.; Jung, Inkyung; Selvaraj, Siddarth; Shen, Yin; Antosiewicz-Bourget, Jessica E.; Lee, Ah Young; Ye, Zhen; Kim, Audrey; Rajagopal, Nisha; Xie, Wei; Diao, Yarui; Liang, Jing; Zhao, Huimin; Lobanenkov, Victor V.; Ecker, Joseph R.; Thomson, James A.; Ren, Bing			Chromatin architecture reorganization during stem cell differentiation	NATURE			English	Article							HUMAN GENOME; GENE-EXPRESSION; HISTONE MODIFICATIONS; DNA METHYLATION; REGULATORY DNA; NUCLEAR LAMINA; ENHANCERS; ORGANIZATION; PRINCIPLES; LANDSCAPE	Higher-order chromatin structure is emerging as an important regulator of gene expression. Although dynamic chromatin structures have been identified in the genome, the full scope of chromatin dynamics during mammalian development and lineage specification remains to be determined. By mapping genome-wide chromatin interactions in human embryonic stem(ES) cells and four human ES-cell-derived lineages, we uncover extensive chromatin reorganization during lineage specification. We observe that although self-associating chromatin domains are stable during differentiation, chromatin interactions both within and between domains change in a striking manner, altering 36% of active and inactive chromosomal compartments throughout the genome. By integrating chromatin interaction maps with haplotype-resolved epigenome and transcriptome data sets, we find widespread allelic bias in gene expression correlated with allele-biased chromatin states of linked promoters and distal enhancers. Our results therefore provide a global view of chromatin dynamics and a resource for studying long-range control of gene expression in distinct human cell lineages.	[Dixon, Jesse R.; Jung, Inkyung; Selvaraj, Siddarth; Shen, Yin; Lee, Ah Young; Ye, Zhen; Kim, Audrey; Rajagopal, Nisha; Diao, Yarui; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Dixon, Jesse R.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA; [Selvaraj, Siddarth] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Antosiewicz-Bourget, Jessica E.; Thomson, James A.] Morgridge Inst Res, Madison, WI 53715 USA; [Xie, Wei] Tsinghua Univ, Tsinghua Univ Peking Univ Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Liang, Jing; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Lobanenkov, Victor V.] NIAID, Lab Immunogenet, Twinbrook NIAID Facil 1, Rockville, MD 20852 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Thomson, James A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Thomson, James A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Inst Genom Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; Tsinghua University; University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; Salk Institute; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Santa Barbara; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Jung, Inkyung/CAJ-5773-2022; Dixon, Jesse/AAT-2914-2020; Ecker, Joseph R/B-9144-2008; Xie, Wei/J-1380-2017; Lobanenkov, Victor V./AGQ-8903-2022; Lobanenkov, Victor/ABD-5710-2021	Dixon, Jesse/0000-0002-6273-2181; Ecker, Joseph R/0000-0001-5799-5895; Xie, Wei/0000-0003-2126-3849; Jung, Inkyung/0000-0002-5885-2754; Diao, Yarui/0000-0001-5842-4082; Lobanenkov, Victor/0000-0001-6665-3635; Liang, Jing/0000-0001-8695-4750	Ludwig Institute for Cancer Research; NIH Roadmap Epigenome Project [U01 ES017166, R01 ES024984]; California Institute of Regenerative Medicine [RN2-00905]; Human Frontier Science Program [LT000576/2014-L]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166, R01ES024984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; NIH Roadmap Epigenome Project; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Ren laboratory for support and suggestions throughout the course of this work. This work is funded in part by the Ludwig Institute for Cancer Research, the NIH Roadmap Epigenome Project (U01 ES017166 and R01 ES024984), and the California Institute of Regenerative Medicine (RN2-00905). Y.D. is supported by a postdoctoral fellowship from the Human Frontier Science Program (LT000576/2014-L).	Bansal V, 2008, BIOINFORMATICS, V24, pI153, DOI 10.1093/bioinformatics/btn298; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Holwerda Sjoerd, 2012, Frontiers in Genetics, V3, P217, DOI 10.3389/fgene.2012.00217; Holwerda SJB, 2013, NUCLEIC ACIDS RES, V41, P6905, DOI 10.1093/nar/gkt491; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Hu M, 2012, BIOINFORMATICS, V28, P3131, DOI 10.1093/bioinformatics/bts570; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035	45	876	902	10	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					331	336		10.1038/nature14222	http://dx.doi.org/10.1038/nature14222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25693564	Green Accepted, hybrid			2022-12-28	WOS:000349547400029
J	Kang, J; Miyajima, D; Mori, T; Inoue, Y; Itoh, Y; Aida, T				Kang, Jiheong; Miyajima, Daigo; Mori, Tadashi; Inoue, Yoshihisa; Itoh, Yoshimitsu; Aida, Takuzo			A rational strategy for the realization of chain-growth supramolecular polymerization	SCIENCE			English	Article							CHEMISTRY; MICELLES	Over the past decade, major progress in supramolecular polymerization has had a substantial effect on the design of functional soft materials. However, despite recent advances, most studies are still based on a preconceived notion that supramolecular polymerization follows a step-growth mechanism, which precludes control over chain length, sequence, and stereochemical structure. Here we report the realization of chain-growth polymerization by designing metastable monomers with a shape-promoted intramolecular hydrogen-bonding network. The monomers are conformationally restricted from spontaneous polymerization at ambient temperatures but begin to polymerize with characteristics typical of a living mechanism upon mixing with tailored initiators. The chain growth occurs stereoselectively and therefore enables optical resolution of a racemic monomer.	[Kang, Jiheong; Miyajima, Daigo; Aida, Takuzo] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Kang, Jiheong; Itoh, Yoshimitsu; Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Mori, Tadashi; Inoue, Yoshihisa] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	RIKEN; University of Tokyo; Osaka University	Miyajima, D (corresponding author), RIKEN, Ctr Emergent Matter Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	daigo.miyajima@riken.jp; aida@macro.t.u-tokyo.ac.jp	Aida, Takuzo/I-9117-2012; Mori, Tadashi/N-1462-2015; Miyajima, Daigo/B-5623-2013; Itoh, Yoshimitsu/G-8162-2012	Mori, Tadashi/0000-0003-3918-0873; Miyajima, Daigo/0000-0002-9578-7349; Itoh, Yoshimitsu/0000-0002-8356-7605; kang, jiheong/0000-0003-4446-5494	 [25000005];  [25888024]; Grants-in-Aid for Scientific Research [15H05487, 15H03779] Funding Source: KAKEN	; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by a Grant-in-Aid for Specially Promoted Research (25000005) on "Physically Perturbed Assembly for Tailoring High-Performance Soft Materials with Controlled Macroscopic Structural Anisotropy" for T.A and a Grant-in-Aid for Research Activity Startup (25888024) for D.M.	Berova N., 2000, CIRCULAR DICHROISM P, DOI DOI 10.1038/natrevmats.2016.21; Childers MI, 2014, CHEM REV, V114, P8129, DOI 10.1021/cr400725x; De Greef TFA, 2009, CHEM REV, V109, P5687, DOI 10.1021/cr900181u; Flory P. J., 1969, PRINCIPLES OF POLYME; Fouquey C., 1990, ADV MATER, V2, P254; Gilroy JB, 2010, NAT CHEM, V2, P566, DOI [10.1038/NCHEM.664, 10.1038/nchem.664]; Helmich F, 2011, J AM CHEM SOC, V133, P12238, DOI 10.1021/ja204543f; Hirahata W, 2008, J AM CHEM SOC, V130, P17658, DOI 10.1021/ja807709j; Ishida Y, 2002, J AM CHEM SOC, V124, P14017, DOI 10.1021/ja028403h; Kang J, 2014, J AM CHEM SOC, V136, P10640, DOI 10.1021/ja505941b; Korevaar PA, 2012, NATURE, V481, P492, DOI 10.1038/nature10720; Lehn J. M., 1995, SUPRAMOLECULAR CHEMI; LEHN JM, 1993, MAKROMOL CHEM-M SYMP, V69, P1, DOI 10.1002/masy.19930690103; Lehn JM, 2002, POLYM INT, V51, P825, DOI 10.1002/pi.852; Miyajima D, 2009, J AM CHEM SOC, V131, P44, DOI 10.1021/ja808396b; Mulhaupt R, 2004, ANGEW CHEM INT EDIT, V43, P1054, DOI 10.1002/anie.200330070; Odian G., 2004, PRINCIPLES POLYM; Ogi S, 2014, NAT CHEM, V6, P188, DOI [10.1038/NCHEM.1849, 10.1038/nchem.1849]; OKAMOTO Y, 1994, CHEM REV, V94, P349, DOI 10.1021/cr00026a004; Ranby B., 1996, MACROMOLECULAR CONCE, P3; REHAGE H, 1988, J PHYS CHEM-US, V92, P4712, DOI 10.1021/j100327a031; Schmidt R, 2011, MACROMOLECULES, V44, P3766, DOI 10.1021/ma2004184; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; Smulders MMJ, 2008, CHIRALITY, V20, P1016, DOI 10.1002/chir.20568; Staudinger H, 1920, BER DTSCH CHEM GES, V53, P1073, DOI 10.1002/cber.19200530627; Tsefrikas VM, 2006, CHEM REV, V106, P4868, DOI 10.1021/cr050553y; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Wu YT, 2006, CHEM REV, V106, P4843, DOI 10.1021/cr050554q; Zhang W, 2011, SCIENCE, V334, P340, DOI 10.1126/science.1210369; Zimmerman N., 1998, CHEM IND, V1998, P604	30	385	389	18	498	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					646	651		10.1126/science.aaa4249	http://dx.doi.org/10.1126/science.aaa4249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657246				2022-12-28	WOS:000349145200041
J	Gaillard, M; Tranchart, H				Gaillard, Martin; Tranchart, Hadrien			Trichobezoar	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gaillard, Martin; Tranchart, Hadrien] Antoine Beclere Hosp, Clamart, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Gaillard, M (corresponding author), Antoine Beclere Hosp, Clamart, France.	hadrien.tranchart@abc.aphp.fr							0	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2015	372	6							e8	10.1056/NEJMicm1403124	http://dx.doi.org/10.1056/NEJMicm1403124			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CH	25651272				2022-12-28	WOS:000349143600011
J	Dimick, JB; Ghaferi, AA				Dimick, Justin B.; Ghaferi, Amir A.			Hospital Readmission as a Quality Measure in Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPLICATIONS; CARE	IMPORTANCE Readmissions after surgery are costly and may reflect quality of care in the index hospitalization. OBJECTIVES To determine the timing of postoperative complications with respect to hospital discharge and the frequency of readmission stratified by predischarge and postdischarge occurrence of complications. DESIGN, SETTING, AND PARTICIPANTS This is a retrospective cohort study of national Veterans Affairs Surgical Quality Improvement Program preoperative risk and outcome data on the Surgical Care Improvement Project cohort for operations performed from January 2005 to August 2009, including colorectal, arthroplasty, vascular, and gynecologic procedures. The association between timing of complication with respect to index hospitalization and 30-day readmission was modeled using generalized estimating equations. MAIN OUTCOME AND MEASURE All-cause readmission within 30 days of the index surgical hospitalization discharge. RESULTS Our study of 59 273 surgical procedures performed at 112 Department of Veterans Affairs (VA) hospitals found an overall complication rate of 22.6%(predischarge complications, 71.9%; postdischarge complications, 28.1%). The proportion of postdischarge complications varied significantly, from 8.7% for respiratory complications to 55.7% for surgical site infection (P<.001). The overall 30-day readmission rate was 11.9%, of which only 56.0% of readmissions were associated with a currently assessed complication. Readmission was predicted by patient comorbid conditions, procedure factors, and the occurrence of postoperative complications. Multivariable generalized estimating equation models of readmission adjusting for patient and procedure characteristics, hospital, and index length of stay found that the occurrence of postdischarge complications had the highest odds of readmission (odds ratio, 7.4-20.8) compared with predischarge complications (odds ratio, 0.9-1.48). CONCLUSIONS AND RELEVANCE More than one-quarter of assessed complications are diagnosed after hospital discharge and strongly predict readmission. Hospital discharge is an insufficient end point for quality assessment. Although readmission is associated with complications, almost half of readmissions are not associated with a complication currently assessed by the Veterans Affairs Surgical Quality Improvement Program.	[Dimick, Justin B.; Ghaferi, Amir A.] Univ Michigan, Dept Surg, Ctr Healthcare Outcomes & Policy, 2800 Plymouth Rd,Bldg 16,Off 136E, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Dimick, JB (corresponding author), Univ Michigan, Dept Surg, Ctr Healthcare Outcomes & Policy, 2800 Plymouth Rd,Bldg 16,Off 136E, Ann Arbor, MI 48109 USA.	jdimick@umich.edu						Girotti ME, 2014, JAMA SURG, V149, P757, DOI 10.1001/jamasurg.2014.163; Glance LG, 2014, JAMA SURG, V149, P439, DOI 10.1001/jamasurg.2014.4; Jha AK, 2014, JAMA-J AM MED ASSOC, V312, P225, DOI 10.1001/jama.2014.7204; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Morris MS, 2014, JAMA SURG, V149, P348, DOI 10.1001/jamasurg.2013.4064; Shih T, 2015, ANN SURG, V261, P1027, DOI 10.1097/SLA.0000000000000778; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118	7	34	34	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					512	+		10.1001/jama.2014.14179	http://dx.doi.org/10.1001/jama.2014.14179			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AV	25647207				2022-12-28	WOS:000349070300015
J	Wang, LW; Grygiel, JJ; O'Neill, JH; Fatkin, D; Feneley, MP				Wang, Louis W.; Grygiel, John J.; O'Neill, John H.; Fatkin, Diane; Feneley, Michael P.			Snowflakes in the heart: an ultrasonic marker of severe hypercoagulability	LANCET			English	Editorial Material							SPONTANEOUS ECHOCARDIOGRAPHIC CONTRAST; SPONTANEOUS ECHO CONTRAST; THROMBOEMBOLIC RISK; BLOOD		[Wang, Louis W.; Fatkin, Diane; Feneley, Michael P.] St Vincents Hosp, Dept Cardiol, Sydney, NSW 2010, Australia; [Grygiel, John J.] St Vincents Hosp, Dept Med Oncol, Sydney, NSW 2010, Australia; [O'Neill, John H.] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia; [Wang, Louis W.; Grygiel, John J.; O'Neill, John H.; Fatkin, Diane; Feneley, Michael P.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Wang, Louis W.; Fatkin, Diane; Feneley, Michael P.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia	St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Victor Chang Cardiac Research Institute	Feneley, MP (corresponding author), St Vincents Hosp, Dept Cardiol, Level 4,Xavier Bldg,390 Victoria St, Sydney, NSW 2010, Australia.	Michael.Feneley@svha.org.au						FATKIN D, 1994, AM J CARDIOL, V73, P672, DOI 10.1016/0002-9149(94)90932-6; FATKIN D, 1994, J AM COLL CARDIOL, V23, P961, DOI 10.1016/0735-1097(94)90644-0; Fatkin D, 1997, CIRCULATION, V96, P889; MERINO A, 1992, J AM COLL CARDIOL, V20, P1661, DOI 10.1016/0735-1097(92)90463-W; Rastegar R, 2003, J AM COLL CARDIOL, V41, P603, DOI 10.1016/S0735-1097(02)02898-X	5	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					302	302		10.1016/S0140-6736(14)62221-2	http://dx.doi.org/10.1016/S0140-6736(14)62221-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ2DL	25706710				2022-12-28	WOS:000348044800033
J	Corrigan, J; Fisher, E; Heiser, S				Corrigan, Janet; Fisher, Elliott; Heiser, Scott			Hospital Community Benefit Programs Increasing Benefits to Communities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Corrigan, Janet; Fisher, Elliott; Heiser, Scott] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA	Dartmouth College	Corrigan, J (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, 35 Centerra Pkwy,Ste 100,HB7251, Lebanon, NH 03766 USA.	janet.m.corrigan@dartmouth.edu						Andrews N., HOW MUCH DO HEALTHY; Bakken E, 2015, J PUBLIC HEALTH MAN, V21, P18, DOI 10.1097/PHH.0000000000000049; Berwick DM, 2014, JAMA-J AM MED ASSOC, V312, P2099, DOI 10.1001/jama.2014.15727; DeLeire T, IMPACT OF INSURANCE; Fisher ES, 2014, JAMA-J AM MED ASSOC, V312, P2093, DOI 10.1001/jama.2014.13815; Rosenbaum S, ENCOURAGING NONPROFI; Somerville MH, HOSPITAL COMMUNITY B	7	26	26	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1211	1212		10.1001/jama.2015.0609	http://dx.doi.org/10.1001/jama.2015.0609			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25643208	Bronze			2022-12-28	WOS:000351435500015
J	Hanchate, AD; Kapoor, A; Katz, JN; McCormick, D; Lasser, KE; Feng, C; Manze, MG; Kressin, NR				Hanchate, Amresh D.; Kapoor, Alok; Katz, Jeffrey N.; McCormick, Danny; Lasser, Karen E.; Feng, Chen; Manze, Meredith G.; Kressin, Nancy R.			Massachusetts health reform and disparities in joint replacement use: difference in differences study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TOTAL KNEE ARTHROPLASTY; TOTAL HIP-REPLACEMENT; UNITED-STATES; CARE REFORM; SOCIOECONOMIC-STATUS; COST-EFFECTIVENESS; ACCESS; OUTCOMES; COVERAGE; RATES	Objective To estimate the impact of the insurance expansion in 2006 on use of knee and hip replacement procedures by race/ethnicity, area income, and the use of hospitals that predominantly serve poor people ("safety net hospitals"). Design Quasi-experimental difference in differences study examining change after reform in the share of procedures performed in safety net hospitals by race/ethnicity and area income, with adjustment for patients' residence, demographics, and comorbidity. Setting State of Massachusetts, United States. Participants Massachusetts residents aged 40-64 as the target beneficiaries of reform and similarly aged residents of New Jersey, New York, and Pennsylvania as the comparison (control) population. Main outcomes measures Number of knee and hip replacement procedures per 10 000 population and use of safety net hospitals. Procedure counts from state discharge data for 2.5 years before and after reform, and multivariate difference in differences. Poisson regression was used to adjust for demographics, economic conditions, secular time, and geographic factors to estimate the change in procedure rate associated with health reform by race/ethnicity and area income. Results Before reform, the number of procedures (/10 000) in Massachusetts was lower among Hispanic people (12.9, P<0.001) than black people (28.1) and white people (30.1). Overall, procedure use increased 22.4% during the 2.5 years after insurance expansion; reform in Massachusetts was associated with a 4.7% increase. The increase associated with reform was significantly higher among Hispanic people (37.9%, P<0.001) and black people (11.4%, P<0.05) than among white people (2.8%). Lower income was not associated with larger increases in procedure use. The share of knee and hip replacement procedures performed in safety net hospitals in Massachusetts decreased by 1.0% from a level of 12.7% before reform. The reduction was larger among Hispanic people (-6.4%, P<0.001) than white people (-1.0%), and among low income residents (-3.9%, p<0.001) than high income residents (0%). Conclusions Insurance expansion can help reduce disparities by race/ethnicity but not by income in access to elective surgical care and could shift some elective surgical care away from safety net hospitals.	[Hanchate, Amresh D.; Kressin, Nancy R.] VA Boston Healthcare Syst, Boston, MA USA; [Hanchate, Amresh D.; Lasser, Karen E.; Kressin, Nancy R.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Kapoor, Alok] Univ Massachusetts, Sch Med, Worcester, MA USA; [Katz, Jeffrey N.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard Univ, Sch Med, Boston, MA USA; [McCormick, Danny] Cambridge Hlth Alliance, Cambridge, MA USA; [McCormick, Danny] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Lasser, Karen E.; Feng, Chen] Boston Med Ctr, Boston, MA USA; [Manze, Meredith G.] CUNY, Sch Publ Hlth, New York, NY 10021 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Cambridge Health Alliance; Harvard University; Boston Medical Center; City University of New York (CUNY) System	Hanchate, AD (corresponding author), Boston Univ, Sch Med, Gen Internal Med Sect, Boston, MA 02118 USA.	hanchate@bu.edu		Hanchate, Amresh/0000-0002-7038-4463; Kressin, Nancy/0000-0003-2767-4286	US National Institutes of Health [1R21NS062677, 1U01HL105342-01]; Rx foundation; Department of Veterans Affairs, Health Services Research and Development Service [RCS 02-066-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062677] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007705] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rx foundation; Department of Veterans Affairs, Health Services Research and Development Service(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was funded by US National Institutes of Health grants (1R21NS062677, ADH, principal investigator, and 1U01HL105342-01, NRK, principal investigator) and a grant from the Rx foundation. NRK is supported in part by a senior research career scientist award from the Department of Veterans Affairs, Health Services Research and Development Service (RCS 02-066-1). The views expressed in this article are those of the authors and do not necessarily represent the views of the National Institutes of Health, the Rx foundation, Boston University, or the Department of Veterans Affairs.	Agency for Health care Research and Quality (AHRQ), 2012, NAT HEALTHC DISP REP; Agency for Healthcare Research and Quality, 2014, HCUPNET TOOL ID TRAC; [Anonymous], 2011, MASS HLTH REF 5 YEAR; [Anonymous], 2010, METH STAT COUNT RES; BILLINGS J, 1993, HEALTH AFFAIR, V12, P162, DOI 10.1377/hlthaff.12.1.162; Blum MA, 2012, CLIN GERIATR MED, V28, P521, DOI 10.1016/j.cger.2012.05.002; Cameron A, 2005, MICROECONOMETRICS ME, DOI DOI 10.1017/CBO9780511811241; Chen C, 2011, NEW ENGL J MED, V365, DOI 10.1056/NEJMp1109273; Chernew M, 2008, J GEN INTERN MED, V23, P1131, DOI 10.1007/s11606-008-0614-0; Cram P, 2012, JAMA-J AM MED ASSOC, V308, P1227, DOI 10.1001/2012.jama.11153; Culliford DJ, 2010, J BONE JOINT SURG BR, V92B, P130, DOI 10.1302/0301-620X.92B1.22654; Daigle ME, 2012, BEST PRACT RES CL RH, V26, P649, DOI 10.1016/j.berh.2012.07.013; Dakin H, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000332; Davis K, 2014, COMMONWEALTH FUND; Diderichsen F, 2012, SCAND J PUBLIC HEALT, V40, P10, DOI 10.1177/1403494812457732; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Dixon T, 2011, ANZ J SURG, V81, P26, DOI 10.1111/j.1445-2197.2010.05485.x; Falbrede I, 2011, ORTHOPADE, V40, P793, DOI 10.1007/s00132-011-1787-5; Hanchate AD, 2012, MED CARE, V50, P569, DOI 10.1097/MLR.0b013e31824e319f; Hawker GA, 2001, MED CARE, V39, P206, DOI 10.1097/00005650-200103000-00002; Ibrahim SA, 2005, ARTHRITIS RHEUM-US, V52, P3143, DOI 10.1002/art.21304; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; Jha AK, 2007, ARCH INTERN MED, V167, P1177, DOI 10.1001/archinte.167.11.1177; Judge A, 2010, BMJ-BRIT MED J, V341, pc4092; Kaiser Family Foundation, 2014, STAT HLTH FACTS; Kane RL, 2007, ARTHRIT RHEUM-ARTHR, V57, P562, DOI 10.1002/art.22675; Katz JN, 2001, J BONE JOINT SURG AM, V83A, P1622, DOI 10.2106/00004623-200111000-00002; Kolstad JT, 2012, J PUBLIC ECON, V96, P909, DOI 10.1016/j.jpubeco.2012.07.003; Lasser KE, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2329; Levy H, 2008, ANNU REV PUBL HEALTH, V29, P399, DOI 10.1146/annurev.publhealth.28.021406.144042; Levy H, 2012, INQUIRY-J HEALTH CAR, V49, P300, DOI 10.5034/inquiryjrnl_49.04.06; Long SK, 2012, INQUIRY-J HEALTH CAR, V49, P303, DOI 10.5034/inquiryjrnl_49.04.03; Long SK, 2012, HEALTH AFFAIR, V31, P444, DOI 10.1377/hlthaff.2011.0653; Long SK, 2009, ESTIMATES HLTH INSUR; Losina E, 2007, ARCH INTERN MED, V167, P182, DOI 10.1001/archinte.167.2.182; Losina E, 2012, J BONE JOINT SURG AM, V94A, P201, DOI [10.2106/JBJS.J.01958, 10.2106/JBJS.K.00009, 10.2106/JBJS.J.101958]; Losina E, 2012, ARTHRITIS RHEUM-US, V64, P339, DOI 10.1002/art.33371; Losina E, 2009, ARCH INTERN MED, V169, P1113, DOI 10.1001/archinternmed.2009.136; Mahomed NN, 2003, J BONE JOINT SURG AM, V85A, P27, DOI 10.2106/00004623-200301000-00005; Mahomed NN, 2005, J BONE JOINT SURG AM, V87A, P1222, DOI 10.2106/JBJS.D.02546; Many Pear R, 2013, NY TIMES; Massachusetts Department of Public Health, 2010, PROF HLTH MASS AD 20; Maxwell J, 2011, HEALTH AFFAIR, V30, P1451, DOI 10.1377/hlthaff.2011.0347; McDonough JE, 2008, HEALTH AFFAIR, V27, pW285, DOI 10.1377/hlthaff.27.4.w285; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Miller S, 2012, INQUIRY-J HEALTH CAR, V49, P317, DOI 10.5034/inquiryjrnl_49.04.05; Nasseh K, 2013, HEALTH AFFAIR, V32, P1639, DOI 10.1377/hlthaff.2012.1332; Pande AH, 2011, AM J PREV MED, V41, P1, DOI 10.1016/j.amepre.2011.03.010; Ravi B, 2012, BEST PRACT RES CL RH, V26, P637, DOI 10.1016/j.berh.2012.07.014; Rodin D, 2012, J EPIDEMIOL COMMUN H, V66, P1050, DOI 10.1136/jech-2011-200273; Schoenman JA, 2005, VAL HOSP DISCH DAT; Skinner J, 2003, NEW ENGL J MED, V349, P1350, DOI 10.1056/NEJMsa021569; Sommers BD, 2013, NEW ENGL J MED, V368, P496, DOI 10.1056/NEJMp1215785; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; StataCorp, 2012, STAT STAT SOFTW REL; van Doorslaer E, 2006, CAN MED ASSOC J, V174, P177, DOI 10.1503/cmaj.050584; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Woodward M., 2013, EPIDEMIOLOGY STUDY D; Wooldridge JM, 2002, MED CARE; Zhu J, 2010, J GEN INTERN MED, V25, P1356, DOI 10.1007/s11606-010-1482-y	61	24	24	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2015	350								h440	10.1136/bmj.h440	http://dx.doi.org/10.1136/bmj.h440			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB8WF	25700849	Green Published, hybrid			2022-12-28	WOS:000349911800002
J	Hardy, H				Hardy, Holly			Why I had to resign from my general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									St Martins Surg, Bristol BS4 2QR, Avon, England		Hardy, H (corresponding author), St Martins Surg, 378 Wells Rd, Bristol BS4 2QR, Avon, England.	hollyhardy@blueyonder.co.uk						Centre for Workforce Intelligence, 2014, IN DEPTH REV GEN PRA; GP Taskforce, 2014, SECURING FUTURE GP W; Welikala J, 2014, HLTH SERVICE J	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2015	350								h940	10.1136/bmj.h940	http://dx.doi.org/10.1136/bmj.h940			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8WC	25694179				2022-12-28	WOS:000349911500025
J	Centor, RM; Atkinson, P; Ratliff, AE; Xiao, L; Crabb, DM; Estrada, CA; Faircloth, MB; Oestreich, L; Hatchett, J; Khalife, W; Waites, KB				Centor, Robert M.; Atkinson, Prescott; Ratliff, Amy E.; Xiao, Li; Crabb, Donna M.; Estrada, Carlos A.; Faircloth, Michael B.; Oestreich, Lisa; Hatchett, Jeremy; Khalife, Walid; Waites, Ken B.			The Clinical Presentation of Fusobacterium-Positive and Streptococcal-Positive Pharyngitis in a University Health Clinic A Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							RESPIRATORY-TRACT; NECROPHORUM; ADULTS; PCR; INFECTIONS	Background: Pharyngitis guidelines focus solely on group A beta-hemolytic streptococcal infection. European data suggest that in patients aged 15 to 30 years, Fusobacterium necrophorum causes at least 10% of cases of pharyngitis; however, few U.S. data exist. Objective: To estimate the prevalence of F. necrophorum; Mycoplasma pneumoniae; and group A and C/G beta-hemolytic streptococcal pharyngitis and to determine whether F. necrophorum pharyngitis clinically resembles group A beta-hemolytic streptococcal pharyngitis. Design: Cross-sectional. Setting: University student health clinic. Patients: 312 students aged 15 to 30 years presenting to a student health clinic with an acute sore throat and 180 asymptomatic students. Measurements: Polymerase chain reaction testing from throat swabs to detect 4 species of bacteria and signs and symptoms used to calculate the Centor score. Results: Fusobacterium necrophorum was detected in 20.5% of patients and 9.4% of asymptomatic students. Group A beta-hemolytic streptococcus was detected in 10.3% of patients and 1.1% of asymptomatic students. Group C/G beta-hemolytic streptococcus was detected in 9.0% of patients and 3.9% of asymptomatic students. Mycoplasma pneumoniae was detected in 1.9% of patients and 0 asymptomatic students. Infection rates with F. necrophorum, group A streptococcus, and group C/G streptococcus increased with higher Centor scores (P < 0.001). Limitations: The study focused on a limited age group and took place at a single institution. Asymptomatic students-rather than seasonal control participants-and a convenience sample were used. Conclusion: Fusobacterium necrophorum-positive pharyngitis occurs more frequently than group A beta-hemolytic streptococcal-positive pharyngitis in a student population, and F. necrophorum-positive pharyngitis clinically resembles streptococcal pharyngitis.	[Atkinson, Prescott] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Atkinson, Prescott] Birmingham Childrens Hosp, Birmingham, AL 35233 USA; [Ratliff, Amy E.; Xiao, Li; Crabb, Donna M.; Waites, Ken B.] Diagnost Mycoplasma Lab, Birmingham, AL 35294 USA; [Estrada, Carlos A.] Univ Alabama Birmingham, Div Gen Internal Med, Birmingham, AL 35294 USA; [Faircloth, Michael B.; Oestreich, Lisa] Univ Alabama Birmingham, Student Hlth & Wellness Ctr, Birmingham, AL 35294 USA; [Khalife, Walid] Sparrow Hosp, Dept Labs, Lansing, MI 48909 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Centor, RM (corresponding author), Univ Alabama Birmingham, Fac Off Tower 720,1530 3rd Ave South, Birmingham, AL 35294 USA.	rcentor@uab.edu			University of Alabama at Birmingham; Justin E. Rodgers Foundation	University of Alabama at Birmingham; Justin E. Rodgers Foundation	University of Alabama at Birmingham and the Justin E. Rodgers Foundation.	Aliyu SH, 2004, J MED MICROBIOL, V53, P1029, DOI 10.1099/jmm.0.45648-0; Bassetti M, 2000, EMERG INFECT DIS, V6, P180, DOI 10.3201/eid0602.000212; Batty A, 2005, BRIT J BIOMED SCI, V62, P66, DOI 10.1080/09674845.2005.11732687; BLANCHARD A, 1993, CLIN INFECT DIS, V17, pS148, DOI 10.1093/clinids/17.Supplement_1.S148; Brandt CM, 2009, CLIN INFECT DIS, V49, P766, DOI 10.1086/605085; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Centor RM, 2009, ANN INTERN MED, V151, P812, DOI 10.7326/0003-4819-151-11-200912010-00011; Chirinos JA, 2002, MEDICINE, V81, P458, DOI 10.1097/00005792-200211000-00006; Dumke R, 2007, J CLIN MICROBIOL, V45, P2726, DOI 10.1128/JCM.00321-07; Eaton C, 2014, J INFECTION, V69, P194, DOI 10.1016/j.jinf.2014.03.005; Jensen A, 2007, CLIN MICROBIOL INFEC, V13, P695, DOI 10.1111/j.1469-0691.2007.01719.x; Klug TE, 2014, EUR J CLIN MICROBIOL, V33, P1163, DOI 10.1007/s10096-014-2052-8; Klug TE, 2009, CLIN INFECT DIS, V49, P1467, DOI 10.1086/644616; Kristensen LH, 2008, EUR J CLIN MICROBIOL, V27, P779, DOI 10.1007/s10096-008-0496-4; Marchand-Austin A, 2014, ANAEROBE, V28, P120, DOI 10.1016/j.anaerobe.2014.05.015; MEIER FA, 1990, ARCH INTERN MED, V150, P825, DOI 10.1001/archinte.150.4.825; Mitchell MS, 2011, CLIN PEDIATR, V50, P1091, DOI 10.1177/0009922811409571; Riordan T, 2007, CLIN MICROBIOL REV, V20, P622, DOI 10.1128/CMR.00011-07; Shulman ST, 2012, CLIN INFECT DIS, V55, pE86, DOI 10.1093/cid/cis629; Tiemstra J, 2009, J AM BOARD FAM MED, V22, P663, DOI 10.3122/jabfm.2009.06.090035; Turner JC, 1997, J CLIN MICROBIOL, V35, P1; Uhl JR, 2003, J CLIN MICROBIOL, V41, P242, DOI 10.1128/JCM.41.1.242-249.2003; Waites Ken B, 2009, Curr Infect Dis Rep, V11, P198, DOI 10.1007/s11908-009-0030-6	23	69	71	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4					241	+		10.7326/M14-1305	http://dx.doi.org/10.7326/M14-1305			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686164				2022-12-28	WOS:000350232500013
J	Walmsley, S				Walmsley, Sharon			Review: Xpert MTB/RIF assay detects extrapulmonary TB in lymph nodes and CSF, but not pleural fluid	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Health Network Toronto	Walmsley, S (corresponding author), Univ Toronto, Univ Hlth Network, Toronto, ON, Canada.			Walmsley, Sharon/0000-0002-3959-5692				WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM	1	2	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4							JC11	10.7326/ACPJC-2015-162-4-011	http://dx.doi.org/10.7326/ACPJC-2015-162-4-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25686186				2022-12-28	WOS:000350232500002
J	Appleby, TC; Perry, JK; Murakami, E; Barauskas, O; Feng, J; Cho, A; Fox, D; Wetmore, DR; McGrath, ME; Ray, AS; Sofia, MJ; Swaminathan, S; Edwards, TE				Appleby, Todd C.; Perry, Jason K.; Murakami, Eisuke; Barauskas, Ona; Feng, Joy; Cho, Aesop; Fox, David, III; Wetmore, Diana R.; McGrath, Mary E.; Ray, Adrian S.; Sofia, Michael J.; Swaminathan, S.; Edwards, Thomas E.			Structural basis for RNA replication by the hepatitis C virus polymerase	SCIENCE			English	Article							DE-NOVO INITIATION; CRYSTAL-STRUCTURE; DRUG-RESISTANCE; NS5B POLYMERASE; MECHANISM; SOFOSBUVIR; INHIBITOR; PSI-7977; NUCLEOSIDE; INFECTION	Nucleotide analog inhibitors have shown clinical success in the treatment of hepatitis C virus (HCV) infection, despite an incomplete mechanistic understanding of NS5B, the viral RNA-dependent RNA polymerase. Here we study the details of HCV RNA replication by determining crystal structures of stalled polymerase ternary complexes with enzymes, RNA templates, RNA primers, incoming nucleotides, and catalytic metal ions during both primed initiation and elongation of RNA synthesis. Our analysis revealed that highly conserved active-site residues in NS5B position the primer for in-line attack on the incoming nucleotide. A beta loop and a C-terminal membrane-anchoring linker occlude the active-site cavity in the apo state, retract in the primed initiation assembly to enforce replication of the HCV genome from the 3' terminus, and vacate the active-site cavity during elongation. We investigated the incorporation of nucleotide analog inhibitors, including the clinically active metabolite formed by sofosbuvir, to elucidate key molecular interactions in the active site.	[Appleby, Todd C.; Perry, Jason K.; Murakami, Eisuke; Barauskas, Ona; Feng, Joy; Cho, Aesop; McGrath, Mary E.; Ray, Adrian S.; Sofia, Michael J.; Swaminathan, S.] Gilead Sci, Foster City, CA 94404 USA; [Fox, David, III; Wetmore, Diana R.; Edwards, Thomas E.] Beryllium, Bainbridge Isl, WA 98110 USA	Gilead Sciences	Appleby, TC (corresponding author), Gilead Sci, 333 Lakeside Dr, Foster City, CA 94404 USA.	todd.appleby@gilead.com; tedwards@be4.com		Ray, Adrian/0000-0002-3508-3008; Edwards, Thomas/0000-0002-0474-8003				Abrol R, 2013, METHOD ENZYMOL, V520, P31, DOI 10.1016/B978-0-12-391861-1.00002-2; Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Dutartre H, 2005, J BIOL CHEM, V280, P6359, DOI 10.1074/jbc.M410191200; Dutartre H, 2006, ANTIMICROB AGENTS CH, V50, P4161, DOI 10.1128/AAC.00433-06; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Harrus D, 2010, J BIOL CHEM, V285, P32906, DOI 10.1074/jbc.M110.151316; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Kim WR, 2014, AM J TRANSPLANT, V14, P69, DOI 10.1111/ajt.12581; Koff RS, 2014, ALIMENT PHARM THER, V39, P478, DOI 10.1111/apt.12601; Lam AM, 2014, ANTIMICROB AGENTS CH, V58, P6861, DOI 10.1128/AAC.03847-14; Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12; Lam AM, 2010, ANTIMICROB AGENTS CH, V54, P3187, DOI 10.1128/AAC.00399-10; Le Pogam S, 2008, J ANTIMICROB CHEMOTH, V61, P1205, DOI 10.1093/jac/dkn085; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Poordad F, 2012, J VIRAL HEPATITIS, V19, P449, DOI 10.1111/j.1365-2893.2012.01617.x; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; Scrima N, 2012, J VIROL, V86, P7107, DOI 10.1128/JVI.00459-12; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; Sofia MJ, 2013, ADV PHARMACOL, V67, P39, DOI 10.1016/B978-0-12-405880-4.00002-0; Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Svarovskaia ES, 2014, CLIN INFECT DIS, V59, P1666, DOI 10.1093/cid/ciu697; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200; Zhong WD, 2000, J VIROL, V74, P9134, DOI 10.1128/JVI.74.19.9134-9143.2000	33	218	227	4	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					771	775		10.1126/science.1259210	http://dx.doi.org/10.1126/science.1259210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25678663				2022-12-28	WOS:000349221300048
J	[Anonymous]				[Anonymous]			LIGHT FANTASTIC	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					153	153		10.1038/518153a	http://dx.doi.org/10.1038/518153a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8SD	25673394	Bronze			2022-12-28	WOS:000349190300010
J	Hagglund, M; Koch, S				Hagglund, Maria; Koch, Sabine			Commentary: Sweden rolls out online access to medical records and is developing new e-health services to enable people to manage their care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hagglund, Maria; Koch, Sabine] Karolinska Inst, Hlth Informat Ctr, LIME, Stockholm, Sweden	Karolinska Institutet	Hagglund, M (corresponding author), Karolinska Inst, Hlth Informat Ctr, LIME, Stockholm, Sweden.	Maria.Hagglund@ki.se	Koch, Sabine/F-8020-2010; Hägglund, Maria/K-2569-2012	Hägglund, Maria/0000-0002-6839-3651; Koch, Sabine/0000-0001-7144-8740				Hagglund M, 2012, STROKE PATIENTS NEED; Inera, 2014, MONTHLY REPORT CITIZ; Lundberg N, 2013, STUD HEALTH TECHNOL, V192, P687, DOI 10.3233/978-1-61499-289-9-687; Lyttkens L., 2014, D6 1 V1 1 SUSTAINS I	4	11	11	2	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2015	350								h359	10.1136/bmj.h359	http://dx.doi.org/10.1136/bmj.h359			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0MG	25673318	Bronze			2022-12-28	WOS:000349319700005
J	Brunkard, JO; Runkel, AM; Zambryski, PC				Brunkard, Jacob O.; Runkel, Anne M.; Zambryski, Patricia C.			Comment on "A promiscuous intermediate underlies the evolution of LEAFY DNA binding specificity"	SCIENCE			English	Editorial Material							LIKELY GENE TREES; LAND PLANTS; SPECIES TREES; MAIZE; DISCORDANCE; ZFL1	Sayou et al. (Reports, 7 February 2014, p. 645) proposed a new model for evolution of transcription factors without gene duplication, using LEAFY as an archetype. Their proposal contradicts the evolutionary history of plants and ignores evidence that LEAFY evolves through gene duplications. Within their data set, we identified a moss with multiple LEAFY orthologs, which contests their model and supports that LEAFY evolves through duplications.	[Brunkard, Jacob O.; Runkel, Anne M.; Zambryski, Patricia C.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zambryski, PC (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	zambrysk@berkeley.edu		Brunkard, Jacob/0000-0001-6407-9393				Bomblies K, 2003, DEVELOPMENT, V130, P2385, DOI 10.1242/dev.00457; Bomblies K, 2006, GENETICS, V172, P519, DOI 10.1534/genetics.105.048595; Bowman JL, 2013, CURR OPIN PLANT BIOL, V16, P70, DOI 10.1016/j.pbi.2012.10.001; Cox CJ, 2014, SYST BIOL, V63, P272, DOI 10.1093/sysbio/syt109; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Johnson MTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050226; Ligrone R, 2012, ANN BOT-LONDON, V110, P935, DOI 10.1093/aob/mcs176; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Moyroud E, 2010, TRENDS PLANT SCI, V15, P346, DOI 10.1016/j.tplants.2010.03.007; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rosenberg NA, 2013, MOL BIOL EVOL, V30, P2709, DOI 10.1093/molbev/mst160; Sayou C, 2014, SCIENCE, V343, P645, DOI 10.1126/science.1248229; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Vazquez-Lobo A, 2007, EVOL DEV, V9, P446, DOI 10.1111/j.1525-142X.2007.00182.x	16	7	8	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222								10.1126/science.1255437	http://dx.doi.org/10.1126/science.1255437			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657240				2022-12-28	WOS:000349145200032
J	Hickman, HD				Hickman, Heather D.			There goes the macrophage neighborhood	SCIENCE			English	Editorial Material							SUBCAPSULAR SINUS MACROPHAGES; CD8(+) T-CELLS; DENDRITIC CELLS; LYMPH-NODES; B-CELLS; VIRUS		NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Hickman, HD (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	hhickman@mail.nih.gov		Hickman, Heather/0000-0003-4168-4894	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001053, ZIAAI001212] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745	12	0	0	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					609	610		10.1126/science.aaa6919	http://dx.doi.org/10.1126/science.aaa6919			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657230				2022-12-28	WOS:000349145200021
J	Mecklenburg, M; Hubbard, WA; White, ER; Dhall, R; Cronin, SB; Aloni, S; Regan, BC				Mecklenburg, Matthew; Hubbard, William A.; White, E. R.; Dhall, Rohan; Cronin, Stephen B.; Aloni, Shaul; Regan, B. C.			Nanoscale temperature mapping in operating microelectronic devices	SCIENCE			English	Article							ELECTRON-MICROSCOPY; THERMAL MICROSCOPY; THERMOMETRY; SCALE; ALUMINUM	Modern microelectronic devices have nanoscale features that dissipate power nonuniformly, but fundamental physical limits frustrate efforts to detect the resulting temperature gradients. Contact thermometers disturb the temperature of a small system, while radiation thermometers struggle to beat the diffraction limit. Exploiting the same physics as Fahrenheit's glass-bulb thermometer, we mapped the thermal expansion of Joule-heated, 80-nanometer-thick aluminum wires by precisely measuring changes in density. With a scanning transmission electron microscope and electron energy loss spectroscopy, we quantified the local density via the energy of aluminum's bulk plasmon. Rescaling density to temperature yields maps with a statistical precision of 3 kelvin/hertz-1/2, an accuracy of 10%, and nanometer-scale resolution. Many common metals and semiconductors have sufficiently sharp plasmon resonances to serve as their own thermometers.	[Mecklenburg, Matthew] Univ So Calif, Ctr Electron Microscopy & Microanal, Los Angeles, CA 90089 USA; [Hubbard, William A.; White, E. R.; Regan, B. C.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Hubbard, William A.; White, E. R.; Regan, B. C.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Dhall, Rohan; Cronin, Stephen B.] Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA; [Aloni, Shaul] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA	University of Southern California; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mecklenburg, M (corresponding author), Univ So Calif, Ctr Electron Microscopy & Microanal, Los Angeles, CA 90089 USA.	matthew.mecklenburg@usc.edu; regan@physics.ucla.edu		Regan, B. C./0000-0003-3923-2688; Cronin, Stephen B/0000-0001-9153-7687; Hubbard, William/0000-0002-2924-0820	National Science Foundation [DMR-1206849]; Function Accelerated nanoMaterial Engineering (FAME), one of six centers of Semiconductor Technology Advanced Research network (STARnet), a Semiconductor Research Corporation; Microelectronics Advanced Research Corporation; Defense Advanced Research Projects Agency; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; Direct For Mathematical & Physical Scien [1206849] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Function Accelerated nanoMaterial Engineering (FAME), one of six centers of Semiconductor Technology Advanced Research network (STARnet), a Semiconductor Research Corporation; Microelectronics Advanced Research Corporation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work has been supported by National Science Foundation award DMR-1206849 and in part by Function Accelerated nanoMaterial Engineering (FAME), one of six centers of Semiconductor Technology Advanced Research network (STARnet), a Semiconductor Research Corporation program sponsored by the Microelectronics Advanced Research Corporation and Defense Advanced Research Projects Agency. Data presented in this article were acquired at the Center for Electron Microscopy and Microanalysis at the University of Southern California. Work at the Molecular Foundry was supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231.	ABE H, 1992, J ELECTRON MICROSC, V41, P465; Begtrup GE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.155901; Brintlinger T, 2008, NANO LETT, V8, P582, DOI 10.1021/nl0729375; Brites CDS, 2012, NANOSCALE, V4, P4799, DOI 10.1039/c2nr30663h; Cahill DG, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4832615; Christofferson J, 2008, J ELECTRON PACKAGING, V130, DOI 10.1115/1.2993145; Deshpande VV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.105501; Dubi Y, 2011, REV MOD PHYS, V83, P131, DOI 10.1103/RevModPhys.83.131; Egerton RF, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/1/016502; Gao YH, 2002, NATURE, V415, P599, DOI 10.1038/415599a; Goodson KE, 1997, MICROSCALE THERM ENG, V1, P225; GSCHNEIDNER KA, 1964, SOLID STATE PHYS, V16, P275; Hartmann M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.080402; Jarenwattananon NN, 2013, NATURE, V502, P537, DOI 10.1038/nature12568; Krivanek OL, 2014, NATURE, V514, P209, DOI 10.1038/nature13870; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; MEYER G, 1957, Z PHYS, V148, P61, DOI 10.1007/BF01327367; NONNENMACHER M, 1992, APPL PHYS LETT, V61, P168, DOI 10.1063/1.108207; Palanisamy P, 2011, J APPL PHYS, V110, DOI 10.1063/1.3609063; Pop E, 2006, P IEEE, V94, P1587, DOI 10.1109/JPROC.2006.879794; Reif F., 1965, FUNDAMENTALS STAT TH; Shi L, 2000, APPL PHYS LETT, V77, P4295, DOI 10.1063/1.1334658; Singer SB, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195468; Steyskal EM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.055504; Tessier G, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2732179; Vendelbo SB, 2013, ULTRAMICROSCOPY, V133, P72, DOI 10.1016/j.ultramic.2013.04.004; White ER, 2012, LANGMUIR, V28, P3695, DOI 10.1021/la2048486; Wilson AJC, 1941, P PHYS SOC, V53, P235, DOI 10.1088/0959-5309/53/3/305; Wu XW, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/46/465707	29	178	179	11	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					629	632		10.1126/science.aaa2433	http://dx.doi.org/10.1126/science.aaa2433			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25657242	Green Submitted			2022-12-28	WOS:000349145200036
J	Kanzaria, HK; Mattke, S; Detz, AA; Brook, RH				Kanzaria, Hemal K.; Mattke, Soeren; Detz, Alissa A.; Brook, Robert H.			Quality Measures Based on Presenting Signs and Symptoms of Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Kanzaria, Hemal K.] Univ Calif Los Angeles, Vet Affairs Robert Wood Johnson Clin Scholars Pro, Los Angeles, CA 90024 USA; [Mattke, Soeren] RAND Corp, Boston, MA USA; [Detz, Alissa A.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Brook, Robert H.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90024 USA	Robert Wood Johnson Foundation (RWJF); University of California System; University of California Los Angeles; RAND Corporation; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kanzaria, HK (corresponding author), Univ Calif Los Angeles, Vet Affairs Robert Wood Johnson Clin Scholars Pro, 10940 Wilshire Blvd, Los Angeles, CA 90024 USA.	hkanzaria@mednet.ucla.edu			PHS HHS [T32-HP-19001] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Goitein L, 2014, JAMA INTERN MED, V174, P845, DOI 10.1001/jamainternmed.2014.1063; Institute of Medicine, 1972, DEV METH EV NEIGHB H; National Quality Forum, PROV ROAD MAP BETT C; US Centers for Disease Control and Prevention, 2010, TABL 10 10 LEAD PRIN; US Centers for Disease Control and Prevention, 2010, TABL 7 20 LEAD PRINC	5	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					520	522		10.1001/jama.2014.17550	http://dx.doi.org/10.1001/jama.2014.17550			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AV	25647210	Bronze			2022-12-28	WOS:000349070300018
J	Millum, J; Sina, B; Glass, R				Millum, Joseph; Sina, Barbara; Glass, Roger			International Research Ethics Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Millum, Joseph; Sina, Barbara; Glass, Roger] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Millum, Joseph] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Millum, J (corresponding author), NIH, Clin Ctr Dept Bioeth, Fogarty Int Ctr, 10 Ctr Dr,10-1C118, Bethesda, MD 20892 USA.	millumj@cc.nih.gov			Intramural NIH HHS [Z99 CL999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bollyky TJ, 2010, CLIN TRIALS, V7, P719, DOI 10.1177/1740774510386390; Glass R, 2013, J EMPIR RES HUM RES, V8, P1, DOI 10.1525/jer.2013.8.5.1; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Matar A, 2014, J EMPIR RES HUM RES, V9, P12, DOI 10.1525/jer.2014.9.2.12; Millum J, 2014, J EMPIR RES HUM RES, V9, P1, DOI 10.1525/jer.2014.9.2.1; Wexler A, US GLOBAL HLTH BUDGE	7	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					461	462		10.1001/jama.2015.203	http://dx.doi.org/10.1001/jama.2015.203			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AV	25647198	Green Accepted, Green Published			2022-12-28	WOS:000349070300006
J	Miras, AD; Mogford, JT; Wright, J; Mendoza, NN; Xekouki, P; Lakhani, A; Pellegata, NS; Stratakis, CA; Roncaroli, F; Russell-Jones, D				Miras, Alexander D.; Mogford, Julianne T.; Wright, John; Mendoza, Nigel N.; Xekouki, Paraskevi; Lakhani, Amish; Pellegata, Natalia S.; Stratakis, Costantine A.; Roncaroli, Federico; Russell-Jones, David			Ovarian hyperstimulation from ectopic hypersecretion of follicle stimulating hormone	LANCET			English	Editorial Material									[Miras, Alexander D.; Mogford, Julianne T.; Wright, John; Russell-Jones, David] Royal Surrey Cty Hosp, Cedar Ctr, Guildford GU2 7XX, Surrey, England; [Mendoza, Nigel N.; Lakhani, Amish; Roncaroli, Federico] Univ London Imperial Coll Sci Technol & Med, London, England; [Xekouki, Paraskevi; Stratakis, Costantine A.] NIH, Sect Endocrinol & Genet, Bethesda, MD 20892 USA; [Pellegata, Natalia S.] Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany	Royal Surrey County Hospital; Imperial College London; National Institutes of Health (NIH) - USA; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Wright, J (corresponding author), Royal Surrey Cty Hosp, Cedar Ctr, Guildford GU2 7XX, Surrey, England.	john.wright5@nhs.net	Xekouki, Paraskevi/AAM-2485-2021; Pellegata, Natalia S/I-1256-2012; MIRAS, ALEXANDER/AAF-9119-2021	Pellegata, Natalia S/0000-0002-8000-7784; MIRAS, ALEXANDER/0000-0003-3830-3173; Roncaroli, Federico/0000-0003-3650-5572	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920] Funding Source: NIH RePORTER; National Institute for Health Research [CL-2013-21-002] Funding Source: researchfish; Intramural NIH HHS [ZIA HD008920-07] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute for Health Research(National Institute for Health Research (NIHR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Burgos J, 2009, FERTIL STERIL, V92, DOI 10.1016/j.fertnstert.2009.06.023; Lania A, 2012, BEST PRACT RES CL EN, V26, P395, DOI [10.1016/j.beem.2011.10.009, 10.1007/s11102-013-0517-x]; Roberts JE, 2005, FERTIL STERIL, V83, P208, DOI 10.1016/j.fertnstert.2004.06.061; Sardella C, 2013, J ENDOCRINOL INVEST, V36, P174, DOI 10.3275/8472	4	7	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					392	392		10.1016/S0140-6736(14)62294-7	http://dx.doi.org/10.1016/S0140-6736(14)62294-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CN	25706853	Green Accepted			2022-12-28	WOS:000348509000032
J	Martin, EE				Martin, Ellen E.			EARTH SCIENCE Ocean circulation and rapid climate change	NATURE			English	Editorial Material							NORTH-ATLANTIC		Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Martin, EE (corresponding author), Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA.	eemartin@ufl.edu						Bohm E, 2015, NATURE, V517, P73, DOI 10.1038/nature14059; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Foster GL, 2007, GEOLOGY, V35, P37, DOI 10.1130/G23204A.1; JEANDEL C, 1993, EARTH PLANET SC LETT, V117, P581, DOI 10.1016/0012-821X(93)90104-H; Lacan F, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000956; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Roberts NL, 2010, SCIENCE, V327, P75, DOI 10.1126/science.1178068; van de Flierdt T, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001294	11	2	2	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					30	31		10.1038/518304a	http://dx.doi.org/10.1038/518304a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25517092	Bronze			2022-12-28	WOS:000347178400028
